Citrus Sinensis ID: 002085

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------97
Protein Sequence
MSKVASVFPKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGFKRSKKVAAEEDNGLA
Secondary Structure (PSIPRED)
ccccccccHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHccccccccccccccccccccEEEEcccccEEEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccccHHHcccccccEEEccccEEEEcccHHcccccccccccccccccccccccccccccccccccccccccEEcccccccccccccEEccccEEEEcccccccccccccEEEcccccccccccHHHHHHccccccEEcccccccccccccEEEcccccccccccHHHHccccccEEEccccEEEEcccHHHHHccccEEcccccccccccHHHHccccccEEEcccccccccccHHHHcccccccccccccccccccHHHHHcccccccEEccccccccccHHHHHccccccEEcccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHcccccccEEccccccEEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHHHcccccccccEEEEEEcccccEEEEcccccccHHHHcccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccccEEEccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHccccccHcccccccccccccEEEEccccEEEEEEccccccccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccccccccHHHcccHcccEEEEccccccccccccHHHcccHHcHEEEEccccccccccHHHcccccccEEEcccccccccccHHHcccHcccEEEEccccccccccHHHcccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHHHHHHcccccccccHHHcccccEEEEEEcccccccccccHHccccccEEEEEccccccccccHHHHHcccEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccHcccEEEccccccccccccHHHcHHHccEEEcccccccccccHHHcccccEcEEEcccccccccccHHHccccEEEEEEEcccccccccccccHcccccHHccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccEEEEcccccccHHHHHHHccHccEEEcccccEEEEEEccccccEEEEEEcccccccccccccHHHHHHHHHHHcHHHHHHHHHHHcccccccEEEEEEcccccHHHHHccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEcccccccHHHHHHHHHHHHccccccccEEHEcccccEcccHEEEEEEcccccEEHHHHEHHHHHcccccccccccccHHHHHHHHHcccccHHHHccHHHcccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccHccccccccccccccc
Coil and Loop (DISEMBL)
mskvasvfpkiPVTLILLVLLSipfevipqspnteERTILLNLKQqlgnppslqswtstsspcdwpeitctfnsvtgislrhkditqkippiicdlknlttidlssnsipgefpeflynctklqnldlsqnyfvgpipsdidrisglqcidlggnnfsgdiprsigrLSELQTLYLYMNEFngtfpkeigdlsnlevlglaynsnfkpamipIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNgnhlegaipSGLFLLNNltqlflydnilsgeipssvealkltdidlsmnnltgsipeefgklknlqllglfsnhlsgevpasIGVVAFEnnlsgavpkslgncrtlrtVQLYsnrfsgelptglwttfnlsslmlsdntisgelpsktawnLTRLEISNNRFSGQIQRGVGSWKNLIVFKasnnlfsgeipvELTSLSHLNTLLldgnklsgklpsqIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDlsgnqfsgeippeigqlklntfnlssnklygnipdefnnlayddsflnnsnlcvknpiinlpkcpsrfrnsdkiSSKHLALILVLAILVLLVTVSLSWFVVRDClrrkrnrdpatwkltsfhqlgftesnilssltesnligsggsgqvyridingAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDrwlhgrkrslvsgsssvhqhvlhwPTRLQIAIGAAQGlcymhhdctpqiihrdvkssnilldseFKAKIADFGLAKMLAkqgephtmsavagsfgyfapeyayttkvnekiDIYSFGVVLLELVtgkeanygdehtSLAEWAWRHYaeekpitdaldkgiaepcyleemTTVYRLALICtstlpssrpsMKEVLQILRRccptenyggkkmgrdvdsapllgtagylfgfKRSKKVAAEEDNGLA
Flexible Loop (DISEMBL)
mskvasvfpkipVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLsgavpkslgncRTLRTVQLYSnrfsgelptGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSwfvvrdclrrkrnrdpatwkltsfhqlgftESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTstlpssrpsMKEVLQILRRCCPTenyggkkmgrdvdsapLLGTAGYLFGFKRSKKVAAEEDNGLA
Low Complexity Region (SEG)
MSKVASVFPKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGlfllnnltqlflYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEltslshlntlllDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHlalilvlailvllvtvslsWFVVRDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGFKRSKKVAAEEDNGLA
Disordered region (IsUnstruct)
*****SVFPKIPVTLILLVLLSIPFEVIPQ*******TILLNL*****************SPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLP******KEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGFK**************
Disordered Region (DISOPRED)
********PKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNP**********************ALILVLAILVLLVTVSLSWFV**********************QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWN**********EFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRS******SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL********************************************NGLA
Disordered Region (DISEMBL)
MSKVASVFPKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLG*************PCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKR***********HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGFKRSKK**********
Disordered Region (DISPRO)
***VASVFPKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPK********DKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGR************QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC********************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSKVASVFPKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGFKRSKKVAAEEDNGLA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	969	2.2.26 [Sep-21-2011]
Q9SGP2	996	Receptor-like protein kin	no	no	0.894	0.870	0.413	0.0
P47735	999	Receptor-like protein kin	no	no	0.884	0.857	0.406	1e-172
C0LGX3	993	LRR receptor-like serine/	no	no	0.880	0.859	0.390	1e-166
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.928	0.888	0.346	1e-150
Q9SYQ8	980	Receptor protein kinase C	no	no	0.885	0.875	0.352	1e-145
Q9FII5	1041	Leucine-rich repeat recep	no	no	0.893	0.831	0.345	1e-144
O49545	1003	Leucine-rich repeat recep	no	no	0.897	0.867	0.360	1e-141
O65440	992	Leucine-rich repeat recep	no	no	0.898	0.878	0.353	1e-141
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.889	0.860	0.355	1e-139
Q9FRS6	1029	Leucine-rich repeat recep	no	no	0.897	0.845	0.356	1e-139

>sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1

 Score =  656 bits (1692), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 399/966 (41%), Positives = 549/966 (56%), Gaps = 99/966 (10%)

Query: 35  EERTILLNLKQQLGNPPS-LQSWTST-SSPCDWPEITCT--FNSVTGISLRHKDITQKIP 90
           ++  IL  +K  L +P S L SW S  +SPC W  ++C   F+SVT + L   ++    P
Sbjct: 18  QDGFILQQVKLSLDDPDSYLSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSANLAGPFP 77

Query: 91  PIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCI 150
            +IC L NL  + L +NSI    P  +  C  LQ LDLSQN   G +P  +  I  L  +
Sbjct: 78  SVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTLVHL 137

Query: 151 DLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAM 210
           DL GNNFSGDIP S G+   L+ L L  N  +GT P  +G++S L++L L+YN  F P+ 
Sbjct: 138 DLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNP-FSPSR 196

Query: 211 IPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLT 270
           IP EFG L  L+ +W+TE +L+G+IP+++  LS L  L L  N L G IP  L  L N+ 
Sbjct: 197 IPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVV 256

Query: 271 QLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSIPEEFGKLK--------------- 314
           Q+ LY+N L+GEIP  +  LK L  +D SMN LTG IP+E  ++                
Sbjct: 257 QIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVPLESLNLYENNLEGEL 316

Query: 315 --------NLQLLGLFSNHLSGEVPASIGV------------------------------ 336
                   NL  + +F N L+G +P  +G+                              
Sbjct: 317 PASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELEE 376

Query: 337 -VAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGEL 395
            +   N+ SG +P+SL +CR+L  ++L  NRFSG +PTG W   +++ L L +N+ SGE+
Sbjct: 377 LLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEI 436

Query: 396 PSKT--AWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNT 453
                 A NL+ L +SNN F+G +   +GS  NL    AS N FSG +P  L SL  L T
Sbjct: 437 SKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELGT 496

Query: 454 LLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEI 513
           L L GN+ SG+L S I SW  LN LNLA NE +G+IP  IGSL V+  LDLSGN FSG+I
Sbjct: 497 LDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKI 556

Query: 514 PPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRN 573
           P  +  LKLN  NLS N+L G++P       Y +SF+ N  LC    I  L  C S    
Sbjct: 557 PVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFIGNPGLC--GDIKGL--CGSENEA 612

Query: 574 SDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRKRNRDPATWKLTSFHQLGFTESN 633
             +     L  I VLA +VLL  V+  +F  R   ++ R  + + W L SFH+LGF+E  
Sbjct: 613 KKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYR-TFKKARAMERSKWTLMSFHKLGFSEHE 671

Query: 634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNN-----------RKLNQKLEKE 682
           IL SL E N+IG+G SG+VY++ +   GE VAVKR+W             +     ++ E
Sbjct: 672 ILESLDEDNVIGAGASGKVYKVVLTN-GETVAVKRLWTGSVKETGDCDPEKGYKPGVQDE 730

Query: 683 -FIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSV 741
            F AE+E LG IRH NIVKLWCC S+ + KLLVYEYM N SL   LH  K  +       
Sbjct: 731 AFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGM------- 783

Query: 742 HQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM 801
               L W TR +I + AA+GL Y+HHD  P I+HRD+KS+NIL+D ++ A++ADFG+AK 
Sbjct: 784 ----LGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKA 839

Query: 802 LAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGD 857
           +   G+ P +MS +AGS GY APEYAYT +VNEK DIYSFGVV+LE+VT K   +   G+
Sbjct: 840 VDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGE 899

Query: 858 EHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
           +   L +W      ++K I   +D  + + C+ EE++ +  + L+CTS LP +RPSM+ V
Sbjct: 900 K--DLVKWVCSTL-DQKGIEHVIDPKL-DSCFKEEISKILNVGLLCTSPLPINRPSMRRV 955

Query: 918 LQILRR 923
           +++L+ 
Sbjct: 956 VKMLQE 961

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1

 Score =  605 bits (1560), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 397/976 (40%), Positives = 546/976 (55%), Gaps = 119/976 (12%)

Query: 35  EERTILLNLKQQLGNPP-SLQSWTSTS--SPCDWPEITCTFNS-VTGISLRHKDITQKIP 90
           ++ TIL   K  L +P  SL SW+  +  +PC W  ++C   S V  + L    +    P
Sbjct: 23  QDATILRQAKLGLSDPAQSLSSWSDNNDVTPCKWLGVSCDATSNVVSVDLSSFMLVGPFP 82

Query: 91  PIICDLKNLTTIDLSSNSIPGEFPEFLYN-CTKLQNLDLSQNYFVGPIPSDID-RISGLQ 148
            I+C L +L ++ L +NSI G      ++ C  L +LDLS+N  VG IP  +   +  L+
Sbjct: 83  SILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNLK 142

Query: 149 CIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKP 208
            +++ GNN S  IP S G   +L++L L  N  +GT P  +G+++ L+ L LAYN  F P
Sbjct: 143 FLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNL-FSP 201

Query: 209 AMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNN 268
           + IP + G L +L+ LW+   NL+G IP ++S L+SL  L L  N L G+IPS +  L  
Sbjct: 202 SQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLKT 261

Query: 269 LTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSIP-------------------- 307
           + Q+ L++N  SGE+P S+  +  L   D SMN LTG IP                    
Sbjct: 262 VEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNLNLLNLESLNLFENMLEG 321

Query: 308 ---EEFGKLKNLQLLGLFSNHLSGEVPASIG----------------------------- 335
              E   + K L  L LF+N L+G +P+ +G                             
Sbjct: 322 PLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEGKL 381

Query: 336 --VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISG 393
             ++  +N+ SG +  +LG C++L  V+L +N+ SG++P G W    LS L LSDN+ +G
Sbjct: 382 EYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTG 441

Query: 394 ELPSKT--AWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHL 451
            +P     A NL+ L IS NRFSG I   +GS   +I    + N FSGEIP  L  L  L
Sbjct: 442 SIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLKQL 501

Query: 452 NTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSG 511
           + L L  N+LSG++P ++  W +LN LNLA N LSGEIPK +G L V+  LDLS NQFSG
Sbjct: 502 SRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSG 561

Query: 512 EIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRF 571
           EIP E+  LKLN  NLS N L G IP  + N  Y   F+ N  LCV     +L     + 
Sbjct: 562 EIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCV-----DLDGLCRKI 616

Query: 572 RNSDKISSKHLAL-ILVLAILVLLVTVSLSWFVVRDCLRRKRNRDPATWKLTSFHQLGFT 630
             S  I    + L I +LA LV +V + +     R  LR  ++   A  K  SFH+L F+
Sbjct: 617 TRSKNIGYVWILLTIFLLAGLVFVVGIVMFIAKCRK-LRALKSSTLAASKWRSFHKLHFS 675

Query: 631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRI----------WNNRKLNQKLE 680
           E  I   L E N+IG G SG+VY++++ G GE VAVK++          +++  LN+ + 
Sbjct: 676 EHEIADCLDEKNVIGFGSSGKVYKVELRG-GEVVAVKKLNKSVKGGDDEYSSDSLNRDV- 733

Query: 681 KEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
             F AE+E LGTIRH +IV+LWCC SS + KLLVYEYM N SL   LHG ++  V     
Sbjct: 734 --FAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGV----- 786

Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK 800
               VL WP RL+IA+ AA+GL Y+HHDC P I+HRDVKSSNILLDS++ AK+ADFG+AK
Sbjct: 787 ----VLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAK 842

Query: 801 MLAKQGE--PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE---ANY 855
           +    G   P  MS +AGS GY APEY YT +VNEK DIYSFGVVLLELVTGK+   +  
Sbjct: 843 VGQMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSEL 902

Query: 856 GDEHTSLAEWAWRHYAEEKPITDALDKGIAEPC--------YLEEMTTVYRLALICTSTL 907
           GD+   +A+W          +  ALDK   EP         + EE++ V  + L+CTS L
Sbjct: 903 GDK--DMAKW----------VCTALDKCGLEPVIDPKLDLKFKEEISKVIHIGLLCTSPL 950

Query: 908 PSSRPSMKEVLQILRR 923
           P +RPSM++V+ +L+ 
Sbjct: 951 PLNRPSMRKVVIMLQE 966

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  586 bits (1510), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 382/978 (39%), Positives = 535/978 (54%), Gaps = 125/978 (12%)

Query: 44  KQQLGNPP-SLQSWTSTS---SPCDWPEITCTFN-----SVTGISLRHKDITQKIPPIIC 94
           K +L +P  +LQ W  T    SPC+W  ITC        +VT I L   +I+   P   C
Sbjct: 36  KTRLFDPDGNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDLSGYNISGGFPYGFC 95

Query: 95  DLKNLTTIDLSSNSIPGEFPEF-LYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLG 153
            ++ L  I LS N++ G      L  C+KLQNL L+QN F G +P        L+ ++L 
Sbjct: 96  RIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLPEFSPEFRKLRVLELE 155

Query: 154 GNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPI 213
            N F+G+IP+S GRL+ LQ L L  N  +G  P  +G L+ L  L LAY S F P+ IP 
Sbjct: 156 SNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAYIS-FDPSPIPS 214

Query: 214 EFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLF 273
             G L  L  L +T +NL+GEIP+++ NL  LE L L  N L G IP  +  L ++ Q+ 
Sbjct: 215 TLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLESVYQIE 274

Query: 274 LYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLK------------------ 314
           LYDN LSG++P S+  L +L + D+S NNLTG +PE+   L+                  
Sbjct: 275 LYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQLISFNLNDNFFTGGLPDV 334

Query: 315 -----NLQLLGLFSNHLSGEVPASIG-------------------------------VVA 338
                NL    +F+N  +G +P ++G                               ++ 
Sbjct: 335 VALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKIIT 394

Query: 339 FENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNT-ISGELPS 397
           F N LSG +P+S G+C +L  +++  N+ SGE+P   W    L+ L L++N  + G +P 
Sbjct: 395 FSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWE-LPLTRLELANNNQLQGSIPP 453

Query: 398 K--TAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLL 455
               A +L++LEIS N FSG I   +   ++L V   S N F G IP  +  L +L  + 
Sbjct: 454 SISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERVE 513

Query: 456 LDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPP 515
           +  N L G++PS + S T L  LNL+ N L G IP  +G L V+  LDLS NQ +GEIP 
Sbjct: 514 MQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPA 573

Query: 516 EIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSD 575
           E+ +LKLN FN+S NKLYG IP  F    +  SFL N NLC  N     P  P R     
Sbjct: 574 ELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLD---PIRPCR----S 626

Query: 576 KISSKHLALILVLAILVLLVTVSLSWFVVRD--CLRRKRNRDPATWKLTSFHQLGFTESN 633
           K  ++++  I +L I+ L  T +L W  ++     +RK  R   T K+T F ++GFTE +
Sbjct: 627 KRETRYILPISILCIVAL--TGALVWLFIKTKPLFKRKPKR---TNKITIFQRVGFTEED 681

Query: 634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
           I   LTE N+IGSGGSG VYR+ +  +G+ +AVK++W       + E  F +E+E LG +
Sbjct: 682 IYPQLTEDNIIGSGGSGLVYRVKLK-SGQTLAVKKLWGETGQKTESESVFRSEVETLGRV 740

Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV--LHWPTR 751
           RH NIVKL  C + E  + LVYE+MEN SL   LH  K          H+ V  L W TR
Sbjct: 741 RHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKE---------HRAVSPLDWTTR 791

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH-- 809
             IA+GAAQGL Y+HHD  P I+HRDVKS+NILLD E K ++ADFGLAK L ++      
Sbjct: 792 FSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVS 851

Query: 810 --TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEAN---YGD------- 857
             +MS VAGS+GY APEY YT+KVNEK D+YSFGVVLLEL+TGK  N   +G+       
Sbjct: 852 DVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKF 911

Query: 858 -------------EHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICT 904
                        E  ++ + +  +Y +   + D   K ++   Y EE+  V  +AL+CT
Sbjct: 912 AMEAALCYPSPSAEDGAMNQDSLGNYRDLSKLVDPKMK-LSTREY-EEIEKVLDVALLCT 969

Query: 905 STLPSSRPSMKEVLQILR 922
           S+ P +RP+M++V+++L+
Sbjct: 970 SSFPINRPTMRKVVELLK 987

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  531 bits (1369), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 345/995 (34%), Positives = 530/995 (53%), Gaps = 95/995 (9%)

Query: 10  KIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPS-LQSW--TSTSSPCDWP 66
           KI V  +    +     V+    N  E ++LL++K  L +P + L+ W  + TS  C+W 
Sbjct: 4   KIIVLFLYYCYIGSTSSVLASIDNVNELSVLLSVKSTLVDPLNFLKDWKLSDTSDHCNWT 63

Query: 67  EITCTFN-SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSN--------SIP------- 110
            + C  N +V  + L   ++T KI   I  L +L + ++S N        SIP       
Sbjct: 64  GVRCNSNGNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSIPPLKSIDI 123

Query: 111 ------------------------------GEFPEFLYNCTKLQNLDLSQNYFVGPIPSD 140
                                         G   E L N   L+ LDL  N+F G +PS 
Sbjct: 124 SQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSS 183

Query: 141 IDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGL 200
              +  L+ + L GNN +G++P  +G+L  L+T  L  NEF G  P E G++++L+ L L
Sbjct: 184 FKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDL 243

Query: 201 AYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIP 260
           A         IP E G LK L+TL + E N  G IP  + ++++L++L  + N L G IP
Sbjct: 244 AIGK--LSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIP 301

Query: 261 SGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLL 319
             +  L NL  L L  N LSG IP ++ +L +L  ++L  N L+G +P + GK   LQ L
Sbjct: 302 MEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWL 361

Query: 320 GLFSNHLSGEVPASI-------GVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELP 372
            + SN  SGE+P+++        ++ F N  +G +P +L  C++L  V++ +N  +G +P
Sbjct: 362 DVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIP 421

Query: 373 TGLWTTFNLSSLMLSDNTISGELPSKTA--WNLTRLEISNNRFSGQIQRGVGSWKNLIVF 430
            G      L  L L+ N +SG +P   +   +L+ ++ S N+    +   + S  NL  F
Sbjct: 422 IGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAF 481

Query: 431 KASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIP 490
             ++N  SGE+P +      L+ L L  N L+G +PS I S   L +LNL  N L+GEIP
Sbjct: 482 LVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIP 541

Query: 491 KAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNKLYGNIP-DEFNNLAYDDS 548
           + I ++  +  LDLS N  +G +P  IG    L   N+S NKL G +P + F      D 
Sbjct: 542 RQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDD 601

Query: 549 FLNNSNLCVKNPIINLPKCPSRFRNSDKISSKH-----------LALILVLAILVLLV-T 596
              NS LC       LP C    R +   SS H           +A +L L IL ++  T
Sbjct: 602 LRGNSGLCGGV----LPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRT 657

Query: 597 VSLSWFVVRDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRID 656
           +   W+    C     ++    W+L +FH+LGFT S+IL+ + ESN+IG G +G VY+ +
Sbjct: 658 LYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAE 717

Query: 657 INGAGEFVAVKRIWNNR-KLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY 715
           ++ +   +AVK++W +   +      +F+ E+ +LG +RH NIV+L   + ++ + ++VY
Sbjct: 718 MSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVY 777

Query: 716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIH 775
           E+M N +L   +HG+        ++  + ++ W +R  IA+G A GL Y+HHDC P +IH
Sbjct: 778 EFMLNGNLGDAIHGK--------NAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIH 829

Query: 776 RDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKI 835
           RD+KS+NILLD+   A+IADFGLA+M+A++ E  T+S VAGS+GY APEY YT KV+EKI
Sbjct: 830 RDIKSNNILLDANLDARIADFGLARMMARKKE--TVSMVAGSYGYIAPEYGYTLKVDEKI 887

Query: 836 DIYSFGVVLLELVTGK---EANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYL-E 891
           DIYS+GVVLLEL+TG+   E  +G E   + EW  R   +   + +ALD  +    Y+ E
Sbjct: 888 DIYSYGVVLLELLTGRRPLEPEFG-ESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQE 946

Query: 892 EMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP 926
           EM  V ++AL+CT+ LP  RPSM++V+ +L    P
Sbjct: 947 EMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAKP 981

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3

 Score =  516 bits (1328), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 339/963 (35%), Positives = 524/963 (54%), Gaps = 105/963 (10%)

Query: 39  ILLNLKQQLGNPPS--LQSWTSTSSP---CDWPEITCTFNS-VTGISLRHKDITQKIPPI 92
           +LLNLK  +  P    L  W  +SSP   C +  ++C  ++ V  +++    +   I P 
Sbjct: 30  VLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLFGTISPE 89

Query: 93  ICDLKNLTTIDLSSNSIPGEFP--------------------------EFLYNCTKLQNL 126
           I  L +L  + L++N+  GE P                          E L     L+ L
Sbjct: 90  IGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAMVDLEVL 149

Query: 127 DLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFP 186
           D   N F G +P ++  +  L+ +  GGN FSG+IP S G +  L+ L L     +G  P
Sbjct: 150 DTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNGAGLSGKSP 209

Query: 187 KEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLE 246
             +  L NL  + + Y +++    +P EFG L KL+ L M    L GEIP ++SNL  L 
Sbjct: 210 AFLSRLKNLREMYIGYYNSYTGG-VPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKHLH 268

Query: 247 ILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGS 305
            L L+ N+L G IP  L  L +L  L L  N L+GEIP S   L  +T I+L  NNL G 
Sbjct: 269 TLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRNNLYGQ 328

Query: 306 IPEEFGKLKNLQLLGLFSNHLSGEVPASIG-------VVAFENNLSGAVPKSL------- 351
           IPE  G+L  L++  ++ N+ + ++PA++G       +   +N+L+G +PK L       
Sbjct: 329 IPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCRGEKLE 388

Query: 352 -----------------GNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGE 394
                            G C++L  +++  N  +G +P GL+    ++ + L+DN  SGE
Sbjct: 389 MLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFFSGE 448

Query: 395 LPSKTAWN-LTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNT 453
           LP   + + L ++ +SNN FSG+I   +G++ NL       N F G IP E+  L HL+ 
Sbjct: 449 LPVTMSGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFELKHLSR 508

Query: 454 LLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEI 513
           +    N ++G +P  I   ++L +++L+RN ++GEIPK I ++  + +L++SGNQ +G I
Sbjct: 509 INTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGSI 568

Query: 514 PPEIGQL-KLNTFNLSSNKLYGNIPDEFNNLAYDD-SFLNNSNLCVKNPIINLPKCPSR- 570
           P  IG +  L T +LS N L G +P     L +++ SF  N+ LC+ + +     CP+R 
Sbjct: 569 PTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRV----SCPTRP 624

Query: 571 ----FRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRKRNRDPATWKLTSFHQ 626
                 N   + S    +I V+A +  L+ +S++   +R  + +K+N+    WKLT+F +
Sbjct: 625 GQTSDHNHTALFSPSRIVITVIAAITGLILISVA---IRQ-MNKKKNQKSLAWKLTAFQK 680

Query: 627 LGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAE 686
           L F   ++L  L E N+IG GG+G VYR  +    + VA+KR+    +   + +  F AE
Sbjct: 681 LDFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVD-VAIKRLVG--RGTGRSDHGFTAE 737

Query: 687 IEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL 746
           I+ LG IRH +IV+L   ++++++ LL+YEYM N SL   LHG K              L
Sbjct: 738 IQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGH-----------L 786

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            W TR ++A+ AA+GLCY+HHDC+P I+HRDVKS+NILLDS+F+A +ADFGLAK L    
Sbjct: 787 QWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGA 846

Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE--ANYGDEHTSLAE 864
               MS++AGS+GY APEYAYT KV+EK D+YSFGVVLLEL+ GK+    +G E   +  
Sbjct: 847 ASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFG-EGVDIVR 905

Query: 865 WAWRHYAEE--KPITDALDKGIAEPCY----LEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           W  R+  EE  +P   A+   I +P      L  +  V+++A++C     ++RP+M+EV+
Sbjct: 906 WV-RNTEEEITQPSDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVV 964

Query: 919 QIL 921
            +L
Sbjct: 965 HML 967

Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1

 Score =  512 bits (1319), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 341/986 (34%), Positives = 522/986 (52%), Gaps = 120/986 (12%)

Query: 48   GNPPSLQSWT------STSSPCDWPEITC--TFNSVTGISLRHKDITQKIPPIICDLKNL 99
            G P + Q W       + +  C W  + C      V  + L H++++ +IP  I  L +L
Sbjct: 48   GPPSAFQDWKVPVNGQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIPIQIRYLSSL 107

Query: 100  TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYF------------------------VG 135
              ++LS NS+ G FP  +++ TKL  LD+S+N F                         G
Sbjct: 108  LYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNNFEG 167

Query: 136  PIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNL 195
             +PSD+ R+  L+ ++ GG+ F G+IP + G L  L+ ++L  N   G  P  +G L+ L
Sbjct: 168  LLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLTEL 227

Query: 196  EVLGLAYN-------------SNFK---------PAMIPIEFGMLKKLKTLWMTEANLIG 233
            + + + YN             SN K            +P E G L  L+TL++ +    G
Sbjct: 228  QHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTG 287

Query: 234  EIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KL 292
            EIPE+ SNL SL++L  + N L G+IPSG   L NLT L L  N LSGE+P  +  L +L
Sbjct: 288  EIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPEL 347

Query: 293  TDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASI-------GVVAFENNLSG 345
            T + L  NN TG +P + G    L+ + + +N  +G +P+S+        ++ F N   G
Sbjct: 348  TTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEG 407

Query: 346  AVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSK--TAWNL 403
             +PKSL  C +L   +  +NR +G +P G  +  NL+ + LS+N  + ++P+   TA  L
Sbjct: 408  ELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVL 467

Query: 404  TRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSG 463
              L +S N F  ++   +    NL +F AS +   GEIP           + L GN L+G
Sbjct: 468  QYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIP-NYVGCKSFYRIELQGNSLNG 526

Query: 464  KLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-L 522
             +P  I     L  LNL++N L+G IP  I +L  +  +DLS N  +G IP + G  K +
Sbjct: 527  TIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTI 586

Query: 523  NTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFR--NSDKISSK 580
             TFN+S N+L G IP           F +N  LC    ++  P    RF   N+D I   
Sbjct: 587  TTFNVSYNQLIGPIPSGSFAHLNPSFFSSNEGLC--GDLVGKPCNSDRFNAGNAD-IDGH 643

Query: 581  HL---------ALILVLAILVLLVTVSLSWFVV---RDCLRRKR-NR---------DPAT 618
            H          A++ +LA       + + +FV+     C ++   NR         D   
Sbjct: 644  HKEERPKKTAGAIVWILA-----AAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGP 698

Query: 619  WKLTSFHQLGFTESNILSSLTES-NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ 677
            WKLT+F +L FT  +++  L+++ N++G G +G VY+ ++   GE +AVK++W   K N 
Sbjct: 699  WKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPN-GEIIAVKKLWGKNKENG 757

Query: 678  KLEKE---FIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSL 734
            K+ +     +AE+++LG +RH NIV+L  C ++ +  +L+YEYM N SLD  LHG  +++
Sbjct: 758  KIRRRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTM 817

Query: 735  VSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA 794
             + +         W    QIAIG AQG+CY+HHDC P I+HRD+K SNILLD++F+A++A
Sbjct: 818  TAAA--------EWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVA 869

Query: 795  DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK--- 851
            DFG+AK++       +MS VAGS+GY APEYAYT +V++K DIYS+GV+LLE++TGK   
Sbjct: 870  DFGVAKLIQTD---ESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSV 926

Query: 852  EANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYL--EEMTTVYRLALICTSTLPS 909
            E  +G E  S+ +W       ++ + + LDK +   C L  EEM  + R+AL+CTS  P+
Sbjct: 927  EPEFG-EGNSIVDWVRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPT 985

Query: 910  SRPSMKEVLQILRRCCPTENYGGKKM 935
             RP M++VL IL+   P     G  +
Sbjct: 986  DRPPMRDVLLILQEAKPKRKTVGDNV 1011

Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  504 bits (1298), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 348/964 (36%), Positives = 507/964 (52%), Gaps = 94/964 (9%)

Query: 32  PNTEERTILLNLKQQL------GNPPSLQSWTSTSSPCDWPEITCTFNS----------- 74
           P +E R  LL+LK  L       N P L SW  ++S C W  +TC  +            
Sbjct: 22  PISEFRA-LLSLKTSLTGAGDDKNSP-LSSWKVSTSFCTWIGVTCDVSRRHVTSLDLSGL 79

Query: 75  ---------------VTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFP-EFLY 118
                          +  +SL    I+  IPP I  L  L  ++LS+N   G FP E   
Sbjct: 80  NLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISS 139

Query: 119 NCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYM 178
               L+ LD+  N   G +P  +  ++ L+ + LGGN F+G IP S G    ++ L +  
Sbjct: 140 GLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSG 199

Query: 179 NEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAM-----------------------IPIEF 215
           NE  G  P EIG+L+ L  L + Y + F+  +                       IP E 
Sbjct: 200 NELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEI 259

Query: 216 GMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLY 275
           G L+KL TL++      G +   +  LSSL+ + L+ N   G IP+    L NLT L L+
Sbjct: 260 GKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLF 319

Query: 276 DNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASI 334
            N L GEIP  +  L +L  + L  NN TGSIP++ G+   L L+ L SN L+G +P ++
Sbjct: 320 RNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNM 379

Query: 335 -------GVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLS 387
                   ++   N L G++P SLG C +L  +++  N  +G +P GL+    L+ + L 
Sbjct: 380 CSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQ 439

Query: 388 DNTISGELP--SKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEL 445
           DN +SGELP     + NL ++ +SNN+ SG +   +G++  +       N F G IP E+
Sbjct: 440 DNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEV 499

Query: 446 TSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLS 505
             L  L+ +    N  SG++  +I     L  ++L+RNELSGEIP  I ++ ++  L+LS
Sbjct: 500 GKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLS 559

Query: 506 GNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPD--EFNNLAYDDSFLNNSNLCVKNPII 562
            N   G IP  I  ++ L + + S N L G +P   +F+   Y  SFL N +LC   P +
Sbjct: 560 RNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYT-SFLGNPDLC--GPYL 616

Query: 563 NLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRR--KRNRDPATWK 620
              K           S   L+  + L +++ L+  S+++ VV     R  K+  +   W+
Sbjct: 617 GPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAWR 676

Query: 621 LTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE 680
           LT+F +L FT  ++L SL E N+IG GG+G VY+  +   G+ VAVKR+    +     +
Sbjct: 677 LTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYK-GVMPNGDLVAVKRLAAMSR-GSSHD 734

Query: 681 KEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
             F AEI+ LG IRH +IV+L    S+  + LLVYEYM N SL   LHG+K         
Sbjct: 735 HGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH------ 788

Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK 800
                LHW TR +IA+ AA+GLCY+HHDC+P I+HRDVKS+NILLDS F+A +ADFGLAK
Sbjct: 789 -----LHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAK 843

Query: 801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE--ANYGDE 858
            L   G    MSA+AGS+GY APEYAYT KV+EK D+YSFGVVLLELVTG++    +GD 
Sbjct: 844 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDG 903

Query: 859 HTSLAEWAWRHYAEEK-PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
              + +W  +     K  +   LD  ++    + E+T V+ +A++C       RP+M+EV
Sbjct: 904 -VDIVQWVRKMTDSNKDSVLKVLDPRLSS-IPIHEVTHVFYVAMLCVEEQAVERPTMREV 961

Query: 918 LQIL 921
           +QIL
Sbjct: 962 VQIL 965

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3

 Score =  503 bits (1295), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 344/973 (35%), Positives = 514/973 (52%), Gaps = 102/973 (10%)

Query: 35  EERTILLNLKQQLGN-PPSLQSWT--STSSPCDWPEITCTF--NSVTGISLRHKDITQKI 89
            +  +L++LKQ   +  PSL SW   + +S C W  ++C     S+T + L + +I+  I
Sbjct: 33  RQANVLISLKQSFDSYDPSLDSWNIPNFNSLCSWTGVSCDNLNQSITRLDLSNLNISGTI 92

Query: 90  PPIICDLK-NLTTIDLSSNSIPGEFPEFLY-------------------------NCTKL 123
            P I  L  +L  +D+SSNS  GE P+ +Y                           T+L
Sbjct: 93  SPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFSQMTQL 152

Query: 124 QNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNG 183
             LD   N F G +P  +  ++ L+ +DLGGN F G+IPRS G    L+ L L  N+  G
Sbjct: 153 VTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGNDLRG 212

Query: 184 TFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLS 243
             P E+ +++ L  L L Y ++++   IP +FG L  L  L +   +L G IP  + NL 
Sbjct: 213 RIPNELANITTLVQLYLGYYNDYRGG-IPADFGRLINLVHLDLANCSLKGSIPAELGNLK 271

Query: 244 SLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNL 302
           +LE+L L  N L G++P  L  + +L  L L +N L GEIP  +  L KL   +L  N L
Sbjct: 272 NLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNRL 331

Query: 303 TGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIG--------------------------- 335
            G IPE   +L +LQ+L L+ N+ +G++P+ +G                           
Sbjct: 332 HGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCFGR 391

Query: 336 ----VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTI 391
               ++ F N L G +P+ LG C  L   +L  N  + +LP GL    NLS L L +N +
Sbjct: 392 RLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNFL 451

Query: 392 SGELPSKTAWN-----LTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELT 446
           +GE+P + A N     LT++ +SNNR SG I   + + ++L +     N  SG+IP E+ 
Sbjct: 452 TGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEIG 511

Query: 447 SLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSG 506
           SL  L  + +  N  SGK P +     SL  L+L+ N++SG+IP  I  + ++  L++S 
Sbjct: 512 SLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSW 571

Query: 507 NQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDE-----FNNLAYDDSFLNNSNLC--VK 558
           N F+  +P E+G +K L + + S N   G++P       FNN     SFL N  LC    
Sbjct: 572 NSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNN----TSFLGNPFLCGFSS 627

Query: 559 NPI---INLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRKRNRD 615
           NP     N  +     +N+ +   +  A   +   L LL    +   +     RR R  +
Sbjct: 628 NPCNGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNN 687

Query: 616 PATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL 675
           P  WKL  F +LGF   +IL  + E+++IG GG G VY+  +   GE VAVK++    K 
Sbjct: 688 PNLWKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYK-GVMPNGEEVAVKKLLTITK- 745

Query: 676 NQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLV 735
               +    AEI+ LG IRH NIV+L    S+++  LLVYEYM N SL   LHG+     
Sbjct: 746 GSSHDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVF- 804

Query: 736 SGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD 795
                     L W TRLQIA+ AA+GLCY+HHDC+P IIHRDVKS+NILL  EF+A +AD
Sbjct: 805 ----------LKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVAD 854

Query: 796 FGLAK-MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEA- 853
           FGLAK M+   G    MS++AGS+GY APEYAYT +++EK D+YSFGVVLLEL+TG++  
Sbjct: 855 FGLAKFMMQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPV 914

Query: 854 -NYGDEHTSLAEWA-WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSR 911
            N+G+E   + +W+  +     + +   +D+ ++    L E   ++ +A++C       R
Sbjct: 915 DNFGEEGIDIVQWSKIQTNCNRQGVVKIIDQRLSN-IPLAEAMELFFVAMLCVQEHSVER 973

Query: 912 PSMKEVLQILRRC 924
           P+M+EV+Q++ + 
Sbjct: 974 PTMREVVQMISQA 986

Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  498 bits (1281), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 341/959 (35%), Positives = 501/959 (52%), Gaps = 97/959 (10%)

Query: 36  ERTILLNLKQQLG---NPPSLQSWTSTSSPCDWPEITC--TFNSVTGI------------ 78
           E   LL+LK       + P L SW  +++ C W  +TC  +   VT +            
Sbjct: 27  ELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLS 86

Query: 79  ------------SLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYN-CTKLQN 125
                       SL    I+  IPP I +L  L  ++LS+N   G FP+ L +    L+ 
Sbjct: 87  SDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRV 146

Query: 126 LDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTF 185
           LDL  N   G +P  +  ++ L+ + LGGN FSG IP + G    L+ L +  NE  G  
Sbjct: 147 LDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKI 206

Query: 186 PKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSL 245
           P EIG+L+ L  L + Y + F+  + P E G L +L         L GEIP  +  L  L
Sbjct: 207 PPEIGNLTTLRELYIGYYNAFENGLPP-EIGNLSELVRFDAANCGLTGEIPPEIGKLQKL 265

Query: 246 EILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTG 304
           + L L  N   G I   L L+++L  + L +N+ +GEIP+S   LK LT ++L  N L G
Sbjct: 266 DTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYG 325

Query: 305 SIPEEFGKLKNLQLLGLFSNHLSGEVPASIG----------------------------- 335
           +IPE  G++  L++L L+ N+ +G +P  +G                             
Sbjct: 326 AIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRL 385

Query: 336 --VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISG 393
             ++   N L G++P SLG C +L  +++  N  +G +P  L+    LS + L DN ++G
Sbjct: 386 MTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTG 445

Query: 394 ELP---SKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSH 450
           ELP      + +L ++ +SNN+ SG +   +G+   +       N FSG IP E+  L  
Sbjct: 446 ELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQ 505

Query: 451 LNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFS 510
           L+ L    N  SG++  +I     L  ++L+RNELSG+IP  +  + ++  L+LS N   
Sbjct: 506 LSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLV 565

Query: 511 GEIPPEIGQLK-LNTFNLSSNKLYGNIPD--EFNNLAYDDSFLNNSNLCVKNPIINLPKC 567
           G IP  I  ++ L + + S N L G +P   +F+   Y  SF+ NS+LC        P  
Sbjct: 566 GSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYT-SFVGNSHLCG-------PYL 617

Query: 568 PSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRK-RNRDPA-TWKLTSFH 625
               + + +   K L+    L +++ L+  S+ + +V     R  RN   A  W+LT+F 
Sbjct: 618 GPCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQ 677

Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           +L FT  ++L SL E N+IG GG+G VY+  +   G+ VAVKR+          +  F A
Sbjct: 678 RLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMP-KGDLVAVKRLATMSH-GSSHDHGFNA 735

Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           EI+ LG IRH +IV+L    S+  + LLVYEYM N SL   LHG+K              
Sbjct: 736 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH----------- 784

Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
           LHW TR +IA+ AA+GLCY+HHDC+P I+HRDVKS+NILLDS F+A +ADFGLAK L   
Sbjct: 785 LHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDS 844

Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE--ANYGDEHTSLA 863
           G    MSA+AGS+GY APEYAYT KV+EK D+YSFGVVLLEL+TGK+    +GD    + 
Sbjct: 845 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDG-VDIV 903

Query: 864 EWAWRHYAEEKP-ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           +W        K  +   +D  ++    + E+T V+ +AL+C       RP+M+EV+QIL
Sbjct: 904 QWVRSMTDSNKDCVLKVIDLRLSS-VPVHEVTHVFYVALLCVEEQAVERPTMREVVQIL 961

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1

 Score =  495 bits (1274), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 331/929 (35%), Positives = 497/929 (53%), Gaps = 59/929 (6%)

Query: 42   NLKQQLGNPPSLQSW--TSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNL 99
            N+  Q+ + PSLQ+   ++ +     P+      S+  I +         P  +     L
Sbjct: 92   NVSDQIQSFPSLQALDLSNNAFESSLPKSLSNLTSLKVIDVSVNSFFGTFPYGLGMATGL 151

Query: 100  TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSG 159
            T ++ SSN+  G  PE L N T L+ LD    YF G +PS    +  L+ + L GNNF G
Sbjct: 152  THVNASSNNFSGFLPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGLSGNNFGG 211

Query: 160  DIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLK 219
             +P+ IG LS L+T+ L  N F G  P+E G L+ L+ L LA  +      IP   G LK
Sbjct: 212  KVPKVIGELSSLETIILGYNGFMGEIPEEFGKLTRLQYLDLAVGN--LTGQIPSSLGQLK 269

Query: 220  KLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNIL 279
            +L T+++ +  L G++P  +  ++SL  L L+ N + G IP  +  L NL  L L  N L
Sbjct: 270  QLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLNLMRNQL 329

Query: 280  SGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASI---- 334
            +G IPS +  L  L  ++L  N+L GS+P   GK   L+ L + SN LSG++P+ +    
Sbjct: 330  TGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGKNSPLKWLDVSSNKLSGDIPSGLCYSR 389

Query: 335  ---GVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTI 391
                ++ F N+ SG +P+ + +C TL  V++  N  SG +P G      L  L L+ N +
Sbjct: 390  NLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDLPMLQHLELAKNNL 449

Query: 392  SGELPSKTAW--NLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLS 449
            +G++P   A   +L+ ++IS N  S        S  NL  F AS+N F+G+IP ++    
Sbjct: 450  TGKIPDDIALSTSLSFIDISFNHLSSLSSSIFSS-PNLQTFIASHNNFAGKIPNQIQDRP 508

Query: 450  HLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQF 509
             L+ L L  N  SG +P +I S+  L +LNL  N+L GEIPKA+  + ++  LDLS N  
Sbjct: 509  SLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSNQLVGEIPKALAGMHMLAVLDLSNNSL 568

Query: 510  SGEIPPEIG-QLKLNTFNLSSNKLYGNIPDEFNNLAYD-DSFLNNSNLC--VKNPIINLP 565
            +G IP ++G    L   N+S NKL G IP      A D    + N+ LC  V  P     
Sbjct: 569  TGNIPADLGASPTLEMLNVSFNKLDGPIPSNMLFAAIDPKDLVGNNGLCGGVLPPCSKSL 628

Query: 566  KCPSRFRNSDKISSKH--LALILVLAILVLLVTVSLS--WF---------VVRDCLRRKR 612
               ++ RN  +I   H     I+  +++V +  + L+  W            R+ +  K+
Sbjct: 629  ALSAKGRNPGRIHVNHAVFGFIVGTSVIVAMGMMFLAGRWIYTRWDLYSNFAREYIFCKK 688

Query: 613  NRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEF-VAVKRIWN 671
             R+   W+L +F +L FT  +ILS + ESN+IG G  G VY+ ++       VAVK++W 
Sbjct: 689  PREEWPWRLVAFQRLCFTAGDILSHIKESNIIGMGAIGIVYKAEVMRRPLLTVAVKKLWR 748

Query: 672  NRKLNQKL---------EKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQS 722
            +      +         E + + E+ +LG +RH NIVK+   + +E   ++VYEYM N +
Sbjct: 749  SPSPQNDIEDHHQEEDEEDDILREVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPNGN 808

Query: 723  LDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSN 782
            L   LH +    +         +  W +R  +A+G  QGL Y+H+DC P IIHRD+KS+N
Sbjct: 809  LGTALHSKDEKFL---------LRDWLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNN 859

Query: 783  ILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGV 842
            ILLDS  +A+IADFGLAKM+  + E  T+S VAGS+GY APEY YT K++EK DIYS GV
Sbjct: 860  ILLDSNLEARIADFGLAKMMLHKNE--TVSMVAGSYGYIAPEYGYTLKIDEKSDIYSLGV 917

Query: 843  VLLELVTGK---EANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPC--YLEEMTTVY 897
            VLLELVTGK   + ++ D    + EW  R   + + + + +D  IA  C   +EEM    
Sbjct: 918  VLLELVTGKMPIDPSFEDS-IDVVEWIRRKVKKNESLEEVIDASIAGDCKHVIEEMLLAL 976

Query: 898  RLALICTSTLPSSRPSMKEVLQILRRCCP 926
            R+AL+CT+ LP  RPS+++V+ +L    P
Sbjct: 977  RIALLCTAKLPKDRPSIRDVITMLAEAKP 1005

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	969
255550970	1026	serine-threonine protein kinase, plant-t	0.996	0.941	0.627	0.0
224143344	1014	predicted protein [Populus trichocarpa]	0.978	0.934	0.632	0.0
224142854	1019	predicted protein [Populus trichocarpa]	0.973	0.925	0.630	0.0
224092252	1014	predicted protein [Populus trichocarpa]	0.978	0.934	0.629	0.0
449461337	1090	PREDICTED: receptor-like protein kinase	0.974	0.866	0.594	0.0
449515460	1004	PREDICTED: receptor-like protein kinase	0.974	0.940	0.594	0.0
359475926	1021	PREDICTED: receptor-like protein kinase	0.991	0.941	0.575	0.0
225429386	1499	PREDICTED: receptor-like protein kinase	0.956	0.618	0.589	0.0
359475921	999	PREDICTED: receptor-like protein kinase	0.969	0.939	0.576	0.0
225429379	1004	PREDICTED: receptor-like protein kinase	0.977	0.943	0.576	0.0

>gi|255550970|ref|XP_002516533.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223544353|gb|EEF45874.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score = 1281 bits (3316), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 644/1026 (62%), Positives = 782/1026 (76%), Gaps = 60/1026 (5%)

Query: 1    MSKVASVFPKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTS 60
            MSK+   F K  + L LL L S PF VI Q  NT+E++ILLN+KQQLGNPPSLQSWT+++
Sbjct: 1    MSKLPLPFQKFSLYLSLLFLTSTPFNVISQITNTQEQSILLNIKQQLGNPPSLQSWTTST 60

Query: 61   SPCDWPEITCTFN-SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYN 119
            SPC WPEI+C+ + SVT + LR K+IT  IP  ICDLKNLT +DL+ N IPG FP FLYN
Sbjct: 61   SPCTWPEISCSDDGSVTALGLRDKNITVAIPARICDLKNLTVLDLAYNYIPGGFPTFLYN 120

Query: 120  CTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN 179
            C+ L+ LDLSQNYFVG +P DIDR+S L+ IDL  NNFSGDIP +IG L ELQTL+L+ N
Sbjct: 121  CSSLERLDLSQNYFVGTVPDDIDRLSNLKSIDLSANNFSGDIPPAIGNLRELQTLFLHQN 180

Query: 180  EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAM 239
            EFNGTFPKEIG+L+NLE L LA+N  F P+ IP+EFG L KL  LW+ +ANLIG IPE++
Sbjct: 181  EFNGTFPKEIGNLANLEQLRLAFNG-FVPSRIPVEFGNLTKLTFLWIRDANLIGSIPESL 239

Query: 240  SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSM 299
            +NLSSLE L L+ N LEG+IP GLFLL NLT L+L+ N LSG++P  VEAL L ++DL +
Sbjct: 240  ANLSSLETLDLSINKLEGSIPDGLFLLKNLTYLYLFHNQLSGDMPKKVEALNLVEVDLGI 299

Query: 300  NNLTGSIPEEFGKLKNLQLLGLFSNHLSGE------------------------VPASIG 335
            NNL GSI E+FGKLKNL+ L L+SN LSGE                        +P  IG
Sbjct: 300  NNLIGSISEDFGKLKNLERLHLYSNQLSGELPQTIGLLPALKSFRVFTNNLSGVLPTEIG 359

Query: 336  -------------------------------VVAFENNLSGAVPKSLGNCRTLRTVQLYS 364
                                           VVAF NNL+G VP+SLG C +L+TVQLY+
Sbjct: 360  LHSKLQYFEVSTNHFSGKLPENLCAGGVLEGVVAFSNNLTGEVPQSLGKCNSLKTVQLYN 419

Query: 365  NRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSW 424
            NRFSGE+P+G+WT  N++ LMLS+N+ SG+LPS  AWNL+RLE+SNN+FSG I  G+ SW
Sbjct: 420  NRFSGEIPSGIWTVINMTYLMLSNNSFSGKLPSSLAWNLSRLELSNNKFSGPIPTGISSW 479

Query: 425  KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNE 484
             NL+VF+ASNNL SGEIPVE+TSLSHLNTLLLDGN+L G+LPS+I+SW +LN LNL+RN 
Sbjct: 480  VNLVVFEASNNLLSGEIPVEVTSLSHLNTLLLDGNQLLGQLPSKIISWKTLNTLNLSRNA 539

Query: 485  LSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLA 544
            LSG+IP AIGSL  ++ LDLS N  SG+IP E GQL L + NLSSN+  G IPD+F+NLA
Sbjct: 540  LSGQIPAAIGSLPDLLYLDLSQNHLSGQIPSEFGQLNLISLNLSSNQFSGQIPDKFDNLA 599

Query: 545  YDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVV 604
            Y++SFLNNSNLC  NPI++LP C +R RNSDK+SSK LA+IL+  +   ++T+ L+ F V
Sbjct: 600  YENSFLNNSNLCAVNPILDLPNCYTRSRNSDKLSSKFLAMILIFTVTAFIITIVLTLFAV 659

Query: 605  RDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFV 664
            RD LR+K  R+ A WKLTSF ++ FT++NIL+SLTESNLIGSGGSG+VYR+ +N AGE V
Sbjct: 660  RDYLRKKHKRELAAWKLTSFQRVDFTQANILASLTESNLIGSGGSGKVYRVAVNRAGELV 719

Query: 665  AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLD 724
            AVKRIW NR+ ++KLEKEF+AE+EILG IRH+NIVKL CCISSE SKLLVYEYMENQSLD
Sbjct: 720  AVKRIWTNRQFDEKLEKEFLAEVEILGAIRHSNIVKLLCCISSEESKLLVYEYMENQSLD 779

Query: 725  RWLHGRKR-SLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI 783
            RWLHG+KR S ++G++SV   VL+WP RLQIA+GAAQGLCYMHHDC+P IIHRDVKSSNI
Sbjct: 780  RWLHGKKRNSSLAGTNSVQDIVLNWPRRLQIAVGAAQGLCYMHHDCSPPIIHRDVKSSNI 839

Query: 784  LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVV 843
            LLDSEFKA+IADFGLAK+L K+GE  TMSAVAGSFGY APEYAYT KVNEKID+YSFGVV
Sbjct: 840  LLDSEFKARIADFGLAKILVKEGEARTMSAVAGSFGYIAPEYAYTIKVNEKIDVYSFGVV 899

Query: 844  LLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALIC 903
            LLELVTG+E N GDE++SLAEWAWR  AE  PI D  D+ I +PCYLEEMT V+ L L C
Sbjct: 900  LLELVTGREPNNGDENSSLAEWAWRQNAEGTPIIDCFDEEIRQPCYLEEMTAVFNLGLFC 959

Query: 904  TSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGFKRSKKVAAE 963
            TS +P+ RPSMK+VLQ+LRR  PT     + MG + D APLL +A YL  +K SK+V+ E
Sbjct: 960  TSNMPNQRPSMKDVLQVLRRYSPTSY--KENMGSEFDVAPLLASATYLSSYKHSKRVSDE 1017

Query: 964  EDNGLA 969
             D  L 
Sbjct: 1018 YDCSLV 1023

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224143344|ref|XP_002336031.1| predicted protein [Populus trichocarpa] gi|222838987|gb|EEE77338.1| predicted protein [Populus trichocarpa]

 Score = 1250 bits (3235), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 637/1007 (63%), Positives = 765/1007 (75%), Gaps = 59/1007 (5%)

Query: 1    MSKVASVFPKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTS 60
            MS++  +F +    L +LVLLS+PF VI Q  NTE +TILL L+QQLGNP S+QSW ++S
Sbjct: 1    MSELTILFLRTSPLLCVLVLLSLPFRVISQDANTE-KTILLKLRQQLGNPSSIQSWNTSS 59

Query: 61   SPCDWPEITCTFN-SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYN 119
            SPC+W  +TC  + SV+ + L  K+IT+ IP  +CDLKNLT +D++ N IPG FP+ LY+
Sbjct: 60   SPCNWTGVTCGGDGSVSELHLGDKNITETIPATVCDLKNLTFLDMNFNYIPGGFPKVLYS 119

Query: 120  CTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN 179
            CTKLQ+LDLSQN+FVGPIP DID++SGL+ I+LGGNNF+G+IP  IG L+ELQTL+L+ N
Sbjct: 120  CTKLQHLDLSQNFFVGPIPDDIDKLSGLRYINLGGNNFTGNIPPQIGNLTELQTLHLFQN 179

Query: 180  EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAM 239
            +FNGTFPKEI  LSNLEVLGLA+N  F P+ IP+EFG LKKL  LWM ++NLIGEIPE++
Sbjct: 180  QFNGTFPKEISKLSNLEVLGLAFNE-FVPSSIPVEFGQLKKLWFLWMRQSNLIGEIPESL 238

Query: 240  SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSM 299
            +NLSSLE L L  N LEG IP GLF L NLT L+L+ N LSGEIP  VE L L +IDL+M
Sbjct: 239  TNLSSLEHLDLAINALEGKIPDGLFSLKNLTNLYLFQNNLSGEIPQRVETLNLVEIDLAM 298

Query: 300  NNLTGSIPEEFGKLKNLQLLGLFSNHLS-------------------------------- 327
            N L GSIP++FGKLK LQ L L  NHLS                                
Sbjct: 299  NQLNGSIPKDFGKLKKLQFLSLLDNHLSGEVPPSIGLLPALTTFKVFSNNLSGALPPKMG 358

Query: 328  ----------------GEVPASI-------GVVAFENNLSGAVPKSLGNCRTLRTVQLYS 364
                            G++P ++       G VAFENNLSG VP+SLGNC +L T+QLYS
Sbjct: 359  LSSKLVEFDVAANQFSGQLPENLCAGGVLLGAVAFENNLSGRVPQSLGNCNSLHTIQLYS 418

Query: 365  NRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSW 424
            N FSGE+P G+WT  N++ LMLSDN+ SG LPSK AWNL+RLE+ NNRFSG I  G+ SW
Sbjct: 419  NSFSGEIPAGVWTASNMTYLMLSDNSFSGGLPSKLAWNLSRLELGNNRFSGPIPPGISSW 478

Query: 425  KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNE 484
             NL+ FKASNNL SGEIPVE+TSL HL+ LLLDGN  SG+LPSQI+SW SL +LNL+RN 
Sbjct: 479  VNLVDFKASNNLLSGEIPVEITSLPHLSNLLLDGNLFSGQLPSQIISWKSLTSLNLSRNA 538

Query: 485  LSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLA 544
            LSG+IPK IGSL  ++ LDLS N FSGEIP E  QLKL + NLSSN L G IPD+F+N A
Sbjct: 539  LSGQIPKEIGSLPDLLYLDLSQNHFSGEIPLEFDQLKLVSLNLSSNHLSGKIPDQFDNHA 598

Query: 545  YDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVV 604
            YD+SFLNNSNLC  NPI+N P C ++ R+S K+ SK LALIL L + + LVT  ++ F+V
Sbjct: 599  YDNSFLNNSNLCAVNPILNFPNCYAKLRDSKKMPSKTLALILALTVTIFLVTTIVTLFMV 658

Query: 605  RDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFV 664
            RD  R+K  RD A WKLTSF +L FTE+N+L+SLTE+NLIGSGGSG+VYR+ IN AG++V
Sbjct: 659  RDYQRKKAKRDLAAWKLTSFQRLDFTEANVLASLTENNLIGSGGSGKVYRVAINRAGDYV 718

Query: 665  AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLD 724
            AVKRIWNN K++  LEKEF+AE++ILGTIRHANIVKL CCISSE+SKLLVYE+MENQSLD
Sbjct: 719  AVKRIWNNEKMDHNLEKEFLAEVQILGTIRHANIVKLLCCISSESSKLLVYEFMENQSLD 778

Query: 725  RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL 784
            RWLHGRKRS   G+SSVH  VL WPTR QIAIGAA+GL YMHHDC+  IIHRDVKSSNIL
Sbjct: 779  RWLHGRKRSSSMGTSSVHNSVLDWPTRFQIAIGAARGLSYMHHDCSTPIIHRDVKSSNIL 838

Query: 785  LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVL 844
            LDSE KA+IADFGLA++LAKQGE HTMS VAGSFGY APEYAYTT+VNEKID+YSFGVVL
Sbjct: 839  LDSELKARIADFGLARILAKQGEVHTMSVVAGSFGYMAPEYAYTTRVNEKIDVYSFGVVL 898

Query: 845  LELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICT 904
            LEL TG+E N GDEHTSLAEWAW+ + + KP+ D LD+ I EPC+L+EMTTV+ L LICT
Sbjct: 899  LELATGREPNSGDEHTSLAEWAWQQFGQGKPVVDCLDQEIKEPCFLQEMTTVFNLGLICT 958

Query: 905  STLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYL 951
             + PS+RPSMKEVL+ILRR     N G KK G ++D  PLLGT  YL
Sbjct: 959  HSSPSTRPSMKEVLEILRRVSADSN-GEKKTGAELDVVPLLGTVTYL 1004

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224142854|ref|XP_002324752.1| predicted protein [Populus trichocarpa] gi|222866186|gb|EEF03317.1| predicted protein [Populus trichocarpa]

 Score = 1236 bits (3198), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 632/1002 (63%), Positives = 764/1002 (76%), Gaps = 59/1002 (5%)

Query: 24   PFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHK 83
            PF+VI Q  N E +TILLNLKQQLGNP S+QSW S+SSPC+WP++ C   +VTG+ L +K
Sbjct: 18   PFKVISQDVNAE-KTILLNLKQQLGNPSSIQSWNSSSSPCEWPDVYCVEGAVTGLDLGNK 76

Query: 84   DITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDR 143
            +ITQ IP  +CDLKNLT ++L+ N IPG FP+ LYNC KL+ LDLSQNYFVGPIP DIDR
Sbjct: 77   NITQTIPASVCDLKNLTYLNLNWNYIPGGFPKLLYNCKKLEELDLSQNYFVGPIPDDIDR 136

Query: 144  ISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYN 203
            +S L+ + L GNNF+G+IP  IG L+EL+TL+L+ N+FNGTFPKEIG LSNLE + LAY 
Sbjct: 137  LSSLRYLYLQGNNFTGNIPPQIGNLTELRTLFLHQNQFNGTFPKEIGKLSNLEEMALAY- 195

Query: 204  SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGL 263
             +F P+ IP+EFG LKKL+ LWM  ANLIGEIPE++SNL+SL  L L GN LEG IP GL
Sbjct: 196  IDFVPSSIPVEFGQLKKLRLLWMKLANLIGEIPESLSNLTSLVHLDLAGNDLEGKIPGGL 255

Query: 264  FLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGK----------- 312
            FLL NLT L+L+ N LSGEIP  VE L L +IDL+MN+L GSI ++FGK           
Sbjct: 256  FLLKNLTNLYLFKNKLSGEIPQIVETLNLVEIDLAMNHLNGSITQDFGKLKKLQLLSLFE 315

Query: 313  -------------LKNLQLLGLFSNHLSGEVPASIGV----------------------- 336
                         L  L+   +F+N+LSG +P  +G+                       
Sbjct: 316  NHLSGEVPASIGLLPELRAFKVFTNNLSGVLPPKMGLHSTLEEFDVSNNQFSGRLPENLC 375

Query: 337  --------VAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSD 388
                    VAFENNLSG VP+SLGNC +LRTVQLYSN FSGE+P G+WT FN++ LMLS+
Sbjct: 376  AGGVLQGAVAFENNLSGQVPQSLGNCNSLRTVQLYSNNFSGEIPAGIWTAFNMTYLMLSE 435

Query: 389  NTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSL 448
            N+ SG LPSK AWNL+RLE++NNRFSG I  GV SW NL+VF+ASNNLFSGEIPVE+TSL
Sbjct: 436  NSFSGGLPSKLAWNLSRLELNNNRFSGPIPPGVSSWVNLVVFEASNNLFSGEIPVEITSL 495

Query: 449  SHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQ 508
             HL+ LLLDGN+ SG+LPS I SW SL +LNL+RN LSG+IP+ IGSL  +  LDLS N 
Sbjct: 496  PHLSNLLLDGNQFSGQLPSTIPSWKSLTSLNLSRNGLSGQIPREIGSLPDLRYLDLSQNH 555

Query: 509  FSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCP 568
            FSGEIPPE GQLKL   NLSSN L G IPD+F+NLAYD+SFL N  LC  NPI+NLP C 
Sbjct: 556  FSGEIPPEFGQLKLIFLNLSSNNLSGKIPDQFDNLAYDNSFLENYKLCAVNPILNLPDCH 615

Query: 569  SRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRKRNRDPATWKLTSFHQLG 628
            ++ R+S+K S K L+LILVL + + LVT+ ++ F+VRDC R K+ RD A+WKLTSF +L 
Sbjct: 616  TKLRDSEKFSFKILSLILVLTVTIFLVTIIVTLFMVRDCPRGKQKRDLASWKLTSFQRLD 675

Query: 629  FTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE 688
            FTE+NIL+SLTE+NLIGSGGSG+VYRI IN AG+FVAVKRIW+N +++ KLEKEF+AE++
Sbjct: 676  FTEANILASLTENNLIGSGGSGKVYRIAINRAGDFVAVKRIWSNEEMDHKLEKEFLAEVQ 735

Query: 689  ILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
            ILGTIRHANIVKL CCISSE SKLLVYEYMEN SLDRWLHG+KRS   G+SSV   VL W
Sbjct: 736  ILGTIRHANIVKLMCCISSEKSKLLVYEYMENHSLDRWLHGKKRSSSMGASSVRHSVLDW 795

Query: 749  PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
            PTR QIAIGAA+GLCYMHHDC+  I+HRDVKSSNILLDSEFKA+IADFGLAKMLAKQGE 
Sbjct: 796  PTRFQIAIGAARGLCYMHHDCSTPIVHRDVKSSNILLDSEFKARIADFGLAKMLAKQGEA 855

Query: 809  HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG-DEHTSLAEWAW 867
            HTMSAVAGSFGY APEYAYTTKVNEKID+YSFGVVLLEL TG+E N G DE TSLAEWAW
Sbjct: 856  HTMSAVAGSFGYIAPEYAYTTKVNEKIDVYSFGVVLLELATGREPNSGDDEDTSLAEWAW 915

Query: 868  RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPT 927
            R + + KP+++ LD+ I EPC+L+EMT V+ L L+CT +LPS+RPSMK+VL+ILRRC P 
Sbjct: 916  RQFGQGKPVSNCLDQEIKEPCFLQEMTAVFNLGLVCTHSLPSNRPSMKDVLEILRRCSP- 974

Query: 928  ENYGGKKMGRDVDSAPLLGTAGYLFGFKRSKKVAAEEDNGLA 969
            +N G K+   + D  PLLG    L   +RS +++ + D+ L 
Sbjct: 975  DNNGEKRTVSEFDIVPLLGNVTCLSSNRRSNRLSDDNDDSLV 1016

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224092252|ref|XP_002309529.1| predicted protein [Populus trichocarpa] gi|222855505|gb|EEE93052.1| predicted protein [Populus trichocarpa]

 Score = 1224 bits (3166), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 634/1007 (62%), Positives = 758/1007 (75%), Gaps = 59/1007 (5%)

Query: 1    MSKVASVFPKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTS 60
            MS++  +F +    L +LVLLS+PF VI Q  NTE +TILL LKQQLGNP S+QSW S+S
Sbjct: 1    MSELTILFLRTSPLLCVLVLLSLPFRVISQDANTE-KTILLKLKQQLGNPSSIQSWNSSS 59

Query: 61   SPCDWPEITCTFN-SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYN 119
            SPC+W  +TC  + SV+ + L  K+IT+ IP  +CDLKNLT +D++ N IPG FP+ LY+
Sbjct: 60   SPCNWTGVTCGGDGSVSELHLGDKNITETIPATVCDLKNLTFLDMNFNHIPGGFPKVLYS 119

Query: 120  CTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN 179
            CTKLQ+LDLSQN+F GPIP DID++SGL+ I+LG NNF+G+IP  +  L+ LQTL+LY N
Sbjct: 120  CTKLQHLDLSQNFFFGPIPDDIDKLSGLRYINLGANNFTGNIPPQMANLTGLQTLHLYQN 179

Query: 180  EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAM 239
            +FNGT PKEI  LSNLE LGLA N  F P+ IP+EFG LKKL+ LWM  ANLIGEIPE++
Sbjct: 180  QFNGTLPKEISKLSNLEELGLAINE-FVPSSIPVEFGQLKKLRYLWMRLANLIGEIPESL 238

Query: 240  SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSM 299
            +NLSSLE L L  N LEG IP GLF L NLT L+L+ N LSGEIP  VE L L +IDL+M
Sbjct: 239  TNLSSLEHLDLAENDLEGKIPDGLFSLKNLTYLYLFQNNLSGEIPQRVETLNLVEIDLAM 298

Query: 300  NNLTGSIPEEFGKLKNLQLLGLFSNHLS-------------------------------- 327
            N L GSIP++FGKLK LQ L L  NHLS                                
Sbjct: 299  NQLNGSIPKDFGKLKKLQFLSLLDNHLSGEVPPSIGLLPALTTFKVFSNNLSGALPPKMG 358

Query: 328  ----------------GEVPASI-------GVVAFENNLSGAVPKSLGNCRTLRTVQLYS 364
                            G++P ++       G VAFENNLSG VP+SLGNC +L T+QLYS
Sbjct: 359  LSSKLVEFDVAANQFSGQLPENLCAGGVLLGAVAFENNLSGRVPQSLGNCNSLHTIQLYS 418

Query: 365  NRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSW 424
            N FSGE+P G+WT  N++ LMLSDN+ SG LPSK AWNL+RLE+ NNRFSG I  G+ SW
Sbjct: 419  NSFSGEIPAGVWTASNMTYLMLSDNSFSGGLPSKLAWNLSRLELGNNRFSGPIPPGISSW 478

Query: 425  KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNE 484
             NL+ FKASNNL SGEIPVE+TSL HL+ LLLDGN  SG+LPSQI+SW SL +LNL+RN 
Sbjct: 479  VNLVDFKASNNLLSGEIPVEITSLPHLSNLLLDGNLFSGQLPSQIISWKSLTSLNLSRNA 538

Query: 485  LSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLA 544
            LSG+IPK IGSL  ++ LDLS N FSGEIP E  QLKL + NLSSN L G IPD+F+N A
Sbjct: 539  LSGQIPKEIGSLPDLLYLDLSQNHFSGEIPLEFDQLKLVSLNLSSNHLSGKIPDQFDNHA 598

Query: 545  YDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVV 604
            YD+SFLNNSNLC  NPI+N P C ++ R+S K+ SK LALIL L + + LVT  ++ F+V
Sbjct: 599  YDNSFLNNSNLCAVNPILNFPNCYAKLRDSKKMPSKTLALILALTVTIFLVTTIVTLFMV 658

Query: 605  RDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFV 664
            RD  R+K  RD A WKLTSF +L FTE+N+L+SLTE+NLIGSGGSG+VYR+ IN AG++V
Sbjct: 659  RDYQRKKAKRDLAAWKLTSFQRLDFTEANVLASLTENNLIGSGGSGKVYRVAINRAGDYV 718

Query: 665  AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLD 724
            AVKRIWNN K++  LEKEF+AE++ILGTIRHANIVKL CCISSE+SKLLVYE+MENQSLD
Sbjct: 719  AVKRIWNNEKMDHNLEKEFLAEVQILGTIRHANIVKLLCCISSESSKLLVYEFMENQSLD 778

Query: 725  RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL 784
            RWLHGRKRS   G+SSVH  VL WPTR QIAIGAA+GL YMHHDC+  IIHRDVKSSNIL
Sbjct: 779  RWLHGRKRSSSMGTSSVHNSVLDWPTRFQIAIGAARGLSYMHHDCSTPIIHRDVKSSNIL 838

Query: 785  LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVL 844
            LDSE KA+IADFGLA++LAKQGE HTMS VAGSFGY APEYAYTT+VNEKID+YSFGVVL
Sbjct: 839  LDSELKARIADFGLARILAKQGEVHTMSVVAGSFGYMAPEYAYTTRVNEKIDVYSFGVVL 898

Query: 845  LELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICT 904
            LEL TG+E N GDEHTSLAEWAW+ + + KP+ D LD+ I EPC+L+EMTTV+ L LICT
Sbjct: 899  LELATGREPNSGDEHTSLAEWAWQQFGQGKPVVDCLDQEIKEPCFLQEMTTVFNLGLICT 958

Query: 905  STLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYL 951
             + PS+RPSMKEVL+ILRR     N G KK G ++D  PLLGT  YL
Sbjct: 959  HSSPSTRPSMKEVLEILRRASADSN-GEKKTGAELDVVPLLGTVTYL 1004

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461337|ref|XP_004148398.1| PREDICTED: receptor-like protein kinase HSL1-like [Cucumis sativus]

 Score = 1158 bits (2995), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 597/1005 (59%), Positives = 738/1005 (73%), Gaps = 61/1005 (6%)

Query: 1    MSKVASVFPKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTS 60
            MS+++  F    + + L   + I F    Q+ N ++  ILL+LK+Q GNPPSL  W ++S
Sbjct: 87   MSRISLPFLTTLLPVYLFYFIYIQFHASSQTVNVDQ-AILLDLKEQWGNPPSLWLWNASS 145

Query: 61   SPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNC 120
             PCDWPEI C  ++V GISLR+K IT K+P +IC+L+NLT +DLS N IPGEFPE LYNC
Sbjct: 146  LPCDWPEIICRDSTVIGISLRNKTITGKVPTVICNLQNLTVLDLSWNYIPGEFPEVLYNC 205

Query: 121  TKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNE 180
            +KL+ LDLS NYFVGPIP D+DR+  LQ +DL  NNFSGD P ++G+LS+L+TL +Y  +
Sbjct: 206  SKLKYLDLSGNYFVGPIPQDVDRLQTLQYMDLSANNFSGDFPAALGQLSDLRTLKIYRTQ 265

Query: 181  FNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMS 240
             NGT P EIG+LSNLE L +AYN+   P+ IP +F  LKKLK +WMT++NLIG+IPE++ 
Sbjct: 266  CNGTLPAEIGNLSNLETLSMAYNTLLVPSPIPEDFRKLKKLKYMWMTKSNLIGQIPESLL 325

Query: 241  NLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMN 300
             L SLE L L+ N+L G+IP GLF L NLT LFLY N LSGEIP S+ A  L ++DLS N
Sbjct: 326  ELLSLEHLDLSSNNLIGSIPVGLFSLQNLTNLFLYQNRLSGEIPKSIRASNLLNVDLSTN 385

Query: 301  NLTGSIPEEFGKLKNLQLLGLFSNHLS--------------------------------- 327
            NL+G+IPE+FGKLK LQ+L LF+N LS                                 
Sbjct: 386  NLSGTIPEDFGKLKKLQVLNLFANQLSGEIPGSLGLLPELKGFRVFNNSLTGGLPQELGL 445

Query: 328  ---------------GEVPASI-------GVVAFENNLSGAVPKSLGNCRTLRTVQLYSN 365
                           G +P  +       GVVAF NNLSG +PK LGNCRTLRTVQL +N
Sbjct: 446  HSNLEALEVSMNKLSGSLPEHLCKNSVLQGVVAFSNNLSGKLPKGLGNCRTLRTVQLSNN 505

Query: 366  RFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWK 425
             FSGE+P GLWTTFNLSS+ML  N+ SGELP   +WNL+RL I+NN+FSGQI + V +W+
Sbjct: 506  NFSGEIPPGLWTTFNLSSIMLDGNSFSGELPDSLSWNLSRLAINNNKFSGQIPQNVSAWR 565

Query: 426  NLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNEL 485
            NLIVF+AS+NL SG+ P  LTSL HL TL+L GN+LSG+LP+ I SW SLN LNL+RNE+
Sbjct: 566  NLIVFEASDNLLSGKFPDGLTSLPHLTTLVLSGNQLSGQLPTTIGSWESLNTLNLSRNEI 625

Query: 486  SGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAY 545
            SG IP A GSL  ++ LDLSGN F+GEIPPEIG L+L + NLSSN+L G IPDE+ N+AY
Sbjct: 626  SGHIPAAFGSLPNLLYLDLSGNNFTGEIPPEIGHLRLASLNLSSNQLSGKIPDEYENIAY 685

Query: 546  DDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVV- 604
              SFLNN  LC    +++LP C SR  +S   S K+L+LIL  A+ V L+ ++L W ++ 
Sbjct: 686  GRSFLNNPKLCTAIGVLDLPSCYSRQIDSKYQSFKYLSLIL--ALTVTLLVIALLWIIIL 743

Query: 605  -RDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEF 663
             +   ++     P TWKLTSF +L FTE+NILS+LTE+NLIGSGGSG+VY IDIN AG +
Sbjct: 744  YKSYCKKDERCHPDTWKLTSFQRLEFTETNILSNLTETNLIGSGGSGKVYCIDINHAGYY 803

Query: 664  VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL 723
            VAVKRIW+N +L++KLEKEF AE++ILG+IRH+NIVKL CC+ +ENSKLLVYEYMENQSL
Sbjct: 804  VAVKRIWSNNELDKKLEKEFQAEVQILGSIRHSNIVKLLCCVWNENSKLLVYEYMENQSL 863

Query: 724  DRWLHGRKRSLVSGSSS-VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSN 782
            DRWLH +K+ L S + + + Q VL WP RLQIAIGAAQGL YMHHDC+P IIHRDVKSSN
Sbjct: 864  DRWLHKKKKRLTSAAMNFLEQSVLDWPRRLQIAIGAAQGLSYMHHDCSPPIIHRDVKSSN 923

Query: 783  ILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGV 842
            ILLD EF+AKIADFGLAKMLA QGEPHT+SA+AGSFGY APEYAYTTKVNEKID+YSFGV
Sbjct: 924  ILLDREFQAKIADFGLAKMLASQGEPHTISAIAGSFGYIAPEYAYTTKVNEKIDVYSFGV 983

Query: 843  VLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALI 902
            VLLEL TG+E N GDEHTSLAEWAW+ Y+E K ITD+LD+ I  PC  EEM+T+++L LI
Sbjct: 984  VLLELTTGREPNSGDEHTSLAEWAWQQYSEGKTITDSLDEEIKNPCNFEEMSTMFKLGLI 1043

Query: 903  CTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGT 947
            CTS LP  RPSMKEVL+ILR+C P E    +K   + D+ PLLGT
Sbjct: 1044 CTSMLPEIRPSMKEVLRILRQCSPPEACDRRKHAIEFDAIPLLGT 1088

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449515460|ref|XP_004164767.1| PREDICTED: receptor-like protein kinase HSL1-like [Cucumis sativus]

 Score = 1157 bits (2993), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 597/1005 (59%), Positives = 738/1005 (73%), Gaps = 61/1005 (6%)

Query: 1    MSKVASVFPKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTS 60
            MS+++  F    + + L   + I F    Q+ N ++  ILL+LK+Q GNPPSL  W ++S
Sbjct: 1    MSRISLPFLTTLLPVYLFYFIYIQFHASSQTVNVDQ-AILLDLKEQWGNPPSLWLWNASS 59

Query: 61   SPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNC 120
             PCDWPEI C  ++V GISLR+K IT K+P +IC+L+NLT +DLS N IPGEFPE LYNC
Sbjct: 60   LPCDWPEIICRDSTVIGISLRNKTITGKVPTVICNLQNLTVLDLSWNYIPGEFPEVLYNC 119

Query: 121  TKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNE 180
            +KL+ LDLS NYFVGPIP D+DR+  LQ +DL  NNFSGD P ++G+LS+L+TL +Y  +
Sbjct: 120  SKLKYLDLSGNYFVGPIPQDVDRLQTLQYMDLSANNFSGDFPAALGQLSDLRTLKIYRTQ 179

Query: 181  FNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMS 240
             NGT P EIG+LSNLE L +AYN+   P+ IP +F  LKKLK +WMT++NLIG+IPE++ 
Sbjct: 180  CNGTLPAEIGNLSNLETLSMAYNTLLVPSPIPEDFRKLKKLKYMWMTKSNLIGQIPESLL 239

Query: 241  NLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMN 300
             L SLE L L+ N+L G+IP GLF L NLT LFLY N LSGEIP S+ A  L ++DLS N
Sbjct: 240  ELLSLEHLDLSSNNLIGSIPVGLFSLQNLTNLFLYQNRLSGEIPKSIRASNLLNVDLSTN 299

Query: 301  NLTGSIPEEFGKLKNLQLLGLFSNHLS--------------------------------- 327
            NL+G+IPE+FGKLK LQ+L LF+N LS                                 
Sbjct: 300  NLSGTIPEDFGKLKKLQVLNLFANQLSGEIPGSLGLLPELKGFRVFNNSLTGGLPQELGL 359

Query: 328  ---------------GEVPASI-------GVVAFENNLSGAVPKSLGNCRTLRTVQLYSN 365
                           G +P  +       GVVAF NNLSG +PK LGNCRTLRTVQL +N
Sbjct: 360  HSNLEALEVSMNKLSGSLPEHLCKNSVLQGVVAFSNNLSGKLPKGLGNCRTLRTVQLSNN 419

Query: 366  RFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWK 425
             FSGE+P GLWTTFNLSS+ML  N+ SGELP   +WNL+RL I+NN+FSGQI + V +W+
Sbjct: 420  NFSGEIPPGLWTTFNLSSIMLDGNSFSGELPDSLSWNLSRLAINNNKFSGQIPQNVSAWR 479

Query: 426  NLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNEL 485
            NLIVF+AS+NL SG+ P  LTSL HL TL+L GN+LSG+LP+ I SW SLN LNL+RNE+
Sbjct: 480  NLIVFEASDNLLSGKFPDGLTSLPHLTTLVLSGNQLSGQLPTTIGSWESLNTLNLSRNEI 539

Query: 486  SGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAY 545
            SG IP A GSL  ++ LDLSGN F+GEIPPEIG L+L + NLSSN+L G IPDE+ N+AY
Sbjct: 540  SGHIPAAFGSLPNLLYLDLSGNNFTGEIPPEIGHLRLASLNLSSNQLSGKIPDEYENIAY 599

Query: 546  DDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVV- 604
              SFLNN  LC    +++LP C SR  +S   S K+L+LIL  A+ V L+ ++L W ++ 
Sbjct: 600  GRSFLNNPKLCTAIGVLDLPSCYSRQIDSKYQSFKYLSLIL--ALTVTLLVIALLWIIIL 657

Query: 605  -RDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEF 663
             +   ++     P TWKLTSF +L FTE+NILS+LTE+NLIGSGGSG+VY IDIN AG +
Sbjct: 658  YKSYCKKDERCHPDTWKLTSFQRLEFTETNILSNLTETNLIGSGGSGKVYCIDINHAGYY 717

Query: 664  VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL 723
            VAVKRIW+N +L++KLEKEF AE++ILG+IRH+NIVKL CC+ +ENSKLLVYEYMENQSL
Sbjct: 718  VAVKRIWSNNELDKKLEKEFQAEVQILGSIRHSNIVKLLCCVWNENSKLLVYEYMENQSL 777

Query: 724  DRWLHGRKRSLVSGSSS-VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSN 782
            DRWLH +K+ L S + + + Q VL WP RLQIAIGAAQGL YMHHDC+P IIHRDVKSSN
Sbjct: 778  DRWLHKKKKRLTSAAMNFLEQSVLDWPRRLQIAIGAAQGLSYMHHDCSPPIIHRDVKSSN 837

Query: 783  ILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGV 842
            ILLD EF+AKIADFGLAKMLA QGEPHT+SA+AGSFGY APEYAYTTKVNEKID+YSFGV
Sbjct: 838  ILLDREFQAKIADFGLAKMLASQGEPHTISAIAGSFGYIAPEYAYTTKVNEKIDVYSFGV 897

Query: 843  VLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALI 902
            VLLEL TG+E N GDEHTSLAEWAW+ Y+E K ITD+LD+ I  PC  EEM+T+++L LI
Sbjct: 898  VLLELTTGREPNSGDEHTSLAEWAWQQYSEGKTITDSLDEEIKNPCNFEEMSTMFKLGLI 957

Query: 903  CTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGT 947
            CTS LP  RPSMKEVL+ILR+C P E    +K   + D+ PLLGT
Sbjct: 958  CTSMLPEIRPSMKEVLRILRQCSPPEACDRRKHAIEFDAIPLLGT 1002

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475926|ref|XP_002278306.2| PREDICTED: receptor-like protein kinase HSL1-like [Vitis vinifera]

 Score = 1141 bits (2951), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 588/1022 (57%), Positives = 741/1022 (72%), Gaps = 61/1022 (5%)

Query: 1    MSKVASVFPKIPV-TLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTST 59
            M K+  +F   P  TL  L++LSI F+VI Q+ + +ER+ILL++KQQLGNPPSLQSW S+
Sbjct: 1    MPKLPLLFATTPFPTLFFLLILSI-FQVISQNLD-DERSILLDVKQQLGNPPSLQSWNSS 58

Query: 60   SSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYN 119
            S PCDWPEITCT N+VT ISL +K I +KIP  ICDLKNL  +DLS+N I GEFP+ L N
Sbjct: 59   SLPCDWPEITCTDNTVTAISLHNKTIREKIPATICDLKNLIVLDLSNNYIVGEFPDIL-N 117

Query: 120  CTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN 179
            C+KL+ L L QN FVGPIP+DIDR+S L+ +DL  NNFSGDIP +IGRL EL  L+L  N
Sbjct: 118  CSKLEYLLLLQNSFVGPIPADIDRLSHLRYLDLTANNFSGDIPAAIGRLRELFYLFLVQN 177

Query: 180  EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAM 239
            EFNGT+P EIG+L+NLE L +AYN  F+P+ +P EFG LKKLK LWMT+ANLIGEIP++ 
Sbjct: 178  EFNGTWPTEIGNLANLEHLAMAYNDKFRPSALPKEFGALKKLKYLWMTQANLIGEIPKSF 237

Query: 240  SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSM 299
            ++LSSLE L L+ N LEG IP  + +L NLT L+L++N LSG IPSS+EAL L +IDLS 
Sbjct: 238  NHLSSLEHLDLSLNKLEGTIPGVMLMLKNLTNLYLFNNRLSGRIPSSIEALNLKEIDLSK 297

Query: 300  NNLTGSIPEEFGKLKNLQLLGLF------------------------------------- 322
            N+LTG IPE FGKL+NL  L LF                                     
Sbjct: 298  NHLTGPIPEGFGKLQNLTGLNLFWNQLSGEIPVNISLIPTLETFKVFSNQLSGVLPPAFG 357

Query: 323  -----------SNHLSGEVPASI-------GVVAFENNLSGAVPKSLGNCRTLRTVQLYS 364
                        N LSGE+P  +       GVVA  NNLSG VPKSLGNCR+L T+QL +
Sbjct: 358  LHSELKRFEVSENKLSGELPQHLCARGVLLGVVASNNNLSGEVPKSLGNCRSLLTIQLSN 417

Query: 365  NRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSW 424
            NRFSGE+P+G+WT+ ++  +ML+ N+ SG LPSK A NL+R+EISNN+FSG I   + SW
Sbjct: 418  NRFSGEIPSGIWTSPDMIWVMLAGNSFSGTLPSKLARNLSRVEISNNKFSGPIPAEISSW 477

Query: 425  KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNE 484
             N+ V  ASNN+ SG+IP+ELTSL +++ LLLDGN+ SG+LPS+I+SW SLNNLNL+RN+
Sbjct: 478  MNIAVLNASNNMLSGKIPMELTSLRNISVLLLDGNQFSGELPSEIISWKSLNNLNLSRNK 537

Query: 485  LSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLA 544
            LSG IPKA+GSL  +  LDLS NQFSG+IPPE+G L LN  +LS N+L G +P EF    
Sbjct: 538  LSGPIPKALGSLPNLNYLDLSENQFSGQIPPELGHLTLNILDLSFNQLSGMVPIEFQYGG 597

Query: 545  YDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVV 604
            Y+ SFLN+  LCV    + LP+C ++  +SDK+S+K+L +IL+  +   L  V  +  ++
Sbjct: 598  YEHSFLNDPKLCVNVGTLKLPRCDAKVVDSDKLSTKYLVMILIFVVSGFLAIVLFTLLMI 657

Query: 605  RDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFV 664
            RD  R+  +RD   WK+T F  L F E  IL++LTE+NLIG GGSG+VYRI  N +GE +
Sbjct: 658  RDDNRKNHSRDHTPWKVTQFQTLDFNEQYILTNLTENNLIGRGGSGEVYRIANNRSGELL 717

Query: 665  AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLD 724
            AVK+I NNR+L+ K +K+FIAE+EILGTIRH+NIVKL CCIS+E+S LLVYEYME QSLD
Sbjct: 718  AVKKICNNRRLDHKFQKQFIAEVEILGTIRHSNIVKLLCCISNESSSLLVYEYMEKQSLD 777

Query: 725  RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL 784
            RWLHG+K+   S +SSVH  VL WPTRLQIAIGAA+GLC+MH +C+  IIHRDVKSSNIL
Sbjct: 778  RWLHGKKQRTTSMTSSVHNFVLDWPTRLQIAIGAAKGLCHMHENCSAPIIHRDVKSSNIL 837

Query: 785  LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVL 844
            LD+EF AKIADFGLAKML KQGE  TMS VAGS+GY APEYAYTTKVNEKID+YSFGVVL
Sbjct: 838  LDAEFNAKIADFGLAKMLVKQGEADTMSGVAGSYGYIAPEYAYTTKVNEKIDVYSFGVVL 897

Query: 845  LELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICT 904
            LELVTG+E N  DEH  L EWAW  + EEK I + +D+ I E C   ++TT++ L L+CT
Sbjct: 898  LELVTGREPNSRDEHMCLVEWAWDQFKEEKTIEEVMDEEIKEQCERAQVTTLFSLGLMCT 957

Query: 905  STLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGFKRSKKVAAEE 964
            +  PS+RP+MKEVL+ILR+C P E +G KK  +D ++APLL    Y   +K S+K +  E
Sbjct: 958  TRSPSTRPTMKEVLEILRQCSPQEGHGRKK--KDHEAAPLLQNGTYPATYKHSEKESDNE 1015

Query: 965  DN 966
            D+
Sbjct: 1016 DD 1017

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225429386|ref|XP_002278343.1| PREDICTED: receptor-like protein kinase HSL1-like [Vitis vinifera]

 Score = 1109 bits (2869), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 581/986 (58%), Positives = 720/986 (73%), Gaps = 59/986 (5%)

Query: 35   EERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIIC 94
            +ER+ILL++KQQLGNPPSLQSW S+SSPCDWPEITCT N++  ISL +K I +KIP  IC
Sbjct: 35   DERSILLDVKQQLGNPPSLQSWNSSSSPCDWPEITCTNNTIIAISLHNKTIREKIPATIC 94

Query: 95   DLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG 154
            DLKNL  +DLS+N IPGEFP+ L NC+KL+ L L QN FVGPIP+DIDR+S L+ +DL  
Sbjct: 95   DLKNLIILDLSNNYIPGEFPDIL-NCSKLEYLLLLQNSFVGPIPADIDRLSRLRYLDLTA 153

Query: 155  NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE 214
            NNFSGDIP +IGRL EL  L+L  NEFNGT+PKEIG+L+NLE L +AYN+ F P+ +P E
Sbjct: 154  NNFSGDIPTAIGRLRELFYLFLVQNEFNGTWPKEIGNLANLEHLVMAYNNKFLPSALPKE 213

Query: 215  FGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFL 274
            FG LKKLK LWM +ANLIGEIPE+ +NL SLE L L+ N LEG IP G+ +L NLT L+L
Sbjct: 214  FGALKKLKYLWMKQANLIGEIPESFNNLWSLEHLDLSLNKLEGTIPGGMLMLKNLTNLYL 273

Query: 275  YDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLF------------ 322
            ++N LSG IP ++EAL L +IDLS N LTG IP  FGKL+NL  L LF            
Sbjct: 274  FNNRLSGRIPMTIEALNLKEIDLSKNYLTGPIPTGFGKLQNLTSLNLFWNQLSGEIPANI 333

Query: 323  ------------SNHLSGEVP-------------------------------ASIGVVAF 339
                        SN LSG +P                               A +GVV  
Sbjct: 334  SLIPTLETFKVFSNQLSGVLPPAFGLHSELKRFEVSENKLSGKLPQHLCARGALLGVVVS 393

Query: 340  ENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKT 399
             NNLSG VPKSLGNC +L T+QL +N FS E+P+G+WT+ ++ S+MLS N+ SG LPS+ 
Sbjct: 394  NNNLSGEVPKSLGNCTSLLTIQLSNNCFSSEIPSGIWTSPDMVSVMLSGNSFSGALPSRL 453

Query: 400  AWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGN 459
            A NL+R++ISNN+FSG I   + SW N+ V  A+NN+ SG+IPVELTSL +++ LLL+GN
Sbjct: 454  ARNLSRVDISNNKFSGPIPAEISSWMNIGVLIANNNMLSGKIPVELTSLWNISILLLNGN 513

Query: 460  KLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQ 519
            + SG+LPSQI+SW SL NLNL+RN+LSG IPKA+GSL  +  LDLS NQFSG+IP E+G 
Sbjct: 514  QFSGELPSQIISWKSLTNLNLSRNKLSGLIPKALGSLTSLTYLDLSENQFSGQIPSELGH 573

Query: 520  LKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISS 579
            LKLN  +LSSN+L G +P EF    Y+ SFLNN  LCV    + LP+C  +  +SDK+S+
Sbjct: 574  LKLNILDLSSNQLSGMVPIEFQYGGYEHSFLNNPKLCVNVGTLKLPRCDVKVVDSDKLST 633

Query: 580  KHLALILVLAILVLLVTVSLSWFVVRDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLT 639
            K+L +IL+ A+   LV V  + F+VRD  R+  +RD  TWKLT F  L F E NILS LT
Sbjct: 634  KYLVMILIFALSGFLVVVFFTLFMVRDYHRKNHSRDHTTWKLTRFQNLDFDEHNILSGLT 693

Query: 640  ESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
            E+NLIG GGSG+VYRI  N +GE +AVKRI NNR+L+ KL+K+FIAE+EILGTIRH+NIV
Sbjct: 694  ENNLIGRGGSGKVYRIANNRSGELLAVKRICNNRRLDHKLQKQFIAEVEILGTIRHSNIV 753

Query: 700  KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
            KL CCIS+E+S LLVYEYME+QSLDRWLHG+K+   S +SSVH  VL WPTRLQIAIGAA
Sbjct: 754  KLLCCISNESSSLLVYEYMESQSLDRWLHGKKQRTSSMTSSVHNFVLDWPTRLQIAIGAA 813

Query: 760  QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            +GL +MH  C+  IIHRDVKSSNILLD+EF AKIADFGLAKML KQGE  TMS +AGS+G
Sbjct: 814  KGLRHMHEYCSAPIIHRDVKSSNILLDAEFNAKIADFGLAKMLVKQGEADTMSGIAGSYG 873

Query: 820  YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
            Y APEYAYTTKVNEKID+YSFGVVLLELVTG+E N G+EH  L EWAW  + EEK I + 
Sbjct: 874  YIAPEYAYTTKVNEKIDVYSFGVVLLELVTGREPNSGNEHMCLVEWAWDQFREEKTIEEV 933

Query: 880  LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDV 939
            +D+ I E C   ++TT++ L L+CT+TLPS+RP+MKEVL+ILR+C P E +G KK  +D 
Sbjct: 934  MDEEIKEECDTAQVTTLFTLGLMCTTTLPSTRPTMKEVLEILRQCNPQEGHGRKK--KDH 991

Query: 940  DSAPLLGTA-GYLFGFKRSKKVAAEE 964
            + APLL +  GY    +R  K  A+E
Sbjct: 992  EVAPLLASQRGYRKLRRRPAKSKAKE 1017

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475921|ref|XP_003631769.1| PREDICTED: receptor-like protein kinase HSL1-like [Vitis vinifera]

 Score = 1091 bits (2821), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 577/1001 (57%), Positives = 724/1001 (72%), Gaps = 62/1001 (6%)

Query: 1   MSKVASVFPKIPV-TLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTST 59
           M K   +F KIP   L LL++ S+ F+VI Q+ + E R+ILL++KQQLGNPPSLQSW S+
Sbjct: 1   MRKPPFLFTKIPFPALFLLLVFSLTFQVISQNLDAE-RSILLDVKQQLGNPPSLQSWNSS 59

Query: 60  SSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYN 119
           SSPCDWPEITC  N VT ISL +K IT+KIP  ICDLKNL  +D+S N IPGEFP+ L N
Sbjct: 60  SSPCDWPEITCIDNIVTEISLSYKTITKKIPARICDLKNLIVLDVSYNYIPGEFPDIL-N 118

Query: 120 CTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN 179
           C+KL+ L L QN FVGPIP+DIDR+S L+ +DL  NNFSGDIP +IGRL EL  L+L  N
Sbjct: 119 CSKLEYLLLLQNSFVGPIPADIDRLSRLRYLDLTANNFSGDIPAAIGRLQELFYLFLVQN 178

Query: 180 EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAM 239
           EFNGT+P EIG+L+NLE L +AYN  F+P+ +P EFG LKKLK LWMTEANLIGEIP++ 
Sbjct: 179 EFNGTWPTEIGNLANLEQLAMAYNDKFRPSALPKEFGALKKLKFLWMTEANLIGEIPKSF 238

Query: 240 SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSM 299
           +NLSSLE L L+ N L G IP G+  L NLT L+L+ N LSG +PSS+EA  L +IDLS 
Sbjct: 239 NNLSSLERLDLSLNELNGTIPVGMLTLKNLTYLYLFCNRLSGRVPSSIEAFNLKEIDLSD 298

Query: 300 NNLTGSIPEEFGKLKNLQLLGLF------------------------------------- 322
           N+LTG IP  F KL+NL  L LF                                     
Sbjct: 299 NHLTGPIPAGFVKLQNLTCLNLFWNQLSGEIPTNISLIPTLETFKVFSNQLSGVLPPAFG 358

Query: 323 -----------SNHLSGEVPASI-------GVVAFENNLSGAVPKSLGNCRTLRTVQLYS 364
                       N LSGE+P  +       GV+A  NNLSG VPKSLGNC++L T+Q+ +
Sbjct: 359 LHSELKFFEIFENKLSGELPQHLCARGTLLGVIASNNNLSGEVPKSLGNCKSLLTIQVSN 418

Query: 365 NRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSW 424
           NRFSGE+P+G+WT+ ++ S+ML+ N+ SG LPS+   NL+R++ISNN+FSGQI   + SW
Sbjct: 419 NRFSGEIPSGIWTSPDMVSVMLAGNSFSGALPSRLTRNLSRVDISNNKFSGQIPAEISSW 478

Query: 425 KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNE 484
            N+ V  A+NN+ SG+IP+ELTSL +++ LLLDGN+ SG+LPSQI+SW SL NLNL+RN+
Sbjct: 479 MNIGVLNANNNMLSGKIPMELTSLWNISVLLLDGNQFSGELPSQIISWKSLTNLNLSRNK 538

Query: 485 LSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLA 544
           LSG IPKA+GSL  +  LDLS NQF G+IP E+G LKLN  NLSSN+L G +P EF N A
Sbjct: 539 LSGLIPKALGSLPSLTYLDLSENQFLGQIPSELGHLKLNILNLSSNQLSGLVPFEFQNEA 598

Query: 545 YDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVV 604
           Y+ SFLNN  LCV    + LP+C ++  +SDK+S+K+L +IL+LA+   L  V  +  +V
Sbjct: 599 YNYSFLNNPKLCVNVGTLKLPRCDAKVVDSDKLSTKYLVMILILALSGFLAVVFFTLVMV 658

Query: 605 RDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFV 664
           RD  R+  +RD  TWKLT F  L F E NILS LTE+NLIG GGSG+VYRI  + +G+  
Sbjct: 659 RDYHRKNHSRDHTTWKLTRFQNLDFDEQNILSGLTENNLIGRGGSGKVYRIANDRSGKIF 718

Query: 665 AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLD 724
           AVK I NN +L+ KL+K FIA+ EILGT+ H+NIVKL CCIS+E + LLVYEYMENQSLD
Sbjct: 719 AVKMICNNGRLDHKLQKPFIAKDEILGTLHHSNIVKLLCCISNETTSLLVYEYMENQSLD 778

Query: 725 RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL 784
           RWLHG+K+  +S +S VH  +L WPTRLQIAIG A+GL +MH  C+  IIHRDVKSSNIL
Sbjct: 779 RWLHGKKQRTLSMTSLVHNFILDWPTRLQIAIGVAKGLRHMHEYCSAPIIHRDVKSSNIL 838

Query: 785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVL 844
           LD+EF AKIADFGLAKML KQGEP TMS VAGS+GY APEYAYTTKVNEKID+YSFGVVL
Sbjct: 839 LDAEFNAKIADFGLAKMLVKQGEPDTMSGVAGSYGYIAPEYAYTTKVNEKIDVYSFGVVL 898

Query: 845 LELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICT 904
           LELVTG+E N  +EH  L EWAW  + E K I + +D+ I E C   ++TT++ L L+CT
Sbjct: 899 LELVTGREPN--NEHMCLVEWAWDQFREGKTIEEVVDEEIKEQCDRAQVTTLFNLGLMCT 956

Query: 905 STLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLL 945
           +TLPS+RP+MKEVL+IL++C P E++G KK  +D ++ PLL
Sbjct: 957 TTLPSTRPTMKEVLEILQQCNPQEDHGRKK--KDHEATPLL 995

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225429379|ref|XP_002278223.1| PREDICTED: receptor-like protein kinase HSL1-like [Vitis vinifera]

 Score = 1085 bits (2806), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 583/1011 (57%), Positives = 724/1011 (71%), Gaps = 64/1011 (6%)

Query: 1    MSKVASVFPKIPV-TLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTST 59
            M K   +F KIP   L LL++ S+ F+VI Q+ + E R+ILL++KQQLGNPPSLQSW S+
Sbjct: 1    MRKPPFLFTKIPFPALFLLLVFSLTFQVISQNLDAE-RSILLDVKQQLGNPPSLQSWNSS 59

Query: 60   SSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYN 119
            SSPCDWPEITC  N VT ISL +K IT+KIP  ICDLKNL  +D+S N IPGEFP+ L N
Sbjct: 60   SSPCDWPEITCIDNIVTEISLSYKTITKKIPARICDLKNLIVLDVSYNYIPGEFPDIL-N 118

Query: 120  CTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN 179
            C+KL+ L L QN FVGPIP+DIDR+S L+ +DL  NNFSGDIP +IGRL EL  L+L  N
Sbjct: 119  CSKLEYLLLLQNSFVGPIPADIDRLSRLRYLDLTANNFSGDIPVAIGRLRELFYLFLVQN 178

Query: 180  EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAM 239
            EFNGT+P EIG+LSNLE L +AYN  F+P+ +P EFG LKKLK LWMT+ANL+GEIPE+ 
Sbjct: 179  EFNGTWPTEIGNLSNLEQLAMAYNDKFRPSALPKEFGALKKLKYLWMTKANLMGEIPESF 238

Query: 240  SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSM 299
            +NLSSLE+L L+ N LEG IP G+  L NL    L+ N LSG IPSS+EAL L +IDLS 
Sbjct: 239  NNLSSLELLDLSNNKLEGTIPGGMLTLKNLNYFLLFINRLSGHIPSSIEALNLKEIDLSD 298

Query: 300  NNLTGSIPEEFGKLKNLQLLGLF------------------------------------- 322
            N+LTGSIP  FGKL+NL  L LF                                     
Sbjct: 299  NHLTGSIPAGFGKLQNLTGLNLFWNQLSGEIPANISLIPTLETFKVFSNQLSGVLPPAFG 358

Query: 323  -----------SNHLSGEVPASI-------GVVAFENNLSGAVPKSLGNCRTLRTVQLYS 364
                        N LSGE+P  +       GVVA  NNLSG VP SLGNC +L T+QL +
Sbjct: 359  LHSELKLFEVSENKLSGELPQHLCARGTLLGVVASNNNLSGEVPTSLGNCTSLLTIQLSN 418

Query: 365  NRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSW 424
            NRFSG +P+G+WT+ ++ S+ML  N+ SG LPSK A NL+R+EI+NN+F G I   + SW
Sbjct: 419  NRFSGGIPSGIWTSPDMVSVMLDGNSFSGTLPSKLARNLSRVEIANNKFYGPIPAEISSW 478

Query: 425  KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNE 484
             N+ V  ASNN+ SG+IPVELTSL ++  LLLDGN+ SG+LPSQI+SW SLN LNL+RN+
Sbjct: 479  MNISVLNASNNMLSGKIPVELTSLWNITVLLLDGNQFSGELPSQIISWKSLNKLNLSRNK 538

Query: 485  LSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLA 544
            LSG IPKA+GSL  +  LDLS NQFSG+IPPE+G L L   +LSSN+L G +P EF + A
Sbjct: 539  LSGLIPKALGSLTSLSYLDLSENQFSGQIPPELGHLNLIILHLSSNQLSGMVPIEFQHEA 598

Query: 545  YDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVV 604
            Y+DSFLNN  LCV  P +NLP+C ++  NSDK+S+K+L   L   + V+ VT+S+    V
Sbjct: 599  YEDSFLNNPKLCVNVPTLNLPRCDAKPVNSDKLSTKYLVFALSGFLAVVFVTLSM----V 654

Query: 605  RDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFV 664
                R+  N++   WK T +H+L   E NILSSLTE+NLIG GGSG+VYR+  N +GE +
Sbjct: 655  HVYHRKNHNQEHTAWKFTPYHKLDLDEYNILSSLTENNLIGCGGSGKVYRVANNRSGELL 714

Query: 665  AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLD 724
            AVK I NNR+L+QKL+K+F  E++IL TIRHANIVKL CCIS+E S LLVYEYM+ QSLD
Sbjct: 715  AVKMICNNRRLDQKLQKQFETEVKILSTIRHANIVKLLCCISNETSSLLVYEYMQKQSLD 774

Query: 725  RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL 784
            RWLHG+K+   S +SSVH  VL WPTRLQIAIGAA+GLC+MH +C+  IIHRDVKSSNIL
Sbjct: 775  RWLHGKKQRTSSMTSSVHNFVLDWPTRLQIAIGAAKGLCHMHENCSAPIIHRDVKSSNIL 834

Query: 785  LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVL 844
            LD+EF AKIADFGLAKML KQGEP TMS +AGS+GY APEYAYTTKVN+KID+YSFGVVL
Sbjct: 835  LDAEFNAKIADFGLAKMLVKQGEPDTMSGIAGSYGYIAPEYAYTTKVNKKIDVYSFGVVL 894

Query: 845  LELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICT 904
            LELVTG+E N GDEH  LAEWAW  + EEK I + +D+ I E C   ++ T+++L + CT
Sbjct: 895  LELVTGREPNNGDEHVCLAEWAWDQFREEKTIEEVMDEEIKEECDRAQVATLFKLGIRCT 954

Query: 905  STLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGFK 955
            + LPS+RP+MK VL+IL++C P E +G  K  +D + AP L    Y   +K
Sbjct: 955  NKLPSNRPTMKGVLKILQQCSPQEGHGRNK--KDHEVAPPLRNDTYPTTYK 1003

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	969
TAIR|locus:2180617	1005	AT5G25930 [Arabidopsis thalian	0.917	0.884	0.488	6.2e-220
TAIR|locus:2005540	999	HAE "HAESA" [Arabidopsis thali	0.853	0.827	0.392	8.1e-147
TAIR|locus:2032553	996	HSL1 "HAESA-like 1" [Arabidops	0.849	0.826	0.388	2.2e-144
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.835	0.799	0.356	9.8e-135
TAIR|locus:2120412	992	BAM3 "BARELY ANY MERISTEM 3" [	0.834	0.815	0.373	1.9e-131
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.859	0.830	0.367	1.2e-129
UNIPROTKB|Q5Z9N5	994	P0481E08.42 "Os06g0717200 prot	0.825	0.804	0.368	1.5e-129
TAIR|locus:2169975	993	HSL2 "HAESA-like 2" [Arabidops	0.788	0.769	0.376	1.6e-128
TAIR|locus:2207036	977	AT1G72180 [Arabidopsis thalian	0.861	0.854	0.352	1.2e-127
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.535	0.454	0.318	1.8e-127

TAIR|locus:2180617 AT5G25930 [Arabidopsis thaliana (taxid:3702)]

 Score = 2124 (752.7 bits), Expect = 6.2e-220, P = 6.2e-220
 Identities = 448/917 (48%), Positives = 605/917 (65%)

Query:    64 DWPEITCTFNSVTGISLRHKDITQKIPPIICDLK-NLTTIDLSSNSIPGEFPEFLYNCTK 122
             ++P +      +  + L    +   +P  I  L   L  +DL++N   G+ P+ L   +K
Sbjct:   102 EFPTVLYNCTKLQYLDLSQNLLNGSLPVDIDRLSPELDYLDLAANGFSGDIPKSLGRISK 161

Query:   123 LQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNN-FS-GDIPRSIGRLSELQTLYLY-MN 179
             L+ L+L Q+ + G  PS+I  +S L+ + L  N+ F+   IP   G+L +L+ ++L  MN
Sbjct:   162 LKVLNLYQSEYDGTFPSEIGDLSELEELRLALNDKFTPAKIPIEFGKLKKLKYMWLEEMN 221

Query:   180 EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAM 239
                   P    ++++LE + L+ N N    +  + FG LK L   ++    L GEIP+++
Sbjct:   222 LIGEISPVVFENMTDLEHVDLSVN-NLTGRIPDVLFG-LKNLTEFYLFANGLTGEIPKSI 279

Query:   240 SNLSSLEILALNGNHLEGAIPSGXXXXXXXXXXXXYDNILSGEIPSSVEALK-LTDIDLS 298
             S  ++L  L L+ N+L G+IP              ++N L+GEIP  +  L  L +  + 
Sbjct:   280 S-ATNLVFLDLSANNLTGSIPVSIGNLTKLQVLNLFNNKLTGEIPPVIGKLPGLKEFKIF 338

Query:   299 MNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASI-------GVVAFENNLSGAVPKSL 351
              N LTG IP E G    L+   +  N L+G++P ++       GVV + NNL+G +P+SL
Sbjct:   339 NNKLTGEIPAEIGVHSKLERFEVSENQLTGKLPENLCKGGKLQGVVVYSNNLTGEIPESL 398

Query:   352 GNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNN 411
             G+C TL TVQL +N FSG+ P+ +W   ++ SL +S+N+ +GELP   AWN++R+EI NN
Sbjct:   399 GDCGTLLTVQLQNNDFSGKFPSRIWNASSMYSLQVSNNSFTGELPENVAWNMSRIEIDNN 458

Query:   412 RFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEXXXXXXXXXXXXDGNKLSGKLPSQIVS 471
             RFSG+I + +G+W +L+ FKA NN FSGE P E            D N L+G+LP +I+S
Sbjct:   459 RFSGEIPKKIGTWSSLVEFKAGNNQFSGEFPKELTSLSNLISIFLDENDLTGELPDEIIS 518

Query:   472 WTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNK 531
             W SL  L+L++N+LSGEIP+A+G L  +++LDLS NQFSG IPPEIG LKL TFN+SSN+
Sbjct:   519 WKSLITLSLSKNKLSGEIPRALGLLPRLLNLDLSENQFSGGIPPEIGSLKLTTFNVSSNR 578

Query:   532 LYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHXXXXXXXXXX 591
             L G IP++ +NLAY+ SFLNNSNLC  NP+++LP C  + R S     K           
Sbjct:   579 LTGGIPEQLDNLAYERSFLNNSNLCADNPVLSLPDCRKQRRGSRGFPGKILAMILVIAVL 638

Query:   592 XXXXXXXXXWFVVRDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQ 651
                      +FVVRD  R++R R   TWKLTSFH++ F ES+I+S+L E  +IGSGGSG+
Sbjct:   639 LLTITLFVTFFVVRDYTRKQRRRGLETWKLTSFHRVDFAESDIVSNLMEHYVIGSGGSGK 698

Query:   652 VYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK 711
             VY+I +  +G+ VAVKRIW+++KL+QKLEKEFIAE+EILGTIRH+NIVKL CCIS E+SK
Sbjct:   699 VYKIFVESSGQCVAVKRIWDSKKLDQKLEKEFIAEVEILGTIRHSNIVKLLCCISREDSK 758

Query:   712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTP 771
             LLVYEY+E +SLD+WLHG+K+       +V  + L W  RL IA+GAAQGLCYMHHDCTP
Sbjct:   759 LLVYEYLEKRSLDQWLHGKKKG-----GTVEANNLTWSQRLNIAVGAAQGLCYMHHDCTP 813

Query:   772 QIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG-EPHTMSAVAGSFGYFAPEYAYTTK 830
              IIHRDVKSSNILLDSEF AKIADFGLAK+L KQ  EPHTMSAVAGSFGY APEYAYT+K
Sbjct:   814 AIIHRDVKSSNILLDSEFNAKIADFGLAKLLIKQNQEPHTMSAVAGSFGYIAPEYAYTSK 873

Query:   831 VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYL 890
             V+EKID+YSFGVVLLELVTG+E N GDEHT+LA+W+W+HY   KP  +A D+ I E    
Sbjct:   874 VDEKIDVYSFGVVLLELVTGREGNNGDEHTNLADWSWKHYQSGKPTAEAFDEDIKEASTT 933

Query:   891 EEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGY 950
             E MTTV++L L+CT+TLPS RPSMKEVL +LR+    E    KK   +   APLL +   
Sbjct:   934 EAMTTVFKLGLMCTNTLPSHRPSMKEVLYVLRQQ-GLE--ATKKTATEAYEAPLLVS--- 987

Query:   951 LFGFKRSKKVAAEEDNG 967
             L G + SK+V  +ED G
Sbjct:   988 LSGRRTSKRVE-DEDLG 1003

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1434 (509.9 bits), Expect = 8.1e-147, P = 8.1e-147
 Identities = 345/879 (39%), Positives = 495/879 (56%)

Query:    71 TFNSVTGISLRHKDITQKIPPII-CDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLS 129
             T +++  + L    +   IP  +  +L NL  +++S N++    P       KL++L+L+
Sbjct:   112 TCHNLISLDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLA 171

Query:   130 QNYFVGPIPSDIDRISGLQCIDLGGNNFS-GDIPRSIGRLSELQTLYLYMNEFNGTFPKE 188
              N+  G IP+ +  ++ L+ + L  N FS   IP  +G L+ELQ L+L      G  P  
Sbjct:   172 GNFLSGTIPASLGNVTTLKELKLAYNLFSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPS 231

Query:   189 IGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEIL 248
             +  L++L  L L +N       IP     LK ++ + +   +  GE+PE+M N+++L+  
Sbjct:   232 LSRLTSLVNLDLTFNQ--LTGSIPSWITQLKTVEQIELFNNSFSGELPESMGNMTTLKRF 289

Query:   249 ALNGNHLEGAIPSGXXXXXXXXXXXXYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSIP 307
               + N L G IP              ++N+L G +P S+   K L+++ L  N LTG +P
Sbjct:   290 DASMNKLTGKIPDNLNLLNLESLNL-FENMLEGPLPESITRSKTLSELKLFNNRLTGVLP 348

Query:   308 EEFGKLKNLQLLGLFSNHLSGEVPASI-G------VVAFENNLSGAVPKSLGNCRTLRTV 360
              + G    LQ + L  N  SGE+PA++ G      ++  +N+ SG +  +LG C++L  V
Sbjct:   349 SQLGANSPLQYVDLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRV 408

Query:   361 QLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKT---AWNLTRLEISNNRFSGQI 417
             +L +N+ SG++P G W    LS L LSDN+ +G +P KT   A NL+ L IS NRFSG I
Sbjct:   409 RLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTGSIP-KTIIGAKNLSNLRISKNRFSGSI 467

Query:   418 QRGVGSWKNLIVFKASNNLFSGEIPVEXXXXXXXXXXXXDGNKLSGKLPSQIVSWTSLNN 477
                +GS   +I    + N FSGEIP                N+LSG++P ++  W +LN 
Sbjct:   468 PNEIGSLNGIIEISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNE 527

Query:   478 LNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIP 537
             LNLA N LSGEIPK +G L V+  LDLS NQFSGEIP E+  LKLN  NLS N L G IP
Sbjct:   528 LNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIPLELQNLKLNVLNLSYNHLSGKIP 587

Query:   538 DEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHXXXXXXXXXXXXXXXX 597
               + N  Y   F+ N  LCV   +  L +  +R +N   +                    
Sbjct:   588 PLYANKIYAHDFIGNPGLCVD--LDGLCRKITRSKNIGYV----WILLTIFLLAGLVFVV 641

Query:   598 XXXWFVVRDC--LRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRI 655
                 F+ + C  LR  ++   A  K  SFH+L F+E  I   L E N+IG G SG+VY++
Sbjct:   642 GIVMFIAK-CRKLRALKSSTLAASKWRSFHKLHFSEHEIADCLDEKNVIGFGSSGKVYKV 700

Query:   656 DINGAGEFVAVKRIWNNRK------LNQKLEKE-FIAEIEILGTIRHANIVKLWCCISSE 708
             ++ G GE VAVK++  + K       +  L ++ F AE+E LGTIRH +IV+LWCC SS 
Sbjct:   701 ELRG-GEVVAVKKLNKSVKGGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSG 759

Query:   709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD 768
             + KLLVYEYM N SL   LHG ++  V         VL WP RL+IA+ AA+GL Y+HHD
Sbjct:   760 DCKLLVYEYMPNGSLADVLHGDRKGGV---------VLGWPERLRIALDAAEGLSYLHHD 810

Query:   769 CTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE--PHTMSAVAGSFGYFAPEYA 826
             C P I+HRDVKSSNILLDS++ AK+ADFG+AK+    G   P  MS +AGS GY APEY 
Sbjct:   811 CVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAPEYV 870

Query:   827 YTTKVNEKIDIYSFGVVLLELVTGKE---ANYGDEHTSLAEWAWRHYAEEKPITDALDKG 883
             YT +VNEK DIYSFGVVLLELVTGK+   +  GD+   +A+W      ++  +   +D  
Sbjct:   871 YTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGDK--DMAKWVCTAL-DKCGLEPVIDPK 927

Query:   884 IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
             + +  + EE++ V  + L+CTS LP +RPSM++V+ +L+
Sbjct:   928 L-DLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVVIMLQ 965

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1411 (501.8 bits), Expect = 2.2e-144, P = 2.2e-144
 Identities = 341/878 (38%), Positives = 479/878 (54%)

Query:    74 SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYF 133
             S+  + L    +T ++P  + D+  L  +DL+ N+  G+ P        L+ L L  N  
Sbjct:   109 SLQTLDLSQNLLTGELPQTLADIPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLL 168

Query:   134 VGPIPSDIDRISGLQCIDLGGNNFSGD-IPRSIGRLSELQTLYLYMNEFNGTFPKEIGDL 192
              G IP  +  IS L+ ++L  N FS   IP   G L+ L+ ++L      G  P  +G L
Sbjct:   169 DGTIPPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQL 228

Query:   193 SNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNG 252
             S L  L LA N       IP   G L  +  + +   +L GEIP  + NL SL +L  + 
Sbjct:   229 SKLVDLDLALNDLV--GHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASM 286

Query:   253 NHLEGAIPSGXXXXXXXXXXXXYDNILSGEIPSSVE-ALKLTDIDLSMNNLTGSIPEEFG 311
             N L G IP              Y+N L GE+P+S+  +  L +I +  N LTG +P++ G
Sbjct:   287 NQLTGKIPD-ELCRVPLESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLG 345

Query:   312 KLKNLQLLGLFSNHLSGEVPASI---G----VVAFENNLSGAVPKSLGNCRTLRTVQLYS 364
                 L+ L +  N  SG++PA +   G    ++   N+ SG +P+SL +CR+L  ++L  
Sbjct:   346 LNSPLRWLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAY 405

Query:   365 NRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKT---AWNLTRLEISNNRFSGQIQRGV 421
             NRFSG +PTG W   +++ L L +N+ SGE+ SK+   A NL+ L +SNN F+G +   +
Sbjct:   406 NRFSGSVPTGFWGLPHVNLLELVNNSFSGEI-SKSIGGASNLSLLILSNNEFTGSLPEEI 464

Query:   422 GSWKNLIVFKASNNLFSGEIPVEXXXXXXXXXXXXDGNKLSGKLPSQIVSWTSLNNLNLA 481
             GS  NL    AS N FSG +P               GN+ SG+L S I SW  LN LNLA
Sbjct:   465 GSLDNLNQLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLA 524

Query:   482 RNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFN 541
              NE +G+IP  IGSL V+  LDLSGN FSG+IP  +  LKLN  NLS N+L G++P    
Sbjct:   525 DNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSLKLNQLNLSYNRLSGDLPPSLA 584

Query:   542 NLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHXXXXXXXXXXXXXXXXXXXW 601
                Y +SF+ N  LC    I  L  C S   N  K                        W
Sbjct:   585 KDMYKNSFIGNPGLC--GDIKGL--CGSE--NEAKKRGYVWLLRSIFVLAAMVLLAGVAW 638

Query:   602 FVVR-DCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGA 660
             F  +    ++ R  + + W L SFH+LGF+E  IL SL E N+IG+G SG+VY++ +   
Sbjct:   639 FYFKYRTFKKARAMERSKWTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVLTN- 697

Query:   661 GEFVAVKRIWNNR-KLNQKLEKE-----------FIAEIEILGTIRHANIVKLWCCISSE 708
             GE VAVKR+W    K     + E           F AE+E LG IRH NIVKLWCC S+ 
Sbjct:   698 GETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTR 757

Query:   709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD 768
             + KLLVYEYM N SL   LH  K  +           L W TR +I + AA+GL Y+HHD
Sbjct:   758 DCKLLVYEYMPNGSLGDLLHSSKGGM-----------LGWQTRFKIILDAAEGLSYLHHD 806

Query:   769 CTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAY 827
               P I+HRD+KS+NIL+D ++ A++ADFG+AK +   G+ P +MS +AGS GY APEYAY
Sbjct:   807 SVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAY 866

Query:   828 TTKVNEKIDIYSFGVVLLELVTGK---EANYGDEHTSLAEWAWRHYAEEKPITDALDKGI 884
             T +VNEK DIYSFGVV+LE+VT K   +   G++   L +W      ++K I   +D  +
Sbjct:   867 TLRVNEKSDIYSFGVVILEIVTRKRPVDPELGEK--DLVKWVCSTL-DQKGIEHVIDPKL 923

Query:   885 AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
              + C+ EE++ +  + L+CTS LP +RPSM+ V+++L+
Sbjct:   924 -DSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQ 960

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 1320 (469.7 bits), Expect = 9.8e-135, P = 9.8e-135
 Identities = 306/858 (35%), Positives = 468/858 (54%)

Query:    99 LTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFS 158
             L  ++ S N++ G   E L N   L+ LDL  N+F G +PS    +  L+ + L GNN +
Sbjct:   142 LVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNLT 201

Query:   159 GDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGML 218
             G++P  +G+L  L+T  L  NEF G  P E G++++L+ L LA         IP E G L
Sbjct:   202 GELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGK--LSGEIPSELGKL 259

Query:   219 KKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGXXXXXXXXXXXXYDNI 278
             K L+TL + E N  G IP  + ++++L++L  + N L G IP                N 
Sbjct:   260 KSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNK 319

Query:   279 LSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASI--- 334
             LSG IP ++ +L +L  ++L  N L+G +P + GK   LQ L + SN  SGE+P+++   
Sbjct:   320 LSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNK 379

Query:   335 G----VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNT 390
             G    ++ F N  +G +P +L  C++L  V++ +N  +G +P G      L  L L+ N 
Sbjct:   380 GNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNR 439

Query:   391 ISGELPS--KTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEXXXX 448
             +SG +P     + +L+ ++ S N+    +   + S  NL  F  ++N  SGE+P +    
Sbjct:   440 LSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDC 499

Query:   449 XXXXXXXXDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQ 508
                       N L+G +PS I S   L +LNL  N L+GEIP+ I ++  +  LDLS N 
Sbjct:   500 PSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNS 559

Query:   509 FSGEIPPEIGQLK-LNTFNLSSNKLYGNIP-DEFNNLAYDDSFLNNSNLCVKNPIINLPK 566
              +G +P  IG    L   N+S NKL G +P + F      D    NS LC    +  LP 
Sbjct:   560 LTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLC--GGV--LPP 615

Query:   567 CPSRF-RNSDKISSKH------------XXXXXXXXXXXXXXXXXXXWFVVRDCLRRKRN 613
             C S+F R +   SS H                               W+    C     +
Sbjct:   616 C-SKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETAS 674

Query:   614 RDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNR 673
             +    W+L +FH+LGFT S+IL+ + ESN+IG G +G VY+ +++ +   +AVK++W + 
Sbjct:   675 KGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSA 734

Query:   674 K-LNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKR 732
               +      +F+ E+ +LG +RH NIV+L   + ++ + ++VYE+M N +L   +HG+  
Sbjct:   735 ADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKN- 793

Query:   733 SLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK 792
                +G     + ++ W +R  IA+G A GL Y+HHDC P +IHRD+KS+NILLD+   A+
Sbjct:   794 --AAG-----RLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDAR 846

Query:   793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK- 851
             IADFGLA+M+A++ E  T+S VAGS+GY APEY YT KV+EKIDIYS+GVVLLEL+TG+ 
Sbjct:   847 IADFGLARMMARKKE--TVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRR 904

Query:   852 --EANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYL-EEMTTVYRLALICTSTLP 908
               E  +G E   + EW  R   +   + +ALD  +    Y+ EEM  V ++AL+CT+ LP
Sbjct:   905 PLEPEFG-ESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLP 963

Query:   909 SSRPSMKEVLQILRRCCP 926
               RPSM++V+ +L    P
Sbjct:   964 KDRPSMRDVISMLGEAKP 981

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1289 (458.8 bits), Expect = 1.9e-131, P = 1.9e-131
 Identities = 318/852 (37%), Positives = 457/852 (53%)

Query:    96 LKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGN 155
             +  L T+D   NS  G  P  L   T+L++LDL  NYF G IP        L+ + L GN
Sbjct:   149 MTQLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGN 208

Query:   156 NFSGDIPRSIGRLSELQTLYL-YMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE 214
             +  G IP  +  ++ L  LYL Y N++ G  P + G L NL  L LA N + K + IP E
Sbjct:   209 DLRGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLA-NCSLKGS-IPAE 266

Query:   215 FGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGXXXXXXXXXXXX 274
              G LK L+ L++    L G +P  + N++SL+ L L+ N LEG IP              
Sbjct:   267 LGNLKNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNL 326

Query:   275 YDNILSGEIPSSVEALK-LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPAS 333
             + N L GEIP  V  L  L  + L  NN TG IP + G   NL  + L +N L+G +P S
Sbjct:   327 FFNRLHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPES 386

Query:   334 I--G-----VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLML 386
             +  G     ++ F N L G +P+ LG C  L   +L  N  + +LP GL    NLS L L
Sbjct:   387 LCFGRRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLEL 446

Query:   387 SDNTISGELPSKTAWN-----LTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEI 441
              +N ++GE+P + A N     LT++ +SNNR SG I   + + ++L +     N  SG+I
Sbjct:   447 QNNFLTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQI 506

Query:   442 PVEXXXXXXXXXXXXDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVS 501
             P E              N  SGK P +     SL  L+L+ N++SG+IP  I  + ++  
Sbjct:   507 PGEIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNY 566

Query:   502 LDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNLAY--DDSFLNNSNLC-- 556
             L++S N F+  +P E+G +K L + + S N   G++P      +Y  + SFL N  LC  
Sbjct:   567 LNVSWNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTS-GQFSYFNNTSFLGNPFLCGF 625

Query:   557 VKNPIINLP-KCPSRFRNSDKISSKHXXXXXXXXXXXXXXXXXXXWFVVRDCL--RRKRN 613
               NP      +  S+  N +   S+                     FVV   +  RR R 
Sbjct:   626 SSNPCNGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRK 685

Query:   614 RDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNR 673
              +P  WKL  F +LGF   +IL  + E+++IG GG G VY+  +   GE VAVK++    
Sbjct:   686 NNPNLWKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYK-GVMPNGEEVAVKKLLTIT 744

Query:   674 KLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRS 733
             K     +    AEI+ LG IRH NIV+L    S+++  LLVYEYM N SL   LHG+   
Sbjct:   745 K-GSSHDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGK--- 800

Query:   734 LVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI 793
                  + V    L W TRLQIA+ AA+GLCY+HHDC+P IIHRDVKS+NILL  EF+A +
Sbjct:   801 -----AGVF---LKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHV 852

Query:   794 ADFGLAK-MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE 852
             ADFGLAK M+   G    MS++AGS+GY APEYAYT +++EK D+YSFGVVLLEL+TG++
Sbjct:   853 ADFGLAKFMMQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRK 912

Query:   853 A--NYGDEHTSLAEWAW-RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPS 909
                N+G+E   + +W+  +     + +   +D+ ++    L E   ++ +A++C      
Sbjct:   913 PVDNFGEEGIDIVQWSKIQTNCNRQGVVKIIDQRLSN-IPLAEAMELFFVAMLCVQEHSV 971

Query:   910 SRPSMKEVLQIL 921
              RP+M+EV+Q++
Sbjct:   972 ERPTMREVVQMI 983

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048437 "floral organ development" evidence=IGI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1272 (452.8 bits), Expect = 1.2e-129, P = 1.2e-129
 Identities = 323/878 (36%), Positives = 471/878 (53%)

Query:    66 PEITCTFNSVTGISLRHKDITQKIPPIICD-LKNLTTIDLSSNSIPGEFPEFLYNCTKLQ 124
             PEI+ + + +  ++L +       P  I   L NL  +D+ +N++ G+ P  + N T+L+
Sbjct:   111 PEIS-SLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLR 169

Query:   125 NLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYL-YMNEFNG 183
             +L L  NYF G IP        ++ + + GN   G IP  IG L+ L+ LY+ Y N F  
Sbjct:   170 HLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFED 229

Query:   184 TFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLI-GEIPEAMSNL 242
               P EIG+LS L     A N       IP E G L+KL TL++ + N+  G +   +  L
Sbjct:   230 GLPPEIGNLSELVRFDGA-NCGLT-GEIPPEIGKLQKLDTLFL-QVNVFSGPLTWELGTL 286

Query:   243 SSLEILALNGNHLEGAIPSGXXXXXXXXXXXXYDNILSGEIPSSVEAL-KLTDIDLSMNN 301
             SSL+ + L+ N   G IP+             + N L GEIP  +  L +L  + L  NN
Sbjct:   287 SSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENN 346

Query:   302 LTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASI--G-----VVAFENNLSGAVPKSLGNC 354
              TGSIP++ G+   L L+ L SN L+G +P ++  G     ++   N L G++P SLG C
Sbjct:   347 FTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKC 406

Query:   355 RTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELP--SKTAWNLTRLEISNNR 412
              +L  +++  N  +G +P GL+    L+ + L DN +SGELP     + NL ++ +SNN+
Sbjct:   407 ESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQ 466

Query:   413 FSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEXXXXXXXXXXXXDGNKLSGKLPSQIVSW 472
              SG +   +G++  +       N F G IP E              N  SG++  +I   
Sbjct:   467 LSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRC 526

Query:   473 TSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNK 531
               L  ++L+RNELSGEIP  I ++ ++  L+LS N   G IP  I  ++ L + + S N 
Sbjct:   527 KLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNN 586

Query:   532 LYGNIPD--EFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHXXXXXXXX 589
             L G +P   +F+   Y  SFL N +LC   P +  P      +   +  SK         
Sbjct:   587 LSGLVPGTGQFSYFNYT-SFLGNPDLC--GPYLG-PCKDGVAKGGHQSHSKGPLSASMKL 642

Query:   590 XXXXXXXXXXXWFVVRDCLRR---KRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGS 646
                         F V   ++    K+  +   W+LT+F +L FT  ++L SL E N+IG 
Sbjct:   643 LLVLGLLVCSIAFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNIIGK 702

Query:   647 GGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCIS 706
             GG+G VY+  +   G+ VAVKR+    +     +  F AEI+ LG IRH +IV+L    S
Sbjct:   703 GGAGIVYK-GVMPNGDLVAVKRLAAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCS 760

Query:   707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMH 766
             +  + LLVYEYM N SL   LHG+K     G    H   LHW TR +IA+ AA+GLCY+H
Sbjct:   761 NHETNLLVYEYMPNGSLGEVLHGKK----GG----H---LHWDTRYKIALEAAKGLCYLH 809

Query:   767 HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYA 826
             HDC+P I+HRDVKS+NILLDS F+A +ADFGLAK L   G    MSA+AGS+GY APEYA
Sbjct:   810 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 869

Query:   827 YTTKVNEKIDIYSFGVVLLELVTGKE--ANYGDEHTSLAEWAWRHYAEEKP-ITDALDKG 883
             YT KV+EK D+YSFGVVLLELVTG++    +GD    + +W  +     K  +   LD  
Sbjct:   870 YTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDG-VDIVQWVRKMTDSNKDSVLKVLDPR 928

Query:   884 IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             ++    + E+T V+ +A++C       RP+M+EV+QIL
Sbjct:   929 LSS-IPIHEVTHVFYVAMLCVEEQAVERPTMREVVQIL 965

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

UNIPROTKB|Q5Z9N5 P0481E08.42 "Os06g0717200 protein" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 1271 (452.5 bits), Expect = 1.5e-129, P = 1.5e-129
 Identities = 314/853 (36%), Positives = 460/853 (53%)

Query:    98 NLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNF 157
             +L  ID  +N++ G  P F  +  +L+ L L  NYF G IP     ++ L+ + L GN  
Sbjct:   149 SLELIDAYNNNLSGLLPPFSASHARLRYLHLGGNYFTGAIPDSYGDLAALEYLGLNGNTL 208

Query:   158 SGDIPRSIGRLSELQTLYL-YMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFG 216
             SG +P S+ RL+ L+ +Y+ Y N+++G  P E GDL  L  L L  +S      +P E G
Sbjct:   209 SGHVPVSLSRLTRLREMYIGYYNQYDGGVPPEFGDLGAL--LRLDMSSCNLTGPVPPELG 266

Query:   217 MLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGXXXXXXXXXXXXYD 276
              L++L TL++    L GEIP  + +LSSL  L L+ N L G IP              + 
Sbjct:   267 RLQRLDTLFLQWNRLSGEIPPQLGDLSSLASLDLSVNDLAGEIPPSLANLSNLKLLNLFR 326

Query:   277 NILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASI- 334
             N L G IP  V    +L  + L  NNLTG+IP   GK   L+ L L +NHL+G +PA + 
Sbjct:   327 NHLRGSIPDFVAGFAQLEVLQLWDNNLTGNIPAGLGKNGRLKTLDLATNHLTGPIPADLC 386

Query:   335 -G-----VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSD 388
              G     +V  EN L G +P SLG+C+TL  V+L  N  +G +P GL+     + + L+D
Sbjct:   387 AGRRLEMLVLMENGLFGPIPDSLGDCKTLTRVRLAKNFLTGPVPAGLFNLPQANMVELTD 446

Query:   389 NTISGELPSKTAWN-LTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEXXX 447
             N ++GELP     + +  L + NN   G+I   +G+   L      +N FSG +P E   
Sbjct:   447 NLLTGELPDVIGGDKIGMLLLGNNGIGGRIPPAIGNLPALQTLSLESNNFSGALPPEIGN 506

Query:   448 XXXXXXXXXDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGN 507
                       GN L+G +P +++   SL  ++L+RN  SGEIP++I SL ++ +L++S N
Sbjct:   507 LKNLSRLNVSGNALTGAIPDELIRCASLAAVDLSRNGFSGEIPESITSLKILCTLNVSRN 566

Query:   508 QFSGEIPPEIGQL-KLNTFNLSSNKLYGNIPDEFNNLAYDDS-FLNNSNLCVKNPIINLP 565
             + +GE+PPE+  +  L T ++S N L G +P +   L +++S F+ N  LC   P+ +  
Sbjct:   567 RLTGELPPEMSNMTSLTTLDVSYNSLSGPVPMQGQFLVFNESSFVGNPGLC-GGPVADA- 624

Query:   566 KCPSRFRNS-----DKISSKHXXXXXXXXXXXXXXXXXXXWFVVRD-CL--RRKRNRDPA 617
              CP            ++  +                    +   R  C   R    R   
Sbjct:   625 -CPPSMAGGGGGAGSQLRLRWDSKKMLVALVAAFAAVAVAFLGARKGCSAWRSAARRRSG 683

Query:   618 TWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ 677
              WK+T+F +L F+  +++  + E N+IG GG+G VY     GA   +A+KR+        
Sbjct:   684 AWKMTAFQKLEFSAEDVVECVKEDNIIGKGGAGIVYHGVTRGAE--LAIKRLVGRG--GG 739

Query:   678 KLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSG 737
             + ++ F AE+  LG IRH NIV+L   +S+  + LL+YEYM N SL   LHG K     G
Sbjct:   740 EHDRGFSAEVTTLGRIRHRNIVRLLGFVSNRETNLLLYEYMPNGSLGEMLHGGK----GG 795

Query:   738 SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG 797
                 H   L W  R ++A  AA GLCY+HHDC P+IIHRDVKS+NILLDS F+A +ADFG
Sbjct:   796 ----H---LGWEARARVAAEAACGLCYLHHDCAPRIIHRDVKSNNILLDSAFEAHVADFG 848

Query:   798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE--ANY 855
             LAK L        MSA+AGS+GY APEYAYT +V+EK D+YSFGVVLLEL+TG+     +
Sbjct:   849 LAKFLGG-ATSECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELITGRRPVGGF 907

Query:   856 GDEHTSLAEWAWRHYAE--EKPITDAL----DKGIA-EPCYLEEMTTVYRLALICTSTLP 908
             GD    +  W  +  AE  +   T A+    D+ +  EP  L  M  +Y++A+ C     
Sbjct:   908 GDG-VDIVHWVRKVTAELPDNSDTAAVLAVADRRLTPEPVAL--MVNLYKVAMACVEEAS 964

Query:   909 SSRPSMKEVLQIL 921
             ++RP+M+EV+ +L
Sbjct:   965 TARPTMREVVHML 977

GO:0010080 "regulation of floral meristem growth" evidence=IMP

GO:0048833 "specification of floral organ number" evidence=IMP

TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1200 (427.5 bits), Expect = 1.6e-128, Sum P(2) = 1.6e-128
 Identities = 311/825 (37%), Positives = 437/825 (52%)

Query:    70 CTFNSVTGISLRHKDITQKI---PPIICD-LKNLTTIDLSSNSIPGEFPEFLYNCTKLQN 125
             C   ++  I+L   ++   I   P  +C  L+NL    L+ N+  G+ PEF     KL+ 
Sbjct:    95 CRIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLI---LNQNNFSGKLPEFSPEFRKLRV 151

Query:   126 LDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGT- 184
             L+L  N F G IP    R++ LQ ++L GN  SG +P  +G L+EL  L L    F+ + 
Sbjct:   152 LELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAYISFDPSP 211

Query:   185 FPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSS 244
              P  +G+LSNL  L L + SN     IP     L  L+ L +   +L GEIPE++  L S
Sbjct:   212 IPSTLGNLSNLTDLRLTH-SNLV-GEIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLES 269

Query:   245 LEILALNGNHLEGAIPSGXXXXXXXXXXXXYDNILSGEIPSSVEALKLTDIDLSMNNLTG 304
             +  + L  N L G +P                N L+GE+P  + AL+L   +L+ N  TG
Sbjct:   270 VYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQLISFNLNDNFFTG 329

Query:   305 SIPEEFGKLKNLQLLGLFSNHLSGEVPASIG----VVAFE---NNLSGAVPKSLGNCRTL 357
              +P+      NL    +F+N  +G +P ++G    +  F+   N  SG +P  L   R L
Sbjct:   330 GLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRKL 389

Query:   358 RTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNL--TRLEISNN-RFS 414
             + +  +SN+ SGE+P       +L+ + ++DN +SGE+P++  W L  TRLE++NN +  
Sbjct:   390 QKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARF-WELPLTRLELANNNQLQ 448

Query:   415 GQIQRGVGSWKNLIVFKASNNLFSGEIPVEXXXXXXXXXXXXDGNKLSGKLPSQIVSWTS 474
             G I   +   ++L   + S N FSG IPV+              N   G +PS I    +
Sbjct:   449 GSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKN 508

Query:   475 LNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLY 533
             L  + +  N L GEIP ++ S   +  L+LS N+  G IPPE+G L  LN  +LS+N+L 
Sbjct:   509 LERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLT 568

Query:   534 GNIPDEFNNLAYDDSFLNNSNLCVKNPI-----INLPKC---PSRFR-NSDKIS---SKH 581
             G IP E   L  +   ++++ L  K P      I  P     P+    N D I    SK 
Sbjct:   569 GEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPIRPCRSKR 628

Query:   582 XXXXXXXXXXX--XXXXXXXXWFVVRD--CLRRKRNRDPATWKLTSFHQLGFTESNILSS 637
                                  W  ++     +RK  R   T K+T F ++GFTE +I   
Sbjct:   629 ETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKR---TNKITIFQRVGFTEEDIYPQ 685

Query:   638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE--FIAEIEILGTIRH 695
             LTE N+IGSGGSG VYR+ +  +G+ +AVK++W   +  QK E E  F +E+E LG +RH
Sbjct:   686 LTEDNIIGSGGSGLVYRVKLK-SGQTLAVKKLWG--ETGQKTESESVFRSEVETLGRVRH 742

Query:   696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV--LHWPTRLQ 753
              NIVKL  C + E  + LVYE+MEN SL   LH  K          H+ V  L W TR  
Sbjct:   743 GNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKE---------HRAVSPLDWTTRFS 793

Query:   754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH---- 809
             IA+GAAQGL Y+HHD  P I+HRDVKS+NILLD E K ++ADFGLAK L ++        
Sbjct:   794 IAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDV 853

Query:   810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEAN 854
             +MS VAGS+GY APEY YT+KVNEK D+YSFGVVLLEL+TGK  N
Sbjct:   854 SMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPN 898

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2207036 AT1G72180 [Arabidopsis thaliana (taxid:3702)]

 Score = 1253 (446.1 bits), Expect = 1.2e-127, P = 1.2e-127
 Identities = 313/888 (35%), Positives = 477/888 (53%)

Query:    66 PEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQN 125
             P I+     ++ +SL    I+ +IPP I + KNL  ++L+SN + G  P  L     L+ 
Sbjct:    92 PSISA-LTKLSTLSLPSNFISGRIPPEIVNCKNLKVLNLTSNRLSGTIPN-LSPLKSLEI 149

Query:   126 LDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFS-GDIPRSIGRLSELQTLYLYMNEFNGT 184
             LD+S N+  G   S I  ++ L  + LG N++  G IP SIG L +L  L+L  +   G 
Sbjct:   150 LDISGNFLNGEFQSWIGNMNQLVSLGLGNNHYEEGIIPESIGGLKKLTWLFLARSNLTGK 209

Query:   185 FPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSS 244
              P  I DL+ L+   +A N+       PI    L  L  + +   +L G+IP  + NL+ 
Sbjct:   210 IPNSIFDLNALDTFDIANNAISDD--FPILISRLVNLTKIELFNNSLTGKIPPEIKNLTR 267

Query:   245 LEILALNGNHLEGAIPSGXXXXXXXXXXXXYDNILSGEIPSSVEALK-LTDIDLSMNNLT 303
             L    ++ N L G +P              ++N  +GE PS    L  LT + +  NN +
Sbjct:   268 LREFDISSNQLSGVLPEELGVLKELRVFHCHENNFTGEFPSGFGDLSHLTSLSIYRNNFS 327

Query:   304 GSIPEEFGKLKNLQLLGLFSNHLSGEVPASIG-------VVAFENNLSGAVPKSLGNCRT 356
             G  P   G+   L  + +  N  +G  P  +        ++A +N  SG +P+S G C++
Sbjct:   328 GEFPVNIGRFSPLDTVDISENEFTGPFPRFLCQNKKLQFLLALQNEFSGEIPRSYGECKS 387

Query:   357 LRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWN--LTRLEISNNRFS 414
             L  +++ +NR SG++  G W+      + LSDN ++GE+  +   +  L++L + NNRFS
Sbjct:   388 LLRLRINNNRLSGQVVEGFWSLPLAKMIDLSDNELTGEVSPQIGLSTELSQLILQNNRFS 447

Query:   415 GQIQRGVGSWKNLIVFKASNNLFSGEIPVEXXXXXXXXXXXXDGNKLSGKLPSQIVSWTS 474
             G+I R +G   N+     SNN  SGEIP+E            + N L+G +P ++ +   
Sbjct:   448 GKIPRELGRLTNIERIYLSNNNLSGEIPMEVGDLKELSSLHLENNSLTGFIPKELKNCVK 507

Query:   475 LNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYG 534
             L +LNLA+N L+GEIP ++  +  + SLD SGN+ +GEIP  + +LKL+  +LS N+L G
Sbjct:   508 LVDLNLAKNFLTGEIPNSLSQIASLNSLDFSGNRLTGEIPASLVKLKLSFIDLSGNQLSG 567

Query:   535 NIPDEFNNLAYDDSFLNNSNLCVK------NPIINLPKCPSRFRNSDKISSKHXXXXXXX 588
              IP +   +    +F  N  LCV       N  + L  C S ++N  + SS         
Sbjct:   568 RIPPDLLAVGGSTAFSRNEKLCVDKENAKTNQNLGLSIC-SGYQNVKRNSSLDGTLLFLA 626

Query:   589 XXXXX----XXXXXXXWFVVR----DCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTE 640
                             + VV+    D   R  N+  A WK+ SFHQ+      I   L E
Sbjct:   627 LAIVVVVLVSGLFALRYRVVKIRELDSENRDINKADAKWKIASFHQMELDVDEICR-LDE 685

Query:   641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE--KEFIAEIEILGTIRHANI 698
              ++IGSG +G+VYR+D+   G  VAVK  W  R   ++ +  +  +AE+EILG IRH N+
Sbjct:   686 DHVIGSGSAGKVYRVDLKKGGGTVAVK--WLKRGGGEEGDGTEVSVAEMEILGKIRHRNV 743

Query:   699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
             +KL+ C+    S+ LV+E+MEN +L + L G     + G        L W  R +IA+GA
Sbjct:   744 LKLYACLVGRGSRYLVFEFMENGNLYQAL-GNN---IKGGLPE----LDWLKRYKIAVGA 795

Query:   759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
             A+G+ Y+HHDC P IIHRD+KSSNILLD ++++KIADFG+AK+ A +G  +  S VAG+ 
Sbjct:   796 AKGIAYLHHDCCPPIIHRDIKSSNILLDGDYESKIADFGVAKV-ADKG--YEWSCVAGTH 852

Query:   819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG---KEANYGDEHTSLAEWAWRHYAEE-K 874
             GY APE AY+ K  EK D+YSFGVVLLELVTG    E  +G E   + ++ +    ++ +
Sbjct:   853 GYMAPELAYSFKATEKSDVYSFGVVLLELVTGLRPMEDEFG-EGKDIVDYVYSQIQQDPR 911

Query:   875 PITDALDKGIAEPCYLEE-MTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              + + LDK +    Y+EE M  V ++ L+CT+ LP+ RPSM+EV++ L
Sbjct:   912 NLQNVLDKQVLST-YIEESMIRVLKMGLLCTTKLPNLRPSMREVVRKL 958

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 691 (248.3 bits), Expect = 1.8e-127, Sum P(2) = 1.8e-127
 Identities = 171/537 (31%), Positives = 267/537 (49%)

Query:    36 ERTILLN-LKQQLGNPPSLQ--SWTST-SSPCD-WPEITCTFNS-VTGISLRHKDITQKI 89
             E +IL + L      P SL   +W S  ++PC+ W  ITC+    +T I +    +   +
Sbjct:    38 EASILYSWLHSSSPTPSSLSLFNWNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSL 97

Query:    90 PPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQC 149
             P  +   ++L  + +S  ++ G  PE L +C  L+ LDLS N  VG IP  + ++  L+ 
Sbjct:    98 PKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLET 157

Query:   150 IDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPA 209
             + L  N  +G IP  I + S+L++L L+ N   G+ P E+G LS LEV+ +  N      
Sbjct:   158 LILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEIS-G 216

Query:   210 MIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGXXXXXXX 269
              IP E G    L  L + E ++ G +P ++  L  LE L++    + G IPS        
Sbjct:   217 QIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSEL 276

Query:   270 XXXXXYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSG 328
                  Y+N LSG IP  +  L KL  + L  N+L G IPEE G   NL+++ L  N LSG
Sbjct:   277 VDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSG 336

Query:   329 EVPASIGVVAF-------ENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNL 381
              +P+SIG ++F       +N  SG++P ++ NC +L  +QL  N+ SG +P+ L T   L
Sbjct:   337 SIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKL 396

Query:   382 SSLMLSDNTISGELPSKTA--WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSG 439
             +      N + G +P   A   +L  L++S N  +G I  G+   +NL      +N  SG
Sbjct:   397 TLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSG 456

Query:   440 EIPVEXXXXXXXXXXXXDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVM 499
              IP E              N+++G++PS I S   +N L+ + N L G++P  IGS   +
Sbjct:   457 FIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSEL 516

Query:   500 VSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNL 555
               +DLS N   G +P  +  L  L   ++S+N+  G IP     L   +  + + NL
Sbjct:   517 QMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNL 573

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	969
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-130
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-98
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-40
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-33
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-32
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-29
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-25
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-22
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-21
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-20
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-20
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	2e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.001
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.002
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  416 bits (1070), Expect = e-130
 Identities = 302/853 (35%), Positives = 438/853 (51%), Gaps = 72/853 (8%)

Query: 85  ITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRI 144
           ++ +IP  I    +L  +DL  N + G+ P  L N T L+ L L+ N  VG IP ++ ++
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211

Query: 145 SGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNS 204
             L+ I LG NN SG+IP  IG L+ L  L L  N   G  P  +G+L NL+ L L  N 
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNK 271

Query: 205 NFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLF 264
              P  IP     L+KL +L +++ +L GEIPE +  L +LEIL L  N+  G IP  L 
Sbjct: 272 LSGP--IPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329

Query: 265 LLNNLTQLFLYDNILSGEIPSSV-EALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFS 323
            L  L  L L+ N  SGEIP ++ +   LT +DLS NNLTG IPE      NL  L LFS
Sbjct: 330 SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS 389

Query: 324 NHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSS 383
           N L GE                 +PKSLG CR+LR V+L  N FSGELP+       +  
Sbjct: 390 NSLEGE-----------------IPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432

Query: 384 LMLSDNTISGELPSKTAWNLTRLE---ISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGE 440
           L +S+N + G + S+  W++  L+   ++ N+F G +    GS K L     S N FSG 
Sbjct: 433 LDISNNNLQGRINSRK-WDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGA 490

Query: 441 IPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMV 500
           +P +L SLS L  L L  NKLSG++P ++ S   L +L+L+ N+LSG+IP +   + V+ 
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550

Query: 501 SLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNLAYDDSFL-NNSNLCVK 558
            LDLS NQ SGEIP  +G ++ L   N+S N L+G++P     LA + S +  N +LC  
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610

Query: 559 NPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRKR-NRDPA 617
           +    LP C  R R +      ++   L   +++ LV     +   R+ L  KR   +  
Sbjct: 611 DTTSGLPPC-KRVRKT-PSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG 668

Query: 618 TWKLTSFHQ---LGFTESNILSSLTESNLIGSGGSGQVYR-IDINGAGEFVAVKRIWNNR 673
           TW+L  F        T ++ILSSL E N+I  G  G  Y+   I    +FV VK I    
Sbjct: 669 TWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFV-VKEI---N 724

Query: 674 KLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRS 733
            +N  +    IA+   +G ++H NIVKL     SE    L++EY+E ++L   L      
Sbjct: 725 DVNS-IPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---- 776

Query: 734 LVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI 793
                       L W  R +IAIG A+ L ++H  C+P ++  ++    I++D + +  +
Sbjct: 777 ------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Query: 794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK-- 851
               L  +L    +    SA      Y APE   T  + EK DIY FG++L+EL+TGK  
Sbjct: 825 R-LSLPGLLCTDTKCFISSA------YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Query: 852 -EANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYL--EEMTTVYRLALICTSTLP 908
            +A +G  H S+ EWA R+   +  +   +D  I     +   E+  V  LAL CT+T P
Sbjct: 878 ADAEFG-VHGSIVEWA-RYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDP 935

Query: 909 SSRPSMKEVLQIL 921
           ++RP   +VL+ L
Sbjct: 936 TARPCANDVLKTL 948

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  329 bits (845), Expect = 9e-98
 Identities = 207/538 (38%), Positives = 304/538 (56%), Gaps = 33/538 (6%)

Query: 12  PVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNP-PSLQSWTSTSSPCDWPEITC 70
           P  + +L  L + F ++    + EE  +LL+ K  + +P   L +W S++  C W  ITC
Sbjct: 10  PYLIFMLFFLFLNFSML----HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITC 65

Query: 71  T-FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFP-EFLYNCTKLQNLDL 128
              + V  I L  K+I+ KI   I  L  + TI+LS+N + G  P +     + L+ L+L
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 129 SQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKE 188
           S N F G IP     I  L+ +DL  N  SG+IP  IG  S L+ L L  N   G  P  
Sbjct: 126 SNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183

Query: 189 IGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEIL 248
           + +L++LE L LA  SN     IP E G +K LK +++   NL GEIP  +  L+SL  L
Sbjct: 184 LTNLTSLEFLTLA--SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHL 241

Query: 249 ALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIP 307
            L  N+L G IPS L  L NL  LFLY N LSG IP S+ +L KL  +DLS N+L+G IP
Sbjct: 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Query: 308 EEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRF 367
           E   +L+NL++L LFSN+ +G++P ++           ++P+       L+ +QL+SN+F
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVAL----------TSLPR-------LQVLQLWSNKF 344

Query: 368 SGELPTGLWTTFNLSSLMLSDNTISGELPSK--TAWNLTRLEISNNRFSGQIQRGVGSWK 425
           SGE+P  L    NL+ L LS N ++GE+P    ++ NL +L + +N   G+I + +G+ +
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404

Query: 426 NLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNEL 485
           +L   +  +N FSGE+P E T L  +  L +  N L G++ S+     SL  L+LARN+ 
Sbjct: 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464

Query: 486 SGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNKLYGNIPDEFNN 542
            G +P + GS   + +LDLS NQFSG +P ++G L +L    LS NKL G IPDE ++
Sbjct: 465 FGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS 521

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  158 bits (403), Expect = 4e-44
 Identities = 77/206 (37%), Positives = 103/206 (50%), Gaps = 21/206 (10%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G GG G VY       G+ VA+K I   ++ +  L +E + EIEIL  + H NIVKL+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
               EN   LV EY E  SL   L   +              L     L+I +   +GL 
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEG------------KLSEDEILRILLQILEGLE 106

Query: 764 YMHHDCTPQIIHRDVKSSNILLDS-EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
           Y+H +    IIHRD+K  NILLDS   K K+ADFGL+K+L        +  + G+  Y A
Sbjct: 107 YLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMA 161

Query: 823 PE-YAYTTKVNEKIDIYSFGVVLLEL 847
           PE        +EK DI+S GV+L EL
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  155 bits (395), Expect = 1e-42
 Identities = 84/281 (29%), Positives = 123/281 (43%), Gaps = 38/281 (13%)

Query: 642 NLIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
             +G G  G+VY   D    G+ VA+K I   +K  +K  +  + EI+IL  ++H NIV+
Sbjct: 5   EKLGEGSFGKVYLARDKKT-GKLVAIKVI--KKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+     E+   LV EY E   L   L  ++  L   S    +  L      QI      
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRL---SEDEARFYLR-----QIL----S 108

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H      I+HRD+K  NILLD +   K+ADFGLA+ L        ++   G+  Y
Sbjct: 109 ALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEY 162

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE        + +DI+S GV+L EL+TGK    GD+        ++   + KP     
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLE---LFKKIGKPKPPFPPP 219

Query: 881 DKGIAEPCYLEEMTTVYRLALI--CTSTLPSSRPSMKEVLQ 919
           +  I+               LI       P  R + +E LQ
Sbjct: 220 EWDISPEA----------KDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  149 bits (378), Expect = 2e-40
 Identities = 76/214 (35%), Positives = 100/214 (46%), Gaps = 30/214 (14%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +GSG  G VY+       G+ VAVK +   R    K ++    EI IL  + H NIV+L 
Sbjct: 7   LGSGSFGTVYKAKHKGT-GKIVAVKIL-KKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                ++   LV EY E   L  +L                  L      +IA+   +GL
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-------------LSEDEAKKIALQILRGL 111

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H +    IIHRD+K  NILLD     KIADFGLAK L K      ++   G+  Y A
Sbjct: 112 EYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPWYMA 166

Query: 823 PE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE       Y  KV    D++S GV+L EL+TGK
Sbjct: 167 PEVLLGGNGYGPKV----DVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  147 bits (374), Expect = 8e-40
 Identities = 81/296 (27%), Positives = 127/296 (42%), Gaps = 51/296 (17%)

Query: 638 LTESNLIGSGGSGQVYR---IDINGA-GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
           LT    +G G  G+VY+       G     VAVK +  +    Q   +EF+ E  I+  +
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKL 58

Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
            H N+VKL    + E    +V EYME   L  +L  RK          ++  L     L 
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RK----------NRPKLSLSDLLS 106

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG---EPHT 810
            A+  A+G+ Y+        IHRD+ + N L+      KI+DFGL++ L       +   
Sbjct: 107 FALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG 163

Query: 811 MSAVAGSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEW 865
              +     + APE      +T+K     D++SFGV+L E+ T G++   G  +  + E+
Sbjct: 164 KLPIR----WMAPESLKEGKFTSKS----DVWSFGVLLWEIFTLGEQPYPGMSNEEVLEY 215

Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
               Y   +P            C  E    +Y L L C +  P  RP+  E+++IL
Sbjct: 216 LKNGYRLPQP----------PNCPPE----LYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  144 bits (367), Expect = 8e-39
 Identities = 82/295 (27%), Positives = 125/295 (42%), Gaps = 48/295 (16%)

Query: 638 LTESNLIGSGGSGQVYR----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
           LT    +G G  G+VY+       +G    VAVK +  +    Q   +EF+ E  I+  +
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKL 58

Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
            H NIVKL    + E   ++V EYM    L  +L   +              L     L 
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-----------KELSLSDLLS 107

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            A+  A+G+ Y+        IHRD+ + N L+      KI+DFGL++ L           
Sbjct: 108 FALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD---DYYKV 161

Query: 814 VAGSFGYF--APE----YAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA 866
             G       APE      +T+K     D++SFGV+L E+ T G+E   G  +  + E+ 
Sbjct: 162 KGGKLPIRWMAPESLKEGKFTSKS----DVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217

Query: 867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            + Y   KP            C  E    +Y+L L C +  P  RP+  E+++IL
Sbjct: 218 KKGYRLPKP----------PNCPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  140 bits (356), Expect = 3e-37
 Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 25/284 (8%)

Query: 642 NLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
             +G G  G+VY+      +G    VAVK +  +    ++  K+F+ E  ++  + H N+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNV 58

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+L    + E    LV EYME   L  +L   +    S   S     L     L  AI  
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKS----TLSLKDLLSFAIQI 114

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A+G+ Y+      + +HRD+ + N L+  +   KI+DFGL++ +         +      
Sbjct: 115 AKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            + APE         K D++SFGV+L E+ T     Y     S  E           + +
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG--LSNEE-----------VLE 218

Query: 879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            L KG   P        +Y L L C    P  RP+  E+++ L 
Sbjct: 219 YLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  138 bits (351), Expect = 1e-36
 Identities = 71/220 (32%), Positives = 106/220 (48%), Gaps = 25/220 (11%)

Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE---FIAEIEILGTI 693
             T   L+G G  G VY       GE +AVK +    +L+   E+E      EI IL ++
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV----ELSGDSEEELEALEREIRILSSL 56

Query: 694 RHANIVK-LWCCISSENSKLLVY-EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
           +H NIV+        E + L ++ EY+   SL         SL+     + + V+   TR
Sbjct: 57  QHPNIVRYYGSERDEEKNTLNIFLEYVSGGSL--------SSLLKKFGKLPEPVIRKYTR 108

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
            QI     +GL Y+H   +  I+HRD+K +NIL+DS+   K+ADFG AK L         
Sbjct: 109 -QIL----EGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160

Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            +V G+  + APE     +     DI+S G  ++E+ TGK
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  138 bits (350), Expect = 1e-36
 Identities = 73/212 (34%), Positives = 105/212 (49%), Gaps = 29/212 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI-AEIEILGTIRHANIVKLW 702
           IG GG G+VY+      G+ VA+K I    KL  K +KE I  EI+IL   +H NIVK +
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVI----KLESKEKKEKIINEIQILKKCKHPNIVKYY 63

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA---IGAA 759
                ++   +V E+    SL   L    ++L               T  QIA       
Sbjct: 64  GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTL---------------TESQIAYVCKELL 108

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           +GL Y+H   +  IIHRD+K++NILL S+ + K+ DFGL+  L+     +TM    G+  
Sbjct: 109 KGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPY 162

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           + APE       + K DI+S G+  +EL  GK
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  135 bits (342), Expect = 1e-35
 Identities = 74/296 (25%), Positives = 120/296 (40%), Gaps = 50/296 (16%)

Query: 638 LTESNLIGSGGSGQVYRIDINGAGEF----VAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
           L     +G G  G+VY+  + G GE     VAVK +      +++  +EF+ E  I+  +
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL 58

Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
            H NIV+L    +      +V EYM    L  +L                  L     LQ
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK------------LTLKDLLQ 106

Query: 754 IAIGAAQGLCYMH-HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
           +A+  A+G+ Y+   +     +HRD+ + N L+      KI+DFGL++ + +        
Sbjct: 107 MALQIAKGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY----- 157

Query: 813 AVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW 867
                 G       APE     K   K D++SFGV+L E+ T      G++         
Sbjct: 158 YRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFT-----LGEQ--------- 203

Query: 868 RHYAEEKP--ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             Y       + + L+ G   P        +Y L L C +  P  RP+  E+++ L
Sbjct: 204 -PYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  133 bits (338), Expect = 7e-35
 Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 57/293 (19%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             IG G  G+VY +     G+   +K I +   +++K  ++ + E++IL  + H NI+K 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +     +    +V EY +   L + +  +K+          Q +L W    Q+ +     
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKE--GKPFPEEQ-ILDWFV--QLCLA---- 115

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA---VAGSF 818
           L Y+H     +I+HRD+K  NI L S    K+ DFG++K+L+      T+     V G+ 
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-----STVDLAKTVVGTP 167

Query: 819 GYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR----HY 870
            Y +PE      Y    N K DI+S G VL EL T K    G+   +L E A +     Y
Sbjct: 168 YYLSPELCQNKPY----NYKSDIWSLGCVLYELCTLKHPFEGE---NLLELALKILKGQY 220

Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTL---PSSRPSMKEVLQI 920
               PI            Y  E+        + +S L   P  RPS+ ++LQ 
Sbjct: 221 ---PPI---------PSQYSSELRN------LVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 2e-33
 Identities = 72/215 (33%), Positives = 113/215 (52%), Gaps = 27/215 (12%)

Query: 641 SNLIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
            +LIG G  G VY+ +++   G+FVA+K+I   +   + L K  + EI++L  ++H NIV
Sbjct: 5   GDLIGRGAFGVVYKGLNLE-TGDFVAIKQISLEKIKEEAL-KSIMQEIDLLKNLKHPNIV 62

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWL--HGR-KRSLVSGSSSVHQHVLHWPTRLQIAI 756
           K    I + +S  ++ EY EN SL + +   G    SLV+    V+Q VL          
Sbjct: 63  KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA--VYVYQ-VL---------- 109

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              QGL Y+H      +IHRD+K++NIL   +   K+ADFG+A  L    +     +V G
Sbjct: 110 ---QGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA--SVVG 161

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +  + APE    +  +   DI+S G  ++EL+TG 
Sbjct: 162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  134 bits (339), Expect = 5e-32
 Identities = 109/340 (32%), Positives = 157/340 (46%), Gaps = 27/340 (7%)

Query: 66  PEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQN 125
           PE+     ++  + L   + T KIP  +  L  L  + L SN   GE P+ L     L  
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360

Query: 126 LDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTF 185
           LDLS N   G IP  +     L  + L  N+  G+IP+S+G    L+ + L  N F+G  
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420

Query: 186 PKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSL 245
           P E   L  +  L ++ N+N +  +   ++ M   L+ L +      G +P++      L
Sbjct: 421 PSEFTKLPLVYFLDIS-NNNLQGRINSRKWDM-PSLQMLSLARNKFFGGLPDS-FGSKRL 477

Query: 246 EILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTG 304
           E L L+ N   GA+P  L  L+ L QL L +N LSGEIP  + + K L  +DLS N L+G
Sbjct: 478 ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSG 537

Query: 305 SIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYS 364
            IP  F ++  L  L L  N LSGE                 +PK+LGN  +L  V +  
Sbjct: 538 QIPASFSEMPVLSQLDLSQNQLSGE-----------------IPKNLGNVESLVQVNISH 580

Query: 365 NRFSGELP-TGLWTTFNLSS-----LMLSDNTISGELPSK 398
           N   G LP TG +   N S+      +   +T SG  P K
Sbjct: 581 NHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCK 620

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  130 bits (329), Expect = 8e-31
 Identities = 77/204 (37%), Positives = 114/204 (55%), Gaps = 2/204 (0%)

Query: 342 NLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTT-FNLSSLMLSDNTISGELPSKTA 400
           N+SG +  ++     ++T+ L +N+ SG +P  ++TT  +L  L LS+N  +G +P  + 
Sbjct: 80  NISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSI 139

Query: 401 WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNK 460
            NL  L++SNN  SG+I   +GS+ +L V     N+  G+IP  LT+L+ L  L L  N+
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199

Query: 461 LSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL 520
           L G++P ++    SL  + L  N LSGEIP  IG L  +  LDL  N  +G IP  +G L
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259

Query: 521 K-LNTFNLSSNKLYGNIPDEFNNL 543
           K L    L  NKL G IP    +L
Sbjct: 260 KNLQYLFLYQNKLSGPIPPSIFSL 283

Length = 968

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  118 bits (298), Expect = 2e-29
 Identities = 87/295 (29%), Positives = 132/295 (44%), Gaps = 27/295 (9%)

Query: 638 LTESNLIGSGGSGQVY--RIDI--NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
           L     +G G  G+V   R D   +  GE VAVK +  N    ++   +F  EIEIL T+
Sbjct: 6   LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTL 63

Query: 694 RHANIVKL--WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
            H NIVK    C      S  L+ EY+ + SL  +L              H+  ++    
Sbjct: 64  DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR------------HRDQINLKRL 111

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
           L  +    +G+ Y+    + + IHRD+ + NIL++SE   KI+DFGLAK+L +  + + +
Sbjct: 112 LLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV 168

Query: 812 SAVAGS--FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                S  F Y APE   T+K +   D++SFGV L EL T  + +       L       
Sbjct: 169 KEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ 227

Query: 870 YAEE-KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
                  + + L +G   P        VY L  +C    P  RPS  +++ I+ R
Sbjct: 228 GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 1e-28
 Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 37/219 (16%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-------FIAEIEILGTIRHA 696
           IG G  GQVY+      GE VA+K+I        ++E E        I EI++L  +RH 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI--------RMENEKEGFPITAIREIKLLQKLRHP 58

Query: 697 NIVKLWCCISSE--NSKLLVYEYMENQSLD-RWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           NIV+L   ++S+   S  +V+EYM++   D   L        +        +  +    Q
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFT-----ESQIKCY--MKQ 108

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
           +     +GL Y+H +    I+HRD+K SNIL++++   K+ADFGLA+   K+      + 
Sbjct: 109 L----LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR 161

Query: 814 VAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
           V  +  Y  PE     T+   ++D++S G +L EL  GK
Sbjct: 162 VI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  113 bits (284), Expect = 2e-27
 Identities = 87/302 (28%), Positives = 132/302 (43%), Gaps = 65/302 (21%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G SG+VY+      G+ VA+K++    +L ++ ++  I EI I+   +H NIV  + 
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKM----RLRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS-SSVHQHVLHWPTRLQIAIGAAQGL 762
                +   +V EYM+  SL   +      +     + V + VL             QGL
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-------------QGL 129

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ--------GEPHTMSAV 814
            Y+H   +  +IHRD+KS NILL  +   K+ADFG A  L K+        G P+ M   
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM--- 183

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
                  APE         K+DI+S G++ +E+  G+                  Y  E 
Sbjct: 184 -------APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP----------------YLREP 220

Query: 875 PITDAL----DKGIAEPCYLEEMTTVYR--LALICTSTLPSSRPSMKEVLQ--ILRRCCP 926
           P+  AL     KGI      E+ +  ++  L   C    P  RPS +E+LQ   L++ CP
Sbjct: 221 PLR-ALFLITTKGIPPLKNPEKWSPEFKDFLNK-CLVKDPEKRPSAEELLQHPFLKKACP 278

Query: 927 TE 928
            E
Sbjct: 279 KE 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (276), Expect = 1e-26
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 35/216 (16%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G SG VY++     G+  A+K+I  +   +++  K+ + E++ L +     +VK + 
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL--QIAIGAAQG 761
               E    +V EYM+  SL                 + + V   P  +   IA    +G
Sbjct: 67  AFYKEGEISIVLEYMDGGSLA---------------DLLKKVGKIPEPVLAYIARQILKG 111

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H      IIHRD+K SN+L++S+ + KIADFG++K+L    +    + V G+  Y 
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFV-GTVTYM 167

Query: 822 APE------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +PE      Y+Y        DI+S G+ LLE   GK
Sbjct: 168 SPERIQGESYSYAA------DIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  112 bits (280), Expect = 2e-26
 Identities = 83/287 (28%), Positives = 119/287 (41%), Gaps = 29/287 (10%)

Query: 643 LIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA-NIVK 700
            +G G  G+VY   D     + VA+K +    +   K  + F+ EI+IL ++ H  NIVK
Sbjct: 7   KLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+     E S  LV EY++  SL+  L    R      S            L I      
Sbjct: 63  LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEA----------LFILAQILS 112

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLA----KQGEPHTMSAVA 815
            L Y+H   +  IIHRD+K  NILLD +    K+ DFGLAK+L         P   S   
Sbjct: 113 ALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 816 GSFGYFAPEYA---YTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE 872
           G+ GY APE          +   DI+S G+ L EL+TG     G++++S      +   E
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229

Query: 873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
               T +L   ++             L     +  P +R S    L 
Sbjct: 230 LP--TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 1e-25
 Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 50/291 (17%)

Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
            L     IG G  G V   D    G+ VAVK +    K +    + F+AE  ++ T+RH 
Sbjct: 7   ELKLGATIGKGEFGDVMLGDY--RGQKVAVKCL----KDDSTAAQAFLAEASVMTTLRHP 60

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           N+V+L   +   N   +V EYM   SL  +L  R R++++ +            +L  A+
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA-----------QQLGFAL 109

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              +G+ Y+        +HRD+ + N+L+  +  AK++DFGLAK  ++  +       +G
Sbjct: 110 DVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-------SG 159

Query: 817 SF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
                + APE     K + K D++SFG++L E+ +     Y      L +          
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKD---------- 207

Query: 875 PITDALDKGI----AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            +   ++KG      E C  E    VY++   C    P+ RP+ K++ + L
Sbjct: 208 -VVPHVEKGYRMEAPEGCPPE----VYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  107 bits (269), Expect = 1e-25
 Identities = 86/294 (29%), Positives = 131/294 (44%), Gaps = 35/294 (11%)

Query: 644 IGSGGSGQV--YRIDIN--GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +G G  G+V  Y  D    G GE VAVK +   R+  Q+    +  EI IL T+ H NIV
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTL--KRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 700 KLWCCISSENSK--LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           K   C S +  K   L+ EY+   SL  +L   K +L                  Q+ + 
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA-----------------QLLLF 112

Query: 758 AAQ---GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           A Q   G+ Y+H   +   IHRD+ + N+LLD++   KI DFGLAK + +  E + +   
Sbjct: 113 AQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169

Query: 815 AGS-FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW--AWRHYA 871
             S   ++A E     K +   D++SFGV L EL+T  ++          E     +   
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFEEMIGPKQGQM 228

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC 925
               + + L++G+  PC       VY L   C  T    RP+ + ++ IL+   
Sbjct: 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  106 bits (266), Expect = 2e-25
 Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 28/212 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G SG V ++     G+ +AVK I    ++N+ ++K+ + E++IL       IV  + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
              +     +  EYM+  SLD+ L       V G   + + +L      +IA+   +GL 
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKIL-----KEVQGR--IPERILG-----KIAVAVLKGLT 114

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML----AKQGEPHTMSAVAGSFG 819
           Y+H     +IIHRDVK SNIL++S  + K+ DFG++  L    AK           G+  
Sbjct: 115 YLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--------TFVGTSS 164

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y APE       + K DI+S G+ L+EL TG+
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  105 bits (264), Expect = 5e-25
 Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 36/291 (12%)

Query: 644 IGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V+      ++     E VAVK +      +    K+F  E E+L   +H NI
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAELLTNFQHENI 70

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           VK +   +  +  ++V+EYME+  L+++L  HG   + +    S     L     LQIA+
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQIAV 129

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG----EPHTMS 812
             A G+ Y+    +   +HRD+ + N L+  +   KI DFG+++ +          HTM 
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYA 871
            +     +  PE     K   + D++SFGVVL E+ T GK+  YG  +  + E       
Sbjct: 187 PIR----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC------ 236

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
               IT          C     + VY + L C    P  R ++K++ + L+
Sbjct: 237 ----ITQGRLLQRPRTC----PSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  104 bits (261), Expect = 8e-25
 Identities = 79/292 (27%), Positives = 142/292 (48%), Gaps = 34/292 (11%)

Query: 636 SSLTESNLIGSGGSGQVYR--IDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           S +T+  +IG+G  G+V+R  + + G  E  VA+K +       +K  ++F++E  I+G 
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEASIMGQ 62

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H NI++L   ++     +++ EYMEN +LD++L         G  S +Q V       
Sbjct: 63  FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH-----DGEFSSYQLV------- 110

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE-PHTM 811
            +  G A G+ Y+        +HRD+ + NIL++S  + K++DFGL+++L    E  +T 
Sbjct: 111 GMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT 167

Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA 871
           S       + APE     K     D++SFG+V+ E+++  E  Y           W    
Sbjct: 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY-----------WDMSN 216

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            E  +  A++ G   P  ++  + VY+L L C     + RP   +++ +L +
Sbjct: 217 HE--VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-24
 Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 36/217 (16%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLE---KEFIAEIEILGTIRHANIV 699
           +G G  G VY+  D    GE VA+K+I    +L+ + E      + EI +L  ++H NIV
Sbjct: 7   LGEGTYGVVYKARDKKT-GEIVALKKI----RLDNEEEGIPSTALREISLLKELKHPNIV 61

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           KL   I +E    LV+EY +   L ++L  R   L   S ++ + ++      Q+     
Sbjct: 62  KLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPL---SPNLIKSIM-----YQLL---- 108

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           +GL Y H     +I+HRD+K  NIL++ +   K+ADFGLA+  A      T +    +  
Sbjct: 109 RGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR--AFGIPLRTYTHEVVTLW 163

Query: 820 YFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y APE       Y+T V    DI+S G +  E++TGK
Sbjct: 164 YRAPEILLGSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (260), Expect = 2e-24
 Identities = 83/288 (28%), Positives = 128/288 (44%), Gaps = 41/288 (14%)

Query: 641 SNLIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
            N IG G  G+VY  ++++  GE +AVK I   +  + K  KE   E+++L  ++H N+V
Sbjct: 5   GNKIGGGTFGKVYTAVNLD-TGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 700 KLWCCISSENSKLLVY-EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           K +  +     K+ ++ EY    +L+  L    R L        +HV+   T LQ+  G 
Sbjct: 63  KYYG-VEVHREKVYIFMEYCSGGTLEELLEH-GRIL-------DEHVIRVYT-LQLLEG- 111

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG--EPHTMSAVAG 816
              L Y+H   +  I+HRD+K +NI LD     K+ DFG A  L          + ++AG
Sbjct: 112 ---LAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165

Query: 817 SFGYFAPEYAYTTKVNEK---IDIYSFGVVLLELVTGKEANYGDEHTSLAEWA--WRHYA 871
           +  Y APE     K        DI+S G V+LE+ TGK      ++    E+   +   A
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQIMFHVGA 221

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
             KP           P  L+           C  + P  RP+  E+LQ
Sbjct: 222 GHKPPI---------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 2e-24
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 20/209 (9%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I   R  ++ + K  + EI++L  + H NI+KL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
               +    LV+E+M+   L + +  R+R L          +  +    Q+     QGL 
Sbjct: 66  VFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLP------ESLIKSY--LYQLL----QGLA 112

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H      I+HRD+K  N+L+++E   K+ADFGLA+       P+T   V   + Y AP
Sbjct: 113 FCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT-HYVVTRW-YRAP 167

Query: 824 EYAYTTKV-NEKIDIYSFGVVLLELVTGK 851
           E     K  +  +DI+S G +  EL++ +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  103 bits (259), Expect = 2e-24
 Identities = 88/290 (30%), Positives = 132/290 (45%), Gaps = 39/290 (13%)

Query: 643 LIGSG--GSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
            +G G  GS ++ R D      GE VAVK++ ++   + +   +F  EIEIL +++H NI
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR---DFEREIEILKSLQHDNI 67

Query: 699 VKL-WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           VK    C S+    L LV EY+   SL  +L              H+  L     L  A 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL------------QKHRERLDHRKLLLYAS 115

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              +G+ Y+    + + +HRD+ + NIL++SE + KI DFGL K+L +  E + +     
Sbjct: 116 QICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172

Query: 817 S--FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
           S  F Y APE    +K +   D++SFGVVL EL T     Y D+  S      R    +K
Sbjct: 173 SPIFWY-APESLTESKFSVASDVWSFGVVLYELFT-----YSDKSCSPPAEFMRMMGNDK 226

Query: 875 P-------ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
                   + + L      P        +Y +   C +  PS RPS  E+
Sbjct: 227 QGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  102 bits (255), Expect = 6e-24
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 26/215 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G +  VY        E VA+KRI +  K    ++ E   E++ +    H N+VK + 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYT 66

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                +   LV  Y+   SL   L   K S   G        L       +     +GL 
Sbjct: 67  SFVVGDELWLVMPYLSGGSL---LDIMKSSYPRG-------GLDEAIIATVLKEVLKGLE 116

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE--PHTMSAVAGSFGYF 821
           Y+H +     IHRD+K+ NILL  +   KIADFG++  LA  G+          G+  + 
Sbjct: 117 YLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173

Query: 822 APE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           APE     + Y    + K DI+SFG+  +EL TG 
Sbjct: 174 APEVMEQVHGY----DFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  101 bits (254), Expect = 9e-24
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 28/212 (13%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G G  G VY+      G+ VA+K +     L Q++ KE    I IL       IVK +
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKE----ISILKQCDSPYIVKYY 64

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI---GAA 759
                     +V EY    S+   +    ++L               T  +IA       
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL---------------TEEEIAAILYQTL 109

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           +GL Y+H +   + IHRD+K+ NILL+ E +AK+ADFG++  L         + V G+  
Sbjct: 110 KGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPF 164

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           + APE       N K DI+S G+  +E+  GK
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 73/291 (25%), Positives = 132/291 (45%), Gaps = 33/291 (11%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           S +T   +IG G  G+V R  +   G+    VA+K +       Q+L+  F+ E  I+G 
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMGQ 61

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H NI++L   ++     +++ EYMEN SLD++L  R+          +         +
Sbjct: 62  FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RE----------NDGKFTVGQLV 109

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
            +  G A G+ Y+        +HRD+ + NIL++S    K++DFGL++ L      +T  
Sbjct: 110 GMLRGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE 872
                  + APE     K     D++SFG+V+ E+++  E  Y         W       
Sbjct: 167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY---------WDM----S 213

Query: 873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            + +  A++ G   P  ++  + +Y+L L C     + RP+  +++  L +
Sbjct: 214 NQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 99.9 bits (249), Expect = 2e-23
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 23/213 (10%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           N IG G  G V+++         A+K+I +  K+N++  +E I E  +L  +  + I++ 
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQI-DLSKMNRREREEAIDEARVLAKLDSSYIIRY 64

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHG-RKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           +     +    +V EY EN  L + L   R R L             W   +QI +G   
Sbjct: 65  YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPED--------QVWRFFIQILLG--- 113

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA--VAGSF 818
            L ++H   + +I+HRD+KS N+ LD+    KI D G+AK+L+     +T  A  + G+ 
Sbjct: 114 -LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS----DNTNFANTIVGTP 165

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            Y +PE       NEK D+++ GVVL E  TGK
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  100 bits (250), Expect = 3e-23
 Identities = 80/280 (28%), Positives = 121/280 (43%), Gaps = 35/280 (12%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKR--IWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           L+GSG  G VY       G+F AVK   + ++ +  Q+  K+   EI +L  ++H NIV+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                  E++  +  E +   SL          L+    S  + V+   TR QI +G   
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLA--------KLLKKYGSFPEPVIRLYTR-QILLG--- 114

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H       +HRD+K +NIL+D+    K+ADFG+AK + +        +  GS  +
Sbjct: 115 -LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYW 167

Query: 821 FAPEY-AYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
            APE  A         DI+S G  +LE+ TGK   +       A +      E  PI D 
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP-WSQLEGVAAVFKIGRSKELPPIPDH 226

Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           L     +              L C    PS RP+  E+L+
Sbjct: 227 LSDEAKD------------FILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 25/211 (11%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G V++      GE VA+K++   R+L   +  + + EI+ L   +H  +VKL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ--- 760
                +  +LV EYM                 S  S V +         Q+         
Sbjct: 67  VFPHGSGFVLVMEYM----------------PSDLSEVLRDEERPLPEAQVKSYMRMLLK 110

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           G+ YMH +    I+HRD+K +N+L+ ++   KIADFGLA++ +++        VA +  Y
Sbjct: 111 GVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWY 166

Query: 821 FAPEYAY-TTKVNEKIDIYSFGVVLLELVTG 850
            APE  Y   K +  +D+++ G +  EL+ G
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  100 bits (250), Expect = 1e-22
 Identities = 70/226 (30%), Positives = 108/226 (47%), Gaps = 37/226 (16%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           LS L   N IGSG  G VY++     G   A+K I+ N      + ++   EIEIL  + 
Sbjct: 73  LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN 130

Query: 695 HANIVKLWCC--ISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
           H N+VK   C  +   N ++ ++ E+M+  SL+    G              H+      
Sbjct: 131 HPNVVK---CHDMFDHNGEIQVLLEFMDGGSLE----GT-------------HIADEQFL 170

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
             +A     G+ Y+H      I+HRD+K SN+L++S    KIADFG++++LA+  +P   
Sbjct: 171 ADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS 227

Query: 812 SAVAGSFGYFAPEYAYTTKVNEKI------DIYSFGVVLLELVTGK 851
           S   G+  Y +PE    T +N         DI+S GV +LE   G+
Sbjct: 228 S--VGTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 36/224 (16%)

Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           + E + +G G  G V +  +   G   A+K I      N  L+K+ + E+EI  + +   
Sbjct: 3   IVELSRLGEGAGGSVTKCRLKNTGMIFALKTI--TTDPNPDLQKQILRELEINKSCKSPY 60

Query: 698 IVKLW--CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           IVK +      S +S  +  EY E  SLD  ++ + +        + + VL      +IA
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKR---GGRIGEKVL-----GKIA 111

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               +GL Y+H   + +IIHRD+K SNILL  + + K+ DFG++      GE   ++++A
Sbjct: 112 ESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS------GE--LVNSLA 160

Query: 816 GSFG----YFAPEY----AYTTKVNEKIDIYSFGVVLLELVTGK 851
           G+F     Y APE      Y+       D++S G+ LLE+   +
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITS----DVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 35/273 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +GSG  G+V+          VA+K + ++  L Q+   +F  E++ L  +RH +++ L+ 
Sbjct: 14  LGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQ---DFQKEVQALKRLRHKHLISLFA 69

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             S      ++ E ME  SL  +L            S    VL   + + +A   A+G+ 
Sbjct: 70  VCSVGEPVYIITELMEKGSLLAFL-----------RSPEGQVLPVASLIDMACQVAEGMA 118

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFA 822
           Y+        IHRD+ + NIL+  +   K+ADFGLA+++    E  +  S     + + A
Sbjct: 119 YLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK---EDVYLSSDKKIPYKWTA 172

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDK 882
           PE A     + K D++SFG++L E+ T  +  Y     +  E           + D +  
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY--PGMNNHE-----------VYDQITA 219

Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK 915
           G   PC  +    +Y++ L C +  P  RPS K
Sbjct: 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFK 252

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.0 bits (240), Expect = 6e-22
 Identities = 69/215 (32%), Positives = 96/215 (44%), Gaps = 32/215 (14%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEF-IAEIEILGTIRHANIVKLW 702
           +G G  G+V  +     G+  A+K +   +K+ ++ E E  + E  IL  I H  IVKL 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVL-KKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA-IGAAQG 761
               +E    LV EY     L  + H  K    S      +       R   A I     
Sbjct: 60  YAFQTEEKLYLVLEYAPGGEL--FSHLSKEGRFS------EER----ARFYAAEI--VLA 105

Query: 762 LCYMH-HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           L Y+H       II+RD+K  NILLD++   K+ DFGLAK L+   E    +   G+  Y
Sbjct: 106 LEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSS--EGSRTNTFCGTPEY 159

Query: 821 FAPEY----AYTTKVNEKIDIYSFGVVLLELVTGK 851
            APE      Y   V    D +S GV+L E++TGK
Sbjct: 160 LAPEVLLGKGYGKAV----DWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 34/276 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    N     VAVK +    K      K+F+AE +I+  +RH  +++L+ 
Sbjct: 14  LGAGQFGEVWEGLWNNTTP-VAVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             + E    +V E M+  SL  +L G                L  P  + +A   A G+ 
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGR-----------ALKLPQLIDMAAQVASGMA 117

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+        IHRD+ + N+L+      K+ADFGLA+++ K+              + AP
Sbjct: 118 YLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAP 173

Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG 883
           E A   + + K D++SFG++L E+VT     YG        +     AE   +   +D+G
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVT-----YGR-----MPYPGMTNAE---VLQQVDQG 220

Query: 884 IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
              PC       +Y + L C    P  RP+  E LQ
Sbjct: 221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTF-ETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 95.3 bits (238), Expect = 2e-21
 Identities = 61/231 (26%), Positives = 92/231 (39%), Gaps = 41/231 (17%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ-KLEKEFIAEIEILG-TIRHANIVK 700
           +IG G    V         +  A+K + + R+L + K  K    E E+L     H  I+K
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH--QHVLHWPTRLQIAIGA 758
           L+     E +   V EY  N  L    + RK     GS      +         +I +  
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGEL--LQYIRKY----GSLDEKCTRFYAA-----EILLA- 114

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML--------------AK 804
              L Y+H   +  IIHRD+K  NILLD +   KI DFG AK+L                
Sbjct: 115 ---LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 805 QGEPHTMSAVAGSF-G---YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
             +         SF G   Y +PE        +  D+++ G ++ +++TGK
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 93.7 bits (233), Expect = 6e-21
 Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 39/225 (17%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE---KEFIAEIEILGTIRHANIVK 700
           IG G  G VY+      GE VA+K+I    +L+ + E      I EI +L  + H NIVK
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKI----RLDTETEGVPSTAIREISLLKELNHPNIVK 63

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRLQIAIG 757
           L   I +EN   LV+E++ +Q L +++     S +      S + Q +            
Sbjct: 64  LLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL------------ 110

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             QGL + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +
Sbjct: 111 --QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--T 163

Query: 818 FGYFAPEYA-----YTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             Y APE       Y+T V    DI+S G +  E+VT +    GD
Sbjct: 164 LWYRAPEILLGCKYYSTAV----DIWSLGCIFAEMVTRRALFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.0 bits (231), Expect = 8e-21
 Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 36/288 (12%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +   ++   ++E EF+ E  ++  I+H
Sbjct: 6   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVE-EFLKEAAVMKEIKH 61

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 62  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 110

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 111 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGA 165

Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME 225

Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           +P          E C       VY L   C    PS RPS  E+ Q  
Sbjct: 226 RP----------EGC----PPKVYELMRACWQWNPSDRPSFAEIHQAF 259

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 93.3 bits (232), Expect = 8e-21
 Identities = 83/310 (26%), Positives = 137/310 (44%), Gaps = 52/310 (16%)

Query: 634 ILSSLTESNLIGSGGSGQVYRIDINGAGEF-----VAVKRIWNNRKLNQKLEKEFIAEIE 688
            LS++     +G G  G+VY+ ++ G  E      VA+K +  N     K+++EF  E E
Sbjct: 3   PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAE 60

Query: 689 ILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH---QHV 745
           ++  ++H NIV L    + E    +++EY+ +  L  +L         G+ S     +  
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 746 LHWPTRLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA---- 799
           L     L IAI  A G+ Y+  HH      +HRD+ + N L+      KI+DFGL+    
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 800 -----KMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKE 852
                ++ +K   P   M   A  +G F  E           DI+SFGVVL E+ + G +
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTES----------DIWSFGVVLWEIFSYGLQ 225

Query: 853 ANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP 912
             YG             ++ ++ I + +      PC  +    VY L + C + +P+ RP
Sbjct: 226 PYYG-------------FSNQEVI-EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRP 271

Query: 913 SMKEVLQILR 922
             K++   LR
Sbjct: 272 RFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 8e-21
 Identities = 76/289 (26%), Positives = 123/289 (42%), Gaps = 44/289 (15%)

Query: 644 IGSGGSGQV----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +G G  G V    Y +  +G    VAVK +        K  KEF+ E  ++  + H  IV
Sbjct: 3   LGHGNFGSVVKGVYLMK-SGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIV 59

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           +L   +      +LV E      L ++L  +KR  +  S      +       Q+A+G  
Sbjct: 60  RL-IGVCKGEPLMLVMELAPLGPLLKYL--KKRREIPVSD-----LKELA--HQVAMG-- 107

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF- 818
                M +  +   +HRD+ + N+LL +  +AKI+DFG+++ L   G  +  +  AG + 
Sbjct: 108 -----MAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL-GAGSDYYRATTAGRWP 161

Query: 819 -GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK--P 875
             ++APE     K + K D++S+GV L E  +     YG           + Y E K   
Sbjct: 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAFS-----YGA----------KPYGEMKGAE 206

Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +   L+ G   P   E    +Y + L C    P  RP+  E+    RR 
Sbjct: 207 VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.8 bits (230), Expect = 9e-21
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 69  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-----------LRLPQLVDMAAQIASGMA 116

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 117 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 169

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 216

Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 217 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQ 254

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 70/229 (30%), Positives = 93/229 (40%), Gaps = 67/229 (29%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIV--- 699
           IGSG  G VY+      GE VA+K I    KL    + E I  EI +L   RH NIV   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVI----KLEPGDDFEIIQQEISMLKECRHPNIVAYF 66

Query: 700 -------KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
                  KLW  +          EY    SL       +  L               + L
Sbjct: 67  GSYLRRDKLWIVM----------EYCGGGSLQDIYQVTRGPL---------------SEL 101

Query: 753 QIAI---GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA----KMLAKQ 805
           QIA       +GL Y+H       IHRD+K +NILL  +   K+ADFG++      +AK+
Sbjct: 102 QIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158

Query: 806 ----GEPHTMSAVAGSFGYFAPEYA---YTTKVNEKIDIYSFGVVLLEL 847
               G P+ M          APE A        + K DI++ G+  +EL
Sbjct: 159 KSFIGTPYWM----------APEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 77/289 (26%), Positives = 125/289 (43%), Gaps = 40/289 (13%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L  LT   +IG G  G V        GE+   K    N K +   +  F+ E  ++  + 
Sbjct: 5   LQKLTLGEIIGEGEFGAVL------QGEYTGQKVAVKNIKCDVTAQA-FLEETAVMTKLH 57

Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H N+V+L   I   N   +V E M   +L  +L  R R+LVS               LQ 
Sbjct: 58  HKNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVS-----------VIQLLQF 105

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           ++  A+G+ Y+    + +++HRD+ + NIL+  +  AK++DFGLA++         +   
Sbjct: 106 SLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV-----GSMGVDNS 157

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
                + APE     K + K D++S+GV+L E+ +   A Y     SL E          
Sbjct: 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY--PKMSLKE---------- 205

Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            + + ++KG            VY L   C  T P  RPS  ++ + L +
Sbjct: 206 -VKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 70/277 (25%), Positives = 126/277 (45%), Gaps = 33/277 (11%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G G  G V+        + V +K+I    ++ +        E ++L  + H NI++ +
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                + + ++V EY    +L  ++  R  SL+         +LH+  ++ +A       
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD-----EDTILHFFVQILLA------- 113

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDS-EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
             +HH  T  I+HRD+K+ NILLD  +   KI DFG++K+L+ + + +T   V G+  Y 
Sbjct: 114 --LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYI 168

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
           +PE       N+K DI++ G VL EL + K A       +L            PI+D   
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--GTFAPISDR-- 224

Query: 882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                  Y  +   + +L L   +  PS RP + +++
Sbjct: 225 -------YSPD---LRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 34/290 (11%)

Query: 636 SSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           S +    +IG+G  G+V   R+ + G  E  VA+K +       +K  ++F++E  I+G 
Sbjct: 4   SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQ 61

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H NI+ L   ++     ++V EYMEN SLD +L  RK     G  +V Q V       
Sbjct: 62  FDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKH---DGQFTVIQLV------- 109

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HTM 811
            +  G A G+ Y+        +HRD+ + NIL++S    K++DFGL+++L    E  +T 
Sbjct: 110 GMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166

Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA 871
                   + APE     K     D++S+G+V+ E+++  E  Y +              
Sbjct: 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE-------------M 213

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             + +  A+++G   P  ++    +++L L C     + RP  ++++ IL
Sbjct: 214 SNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 72/219 (32%), Positives = 99/219 (45%), Gaps = 34/219 (15%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-----EIEILGTIRHA 696
           N IG G  G VYR     +GE VA+K++  +       E++ I      EI +L  +RH 
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDN------ERDGIPISSLREITLLLNLRHP 66

Query: 697 NIVKLWCCI--SSENSKLLVYEYMENQSLDRWLHGRKRSLV-SGSSSVHQHVLHWPTRLQ 753
           NIV+L   +     +S  LV EY E Q L   L         S    +   +L       
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLR------ 119

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
                  GL Y+H +    IIHRD+K SN+LL  +   KIADFGLA+      +P T   
Sbjct: 120 -------GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169

Query: 814 VAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
           V  +  Y APE     T     ID+++ G +L EL+  K
Sbjct: 170 V--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 73/290 (25%), Positives = 117/290 (40%), Gaps = 50/290 (17%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G V ++     G+ +  K I +   + +K +++ ++E+ IL  ++H NIV+ + 
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEI-DYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH---WPTRLQIAIGAAQ 760
            I   +++ L Y  ME         G    L+       +++     W    Q+ +  A 
Sbjct: 67  RIIDRSNQTL-YIVMEYCE-----GGDLAQLIQKCKKERKYIEEEFIWRILTQLLL--AL 118

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ--------GEPHTMS 812
             C+   D    ++HRD+K +NI LD+    K+ DFGLAK+L           G P+ MS
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE 872
                     PE       +EK DI+S G ++ EL              LA        +
Sbjct: 179 ----------PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI--KEGK 226

Query: 873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTL---PSSRPSMKEVLQ 919
            + I            Y  E      L  +  S L   P  RPS +E+LQ
Sbjct: 227 FRRIPYR---------YSSE------LNEVIKSMLNVDPDKRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.6 bits (225), Expect = 5e-20
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 25/215 (11%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA---EIEILGTIRHANIV 699
           L+G G  G+VY       G  +AVK++  +   + + +KE  A   EI++L  ++H  IV
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDP-DSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           + + C+  + +  +  EYM   S+   L  +G     V+             TR QI   
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY----------TR-QIL-- 114

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT-MSAVAG 816
             +G+ Y+H   +  I+HRD+K +NIL DS    K+ DFG +K L       T M +V G
Sbjct: 115 --EGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +  + +PE         K D++S G  ++E++T K
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 90.7 bits (225), Expect = 5e-20
 Identities = 70/288 (24%), Positives = 124/288 (43%), Gaps = 34/288 (11%)

Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRI---WNNRKLNQKLEKEFIAEIEILGTIRH 695
            +   +G+G     Y+      G  +AVK++    N     +++ +    EI ++  + H
Sbjct: 3   LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            +I+++      ++   L  E+M   S+   L        +   +V  +        Q+ 
Sbjct: 63  PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTE-----QLL 113

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK-AKIADFGLAKMLAKQ--GEPHTMS 812
               +GL Y+H +   QIIHRDVK +N+L+DS  +  +IADFG A  LA +  G      
Sbjct: 114 ----RGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG 166

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE 872
            + G+  + APE     +     D++S G V++E+ T K     ++H++       H A 
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-------HLAL 219

Query: 873 EKPITDALDKGIAEPCYLEEMTTVYR-LALICTSTLPSSRPSMKEVLQ 919
              I  A       P   E ++   R + L C    P  RP  +E+L+
Sbjct: 220 IFKIASA----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 46/290 (15%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
            SL     +G+G  G+V+    NG  + VAVK +    K      + F+ E +I+  +RH
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTK-VAVKTL----KPGTMSPEAFLQEAQIMKKLRH 60

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLH---GRKRSLVSGSSSVHQHVLHWPTRL 752
             +V+L+   S E    +V EYM   SL  +L    G+K              L  P  +
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK--------------LRLPQLV 106

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
            +A   A+G+ Y+        IHRD+ + NIL+      KIADFGLA+++    E    +
Sbjct: 107 DMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI----EDDEYT 159

Query: 813 AVAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
           A  G+     + APE A   +   K D++SFG++L E+VT     YG        +    
Sbjct: 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT-----YGR-----VPYPGMT 209

Query: 870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
             E   + + +++G   P        +Y L L C    P  RP+  E LQ
Sbjct: 210 NRE---VLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTF-EYLQ 255

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 91.9 bits (229), Expect = 7e-20
 Identities = 78/226 (34%), Positives = 112/226 (49%), Gaps = 48/226 (21%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWN---NRKLNQKLEKEFIAEIEILGTIR-HANI 698
           +G G  G V++ ID     E VA+K+I++   N    Q+  +E    I  L  +  H NI
Sbjct: 15  LGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRNATDAQRTFRE----IMFLQELGDHPNI 69

Query: 699 VKLWCCISSENSK--LLVYEYMENQSLDRWLHG--RKRSLVSGSSSVHQHVLHWPTRLQI 754
           VKL   I +EN K   LV+EYME       LH   R   L      VH+  + +    Q+
Sbjct: 70  VKLLNVIKAENDKDIYLVFEYMETD-----LHAVIRANIL----EDVHKRYIMY----QL 116

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA- 813
                + L Y+H   +  +IHRD+K SNILL+S+ + K+ADFGLA+ L++  E       
Sbjct: 117 L----KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169

Query: 814 ---VAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
              VA  + Y APE       YT  V    D++S G +L E++ GK
Sbjct: 170 TDYVATRW-YRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.9 bits (223), Expect = 1e-19
 Identities = 72/285 (25%), Positives = 136/285 (47%), Gaps = 36/285 (12%)

Query: 643 LIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG+G  G+V R  +   G+   FVA+K + +     Q+  ++F++E  I+G   H NI+
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNII 68

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
            L   ++     +++ E+MEN +LD +L         G  +V Q V        +  G A
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLR-----QNDGQFTVIQLV-------GMLRGIA 116

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK-QGEPHTMSAVAGSF 818
            G+ Y+        +HRD+ + NIL++S    K++DFGL++ L     +P   S++ G  
Sbjct: 117 AGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173

Query: 819 G--YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + APE     K     D++S+G+V+ E+++  E  Y D                + +
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-------------MSNQDV 220

Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            +A+++    P  ++  T +++L L C     ++RP   +++  L
Sbjct: 221 INAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 72/293 (24%), Positives = 124/293 (42%), Gaps = 49/293 (16%)

Query: 644 IGSGGSGQVY----RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +GSG  G VY      +       VA+K +      + K  KE + E  ++ ++ H ++V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVV 72

Query: 700 KLWC-CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           +L   C+SS     L+ + M    L  ++   K ++ S      Q++L+W    QIA   
Sbjct: 73  RLLGICLSS--QVQLITQLMPLGCLLDYVRNHKDNIGS------QYLLNWCV--QIA--- 119

Query: 759 AQGLCY--MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
            +G+ Y          ++HRD+ + N+L+ +    KI DFGLAK+L    + +       
Sbjct: 120 -KGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + A E         K D++S+GV + EL+T     Y                    I
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------------VEI 220

Query: 877 TDALDKG--IAEP--CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC 925
            D L+KG  + +P  C ++    VY + + C      SRP+ KE++    +  
Sbjct: 221 PDLLEKGERLPQPPICTID----VYMVLVKCWMIDAESRPTFKELINEFSKMA 269

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 88.7 bits (220), Expect = 3e-19
 Identities = 66/222 (29%), Positives = 114/222 (51%), Gaps = 33/222 (14%)

Query: 643 LIGSGGSGQVYRIDIN-GAGEFVAVKRIWNNRKLNQK---LEKEFI----AEIEILGTIR 694
           LIG G  G+VY + +N   GE +AVK++     +  +    +K+ +    +EIE L  + 
Sbjct: 8   LIGKGTYGRVY-LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWL--HGR-KRSLVSGSSSVHQHVLHWPTR 751
           H NIV+     ++E    +  EY+   S+   L  +GR +  LV       + VL     
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR---FFTEQVL----- 118

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
                   +GL Y+H   +  I+HRD+K+ N+L+D++   KI+DFG++K      +    
Sbjct: 119 --------EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167

Query: 812 SAVAGSFGYFAPE--YAYTTKVNEKIDIYSFGVVLLELVTGK 851
            ++ GS  + APE  ++Y+   + K+DI+S G V+LE+  G+
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 89.5 bits (222), Expect = 3e-19
 Identities = 80/297 (26%), Positives = 122/297 (41%), Gaps = 57/297 (19%)

Query: 634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
           + + L E   IG G  G VY        E VA+K++  + K + +  ++ I E+  L  +
Sbjct: 16  LFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL 72

Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS----VHQHVLHWP 749
           RH N ++   C   E++  LV EY                   GS+S    VH+  L   
Sbjct: 73  RHPNTIEYKGCYLREHTAWLVMEY-----------------CLGSASDILEVHKKPLQEV 115

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ---- 805
               I  GA QGL Y+H       IHRD+K+ NILL      K+ADFG A +++      
Sbjct: 116 EIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV 172

Query: 806 GEPHTMSAVAGSFGYFAPEYAYTT---KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
           G P+ M          APE        + + K+D++S G+  +EL   K   +     S 
Sbjct: 173 GTPYWM----------APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS- 221

Query: 863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
              A  H A+    T  L        +   + +       C   +P  RPS +E+L+
Sbjct: 222 ---ALYHIAQNDSPT--LSSNDWSDYFRNFVDS-------CLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 74/285 (25%), Positives = 115/285 (40%), Gaps = 47/285 (16%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G G  G VY++      +F A+K + +   ++QK  ++ + EI IL ++ H NI+   
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRK--RSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                 N   +V EY     L + +  RK  R L+            W   +Q+     +
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQ-------EIWRIFIQLL----R 114

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ------GEPHTMSAV 814
           GL  +H     +I+HRD+KS+NILL +    KI D G++K+L K       G PH     
Sbjct: 115 GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH----- 166

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
                Y APE       + K DI+S G +L E+ T            L     R      
Sbjct: 167 -----YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221

Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           P           P Y +++    R  L      P  RP+  ++L 
Sbjct: 222 P-----------PIYSQDLQNFIRSMLQ---VKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 81/280 (28%), Positives = 131/280 (46%), Gaps = 43/280 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K      + F+ E +I+  +RH  +V+L+ 
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-VAVKTL----KPGTMSPESFLEEAQIMKKLRHDKLVQLYA 68

Query: 704 CISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
            +S E    +V EYM   SL  +L  G  R+L              P  + +A   A G+
Sbjct: 69  VVSEE-PIYIVTEYMSKGSLLDFLKDGEGRAL------------KLPNLVDMAAQVAAGM 115

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FG 819
            Y+        IHRD++S+NIL+      KIADFGLA+++    E +  +A  G+     
Sbjct: 116 AYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLI----EDNEYTARQGAKFPIK 168

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           + APE A   +   K D++SFG++L ELVT     Y   +              + + + 
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------------REVLEQ 215

Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +++G   PC  +   +++ L L C    P  RP+  E LQ
Sbjct: 216 VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTF-EYLQ 254

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 88.3 bits (219), Expect = 4e-19
 Identities = 63/218 (28%), Positives = 110/218 (50%), Gaps = 37/218 (16%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIRHAN 697
           +G G    VY+      GE VA+K I         L+ E       I EI ++  ++H N
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEI--------HLDAEEGTPSTAIREISLMKELKHEN 59

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           IV+L   I +EN  +LV+EYM+ + L +++  HG + +L   +     + L         
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQL--------- 109

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HTMSAV 814
               +G+ + H +   +++HRD+K  N+L++   + K+ADFGLA+     G P +T S  
Sbjct: 110 ---LKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF---GIPVNTFSNE 160

Query: 815 AGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGK 851
             +  Y AP+    ++  +  IDI+S G ++ E++TG+
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 73/284 (25%), Positives = 115/284 (40%), Gaps = 41/284 (14%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            IG G  G VY+  + G  E VAVK       L   L+++F+ E EIL    H NIVKL 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTE-VAVKTC--RSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                +    +V E +   SL  +L  +K  L                 LQ+++ AA G+
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK------------KLLQMSLDAAAGM 106

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG--- 819
            Y+        IHRD+ + N L+      KI+DFG+++      E   +  V+       
Sbjct: 107 EYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSRE-----EEGGIYTVSDGLKQIP 158

Query: 820 --YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             + APE     +   + D++S+G++L E  +  +  Y                      
Sbjct: 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR------------- 205

Query: 878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           + ++ G   P        +YRL L C +  P +RPS  E+   L
Sbjct: 206 ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 87.6 bits (217), Expect = 7e-19
 Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 44/288 (15%)

Query: 643 LIGSGGSGQVYRI-DINGAGEFVAVKRIW----NNRKLNQKLEKEF---IAEIEILG-TI 693
            +GSG  G VY++   N     +A+K I        K  ++ +K     ++E+ I+   +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 694 RHANIVKLWCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH---WP 749
           RH NIV+ +     EN +L +V + +E   L            +      Q       W 
Sbjct: 67  RHPNIVRYYK-TFLENDRLYIVMDLIEGAPL--------GEHFNSLKEKKQRFTEERIWN 117

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+ +     L Y+H +   +I+HRD+  +NI+L  + K  I DFGLAK   ++    
Sbjct: 118 IFVQMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPES 168

Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
            +++V G+  Y  PE        EK D+++FG +L ++ T +   Y     SLA      
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA------ 222

Query: 870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
                 I +A+ + + E  Y E++T V      C +    +RP + +V
Sbjct: 223 ----TKIVEAVYEPLPEGMYSEDVTDVITS---CLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 88.5 bits (219), Expect = 7e-19
 Identities = 76/282 (26%), Positives = 123/282 (43%), Gaps = 44/282 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRI-WNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           IG G  G VY    +   E VAVK++ ++ ++ N+K + + I E++ L  ++H N ++  
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ-DIIKEVKFLQQLKHPNTIEYK 87

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
            C   E++  LV EY    + D                VH+  L       I  GA QGL
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLL-------------EVHKKPLQEVEIAAITHGALQGL 134

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H      +IHRD+K+ NILL    + K+ADFG A   +        ++  G+  + A
Sbjct: 135 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMA 185

Query: 823 PEYAYTT---KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE-EKPITD 878
           PE        + + K+D++S G+  +EL   K   +     S    A  H A+ + P   
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQNDSPTLQ 241

Query: 879 ALDKGIAEPCYLEEMTTVYR-LALICTSTLPSSRPSMKEVLQ 919
           +            E T  +R     C   +P  RP+  E+L+
Sbjct: 242 S-----------NEWTDSFRGFVDYCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 87.4 bits (216), Expect = 9e-19
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 28/288 (9%)

Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V+  + +          VAVK +   ++ ++   ++F  E E+L  ++H +I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTVLQHQHI 69

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           V+ +   +     L+V+EYM +  L+R+L  HG    +++G   V    L     L IA 
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A G+ Y+    +   +HRD+ + N L+      KI DFG+++ +              
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKP 875
              +  PE     K   + DI+SFGVVL E+ T GK+  Y   +T   E   +    E+P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERP 246

Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            T          C  E    VY +   C    P  R  +K++   L+ 
Sbjct: 247 RT----------CPPE----VYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 65/223 (29%), Positives = 111/223 (49%), Gaps = 34/223 (15%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRI------WNNRKLNQKLEKEFIAEIEILGTIRHA 696
           LIGSG  G VY      +GE +AVK++       +++   + +      EI +L  ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           NIV+        +   +  EY+   S+         +L++   +  + ++    R QI  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSV--------AALLNNYGAFEETLVRNFVR-QI-- 115

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS---- 812
              +GL Y+H      IIHRD+K +NIL+D++   KI+DFG++K L    E +++S    
Sbjct: 116 --LKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL----EANSLSTKTN 166

Query: 813 ----AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
               ++ GS  + APE    T    K DI+S G +++E++TGK
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 66/295 (22%), Positives = 124/295 (42%), Gaps = 35/295 (11%)

Query: 636 SSLTESNLIGSGGSGQVY-----RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           S+L E   +G G  G+V+      I+  G    V VK +   +  ++ L+ EF  E+++ 
Sbjct: 5   SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMF 62

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
             + H N+V+L           ++ EY +   L ++L   K    S    +    L    
Sbjct: 63  RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATK----SKDEKLKPPPLSTKQ 118

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
           ++ +    A G   M H    + +HRD+ + N L+ S+ + K++   L+K +        
Sbjct: 119 KVALCTQIALG---MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL 175

Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
            +A+     + APE       + K D++SFGV++ E+ T  E  +               
Sbjct: 176 RNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG------------L 222

Query: 871 AEEKPITDA----LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           ++E+ +       L+  + E C     + +Y+L   C +  P  RPS  E++  L
Sbjct: 223 SDEEVLNRLQAGKLELPVPEGC----PSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 84/287 (29%), Positives = 130/287 (45%), Gaps = 46/287 (16%)

Query: 642 NLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
            +IG G  G VY    ID +G     AVK +  NR  + +  ++F+ E  I+    H N+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58

Query: 699 VKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-RLQIAI 756
           + L   C+ SE S L+V  YM+        HG  R+ +   +       H PT +  I  
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMK--------HGDLRNFIRSET-------HNPTVKDLIGF 103

Query: 757 G--AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQ-GEPHTMS 812
           G   A+G+ Y+    + + +HRD+ + N +LD  F  K+ADFGLA+ +  K+    H  +
Sbjct: 104 GLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE 872
                  + A E   T K   K D++SFGV+L EL+T     Y D              +
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------------VD 207

Query: 873 EKPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
              IT  L +G  + +P Y  +   +Y + L C    P  RP+  E+
Sbjct: 208 SFDITVYLLQGRRLLQPEYCPD--PLYEVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.1 bits (214), Expect = 3e-18
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 29/217 (13%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA--EIEILGTIRHANIV 699
             +G G    VY+      G  VA+K+I    +   K    F A  EI++L  ++H NI+
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
            L      +++  LV+E+ME   L++ +  + +S+V   + +  ++L             
Sbjct: 66  GLLDVFGHKSNINLVFEFMET-DLEKVI--KDKSIVLTPADIKSYML------MTL---- 112

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           +GL Y+H +    I+HRD+K +N+L+ S+   K+ADFGLA+         T   V     
Sbjct: 113 RGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT--RW 167

Query: 820 YFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y APE       Y   V    D++S G +  EL+   
Sbjct: 168 YRAPELLFGARHYGVGV----DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 84.0 bits (208), Expect = 7e-18
 Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 40/289 (13%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S LT    +GSG  G V+     G  + VA+K I     ++   E +FI E +++  + H
Sbjct: 4   SELTFLKELGSGQFGVVHLGKWRGKID-VAIKMI-REGAMS---EDDFIEEAKVMMKLSH 58

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L+   + +    +V EYM N  L  +L  RK              L     L + 
Sbjct: 59  PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK------------GKLGTEWLLDMC 106

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               + + Y+  +     IHRD+ + N L+  +   K++DFGLA+ +    +    S+  
Sbjct: 107 SDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL---DDQYTSSQG 160

Query: 816 GSF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD-EHTSLAEWAWRHYAE 872
             F   +  PE    ++ + K D++SFGV++ E+ +  +  Y    ++ + E     Y  
Sbjct: 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220

Query: 873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            +P                  T VY +   C    P  RP+ K++L  L
Sbjct: 221 YRPKLAP--------------TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 83.9 bits (208), Expect = 9e-18
 Identities = 65/249 (26%), Positives = 97/249 (38%), Gaps = 35/249 (14%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA----EIEILGTIRHAN 697
            +IG G  G+V  +      +  A+K + N +K    +EK  +     E  IL  + H  
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYM-NKQKC---VEKGSVRNVLNERRILQELNHPF 61

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA-I 756
           +V LW     E +  LV + +    L R+   +K                   +  I  I
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQ-----------VKFWICEI 109

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A  L Y+H   +  IIHRD+K  NILLD +    I DF +A  +       + S   G
Sbjct: 110 VLA--LEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---G 161

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK-- 874
           + GY APE       +  +D +S GV   E + GK    G  H+       R   E    
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG--HSRTIRDQIRAKQETADV 219

Query: 875 --PITDALD 881
             P T + +
Sbjct: 220 LYPATWSTE 228

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 83.7 bits (208), Expect = 1e-17
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 44/221 (19%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEK--EFIA--EIEILGTI-RHANI 698
           +G G  G VY       GE VA+K      K+ +K     E +   E++ L  +  H NI
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK------KMKKKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 699 VKLWCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           VKL      EN +L  V+EYME  +L + +  RK    S   SV + ++      QI   
Sbjct: 61  VKLKEVFR-ENDELYFVFEYME-GNLYQLMKDRKGKPFS--ESVIRSII-----YQIL-- 109

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             QGL ++H        HRD+K  N+L+      KIADFGLA+ +  +  P+T      +
Sbjct: 110 --QGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-PPYT--DYVST 161

Query: 818 FGYFAPE-------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
             Y APE       Y      +  +DI++ G ++ EL T +
Sbjct: 162 RWYRAPEILLRSTSY------SSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 83.7 bits (208), Expect = 2e-17
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 29/211 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V  +   G+G++ A+K +   + +  K  +  + E  IL +IRH  +V L+ 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA-IGAAQ-- 760
               +++  LV EY+    L   L  RK                      +A   AAQ  
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHL--RKSGRFP---------------EPVARFYAAQVV 111

Query: 761 -GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
             L Y+H      I++RD+K  N+LLDS+   KI DFG AK +    +  T + + G+  
Sbjct: 112 LALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYT-LCGTPE 163

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y APE   +    + +D ++ G+++ E++ G
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 27/214 (12%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           +  L     IG G  G V   D  G    VAVK I N+        + F+AE  ++  +R
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKND-----ATAQAFLAEASVMTQLR 57

Query: 695 HANIVKLWCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           H+N+V+L   I  E   L +V EYM   SL  +L  R RS++ G   +            
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK----------- 106

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            ++   + + Y+  +     +HRD+ + N+L+  +  AK++DFGL K  +      T   
Sbjct: 107 FSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDT 158

Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL 847
                 + APE     K + K D++SFG++L E+
Sbjct: 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 27/210 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+VY+      G F A K I    +  ++LE +F+ EI+IL   +H NIV L+ 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKII--QIESEEELE-DFMVEIDILSECKHPNIVGLYE 69

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS-SSVHQHVLHWPTRLQIAIGAAQGL 762
               EN   ++ E+ +  +LD  +   +R L       V + +L             + L
Sbjct: 70  AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-------------EAL 116

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            ++H     ++IHRD+K+ NILL  +   K+ADFG++       +        G+  + A
Sbjct: 117 NFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMA 171

Query: 823 PEYAYT-----TKVNEKIDIYSFGVVLLEL 847
           PE            + K DI+S G+ L+EL
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 71/231 (30%), Positives = 107/231 (46%), Gaps = 51/231 (22%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-------FIAEIEILGTIRHA 696
           IG G  G VY+      GE VA+K+I        +LE E        I EI +L  + H 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI--------RLETEDEGVPSTAIREISLLKELNHP 58

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWL-----HGRKRSLVSGSSSVHQHVLHWPTR 751
           NIV+L   + SEN   LV+E++ +  L +++      G    L+   S ++Q +      
Sbjct: 59  NIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIK--SYLYQLL------ 109

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
                   QG+ Y H   + +++HRD+K  N+L+D E   K+ADFGLA+        +T 
Sbjct: 110 --------QGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158

Query: 812 SAVAGSFGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             V  +  Y APE       Y+T V    DI+S G +  E+V  +    GD
Sbjct: 159 EVV--TLWYRAPEILLGSRQYSTPV----DIWSIGCIFAEMVNRRPLFPGD 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 79/297 (26%), Positives = 125/297 (42%), Gaps = 38/297 (12%)

Query: 644 IGSGGSGQVYRIDING--AGE---FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           IG G  G+V++    G    E    VAVK +      + +   +F  E  ++    H NI
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMAEFDHPNI 70

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV-----------LH 747
           VKL    +      L++EYM    L+ +L  R RS  +  S  H              L 
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFL--RHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
              +L IA   A G+ Y+      + +HRD+ + N L+      KIADFGL++ +     
Sbjct: 129 CTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 808 PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA 866
                  A    +  PE  +  +   + D++++GVVL E+ + G +  YG  H  +  + 
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY- 244

Query: 867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
                    + D       + C LE    +Y L  +C S LPS RPS   + +IL+R
Sbjct: 245 ---------VRDGNVLSCPDNCPLE----LYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 83.6 bits (206), Expect = 3e-17
 Identities = 75/281 (26%), Positives = 122/281 (43%), Gaps = 42/281 (14%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY        E VA+K++  + K + +  ++ I E++ L  I+H N ++   
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
           C   E++  LV EY    + D                VH+  L       I  GA QGL 
Sbjct: 93  CYLREHTAWLVMEYCLGSASDLL-------------EVHKKPLQEVEIAAITHGALQGLA 139

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H   +  +IHRD+K+ NILL    + K+ADFG A + +        ++  G+  + AP
Sbjct: 140 YLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAP 190

Query: 824 EYAYTT---KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE-EKPITDA 879
           E        + + K+D++S G+  +EL   K   +     S    A  H A+ E P   +
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQNESPTLQS 246

Query: 880 LDKGIAEPCYLEEMTTVYR-LALICTSTLPSSRPSMKEVLQ 919
                       E +  +R     C   +P  RP+ +E+L+
Sbjct: 247 -----------NEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 40/281 (14%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG  + VA+K +    K    + + F+ E +I+  +RH  +V L+ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTL----KPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V E+M   SL  +L         G        L  P  + +A   A G+ 
Sbjct: 69  VVSEE-PIYIVTEFMGKGSLLDFLK-------EGDGKY----LKLPQLVDMAAQIADGMA 116

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        IHRD++++NIL+      KIADFGLA+++    E +  +A  G+     +
Sbjct: 117 YIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLI----EDNEYTARQGAKFPIKW 169

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L ELVT     Y                  + + + +
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-------------MVNREVLEQV 216

Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           ++G   PC      +++ L  +C    P  RP+ + +   L
Sbjct: 217 ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.4 bits (203), Expect = 5e-17
 Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 37/291 (12%)

Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V     Y +        VAVK +   +       K+F  E E+L  ++H +I
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHEHI 69

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRS-LVSGSSSVHQHVLHWPTRLQIA 755
           VK +      +  ++V+EYM++  L+++L  HG     LV G     +  L     L IA
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE----PHTM 811
              A G+ Y+    +   +HRD+ + N L+ +    KI DFG+++ +          HTM
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY 870
             +     +  PE     K   + D++SFGV+L E+ T GK+  +   +T + E   +  
Sbjct: 187 LPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242

Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             E+P            C  E    VY + L C    P  R ++KE+ +IL
Sbjct: 243 VLERP----------RVCPKE----VYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.5 bits (204), Expect = 6e-17
 Identities = 76/228 (33%), Positives = 109/228 (47%), Gaps = 43/228 (18%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-----FIAEIEILGTIRHA 696
             IG G  GQVY+      GE VA+K++   R  N   EKE      I EI+IL  + H 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKV---RLDN---EKEGFPITAIREIKILRQLNHR 66

Query: 697 NIVKLWCCISSENSKL----------LVYEYMENQSLDRWLHGRKRS-LVSGSSSVHQHV 745
           NIV L   ++ +   L          LV+EYM     D  L G   S LV  S     H+
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFS---EDHI 118

Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML-AK 804
             +  +L       +GL Y H       +HRD+K SNILL+++ + K+ADFGLA++  ++
Sbjct: 119 KSFMKQL------LEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169

Query: 805 QGEPHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
           +  P+T   +  +  Y  PE      +    ID++S G +L EL T K
Sbjct: 170 ESRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 7e-17
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 39/217 (17%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V ++     G  +A K +    K    + K+ + E++I+   R   IV  + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 704 CISSENSKLLVYEYMENQSLDRWLH--GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
              +EN+  +  E+M+  SLDR     G     + G               +IA+   +G
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG---------------KIAVAVVEG 115

Query: 762 LCYM---HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           L Y+   H      I+HRD+K SNIL++S  + K+ DFG++      GE   ++++A +F
Sbjct: 116 LTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVS------GE--LINSIADTF 162

Query: 819 ----GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
                Y +PE     K   K D++S G+ ++EL  GK
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 26/220 (11%)

Query: 643 LIGSGGSGQVYRID-INGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
            +G G  G V R +     G+   VAVK    + KL   +  +F+ E  I+ ++ H N++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKL-SDIMDDFLKEAAIMHSLDHENLI 59

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           +L+  + +    ++V E     SL   L                  L        A+  A
Sbjct: 60  RLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFL------ISTLC-----DYAVQIA 107

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA-VAGSF 818
            G+ Y+    + + IHRD+ + NILL S+ K KI DFGL + L +  + + M   +   F
Sbjct: 108 NGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
            + APE   T   +   D++ FGV L E+ T     YG+E
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFT-----YGEE 199

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 18/209 (8%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G++Y        E   +K I +  K+  K ++    E+ +L  ++H NIV  + 
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEI-DLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    +V EY +   L + ++ ++  L S        +L W   +QI++G      
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS-----EDQILSW--FVQISLG------ 113

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFK-AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            + H    +I+HRD+KS NI L      AK+ DFG+A+ L    E        G+  Y +
Sbjct: 114 -LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLS 170

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE       N K DI+S G VL EL T K
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 34/289 (11%)

Query: 644 IGSGGSGQVY-----RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G VY      +        VA+K +  N  + +++E  F+ E  ++      ++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE--FLNEASVMKEFNCHHV 71

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR---LQIA 755
           V+L   +S+    L+V E M    L  +L  R+        + +   L  PT    +Q+A
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRR------PEAENNPGLGPPTLQKFIQMA 125

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              A G+ Y+      + +HRD+ + N ++  +   KI DFG+ + + +           
Sbjct: 126 AEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182

Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               + APE         K D++SFGVVL E+ T            LAE  ++  + E+ 
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT------------LAEQPYQGLSNEEV 230

Query: 876 ITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
           +   +D G  + P    +   +  L  +C    P  RP+  E++  L+ 
Sbjct: 231 LKFVIDGGHLDLPENCPDK--LLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 80.9 bits (199), Expect = 2e-16
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 27/212 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRI-WNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           IG G  G VY        E VA+K++ ++ ++ N+K + + I E+  L  +RH N ++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHPNTIQYR 81

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
            C   E++  LV EY    + D                VH+  L       +  GA QGL
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLL-------------EVHKKPLQEVEIAAVTHGALQGL 128

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H      +IHRDVK+ NILL      K+ DFG A ++A        +   G+  + A
Sbjct: 129 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMA 179

Query: 823 PEYAYTT---KVNEKIDIYSFGVVLLELVTGK 851
           PE        + + K+D++S G+  +EL   K
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 70/282 (24%), Positives = 125/282 (44%), Gaps = 29/282 (10%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +VYR      G  VA+K++     ++ K   + I EI++L  + H N++K + 
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 704 CISSENSKLLVYEYMENQSLDRWL-HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               +N   +V E  +   L R + H +K+  +    +V      W   +Q+       L
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV------WKYFVQL----CSAL 119

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML-AKQGEPHTMSAVAGSFGYF 821
            +MH   + +++HRD+K +N+ + +    K+ D GL +   +K    H++    G+  Y 
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYM 173

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
           +PE  +    N K DI+S G +L E+   +   YGD+           Y+  K I     
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--------YSLCKKIEQCDY 225

Query: 882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
             +    Y EE+    +L  +C +  P  RP +  V  + +R
Sbjct: 226 PPLPSDHYSEELR---QLVNMCINPDPEKRPDITYVYDVAKR 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 59/220 (26%), Positives = 110/220 (50%), Gaps = 24/220 (10%)

Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIW---NNRKLNQKLEKEFIAEIEILGTIRH 695
           T+  ++G G  G VY   +   G+ +AVK++    +N    +K  ++   E+++L +++H
Sbjct: 3   TKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            NIV+       +N+  +  E++   S+         S+++    + + V    T+ QI 
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSIS--------SILNRFGPLPEPVFCKYTK-QIL 112

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS--- 812
                G+ Y+H++C   ++HRD+K +N++L      K+ DFG A+ LA  G   T S   
Sbjct: 113 ----DGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165

Query: 813 -AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            ++ G+  + APE    +    K DI+S G  + E+ TGK
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 70/283 (24%), Positives = 125/283 (44%), Gaps = 31/283 (10%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G    VY+      G  VA+K++     ++ K  ++ + EI++L  + H N++K   
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 704 CISSENSKLLVYEYMENQSLDRWL-HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                N   +V E  +   L R + H +K+  +    ++      W   +Q+       L
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI------WKYFVQL----CSAL 119

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA--VAGSFGY 820
            +MH   + +I+HRD+K +N+ + +    K+ D GL +  + +    T +A  + G+  Y
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK----TTAAHSLVGTPYY 172

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            +PE  +    N K DI+S G +L E+   +   YGD+  +L       Y+  K I    
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNL-------YSLCKKIEKCD 224

Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
              +    Y EE+     L   C +  P  RP +  VLQ+ + 
Sbjct: 225 YPPLPADHYSEELRD---LVSRCINPDPEKRPDISYVLQVAKE 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 25/212 (11%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G G  G V +      GE VA+K+   +   ++ ++K  + E+++L  +RH NIV L 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 703 CCISSENSKLLVYEYMEN---QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
                +    LV+EY+E    + L+    G     V   S + Q                
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVR--SYIWQ--------------LL 110

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           Q + Y H      IIHRD+K  NIL+      K+ DFG A+ L  +        VA  + 
Sbjct: 111 QAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW- 166

Query: 820 YFAPEYAY-TTKVNEKIDIYSFGVVLLELVTG 850
           Y APE     T   + +D+++ G ++ EL+ G
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 80.3 bits (199), Expect = 3e-16
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 38/221 (17%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE---F----IAEIEILGTIR 694
           N I  G  G VYR      GE VA+K++        K+EKE   F    + EI IL  ++
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKL--------KMEKEKEGFPITSLREINILLKLQ 62

Query: 695 HANIVKLWCCI--SSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
           H NIV +   +  S+ +   +V EY+E+         ++  L S    +   +L      
Sbjct: 63  HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL------ 116

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HTM 811
                   G+ ++H +    I+HRD+K+SN+LL++    KI DFGLA+   + G P    
Sbjct: 117 -------SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR---EYGSPLKPY 163

Query: 812 SAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGK 851
           + +  +  Y APE     K  +  ID++S G +  EL+T K
Sbjct: 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 26/208 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY+         +AVK I     +  +L+K+ ++E+EIL       I+  + 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
               EN   +  E+M+  SLD +              + +HVL      +IA+   +GL 
Sbjct: 67  AFFVENRISICTEFMDGGSLDVY------------RKIPEHVLG-----RIAVAVVKGLT 109

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+    + +I+HRDVK SN+L+++  + K+ DFG++  L             G+  Y AP
Sbjct: 110 YL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAP 162

Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           E     +     D++S G+  +EL  G+
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 88/292 (30%), Positives = 130/292 (44%), Gaps = 52/292 (17%)

Query: 644 IGSGGSGQVY--RIDING--AGEFVAVKRIWNNRKLNQ--KLEKEFIAEIEILGTIRHAN 697
           +G G  G+V   R D  G   GE VAVK +      N    L+KE    IEIL  + H N
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE----IEILRNLYHEN 67

Query: 698 IVKL--WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           IVK    C     N   L+ E++ + SL  +L   K  +            +   +L+ A
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI------------NLKQQLKYA 115

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           +   +G+ Y+    + Q +HRD+ + N+L++SE + KI DFGL K +    E +T+    
Sbjct: 116 VQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172

Query: 816 GS-FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
            S   ++APE    +K     D++SFGV L EL+T     Y D             +E  
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-----YCD-------------SESS 214

Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTS--TLPSSRPSMKEVLQILRRC 924
           P+T  L K I          TV RL  +      LP      +EV Q++R+C
Sbjct: 215 PMTLFL-KMIGPT---HGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKC 262

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 82.6 bits (204), Expect = 4e-16
 Identities = 54/155 (34%), Positives = 79/155 (50%), Gaps = 16/155 (10%)

Query: 25  FEVIPQSPNT--EERTILLNLKQQLGNPPSLQSWTSTSSPC-----DWPEITCTFNS--- 74
           FE+I     T  EE + L  LK  LG P     W     PC      W    C F+S   
Sbjct: 360 FEIITAESKTLLEEVSALQTLKSSLGLPLRF-GWNG--DPCVPQQHPWSGADCQFDSTKG 416

Query: 75  ---VTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
              + G+ L ++ +   IP  I  L++L +I+LS NSI G  P  L + T L+ LDLS N
Sbjct: 417 KWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIG 166
            F G IP  + +++ L+ ++L GN+ SG +P ++G
Sbjct: 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 42/231 (18%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
             L +   IG G  G V ++    +G  +AVKRI +   +++K +K  + ++++   +R 
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDEKEQKRLLMDLDV--VMRS 59

Query: 696 AN---IVKLWCCISSENSKLLVYEYMENQSLD---RWLHGRKRSLVSGSSSVHQHVLHWP 749
           ++   IVK +  +  E    +  E M+  SLD   ++++   +S               P
Sbjct: 60  SDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKS-------------VIP 105

Query: 750 TRL--QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML----A 803
             +  +IA+   + L Y+  +   +IIHRDVK SNILLD     K+ DFG++  L    A
Sbjct: 106 EEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163

Query: 804 KQGEPHTMSAVAGSFGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
           K  +       AG   Y APE    +  +    + D++S G+ L E+ TGK
Sbjct: 164 KTRD-------AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 82.2 bits (203), Expect = 5e-16
 Identities = 52/161 (32%), Positives = 76/161 (47%), Gaps = 11/161 (6%)

Query: 454 LLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEI 513
           L LD   L G +P+ I     L ++NL+ N + G IP ++GS+  +  LDLS N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 514 PPEIGQL-KLNTFNLSSNKLYGNIPDEFNNLAYDDS---FLNNSNLCVKNPIINLPKCPS 569
           P  +GQL  L   NL+ N L G +P          +   F +N+ LC    I  L  C  
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC---GIPGLRACGP 539

Query: 570 RFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRR 610
                 KI    +A  + +A L  LV  ++ W+  R  + R
Sbjct: 540 HLSVGAKIG---IAFGVSVAFL-FLVICAMCWWKRRQNILR 576

Length = 623

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 32/222 (14%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-------FIAEIEILGTIRHA 696
           IG G  G VY+      G+ VA+K+I        +LE E        I EI +L  ++H 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI--------RLESEEEGVPSTAIREISLLKELQHP 59

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           NIV L   +  E+   L++E++ +  L ++L    +     +  V  ++       QI  
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLY------QIL- 111

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              QG+ + H   + +++HRD+K  N+L+D++   K+ADFGLA+        +T   V  
Sbjct: 112 ---QGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-- 163

Query: 817 SFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           +  Y APE    + + +  +DI+S G +  E+ T K   +GD
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 26/212 (12%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           L+G G  G V +      G+ VA+K+   +   ++ ++K  + EI +L  +RH N+V L 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 703 CCISSENSKLLVYEYMENQSLD---RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
                +    LV+E++++  LD   ++ +G   S V       +  L      QI  G  
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRV-------RKYL-----FQILRGI- 113

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
              C+ H+     IIHRD+K  NIL+      K+ DFG A+ LA  GE +T   VA  + 
Sbjct: 114 -EFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT-DYVATRW- 165

Query: 820 YFAPEYAY-TTKVNEKIDIYSFGVVLLELVTG 850
           Y APE     TK    +DI++ G ++ E++TG
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 66/219 (30%), Positives = 95/219 (43%), Gaps = 41/219 (18%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEK-----EFIA-EIEILGTIRHA 696
            IG G  G+VY+       + VA+K I         LE+     E I  EI+ L   R  
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVI--------DLEEAEDEIEDIQQEIQFLSQCRSP 59

Query: 697 NIVKLWCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            I K +     + SKL ++ EY    S    L   K      +  + + VL         
Sbjct: 60  YITKYYGSFL-KGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILRE-VLL-------- 109

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS--- 812
                GL Y+H +     IHRD+K++NILL  E   K+ADFG++  L       TMS   
Sbjct: 110 -----GLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT-----STMSKRN 156

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
              G+  + APE    +  +EK DI+S G+  +EL  G+
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.4 bits (196), Expect = 6e-16
 Identities = 76/299 (25%), Positives = 131/299 (43%), Gaps = 29/299 (9%)

Query: 635 LSSLTESNLIGSGGSGQVYR---IDINGAGE--FVAVKRIWNNRKLNQKLEKEFIAEIEI 689
              LT    +G G  GQV +   + ++   E   VAVK + ++    +K   + ++E+E+
Sbjct: 11  RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEM 68

Query: 690 LGTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS---VHQHV 745
           +  I +H NI+ L    + E    +V EY  + +L  +L  R+      S       +  
Sbjct: 69  MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128

Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
           L     +  A   A+G+ ++    + + IHRD+ + N+L+  +   KIADFGLA+ +   
Sbjct: 129 LTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185

Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAE 864
                 +       + APE  +      + D++SFGV+L E+ T   + Y G     L +
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245

Query: 865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
                Y  EKP            C  E    +Y L   C   +PS RP+ K++++ L R
Sbjct: 246 LLKEGYRMEKPQN----------CTQE----LYHLMRDCWHEVPSQRPTFKQLVEDLDR 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 78.4 bits (193), Expect = 6e-16
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 37/206 (17%)

Query: 659 GAGEFVAVKRIW-----NNRKLNQKLEKE-------FIAEIEILGTIRHANIVKLWCCIS 706
           GAG+F  V   W      + K+  K  K+       F+AE  ++  ++H  +V+L+  ++
Sbjct: 15  GAGQFGEV---WMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMH 766
            E    ++ EYMEN SL  +L            +     L     + +A   A+G+ ++ 
Sbjct: 72  QE-PIYIITEYMENGSLVDFL-----------KTPEGIKLTINKLIDMAAQIAEGMAFIE 119

Query: 767 HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGYFAP 823
                  IHRD++++NIL+      KIADFGLA+++    E +  +A  G+     + AP
Sbjct: 120 RK---NYIHRDLRAANILVSETLCCKIADFGLARLI----EDNEYTAREGAKFPIKWTAP 172

Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVT 849
           E         K D++SFG++L E+VT
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 27/210 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEK--EFIAEIEILGTIRHANIVKL 701
           +G GG GQV+       GE VA+KR+   + L  KL +    + E +IL T +   +VKL
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRM--KKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ-HVLHWPTRLQIAIGAAQ 760
                 +    L  EY+          G  R+L++    + + H   +   +  A+ A  
Sbjct: 67  LYAFQDDEYLYLAMEYVPG--------GDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y         IHRD+K  N L+D+    K+ DFGL+K     G     ++V GS  Y
Sbjct: 119 ELGY---------IHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDY 164

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            APE       +  +D +S G +L E + G
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 26/215 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI-AEIEILGTIRHANIVKLW 702
           I  G  G+V+       G+  A+K I     + +K + + +  E +IL   +   +VKL+
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVI-KKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA-IGAAQG 761
                + +  LV EY+    L         SL+    S+ + V     R+ IA I     
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDL--------ASLLENVGSLDEDV----ARIYIAEI--VLA 105

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM------LAKQGEPHTMSAVA 815
           L Y+H +    IIHRD+K  NIL+DS    K+ DFGL+K+      +    +      + 
Sbjct: 106 LEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162

Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           G+  Y APE       ++ +D +S G +L E + G
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 78.7 bits (195), Expect = 1e-15
 Identities = 70/226 (30%), Positives = 100/226 (44%), Gaps = 43/226 (19%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             IGSG  G V        G  VA+K+I N    +    K  + EI++L  +RH NI+ L
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGL 64

Query: 702 WCCI-----SSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH-QHVLHWPTRLQIA 755
              +        N   +V E ME   L + +    + L    +  H Q+ L+     QI 
Sbjct: 65  LDILRPPSPEDFNDVYIVTELMET-DLHKVIK-SPQPL----TDDHIQYFLY-----QIL 113

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               +GL Y+H   +  +IHRD+K SNIL++S    KI DFG    LA+  +P       
Sbjct: 114 ----RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFG----LARGVDPDEDEKGF 162

Query: 816 GSFG-----YFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
            +       Y APE       YT    + IDI+S G +  EL+T K
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYT----KAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 68/273 (24%), Positives = 118/273 (43%), Gaps = 38/273 (13%)

Query: 664 VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL 723
           VAVK +  +   +    ++F+ E++IL  +   NI +L    + +    ++ EYMEN  L
Sbjct: 49  VAVKVLRPD--ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 724 DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI 783
           +++L  +K    +   + +   L + T L +A   A G   M +  +   +HRD+ + N 
Sbjct: 107 NQFL--QKHVAETSGLACNSKSLSFSTLLYMATQIASG---MRYLESLNFVHRDLATRNC 161

Query: 784 LLDSEFKAKIADFGLAKMLAK------QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDI 837
           L+   +  KIADFG+++ L        QG      A      + A E     K   K D+
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQG-----RAPL-PIRWMAWESVLLGKFTTKSDV 215

Query: 838 YSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDA--LDKGIAEPCYLEEMT 894
           ++FGV L E++T  +E  Y             H  +++ I +A    +      YL    
Sbjct: 216 WAFGVTLWEILTLCREQPYE------------HLTDQQVIENAGHFFRDDGRQIYLPRPP 263

Query: 895 ----TVYRLALICTSTLPSSRPSMKEVLQILRR 923
                +Y L L C       RP+ +E+   L+R
Sbjct: 264 NCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 17/210 (8%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G+   +     G+   +K I N  K++ K  +E   E+ +L  ++H NIV+   
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEI-NISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                 +  +V +Y E   L + ++ ++  L          +L W  ++ +A        
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP-----EDQILDWFVQICLA-------- 113

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            + H    +I+HRD+KS NI L  +   K+ DFG+A++L    E        G+  Y +P
Sbjct: 114 -LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSP 170

Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEA 853
           E       N K DI++ G VL E+ T K A
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 25/222 (11%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI-LGTI 693
           L+ L     IGSG  GQVY++     G  +AVK++   R  N++  K  + ++++ L + 
Sbjct: 14  LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKEENKRILMDLDVVLKSH 71

Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
               IVK +    +++   +  E M    LD+ L   KR        + + +L      +
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELMST-CLDKLL---KRI----QGPIPEDILG-----K 118

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
           + +   + L Y+       +IHRDVK SNILLD+    K+ DFG++  L    +  T S 
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRS- 174

Query: 814 VAGSFGYFAPEYAYTTKVNEKIDI----YSFGVVLLELVTGK 851
            AG   Y APE       N K DI    +S G+ L+EL TG+
Sbjct: 175 -AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 33/230 (14%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKL 701
           +IG G  G+VY+      G+ VA+K +     + +  E+E   E  IL     H NI   
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIM----DIIEDEEEEIKEEYNILRKYSNHPNIATF 68

Query: 702 WCCI-----SSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           +           + +L LV E     S+   +   K     G     + + +      I 
Sbjct: 69  YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAY------IL 119

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK-QGEPHTMSAV 814
               +GL Y+H +   ++IHRD+K  NILL    + K+ DFG++  L    G  +T    
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT---F 173

Query: 815 AGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
            G+  + APE            + + D++S G+  +EL  GK     D H
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK-PPLCDMH 222

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 81/301 (26%), Positives = 126/301 (41%), Gaps = 55/301 (18%)

Query: 642 NLIGSGGSGQVYR-----IDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           N +GSG  G+VY      I   G+G   VAVK +       +K  KEF+ E  ++    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNH 58

Query: 696 ANIVK-LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
            NIVK L  C+ +E  + ++ E ME   L  +L   +             +L     L I
Sbjct: 59  PNIVKLLGVCLLNE-PQYIIMELMEGGDLLSYLRDARVERFGPP------LLTLKELLDI 111

Query: 755 AIGAAQGLCY---MHHDCTPQIIHRDVKSSNILL-----DSEFKAKIADFGLAKMLAK-- 804
            +  A+G  Y   MH       IHRD+ + N L+     D++   KI DFGLA+ + K  
Sbjct: 112 CLDVAKGCVYLEQMH------FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD 165

Query: 805 --QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
             + E   +  V     + APE     K   + D++SFGV++ E++T  +  Y     +L
Sbjct: 166 YYRKEGEGLLPVR----WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY----PAL 217

Query: 863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTT--VYRLALICTSTLPSSRPSMKEVLQI 920
                  +            G  +     E     +Y+L   C +  PS RP+   + +I
Sbjct: 218 NNQEVLQHVTA--------GGRLQK---PENCPDKIYQLMTNCWAQDPSERPTFDRIQEI 266

Query: 921 L 921
           L
Sbjct: 267 L 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 50/264 (18%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    N + + VAVK +    K      + F+ E  ++ T++H  +V+L+ 
Sbjct: 14  LGAGQFGEVWMGYYNNSTK-VAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYM   SL  +L   +   V             P  +  +   A+G+ 
Sbjct: 69  VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKV-----------LLPKLIDFSAQIAEGMA 117

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        IHRD++++N+L+      KIADFGLA+++    E +  +A  G+     +
Sbjct: 118 YIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI----EDNEYTAREGAKFPIKW 170

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVT-GK-----------------------EANYG 856
            APE         K D++SFG++L E+VT GK                         N  
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCP 230

Query: 857 DEHTSLAEWAWRHYAEEKPITDAL 880
           DE   + +  W+  AEE+P  D L
Sbjct: 231 DELYDIMKTCWKEKAEERPTFDYL 254

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.4 bits (190), Expect = 3e-15
 Identities = 80/293 (27%), Positives = 135/293 (46%), Gaps = 49/293 (16%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           + L    ++GSG  G VY+      GE V    A+K +  N     K   EF+ E  I+ 
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMA 64

Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ H ++V+L   C+S   +  LV + M +  L  ++H  K ++ S      Q +L+W  
Sbjct: 65  SMDHPHLVRLLGVCLSP--TIQLVTQLMPHGCLLDYVHEHKDNIGS------QLLLNWCV 116

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
           ++      A+G+ Y+      +++HRD+ + N+L+ S    KI DFGLA++L  +G+   
Sbjct: 117 QI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL--EGDEKE 165

Query: 811 MSAVAGSF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
            +A  G     + A E  +  K   + D++S+GV + EL+T     Y    T        
Sbjct: 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------- 217

Query: 869 HYAEEKPITDALDKGIAEP----CYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
                + I D L+KG   P    C ++    VY + + C      SRP  KE+
Sbjct: 218 -----REIPDLLEKGERLPQPPICTID----VYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 645 GSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCC 704
           G+ G   +YR   + +   V  K + N  +L++K  ++ + EI IL  ++H NI+  +  
Sbjct: 11  GAFGEATLYRRTEDDS--LVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 705 ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA--IGAAQGL 762
              +N+ L+  EY    +L   +             V Q    +   + +         +
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKI-------------VRQKGQLFEEEMVLWYLFQIVSAV 114

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS-AVAGSFGYF 821
            Y+H      I+HRD+K+ NI L      K+ DFG++K+L   G  ++M+  V G+  Y 
Sbjct: 115 SYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAETVVGTPYYM 168

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEA 853
           +PE     K N K DI++ G VL EL+T K  
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRT 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 59/232 (25%), Positives = 108/232 (46%), Gaps = 31/232 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEF--------------VAVKRIWNNRKLNQKLEKEFIAEIEI 689
           +G G  G+V+  +  G  EF              VAVK +  +  + +    +F+ EI+I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKI 70

Query: 690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK-RSLVSGSSSV----HQH 744
           +  +++ NI++L     S++   ++ EYMEN  L+++L  R+  S  + ++++      +
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 745 VLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
           +L+     QIA G       M +  +   +HRD+ + N L+ + +  KIADFG+++ L  
Sbjct: 131 LLYMAV--QIASG-------MKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANY 855
                          + A E     K     D+++FGV L E+ T  KE  Y
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 72/223 (32%), Positives = 102/223 (45%), Gaps = 34/223 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE---KEFIAEIEILGTIRHANIVK 700
           IG G  G VY+       E +A+K+I    +L Q+ E      I EI +L  ++H NIV+
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKI----RLEQEDEGVPSTAIREISLLKEMQHGNIVR 65

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   + SE    LV+EY++   LD      K+ + S         L      QI  G A 
Sbjct: 66  LQDVVHSEKRLYLVFEYLD---LD-----LKKHMDSSPDFAKNPRLIKTYLYQILRGIA- 116

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGEPHTMSAVAGSFG 819
             C+ H     +++HRD+K  N+L+D    A K+ADFGLA+         T   V  +  
Sbjct: 117 -YCHSH-----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLW 168

Query: 820 YFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           Y APE       Y+T V    DI+S G +  E+V  K    GD
Sbjct: 169 YRAPEILLGSRHYSTPV----DIWSVGCIFAEMVNQKPLFPGD 207

Length = 294

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 76.5 bits (188), Expect = 6e-15
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 23/223 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKL 701
           ++G G  G+V+  ++ G  +F A+K +  +  L     +  + E  +L     H  +  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +C   ++ +   V EY+                  G    H    H     +    AA+ 
Sbjct: 62  YCTFQTKENLFFVMEYLN----------------GGDLMFHIQSCHKFDLPRATFYAAEI 105

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK--MLAKQGEPHTMSAVAGSFG 819
           +C +    +  I++RD+K  NILLD++   KIADFG+ K  ML   G+  T     G+  
Sbjct: 106 ICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML---GDAKT-CTFCGTPD 161

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
           Y APE     K N  +D +SFGV+L E++ G+   +G +   L
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 7e-15
 Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 47/223 (21%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA---NIV 699
           LIG G  G VYR      G  VA+K I  N         +   E+ +L  +R +   NI 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKII--NLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS-------SSVHQHVLHWPTRL 752
           K +          ++ EY E  S+        R+L+          S + + VL      
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSV--------RTLMKAGPIAEKYISVIIREVL------ 111

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
                    L Y+H      +IHRD+K++NIL+ +    K+ DFG+A +L +       S
Sbjct: 112 -------VALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR--S 159

Query: 813 AVAGSFGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTG 850
              G+  + APE       Y TK     DI+S G+ + E+ TG
Sbjct: 160 TFVGTPYWMAPEVITEGKYYDTKA----DIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 75.3 bits (186), Expect = 8e-15
 Identities = 61/212 (28%), Positives = 89/212 (41%), Gaps = 27/212 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G GG G+V  + +       A+K +     +    ++   +E EIL    H  IVKL+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
               +    ++ EY     L  W   R R L             +  R  IA        
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL--WTILRDRGLFD----------EYTARFYIA-CVVLAFE 107

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H+     II+RD+K  N+LLDS    K+ DFG AK L    +  T     G+  Y AP
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF---CGTPEYVAP 161

Query: 824 EY----AYTTKVNEKIDIYSFGVVLLELVTGK 851
           E      Y   V    D +S G++L EL+TG+
Sbjct: 162 EIILNKGYDFSV----DYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.2 bits (187), Expect = 1e-14
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 21/208 (10%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V ++    +G  +A K I  + ++   +  + I E+++L       IV  + 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
              S+    +  E+M+  SLD+ L   KR        + + +L      +++I   +GL 
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVLKEAKR--------IPEEILG-----KVSIAVLRGLA 117

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+      QI+HRDVK SNIL++S  + K+ DFG++  L         ++  G+  Y +P
Sbjct: 118 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 171

Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           E    T  + + DI+S G+ L+EL  G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 24/217 (11%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S L     IG G +G V        G  VAVK++ + RK  Q+ E  F  E+ I+   +H
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM-DLRK-QQRRELLF-NEVVIMRDYQH 75

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
            NIV+++      +   +V E++E  +L D   H R               ++      +
Sbjct: 76  PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---------------MNEEQIATV 120

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
            +   + L ++H      +IHRD+KS +ILL S+ + K++DFG    ++K+  P   S V
Sbjct: 121 CLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-VPRRKSLV 176

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            G+  + APE         ++DI+S G++++E+V G+
Sbjct: 177 -GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 39/224 (17%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKLW 702
           IG G SG VY       G+ VA+K++     L Q+ +KE I  EI ++   +H NIV   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM----NLQQQPKKELIINEILVMRENKHPNIVNYL 82

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA--- 759
                 +   +V EY+   SL          +V+             T +     AA   
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLT--------DVVT------------ETCMDEGQIAAVCR 122

Query: 760 ---QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL-AKMLAKQGEPHTMSAVA 815
              Q L ++H +   Q+IHRD+KS NILL  +   K+ DFG  A++  +Q +  TM    
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---V 176

Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           G+  + APE         K+DI+S G++ +E+V G E  Y +E+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG-EPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 59/266 (22%), Positives = 112/266 (42%), Gaps = 49/266 (18%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S LT    IGSG  G V+        + VA+K I    +     E++FI E +++  + H
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTI----REGAMSEEDFIEEAQVMMKLSH 58

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+   +  +   LV+E+ME+  L  +L  ++                  T L + 
Sbjct: 59  PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQ------------ETLLGMC 106

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           +   +G+ Y+       +IHRD+ + N L+      K++DFG+ + +    +    S+  
Sbjct: 107 LDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL---DDQYTSSTG 160

Query: 816 GSF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS------------ 861
             F   + +PE    +K + K D++SFGV++ E+ +  +  Y +   S            
Sbjct: 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL 220

Query: 862 ------------LAEWAWRHYAEEKP 875
                       L +  W+   E++P
Sbjct: 221 YKPRLASQSVYELMQHCWKERPEDRP 246

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 23/215 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA---EIEILGTIRHANIV 699
           L+G G  G+VY       G  +AVK++  +   +Q+  KE  A   EI++L  +RH  IV
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPD-SQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 700 KLWCCISS-ENSKLLVY-EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           + + C+   E  KL ++ EYM   S+        +  +    ++ ++V    TR QI   
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSI--------KDQLKAYGALTENVTRRYTR-QIL-- 116

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT-MSAVAG 816
             QG+ Y+H +    I+HRD+K +NIL DS    K+ DFG +K +       T + +V G
Sbjct: 117 --QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +  + +PE         K D++S    ++E++T K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 80/298 (26%), Positives = 133/298 (44%), Gaps = 41/298 (13%)

Query: 644 IGSGGSGQVYRIDI-NGAGE----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V+  +  N   E     VAVK +   +  +    K+F  E E+L  ++H +I
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQHEHI 69

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           VK +      +  ++V+EYM++  L+++L  HG    L++  +   +  L     L IA 
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE--LTQSQMLHIAQ 127

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE----PHTMS 812
             A G+ Y+    +   +HRD+ + N L+      KI DFG+++ +          HTM 
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYA 871
            +     +  PE     K   + D++S GVVL E+ T GK+  Y   +  + E   +   
Sbjct: 185 PIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV---LQILRRCCP 926
            ++P T          C  E    VY L L C    P  R ++KE+   LQ L +  P
Sbjct: 241 LQRPRT----------CPKE----VYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 45/225 (20%)

Query: 640 ESNLIGSGGSGQVYRIDINGAGEFVAVK--RIWNNRKLNQKLEKEFIAEIEILGTIR--- 694
           E   IG G  G VY+      G FVA+K  R+  +    + +    + EI +L  +    
Sbjct: 3   ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE---EGIPLSTLREIALLKQLESFE 59

Query: 695 HANIVKLW-----CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSG-SSSVHQHVLHW 748
           H NIV+L           E    LV+E+++ Q L  +L    +    G      + ++  
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYL---SKCPKPGLPPETIKDLMR- 114

Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
               Q+     +G+ ++H   + +I+HRD+K  NIL+ S+ + KIADFGLA++ + +   
Sbjct: 115 ----QLL----RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--- 160

Query: 809 HTMS--AVAGSFGYFAPEY----AYTTKVNEKIDIYSFGVVLLEL 847
             M+  +V  +  Y APE     +Y T V    D++S G +  EL
Sbjct: 161 --MALTSVVVTLWYRAPEVLLQSSYATPV----DMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 76/292 (26%), Positives = 135/292 (46%), Gaps = 47/292 (16%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEF----VAVKRI--WNNRKLNQKLEKEFIAEIEI 689
           + L +  L+GSG  G V++      G+     VA+K I   + R+  Q++    +A    
Sbjct: 7   TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA---- 62

Query: 690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
           +G++ HA IV+L   I    S  LV +     SL   +   + SL        Q +L+W 
Sbjct: 63  MGSLDHAYIVRL-LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDP------QRLLNWC 115

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
            ++      A+G+ Y+       ++HR++ + NILL S+   +IADFG+A +L    + +
Sbjct: 116 VQI------AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166

Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
             S       + A E     +   + D++S+GV + E+++     YG E      +A   
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS-----YGAE-----PYAGMR 216

Query: 870 YAEEKPITDALDKG--IAEP--CYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
             E   + D L+KG  +A+P  C ++    VY + + C     + RP+ KE+
Sbjct: 217 PHE---VPDLLEKGERLAQPQICTID----VYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 61/259 (23%), Positives = 112/259 (43%), Gaps = 41/259 (15%)

Query: 664 VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL 723
           VA+K I    K     E EFI E +++  + H  +V+L+   + +    +V EYM N  L
Sbjct: 31  VAIKMI----KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86

Query: 724 DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI 783
             +L    R         H         L++     +G+ Y+    + Q IHRD+ + N 
Sbjct: 87  LNYL----RE--------HGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNC 131

Query: 784 LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF--GYFAPEYAYTTKVNEKIDIYSFG 841
           L+D +   K++DFGL++ +    +    S+V   F   +  PE    +K + K D+++FG
Sbjct: 132 LVDDQGCVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFG 188

Query: 842 VVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG--IAEPCYLEEMTTVYRL 899
           V++ E+             SL +  +  +   +   + + +G  +  P    E   VY +
Sbjct: 189 VLMWEVY------------SLGKMPYERFNNSE-TVEKVSQGLRLYRPHLASE--KVYAI 233

Query: 900 ALICTSTLPSSRPSMKEVL 918
              C       RP+ +++L
Sbjct: 234 MYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 2e-14
 Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 39/232 (16%)

Query: 633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-----EI 687
           ++       + IG G  G V        G  VA+K+I          E +        EI
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-------SPFEHQTFCQRTLREI 54

Query: 688 EILGTIRHANIVKLWCCISSE-----NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
           +IL   +H NI+ +   I        N   +V E ME       L+   + + +   S +
Sbjct: 55  KILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LY---KLIKTQHLS-N 105

Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
            H+ ++    QI     +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +
Sbjct: 106 DHIQYF--LYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR-I 155

Query: 803 AKQGEPHT--MSAVAGSFGYFAPEYAYTTKVNEK-IDIYSFGVVLLELVTGK 851
           A     HT  ++    +  Y APE    +K   K IDI+S G +L E+++ +
Sbjct: 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 75.5 bits (186), Expect = 2e-14
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 34/218 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G V     +   E VA+K+I  N   N+   K  + EI++L  + H N++ +  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKI-ANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71

Query: 704 CI-----SSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
            +      + N   +VYE M     D  LH   RS  + S    Q+ L+   R       
Sbjct: 72  IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLR------- 119

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
             GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+  +++G+  T   V  + 
Sbjct: 120 --GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TR 172

Query: 819 GYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTGK 851
            Y APE       YTT     ID++S G +  EL+  K
Sbjct: 173 WYRAPELLLNCSEYTT----AIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 75.0 bits (185), Expect = 3e-14
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 41/232 (17%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-----EIEILGTIRHA 696
           + +GSG  GQV        G  VA+K      KL++  +    A     E+ +L  + H 
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 697 NIVKLWCCI--SSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           N++ L      +S         LV   M        L+   +        + Q +++   
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLM-----GADLNNIVKCQKLSDDHI-QFLVY--- 125

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
             QI     +GL Y+H   +  IIHRD+K SNI ++ + + KI DFGLA+    +     
Sbjct: 126 --QIL----RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----- 171

Query: 811 MSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS 861
           M+    +  Y APE        N+ +DI+S G ++ EL+TGK    G +H  
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 28/212 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE---KEFIAEIEILGTIRHANIVK 700
           IG G  G V++       E VA+KR+    +L+   E      + EI +L  ++H NIV+
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNIVR 63

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+  + S+    LV+EY + Q L       K+   S +  +   ++      Q+  G A 
Sbjct: 64  LYDVLHSDKKLTLVFEYCD-QDL-------KKYFDSCNGDIDPEIVKSFM-FQLLKGLA- 113

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HTMSAVAGSFG 819
             C+ H+     ++HRD+K  N+L++   + K+ADFGLA+     G P    SA   +  
Sbjct: 114 -FCHSHN-----VLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVRCYSAEVVTLW 164

Query: 820 YFAPEYAYTTKV-NEKIDIYSFGVVLLELVTG 850
           Y  P+  +  K+ +  ID++S G +  EL   
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 77.1 bits (190), Expect = 3e-14
 Identities = 62/227 (27%), Positives = 95/227 (41%), Gaps = 29/227 (12%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           LIG GG G+VY          VA+K+I  +   N  L+K F+ E +I   + H  IV ++
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHG--RKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
              S  +       Y+E  +L   L    +K SL    S            L I      
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL----SKELAEKTSVGAFLSIFHKICA 124

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP------------ 808
            + Y+H   +  ++HRD+K  NILL    +  I D+G A    K+ E             
Sbjct: 125 TIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIF--KKLEEEDLLDIDVDERN 179

Query: 809 ---HTMS---AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
               +M+    + G+  Y APE       +E  DIY+ GV+L +++T
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 74/292 (25%), Positives = 127/292 (43%), Gaps = 38/292 (13%)

Query: 644 IGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V +     + G   +  VAVK +  N   +    ++ ++E  +L  + H ++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHV 65

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKR-------SLVSGSSSVHQHVLHWPTR 751
           +KL+   S +   LL+ EY +  SL  +L   ++       S  + +SS   +       
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 752 LQIAIGAAQGLCY-MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
           +   I  A  +   M +    +++HRD+ + N+L+    K KI+DFGL++ + ++     
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185

Query: 811 MSAVAGSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEW 865
            S       + A E    + YTT+     D++SFGV+L E+VT G     G     L   
Sbjct: 186 RSKGRIPVKWMAIESLFDHIYTTQS----DVWSFGVLLWEIVTLGGNPYPGIAPERLFNL 241

Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
               Y  E+P          E C  EEM   Y L L C    P  RP+  ++
Sbjct: 242 LKTGYRMERP----------ENCS-EEM---YNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.9 bits (181), Expect = 4e-14
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 28/213 (13%)

Query: 644 IGSGGSGQVYRI-DINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL---GTIRHANIV 699
           IG G  G+V++  D+   G FVA+KR+   +   + +    I E+ +L    T  H N+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 700 KLW--CCISS---ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           +L+  C +S    E    LV+E+++ Q L  +L       V              T   +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTE-----------TIKDM 115

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
                +GL ++H   + +++HRD+K  NIL+ S  + K+ADFGLA++ + Q     +++V
Sbjct: 116 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSV 169

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL 847
             +  Y APE    +     +D++S G +  E+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 74.1 bits (182), Expect = 4e-14
 Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)

Query: 634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
           I +   +   +G G  G V        G+ VA+K+I         L K    E+++L  +
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHL 66

Query: 694 RHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
           RH NI+ L    IS       V E +    L R L  R            Q+ L+     
Sbjct: 67  RHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRPL-----EKQFIQYFLY----- 115

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
           QI     +GL Y+H   +  ++HRD+K SNIL++     KI DFGLA++     +   M+
Sbjct: 116 QI----LRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMT 163

Query: 813 AVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
               +  Y APE   T  K + ++DI+S G +  E++ GK    G +H
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.8 bits (181), Expect = 4e-14
 Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 31/292 (10%)

Query: 644 IGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RH 695
           +G G  GQV R +  G  +        VAVK + +N     K   + I+E+E++  I +H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKH 77

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK---RSLVSGSSSVHQHVLHWPTRL 752
            NI+ L    + E    ++ EY    +L  +L  R+          + V +  L +   +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +         S
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
                  + APE  +      + D++SFG+++ E+ T   + Y G     L +     + 
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR 254

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +KP            C  E    +Y L   C   +P+ RP+ K++++ L +
Sbjct: 255 MDKP----------SNCTHE----LYMLMRECWHAVPTQRPTFKQLVEALDK 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 73.6 bits (180), Expect = 5e-14
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 26/215 (12%)

Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHAN 697
           T    IG G SG V+       G+ VA+K+I     L ++ +KE I  EI ++  +++ N
Sbjct: 22  TRYEKIGQGASGTVFTAIDVATGQEVAIKQI----NLQKQPKKELIINEILVMKELKNPN 77

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV         +   +V EY+   SL              +  V +  +       +   
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSL--------------TDVVTETCMDEAQIAAVCRE 123

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL-AKMLAKQGEPHTMSAVAG 816
             Q L ++H +   Q+IHRD+KS N+LL  +   K+ DFG  A++  +Q +  TM    G
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM---VG 177

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +  + APE         K+DI+S G++ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 46/221 (20%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIA--EIEILGTIRH 695
           IG G  G V++      G+ VA+K+          +E E       IA  EI +L  ++H
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF---------VESEDDPVIKKIALREIRMLKQLKH 59

Query: 696 ANIVKLWCCISSENSKL-LVYEYMEN---QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
            N+V L   +     KL LV+EY ++     L++   G    L+          + W T 
Sbjct: 60  PNLVNL-IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK--------IIWQT- 109

Query: 752 LQIAIGAAQGLCYMH-HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                   Q + + H H+C    IHRDVK  NIL+  + + K+ DFG A++L   G+ +T
Sbjct: 110 -------LQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158

Query: 811 MSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTG 850
              VA  + Y APE     T+    +D+++ G V  EL+TG
Sbjct: 159 -DYVATRW-YRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 72.6 bits (178), Expect = 6e-14
 Identities = 65/297 (21%), Positives = 123/297 (41%), Gaps = 46/297 (15%)

Query: 636 SSLTESNLIGSGGSGQVYR--IDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
            S+    ++G+G  G++ R  + +    E  VA+  +       Q+    F+AE   LG 
Sbjct: 5   KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG--FLAEALTLGQ 62

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H+NIV+L   I+  N+ ++V EYM N +LD +L   +  LV+G              +
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQ------------LM 110

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
            +  G A G+ Y+        +H+ + +  +L++S+   KI+ F        + +     
Sbjct: 111 GMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR-------RLQEDKSE 160

Query: 813 AVAGSFG------YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
           A+  +        + APE       +   D++SFG+V+ E+++  E  Y         W 
Sbjct: 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY---------WD 211

Query: 867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
                  + +  A++ G   P        +++L L C       RP   ++  IL +
Sbjct: 212 MSG----QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 73.7 bits (181), Expect = 6e-14
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 37/237 (15%)

Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK 674
           D ++WKL+ F ++G T             +G+G  G+V      G GE+ A+K +     
Sbjct: 11  DTSSWKLSDF-EMGET-------------LGTGSFGRVRIAKHKGTGEYYAIKCLKKREI 56

Query: 675 LNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSL 734
           L  K  +    E  IL  + H  IV + C    EN    + E++    L  + H RK   
Sbjct: 57  LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAG- 113

Query: 735 VSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMH-HDCTPQIIHRDVKSSNILLDSEFKAKI 793
                        +P  +     A   L + + H     II+RD+K  N+LLD++   K+
Sbjct: 114 ------------RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKV 159

Query: 794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            DFG AK +     P     + G+  Y APE   +    + +D ++ GV+L E + G
Sbjct: 160 TDFGFAKKV-----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 21/215 (9%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G+G  G+V+ +    +  + A+K +     +  K E+    E  +L  + H  I++L+
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                +    ++ EY+    L  +L    R   S S+      L + + +  A+      
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTG-----LFYASEIVCALE----- 115

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   + +I++RD+K  NILLD E   K+ DFG AK L  +    T+    G+  Y A
Sbjct: 116 -YLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTL---CGTPEYLA 166

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           PE   +   N+ +D ++ G+++ E++ G    + D
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 29/212 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V ++    +G  +A K I  + ++   +  + I E+++L       IV  + 
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLI--HLEIKPAIRNQIIRELKVLHECNSPYIVGFYG 66

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
              S+    +  E+M+  SLD+ L    R        + +++L      +I+I   +GL 
Sbjct: 67  AFYSDGEISICMEHMDGGSLDQVLKKAGR--------IPENILG-----KISIAVLRGLT 113

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF----G 819
           Y+      +I+HRDVK SNIL++S  + K+ DFG++  L        + ++A SF     
Sbjct: 114 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--------IDSMANSFVGTRS 163

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y +PE    T    + DI+S G+ L+E+  G+
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.2 bits (185), Expect = 8e-14
 Identities = 37/89 (41%), Positives = 54/89 (60%), Gaps = 1/89 (1%)

Query: 248 LALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSI 306
           L L+   L G IP+ +  L +L  + L  N + G IP S+ ++  L  +DLS N+  GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 307 PEEFGKLKNLQLLGLFSNHLSGEVPASIG 335
           PE  G+L +L++L L  N LSG VPA++G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 72.8 bits (179), Expect = 8e-14
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 39/217 (17%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEF--IAEIEILGTIRHANIVKL 701
           +G G    VY+      G+ VA+K I    +L  +    F  I E  +L  ++HANIV L
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEI----RLEHEEGAPFTAIREASLLKDLKHANIVTL 68

Query: 702 WCCISSENSKLLVYEYMEN---QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
              I ++ +  LV+EY++    Q +D    G       G  S+H   L     L      
Sbjct: 69  HDIIHTKKTLTLVFEYLDTDLKQYMDD--CG-------GGLSMHNVRLFLFQLL------ 113

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
            +GL Y H     +++HRD+K  N+L+    + K+ADFGLA+  AK     T S    + 
Sbjct: 114 -RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR--AKSVPSKTYSNEVVTL 167

Query: 819 GYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTG 850
            Y  P+       Y+T     +D++  G +  E+ TG
Sbjct: 168 WYRPPDVLLGSTEYST----SLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.4 bits (177), Expect = 8e-14
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 23/215 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA---EIEILGTIRHANIV 699
           L+G G  G+VY       G  +A K++  + + + +  KE  A   EI++L  ++H  IV
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPE-SPETSKEVSALECEIQLLKNLQHERIV 67

Query: 700 KLWCCISSENSKLLV--YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           + + C+     K L    EYM   S+        +  +    ++ + V    TR QI   
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSV--------KDQLKAYGALTESVTRKYTR-QIL-- 116

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT-MSAVAG 816
             +G+ Y+H +    I+HRD+K +NIL DS    K+ DFG +K L       T + +V G
Sbjct: 117 --EGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +  + +PE         K D++S G  ++E++T K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 44/224 (19%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI-LGTIRHANIVKLW 702
           +G G  G V ++     G  +AVKRI     +N + +K  + +++I + ++     V  +
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL--QIAIGAAQ 760
             +  E    +  E M+  SLD++              V+   L  P  +  +IA+   +
Sbjct: 67  GALFREGDVWICMEVMDT-SLDKFY-----------KKVYDKGLTIPEDILGKIAVSIVK 114

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG----LAKMLAKQGEPHTMSAVAG 816
            L Y+H      +IHRDVK SN+L++   + K+ DFG    L   +AK     T+   AG
Sbjct: 115 ALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK-----TID--AG 165

Query: 817 SFGYFAPEYAYTTKVNE---------KIDIYSFGVVLLELVTGK 851
              Y APE     ++N          K D++S G+ ++EL TG+
Sbjct: 166 CKPYMAPE-----RINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 73.1 bits (180), Expect = 9e-14
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 33/220 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IGSG  G V       +G+ VA+K+I +   +   L K  + E++IL   +H NI+ +  
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT-LAKRTLRELKILRHFKHDNIIAIRD 71

Query: 704 CISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
            +    +      +V + ME+  L   +H       S      +H+ ++  +L       
Sbjct: 72  ILRPPGADFKDVYVVMDLMES-DLHHIIH-------SDQPLTEEHIRYFLYQL------L 117

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAGS 817
           +GL Y+H      +IHRD+K SN+L++ + + +I DFG+A+ L+     H   M+    +
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 818 FGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGKE 852
             Y APE       YTT     ID++S G +  E++  ++
Sbjct: 175 RWYRAPELLLSLPEYTT----AIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 1e-13
 Identities = 61/245 (24%), Positives = 91/245 (37%), Gaps = 63/245 (25%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK---LNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G+V+ +     G+  A+K +   RK   + +       AE +IL       IV
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVL---RKSDMIKRNQIAHVRAERDILADADSPWIV 64

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL--HWPTRLQI--- 754
           KL+     E    LV EYM    L   L             + + V       R  I   
Sbjct: 65  KLYYSFQDEEHLYLVMEYMPGGDLMNLL-------------IRKDVFPEET-ARFYIAEL 110

Query: 755 --AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A+ +   L +         IHRD+K  NIL+D++   K+ADFGL K + K  +     
Sbjct: 111 VLALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161

Query: 813 ---------------------------AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLL 845
                                      +  G+  Y APE    T    + D +S GV+L 
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221

Query: 846 ELVTG 850
           E++ G
Sbjct: 222 EMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 62/228 (27%), Positives = 93/228 (40%), Gaps = 42/228 (18%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAE-------------IEIL 690
           +G G  G+V   +    GE  A+K           L+K  I                E  
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIK----------ALKKGDIIARDEVESLMCEKRIFETA 56

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
            + RH  +V L+ C  +E+    V EY      D  +H            +H  V   P 
Sbjct: 57  NSERHPFLVNLFACFQTEDHVCFVMEYAAGG--DLMMH------------IHTDVFSEPR 102

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            +  A     GL Y+H +   +I++RD+K  N+LLD+E   KIADFGL K     G    
Sbjct: 103 AVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDR 157

Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
            S   G+  + APE    T     +D +  GV++ E++ G+    GD+
Sbjct: 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 25/212 (11%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G GG G+V    +   G+  A K++   R   +K E+  + E +IL  +    IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL----QIAIGAA 759
              +++   LV   M    L                    H+ +         +    AA
Sbjct: 61  AFETKDDLCLVMTLMNGGDL------------------KYHIYNVGEPGFPEARAIFYAA 102

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           Q +C + H    +I++RD+K  N+LLD     +I+D GLA  L    +       AG+ G
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPG 159

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y APE       +  +D ++ G  L E++ G+
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 71/285 (24%), Positives = 115/285 (40%), Gaps = 44/285 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G+V+   +      VAVK       L   L+ +F+ E  IL    H NIV+L  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             + +    +V E ++      +L          +       L     +Q+   AA G+ 
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLR---------TEGPR---LKVKELIQMVENAAAGME 108

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG----SFG 819
           Y+        IHRD+ + N L+  +   KI+DFG    ++++ E    ++  G       
Sbjct: 109 YLESKHC---IHRDLAARNCLVTEKNVLKISDFG----MSREEEDGVYASTGGMKQIPVK 161

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLE---LVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
           + APE     + + + D++SFG++L E   L     AN  ++ T                
Sbjct: 162 WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR--------------- 206

Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            +A+++G+  PC       VYRL   C    P  RPS   V Q L
Sbjct: 207 -EAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 33/224 (14%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIE 688
           L +  + + +G G    VY+         VA+K I        +LE E       I E+ 
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI--------RLEHEEGAPCTAIREVS 56

Query: 689 ILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           +L  ++HANIV L   I +E S  LV+EY     LD+ L   K+ L    +S++ H +  
Sbjct: 57  LLKDLKHANIVTLHDIIHTEKSLTLVFEY-----LDKDL---KQYLDDCGNSINMHNVKL 108

Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
                      +GL Y H     +++HRD+K  N+L++   + K+ADFGLA+  AK    
Sbjct: 109 -----FLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPT 158

Query: 809 HTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
            T S    +  Y  P+    +T  + +ID++  G +  E+ TG+
Sbjct: 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 81/296 (27%), Positives = 122/296 (41%), Gaps = 36/296 (12%)

Query: 638 LTESNLIGSGGSGQVYR--IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-R 694
           +   ++IG G  GQV R  I  +G     A+K +      N    ++F  E+E+L  +  
Sbjct: 4   IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND--HRDFAGELEVLCKLGH 61

Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQH----VLHWPT 750
           H NI+ L     +     +  EY    +L  +L  + R L +  +   +H     L    
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            LQ A   A G   M +    Q IHRD+ + N+L+     +KIADFGL++     GE   
Sbjct: 121 LLQFASDVATG---MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVY 172

Query: 811 MSAVAGSFG--YFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAW 867
           +    G     + A E    +    K D++SFGV+L E+V+ G     G     L E   
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232

Query: 868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV-LQILR 922
           + Y  EKP            C  E    VY L   C    P  RP   ++ +Q+ R
Sbjct: 233 QGYRMEKP----------RNCDDE----VYELMRQCWRDRPYERPPFAQISVQLSR 274

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 33/215 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIRHAN 697
           +G G    V++         VA+K I        +LE E       I E+ +L  ++HAN
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEI--------RLEHEEGAPCTAIREVSLLKNLKHAN 64

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV L   I +E    LV+EY+++  L ++L            S+H   +     L     
Sbjct: 65  IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDN-----CGNLMSMHNVKIFMFQLL----- 113

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +GL Y H     +I+HRD+K  N+L++ + + K+ADFGLA+  AK     T S    +
Sbjct: 114 --RGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVT 166

Query: 818 FGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
             Y  P+    +T+ +  ID++  G +L E+ TG+
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 61/282 (21%), Positives = 123/282 (43%), Gaps = 29/282 (10%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +VYR       + VA+K++     ++ K  ++ + EI++L  + H N++K   
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 704 CISSENSKLLVYEYMENQSLDRWL-HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               +N   +V E  +   L + + + +K+  +    +V      W   +Q+       +
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV------WKYFVQLC----SAV 119

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            +MH   + +++HRD+K +N+ + +    K+ D GL +  +   +     ++ G+  Y +
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMS 174

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDK 882
           PE  +    N K DI+S G +L E+   +   YGD+    +            +   +++
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS------------LCQKIEQ 222

Query: 883 GIAEPCYLEEMTTVYR-LALICTSTLPSSRPSMKEVLQILRR 923
               P   E  +   R L  +C    P  RP +  V QI ++
Sbjct: 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 74/297 (24%), Positives = 123/297 (41%), Gaps = 28/297 (9%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAG----EFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           LS++     +G    G++Y+  +   G    + VA+K + +    N +   EF  E  ++
Sbjct: 4   LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLM 61

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS----VHQHVL 746
             + H NIV L   ++ E    +++EY+    L  +L  R      G SS      +  L
Sbjct: 62  AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
                L IAI  A G+ Y+    +   +H+D+ + NIL+  +   KI+D GL++ +    
Sbjct: 122 DHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEW 865
                        +  PE     K +   DI+SFGVVL E+ + G +  YG  +  + E 
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE- 237

Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                         + K    PC  +    +Y L   C    PS RP  K++   LR
Sbjct: 238 -------------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 72.1 bits (177), Expect = 3e-13
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +IG G  G V        GE VA+K+I N+   +       + EI++L  +RH +IV++ 
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 703 CCISSENSK-----LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
             +   + +      +V+E ME+      LH   ++    +   HQ  L+   R      
Sbjct: 66  HIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQLLR------ 114

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM--SAVA 815
               L Y+H   T  + HRD+K  NIL +++ K KI DFGLA++              VA
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168

Query: 816 GSFGYFAPEY--AYTTKVNEKIDIYSFGVVLLELVTGK 851
             + Y APE   ++ +K    IDI+S G +  E++TGK
Sbjct: 169 TRW-YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 41/217 (18%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+VY+      G   A K I    K  ++LE +++ EIEIL T  H  IVKL  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELE-DYMVEIEILATCNHPYIVKLLG 76

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
               +    ++ E+    ++D  +    R L               T  QI +   Q L 
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELDRGL---------------TEPQIQVICRQMLE 121

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA----KMLAKQ----GEPHTMSAVA 815
            + +  + +IIHRD+K+ N+LL  +   K+ADFG++    K L ++    G P+ M    
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWM---- 177

Query: 816 GSFGYFAPEYAYT-----TKVNEKIDIYSFGVVLLEL 847
                 APE         T  + K DI+S G+ L+E+
Sbjct: 178 ------APEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 83/299 (27%), Positives = 128/299 (42%), Gaps = 49/299 (16%)

Query: 642 NLIGSGGSGQVY--RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANI 698
           ++IG G  GQV   RI  +G     A+KR+      ++   ++F  E+E+L  +  H NI
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLV-----------SGSSSVHQHVLH 747
           + L           L  EY  + +L  +L  RK  ++           + S+   Q +LH
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQQLLH 128

Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
           +      A   A+G+ Y+      Q IHRD+ + NIL+   + AKIADFGL++     G+
Sbjct: 129 F------AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQ 174

Query: 808 PHTMSAVAGSFG--YFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAE 864
              +    G     + A E    +      D++S+GV+L E+V+ G     G     L E
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234

Query: 865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
              + Y  EKP+           C  E    VY L   C    P  RPS  ++L  L R
Sbjct: 235 KLPQGYRLEKPLN----------CDDE----VYDLMRQCWREKPYERPSFAQILVSLNR 279

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.7 bits (173), Expect = 4e-13
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G GG G+V  + +   G+  A K++   R   +  EK  + E EIL  +    IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR----LQIAIGAA 759
              S+    LV                  SL++G   +  H+ +   R     ++   +A
Sbjct: 61  AFESKTHLCLVM-----------------SLMNGGD-LKYHIYNVGERGLEMERVIHYSA 102

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           Q  C + H  +  I++RD+K  N+LLD +   +++D GLA  L K G+  T    AG+ G
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQR--AGTNG 159

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y APE       +  +D ++ G  + E+V G+
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 72/298 (24%), Positives = 115/298 (38%), Gaps = 42/298 (14%)

Query: 637 SLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
           S+T    +G G  G+VY       +G    + V         +++ E +F+ E  I+   
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
            H NIV+L         + ++ E M    L  +L   +      SS   + +L       
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF------ 120

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKML------AK 804
            A   A+G  Y+        IHRD+ + N LL  +     AKIADFG+A+ +       K
Sbjct: 121 CARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177

Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLA 863
            G    M  +     +  PE         K D++SFGV+L E+ +     Y G  +  + 
Sbjct: 178 GGR--AMLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231

Query: 864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           E+       + P      KG   P        VYR+   C    P  RP+   +L+ +
Sbjct: 232 EFVTGGGRLDPP------KGCPGP--------VYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 72.2 bits (177), Expect = 5e-13
 Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 24/164 (14%)

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           Q L  +HH  +  +IHRD+KS+NILL S    K+ DFG +KM A            G+  
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE-----HTSLAEWAWRHYAEEK 874
           Y APE       ++K D++S GV+L EL+T K    G+      H +LA           
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-------GRYD 263

Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           P+  ++           EM  +    L   S+ P  RPS  ++L
Sbjct: 264 PLPPSISP---------EMQEIVTALL---SSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.9 bits (174), Expect = 5e-13
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 31/227 (13%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK--LNQKLEKEF-IAEIEILGTI-RHANI 698
           ++G G  G+V   ++ G  E  AVK +   +K  + Q  + E  + E  +L    +H  +
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVL---KKDVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
            +L  C  +++    V EY+    L   +                     P     A   
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-------------RSGRFDEPRARFYAAEI 105

Query: 759 AQGLCYMH-HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK--MLAKQGEPHTMSAVA 815
             GL ++H       II+RD+K  N+LLDSE   KIADFG+ K  +L       T S   
Sbjct: 106 VLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157

Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
           G+  Y APE          +D ++ GV+L E++ G+    GD+   L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.1 bits (171), Expect = 6e-13
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 28/211 (13%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKL 701
           IG G SG VY  IDI   G+ VA+K++     L Q+ +KE I  EI ++   ++ NIV  
Sbjct: 27  IGQGASGTVYTAIDI-ATGQEVAIKQM----NLQQQPKKELIINEILVMRENKNPNIVNY 81

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                  +   +V EY+   SL              +  V +  +       +     Q 
Sbjct: 82  LDSYLVGDELWVVMEYLAGGSL--------------TDVVTETCMDEGQIAAVCRECLQA 127

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL-AKMLAKQGEPHTMSAVAGSFGY 820
           L ++H +   Q+IHRD+KS NILL  +   K+ DFG  A++  +Q +  TM    G+  +
Sbjct: 128 LDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYW 181

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            APE         K+DI+S G++ +E+V G+
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.4 bits (172), Expect = 6e-13
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 22/214 (10%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G +G V       +G  VAVK + + RK  Q+  +    E+ I+   +H N+V+++ 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM-DLRK--QQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    ++ E+++  +L              +  V Q  L+      +     Q LC
Sbjct: 86  SYLVGEELWVLMEFLQGGAL--------------TDIVSQTRLNEEQIATVCESVLQALC 131

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H   +  +IHRD+KS +ILL  + + K++DFG    ++K   P   S V   + + AP
Sbjct: 132 YLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-VPKRKSLVGTPY-WMAP 186

Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           E    T    ++DI+S G++++E+V G+   + D
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 70.1 bits (171), Expect = 6e-13
 Identities = 54/215 (25%), Positives = 106/215 (49%), Gaps = 23/215 (10%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G +G V    +  +G+ VAVK++ + RK  Q+  +    E+ I+   +H N+V+++ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM-DLRK--QQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                +   +V E++E  +L          +V+ +    + +        + +   + L 
Sbjct: 85  SYLVGDELWVVMEFLEGGALT--------DIVTHTRMNEEQIA------AVCLAVLKALS 130

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            +H      +IHRD+KS +ILL  + + K++DFG    ++K  E     ++ G+  + AP
Sbjct: 131 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAP 185

Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
           E         ++DI+S G++++E+V G E  Y +E
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDG-EPPYFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 6e-13
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G    VY+      G+ VA+K I  + K  + +    I E  +L  ++HANIV L  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I ++ +   V+EYM    L +++              H   LH            +GL 
Sbjct: 71  IIHTKETLTFVFEYMHT-DLAQYM------------IQHPGGLHPYNVRLFMFQLLRGLA 117

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I+HRD+K  N+L+    + K+ADFGLA+  AK     T S+   +  Y  P
Sbjct: 118 YIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPP 172

Query: 824 EYAY-TTKVNEKIDIYSFGVVLLELVTGKEA 853
           +     T  +  +DI+  G + +E++ G+ A
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.0 bits (171), Expect = 6e-13
 Identities = 73/286 (25%), Positives = 125/286 (43%), Gaps = 30/286 (10%)

Query: 644 IGSGGSGQVY----RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G VY    R  I G  E  VAVK +  +  L +++E  F+ E  ++      ++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 71

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL-HWPTRLQIAIG 757
           V+L   +S     L+V E M +  L  +L    RSL   + +            +Q+A  
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAE 127

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            A G+ Y++     + +HRD+ + N ++  +F  KI DFG+ + + +             
Sbjct: 128 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             + APE           D++SFGVVL E+            TSLAE  ++  + E+ + 
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEI------------TSLAEQPYQGLSNEQVLK 232

Query: 878 DALDKG-IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
             +D G + +P    E   V  L  +C    P  RP+  E++ +L+
Sbjct: 233 FVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 70.2 bits (172), Expect = 7e-13
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 41/232 (17%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAE--------IE----IL 690
           ++G G  G+V   ++ G  EF A+K           L+K+ + E        +E     L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIK----------ALKKDVVLEDDDVECTMVERRVLAL 51

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
               H  +  L+C   ++     V EY+    L   +    R   + +      ++    
Sbjct: 52  AW-EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEII---- 106

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                     GL ++H      II+RD+K  N+LLD +   KIADFG+ K     GE   
Sbjct: 107 ---------CGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGE-GK 152

Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
            S   G+  Y APE     K NE +D +SFGV+L E++ G+   +G++   L
Sbjct: 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 70.1 bits (171), Expect = 8e-13
 Identities = 68/277 (24%), Positives = 128/277 (46%), Gaps = 36/277 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G +G V        G+ VAVK++ + RK  Q+  +    E+ I+    H N+V ++ 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM-DLRK--QQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                +   +V E++E  +L          +V+ +    + +        + +   + L 
Sbjct: 87  SYLVGDELWVVMEFLEGGALT--------DIVTHTRMNEEQIA------TVCLSVLRALS 132

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      +IHRD+KS +ILL S+ + K++DFG    ++K  E     ++ G+  + AP
Sbjct: 133 YLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAP 187

Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG 883
           E         ++DI+S G++++E++ G E  Y +E    A          + I D L   
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDG-EPPYFNEPPLQA---------MRRIRDNLPPR 237

Query: 884 IAEPCYLEEMTTVYRLAL-ICTSTLPSSRPSMKEVLQ 919
           + +     ++++V R  L +     PS R + +E+LQ
Sbjct: 238 VKD---SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 75/292 (25%), Positives = 130/292 (44%), Gaps = 46/292 (15%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
            SL     +G+G  G+V+    N   + VAVK +    K      + F+AE  ++ T++H
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTM----KPGSMSVEAFLAEANVMKTLQH 60

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWL---HGRKRSLVSGSSSVHQHVLHWPTRL 752
             +VKL   ++ E    ++ E+M   SL  +L    G K+ L              P  +
Sbjct: 61  DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--------------PKLI 105

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             +   A+G+ ++        IHRD++++NIL+ +    KIADFGLA+++    E +  +
Sbjct: 106 DFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI----EDNEYT 158

Query: 813 AVAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
           A  G+     + APE         K D++SFG++L+E+VT     Y     S  E     
Sbjct: 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY--PGMSNPE----- 211

Query: 870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                 +  AL++G   P        +Y + + C    P  RP+ + +  +L
Sbjct: 212 ------VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.4 bits (172), Expect = 9e-13
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 21/208 (10%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V+++    +G  +A K I  + ++   +  + I E+++L       IV  + 
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
              S+    +  E+M+  SLD+ L          +  + + +L      +++I   +GL 
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVL--------KKAGRIPEQILG-----KVSIAVIKGLT 117

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+      +I+HRDVK SNIL++S  + K+ DFG++  L         ++  G+  Y +P
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 171

Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           E    T  + + DI+S G+ L+E+  G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 36/292 (12%)

Query: 642 NLIGSGGSGQVYR--IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANI 698
           ++IG G  GQV +  I  +G     A+KR+      +    ++F  E+E+L  +  H NI
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNI 58

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQH----VLHWPTRLQI 754
           + L           L  EY  + +L  +L  + R L +  +    +     L     L  
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           A   A+G+ Y+      Q IHRD+ + NIL+   + AKIADFGL++     G+   +   
Sbjct: 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKT 169

Query: 815 AGSFG--YFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYA 871
            G     + A E    +      D++S+GV+L E+V+ G     G     L E   + Y 
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV-LQILR 922
            EKP            C  E    VY L   C    P  RPS  ++ + + R
Sbjct: 230 LEKP----------LNCDDE----VYDLMRQCWREKPYERPSFAQILVSLNR 267

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 23/215 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA---EIEILGTIRHANIV 699
           L+G G  G+VY       G  +AVK++  + + + +  KE  A   EI++L  + H  IV
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPE-SPETSKEVNALECEIQLLKNLLHERIV 67

Query: 700 KLWCCISSENSKLL--VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           + + C+     + L    E+M   S+        +  +    ++ ++V    TR QI   
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSI--------KDQLKSYGALTENVTRKYTR-QIL-- 116

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT-MSAVAG 816
             +G+ Y+H   +  I+HRD+K +NIL DS    K+ DFG +K L       T M +V G
Sbjct: 117 --EGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +  + +PE         K DI+S G  ++E++T K
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 31/224 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVK--RIWNNRKLNQKLEKEFIAEIEILGTIR---HANI 698
           IG G  G VY+     +G FVA+K  R+  N      L    + E+ +L  +    H NI
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNE---DGLPLSTVREVALLKRLEAFDHPNI 64

Query: 699 VKLW-CCISS----ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           V+L   C +S    E    LV+E+++ Q L  +L             V    L   T   
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYL-----------DKVPPPGLPAETIKD 112

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
           +     +GL ++H +C   I+HRD+K  NIL+ S  + K+ADFGLA++ + Q     ++ 
Sbjct: 113 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTP 166

Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           V  +  Y APE    +     +D++S G +  E+   K    G+
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 57/235 (24%), Positives = 105/235 (44%), Gaps = 24/235 (10%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRK--------------LNQKLEKEFIAEIEI 689
           +G G  G+V+  ++    +   ++  +N RK               N+    +F+ E++I
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQH--- 744
           L  ++  NI++L      E+   ++ EYMEN  L+++L  H       +G+ +V      
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 745 -VLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA 803
             + + + L +A+  A G+ Y+    +   +HRD+ + N L+      KIADFG+++ L 
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 804 KQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLE-LVTGKEANYGD 857
                           + A E     K     D+++FGV L E L+  KE  YG+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.1 bits (171), Expect = 1e-12
 Identities = 68/246 (27%), Positives = 103/246 (41%), Gaps = 31/246 (12%)

Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           Q+  +   +L    +   IGSG  G V        G  VAVK++    + NQ   K    
Sbjct: 11  QVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYR 69

Query: 686 EIEILGTIRHANIVKLWCCISSENS------KLLVYEYMENQSLDRWLHGRKRSLVSGSS 739
           E+ +L  + H NI+ L    + + S        LV E M+                +   
Sbjct: 70  ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD---------------ANLCQ 114

Query: 740 SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
            +H  + H   R+   +   Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA
Sbjct: 115 VIHMELDH--ERMSYLL--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170

Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           +          M+    +  Y APE        E +DI+S G ++ ELV G     G +H
Sbjct: 171 RTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 227

Query: 860 TSLAEW 865
             + +W
Sbjct: 228 --IDQW 231

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 33/213 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+VY+      G   A K I  + K  ++LE +++ EI+IL +  H NIVKL  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELE-DYMVEIDILASCDHPNIVKLLD 69

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ--- 760
               EN+  ++ E+    ++D  +   +R L               T  QI +   Q   
Sbjct: 70  AFYYENNLWILIEFCAGGAVDAVMLELERPL---------------TEPQIRVVCKQTLE 114

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HTMSAVAGSFG 819
            L Y+H +   +IIHRD+K+ NIL   +   K+ADFG++   AK         +  G+  
Sbjct: 115 ALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPY 168

Query: 820 YFAPEYAY--TTK---VNEKIDIYSFGVVLLEL 847
           + APE     T+K    + K D++S G+ L+E+
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 67/241 (27%), Positives = 98/241 (40%), Gaps = 65/241 (26%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEF-----IAEIEILGTIRHANI 698
           +G G  G+VY+      G  VA+K+I          EK+      + EI+IL  ++H N+
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKIL------MHNEKDGFPITALREIKILKKLKHPNV 69

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQH----VLHWP----T 750
           V L      +    +  E  +          RKR  V   +    H    +L  P    T
Sbjct: 70  VPL-----ID----MAVERPDK-------SKRKRGSVYMVTPYMDHDLSGLLENPSVKLT 113

Query: 751 RLQIAIGAAQ---GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
             QI     Q   G+ Y+H +    I+HRD+K++NIL+D++   KIADFGLA+       
Sbjct: 114 ESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD---G 167

Query: 808 PHTMSAVAGSFG------------YFAPEYA-----YTTKVNEKIDIYSFGVVLLELVTG 850
           P       G  G            Y  PE       YTT     +DI+  G V  E+ T 
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTT----AVDIWGIGCVFAEMFTR 223

Query: 851 K 851
           +
Sbjct: 224 R 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 50/237 (21%)

Query: 644 IGSGGSGQVY--RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           IG G  G+VY  +      G+  A+K+   +++    + +    EI +L  ++H N+V L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 702 W-CCISSENSKL-LVYEYMENQSLDRW----LHGRKRSLVSGSSSVHQHVLH---WPTRL 752
               +   +  + L+++Y E+   D W     H + + +     S+   ++    W    
Sbjct: 68  VEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRV-----SIPPSMVKSLLW---- 115

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA----KIADFGLAKMLAKQGEP 808
           QI      G+ Y+H +    ++HRD+K +NIL+  E       KI D GLA++     +P
Sbjct: 116 QIL----NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 809 -HTMSAVAGSFGYFAPEYA-----YTTKVNEKIDIYSFGVVLLELVT------GKEA 853
              +  V  +  Y APE       YT    + IDI++ G +  EL+T      G+EA
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYT----KAIDIWAIGCIFAELLTLEPIFKGREA 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 62/248 (25%), Positives = 109/248 (43%), Gaps = 54/248 (21%)

Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-F- 683
           Q  F   + +S   +   IG G  G+V++       + VA+K++          EKE F 
Sbjct: 2   QYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN------EKEGFP 55

Query: 684 ---IAEIEILGTIRHANIVKLWCCISSENSK--------LLVYEYME--------NQSLD 724
              + EI+IL  ++H N+V L     ++ +          LV+E+ E        N+++ 
Sbjct: 56  ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK 115

Query: 725 RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL 784
             L   K+        V + +L              GL Y+H     +I+HRD+K++NIL
Sbjct: 116 FTLSEIKK--------VMKMLL-------------NGLYYIH---RNKILHRDMKAANIL 151

Query: 785 LDSEFKAKIADFGLAK--MLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFG 841
           +  +   K+ADFGLA+   L+K  +P+  +    +  Y  PE     +     ID++  G
Sbjct: 152 ITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211

Query: 842 VVLLELVT 849
            ++ E+ T
Sbjct: 212 CIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKLW 702
           IG G SG VY       G+ VA++++     L Q+ +KE I  EI ++   ++ NIV   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V EY+   SL              +  V +  +       +     Q L
Sbjct: 84  DSYLVGDELWVVMEYLAGGSL--------------TDVVTETCMDEGQIAAVCRECLQAL 129

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            ++H +   Q+IHRD+KS NILL  +   K+ DFG    +    E    S + G+  + A
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMA 184

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE         K+DI+S G++ +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.8 bits (171), Expect = 4e-12
 Identities = 35/91 (38%), Positives = 52/91 (57%), Gaps = 2/91 (2%)

Query: 126 LDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTF 185
           L L      G IP+DI ++  LQ I+L GN+  G+IP S+G ++ L+ L L  N FNG+ 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 186 PKEIGDLSNLEVLGLAYNSNFKPAMIPIEFG 216
           P+ +G L++L +L L  N N     +P   G
Sbjct: 483 PESLGQLTSLRILNL--NGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 73/298 (24%), Positives = 129/298 (43%), Gaps = 30/298 (10%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAG-----EFVAVKRIWNNRKLNQKLEKEFIAEIEI 689
           LS++     +G    G+VY+  + G       + VA+K + +  K    L +EF  E  +
Sbjct: 4   LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD--KAEGPLREEFKHEAMM 61

Query: 690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV---L 746
              ++H NIV L   ++ E    +++ Y  +  L  +L  R      GS+   + V   L
Sbjct: 62  RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTL 121

Query: 747 HWPTRLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
                + I    A G+ ++  HH     ++H+D+ + N+L+  +   KI+D GL + +  
Sbjct: 122 EPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
                 M        + +PE     K +   DI+S+GVVL E+ +     YG +      
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS-----YGLQ------ 225

Query: 865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
             +  Y+ +  I    ++ +  PC  +    VY L L C +  PS RP  K++   LR
Sbjct: 226 -PYCGYSNQDVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 74/300 (24%), Positives = 129/300 (43%), Gaps = 62/300 (20%)

Query: 636 SSLTESNLIGSGGSGQV----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILG 691
           S LT    +GSG  G V    +R  I      VA+K I          E++FI E +++ 
Sbjct: 4   SELTFMKELGSGQFGVVHLGKWRAQIK-----VAIKAI----NEGAMSEEDFIEEAKVMM 54

Query: 692 TIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
            + H  +V+L+   + +    +V E+MEN  L  +L  R+  L        + +L     
Sbjct: 55  KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKL-------SKDML----- 102

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
           L +     +G+ Y+  +     IHRD+ + N L+ S    K++DFG+ + +    +    
Sbjct: 103 LSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL---DDEYT 156

Query: 812 SAVAGSF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVT------GKEANYGDEHTSLA 863
           S+    F   +  PE    +K + K D++SFGV++ E+ T       K++NY        
Sbjct: 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------- 208

Query: 864 EWAWRHYAEEKPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                       + + + +G  +  P  L  M TVY +   C    P  RP+  E+L+ +
Sbjct: 209 -----------EVVEMISRGFRLYRP-KLASM-TVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 33/217 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA--EIEILGTIRHANIVKL 701
           +G G    VY+      G+ VA+K I    +L ++    F A  E  +L  ++HANIV L
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVI----RLQEEEGTPFTAIREASLLKGLKHANIVLL 68

Query: 702 WCCISSENSKLLVYEYMEN---QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-G 757
              I ++ +  LV+EY+     Q +D+                H   LH P  +++ +  
Sbjct: 69  HDIIHTKETLTLVFEYVHTDLCQYMDK----------------HPGGLH-PENVKLFLFQ 111

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +GL Y+H      I+HRD+K  N+L+    + K+ADFGLA+  AK    HT S    +
Sbjct: 112 LLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVT 166

Query: 818 FGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEA 853
             Y  P+    +T+ +  +D++  G + +E++ G  A
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 45/233 (19%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-----EIEILGTIRHAN- 697
           IG G  G+VY+      G+ VA+K      K   ++++E I      EI +L  +  +  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALK------KTRLEMDEEGIPPTALREISLLQMLSESIY 62

Query: 698 IVKLWCCISSENSK-----LLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPT 750
           IV+L      E         LV+EY++   L +++  +GR       + ++   +     
Sbjct: 63  IVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMY---- 117

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEPH 809
             Q+  G A   C+ H      ++HRD+K  N+L+D +    KIAD GL +  +   + +
Sbjct: 118 --QLLKGVAH--CHKH-----GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY 168

Query: 810 TMSAVAGSFGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           T   V  +  Y APE       Y+T V    DI+S G +  E+   +    GD
Sbjct: 169 THEIV--TLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRKQPLFPGD 215

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 67.0 bits (163), Expect = 6e-12
 Identities = 70/222 (31%), Positives = 95/222 (42%), Gaps = 54/222 (24%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIV--- 699
           +GSG  G VY+      GE  AVK I    KL    +   I  EI ++   +H NIV   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKII----KLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72

Query: 700 -------KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
                  KLW C+          EY    SL    H      V+G  S           L
Sbjct: 73  GSYLSREKLWICM----------EYCGGGSLQDIYH------VTGPLS----------EL 106

Query: 753 QIAI---GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL-AKMLAKQGEP 808
           QIA       QGL Y+H   +   +HRD+K +NILL      K+ADFG+ AK+ A   + 
Sbjct: 107 QIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK- 162

Query: 809 HTMSAVAGSFGYFAPEYAYTTK---VNEKIDIYSFGVVLLEL 847
               +  G+  + APE A   K    N+  DI++ G+  +EL
Sbjct: 163 --RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.4 bits (164), Expect = 7e-12
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 22/224 (9%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           L+G G  G+V  +    +G++ A+K +     + +      + E  +L   RH  +  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               +++    V EY+    L  + H  +  + S             TR   A      L
Sbjct: 62  YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDR----------TRFYGA-EIVSAL 108

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG--EPHTMSAVAGSFGY 820
            Y+H   + +I++RD+K  N++LD +   KI DFGL K    +G  +  TM    G+  Y
Sbjct: 109 DYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEY 161

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 66.9 bits (163), Expect = 9e-12
 Identities = 66/285 (23%), Positives = 125/285 (43%), Gaps = 45/285 (15%)

Query: 643 LIGSGGSGQVYRIDINGAGEF----VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           ++GSG  G VY+      GE     VA+K +      + K  KE + E  ++ ++ + ++
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPHV 71

Query: 699 VKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
            +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  ++     
Sbjct: 72  CRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNWCVQI----- 118

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L    + +        
Sbjct: 119 -AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             + A E         + D++S+GV + EL+T     Y                    I+
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-------------IPASEIS 221

Query: 878 DALDKGIAEP----CYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             L+KG   P    C ++    VY + + C      SRP  +E++
Sbjct: 222 SILEKGERLPQPPICTID----VYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.9 bits (163), Expect = 1e-11
 Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 19/223 (8%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTIRHANIVKL 701
           ++G G  G+V   ++ G GE+ AVK +  +  L +  +E   + +  +     +  +  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +C   ++     V E++    L    H + +    G   +++   +          AA+ 
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDL--MFHIQDK----GRFDLYRATFY----------AAEI 105

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           +C +    +  II+RD+K  N++LD +   KIADFG+ K     G+ +  S   G+  Y 
Sbjct: 106 VCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV-FGD-NRASTFCGTPDYI 163

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
           APE     K    +D +SFGV+L E++ G+   +GD+   L E
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 17/209 (8%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G GG G+V    +   G+  A K++   R   +K E   + E +IL  +    +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               ++++  LV   M    L   ++             H     +    +    AA+  
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIY-------------HMGEAGFEEG-RAVFYAAEIC 112

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
           C +      +I++RD+K  NILLD     +I+D GLA  +    E  T+    G+ GY A
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMA 169

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE     +     D ++ G +L E++ G+
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 29/218 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLW 702
           IG G  G+VY++     G   AVK +     +++++E    AE  IL ++  H N+VK +
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIE----AEYNILQSLPNHPNVVKFY 85

Query: 703 CCISSENSKL-----LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
                 +  +     LV E     S+   + G    L+     + + ++ +     I  G
Sbjct: 86  GMFYKADKLVGGQLWLVLELCNGGSVTELVKG----LLICGQRLDEAMISY-----ILYG 136

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
           A  GL ++H++   +IIHRDVK +NILL +E   K+ DFG++  L         S   G+
Sbjct: 137 ALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 191

Query: 818 FGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTG 850
             + APE       Y    + + D++S G+  +EL  G
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 67.0 bits (164), Expect = 1e-11
 Identities = 64/230 (27%), Positives = 94/230 (40%), Gaps = 45/230 (19%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTIRHANIVKLW 702
           IGSG  G V        G+ VA+K++  +R   N    K    E+ ++  + H NI+ L 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 703 CCISSENS------KLLVYEYME-------NQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
              + + S        LV E M+          LD   H R   L+              
Sbjct: 82  NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD---HERMSYLLY------------- 125

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
                     Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     G   
Sbjct: 126 ----------QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSF 172

Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
            M+    +  Y APE        E +DI+S G ++ E++ G     G +H
Sbjct: 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 46/229 (20%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G +G V+    +   + VAVK+I       Q + K  + EI+I+  + H NIVK++ 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSV-KHALREIKIIRRLDHDNIVKVYE 69

Query: 704 CISSENSKL--------------LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
            +    S L              +V EYME    +    G         S  H  +  + 
Sbjct: 70  VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-------LSEEHARLFMY- 121

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEP 808
              Q+     +GL Y+H   +  ++HRD+K +N+ +++E    KI DFGLA+++    +P
Sbjct: 122 ---QLL----RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV----DP 167

Query: 809 HT-----MSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGK 851
           H      +S    +  Y +P    +     + ID+++ G +  E++TGK
Sbjct: 168 HYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 64/291 (21%), Positives = 124/291 (42%), Gaps = 28/291 (9%)

Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +     + +++E  F+ E  ++  
Sbjct: 8   ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKE 65

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
               ++V+L   +S     L++ E M    L  +L    R  +  +       L     +
Sbjct: 66  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVQAPPSLK--KMI 122

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
           Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +        
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE 872
                  + +PE           D++SFGVVL E+ T            LAE  ++  + 
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQGMSN 227

Query: 873 EKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           E+ +   ++ G+ + P    +M  ++ L  +C    P  RPS  E++  ++
Sbjct: 228 EQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 38/221 (17%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRI---WNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           +G G  G VY++     G  +A+K I    +  K NQ      I E++IL       IV 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ-----IIMELDILHKAVSPYIVD 63

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
            +     E +  +  EYM+  SLD+   G        +  + + VL      +I     +
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSLDKLYAGG-----VATEGIPEDVLR-----RITYAVVK 113

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG----LAKMLAKQGEPHTMSAVAG 816
           GL ++  +    IIHRDVK +N+L++   + K+ DFG    L   LAK           G
Sbjct: 114 GLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--------IG 163

Query: 817 SFGYFAPEYAYTTKVNEKI------DIYSFGVVLLELVTGK 851
              Y APE   +   N+        D++S G+ +LE+  G+
Sbjct: 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 68/304 (22%), Positives = 126/304 (41%), Gaps = 44/304 (14%)

Query: 638 LTESNLIGSGGSGQVYRIDINGAGEF----------------VAVKRIWNNRKLNQKLEK 681
           LT    +G G  G+V+  +  G  +F                VAVK +      N+    
Sbjct: 7   LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML--REDANKNARN 64

Query: 682 EFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSS 739
           +F+ EI+I+  ++  NI++L     + +   ++ EYMEN  L+++L  H  + +      
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 740 SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
                 + + T + +A   A G+ Y+    +   +HRD+ + N L+   +  KIADFG++
Sbjct: 125 V----TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           + L                 + + E     K     D+++FGV L E++T  +       
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK------- 230

Query: 860 TSLAEWAWRHYAEEKPI--TDALDKGIAEPCYLEEMT----TVYRLALICTSTLPSSRPS 913
               E  +   ++E+ I  T    +      YL +      ++Y+L L C       RPS
Sbjct: 231 ----EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS 286

Query: 914 MKEV 917
            +E+
Sbjct: 287 FQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 14/208 (6%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G GG G+V    +   G+  A K++   R   +K  +  + E  IL  +    IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
              ++    LV   M    L   ++       +      +   +           AQ + 
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEE--NPGFPEPRACFY----------TAQIIS 108

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            + H    +II+RD+K  N+LLD++   +I+D GLA  L K G+  T    AG+ G+ AP
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSKT-KGYAGTPGFMAP 166

Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           E     + +  +D ++ GV L E++  +
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 66.2 bits (161), Expect = 2e-11
 Identities = 71/292 (24%), Positives = 129/292 (44%), Gaps = 31/292 (10%)

Query: 644 IGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RH 695
           +G G  GQV   +  G  +        VAVK + ++    +K   + I+E+E++  I +H
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKH 83

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRL 752
            NI+ L    + +    ++ EY    +L  +L  R+   +      + V +  L +   +
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +         +
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
                  + APE  +      + D++SFGV+L E+ T   + Y G     L +     + 
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 260

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 261 MDKPSN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 17/209 (8%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G GG G+V    +   G+  A KR+   R   +K E   + E +IL  +    +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               ++++  LV   M    L   ++        G+    +         +    AA+ L
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNM------GNPGFEEE--------RALFYAAEIL 112

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
           C +        ++RD+K  NILLD     +I+D GLA    K  E  ++    G+ GY A
Sbjct: 113 CGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA---VKIPEGESIRGRVGTVGYMA 169

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE     +     D +  G ++ E++ G+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 6/107 (5%)

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           +GL Y+H     +IIHRDVK+ NI ++   +  I D G A+       P  +  +AG+  
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFL-GLAGTVE 221

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
             APE     K N K DI+S G+VL E++      + D  ++  E+ 
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268

Length = 357

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 46/288 (15%)

Query: 644 IGSGGSGQVYR--IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +GSG  G V +    +  + + VAVK I  N   +  L+ E + E  ++  + +  IV++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS-VHQHVLHWPTRLQIAIGAAQ 760
                +E S +LV E  E   L+++L   K       +  VHQ               + 
Sbjct: 62  IGICEAE-SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQ--------------VSM 106

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF-- 818
           G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L    E +  +   G +  
Sbjct: 107 GMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENYYKAKTHGKWPV 162

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY----GDEHTSLAEWAWRHYAEEK 874
            ++APE     K + K D++SFGV++ E  +  +  Y    G+E T + E   R    ++
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222

Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                        C  E    +Y L  +C +     RP    V   LR
Sbjct: 223 -------------CPPE----MYDLMKLCWTYGVDERPGFAVVELRLR 253

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 34/225 (15%)

Query: 638 LTESN---LIGSGGSGQVYRIDINGAGEFVAVKRI-WNNRKLNQKLEKEFIAEIEILGTI 693
             E+    ++G G  G VY          +A+K I   + +  Q L +E    I +   +
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEE----IALHSYL 62

Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           +H NIV+     S      +  E +   SL   L  +      G    ++  + + T+ Q
Sbjct: 63  KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK-----WGPLKDNEQTIIFYTK-Q 116

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-EFKAKIADFGLAKMLAKQGEPHTMS 812
           I     +GL Y+H +   QI+HRD+K  N+L+++     KI+DFG +K LA    P T  
Sbjct: 117 IL----EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI-NPCT-E 167

Query: 813 AVAGSFGYFAPEY------AYTTKVNEKIDIYSFGVVLLELVTGK 851
              G+  Y APE        Y        DI+S G  ++E+ TGK
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPA----DIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 70/298 (23%), Positives = 129/298 (43%), Gaps = 31/298 (10%)

Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           LT    +G G  GQV   +  G  +        VAVK + ++    +K   + ++E+E++
Sbjct: 17  LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMM 74

Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVL 746
             I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S   + V    +
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +    
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251

Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 252 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAIPSHRPTFKQLVEDLDR 295

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.4 bits (162), Expect = 4e-11
 Identities = 44/125 (35%), Positives = 58/125 (46%), Gaps = 29/125 (23%)

Query: 142 DRISGLQCID-LGGNN--FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVL 198
           D   G   ID LG +N    G IP  I +L  LQ++ L  N   G  P  +G +++LEVL
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL 471

Query: 199 GLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGA 258
            L+YNS                            G IPE++  L+SL IL LNGN L G 
Sbjct: 472 DLSYNS--------------------------FNGSIPESLGQLTSLRILNLNGNSLSGR 505

Query: 259 IPSGL 263
           +P+ L
Sbjct: 506 VPAAL 510

Length = 623

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.4 bits (159), Expect = 4e-11
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 25/212 (11%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL-GTIRHANIVKL 701
           +IG G  G+V        G F AVK +     L +K +   +AE  +L   ++H  +V L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                +      V +Y+    L  + H  R+R  +             P     A   A 
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLE------------PRARFYAAEVAS 107

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG-EPH-TMSAVAGSF 818
            + Y+H   +  II+RD+K  NILLDS+    + DFG    L K+G EP  T S   G+ 
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFG----LCKEGVEPEETTSTFCGTP 160

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            Y APE       +  +D +  G VL E++ G
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 21/210 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL-GTIRHANIVKL 701
           +IG G  G+V         +F AVK +     L +K EK  ++E  +L   ++H  +V L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                + +    V +Y+    L   L  R+R  +             P     A   A  
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLE------------PRARFYAAEIASA 108

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH-TMSAVAGSFGY 820
           L Y+H   +  I++RD+K  NILLDS+    + DFGL K   +  E + T S   G+  Y
Sbjct: 109 LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEY 162

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            APE  +    +  +D +  G VL E++ G
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 34/217 (15%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G G  G V +       E VA+K+ + + + N+++++  + E+++L T++  NIV+L 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKK-FKDSEENEEVKETTLRELKMLRTLKQENIVELK 66

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS------SSVHQHV--LHWPTRLQI 754
                     LV+EY+E   L+         + +G       S ++Q +  +HW      
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELL-----EEMPNGVPPEKVRSYIYQLIKAIHW------ 115

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
                   C+ +      I+HRD+K  N+L+      K+ DFG A+ L++    +    V
Sbjct: 116 --------CHKN-----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV 162

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           A  + Y +PE        + +D++S G +L EL  G+
Sbjct: 163 ATRW-YRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 23/225 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 703 CCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGA--A 759
               + +    V EY     L  + H  R+R      +  +              GA   
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFY--------------GAEIV 105

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
             L Y+H +    +++RD+K  N++LD +   KI DFGL K   K G   TM    G+  
Sbjct: 106 SALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPE 161

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
           Y APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 18/220 (8%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V  +     G+   +K++ N R  +++  K    E ++L  ++H NIV    
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 704 CISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               E+  L +V  + E   L   L  +K  L+         V+ W   +QIA+     L
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLL-----PENQVVEW--FVQIAMA----L 115

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H      I+HRD+K+ N+ L      K+ D G+A++L  Q +    S + G+  Y +
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMS 170

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
           PE       N K D+++ G  + E+ T K A    +  SL
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 71/279 (25%), Positives = 117/279 (41%), Gaps = 31/279 (11%)

Query: 644 IGSGGSGQVYRIDINGA--GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +G G  G VY +    A   E + V +     +LN     +   E ++L  + H  IVK 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                  ++  ++ EY E + LD  L   K +   G +     V  W  +L +      G
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHT---GKTLSENQVCEWFIQLLL------G 118

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           + YMH     +I+HRD+K+ NI L +    KI DFG++++L   G     +   G+  Y 
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYYM 172

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
           +PE       + K DI+S G +L E+     A  G    S+             I +   
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV----------LRIVEGPT 222

Query: 882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI 920
             + E  Y  ++ ++ +  L   +  PS RPS  E+L+ 
Sbjct: 223 PSLPE-TYSRQLNSIMQSML---NKDPSLRPSAAEILRN 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.4 bits (162), Expect = 6e-11
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 28/218 (12%)

Query: 661 GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL-VYEYME 719
           G  VA+K +  +    +     F  E  +   + H NIV L     +    L  V+EY+ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK 779
            ++L      R+     G+    +       RL       Q L  +       I+HRD+K
Sbjct: 63  GRTL------REVLAADGALPAGETG-----RLM-----LQVLDALACAHNQGIVHRDLK 106

Query: 780 SSNILL---DSEFKAKIADFGLAKMLAKQGEPHTMSA-----VAGSFGYFAPEYAYTTKV 831
             NI++        AK+ DFG+  +L    +    +      V G+  Y APE      V
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166

Query: 832 NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
               D+Y++G++ LE +TG+    G    S+AE  ++ 
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRVVQG---ASVAEILYQQ 201

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 64.7 bits (157), Expect = 7e-11
 Identities = 72/300 (24%), Positives = 131/300 (43%), Gaps = 31/300 (10%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIE 688
           + LT    +G G  GQV   +  G  +        VAVK + ++     K   + ++E+E
Sbjct: 12  TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEME 69

Query: 689 ILGTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQH 744
           ++  I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S     + + 
Sbjct: 70  MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129

Query: 745 VLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
            L +   +  A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +  
Sbjct: 130 QLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN 186

Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLA 863
                  +       + APE  +      + D++SFGV+L E+ T   + Y G     L 
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246

Query: 864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
           +     +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 247 KLLKEGHRMDKPAN----------CTHE----LYMIMRECWHAVPSQRPTFKQLVEDLDR 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 16/166 (9%)

Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E  +L  ++H NIV       ++    +V EY +   L + +  ++  L          +
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFP-----EDTI 102

Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
           L W  ++ + +          H    +++HRD+KS NI L    K K+ DFG A++L   
Sbjct: 103 LQWFVQMCLGV---------QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153

Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G         G+  Y  PE       N K DI+S G +L EL T K
Sbjct: 154 GA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 9e-11
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 17/209 (8%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G GG G+V    +   G+  A K++   R   +K E   + E +IL  +    +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               ++++  LV   M    L   ++    ++ +      + V +          AA+  
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIY----NMGNPGFDEERAVFY----------AAEIT 112

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
           C +      +I++RD+K  NILLD     +I+D GLA  +  +GE   +    G+ GY A
Sbjct: 113 CGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGET--IRGRVGTVGYMA 169

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE     +     D +  G ++ E++ GK
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 64.0 bits (156), Expect = 9e-11
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 32/202 (15%)

Query: 661 GEFVAVKRIWN--NRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCC-ISSENSKLLVYE 716
            E VA+K+I N  ++K+   L K  + E+++L   R H NI  L+   I    +   +Y 
Sbjct: 27  EETVAIKKITNVFSKKI---LAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL 83

Query: 717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHR 776
           Y E    D  LH   RS    + +  Q  ++     QI  G    L Y+H   +  ++HR
Sbjct: 84  YEELMEAD--LHQIIRSGQPLTDAHFQSFIY-----QILCG----LKYIH---SANVLHR 129

Query: 777 DVKSSNILLDSEFKAKIADFGLAKML---AKQGEPHTMSAVAGSFGYFAPE----YAYTT 829
           D+K  N+L++++ + KI DFGLA+       +        VA  + Y APE    +   T
Sbjct: 130 DLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW-YRAPEIMLSFQSYT 188

Query: 830 KVNEKIDIYSFGVVLLELVTGK 851
           K    ID++S G +L EL+  K
Sbjct: 189 K---AIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 19/209 (9%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL-GTIRHANIVKL 701
           +IG G  G+V        G+  AVK +     LN+K +K  +AE  +L   ++H  +V L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                +      V +++    L   L  R+RS     +  +            A   A  
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFY------------AAEIASA 108

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  I++RD+K  NILLDS+    + DFGL K    Q +  T +   G+  Y 
Sbjct: 109 LGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYL 163

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           APE       +  +D +  G VL E++ G
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A GL ++H   +  II+RD+K  N++LD+E   KIADFG+ K         T     G+ 
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTP 165

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            Y APE        + +D ++FGV+L E++ G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 24/225 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 703 CCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGA--A 759
               + +    V EY     L  + H  R+R      +  +              GA   
Sbjct: 62  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY--------------GAEIV 105

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
             L Y+H   +  +++RD+K  N++LD +   KI DFGL K     G   TM    G+  
Sbjct: 106 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPE 160

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
           Y APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 205

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 29/233 (12%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK------LEKEFIAEIEILGTIRHA 696
           ++G G  G+V   +  G  E  A+K +  +  +         +EK  +A  +     +  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-----KPP 61

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
            + +L  C  + +    V EY+    L    H ++     G     Q V +       A 
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQ----VGKFKEPQAVFY-------AA 108

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             + GL ++H      II+RD+K  N++LDSE   KIADFG+ K     G   T     G
Sbjct: 109 EISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCG 163

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
           +  Y APE        + +D +++GV+L E++ G+    G++   L +    H
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.1 bits (154), Expect = 2e-10
 Identities = 50/222 (22%), Positives = 76/222 (34%), Gaps = 42/222 (18%)

Query: 645 GSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCC 704
                  + +         VAVK+I  +    + L K    EI     ++H NI+     
Sbjct: 11  EDLMIVHLAKH--KPTNTLVAVKKINLDSCSKEDL-KLLQQEIITSRQLQHPNILPYVTS 67

Query: 705 ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL------QIAIGA 758
              ++   +V   M         +G    L+           H+P  L       I    
Sbjct: 68  FIVDSELYVVSPLMA--------YGSCEDLLKT---------HFPEGLPELAIAFILKDV 110

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
              L Y+H       IHR VK+S+ILL  + K  ++    +  + K G+      V   F
Sbjct: 111 LNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ---RVVHDF 164

Query: 819 G--------YFAPEYAYTT--KVNEKIDIYSFGVVLLELVTG 850
                    + +PE         NEK DIYS G+   EL  G
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 35/289 (12%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
             +T    IG G  G VY+   +        VAVK   N    +  + ++F+ E  I+  
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQ 63

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H +IVKL   + +EN   +V E      L  +L   K SL   S  ++          
Sbjct: 64  FDHPHIVKL-IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS--------Y 114

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
           Q++      L Y+    + + +HRD+ + N+L+ S    K+ DFGL++ L  +   +  S
Sbjct: 115 QLS----TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE-SYYKAS 166

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE 872
                  + APE     +     D++ FGV + E++       G     +  +      +
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL-----MLG-----VKPFQG---VK 213

Query: 873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              +   ++ G   P       T+Y L   C +  PS RP   E+   L
Sbjct: 214 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 39/207 (18%)

Query: 659 GAGEFVAVKR-IWNNRK---------LNQKLEK----EFIAEIEILGTIRHANIVKLWCC 704
           G+G F  VK+ ++  RK         L  + EK    E + E EI+  + +  IV++   
Sbjct: 4   GSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGV 63

Query: 705 ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCY 764
             +E   +LV E      L+++L G+K  +   +     H        Q+++G       
Sbjct: 64  CEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMH--------QVSMG------- 107

Query: 765 MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG----- 819
           M +      +HRD+ + N+LL ++  AKI+DFGL+K L      +     A S G     
Sbjct: 108 MKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----ARSAGKWPLK 163

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLE 846
           ++APE     K + + D++S+G+ + E
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 33/215 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIRHAN 697
           +G G    V++         VA+K I        +LE E       I E+ +L  ++HAN
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEI--------RLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV L   + ++ S  LV+EY++ + L +++            S+H   +      QI   
Sbjct: 66  IVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDD-----CGNIMSMHNVKIFL---YQI--- 113

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +GL Y H     +++HRD+K  N+L++   + K+ADFGLA+  AK     T S    +
Sbjct: 114 -LRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVT 167

Query: 818 FGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
             Y  P+    +++ + +ID++  G +  E+ +G+
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 69/295 (23%), Positives = 124/295 (42%), Gaps = 41/295 (13%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEF----VAVKRIWNNRKLNQKLEKEFIAEIEILG 691
           + L +  ++GSG  G VY+      GE     VA+K +  N   + K  KE + E  ++ 
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMA 64

Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
            +    + +L   C++S  +  LV + M    L  ++   K  + S      Q +L+W  
Sbjct: 65  GVGSPYVCRLLGICLTS--TVQLVTQLMPYGCLLDYVRENKDRIGS------QDLLNWCV 116

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
           ++      A+G+ Y+      +++HRD+ + N+L+ S    KI DFGLA++L      + 
Sbjct: 117 QI------AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167

Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E     +   + D++S+GV + EL+T     Y               
Sbjct: 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG------------- 214

Query: 871 AEEKPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
              + I D L+KG  + +P        VY + + C       RP  +E++    R
Sbjct: 215 IPAREIPDLLEKGERLPQPPIC--TIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 62.7 bits (152), Expect = 3e-10
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 83  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 132

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 133 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 184

Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 41/234 (17%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNR-KLNQKLEKEFIA----------EIEIL 690
             +G G  G+V +      G+ VA+K++       +   +++ +           E++I+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
             I+H NI+ L       +   LV + M +  L + +  + R   S         +    
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTES-----QVKCILL-- 126

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK---------M 801
             QI      GL  +H       +HRD+  +NI ++S+   KIADFGLA+          
Sbjct: 127 --QIL----NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177

Query: 802 LAKQGEPHT---MSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
           L+K         M++   +  Y APE      K +  +D++S G +  EL+TGK
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 19/210 (9%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G GG G+V    +   G+  A K++   R   +K E   + E  IL  +    +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               ++++  LV   M    L   ++        G+    +         Q AI  A  L
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNM------GNPGFDE---------QRAIFYAAEL 111

Query: 763 CYMHHDCTPQ-IIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           C    D   + I++RD+K  NILLD     +I+D GLA  +    E  T+    G+ GY 
Sbjct: 112 CCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRVGTVGYM 168

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           APE     K     D +  G ++ E++ G+
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 23/224 (10%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL-GTIRHANIVKLW 702
           IG G  G+V        G+F AVK +     L +K +K  +AE  +L   ++H  +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               + +    V +Y+    L   L  R+RS     +  +            A   A  L
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARFY------------AAEIASAL 109

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH--TMSAVAGSFGY 820
            Y+H   +  II+RD+K  NILLDS+    + DFG    L K+G  H  T S   G+  Y
Sbjct: 110 GYLH---SLNIIYRDLKPENILLDSQGHVVLTDFG----LCKEGIEHSKTTSTFCGTPEY 162

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE       +  +D +  G VL E++ G    Y  +   + +
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 5/103 (4%)

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  +++RD+K  N++LD +   KI DFGL K     G   TM    G+  Y 
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYL 162

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
           APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.0 bits (150), Expect = 4e-10
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 18/157 (11%)

Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  +V L  C  +E+    V EY+    L   +  R+R L        +H   +   + +
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP------EEHARFYSAEISL 107

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           A      L Y+H      II+RD+K  N+LLDSE   K+ D+G+ K   + G+  T S  
Sbjct: 108 A------LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTF 156

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            G+  Y APE          +D ++ GV++ E++ G+
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 37/113 (32%), Positives = 53/113 (46%), Gaps = 4/113 (3%)

Query: 773 IIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV- 831
           II+RD+K  NILLDSE    + DFGL+K    + E    S   G+  Y APE        
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGG 184

Query: 832 -NEKIDIYSFGVVLLELVTGKEA-NYGDEHTSLAEWAWRHYAEEKPITDALDK 882
            ++ +D +S GV+  EL+TG        E  S +E + R    + P    +  
Sbjct: 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.1 bits (149), Expect = 5e-10
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNN-RKLNQKLEKEFIAEIEILGTIR-HANIVKL 701
           IG G   +V +      G++ A+K +  + + L Q      + EI+ L  +  H NI++L
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRL 63

Query: 702 WCCI--SSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
              +         LV+E M+  +L   + GRKR L        + V  +  +L       
Sbjct: 64  IEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPE------KRVKSYMYQL------L 110

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           + L +MH +    I HRD+K  NIL+  +   K+ADFG  + +  +  P+T      +  
Sbjct: 111 KSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP-PYT--EYISTRW 163

Query: 820 YFAPEYAYTTKV-NEKIDIYSFGVVLLELVT 849
           Y APE   T      K+DI++ G V  E+++
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 60.5 bits (146), Expect = 8e-10
 Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 26/173 (15%)

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA-KQGEPHTMSAVAGSF 818
           +GL Y+H +   + IHRD+K++N+LL  +   K+ADFG+A  L   Q + +T     G+ 
Sbjct: 112 KGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF---VGTP 165

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            + APE    +  + K DI+S G+  +EL  G+  N  D H     +      +  P   
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN-SDMHPMRVLF---LIPKNNP--- 218

Query: 879 ALDKGIAEPCYLEEMTTVYR-LALICTSTLPSSRPSMKEVLQ---ILRRCCPT 927
                   P    E +  ++     C +  PS RP+ KE+L+   I++    T
Sbjct: 219 --------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKT 263

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 9e-10
 Identities = 27/82 (32%), Positives = 49/82 (59%)

Query: 211 IPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLT 270
           IP +   L+ L+++ ++  ++ G IP ++ +++SLE+L L+ N   G+IP  L  L +L 
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 271 QLFLYDNILSGEIPSSVEALKL 292
            L L  N LSG +P+++    L
Sbjct: 494 ILNLNGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.8 bits (150), Expect = 1e-09
 Identities = 30/88 (34%), Positives = 48/88 (54%), Gaps = 9/88 (10%)

Query: 297 LSMNN--LTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVA-------FENNLSGAV 347
           L ++N  L G IP +  KL++LQ + L  N + G +P S+G +          N+ +G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 348 PKSLGNCRTLRTVQLYSNRFSGELPTGL 375
           P+SLG   +LR + L  N  SG +P  L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.2 bits (148), Expect = 1e-09
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 22/219 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +IG G  G+V  +    + +  A+K +     + +     F  E +I+       +V+L+
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
           C    +    +V EYM    L         +L+S      +    +   + +A+ A   +
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDL--------VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
                     +IHRDVK  N+LLD     K+ADFG    + + G     +AV G+  Y +
Sbjct: 162 ---------GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYIS 211

Query: 823 PEYAYTTK----VNEKIDIYSFGVVLLELVTGKEANYGD 857
           PE   +         + D +S GV L E++ G    Y D
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 5/111 (4%)

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A GL ++H   +  II+RD+K  N++LDSE   KIADFG+ K     G   T     G+ 
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTP 165

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
            Y APE        + +D ++FGV+L E++ G+    G++   L +    H
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 216

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 80/333 (24%), Positives = 130/333 (39%), Gaps = 40/333 (12%)

Query: 1   MSKVASVFPKIPVTLILLVL-LSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTST 59
            + +  V            + L+ P   +           L +    L  P SL    S 
Sbjct: 14  SNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLL-LPSSLSRLLSL 72

Query: 60  SSP----CDWPEITCTFNSVTGI-SLRHKDITQKIPPIIC-DLKNLTTIDLSSNSIPGEF 113
                      + +    ++  + SL       +       +L NLT++DL +N+I    
Sbjct: 73  DLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNI---- 128

Query: 114 PEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQT 173
                  T +  L                  S L+ +DL  N     +P  +  L  L+ 
Sbjct: 129 -------TDIPPLIGLLK-------------SNLKELDLSDNKIE-SLPSPLRNLPNLKN 167

Query: 174 LYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIG 233
           L L  N+ +   PK + +LSNL  L     S  K + +P E  +L  L+ L ++  N I 
Sbjct: 168 LDLSFNDLS-DLPKLLSNLSNLNNL---DLSGNKISDLPPEIELLSALEELDLSN-NSII 222

Query: 234 EIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLT 293
           E+  ++SNL +L  L L+ N LE  +P  +  L+NL  L L +N +S  I S      L 
Sbjct: 223 ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLR 280

Query: 294 DIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL 326
           ++DLS N+L+ ++P     L  L+LL      L
Sbjct: 281 ELDLSGNSLSNALPLIALLLLLLELLLNLLLTL 313

Length = 394

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 64/276 (23%), Positives = 115/276 (41%), Gaps = 34/276 (12%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           L+G G  G+V++  +      VAVK       L Q+L+ +F++E  IL    H NIVKL 
Sbjct: 2   LLGKGNFGEVFKGTLKDKTP-VAVKTC--KEDLPQELKIKFLSEARILKQYDHPNIVKLI 58

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +      +V E +       +L  +K  L +               ++ A+ AA G+
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQ------------LVKFALDAAAGM 106

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG-SFGYF 821
            Y+    +   IHRD+ + N L+      KI+DFG+++   +    ++ S +      + 
Sbjct: 107 AYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWT 161

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
           APE     + + + D++S+G++L E  +     Y       A              + ++
Sbjct: 162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-------------EQVE 208

Query: 882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
           KG    C  +    VY++   C    P +RP   E+
Sbjct: 209 KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 5/106 (4%)

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     G    M+    +  
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRY 190

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           Y APE        E +DI+S G ++ E++ G     G +H  + +W
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQW 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 67/229 (29%), Positives = 96/229 (41%), Gaps = 68/229 (29%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE--KEFIA---EIEILGTIRHANI 698
           IGSG  G VY+      GE  A+K I        KLE  ++F     EI ++   +H+NI
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVI--------KLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 699 V----------KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           V          KLW C+          E+    SL    H      V+G  S        
Sbjct: 69  VAYFGSYLRRDKLWICM----------EFCGGGSLQDIYH------VTGPLS-------- 104

Query: 749 PTRLQIAI---GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM---- 801
               QIA       QGL Y+H       +HRD+K +NILL      K+ADFG++      
Sbjct: 105 --ESQIAYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT 159

Query: 802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTK---VNEKIDIYSFGVVLLEL 847
           +AK+       +  G+  + APE A   +    N+  DI++ G+  +EL
Sbjct: 160 IAKR------KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 26/224 (11%)

Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            T+   IG G  G+VY+   N   E VA+K I +  +   ++E +   EI +L       
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIK-IIDLEEAEDEIE-DIQQEITVLSQCDSPY 63

Query: 698 IVKLWCCISSENSKLLVYEYMENQS-LDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           I + +          ++ EY+   S LD    G      +  +++ + +L          
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEE--TYIATILREIL---------- 111

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA-KQGEPHTMSAVA 815
              +GL Y+H +   + IHRD+K++N+LL  +   K+ADFG+A  L   Q + +T     
Sbjct: 112 ---KGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF---V 162

Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           G+  + APE    +  + K DI+S G+  +EL  G E    D H
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG-EPPNSDLH 205

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 26/213 (12%)

Query: 643 LIGSGGSGQVY---RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE--ILGTIRHAN 697
           ++G G  G+V+   +I    AG+  A+K +   +K   K+      ++E  IL  + H  
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVL---KKATLKVRDRVRTKMERDILAEVNHPF 59

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IVKL     +E    L+ +++    L   L   K  + +      + V  +   L +A+ 
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFT-----EEDVKFYLAELALALD 112

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
               L          II+RD+K  NILLD E   K+ DFGL+K  +   E    S   G+
Sbjct: 113 HLHSL---------GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYS-FCGT 161

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
             Y APE        +  D +SFGV++ E++TG
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 29/211 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA-NIVKLW 702
           I  G  G VY       G++ A+K +  +  + +       AE  I+     +  + KL+
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSV-HQHVLHWPTRLQIAIGAAQG 761
               S++   LV EY+          G   SL+     +       +   + + +     
Sbjct: 64  YSFQSKDYLYLVMEYLNG--------GDCASLIKTLGGLPEDWAKQYIAEVVLGVE---- 111

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM--LAKQGEPHTMSAVAGSFG 819
              +H      IIHRD+K  N+L+D     K+ DFGL++     K+          G+  
Sbjct: 112 --DLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK--------FVGTPD 158

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y APE       ++  D +S G V+ E + G
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.1 bits (145), Expect = 3e-09
 Identities = 54/189 (28%), Positives = 82/189 (43%), Gaps = 29/189 (15%)

Query: 667 KRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRW 726
           KR+    +   +LE E +A    LG + H NI+K+   + SE        YM  Q  D  
Sbjct: 198 KRVKAGSRAAIQLENEILA----LGRLNHENILKIEEILRSEA-----NTYMITQKYDFD 248

Query: 727 LHGRKRSLVSGSSSVHQHVLHW---PTRLQIAIGAAQGLC---YMHHDCTPQIIHRDVKS 780
           L+          S ++     W   P   Q      Q LC   Y+H     ++IHRD+K 
Sbjct: 249 LY----------SFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKL 295

Query: 781 SNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSF 840
            NI L+ + K  + DFG A    K+ E      V G+    +PE        E  DI+S 
Sbjct: 296 ENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSC 354

Query: 841 GVVLLELVT 849
           G++LL++++
Sbjct: 355 GLILLDMLS 363

Length = 501

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 24/221 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKL 701
           ++G G  G+V   ++ G  E  A+K +  +  L        + E  IL     H  +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
            CC  +++    V EY+    L   +  R R      S  +            A      
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFDEPRSRFY------------AAEVTLA 108

Query: 762 LCYMH-HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           L ++H H     +I+RD+K  NILLD+E   K+ADFG+ K     G   T +   G+  Y
Sbjct: 109 LMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDY 162

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
            APE     +    +D ++ GV++ E++ G+   EA+  D+
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 4e-09
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 28/173 (16%)

Query: 685 AEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQH 744
           +E+  L    H  IVK +    S++  LL+ EY     L++ +  R +            
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE----------- 162

Query: 745 VLHWPTR--------LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF 796
             H P +         QI +     L  +H      ++HRD+KS+NI L      K+ DF
Sbjct: 163 --HLPFQEYEVGLLFYQIVL----ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDF 213

Query: 797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           G +K  +        S+  G+  Y APE     + ++K D++S GV+L EL+T
Sbjct: 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 59.1 bits (143), Expect = 4e-09
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 42/225 (18%)

Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-----EIEILGTI 693
           T    +GSG  G V        GE VA+K      KL++  + E  A     E+ +L  +
Sbjct: 18  TSLKQVGSGAYGSVCSAIDKRTGEKVAIK------KLSRPFQSEIFAKRAYRELTLLKHM 71

Query: 694 RHANIVKLWCCISSENSK------LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
           +H N++ L    +S  S        LV  YM+   L + + G   S       V+Q +  
Sbjct: 72  QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQK-IMGHPLSEDKVQYLVYQML-- 127

Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
                        GL Y+H   +  IIHRD+K  N+ ++ + + KI DFGLA+    +  
Sbjct: 128 ------------CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 170

Query: 808 PHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGK 851
              M+    +  Y APE        N+ +DI+S G ++ E++TGK
Sbjct: 171 ---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 59.2 bits (143), Expect = 4e-09
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 25/221 (11%)

Query: 642 NLIGSGGSGQVYRIDI----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           N I + G+G   R+ +    N     VA+KR   ++ + QK      +E +IL  I H  
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
            V L+     E+   LV E++       +L   KR               +P  +     
Sbjct: 93  CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR---------------FPNDVG-CFY 136

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
           AAQ +    +  +  I++RD+K  N+LLD +   K+ DFG AK++    +  T + + G+
Sbjct: 137 AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV----DTRTYT-LCGT 191

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
             Y APE        +  D ++ G+ + E++ G    Y +E
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232

Length = 340

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.8 bits (142), Expect = 5e-09
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 41/228 (17%)

Query: 644 IGSGGSGQV-YRIDINGAGEFVAVKRIWNNRKLNQKL-EKEFIAEIEILGTIRHANIVKL 701
           +GSG  G V   +D    G  VA+K+++  R    +L  K    E+ +L  ++H N++ L
Sbjct: 23  VGSGAYGTVCSALD-RRTGAKVAIKKLY--RPFQSELFAKRAYRELRLLKHMKHENVIGL 79

Query: 702 WCCISSE------NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
               + +      +   LV  +M    L + +   K S       V+Q +          
Sbjct: 80  LDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQML---------- 128

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               +GL Y+H      IIHRD+K  N+ ++ + + KI DFGLA+         T S + 
Sbjct: 129 ----KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMT 173

Query: 816 G---SFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           G   +  Y APE         + +DI+S G ++ E++TGK    G +H
Sbjct: 174 GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 58.8 bits (142), Expect = 5e-09
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 22/220 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKL 701
           ++G G  G+V    +  +G   AVK +  +  L     +  + E  IL   R H  + +L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +CC  + +    V E++    L   +   +R                      A      
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-------------FDEARARFYAAEITSA 108

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L ++H      II+RD+K  N+LLD E   K+ADFG+ K     G+  T S   G+  Y 
Sbjct: 109 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYI 163

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           APE          +D ++ GV+L E++ G    EA   D+
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.0 bits (143), Expect = 6e-09
 Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 28/222 (12%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN---IV 699
           +IG G  G+V  +    + +  A+K +     + +     F  E +I+    HAN   IV
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA---HANSEWIV 106

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           +L      +    +V EYM          G   +L+S      +    +   + +A+ A 
Sbjct: 107 QLHYAFQDDKYLYMVMEYMPG--------GDLVNLMSNYDIPEKWARFYTAEVVLALDAI 158

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
             + +         IHRDVK  N+LLD     K+ADFG    +   G     +AV G+  
Sbjct: 159 HSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPD 208

Query: 820 YFAPEYAYTTKVN----EKIDIYSFGVVLLELVTGKEANYGD 857
           Y +PE   +   +     + D +S GV L E++ G    Y D
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 58.6 bits (142), Expect = 7e-09
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 13/97 (13%)

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           +GL Y+H   +  I+HRD+K  N+L++S    KI DFGLA+ + +  E   M+    +  
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQY 169

Query: 820 YFAPEYA-----YTTKVNEKIDIYSFGVVLLELVTGK 851
           Y APE       YT+ V    DI+S G +  EL+  +
Sbjct: 170 YRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.2 bits (140), Expect = 8e-09
 Identities = 35/92 (38%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     G    M+    +  
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRY 183

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y APE        E +DI+S G ++ E+V  K
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.4 bits (143), Expect = 8e-09
 Identities = 56/233 (24%), Positives = 107/233 (45%), Gaps = 38/233 (16%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK-LW 702
           IG+G  G+V+ +      EF   K I + R L ++ + + + E+ ++  ++H NIV+ + 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAI-SYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79

Query: 703 CCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
             ++  N KL ++ E+ +   L R +    +        + +H +   TR  +       
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF----GKIEEHAIVDITRQLL-----HA 130

Query: 762 LCYMHH----DCTPQIIHRDVKSSNILLDSEFK-----------------AKIADFGLAK 800
           L Y H+        +++HRD+K  NI L +  +                 AKI DFGL+K
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 801 MLAKQGEPHTMSAVAGSFGYFAPEYAY--TTKVNEKIDIYSFGVVLLELVTGK 851
            +  +   H+     G+  Y++PE     T   ++K D+++ G ++ EL +GK
Sbjct: 191 NIGIESMAHS---CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 29/218 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLW 702
           IG G  G+V+++     G   AVK +     +++++E    AE  IL  +  H N+VK +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE----AEYNILKALSDHPNVVKFY 81

Query: 703 CCISSENSK-----LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
                ++ K      LV E     S+   + G  +        +  ++LH          
Sbjct: 82  GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH---------E 132

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
           A  GL ++H + T   IHRDVK +NILL +E   K+ DFG++  L         +   G+
Sbjct: 133 ALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--RLRRNTSVGT 187

Query: 818 FGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTG 850
             + APE         +  + + D++S G+  +EL  G
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.4 bits (138), Expect = 8e-09
 Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 22/166 (13%)

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           +GL Y+H +   + IHRD+K++N+LL    + K+ADFG+A  L         +   G+  
Sbjct: 112 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPF 166

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           + APE    +  + K DI+S G+  +EL  G E  + + H     +      +  P T  
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKG-EPPHSELHPMKVLFL---IPKNNPPT-- 220

Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ---ILR 922
           L+   ++P  L+E          C +  PS RP+ KE+L+   I+R
Sbjct: 221 LEGNYSKP--LKEFVEA------CLNKEPSFRPTAKELLKHKFIVR 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 69/301 (22%), Positives = 126/301 (41%), Gaps = 49/301 (16%)

Query: 638 LTESNLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L    ++G G  G V    ++   G+   VAVK +  +     ++E EF++E   +    
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE-EFLSEAACMKDFD 59

Query: 695 HANIVKLW-CCISSEN-----SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           H N++KL   C  + +       +++  +M++  L  +L           S +       
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---------YSRLGGLPEKL 110

Query: 749 PTR--LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML---- 802
           P +  L+  +  A G+ Y+        IHRD+ + N +L  +    +ADFGL+K +    
Sbjct: 111 PLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Query: 803 -AKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHT 860
             +QG    M     +    A +  YT+K     D+++FGV + E+ T  +  Y G E+ 
Sbjct: 168 YYRQGRIAKMPVKWIAIESLA-DRVYTSKS----DVWAFGVTMWEIATRGQTPYPGVENH 222

Query: 861 SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI 920
            + ++  RH    K   D LD+             +Y L   C    P  RP+  ++ ++
Sbjct: 223 EIYDYL-RHGNRLKQPEDCLDE-------------LYDLMYSCWRADPKDRPTFTKLREV 268

Query: 921 L 921
           L
Sbjct: 269 L 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 31/229 (13%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRI-WNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           LI +G  G VY +      +  A+K+I   N  L  ++++ F  E +IL    +  +V +
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM 66

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +C   ++    +V EY+E         G   +L+    ++   +     R+  A      
Sbjct: 67  FCSFETKRHLCMVMEYVEG--------GDCATLLKNIGALPVDM----ARMYFA-ETVLA 113

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM-------------LAKQGEP 808
           L Y+H      I+HRD+K  N+L+ S    K+ DFGL+K+             + K    
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 809 HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
                V G+  Y APE        + +D ++ G++L E + G    +GD
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 30/216 (13%)

Query: 643 LIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKL----NQKLEKEFIAEIEILGTIRH 695
           ++G GG G+V+++        G+  A+K +   +K     NQK      AE  IL  ++H
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVL---KKATIVRNQKDTAHTKAERNILEAVKH 59

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             IV L     +     L+ EY+    L  ++H  +  +    ++       + + + +A
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACF-----YLSEISLA 112

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE-PHTMSAV 814
           +       ++H      II+RD+K  NILLD++   K+ DFGL K    +G   HT    
Sbjct: 113 LE------HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF--- 160

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            G+  Y APE    +   + +D +S G ++ +++TG
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 8/91 (8%)

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           GL +MH+     +++RD+K +NILLD     +I+D GLA   +K+ +PH   A  G+ GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPH---ASVGTHGY 161

Query: 821 FAPEYAYT-TKVNEKIDIYSFGVVLLELVTG 850
            APE     T  +   D +S G +L +L+ G
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 8/91 (8%)

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           GL +MH+     +++RD+K +NILLD     +I+D GLA   +K+ +PH   A  G+ GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPH---ASVGTHGY 161

Query: 821 FAPE-YAYTTKVNEKIDIYSFGVVLLELVTG 850
            APE        +   D +S G +L +L+ G
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 18/154 (11%)

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           +V L  C  + +   LV EY+    L   +  R+R L        +H   +   + IA  
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-RQRKLP------EEHARFYAAEICIA-- 108

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
               L ++H      II+RD+K  N+LLD++   K+ D+G+ K     G+  T S   G+
Sbjct: 109 ----LNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGT 159

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
             Y APE     +    +D ++ GV++ E++ G+
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 31/79 (39%), Positives = 46/79 (58%), Gaps = 2/79 (2%)

Query: 773 IIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVN 832
           I++RD+K  NILLDSE    + DFGL+K    + +  T S   G+  Y APE       +
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGGH 184

Query: 833 EK-IDIYSFGVVLLELVTG 850
            K +D +S G+++ EL+TG
Sbjct: 185 GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 9/101 (8%)

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           +GL Y+H   +  IIHRD+K SN+ ++ + + +I DFGLA+    +     M+    +  
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRW 180

Query: 820 YFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           Y APE        N+ +DI+S G ++ EL+ GK    G+++
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 59/257 (22%), Positives = 111/257 (43%), Gaps = 45/257 (17%)

Query: 681 KEFIAEIEILGTIRHANIVKLW--CCISSEN----SKLLVYEYMENQSLDRWLHGRKRSL 734
           ++F++E   +    H N+++L   C  + E+    S +++  +M++  L  +L       
Sbjct: 45  EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL------ 98

Query: 735 VSGSSSVHQHVLHWPTRLQIAIGA--AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK 792
               S +     + PT++ +      A G+ Y+    +   IHRD+ + N +L+      
Sbjct: 99  ---YSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVC 152

Query: 793 IADFGLAKML-----AKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL 847
           +ADFGL+K +      +QG    M     +    A +  YTTK     D++SFGV + E+
Sbjct: 153 VADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLA-DRVYTTKS----DVWSFGVTMWEI 207

Query: 848 VTGKEANY-GDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTST 906
            T  +  Y G E++ + ++  +    ++P  D LD              +Y L   C   
Sbjct: 208 ATRGQTPYPGVENSEIYDYLRQGNRLKQP-PDCLD-------------GLYSLMSSCWLL 253

Query: 907 LPSSRPSMKEVLQILRR 923
            P  RPS + +   L +
Sbjct: 254 NPKDRPSFETLRCELEK 270

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 68/300 (22%), Positives = 118/300 (39%), Gaps = 65/300 (21%)

Query: 644 IGSGGSGQVYR--------IDINGAGEFVAVKRIWNNRKLNQKLEK--EFIAEIEILGTI 693
           +G G    +Y+        +DI G G+ V+V      + L         F     ++  +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVL----KVLGSDHRDSLAFFETASLMSQL 58

Query: 694 RHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
            H ++VKL+  C+  EN  ++V EY++   LD +LH R+++ VS          HW  +L
Sbjct: 59  SHKHLVKLYGVCVRDEN--IMVEEYVKFGPLDVFLH-REKNNVSL---------HW--KL 104

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK-------AKIADFGLAKMLAKQ 805
            +A   A  L Y+      +++H +V   NIL+             K++D G+   +  +
Sbjct: 105 DVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161

Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKI--DIYSFGVVLLELVTGKEANYGDEHTSLA 863
            E            + APE     + +  I  D +SFG  LLE+ +  E       +S  
Sbjct: 162 EERVERIP------WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215

Query: 864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
           E     + +++      D              +  L   C +  P+ RPS +    ILR 
Sbjct: 216 E----RFYQDQHRLPMPDCA-----------ELANLINQCWTYDPTKRPSFR---AILRD 257

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.7 bits (134), Expect = 6e-08
 Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 13/263 (4%)

Query: 230 NLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEA 289
           N +      +  L++L  L L+ N++    P    L +NL +L L DN +   +PS +  
Sbjct: 103 NRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRN 161

Query: 290 LK-LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLS-----GEVPASIGVVAFENNL 343
           L  L ++DLS N+L+  +P+    L NL  L L  N +S      E+ +++  +   NN 
Sbjct: 162 LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNS 220

Query: 344 SGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNL 403
              +  SL N + L  ++L +N+   +LP  +    NL +L LS+N IS      +  NL
Sbjct: 221 IIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNL 279

Query: 404 TRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSG 463
             L++S N  S  +         L      N L + +      +   LN  +L   + S 
Sbjct: 280 RELDLSGNSLSNALPLIALLLLLLE--LLLNLLLTLKALELKLNSILLNNNILSNGETS- 336

Query: 464 KLPSQIVSWTSLNNLNLARNELS 486
             P  +    SLNNL    N L 
Sbjct: 337 -SPEALSILESLNNLWTLDNALD 358

Length = 394

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 54.7 bits (132), Expect = 7e-08
 Identities = 69/283 (24%), Positives = 108/283 (38%), Gaps = 43/283 (15%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           LI       +Y+   N   + V ++      K ++ L      EI+ L  I   NI+K++
Sbjct: 27  LIKENDQNSIYKGIFNN--KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84

Query: 703 CCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
             I      L    L+ EY     L   L   K              L + T+L +AI  
Sbjct: 85  GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD-------------LSFKTKLDMAIDC 131

Query: 759 AQGLCYMH-HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            +GL  ++ +   P   ++++ S + L+   +K KI   GL K+L+     +    V   
Sbjct: 132 CKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV--- 185

Query: 818 FGYFAPEYAYT--TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
             YF+ +      ++   K DIYS GVVL E+ TGK          + +         K 
Sbjct: 186 --YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL 243

Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             D         C LE    V      CTS     RP++KE+L
Sbjct: 244 PLD---------CPLEIKCIVEA----CTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 8e-08
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 20/218 (9%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  GQVY++         A+K +          +KE +A+ E+  TI   NI  L  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL---------SKKEIVAKKEVAHTIGERNI--LVR 49

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH-QHVLHWP-TRLQIAIGAAQG 761
            +  E+  ++  ++      D +L     S   G    H Q    +   R +  I  A+ 
Sbjct: 50  TLLDESPFIVGLKFSFQTDSDLYLVTDYMS--GGELFWHLQKEGRFSEDRAKFYI--AEL 105

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           +  + H     I++RD+K  NILLD+     + DFGL+K  A   +  T +   G+  Y 
Sbjct: 106 VLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 822 APEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDE 858
           APE     K   + +D +S GV++ E+  G    Y ++
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 54.6 bits (131), Expect = 9e-08
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 25/241 (10%)

Query: 643 LIGSGGSGQVY---RIDINGAGEFVAVKRIWNNRKLNQKLEKEFI-AEIEILGTIRHAN- 697
           ++G+G  G+V+   ++  + +G+  A+K +     + +    E    E ++L  IR +  
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           +V L     ++    L+ +Y+    L   L  R+R                    ++ I 
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF----------------KEQEVQIY 110

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
           + + +  + H     II+RD+K  NILLDS     + DFGL+K   +  E     +  G+
Sbjct: 111 SGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-EVERAYSFCGT 169

Query: 818 FGYFAPEYAY--TTKVNEKIDIYSFGVVLLELVTGKEANYGD-EHTSLAEWAWRHYAEEK 874
             Y AP+         ++ +D +S GV++ EL+TG      D E  S AE + R    E 
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 229

Query: 875 P 875
           P
Sbjct: 230 P 230

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.8 bits (132), Expect = 9e-08
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)

Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  +V L  C  +E+    V E++    L   +  R+R L        +H   +   + +
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ-RQRKLP------EEHARFYSAEISL 107

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           A      L ++H      II+RD+K  N+LLD+E   K+ D+G+ K   + G+  T S  
Sbjct: 108 A------LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTF 156

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            G+  Y APE          +D ++ GV++ E++ G+
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.0 bits (132), Expect = 1e-07
 Identities = 91/329 (27%), Positives = 141/329 (42%), Gaps = 51/329 (15%)

Query: 227 TEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSS 286
             +N +  +P ++S L SL++L+ +G        + L LL  L  L L  N L   I   
Sbjct: 54  LSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLP-LPSLDLNLNRLRSNISEL 112

Query: 287 VEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGA 346
           +E   LT +DL  NN+T   P       NL+ L L  N +                   +
Sbjct: 113 LELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE------------------S 154

Query: 347 VPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAW--NLT 404
           +P  L N   L+ + L  N  S +LP  L    NL++L LS N IS +LP +      L 
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212

Query: 405 RLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGK 464
            L++SNN                            E+   L++L +L+ L L  NKL   
Sbjct: 213 ELDLSNNSII-------------------------ELLSSLSNLKNLSGLELSNNKLE-D 246

Query: 465 LPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNT 524
           LP  I + ++L  L+L+ N++S  I   +GSL  +  LDLSGN  S  +P     L L  
Sbjct: 247 LPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIALLLLLLE 304

Query: 525 FNLSSNKLYGNIPDEFNNLAYDDSFLNNS 553
             L+       +  + N++  +++ L+N 
Sbjct: 305 LLLNLLLTLKALELKLNSILLNNNILSNG 333

Length = 394

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 1e-07
 Identities = 56/246 (22%), Positives = 93/246 (37%), Gaps = 63/246 (25%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           L+G G  G+V+ + + G G+  A+K +     + +   K  + E EIL T+ H  +  L+
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG---AA 759
               +E    LV +Y     L R L  +                     L   +    AA
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGK-----------------CLSEEVARFYAA 110

Query: 760 QGLC---YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-------- 808
           + L    Y+H      I++RD+K  NILL       ++DF L+K    +  P        
Sbjct: 111 EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167

Query: 809 --------------------HTMSAVAGSFGYFAPE----YAYTTKVNEKIDIYSFGVVL 844
                                + S V G+  Y APE      + + V    D ++ G++L
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFV-GTEEYIAPEVISGDGHGSAV----DWWTLGILL 222

Query: 845 LELVTG 850
            E++ G
Sbjct: 223 YEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 48/212 (22%), Positives = 97/212 (45%), Gaps = 22/212 (10%)

Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G+G  G+V     Y +  + A   VAVK +      +++  +  ++E++I+  +  H N
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHLGNHEN 100

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV L    +     L++ EY     L  +L  ++ S ++      + +L +  ++     
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLT-----LEDLLSFSYQV----- 150

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            A+G+ ++    +   IHRD+ + N+LL      KI DFGLA+ +               
Sbjct: 151 -AKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
             + APE  +      + D++S+G++L E+ +
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.2 bits (130), Expect = 2e-07
 Identities = 78/340 (22%), Positives = 133/340 (39%), Gaps = 83/340 (24%)

Query: 643 LIGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHA 696
           ++G G  G+V     + ID   +   VAVK +      ++   K  ++E++IL  I  H 
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASE--HKALMSELKILIHIGNHL 71

Query: 697 NIVKLWCCISSENSKLLV-YEYMENQSLDRWL-----------------HGRKRSLV--- 735
           N+V L    +  N  L+V  E+ +  +L  +L                  GR R++V   
Sbjct: 72  NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131

Query: 736 -------SGSSSVHQ--HVLH--------------WPTRLQI------AIGAAQGLCYMH 766
                  +G +SV                      W + L +      +   A+G+ ++ 
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL- 190

Query: 767 HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYA 826
              + + IHRD+ + NILL      KI DFGLA+ + K  +     +      + APE  
Sbjct: 191 --ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248

Query: 827 YTTKVNEKIDIYSFGVVLLELVTGKEANY-----GDEHTSLAEWAWRHYAEEKPITDALD 881
           +      + D++SFGV+L E+ +   + Y      +E     +   R  A E        
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPE-------- 300

Query: 882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              A P        +YR+ L C    P  RP+   +++IL
Sbjct: 301 --NATP-------EIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 3/102 (2%)

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A+ LC + +     +I+RD+K  NILLD +    + DFGL K+  K  +    +   G+ 
Sbjct: 100 AELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTP 157

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT 860
            Y APE        + +D ++ GV+L E++TG    Y DE+ 
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY-DENV 198

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 24/224 (10%)

Query: 644 IGSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           IG+G  G+V   + +   +   V VK +  +   +++L   F+ E++    + H N+++ 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVLQC 60

Query: 702 WC-CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
              CI S    LLV E+     L  +L    R +V+  +             ++A   A 
Sbjct: 61  LGQCIES-IPYLLVLEFCPLGDLKNYLR-SNRGMVAQMAQKD-------VLQRMACEVAS 111

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           GL ++H       IH D+   N  L ++   KI D+GLA     +    T    A    +
Sbjct: 112 GLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168

Query: 821 FAPEYA-------YTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
            APE               +K +I+S GV + EL T  +  Y D
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 29/221 (13%)

Query: 644 IGSGGSGQVY---RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           +G G  G VY   R D     E+ A+K+I         +      EI +L  ++H N++ 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEY-ALKQIEGT-----GISMSACREIALLRELKHPNVIA 62

Query: 701 LWCCISSENSK--LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL--QIAI 756
           L     S + +   L+++Y E+   D W H  K      +S  ++  +  P  +   +  
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEH---DLW-HIIK---FHRASKANKKPMQLPRSMVKSLLY 115

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE----FKAKIADFGLAKMLAKQGEP-HTM 811
               G+ Y+H +    ++HRD+K +NIL+  E     + KIAD G A++     +P   +
Sbjct: 116 QILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172

Query: 812 SAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
             V  +F Y APE     +   + IDI++ G +  EL+T +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 2e-07
 Identities = 66/253 (26%), Positives = 100/253 (39%), Gaps = 70/253 (27%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI----AEIEILGTIRHANI 698
           +IG G  G+V  +     G   A+K++   RK ++ LEKE +    AE +IL    +  +
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKL---RK-SEMLEKEQVAHVRAERDILAEADNPWV 63

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI---- 754
           VKL+     EN   L+ EY+    +   L   K+   +             TR  I    
Sbjct: 64  VKLYYSFQDENYLYLIMEYLPGGDMMTLL--MKKDTFT----------EEETRFYIAETI 111

Query: 755 -AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP----- 808
            AI +   L Y         IHRD+K  N+LLD++   K++DFGL   L K         
Sbjct: 112 LAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162

Query: 809 --------------HTMS-----------------AVAGSFGYFAPEYAYTTKVNEKIDI 837
                           MS                 +  G+  Y APE    T  N++ D 
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222

Query: 838 YSFGVVLLELVTG 850
           +S GV++ E++ G
Sbjct: 223 WSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 22/219 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +IG G  G+V  +      +  A+K +     + +     F  E +I+       +V+L+
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                +    +V EYM    L         +L+S      +    +   + +A+ A   +
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDL--------VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            +         IHRDVK  N+LLD     K+ADFG    + K+G     +AV G+  Y +
Sbjct: 162 GF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 211

Query: 823 PEYAYTTK----VNEKIDIYSFGVVLLELVTGKEANYGD 857
           PE   +         + D +S GV L E++ G    Y D
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.9 bits (127), Expect = 4e-07
 Identities = 63/220 (28%), Positives = 88/220 (40%), Gaps = 33/220 (15%)

Query: 630 TESNILSSLTESNLIGSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEI 687
            + NILSSLT       G  G+V+    +G    + V VK +   +   +        EI
Sbjct: 92  MQYNILSSLT------PGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR--------EI 137

Query: 688 EILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
           +IL TI H  I+ L   I +   K  V   M     D + +      V  S       L 
Sbjct: 138 DILKTISHRAIINL---IHAYRWKSTVCMVMPKYKCDLFTY------VDRSGP-----LP 183

Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
               + I     + L Y+H      IIHRDVK+ NI LD    A + DFG A  L    +
Sbjct: 184 LEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240

Query: 808 PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL 847
                  +G+    +PE         K DI+S G+VL E+
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 52.7 bits (126), Expect = 5e-07
 Identities = 61/245 (24%), Positives = 99/245 (40%), Gaps = 57/245 (23%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEI----EILGTIRHANI 698
           +IG G  G+V  +     G   A+K +   RK +  LEKE +A I    +IL     A +
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKIL---RKADM-LEKEQVAHIRAERDILVEADGAWV 63

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           VK++     + +  L+ E++    +   L  +K +L   ++        +     +AI A
Sbjct: 64  VKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-KKDTLSEEATQF------YIAETVLAIDA 116

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK-----------QGE 807
              L +         IHRD+K  N+LLD++   K++DFGL   L K              
Sbjct: 117 IHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167

Query: 808 PHTMS----------------------AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLL 845
           P   S                      +  G+  Y APE    T  N+  D +S GV++ 
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227

Query: 846 ELVTG 850
           E++ G
Sbjct: 228 EMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 67/297 (22%), Positives = 118/297 (39%), Gaps = 41/297 (13%)

Query: 638 LTESNLIGSGGSGQVYRIDI---NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
            T   ++G G  G V    +   +G+ + VAVK +  +   +  +E EF+ E   +    
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFD 59

Query: 695 HANIVKLWCCISSENSK------LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           H N++KL        +K      +++  +M++  L  +L           S + +     
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL---------MSRIGEEPFTL 110

Query: 749 P--TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
           P  T ++  I  A G+ Y+    +   IHRD+ + N +L+      +ADFGL+K +    
Sbjct: 111 PLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
                 A      + A E           D+++FGV + E++T  +  Y           
Sbjct: 168 YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG--------- 218

Query: 867 WRHYAEEKPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                E   I + L KG  + +P   + +  VY L   C S  P  RPS + +   L
Sbjct: 219 ----VENSEIYNYLIKGNRLKQP--PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.4 bits (125), Expect = 5e-07
 Identities = 49/179 (27%), Positives = 86/179 (48%), Gaps = 26/179 (14%)

Query: 686 EIEILGTIRHANIVKLW-CCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
           EI +L  ++H N++ L    +S  + K+ L+++Y E+   D W H  K    S ++    
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH---DLW-HIIKFHRASKANK--- 100

Query: 744 HVLHWPTRLQIAIGAAQGLCY-----MHHDCTPQIIHRDVKSSNILLDSE----FKAKIA 794
                   +Q+  G  + L Y     +H+     ++HRD+K +NIL+  E     + KIA
Sbjct: 101 ------KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154

Query: 795 DFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           D G A++     +P   +  V  +F Y APE     +   + IDI++ G +  EL+T +
Sbjct: 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.0 bits (127), Expect = 6e-07
 Identities = 44/161 (27%), Positives = 72/161 (44%), Gaps = 22/161 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           I  G  G+VY        +  AVK +     +N+ +  +  AE + L   +   IV L+ 
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW---PTRLQIAIGAAQ 760
            + S N+  LV EY+        + G  +SL+        H+  +      ++     A 
Sbjct: 72  SLQSANNVYLVMEYL--------IGGDVKSLL--------HIYGYFDEEMAVKYISEVAL 115

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM 801
            L Y+H      IIHRD+K  N+L+ +E   K+ DFGL+K+
Sbjct: 116 ALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 56/303 (18%)

Query: 639 TESNLIGSGGSGQVYR---IDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           T S+L+  G  G+++    ID     E  V VK + ++    Q      + E  +L  + 
Sbjct: 9   TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQV--TLLLQESCLLYGLS 66

Query: 695 HANIVKLWC-CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           H NI+ +   CI       ++Y YM   +L  +L   +    +   ++    L     + 
Sbjct: 67  HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL-----VH 121

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
           +AI  A G+ Y+H      +IH+D+ + N ++D E + KI D  L++ L    + H    
Sbjct: 122 MAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP-MDYH---- 173

Query: 814 VAGSFG--------YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
                G        + A E     + +   D++SFGV+L EL+T            L + 
Sbjct: 174 ---CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT------------LGQT 218

Query: 866 AWRHYAEEKP--ITDALDKG--IAEP--CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
               Y E  P  +   L  G  +A+P  C  E    ++ +   C +  P  RPS  +++Q
Sbjct: 219 P---YVEIDPFEMAAYLKDGYRLAQPINCPDE----LFAVMACCWALDPEERPSFSQLVQ 271

Query: 920 ILR 922
            L 
Sbjct: 272 CLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.1 bits (119), Expect = 3e-06
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 23/221 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTIRHANIVKL 701
           +IG G  G+V  + +  A +  A+K I N  ++ ++ E   F  E ++L    +  I  L
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                 EN+  LV +Y     L   L   +  L    +  +         + IAI +   
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL------AEMVIAIDSVHQ 120

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y         +HRD+K  NIL+D     ++ADFG    L + G   +  AV G+  Y 
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170

Query: 822 APEYAYTT-----KVNEKIDIYSFGVVLLELVTGKEANYGD 857
           +PE          K   + D +S GV + E++ G+   Y +
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.8 bits (119), Expect = 4e-06
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 24/154 (15%)

Query: 774 IHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNE 833
           IHRD+ + NILL      KI DFGLA+ + K  +            + APE  +      
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 834 KIDIYSFGVVLLELVTGKEANYG----DEHTSLAEWAWRHYAEEKPITDALDKG--IAEP 887
           + D++SFGV+L E+ +   + Y     DE     E+  R           L +G  +  P
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPGVQIDE-----EFCRR-----------LKEGTRMRAP 298

Query: 888 CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            Y      +Y + L C    P  RP+  E+++IL
Sbjct: 299 EYATP--EIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 48.9 bits (116), Expect = 5e-06
 Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 60/234 (25%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKL 701
           L+G+G  GQVY+      G+  A+K +     +    E+E   EI +L     H NI   
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVM----DVTGDEEEEIKQEINMLKKYSHHRNIATY 68

Query: 702 WCCISSENSK------LLVYEYMENQSL-------------DRWLHGRKRSLVSGSSSVH 742
           +     +N         LV E+    S+             + W+    R ++ G S +H
Sbjct: 69  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128

Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
           QH                           ++IHRD+K  N+LL    + K+ DFG++  L
Sbjct: 129 QH---------------------------KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161

Query: 803 AKQ-GEPHTMSAVAGSFGYFAPEYAYTTK-----VNEKIDIYSFGVVLLELVTG 850
            +  G  +T     G+  + APE     +      + K D++S G+  +E+  G
Sbjct: 162 DRTVGRRNTF---IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.6 bits (118), Expect = 5e-06
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 33/219 (15%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           N+IG+G  G VY        E VA+K++  + +   +       E+ I+  + H NI+ L
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-------ELLIMKNLNHINIIFL 124

Query: 702 ------WCCISSENSKLL--VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
                  C   +E +  L  V E++  Q++ +++    R+          H L       
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARN---------NHALPLFLVKL 174

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGEPHTMS 812
            +    + L Y+H   +  I HRD+K  N+L+D      K+ DFG AK L       ++S
Sbjct: 175 YSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL--AGQRSVS 229

Query: 813 AVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTG 850
            +   F Y APE     T     ID++S G ++ E++ G
Sbjct: 230 YICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 42/148 (28%), Positives = 64/148 (43%), Gaps = 12/148 (8%)

Query: 774 IHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNE 833
           IHRD+ + NILL      KI DFGLA+ + K  +            + APE  +      
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 834 KIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEM 893
           + D++SFGV+L E+ +   + Y        E+  R   +E     A D    E       
Sbjct: 261 QSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRR--LKEGTRMRAPDYTTPE------- 310

Query: 894 TTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +Y+  L C    PS RP+  E+++ L
Sbjct: 311 --MYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 22/216 (10%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +L+G G  G+V  +     G+  A+K +  +  L Q+    F  E +IL       I +L
Sbjct: 7   SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                 +++  LV EY     L   L+  +         + Q  L     L +AI +   
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF---DEDMAQFYL---AELVLAIHSVHQ 120

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           + Y         +HRD+K  N+L+D     K+ADFG A  L      ++   V G+  Y 
Sbjct: 121 MGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYI 170

Query: 822 APEYAYTTKVNEK------IDIYSFGVVLLELVTGK 851
           APE   T   + K       D +S GV+  E++ G+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 18/170 (10%)

Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E  IL  I H +I++L    +      L+    +   L  +L  ++   +    ++ +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIER 189

Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA 803
            VL             + + Y+H +   +IIHRD+K+ NI ++      + DFG A    
Sbjct: 190 SVL-------------RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFP 232

Query: 804 KQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEA 853
                +     AG+    APE          +DI+S G+VL E+ T  ++
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282

Length = 391

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 21/155 (13%)

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           N+V L   I SE+S  LV ++ E   L  W H  K   +       + V  W   + +A+
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKL--WSHISKFLNIP-----EECVKRWAAEMVVAL 98

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
            A      +H +    I+ RD+  +NILLD     ++  F     +    +   +  +  
Sbjct: 99  DA------LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-- 147

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
              Y APE    ++  E  D +S G +L EL+TGK
Sbjct: 148 ---YCAPEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 48.7 bits (116), Expect = 2e-05
 Identities = 26/64 (40%), Positives = 36/64 (56%), Gaps = 1/64 (1%)

Query: 499 MVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCV 557
           +VS+DLSG   SG+I   I +L  + T NLS+N+L G IPD+    +    +LN SN   
Sbjct: 71  VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130

Query: 558 KNPI 561
              I
Sbjct: 131 TGSI 134

Length = 968

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.8 bits (112), Expect = 3e-05
 Identities = 28/87 (32%), Positives = 44/87 (50%), Gaps = 19/87 (21%)

Query: 772 QIIHRDVKSSNILLD-SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPE------ 824
            IIH D+K  N+L D ++ +  + D+GL K++       T S   G+  YF+PE      
Sbjct: 129 NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII------GTPSCYDGTLDYFSPEKIKGHN 182

Query: 825 YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y  +       D ++ GV+  EL+TGK
Sbjct: 183 YDVS------FDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.4 bits (112), Expect = 3e-05
 Identities = 59/245 (24%), Positives = 98/245 (40%), Gaps = 57/245 (23%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI----AEIEILGTIRHANI 698
           +IG G  G+V  +     G   A+K +   RK +  LEKE +    AE +IL       +
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKIL---RKADM-LEKEQVGHIRAERDILVEADSLWV 63

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           VK++     + +  L+ E++    +   L  +K +L    +        +     +AI +
Sbjct: 64  VKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-KKDTLTEEETQF------YIAETVLAIDS 116

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-------HTM 811
              L +         IHRD+K  N+LLDS+   K++DFGL   L K           H++
Sbjct: 117 IHQLGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167

Query: 812 S--------------------------AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLL 845
                                      +  G+  Y APE    T  N+  D +S GV++ 
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227

Query: 846 ELVTG 850
           E++ G
Sbjct: 228 EMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 51/221 (23%), Positives = 96/221 (43%), Gaps = 34/221 (15%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKL 701
           ++G+G  GQVY+      G+  A+K +     + +  E+E   EI +L     H NI   
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVM----DVTEDEEEEIKLEINMLKKYSHHRNIATY 78

Query: 702 WCCI------SSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           +           ++   LV E+    S+   +   K       +++ +  + +  R  + 
Sbjct: 79  YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK------GNALKEDWIAYICREIL- 131

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ-GEPHTMSAV 814
               +GL ++H     ++IHRD+K  N+LL    + K+ DFG++  L +  G  +T    
Sbjct: 132 ----RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--- 181

Query: 815 AGSFGYFAPEYAYT-----TKVNEKIDIYSFGVVLLELVTG 850
            G+  + APE            + + DI+S G+  +E+  G
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.5 bits (110), Expect = 4e-05
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 9/96 (9%)

Query: 774 IHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT---- 829
           +HRD+K  N+LLD     ++ADFG    + + G   +  AV G+  Y +PE         
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAMEDGM 182

Query: 830 -KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            K   + D +S GV + E++ G+   Y +   SL E
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 45.3 bits (107), Expect = 7e-05
 Identities = 55/244 (22%), Positives = 105/244 (43%), Gaps = 36/244 (14%)

Query: 644 IGSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           IG+G  G+V   ++N       V VK +  +  + ++++  F+ E +   +++H+N+++ 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK--FLEEAQPYRSLQHSNLLQC 60

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHG-RKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
               +     LLV E+     L  +L   RK  L++   +  Q         ++A   A 
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ---------RMACEIAL 111

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           GL ++H +     IH D+   N LL ++   KI D+GL+    K+    T   +     +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168

Query: 821 FAPEYAYTTKVN-------EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
            APE       N       ++ +++S GV + EL              L    +RH ++E
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF------------ELGSQPYRHLSDE 216

Query: 874 KPIT 877
           + +T
Sbjct: 217 QVLT 220

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 9e-05
 Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 11/97 (11%)

Query: 774 IHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA-GSFGYFAPEYAY----- 827
           +HRD+K  N+LLD     ++ADFG    L   G     S VA G+  Y +PE        
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDG 181

Query: 828 TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
             +   + D +S GV + E++ G+   Y +   SL E
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVE 215

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 32/109 (29%), Positives = 50/109 (45%), Gaps = 18/109 (16%)

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
           I  GA +GL Y+H +     IHR++K+S+IL+  +    ++       L + G+   +  
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162

Query: 814 VAGSFG-----YFAPE------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
               F      + +PE      Y Y    N K DIYS G+   EL TG+
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGY----NVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 40/175 (22%), Positives = 77/175 (44%), Gaps = 21/175 (12%)

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
           L+ +   AQG+ ++    +   IHRDV + N+LL     AKI DFGLA+ +         
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271

Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA 871
                   + APE  +      + D++S+G++L E+             SL +  +    
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGKSPYPGIL 319

Query: 872 EEKPITDALDKG--IAEPCY-LEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
                   + +G  ++ P +   E+   Y +  +C +  P+ RP+  ++ Q+++R
Sbjct: 320 VNSKFYKMVKRGYQMSRPDFAPPEI---YSIMKMCWNLEPTERPTFSQISQLIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 39.2 bits (92), Expect = 2e-04
 Identities = 17/40 (42%), Positives = 21/40 (52%), Gaps = 3/40 (7%)

Query: 35 EERTILLNLKQQLGNPPS--LQSWT-STSSPCDWPEITCT 71
          ++R  LL  K  L   PS  L SW  S+S PC W  +TC 
Sbjct: 3  DDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 3e-04
 Identities = 29/99 (29%), Positives = 44/99 (44%), Gaps = 6/99 (6%)

Query: 751 RLQIAIGAAQGLC---YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
             Q+   A Q L    Y+H +    IIHRD+K+ N+L++      + DFG A        
Sbjct: 259 LAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315

Query: 808 PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLE 846
                 +AG+    APE          +DI+S G+V+ E
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 34/161 (21%), Positives = 59/161 (36%), Gaps = 29/161 (18%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV--K 700
           L+  G + +VY +      ++V   +I  +R+     E+E      IL  +    +   K
Sbjct: 5   LLKGGLTNRVYLLG-TKDEDYVL--KINPSREKGADREREV----AILQLLARKGLPVPK 57

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           +     S+    L+ E++E ++LD          VS                 IA   A+
Sbjct: 58  VLASGESDGWSYLLMEWIEGETLDE---------VSEEEKE-----------DIAEQLAE 97

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM 801
            L  +H      + H D+   NIL+D      I D+  A  
Sbjct: 98  LLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.2 bits (99), Expect = 0.001
 Identities = 40/172 (23%), Positives = 69/172 (40%), Gaps = 29/172 (16%)

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A+G+ ++    +   IHRD+ + NILL      KI DFGLA+ +                
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            + APE  +      + D++S+G++L E+ +   + Y                   P+  
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY----------------PGMPVDS 324

Query: 879 ALDKGIAE-------PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
              K I E        C   EM   Y +   C    P  RP+ K+++Q++ +
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEM---YDIMKSCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.1 bits (99), Expect = 0.001
 Identities = 30/119 (25%), Positives = 45/119 (37%), Gaps = 41/119 (34%)

Query: 774 IHRDVKSSNILLDSEFKAKIADFGLA---------------------------------- 799
           IHRD+K  NIL+D +   K+ DFGL                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 800 ---KML----AKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
              K L     +Q +     ++ G+  Y APE    T   +  D +S GV+L E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 22/76 (28%), Positives = 39/76 (51%)

Query: 774 IHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNE 833
           +HRD+ + N+L+      KI DFGLA+ + +     +  +      + APE  +      
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 834 KIDIYSFGVVLLELVT 849
             D++SFG++L E+ T
Sbjct: 321 LSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 42.1 bits (99), Expect = 0.002
 Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 2/77 (2%)

Query: 478 LNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL--KLNTFNLSSNKLYGN 535
           ++L+   +SG+I  AI  L  + +++LS NQ SG IP +I      L   NLS+N   G+
Sbjct: 74  IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133

Query: 536 IPDEFNNLAYDDSFLNN 552
           IP             NN
Sbjct: 134 IPRGSIPNLETLDLSNN 150

Length = 968

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 41.7 bits (98), Expect = 0.002
 Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 4/83 (4%)

Query: 343 LSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWN 402
           L G +P  +   R L+++ L  N   G +P  L +  +L  L LS N+ +G +P ++   
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP-ESLGQ 488

Query: 403 LTRLEISN---NRFSGQIQRGVG 422
           LT L I N   N  SG++   +G
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 35/155 (22%), Positives = 65/155 (41%), Gaps = 16/155 (10%)

Query: 774 IHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNE 833
           +HRD+ + N+LL      KI DFGLA+ +       +  +      + APE  +      
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 834 KIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG--IAEPCYLE 891
             D++S+G++L E+             SL    +     +    + +  G  +A+P +  
Sbjct: 319 LSDVWSYGILLWEIF------------SLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHAT 366

Query: 892 EMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP 926
           +   VY + + C ++ P  RPS   +  I+    P
Sbjct: 367 Q--EVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.2 bits (94), Expect = 0.003
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 25/214 (11%)

Query: 644 IGSGGSGQVY--RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK- 700
           IG+G  G+V    I  +     V VK +  N   + K + EF+ + +    ++H NI++ 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L  C+ +    LLV+EY E   L  +L   +    +    + Q         ++A   A 
Sbjct: 61  LGQCVEAI-PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---------RMACEIAA 110

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           G+ +MH       +H D+   N  L S+   K+ D+G+     K+    T         +
Sbjct: 111 GVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167

Query: 821 FAPEYA-------YTTKVNEKIDIYSFGVVLLEL 847
            APE          T +  +  ++++ GV L EL
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.003
 Identities = 19/59 (32%), Positives = 30/59 (50%), Gaps = 2/59 (3%)

Query: 220 KLKTLWMTEANLIGEIPEAM-SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDN 277
            LK+L ++  N +  IP+     L +L++L L+GN+L    P     L +L  L L  N
Sbjct: 1   NLKSLDLS-NNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 0.004
 Identities = 29/123 (23%), Positives = 45/123 (36%), Gaps = 45/123 (36%)

Query: 774 IHRDVKSSNILLDSEFKAKIADFGLA---------------------------------- 799
           IHRD+K  NIL+D +   K+ DFGL                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 800 -----------KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELV 848
                      +  A+Q +     ++ G+  Y APE    T   +  D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 849 TGK 851
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	969
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.79
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.78
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.74
PRK10345	210	hypothetical protein; Provisional	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.71
smart00090	237	RIO RIO-like kinase.	99.7
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.69
PLN03150	623	hypothetical protein; Provisional	99.67
PRK14879	211	serine/threonine protein kinase; Provisional	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.63
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.55
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.53
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.52
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.52
PLN03150	623	hypothetical protein; Provisional	99.49
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.43
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.39
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.38
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.31
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.26
KOG1243	690	consensus Protein kinase [General function predict	99.26
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.16
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.14
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.14
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.12
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.09
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.06
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.05
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.05
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.05
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.04
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.02
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.01
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.01
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.01
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.98
COG4248	637	Uncharacterized protein with protein kinase and he	98.95
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.95
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.82
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.78
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.75
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.75
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.73
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.72
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.67
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.64
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.6
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.57
PRK09902	216	hypothetical protein; Provisional	98.54
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.54
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.49
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.46
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.45

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.9e-107  Score=1034.53  Aligned_cols=856  Identities=36%  Similarity=0.580  Sum_probs=584.6

Q ss_pred             CHHHHHHHHHHHHHcCCCC-CCCCCCCCCCCCCCCcceeeC-CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCC
Q 002085           33 NTEERTILLNLKQQLGNPP-SLQSWTSTSSPCDWPEITCTF-NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIP  110 (969)
Q Consensus        33 ~~~~~~all~~k~~~~~~~-~l~sw~~~~~~c~w~gv~C~~-~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~  110 (969)
                      .++|++||++||+++.++. .+.+|+.+++||.|.||+|+. ++|+.|+|+++++.+.+++.|..+++|++|+|++|+++
T Consensus        27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~  106 (968)
T PLN00113         27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS  106 (968)
T ss_pred             CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccC
Confidence            5689999999999997654 478999888999999999974 68999999999999999999999999999999999999


Q ss_pred             CCCCcccC-CCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCccc
Q 002085          111 GEFPEFLY-NCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEI  189 (969)
Q Consensus       111 ~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  189 (969)
                      |.+|..+. .+++|++|+|++|++++.+|.  +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..|
T Consensus       107 ~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~  184 (968)
T PLN00113        107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL  184 (968)
T ss_pred             CcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhh
Confidence            88887654 777788777777777655553  234455555555555554445445555555555555555544444444


Q ss_pred             CCCCCcceeecccCCCC----------------------CCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhh
Q 002085          190 GDLSNLEVLGLAYNSNF----------------------KPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEI  247 (969)
Q Consensus       190 ~~l~~L~~L~L~~N~~~----------------------~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  247 (969)
                      +++++|++|+|++|++.                      ..+.+|..++++++|++|++++|++.+.+|..|+++++|+.
T Consensus       185 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  264 (968)
T PLN00113        185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQY  264 (968)
T ss_pred             hhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCE
Confidence            55555555555444311                      12234444455555555555555554455555555555555


Q ss_pred             hhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccC
Q 002085          248 LALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL  326 (969)
Q Consensus       248 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  326 (969)
                      |+|++|++++.+|..+..+++|++|+|++|.+++.+|..+..+ +|+.|++++|.+++.+|..+..+++|+.|++++|.+
T Consensus       265 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l  344 (968)
T PLN00113        265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF  344 (968)
T ss_pred             EECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCC
Confidence            5555555554445555555555555555555554444444333 355555555555544444455555555555555555


Q ss_pred             cCcCCccccc------ccc-cC------------------------cccccCCCCCCCCccCcEEEcccccccCCCCccc
Q 002085          327 SGEVPASIGV------VAF-EN------------------------NLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGL  375 (969)
Q Consensus       327 ~~~~p~~~~~------l~~-~n------------------------~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  375 (969)
                      .+.+|..++.      +.+ .|                        ++.+.+|..+..+++|+.|++++|++++.+|..+
T Consensus       345 ~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~  424 (968)
T PLN00113        345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF  424 (968)
T ss_pred             cCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhH
Confidence            5444433221      111 12                        2333334444444455555555555555555555


Q ss_pred             ccccCCCccccCCCccccccCcc--ccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccch
Q 002085          376 WTTFNLSSLMLSDNTISGELPSK--TAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNT  453 (969)
Q Consensus       376 ~~l~~L~~L~Ls~N~l~~~~~~~--~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  453 (969)
                      ..+++|+.|++++|.+++.++..  ..++|+.|+|++|++.+.+|..+ ..++|+.|++++|++++.+|..+.++++|+.
T Consensus       425 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~  503 (968)
T PLN00113        425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQ  503 (968)
T ss_pred             hcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCE
Confidence            55555555555555555544432  23456666666666666666544 3467888888888888888989999999999


Q ss_pred             hhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecCcC
Q 002085          454 LLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKL  532 (969)
Q Consensus       454 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l  532 (969)
                      |+|++|++++.+|+.+.++++|++|+|++|.++|.+|..|..+++|+.|||++|+++|.+|..+..+. |++|++++|++
T Consensus       504 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l  583 (968)
T PLN00113        504 LKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL  583 (968)
T ss_pred             EECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999885 99999999999


Q ss_pred             CCCCCccccccccc-ccccCCCCCCCCCCCCCCCCCCCCCCCCCcCCcchhhhHHHHHHHHHHHHHhhheeeeeehhhhc
Q 002085          533 YGNIPDEFNNLAYD-DSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRRK  611 (969)
Q Consensus       533 ~~~~p~~~~~~~~~-~~~~~n~~l~~~~~~~~l~~c~~~~~~~~~~~~~~~~~iiv~~~~~~l~~~~l~~~~~~~~~~~~  611 (969)
                      +|.+|..-+..++. .+|.+|+++|+..+....+.|....    +......++++++++++++++++++++++|+..+.+
T Consensus       584 ~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  659 (968)
T PLN00113        584 HGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR----KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLE  659 (968)
T ss_pred             eeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc----ccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccc
Confidence            99999775555443 5689999999987666677775321    111111222222222222222222222222111110


Q ss_pred             cCC---CCCCcccccccc---cccchhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHH
Q 002085          612 RNR---DPATWKLTSFHQ---LGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA  685 (969)
Q Consensus       612 ~~~---~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~  685 (969)
                      .++   +...|....+..   ..++.+++...++..++||+|+||.||+|+...++..||||++.....       ....
T Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~  732 (968)
T PLN00113        660 LKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSS  732 (968)
T ss_pred             ccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHH
Confidence            011   111232222211   123344556778888999999999999999988899999998854321       1234


Q ss_pred             HHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhh
Q 002085          686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYM  765 (969)
Q Consensus       686 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L  765 (969)
                      |++++++++|||||++++++.+++..|+||||+++|+|.++++.                ++|..+.+++.|+|+||+||
T Consensus       733 ~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----------------l~~~~~~~i~~~ia~~L~yL  796 (968)
T PLN00113        733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----------------LSWERRRKIAIGIAKALRFL  796 (968)
T ss_pred             HHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----------------CCHHHHHHHHHHHHHHHHHh
Confidence            68889999999999999999999999999999999999999952                78999999999999999999


Q ss_pred             cccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHH
Q 002085          766 HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLL  845 (969)
Q Consensus       766 H~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~  845 (969)
                      |..++++|+||||||+||+++.++.+++. ||.+.....      .....+|+.|+|||++.+..++.++|||||||++|
T Consensus       797 H~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~  869 (968)
T PLN00113        797 HCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILI  869 (968)
T ss_pred             ccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHH
Confidence            97767799999999999999999888875 665543211      12236789999999999999999999999999999


Q ss_pred             HHHhCCCCCCCC--CccchHHHHHHHhhccCCchhhhccCCCC--cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          846 ELVTGKEANYGD--EHTSLAEWAWRHYAEEKPITDALDKGIAE--PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       846 elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      ||++|+.||...  ......+|+...+. .......+++.+..  ....++..++.+++.+||+.||++||+|+|++++|
T Consensus       870 el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  948 (968)
T PLN00113        870 ELLTGKSPADAEFGVHGSIVEWARYCYS-DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL  948 (968)
T ss_pred             HHHhCCCCCCcccCCCCcHHHHHHHhcC-ccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence            999999998643  23345555543322 22233344444322  23455667889999999999999999999999999


Q ss_pred             hhcCC
Q 002085          922 RRCCP  926 (969)
Q Consensus       922 ~~~~~  926 (969)
                      +++..
T Consensus       949 ~~~~~  953 (968)
T PLN00113        949 ESASR  953 (968)
T ss_pred             HHhhc
Confidence            98863

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.4e-53  Score=541.63  Aligned_cols=456  Identities=38%  Similarity=0.585  Sum_probs=327.4

Q ss_pred             EEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCC
Q 002085           77 GISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNN  156 (969)
Q Consensus        77 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  156 (969)
                      .|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|.+++.+|..++++++|++|+|++|+
T Consensus       144 ~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~  223 (968)
T PLN00113        144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN  223 (968)
T ss_pred             EEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCc
Confidence            33333344444444455555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCc
Q 002085          157 FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIP  236 (969)
Q Consensus       157 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  236 (969)
                      +++.+|..|+++++|++|+|++|++++.+|..|+++++|++|++++|.+  .+.+|..+..+++|++|++++|++.+.+|
T Consensus       224 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l--~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p  301 (968)
T PLN00113        224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL--SGPIPPSIFSLQKLISLDLSDNSLSGEIP  301 (968)
T ss_pred             cCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCee--eccCchhHhhccCcCEEECcCCeeccCCC
Confidence            5555555555555555555555555555555555555555555555542  23455555556666666666666655666


Q ss_pred             hhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCccc
Q 002085          237 EAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKN  315 (969)
Q Consensus       237 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~  315 (969)
                      ..+.++++|+.|++++|.+++.+|..+..+++|+.|+|++|.+++.+|..+... +|+.|++++|++++.+|..+..+++
T Consensus       302 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~  381 (968)
T PLN00113        302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGN  381 (968)
T ss_pred             hhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCC
Confidence            666666666666666666666666666666666666666666666666555544 4666666666666666666666666


Q ss_pred             chhhhhccccCcCcCCccccc------cc-ccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCC
Q 002085          316 LQLLGLFSNHLSGEVPASIGV------VA-FENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSD  388 (969)
Q Consensus       316 L~~L~L~~N~l~~~~p~~~~~------l~-~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  388 (969)
                      |+.|++++|.+.+.+|..+..      +. ..|++.+.+|..+.+++.|+.|++++|++++.+|..++.+++|+.|+|++
T Consensus       382 L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  461 (968)
T PLN00113        382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR  461 (968)
T ss_pred             CCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcC
Confidence            666666666666666654432      22 25678889999999999999999999999999999999999999999999


Q ss_pred             CccccccCcccc-ccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCc
Q 002085          389 NTISGELPSKTA-WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPS  467 (969)
Q Consensus       389 N~l~~~~~~~~~-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  467 (969)
                      |++.+.+|.... .+|+.|+|++|++++.+|..+.++++|+.|++++|++++.+|..+..+++|+.|+|++|++++.+|.
T Consensus       462 n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  541 (968)
T PLN00113        462 NKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA  541 (968)
T ss_pred             ceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCCh
Confidence            999998887543 6899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCccccccccEEEeecCc-CCC
Q 002085          468 QIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNK-LYG  534 (969)
Q Consensus       468 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~-l~~  534 (969)
                      .+..+++|+.|+|++|+++|.+|..+.++++|+.|++++|+++|.+|..-.-..+....+.+|. ++|
T Consensus       542 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~  609 (968)
T PLN00113        542 SFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCG  609 (968)
T ss_pred             hHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccC
Confidence            9999999999999999999999999999999999999999999999965222235555667776 444

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=413.84  Aligned_cols=275  Identities=47%  Similarity=0.764  Sum_probs=235.2

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC-ce
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN-SK  711 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~  711 (969)
                      ..+++|...++||+|+||.||+|...+ |+.||||++.....  +. .++|..|++++.+++|||+|+++|||.+.+ +.
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~--~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~  147 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSG--QG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR  147 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCC--cc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence            456799999999999999999999974 58899998754332  11 456999999999999999999999999988 49


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      +||||||++|+|.++++....          . .++|.+|++||.++|+||+|||+.+.+.|+||||||+|||+|+++++
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~----------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKG----------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCC----------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            999999999999999998653          1 58999999999999999999999988899999999999999999999


Q ss_pred             EEeecccceecccCCCCcccccc-ccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCC---CccchHHHHH
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAV-AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD---EHTSLAEWAW  867 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~---~~~~~~~~~~  867 (969)
                      ||+|||+|+.....  ....... .||.+|+|||+...+..+.++|||||||+|.|++||+.+.+..   ....+..|++
T Consensus       217 KlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~  294 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK  294 (361)
T ss_pred             EccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence            99999999654321  1111112 8999999999999999999999999999999999999887643   3445788886


Q ss_pred             HHhhccCCchhhhccCCC-CcccH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          868 RHYAEEKPITDALDKGIA-EPCYL-EEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ...... .+.+++|+.+. ..... +....+..++.+|++.+|.+||+|.||+++|+...
T Consensus       295 ~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  295 PLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            666655 78999999986 44443 67888999999999999999999999999996664

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=401.90  Aligned_cols=258  Identities=36%  Similarity=0.498  Sum_probs=215.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcE-EEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC-ceEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN-SKLL  713 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~l  713 (969)
                      .++...+.||+|+||+||+|.+.  |+. ||||++......+.. .+.|.+|+.++.+++|||||+++|+|.++. ..++
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            34455566999999999999996  555 999999765544444 789999999999999999999999999887 7999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCC-eEecCCCCCcEEECCCC-cE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQ-IIHRDVKSSNILLDSEF-KA  791 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~  791 (969)
                      |||||++|+|.++++...           ...+++..+++||.|||+||.|||+.   + ||||||||+|||++.++ ++
T Consensus       118 VtEy~~~GsL~~~l~~~~-----------~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~  183 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKR-----------KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTL  183 (362)
T ss_pred             EEEeCCCCcHHHHHhhcc-----------cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEE
Confidence            999999999999998741           14599999999999999999999998   6 99999999999999998 99


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY--TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      ||+|||+++......  ..++...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.+.........+   
T Consensus       184 KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v---  258 (362)
T KOG0192|consen  184 KIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV---  258 (362)
T ss_pred             EECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH---
Confidence            999999998764321  4445578999999999999  669999999999999999999999999877653322222   


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                ...+.+.+.+..+...+..+|.+||..||++||++.|++..|+.+.
T Consensus       259 ----------~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  259 ----------VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             ----------HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence                      1112222223335578999999999999999999999999998775

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-46  Score=381.61  Aligned_cols=252  Identities=32%  Similarity=0.474  Sum_probs=214.6

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc-eEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS-KLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~l  713 (969)
                      .++++..+.||+|..|+||+++++.+++.+|+|.+...  .+....+.+.+|++++++++||+||+++|+|...+. ..|
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            44677789999999999999999999999999999433  345667899999999999999999999999999884 999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEecCCCCCcEEECCCCcEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||++|||++++...++             +++...-+|+.+|++||.|||+ +   +||||||||+|||++..|+||
T Consensus       156 ~mEYMDgGSLd~~~k~~g~-------------i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVK  219 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGR-------------IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVK  219 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCC-------------CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEE
Confidence            9999999999999987643             8899999999999999999996 5   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCC--CccchHHHHHHHh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD--EHTSLAEWAWRHY  870 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~--~~~~~~~~~~~~~  870 (969)
                      |||||.++.+.+.    .....+||..|||||.+.+..|+.++||||||++++|+++|+.|+...  ......+.+....
T Consensus       220 icDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv  295 (364)
T KOG0581|consen  220 ICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV  295 (364)
T ss_pred             eccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh
Confidence            9999999887543    445678999999999999999999999999999999999999998764  2223333222222


Q ss_pred             hccCCchhhhccCCCCcccH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYL-EEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+..+           ..+. .++.++.+++..|+++||.+||+++|+++
T Consensus       296 ~~ppP-----------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  296 DEPPP-----------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cCCCC-----------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            21111           1122 36688999999999999999999999986

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=376.88  Aligned_cols=272  Identities=25%  Similarity=0.349  Sum_probs=224.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||+||.++..++++.+|+|++++.........+...+|..++.+++||+||+++..|++++..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46799999999999999999999999999999999887776666778999999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      +||+.||.|..+|++.+.             +++..+.-++..|+.||.|||+.   +||||||||+|||+|.+|.++|+
T Consensus       104 ld~~~GGeLf~hL~~eg~-------------F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~Lt  167 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR-------------FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLT  167 (357)
T ss_pred             EeccCCccHHHHHHhcCC-------------cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEe
Confidence            999999999999997664             89999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+++.....  .......+||+.|||||++.+..|+.++|.||+|+++|||++|.+||++.+.....+.+.+.    +
T Consensus       168 DFgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~----k  241 (357)
T KOG0598|consen  168 DFGLCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG----K  241 (357)
T ss_pred             ccccchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC----c
Confidence            99999854332  22334479999999999999999999999999999999999999999987765444333211    1


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCcccccCCCCCCCCCcccceecc
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGF  954 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  954 (969)
                               .. ..+.-.+.+..+++.+.+..||++|-                  |+..+..+++.||+|+  ++.|+.
T Consensus       242 ---------~~-~~p~~ls~~ardll~~LL~rdp~~RL------------------g~~~d~~~ik~HpfF~--~inW~~  291 (357)
T KOG0598|consen  242 ---------LP-LPPGYLSEEARDLLKKLLKRDPRQRL------------------GGPGDAEEIKRHPFFK--GINWEK  291 (357)
T ss_pred             ---------CC-CCCccCCHHHHHHHHHHhccCHHHhc------------------CCCCChHHhhcCcccc--cCCHHH
Confidence                     00 00111224556666666666666664                  3455566799999999  555554


Q ss_pred             cccc
Q 002085          955 KRSK  958 (969)
Q Consensus       955 ~~~~  958 (969)
                      ..++
T Consensus       292 l~~k  295 (357)
T KOG0598|consen  292 LLAK  295 (357)
T ss_pred             HHhc
Confidence            4433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-45  Score=395.69  Aligned_cols=251  Identities=28%  Similarity=0.388  Sum_probs=221.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ..|...+.||+|||+.||++++..+|+.||+|++.+.........+.+.+|++|.++++|||||+++++|+|..+.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999998877777788899999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |+|++++|.++++.++             .+++.+++.+++||+.|+.|||+.   +|+|||||..|+|++++.+|||+|
T Consensus        98 ELC~~~sL~el~Krrk-------------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgD  161 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK-------------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGD  161 (592)
T ss_pred             EecCCccHHHHHHhcC-------------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecc
Confidence            9999999999998543             599999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+|..+...+  ......+|||.|.|||++....++..+||||+|||||-|++|++||...+..+....+...    . 
T Consensus       162 FGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~----~-  234 (592)
T KOG0575|consen  162 FGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN----E-  234 (592)
T ss_pred             cceeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc----C-
Confidence            99999886432  2334578999999999999999999999999999999999999999877655544433211    1 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                ...|...+.+..++|.++++.||.+|||+++|+.
T Consensus       235 ----------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  235 ----------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ----------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                      0122344577889999999999999999999995

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-45  Score=377.81  Aligned_cols=257  Identities=28%  Similarity=0.337  Sum_probs=214.7

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHH----HHHHHHHHHHHHhccccCceeeEEEEEEcC
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK----LEKEFIAEIEILGTIRHANIVKLWCCISSE  708 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  708 (969)
                      .+-+.|.+.+.||+|+||.|-+|....+|+.||||++.+.......    ....+.+|+++|++++|||||+++++++.+
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            3556788899999999999999999999999999999765443322    234578999999999999999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      +..|+|||||+||+|.+.+-..+.             +.+....-+++|++.|+.|||+.   ||+||||||+|||+..+
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~-------------l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~  312 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKY-------------LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSND  312 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccc-------------cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccC
Confidence            999999999999999999987653             67777889999999999999998   99999999999999766


Q ss_pred             ---CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCC---CCccchhhHHHHHHHHHhCCCCCCCCCccc-
Q 002085          789 ---FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV---NEKIDIYSFGVVLLELVTGKEANYGDEHTS-  861 (969)
Q Consensus       789 ---~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslG~il~elltg~~p~~~~~~~~-  861 (969)
                         ..+||+|||+|+..+   ....+...+|||.|.|||++.+..+   ..+.|+||+||+||-+++|..||.+..... 
T Consensus       313 ~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s  389 (475)
T KOG0615|consen  313 AEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS  389 (475)
T ss_pred             CcceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc
Confidence               679999999999864   3455667899999999999987643   347899999999999999999998654332 


Q ss_pred             hHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +.+++.+.-..           +..+.+.+.+++..++|.+|+..||++|||++|+++
T Consensus       390 l~eQI~~G~y~-----------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  390 LKEQILKGRYA-----------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHHHhcCccc-----------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            44443221111           122345666789999999999999999999999985

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-45  Score=394.52  Aligned_cols=255  Identities=31%  Similarity=0.475  Sum_probs=216.8

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      .++..+.||+|.||+||.|.+.. ...||+|.++...    -..+.|.+|+++|++++|++||+++++|..++..|||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS----MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc----cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            45667889999999999999974 3379999986532    223678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      ||+.|+|.++|+....           ..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+||
T Consensus       282 ~m~~GsLl~yLr~~~~-----------~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDF  347 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREG-----------GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDF  347 (468)
T ss_pred             ecccCcHHHHhhhcCC-----------CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccc
Confidence            9999999999997332           4588889999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCC
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      |+|+...+ +.........-...|.|||.+..++++.|||||||||+||||+| |+.|+.+....+.             
T Consensus       348 GLAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-------------  413 (468)
T KOG0197|consen  348 GLARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-------------  413 (468)
T ss_pred             ccccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-------------
Confidence            99995433 23333334445678999999999999999999999999999999 6666666554443             


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                       .+.++.+.+-++|..++..++++|..||+.+|++|||++.+...++...
T Consensus       414 -~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  414 -LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             -HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence             3445566677788888999999999999999999999999999888774

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=374.73  Aligned_cols=212  Identities=33%  Similarity=0.499  Sum_probs=190.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +.+|...+.||+|+||+||+|++..++..||||.+..... .....+.+..|+++++.++|||||++++++..++..|+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            4678888999999999999999999999999999965432 456678899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC------
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE------  788 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~------  788 (969)
                      ||||.||+|.+|++.++.             +++.++..++.|+|.||++||++   +||||||||.|||++..      
T Consensus        88 MEyC~gGDLs~yi~~~~~-------------l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~  151 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGR-------------LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTS  151 (429)
T ss_pred             EEeCCCCCHHHHHHHcCC-------------CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCC
Confidence            999999999999998764             89999999999999999999998   99999999999999875      


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      -.+||+|||+|+.+...   ......+|++.|||||+++..+|+.|+|+||+|+++|||++|+.||......++...+
T Consensus       152 ~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~  226 (429)
T KOG0595|consen  152 PVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI  226 (429)
T ss_pred             ceEEecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            35899999999988532   2334578999999999999999999999999999999999999999987776665533

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-45  Score=361.24  Aligned_cols=263  Identities=26%  Similarity=0.400  Sum_probs=218.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEE-EEEcCC-ceE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC-CISSEN-SKL  712 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~-~~~  712 (969)
                      ..+|++.++||+|+||+||++....+|..||.|.+. -...+....+....|+.+|++++|||||++++ .+.++. ..+
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            457899999999999999999999999999999986 33446677889999999999999999999998 344444 489


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCC--eEecCCCCCcEEECCCCc
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQ--IIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~  790 (969)
                      ||||||.+|+|.+.++..+..         ...+++.++|+++.|+++||.++|... ++  |+||||||.||+++..|.
T Consensus        97 ivmE~c~~GDLsqmIk~~K~q---------kr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gv  166 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQ---------KRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGV  166 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhc---------cccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCc
Confidence            999999999999999865542         346899999999999999999999842 24  899999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||++|||+++++...  .......+|||.||+||.+.+..|+++|||||+||++|||+.-+.||+++.--++.+.+.+  
T Consensus       167 vKLGDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q--  242 (375)
T KOG0591|consen  167 VKLGDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ--  242 (375)
T ss_pred             eeeccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc--
Confidence            999999999988542  2334567899999999999999999999999999999999999999998844333332211  


Q ss_pred             hccCCchhhhccCCCCccc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          871 AEEKPITDALDKGIAEPCY-LEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                                  +--.+.+ .-.+..+..++..|+..||+.||+...++..++..
T Consensus       243 ------------gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  243 ------------GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             ------------CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence                        1112234 45678899999999999999999976676666554

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=347.55  Aligned_cols=267  Identities=24%  Similarity=0.337  Sum_probs=225.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +++|+..+.||.|+||.|.+++.+.+|..+|+|++.+.........+...+|.++++.+.||+++++++.+.+....|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            56889999999999999999999999999999999888888888889999999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||.|..++++.++             ++.+.+..+|.||+.|++|||+.   +|++|||||+|||+|++|.+||.
T Consensus       123 meyv~GGElFS~Lrk~~r-------------F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKit  186 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR-------------FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKIT  186 (355)
T ss_pred             EeccCCccHHHHHHhcCC-------------CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEE
Confidence            999999999999998765             89999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+|+.+..     ..-..+|||.|+|||++....+..++|.|||||++|||+.|..||+...+..+.+.+        
T Consensus       187 DFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--------  253 (355)
T KOG0616|consen  187 DFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--------  253 (355)
T ss_pred             eccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--------
Confidence            9999998632     234578999999999999999999999999999999999999999987664333322        


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCcc-cccCCCCCCCCCcccceec
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKK-MGRDVDSAPLLGTAGYLFG  953 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  953 (969)
                           +.....  .|.-...++.+++...++.|-.+|                  +|..+ +.++++.||+|+  +++|.
T Consensus       254 -----~~~~v~--fP~~fs~~~kdLl~~LL~vD~t~R------------------~gnlknG~~dIk~H~wF~--~v~W~  306 (355)
T KOG0616|consen  254 -----LEGKVK--FPSYFSSDAKDLLKKLLQVDLTKR------------------FGNLKNGVEDIKNHPWFK--GVDWE  306 (355)
T ss_pred             -----HhCccc--CCcccCHHHHHHHHHHHhhhhHhh------------------hcCcCCCccccccCcccc--cccHH
Confidence                 111111  122223445555555555555544                  55555 679999999999  55555


Q ss_pred             cccc
Q 002085          954 FKRS  957 (969)
Q Consensus       954 ~~~~  957 (969)
                      +..+
T Consensus       307 ~i~~  310 (355)
T KOG0616|consen  307 AILQ  310 (355)
T ss_pred             HHhh
Confidence            4433

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.9e-44  Score=402.17  Aligned_cols=271  Identities=27%  Similarity=0.430  Sum_probs=226.2

Q ss_pred             CCCccceeeecCcEEEEEEEEc-----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          637 SLTESNLIGSGGSGQVYRIDIN-----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      +....+.||+|+||+||+|+..     .+...||||.++...  +.+..++|++|+++++.++|||||+++|.|.+++..
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            4455688999999999999873     234579999996543  345678999999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCc-ccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSV-HQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      ++|+|||..|||.++|....+...-...+. ....++..+.+.||.|||.||.||-++   .+|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence            999999999999999997655322221111 155688999999999999999999988   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  869 (969)
                      |||+|||+++.+-..+.+.......-.++|||||.+..++|+.+||||||||+|||+++ |+.||++-..++..+.+.+ 
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~-  720 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA-  720 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc-
Confidence            99999999997654433333334556789999999999999999999999999999999 8889988776655544322 


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                                   +..-+++..++.++++||..||+..|++||+++||-..|+....
T Consensus       721 -------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  721 -------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             -------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence                         22346777888999999999999999999999999999988863

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=377.94  Aligned_cols=251  Identities=24%  Similarity=0.291  Sum_probs=215.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .+|..++.||+|+|++||+|+...+++.||||++.+.-...+...+-+.+|-++|.+| .||.|++++..|+|+...|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            4788889999999999999999999999999999766555555567788999999999 899999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      +||+++|+|.+++++.+.             +++.....+|.+|+.|++|||+.   |||||||||+|||+|++++++|.
T Consensus       153 Le~A~nGdll~~i~K~Gs-------------fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikIT  216 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGS-------------FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKIT  216 (604)
T ss_pred             EEecCCCcHHHHHHHhCc-------------chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEe
Confidence            999999999999998764             89999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCC---------cc--ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          795 DFGLAKMLAKQGEP---------HT--MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       795 Dfgla~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                      |||.|+.+.+....         ..  ....+||..|++||++..+..++++|+|+|||++|+|+.|.+||.+..+--+.
T Consensus       217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF  296 (604)
T KOG0592|consen  217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF  296 (604)
T ss_pred             eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH
Confidence            99999987543211         11  14578999999999999999999999999999999999999999987665444


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV  917 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev  917 (969)
                      +.+....           -    ..+...++.+.+|+.+.+..||.+|++..||
T Consensus       297 qkI~~l~-----------y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI  335 (604)
T KOG0592|consen  297 QKIQALD-----------Y----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQI  335 (604)
T ss_pred             HHHHHhc-----------c----cCCCCCCHHHHHHHHHHHccCccccccHHHH
Confidence            4432211           1    1223333778899999999999999999443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.6e-44  Score=352.35  Aligned_cols=265  Identities=22%  Similarity=0.326  Sum_probs=215.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +.|+...++|+|+||.||+++++.+|+.||||++..+. .++...+-..+|++++++++|||+|.++++|......++||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            46788889999999999999999999999999996543 35566778999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |||+. ++.+-+...+            ..++...+.+++.|++.|+.|+|++   +|+||||||+|||++..|.+|+||
T Consensus        81 E~~dh-TvL~eLe~~p------------~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCD  144 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYP------------NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCD  144 (396)
T ss_pred             eecch-HHHHHHHhcc------------CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEecc
Confidence            99985 4444455443            3478889999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+|+.+...  ....+.++.|.+|+|||.+.+ ..|....||||+||++.||++|.+.|.+.++.+....+......--
T Consensus       145 FGFAR~L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~  222 (396)
T KOG0593|consen  145 FGFARTLSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI  222 (396)
T ss_pred             chhhHhhcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC
Confidence            9999988643  334456789999999999988 6899999999999999999999999988877766655544332221


Q ss_pred             C-----------chhhhccCCCCcc-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 P-----------ITDALDKGIAEPC-----YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~-----------~~~~~~~~~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +           +..+.-+....+.     ....+..+.++++.|++.||++|++-+|++.
T Consensus       223 prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  223 PRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1           1111111111111     2233467889999999999999999998874

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-42  Score=371.72  Aligned_cols=277  Identities=22%  Similarity=0.300  Sum_probs=226.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|..++.||+|+||+||.|+-+.+|+.+|+|+++++.-........+..|-.+|...++|+||+++..|++.++.|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            57899999999999999999999999999999999888777777788999999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||++..+|....             .+++..+..++.+.+.|+.-+|+.   |++||||||+|+|||..|++||+
T Consensus       220 MEylPGGD~mTLL~~~~-------------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLS  283 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKD-------------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLS  283 (550)
T ss_pred             EEecCCccHHHHHHhcC-------------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeec
Confidence            99999999999998765             489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecccC----------------------CCC-----cc------------------ccccccCcccCchhhcccC
Q 002085          795 DFGLAKMLAKQ----------------------GEP-----HT------------------MSAVAGSFGYFAPEYAYTT  829 (969)
Q Consensus       795 Dfgla~~~~~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~  829 (969)
                      |||++.-+...                      ..+     ..                  ....+|||-|||||++.+.
T Consensus       284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k  363 (550)
T KOG0605|consen  284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK  363 (550)
T ss_pred             cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence            99999543210                      000     00                  0124699999999999999


Q ss_pred             CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCC
Q 002085          830 KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPS  909 (969)
Q Consensus       830 ~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~  909 (969)
                      .|+..+|.||+|||+|||+.|-+||.++++.+..+.+...- .          .+..|.....+.+..++|.+|+. ||+
T Consensus       364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-~----------~l~fP~~~~~s~eA~DLI~rll~-d~~  431 (550)
T KOG0605|consen  364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR-E----------TLKFPEEVDLSDEAKDLITRLLC-DPE  431 (550)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-h----------hccCCCcCcccHHHHHHHHHHhc-CHH
Confidence            99999999999999999999999999988876655443211 1          11112222233667778888887 777


Q ss_pred             CCCCHHHHHHHHhhcCCCCCCCCcccccCCCCCCCCCcccceeccccccch
Q 002085          910 SRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGFKRSKKV  960 (969)
Q Consensus       910 ~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  960 (969)
                      +|-                  | ..+..+++.||||+  +++|+..+...+
T Consensus       432 ~RL------------------G-~~G~~EIK~HPfF~--~v~W~~l~~~~a  461 (550)
T KOG0605|consen  432 NRL------------------G-SKGAEEIKKHPFFK--GVDWDHLREMPA  461 (550)
T ss_pred             Hhc------------------C-cccHHHHhcCCccc--cCCcchhhcCCC
Confidence            763                  3 33446678888888  666666655443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=387.98  Aligned_cols=258  Identities=26%  Similarity=0.484  Sum_probs=224.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCc---EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ....+.++||.|.||+||+|+.+..|+   .||||.++..  ..++.+.+|..|+.||.+++||||+++.|++......+
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence            344567999999999999999976654   7999999653  45667789999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      ||+|||++|+|+.+|+...            ..+.|.+...|.++||.||+||.+.   ++|||||.++|||++.+..+|
T Consensus       707 IiTEyMENGsLDsFLR~~D------------GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCK  771 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQND------------GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCK  771 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcC------------CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEE
Confidence            9999999999999999865            3589999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCCcccccccc--CcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHH
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAG--SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  869 (969)
                      ++|||+++.+.++. +...+...|  ..+|.|||.+...+++.+|||||||++|||.++ |..||+....++..      
T Consensus       772 VsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI------  844 (996)
T KOG0196|consen  772 VSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI------  844 (996)
T ss_pred             eccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH------
Confidence            99999999775543 233333333  579999999999999999999999999999888 88898877655443      


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                              +.++.+.+-|.+++++..++++|..||++|-.+||++.+|+..|.++.
T Consensus       845 --------kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  845 --------KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             --------HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence                    344556667788899999999999999999999999999999998875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=362.54  Aligned_cols=268  Identities=23%  Similarity=0.294  Sum_probs=218.5

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCC-
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSEN-  709 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-  709 (969)
                      ..+.++|+..++||.|.||.||+|+...+|+.||||+++.....  ..+-.-.||++-+++++ |||||++.+++.+.+ 
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~ee~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            34677899999999999999999999999999999998665432  33445678999999998 999999999999888 


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..|+|||||+ .+|+++++.+.            ..+++..+..|+.||++||+|+|.+   |+.|||+||+|||+....
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R~------------r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~  147 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDRN------------RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGND  147 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhcC------------CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccc
Confidence            8999999996 89999999875            4699999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      .+||+|||+||.+.   .....+.++.|.+|+|||++. .+-|+.+.||||+|||++|+.+-++.|-|.++.+....+-.
T Consensus       148 ~iKiaDFGLARev~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~  224 (538)
T KOG0661|consen  148 VIKIADFGLAREVR---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE  224 (538)
T ss_pred             eeEecccccccccc---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence            99999999999773   334456788999999999865 56789999999999999999999999988766554444433


Q ss_pred             Hhhcc--------CCchhhhccCCCC-------cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          869 HYAEE--------KPITDALDKGIAE-------PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       869 ~~~~~--------~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .....        ..+...+.-.+..       ......+.+..+++.+|+.+||.+||||+|++++
T Consensus       225 VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  225 VLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            22111        1111111111111       1112256789999999999999999999999974

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.4e-41  Score=328.84  Aligned_cols=266  Identities=22%  Similarity=0.348  Sum_probs=217.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|...+++|+|.||.||+|++..+|+.||||+++.... .+.......+|++.++.++||||+.++++|...+...||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            468888999999999999999999999999999976533 2333467889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |||+ .+|+..++...            -.+...++..++.++++|++|||++   .|+||||||.|+|++++|.+||+|
T Consensus        81 Efm~-tdLe~vIkd~~------------i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiAD  144 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKN------------IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIAD  144 (318)
T ss_pred             Eecc-ccHHHHhcccc------------cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeec
Confidence            9997 79999998765            3588889999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+|+.+......  .+..+.|.+|+|||.+.|. .|+...||||.||++.||+-|.+-|.++.+.+....+.+.+....
T Consensus       145 FGLAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~  222 (318)
T KOG0659|consen  145 FGLARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPT  222 (318)
T ss_pred             ccchhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCC
Confidence            9999988654332  2334789999999999876 589999999999999999999988888776666555544332211


Q ss_pred             --------CchhhhccC-----CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          875 --------PITDALDKG-----IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       875 --------~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                              .+.+..+-.     ........++.+..+++..++..||.+|.++.|++++
T Consensus       223 ~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  223 PDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                    111111111     1111334456778999999999999999999999864

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=367.52  Aligned_cols=261  Identities=29%  Similarity=0.391  Sum_probs=212.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++.....+||+|+||+||+|+|.  | .||||++..+.. .++..+.|+.|+.++++-+|.||+-+.|||..++. .||+
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT  466 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT  466 (678)
T ss_pred             HHhhccceeccccccceeecccc--c-ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence            45667789999999999999995  3 399999966544 34478999999999999999999999999998877 9999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      .+|+|-+|+.+++..+            ..++..+.+.||.|||+||.|||.+   +|||||||..|||+.+++.|||+|
T Consensus       467 qwCeGsSLY~hlHv~e------------tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQE------------TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             hhccCchhhhhccchh------------hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEec
Confidence            9999999999999765            3588899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT---KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ||++..-.............|...|||||+++..   +|++++||||||+|+|||++|..||.......+.-.+-+++..
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~  611 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM  611 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC
Confidence            9999865443333334456688999999998754   6899999999999999999999999733222111111111100


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      .    +.      ......++.++.+|+..||..++++||.+.+|+..|+...+
T Consensus       612 p----d~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  612 P----DL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             c----cc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            0    00      11233456789999999999999999999999998888865

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=371.93  Aligned_cols=266  Identities=24%  Similarity=0.378  Sum_probs=228.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      +++|...++||+|+||.|++++.+.+++.+|||++++......+..+....|.+|+... +||.+++++++|+..++.|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            46788999999999999999999999999999999998887778888999999999988 59999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+.||++..+.+.              ..+++..+..+|..|+.||.|||++   +|||||||.+|||+|.+|.+||
T Consensus       447 vmey~~Ggdm~~~~~~--------------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~ki  509 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIHT--------------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKI  509 (694)
T ss_pred             EEEecCCCcEEEEEec--------------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEe
Confidence            9999999995554442              3599999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+++.-...  ....+..+|||.|||||++.+..|+.++|.|||||+||||+.|..||.+++..++.+.+..    +
T Consensus       510 ADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~----d  583 (694)
T KOG0694|consen  510 ADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN----D  583 (694)
T ss_pred             cccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----C
Confidence            999999864322  2355678999999999999999999999999999999999999999999887776655421    1


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCcccccCCCCCCCCCcccce
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYL  951 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  951 (969)
                      .           ..+|.-.+.+...++++++..+|++|.-+.                 +....+++.||||++.+|+
T Consensus       584 ~-----------~~yP~~ls~ea~~il~~ll~k~p~kRLG~~-----------------e~d~~~i~~hpFFr~i~w~  633 (694)
T KOG0694|consen  584 E-----------VRYPRFLSKEAIAIMRRLLRKNPEKRLGSG-----------------ERDAEDIKKHPFFRSIDWD  633 (694)
T ss_pred             C-----------CCCCCcccHHHHHHHHHHhccCcccccCCC-----------------CCCchhhhhCCccccCCHH
Confidence            1           123344457888999999999999885431                 4567899999999966655

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.7e-42  Score=363.60  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=217.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|-+.+.||+|+||.||||+.+.+.+.||+|.+.+... .+...+.+.+|++|+++++|||||.++++|+...+.++|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            567888899999999999999999999999999976544 3445688999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+.| +|++++...+.             ++++.+..++.++..||.|||+.   +|+|||+||+||+++..|.+|++|
T Consensus        81 e~a~g-~L~~il~~d~~-------------lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~Klcd  143 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGK-------------LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCD  143 (808)
T ss_pred             hhhhh-hHHHHHHhccC-------------CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeech
Confidence            99986 99999997654             89999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+|+.+..  .....+...|||-|||||...+..|+..+|+||+||++||+++|++||+......+.+.+..   + . 
T Consensus       144 Fg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~---d-~-  216 (808)
T KOG0597|consen  144 FGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK---D-P-  216 (808)
T ss_pred             hhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc---C-C-
Confidence            999997643  44455678899999999999999999999999999999999999999987665544443321   1 1 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                ...+...+..+..++...+.+||.+|.+..+++.
T Consensus       217 ----------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 ----------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ----------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                      1123355678999999999999999999999885

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-41  Score=356.01  Aligned_cols=267  Identities=28%  Similarity=0.393  Sum_probs=215.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--CceE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--NSKL  712 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  712 (969)
                      .+.|+..++||+|.||.||+|++..+|+.||+|++.-+.. .+.......+||.||++++||||+++.+.+.+.  +..|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            3567888999999999999999999999999999865432 334457789999999999999999999998776  7899


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +|||||+ -+|.-++....            -.++..++..++.|++.||+|||.+   +|+|||||.+|||||.+|.+|
T Consensus       195 lVFeYMd-hDL~GLl~~p~------------vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LK  258 (560)
T KOG0600|consen  195 LVFEYMD-HDLSGLLSSPG------------VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLK  258 (560)
T ss_pred             EEEeccc-chhhhhhcCCC------------cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEE
Confidence            9999997 57887776533            3589999999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |+|||+|+++... .....+..+.|.+|+|||.+.+. .|+.+.|+||.||||.||+.|++.|.+..+.+....+.+...
T Consensus       259 iaDFGLAr~y~~~-~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG  337 (560)
T KOG0600|consen  259 IADFGLARFYTPS-GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG  337 (560)
T ss_pred             eccccceeeccCC-CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC
Confidence            9999999988654 33446778899999999998875 699999999999999999999999998876665555544322


Q ss_pred             ccC----CchhhhccCC-C--Ccc-------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          872 EEK----PITDALDKGI-A--EPC-------YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       872 ~~~----~~~~~~~~~~-~--~~~-------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...    +..+...... .  .++       ....+....+++..++..||.+|.||.++++
T Consensus       338 SP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  338 SPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            111    1001110000 0  000       1122466889999999999999999999885

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-40  Score=344.61  Aligned_cols=272  Identities=21%  Similarity=0.295  Sum_probs=227.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .+.|+..++||.|.-|+||+++..+++..+|+|++.+..........+++.|-+||+.++||.++.+++.++.++..|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            35677889999999999999999999999999999887776677778899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      ||||+||+|..+.+.++.           ..++...+..+|.+|+-||+|||-.   |||+|||||+||||.++|.+-|+
T Consensus       156 meyCpGGdL~~LrqkQp~-----------~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLs  221 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPG-----------KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLS  221 (459)
T ss_pred             EecCCCccHHHHHhhCCC-----------CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEee
Confidence            999999999999998874           6799999999999999999999998   99999999999999999999999


Q ss_pred             ecccceeccc---------------------------------CCCC---------------------ccccccccCccc
Q 002085          795 DFGLAKMLAK---------------------------------QGEP---------------------HTMSAVAGSFGY  820 (969)
Q Consensus       795 Dfgla~~~~~---------------------------------~~~~---------------------~~~~~~~gt~~y  820 (969)
                      ||.++....-                                 ....                     ......+||-.|
T Consensus       222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY  301 (459)
T KOG0610|consen  222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY  301 (459)
T ss_pred             eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence            9998854311                                 0000                     011235699999


Q ss_pred             CchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHH
Q 002085          821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLA  900 (969)
Q Consensus       821 ~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  900 (969)
                      .|||++.+...+.++|+|+||+++|||+.|..||.+....+....             ++.+...-+.....+....++|
T Consensus       302 lAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N-------------Iv~~~l~Fp~~~~vs~~akDLI  368 (459)
T KOG0610|consen  302 LAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN-------------IVGQPLKFPEEPEVSSAAKDLI  368 (459)
T ss_pred             ccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH-------------HhcCCCcCCCCCcchhHHHHHH
Confidence            999999999999999999999999999999999998766544332             2333333333345567788888


Q ss_pred             HHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCcccccCCCCCCCCCcccce
Q 002085          901 LICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYL  951 (969)
Q Consensus       901 ~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  951 (969)
                      ++.+.+||++|                  .|.+.++.+++.||||+...|+
T Consensus       369 r~LLvKdP~kR------------------lg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  369 RKLLVKDPSKR------------------LGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             HHHhccChhhh------------------hccccchHHhhcCccccCCChh
Confidence            88888888877                  4666777888999999944444

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-40  Score=341.65  Aligned_cols=270  Identities=24%  Similarity=0.339  Sum_probs=220.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .+.|+..+.||.|..++||+|+....++.||||++.-+...  ...+.+.+|+..++.++||||++++..|..+...|+|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            46899999999999999999999999999999999665432  2368999999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |.||.+||+.++++..-+           ..+++..+..|.++++.||.|||++   |.+|||||+.|||++++|.|||+
T Consensus       103 mpfMa~GS~ldIik~~~~-----------~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLa  168 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYP-----------DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLA  168 (516)
T ss_pred             ehhhcCCcHHHHHHHHcc-----------ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEc
Confidence            999999999999986543           4588999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecccCCCCccc--cccccCcccCchhhcccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          795 DFGLAKMLAKQGEPHTM--SAVAGSFGYFAPEYAYTT--KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |||.+..+...+.....  ....||+.|||||+++..  .|+.|+||||||++..|+.+|..||..-.+-.+   .....
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv---Ll~tL  245 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV---LLLTL  245 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH---HHHHh
Confidence            99998776555433222  456899999999996543  699999999999999999999999975443221   22222


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~~  925 (969)
                      ....+...  -..............+.+++..|+++||.+|||++++++  +++++.
T Consensus       246 qn~pp~~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  246 QNDPPTLL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             cCCCCCcc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            22222111  122223334445568999999999999999999999985  555554

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=380.42  Aligned_cols=264  Identities=26%  Similarity=0.373  Sum_probs=215.7

Q ss_pred             CCCccceeeecCcEEEEEEEEcCC-C----cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGA-G----EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ..+..+.||+|+||.||.|...+. |    ..||||.++.  ..+.+...+|.+|..+|+.++|||||+++|.+-+.+..
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            345568899999999999988543 2    2488888754  34566678999999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      +|++|||+||+|..+|++.+.....      ...+...+.+.++.|||+|+.||+++   ++|||||.++|+|++....|
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~------~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~V  841 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQ------PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVV  841 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCC------CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcE
Confidence            9999999999999999987543222      34588899999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCC-CCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG-DEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~-~~~~~~~~~~~~~~  870 (969)
                      ||+|||+|+.+.+...+.......-...|||||.+..+.++.|+|||||||++||++|.+.++++ .+..++..      
T Consensus       842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------  915 (1025)
T KOG1095|consen  842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------  915 (1025)
T ss_pred             EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------
Confidence            99999999965554344333333445789999999999999999999999999999995554444 33322211      


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                             ..+..+ +-+.+..++..++++|..||+.+|++||++..+++.+.++.
T Consensus       916 -------~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  916 -------DVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             -------HHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence                   122222 44556677789999999999999999999999999887775

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=347.71  Aligned_cols=260  Identities=28%  Similarity=0.352  Sum_probs=207.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC--ceEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN--SKLL  713 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  713 (969)
                      .+|...+.||+|+||+||++....+|+..|||.+.....   ...+.+.+|++++++++|||||+++|......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            467788999999999999999998899999998855421   11577999999999999999999999855444  6899


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC-CCcEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-EFKAK  792 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~k  792 (969)
                      +|||+++|+|.+++...+.            .+++..+..++.||++||+|||++   |||||||||+|||++. ++.+|
T Consensus        94 ~mEy~~~GsL~~~~~~~g~------------~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~K  158 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG------------KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVK  158 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC------------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEE
Confidence            9999999999999997652            389999999999999999999988   9999999999999999 79999


Q ss_pred             Eeecccceeccc-CCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          793 IADFGLAKMLAK-QGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       793 l~Dfgla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |+|||+++.... ...........||+.|||||++..+ ...+++||||+||++.||+||+.||...  .....++....
T Consensus       159 laDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig  236 (313)
T KOG0198|consen  159 LADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIG  236 (313)
T ss_pred             eccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHh
Confidence            999999987643 1122334457899999999999954 3446999999999999999999998753  11111111111


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ... ..     +    ..+...+....+++.+|+..||++||||.|+++.---..
T Consensus       237 ~~~-~~-----P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  237 RED-SL-----P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             ccC-CC-----C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            111 00     1    122234467889999999999999999999998665544

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=361.68  Aligned_cols=262  Identities=26%  Similarity=0.386  Sum_probs=217.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCc---E-EEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGE---F-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      +....++||+|+||.||+|+....+.   . ||||..+.+.........++.+|+++|+.++|||||+++|++.+....|
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            44455899999999999999865422   3 8999987655556777899999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +|||+|.||+|.++|+..+.            .++..++.+++.++|.||+|||++   +++||||.++|+|++.++.+|
T Consensus       238 ivmEl~~gGsL~~~L~k~~~------------~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK------------SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC------------CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence            99999999999999998763            488999999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCcccc-ccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          793 IADFGLAKMLAKQGEPHTMS-AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |+|||+++.-.   ...... ...-..+|+|||.+..+.|++++|||||||++||+++ |..||.+....+...++.   
T Consensus       303 ISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~---  376 (474)
T KOG0194|consen  303 ISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV---  376 (474)
T ss_pred             eCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH---
Confidence            99999987532   111111 2235689999999999999999999999999999999 788888776655444431   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTEN  929 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  929 (969)
                                ..+.+.+.+...+..+..++.+||..||++||+|.++.+.++.......
T Consensus       377 ----------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  377 ----------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ----------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                      1222333344556788899999999999999999999999988875444

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=339.40  Aligned_cols=265  Identities=25%  Similarity=0.333  Sum_probs=207.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc--ccCceeeEEEEEEcCC---
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI--RHANIVKLWCCISSEN---  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~---  709 (969)
                      ....+..+.||+|.||.||||+..  ++.||||++.      .+..+.|+.|.+|++..  +|+||++|+++-....   
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            456777889999999999999994  6899999984      34467899999998875  7999999998865444   


Q ss_pred             -ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhccc------CCCCeEecCCCCCc
Q 002085          710 -SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD------CTPQIIHRDVKSSN  782 (969)
Q Consensus       710 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~Dlkp~N  782 (969)
                       .++||+||.++|+|.+||...              .++|....+|+..+++||+|||+.      .+++|+|||||.+|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~n--------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkN  346 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKAN--------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKN  346 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhc--------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccc
Confidence             789999999999999999864              599999999999999999999966      37789999999999


Q ss_pred             EEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCC-C-----CCccchhhHHHHHHHHHhCCCCCCC
Q 002085          783 ILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-V-----NEKIDIYSFGVVLLELVTGKEANYG  856 (969)
Q Consensus       783 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~sDvwslG~il~elltg~~p~~~  856 (969)
                      ||+..|+++.|+|||+|..+.........-..+||.+|||||++.+.. +     -.+.||||+|.|||||+++...++.
T Consensus       347 VLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~  426 (534)
T KOG3653|consen  347 VLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP  426 (534)
T ss_pred             eEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence            999999999999999999987655555555689999999999997653 2     2368999999999999998876542


Q ss_pred             CCccc-------------hHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          857 DEHTS-------------LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       857 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      +...+             ..+.++..+...+....+.+. ..   .-..+..+.+.+..||..||+.|.|+.=+.+.+.+
T Consensus       427 ~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~-W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~  502 (534)
T KOG3653|consen  427 GPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDA-WR---KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE  502 (534)
T ss_pred             CCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhh-hh---cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence            11111             111122222221111111111 11   11234678899999999999999999999888877


Q ss_pred             cC
Q 002085          924 CC  925 (969)
Q Consensus       924 ~~  925 (969)
                      +.
T Consensus       503 l~  504 (534)
T KOG3653|consen  503 LM  504 (534)
T ss_pred             Hh
Confidence            75

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=352.58  Aligned_cols=246  Identities=29%  Similarity=0.438  Sum_probs=209.2

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      .....+-||+|+.|.||+|+..  ++.||||+++          +--..+++.|++++||||+.|.|+|.....++||||
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~----------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME  192 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRLH--NETVAVKKVR----------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME  192 (904)
T ss_pred             HhhhhhhhccCcccceeeeecc--CceehhHHHh----------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence            3456678999999999999994  7889999873          223357889999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      ||+.|-|+..|+....             +......+|..+||.||.|||.+   .|||||||.-||||+.+..|||+||
T Consensus       193 fCa~GqL~~VLka~~~-------------itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDF  256 (904)
T KOG4721|consen  193 FCAQGQLYEVLKAGRP-------------ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDF  256 (904)
T ss_pred             ccccccHHHHHhccCc-------------cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccc
Confidence            9999999999997653             67778889999999999999998   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |-++...+   ..+...++||..|||||+++..+.++|+||||||||||||+||..||...+...+             +
T Consensus       257 GTS~e~~~---~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------------I  320 (904)
T KOG4721|consen  257 GTSKELSD---KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------------I  320 (904)
T ss_pred             cchHhhhh---hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------------E
Confidence            99987643   2445568999999999999999999999999999999999999999875443221             1


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      ..+=...+..+.+..++.-+.-+++.||+..|..||+|.+|+..|+-+.|
T Consensus       321 wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  321 WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            11112223345666777889999999999999999999999999987764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=356.99  Aligned_cols=254  Identities=29%  Similarity=0.385  Sum_probs=212.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc--HHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCc
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN--QKLEKEFIAEIEILGTIR-HANIVKLWCCISSENS  710 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  710 (969)
                      ....|...+.||+|+||.|+.|.+..+++.||+|++.......  ....+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3567999999999999999999999999999999775542211  134567779999999998 9999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC-C
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-F  789 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~  789 (969)
                      .|+||||+.||+|.+++...++             +.+..+..++.|+++|++|||+.   ||+||||||+|+++|.+ +
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~-------------l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~  158 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGR-------------LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEG  158 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCC-------------CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCC
Confidence            9999999999999999998543             78899999999999999999998   99999999999999999 9


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCC-CC-CccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      ++||+|||++....  +........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...+...+.
T Consensus       159 ~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~  236 (370)
T KOG0583|consen  159 NLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR  236 (370)
T ss_pred             CEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence            99999999998763  2233445678999999999999977 86 78999999999999999999998865544433321


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +   ..-.+          +.... +.++.+++.+|+..||.+|+++.||++
T Consensus       237 ~---~~~~~----------p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  237 K---GEFKI----------PSYLL-SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             c---CCccC----------CCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            1   11111          11111 578899999999999999999999994

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3.4e-43  Score=360.00  Aligned_cols=440  Identities=26%  Similarity=0.425  Sum_probs=366.3

Q ss_pred             CeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecC
Q 002085           74 SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLG  153 (969)
Q Consensus        74 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  153 (969)
                      ..+.+++.++.+. .+|++++.+..++.|+.++|++. ++|+.++.+.+|..|+.++|.+. .+|++++.+..|+.|+..
T Consensus        69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~  145 (565)
T KOG0472|consen   69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT  145 (565)
T ss_pred             ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence            4778888888887 47888999999999999999998 88999999999999999999998 788899999999999999


Q ss_pred             CCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccc
Q 002085          154 GNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIG  233 (969)
Q Consensus       154 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~  233 (969)
                      +|+++ ..|..++++.+|..|++.+|+++...|. .-+++.|++||..+|   ..+.+|..++.+.+|..|||..|.+. 
T Consensus       146 ~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~-~i~m~~L~~ld~~~N---~L~tlP~~lg~l~~L~~LyL~~Nki~-  219 (565)
T KOG0472|consen  146 NNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPEN-HIAMKRLKHLDCNSN---LLETLPPELGGLESLELLYLRRNKIR-  219 (565)
T ss_pred             ccccc-cCchHHHHHHHHHHhhccccchhhCCHH-HHHHHHHHhcccchh---hhhcCChhhcchhhhHHHHhhhcccc-
Confidence            99999 7888999999999999999999954444 445999999999998   67889999999999999999998875 


Q ss_pred             cCchhhcCCCchhhhhccCCcCCCCCCchhh-cCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCcccc
Q 002085          234 EIPEAMSNLSSLEILALNGNHLEGAIPSGLF-LLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFG  311 (969)
Q Consensus       234 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~  311 (969)
                      .+| .|.+++.|.+|+++.|+++ .+|.... ++++|..|||.+|+++ ..|+.+..+ +|++||+|+|.|+ .+|..++
T Consensus       220 ~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLg  295 (565)
T KOG0472|consen  220 FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLG  295 (565)
T ss_pred             cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccc
Confidence            456 7999999999999999999 7777666 8999999999999999 677777666 5999999999999 6788999


Q ss_pred             CcccchhhhhccccCcCc----CCc----ccccccc-------cCc-----ccccCCC----CCCCCccCcEEEcccccc
Q 002085          312 KLKNLQLLGLFSNHLSGE----VPA----SIGVVAF-------ENN-----LSGAVPK----SLGNCRTLRTVQLYSNRF  367 (969)
Q Consensus       312 ~l~~L~~L~L~~N~l~~~----~p~----~~~~l~~-------~n~-----l~~~~p~----~l~~l~~L~~L~L~~N~l  367 (969)
                      ++ +|++|-+.+|.+...    +..    -+..+..       .+.     -.+..|.    ......+.+.|+++.-++
T Consensus       296 nl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ql  374 (565)
T KOG0472|consen  296 NL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQL  374 (565)
T ss_pred             cc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccc
Confidence            99 999999999988621    100    0111100       000     0011111    123456789999999999


Q ss_pred             cCCCCcccccccC---CCccccCCCccccccCcccc---ccccEEEeeccccCCCcccccCCcccchhhcccCCcccccc
Q 002085          368 SGELPTGLWTTFN---LSSLMLSDNTISGELPSKTA---WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEI  441 (969)
Q Consensus       368 ~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~~~~~~---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  441 (969)
                      + .+|..++....   ....+++.|++. ++|....   .-.+.+++++|.++ .+|..++.+++|..|+|++|-+. .+
T Consensus       375 t-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~L  450 (565)
T KOG0472|consen  375 T-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DL  450 (565)
T ss_pred             c-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hc
Confidence            9 88988888766   888999999998 6665433   23556777777776 88889999999999999999998 89


Q ss_pred             CccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc
Q 002085          442 PVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK  521 (969)
Q Consensus       442 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~  521 (969)
                      |.+++.+..|+.||+|.|++. .+|..+..+..|+.+-.++|++...-|+.+.+|.+|..|||.+|.+. .||+.+|++.
T Consensus       451 P~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~Lgnmt  528 (565)
T KOG0472|consen  451 PEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMT  528 (565)
T ss_pred             chhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhcccc
Confidence            999999999999999999998 89998888888888888889998555556999999999999999998 8999999996


Q ss_pred             -ccEEEeecCcCC
Q 002085          522 -LNTFNLSSNKLY  533 (969)
Q Consensus       522 -L~~l~ls~N~l~  533 (969)
                       |++|++++|++.
T Consensus       529 nL~hLeL~gNpfr  541 (565)
T KOG0472|consen  529 NLRHLELDGNPFR  541 (565)
T ss_pred             ceeEEEecCCccC
Confidence             999999999998

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.5e-39  Score=360.40  Aligned_cols=272  Identities=22%  Similarity=0.371  Sum_probs=208.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEc-----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC-
Q 002085          636 SSLTESNLIGSGGSGQVYRIDIN-----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE-  708 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  708 (969)
                      ++|++.++||+|+||.||+|.+.     .+++.||||+++...  .....+.+.+|++++..+ +||||+++++++... 
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            47888999999999999999752     345689999986432  233456799999999999 899999999988764 


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCcccc-------------------------------------------------CCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVS-------------------------------------------------GSS  739 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~-------------------------------------------------~~~  739 (969)
                      +..++||||+++|+|.+++.........                                                 ...
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            4688999999999999999764321000                                                 000


Q ss_pred             CcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcc
Q 002085          740 SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG  819 (969)
Q Consensus       740 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  819 (969)
                      ......+++.++.+++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.+.............+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence            11234588899999999999999999988   999999999999999999999999999986543222222233456788


Q ss_pred             cCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHH
Q 002085          820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYR  898 (969)
Q Consensus       820 y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  898 (969)
                      |+|||++.+..++.++|||||||++|||++ |..||.+......   ..........          ...+...+..+.+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---~~~~~~~~~~----------~~~~~~~~~~l~~  308 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---FCQRLKDGTR----------MRAPENATPEIYR  308 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---HHHHHhcCCC----------CCCCCCCCHHHHH
Confidence            999999999999999999999999999997 8888876433211   1111111111          0112223467899


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          899 LALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       899 l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ++.+||+.||++||++.|+++.|+++.
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.7e-39  Score=347.97  Aligned_cols=254  Identities=22%  Similarity=0.296  Sum_probs=206.1

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |+..+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+++++.++|++|+++.+++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66778999999999999999989999999998654433334445688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++|+|.+++.....           ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||
T Consensus        82 ~~~g~L~~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg  147 (285)
T cd05631          82 MNGGDLKFHIYNMGN-----------PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLG  147 (285)
T ss_pred             cCCCcHHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCC
Confidence            999999988865332           2488999999999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      ++......   .......||..|+|||++.+..++.++||||+||++|||++|+.||...........+.......    
T Consensus       148 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----  220 (285)
T cd05631         148 LAVQIPEG---ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----  220 (285)
T ss_pred             CcEEcCCC---CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----
Confidence            99865322   12234578999999999999999999999999999999999999998755433222222211110    


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-----MKEVLQ  919 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~  919 (969)
                             ....+...+..+.+++.+||+.||++||+     ++|+++
T Consensus       221 -------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 -------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             -------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                   01112233467889999999999999997     555553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-39  Score=355.10  Aligned_cols=253  Identities=26%  Similarity=0.324  Sum_probs=219.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      .+.-|+.++.||+|+.|.|..|++..+|+.+|||++.+.....+.....+.+|+-||+.+.||||+++++++++..++|+
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            34567788999999999999999999999999999977755566666789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      |.||++||.|++++..+++             +++.++.+++.||+.|+.|+|..   +|+||||||+|+|+|..+++||
T Consensus        90 vlEyv~gGELFdylv~kG~-------------l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKI  153 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGP-------------LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKI  153 (786)
T ss_pred             EEEecCCchhHHHHHhhCC-------------CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEee
Confidence            9999999999999998764             88999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||+|..-..   .......+|+|.|.|||++++.+|+ .++||||+|||||.|+||+.||+++....+...+.++..+
T Consensus       154 ADFGMAsLe~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~  230 (786)
T KOG0588|consen  154 ADFGMASLEVP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE  230 (786)
T ss_pred             eccceeecccC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc
Confidence            99999976422   2233456899999999999999985 6899999999999999999999976554444433332211


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                                     .+...+.+..+++.+|+..||++|.|+.||++.
T Consensus       231 ---------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  231 ---------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ---------------CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                           233445788999999999999999999999984

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=351.93  Aligned_cols=259  Identities=26%  Similarity=0.350  Sum_probs=217.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      -...|+.-++||+|+.|.||.|+...+++.||||++....   +...+-+..|+.+|+..+|+|||++++.|...+..|+
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            3456778889999999999999999999999999995543   2334678999999999999999999999988899999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      |||||+||+|.+.+...              .+++.++..|+.++++||+|||.+   +|+|||||.+|||++.+|.+||
T Consensus       348 VMEym~ggsLTDvVt~~--------------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKl  410 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT--------------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKL  410 (550)
T ss_pred             EEeecCCCchhhhhhcc--------------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEE
Confidence            99999999999998754              388999999999999999999988   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||++..+.....  .....+|||.|||||+.....|.++.||||||++++||+-|.+||..+.+-.   .++.....+
T Consensus       411 tDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr---AlyLIa~ng  485 (550)
T KOG0578|consen  411 TDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNG  485 (550)
T ss_pred             eeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH---HHHHHhhcC
Confidence            99999988765433  4456789999999999999999999999999999999999999998644321   111111111


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcCC
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRCCP  926 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~~~  926 (969)
                      .+         ....+...+..+.+++.+|++.||++|++++|+++  +|+.+.+
T Consensus       486 ~P---------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  486 TP---------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             CC---------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            11         11234445688999999999999999999999996  4544443

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=338.07  Aligned_cols=266  Identities=25%  Similarity=0.306  Sum_probs=213.4

Q ss_pred             chhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH-----------HHHHHHHHHHHHHhccccCce
Q 002085          630 TESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ-----------KLEKEFIAEIEILGTIRHANI  698 (969)
Q Consensus       630 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni  698 (969)
                      .....+++|++.+.||+|.||.|-+|++..+++.||||++.+.....+           ...+.+++|+.+|++++||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            344567899999999999999999999999999999999965432211           113589999999999999999


Q ss_pred             eeEEEEEEcC--CceEEEEeeccCCCHHHHhccCcCccccCCCCccccc-CChHHHHHHHHHHHHhhhhhcccCCCCeEe
Q 002085          699 VKLWCCISSE--NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV-LHWPTRLQIAIGAAQGLCYMHHDCTPQIIH  775 (969)
Q Consensus       699 v~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  775 (969)
                      |+++++..++  +..|||+|||..|.+...=.              ... ++..++++++.++..||+|||.+   +|+|
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~--------------d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiH  233 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP--------------DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIH  233 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCCC--------------CcccccHHHHHHHHHHHHHHHHHHHhc---Ceec
Confidence            9999998774  57899999999887642211              122 88999999999999999999988   9999


Q ss_pred             cCCCCCcEEECCCCcEEEeecccceecccC---CCCccccccccCcccCchhhcccCC----CCCccchhhHHHHHHHHH
Q 002085          776 RDVKSSNILLDSEFKAKIADFGLAKMLAKQ---GEPHTMSAVAGSFGYFAPEYAYTTK----VNEKIDIYSFGVVLLELV  848 (969)
Q Consensus       776 ~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~ell  848 (969)
                      |||||+|+|++++|.|||+|||.+......   +.........|||.|+|||...++.    .+.+.||||+||+||.|+
T Consensus       234 RDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll  313 (576)
T KOG0585|consen  234 RDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL  313 (576)
T ss_pred             cccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh
Confidence            999999999999999999999999765332   1222234478999999999988743    356899999999999999


Q ss_pred             hCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          849 TGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       849 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .|+.||.++...++.+.             +....+..+...+....+.+++++++++||++|.+..+|.....-..
T Consensus       314 fG~~PF~~~~~~~l~~K-------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  314 FGQLPFFDDFELELFDK-------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             hccCCcccchHHHHHHH-------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            99999988765444333             23333444444455678999999999999999999999987665443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.5e-38  Score=346.86  Aligned_cols=276  Identities=22%  Similarity=0.327  Sum_probs=210.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC----------------CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCcee
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING----------------AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV  699 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  699 (969)
                      ++|+..++||+|+||.||+|.+..                ++..||+|++....  .......+.+|++++++++||||+
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence            468888999999999999997532                34479999986532  234457899999999999999999


Q ss_pred             eEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCC------CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCe
Q 002085          700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS------SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQI  773 (969)
Q Consensus       700 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  773 (969)
                      ++++++.+.+..++||||+++|+|.+++...........      .......++|..+..++.|++.||+|||+.   +|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence            999999999999999999999999999975432111100      011224578999999999999999999988   99


Q ss_pred             EecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh--CC
Q 002085          774 IHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT--GK  851 (969)
Q Consensus       774 vH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~  851 (969)
                      +||||||+||+++.++.+||+|||+++.+.............++..|+|||++.++.++.++|||||||++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999999986643322222334456789999999998899999999999999999987  45


Q ss_pred             CCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          852 EANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       852 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      .||...........+...+.......   .    ...+..++..+.+++.+||+.||++|||+.||.+.|++
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~---~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQV---Y----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccc---c----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            56665444333333322221111000   0    01112234678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-39  Score=332.50  Aligned_cols=254  Identities=25%  Similarity=0.365  Sum_probs=224.5

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ...+|.+.+.||+|.||.|-+|.....|+.||||.++++...+++..-.+.+|++||..++||||+.++++|+..+...|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            44578888999999999999999988999999999998888888888899999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||..+|.|++|+.+++.             +++.++..++.||.+|+.|+|.+   +++|||||.+|||+|+++++||
T Consensus       131 vMEYaS~GeLYDYiSer~~-------------LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKI  194 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGS-------------LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKI  194 (668)
T ss_pred             EEEecCCccHHHHHHHhcc-------------ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeee
Confidence            9999999999999998764             89999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||++-.|.+.   ...+.++|+|-|.+||++.+..| .+..|.||+||+||.++.|..||++.+...+++++.+....
T Consensus       195 ADFGLSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr  271 (668)
T KOG0611|consen  195 ADFGLSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR  271 (668)
T ss_pred             eccchhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc
Confidence            999999887543   33456799999999999999988 47899999999999999999999998887776665443221


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                      +.                +.+....-+|++|+..+|++|-|..+|...+.
T Consensus       272 EP----------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  272 EP----------------ETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             CC----------------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            11                11245667999999999999999999987663

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-39  Score=324.48  Aligned_cols=268  Identities=24%  Similarity=0.307  Sum_probs=215.1

Q ss_pred             chhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc--
Q 002085          630 TESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS--  707 (969)
Q Consensus       630 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  707 (969)
                      .-.+-+++|+..++|++|+||.||+|++..+++.||+|+++-+.... ..--...+|+.++.+.+|||||.+.+++..  
T Consensus        70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSN  148 (419)
T ss_pred             cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence            33455678999999999999999999999999999999997654222 122356789999999999999999988765  


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      -+..|+|||||+ -+|..++...+            ..+...++..++.|+++|++|||..   .|+|||||++|+|+..
T Consensus       149 ~d~iy~VMe~~E-hDLksl~d~m~------------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~  212 (419)
T KOG0663|consen  149 MDKIYIVMEYVE-HDLKSLMETMK------------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSH  212 (419)
T ss_pred             cceeeeeHHHHH-hhHHHHHHhcc------------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeecc
Confidence            457999999997 68999998765            3588899999999999999999999   8999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      .|.+||+|||+|+.|...  ...++..+.|.+|+|||.+.+. .|+++.|+||+|||+.||+++++.|.+....+....+
T Consensus       213 ~G~lKiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I  290 (419)
T KOG0663|consen  213 KGILKIADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI  290 (419)
T ss_pred             CCcEEecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH
Confidence            999999999999988543  3445677899999999998876 5899999999999999999999999887766555555


Q ss_pred             HHHhhccCCchhhhccCC-------------------CCcccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEKPITDALDKGI-------------------AEPCYLE-EMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~-------------------~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+...-..   +...+++                   +...... ....-++++...+..||.+|.|+.|.++
T Consensus       291 f~llGtPt---e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  291 FKLLGTPS---EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             HHHhCCCc---cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            44321110   0011110                   0001111 2356789999999999999999999986

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=330.68  Aligned_cols=268  Identities=27%  Similarity=0.348  Sum_probs=209.3

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc--ccCceeeEEEEEEcC--
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI--RHANIVKLWCCISSE--  708 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~--  708 (969)
                      .+.++.+..+.||+|.||+||+|+++  |+.||||++...      .++.+.+|.+|++.+  +|+||+.|++.-..+  
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNG  279 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence            35567888899999999999999995  888999998432      257888999999875  999999999875433  


Q ss_pred             --CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhccc-----CCCCeEecCCCCC
Q 002085          709 --NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD-----CTPQIIHRDVKSS  781 (969)
Q Consensus       709 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~  781 (969)
                        ...+||++|.+.|||+|||...              .++-...++++..+|.||+|||..     ..|.|.|||||+.
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r~--------------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK  345 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNRN--------------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK  345 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhhc--------------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence              2568999999999999999863              388889999999999999999954     3788999999999


Q ss_pred             cEEECCCCcEEEeecccceecccCCCCc--cccccccCcccCchhhcccCC------CCCccchhhHHHHHHHHHhCC--
Q 002085          782 NILLDSEFKAKIADFGLAKMLAKQGEPH--TMSAVAGSFGYFAPEYAYTTK------VNEKIDIYSFGVVLLELVTGK--  851 (969)
Q Consensus       782 Nill~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~elltg~--  851 (969)
                      |||+..++.+.|+|+|+|..+....+..  .....+||.+|||||++...-      .-..+||||||.|+||++.+.  
T Consensus       346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~  425 (513)
T KOG2052|consen  346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES  425 (513)
T ss_pred             cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc
Confidence            9999999999999999998876543322  234568999999999987542      224699999999999998753  


Q ss_pred             --------CCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          852 --------EANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       852 --------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                              .||++.-+.+.-..-.+.+...++++..++...   ...+....+.++|+.||..+|+.|-|+--+-+.|.+
T Consensus       426 ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  426 GGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             CCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence                    466653322221112223333333333333222   234567889999999999999999999999999988


Q ss_pred             cC
Q 002085          924 CC  925 (969)
Q Consensus       924 ~~  925 (969)
                      +.
T Consensus       503 l~  504 (513)
T KOG2052|consen  503 LS  504 (513)
T ss_pred             Hh
Confidence            86

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.8e-38  Score=341.95  Aligned_cols=249  Identities=24%  Similarity=0.269  Sum_probs=203.8

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc----CCceEEEEee
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS----ENSKLLVYEY  717 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  717 (969)
                      ..||+|++|.||+|..  +|+.||||++...........+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999998  688999999976544444446788999999999999999999999876    3467899999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++|+|.+++....             .++|....+++.|++.|++|||+..  +++||||||+||++++++.+||+|||
T Consensus       104 ~~~g~L~~~l~~~~-------------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg  168 (283)
T PHA02988        104 CTRGYLREVLDKEK-------------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHG  168 (283)
T ss_pred             CCCCcHHHHHhhCC-------------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccc
Confidence            99999999998643             3789999999999999999999631  78899999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT--TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      +++.+...     .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.+....+....+..   ... 
T Consensus       169 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~---~~~-  239 (283)
T PHA02988        169 LEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN---KNN-  239 (283)
T ss_pred             hHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---cCC-
Confidence            99865321     123468899999999976  6899999999999999999999999986654333222211   111 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                               ..+.+...+..+.+++.+||+.||++|||++|+++.|++..
T Consensus       240 ---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        240 ---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                     11112234567899999999999999999999999998764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.4e-38  Score=352.66  Aligned_cols=245  Identities=24%  Similarity=0.332  Sum_probs=204.0

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQ  721 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  721 (969)
                      +.||+|+||.||+|+...+|+.||+|+++............+.+|++++++++||||+++++++.+.+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997654434445567889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          722 SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       722 sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                      +|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~  144 (323)
T cd05571          81 ELFFHLSRER-------------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             cHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence            9999997643             388999999999999999999988   999999999999999999999999999875


Q ss_pred             cccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhc
Q 002085          802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD  881 (969)
Q Consensus       802 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  881 (969)
                      ....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+.   ....       
T Consensus       145 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~-------  212 (323)
T cd05571         145 GISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---MEEI-------  212 (323)
T ss_pred             cccC--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH---cCCC-------
Confidence            3221  222334579999999999999999999999999999999999999998765433322221   1110       


Q ss_pred             cCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       882 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                           ..+......+.+++.+||+.||++||     ++.|+++
T Consensus       213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                 11122346788999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-38  Score=351.75  Aligned_cols=249  Identities=24%  Similarity=0.320  Sum_probs=207.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++..+++.||+|++...........+.+.+|++++++++||||+++++++.+++..|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            46788999999999999999999999999999999655433444557789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        97 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~  160 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-------------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVT  160 (329)
T ss_pred             EcCCCCChHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEe
Confidence            99999999999998644             378888999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.......+.+    ....
T Consensus       161 Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i----~~~~  231 (329)
T PTZ00263        161 DFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI----LAGR  231 (329)
T ss_pred             eccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH----hcCC
Confidence            99999865322     12356899999999999999999999999999999999999999876543322221    1111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-----MKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~  919 (969)
                               ..  .+......+.+++.+||+.||.+||+     +++++.
T Consensus       232 ---------~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        232 ---------LK--FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ---------cC--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                     00  11112356889999999999999996     566654

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=317.86  Aligned_cols=255  Identities=24%  Similarity=0.320  Sum_probs=217.6

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +.++|++-+.||+|.|+.||++.+..+|+.+|+|++.... ......+++.+|++|-+.++||||+++.+.+.+.+..|+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k-~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhh-hccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            4567888999999999999999999999999999885443 234467889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC---Cc
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE---FK  790 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~  790 (969)
                      |+|+|.|++|..-+-.+             ..+++..+-..+.||++++.|+|..   +|||||+||+|+++...   ..
T Consensus        88 vFe~m~G~dl~~eIV~R-------------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~  151 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR-------------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAA  151 (355)
T ss_pred             EEecccchHHHHHHHHH-------------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCc
Confidence            99999999997665543             2477888899999999999999998   99999999999999543   46


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      +|++|||+|..+.   +.......+|||+|||||++...+|+..+|||+.||+||-++.|..||++++...+.+.+.+..
T Consensus       152 vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~  228 (355)
T KOG0033|consen  152 VKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA  228 (355)
T ss_pred             eeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc
Confidence            9999999999875   3344556789999999999999999999999999999999999999999988777776664432


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+           ...++.....++..+++++|+..||++|.|+.|.+.
T Consensus       229 yd-----------~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  229 YD-----------YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cC-----------CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            22           223344455678899999999999999999999875

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=347.65  Aligned_cols=248  Identities=23%  Similarity=0.292  Sum_probs=206.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|....+++.||+|++...........+.+.+|++++++++||||+++++++.++...|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999999899999999986543333345577899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~D  144 (291)
T cd05612          81 EYVPGGELFSYLRNSG-------------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTD  144 (291)
T ss_pred             eCCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEe
Confidence            9999999999997644             378889999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+++.....     .....|++.|+|||++.+..++.++||||+||++|||++|+.||.+.........+..   ... 
T Consensus       145 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~---~~~-  215 (291)
T cd05612         145 FGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA---GKL-  215 (291)
T ss_pred             cCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCc-
Confidence            9999765321     1234689999999999998999999999999999999999999987654333322211   100 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-----MKEVLQ  919 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~  919 (969)
                                 ..+......+.+++.+|++.||.+||+     +.|+++
T Consensus       216 -----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         216 -----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             -----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                       011122367889999999999999995     666553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=343.92  Aligned_cols=251  Identities=22%  Similarity=0.301  Sum_probs=203.7

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      .|+..++||+|+||.||++.+..+++.||||++.............+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            37788999999999999999988899999999865443333344567889999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++|+|.+++.....           ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+||
T Consensus        81 ~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Df  146 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-----------PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDL  146 (285)
T ss_pred             ccCCCcHHHHHHhcCc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeC
Confidence            9999999998865431           3488999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |+++.....   .......|+..|+|||++.+..++.++||||+||++|||++|+.||.+.......+.+........  
T Consensus       147 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--  221 (285)
T cd05605         147 GLAVEIPEG---ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--  221 (285)
T ss_pred             CCceecCCC---CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--
Confidence            999865322   122345689999999999988999999999999999999999999986544332222222211110  


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK  915 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~  915 (969)
                               ...+...+..+.+++.+||+.||++||+..
T Consensus       222 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05605         222 ---------EEYSEKFSEAARSICRQLLTKDPGFRLGCR  251 (285)
T ss_pred             ---------cccCcccCHHHHHHHHHHccCCHHHhcCCC
Confidence                     112223456789999999999999999443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=348.50  Aligned_cols=396  Identities=24%  Similarity=0.255  Sum_probs=309.6

Q ss_pred             CCCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCc
Q 002085           62 PCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI  141 (969)
Q Consensus        62 ~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  141 (969)
                      +|.=+-..|+...+..++-  ..+.|.+|+      ..+.||+++|.+...-+..|.++++|++++|.+|.++ .||...
T Consensus        51 ~c~~~lldcs~~~lea~~~--~~l~g~lp~------~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~  121 (873)
T KOG4194|consen   51 PCNTRLLDCSDRELEAIDK--SRLKGFLPS------QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFG  121 (873)
T ss_pred             CCCceeeecCccccccccc--cccCCcCcc------ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccc
Confidence            3443444455444444332  234455554      4678999999999888999999999999999999999 889877


Q ss_pred             ccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCC
Q 002085          142 DRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKL  221 (969)
Q Consensus       142 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L  221 (969)
                      ....+|+.|+|.+|.|+..-...+..++.|+.||||.|.|+.+.-.+|..-.++++|+|++|++  ...-...|.++.+|
T Consensus       122 ~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~I--t~l~~~~F~~lnsL  199 (873)
T KOG4194|consen  122 HESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRI--TTLETGHFDSLNSL  199 (873)
T ss_pred             ccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccc--cccccccccccchh
Confidence            7778899999999999988888899999999999999999966667888889999999999984  44556778899999


Q ss_pred             cEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCc
Q 002085          222 KTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMN  300 (969)
Q Consensus       222 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N  300 (969)
                      ..|.|+.|.++...+..|.+|++|+.|+|..|+|.-.--..|..+++|+.|.|..|.+...-...|..+ ++++|+|+.|
T Consensus       200 ~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N  279 (873)
T KOG4194|consen  200 LTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETN  279 (873)
T ss_pred             eeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccc
Confidence            999999999988888899999999999999999974334567789999999999999987777777666 6888999999


Q ss_pred             cccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccC
Q 002085          301 NLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFN  380 (969)
Q Consensus       301 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  380 (969)
                      +++..-..++-+++.|+.|+|++|.|..                 ..++....+++|+.|+|++|+|+...+..|..+..
T Consensus       280 ~l~~vn~g~lfgLt~L~~L~lS~NaI~r-----------------ih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~  342 (873)
T KOG4194|consen  280 RLQAVNEGWLFGLTSLEQLDLSYNAIQR-----------------IHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQ  342 (873)
T ss_pred             hhhhhhcccccccchhhhhccchhhhhe-----------------eecchhhhcccceeEeccccccccCChhHHHHHHH
Confidence            8887777788888888888888888873                 23445566778888888888888666677776766


Q ss_pred             CCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccC---ccccCccccchhhcc
Q 002085          381 LSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIP---VELTSLSHLNTLLLD  457 (969)
Q Consensus       381 L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~Ls  457 (969)
                      |+.|+|++|.++                      ......|..+++|++|||++|.|++.+.   ..|.+|++|+.|+|.
T Consensus       343 Le~LnLs~Nsi~----------------------~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~  400 (873)
T KOG4194|consen  343 LEELNLSHNSID----------------------HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLT  400 (873)
T ss_pred             hhhhcccccchH----------------------HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeec
Confidence            666666666554                      3334456667777777777777776553   346678888888888


Q ss_pred             CcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCcc
Q 002085          458 GNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQ  508 (969)
Q Consensus       458 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~  508 (969)
                      ||+|....-..|..+.+|+.|||.+|.|...-|.+|..+ .|+.|-+..-.
T Consensus       401 gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSss  450 (873)
T KOG4194|consen  401 GNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSS  450 (873)
T ss_pred             CceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccc
Confidence            888874444667788888888888888877778888777 77777665433

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=344.73  Aligned_cols=261  Identities=26%  Similarity=0.383  Sum_probs=220.2

Q ss_pred             CCccceeeecCcEEEEEEEEcCC----CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          638 LTESNLIGSGGSGQVYRIDINGA----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      .+..++||+|.||.||+|.....    ...||||.-+.+..  ....+.|..|..+|+.++||||++++|.|.+. ..+|
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            45568899999999999987432    33688998765443  33468899999999999999999999999764 6899


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      |||.++-|.|..|++..+.            .++..+...++.|++.||+|||+.   ++|||||.++|||+.....||+
T Consensus       468 vmEL~~~GELr~yLq~nk~------------sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKL  532 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKD------------SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKL  532 (974)
T ss_pred             EEecccchhHHHHHHhccc------------cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeee
Confidence            9999999999999998764            488889999999999999999988   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||+++.+.++.. +..+...-.+.|||||.+.-.+++.++|||.|||.+||++. |..||.+....+           
T Consensus       533 aDFGLSR~~ed~~y-YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------  600 (974)
T KOG4257|consen  533 ADFGLSRYLEDDAY-YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------  600 (974)
T ss_pred             cccchhhhccccch-hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------
Confidence            99999998866533 33334455788999999999999999999999999999887 888998754332           


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCC
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYG  931 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  931 (969)
                         +-..++.+-+.|++..+++.++.+|.+||..||.+||.+.|+...|..+...+...
T Consensus       601 ---VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~  656 (974)
T KOG4257|consen  601 ---VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN  656 (974)
T ss_pred             ---eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence               33345566677889999999999999999999999999999999888776544433

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-39  Score=309.27  Aligned_cols=254  Identities=24%  Similarity=0.328  Sum_probs=220.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +++|.+++.||+|.||.||.|+...++-.||+|++.++........+.+.+|++|.+.++||||++++++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            56899999999999999999999999999999999887766666678999999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      +||.++|+++..+++.+.           ..+++.....+..|+|.|+.|+|..   +|+||||||+|+|++.++.+|++
T Consensus       101 lEya~~gel~k~L~~~~~-----------~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRM-----------KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             EEecCCchHHHHHHhccc-----------ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeecc
Confidence            999999999999996553           4588888899999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||.+..-    ........+||..|.+||...+..++...|+|++|++.||++.|..||......+..+.+.+.-    
T Consensus       167 dfGwsV~~----p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~----  238 (281)
T KOG0580|consen  167 DFGWSVHA----PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD----  238 (281)
T ss_pred             CCCceeec----CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc----
Confidence            99998653    2334445789999999999999999999999999999999999999998776555444432211    


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                               +  ..+...+....+++.+|+..+|.+|.+..|+++.-
T Consensus       239 ---------~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  239 ---------L--KFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             ---------c--cCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence                     1  12233447789999999999999999999998753

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-38  Score=351.26  Aligned_cols=257  Identities=23%  Similarity=0.293  Sum_probs=210.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|++++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999999899999999997654333344567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 e~~~g~~L~~~l~~~~-------------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~D  144 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-------------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTD  144 (333)
T ss_pred             eCCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEe
Confidence            9999999999997543             378899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+++....     ......||+.|+|||++.+..++.++||||+||++|||++|..||...........+.... .   
T Consensus       145 fg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~---  215 (333)
T cd05600         145 FGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-E---  215 (333)
T ss_pred             CcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-c---
Confidence            999976532     2234578999999999999999999999999999999999999998765443332221110 0   


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                         ..............+..+.+++.+|+..+|.+||++.|+++.
T Consensus       216 ---~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         216 ---TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ---cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence               000000000011234678899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.5e-38  Score=355.98  Aligned_cols=270  Identities=22%  Similarity=0.346  Sum_probs=207.9

Q ss_pred             cCCCccceeeecCcEEEEEEEE-----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDI-----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSEN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  709 (969)
                      ++|+..++||+|+||.||+|.+     ..++..||||+++....  ....+.+.+|+++++.+ +||||+++++++.+++
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            4788999999999999999974     34566899999864332  23356788999999999 8999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCcccc-----------------------------------------CC----------
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVS-----------------------------------------GS----------  738 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~-----------------------------------------~~----------  738 (969)
                      ..++||||+++|+|.++++........                                         ..          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            999999999999999999764321000                                         00          


Q ss_pred             -----------CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCC
Q 002085          739 -----------SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE  807 (969)
Q Consensus       739 -----------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  807 (969)
                                 .......++|..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                       000113578999999999999999999988   999999999999999999999999999987644322


Q ss_pred             CccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCcc-chHHHHHHHhhccCCchhhhccCCC
Q 002085          808 PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHT-SLAEWAWRHYAEEKPITDALDKGIA  885 (969)
Q Consensus       808 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  885 (969)
                      ........++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+    ....          .
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~----~~~~----------~  335 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI----KEGY----------R  335 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH----HhCc----------c
Confidence            222233445678999999999999999999999999999998 77777553322 111111    1111          0


Q ss_pred             CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          886 EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       886 ~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      ...+...+.++.+++.+||+.||++||+++|++++|++.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            011111236789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=340.32  Aligned_cols=264  Identities=25%  Similarity=0.373  Sum_probs=216.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      .....++||+|-||+|..++... +..||||.++...  ....+.+|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             heehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            45567899999999999999864 6899999997654  34556899999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      ||++|+|.+++.++...           ...-....+|+.|||+||+||.+.   ++||||+.++|+|+|.++++||+||
T Consensus       616 YmEnGDLnqFl~aheap-----------t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadf  681 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELP-----------TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADF  681 (807)
T ss_pred             HHhcCcHHHHHHhccCc-----------ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCc
Confidence            99999999999987531           133345667999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh--CCCCCCCCCccchHHHHHHHhhccC
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT--GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |+++-+-....++..+..+-..+|||||.+..++++.++|||+||+++||+++  ...||......+..+.....+....
T Consensus       682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~  761 (807)
T KOG1094|consen  682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG  761 (807)
T ss_pred             ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence            99996655444555555567789999999999999999999999999999876  5678776655555554433332211


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      . .      .....+.-++..++++|.+||+.|-++||++.++...|++.
T Consensus       762 ~-~------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 R-Q------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             c-c------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1 1      11233455668899999999999999999999999998765

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=337.72  Aligned_cols=250  Identities=26%  Similarity=0.349  Sum_probs=208.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ..|+..++||+|+||.||+|.+..+++.||+|++.-+..  .....++++|+.++..++++||.++++.+..+...+++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            357777999999999999999999999999999965543  344578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |||.||++.+.++...             .+++..+..|+.++..|+.|||.+   +.+|||||+.||++..+|.+|++|
T Consensus        91 ey~~gGsv~~lL~~~~-------------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~D  154 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGN-------------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLAD  154 (467)
T ss_pred             HHhcCcchhhhhccCC-------------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEe
Confidence            9999999999998654             246677778999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||++..+.....  .....+|||.|||||++.+..|+.|+||||+|++.+||++|.+|+....+....      +    -
T Consensus       155 fgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------f----l  222 (467)
T KOG0201|consen  155 FGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------F----L  222 (467)
T ss_pred             cceeeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------E----e
Confidence            999987754322  225678999999999999989999999999999999999999998654431100      0    0


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +.+...+.+    ....+..+.+++..|+++||+.||+|+++++
T Consensus       223 Ipk~~PP~L----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  223 IPKSAPPRL----DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccCCCCCcc----ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            111111111    2245577999999999999999999999985

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=352.46  Aligned_cols=257  Identities=27%  Similarity=0.367  Sum_probs=222.5

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCc----EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGE----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ..+..++||+|+||+||+|.+...|+    +||+|++...  ...+...++.+|+-+|.+++|||++|++++|.... ..
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            34567899999999999999976665    7999988443  34455688999999999999999999999998765 88


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      ||++||+.|+|.+|++.++            ..+.-...+.|..|||+||.|||++   ++|||||.++|||+.+...+|
T Consensus       774 lvtq~mP~G~LlDyvr~hr------------~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvk  838 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHR------------DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVK  838 (1177)
T ss_pred             HHHHhcccchHHHHHHHhh------------ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEE
Confidence            9999999999999999865            3577788999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |.|||+|+....++.........-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+          
T Consensus       839 itdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------  908 (1177)
T KOG1025|consen  839 ITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------  908 (1177)
T ss_pred             EEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------
Confidence            999999999887777666666666788999999999999999999999999999999 888887754432          


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                          +.+.+..+.+-++++-++.+++.+|.+||..|+..||+++++...+.+..
T Consensus       909 ----I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  909 ----IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             ----hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence                44555555566778888899999999999999999999999998887664

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.6e-38  Score=354.55  Aligned_cols=271  Identities=24%  Similarity=0.348  Sum_probs=209.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCC-----CcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGA-----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSEN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  709 (969)
                      ++|+..+.||+|+||.||+|.+...     +..||+|+++....  ......+.+|+++++.+ +||||+++++++.+.+
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            4788999999999999999986433     35799999865432  23356788999999999 8999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCcccc-----------------------------------------------------
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVS-----------------------------------------------------  736 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~-----------------------------------------------------  736 (969)
                      ..++||||+++|+|.++++........                                                     
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            999999999999999999754321000                                                     


Q ss_pred             ----CCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCcccc
Q 002085          737 ----GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS  812 (969)
Q Consensus       737 ----~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  812 (969)
                          .........+++..+++++.|++.||+|||+.   +|+||||||+||++++++.++|+|||+++.+..........
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                00001123578899999999999999999988   99999999999999999999999999998664332222222


Q ss_pred             ccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHH
Q 002085          813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLE  891 (969)
Q Consensus       813 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  891 (969)
                      ...+++.|+|||++.+..++.++|||||||++|||++ |+.||............   ...          +.....+..
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~---~~~----------~~~~~~~~~  339 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM---VKR----------GYQMSRPDF  339 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH---HHc----------ccCccCCCC
Confidence            3345678999999999999999999999999999997 99898754332211111   111          111111111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          892 EMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       892 ~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      .+.++.+++.+||+.||++||++.+++++|+++
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            236789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-38  Score=343.72  Aligned_cols=255  Identities=25%  Similarity=0.347  Sum_probs=223.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc-eEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS-KLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~l  713 (969)
                      .++|..++.+|+|+||.++.+++..++..|++|.+.-.+... ..++....|+.++++++|||||.+.+.|.+++. .+|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            467889999999999999999999999999999997655433 335588999999999999999999999998888 999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||+|++||++.+.+.+++.           ..+++..+..|+.|++.|+.|||+.   +|+|||||+.|||++.++.|||
T Consensus        82 vm~Y~eGg~l~~~i~~~k~-----------~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkL  147 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKG-----------VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKL  147 (426)
T ss_pred             EEeecCCCCHHHHHHHHhh-----------ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceee
Confidence            9999999999999998763           4588999999999999999999988   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+|+......  .......||+.||.||.+.+.+|..|+||||+||++|||++-+++|.+.+...+...+.+..   
T Consensus       148 gDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---  222 (426)
T KOG0589|consen  148 GDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---  222 (426)
T ss_pred             cchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc---
Confidence            9999999874432  24456789999999999999999999999999999999999999999887766655443322   


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                                 ..+.+...+.++..++..|++.+|..||++.+++.+
T Consensus       223 -----------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -----------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -----------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                       224455566889999999999999999999999975

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-37  Score=345.72  Aligned_cols=264  Identities=24%  Similarity=0.343  Sum_probs=209.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||++++..++..||+|++....  .......+.+|++++++++||||+++++++.+++..++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            57899999999999999999999999999999986532  2344578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....             .+++..+..++.|++.|++|||+.  .+|+||||||+||+++.++.++|+|
T Consensus        83 e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~D  147 (331)
T cd06649          83 EHMDGGSLDQVLKEAK-------------RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCD  147 (331)
T ss_pred             ecCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEcc
Confidence            9999999999997643             378899999999999999999974  1699999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||++......    ......|++.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+.........
T Consensus       148 fg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  223 (331)
T cd06649         148 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEE  223 (331)
T ss_pred             Cccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccccc
Confidence            9998765321    223456899999999999999999999999999999999999999765443332221111000000


Q ss_pred             -----------------------------chhhhc---cC-CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          876 -----------------------------ITDALD---KG-IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       876 -----------------------------~~~~~~---~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                                                   ..+..+   .. ...........++.+++.+||+.||++||++.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         224 GEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             CCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                         000000   00 0000011234678999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-37  Score=339.13  Aligned_cols=269  Identities=28%  Similarity=0.462  Sum_probs=214.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCC-----cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAG-----EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ++|+..+.||+|+||.||+|.....+     ..||+|.++...  .......+.+|++++++++||||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            47888999999999999999886554     679999885432  33445679999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCC---CcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSS---SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      .+++|||+++++|.+++............   ......+++..+..++.|++.||+|||+.   +++||||||+||++++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence            99999999999999999865332111100   11124588999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~  866 (969)
                      ++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999999986543322223334456889999999998899999999999999999998 99998876544333322


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      ..              +...+.+...+.++.+++.+||+.||++||++.||++.|++
T Consensus       240 ~~--------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         240 RS--------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             Hc--------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11              11111223445789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-38  Score=346.94  Aligned_cols=243  Identities=23%  Similarity=0.282  Sum_probs=200.1

Q ss_pred             eeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCH
Q 002085          644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL  723 (969)
Q Consensus       644 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  723 (969)
                      ||+|+||.||+|++..+++.||+|++.............+.+|++++++++||||+++++++.+++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999989999999999654433445567788999999999999999999999999999999999999999


Q ss_pred             HHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecc
Q 002085          724 DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA  803 (969)
Q Consensus       724 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  803 (969)
                      .+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++...
T Consensus        81 ~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~  144 (312)
T cd05585          81 FHHLQREG-------------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNM  144 (312)
T ss_pred             HHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence            99997543             388999999999999999999988   99999999999999999999999999987543


Q ss_pred             cCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccC
Q 002085          804 KQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG  883 (969)
Q Consensus       804 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  883 (969)
                      ..  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+   .....         
T Consensus       145 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~---~~~~~---------  210 (312)
T cd05585         145 KD--DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI---LQEPL---------  210 (312)
T ss_pred             cC--CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH---HcCCC---------
Confidence            22  12233457999999999999999999999999999999999999999865443322211   11110         


Q ss_pred             CCCcccHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 002085          884 IAEPCYLEEMTTVYRLALICTSTLPSSRPS---MKEVLQ  919 (969)
Q Consensus       884 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~evl~  919 (969)
                         ..+......+.+++.+||+.||++||+   +.|++.
T Consensus       211 ---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         211 ---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             ---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence               111223467889999999999999985   555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.4e-38  Score=348.09  Aligned_cols=245  Identities=23%  Similarity=0.326  Sum_probs=201.6

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +|+..+.||+|+||.||+|++..+++.||+|++.............+..|.+++..+ +|++|+++.+++.+.+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            477889999999999999999989999999999765433334445677788888877 5899999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        81 E~~~~g~L~~~~~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~D  144 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-------------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD  144 (323)
T ss_pred             cCCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEcc
Confidence            9999999999987543             378899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..    .. 
T Consensus       145 fG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~----~~-  217 (323)
T cd05616         145 FGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----HN-  217 (323)
T ss_pred             CCCceecCCC--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh----CC-
Confidence            9998754221  1223345789999999999999999999999999999999999999987655443332211    10 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                              .  ..+...+..+.+++.+|++.||++|++.
T Consensus       218 --------~--~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 --------V--AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --------C--CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                    0  1122234678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=346.15  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=214.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++.+..++||+|.||.|++|.|...   ...||||.++.....  ...++|.+|+.+|.+++|||+++++|.+.+ ....
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            3556678999999999999999542   337999999655432  256899999999999999999999999987 6788


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +|||.++.|+|.+.|++..           +..+.......++.|||.||.||..+   ++|||||.++|+++-....||
T Consensus       187 MV~ELaplGSLldrLrka~-----------~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVK  252 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAK-----------KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVK  252 (1039)
T ss_pred             HHhhhcccchHHHHHhhcc-----------ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceee
Confidence            9999999999999999833           35688889999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccc-cCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVA-GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~-gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |+|||+++-+....+.+.+.... -.+.|+|||.+...+++.++|||+|||++|||++ |..||.+-....+        
T Consensus       253 I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI--------  324 (1039)
T KOG0199|consen  253 ICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI--------  324 (1039)
T ss_pred             eecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH--------
Confidence            99999999988777777665443 5678999999999999999999999999999999 5567766544332        


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                            .+.+|.+-+-+.+..+++++|++|+.||...|++||+|..|.+.
T Consensus       325 ------L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  325 ------LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ------HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                  23344444556677888999999999999999999999999843

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.4e-37  Score=350.25  Aligned_cols=258  Identities=21%  Similarity=0.280  Sum_probs=202.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||+||+|+...+++.||+|++.............+.+|++++.+++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36888999999999999999999899999999996554334445577899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 E~~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~D  144 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-------------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSD  144 (363)
T ss_pred             cCCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEee
Confidence            9999999999997643             388999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCC---------------------------------ccccccccCcccCchhhcccCCCCCccchhhHHH
Q 002085          796 FGLAKMLAKQGEP---------------------------------HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGV  842 (969)
Q Consensus       796 fgla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~  842 (969)
                      ||+++.+......                                 .......||+.|+|||++.+..++.++|||||||
T Consensus       145 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGv  224 (363)
T cd05628         145 FGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV  224 (363)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHH
Confidence            9998754321100                                 0012346999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHH
Q 002085          843 VLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTS--TLPSSRPSMKEVLQI  920 (969)
Q Consensus       843 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~--~dP~~RPs~~evl~~  920 (969)
                      ++|||++|+.||.+.........+...   ....        ..+........+.+++.+++.  .++..||++.|+++.
T Consensus       225 il~ell~G~~Pf~~~~~~~~~~~i~~~---~~~~--------~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         225 IMYEMLIGYPPFCSETPQETYKKVMNW---KETL--------IFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHcC---cCcc--------cCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999999999999876544333222110   0000        001011122456667766443  233456899999763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.4e-38  Score=346.59  Aligned_cols=245  Identities=24%  Similarity=0.342  Sum_probs=203.2

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQ  721 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  721 (969)
                      +.||+|+||.||+++...+|+.||+|++.............+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999999899999999997654434445567889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          722 SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       722 sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                      +|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  144 (323)
T cd05595          81 ELFFHLSRER-------------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             cHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence            9999887543             388999999999999999999988   999999999999999999999999999875


Q ss_pred             cccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhc
Q 002085          802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD  881 (969)
Q Consensus       802 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  881 (969)
                      ...  .........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.   .....      
T Consensus       145 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~---~~~~~------  213 (323)
T cd05595         145 GIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL---MEEIR------  213 (323)
T ss_pred             ccC--CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCCCC------
Confidence            322  1222334579999999999999999999999999999999999999997665443322221   11110      


Q ss_pred             cCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       882 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                            .+...+..+.+++.+||+.||++||     ++.++++
T Consensus       214 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         214 ------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                  1122346788999999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.9e-38  Score=345.24  Aligned_cols=244  Identities=25%  Similarity=0.376  Sum_probs=197.8

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      +.||+|+||.||+|+...+++.||+|+++..........+.+..|.+++... +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999765433334445666777777754 899999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 g~L~~~~~~~~-------------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~  144 (316)
T cd05592          81 GDLMFHIQSSG-------------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK  144 (316)
T ss_pred             CcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCe
Confidence            99999987543             378889999999999999999988   99999999999999999999999999997


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+    ....+     
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i----~~~~~-----  213 (316)
T cd05592         145 ENMNG--EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI----LNDRP-----  213 (316)
T ss_pred             ECCCC--CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH----HcCCC-----
Confidence            64322  12233457999999999999999999999999999999999999999876543332221    11110     


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK-EVL  918 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl  918 (969)
                            ..+......+.+++.+||+.||++||++. ++.
T Consensus       214 ------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         214 ------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                  11122335678999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9.4e-38  Score=347.22  Aligned_cols=250  Identities=22%  Similarity=0.262  Sum_probs=206.5

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCC-cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAG-EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ..++|+..+.||+|+||.||+|.+..++ ..||+|++...........+.+.+|+++++.++||||+++++++.+++..|
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3467999999999999999999876554 689999986554434445677899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       108 lv~Ey~~~g~L~~~i~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ik  171 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK-------------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIK  171 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEE
Confidence            9999999999999997654             388899999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      |+|||+++.....     .....||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.......+.    .
T Consensus       172 L~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~----~  242 (340)
T PTZ00426        172 MTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL----E  242 (340)
T ss_pred             EecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh----c
Confidence            9999999865321     224578999999999999889999999999999999999999998765433322221    1


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                      ..         .  ..+......+.+++.+|++.||++|+     +++|+++
T Consensus       243 ~~---------~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        243 GI---------I--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             CC---------C--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            10         0  01112235678999999999999995     7877765

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.6e-38  Score=346.65  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=203.8

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQ  721 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  721 (969)
                      +.||+|+||.||+++...+++.||+|++.............+.+|+++++.++||||+++.+++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997654444455678889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          722 SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       722 sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                      +|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~  144 (328)
T cd05593          81 ELFFHLSRER-------------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (328)
T ss_pred             CHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence            9999887543             388999999999999999999988   999999999999999999999999999875


Q ss_pred             cccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhc
Q 002085          802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD  881 (969)
Q Consensus       802 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  881 (969)
                      ...  .........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+   .....       
T Consensus       145 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~---~~~~~-------  212 (328)
T cd05593         145 GIT--DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---LMEDI-------  212 (328)
T ss_pred             CCC--cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh---ccCCc-------
Confidence            322  122233457999999999999999999999999999999999999999765543322211   11110       


Q ss_pred             cCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002085          882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQI  920 (969)
Q Consensus       882 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~  920 (969)
                           ..+...+..+.+++.+|++.||++||     ++.|+++.
T Consensus       213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         213 -----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                 11122346788999999999999997     88998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.9e-38  Score=347.91  Aligned_cols=245  Identities=22%  Similarity=0.316  Sum_probs=201.2

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcccc-CceeeEEEEEEcCCceEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH-ANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  715 (969)
                      +|+..+.||+|+||.||+|+...+++.||||++...........+.+..|++++..++| ++|+++.+++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            47788999999999999999998999999999976543334445678889999999976 56888999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 E~~~~g~L~~~~~~~~-------------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~D  144 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-------------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIAD  144 (324)
T ss_pred             cCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEee
Confidence            9999999999987543             378899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+++.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+..   ... 
T Consensus       145 fg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~---~~~-  218 (324)
T cd05587         145 FGMCKENIFG--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME---HNV-  218 (324)
T ss_pred             cCcceecCCC--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc---CCC-
Confidence            9998753221  1223345689999999999999999999999999999999999999987654433332211   100 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                                 ..+...+..+.+++.+|+..||++|++.
T Consensus       219 -----------~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 -----------SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -----------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                       1112233678899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.2e-38  Score=346.58  Aligned_cols=244  Identities=21%  Similarity=0.285  Sum_probs=197.3

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      +.||+|+||.||+|+...+++.||+|+++..........+.+.+|+.++.++ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999765444445556788999998877 799999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~L~~~~~~~~-------------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~  144 (329)
T cd05618          81 GDLMFHMQRQR-------------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK  144 (329)
T ss_pred             CCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccc
Confidence            99999887543             388999999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----ccchHHHHHHHhhccCC
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE-----HTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~-----~~~~~~~~~~~~~~~~~  875 (969)
                      .....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||....     ......++........ 
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-  221 (329)
T cd05618         145 EGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-  221 (329)
T ss_pred             cccCC--CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-
Confidence            53221  112234578999999999999999999999999999999999999995321     1111222222221111 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                              .  ..+......+.+++.+||+.||++||++
T Consensus       222 --------~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         222 --------I--RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             --------C--CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                    0  1122234678899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=306.96  Aligned_cols=264  Identities=23%  Similarity=0.286  Sum_probs=212.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC-----Cc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE-----NS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  710 (969)
                      ++|++.+.+|+|||+.||.++...+++.||+|++....   .+..+...+|++..++++|||+++++++...+     ..
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            57999999999999999999999999999999986543   45567899999999999999999999876432     35


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .||+++|...|+|.+.+.....         ....+++.++++|+.+|++||++||+. .++++||||||.||++++++.
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~---------kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKI---------KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhh---------cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCc
Confidence            8999999999999999987654         134689999999999999999999998 456999999999999999999


Q ss_pred             EEEeecccceecccCCCC-------ccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 002085          791 AKIADFGLAKMLAKQGEP-------HTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT  860 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~  860 (969)
                      +++.|||.++...-.-..       ........|..|+|||.+.   +...++++|||||||+||+|+.|..||...   
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---  244 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---  244 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---
Confidence            999999999765321111       1123445889999999876   345788999999999999999999998532   


Q ss_pred             chHHHHHHHhhccCCch-hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          861 SLAEWAWRHYAEEKPIT-DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       861 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                               +..+..+. ......+..|.....++.+.+++++|++.||.+||++.|++..++..
T Consensus       245 ---------~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  245 ---------YQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ---------hhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                     11122222 22222333344444678899999999999999999999999988765

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.2e-41  Score=348.71  Aligned_cols=435  Identities=28%  Similarity=0.435  Sum_probs=367.3

Q ss_pred             eEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCC
Q 002085           75 VTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG  154 (969)
Q Consensus        75 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  154 (969)
                      .+.+.+++|++.. +.+.+.+|..|++|++++|++. ..|++++.+..++.|+.|+|+++ .+|.+++.+.+|+.|+.+.
T Consensus        47 l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~  123 (565)
T KOG0472|consen   47 LQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS  123 (565)
T ss_pred             hhhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence            5678889998864 4556788999999999999999 88999999999999999999999 8999999999999999999


Q ss_pred             CCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccccc
Q 002085          155 NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGE  234 (969)
Q Consensus       155 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  234 (969)
                      |.+. .+|+.++.+..|+.|+..+|+++ ..|..++.+.+|..|++.+|.   ....|...-+++.|++|+...| +.+.
T Consensus       124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~---l~~l~~~~i~m~~L~~ld~~~N-~L~t  197 (565)
T KOG0472|consen  124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNK---LKALPENHIAMKRLKHLDCNSN-LLET  197 (565)
T ss_pred             ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccc---hhhCCHHHHHHHHHHhcccchh-hhhc
Confidence            9999 88999999999999999999999 889999999999999999995   4456666666999999999875 5578


Q ss_pred             CchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchh-hc-ccccccccCccccccCCccccC
Q 002085          235 IPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVE-AL-KLTDIDLSMNNLTGSIPEEFGK  312 (969)
Q Consensus       235 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~-~~-~L~~L~Ls~N~l~~~~p~~~~~  312 (969)
                      +|+.++.|.+|+.|+|..|++. .+| .|..+..|++|+++.|+|. .+|.... .+ ++..|||..|++. ..|..++.
T Consensus       198 lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl  273 (565)
T KOG0472|consen  198 LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL  273 (565)
T ss_pred             CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence            8999999999999999999999 667 7999999999999999998 5555444 44 6999999999999 78999999


Q ss_pred             cccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccC-----------------------
Q 002085          313 LKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSG-----------------------  369 (969)
Q Consensus       313 l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-----------------------  369 (969)
                      +++|.+||+++|.|+                  .+|.+++++ .|+.|-+.+|.+..                       
T Consensus       274 LrsL~rLDlSNN~is------------------~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~  334 (565)
T KOG0472|consen  274 LRSLERLDLSNNDIS------------------SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKD  334 (565)
T ss_pred             hhhhhhhcccCCccc------------------cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhcc
Confidence            999999999999999                  567778888 88888888887641                       


Q ss_pred             --------------CCCcc----cccccCCCccccCCCccccccCcccc-----ccccEEEeeccccCCCcccccCCccc
Q 002085          370 --------------ELPTG----LWTTFNLSSLMLSDNTISGELPSKTA-----WNLTRLEISNNRFSGQIQRGVGSWKN  426 (969)
Q Consensus       370 --------------~~p~~----~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~~L~~L~Ls~N~l~~~~~~~~~~l~~  426 (969)
                                    ..|.+    ...+-+.+.|++++-+++ .+|...+     .-.+..+++.|++. .+|..+..++.
T Consensus       335 dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lke  412 (565)
T KOG0472|consen  335 DGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKE  412 (565)
T ss_pred             CCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHH
Confidence                          00111    112345677788887777 4454322     23778999999998 67777877777


Q ss_pred             chh-hcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEecc
Q 002085          427 LIV-FKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLS  505 (969)
Q Consensus       427 L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  505 (969)
                      +.+ +.+++|.++ .+|..+..+++|..|+|++|-+. .+|.+++.+..|+.||+|.|++. .+|..+..+..|+.+-.+
T Consensus       413 lvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas  489 (565)
T KOG0472|consen  413 LVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLAS  489 (565)
T ss_pred             HHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhc
Confidence            665 556666665 99999999999999999999998 89999999999999999999998 899999999999999999


Q ss_pred             CccccccCCCcccccc-ccEEEeecCcCCCCCCcccccccccc
Q 002085          506 GNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNLAYDD  547 (969)
Q Consensus       506 ~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~~~~~~~~~  547 (969)
                      +|++...-|..+..|+ |.+|||.+|.+. .||+.+++++-..
T Consensus       490 ~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~  531 (565)
T KOG0472|consen  490 NNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLR  531 (565)
T ss_pred             cccccccChHHhhhhhhcceeccCCCchh-hCChhhcccccee
Confidence            9999844444488885 999999999998 7888888776443

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.5e-38  Score=346.08  Aligned_cols=242  Identities=23%  Similarity=0.326  Sum_probs=198.7

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      +.||+|+||.||+|++..+++.||||++...........+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999999989999999999755433334456778888888876 699999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 g~L~~~i~~~~-------------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~  144 (320)
T cd05590          81 GDLMFHIQKSR-------------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK  144 (320)
T ss_pred             chHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCe
Confidence            99999987644             388899999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+.    ....     
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~----~~~~-----  213 (320)
T cd05590         145 EGIFN--GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL----NDEV-----  213 (320)
T ss_pred             ecCcC--CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh----cCCC-----
Confidence            54221  122334579999999999999999999999999999999999999998765443332221    1110     


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKE  916 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e  916 (969)
                            ..+...+..+.+++.+|++.||++||++.+
T Consensus       214 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         214 ------VYPTWLSQDAVDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence                  011122367889999999999999999844

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-38  Score=321.74  Aligned_cols=266  Identities=28%  Similarity=0.353  Sum_probs=212.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-----CCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-----ENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  710 (969)
                      ..|...+.||+|+||.|.+|.+..+|+.||||++..... ..-..++..+|+++++.++|+||+.+.+.+..     -..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~-~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE-NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh-chHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            355557899999999999999999999999999864433 44456788999999999999999999998754     357


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .|+|+|+| +.+|.+.++...             .+....+.-+.+|+++||.|+|+.   +|+||||||+|++++.+..
T Consensus       101 vYiV~elM-etDL~~iik~~~-------------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~  163 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQ-------------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCD  163 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCc-------------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCC
Confidence            89999999 589999998654             388899999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      +||+|||+|+..........++..+.|.+|+|||++. ...|+.+.||||.|||+.||++|+..|.|.+.......+...
T Consensus       164 lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~  243 (359)
T KOG0660|consen  164 LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL  243 (359)
T ss_pred             EEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence            9999999999886543445567888999999999865 467999999999999999999999999887755444444332


Q ss_pred             hhccCC----------chhhhc---cCCCCc---ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          870 YAEEKP----------ITDALD---KGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       870 ~~~~~~----------~~~~~~---~~~~~~---~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .....+          ....+.   ..-..+   ..........+++.+|+..||.+|+|++|+++
T Consensus       244 lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  244 LGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             cCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            211110          001111   000000   01123467889999999999999999999987

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.6e-37  Score=334.52  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=207.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEc---CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++|+..+.||+|+||.||+|.+.   ..+..||+|.++...  .......+.+|+.++++++||||+++++++..++..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            46888899999999999999764   346689999986542  2334567999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++|+|.+++....            ..++|..++.++.|++.|++|||+.   +++||||||+||+++.++.++
T Consensus        83 lv~e~~~~~~L~~~l~~~~------------~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~  147 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE------------GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCK  147 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEE
Confidence            9999999999999997543            2488999999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      ++|||.+...... .........++..|+|||.+.+..++.++|||||||++||+++ |..||.........+.+.    
T Consensus       148 l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~----  222 (266)
T cd05064         148 ISGFRRLQEDKSE-AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE----  222 (266)
T ss_pred             ECCCccccccccc-chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH----
Confidence            9999987653221 1111122345678999999999999999999999999999875 888987665443333221    


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      ..          ...+.+...+..+.+++.+||+.+|++||++.||.+.|.+.
T Consensus       223 ~~----------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         223 DG----------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CC----------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            11          11112233456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-38  Score=351.85  Aligned_cols=257  Identities=26%  Similarity=0.310  Sum_probs=210.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||+||+|++..+++.||+|+++............+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999999899999999997654433345678899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~D  144 (350)
T cd05573          81 EYMPGGDLMNLLIRKD-------------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLAD  144 (350)
T ss_pred             cCCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeec
Confidence            9999999999998653             388899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCC---------------------------CCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHH
Q 002085          796 FGLAKMLAKQG---------------------------EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELV  848 (969)
Q Consensus       796 fgla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell  848 (969)
                      ||+++.+....                           .........||+.|+|||++.+..++.++|||||||++|||+
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  224 (350)
T cd05573         145 FGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML  224 (350)
T ss_pred             CCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhc
Confidence            99998664332                           011223456899999999999999999999999999999999


Q ss_pred             hCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 002085          849 TGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-MKEVLQI  920 (969)
Q Consensus       849 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~~  920 (969)
                      +|+.||...........+..    ..       .....+.....+..+.+++.+|+. ||.+||+ +.|+++.
T Consensus       225 ~g~~Pf~~~~~~~~~~~i~~----~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         225 YGFPPFYSDTLQETYNKIIN----WK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             cCCCCCCCCCHHHHHHHHhc----cC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            99999987653322221111    00       001111111134678899999997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.3e-37  Score=349.52  Aligned_cols=256  Identities=20%  Similarity=0.259  Sum_probs=203.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      .|+..+.||+|+||+||+|++..+++.||+|++.............+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            57888999999999999999999999999999976544445556789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        82 ~~~gg~L~~~l~~~~-------------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DF  145 (381)
T cd05626          82 YIPGGDMMSLLIRME-------------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDF  145 (381)
T ss_pred             cCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeC
Confidence            999999999997643             378889999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCC---------------------------------------------ccccccccCcccCchhhcccCCC
Q 002085          797 GLAKMLAKQGEP---------------------------------------------HTMSAVAGSFGYFAPEYAYTTKV  831 (969)
Q Consensus       797 gla~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~  831 (969)
                      |+++.+......                                             .......||+.|+|||++.+..+
T Consensus       146 Gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  225 (381)
T cd05626         146 GLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY  225 (381)
T ss_pred             cCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC
Confidence            997643210000                                             00123469999999999999899


Q ss_pred             CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHH--ccCCCCC
Q 002085          832 NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALI--CTSTLPS  909 (969)
Q Consensus       832 ~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--cl~~dP~  909 (969)
                      +.++||||+||++|||++|..||...........+..   ...        ....+.....+.++.+++.+  |+..+|.
T Consensus       226 ~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~---~~~--------~~~~~~~~~~s~~~~dli~~ll~~~~~~~  294 (381)
T cd05626         226 TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVIN---WEN--------TLHIPPQVKLSPEAVDLITKLCCSAEERL  294 (381)
T ss_pred             CCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHc---ccc--------ccCCCCCCCCCHHHHHHHHHHccCccccc
Confidence            9999999999999999999999987654332221110   000        00111111233567788877  5556666


Q ss_pred             CCCCHHHHHH
Q 002085          910 SRPSMKEVLQ  919 (969)
Q Consensus       910 ~RPs~~evl~  919 (969)
                      .||++.|++.
T Consensus       295 ~R~~~~~~l~  304 (381)
T cd05626         295 GRNGADDIKA  304 (381)
T ss_pred             CCCCHHHHhc
Confidence            7999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=338.82  Aligned_cols=257  Identities=26%  Similarity=0.366  Sum_probs=216.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +.+..++||-|.||.||.|.|+...-.||||.++.+.    -..++|..|+.+|+.++|||+|+++|+|..+...|||+|
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            4566789999999999999999888899999985532    235789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      ||.+|+|.+||++..+.           -++-...+.||.||++||+||..+   .+|||||.++|.|+.++..||++||
T Consensus       344 fM~yGNLLdYLRecnr~-----------ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADF  409 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRS-----------EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADF  409 (1157)
T ss_pred             cccCccHHHHHHHhchh-----------hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeecc
Confidence            99999999999987753           244556789999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCC
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      |+++.+..+. +.......-.+.|.|||.+....++-|+|||+|||+|||+.| |..||-+-+...              
T Consensus       410 GLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq--------------  474 (1157)
T KOG4278|consen  410 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------  474 (1157)
T ss_pred             chhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH--------------
Confidence            9999874431 111222234678999999999999999999999999999999 666766554332              


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      +.+.++.+.+...+..|++.++++|+.||++.|++||+++|+-+.++.+-.
T Consensus       475 VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  475 VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            234455566666777788999999999999999999999999998877643

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.3e-37  Score=340.93  Aligned_cols=260  Identities=22%  Similarity=0.346  Sum_probs=208.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcE----EEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEF----VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .+|+..+.||+|+||.||+|.+..+++.    ||+|+++..  ......+.+.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            4688899999999999999998665553    899988543  2234457789999999999999999999998764 57


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++|+||+++|+|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~  148 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHV  148 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc------------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcE
Confidence            89999999999999998643            2478899999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.+..........    
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~----  224 (316)
T cd05108         149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----  224 (316)
T ss_pred             EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence            9999999987654332222233345678999999999999999999999999999998 88888654433222211    


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPT  927 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  927 (969)
                      ....          ..+.+..+...+.+++.+||..||++||++.+++..+.++...
T Consensus       225 ~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         225 EKGE----------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             hCCC----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            1111          1111222336788999999999999999999999999888643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.3e-37  Score=348.62  Aligned_cols=257  Identities=21%  Similarity=0.259  Sum_probs=206.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||.||+|+...+++.||+|++...........+.+.+|+++++.++||||+++++++.++...|+|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            35788899999999999999999999999999999654333334456688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++|+|.+++...              .++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       122 ~Ey~~gg~L~~~l~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~  184 (370)
T cd05596         122 MEYMPGGDLVNLMSNY--------------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA  184 (370)
T ss_pred             EcCCCCCcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEE
Confidence            9999999999998643              267788889999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccC----CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT----KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |||+++....... .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||.+.+.......+.   
T Consensus       185 DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~---  260 (370)
T cd05596         185 DFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM---  260 (370)
T ss_pred             eccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH---
Confidence            9999986543221 122345799999999998653    47889999999999999999999998765433222221   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS--RPSMKEVLQI  920 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~  920 (969)
                       ....       ....+.....+..+.+++.+|++.+|.+  ||++.|+++.
T Consensus       261 -~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         261 -DHKN-------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -cCCC-------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence             1100       0111111223467889999999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-38  Score=308.47  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=218.0

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccch-----hcHHHHHHHHHHHHHHhcc-ccCceeeEEEE
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-----LNQKLEKEFIAEIEILGTI-RHANIVKLWCC  704 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  704 (969)
                      .+.+...|...+.||.|..++|.++....+|..+|+|++.....     ...+..++-.+|++|++++ .||+|+++.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            34567789999999999999999999999999999999853221     1344567788999999999 69999999999


Q ss_pred             EEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          705 ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       705 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                      ++.+...++|+|.|+.|.|.|++...-             .+++....+|+.|+..|++|||..   .||||||||+|||
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~V-------------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENIL  155 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKV-------------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENIL  155 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhhe-------------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhhee
Confidence            999999999999999999999998653             488999999999999999999998   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT------TKVNEKIDIYSFGVVLLELVTGKEANYGDE  858 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~il~elltg~~p~~~~~  858 (969)
                      +|++.++||+|||+|+.+.++   ......+|||+|.|||.+..      ..|+...|+||+||++|.++.|.+||+...
T Consensus       156 lddn~~i~isDFGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk  232 (411)
T KOG0599|consen  156 LDDNMNIKISDFGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK  232 (411)
T ss_pred             eccccceEEeccceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence            999999999999999987543   34456789999999998863      357788999999999999999999998654


Q ss_pred             ccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          859 HTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .-.+.+.+.+    ++       -.+..+.+.+.+..+.+++.+|++.||.+|.|++|+++
T Consensus       233 QmlMLR~Ime----Gk-------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  233 QMLMLRMIME----GK-------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHHHHh----cc-------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            3332222211    11       12345667778889999999999999999999999985

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.4e-38  Score=322.97  Aligned_cols=261  Identities=30%  Similarity=0.355  Sum_probs=204.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC-----c
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN-----S  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  710 (969)
                      -.|...+++|.|+||.||+|....+++.||||++..+..       ---+|+++|+.++|||||++.-+|....     .
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            357778999999999999999999999999999976543       2346899999999999999998875422     3


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC-C
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-F  789 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~  789 (969)
                      ..+|||||| .+|+++++.....         ...++.-.+.-++.|+.+||+|||+.   +|+||||||.|+|+|.+ |
T Consensus        97 lnlVleymP-~tL~~~~r~~~~~---------~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg  163 (364)
T KOG0658|consen   97 LNLVLEYMP-ETLYRVIRHYTRA---------NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTG  163 (364)
T ss_pred             HHHHHHhch-HHHHHHHHHHhhc---------CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCC
Confidence            358999997 7999999853211         23477778889999999999999987   99999999999999987 8


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      .+||||||.|+.+..+...   .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.|++..+....+.+
T Consensus       164 ~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik  240 (364)
T KOG0658|consen  164 VLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIK  240 (364)
T ss_pred             eEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHH
Confidence            9999999999988654322   446788999999998875 699999999999999999999999998776655555444


Q ss_pred             HhhccCC--c-------hhhhccCCCC-----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKP--I-------TDALDKGIAE-----PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~--~-------~~~~~~~~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+.-...  +       .+.-.+.+..     -.......+.++++.+++..+|.+|.++.|++.
T Consensus       241 ~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  241 VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            3321110  0       0000111111     122334578999999999999999999999984

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-37  Score=333.77  Aligned_cols=252  Identities=35%  Similarity=0.517  Sum_probs=197.4

Q ss_pred             ccceeeecCcEEEEEEEEc----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          640 ESNLIGSGGSGQVYRIDIN----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       640 ~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ..+.||.|.||.||+|.+.    ..+..|+||.++..  ......+.+.+|++.+++++||||++++|++...+..++||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence            3578999999999999997    34668999999442  23444788999999999999999999999999888899999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++.....           ..+++..+.+|+.|++.||+|||+.   +++|+||+++||++++++.+||+|
T Consensus        81 e~~~~g~L~~~L~~~~~-----------~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~  146 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNK-----------EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSD  146 (259)
T ss_dssp             E--TTEBHHHHHHHTCT-----------TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEES
T ss_pred             ccccccccccccccccc-----------ccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            99999999999998621           3489999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||++................+...|+|||.+.+..++.++||||||+++|||++ |+.|+...........+    ....
T Consensus       147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~----~~~~  222 (259)
T PF07714_consen  147 FGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL----KQGQ  222 (259)
T ss_dssp             TTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH----HTTE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccc
Confidence            999987633222223334457789999999999999999999999999999999 56777655433322222    1111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                                ..+.+...+..+++++..||+.||++||++.|+++.|
T Consensus       223 ----------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 ----------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                      1111222346789999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.5e-37  Score=329.36  Aligned_cols=265  Identities=22%  Similarity=0.331  Sum_probs=214.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|+...+++.||||.+.............+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999998899999999886544444555678899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++......         ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++|
T Consensus        82 e~~~~~~L~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d  149 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQ---------KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             EecCCCcHHHHHHHhhhc---------cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECc
Confidence            999999999988643220         13478889999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||++..+....  .......|++.|+|||.+.+..++.++|+||+|+++|||++|+.||...... ....... ....  
T Consensus       150 ~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~-~~~~--  223 (267)
T cd08228         150 LGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQK-IEQC--  223 (267)
T ss_pred             cccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHH-HhcC--
Confidence            99988754321  1222356888999999999888999999999999999999999998765322 1121111 1110  


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                             ..........+..+.+++.+||..+|++||++.|+++.++++.
T Consensus       224 -------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         224 -------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -------CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                   0011112234467899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.3e-37  Score=337.53  Aligned_cols=266  Identities=20%  Similarity=0.283  Sum_probs=205.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            368889999999999999999998999999999865432 2334567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||++++.+..+....             ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 e~~~~~~l~~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~D  143 (287)
T cd07848          80 EYVEKNMLELLEEMP-------------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCD  143 (287)
T ss_pred             ecCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence            999987776554322             2488899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh----
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA----  871 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~----  871 (969)
                      ||+++..... .........|++.|+|||++.+..++.++||||+||++|||++|+.||.+.........+.....    
T Consensus       144 fg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (287)
T cd07848         144 FGFARNLSEG-SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA  222 (287)
T ss_pred             ccCccccccc-ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCH
Confidence            9999875332 12222345689999999999998999999999999999999999999976543222111111100    


Q ss_pred             -------ccCCchhhhccCCCCc------ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          872 -------EEKPITDALDKGIAEP------CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       872 -------~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                             ..........+.....      .....+..+.+++.+|++.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                   0000000000000000      01113467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.6e-37  Score=341.18  Aligned_cols=243  Identities=21%  Similarity=0.282  Sum_probs=196.9

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      ++||+|+||.||+|++..+++.||+|+++..........+.+.+|..++..+ +||||+++++++.+....|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999999999999999999765444444556788999999998 799999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 g~L~~~~~~~~-------------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  144 (329)
T cd05588          81 GDLMFHMQRQR-------------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK  144 (329)
T ss_pred             CCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccc
Confidence            99999887543             388999999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCc-----cchHHHHHHHhhccCC
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH-----TSLAEWAWRHYAEEKP  875 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~  875 (969)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .....+..+...... 
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-  221 (329)
T cd05588         145 EGIRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-  221 (329)
T ss_pred             ccccC--CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-
Confidence            43221  1222345789999999999999999999999999999999999999963211     111122222221111 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS  913 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs  913 (969)
                              ..  .+...+..+.+++.+|++.||++||+
T Consensus       222 --------~~--~p~~~~~~~~~li~~~L~~dP~~R~~  249 (329)
T cd05588         222 --------IR--IPRSLSVKASSVLKGFLNKDPKERLG  249 (329)
T ss_pred             --------CC--CCCCCCHHHHHHHHHHhccCHHHcCC
Confidence                    11  11223367889999999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.8e-37  Score=334.19  Aligned_cols=265  Identities=24%  Similarity=0.324  Sum_probs=205.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||.||+|....+++.||+|+++....  ......+.+|++++++++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            4579999999999999999999998999999999864322  22235678899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++ ++|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        82 ~e~~~-~~l~~~l~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~  145 (288)
T cd07871          82 FEYLD-SDLKQYLDNCG------------NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLA  145 (288)
T ss_pred             EeCCC-cCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEC
Confidence            99997 59999887543            2378889999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++.....  ........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+..+....+.+.....
T Consensus       146 DfG~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  223 (288)
T cd07871         146 DFGLARAKSVP--TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP  223 (288)
T ss_pred             cCcceeeccCC--CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999764322  122234568999999998865 568999999999999999999999998765443333332221110


Q ss_pred             -----------CCchhhhccCCCCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 -----------KPITDALDKGIAEPC----YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 -----------~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                 ........+......    ......+..+++.+|++.||.+|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         224 TEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                       000011111000000    0112356789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=328.23  Aligned_cols=269  Identities=23%  Similarity=0.304  Sum_probs=215.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +.|+.-++||+||||.||.++...+|+.||+|.+.+.+......+.....|..|+.+++.+.||.+-.+|+.++..++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45667789999999999999999999999999998777766777788999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ..|.||+|.-++...+.           ..++++.+..+|.+|+.||++||+.   +||+||+||+|||+|+.|+|+|+|
T Consensus       265 tlMNGGDLkfHiyn~g~-----------~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISD  330 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-----------PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISD  330 (591)
T ss_pred             EeecCCceeEEeeccCC-----------CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeec
Confidence            99999999999987763           4599999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      +|+|..+...   ......+||.+|||||++....|+...|.||+||++|||+.|+.||.......-.+.+.+...+.  
T Consensus       331 LGLAvei~~g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--  405 (591)
T KOG0986|consen  331 LGLAVEIPEG---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--  405 (591)
T ss_pred             cceEEecCCC---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--
Confidence            9999887432   23344589999999999999999999999999999999999999996432211111111111100  


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCc-ccccCCCCCCCCCcccc
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGK-KMGRDVDSAPLLGTAGY  950 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  950 (969)
                               ...++...+++..++....+.+||++|                  .|.. +...++++||+|++.+|
T Consensus       406 ---------~~ey~~kFS~eakslc~~LL~Kdp~~R------------------LGcrg~ga~evk~HpfFk~lnw  454 (591)
T KOG0986|consen  406 ---------PEEYSDKFSEEAKSLCEGLLTKDPEKR------------------LGCRGEGAQEVKEHPFFKDLNW  454 (591)
T ss_pred             ---------hhhcccccCHHHHHHHHHHHccCHHHh------------------ccCCCcCcchhhhCcccccCCH
Confidence                     111223333444455555555555544                  5555 46789999999995443

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.2e-37  Score=345.98  Aligned_cols=257  Identities=21%  Similarity=0.279  Sum_probs=204.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||.||+|++..+++.||+|++.............+.+|+++++.++||||+++++++.+++..|+|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            35789999999999999999999999999999998654333344456788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++|+|.+++...              .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+
T Consensus       122 ~Ey~~gg~L~~~l~~~--------------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~  184 (370)
T cd05621         122 MEYMPGGDLVNLMSNY--------------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLA  184 (370)
T ss_pred             EcCCCCCcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEE
Confidence            9999999999999643              267888999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCC----CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK----VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |||++..+.... ........||+.|+|||++.+..    ++.++||||+||++|||++|+.||.+.........+..  
T Consensus       185 DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~--  261 (370)
T cd05621         185 DFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD--  261 (370)
T ss_pred             ecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh--
Confidence            999998764321 11223457999999999987543    78899999999999999999999987654332222111  


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS--RPSMKEVLQI  920 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~  920 (969)
                       ...        ....+.....+..+.+++..|+..+|.+  |+++.|+++.
T Consensus       262 -~~~--------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         262 -HKN--------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -CCc--------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence             000        0111112223467788999999855544  8899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-37  Score=349.00  Aligned_cols=256  Identities=23%  Similarity=0.299  Sum_probs=206.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||.||+|++..+++.||||++.............+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36888999999999999999999999999999996544333445567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|
T Consensus        81 E~~~~g~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  144 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-------------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSD  144 (364)
T ss_pred             CCCCCcHHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEee
Confidence            9999999999997643             388899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCc------------------------------------cccccccCcccCchhhcccCCCCCccchhh
Q 002085          796 FGLAKMLAKQGEPH------------------------------------TMSAVAGSFGYFAPEYAYTTKVNEKIDIYS  839 (969)
Q Consensus       796 fgla~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvws  839 (969)
                      ||+++.+.......                                    ......||+.|+|||++.+..++.++||||
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  224 (364)
T cd05599         145 FGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS  224 (364)
T ss_pred             cccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeec
Confidence            99987643211000                                    011246999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC---HHH
Q 002085          840 FGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS---MKE  916 (969)
Q Consensus       840 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~e  916 (969)
                      +||++|||++|..||.+.........+.    ....       ....+.....+..+.+++.+|+. +|.+|++   +.|
T Consensus       225 lG~il~el~~G~~Pf~~~~~~~~~~~i~----~~~~-------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~  292 (364)
T cd05599         225 LGVIMYEMLVGYPPFCSDNPQETYRKII----NWKE-------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE  292 (364)
T ss_pred             chhHHHHhhcCCCCCCCCCHHHHHHHHH----cCCC-------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence            9999999999999998765433222221    1000       00111111223577889999996 9999997   888


Q ss_pred             HHH
Q 002085          917 VLQ  919 (969)
Q Consensus       917 vl~  919 (969)
                      +++
T Consensus       293 ll~  295 (364)
T cd05599         293 IKS  295 (364)
T ss_pred             Hhc
Confidence            876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.5e-37  Score=344.72  Aligned_cols=246  Identities=25%  Similarity=0.331  Sum_probs=202.6

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQ  721 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  721 (969)
                      +.||+|+||.||++++..+++.||+|++.............+..|+++++.++||||+++.+++.+.+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999899999999997654434444567888999999999999999999999999999999999999


Q ss_pred             CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          722 SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       722 sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      +|.+++....             .+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~  144 (325)
T cd05594          81 ELFFHLSRER-------------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK  144 (325)
T ss_pred             cHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCe
Confidence            9999887543             38899999999999999999996 5   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      .....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.   ....      
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~---~~~~------  213 (325)
T cd05594         145 EGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---MEEI------  213 (325)
T ss_pred             ecCCC--CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh---cCCC------
Confidence            54221  122234569999999999999999999999999999999999999997655433222221   1110      


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQI  920 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~  920 (969)
                            ..+......+.+++.+|++.||++|+     ++.++++.
T Consensus       214 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 ------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                  01112336788999999999999996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.6e-37  Score=341.60  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=200.2

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHH---hccccCceeeEEEEEEcCCceEEE
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL---GTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      |++.+.||+|+||.||+|.+..+++.||||+++..........+.+.+|++++   +.++||||+++++++.+++..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            56778999999999999999999999999999765433334456677777665   456799999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|..+++..              .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        81 ~E~~~~~~L~~~~~~~--------------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~  143 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--------------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIA  143 (324)
T ss_pred             EcCCCCCcHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeC
Confidence            9999999999888642              388999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+++....  .........|++.|+|||.+.+..++.++|||||||++|||++|+.||.+.+.......+.    ...
T Consensus       144 Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~----~~~  217 (324)
T cd05589         144 DFGLCKEGMG--FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV----NDE  217 (324)
T ss_pred             cccCCccCCC--CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCC
Confidence            9999875322  1222334679999999999999999999999999999999999999998765433322211    110


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-----MKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~  919 (969)
                               .  ..+...+..+.+++.+||+.||++||+     +.++++
T Consensus       218 ---------~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 ---------V--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ---------C--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                     0  011223467889999999999999994     555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-37  Score=349.56  Aligned_cols=257  Identities=19%  Similarity=0.246  Sum_probs=204.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||.||+|+...+++.||||++...........+.+.+|++++++++||||+++++++.++...|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888999999999999999999999999999986544334445677899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~D  144 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-------------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSD  144 (377)
T ss_pred             eCCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEee
Confidence            9999999999997543             378889999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCC-----------c----------------------------------cccccccCcccCchhhcccCC
Q 002085          796 FGLAKMLAKQGEP-----------H----------------------------------TMSAVAGSFGYFAPEYAYTTK  830 (969)
Q Consensus       796 fgla~~~~~~~~~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~  830 (969)
                      ||+++.+......           .                                  ......||+.|+|||++.+..
T Consensus       145 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  224 (377)
T cd05629         145 FGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG  224 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC
Confidence            9999643221000           0                                  001246999999999999999


Q ss_pred             CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCC
Q 002085          831 VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS  910 (969)
Q Consensus       831 ~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~  910 (969)
                      ++.++||||+||++|||++|..||.+.........+..   ...        ....+.....+..+.+++.+|+. +|.+
T Consensus       225 ~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~--------~~~~p~~~~~s~~~~dli~~lL~-~~~~  292 (377)
T cd05629         225 YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIIN---WRE--------TLYFPDDIHLSVEAEDLIRRLIT-NAEN  292 (377)
T ss_pred             CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHc---cCC--------ccCCCCCCCCCHHHHHHHHHHhc-CHhh
Confidence            99999999999999999999999976654332222111   000        00111111233678899999997 6766


Q ss_pred             C---CCHHHHHHH
Q 002085          911 R---PSMKEVLQI  920 (969)
Q Consensus       911 R---Ps~~evl~~  920 (969)
                      |   +++.|+++.
T Consensus       293 r~~r~~~~~~l~h  305 (377)
T cd05629         293 RLGRGGAHEIKSH  305 (377)
T ss_pred             cCCCCCHHHHhcC
Confidence            5   599998864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.1e-37  Score=342.93  Aligned_cols=246  Identities=22%  Similarity=0.317  Sum_probs=200.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +|+..+.||+|+||+||+|+...+|+.||+|++...........+.+..|.++++.+. |++|+++.+++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999999999999999997654333444567888999998885 678888999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 Ey~~~g~L~~~i~~~~-------------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~D  144 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-------------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIAD  144 (323)
T ss_pred             cCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEec
Confidence            9999999999987543             388999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+++.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+..   ... 
T Consensus       145 fg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~---~~~-  218 (323)
T cd05615         145 FGMCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME---HNV-  218 (323)
T ss_pred             cccccccCCC--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCC-
Confidence            9998754221  1122345689999999999999999999999999999999999999987654433332221   110 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK  915 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~  915 (969)
                                 ..+...+..+.+++.+|++.||++|++..
T Consensus       219 -----------~~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         219 -----------SYPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             -----------CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence                       11122336788999999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=353.34  Aligned_cols=261  Identities=24%  Similarity=0.298  Sum_probs=216.6

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEE-EEc------C
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCC-ISS------E  708 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~  708 (969)
                      ++++.+.|.+|||+.||.|++...|..||+|++...   ++...+.+.+|+++|+.|+ |+|||.+++. ...      .
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            567789999999999999999988799999998543   6677889999999999996 9999999993 211      2


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      .+++|.||||+||.|-+++..+..           ..+.+.++++|+.|+++|+++||.. .++|+|||||-+|||++.+
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq-----------~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~  182 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQ-----------TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSAD  182 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHh-----------ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCC
Confidence            467899999999999999997653           3499999999999999999999987 7889999999999999999


Q ss_pred             CcEEEeecccceecccCCC-Cccc------cccccCcccCchhhc---ccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002085          789 FKAKIADFGLAKMLAKQGE-PHTM------SAVAGSFGYFAPEYA---YTTKVNEKIDIYSFGVVLLELVTGKEANYGDE  858 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~-~~~~------~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~elltg~~p~~~~~  858 (969)
                      +..||||||.|........ ....      -...-|+.|+|||.+   .+...++|+||||+||+||-|+....||....
T Consensus       183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg  262 (738)
T KOG1989|consen  183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG  262 (738)
T ss_pred             CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence            9999999999975433221 1111      012468999999976   46789999999999999999999999997643


Q ss_pred             ccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCC
Q 002085          859 HTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTEN  929 (969)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  929 (969)
                      .                 ..++......|.....+..+.+||+.||+.||.+||++.++++.+.++..++.
T Consensus       263 ~-----------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  263 K-----------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             c-----------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence            2                 23444455555566788999999999999999999999999999888765443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-39  Score=343.35  Aligned_cols=387  Identities=24%  Similarity=0.214  Sum_probs=289.9

Q ss_pred             EEEccCCCCCCCCCcccCCC--CCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceeccc
Q 002085          101 TIDLSSNSIPGEFPEFLYNC--TKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYM  178 (969)
Q Consensus       101 ~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  178 (969)
                      .||.+++.+.......+..+  +.-+.||||+|+++.+-+..|.++++|+.+++..|.++ .||...+...+|+.|+|.+
T Consensus        56 lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~  134 (873)
T KOG4194|consen   56 LLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRH  134 (873)
T ss_pred             eeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeec
Confidence            45555555543222222111  33567999999999888888899999999999999998 8888777777799999999


Q ss_pred             ccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCC
Q 002085          179 NEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGA  258 (969)
Q Consensus       179 N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  258 (969)
                      |.|+..-.+.+..++.|+.||||.|.+.  .+...+|..-.+                        +++|+|++|+|+..
T Consensus       135 N~I~sv~se~L~~l~alrslDLSrN~is--~i~~~sfp~~~n------------------------i~~L~La~N~It~l  188 (873)
T KOG4194|consen  135 NLISSVTSEELSALPALRSLDLSRNLIS--EIPKPSFPAKVN------------------------IKKLNLASNRITTL  188 (873)
T ss_pred             cccccccHHHHHhHhhhhhhhhhhchhh--cccCCCCCCCCC------------------------ceEEeecccccccc
Confidence            9998777788888889999999888522  112223444444                        44555555555444


Q ss_pred             CCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccc
Q 002085          259 IPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVV  337 (969)
Q Consensus       259 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  337 (969)
                      -...|..+.+|..|.|++|+++..++..|..+ +|+.|+|..|+|.-.---.|.++++|+.|.|..|.++.-        
T Consensus       189 ~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL--------  260 (873)
T KOG4194|consen  189 ETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKL--------  260 (873)
T ss_pred             ccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccc--------
Confidence            44444444455555555555554444444433 455555555555533244677888888888888887721        


Q ss_pred             cccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCc--cccccccEEEeeccccCC
Q 002085          338 AFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPS--KTAWNLTRLEISNNRFSG  415 (969)
Q Consensus       338 ~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~~~L~~L~Ls~N~l~~  415 (969)
                               --..|-.|.++++|+|+.|+++..-..+++.+..|+.|+||.|.|...-+.  .+..+|++|+|++|+|+.
T Consensus       261 ---------~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~  331 (873)
T KOG4194|consen  261 ---------DDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITR  331 (873)
T ss_pred             ---------cCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccccccc
Confidence                     112466788888888888888877778889999999999999998865554  345789999999999999


Q ss_pred             CcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCc---ccccccCCCEEEccCccccCCCCcc
Q 002085          416 QIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPS---QIVSWTSLNNLNLARNELSGEIPKA  492 (969)
Q Consensus       416 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~  492 (969)
                      ..++.|..+..|++|+|++|.++......|..+++|+.|||++|.|+..+-+   .|..+++|+.|+|.+|+|....-.+
T Consensus       332 l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krA  411 (873)
T KOG4194|consen  332 LDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRA  411 (873)
T ss_pred             CChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhh
Confidence            9999999999999999999999988888899999999999999999976643   4778999999999999999544578


Q ss_pred             cccccccceEeccCccccccCCCccccccccEEEeecCc
Q 002085          493 IGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNK  531 (969)
Q Consensus       493 ~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~  531 (969)
                      |..+..|+.|||.+|.|...-|..+..+.|+.|-++.-.
T Consensus       412 fsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSss  450 (873)
T KOG4194|consen  412 FSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSS  450 (873)
T ss_pred             hccCcccceecCCCCcceeecccccccchhhhhhhcccc
Confidence            999999999999999999888889999888877765433

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.3e-37  Score=346.88  Aligned_cols=274  Identities=23%  Similarity=0.328  Sum_probs=211.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCC-----CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGA-----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSE  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  708 (969)
                      .++|++.++||+|+||.||+|.+...     +..||||++....  .....+.+.+|+++++++. ||||+++++++.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            35788899999999999999987432     3469999985432  2344578999999999995 99999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCC--------------------------------------------------
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGS--------------------------------------------------  738 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~--------------------------------------------------  738 (969)
                      +..|+||||+++|+|.++++..........                                                  
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            999999999999999999976432100000                                                  


Q ss_pred             ---------------------------------CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE
Q 002085          739 ---------------------------------SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL  785 (969)
Q Consensus       739 ---------------------------------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill  785 (969)
                                                       .......+++..+..++.|++.|++|||+.   +|+||||||+||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence                                             000113478899999999999999999988   99999999999999


Q ss_pred             CCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHH
Q 002085          786 DSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAE  864 (969)
Q Consensus       786 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~  864 (969)
                      +.++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |+.||........  
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--  348 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--  348 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence            9999999999999987644322222333457788999999999999999999999999999997 8888765422111  


Q ss_pred             HHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                       ........          ...+.+...+..+.+++.+||+.||++||++.++.++|++..+
T Consensus       349 -~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 -FYNKIKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -HHHHHhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence             11111111          1111222344678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-37  Score=319.62  Aligned_cols=270  Identities=25%  Similarity=0.331  Sum_probs=212.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCc-eeeEEEEEEcCC----
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN-IVKLWCCISSEN----  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----  709 (969)
                      ...|...++||+|+||+||+|+...+|+.||+|++.-+... +.......+|+.++++++|+| |+++.+++....    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            45677888999999999999999999999999999655432 223456789999999999999 999999998766    


Q ss_pred             --ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          710 --SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       710 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                        ..++||||++ -+|.+++....+..         ..++...+..++.|+++|++|||++   +|+||||||.||++++
T Consensus        89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~---------~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~  155 (323)
T KOG0594|consen   89 IGKLYLVFEFLD-RDLKKYMDSLPKKP---------QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISS  155 (323)
T ss_pred             cceEEEEEEeec-ccHHHHHHhccccc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECC
Confidence              7899999996 79999998766421         2355578999999999999999999   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      +|.+||+|||+|+.+.-  .....+..++|.+|+|||++.+. .|+...||||+||+++||++++..|.++.+.+....+
T Consensus       156 ~G~lKlaDFGlAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I  233 (323)
T KOG0594|consen  156 SGVLKLADFGLARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI  233 (323)
T ss_pred             CCcEeeeccchHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence            99999999999996532  22335567889999999999887 6899999999999999999999999888775555555


Q ss_pred             HHHhhcc--CCchhhh---cc--CCCCcc-c-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          867 WRHYAEE--KPITDAL---DK--GIAEPC-Y-------LEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       867 ~~~~~~~--~~~~~~~---~~--~~~~~~-~-------~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .+.....  +......   +.  ...... +       .....+..+++.+|++.+|.+|.|++.++++
T Consensus       234 f~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  234 FRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            4433221  1111000   10  111111 1       1111478899999999999999999999875

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9e-37  Score=339.28  Aligned_cols=263  Identities=23%  Similarity=0.334  Sum_probs=205.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||.||+|.+..++..||+|++....  .......+.+|++++++++||||+++++++.+++..++||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            57999999999999999999999899999999886532  2344567999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....             .+++..+..++.|++.|++|||+.  .+|+||||||+||++++++.+||+|
T Consensus        83 e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~D  147 (333)
T cd06650          83 EHMDGGSLDQVLKKAG-------------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCD  147 (333)
T ss_pred             ecCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEee
Confidence            9999999999997543             378889999999999999999963  1799999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||++..+...    ......|+..|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus       148 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  223 (333)
T cd06650         148 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPA  223 (333)
T ss_pred             CCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcc
Confidence            9998765321    223356899999999999989999999999999999999999998755432222111000000000


Q ss_pred             ---------------------------chhhhc---cCCCCcc-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ---------------------------ITDALD---KGIAEPC-YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ---------------------------~~~~~~---~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                                 .....+   ....... ......++.+++.+||+.||++||++.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         224 ESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                       000000   0000000 0012356889999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.8e-37  Score=345.21  Aligned_cols=256  Identities=20%  Similarity=0.213  Sum_probs=208.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|+...+++.||+|+++..........+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999999999999999997654444555678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 e~~~~~~L~~~l~~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~D  145 (330)
T cd05601          81 EYQPGGDLLSLLNRYE------------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLAD  145 (330)
T ss_pred             CCCCCCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEecc
Confidence            9999999999998653            2488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY------TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      ||++..+..... .......||+.|+|||++.      +..++.++|||||||++|||++|+.||...........+.  
T Consensus       146 fg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--  222 (330)
T cd05601         146 FGSAARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM--  222 (330)
T ss_pred             CCCCeECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH--
Confidence            999987643222 2223457899999999986      4567889999999999999999999997655433222111  


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                        .....       ...+.....+..+.+++..|++ +|++||++.+++.
T Consensus       223 --~~~~~-------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         223 --NFQRF-------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             --cCCCc-------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence              11110       0111111234678899999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-36  Score=329.82  Aligned_cols=251  Identities=23%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             eeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCH
Q 002085          644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL  723 (969)
Q Consensus       644 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  723 (969)
                      ||+|+||.||+++...+|+.||+|.+.............+..|++++++++||||+++.+++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999989999999998654333333345667799999999999999999999999999999999999999


Q ss_pred             HHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecc
Q 002085          724 DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA  803 (969)
Q Consensus       724 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  803 (969)
                      .+++.....           ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++....
T Consensus        81 ~~~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~  146 (277)
T cd05607          81 KYHIYNVGE-----------RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK  146 (277)
T ss_pred             HHHHHhccc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecC
Confidence            988865432           3478999999999999999999988   99999999999999999999999999987653


Q ss_pred             cCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccC
Q 002085          804 KQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG  883 (969)
Q Consensus       804 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  883 (969)
                      ..   .......|+..|+|||++.+..++.++||||+||++|||++|+.||...........+.......         .
T Consensus       147 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------~  214 (277)
T cd05607         147 DG---KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED---------E  214 (277)
T ss_pred             CC---ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc---------c
Confidence            22   12234568999999999999899999999999999999999999987543221111111111110         0


Q ss_pred             CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          884 IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       884 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      ... .....+.++.+++.+||+.||++||+++|+++..
T Consensus       215 ~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         215 VKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            000 0112346789999999999999999998887443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.6e-37  Score=339.62  Aligned_cols=245  Identities=23%  Similarity=0.352  Sum_probs=200.9

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      ++||+|+||.||+|++..+++.||+|++...........+.+..|.+++..+ +||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4689999999999999989999999999765443444456778899999876 799999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~  144 (321)
T cd05591          81 GDLMFQIQRSR-------------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK  144 (321)
T ss_pred             CcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccce
Confidence            99999987544             378899999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.    ....     
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~----~~~~-----  213 (321)
T cd05591         145 EGILN--GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL----HDDV-----  213 (321)
T ss_pred             ecccC--CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH----cCCC-----
Confidence            54322  122334568999999999999999999999999999999999999998765443333221    1110     


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHH
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-------SMKEVLQ  919 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-------s~~evl~  919 (969)
                            ..+...+..+.+++.+|++.||++||       ++.++++
T Consensus       214 ------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         214 ------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                  01111236788999999999999999       6666664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.9e-37  Score=330.88  Aligned_cols=246  Identities=21%  Similarity=0.273  Sum_probs=197.0

Q ss_pred             eeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCH
Q 002085          644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL  723 (969)
Q Consensus       644 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  723 (969)
                      ||+|+||+||++.+..+++.||+|.+...........+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999989999999998654433333446788999999999999999999999999999999999999999


Q ss_pred             HHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecc
Q 002085          724 DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA  803 (969)
Q Consensus       724 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  803 (969)
                      .+++.....         ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++..+.
T Consensus        81 ~~~~~~~~~---------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  148 (280)
T cd05608          81 RYHIYNVDE---------ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK  148 (280)
T ss_pred             HHHHHhccc---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence            988854321         123588999999999999999999988   99999999999999999999999999997653


Q ss_pred             cCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccC
Q 002085          804 KQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG  883 (969)
Q Consensus       804 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  883 (969)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..................         ..
T Consensus       149 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------~~  217 (280)
T cd05608         149 DGQ--SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN---------DS  217 (280)
T ss_pred             CCC--ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc---------cC
Confidence            321  1223457899999999999999999999999999999999999999765432211111111111         00


Q ss_pred             CCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          884 IAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       884 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                        ...+...+..+.+++.+||+.||++||++
T Consensus       218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (280)
T cd05608         218 --VTYPDKFSPASKSFCEALLAKDPEKRLGF  246 (280)
T ss_pred             --CCCcccCCHHHHHHHHHHhcCCHHHhcCC
Confidence              01122344678899999999999999944

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.4e-37  Score=340.35  Aligned_cols=245  Identities=20%  Similarity=0.257  Sum_probs=198.5

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      ++||+|+||.||+|+...+++.||+|++...........+.+.+|+.++.++ +||+|+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999765444455567789999999988 699999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....             .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~L~~~~~~~~-------------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~  144 (327)
T cd05617          81 GDLMFHMQRQR-------------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK  144 (327)
T ss_pred             CcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccce
Confidence            99999887543             388999999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCc---cchHHHHHHHhhccCCch
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH---TSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~  877 (969)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....   ..............    
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  218 (327)
T cd05617         145 EGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----  218 (327)
T ss_pred             eccCC--CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----
Confidence            53221  1222345799999999999999999999999999999999999999964321   11122222222111    


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK  915 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~  915 (969)
                           ..  ..+...+..+.+++.+|++.||++|+++.
T Consensus       219 -----~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         219 -----PI--RIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             -----CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence                 11  11222336678999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-36  Score=335.42  Aligned_cols=244  Identities=25%  Similarity=0.390  Sum_probs=197.7

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      +.||+|+||.||+|++..+++.||||+++............+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4689999999999999989999999999664332233345667788888764 899999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 g~L~~~l~~~~-------------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  144 (316)
T cd05619          81 GDLMFHIQSCH-------------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK  144 (316)
T ss_pred             CcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcce
Confidence            99999997543             378899999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.....+.+.    ....     
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~----~~~~-----  213 (316)
T cd05619         145 ENMLG--DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR----MDNP-----  213 (316)
T ss_pred             ECCCC--CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCC-----
Confidence            53221  112234568999999999999999999999999999999999999998765433332221    1110     


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK-EVL  918 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl  918 (969)
                        .    .+......+.+++.+||+.||++||++. ++.
T Consensus       214 --~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         214 --C----YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             --C----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence              0    1111235688999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.7e-37  Score=339.87  Aligned_cols=242  Identities=26%  Similarity=0.351  Sum_probs=195.1

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHH-HHhccccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE-ILGTIRHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      +.||+|+||+||+|++..+|+.||+|++.............+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999986543323333345555554 56788999999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 g~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~  144 (323)
T cd05575          81 GELFFHLQRER-------------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK  144 (323)
T ss_pred             CCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCc
Confidence            99999987543             378889999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      ....  .........||+.|+|||++.+..++.++|||||||++|||++|..||...+.....+.+..   ...      
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~------  213 (323)
T cd05575         145 EGIE--HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN---KPL------  213 (323)
T ss_pred             cccc--CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc---CCC------
Confidence            5322  12223345799999999999999999999999999999999999999987654333222211   100      


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKE  916 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e  916 (969)
                        ..    ....+..+.+++.+|++.||++||++.+
T Consensus       214 --~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (323)
T cd05575         214 --RL----KPNISVSARHLLEGLLQKDRTKRLGAKD  243 (323)
T ss_pred             --CC----CCCCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence              01    1122467889999999999999999853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-36  Score=332.50  Aligned_cols=270  Identities=24%  Similarity=0.395  Sum_probs=211.9

Q ss_pred             cCCCccceeeecCcEEEEEEEE-----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDI-----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ++|.+.+.||+|+||.||++..     ..++..||+|.+...   .....+.+.+|++++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            4688889999999999999985     234567999988543   23445779999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||+++++|.+++..................+++..++.++.|++.||+|||+.   +++||||||+||++++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            9999999999999999986543211111112233589999999999999999999988   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  869 (969)
                      ++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...........+   
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i---  235 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI---  235 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence            99999999986543322222233446788999999998899999999999999999999 78887655433322222   


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                       ......          ..+...+..+.+++.+||+.||.+||++.|+.+.|+++.
T Consensus       236 -~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         236 -TQGRVL----------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             -HcCCcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence             111100          011122357899999999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.2e-37  Score=355.60  Aligned_cols=255  Identities=22%  Similarity=0.277  Sum_probs=206.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCC-CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGA-GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      ..|...+.||+|+||.||+|....+ ++.||+|.+...   .......+.+|+++++.++||||+++++++..++..|+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            3488899999999999999988776 778999976432   234446788899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++|+|.++++....         ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       144 ~E~~~gg~L~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~  211 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLK---------EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLG  211 (478)
T ss_pred             EECCCCCCHHHHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEE
Confidence            999999999998865321         023478889999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.+............   .. 
T Consensus       212 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~---~~-  287 (478)
T PTZ00267        212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY---GK-  287 (478)
T ss_pred             eCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CC-
Confidence            99999876443222233455799999999999999999999999999999999999999976544322222111   10 


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                ..+.+...+..+.+++.+||..||++||++.+++.
T Consensus       288 ----------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        288 ----------YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ----------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                      00112223467899999999999999999999864

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7e-37  Score=343.48  Aligned_cols=251  Identities=28%  Similarity=0.412  Sum_probs=199.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||.||+|++..+++.||||++....  .......+.+|+++++.++|+||+++++++.+.+..++|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            456778899999999999999999899999999985432  334457899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+..                 ...+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       151 ~e~~~~~~L~~~~-----------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~  210 (353)
T PLN00034        151 LEFMDGGSLEGTH-----------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIA  210 (353)
T ss_pred             EecCCCCcccccc-----------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEc
Confidence            9999999986432                 245677889999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-----TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      |||+++.+....  .......||..|+|||++..     ...+.++|||||||++|||++|+.||...............
T Consensus       211 DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~  288 (353)
T PLN00034        211 DFGVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI  288 (353)
T ss_pred             ccccceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence            999998764321  12234578999999998743     23356899999999999999999999744333322222111


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ....           ...........+.+++.+||+.||++||++.|+++.
T Consensus       289 ~~~~-----------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        289 CMSQ-----------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             hccC-----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1110           011122334678999999999999999999999973

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=327.80  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=209.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++|+..+.||+|+||.||+|.+...   ...||||.++...  .......+.+|+.++++++||||+++++++.+.+..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            4688899999999999999998643   4579999885432  3444567899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++++|.+++....            ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++
T Consensus        82 iv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~  146 (266)
T cd05033          82 IITEYMENGSLDKFLREND------------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCK  146 (266)
T ss_pred             EEEEcCCCCCHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEE
Confidence            9999999999999997643            2488999999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      ++|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||...........+.    
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~----  222 (266)
T cd05033         147 VSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE----  222 (266)
T ss_pred             ECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH----
Confidence            999999987752222222223345678999999999999999999999999999998 888886544333222221    


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      ...          ..+.+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       223 ~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         223 DGY----------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             cCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            110          1111223346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.3e-37  Score=328.17  Aligned_cols=256  Identities=25%  Similarity=0.358  Sum_probs=208.3

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      .+|+..++||+|+||.||+|.+..+++.||+|.+...    ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            3577788999999999999999888999999988543    223467889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....           ..+++..++.++.|++.|++|||+.   +++||||||+||++++++.+||+|
T Consensus        82 e~~~~~~L~~~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~d  147 (263)
T cd05052          82 EFMTYGNLLDYLRECNR-----------QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD  147 (263)
T ss_pred             EeCCCCcHHHHHHhCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCC
Confidence            99999999999975432           3488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+........    ... 
T Consensus       148 f~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~----~~~-  221 (263)
T cd05052         148 FGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKG-  221 (263)
T ss_pred             Cccccccccce-eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCC-
Confidence            99998664321 111122334678999999999999999999999999999998 88887665433322221    111 


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                               .....+...+..+.+++.+||+.||++||++.+++++|+.+
T Consensus       222 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 ---------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                     11111223346789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.3e-37  Score=349.42  Aligned_cols=256  Identities=20%  Similarity=0.251  Sum_probs=203.4

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|++.+.||+|+||.||+|+...+++.||||++.............+.+|++++++++||||+++++.+.+++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            68899999999999999999999999999999865433333445678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        82 ~~~~g~L~~~i~~~~-------------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DF  145 (376)
T cd05598          82 YIPGGDMMSLLIRLG-------------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  145 (376)
T ss_pred             CCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999997643             377888899999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCC-----------------------------------------CccccccccCcccCchhhcccCCCCCcc
Q 002085          797 GLAKMLAKQGE-----------------------------------------PHTMSAVAGSFGYFAPEYAYTTKVNEKI  835 (969)
Q Consensus       797 gla~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~s  835 (969)
                      |+|..+.....                                         ........||+.|+|||++.+..++.++
T Consensus       146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  225 (376)
T cd05598         146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC  225 (376)
T ss_pred             CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence            99753311000                                         0011234699999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC---
Q 002085          836 DIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP---  912 (969)
Q Consensus       836 DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP---  912 (969)
                      ||||+||++|||++|+.||.+.........+..    ...       ....+.....+..+.+++.+|+ .+|++|+   
T Consensus       226 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~----~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~  293 (376)
T cd05598         226 DWWSVGVILYEMLVGQPPFLADTPAETQLKVIN----WET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKN  293 (376)
T ss_pred             eeeeccceeeehhhCCCCCCCCCHHHHHHHHhc----cCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence            999999999999999999987654332221110    000       0011111123356677888876 5999999   


Q ss_pred             CHHHHHHH
Q 002085          913 SMKEVLQI  920 (969)
Q Consensus       913 s~~evl~~  920 (969)
                      ++.|+++.
T Consensus       294 t~~ell~h  301 (376)
T cd05598         294 GADEIKAH  301 (376)
T ss_pred             CHHHHhCC
Confidence            88988853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-36  Score=329.54  Aligned_cols=258  Identities=24%  Similarity=0.320  Sum_probs=205.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCc----EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGE----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ++|+..+.||+|+||.||+|.+..+++    .|++|.+...  .......++..|+.++++++||||+++++++.+ ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            467888999999999999999976666    4777776422  223344678889999999999999999998754 557


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++++||+++|+|.+++....            ..++|..+..++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~  148 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHR------------DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIV  148 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcE
Confidence            89999999999999997643            2488999999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+++...............++..|+|||.+.++.++.++|||||||++||+++ |..||.+.......+.+.   
T Consensus       149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---  225 (279)
T cd05111         149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---  225 (279)
T ss_pred             EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---
Confidence            9999999987644333333344567789999999998899999999999999999998 888887655433322221   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                       ....          .+.+..+...+.+++.+||..||++||++.|+++.|..+.
T Consensus       226 -~~~~----------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         226 -KGER----------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             -CCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence             1111          0111112356788999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.9e-37  Score=325.78  Aligned_cols=251  Identities=27%  Similarity=0.363  Sum_probs=200.7

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQ  721 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  721 (969)
                      +.||+|+||.||+|++..+++.||+|.+...  ........+.+|++++++++||||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            4689999999999999889999999987533  23445578999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          722 SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       722 sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                      +|.+++....            ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+|++|||++..
T Consensus        79 ~L~~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  143 (252)
T cd05084          79 DFLTFLRTEG------------PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE  143 (252)
T ss_pred             cHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcc
Confidence            9999997533            2378999999999999999999988   999999999999999999999999999875


Q ss_pred             cccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       802 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      ...............+..|+|||.+.++.++.++||||+||++|||++ |..||...........+    .         
T Consensus       144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~----~---------  210 (252)
T cd05084         144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI----E---------  210 (252)
T ss_pred             cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH----H---------
Confidence            432111111111223467999999999999999999999999999998 77777544332211111    1         


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                       .....+.+...+..+.+++.+|++.+|++||++.|+.++|++
T Consensus       211 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         211 -QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             -cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence             111112222334678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3e-37  Score=347.39  Aligned_cols=255  Identities=22%  Similarity=0.292  Sum_probs=201.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|+...+++.||+|++.............+.+|++++..++||+|+++++++.+++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999999999999999996544334455678899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|
T Consensus        81 E~~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~D  144 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-------------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSD  144 (360)
T ss_pred             eCCCCccHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEee
Confidence            9999999999997643             378899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCC---------------------------------ccccccccCcccCchhhcccCCCCCccchhhHHH
Q 002085          796 FGLAKMLAKQGEP---------------------------------HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGV  842 (969)
Q Consensus       796 fgla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~  842 (969)
                      ||+++.+......                                 .......||+.|+|||++.+..++.++||||+||
T Consensus       145 fG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv  224 (360)
T cd05627         145 FGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV  224 (360)
T ss_pred             ccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccc
Confidence            9998754321100                                 0012346999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC---HHHHH
Q 002085          843 VLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS---MKEVL  918 (969)
Q Consensus       843 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs---~~evl  918 (969)
                      ++|||++|+.||.+.........+.    ....       ....+.....+..+.+++.+|+ .||.+|++   +.|++
T Consensus       225 ilyel~tG~~Pf~~~~~~~~~~~i~----~~~~-------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  291 (360)
T cd05627         225 IMYEMLIGYPPFCSETPQETYRKVM----NWKE-------TLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK  291 (360)
T ss_pred             eeeecccCCCCCCCCCHHHHHHHHH----cCCC-------ceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence            9999999999998765433322221    1000       0000001112356777888766 49999986   44544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.2e-37  Score=354.47  Aligned_cols=260  Identities=25%  Similarity=0.286  Sum_probs=209.9

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN----  709 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  709 (969)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.++..++|+|++++.+.+...+    
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34689999999999999999999998999999999865432 3344567889999999999999999987765332    


Q ss_pred             ----ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE
Q 002085          710 ----SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL  785 (969)
Q Consensus       710 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill  785 (969)
                          ..++||||+++|+|.+++......         ...+++..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~---------~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl  176 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKT---------NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILL  176 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEE
Confidence                367999999999999999754321         23588899999999999999999988   99999999999999


Q ss_pred             CCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          786 DSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       786 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      +.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........
T Consensus       177 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~  256 (496)
T PTZ00283        177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK  256 (496)
T ss_pred             eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            99999999999999876543223333456799999999999999999999999999999999999999976543322221


Q ss_pred             HHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .   ....           ..+.+...+..+.+++.+||+.||++||++.++++.
T Consensus       257 ~---~~~~-----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 T---LAGR-----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             H---hcCC-----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1   1110           111222334678999999999999999999999863

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.1e-37  Score=338.66  Aligned_cols=245  Identities=25%  Similarity=0.347  Sum_probs=201.5

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      +.||+|+||.||+|++..+++.||||+++............+..|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999989999999999765433444456778899999888 799999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++
T Consensus        81 ~~L~~~~~~~~-------------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  144 (318)
T cd05570          81 GDLMFHIQRSG-------------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK  144 (318)
T ss_pred             CCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCe
Confidence            99999987643             388999999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      .....  ........|++.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+.    ....     
T Consensus       145 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~----~~~~-----  213 (318)
T cd05570         145 EGILG--GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL----EDEV-----  213 (318)
T ss_pred             ecCcC--CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH----cCCC-----
Confidence            53221  122234568999999999999999999999999999999999999997665433322221    1110     


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM-----KEVLQ  919 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~evl~  919 (969)
                            ..+...+..+.+++.+||+.||++||++     .++++
T Consensus       214 ------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         214 ------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                  0111234678999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1e-36  Score=343.26  Aligned_cols=258  Identities=21%  Similarity=0.256  Sum_probs=204.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.++...|+|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            36899999999999999999999999999999998654333344456788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++|+|.+++...              .++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       122 ~Ey~~gg~L~~~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~  184 (371)
T cd05622         122 MEYMPGGDLVNLMSNY--------------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA  184 (371)
T ss_pred             EcCCCCCcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEE
Confidence            9999999999998643              267788889999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccC----CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT----KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |||+++...... ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||.+.+.......+.   
T Consensus       185 DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---  260 (371)
T cd05622         185 DFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM---  260 (371)
T ss_pred             eCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH---
Confidence            999998764322 1222345799999999998754    37889999999999999999999998765433222221   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS--RPSMKEVLQIL  921 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~L  921 (969)
                       .....       ...+.....+..+.+++..|+..++.+  ||++.|+++..
T Consensus       261 -~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         261 -NHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             -cCCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence             11100       011112233467888999999844433  67888888643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.9e-37  Score=341.00  Aligned_cols=265  Identities=25%  Similarity=0.329  Sum_probs=201.1

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC-----Cce
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE-----NSK  711 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  711 (969)
                      +|+..++||+|+||.||+|.+..+++.||||++..... .......+.+|++++++++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            47788999999999999999998999999999864322 223345788999999999999999999987543     247


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      |+||||++ ++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  142 (338)
T cd07859          80 YVVFELME-SDLHQVIKAND-------------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKL  142 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcc-------------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcE
Confidence            99999995 78999887543             388999999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCC-ccccccccCcccCchhhccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          792 KIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYT--TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      ||+|||+++........ .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus       143 kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~  222 (338)
T cd07859         143 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITD  222 (338)
T ss_pred             EEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Confidence            99999999865332211 12234578999999999876  6789999999999999999999999976554332222211


Q ss_pred             HhhccC-------------CchhhhccCCCCc---ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEK-------------PITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~-------------~~~~~~~~~~~~~---~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ......             .....+......+   ........+.+++.+||+.||++||+++|+++
T Consensus       223 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            111000             0000000000000   00112356789999999999999999999996

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-36  Score=335.83  Aligned_cols=244  Identities=24%  Similarity=0.348  Sum_probs=197.8

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      ++||+|+||.||+|++..+|+.||+|+++...............|.+++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999999999999999999654332233445677788888765 899999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++
T Consensus        81 g~L~~~i~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~  144 (316)
T cd05620          81 GDLMFHIQDKG-------------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK  144 (316)
T ss_pred             CcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCe
Confidence            99999987643             378899999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.....+.+.    ...+     
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~----~~~~-----  213 (316)
T cd05620         145 ENVFG--DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR----VDTP-----  213 (316)
T ss_pred             ecccC--CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCC-----
Confidence            53221  122334678999999999999999999999999999999999999998765443332221    1110     


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK-EVL  918 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl  918 (969)
                        .    .+.....++.+++.+||+.||++||++. ++.
T Consensus       214 --~----~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 --H----YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --C----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              0    1111235788999999999999999985 544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-36  Score=331.38  Aligned_cols=265  Identities=24%  Similarity=0.335  Sum_probs=200.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc---ccCceeeEEEEEE-----
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI---RHANIVKLWCCIS-----  706 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----  706 (969)
                      ++|+..+.||+|+||.||+|++.. +++.||+|+++..... ......+.+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            368899999999999999999854 4688999988654322 22234556777777665   6999999999885     


Q ss_pred             cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       707 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                      .....++||||++ ++|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~  144 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPE-----------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVT  144 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEc
Confidence            2456899999996 699999875432           3478999999999999999999988   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      .++.+||+|||+++.+...   .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+....+....+
T Consensus       145 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i  221 (290)
T cd07862         145 SSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI  221 (290)
T ss_pred             CCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence            9999999999999865332   2233456899999999999889999999999999999999999999876654444333


Q ss_pred             HHHhhccC--Cchhhh---ccCC--CCcc-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEK--PITDAL---DKGI--AEPC-----YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~--~~~~~~---~~~~--~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ........  ......   ....  ....     .......+.+++.+|++.||++||++.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            32211100  000000   0000  0000     0122356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-36  Score=338.48  Aligned_cols=255  Identities=21%  Similarity=0.259  Sum_probs=202.4

Q ss_pred             CCCccceeeecCcEEEEEEEEc---CCCcEEEEEEEeccchh-cHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCce
Q 002085          637 SLTESNLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSK  711 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  711 (969)
                      +|++.+.||+|+||.||+++..   .+++.||+|++...... .....+.+..|+++++.+ +||+|+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999998864   46889999998654322 223346788999999999 599999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~  144 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-------------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHV  144 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCE
Confidence            99999999999999997543             388899999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+++.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+....
T Consensus       145 kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  223 (332)
T cd05614         145 VLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI  223 (332)
T ss_pred             EEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH
Confidence            9999999986543222 222345799999999998865 47889999999999999999999997544332222222222


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                      ....       .    +.+...+..+.+++.+||+.||++||     ++.++++
T Consensus       224 ~~~~-------~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         224 LKCD-------P----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             hcCC-------C----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            1111       1    11122346788999999999999999     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-36  Score=345.96  Aligned_cols=255  Identities=19%  Similarity=0.242  Sum_probs=201.4

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      .|+..++||+|+||+||+|+...+++.||+|++.............+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            57888999999999999999999999999999865443344556789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        82 ~~~gg~L~~~l~~~~-------------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DF  145 (382)
T cd05625          82 YIPGGDMMSLLIRMG-------------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  145 (382)
T ss_pred             CCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeEC
Confidence            999999999997543             377888999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCC---------------------------------------------CccccccccCcccCchhhcccCCC
Q 002085          797 GLAKMLAKQGE---------------------------------------------PHTMSAVAGSFGYFAPEYAYTTKV  831 (969)
Q Consensus       797 gla~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~  831 (969)
                      |+++.+.....                                             ........||+.|+|||++.+..+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  225 (382)
T cd05625         146 GLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY  225 (382)
T ss_pred             CCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC
Confidence            99753311000                                             000112468999999999999999


Q ss_pred             CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCC
Q 002085          832 NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSR  911 (969)
Q Consensus       832 ~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R  911 (969)
                      +.++||||+||++|||++|+.||.+.+.......+..   ..        .....+.....+.+..+++.+|+ .+|++|
T Consensus       226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~--------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R  293 (382)
T cd05625         226 TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN---WQ--------TSLHIPPQAKLSPEASDLIIKLC-RGPEDR  293 (382)
T ss_pred             CCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHc---cC--------CCcCCCCcccCCHHHHHHHHHHc-cCHhHc
Confidence            9999999999999999999999987654322211110   00        00111111222356677777765 599999


Q ss_pred             CC---HHHHHH
Q 002085          912 PS---MKEVLQ  919 (969)
Q Consensus       912 Ps---~~evl~  919 (969)
                      ++   +.|+++
T Consensus       294 ~~~~~~~ei~~  304 (382)
T cd05625         294 LGKNGADEIKA  304 (382)
T ss_pred             CCCCCHHHHhc
Confidence            87   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.9e-36  Score=329.60  Aligned_cols=269  Identities=26%  Similarity=0.417  Sum_probs=209.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEc----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDIN----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ++|+..+.||+|+||.||+|...    .++..||+|.+....  .......+.+|++++++++||||+++++++..+...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            56788899999999999999852    356789999986432  234456789999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCC----CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGS----SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      |+||||+++++|.+++.........+.    .......+++..+..++.|++.||+|||+.   +++||||||+||++++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence            999999999999999965432111110    011123578999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~  866 (969)
                      ++.+|++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+.......+.+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999999986643322223334456778999999998899999999999999999999 88888665432222222


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                          .....          .+.+...+..+.+++.+||+.||++||++.+|.+.|.+
T Consensus       240 ----~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 ----RKRQL----------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----HcCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                11110          11122234678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.7e-36  Score=359.22  Aligned_cols=273  Identities=25%  Similarity=0.287  Sum_probs=212.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      .+|++.++||+|+||.||+|.+..+|+.||+|++...........+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999999899999999996554444555678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||++||+|.+++.......  ..........++..+++++.|++.||+|||+.   +|+||||||+||+++.++.++|+|
T Consensus        82 EY~eGGSL~~lL~s~~~~~--~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKE--SLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EcCCCCCHHHHHHHhhhcc--ccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEe
Confidence            9999999999997532110  00011123467888999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCC----------------ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCc
Q 002085          796 FGLAKMLAKQGEP----------------HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH  859 (969)
Q Consensus       796 fgla~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~  859 (969)
                      ||+++........                .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            9999866211100                011234699999999999999999999999999999999999999976433


Q ss_pred             cchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcC
Q 002085          860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-SMKEVLQILRRCC  925 (969)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~  925 (969)
                      ......  ......          .......+.+..+.+++.+|++.||++|| ++.++.+.|+...
T Consensus       237 ~ki~~~--~~i~~P----------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        237 RKISYR--DVILSP----------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             hhhhhh--hhccCh----------hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            221110  000000          00001122346788999999999999995 5677777777664

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-36  Score=328.82  Aligned_cols=267  Identities=22%  Similarity=0.349  Sum_probs=207.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      .++|+..+.||+|+||.||+|.+.+     +++.||+|++....  .......+.+|+.+++.++||||+++++++.+..
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            4578899999999999999998642     35679999885432  2234567899999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++++|.+++.........   ......+++..+..++.|++.|++|||+.   +++||||||+||++++++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMEN---NPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccc---cccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCC
Confidence            999999999999999999764321110   01123468889999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  868 (969)
                      .++++|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+  
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~--  234 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV--  234 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence            999999999876543222222223345788999999998899999999999999999999 57777654433222211  


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                        .... .         .+.+...+..+.+++.+||+.||++||++.|+++.|++
T Consensus       235 --~~~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 --MEGG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             --HcCC-c---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence              1111 0         01112234678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.5e-36  Score=325.76  Aligned_cols=264  Identities=23%  Similarity=0.365  Sum_probs=213.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      .+|+..+.||+|+||.||+|....+++.||||.+......+......+.+|+++++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999998899999999886544444455678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....         ....+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++.++++|
T Consensus        82 e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d  149 (267)
T cd08229          82 ELADAGDLSRMIKHFKK---------QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             EecCCCCHHHHHHHhhc---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECc
Confidence            99999999999874321         123588999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||++..+....  .......++..|+|||.+.+..++.++||||||+++|||++|..||.+.... ...... ....   
T Consensus       150 fg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~-~~~~---  222 (267)
T cd08229         150 LGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK-KIEQ---  222 (267)
T ss_pred             chhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhh-hhhc---
Confidence            99987654321  1223356889999999999889999999999999999999999998754322 111111 1100   


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                         .   ..........+..+.+++.+||..||++|||+.+|++++++.
T Consensus       223 ---~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         223 ---C---DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ---C---CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence               0   001111123456789999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=332.89  Aligned_cols=259  Identities=24%  Similarity=0.306  Sum_probs=223.0

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCC
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSEN  709 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  709 (969)
                      ..++...|+..+.||.|.||.||+++...+|+.+|+|.+.+...........+.+|+++|+++. |||||.+.+++++..
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            3455668888999999999999999999999999999998766555556689999999999998 999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC-
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-  788 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-  788 (969)
                      ..++|||++.||.|.+.+...              .+++..+..++.|++.+++|||+.   ||+||||||+|+|+... 
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~--------------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~  172 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK--------------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKD  172 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc--------------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeecccc
Confidence            999999999999999999864              178899999999999999999988   99999999999999654 


Q ss_pred             ---CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          789 ---FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       789 ---~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                         +.++++|||+|..+..   .......+||+.|+|||++....|+..+||||+||++|.|++|..||++.........
T Consensus       173 ~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~  249 (382)
T KOG0032|consen  173 EGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA  249 (382)
T ss_pred             CCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH
Confidence               4799999999998744   3455668999999999999999999999999999999999999999998775544432


Q ss_pred             HHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      +...   .        ..+..+.+...+..+.+++..|+..||.+|+++.++++.
T Consensus       250 i~~~---~--------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  250 ILRG---D--------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHcC---C--------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            2111   0        123344555667889999999999999999999999983

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-36  Score=328.41  Aligned_cols=269  Identities=26%  Similarity=0.404  Sum_probs=212.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ++|...+.||+|+||.||+|....     +++.||||.++...  .....+.+.+|+++++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            467888999999999999998743     35789999986432  23345789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccC-CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSG-SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      .++||||+++++|.+++.......... ........+++..+..++.|++.|++|||+.   +++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence            999999999999999998654211000 0111234588999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  868 (969)
                      .++|+|||+++.+.............+++.|+|||++.+..++.++||||+||++|||++ |..||...+.......+..
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ  239 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            999999999976533222222233456789999999999999999999999999999998 9999876654443333221


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      .              .....+...+..+.+++.+||+.||++||++.|+++.|++
T Consensus       240 ~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         240 G--------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             C--------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1              1111112234678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-36  Score=342.80  Aligned_cols=257  Identities=22%  Similarity=0.289  Sum_probs=199.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      .+|++.++||+|+||.||+|.+..+++.||+|...         ...+.+|++++++++||||+++++++......++|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            47999999999999999999999999999999652         245678999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |++. ++|.+++....             .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       163 e~~~-~~L~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~D  225 (391)
T PHA03212        163 PRYK-TDLYCYLAAKR-------------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGD  225 (391)
T ss_pred             ecCC-CCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEe
Confidence            9995 78988886543             378999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc-------chHHHHHH
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT-------SLAEWAWR  868 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~-------~~~~~~~~  868 (969)
                      ||+|+..... .........||+.|+|||++.+..++.++||||+||++|||++|+.||...+..       .....+..
T Consensus       226 FG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~  304 (391)
T PHA03212        226 FGAACFPVDI-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR  304 (391)
T ss_pred             CCcccccccc-cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence            9999754322 112233457999999999999999999999999999999999999887653211       11111111


Q ss_pred             Hhhc---cCC------chhhh----ccCCC----Cc---ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAE---EKP------ITDAL----DKGIA----EP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~---~~~------~~~~~----~~~~~----~~---~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....   ..+      .....    .....    .+   .....+.++.+++.+|++.||++|||+.|+++
T Consensus       305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            1000   000      00000    00000    00   01123457889999999999999999999985

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-36  Score=336.48  Aligned_cols=248  Identities=24%  Similarity=0.328  Sum_probs=197.6

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHH-HHhccccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE-ILGTIRHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      +.||+|+||.||+|++..+++.||+|++.............+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999999899999999986543322233344444544 56778999999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      ++|.+++....             .+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~L~~~~~~~~-------------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~  144 (325)
T cd05602          81 GELFYHLQRER-------------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK  144 (325)
T ss_pred             CcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCc
Confidence            99999997643             367788889999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.......+..   ...      
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~~------  213 (325)
T cd05602         145 ENIEH--NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN---KPL------  213 (325)
T ss_pred             ccccC--CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh---CCc------
Confidence            54221  2223345799999999999999999999999999999999999999987654433332211   100      


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                            ......+..+.+++.+|++.||.+||++.+.+..+.
T Consensus       214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~  249 (325)
T cd05602         214 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK  249 (325)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence                  011123367889999999999999999876554443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.7e-36  Score=321.91  Aligned_cols=264  Identities=23%  Similarity=0.359  Sum_probs=214.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|....+|+.||+|.++.....+....+.+.+|++++++++|++++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            47888999999999999999999899999999886544444455678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++......         ...+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++++|
T Consensus        82 e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d  149 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQ---------KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             ecCCCCCHHHHHHHhccc---------CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEec
Confidence            999999999998753210         23478999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||++.......  .......+++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.... ..    
T Consensus       150 ~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-~~----  221 (267)
T cd08224         150 LGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK-IE----  221 (267)
T ss_pred             cceeeeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhh-hh----
Confidence            99987653321  1122346888999999999889999999999999999999999998654321 1111111 00    


Q ss_pred             chhhhccCCCCcccH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          876 ITDALDKGIAEPCYL-EEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                            .+...+.+. ..+..+.+++.+||..+|++||++.+|+++|+++.
T Consensus       222 ------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 ------KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ------cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                  111111122 34467899999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.7e-36  Score=337.26  Aligned_cols=272  Identities=24%  Similarity=0.373  Sum_probs=207.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc-C
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS-E  708 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~  708 (969)
                      ++|++.+.||+|+||.||+|...+     +++.||+|+++...  .....+.+.+|++++.++ +|+||+++++++.. +
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            368889999999999999997533     35789999986432  233346788899999999 89999999998865 4


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCcccc------------------------------------------------CCCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVS------------------------------------------------GSSS  740 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------~~~~  740 (969)
                      ...+++|||+++++|.+++.........                                                ....
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            5688999999999999999754321000                                                0000


Q ss_pred             cccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCccc
Q 002085          741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY  820 (969)
Q Consensus       741 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y  820 (969)
                      .....++|..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||+++.+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence            0123689999999999999999999988   9999999999999999999999999999876433222223344567889


Q ss_pred             CchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHH
Q 002085          821 FAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRL  899 (969)
Q Consensus       821 ~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  899 (969)
                      +|||++.+..++.++|||||||++|||++ |..||.+....+..   .......          .....+.....++.++
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~---~~~~~~~----------~~~~~~~~~~~~~~~l  308 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF---CRRLKEG----------TRMRAPEYATPEIYSI  308 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH---HHHHhcc----------CCCCCCccCCHHHHHH
Confidence            99999999999999999999999999998 88888653322111   1111111          1111122234678999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          900 ALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       900 ~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      +.+||+.+|++||++.|++++|+++.
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-36  Score=337.20  Aligned_cols=241  Identities=25%  Similarity=0.343  Sum_probs=194.3

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHH-HHhccccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE-ILGTIRHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      ++||+|+||.||+|++..+++.||+|++.............+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999986544333333445555654 67888999999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      ++|..++....             .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  144 (321)
T cd05603          81 GELFFHLQRER-------------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK  144 (321)
T ss_pred             CCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCc
Confidence            99998887543             377888899999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      ....  .........||+.|+|||.+.+..++.++||||+||++|||++|..||.+.+.....+.+.    ..       
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~----~~-------  211 (321)
T cd05603         145 EGVE--PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL----HK-------  211 (321)
T ss_pred             cCCC--CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh----cC-------
Confidence            5322  1222334568999999999999899999999999999999999999998765433322221    10       


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK  915 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~  915 (969)
                        ..  ..+......+.+++.+|++.||.+||++.
T Consensus       212 --~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 --PL--QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CC--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              00  11122346788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.7e-36  Score=328.87  Aligned_cols=274  Identities=24%  Similarity=0.379  Sum_probs=211.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCC----------------cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCcee
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAG----------------EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV  699 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  699 (969)
                      ++|+..+.||+|+||.||+|.....+                ..||+|++....  .....+.+.+|++++++++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEe
Confidence            47889999999999999998875433                568999986443  234567899999999999999999


Q ss_pred             eEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCC
Q 002085          700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK  779 (969)
Q Consensus       700 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  779 (969)
                      ++++++..++..++||||+++++|.+++..........  ......+++..++.++.|++.||+|||+.   +++|||||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk  157 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL--ACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA  157 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc--cccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence            99999999999999999999999999997654211000  11123589999999999999999999988   99999999


Q ss_pred             CCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh--CCCCCCCC
Q 002085          780 SSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT--GKEANYGD  857 (969)
Q Consensus       780 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~  857 (969)
                      |+||+++.++.++++|||+++...............+++.|+|||++.+..++.++|||||||++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999999999999999986543322233334556789999999998899999999999999999998  56676554


Q ss_pred             CccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          858 EHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      ........+...+.....       ....+.+...+.++.+++.+||+.||++||++.|+++.|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         238 TDQQVIENAGHFFRDDGR-------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ChHHHHHHHHhccccccc-------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            433333333222111110       00011122234679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.4e-36  Score=334.72  Aligned_cols=245  Identities=25%  Similarity=0.334  Sum_probs=198.3

Q ss_pred             ceeeecCcEEEEEEEEc---CCCcEEEEEEEeccchh-cHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          642 NLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      +.||+|+||.||+++..   .+++.||+|+++..... .......+.+|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999863   46889999998654322 223345678999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++++|.+++....             .+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~L~~~~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  145 (323)
T cd05584          82 LSGGELFMHLEREG-------------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFG  145 (323)
T ss_pred             CCCchHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCc
Confidence            99999999997543             377888899999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      +++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+   .....   
T Consensus       146 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~---~~~~~---  217 (323)
T cd05584         146 LCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI---LKGKL---  217 (323)
T ss_pred             CCeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH---HcCCC---
Confidence            987543221  1223456899999999999988999999999999999999999999875543222211   11111   


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                               ..+...+..+.+++.+||+.||++||     ++.++++
T Consensus       218 ---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 ---------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                     11122236788999999999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.5e-36  Score=330.53  Aligned_cols=270  Identities=26%  Similarity=0.376  Sum_probs=212.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCC-----CcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGA-----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSEN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  709 (969)
                      ++|+..+.||+|+||.||++.....     ...||+|.+....  .......+.+|+++++++ +||||+++++++..++
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            4688889999999999999987533     3689999886432  233456789999999999 8999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCC---CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                      ..++||||+++|+|.++++..........   .......+++..++.++.|++.|++|||+.   +|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence            99999999999999999976532111111   001234689999999999999999999988   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEW  865 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~  865 (969)
                      +++.+|++|||+++.+.............++..|+|||+..+..++.++|||||||++|||++ |..||...........
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            999999999999987654322222333445678999999988899999999999999999998 8888765543333222


Q ss_pred             HHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      ...    ..          ....+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       247 ~~~----~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         247 LKE----GY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHc----CC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            211    11          1111223346789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.6e-36  Score=330.67  Aligned_cols=265  Identities=25%  Similarity=0.352  Sum_probs=200.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|++.+.||+|+||.||+|+...+++.||||++.....  ......+.+|+++++.++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            3579999999999999999999998999999999854322  12234577899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++ ++|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+
T Consensus        82 ~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~  145 (303)
T cd07869          82 FEYVH-TDLCQYMDKHP------------GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLA  145 (303)
T ss_pred             EECCC-cCHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEC
Confidence            99996 68888876543            2378889999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHhhc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHT-SLAEWAWRHYAE  872 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~  872 (969)
                      |||+++.....  ........+++.|+|||++.+ ..++.++||||+||++|||++|..||.+.... .....+......
T Consensus       146 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  223 (303)
T cd07869         146 DFGLARAKSVP--SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT  223 (303)
T ss_pred             CCCcceeccCC--CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCC
Confidence            99998754321  222334568999999998865 45788999999999999999999999764332 111111111100


Q ss_pred             cC--------CchhhhccCCC--CcccH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EK--------PITDALDKGIA--EPCYL-------EEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~--------~~~~~~~~~~~--~~~~~-------~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..        ...........  .+...       .....+.+++.+|++.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00        00000000000  00000       01246789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.5e-36  Score=328.71  Aligned_cols=270  Identities=23%  Similarity=0.341  Sum_probs=210.5

Q ss_pred             CCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          637 SLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      +|+..+.||+|+||.||+|....     ....||+|.+....  .....+.+.+|+++++.++||||+++++++..++..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            46778999999999999998743     23578999885433  233456799999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCC-----------CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGS-----------SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKS  780 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  780 (969)
                      ++|+||+++++|.+++...........           .......+++.+++.++.|++.|++|||+.   +++||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence            999999999999999876432111000           001123588999999999999999999988   999999999


Q ss_pred             CcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCc
Q 002085          781 SNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEH  859 (969)
Q Consensus       781 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~  859 (969)
                      +||++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||.+...
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999986544332222233456778999999988889999999999999999999 8888866544


Q ss_pred             cchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..+.....    ..          ...+.+...+.++.+++.+||+.+|++||+++|+++.|+++.
T Consensus       236 ~~~~~~~~----~~----------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         236 ERLFNLLK----TG----------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHHHHHh----CC----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            33322221    11          111112233467889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.4e-36  Score=326.74  Aligned_cols=250  Identities=22%  Similarity=0.304  Sum_probs=202.7

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|++++++++|++++++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999999999999999998654433334456678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++++|.+++.....           ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||
T Consensus        82 ~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg  147 (285)
T cd05632          82 MNGGDLKFHIYNMGN-----------PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             ccCccHHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCC
Confidence            999999998875432           2489999999999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      ++......   .......|+..|+|||++.+..++.++|+||+||++|||++|..||...........+.........  
T Consensus       148 ~~~~~~~~---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~--  222 (285)
T cd05632         148 LAVKIPEG---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE--  222 (285)
T ss_pred             cceecCCC---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc--
Confidence            98765321   1223457899999999999889999999999999999999999999765433222222221111110  


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK  915 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~  915 (969)
                               ......+..+.+++..||+.||++||++.
T Consensus       223 ---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         223 ---------VYSAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             ---------ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence                     11122345788999999999999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.2e-36  Score=324.90  Aligned_cols=254  Identities=25%  Similarity=0.407  Sum_probs=206.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||.||+|... ++..||+|.+....    ...+.+.+|+.++++++|+||+++++++.+++..++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            57888999999999999999875 56679999875432    22467899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.++++....           ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|
T Consensus        81 e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d  146 (261)
T cd05072          81 EYMAKGSLLDFLKSDEG-----------GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIAD  146 (261)
T ss_pred             ecCCCCcHHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECC
Confidence            99999999999975432           3478899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...........+...    .
T Consensus       147 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----~  221 (261)
T cd05072         147 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG----Y  221 (261)
T ss_pred             CccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC----C
Confidence            999987643211 12223346778999999998899999999999999999998 88888665443333322111    1


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                                ..+.....+..+.+++.+||..+|++||+++++.+.|+.
T Consensus       222 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         222 ----------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                      111112233678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-36  Score=336.94  Aligned_cols=247  Identities=24%  Similarity=0.315  Sum_probs=198.0

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHH-HHhccccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE-ILGTIRHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      +.||+|+||+||+|+...+|+.||+|++.............+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999999999999999996554333344455666655 46778999999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|..++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~  144 (325)
T cd05604          81 GELFFHLQRER-------------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK  144 (325)
T ss_pred             CCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcc
Confidence            99999887543             388999999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      ....  .........||+.|+|||++.+..++.++||||+||++|||++|..||...+.....+.+..   ....     
T Consensus       145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~---~~~~-----  214 (325)
T cd05604         145 EGIA--QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH---KPLV-----  214 (325)
T ss_pred             cCCC--CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc---CCcc-----
Confidence            5322  12223345799999999999999999999999999999999999999987654333222211   1000     


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                             .....+..+.+++.+|++.||.+||++.+.++.+
T Consensus       215 -------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         215 -------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             -------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence                   0112235678999999999999999886544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.1e-36  Score=324.03  Aligned_cols=251  Identities=27%  Similarity=0.374  Sum_probs=202.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|++. ++..+|+|.+.....    ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            45778899999999999999886 456799998754321    2356888999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.++++...            ..++|..+..++.|++.||+|||+.   +|+||||+|+||++++++.+|++|
T Consensus        79 e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d  143 (256)
T cd05114          79 EFMENGCLLNYLRQRQ------------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSD  143 (256)
T ss_pred             EcCCCCcHHHHHHhCc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECC
Confidence            9999999999987543            2378999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||.++...... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.......+..    ..
T Consensus       144 ~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~----~~  218 (256)
T cd05114         144 FGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR----GF  218 (256)
T ss_pred             CCCccccCCCc-eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----CC
Confidence            99988653321 111223345678999999998889999999999999999999 8888876554433333211    11


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      ..          ..+...+..+.+++.+||+.+|++||+++|+++.|
T Consensus       219 ~~----------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         219 RL----------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            00          01111235789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.9e-36  Score=329.68  Aligned_cols=269  Identities=25%  Similarity=0.394  Sum_probs=209.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      .+|...+.||+|+||.||+|....     ++..||+|+++...  .....+.+.+|+.+++.++||||+++++++.+...
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            357778899999999999998753     35789999986433  23345678999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccC---CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSG---SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      .++++||+++++|.+++.........+   ........+++..+..++.|++.||+|+|+.   +|+||||||+||++++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence            999999999999999996432211100   0111134588999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~  866 (969)
                      ++.+||+|||+++...............+++.|+|||.+.++.++.++||||+||++|||++ |..||.+.......+.+
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999999886543322222334456789999999988899999999999999999998 66777654433322221


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      .    ...          ..+.+...+..+.+++..||+.+|++||+++||+..|+.
T Consensus       240 ~----~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 R----NRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H----cCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1    110          111223345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.2e-37  Score=337.54  Aligned_cols=241  Identities=24%  Similarity=0.293  Sum_probs=196.6

Q ss_pred             ceeeecCcEEEEEEEE---cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeec
Q 002085          642 NLIGSGGSGQVYRIDI---NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYM  718 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  718 (969)
                      +.||+|+||.||+++.   ..+|+.||+|++..... .......+..|++++++++||||+++++++.+++..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5799999999999876   35688999999965432 2233456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccc
Q 002085          719 ENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL  798 (969)
Q Consensus       719 ~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  798 (969)
                      ++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~L~~~l~~~~-------------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~  144 (318)
T cd05582          81 RGGDLFTRLSKEV-------------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL  144 (318)
T ss_pred             CCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccC
Confidence            9999999987543             388999999999999999999988   999999999999999999999999999


Q ss_pred             ceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchh
Q 002085          799 AKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD  878 (969)
Q Consensus       799 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  878 (969)
                      ++.....  ........|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.   ....    
T Consensus       145 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~---~~~~----  215 (318)
T cd05582         145 SKESIDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL---KAKL----  215 (318)
T ss_pred             CcccCCC--CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH---cCCC----
Confidence            8765322  122334578999999999998889999999999999999999999997655433222211   1110    


Q ss_pred             hhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002085          879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKE  916 (969)
Q Consensus       879 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e  916 (969)
                              ..+...+..+.+++.+||+.||++||++.+
T Consensus       216 --------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 --------GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                    011223367889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.1e-36  Score=326.11  Aligned_cols=254  Identities=23%  Similarity=0.311  Sum_probs=204.2

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |+..+.||+|+||.||+|.+..+++.||||.+.............+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            56678999999999999999999999999998654433334446678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++++|.+++.....           ..+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++|+|||
T Consensus        82 ~~g~~L~~~l~~~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05630          82 MNGGDLKFHIYHMGE-----------AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLG  147 (285)
T ss_pred             cCCCcHHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeecc
Confidence            999999999865432           3488899999999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      ++......   .......|+..|+|||++.+..++.++||||+||++|||++|+.||..................   ..
T Consensus       148 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~  221 (285)
T cd05630         148 LAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQ  221 (285)
T ss_pred             ceeecCCC---ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hh
Confidence            98764322   1223347899999999999999999999999999999999999999765432211111111110   00


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-----MKEVLQ  919 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~  919 (969)
                          .    .........+.+++..||+.||++||+     +.|+++
T Consensus       222 ----~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 ----E----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ----h----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                0    111223356889999999999999999     677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-36  Score=324.04  Aligned_cols=262  Identities=22%  Similarity=0.327  Sum_probs=206.0

Q ss_pred             CCccceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc----
Q 002085          638 LTESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS----  710 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  710 (969)
                      |++.+.||+|+||.||+|....+   +..||+|+++.... .......+.+|+++++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            56778999999999999987643   47899999865432 23445689999999999999999999998866544    


Q ss_pred             --eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          711 --KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       711 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                        .++||||+++|+|.+++......       .....+++..+..++.|++.||+|||+.   +++||||||+||+++++
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~-------~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~  149 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLG-------GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLRED  149 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhcc-------CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCC
Confidence              79999999999999998654321       0123588999999999999999999988   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  867 (969)
                      +.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.+.......+...
T Consensus       150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~  229 (273)
T cd05035         150 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR  229 (273)
T ss_pred             CeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999987644322222223345678999999988899999999999999999999 777776544333322221


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      .    ..          ....+...+..+.+++.+||+.||++||++.|+++.|+++
T Consensus       230 ~----~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 H----GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             c----CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1    11          1111223446889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.6e-36  Score=325.83  Aligned_cols=258  Identities=23%  Similarity=0.354  Sum_probs=207.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCc----EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGE----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ++|+..++||+|+||+||+|++..+++    .||+|++....  .......+.+|+.+++.++||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            468888999999999999999876666    48999885432  34445788999999999999999999999875 457


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++++||+++|+|.++++...            ..+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~  148 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK------------DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHV  148 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcE
Confidence            89999999999999997643            2488999999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+++.+.............+++.|+|||...+..++.++|||||||++|||++ |..||...........+..  
T Consensus       149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--  226 (279)
T cd05109         149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK--  226 (279)
T ss_pred             EECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--
Confidence            9999999987643322222223345678999999999899999999999999999998 7788765443333222211  


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                        ..          ..+.+...+..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus       227 --~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         227 --GE----------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             --CC----------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence              11          11112233467899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.1e-36  Score=325.79  Aligned_cols=263  Identities=25%  Similarity=0.352  Sum_probs=207.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ++|+..+.||+|+||.||+|.+..     .+..||+|.+....  .......+.+|+.++++++|+||+++++++.+.+.
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            468888999999999999999976     67789999875332  23445678999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-  789 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-  789 (969)
                      .++||||+++++|.+++........      ....++|..+.+++.||+.|++|||+.   +++||||||+||+++.++ 
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~  154 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPE------RPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGP  154 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCC
Confidence            9999999999999999986542111      123589999999999999999999988   999999999999998765 


Q ss_pred             --cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHH
Q 002085          790 --KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA  866 (969)
Q Consensus       790 --~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~  866 (969)
                        .+|++|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||...........+
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~  234 (277)
T cd05036         155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV  234 (277)
T ss_pred             CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence              599999999987633222222222334568999999999999999999999999999997 88888765443322221


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                          ....          ....+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       235 ----~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         235 ----TGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             ----HcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                1111          011122234678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.5e-36  Score=324.47  Aligned_cols=254  Identities=27%  Similarity=0.429  Sum_probs=209.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      .+|+..++||+|+||.||+|.+.. ++.||+|.+....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            468889999999999999999986 8889999985432   233467889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....           ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|
T Consensus        82 e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d  147 (261)
T cd05148          82 ELMEKGSLLAFLRSPEG-----------QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVAD  147 (261)
T ss_pred             eecccCCHHHHHhcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcc
Confidence            99999999999986432           3488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||.+..+...  ........++..|+|||...+..++.++||||||+++|+|++ |+.||......+....+...     
T Consensus       148 ~g~~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----  220 (261)
T cd05148         148 FGLARLIKED--VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-----  220 (261)
T ss_pred             ccchhhcCCc--cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-----
Confidence            9999765332  112223456778999999998899999999999999999998 78888665543333322211     


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                               ...+.+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus       221 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         221 ---------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                     1111223344678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.6e-36  Score=326.56  Aligned_cols=269  Identities=29%  Similarity=0.422  Sum_probs=205.3

Q ss_pred             CC-CccceeeecCcEEEEEEEE----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--C
Q 002085          637 SL-TESNLIGSGGSGQVYRIDI----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--N  709 (969)
Q Consensus       637 ~~-~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  709 (969)
                      +| +..+.||+|+||+||++..    ..++..||+|.++...  .......+.+|++++++++||||+++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence            44 7889999999999987653    3467889999986432  233456788999999999999999999988653  4


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++++|.+++...              .+++..+..++.|++.|++|||+.   +|+||||||+||++++++
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~--------------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~  144 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKH--------------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDR  144 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCC
Confidence            578999999999999999643              389999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCcc-ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHT-MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      .++|+|||+++.+........ .....++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..+....
T Consensus       145 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~  223 (283)
T cd05080         145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGP  223 (283)
T ss_pred             cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcc
Confidence            999999999987643222111 12234567799999999889999999999999999999999997543221 0000000


Q ss_pred             H--hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          869 H--YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       869 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .  ........+..+.....+.+...+..+.+++..||+.||++||++++++++|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         224 KQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0  00001111222222222223344578999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-36  Score=326.92  Aligned_cols=275  Identities=23%  Similarity=0.343  Sum_probs=207.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCC--------------CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGA--------------GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL  701 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  701 (969)
                      ++|++.++||+|+||.||+|.....              ...||+|.++...  .......+.+|++++++++|||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            4788899999999999999887532              2358999886432  23445679999999999999999999


Q ss_pred             EEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCC
Q 002085          702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSS  781 (969)
Q Consensus       702 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~  781 (969)
                      ++++......++||||+++++|.+++......... ........++|..++.++.|++.|++|||+.   +++||||||+
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~  158 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTF-THANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR  158 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccc-cccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence            99999999999999999999999999654210000 0000112478899999999999999999988   9999999999


Q ss_pred             cEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh--CCCCCCCCCc
Q 002085          782 NILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT--GKEANYGDEH  859 (969)
Q Consensus       782 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~~~  859 (969)
                      ||+++.++.+||+|||+++...............++..|+|||+..++.++.++|||||||++|||++  |..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            99999999999999999976543222222233455778999999998999999999999999999998  5556665443


Q ss_pred             cchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      ..........+......       .....+...+..+.+++.+||+.||++||++++|++.|++
T Consensus       239 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 EQVIENTGEFFRNQGRQ-------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHHHhhhhcccc-------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            33322222211111000       0000111233689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.8e-36  Score=338.81  Aligned_cols=271  Identities=20%  Similarity=0.324  Sum_probs=208.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSEN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  709 (969)
                      ++|.+.++||+|+||.||+|++..     .++.||+|+++....  ....+.+.+|++++.++. ||||+++++++...+
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            467788999999999999998642     456899999965432  233457889999999997 999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccC----------------------------------------------------
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSG----------------------------------------------------  737 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~----------------------------------------------------  737 (969)
                      ..++||||+++|+|.++++..+......                                                    
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999998643210000                                                    


Q ss_pred             ---------------------------------CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          738 ---------------------------------SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       738 ---------------------------------~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                                                       ........++|..+..++.|++.||+|||+.   +++||||||+||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence                                             0001123578889999999999999999987   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchH
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLA  863 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~  863 (969)
                      +++++.++++|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |+.||........ 
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-  350 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-  350 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence            99999999999999986543322222233457789999999998889999999999999999998 7778754332221 


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                        .......+          ...+.+...+..+.+++.+||..+|++||+++||++.|+++
T Consensus       351 --~~~~~~~~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         351 --FYNAIKRG----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             --HHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              11111111          11111222346889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-36  Score=325.33  Aligned_cols=267  Identities=22%  Similarity=0.338  Sum_probs=210.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCC-----CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGA-----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      .++|++.+.||+|+||.||+|.....     +..||+|.+....  .......+.+|+.+++.++||||+++++++.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            35788889999999999999988643     3789999985432  2334567889999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++++|.+++.........   ......++|..++.++.|++.|++|||+.   +++||||||+||++++++
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAEN---NPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhh---ccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence            999999999999999999764421100   01123578999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  868 (969)
                      .+||+|||+++.+.............++..|+|||.+.++.++.++|||||||++||+++ |..||.+.+.....+... 
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-  235 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-  235 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-
Confidence            999999999986544322222333456789999999998899999999999999999998 888876655443333221 


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                         ...          ....+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       236 ---~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 ---DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ---cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence               111          001112234788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.9e-36  Score=326.42  Aligned_cols=270  Identities=24%  Similarity=0.404  Sum_probs=211.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      .+|...+.||+|+||.||+|+...     ++..|++|.+....   ....+.+.+|++++++++||||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            357777899999999999998632     45569999875432   3444678999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccc---cCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLV---SGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~---~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      .++||||+++++|.+++........   ..........++|..++.++.|++.|++|||+.   +|+||||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence            9999999999999999976542100   001111123589999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~  866 (969)
                      ++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.........+.+
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999999999976543222222334456789999999999999999999999999999999 88888665443332221


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                          ....          ....+...+..+.+++.+||+.||++||++.+++++|+++.
T Consensus       239 ----~~~~----------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         239 ----TQGR----------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             ----hCCC----------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                1110          00111223467899999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.4e-35  Score=324.95  Aligned_cols=274  Identities=23%  Similarity=0.370  Sum_probs=209.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC----------------CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCcee
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING----------------AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV  699 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  699 (969)
                      ++|+..++||+|+||.||+++...                ++..||+|++....  .......+.+|+++++.++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            468889999999999999986432                34479999885432  344457899999999999999999


Q ss_pred             eEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCC
Q 002085          700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK  779 (969)
Q Consensus       700 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  779 (969)
                      ++++++..++..++||||+++++|.+++.......  .........+++.++..++.|++.|++|||+.   +++|||||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk  157 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE--AAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA  157 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccc--ccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence            99999999999999999999999999998654321  11122234588899999999999999999988   99999999


Q ss_pred             CCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh--CCCCCCCC
Q 002085          780 SSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT--GKEANYGD  857 (969)
Q Consensus       780 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~  857 (969)
                      |+||++++++.++++|||+++.+.............+++.|+|||...++.++.++|||||||++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9999999999999999999986543322222223345678999999888899999999999999999998  66777654


Q ss_pred             CccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          858 EHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      ............+.....       ....+.+..++..+.+++.+||+.||++||++.||++.|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         238 SDEQVIENTGEFFRDQGR-------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ChHHHHHHHHHHHhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            433322222111111100       00011122234678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=9.6e-36  Score=318.97  Aligned_cols=253  Identities=26%  Similarity=0.374  Sum_probs=208.7

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|++|.||+|....+++.||+|.+.... ......+.+.+|+++++.++|||++++++++.+++..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh-CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            4677789999999999999999899999999985432 234556789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++.....           ..+++..++.++.|++.|+.|||+.   +++||||+|+||+++.++.++++||
T Consensus        80 ~~~~~~L~~~l~~~~~-----------~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df  145 (256)
T cd08529          80 YAENGDLHKLLKMQRG-----------RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDL  145 (256)
T ss_pred             eCCCCcHHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEccc
Confidence            9999999999986421           3488999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |+++.+....  .......|++.|+|||+..+..++.++|+|||||++|||++|+.||...........+    ...   
T Consensus       146 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~---  216 (256)
T cd08529         146 GVAKLLSDNT--NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI----IRG---  216 (256)
T ss_pred             ccceeccCcc--chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HcC---
Confidence            9998664321  1223346889999999999999999999999999999999999999766533222211    110   


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                             ...+........+.+++.+||+.+|++||++.|+++.
T Consensus       217 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         217 -------VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -------CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                   0111112334678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.4e-36  Score=326.29  Aligned_cols=269  Identities=26%  Similarity=0.451  Sum_probs=209.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ++|+..+.||+|+||.||+|....     ++..||+|++....  .....+.+.+|+.++++++||||+++++++.++..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            568888999999999999998743     56789999885432  23445679999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCC---------CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGS---------SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSS  781 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~---------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~  781 (969)
                      .++||||+++++|.+++...........         .......+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence            9999999999999999985432111100         111123578999999999999999999988   9999999999


Q ss_pred             cEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCcc
Q 002085          782 NILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHT  860 (969)
Q Consensus       782 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~  860 (969)
                      ||++++++.++++|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876543222222223345678999999998899999999999999999998 77788765443


Q ss_pred             chHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          861 SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       861 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      .....+    .....          .+.+...+..+.+++.+||+.||++||++.|+++.|++
T Consensus       240 ~~~~~~----~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 EVIYYV----RDGNV----------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHH----hcCCC----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            322211    11110          01122334678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8e-36  Score=327.31  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=207.4

Q ss_pred             cCCCccceeeecCcEEEEEEEE-----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDI-----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSEN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  709 (969)
                      ++|...+.||+|+||.||+|..     ..++..||||+++...  .....+.+.+|+++++++ +||||+++++++...+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            4688889999999999999975     2345689999885432  233456789999999999 7999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++|+|.++++....           ..+++.++..++.|++.|++|||+.   +|+|+||||+||+++.++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~  178 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE-----------SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGK  178 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCC
Confidence            99999999999999999975432           2378999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  868 (969)
                      .++++|||+++.+.............++..|+|||.+.+..++.++||||+||++|||++ |..||..........   .
T Consensus       179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~---~  255 (302)
T cd05055         179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY---K  255 (302)
T ss_pred             eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH---H
Confidence            999999999986644322222233456788999999999999999999999999999998 888886543322111   1


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      ....          +.....+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       256 ~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         256 LIKE----------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHc----------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1111          111111112236789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.8e-36  Score=329.37  Aligned_cols=269  Identities=27%  Similarity=0.373  Sum_probs=207.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcE--EEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  711 (969)
                      .++|+..+.||+|+||.||+|.+..++..  +|+|.++..  ........+.+|++++.++ +||||+++++++.+++..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            35788889999999999999998776654  577766432  2334457889999999999 899999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCC---CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      |+||||+++++|.++++..........   .......+++.+++.++.|++.|++|||+.   +++||||||+||+++++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence            999999999999999986542111000   001123588999999999999999999988   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  867 (969)
                      +.+||+|||+++....   ........++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..... 
T Consensus       161 ~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-  236 (303)
T cd05088         161 YVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-  236 (303)
T ss_pred             CcEEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-
Confidence            9999999999863211   111112234678999999988889999999999999999998 88888765443322221 


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                         ..          ......+...+..+.+++.+||+.+|++||++.++++.++++.
T Consensus       237 ---~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         237 ---PQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             ---hc----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               11          0011111223457889999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=329.74  Aligned_cols=249  Identities=29%  Similarity=0.408  Sum_probs=211.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +-|...+.||.|+||.||-|++..+.+.||||++..+.....+...++..|++.+++++|||++.+.|||-.+...||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            45777889999999999999999999999999997666666666789999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |||- |+-.|++...+            .++....+..|+.+++.||+|||++   +.||||||+.|||+++.|.||++|
T Consensus       106 EYCl-GSAsDlleVhk------------KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaD  169 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHK------------KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLAD  169 (948)
T ss_pred             HHHh-ccHHHHHHHHh------------ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecc
Confidence            9995 78888887655            4588889999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ||.|.+..+      ...++|||.|||||++.   .+.|+-++||||+|++..|+..+++|.+....-+-...+   ...
T Consensus       170 FGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI---AQN  240 (948)
T KOG0577|consen  170 FGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQN  240 (948)
T ss_pred             ccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH---Hhc
Confidence            999987643      24578999999999875   568999999999999999999999998776543222221   111


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +.+       .+   ...+.+..+..++..|+++-|.+|||..++++
T Consensus       241 esP-------tL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  241 ESP-------TL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCC-------CC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            111       11   23456678999999999999999999999875

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.7e-36  Score=328.26  Aligned_cols=272  Identities=24%  Similarity=0.359  Sum_probs=212.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEc-------CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDIN-------GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCIS  706 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  706 (969)
                      .++|++.+.||+|+||.||+|+..       .++..||+|.+....  .....+.+.+|+.+++.+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            356888899999999999999752       234579999885432  234457899999999999 8999999999999


Q ss_pred             cCCceEEEEeeccCCCHHHHhccCcCccccC---CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcE
Q 002085          707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSG---SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI  783 (969)
Q Consensus       707 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Ni  783 (969)
                      ..+..++||||+++|+|.+++..........   ........++|.++..++.|++.||+|||+.   +++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            9999999999999999999998654311000   0011234588999999999999999999988   999999999999


Q ss_pred             EECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccch
Q 002085          784 LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSL  862 (969)
Q Consensus       784 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~  862 (969)
                      ++++++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |..||.+.....+
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            999999999999999987644333223333456788999999998899999999999999999998 6677755443332


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .+.+    .....          ...+...+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus       249 ~~~~----~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         249 FKLL----KEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             HHHH----HcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            2222    11111          1112233467899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=319.28  Aligned_cols=256  Identities=24%  Similarity=0.323  Sum_probs=206.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh--cHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL--NQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ++|+..+.||+|++|.||+|....+++.||+|.+......  .....+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688899999999999999999888999999998654322  12234678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      |+||+++++|.+++....             .+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|
T Consensus        82 v~e~~~~~~l~~~~~~~~-------------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l  145 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-------------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKL  145 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            999999999999987543             377889999999999999999988   9999999999999999999999


Q ss_pred             eecccceecccCCCCc-cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||+++......... ......++..|+|||.+.+..++.++||||+|+++|||++|+.||...+......   .....
T Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~  222 (263)
T cd06625         146 GDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF---KIATQ  222 (263)
T ss_pred             eecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH---HHhcc
Confidence            9999997653321111 1123457889999999999999999999999999999999999987643322111   11111


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .          .....+......+.+++.+||..+|++||++.|+++.
T Consensus       223 ~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 P----------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             C----------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            0          1111222334678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=339.02  Aligned_cols=240  Identities=23%  Similarity=0.270  Sum_probs=190.3

Q ss_pred             eeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc---ccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI---RHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       644 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      ||+|+||+||+|++..+++.||||++.............+..|..++...   +||||+++++++.++...|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999999989999999998654333333344556677777665   699999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++
T Consensus        81 g~L~~~l~~~~-------------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~  144 (330)
T cd05586          81 GELFWHLQKEG-------------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK  144 (330)
T ss_pred             ChHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCc
Confidence            99999987543             388899999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA  879 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  879 (969)
                      .....  ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.......+.   .....    
T Consensus       145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~---~~~~~----  215 (330)
T cd05586         145 ANLTD--NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA---FGKVR----  215 (330)
T ss_pred             CCCCC--CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH---cCCCC----
Confidence            53221  1222345799999999998765 47899999999999999999999998765433322211   11100    


Q ss_pred             hccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002085          880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK  915 (969)
Q Consensus       880 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~  915 (969)
                          +..   ......+.+++.+||+.||.+||++.
T Consensus       216 ----~~~---~~~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         216 ----FPK---NVLSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             ----CCC---ccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence                000   11235678999999999999999543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=319.42  Aligned_cols=254  Identities=27%  Similarity=0.423  Sum_probs=205.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|... +++.||+|.++....    ..+.+.+|++++++++||||+++++++...+..++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            46888899999999999999875 457899999854321    2456889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....           ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|
T Consensus        81 e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d  146 (261)
T cd05068          81 ELMKYGSLLEYLQGGAG-----------RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVAD  146 (261)
T ss_pred             ecccCCcHHHHHhccCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECC
Confidence            99999999999976431           3488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++.+.... .........+..|+|||+..+..++.++||||||+++|||++ |+.||.+.........+.    ...
T Consensus       147 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~----~~~  221 (261)
T cd05068         147 FGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD----QGY  221 (261)
T ss_pred             cceEEEccCCc-ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH----cCC
Confidence            99998764221 111122233468999999998899999999999999999999 888886654332222211    110


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                                ..+.+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       222 ----------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         222 ----------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ----------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                      111122334678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.5e-36  Score=345.73  Aligned_cols=266  Identities=23%  Similarity=0.264  Sum_probs=197.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC-------
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE-------  708 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  708 (969)
                      .+|+..++||+|+||.||+|....+++.||||++....       ....+|+.+++.++||||+++++++...       
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            46889999999999999999999899999999885432       2345799999999999999998876432       


Q ss_pred             -CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          709 -NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       709 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                       ...++||||++ ++|.+++.....         ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.
T Consensus       139 ~~~l~lvmE~~~-~~l~~~~~~~~~---------~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~  205 (440)
T PTZ00036        139 NIFLNVVMEFIP-QTVHKYMKHYAR---------NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDP  205 (440)
T ss_pred             ceEEEEEEecCC-ccHHHHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcC
Confidence             23568999997 578777754321         123588999999999999999999988   9999999999999997


Q ss_pred             CC-cEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          788 EF-KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       788 ~~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      ++ .+||+|||+|+.+....   ......||+.|+|||++.+. .++.++||||+||++|||++|..||.+.........
T Consensus       206 ~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  282 (440)
T PTZ00036        206 NTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR  282 (440)
T ss_pred             CCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            65 79999999998664321   22345689999999988764 689999999999999999999999987654433333


Q ss_pred             HHHHhhccCC---------chhhhccC-----CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhc
Q 002085          866 AWRHYAEEKP---------ITDALDKG-----IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRC  924 (969)
Q Consensus       866 ~~~~~~~~~~---------~~~~~~~~-----~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~  924 (969)
                      +.+.......         ..+...+.     +....+...+.++.+++.+||+.||.+|||+.|+++  .++.+
T Consensus       283 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence            3222111000         00000000     000011123467899999999999999999999984  44443

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-35  Score=323.68  Aligned_cols=269  Identities=22%  Similarity=0.324  Sum_probs=207.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      .++|++.++||+|+||.||+|....     .+..||+|.+....  .......+.+|+.++++++||||+++++++.+..
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            3578899999999999999987642     34589999875432  2233456889999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++|+|.+++........   ........++..+..++.|++.||+|||+.   +|+||||||+||++++++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~  156 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAE---NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCC
Confidence            99999999999999999976432111   001123467788899999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  868 (969)
                      .++++|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.+.+.......+  
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~--  234 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV--  234 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--
Confidence            999999999986543222222223345678999999999899999999999999999999 66677654433222211  


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                        .....          ...+...+..+.+++.+|++.||++||++.++++.+++..
T Consensus       235 --~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 --MDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             --HcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence              11100          0111222468999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.9e-36  Score=321.74  Aligned_cols=258  Identities=25%  Similarity=0.447  Sum_probs=208.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCc---EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ..|+..+.||+|+||.||+|....+++   .||||.++...  .......+..|+.+++.++||||+++++++.+++..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            357788999999999999999876654   69999985432  3445678999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++++|.+++....            ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++
T Consensus        82 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~k  146 (269)
T cd05065          82 IITEFMENGALDSFLRQND------------GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCK  146 (269)
T ss_pred             EEEecCCCCcHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEE
Confidence            9999999999999997543            2478999999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccc-cc--cCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002085          793 IADFGLAKMLAKQGEPHTMSA-VA--GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  868 (969)
                      ++|||++..+........... ..  .+..|+|||++.+..++.++||||+||++|||++ |..||...+......++. 
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-  225 (269)
T cd05065         147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-  225 (269)
T ss_pred             ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-
Confidence            999999876643222211111 11  2457999999999999999999999999999886 888987655443333221 


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                         ...          ..+.+.+.+..+.+++.+||+.+|++||++.+++..|+++
T Consensus       226 ---~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 ---QDY----------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---cCC----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               111          1111223346788999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-35  Score=319.86  Aligned_cols=258  Identities=26%  Similarity=0.470  Sum_probs=207.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCc---EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++|+..+.||+|+||.||+|....++.   .||+|.++...  .....+.+..|++++++++|||++++.+++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            467778999999999999999865554   79999885432  2334577899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++++|.+++....            ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.++
T Consensus        83 lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~k  147 (268)
T cd05063          83 IITEYMENGALDKYLRDHD------------GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECK  147 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEE
Confidence            9999999999999997543            2488999999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCcc-ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          793 IADFGLAKMLAKQGEPHT-MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ++|||++........... ......++.|+|||++.+..++.++|||||||++|||++ |..||...........+.   
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~---  224 (268)
T cd05063         148 VSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN---  224 (268)
T ss_pred             ECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh---
Confidence            999999986643221111 112223567999999998899999999999999999998 999987654433222221   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                       ..          ...+...+.+..+.+++.+||..+|++||++.++++.|+++
T Consensus       225 -~~----------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         225 -DG----------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -cC----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             11          11112223446789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-35  Score=322.81  Aligned_cols=268  Identities=25%  Similarity=0.384  Sum_probs=207.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEc-----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDIN-----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ++|...++||+|+||.||+++..     .++..||+|.+...   .......+.+|+++++.++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            46777899999999999999753     34668999987543   23445789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccc--cCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLV--SGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      .++||||+++++|.+++........  ..........+++..++.++.|++.|++|||+.   +++||||||+||+++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence            9999999999999999986543110  011112224589999999999999999999988   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  867 (969)
                      +.++|+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |..||............ 
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-  237 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-  237 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH-
Confidence            9999999999976533221122223345788999999999999999999999999999998 78887654433222111 


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                         .....          ...+...+..+.+++.+||+.||++||++.||.+.|++
T Consensus       238 ---~~~~~----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         238 ---TQGRE----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ---HcCcc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence               11110          01112234678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.5e-35  Score=320.61  Aligned_cols=261  Identities=21%  Similarity=0.312  Sum_probs=201.9

Q ss_pred             CccceeeecCcEEEEEEEEcCCCc--EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC------Cc
Q 002085          639 TESNLIGSGGSGQVYRIDINGAGE--FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE------NS  710 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  710 (969)
                      .+.++||+|+||.||+|.+..++.  .||+|.++... ......+.+.+|+++++.++||||+++++++...      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            456889999999999999876665  69999885432 2334457889999999999999999999987432      24


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||+++|+|.+++......       .....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  150 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLG-------DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMN  150 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhccc-------CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCC
Confidence            68999999999999988543210       0123488999999999999999999988   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  869 (969)
                      ++|+|||+++.+.............+++.|+|||...+..++.++|||||||++|||++ |..||.+.+.....+.    
T Consensus       151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----  226 (272)
T cd05075         151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY----  226 (272)
T ss_pred             EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence            99999999987643322112223346778999999999999999999999999999999 6777765443322221    


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      .......          +.+...+..+.+++.+||+.||++||++.|+++.|+++
T Consensus       227 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         227 LRQGNRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111110          11122346789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-35  Score=324.06  Aligned_cols=270  Identities=28%  Similarity=0.389  Sum_probs=204.1

Q ss_pred             cCCCccceeeecCcEEEEEEEE----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc--CC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDI----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS--EN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  709 (969)
                      +.|+..+.||+|+||.||+|..    ..+++.||+|.+...   .....+.+.+|++++++++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            3678889999999999999974    346889999998543   23445678999999999999999999998754  34


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++++|.+++....            ..++|..+..++.|++.||+|||+.   +|+||||||+||++++++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~------------~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~  145 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR------------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESEN  145 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC------------cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCC
Confidence            6899999999999999997543            2488999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccc-cccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTM-SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      .++|+|||+++........... ....++..|+|||++.+..++.++|||||||++|||++|..++...... ..+....
T Consensus       146 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~  224 (284)
T cd05081         146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGN  224 (284)
T ss_pred             eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhccc
Confidence            9999999999876433222111 1223445699999999889999999999999999999988775432211 0000000


Q ss_pred             HhhccC---CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          869 HYAEEK---PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       869 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      ......   .+.+.+......+.+...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         225 DKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             ccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            000000   01111222222222233446799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.7e-35  Score=325.75  Aligned_cols=264  Identities=24%  Similarity=0.328  Sum_probs=205.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||.||++.+..++..||+|.+....  .......+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            36888999999999999999999899999999885432  2334567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.++++...             .+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.++|+|
T Consensus        79 ey~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~d  143 (308)
T cd06615          79 EHMDGGSLDQVLKKAG-------------RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCD  143 (308)
T ss_pred             eccCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEcc
Confidence            9999999999997643             378899999999999999999962  1899999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||++......    ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...+.................
T Consensus       144 fg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  219 (308)
T cd06615         144 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEA  219 (308)
T ss_pred             CCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccc
Confidence            9998755321    123456889999999998888999999999999999999999998755433222211110000000


Q ss_pred             -------------------chhhhcc----CCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          876 -------------------ITDALDK----GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       876 -------------------~~~~~~~----~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                                         ..+..+.    ............++.+++.+||..||++||++.|+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                               0000000    00000001134568899999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-35  Score=317.78  Aligned_cols=252  Identities=24%  Similarity=0.312  Sum_probs=206.7

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|+||.||++++..+++.||+|.++....  ....+.+.+|+.+++.++||||+++.+++.+++..|+|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            47788999999999999999999999999999854332  3345678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++.....           ..+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.++++||
T Consensus        79 ~~~~~~l~~~~~~~~~-----------~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~df  144 (255)
T cd08219          79 YCDGGDLMQKIKLQRG-----------KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDF  144 (255)
T ss_pred             eCCCCcHHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEccc
Confidence            9999999999875432           3478889999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |.++.......  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..    .   
T Consensus       145 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~---  215 (255)
T cd08219         145 GSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ----G---  215 (255)
T ss_pred             Ccceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc----C---
Confidence            99976543221  22335688999999999998999999999999999999999999976543322221111    0   


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                             ...+.+...+..+.+++.+||+.||++||++.|++..
T Consensus       216 -------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         216 -------SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                   0111122234578899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-35  Score=316.67  Aligned_cols=250  Identities=25%  Similarity=0.357  Sum_probs=200.9

Q ss_pred             ceeeecCcEEEEEEEEcCCC---cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeec
Q 002085          642 NLIGSGGSGQVYRIDINGAG---EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYM  718 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  718 (969)
                      ++||+|+||.||+|.....+   ..||+|.+......  ...+.+.+|+++++.++||||+++++++. ....++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            46899999999999875544   78999998654332  44578999999999999999999999876 45689999999


Q ss_pred             cCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccc
Q 002085          719 ENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL  798 (969)
Q Consensus       719 ~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  798 (969)
                      ++++|.+++....             .+++..+..++.|++.|++|||..   +++||||||+||+++.++.+||+|||+
T Consensus        78 ~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~  141 (257)
T cd05060          78 PLGPLLKYLKKRR-------------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGM  141 (257)
T ss_pred             CCCcHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccc
Confidence            9999999998643             378999999999999999999988   999999999999999999999999999


Q ss_pred             ceecccCCCCcc-ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          799 AKMLAKQGEPHT-MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       799 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      ++.......... .....++..|+|||...+..++.++|||||||++|||++ |..||...+.......+.    .... 
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~----~~~~-  216 (257)
T cd05060         142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE----SGER-  216 (257)
T ss_pred             cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH----cCCc-
Confidence            987644322211 112224568999999999999999999999999999998 888886654433333221    1111 


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                               .+.+...+..+.+++.+||..+|++||++.++++.|++.
T Consensus       217 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 ---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                     112223346788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.4e-35  Score=317.80  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=199.8

Q ss_pred             eeeecCcEEEEEEEE--cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          643 LIGSGGSGQVYRIDI--NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       643 ~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      .||+|+||.||+|.+  ..++..||+|+++... .+....+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            589999999999965  4567899999885432 23445678999999999999999999999885 4567899999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      ++|.+++....             .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        80 ~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~  143 (257)
T cd05116          80 GPLNKFLQKNK-------------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSK  143 (257)
T ss_pred             CcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcccc
Confidence            99999997543             378999999999999999999988   99999999999999999999999999998


Q ss_pred             ecccCCCCcc-ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCchh
Q 002085          801 MLAKQGEPHT-MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITD  878 (969)
Q Consensus       801 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  878 (969)
                      .+........ .....+++.|+|||.+....++.++|||||||++|||++ |..||...........+    ....    
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i----~~~~----  215 (257)
T cd05116         144 ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI----ESGE----  215 (257)
T ss_pred             ccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HCCC----
Confidence            7644322211 122234678999999988889999999999999999998 88888765443322222    1111    


Q ss_pred             hhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       879 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                            ..+.+...+..+.+++.+||+.||++||++++|.+.|+..
T Consensus       216 ------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 ------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                  1112223446788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.2e-35  Score=316.14  Aligned_cols=250  Identities=24%  Similarity=0.362  Sum_probs=199.1

Q ss_pred             eeeecCcEEEEEEEEc--CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          643 LIGSGGSGQVYRIDIN--GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       643 ~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|++++++++||||+++++++. ....++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            3899999999999764  445679999885442  2444577999999999999999999999875 4578999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      ++|.+++....            ..+++..+++++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++
T Consensus        79 ~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~  143 (257)
T cd05115          79 GPLNKFLSGKK------------DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSK  143 (257)
T ss_pred             CCHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccc
Confidence            99999987543            2488999999999999999999988   99999999999999999999999999998


Q ss_pred             ecccCCCCcc-ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCchh
Q 002085          801 MLAKQGEPHT-MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITD  878 (969)
Q Consensus       801 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  878 (969)
                      .+........ .....++..|+|||.+.+..++.++|||||||++||+++ |..||...........+    ...     
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~-----  214 (257)
T cd05115         144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI----EQG-----  214 (257)
T ss_pred             cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----HCC-----
Confidence            6543222111 122234678999999988889999999999999999996 88888765443322221    111     


Q ss_pred             hhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       879 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                           ...+.+...+.++.+++.+||..||++||++.+|.+.|+..
T Consensus       215 -----~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         215 -----KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                 11122233457888999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=329.49  Aligned_cols=259  Identities=20%  Similarity=0.249  Sum_probs=202.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+++...+++.||+|++.+.........+.+.+|+.++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999999899999999996543333444567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 e~~~g~~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D  145 (331)
T cd05597          81 DYYVGGDLLTLLSKFE------------DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLAD  145 (331)
T ss_pred             ecCCCCcHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEE
Confidence            9999999999997532            2478889999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-----TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||++....... ........||+.|+|||++.+     ..++.++||||+||++|||++|+.||...........+.   
T Consensus       146 fg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~---  221 (331)
T cd05597         146 FGSCLRLLADG-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---  221 (331)
T ss_pred             CCceeecCCCC-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH---
Confidence            99987654322 122223468999999999863     457889999999999999999999997654432222111   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS--RPSMKEVLQI  920 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~  920 (969)
                       .......     +. +.....+..+.+++.+|+..++++  ||++.++++.
T Consensus       222 -~~~~~~~-----~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         222 -NHKEHFQ-----FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -cCCCccc-----CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence             1110000     00 011113456788888877654433  7899888864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-35  Score=319.17  Aligned_cols=255  Identities=32%  Similarity=0.420  Sum_probs=205.0

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |+..+.||+|+||+||+++...+++.||+|++....... .......+|+.++++++||||+++++++.+....++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence            567789999999999999999999999999997654322 2233445699999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++++|.+++....             .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        80 ~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg  143 (260)
T PF00069_consen   80 CPGGSLQDYLQKNK-------------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFG  143 (260)
T ss_dssp             ETTEBHHHHHHHHS-------------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGT
T ss_pred             cccccccccccccc-------------cccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            99999999998332             488999999999999999999998   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      .+..+  ...........++..|+|||.+. +..++.++||||+|+++|+|++|..||.............+.....  .
T Consensus       144 ~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~--~  219 (260)
T PF00069_consen  144 SSVKL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP--L  219 (260)
T ss_dssp             TTEES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH--H
T ss_pred             ccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc--c
Confidence            99764  12233445567899999999998 8889999999999999999999999998652222222221111100  0


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                         ... ..  ........+.+++.+||+.||++||++.++++
T Consensus       220 ---~~~-~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  220 ---PSS-SQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ---HHH-TT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ---ccc-cc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000 00  00011278999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-35  Score=317.81  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=202.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|++.. +..||+|.+.....    ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            457888999999999999998764 45699998854321    2356889999999999999999999999988999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....            ..+++..++.++.|++.|++|||+.   +++|+||||+||+++.++.+||+|
T Consensus        79 e~~~~~~l~~~i~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d  143 (256)
T cd05113          79 EYMSNGCLLNYLREHG------------KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSD  143 (256)
T ss_pred             EcCCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECC
Confidence            9999999999997543            2478999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||.++...... ........++..|+|||...+..++.++|||||||++|||++ |..||...........+.    ...
T Consensus       144 ~g~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~----~~~  218 (256)
T cd05113         144 FGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS----QGL  218 (256)
T ss_pred             CccceecCCCc-eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh----cCC
Confidence            99988654321 112223345678999999998889999999999999999999 888886544332222221    111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                      .          ...+...+..+.+++.+||+.||++||++.++++.++
T Consensus       219 ~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         219 R----------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             C----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            0          0111122468899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2e-35  Score=317.49  Aligned_cols=254  Identities=28%  Similarity=0.459  Sum_probs=202.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      .+|+..++||+|+||.||+|++..+ ..||+|++.....    ..+.+.+|++++++++||||+++++++. ....++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT   79 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence            4688999999999999999988654 4699999864322    1356889999999999999999999875 45689999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++.....           ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|
T Consensus        80 e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~d  145 (262)
T cd05071          80 EYMSKGSLLDFLKGEMG-----------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD  145 (262)
T ss_pred             EcCCCCcHHHHHhhccc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEecc
Confidence            99999999999975431           3478999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||.++.+..... .......++..|+|||+..+..++.++|||||||++|||++ |..||.+..........    ..  
T Consensus       146 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~----~~--  218 (262)
T cd05071         146 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----ER--  218 (262)
T ss_pred             CCceeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH----hc--
Confidence            999986643221 12223446778999999988899999999999999999999 66676554332221111    11  


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                              ....+...+.+..+.+++.+|++.||++||+++++++.|+..
T Consensus       219 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 --------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                    111122234457789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-35  Score=329.12  Aligned_cols=259  Identities=20%  Similarity=0.238  Sum_probs=204.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||.||+++...+++.||+|++.+...........+.+|+.++..++|++|+++.+++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888999999999999999999899999999986543333444566889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....            ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 ey~~~g~L~~~l~~~~------------~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~D  145 (332)
T cd05623          81 DYYVGGDLLTLLSKFE------------DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  145 (332)
T ss_pred             eccCCCcHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEee
Confidence            9999999999997643            2378889999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||++..+.... ........||+.|+|||++.     ...++.++|||||||++|||++|+.||...+.......+.   
T Consensus       146 fG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~---  221 (332)
T cd05623         146 FGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---  221 (332)
T ss_pred             cchheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh---
Confidence            99997653322 22223457999999999986     3467899999999999999999999998765433222221   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS--RPSMKEVLQI  920 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~~  920 (969)
                      ......      ... ......+..+.+++.+|+..++.+  |+++.|+++.
T Consensus       222 ~~~~~~------~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         222 NHKERF------QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCccc------cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            111000      000 111223467888999988665544  6889988764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-35  Score=322.48  Aligned_cols=253  Identities=24%  Similarity=0.320  Sum_probs=206.5

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      +...+|+..+.||+|+||.||+|....+++.||+|.+.....   ...+.+.+|+.+++.++|||++++++++..+...+
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence            345689999999999999999999988899999998864332   22467889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++++|.+++...              .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++
T Consensus        94 lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~k  156 (296)
T cd06654          94 VVMEYLAGGSLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK  156 (296)
T ss_pred             EeecccCCCCHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence            999999999999998642              278889999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      |+|||++.......  .......+++.|+|||.+.+..++.++|||||||++|||++|+.||..........   .....
T Consensus       157 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~---~~~~~  231 (296)
T cd06654         157 LTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATN  231 (296)
T ss_pred             ECccccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH---HHhcC
Confidence            99999987643221  12233468899999999998889999999999999999999999997654322111   11111


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...         ....+......+.+++.+||..||++||++.|+++
T Consensus       232 ~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         232 GTP---------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCC---------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            000         01112234467889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-35  Score=335.77  Aligned_cols=264  Identities=22%  Similarity=0.273  Sum_probs=203.4

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC-----ce
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN-----SK  711 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  711 (969)
                      +|+..++||+|+||.||+|.+..+++.||+|++.... .+....+.+.+|+++++.++||||+++++++...+     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            4678899999999999999998899999999885432 22334567889999999999999999999998766     78


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      |+||||+. ++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~  142 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQ-------------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVL  142 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCE
Confidence            99999996 67888776433             388999999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+++..... .........+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.........+....
T Consensus       143 kL~Dfg~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~  221 (372)
T cd07853         143 KICDFGLARVEEPD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL  221 (372)
T ss_pred             EeccccceeecccC-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence            99999999865332 22223345688999999998874 47899999999999999999999998765443333222211


Q ss_pred             hccCCch----------hhhccC-CCC-------cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          871 AEEKPIT----------DALDKG-IAE-------PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       871 ~~~~~~~----------~~~~~~-~~~-------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .. ....          ..+... ...       .........+.+++.+|++.||++|||+.|+++.
T Consensus       222 g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         222 GT-PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CC-CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            10 0000          000000 000       0011124678899999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.5e-35  Score=316.45  Aligned_cols=253  Identities=30%  Similarity=0.474  Sum_probs=203.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|++.++||+|+||.||+|... ++..||+|.+.....    ..+.+.+|+.++++++|++++++++++. ....+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT   79 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence            57888999999999999999876 466799999865332    1356899999999999999999999875 45689999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.++++....           ..+++.++..++.|++.|++|||+.   +++||||||+||++++++.++++|
T Consensus        80 e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~d  145 (260)
T cd05070          80 EYMSKGSLLDFLKDGEG-----------RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIAD  145 (260)
T ss_pred             EecCCCcHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCC
Confidence            99999999999975431           3478999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||.+..+..... .......++..|+|||...+..++.++||||||+++|||++ |..||.+.+..+..+.+..      
T Consensus       146 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~------  218 (260)
T cd05070         146 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER------  218 (260)
T ss_pred             ceeeeeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------
Confidence            999987643221 11222345678999999988899999999999999999999 7778766544333222211      


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                              ....+.+...+..+.+++.+|+..+|++|||++++.+.|++
T Consensus       219 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 --------GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --------CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                    11112223344679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.5e-35  Score=331.87  Aligned_cols=265  Identities=27%  Similarity=0.316  Sum_probs=202.1

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC---
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN---  709 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  709 (969)
                      .+.++|+..+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...+   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            46789999999999999999999999899999999986442 23344567889999999999999999999986543   


Q ss_pred             ---ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          710 ---SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       710 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                         ..|+||||+++ +|.+.++.               .+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~---------------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~  157 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIHM---------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK  157 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHhc---------------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEC
Confidence               47999999974 66666542               267888999999999999999988   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      .++.+||+|||+++....   ........||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.+........
T Consensus       158 ~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~  234 (359)
T cd07876         158 SDCTLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV  234 (359)
T ss_pred             CCCCEEEecCCCcccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999975422   22233457899999999999999999999999999999999999999866533221111


Q ss_pred             HHHhh------------------ccCC-c-----hhhhccCC---CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYA------------------EEKP-I-----TDALDKGI---AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~------------------~~~~-~-----~~~~~~~~---~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .....                  ...+ .     .+......   ...........+.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         235 IEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            11110                  0000 0     00000000   00001112356889999999999999999999987


Q ss_pred             H
Q 002085          920 I  920 (969)
Q Consensus       920 ~  920 (969)
                      .
T Consensus       315 h  315 (359)
T cd07876         315 H  315 (359)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=317.70  Aligned_cols=251  Identities=26%  Similarity=0.356  Sum_probs=202.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      .+|+..+.||+|+||.||+|.+. ++..+|+|++.....    ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            35788899999999999999886 466799998854321    1346788999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....            ..++|..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|
T Consensus        79 e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d  143 (256)
T cd05059          79 EYMANGCLLNYLRERK------------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSD  143 (256)
T ss_pred             ecCCCCCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECC
Confidence            9999999999997543            2488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++..... .........++..|+|||.+.+..++.++||||||+++|||++ |..||...+.......+.    .. 
T Consensus       144 fg~~~~~~~~-~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~----~~-  217 (256)
T cd05059         144 FGLARYVLDD-QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS----AG-  217 (256)
T ss_pred             cccceecccc-cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH----cC-
Confidence            9999865322 1111122234568999999999999999999999999999999 777876554433322221    11 


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                               .....+...+..+.+++.+||..+|++||++.|+++.|
T Consensus       218 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 ---------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                     11111122346899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-35  Score=326.10  Aligned_cols=272  Identities=25%  Similarity=0.371  Sum_probs=209.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-------CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-------AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS  707 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  707 (969)
                      ++|.+.+.||+|+||.||+|++..       ++..||+|.++...  .......+.+|+++++.+ +||||+++++++.+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            578899999999999999998643       23469999986532  233356788999999999 79999999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccC---CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSG---SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                      .+..|+||||+++|+|.+++..........   ........++|.+++.++.|++.||+|||+.   +++||||||+||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil  172 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  172 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence            999999999999999999998654211000   0011123589999999999999999999988   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchH
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLA  863 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~  863 (969)
                      +++++.++|+|||.++...............+++.|+|||.+.+..++.++||||+||++|||++ |..||.........
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            99999999999999876533211111222334578999999998899999999999999999998 77777554332222


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      ..+    ...          .....+...+..+.+++.+||..+|++||++.|+++.|+++.+
T Consensus       253 ~~~----~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         253 KLL----KEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             HHH----HcC----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            211    111          1111222334688899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=304.89  Aligned_cols=273  Identities=21%  Similarity=0.302  Sum_probs=219.4

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ..++|...++||+|.||.|-+++-+.+++.||+|+++++..........-..|-++++..+||.+..+.-.|+..++.++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            35678889999999999999999999999999999988877777777888899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+.||.|.-++...+             .+++.....+-..|..||.|||+.   +||+||+|.+|.++|.+|.+||
T Consensus       246 VMeyanGGeLf~HLsrer-------------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKi  309 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER-------------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKI  309 (516)
T ss_pred             EEEEccCceEeeehhhhh-------------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEe
Confidence            999999999998887654             488888889999999999999988   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      .|||+++.-.  ....++...+|||.|.|||++....|..+.|.|.+||++|||++|+.||+..+...+.+.+...   +
T Consensus       310 tDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e---d  384 (516)
T KOG0690|consen  310 TDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME---D  384 (516)
T ss_pred             eecccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh---h
Confidence            9999997532  2344566789999999999999999999999999999999999999999987665444433110   0


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCc-ccccCCCCCCCCCccccee
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGK-KMGRDVDSAPLLGTAGYLF  952 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  952 (969)
                                +  ..+...+++...++...+.+||.+|                  .|+. ....++..|++|+..+|+.
T Consensus       385 ----------~--kFPr~ls~eAktLLsGLL~kdP~kR------------------LGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  385 ----------L--KFPRTLSPEAKTLLSGLLKKDPKKR------------------LGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             ----------c--cCCccCCHHHHHHHHHHhhcChHhh------------------cCCCchhHHHHHhhhhhccCCHHH
Confidence                      0  0111112334444455555555544                  4433 4556777788888666554


Q ss_pred             ccccc
Q 002085          953 GFKRS  957 (969)
Q Consensus       953 ~~~~~  957 (969)
                      ..+|+
T Consensus       435 ~~~Kk  439 (516)
T KOG0690|consen  435 TYRKK  439 (516)
T ss_pred             HHHhc
Confidence            44444

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=326.06  Aligned_cols=259  Identities=23%  Similarity=0.315  Sum_probs=207.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|....+++.||+|.+...........+.+..|+++++.++||||+++++.+.+.+..|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999999889999999997654433345678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....           ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|
T Consensus        81 e~~~~~~L~~~~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~d  146 (316)
T cd05574          81 DYCPGGELFRLLQRQPG-----------KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSD  146 (316)
T ss_pred             EecCCCCHHHHHHhCCC-----------CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEee
Confidence            99999999999875432           3588999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCc---------------------------cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHH
Q 002085          796 FGLAKMLAKQGEPH---------------------------TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELV  848 (969)
Q Consensus       796 fgla~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell  848 (969)
                      ||++..........                           ......|+..|+|||++.+..++.++||||||+++|+|+
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~  226 (316)
T cd05574         147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML  226 (316)
T ss_pred             cchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHh
Confidence            99987553221100                           111235788999999999988999999999999999999


Q ss_pred             hCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          849 TGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       849 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      +|..||.+.+.......+.             ......+.....+..+.+++.+||+.||++||+++..++.+
T Consensus       227 ~g~~pf~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l  286 (316)
T cd05574         227 YGTTPFKGSNRDETFSNIL-------------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI  286 (316)
T ss_pred             hCCCCCCCCchHHHHHHHh-------------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence            9999997655432221111             11111111112457899999999999999999954444433

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.2e-35  Score=323.44  Aligned_cols=269  Identities=26%  Similarity=0.336  Sum_probs=207.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCc--EEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGE--FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  712 (969)
                      ++|+..+.||+|+||.||+|....++.  .+++|.++...  .....+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            578889999999999999999876664  47888775321  233456789999999999 7999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCcccc---CCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      +|+||+++++|.+++.........   .........+++..+..++.|++.|++|||+.   +|+||||||+||++++++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence            999999999999999764421110   00111123588999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  868 (969)
                      .+||+|||++.....   .........+..|+|||+..+..++.++|||||||++|||++ |..||............  
T Consensus       157 ~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~--  231 (297)
T cd05089         157 ASKIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL--  231 (297)
T ss_pred             eEEECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence            999999999864211   111111233567999999998899999999999999999998 88898765443322211  


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                        ..          +...+.+...+..+.+++.+||+.+|.+||+++++++.|+.+..
T Consensus       232 --~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         232 --PQ----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             --hc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              11          11111122234678899999999999999999999999988863

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.4e-36  Score=328.27  Aligned_cols=260  Identities=25%  Similarity=0.298  Sum_probs=208.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-c-----CceeeEEEEEEcCC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-H-----ANIVKLWCCISSEN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~  709 (969)
                      .+|.+.+.||+|+||+|.+|.+..+++.||||+++...    ........|+++|..++ |     -|+|+++++|.-.+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            37889999999999999999999999999999997653    33456778999999996 4     38999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      +.|||+|.+. .+|+++++...-           ..++...+..|+.||+.||.+||+.   +|||+||||+|||+.+.+
T Consensus       262 HlciVfELL~-~NLYellK~n~f-----------~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~  326 (586)
T KOG0667|consen  262 HLCIVFELLS-TNLYELLKNNKF-----------RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPK  326 (586)
T ss_pred             ceeeeehhhh-hhHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCC
Confidence            9999999995 899999998764           4588999999999999999999998   999999999999997654


Q ss_pred             --cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          790 --KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       790 --~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                        .|||+|||.|++..+.     .....-+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+++..+....+.
T Consensus       327 r~~vKVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~  401 (586)
T KOG0667|consen  327 RSRIKVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARII  401 (586)
T ss_pred             cCceeEEecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHH
Confidence              7999999999875332     225667889999999999999999999999999999999988887776555444443


Q ss_pred             HHhhccC--------Cchhhhcc-------------------------------CCCCc---------ccHHHHHHHHHH
Q 002085          868 RHYAEEK--------PITDALDK-------------------------------GIAEP---------CYLEEMTTVYRL  899 (969)
Q Consensus       868 ~~~~~~~--------~~~~~~~~-------------------------------~~~~~---------~~~~~~~~~~~l  899 (969)
                      +.+....        ......+.                               ....+         ........+.++
T Consensus       402 e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~df  481 (586)
T KOG0667|consen  402 EVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDF  481 (586)
T ss_pred             HHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHH
Confidence            2211000        00000000                               00011         011234678999


Q ss_pred             HHHccCCCCCCCCCHHHHHH
Q 002085          900 ALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       900 ~~~cl~~dP~~RPs~~evl~  919 (969)
                      +++|+.+||.+|+|+.|+++
T Consensus       482 lk~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  482 LKRCLEWDPAERITPAQALN  501 (586)
T ss_pred             HHHHhccCchhcCCHHHHhc
Confidence            99999999999999999986

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.9e-35  Score=321.18  Aligned_cols=266  Identities=21%  Similarity=0.302  Sum_probs=211.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-CCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-ENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  710 (969)
                      ++|+..+.||+|+||.||+|.+..    .+..||+|++...  ......+.+.+|+.++++++||||+++++++.. +..
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            468888999999999999999865    2578999988543  234456788999999999999999999998765 577


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++++||+++++|.+++.......     ......+++.+++.++.|++.||+|||+.   +++||||||+||++++++.
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGE-----ANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccc-----cccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCc
Confidence            899999999999999997654211     00124589999999999999999999988   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  869 (969)
                      +|++|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||...+......++.  
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--  233 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK--  233 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH--
Confidence            99999999986543322222223456778999999998889999999999999999999 888887655433322221  


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                        ....          .......+..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus       234 --~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         234 --DGYR----------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             --cCCC----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence              1111          1111223467899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-35  Score=315.82  Aligned_cols=258  Identities=27%  Similarity=0.427  Sum_probs=208.4

Q ss_pred             ceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeec
Q 002085          642 NLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYM  718 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  718 (969)
                      +.||+|+||.||+|.....   +..||+|.+......  ...+.+.+|+++++.++|+|++++++++.+....++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4689999999999999865   889999998654332  24678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccc
Q 002085          719 ENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL  798 (969)
Q Consensus       719 ~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  798 (969)
                      ++++|.+++.......    .......+++..++.++.|++.|++|||+.   +++||||+|+||++++++.++++|||.
T Consensus        79 ~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          79 EGGDLLDYLRKSRPVF----PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             cCCcHHHHHhhccccc----cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence            9999999998753110    001124589999999999999999999988   999999999999999999999999999


Q ss_pred             ceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          799 AKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       799 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      +................+++.|+|||.+.+..++.++||||+||++|||++ |..||.........+...    ..    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~----~~----  223 (262)
T cd00192         152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR----KG----  223 (262)
T ss_pred             ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH----cC----
Confidence            987654332233445567889999999998899999999999999999999 577877654433322221    11    


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                            .....+...+.++.+++.+||+.+|++||++.|+++.|+
T Consensus       224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  111122233578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2e-35  Score=318.53  Aligned_cols=258  Identities=26%  Similarity=0.426  Sum_probs=207.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCC---cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAG---EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      .+|++.+.||+|+||.||+|++..++   ..||+|.++...  .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            46788899999999999999875443   379999885432  2344578999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++++|.+++....            ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++
T Consensus        82 lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~  146 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHD------------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCK  146 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEE
Confidence            9999999999999997543            2478999999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCc-cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          793 IADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ++|||++..+....... ......++..|+|||++.+..++.++|||||||++||+++ |..||...........+.   
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---  223 (267)
T cd05066         147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE---  223 (267)
T ss_pred             eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh---
Confidence            99999998764322111 1122234578999999998899999999999999999887 999987655433333221   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                       ...          ..+.....+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       224 -~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         224 -EGY----------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -CCC----------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence             111          1111222346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-35  Score=318.87  Aligned_cols=256  Identities=24%  Similarity=0.272  Sum_probs=202.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|++.+.||+|+||.||+|+...+++.||+|++....   ......+.+|+.++++++||||+++++++..++..++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            357999999999999999999998899999999985432   12235688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.++++...             .+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+
T Consensus        85 ~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~  148 (267)
T cd06646          85 MEYCGGGSLQDIYHVTG-------------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLA  148 (267)
T ss_pred             EeCCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEC
Confidence            99999999999987543             378899999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |||+++.+....  .......|++.|+|||.+.   ...++.++||||+||++|||++|+.||............     
T Consensus       149 dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----  221 (267)
T cd06646         149 DFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----  221 (267)
T ss_pred             cCccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----
Confidence            999998663221  1123346889999999874   445788999999999999999999998654321110000     


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      ....   ...+..  ......+..+.+++.+||..||++||+++++++.+
T Consensus       222 ~~~~---~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         222 SKSN---FQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ecCC---CCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0000   000000  01112346789999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3e-35  Score=324.97  Aligned_cols=271  Identities=25%  Similarity=0.372  Sum_probs=209.3

Q ss_pred             cCCCccceeeecCcEEEEEEEEc-------CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDIN-------GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS  707 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  707 (969)
                      ++|.+.++||+|+||.||+|+..       .....||+|.++...  .......+.+|+++++++ +||||+++++++.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            46788899999999999999763       234579999886432  233456788999999999 69999999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccC---CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSG---SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                      .+..++||||+++|+|.+++..........   ........++|.++..++.|++.|++|||+.   +++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence            999999999999999999998654211110   0111224589999999999999999999988   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchH
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLA  863 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~  863 (969)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+.......
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999986543221111222234568999999998899999999999999999999 77787655433333


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ....    ....          ...+...+..+.+++.+||..||++||++.|+++.|+++.
T Consensus       247 ~~~~----~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         247 KLLR----EGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HHHH----cCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            2221    1110          0112223457889999999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2e-35  Score=325.72  Aligned_cols=265  Identities=21%  Similarity=0.317  Sum_probs=204.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|...+.||+|+||.||+|++..+++.||+|.++....  ......+.+|++++++++||||+++++++..++..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            3578999999999999999999998999999999864332  22234677899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++ ++|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        83 ~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~  146 (309)
T cd07872          83 FEYLD-KDLKQYMDDCG------------NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLA  146 (309)
T ss_pred             EeCCC-CCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEC
Confidence            99997 58888886543            2478889999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++.....  ........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+..+....+.+.....
T Consensus       147 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  224 (309)
T cd07872         147 DFGLARAKSVP--TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP  224 (309)
T ss_pred             ccccceecCCC--ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999764322  122233467899999998865 468899999999999999999999997765443333322221110


Q ss_pred             CC-----------chhhhccCCCC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KP-----------ITDALDKGIAE----PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~-----------~~~~~~~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..           ....-.+....    ......+.++.+++.+|++.||.+|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         225 TEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00           00000000000    000122456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=4.2e-38  Score=337.43  Aligned_cols=368  Identities=25%  Similarity=0.359  Sum_probs=220.0

Q ss_pred             ccEEEccCCCCC-CCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecc
Q 002085           99 LTTIDLSSNSIP-GEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLY  177 (969)
Q Consensus        99 L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  177 (969)
                      ++-.|+++|.++ +.+|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..++.|+.|+.+.+.
T Consensus         9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R   86 (1255)
T KOG0444|consen    9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR   86 (1255)
T ss_pred             eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence            344444444444 234444444444444444444444 44444444444444444444444 333334444444444444


Q ss_pred             cccccC-cCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCC
Q 002085          178 MNEFNG-TFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLE  256 (969)
Q Consensus       178 ~N~l~~-~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  256 (969)
                      .|++.. -+|..+..|..|+.||||+|+   ....|..+..-+++-.|+|++|++.++.-.-|.+++.|-.||||+|++.
T Consensus        87 ~N~LKnsGiP~diF~l~dLt~lDLShNq---L~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe  163 (1255)
T KOG0444|consen   87 DNNLKNSGIPTDIFRLKDLTILDLSHNQ---LREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE  163 (1255)
T ss_pred             ccccccCCCCchhcccccceeeecchhh---hhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence            444431 234444444444444444442   1222333333333333333333333322234566777777777777776


Q ss_pred             CCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCccccc
Q 002085          257 GAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGV  336 (969)
Q Consensus       257 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  336 (969)
                       .+|+.+..+.+|++|.|++|.+.                       -.--..+..+++|+.|.+++.+=+         
T Consensus       164 -~LPPQ~RRL~~LqtL~Ls~NPL~-----------------------hfQLrQLPsmtsL~vLhms~TqRT---------  210 (1255)
T KOG0444|consen  164 -MLPPQIRRLSMLQTLKLSNNPLN-----------------------HFQLRQLPSMTSLSVLHMSNTQRT---------  210 (1255)
T ss_pred             -hcCHHHHHHhhhhhhhcCCChhh-----------------------HHHHhcCccchhhhhhhcccccch---------
Confidence             56666666666777666666653                       111123445677777777766533         


Q ss_pred             ccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCc-cccccccEEEeeccccCC
Q 002085          337 VAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPS-KTAWNLTRLEISNNRFSG  415 (969)
Q Consensus       337 l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~L~~L~Ls~N~l~~  415 (969)
                             ...+|.++..+.+|+.+|||.|.+. .+|+.+.++.+|+.|+||+|+|+..--. ..-.+|++|+||+|+++ 
T Consensus       211 -------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-  281 (1255)
T KOG0444|consen  211 -------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-  281 (1255)
T ss_pred             -------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-
Confidence                   1256777778888888888888888 8888888888888888888888732111 11236777777777777 


Q ss_pred             CcccccCCcccchhhcccCCcccc-ccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccc
Q 002085          416 QIQRGVGSWKNLIVFKASNNLFSG-EIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIG  494 (969)
Q Consensus       416 ~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  494 (969)
                      ..|..++.++.|+.|.+.+|+++- -+|..++.+.+|+.+..++|.|. ..|+.+..|.+|+.|.|++|+|- .+|+++-
T Consensus       282 ~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIH  359 (1255)
T KOG0444|consen  282 VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIH  359 (1255)
T ss_pred             cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhh
Confidence            667777777777777777777653 36777777777777777777776 67777777777777777777776 5777777


Q ss_pred             cccccceEeccCccccccCCCc
Q 002085          495 SLLVMVSLDLSGNQFSGEIPPE  516 (969)
Q Consensus       495 ~l~~L~~L~ls~N~l~g~~p~~  516 (969)
                      -|+.|+.|||..|+=- .+|+.
T Consensus       360 lL~~l~vLDlreNpnL-VMPPK  380 (1255)
T KOG0444|consen  360 LLPDLKVLDLRENPNL-VMPPK  380 (1255)
T ss_pred             hcCCcceeeccCCcCc-cCCCC
Confidence            7777777777777654 45543

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-35  Score=319.34  Aligned_cols=258  Identities=24%  Similarity=0.367  Sum_probs=208.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCc----EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGE----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .+|+..+.||+|+||.||+|.+..+|+    .||+|.......  ......+.+|++++++++|||++++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            467888999999999999999876554    589998754432  3445788999999999999999999999887 788


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++|+|.+++....            ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~  148 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHK------------DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHV  148 (279)
T ss_pred             EEEEecCCCCcHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeE
Confidence            99999999999999997643            2388999999999999999999987   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||.++...............++..|+|||......++.++|+|||||++||+++ |+.||.+....++...+.   
T Consensus       149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---  225 (279)
T cd05057         149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE---  225 (279)
T ss_pred             EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh---
Confidence            9999999987653322222222334678999999988899999999999999999998 999987655433332221   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                       ...          ..+.+......+.+++.+||..||++||++.++++.|.++.
T Consensus       226 -~~~----------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         226 -KGE----------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             -CCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence             111          11112223357889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.9e-35  Score=315.23  Aligned_cols=249  Identities=27%  Similarity=0.391  Sum_probs=201.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEE-cCCceEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCIS-SENSKLLV  714 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv  714 (969)
                      ++|+..+.||+|+||.||++...  |..||+|.+....     ..+.+.+|+.++++++|+|++++++++. +++..++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            47888899999999999999874  7789999885432     2467889999999999999999999764 55678999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++.....           ..+++..++.++.|++.|++|||+.   +++||||||+||++++++.+|++
T Consensus        79 ~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~  144 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGR-----------SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVS  144 (256)
T ss_pred             EECCCCCcHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEec
Confidence            999999999999976442           3478999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++.....     .....++..|+|||+..+..++.++|||||||++|||++ |+.||...........+....   
T Consensus       145 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---  216 (256)
T cd05082         145 DFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---  216 (256)
T ss_pred             CCccceecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---
Confidence            99998754321     122344678999999998899999999999999999998 888876544333322221110   


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                                 ....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       217 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 -----------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                       0111122346789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.9e-35  Score=328.53  Aligned_cols=258  Identities=19%  Similarity=0.237  Sum_probs=203.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||+||+++...+++.||+|++.............+.+|+.++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999999999999999986543333444566889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||++||+|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 Ey~~gg~L~~~l~~~~------------~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~D  145 (331)
T cd05624          81 DYYVGGDLLTLLSKFE------------DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLAD  145 (331)
T ss_pred             eCCCCCcHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEe
Confidence            9999999999997632            2478889999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-----TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+++.+.... ........||+.|+|||++.+     +.++.++||||+||++|||++|+.||...+.......+.   
T Consensus       146 fG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~---  221 (331)
T cd05624         146 FGSCLKMNQDG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---  221 (331)
T ss_pred             ccceeeccCCC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH---
Confidence            99998664322 122233569999999999875     467889999999999999999999998665433222111   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS--RPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~  919 (969)
                      ...... .     .. ....+.+..+.+++.+|+..++.+  |++++++++
T Consensus       222 ~~~~~~-~-----~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         222 NHEERF-Q-----FP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cCCCcc-c-----CC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            111000 0     00 011123467888999999866544  467887765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-35  Score=330.75  Aligned_cols=272  Identities=24%  Similarity=0.363  Sum_probs=205.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEc-----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC-
Q 002085          636 SSLTESNLIGSGGSGQVYRIDIN-----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE-  708 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  708 (969)
                      ++|+..+.||+|+||.||+|.+.     .+++.||||+++...  .......+.+|+.++.++ +||||+++++++... 
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            47899999999999999999852     457789999986432  223356788999999999 689999999987654 


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCcccc----------------------------------------------------
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVS----------------------------------------------------  736 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~----------------------------------------------------  736 (969)
                      ...++||||+++|+|.++++........                                                    
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            5678999999999999999754311000                                                    


Q ss_pred             --CCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCcccccc
Q 002085          737 --GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV  814 (969)
Q Consensus       737 --~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  814 (969)
                        .........++|..+..++.|++.|++|||+.   +|+||||||+||++++++.+|++|||+++.+............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence              00001123578999999999999999999988   9999999999999999999999999999865332222222234


Q ss_pred             ccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHH
Q 002085          815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEM  893 (969)
Q Consensus       815 ~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (969)
                      .+++.|+|||.+.+..++.++||||||+++|||++ |..||........   ..........          ...+....
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~----------~~~~~~~~  308 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGTR----------MRAPDYTT  308 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---HHHHHhccCC----------CCCCCCCC
Confidence            46678999999998899999999999999999997 7778765332211   1111111111          00111123


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          894 TTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       894 ~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..+.+++..||+.||++||++.|+++.|+.+.
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            57899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.8e-35  Score=321.38  Aligned_cols=264  Identities=25%  Similarity=0.324  Sum_probs=198.2

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc---ccCceeeEEEEEEc-----C
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI---RHANIVKLWCCISS-----E  708 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~  708 (969)
                      +|+..+.||+|+||.||+|++..+++.||+|.++..... ......+.+|+++++.+   +||||+++++++.+     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            478889999999999999999999999999998643221 11123455677777665   69999999998764     2


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      ...++||||++ ++|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~  144 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVPP-----------PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG  144 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence            45789999997 589988875432           3488999999999999999999988   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +.+||+|||+++.....   .......||..|+|||++.+..++.++||||+||++|||++|+.||.+.........+..
T Consensus       145 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~  221 (288)
T cd07863         145 GQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  221 (288)
T ss_pred             CCEEECccCccccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence            99999999999866322   122335688999999999998999999999999999999999999876554333322222


Q ss_pred             HhhccC--Cchhh-------hccCCC---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEK--PITDA-------LDKGIA---EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~--~~~~~-------~~~~~~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ......  .....       ..+...   .....+....+.+++.+|++.||++||++.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         222 LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            111100  00000       000000   0011123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.5e-35  Score=317.20  Aligned_cols=249  Identities=23%  Similarity=0.347  Sum_probs=199.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..++||+|+||.||+|.+..+++.||+|++....  .......+.+|++++++++||||+++++++..++..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            5778899999999999999998899999999985432  23445679999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|..+.                 .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+||
T Consensus        80 ~~~~~~l~~~~-----------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~df  139 (279)
T cd06619          80 FMDGGSLDVYR-----------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDF  139 (279)
T ss_pred             cCCCCChHHhh-----------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeC
Confidence            99999997542                 267788899999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccch---HHHHHHHhhcc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL---AEWAWRHYAEE  873 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~  873 (969)
                      |++......    ......|+..|+|||++.+..++.++|||||||++|||++|+.||........   ...........
T Consensus       140 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  215 (279)
T cd06619         140 GVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE  215 (279)
T ss_pred             Ccceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc
Confidence            999765322    22345789999999999998999999999999999999999999865322110   00000110000


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .      ....   .....+.++.+++.+||+.||++||++.|+++.
T Consensus       216 ~------~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         216 D------PPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             C------CCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0      0000   011123578899999999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-35  Score=335.10  Aligned_cols=260  Identities=20%  Similarity=0.252  Sum_probs=199.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ..|.+.+.||+|+||.||+|.+..+++.||||....         ..+.+|++++++++||||+++++++..++..++||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            468889999999999999999999999999996421         34568999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |++. ++|.+++....            ..++|..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       240 e~~~-~~L~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~D  303 (461)
T PHA03211        240 PKYR-SDLYTYLGARL------------RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGD  303 (461)
T ss_pred             EccC-CCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcc
Confidence            9995 78998886543            2489999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc--------chHHHHH
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT--------SLAEWAW  867 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~--------~~~~~~~  867 (969)
                      ||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|..+++.....        .+.+.+.
T Consensus       304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~  383 (461)
T PHA03211        304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR  383 (461)
T ss_pred             cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence            99998764322222223456999999999999999999999999999999999988776542211        1111111


Q ss_pred             HHhhccCCchh--------hh--------ccCCCCccc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          868 RHYAEEKPITD--------AL--------DKGIAEPCY---LEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       868 ~~~~~~~~~~~--------~~--------~~~~~~~~~---~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ...........        ..        ......+.+   ......+.+++.+||+.||.+|||+.|+++.
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11000000000        00        000000000   1123468899999999999999999999873

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.2e-35  Score=315.44  Aligned_cols=253  Identities=26%  Similarity=0.327  Sum_probs=204.7

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc------HHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN------QKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      +|...+.||+|+||.||+|.+..+++.||+|.+.......      ....+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999998889999999886543221      2334678999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||+++++|.+++....             .+++..+..++.|++.|++|||+.   +++||||+|+||++++++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~  144 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-------------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGG  144 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-------------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCC
Confidence            999999999999999997643             378889999999999999999988   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCc----cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPH----TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      ++|+|||.++.+.......    ......|+..|+|||.+.+..++.++||||+||++|||++|+.||............
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  224 (267)
T cd06628         145 IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI  224 (267)
T ss_pred             EEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH
Confidence            9999999998764321111    112345888999999999889999999999999999999999999764322111110


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .    .          ......+...+..+.+++.+||+.||.+||++.|+++
T Consensus       225 ~----~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 G----E----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             h----c----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            0    0          0011112233467889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3e-35  Score=330.88  Aligned_cols=265  Identities=24%  Similarity=0.280  Sum_probs=202.8

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC----
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE----  708 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  708 (969)
                      ...++|+..+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            456899999999999999999999988899999999864322 334456788999999999999999999988643    


Q ss_pred             --CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          709 --NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       709 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                        ...|+||||++ +++.+.+..               .+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        93 ~~~~~~lv~e~~~-~~l~~~~~~---------------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~  153 (355)
T cd07874          93 EFQDVYLVMELMD-ANLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK  153 (355)
T ss_pred             ccceeEEEhhhhc-ccHHHHHhh---------------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEC
Confidence              35699999997 467666642               277888999999999999999988   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      .++.+||+|||+++....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+........
T Consensus       154 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (355)
T cd07874         154 SDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV  230 (355)
T ss_pred             CCCCEEEeeCcccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999976422   22233457899999999999999999999999999999999999999765533222211


Q ss_pred             HHHhhccC---------Cchhhhc---------------cCC---CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEK---------PITDALD---------------KGI---AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~---------~~~~~~~---------------~~~---~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...+....         ......+               ...   ...........+.+++.+|++.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence            11110000         0000000               000   00011112356789999999999999999999997


Q ss_pred             H
Q 002085          920 I  920 (969)
Q Consensus       920 ~  920 (969)
                      .
T Consensus       311 h  311 (355)
T cd07874         311 H  311 (355)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.3e-35  Score=314.64  Aligned_cols=253  Identities=29%  Similarity=0.454  Sum_probs=202.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|...+.||+|+||.||+|.+... ..||+|.+.....    ..+.+.+|++++++++|||++++++++. .+..++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT   79 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence            4578889999999999999988654 4699998754322    2356889999999999999999998875 45688999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.++++....           ..++|..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|
T Consensus        80 e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~d  145 (260)
T cd05069          80 EFMGKGSLLDFLKEGDG-----------KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIAD  145 (260)
T ss_pred             EcCCCCCHHHHHhhCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECC
Confidence            99999999999975432           3478999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||.++....... .......++..|+|||...+..++.++|||||||++|||++ |..||.+........++..    ..
T Consensus       146 fg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~  220 (260)
T cd05069         146 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER----GY  220 (260)
T ss_pred             CccceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----CC
Confidence            999986643211 11223346678999999998899999999999999999999 7778766544332222211    10


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                                ..+.+...+..+.+++.+||+.||++||+++++++.|++
T Consensus       221 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 ----------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                      111222345778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.3e-35  Score=322.88  Aligned_cols=258  Identities=26%  Similarity=0.375  Sum_probs=205.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCc----EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGE----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ++|+..+.||+|+||.||+|.+..+++    .||+|.+....  .......+.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            467788999999999999999876665    47888875432  233345788999999999999999999998754 46


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++++||+++|+|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~  148 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHK------------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHV  148 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCce
Confidence            79999999999999987643            2478899999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.........+.   
T Consensus       149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~---  225 (303)
T cd05110         149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE---  225 (303)
T ss_pred             EEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---
Confidence            9999999987643322222233446778999999998899999999999999999997 888886654333222221   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                       ....          .+.+...+..+.+++..||..+|++||+++++++.++++.
T Consensus       226 -~~~~----------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         226 -KGER----------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             -CCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             1111          0111123357889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5e-35  Score=347.80  Aligned_cols=267  Identities=22%  Similarity=0.340  Sum_probs=207.2

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc--CCc
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS--ENS  710 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~  710 (969)
                      ....+|.+.+.||+|+||+||+|++..++..||+|++.... ........+..|+.+++.++||||+++++++.+  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~-l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG-LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc-cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            45678999999999999999999999999999999986443 234445788999999999999999999998854  456


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC----CCCeEecCCCCCcEEEC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC----TPQIIHRDVKSSNILLD  786 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~ivH~Dlkp~Nill~  786 (969)
                      .|+||||+++|+|.+++......         ...+++..++.|+.||+.||+|||...    .++||||||||+|||++
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~---------~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~  159 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKM---------FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS  159 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence            89999999999999999754221         134899999999999999999999752    13699999999999996


Q ss_pred             CC-----------------CcEEEeecccceecccCCCCccccccccCcccCchhhccc--CCCCCccchhhHHHHHHHH
Q 002085          787 SE-----------------FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT--TKVNEKIDIYSFGVVLLEL  847 (969)
Q Consensus       787 ~~-----------------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~el  847 (969)
                      .+                 +.+||+|||++..+...   .......||+.|+|||++.+  ..++.++|||||||++|||
T Consensus       160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             cCccccccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence            42                 34899999999865322   12234578999999999864  4588999999999999999


Q ss_pred             HhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HHHhhcC
Q 002085          848 VTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL--QILRRCC  925 (969)
Q Consensus       848 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl--~~L~~~~  925 (969)
                      ++|..||.......  . +.........        ..   ....+..+.+++..||..+|.+||++.|++  ..+..+.
T Consensus       237 LTGk~PF~~~~~~~--q-li~~lk~~p~--------lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        237 CSGKTPFHKANNFS--Q-LISELKRGPD--------LP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HHCCCCCCcCCcHH--H-HHHHHhcCCC--------CC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            99999997543321  1 1111111110        00   011236788999999999999999999998  4555554


Q ss_pred             C
Q 002085          926 P  926 (969)
Q Consensus       926 ~  926 (969)
                      +
T Consensus       303 ~  303 (1021)
T PTZ00266        303 P  303 (1021)
T ss_pred             C
Confidence            3

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.7e-35  Score=314.39  Aligned_cols=258  Identities=23%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             ceeeecCcEEEEEEEEcC--CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeecc
Q 002085          642 NLIGSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      +.||+|+||.||+|....  ++..+|+|.+.....  ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            368999999999998643  456799998854432  2334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccc
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA  799 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  799 (969)
                      +|+|.+++......        .....++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+
T Consensus        79 ~g~L~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~  147 (269)
T cd05087          79 LGDLKGYLRSCRKA--------ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS  147 (269)
T ss_pred             CCcHHHHHHHhhhc--------ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccc
Confidence            99999999764321        012467788889999999999999988   9999999999999999999999999998


Q ss_pred             eecccCCCCccccccccCcccCchhhcccC-------CCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhh
Q 002085          800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-------KVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       800 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      +...............++..|+|||++.+.       .++.++|||||||++|||++ |..||..............   
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~---  224 (269)
T cd05087         148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR---  224 (269)
T ss_pred             ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---
Confidence            754332222222334578899999988642       35789999999999999996 8888865443322211111   


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                      ..  ......+...    ......+.+++..|| .+|++||+++||++.|+
T Consensus       225 ~~--~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         225 EQ--QLKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cc--cCCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            10  0111111111    112356788999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.2e-35  Score=320.92  Aligned_cols=262  Identities=24%  Similarity=0.324  Sum_probs=211.1

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .+..++|+..+.||+|+||.||+|....+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++..++..
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            3455789999999999999999999988899999999854322   2346688999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++++|.+++...              .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+
T Consensus        92 ~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~  154 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTET--------------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSV  154 (297)
T ss_pred             EEeecccCCCCHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence            9999999999999998642              378889999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      +++|||++.......  .......+++.|+|||.+.+..++.++|||||||++|+|++|..||...+........   ..
T Consensus       155 ~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~  229 (297)
T cd06656         155 KLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---AT  229 (297)
T ss_pred             EECcCccceEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---cc
Confidence            999999987653321  1223356889999999999988999999999999999999999999765432111100   00


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcCCC
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRCCPT  927 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~~~~  927 (969)
                      ...+         ....+...+..+.+++.+||+.+|++||+++++++  .++.+.+.
T Consensus       230 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         230 NGTP---------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             CCCC---------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence            0000         00112233466889999999999999999999997  55555543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.3e-35  Score=326.62  Aligned_cols=271  Identities=25%  Similarity=0.375  Sum_probs=209.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-------CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-------AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS  707 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  707 (969)
                      .+|++.+.||+|+||.||+|++..       ++..||+|.++...  .....+.+.+|+++++++ +||||+++++++.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            368889999999999999998642       22369999875432  234457899999999999 79999999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccC---CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSG---SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                      .+..+++|||+++|+|.+++..........   ........++|.++..++.|++.||+|||+.   +++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence            999999999999999999998653211100   0011234588999999999999999999988   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchH
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLA  863 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~  863 (969)
                      +++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+.......
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999986643222222223345678999999999999999999999999999999 77777655433322


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..+.    ...          ..+.+...+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus       247 ~~~~----~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         247 KLLK----EGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHH----cCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            2221    111          11112223467889999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.8e-35  Score=313.13  Aligned_cols=251  Identities=26%  Similarity=0.385  Sum_probs=202.9

Q ss_pred             ceeeecCcEEEEEEEEcC-CC--cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeec
Q 002085          642 NLIGSGGSGQVYRIDING-AG--EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYM  718 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  718 (969)
                      ++||+|++|.||+|.+.. .+  ..||+|.+......  ...+.+.+|++++++++||||+++++++.+ ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999999854 33  36999998654432  556789999999999999999999999988 8899999999


Q ss_pred             cCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccc
Q 002085          719 ENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL  798 (969)
Q Consensus       719 ~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  798 (969)
                      ++++|.+++.....           ..++|..++.++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||+
T Consensus        78 ~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~  143 (257)
T cd05040          78 PLGSLLDRLRKDAL-----------GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGL  143 (257)
T ss_pred             CCCcHHHHHHhccc-----------ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccc
Confidence            99999999986431           2488999999999999999999988   999999999999999999999999999


Q ss_pred             ceecccCCCCcc-ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          799 AKMLAKQGEPHT-MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       799 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      ++.+........ .....++..|+|||++.+..++.++|||||||++|||++ |..||..............   ...  
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~--  218 (257)
T cd05040         144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK---EGE--  218 (257)
T ss_pred             cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---cCC--
Confidence            987654322221 223457789999999999999999999999999999999 9999865544333222211   100  


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                              ....+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       219 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 --------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                    01112223467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.7e-35  Score=314.37  Aligned_cols=253  Identities=26%  Similarity=0.416  Sum_probs=204.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||.||+|... +++.||+|.+.....    ....+.+|++++++++|||++++++++. .+..+++|
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            56888999999999999999865 578899998864332    2357889999999999999999998874 45789999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....           ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++|
T Consensus        80 e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d  145 (260)
T cd05067          80 EYMENGSLVDFLKTPEG-----------IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIAD  145 (260)
T ss_pred             EcCCCCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEcc
Confidence            99999999999875432           3488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||++....... ........++..|+|||++.+..++.++||||||+++||+++ |+.||.+.+...........     
T Consensus       146 fg~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----  219 (260)
T cd05067         146 FGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-----  219 (260)
T ss_pred             CcceeecCCCC-cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-----
Confidence            99997764221 112223346778999999998899999999999999999999 88888765543333222111     


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                               ...+.+...+.++.+++.+||+.+|++||+++++...|+.
T Consensus       220 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         220 ---------YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                     1111122234679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-35  Score=333.99  Aligned_cols=261  Identities=24%  Similarity=0.273  Sum_probs=201.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcC--CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ..+|.+.+.||+|+||.||+|...+  .++.||+|.+...        ....+|++++++++||||+++++++......+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            3479999999999999999997643  4678999987432        23567999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+. ++|.+++....             .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++
T Consensus       163 lv~e~~~-~~l~~~l~~~~-------------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~  225 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSG-------------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAV  225 (392)
T ss_pred             EEehhcC-CCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEE
Confidence            9999995 78888885332             489999999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      |+|||+++.+.............||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+......
T Consensus       226 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~  305 (392)
T PHA03207        226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC  305 (392)
T ss_pred             EccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence            99999998665433333334567999999999999999999999999999999999999999875543222111111100


Q ss_pred             c--CC----------chhh---hccCCCCccc-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          873 E--KP----------ITDA---LDKGIAEPCY-------LEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       873 ~--~~----------~~~~---~~~~~~~~~~-------~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .  .+          +.+.   .......+..       .....++.+++.+|+..||++||++.|++..
T Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0  00          0000   0000000000       1123567889999999999999999999863

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-35  Score=315.06  Aligned_cols=261  Identities=27%  Similarity=0.370  Sum_probs=200.9

Q ss_pred             ceeeecCcEEEEEEEEcCCCc--EEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEeec
Q 002085          642 NLIGSGGSGQVYRIDINGAGE--FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYM  718 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  718 (969)
                      +.||+|+||.||+|.+..++.  .+|+|.++..  ......+.+.+|++++.++ +||||+++++++...+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            368999999999999977765  4688877532  2234456789999999999 7999999999999999999999999


Q ss_pred             cCCCHHHHhccCcCccccC---CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          719 ENQSLDRWLHGRKRSLVSG---SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       719 ~~gsL~~~l~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ++|+|.+++..........   ........+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence            9999999998654211000   0011123588999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||++.....   .........+..|+|||++....++.++|||||||++|||++ |..||.+.+.......+    ....
T Consensus       156 fgl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----~~~~  228 (270)
T cd05047         156 FGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----PQGY  228 (270)
T ss_pred             CCCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH----hCCC
Confidence            999863211   111111234567999999988899999999999999999997 88898765443322221    1110


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                                ....+......+.+++.+||+.||.+||++.|+++.|+++
T Consensus       229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         229 ----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ----------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                      0011122335788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.2e-35  Score=320.63  Aligned_cols=260  Identities=21%  Similarity=0.287  Sum_probs=207.6

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|+||.||++.+..+++.||+|.+...........+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            67888999999999999999999999999999865543334455688899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |++|++|.+++....             .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++||
T Consensus        82 ~~~g~~L~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~df  145 (305)
T cd05609          82 YVEGGDCATLLKNIG-------------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDF  145 (305)
T ss_pred             cCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeC
Confidence            999999999997543             378899999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCC-------------CCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          797 GLAKMLAKQG-------------EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       797 gla~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                      |+++......             .........++..|+|||.+.+..++.++|+|||||++|||++|..||.+.......
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~  225 (305)
T cd05609         146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF  225 (305)
T ss_pred             CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9986421100             000111235788999999998888999999999999999999999999865543322


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      ...   .......     +.    .....+..+.+++.+||+.||++||++.++.+.++..
T Consensus       226 ~~~---~~~~~~~-----~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         226 GQV---ISDDIEW-----PE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHH---HhcccCC-----CC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            211   1110000     00    0012336789999999999999999987777766553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.1e-35  Score=324.34  Aligned_cols=265  Identities=21%  Similarity=0.242  Sum_probs=198.9

Q ss_pred             ccceeeec--CcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          640 ESNLIGSG--GSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       640 ~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      ..++||+|  +|++||++....+|+.||+|++..... .....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            35789999  789999999999999999999865432 234456788899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++|+|.+++.....           ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++++||+
T Consensus        81 ~~~~~l~~~~~~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~  146 (327)
T cd08227          81 MAYGSAKDLICTHFM-----------DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR  146 (327)
T ss_pred             cCCCcHHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccc
Confidence            999999999975432           2488999999999999999999988   99999999999999999999999998


Q ss_pred             cceecccCCCCc-----cccccccCcccCchhhccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          798 LAKMLAKQGEPH-----TMSAVAGSFGYFAPEYAYT--TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       798 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      .+......+...     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||................
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  226 (327)
T cd08227         147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT  226 (327)
T ss_pred             hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCC
Confidence            765432211111     1122346778999999876  458899999999999999999999997543222111110000


Q ss_pred             hcc--------------CCchhhhcc-----------------CCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEE--------------KPITDALDK-----------------GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~--------------~~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...              .......+.                 ....+........+.+++.+||+.||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000              000000000                 0001112233467899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=325.69  Aligned_cols=248  Identities=27%  Similarity=0.355  Sum_probs=205.3

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQ  721 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  721 (969)
                      -+||+|.||+||.|++.++....|||-+...   +.+..+-+..|+.+-+.++|.|||+++|.+.+.+..-|.||-+|||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            4689999999999999999999999988432   3344577999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC-CCCcEEEeecccce
Q 002085          722 SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD-SEFKAKIADFGLAK  800 (969)
Q Consensus       722 sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfgla~  800 (969)
                      +|.++++..-..          -.-.+.+.-.+..||++||.|||+.   .|||||||-.|||+. -.|.+||+|||-++
T Consensus       658 SLSsLLrskWGP----------lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsK  724 (1226)
T KOG4279|consen  658 SLSSLLRSKWGP----------LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSK  724 (1226)
T ss_pred             cHHHHHHhccCC----------CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccch
Confidence            999999875431          1125678888999999999999999   999999999999996 46899999999998


Q ss_pred             ecccCCCCccccccccCcccCchhhcccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTT--KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD  878 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  878 (969)
                      .+..  .........||..|||||++..+  .|..++|||||||++.||.||++||.......-+-+. -++.+      
T Consensus       725 RLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-VGmyK------  795 (1226)
T KOG4279|consen  725 RLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-VGMYK------  795 (1226)
T ss_pred             hhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-hccee------
Confidence            7743  34455667899999999999876  4889999999999999999999999764432211111 11111      


Q ss_pred             hhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       879 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                           .-.+.+.+.+.+...++.+|+..||..||++.++++
T Consensus       796 -----vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  796 -----VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             -----cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence                 122456777788999999999999999999999986

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-35  Score=312.55  Aligned_cols=249  Identities=28%  Similarity=0.422  Sum_probs=205.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||.|+||.||+|...  |+.||+|.++....    ..+.+.+|+.++++++|+||+++++++.+....++||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            46888899999999999999874  78899999865432    4577999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....           ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|
T Consensus        80 e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d  145 (256)
T cd05039          80 EYMAKGSLVDYLRSRGR-----------AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSD  145 (256)
T ss_pred             EecCCCcHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcc
Confidence            99999999999976542           2489999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||.++.....     .....++..|+|||++.+..++.++||||||+++||+++ |..||.......+...+..    ..
T Consensus       146 ~g~~~~~~~~-----~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~  216 (256)
T cd05039         146 FGLAKEASQG-----QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK----GY  216 (256)
T ss_pred             cccccccccc-----cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc----CC
Confidence            9999865221     112345678999999998899999999999999999997 8888865543332222211    10


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                                ....+...+..+.+++.+||..+|++||++.|++++|+.
T Consensus       217 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         217 ----------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ----------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                      001112234678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.7e-35  Score=310.38  Aligned_cols=248  Identities=25%  Similarity=0.366  Sum_probs=199.5

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQ  721 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  721 (969)
                      ++||+|+||.||+|... ++..||+|.+....  .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            46899999999999865 67889999885432  3344567899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          722 SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       722 sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                      +|.+++....            ..+++..+..++.|++.|+.|+|+.   +++||||+|+||+++.++.++++|||++..
T Consensus        78 ~L~~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  142 (250)
T cd05085          78 DFLSFLRKKK------------DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQ  142 (250)
T ss_pred             cHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCcccee
Confidence            9999987543            2378999999999999999999988   999999999999999999999999999875


Q ss_pred             cccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       802 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      .... .........+++.|+|||++.+..++.++||||||+++||+++ |..||.+.........+.    ...      
T Consensus       143 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~----~~~------  211 (250)
T cd05085         143 EDDG-IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE----KGY------  211 (250)
T ss_pred             cccc-ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH----cCC------
Confidence            4322 1111122344678999999998899999999999999999998 888886654332222111    110      


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                          ....+...+..+.+++.+||..+|++||++.|+++.|.
T Consensus       212 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 ----RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                01111223468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.2e-35  Score=329.95  Aligned_cols=265  Identities=24%  Similarity=0.287  Sum_probs=203.1

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC----
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE----  708 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  708 (969)
                      ...++|+..+.||+|+||.||+|.+...++.||||++..... .......+.+|+.+++.++||||+++++++...    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            356789999999999999999999988899999999864322 233456788999999999999999999887543    


Q ss_pred             --CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          709 --NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       709 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                        ...|+||||++ ++|.+++..               .+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  160 (364)
T cd07875         100 EFQDVYIVMELMD-ANLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK  160 (364)
T ss_pred             ccCeEEEEEeCCC-CCHHHHHHh---------------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEEC
Confidence              35799999997 577777642               267888999999999999999988   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      .++.+||+|||+++....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+
T Consensus       161 ~~~~~kL~DfG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  237 (364)
T cd07875         161 SDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV  237 (364)
T ss_pred             CCCcEEEEeCCCccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999976532   22223457899999999999999999999999999999999999999876543332222


Q ss_pred             HHHhhccCC---------chhhhc--------------cCCC----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEKP---------ITDALD--------------KGIA----EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~~---------~~~~~~--------------~~~~----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ........+         ......              ....    ..........+.+++.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         238 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            211110000         000000              0000    0001112356789999999999999999999987


Q ss_pred             H
Q 002085          920 I  920 (969)
Q Consensus       920 ~  920 (969)
                      .
T Consensus       318 h  318 (364)
T cd07875         318 H  318 (364)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6e-35  Score=317.91  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=206.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||+||++....+++.||+|++....  .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            46888899999999999999998889999999885432  2344678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++...+             .+++..+..++.+++.|+.|||+.  .+++||||+|+||+++.++.++|+|
T Consensus        83 e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d  147 (284)
T cd06620          83 EFMDCGSLDRIYKKGG-------------PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCD  147 (284)
T ss_pred             ecCCCCCHHHHHHhcc-------------CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEcc
Confidence            9999999999987543             388999999999999999999963  2899999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc--------chHHHHH
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT--------SLAEWAW  867 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~--------~~~~~~~  867 (969)
                      ||++......    ......|+..|+|||++.+..++.++|||||||++||+++|+.||......        .......
T Consensus       148 ~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd06620         148 FGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ  223 (284)
T ss_pred             CCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH
Confidence            9998654221    122356899999999998889999999999999999999999999754331        1111111


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      ....+.          .......+.+..+.+++.+||+.||++||++.|++++.
T Consensus       224 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         224 QIVQEP----------PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHhhcc----------CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            111110          00011112446789999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1e-34  Score=310.99  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=208.7

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      .|+..+.||.|+||.||.++...+++.|++|.+..... .....+.+.+|++++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            47888999999999999999999999999998854432 33445678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++.....           ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.+||+||
T Consensus        80 ~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~  145 (256)
T cd08221          80 YANGGTLYDKIVRQKG-----------QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDF  145 (256)
T ss_pred             ecCCCcHHHHHHhccc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcC
Confidence            9999999999986532           3478999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |.+........  ......+++.|+|||...+..++.++||||+|+++|||++|..||...........+   ....   
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~---~~~~---  217 (256)
T cd08221         146 GISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI---VQGN---  217 (256)
T ss_pred             cceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---HcCC---
Confidence            99987643221  233456899999999998888999999999999999999999998765433322211   1110   


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                              ..+.+...+..+.+++.+||+.+|++||++.|+++.
T Consensus       218 --------~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         218 --------YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             --------CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                    011112334678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-35  Score=310.21  Aligned_cols=250  Identities=28%  Similarity=0.388  Sum_probs=200.8

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQ  721 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  721 (969)
                      ++||+|+||.||+|.+.. ++.||+|.+.....  ......+.+|++++++++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            468999999999999976 89999998855432  234578999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          722 SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       722 sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                      +|.+++....            ..+++..+..++.+++.|++|||+.   +++||||+|+||+++.++.++|+|||.+..
T Consensus        78 ~l~~~l~~~~------------~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~  142 (251)
T cd05041          78 SLLTFLRKKK------------NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRE  142 (251)
T ss_pred             cHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccc
Confidence            9999997543            2378889999999999999999988   999999999999999999999999999976


Q ss_pred             cccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       802 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      ..............++..|+|||.+.++.++.++|||||||++|||++ |..||...........+..            
T Consensus       143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~------------  210 (251)
T cd05041         143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES------------  210 (251)
T ss_pred             ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc------------
Confidence            532211111122234667999999998899999999999999999999 6777765543332222211            


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                        ....+.+...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus       211 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         211 --GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             --CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence              11111222334689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-34  Score=310.73  Aligned_cols=253  Identities=24%  Similarity=0.329  Sum_probs=205.3

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-CCceEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-ENSKLLVY  715 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  715 (969)
                      +|+..+.||+|++|.||++.+..+++.||+|.+.... ......+.+.+|++++++++|||++++.+.+.. ....++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            4788899999999999999998889999999985432 233445678999999999999999999988764 44678999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....           ..+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|
T Consensus        80 e~~~~~~l~~~l~~~~~-----------~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~d  145 (257)
T cd08223          80 GFCEGGDLYHKLKEQKG-----------KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGD  145 (257)
T ss_pred             cccCCCcHHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEec
Confidence            99999999999975432           3488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||++.......  .......+++.|+|||+..+..++.++||||+||++|||++|+.||...+..........   .   
T Consensus       146 f~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~---~---  217 (257)
T cd08223         146 LGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE---G---  217 (257)
T ss_pred             ccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---c---
Confidence            99998764321  222345688999999999999999999999999999999999999875543222111111   1   


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                              .....+...+..+.+++.+||+.||++||++.|+++.
T Consensus       218 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         218 --------KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             --------CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                    0011223344688999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.8e-35  Score=317.13  Aligned_cols=271  Identities=29%  Similarity=0.385  Sum_probs=208.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc--CC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS--EN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  709 (969)
                      +.|+..+.||+|+||.||+|....    +++.||||++......  ...+.+.+|+++++.++||||+++++++..  +.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            357778999999999999998643    4789999998654332  346789999999999999999999999877  55


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++++|.+++....            ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~------------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~  146 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHR------------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESED  146 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCc------------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCC
Confidence            7899999999999999998654            2489999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCcc-ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHT-MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      .++++|||.+........... .....++..|+|||...+..++.++||||||+++|||++|+.|+......... .+..
T Consensus       147 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~  225 (284)
T cd05038         147 LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGI  225 (284)
T ss_pred             CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-cccc
Confidence            999999999987653322211 11234566799999998889999999999999999999999987653221100 0000


Q ss_pred             --HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          869 --HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       869 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                        .........+.+......+.+...+.++.+++.+||+.+|++||++.|++++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         226 AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence              00000000111111122222233446799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5e-35  Score=318.52  Aligned_cols=269  Identities=27%  Similarity=0.381  Sum_probs=204.6

Q ss_pred             CCCccceeeecCcEEEEEEEE----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--Cc
Q 002085          637 SLTESNLIGSGGSGQVYRIDI----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--NS  710 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  710 (969)
                      -|++.+.||+|+||.||+|+.    ..++..||+|.++...  .......+.+|+++++.++|||++++.+++.+.  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            467889999999999999975    3467889999985432  234456899999999999999999999998775  56


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||+++++|.+++....            ..++|.++..++.|++.||+|||+.   +++||||||+||+++.++.
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~------------~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  147 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK------------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQ  147 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCC
Confidence            899999999999999986543            2488999999999999999999988   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCc-cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      ++|+|||+++.+....... ......++..|+|||.+.+..++.++|||||||++|||++++.|......... . ....
T Consensus       148 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~-~-~~~~  225 (284)
T cd05079         148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL-K-MIGP  225 (284)
T ss_pred             EEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh-h-hccc
Confidence            9999999998764332211 12234567789999999888899999999999999999998776532111000 0 0000


Q ss_pred             hhccCC---chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          870 YAEEKP---ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       870 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      ......   ..+.+..+...+.+...+..+.+++.+||+.+|++||++.++++.++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         226 THGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000000   0001111111122233457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-35  Score=313.37  Aligned_cols=255  Identities=30%  Similarity=0.449  Sum_probs=206.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|++.++||+|+||.||+|... ++..||||.+.....    ..+.+.+|++++++++|||++++++++.+....++|
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            357888999999999999999876 457899998864322    235788999999999999999999999998999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++.....           ..+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++++
T Consensus        80 ~e~~~~~~L~~~i~~~~~-----------~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~  145 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEG-----------KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIA  145 (261)
T ss_pred             EeccCCCCHHHHHhcccc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEEC
Confidence            999999999999976432           3489999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||.++.+... .........++..|+|||.+.+..++.++||||+||++||+++ |+.||.+.........+...+   
T Consensus       146 d~g~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---  221 (261)
T cd05034         146 DFGLARLIEDD-EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY---  221 (261)
T ss_pred             ccccceeccch-hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence            99999866431 1111122334578999999998899999999999999999999 888886554333222221111   


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                                 ..+.+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       222 -----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 -----------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                       111122234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.1e-35  Score=314.27  Aligned_cols=258  Identities=22%  Similarity=0.302  Sum_probs=191.7

Q ss_pred             ceeeecCcEEEEEEEEcC--CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeecc
Q 002085          642 NLIGSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      +.||+|+||.||+|....  ....+|+|.+....  .......+.+|+++++.++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            358999999999997532  34578888774332  33445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccc
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA  799 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  799 (969)
                      +|+|.+++......        .....++.....++.|++.|++|||+.   +|+||||||+||++++++.+||+|||++
T Consensus        79 ~g~L~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~  147 (269)
T cd05042          79 LGDLKNYLRSNRGM--------VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA  147 (269)
T ss_pred             CCcHHHHHHhcccc--------ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccc
Confidence            99999999765421        012356788899999999999999988   9999999999999999999999999998


Q ss_pred             eecccCCCCccccccccCcccCchhhccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhh
Q 002085          800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYT-------TKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       800 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      ................+++.|+|||+...       ..++.++||||+||++|||++ |..||......+.....   ..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~  224 (269)
T cd05042         148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV---VR  224 (269)
T ss_pred             cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---hh
Confidence            75433222222233456778999998743       356789999999999999999 56666544332221111   11


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                      ...  .....+..    ....+..+.+++..|| .||++||+++||++.|.
T Consensus       225 ~~~--~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         225 EQD--IKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccC--ccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            110  01111111    1223356778899999 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.3e-35  Score=313.32  Aligned_cols=253  Identities=25%  Similarity=0.374  Sum_probs=195.3

Q ss_pred             ceeeecCcEEEEEEEEcC---CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEE-cCCceEEEEee
Q 002085          642 NLIGSGGSGQVYRIDING---AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCIS-SENSKLLVYEY  717 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~  717 (969)
                      +.||+|+||.||+|.+..   .+..||+|.+...  ......+.+.+|+.+++.++||||+++++++. .++..++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998643   3457999987432  22344578889999999999999999999765 45668999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++++|.+++.....            ..++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||
T Consensus        79 ~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg  143 (262)
T cd05058          79 MKHGDLRNFIRSETH------------NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFG  143 (262)
T ss_pred             CCCCCHHHHHHhcCC------------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcc
Confidence            999999999975432            356778899999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCC--ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCC-CCCccchHHHHHHHhhccC
Q 002085          798 LAKMLAKQGEP--HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       798 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~-~~~~~~~~~~~~~~~~~~~  874 (969)
                      +++.+......  .......++..|+|||.+.+..++.++|||||||++|||++|+.|++ ..+.......+.    ...
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~----~~~  219 (262)
T cd05058         144 LARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----QGR  219 (262)
T ss_pred             ccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----cCC
Confidence            99765332111  11123346778999999988899999999999999999999765544 333222222111    110


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                ....+...+..+.+++.+||..+|++||++.|+++.|+++.
T Consensus       220 ----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 ----------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                      01111122367889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.3e-35  Score=316.91  Aligned_cols=265  Identities=23%  Similarity=0.344  Sum_probs=204.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|++++++++|||++++++++.++...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            368888999999999999999998899999998864432 2223456889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|..+.....             .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|
T Consensus        80 e~~~~~~l~~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~d  143 (286)
T cd07847          80 EYCDHTVLNELEKNPR-------------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCD  143 (286)
T ss_pred             eccCccHHHHHHhCCC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECc
Confidence            9999998888765432             388999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||++........  ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+....+........
T Consensus       144 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  221 (286)
T cd07847         144 FGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLI  221 (286)
T ss_pred             cccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999987643221  2233457889999999876 4578999999999999999999999976554332222211111100


Q ss_pred             ----------Cc-hhhhccCCCCc-----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 ----------PI-TDALDKGIAEP-----CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ----------~~-~~~~~~~~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                .. .....+.....     .....+..+.+++.+||+.||++||++.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         222 PRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                      00 00000000000     01122467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6e-35  Score=315.34  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=202.0

Q ss_pred             ceeeecCcEEEEEEEEcCCC------cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          642 NLIGSGGSGQVYRIDINGAG------EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +.||+|+||.||+|+.....      +.||+|.+....  .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36899999999999886433      679999875432  2233567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-----c
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-----K  790 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~  790 (969)
                      ||+++++|.+++.......      .....++|..++.++.|++.|++|||+.   +++|+||+|+||+++.++     .
T Consensus        79 e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~  149 (269)
T cd05044          79 ELMEGGDLLSYLRDARVER------FGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRV  149 (269)
T ss_pred             eccCCCcHHHHHHHhhhcc------cCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcc
Confidence            9999999999997643210      0123478999999999999999999988   999999999999999887     8


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  869 (969)
                      ++++|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||...........+   
T Consensus       150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~---  226 (269)
T cd05044         150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV---  226 (269)
T ss_pred             eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH---
Confidence            99999999976543322222233456788999999999999999999999999999998 88888654433222211   


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                       ....          ....+...+..+.+++.+||+.+|++||+++++.+.|++
T Consensus       227 -~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         227 -TAGG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -hcCC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             1110          111122344678899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.1e-34  Score=310.90  Aligned_cols=252  Identities=24%  Similarity=0.331  Sum_probs=207.3

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..++||+|+||.||++....+++.||+|.+..... .....+.+.+|++++++++||||+++.+++.+.+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            47888999999999999999988999999999864322 23345688999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++.....           ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++||
T Consensus        80 ~~~~~~l~~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~  145 (256)
T cd08218          80 YCEGGDLYKKINAQRG-----------VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDF  145 (256)
T ss_pred             cCCCCcHHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeec
Confidence            9999999999875432           2478899999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |.+..+....  .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+   ....   
T Consensus       146 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~---~~~~---  217 (256)
T cd08218         146 GIARVLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI---IRGS---  217 (256)
T ss_pred             cceeecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH---hcCC---
Confidence            9997653321  1222345888999999999989999999999999999999999998765433322211   1111   


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                              ..+.+......+.+++.+||+.+|++||++.|+++
T Consensus       218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 --------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                    01112233467899999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.8e-35  Score=318.33  Aligned_cols=266  Identities=24%  Similarity=0.346  Sum_probs=201.3

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|++|.||+|....+++.||+|++..... .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            47788999999999999999988899999999854322 22234678889999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |++ ++|.+++.....          ...+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+||
T Consensus        80 ~~~-~~l~~~~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  145 (285)
T cd07861          80 FLS-MDLKKYLDSLPK----------GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADF  145 (285)
T ss_pred             cCC-CCHHHHHhcCCC----------CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcc
Confidence            997 689888875432          13588999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc--
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE--  873 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--  873 (969)
                      |++......  ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.................  
T Consensus       146 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~  223 (285)
T cd07861         146 GLARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE  223 (285)
T ss_pred             cceeecCCC--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            998754321  1222334678899999988654 47889999999999999999999997654322111111100000  


Q ss_pred             ---------CCchhhhcc---CCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 ---------KPITDALDK---GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ---------~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                               .........   ..........+.++.+++.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                     000000000   0000001113467789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=309.74  Aligned_cols=255  Identities=22%  Similarity=0.305  Sum_probs=217.0

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      +..+..-|...+.||+|.|+.|-+|++.-+|+.||||++.+.. .+......+.+|+++|+.++|||||++|++...+..
T Consensus        13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTK-lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK   91 (864)
T KOG4717|consen   13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK   91 (864)
T ss_pred             ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccc-cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence            3344556888899999999999999999999999999997653 455566789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC-CCC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD-SEF  789 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~  789 (969)
                      .|||+|.=++|+|++|+-++..            .+.+..+.+++.||+.|+.|+|+.   .+|||||||+||.+- .-|
T Consensus        92 lyLiLELGD~GDl~DyImKHe~------------Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlG  156 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEE------------GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLG  156 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhc------------cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecC
Confidence            9999999999999999987653            488889999999999999999999   899999999998775 458


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      -||+.|||++-.+.+.   ......+|+..|.|||++.+..|+ ++.||||+|||||-+++|+.||....+.+.      
T Consensus       157 lVKLTDFGFSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------  227 (864)
T KOG4717|consen  157 LVKLTDFGFSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------  227 (864)
T ss_pred             ceEeeeccccccCCCc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------
Confidence            9999999999877443   334557899999999999999986 589999999999999999999986544332      


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                             +.-++|...  ..+...+.+..++|..|+..||.+|.+..||+.
T Consensus       228 -------LTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  228 -------LTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -------hhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                   233444433  235566788999999999999999999999985

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.6e-35  Score=314.61  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=202.6

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|.+..+++.||+|.++...   ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            357888899999999999999999899999999985432   22345688899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....             .+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+
T Consensus        85 ~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~  148 (267)
T cd06645          85 MEFCGGGSLQDIYHVTG-------------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLA  148 (267)
T ss_pred             EeccCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEC
Confidence            99999999999987543             388999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |||++......  ........|+..|+|||++.   ...++.++||||+||++|||++|..||..........   ....
T Consensus       149 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~---~~~~  223 (267)
T cd06645         149 DFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTK  223 (267)
T ss_pred             cceeeeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH---hhhc
Confidence            99998765321  22223457899999999874   4568899999999999999999999986544321111   0000


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....     .....  .....+..+.+++.+|+..+|++||+++++++
T Consensus       224 ~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         224 SNFQ-----PPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cCCC-----CCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0000     00000  00112356889999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-34  Score=315.31  Aligned_cols=250  Identities=23%  Similarity=0.327  Sum_probs=200.9

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |+..+.||+|+||.||+|.+..++..+|+|.+...   .....+.+.+|+++++.++|||++++++++..++..++||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            56778999999999999999988999999988443   233456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++++|..++....            ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||
T Consensus        84 ~~~~~l~~~~~~~~------------~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg  148 (282)
T cd06643          84 CAGGAVDAVMLELE------------RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG  148 (282)
T ss_pred             cCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccc
Confidence            99999999886532            2488999999999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ++......  ........+++.|+|||++.     +..++.++|||||||++|||++|+.||...+.........   ..
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~~  223 (282)
T cd06643         149 VSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KS  223 (282)
T ss_pred             cccccccc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh---hc
Confidence            98764321  12223456889999999874     4457889999999999999999999987654322211111   11


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...       ..  ..+...+..+.+++.+||+.||++||++.++++
T Consensus       224 ~~~-------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         224 EPP-------TL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CCC-------CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000       00  112223467899999999999999999998875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.9e-35  Score=317.69  Aligned_cols=257  Identities=25%  Similarity=0.336  Sum_probs=208.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .+.|+..+.||.|+||.||+|.+..+++.||+|.+....   ....+.+.+|+++++.++|||++++++++.+.+..++|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            457889999999999999999998899999999885432   22346788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      +||+++++|.+++...              .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+
T Consensus        95 ~e~~~~~~L~~~~~~~--------------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~  157 (296)
T cd06655          95 MEYLAGGSLTDVVTET--------------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLT  157 (296)
T ss_pred             EEecCCCcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEc
Confidence            9999999999988642              378999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||++.......  .......++..|+|||.+.+..++.++|||||||++|||++|+.||...+.........   ....
T Consensus       158 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~  232 (296)
T cd06655         158 DFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGT  232 (296)
T ss_pred             cCccchhccccc--ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCC
Confidence            999987653321  12233468899999999998889999999999999999999999997655422211111   1100


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRCC  925 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~~  925 (969)
                      +.         ...+...+..+.+++.+||..||++||++.++++  .++.+.
T Consensus       233 ~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         233 PE---------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             cc---------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            00         0112223467889999999999999999999985  444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.1e-34  Score=310.34  Aligned_cols=254  Identities=23%  Similarity=0.343  Sum_probs=203.0

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccch---hcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK---LNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +|+..+.||+|+||+||+|... +++.+|+|.+.....   ........+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4788899999999999999874 688999998864322   123344679999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++++|.+++....             .+++..+..++.|++.|++|||+.   +|+|+||+|+||++++++.++|
T Consensus        80 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l  143 (265)
T cd06631          80 FMEFVPGGSISSILNRFG-------------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKL  143 (265)
T ss_pred             EEecCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEe
Confidence            999999999999997543             378889999999999999999988   9999999999999999999999


Q ss_pred             eecccceecccCCC----CccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          794 ADFGLAKMLAKQGE----PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       794 ~Dfgla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      +|||.+........    ........|+..|+|||++.+..++.++||||+||++|||++|..||...+.......... 
T Consensus       144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-  222 (265)
T cd06631         144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA-  222 (265)
T ss_pred             ccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh-
Confidence            99999876532111    1122345688999999999998999999999999999999999999976543221111100 


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                        ....         ....+......+.+++.+||+.+|++||++.|+++
T Consensus       223 --~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 --HRGL---------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --ccCC---------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              0000         00111223467899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.2e-34  Score=313.05  Aligned_cols=258  Identities=25%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++|+..++||+|+||.||+|.+...   ...||+|......  .....+.+.+|++++++++||||+++++++.+ ...+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            3577889999999999999987543   3479999875432  23445789999999999999999999998875 4578


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++++|.+++....            ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++
T Consensus        83 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~  147 (270)
T cd05056          83 IVMELAPLGELRSYLQVNK------------YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVK  147 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeE
Confidence            9999999999999997543            2378999999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      ++|||+++...... ........++..|+|||.+....++.++|||||||++||+++ |..||.+.........+    .
T Consensus       148 l~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----~  222 (270)
T cd05056         148 LGDFGLSRYLEDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI----E  222 (270)
T ss_pred             EccCceeeeccccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----H
Confidence            99999998664331 122223345578999999988889999999999999999996 99998765543322221    1


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      ....          .+.+...+..+.+++.+|+..+|++||++.|+++.|++...
T Consensus       223 ~~~~----------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         223 NGER----------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             cCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1110          11122334678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.4e-34  Score=310.05  Aligned_cols=250  Identities=26%  Similarity=0.328  Sum_probs=205.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||.||+|....+++.||+|.+.....     .+.+.+|++++++++||||+++++++.++...|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            578889999999999999999988889999999854321     578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....            ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|
T Consensus        78 e~~~~~~L~~~l~~~~------------~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~d  142 (256)
T cd06612          78 EYCGAGSVSDIMKITN------------KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLAD  142 (256)
T ss_pred             ecCCCCcHHHHHHhCc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcc
Confidence            9999999999997543            3489999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||++.......  .......++..|+|||++.+..++.++||||||+++|||++|+.||.............    .   
T Consensus       143 fg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~----~---  213 (256)
T cd06612         143 FGVSGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP----N---  213 (256)
T ss_pred             cccchhcccCc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc----c---
Confidence            99998664321  12233457889999999999999999999999999999999999987543322111100    0   


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                         ......  ..+......+.+++.+||+.||++||++.|+++
T Consensus       214 ---~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 ---KPPPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ---CCCCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence               000000  112223467899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-34  Score=315.92  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=204.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.+....  .......+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            36888899999999999999998889999999885432  3334567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....          ...+++..+..++.|++.|+.|||+.  .+|+||||||+||+++.++.++++|
T Consensus        79 e~~~~~~l~~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d  146 (286)
T cd06622          79 EYMDAGSLDKLYAGGVA----------TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCD  146 (286)
T ss_pred             eecCCCCHHHHHHhccc----------cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEee
Confidence            99999999999875321          13589999999999999999999953  2899999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCC------CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK------VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      ||.+..+...    ......+++.|+|||.+.+..      ++.++||||+||++|||++|+.||...............
T Consensus       147 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  222 (286)
T cd06622         147 FGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI  222 (286)
T ss_pred             cCCcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH
Confidence            9998765321    222345788999999986543      478999999999999999999999764433222211111


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...           .....+.....++.+++.+||+.+|++||++.+++.
T Consensus       223 ~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         223 VDG-----------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hhc-----------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            100           011123335578899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5e-37  Score=302.82  Aligned_cols=249  Identities=23%  Similarity=0.306  Sum_probs=209.0

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      -|.++.+||+|+||.||+|.++..|..||+|.+..+.     ..+++..|+.++++++.|++|+++|.+-.....++|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            3667889999999999999999999999999985543     35789999999999999999999999998899999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      ||..|+..+.++.+.            ..+.+.++..++...+.||+|||..   .-+|||||+.|||+..+|.+|++||
T Consensus       109 YCGAGSiSDI~R~R~------------K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADF  173 (502)
T KOG0574|consen  109 YCGAGSISDIMRARR------------KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADF  173 (502)
T ss_pred             hcCCCcHHHHHHHhc------------CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhc
Confidence            999999999998765            4689999999999999999999998   8899999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |.|..+.+.  -.......|||.|||||++..-.|+.++||||+|++..||..|++||.+--+-      +..+.-    
T Consensus       174 GVAGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM------RAIFMI----  241 (502)
T KOG0574|consen  174 GVAGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM------RAIFMI----  241 (502)
T ss_pred             cccchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc------ceeEec----
Confidence            999766432  22334578999999999999999999999999999999999999998642210      000000    


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .-...+.+  ..+...+.++-++++.|+-+.|++|.|+.++++
T Consensus       242 PT~PPPTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  242 PTKPPPTF--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             cCCCCCCC--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            00001111  235666788999999999999999999998876

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.4e-34  Score=311.85  Aligned_cols=250  Identities=24%  Similarity=0.310  Sum_probs=206.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ..|+..++||+|+||.||+|.+..+++.||+|++....  .......+.+|++++++++||||+++++++.+....++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35778899999999999999998889999999986432  2344578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++...              .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|
T Consensus        82 e~~~~~~L~~~i~~~--------------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~d  144 (277)
T cd06640          82 EYLGGGSALDLLRAG--------------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLAD  144 (277)
T ss_pred             ecCCCCcHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcc
Confidence            999999999998642              277888999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||++.......  .......++..|+|||++.+..++.++|||||||++|||++|..||............         
T Consensus       145 fg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---------  213 (277)
T cd06640         145 FGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI---------  213 (277)
T ss_pred             cccceeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh---------
Confidence            99997654321  1223346788999999999889999999999999999999999998765432221111         


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                           ............+..+.+++.+||+.+|++||++.++++.
T Consensus       214 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 -----PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -----hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                 1111112233456788999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-34  Score=315.69  Aligned_cols=252  Identities=24%  Similarity=0.324  Sum_probs=202.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +.|++.++||.|+||.||+|++..+++.||+|.+...   .....+.+.+|+++++.++||||+++++++..++..++||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            5688999999999999999999988999999998543   3344677889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|..++....            ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|
T Consensus        89 e~~~~~~l~~~~~~~~------------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d  153 (292)
T cd06644          89 EFCPGGAVDAIMLELD------------RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLAD  153 (292)
T ss_pred             ecCCCCcHHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEcc
Confidence            9999999998876533            2488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||++......  ........+++.|+|||++.     ...++.++|||||||++|||++|..||...+......   ...
T Consensus       154 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~~  228 (292)
T cd06644         154 FGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL---KIA  228 (292)
T ss_pred             Cccceecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHH---HHh
Confidence            9998754221  12223456888999999884     3456889999999999999999999987644322111   111


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....       +..  ..+...+..+.+++.+||+.||++||++.|+++
T Consensus       229 ~~~~-------~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         229 KSEP-------PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cCCC-------ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1100       000  112233467889999999999999999999865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-34  Score=309.59  Aligned_cols=240  Identities=21%  Similarity=0.338  Sum_probs=187.6

Q ss_pred             ceeeecCcEEEEEEEEcCC------------CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          642 NLIGSGGSGQVYRIDINGA------------GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      +.||+|+||.||+|....+            ...||+|.+...   .......+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            4689999999999986432            235899987543   2334467889999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++++|..++....            ..+++..+.+++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~  142 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKS------------DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREG  142 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCC
Confidence            9999999999999999887543            2488999999999999999999988   999999999999998766


Q ss_pred             c-------EEEeecccceecccCCCCccccccccCcccCchhhcc-cCCCCCccchhhHHHHHHHHHh-CCCCCCCCCcc
Q 002085          790 K-------AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHT  860 (969)
Q Consensus       790 ~-------~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~  860 (969)
                      .       ++++|||++.....      .....++..|+|||.+. +..++.++|||||||++|||++ |..|+......
T Consensus       143 ~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~  216 (262)
T cd05077         143 IDGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA  216 (262)
T ss_pred             ccCCCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh
Confidence            4       89999999865421      12345788899999886 4668899999999999999985 66666543322


Q ss_pred             chHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          861 SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       861 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      +... .   .....        ...    ......+.+++.+||+.||.+||++.+|++.+
T Consensus       217 ~~~~-~---~~~~~--------~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         217 EKER-F---YEGQC--------MLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHH-H---HhcCc--------cCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1111 1   00000        001    11235788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.6e-35  Score=316.36  Aligned_cols=250  Identities=25%  Similarity=0.312  Sum_probs=204.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +.|+..+.||+|+||.||+|.+..+++.||+|.+....  .....+.+.+|++++++++||||+++++++.++...++||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            34667788999999999999998889999999885432  2334578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++...              .+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|
T Consensus        82 e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06642          82 EYLGGGSALDLLKPG--------------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLAD  144 (277)
T ss_pred             EccCCCcHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcc
Confidence            999999999998642              378899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||++..+....  .......++..|+|||++.+..++.++|||||||++|||++|+.|+...........+    ...  
T Consensus       145 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~----~~~--  216 (277)
T cd06642         145 FGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI----PKN--  216 (277)
T ss_pred             ccccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh----hcC--
Confidence            99997654321  1222346788999999999989999999999999999999999998654332221111    000  


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                              .........+..+.+++.+||+.+|++||++.|+++.
T Consensus       217 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         217 --------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                    0011112334678899999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=313.45  Aligned_cols=250  Identities=26%  Similarity=0.323  Sum_probs=205.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||.|+||.||+|.+..+++.||+|++....  .......+.+|+++++.++|+|++++.+++.++...++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            36788899999999999999999899999999985432  2334567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++...              .+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++++|
T Consensus        79 e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d  141 (274)
T cd06609          79 EYCGGGSCLDLLKPG--------------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLAD  141 (274)
T ss_pred             EeeCCCcHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcc
Confidence            999999999998753              388999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+++......  .......+++.|+|||++.+..++.++|||||||++|||++|..||...+.......+..    .. 
T Consensus       142 ~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----~~-  214 (274)
T cd06609         142 FGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK----NN-  214 (274)
T ss_pred             cccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----cC-
Confidence            99998764321  222345688899999999998899999999999999999999999976543222111111    00 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                           .+....   ...+..+.+++.+||..||++||+++++++
T Consensus       215 -----~~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         215 -----PPSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -----CCCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 000000   013467889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.7e-34  Score=309.60  Aligned_cols=253  Identities=24%  Similarity=0.355  Sum_probs=198.7

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccch--hcHHHHHHHHHHHHHHhccccCceeeEEEEEEc--CCceE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK--LNQKLEKEFIAEIEILGTIRHANIVKLWCCISS--ENSKL  712 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  712 (969)
                      +|+..+.||+|+||.||+|....++..||+|++.....  ........+.+|+.++++++||||+++++++.+  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            68889999999999999999988899999998854322  122345678999999999999999999998875  35678


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +++||+++++|.+++....             .+++..++.++.|++.||+|||+.   +|+||||+|+||+++.++.++
T Consensus        83 l~~e~~~~~~L~~~l~~~~-------------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~  146 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYG-------------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVK  146 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEE
Confidence            9999999999999997543             378889999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCC-ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          793 IADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |+|||+++........ .......++..|+|||.+.+..++.++||||+||++|||++|+.||...+....   +.....
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---~~~~~~  223 (266)
T cd06651         147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---IFKIAT  223 (266)
T ss_pred             EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---HHHHhc
Confidence            9999998765321111 112234588999999999998899999999999999999999999875432211   111110


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..          .....+......+.+++ +||..+|++||+++|+++
T Consensus       224 ~~----------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         224 QP----------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CC----------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            00          00111222335566676 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.6e-35  Score=320.11  Aligned_cols=264  Identities=25%  Similarity=0.381  Sum_probs=203.4

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..++||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            678889999999999999999888999999987554322 2345678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.++.....             .++|..+..++.|++.|++|||+.   +++||||+|+||++++++.++++||
T Consensus        81 ~~~~~~l~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~df  144 (286)
T cd07846          81 FVDHTVLDDLEKYPN-------------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDF  144 (286)
T ss_pred             cCCccHHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEee
Confidence            999999988765432             388999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc-C
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE-K  874 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~  874 (969)
                      |++.......  .......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......- .
T Consensus       145 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07846         145 GFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP  222 (286)
T ss_pred             eeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch
Confidence            9998654322  22234567899999998875 457889999999999999999998886554322211111110000 0


Q ss_pred             Cchhhh----------ccCCCC-----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDAL----------DKGIAE-----PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~----------~~~~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ......          .+....     ......+..+.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000          000000     001123467899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.9e-37  Score=332.49  Aligned_cols=379  Identities=28%  Similarity=0.413  Sum_probs=325.8

Q ss_pred             CeEEEEecCCCCC-CCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           74 SVTGISLRHKDIT-QKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        74 ~v~~l~l~~~~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      -|.++|+++|+.+ +..|.....+++++.|-|...++. .+|+.++.|.+|++|.+++|++. .+-..++.|+.|+.+++
T Consensus         8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~   85 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV   85 (1255)
T ss_pred             eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence            5899999999998 568999999999999999999998 89999999999999999999998 77788999999999999


Q ss_pred             CCCCCCC-cCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCc-cccccCCCcEEEccCCc
Q 002085          153 GGNNFSG-DIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPI-EFGMLKKLKTLWMTEAN  230 (969)
Q Consensus       153 ~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~-~~~~l~~L~~L~L~~n~  230 (969)
                      .+|++.. -+|..+..|..|+.||||+|+++ ..|..+..-+++-+|+||+|+   +..||. -|-+|+.|-.|+|++|.
T Consensus        86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~---IetIPn~lfinLtDLLfLDLS~Nr  161 (1255)
T KOG0444|consen   86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNN---IETIPNSLFINLTDLLFLDLSNNR  161 (1255)
T ss_pred             hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCc---cccCCchHHHhhHhHhhhccccch
Confidence            9999863 57888999999999999999999 889999999999999999996   344554 48899999999999988


Q ss_pred             ccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccc-cCCCCchhhc-ccccccccCccccccCCc
Q 002085          231 LIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILS-GEIPSSVEAL-KLTDIDLSMNNLTGSIPE  308 (969)
Q Consensus       231 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~  308 (969)
                      +. .+|..+..+..|+.|+|++|.+...--..+..+++|+.|.+++.+=+ ..+|.++..+ +|..+|+|.|.+. .+|+
T Consensus       162 Le-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPe  239 (1255)
T KOG0444|consen  162 LE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPE  239 (1255)
T ss_pred             hh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchH
Confidence            75 67777899999999999999997544445556788889999887644 3678887776 7999999999999 8899


Q ss_pred             cccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCC
Q 002085          309 EFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSD  388 (969)
Q Consensus       309 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  388 (969)
                      .+-.+++|+.|+|++|+|+                  .+....+...+|++|+||.|+++ .+|..++.++.|+.|++.+
T Consensus       240 cly~l~~LrrLNLS~N~it------------------eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~  300 (1255)
T KOG0444|consen  240 CLYKLRNLRRLNLSGNKIT------------------ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANN  300 (1255)
T ss_pred             HHhhhhhhheeccCcCcee------------------eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhcc
Confidence            9999999999999999998                  23334455678899999999999 8999999999999998888


Q ss_pred             CccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcc
Q 002085          389 NTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQ  468 (969)
Q Consensus       389 N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  468 (969)
                      |+++                    |. -+|..++.+.+|+++..++|.+. .+|+.+..+..|+.|.|++|+|- .+|+.
T Consensus       301 NkL~--------------------Fe-GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPea  357 (1255)
T KOG0444|consen  301 NKLT--------------------FE-GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEA  357 (1255)
T ss_pred             Cccc--------------------cc-CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhh
Confidence            8876                    22 57889999999999999999999 99999999999999999999998 89999


Q ss_pred             cccccCCCEEEccCccccCCCCcccccccccceE
Q 002085          469 IVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSL  502 (969)
Q Consensus       469 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  502 (969)
                      +.-++.|+.|||..|.=--..|.--..-++|+.-
T Consensus       358 IHlL~~l~vLDlreNpnLVMPPKP~da~~~lefY  391 (1255)
T KOG0444|consen  358 IHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFY  391 (1255)
T ss_pred             hhhcCCcceeeccCCcCccCCCCcchhhhcceee
Confidence            9999999999999997543444322222444443

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-34  Score=315.07  Aligned_cols=247  Identities=24%  Similarity=0.345  Sum_probs=205.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||++.+..+++.||+|++...........+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999999899999999986654444455678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....             .+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|
T Consensus        81 e~~~~~~L~~~~~~~~-------------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d  144 (290)
T cd05580          81 EYVPGGELFSHLRKSG-------------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITD  144 (290)
T ss_pred             ecCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEee
Confidence            9999999999997653             388899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+++.....     .....+++.|+|||.+.+...+.++||||||+++|||++|..||...+.......+    .... 
T Consensus       145 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~-  214 (290)
T cd05580         145 FGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI----LEGK-  214 (290)
T ss_pred             CCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hcCC-
Confidence            9998865332     23346889999999998888899999999999999999999998765532222111    1110 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVL  918 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl  918 (969)
                              .  ..+......+.+++.+||..||.+|+     +++|++
T Consensus       215 --------~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         215 --------V--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             --------c--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                    0  11112246788999999999999998     555554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-34  Score=312.44  Aligned_cols=240  Identities=20%  Similarity=0.321  Sum_probs=187.7

Q ss_pred             eeeecCcEEEEEEEEcCC------------------------CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCce
Q 002085          643 LIGSGGSGQVYRIDINGA------------------------GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI  698 (969)
Q Consensus       643 ~lG~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  698 (969)
                      .||+|+||.||+|....+                        ...||+|++...   .......+.+|+++++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence            689999999999875321                        235899988433   22344678899999999999999


Q ss_pred             eeEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCC
Q 002085          699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDV  778 (969)
Q Consensus       699 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  778 (969)
                      +++++++.+....++||||+++|+|..++....            ..+++..+..++.|++.||+|||+.   +|+||||
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dl  143 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK------------GRVPVAWKITVAQQLASALSYLEDK---NLVHGNV  143 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCC
Confidence            999999999999999999999999999987532            2478999999999999999999988   9999999


Q ss_pred             CCCcEEECCCC-------cEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHH-h
Q 002085          779 KSSNILLDSEF-------KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELV-T  849 (969)
Q Consensus       779 kp~Nill~~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell-t  849 (969)
                      ||+||+++..+       .++++|||.+......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +
T Consensus       144 kp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~  217 (274)
T cd05076         144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD  217 (274)
T ss_pred             CcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            99999997654       3899999987643211      22357788999998865 56899999999999999995 6


Q ss_pred             CCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          850 GKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       850 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                      |..||............    .....        ...+    ....+.+++.+||+.+|++||++.++++.|.
T Consensus       218 g~~p~~~~~~~~~~~~~----~~~~~--------~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         218 GEVPLKERTPSEKERFY----EKKHR--------LPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             CCCCccccChHHHHHHH----HhccC--------CCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            88887655433322211    11110        1111    1246889999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-34  Score=309.76  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=204.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||.||+|... .+..||+|.+...    ....+.+.+|++++++++|+||+++.+++.+ ...+++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            357888999999999999999865 4567999987542    2234678899999999999999999999887 778999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++.....           ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++
T Consensus        79 ~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEG-----------SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIA  144 (260)
T ss_pred             EEeCCCCcHHHHHHhCCc-----------cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEEC
Confidence            999999999999976432           3478899999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||.+...... .........++..|+|||++.+..++.++|+|||||++||+++ |..||.+.+.......+...    
T Consensus       145 d~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----  219 (260)
T cd05073         145 DFGLARVIEDN-EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG----  219 (260)
T ss_pred             CCcceeeccCC-CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC----
Confidence            99999765332 1122223345678999999998889999999999999999999 78888765443333222111    


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                                ...+.....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       220 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 ----------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                      0111112334678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-35  Score=329.10  Aligned_cols=256  Identities=23%  Similarity=0.302  Sum_probs=194.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ..|++.+.||+|+||.||+|+...+++.||+|+....         ....|+.++++++||||+++++++..+...++||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            3689999999999999999999988999999975322         2356899999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+. ++|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       137 e~~~-~~l~~~l~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D  200 (357)
T PHA03209        137 PHYS-SDLYTYLTKRS------------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGD  200 (357)
T ss_pred             EccC-CcHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEec
Confidence            9995 68888886543            3488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH-------HHH
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW-------AWR  868 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~-------~~~  868 (969)
                      ||+++....   ........||+.|+|||++.+..++.++|||||||++|||+++..++...........       +..
T Consensus       201 fG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~  277 (357)
T PHA03209        201 LGAAQFPVV---APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK  277 (357)
T ss_pred             Ccccccccc---CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHH
Confidence            999875322   1122345689999999999999999999999999999999997777654332221111       000


Q ss_pred             Hhhc----cCCc---------hhhhccC--CCCcc-------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAE----EKPI---------TDALDKG--IAEPC-------YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~----~~~~---------~~~~~~~--~~~~~-------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....    ...+         ....+..  ...+.       .........+++.+||+.||++|||+.|+++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        278 IISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             HHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            0000    0000         0000000  00000       0011234567999999999999999999986

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.5e-35  Score=319.11  Aligned_cols=265  Identities=23%  Similarity=0.346  Sum_probs=203.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||.||+|.+..+++.||+|.+.....  ......+.+|+++++.++||||+++++++..++..++|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            4678999999999999999999988899999999854322  12234677899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++ ++|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+
T Consensus        83 ~e~~~-~~l~~~l~~~~------------~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  146 (301)
T cd07873          83 FEYLD-KDLKQYLDDCG------------NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLA  146 (301)
T ss_pred             Eeccc-cCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEEC
Confidence            99997 68999887543            2378889999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||++......  ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||...+.......+.......
T Consensus       147 dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~  224 (301)
T cd07873         147 DFGLARAKSIP--TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP  224 (301)
T ss_pred             cCcchhccCCC--CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            99998754321  1222334578899999988654 57889999999999999999999997665433332222211110


Q ss_pred             C--Cchhhhc---------cCCCCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 K--PITDALD---------KGIAEPC----YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~--~~~~~~~---------~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .  .....+.         +.....+    ....+..+.+++.+|++.||.+|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0  0000000         0000000    0122456789999999999999999999886

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.3e-34  Score=310.43  Aligned_cols=259  Identities=26%  Similarity=0.370  Sum_probs=208.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||.|+||+||+|....++..||+|++......  ...+.+.+|+++++.++|+|++++++.+.+++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            4688899999999999999999888999999998644322  24578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....          ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|
T Consensus        79 e~~~~~~l~~~~~~~~~----------~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~d  145 (267)
T cd06610          79 PYLSGGSLLDIMKSSYP----------RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIAD  145 (267)
T ss_pred             eccCCCcHHHHHHHhcc----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence            99999999999975432          13488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCc--cccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          796 FGLAKMLAKQGEPH--TMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       796 fgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ||++..+.......  ......|+..|+|||++... .++.++|+|||||++|||++|+.||..........   +....
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~---~~~~~  222 (267)
T cd06610         146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM---LTLQN  222 (267)
T ss_pred             cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH---HHhcC
Confidence            99998765432221  22334688999999998877 78999999999999999999999997654322111   11111


Q ss_pred             cCCchhhhccCCCCc-ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEP-CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...       ..... .....+..+.+++.+||+.||++||++.|+++
T Consensus       223 ~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 DPP-------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCC-------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            110       01110 11234467899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.1e-35  Score=314.48  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=199.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC------
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE------  708 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  708 (969)
                      ..|+..+.||+|+||.||+|....+++.||+|++....    .....+.+|+.+++++ +||||+++++++...      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            46788899999999999999999899999999985432    2235688899999998 799999999998653      


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      ...|+||||+++++|.+++.....           ..++|..+..++.|++.|++|||+.   +|+||||+|+||+++++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~-----------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~  147 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG-----------NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN  147 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCC
Confidence            457899999999999999986432           3488999999999999999999988   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                      +.++|+|||++......  ........|++.|+|||++.     +..++.++||||+||++|||++|+.||.........
T Consensus       148 ~~~~l~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~  225 (272)
T cd06637         148 AEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL  225 (272)
T ss_pred             CCEEEccCCCceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence            99999999999765321  12233456899999999986     345788999999999999999999998654332211


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....    . ..        .........+..+.+++.+||..||.+||++.|+++
T Consensus       226 ~~~~----~-~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         226 FLIP----R-NP--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHh----c-CC--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            1110    0 00        000111123357889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.3e-34  Score=311.30  Aligned_cols=258  Identities=26%  Similarity=0.386  Sum_probs=202.3

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh-------cHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL-------NQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      +|...+.||+|+||.||+|....+++.||+|.++.....       .....+.+.+|++++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999999888999999988532211       1123457889999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++++|.+++....             .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~  145 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-------------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADG  145 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-------------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCC
Confidence            9999999999999999997643             378889999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK--VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      .++++|||+++...............|+..|+|||.+....  ++.++||||+|+++||+++|..||...+...   ...
T Consensus       146 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~  222 (272)
T cd06629         146 ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---AMF  222 (272)
T ss_pred             eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH---HHH
Confidence            99999999997653322222223456889999999987655  7899999999999999999999986433211   111


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ......  ....    .........+..+.+++.+||..||++||+++++++
T Consensus       223 ~~~~~~--~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         223 KLGNKR--SAPP----IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             Hhhccc--cCCc----CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            111000  0000    011111223467889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.3e-34  Score=309.35  Aligned_cols=257  Identities=24%  Similarity=0.404  Sum_probs=207.3

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh---cHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL---NQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +|+..+.||+|+||.||+|....+++.||+|++......   .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999999889999999998643321   12345789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-cEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-KAK  792 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~k  792 (969)
                      ||||+++++|.+++....             .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++ .++
T Consensus        81 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~  144 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-------------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLR  144 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            999999999999997543             378899999999999999999988   999999999999998876 599


Q ss_pred             EeecccceecccCCCC--ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          793 IADFGLAKMLAKQGEP--HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |+|||.+..+......  .......++..|+|||.+.+..++.++||||+|+++|||++|..||...+............
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  224 (268)
T cd06630         145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA  224 (268)
T ss_pred             EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh
Confidence            9999999776433111  11223468899999999988889999999999999999999999987554333222222111


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..          ......+......+.+++.+|+..+|++||++.|+++
T Consensus       225 ~~----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 SA----------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             cc----------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            10          1111223344578899999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.7e-34  Score=308.33  Aligned_cols=254  Identities=24%  Similarity=0.306  Sum_probs=201.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccch--hcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--Cce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK--LNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--NSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  711 (969)
                      .+|+..++||+|+||.||+|.+..+++.||+|.+.....  ......+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            368889999999999999999998999999998853321  1234457889999999999999999999998764  457


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++++|.+++....             .+++..+.+++.|++.||+|||+.   +++|+||+|+||+++.++.+
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~  145 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-------------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNV  145 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCE
Confidence            89999999999999987543             277888999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCC-ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      +|+|||.++........ .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........   +....
T Consensus       146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~  222 (265)
T cd06652         146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---IFKIA  222 (265)
T ss_pred             EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---HHHHh
Confidence            99999998765321111 122334588999999999888899999999999999999999999875432211   11111


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..          ......+......+.+++.+|+. +|++||+++|+++
T Consensus       223 ~~----------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         223 TQ----------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             cC----------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            11          01112233445678889999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.7e-34  Score=335.88  Aligned_cols=264  Identities=18%  Similarity=0.208  Sum_probs=196.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc------cCceeeEEEEEEcC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR------HANIVKLWCCISSE  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~  708 (969)
                      ..+|++.++||+|+||+||+|.+..+++.||||+++...    ...+.+..|+++++.++      |++++++++++...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            467999999999999999999998889999999985422    12344556777776664      45689999988764


Q ss_pred             -CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEecCCCCCcEEEC
Q 002085          709 -NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       709 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~Nill~  786 (969)
                       +..++|||++ +++|.+++....             .+++..+..|+.||+.||+|||+ .   +|+||||||+|||++
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~  266 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHG-------------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILME  266 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEe
Confidence             5688999988 788999887543             38899999999999999999996 5   899999999999998


Q ss_pred             CCC----------------cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhC
Q 002085          787 SEF----------------KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG  850 (969)
Q Consensus       787 ~~~----------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg  850 (969)
                      .++                .+||+|||.+...     ........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG  341 (467)
T PTZ00284        267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG  341 (467)
T ss_pred             cCCcccccccccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence            765                4999999987542     1223356799999999999999999999999999999999999


Q ss_pred             CCCCCCCCccchHHHHHHHhhcc----------CCchhhhcc------CCC--------C---cccHHHHHHHHHHHHHc
Q 002085          851 KEANYGDEHTSLAEWAWRHYAEE----------KPITDALDK------GIA--------E---PCYLEEMTTVYRLALIC  903 (969)
Q Consensus       851 ~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~------~~~--------~---~~~~~~~~~~~~l~~~c  903 (969)
                      +.||.+.+..+....+.......          ....+....      ...        .   .........+.+++.+|
T Consensus       342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  421 (467)
T PTZ00284        342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL  421 (467)
T ss_pred             CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence            99998765433322221111000          000000000      000        0   00001135678999999


Q ss_pred             cCCCCCCCCCHHHHHH--HHhhc
Q 002085          904 TSTLPSSRPSMKEVLQ--ILRRC  924 (969)
Q Consensus       904 l~~dP~~RPs~~evl~--~L~~~  924 (969)
                      ++.||++|||++|+++  .+.+.
T Consensus       422 L~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        422 LHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             CCcChhhCCCHHHHhcCcccccc
Confidence            9999999999999996  44443

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.2e-34  Score=308.38  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=206.2

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|+||.||+|....+++.||+|.+..... .......+.+|++++++++|||++++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            47788999999999999999988999999999865432 33446789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-cEEEee
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-KAKIAD  795 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~D  795 (969)
                      |+++++|.+++.....           ..+++..+.+++.|++.|++|||+.   +++||||+|+||++++++ .++++|
T Consensus        80 ~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d  145 (256)
T cd08220          80 YAPGGTLAEYIQKRCN-----------SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGD  145 (256)
T ss_pred             cCCCCCHHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcc
Confidence            9999999999976432           3478999999999999999999988   999999999999998654 589999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||.+.......   ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..   ..  
T Consensus       146 ~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~---~~--  217 (256)
T cd08220         146 FGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS---GT--  217 (256)
T ss_pred             CCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh---cC--
Confidence            99998764321   22235688999999999988899999999999999999999999876554333222211   10  


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                               ..+.+...+..+.+++.+||+.||++||++.|+++
T Consensus       218 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 ---------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ---------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                     00111123467889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.2e-34  Score=307.74  Aligned_cols=254  Identities=24%  Similarity=0.302  Sum_probs=199.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +.+.....||+|+||.||+|.+..++..||+|.+....   ....+.+.+|++++++++|+||+++++++..++..++|+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34445578999999999999998889999999885432   234568899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC-CCcEEEe
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-EFKAKIA  794 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~  794 (969)
                      ||+++++|.+++.....          ....++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.++|+
T Consensus        85 e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~  151 (268)
T cd06624          85 EQVPGGSLSALLRSKWG----------PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKIS  151 (268)
T ss_pred             ecCCCCCHHHHHHHhcc----------cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEe
Confidence            99999999999985421          01127788899999999999999988   9999999999999987 6799999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK--VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      |||.+..+...  ........|++.|+|||++.+..  ++.++||||||+++|||++|+.||...+......+.......
T Consensus       152 dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~  229 (268)
T cd06624         152 DFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI  229 (268)
T ss_pred             cchhheecccC--CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhcc
Confidence            99998765322  11222345889999999986644  788999999999999999999998654332211111100000


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                  ....+......+.+++.+||+.+|++||++.|+++
T Consensus       230 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         230 ------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                        01112233467889999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=313.37  Aligned_cols=252  Identities=25%  Similarity=0.359  Sum_probs=203.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|++.+.||.|+||.||+|.+..++..||+|++...   .....+.+.+|++++++++||||+++++++.++...|+||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            4688899999999999999999888999999998543   2344567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....            ..+++..+..++.|++.|+.|||+.   +|+|+||+|+||+++.++.++|+|
T Consensus        82 e~~~~~~L~~~~~~~~------------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d  146 (280)
T cd06611          82 EFCDGGALDSIMLELE------------RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLAD  146 (280)
T ss_pred             eccCCCcHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEcc
Confidence            9999999999987643            2488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||++......  ........+++.|+|||.+.     +..++.++|||||||++|||++|+.||...+.......+   .
T Consensus       147 ~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~---~  221 (280)
T cd06611         147 FGVSAKNKST--LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI---L  221 (280)
T ss_pred             Cccchhhccc--ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH---h
Confidence            9998754322  11223456889999999875     345678999999999999999999998765432221111   1


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....+       ..  ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       222 ~~~~~-------~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         222 KSEPP-------TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             cCCCC-------Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            11000       00  111223467889999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.8e-35  Score=325.15  Aligned_cols=260  Identities=23%  Similarity=0.297  Sum_probs=200.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC-----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE-----  708 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  708 (969)
                      +.++|+..+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|++++++++||||+++++++...     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            45689999999999999999999988999999999864322 223345678899999999999999999887543     


Q ss_pred             -CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          709 -NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       709 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                       ...|+++|++ +++|.+++...              .+++..+..++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~  153 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ--------------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNE  153 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECC
Confidence             3468999988 78998887632              388999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      ++.+||+|||+++....     ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.......+
T Consensus       154 ~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  228 (343)
T cd07878         154 DCELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI  228 (343)
T ss_pred             CCCEEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999986532     1234568999999999877 56889999999999999999999999765443322222


Q ss_pred             HHHhhccCCchhhhc-----------cCCCCcc-------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEKPITDALD-----------KGIAEPC-------YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~-----------~~~~~~~-------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .......  ..+...           ..+....       .......+.+++.+|++.||++|||+.|+++
T Consensus       229 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         229 MEVVGTP--SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHhCCC--CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1111100  000000           0000000       0011245789999999999999999999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.6e-34  Score=307.89  Aligned_cols=252  Identities=25%  Similarity=0.395  Sum_probs=202.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      .+|+..+.||+|+||.||+|.+. .++.+|+|.+.....    ....+.+|++++++++|||++++++++.+....++||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            36778899999999999999885 467899998854322    1356889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....            ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|
T Consensus        79 e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d  143 (256)
T cd05112          79 EFMEHGCLSDYLRAQR------------GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSD  143 (256)
T ss_pred             EcCCCCcHHHHHHhCc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECC
Confidence            9999999999987543            2378999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||.++..... .........++.+|+|||.+.+..++.++||||+|+++|||++ |..||.........+..    ....
T Consensus       144 ~g~~~~~~~~-~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~  218 (256)
T cd05112         144 FGMTRFVLDD-QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI----NAGF  218 (256)
T ss_pred             CcceeecccC-cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH----hCCC
Confidence            9998765332 1111222345678999999998899999999999999999998 88888655433322221    1110


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                      .          ...+...+..+.+++.+||+.+|++||++.|++++|+
T Consensus       219 ~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         219 R----------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             C----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            0          0001112367999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-34  Score=307.75  Aligned_cols=254  Identities=25%  Similarity=0.293  Sum_probs=205.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|....+++.+|+|.+.....   ...+.+.+|++++++++||||+++++++.+.+..+++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            468888999999999999999988889999999865422   24578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....            ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        80 e~~~~~~l~~~~~~~~------------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d  144 (262)
T cd06613          80 EYCGGGSLQDIYQVTR------------GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLAD  144 (262)
T ss_pred             eCCCCCcHHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECc
Confidence            9999999999987642            2478899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT---KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ||.+.......  .......++..|+|||.+.+.   .++.++|||||||++|||++|+.||.............   ..
T Consensus       145 ~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~---~~  219 (262)
T cd06613         145 FGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS---KS  219 (262)
T ss_pred             cccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc
Confidence            99987653321  122345688899999998776   88999999999999999999999987654322111110   00


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .  .    .. .........+..+.+++.+||..+|.+||++.+++.
T Consensus       220 ~--~----~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         220 N--F----PP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             c--C----CC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0  0    00 000112234567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.9e-34  Score=308.55  Aligned_cols=247  Identities=28%  Similarity=0.420  Sum_probs=199.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||++..  +++.||+|.++...     ..+.+.+|+.++++++|||++++++++... ..++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            4688899999999999999875  57889999885432     235788999999999999999999998764 479999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....           ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++|+|
T Consensus        78 e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~D  143 (254)
T cd05083          78 ELMSKGNLVNFLRTRGR-----------ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSD  143 (254)
T ss_pred             ECCCCCCHHHHHHhcCc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECC
Confidence            99999999999976432           3478899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||.+......     ......+..|+|||.+.+..++.++|||||||++|||++ |+.||...........+.+      
T Consensus       144 fg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------  212 (254)
T cd05083         144 FGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------  212 (254)
T ss_pred             Cccceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC------
Confidence            9998754221     112334568999999998899999999999999999998 8888866544333222211      


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                              +.........+..+.+++.+||+.+|++||+++++++.|++
T Consensus       213 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         213 --------GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --------CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                    11111112234678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.3e-34  Score=316.09  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=202.2

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      .|.....||+|+||.||++....++..||||.+...   .....+.+.+|+.+++.++||||+++++.+..++..++|||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            444557799999999999999888999999988542   23345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++...              .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+||
T Consensus       100 ~~~~~~L~~~~~~~--------------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~df  162 (292)
T cd06658         100 FLEGGALTDIVTHT--------------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDF  162 (292)
T ss_pred             CCCCCcHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccC
Confidence            99999999988532              378899999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |++......  ........|+..|+|||...+..++.++|||||||++|||++|+.||...+.......+...       
T Consensus       163 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-------  233 (292)
T cd06658         163 GFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-------  233 (292)
T ss_pred             cchhhcccc--cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------
Confidence            998755322  11223356889999999998889999999999999999999999999765443222211111       


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                         ......  ........+.+++.+||..||++||++.|+++.
T Consensus       234 ---~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         234 ---LPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ---CCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               011111  111223568899999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.7e-34  Score=311.50  Aligned_cols=245  Identities=24%  Similarity=0.291  Sum_probs=196.9

Q ss_pred             eeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCH
Q 002085          644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL  723 (969)
Q Consensus       644 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  723 (969)
                      ||+|+||+||+|....+|+.||+|.+.............+..|++++++++||||+++.+++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999999989999999998654333333456678899999999999999999999999999999999999999


Q ss_pred             HHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecc
Q 002085          724 DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA  803 (969)
Q Consensus       724 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  803 (969)
                      .+++.....           ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||.+....
T Consensus        81 ~~~l~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          81 KYHIYNVGE-----------PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             HHHHHHcCc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            999976542           2488999999999999999999988   99999999999999999999999999987653


Q ss_pred             cCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccC
Q 002085          804 KQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG  883 (969)
Q Consensus       804 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  883 (969)
                      .   ........++..|+|||.+.+..++.++||||+||++|+|++|+.||...........+......           
T Consensus       147 ~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  212 (277)
T cd05577         147 G---GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-----------  212 (277)
T ss_pred             c---CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----------
Confidence            3   12223346788999999998888999999999999999999999999765442222211111100           


Q ss_pred             CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002085          884 IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKE  916 (969)
Q Consensus       884 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e  916 (969)
                      .....+...+..+.+++.+||+.||++||++.|
T Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             ccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence            011112223467899999999999999995554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.5e-34  Score=314.28  Aligned_cols=265  Identities=23%  Similarity=0.354  Sum_probs=204.2

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh--cHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL--NQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+......  .......+..|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            367788999999999999999888999999998654332  133456678899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+ +++|.+++....            ..+++..+..++.|+++||+|||+.   +|+|+||+|+||+++.++.++|+
T Consensus        81 ~e~~-~~~L~~~i~~~~------------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~  144 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS------------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLA  144 (298)
T ss_pred             Eccc-CCCHHHHHhccC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEc
Confidence            9999 899999997543            1488999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++.+....  .......+++.|+|||.+.+ ..++.++|||||||++|||++|..+|.+.............+...
T Consensus       145 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~  222 (298)
T cd07841         145 DFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP  222 (298)
T ss_pred             cceeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCC
Confidence            999998764322  12233456888999998865 457889999999999999999977776554433222222111100


Q ss_pred             C--------CchhhhccCCCCc-----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 K--------PITDALDKGIAEP-----CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~--------~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .        ............+     ........+.+++.+||+.||++||+++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            0        0000000000000     11223467889999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.8e-34  Score=310.18  Aligned_cols=265  Identities=23%  Similarity=0.396  Sum_probs=205.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ++|+..+.||+|+||.||+|+...     +.+.||+|.+....  .....+.+.+|++++++++||||+++++++.+...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            468888999999999999999743     34679999875432  23345789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||+++++|.+++.......    .......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~----~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKD----EKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhccccc----ccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCc
Confidence            999999999999999998654210    001112589999999999999999999988   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  869 (969)
                      ++++|||++...... .........++..|+|||.+.+..++.++||||||+++|||++ |..||............   
T Consensus       156 ~~l~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~---  231 (275)
T cd05046         156 VKVSLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL---  231 (275)
T ss_pred             EEEcccccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH---
Confidence            999999998754221 1222233456778999999988889999999999999999999 66677554332222211   


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                       ... ..        ..+.....+..+.+++.+||+.+|++||++.|+++.|.+
T Consensus       232 -~~~-~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         232 -QAG-KL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -HcC-Cc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence             100 00        001112233678999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.5e-34  Score=308.44  Aligned_cols=258  Identities=24%  Similarity=0.375  Sum_probs=205.3

Q ss_pred             CCCccceeeecCcEEEEEEEEcC-CCcEEEEEEEeccc-------hhcHHHHHHHHHHHHHHhc-cccCceeeEEEEEEc
Q 002085          637 SLTESNLIGSGGSGQVYRIDING-AGEFVAVKRIWNNR-------KLNQKLEKEFIAEIEILGT-IRHANIVKLWCCISS  707 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  707 (969)
                      .|+..+.||+|+||.||+|.+.. .++.+|+|.+....       .........+.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37788999999999999999977 67899999875322       1223345667889998875 699999999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEecCCCCCcEEEC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~Nill~  786 (969)
                      .+..++||||+++++|.+++.....         ....+++..+++++.|++.|+.|||+ .   +++|+||+|+||+++
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~  148 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKE---------KKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLG  148 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEEC
Confidence            9999999999999999999864321         12358889999999999999999995 4   899999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      +++.++|+|||.+.......   ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+.......+
T Consensus       149 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~  225 (269)
T cd08528         149 EDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI  225 (269)
T ss_pred             CCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH
Confidence            99999999999998654322   334456889999999999988999999999999999999999998765433222211


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                      ..    .. ...        ......+..+.+++.+||+.||++||++.|+.++++
T Consensus       226 ~~----~~-~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 VE----AV-YEP--------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hh----cc-CCc--------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11    00 000        001122367889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.8e-34  Score=316.12  Aligned_cols=204  Identities=25%  Similarity=0.384  Sum_probs=163.1

Q ss_pred             cceeeecCcEEEEEEEEc--CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc--CCceEEEEe
Q 002085          641 SNLIGSGGSGQVYRIDIN--GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS--ENSKLLVYE  716 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  716 (969)
                      .++||+|+||+||+|+..  .+++.||+|.+.....     ...+.+|++++++++||||+++++++..  +...++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            468999999999999975  3568899999854321     2456789999999999999999998854  456789999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE----CCCCcEE
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL----DSEFKAK  792 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~k  792 (969)
                      |++ ++|.+++........    ......+++..+..++.|++.||+|||+.   +|+||||||+||++    +..+.+|
T Consensus        81 ~~~-~~l~~~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~k  152 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKA----NKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK  152 (317)
T ss_pred             ccC-CCHHHHHHhcccccc----cCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEE
Confidence            996 688888764332110    11123588899999999999999999988   99999999999999    4567899


Q ss_pred             EeecccceecccCCCC-ccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 002085          793 IADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGD  857 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~  857 (969)
                      |+|||+++.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9999999876432211 223346789999999998774 5889999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.2e-34  Score=308.65  Aligned_cols=245  Identities=24%  Similarity=0.261  Sum_probs=190.6

Q ss_pred             eeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhc---cccCceeeEEEEEEcCCceEEEEeecc
Q 002085          643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT---IRHANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       643 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      +||+|+||.||++....+++.||+|.+.............+.+|..+++.   .+||+++.+.+++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999998999999998865433222223334455544443   479999999999999999999999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccc
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA  799 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  799 (969)
                      +++|.+++....             .+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++|||++
T Consensus        81 ~~~L~~~i~~~~-------------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~  144 (279)
T cd05633          81 GGDLHYHLSQHG-------------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  144 (279)
T ss_pred             CCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcc
Confidence            999999987543             389999999999999999999988   9999999999999999999999999998


Q ss_pred             eecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchh
Q 002085          800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD  878 (969)
Q Consensus       800 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  878 (969)
                      ......    ......|+..|+|||.+.+ ..++.++||||+||++|||++|..||.................       
T Consensus       145 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-------  213 (279)
T cd05633         145 CDFSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------  213 (279)
T ss_pred             eecccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-------
Confidence            755322    1223468999999998864 5688999999999999999999999976543322211111110       


Q ss_pred             hhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       879 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                           .....+...+..+.+++.+|++.||++||     +++|+++
T Consensus       214 -----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         214 -----VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             -----CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence                 01112223446788999999999999999     4766654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=303.23  Aligned_cols=267  Identities=23%  Similarity=0.343  Sum_probs=220.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      ..+|....+||+|+||.|-+|+.+++.+.||||+++++....+...+--..|-++|... +-|.++.+..+++.-++.|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            45788889999999999999999999999999999887655555455556677888776 67899999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+.||+|--++++.++             +.++.+..+|..||-||-+||++   ||++||||..|||+|.+|.+||
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk-------------FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi  491 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK-------------FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKI  491 (683)
T ss_pred             EEEEecCchhhhHHHHhcc-------------cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEe
Confidence            9999999999999988765             77788999999999999999988   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+++.-.-  ...+....+|||.|+|||++...+|..++|.|||||+||||+.|+.||.+++..++.+.+..+-.  
T Consensus       492 ~DFGmcKEni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--  567 (683)
T KOG0696|consen  492 ADFGMCKENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--  567 (683)
T ss_pred             eeccccccccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--
Confidence            99999874322  23344567899999999999999999999999999999999999999999988777665543221  


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCcccccCCCCCCCCCcccce
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYL  951 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  951 (969)
                                   .++...+.+..++....+-+.|.+|...                 +....+++++||+|...+|+
T Consensus       568 -------------syPKslSkEAv~ickg~ltK~P~kRLGc-----------------g~~ge~di~~H~FFR~iDWe  615 (683)
T KOG0696|consen  568 -------------SYPKSLSKEAVAICKGLLTKHPGKRLGC-----------------GPEGERDIREHPFFRRIDWE  615 (683)
T ss_pred             -------------cCcccccHHHHHHHHHHhhcCCccccCC-----------------CCccccchhhCcchhhccHH
Confidence                         2344445677777777777777777321                 12355899999999954444

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.2e-34  Score=306.56  Aligned_cols=252  Identities=30%  Similarity=0.468  Sum_probs=203.6

Q ss_pred             CccceeeecCcEEEEEEEEcCCC----cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          639 TESNLIGSGGSGQVYRIDINGAG----EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +..+.||.|+||.||++.+...+    ..||+|++....  .....+.+..|+++++.++|+||+++++++.+.+..+++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            45688999999999999998765    889999985442  222567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++.....           ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++
T Consensus        80 ~e~~~~~~l~~~~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~  145 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRP-----------KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKIS  145 (258)
T ss_pred             EeccCCCCHHHHHHhhhh-----------ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEc
Confidence            999999999999986442           1288999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++........ ......+++.|+|||...+..++.++||||+|+++|||++ |..||.........+....    .
T Consensus       146 dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----~  220 (258)
T smart00219      146 DFGLSRDLYDDDYY-KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK----G  220 (258)
T ss_pred             ccCCceeccccccc-ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc----C
Confidence            99999876443221 1112347789999999988889999999999999999999 6667665443333222211    1


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      .          ....+...+..+.+++.+|+..||++|||+.|+++.|
T Consensus       221 ~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      221 Y----------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C----------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1          0111122446789999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4e-34  Score=308.00  Aligned_cols=258  Identities=25%  Similarity=0.366  Sum_probs=207.1

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc--CCceEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS--ENSKLLV  714 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  714 (969)
                      +|+..+.||.|+||.||+|.+..+++.||+|++..... .....+.+..|++++++++||||+++++++..  +...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            47778999999999999999998999999998865432 34446778999999999999999999998754  4567999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC--CCCeEecCCCCCcEEECCCCcEE
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC--TPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      |||+++++|.+++.....         ....+++..++.++.|++.|++|||..+  +.+++|+||+|+||+++.++.+|
T Consensus        80 ~e~~~~~~L~~~l~~~~~---------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~k  150 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKK---------ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVK  150 (265)
T ss_pred             ehhccCCCHHHHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEE
Confidence            999999999999976422         1235889999999999999999999221  22999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ++|||++.......  .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+...+.+.+.    .
T Consensus       151 l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~  224 (265)
T cd08217         151 LGDFGLAKILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK----E  224 (265)
T ss_pred             EecccccccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh----c
Confidence            99999998764322  11233568999999999998889999999999999999999999997665332222211    1


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                                +.....+...+..+.+++.+|++.+|++||++.||++.
T Consensus       225 ----------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         225 ----------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                      11111223345788999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-34  Score=310.59  Aligned_cols=241  Identities=20%  Similarity=0.337  Sum_probs=189.7

Q ss_pred             ceeeecCcEEEEEEEEcCCCc-------EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          642 NLIGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +.||+|+||.||+|.....+.       .||+|.+...   .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            468999999999998865443       4888887432   234456788999999999999999999999998999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc----
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK----  790 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~----  790 (969)
                      |||+++|+|.++++....            .+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.    
T Consensus        78 ~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~  142 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKN------------LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTG  142 (258)
T ss_pred             EecCCCCcHHHHHhcCCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccC
Confidence            999999999999986542            478999999999999999999988   9999999999999988765    


Q ss_pred             ----EEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCC-CccchHH
Q 002085          791 ----AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGD-EHTSLAE  864 (969)
Q Consensus       791 ----~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~-~~~~~~~  864 (969)
                          ++++|||.+.....      .....++..|+|||++.+. .++.++|||||||++|||++|..++... +......
T Consensus       143 ~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~  216 (258)
T cd05078         143 NPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ  216 (258)
T ss_pred             CCceEEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH
Confidence                69999998865422      1234578899999998864 5789999999999999999996554332 2211111


Q ss_pred             HHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                       .   .....            ..+......+.+++.+||+.||++||+++++++.|.
T Consensus       217 -~---~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         217 -F---YEDRH------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -H---HHccc------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             1   11100            111122357899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.9e-34  Score=311.18  Aligned_cols=257  Identities=23%  Similarity=0.292  Sum_probs=200.3

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEE-----c
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCIS-----S  707 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~  707 (969)
                      ..++|+..+.||+|+||.||+|....+++.||+|++....    .....+.+|+.+++++ +||||+++++++.     .
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            4578999999999999999999999899999999874322    1235678899999999 6999999999873     3


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      ++..++||||+++++|.+++.....         ....+++..+..++.|++.|+.|||+.   +++||||||+||++++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~  159 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLK---------RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT  159 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhc---------cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence            4568999999999999998864321         123478899999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCccch
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-----TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL  862 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  862 (969)
                      ++.++++|||+++.+....  .......|++.|+|||++..     ..++.++||||+||++|||++|+.||........
T Consensus       160 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~  237 (286)
T cd06638         160 EGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA  237 (286)
T ss_pred             CCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence            9999999999998653321  12233468999999998753     4578899999999999999999999876543211


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ..   . .....      ....  ..+......+.+++.+||+.||++||++.|+++.
T Consensus       238 ~~---~-~~~~~------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         238 LF---K-IPRNP------PPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             Hh---h-ccccC------CCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11   0 00000      0000  0111123568899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.5e-34  Score=312.82  Aligned_cols=252  Identities=28%  Similarity=0.387  Sum_probs=203.9

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ..+.|+..+.||+|+||.||+|....+++.||+|.+...........+.+.+|+++++.++|||++++.+++.+.+..|+
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            34568889999999999999999988899999999865444444555788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||++ |++.+++....            ..+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.++|
T Consensus        93 v~e~~~-g~l~~~~~~~~------------~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL  156 (307)
T cd06607          93 VMEYCL-GSASDILEVHK------------KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKL  156 (307)
T ss_pred             EHHhhC-CCHHHHHHHcc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEE
Confidence            999997 67777765432            2488999999999999999999988   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      +|||++......      ....+++.|+|||++.   ...++.++||||||+++|||++|..||...+.......+    
T Consensus       157 ~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~----  226 (307)
T cd06607         157 ADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----  226 (307)
T ss_pred             eecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH----
Confidence            999998754321      2346788999999874   456889999999999999999999998765433221111    


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ....         .........+..+.+++.+||+.||++||++.+++..
T Consensus       227 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         227 AQND---------SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             hcCC---------CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000         0011122345678999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.1e-34  Score=309.50  Aligned_cols=262  Identities=23%  Similarity=0.348  Sum_probs=202.5

Q ss_pred             CCccceeeecCcEEEEEEEEc---CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC-----
Q 002085          638 LTESNLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN-----  709 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  709 (969)
                      |+..+.||+|+||.||+|.+.   .+++.||||++..... .....+.+.+|++++++++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            556788999999999999864   3578899999865432 3334577899999999999999999999886532     


Q ss_pred             -ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          710 -SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       710 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                       ..++++||+++|+|.+++.......       ....+++..+.+++.|++.|++|||+.   +|+||||||+||+++.+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~  149 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGE-------EPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNEN  149 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCC
Confidence             2478999999999998876432100       012478899999999999999999988   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  867 (969)
                      +.+|++|||.++...............+++.|++||.+....++.++|||||||++|||++ |..||.+.+.........
T Consensus       150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~  229 (273)
T cd05074         150 MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI  229 (273)
T ss_pred             CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999986543222222223345678999999998889999999999999999999 777776554433332221


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      .    ....          ..+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       230 ~----~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 K----GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             c----CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1    1110          01112346899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-34  Score=315.22  Aligned_cols=264  Identities=23%  Similarity=0.358  Sum_probs=200.2

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|+||.||+|.+..+|+.||+|+++.... .......+.+|++++++++||||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            47778999999999999999999999999999865322 22334567889999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |++ ++|.+++....            ..+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.++|+||
T Consensus        80 ~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~df  143 (284)
T cd07839          80 YCD-QDLKKYFDSCN------------GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADF  143 (284)
T ss_pred             cCC-CCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECcc
Confidence            997 58888876432            2488999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCc-cchHHHHHHHhhccC
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEH-TSLAEWAWRHYAEEK  874 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~  874 (969)
                      |+++.....  ........+++.|+|||.+.+.. ++.++||||+||++|||++|+.|+..... ....+.+.+......
T Consensus       144 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  221 (284)
T cd07839         144 GLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  221 (284)
T ss_pred             chhhccCCC--CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            999765321  12223346788999999987654 68999999999999999999999764432 222111111110000


Q ss_pred             C-----chhhhccC----CC-----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 P-----ITDALDKG----IA-----EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~-----~~~~~~~~----~~-----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .     .....+..    ..     .......+..+.+++.+||+.||.+|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0     00000000    00     0011123467889999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.7e-34  Score=312.14  Aligned_cols=266  Identities=25%  Similarity=0.344  Sum_probs=206.8

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.++++++|||++++++++.++...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            47788999999999999999988899999999865432 23445679999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+ +++|.+++....            ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++++||
T Consensus        80 ~~-~~~L~~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~df  143 (286)
T cd07832          80 YM-PSDLSEVLRDEE------------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADF  143 (286)
T ss_pred             cc-CCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeee
Confidence            99 999999987543            2488999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      |.+........ .......|+..|+|||.+.+. .++.++||||+||++|||++|..+|.+.........+...+.....
T Consensus       144 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07832         144 GLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE  222 (286)
T ss_pred             eecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCCh
Confidence            99986643321 223345689999999988654 4688999999999999999997777665543333333222211100


Q ss_pred             -----------chhhhccCCC----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          876 -----------ITDALDKGIA----EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       876 -----------~~~~~~~~~~----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                                 ..........    .....+....+.+++.+|++.||++||+++++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                       0000000000    00011234788999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.7e-34  Score=308.10  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=207.0

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||.|+||.||+|.+..+++.||+|++...........+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            47788999999999999999988899999999976544444556789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++....             .+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++++||
T Consensus        81 ~~~~~~L~~~l~~~~-------------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~  144 (258)
T cd05578          81 LLLGGDLRYHLSQKV-------------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDF  144 (258)
T ss_pred             CCCCCCHHHHHHhcC-------------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeec
Confidence            999999999997542             378899999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |.+.......   ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||........ ..........   
T Consensus       145 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~---  217 (258)
T cd05578         145 NIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQETA---  217 (258)
T ss_pred             ccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHHHHhccc---
Confidence            9987653321   22345688899999999988899999999999999999999999986654311 1111111100   


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM--KEVL  918 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~--~evl  918 (969)
                              ....+...+..+.+++.+||+.||.+||++  +|++
T Consensus       218 --------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 --------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                    011222334788999999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.5e-34  Score=305.03  Aligned_cols=255  Identities=29%  Similarity=0.407  Sum_probs=205.4

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|+||.||+|....+++.||+|.++.... .....+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            47788999999999999999988899999999865533 24567889999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++....             .+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.+||+||
T Consensus        80 ~~~~~~L~~~~~~~~-------------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~  143 (264)
T cd06626          80 YCSGGTLEELLEHGR-------------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDF  143 (264)
T ss_pred             cCCCCcHHHHHhhcC-------------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccc
Confidence            999999999997543             377889999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCcc--ccccccCcccCchhhcccCC---CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          797 GLAKMLAKQGEPHT--MSAVAGSFGYFAPEYAYTTK---VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       797 gla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |++...........  .....+++.|+|||++.+..   ++.++||||||+++||+++|+.||...+......  .....
T Consensus       144 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~~~~  221 (264)
T cd06626         144 GCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--FHVGA  221 (264)
T ss_pred             ccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--HHHhc
Confidence            99987644322111  12356789999999998766   8899999999999999999999997543221111  11000


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...       .  ..+........+.+++.+||+.+|++||++.|++.
T Consensus       222 ~~~-------~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 GHK-------P--PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCC-------C--CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000       0  00111122467789999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.7e-34  Score=305.34  Aligned_cols=240  Identities=25%  Similarity=0.283  Sum_probs=197.6

Q ss_pred             eeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCH
Q 002085          644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL  723 (969)
Q Consensus       644 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  723 (969)
                      ||.|+||.||+|....+++.||+|++...........+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999888999999999765544455567899999999999999999999999999999999999999999


Q ss_pred             HHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecc
Q 002085          724 DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA  803 (969)
Q Consensus       724 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  803 (969)
                      .+++....             .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.++...
T Consensus        81 ~~~l~~~~-------------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~  144 (262)
T cd05572          81 WTILRDRG-------------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK  144 (262)
T ss_pred             HHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccC
Confidence            99997643             278889999999999999999988   99999999999999999999999999998664


Q ss_pred             cCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccC
Q 002085          804 KQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG  883 (969)
Q Consensus       804 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  883 (969)
                      ...   ......+++.|+|||.+.+..++.++|+||+|+++|||++|..||...+... .+........          .
T Consensus       145 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~----------~  210 (262)
T cd05572         145 SGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDILKG----------N  210 (262)
T ss_pred             ccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHHhcc----------C
Confidence            321   2233468889999999988889999999999999999999999997655211 1111111100          0


Q ss_pred             CCCcccHHHHHHHHHHHHHccCCCCCCCCC
Q 002085          884 IAEPCYLEEMTTVYRLALICTSTLPSSRPS  913 (969)
Q Consensus       884 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs  913 (969)
                      .....+......+.+++.+||+.+|++||+
T Consensus       211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence            011112222478999999999999999999

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-33  Score=306.41  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=203.7

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      -|+..+.||+|+||.||+|.+..+++.||+|.+....  .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            4677889999999999999998889999999875432  22345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++...              .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        83 ~~~~~~l~~~i~~~--------------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~df  145 (277)
T cd06641          83 YLGGGSALDLLEPG--------------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF  145 (277)
T ss_pred             eCCCCcHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeec
Confidence            99999999998642              378999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |++..+....  .......++..|+|||.+.+..++.++|||||||++|||++|..||...........+    ....  
T Consensus       146 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~--  217 (277)
T cd06641         146 GVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI----PKNN--  217 (277)
T ss_pred             ccceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH----hcCC--
Confidence            9987653321  1223346788999999999888999999999999999999999998654332211111    1100  


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                              ........+..+.+++.+||+.+|++||++.++++.
T Consensus       218 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 --------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             --------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                    001112234678899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.5e-34  Score=304.67  Aligned_cols=251  Identities=28%  Similarity=0.370  Sum_probs=203.7

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccch--hcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK--LNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +|+..+.||+|+||.||+|....+++.||+|.+.....  ..++..+.+.+|+++++.++|+||+++++++.++...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            36777899999999999999988899999998854321  2234567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      +||+++++|.+++....             .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+
T Consensus        81 ~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~  144 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-------------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLA  144 (258)
T ss_pred             EEecCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEc
Confidence            99999999999997543             378899999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||.+.......   ......|+..|+|||.+.... ++.++|+|||||++|||++|+.||.......   ........ 
T Consensus       145 d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~-  217 (258)
T cd06632         145 DFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA---AVFKIGRS-  217 (258)
T ss_pred             cCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH---HHHHHHhc-
Confidence            999987653322   223456889999999987766 8999999999999999999999986544211   11111110 


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...         ...+......+.+++.+||+.+|++||++.++++
T Consensus       218 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         218 KEL---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ccC---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            000         0111223467889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.3e-34  Score=313.75  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=201.2

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |.....||+|+||.||+|....+++.||+|++....   ....+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            344567999999999999998889999999985432   22346688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++++|.+++...              .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||
T Consensus       100 ~~~~~L~~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg  162 (297)
T cd06659         100 LQGGALTDIVSQT--------------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG  162 (297)
T ss_pred             CCCCCHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeech
Confidence            9999999987542              378999999999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      ++..+...  ........|+..|+|||++.+..++.++|||||||++|||++|+.||...+.......+.    ......
T Consensus       163 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~~  236 (297)
T cd06659         163 FCAQISKD--VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR----DSPPPK  236 (297)
T ss_pred             hHhhcccc--cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----ccCCCC
Confidence            98754332  112234568899999999999899999999999999999999999997654433222111    110000


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                            .  .........+.+++.+||+.+|++||++.|+++.
T Consensus       237 ------~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         237 ------L--KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ------c--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                  0  0011223568899999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.7e-34  Score=305.81  Aligned_cols=239  Identities=21%  Similarity=0.347  Sum_probs=190.2

Q ss_pred             ceeeecCcEEEEEEEEcCCC----------cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          642 NLIGSGGSGQVYRIDINGAG----------EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      +.||+|+||.||+|.+..++          ..|++|.+.....    ....+.+|+.++++++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46899999999999997666          3588887643321    15788999999999999999999999988 778


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC--
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF--  789 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~--  789 (969)
                      ++||||+++|+|.+++.....            .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++  
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~  140 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN------------NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLN  140 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc------------CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccc
Confidence            999999999999999986541            488999999999999999999988   999999999999999887  


Q ss_pred             -----cEEEeecccceecccCCCCccccccccCcccCchhhcccC--CCCCccchhhHHHHHHHHHhC-CCCCCCCCccc
Q 002085          790 -----KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT--KVNEKIDIYSFGVVLLELVTG-KEANYGDEHTS  861 (969)
Q Consensus       790 -----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg-~~p~~~~~~~~  861 (969)
                           .++++|||++.....      .....++..|+|||++.+.  .++.++|||||||++|||++| ..|+.......
T Consensus       141 ~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~  214 (259)
T cd05037         141 EGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE  214 (259)
T ss_pred             cCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh
Confidence                 799999999876532      1234567789999998876  789999999999999999995 55555443221


Q ss_pred             hHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                      .....    ....        ....+    ....+.+++.+||..+|.+||++.|+++.|.
T Consensus       215 ~~~~~----~~~~--------~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         215 KERFY----QDQH--------RLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHH----hcCC--------CCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11111    1100        00011    1167889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-33  Score=306.50  Aligned_cols=260  Identities=25%  Similarity=0.356  Sum_probs=202.5

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc--CCceEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS--ENSKLLV  714 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  714 (969)
                      +|...++||.|++|.||+|.+..+++.||+|.+.....  ......+.+|++++++++||||+++++++.+  .+..++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            57778999999999999999988899999999864322  2445779999999999999999999998865  3468999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++.....         ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+
T Consensus        80 ~e~~~~~~L~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~  147 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKK---------RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLC  147 (287)
T ss_pred             EEecCCCCHHHHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEe
Confidence            999999999998764321         123478889999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCc--cchHHHHHHHhhc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH--TSLAEWAWRHYAE  872 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~  872 (969)
                      |||++......    ......++..|+|||.+.+..++.++||||+||++|||++|+.||.....  ....+.. .....
T Consensus       148 dfg~~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~  222 (287)
T cd06621         148 DFGVSGELVNS----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVN  222 (287)
T ss_pred             ecccccccccc----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhc
Confidence            99998754321    11234578899999999999999999999999999999999999976532  1111111 11111


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       ..... +....  ......+..+.+++.+||+.+|++|||+.|+++
T Consensus       223 -~~~~~-~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         223 -MPNPE-LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -CCchh-hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             00000 00000  101123467899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=340.59  Aligned_cols=214  Identities=24%  Similarity=0.275  Sum_probs=187.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|.+.++||+|+||.|..++.+.+++.||.|++.+..-.......-|..|-.+|..-+.+-|+.+.-+|+|..+.|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            57899999999999999999999999999999996643333344567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |||+||+|-.++....             .++..++..++..|..||.-+|+.   |+|||||||+|||+|..|++||+|
T Consensus       155 dY~pGGDlltLlSk~~-------------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFD-------------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             ecccCchHHHHHhhcC-------------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence            9999999999998754             388999999999999999999999   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcc----c-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY----T-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      ||.+-.+..+|.. .....+|||-|.+||++.    + +.|++.+|.||+||++|||+.|..||+.+.-.+.+..+
T Consensus       219 FGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI  293 (1317)
T KOG0612|consen  219 FGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI  293 (1317)
T ss_pred             chhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH
Confidence            9999877654433 334568999999999986    2 57899999999999999999999999987665554444

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.7e-34  Score=311.77  Aligned_cols=266  Identities=24%  Similarity=0.316  Sum_probs=204.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--CceE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--NSKL  712 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  712 (969)
                      .++|+..+.||+|+||.||+|.+..+++.||+|.++..... ......+.+|++++++++||||+++.+++.+.  ...|
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            45788999999999999999999988999999998654322 23334677899999999999999999998877  8899


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||++ ++|.+++....            ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++
T Consensus        83 lv~e~~~-~~L~~~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~  146 (293)
T cd07843          83 MVMEYVE-HDLKSLMETMK------------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILK  146 (293)
T ss_pred             EEehhcC-cCHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEE
Confidence            9999997 59999887543            2488999999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |+|||++..+....  .......+++.|+|||.+.+.. ++.++|+||+|+++|||++|..||...........+.....
T Consensus       147 l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~  224 (293)
T cd07843         147 ICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG  224 (293)
T ss_pred             EeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            99999998664321  2223345788999999887654 68899999999999999999999976554332222221111


Q ss_pred             cc-----------C-----CchhhhccCCCCcccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          872 EE-----------K-----PITDALDKGIAEPCYLE-EMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       872 ~~-----------~-----~~~~~~~~~~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..           .     .........+....+.. ....+.+++.+||+.||++||++.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         225 TPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             CCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00           0     00000000000111111 2467889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.3e-33  Score=304.56  Aligned_cols=257  Identities=21%  Similarity=0.309  Sum_probs=189.7

Q ss_pred             ceeeecCcEEEEEEEEcCC--CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeecc
Q 002085          642 NLIGSGGSGQVYRIDINGA--GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      +.||+|+||.||+|+....  ...+++|.+....  .....+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            3589999999999976432  2356677664332  23345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccc
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA  799 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  799 (969)
                      +|+|.++++.....         ....++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        79 ~~~L~~~l~~~~~~---------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~  146 (268)
T cd05086          79 LGDLKSYLSQEQWH---------RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG  146 (268)
T ss_pred             CCcHHHHHHhhhcc---------cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccc
Confidence            99999999864321         12356777889999999999999988   9999999999999999999999999998


Q ss_pred             eecccCCCCccccccccCcccCchhhccc-------CCCCCccchhhHHHHHHHHHhCC-CCCCCCCccchHHHHHHHhh
Q 002085          800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYT-------TKVNEKIDIYSFGVVLLELVTGK-EANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       800 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~  871 (969)
                      ................++..|+|||++.+       ..++.++|||||||++|||++++ .||...+.......+..   
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---  223 (268)
T cd05086         147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK---  223 (268)
T ss_pred             cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---
Confidence            64322111122234567889999998753       24578999999999999999854 46544433222222111   


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                      +.  .....++.+...    ....+.+++..|| .+|++||+++||++.|.
T Consensus       224 ~~--~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         224 DQ--QVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             hc--ccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11  111122222211    2356788999999 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1e-33  Score=313.58  Aligned_cols=204  Identities=25%  Similarity=0.392  Sum_probs=162.6

Q ss_pred             cceeeecCcEEEEEEEEcC--CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc--CCceEEEEe
Q 002085          641 SNLIGSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS--ENSKLLVYE  716 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  716 (969)
                      ..+||+|+||.||+|+...  ++..||+|.+.....     ...+.+|+++++.++||||+++++++..  +...++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            3689999999999999753  567899998854321     2457789999999999999999998853  557899999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE----CCCCcEE
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL----DSEFKAK  792 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~k  792 (969)
                      |++ ++|.+++.......    .......+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+|
T Consensus        81 ~~~-~~l~~~~~~~~~~~----~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~k  152 (317)
T cd07867          81 YAE-HDLWHIIKFHRASK----ANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK  152 (317)
T ss_pred             eeC-CcHHHHHHhhhccc----cCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEE
Confidence            986 58888876433210    011123588999999999999999999988   99999999999999    5567899


Q ss_pred             EeecccceecccCCCC-ccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 002085          793 IADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGD  857 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~  857 (969)
                      |+|||+++.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             EeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9999999876432211 122345689999999998764 5789999999999999999999998754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-35  Score=288.39  Aligned_cols=259  Identities=24%  Similarity=0.312  Sum_probs=212.0

Q ss_pred             cchhhhccCCCcc-ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEE
Q 002085          629 FTESNILSSLTES-NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCIS  706 (969)
Q Consensus       629 ~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  706 (969)
                      |.+..++++|++. ++||-|-.|.|-.+..+.+++.+|+|++...        ...++|+++--+. .|||||.++++|+
T Consensus        54 ~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVye  125 (400)
T KOG0604|consen   54 FKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYE  125 (400)
T ss_pred             hhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhh
Confidence            3445567778765 6789999999999999999999999998432        4567788876666 6999999999875


Q ss_pred             c----CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCc
Q 002085          707 S----ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSN  782 (969)
Q Consensus       707 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  782 (969)
                      .    .....+|||.|+||.|.+.+++++.           ..+.+.++.+|+.||+.|+.|||+.   +|.||||||+|
T Consensus       126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~-----------~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpEN  191 (400)
T KOG0604|consen  126 NSYQGRKCLLIVMECMEGGELFSRIQDRGD-----------QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPEN  191 (400)
T ss_pred             hhccCceeeEeeeecccchHHHHHHHHccc-----------ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhh
Confidence            4    4567899999999999999998774           4689999999999999999999998   99999999999


Q ss_pred             EEECCC---CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCc
Q 002085          783 ILLDSE---FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH  859 (969)
Q Consensus       783 ill~~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~  859 (969)
                      +|.+..   ..+||+|||+|+.-.   .+......+-||.|.|||++...+|+...|+||+||++|-|++|.+||+....
T Consensus       192 LLyt~t~~na~lKLtDfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg  268 (400)
T KOG0604|consen  192 LLYTTTSPNAPLKLTDFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  268 (400)
T ss_pred             eeeecCCCCcceEecccccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence            999754   579999999998642   24556677889999999999999999999999999999999999999997644


Q ss_pred             cchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..+-.-+.+....+       .-.+..+.+...++...++|+.+++.+|++|.|..|++.
T Consensus       269 ~aispgMk~rI~~g-------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  269 LAISPGMKRRIRTG-------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ccCChhHHhHhhcc-------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            32222122221111       122445666777889999999999999999999999986

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8e-34  Score=305.82  Aligned_cols=251  Identities=29%  Similarity=0.405  Sum_probs=204.7

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+.....  ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            57778899999999999999998899999999865432  3455788999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |+++++|.+++....            ..+++..+.+++.|++.|++|||+ .   +++|+||+|+||++++++.++|+|
T Consensus        80 ~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d  144 (265)
T cd06605          80 YMDGGSLDKILKEVQ------------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCD  144 (265)
T ss_pred             ecCCCcHHHHHHHcc------------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEee
Confidence            999999999998642            247888999999999999999998 6   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCc--cchHHHHHHHhhcc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH--TSLAEWAWRHYAEE  873 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~  873 (969)
                      ||.+.......    .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...+.  ....+.+.......
T Consensus       145 ~g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  220 (265)
T cd06605         145 FGVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP  220 (265)
T ss_pred             cccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC
Confidence            99987653211    1126688899999999999999999999999999999999999875421  11222221111111


Q ss_pred             CCchhhhccCCCCcccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLE-EMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .           ...+.. .+..+.+++.+||..||++||++.|++.
T Consensus       221 ~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         221 P-----------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             C-----------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            0           001111 4467899999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-34  Score=314.84  Aligned_cols=248  Identities=24%  Similarity=0.383  Sum_probs=199.0

Q ss_pred             ccceeeecCcEEEEEEEEcCCCcEEEEEEEecc-chhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc--eEEEEe
Q 002085          640 ESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNN-RKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS--KLLVYE  716 (969)
Q Consensus       640 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  716 (969)
                      ...+||+|+|-+||+|.+..+|..||=-.++.. ........++|..|+++|+.|+||||+++++++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            346899999999999999888888774333211 12234456899999999999999999999999987655  678999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC-CcEEEee
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIAD  795 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~D  795 (969)
                      .|..|+|..|+++.++             .+......|+.||+.||.|||++ .|+|+|||||-+||||+.+ |.|||+|
T Consensus       124 L~TSGtLr~Y~kk~~~-------------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGD  189 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRR-------------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGD  189 (632)
T ss_pred             cccCCcHHHHHHHhcc-------------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecc
Confidence            9999999999998875             77789999999999999999998 8999999999999999876 8999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      +|+|+....    .......|||.|||||... ..|++..||||||+.++||+|+..||..=..   ...+++.+..+.+
T Consensus       190 LGLAtl~r~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n---~AQIYKKV~SGiK  261 (632)
T KOG0584|consen  190 LGLATLLRK----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN---PAQIYKKVTSGIK  261 (632)
T ss_pred             hhHHHHhhc----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC---HHHHHHHHHcCCC
Confidence            999987632    1223378999999999876 7899999999999999999999999853211   1223333333322


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      -..+  ...       ..+++.+||.+|+.. .++|||+.|+++
T Consensus       262 P~sl--~kV-------~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  262 PAAL--SKV-------KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHh--hcc-------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            1111  011       126789999999999 999999999986

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-34  Score=310.90  Aligned_cols=265  Identities=23%  Similarity=0.330  Sum_probs=204.6

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|+||.||+|.+..+++.||+|+++.... .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            58888999999999999999998899999998854322 33445788999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |++++.+..+.....             .+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+||
T Consensus        81 ~~~~~~l~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  144 (288)
T cd07833          81 YVERTLLELLEASPG-------------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDF  144 (288)
T ss_pred             cCCCCHHHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEee
Confidence            999877766654322             378899999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc---
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE---  872 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---  872 (969)
                      |++........ .......++..|+|||++.+. .++.++||||||+++|||++|+.||.+....+...........   
T Consensus       145 g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  223 (288)
T cd07833         145 GFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP  223 (288)
T ss_pred             ecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99987644322 122345678899999999888 7899999999999999999999988765433222111111100   


Q ss_pred             --------cCCchhhhccCCC------CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 --------EKPITDALDKGIA------EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 --------~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                              .............      ...+...+..+.+++.+||..+|++||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                    0000000000000      0011122577999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-33  Score=311.28  Aligned_cols=255  Identities=28%  Similarity=0.377  Sum_probs=205.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ..|+..+.||+|+||.||+|++..++..||+|++.............+..|++++++++|||++++++++.++...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            45778899999999999999998889999999986544434455577899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||++ |++.+++....            ..++|..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|
T Consensus       105 e~~~-g~l~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~d  168 (317)
T cd06635         105 EYCL-GSASDLLEVHK------------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLAD  168 (317)
T ss_pred             eCCC-CCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEec
Confidence            9997 57877775432            2488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ||++.....      .....|++.|+|||++.   ++.++.++|||||||++|||++|+.||...+.......+..   .
T Consensus       169 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~  239 (317)
T cd06635         169 FGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---N  239 (317)
T ss_pred             CCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh---c
Confidence            999865422      12346888999999874   45688999999999999999999999876543322211111   1


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .          .........+..+.+++.+||+.+|.+||++.++++......
T Consensus       240 ~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         240 E----------SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             c----------CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            1          011112233467889999999999999999999998665543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.3e-33  Score=302.07  Aligned_cols=252  Identities=29%  Similarity=0.434  Sum_probs=207.5

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|...+.||+|++|.||+|....+++.||+|++.....  ....+.+.+|++++.+++|+|++++++++..++..++|||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            57788999999999999999998899999999865432  1446789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |+++++|.+++....             .+++..++.++.|++.|++|||+ .   +++||||+|+||+++.++.++|+|
T Consensus        80 ~~~~~~L~~~l~~~~-------------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~d  143 (264)
T cd06623          80 YMDGGSLADLLKKVG-------------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIAD  143 (264)
T ss_pred             ecCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEcc
Confidence            999999999997643             37899999999999999999998 7   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||.+........  ......++..|+|||.+.+..++.++||||||+++|||++|..||...+.....+.... ..... 
T Consensus       144 f~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~-  219 (264)
T cd06623         144 FGISKVLENTLD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-ICDGP-  219 (264)
T ss_pred             CccceecccCCC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-HhcCC-
Confidence            999987643221  11245678999999999998999999999999999999999999876543222221111 11110 


Q ss_pred             chhhhccCCCCcccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ITDALDKGIAEPCYLE-EMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                               ....+.. .+..+.+++.+||..+|++||++.|+++
T Consensus       220 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         220 ---------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             ---------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                     0111112 3468899999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.7e-34  Score=310.74  Aligned_cols=252  Identities=25%  Similarity=0.328  Sum_probs=205.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|...+.||+|+||.||++....++..||+|.+...   .....+.+.+|+.+++.++|||++++++++...+..|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            46888999999999999999998888999999998432   223346788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      +||+++++|.+++...              .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+
T Consensus        95 ~e~~~~~~L~~~~~~~--------------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~  157 (293)
T cd06647          95 MEYLAGGSLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT  157 (293)
T ss_pred             EecCCCCcHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEc
Confidence            9999999999998743              277889999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||++.......  .......+++.|+|||.+.+..++.++|||||||++||+++|+.||...........+.   ....
T Consensus       158 dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---~~~~  232 (293)
T cd06647         158 DFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGT  232 (293)
T ss_pred             cCcceecccccc--cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh---cCCC
Confidence            999987654322  12233468889999999988889999999999999999999999997654321111110   0000


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      +         ....+......+.+++.+||..+|++||++.+++.+
T Consensus       233 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 P---------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             C---------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0         011122234578899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-33  Score=306.35  Aligned_cols=249  Identities=22%  Similarity=0.360  Sum_probs=202.6

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      .|...++||+|++|.||++....+++.||+|++...   .....+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            455568999999999999999888999999988432   22334668899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++...              .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++||
T Consensus        97 ~~~~~~L~~~~~~~--------------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~  159 (285)
T cd06648          97 FLEGGALTDIVTHT--------------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDF  159 (285)
T ss_pred             ccCCCCHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEccc
Confidence            99999999998752              278899999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |.+......  ........|++.|+|||...+..++.++|||||||++|||++|+.||...+.......+..    ... 
T Consensus       160 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~----~~~-  232 (285)
T cd06648         160 GFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD----NLP-  232 (285)
T ss_pred             ccchhhccC--CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh----cCC-
Confidence            988754322  1122335688999999999988899999999999999999999999976554332222211    100 


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                           ....  .....+..+.+++.+||..+|++||++.++++
T Consensus       233 -----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         233 -----PKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -----CCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                 0010  11123367899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-34  Score=305.65  Aligned_cols=253  Identities=22%  Similarity=0.302  Sum_probs=199.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  714 (969)
                      ..|++.+.||+||.+.||++...+ .+.||+|++... ..+....+.|..|+..|.++ .|.+||++++|-..++..|+|
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            479999999999999999998864 455777765332 33566678999999999999 599999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||= ..+|..+|++...           ...+| .+..+..|++.++.+.|.+   ||||.||||.|+++-. |.+||+
T Consensus       439 mE~G-d~DL~kiL~k~~~-----------~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLI  501 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKS-----------IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLI  501 (677)
T ss_pred             eecc-cccHHHHHHhccC-----------CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEee
Confidence            9976 4899999998764           22345 7889999999999999999   9999999999999854 589999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccC-----------CCCCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-----------KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                      |||.|..+..+.........+||+.||+||.+...           +.++++||||+|||||+|+.|+.||..-     .
T Consensus       502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~  576 (677)
T KOG0596|consen  502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----I  576 (677)
T ss_pred             eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----H
Confidence            99999988766666666778999999999988643           2567899999999999999999998531     1


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLE-EMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       ..+..      +..+.+++-..+++.- ...+++++|+.|+..||.+||+..|+++
T Consensus       577 -n~~aK------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  577 -NQIAK------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -HHHHH------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence             11111      2223333221111100 1123899999999999999999999986

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.1e-33  Score=304.49  Aligned_cols=245  Identities=23%  Similarity=0.250  Sum_probs=190.2

Q ss_pred             eeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHH---HHhccccCceeeEEEEEEcCCceEEEEeecc
Q 002085          643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE---ILGTIRHANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       643 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      .||+|+||.||+|....+++.||+|.+.............+..|..   .++...||+|+++.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4799999999999998889999999986543222222223444443   4444579999999999999999999999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccc
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA  799 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  799 (969)
                      |++|.+++....             .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        81 g~~L~~~l~~~~-------------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~  144 (278)
T cd05606          81 GGDLHYHLSQHG-------------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  144 (278)
T ss_pred             CCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCc
Confidence            999999886533             489999999999999999999988   9999999999999999999999999998


Q ss_pred             eecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchh
Q 002085          800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD  878 (969)
Q Consensus       800 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  878 (969)
                      ..+...    ......|+..|+|||.+.++ .++.++||||+||++|||++|+.||..................      
T Consensus       145 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------  214 (278)
T cd05606         145 CDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------  214 (278)
T ss_pred             cccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc------
Confidence            755321    11234689999999998754 6899999999999999999999999765332222111111100      


Q ss_pred             hhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       879 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                        ..    ..+...+..+.+++.+|+..+|++||     ++.|+++
T Consensus       215 --~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         215 --AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --CC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              00    11112346889999999999999999     8888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=306.61  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=201.4

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc---cCceeeEEEEEEcCCceEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR---HANIVKLWCCISSENSKLL  713 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  713 (969)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+....  .......+.+|++++++++   |||++++++++.++...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4777889999999999999998899999999885432  2333467889999999996   9999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++++|.+++...              .+++..++.++.|++.|+.|||+.   +|+||||+|+||++++++.+++
T Consensus        80 v~e~~~~~~L~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l  142 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG--------------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKL  142 (277)
T ss_pred             EEecCCCCcHHHHHHcc--------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEE
Confidence            99999999999998642              378999999999999999999988   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||++..+....  .......|+..|+|||.+.++ .++.++|||||||++|+|++|..||...+........    ..
T Consensus       143 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~----~~  216 (277)
T cd06917         143 CDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI----PK  216 (277)
T ss_pred             ccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc----cc
Confidence            9999998764432  222344688999999988754 4688999999999999999999999765432211110    00


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .      ..+.+..   ...+..+.+++.+||+.||++||++.|+++
T Consensus       217 ~------~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         217 S------KPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             C------CCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            0      0011111   113467899999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1e-33  Score=308.03  Aligned_cols=252  Identities=22%  Similarity=0.301  Sum_probs=198.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc------
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS------  707 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------  707 (969)
                      ...|+..+.||.|+||.||+|.+..+++.||+|++...    ......+..|+.+++++ +||||+++++++..      
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            35788889999999999999999989999999988443    22345688899999998 69999999999853      


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      ....+++|||+++|+|.+++.....           ..+++..+..++.|++.|++|||+.   +|+||||+|+||++++
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~  156 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKG-----------NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTE  156 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence            4567999999999999999976432           3477888999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccch
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL  862 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  862 (969)
                      ++.++|+|||++......  ........|+..|+|||.+.     +..++.++|||||||++|||++|+.||........
T Consensus       157 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~  234 (282)
T cd06636         157 NAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA  234 (282)
T ss_pred             CCCEEEeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence            999999999998754321  11223456889999999875     34678899999999999999999999875432211


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...+    ..         ...........+..+.+++.+||+.||.+||++.|+++
T Consensus       235 ~~~~----~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 LFLI----PR---------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhhH----hh---------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            1100    00         00000111123467899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-34  Score=310.24  Aligned_cols=265  Identities=24%  Similarity=0.356  Sum_probs=199.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +++|+..+.||+|++|.||+|....+++.||+|.+......  .....+.+|++++++++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            46789999999999999999999888999999998643221  1224567899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++ ++|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+
T Consensus        82 ~e~~~-~~L~~~~~~~~------------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~  145 (291)
T cd07844          82 FEYLD-TDLKQYMDDCG------------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLA  145 (291)
T ss_pred             EecCC-CCHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEEC
Confidence            99998 59999887543            2478899999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCc-cchHHHHHHHhhc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH-TSLAEWAWRHYAE  872 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~  872 (969)
                      |||+++.....  ........++..|+|||++.+ ..++.++||||+||++|||++|+.||.+... ......++.....
T Consensus       146 dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  223 (291)
T cd07844         146 DFGLARAKSVP--SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT  223 (291)
T ss_pred             ccccccccCCC--CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC
Confidence            99998754221  112223356889999998875 4578999999999999999999999865441 1111111111110


Q ss_pred             cCC--chhh------hccCCCC--cc-------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKP--ITDA------LDKGIAE--PC-------YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~--~~~~------~~~~~~~--~~-------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..+  ....      .......  +.       .........+++.+|++.+|++||++.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             CChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000  0000      0000000  00       0011256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=345.47  Aligned_cols=255  Identities=27%  Similarity=0.343  Sum_probs=207.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      -++....+||.|.||.||.|....+|+..|+|.++-... .......+.+|..++..++|||+|+++|+-..++..+|.|
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~-~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS-DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc-ccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            467778999999999999999999999999998754322 2444567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |||++|+|.+.+...+             ..++.....+..|++.|++|||++   |||||||||.||+++.+|.+|++|
T Consensus      1314 EyC~~GsLa~ll~~gr-------------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-------------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred             HHhccCcHHHHHHhcc-------------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeec
Confidence            9999999999998543             255666677889999999999999   999999999999999999999999


Q ss_pred             cccceecccCC--CCccccccccCcccCchhhcccCC---CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          796 FGLAKMLAKQG--EPHTMSAVAGSFGYFAPEYAYTTK---VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       796 fgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||.|..+....  .+.......||+.|||||++.+..   ...++||||+|||+.||+||+.||..-+....   +.-++
T Consensus      1378 FGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---IMy~V 1454 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---IMYHV 1454 (1509)
T ss_pred             ccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---HHhHH
Confidence            99999876532  223345668999999999998754   56789999999999999999999976544211   11111


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ..+.          ..+.|...+.+-.+++..|++.||++|.++.|+++.
T Consensus      1455 ~~gh----------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGH----------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hccC----------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1111          122344466778899999999999999988887763

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.7e-33  Score=307.69  Aligned_cols=256  Identities=25%  Similarity=0.319  Sum_probs=200.3

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE----  708 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----  708 (969)
                      ..++|...+.||+|+||.||+|....+++.||+|++....    .....+.+|+.+++++ +|||++++++++...    
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            4578999999999999999999999899999999985432    2235677899999999 799999999998653    


Q ss_pred             -CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          709 -NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       709 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                       +..++||||+++++|.++++....         ....+++..++.++.|++.||+|||+.   +++||||||+||+++.
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~  163 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLI---------CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTT  163 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcC
Confidence             358999999999999998864321         123488999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCccch
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-----KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL  862 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  862 (969)
                      ++.++|+|||++.......  .......|+..|+|||.+...     .++.++|||||||++|||++|+.||...+....
T Consensus       164 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~  241 (291)
T cd06639         164 EGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT  241 (291)
T ss_pred             CCCEEEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence            9999999999987653221  112234688999999987643     368899999999999999999999876543221


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....    .... .     ...  ..+.+....+.+++.+||+.+|++||++.|+++
T Consensus       242 ~~~~----~~~~-~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         242 LFKI----PRNP-P-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHH----hcCC-C-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111    0000 0     001  011223357899999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.9e-34  Score=310.81  Aligned_cols=265  Identities=27%  Similarity=0.382  Sum_probs=201.6

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|++|.||+|+...+++.||||++..... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            47788999999999999999988899999998864432 22334678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |++ ++|.+++.....           ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++||
T Consensus        80 ~~~-~~l~~~~~~~~~-----------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~df  144 (284)
T cd07860          80 FLH-QDLKKFMDASPL-----------SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADF  144 (284)
T ss_pred             ccc-cCHHHHHHhCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            996 689998875432           3488999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      |+++.....  ........+++.|+|||.+.+.. ++.++|||||||++|||+||+.||.+.+.........+.......
T Consensus       145 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd07860         145 GLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE  222 (284)
T ss_pred             cchhhcccC--ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            998765322  11223345788999999887654 588999999999999999999999765543222211111111000


Q ss_pred             -c----------hhhhccCCCC---cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 -I----------TDALDKGIAE---PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 -~----------~~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       .          ..........   .........+.+++.+||+.||++||+++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         223 VVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence             0          0000000000   000112356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-33  Score=315.79  Aligned_cols=263  Identities=24%  Similarity=0.308  Sum_probs=202.2

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC-----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE-----  708 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  708 (969)
                      +.++|+..+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|++++++++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            56789999999999999999999998999999998854322 233446678899999999999999999988643     


Q ss_pred             -CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          709 -NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       709 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                       ...|+||||++ ++|.+.+..               .+++..+..++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~---------------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~  153 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM---------------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS  153 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh---------------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECC
Confidence             35799999996 588887752               167788899999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      ++.+||+|||+++.....   .......++..|+|||.+.+..++.++||||+||++|+|++|+.||...+.......+.
T Consensus       154 ~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~  230 (353)
T cd07850         154 DCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII  230 (353)
T ss_pred             CCCEEEccCccceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            999999999999865322   12233467889999999999999999999999999999999999997655332222211


Q ss_pred             HHhhcc------------------C------CchhhhccCC----CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          868 RHYAEE------------------K------PITDALDKGI----AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       868 ~~~~~~------------------~------~~~~~~~~~~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..+...                  .      ...+......    ...........+.+++.+|++.||++||++.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         231 EQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111000                  0      0000000000    00001123456889999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-33  Score=307.09  Aligned_cols=255  Identities=24%  Similarity=0.341  Sum_probs=195.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHH-HhccccCceeeEEEEEEcCCceEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI-LGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      ++|+..+.||+|+||.||+|.+..+|+.||+|+++.....  .....+..|+.+ ++..+||||+++++++..++..|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            3688889999999999999999999999999998654321  223455556665 5666899999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++ ++|.+++.....         ....+++..++.++.|++.||+|||+++  +++||||||+||+++.++.+||+
T Consensus        79 ~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~  146 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYD---------KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLC  146 (283)
T ss_pred             hhhhc-ccHHHHHHHhcc---------CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEe
Confidence            99996 788888865321         0235899999999999999999999742  79999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhccc----CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT----TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |||+++.+...   .......++..|+|||.+.+    ..++.++|+||+||++|||++|+.||......  .+......
T Consensus       147 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~  221 (283)
T cd06617         147 DFGISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVV  221 (283)
T ss_pred             ecccccccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHH
Confidence            99999865321   12223467889999998865    34688999999999999999999998643211  11111111


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...       .....   ....+..+.+++.+||..+|++||++.++++
T Consensus       222 ~~~-------~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         222 EEP-------SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             hcC-------CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            110       00010   1123467899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.4e-34  Score=304.11  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=204.0

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|+||.||+|....+|..||+|.+..... .....+.+.+|+++++.++|+||+++++++.+....++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            46778999999999999999999999999999865322 22335678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-cEEEee
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-KAKIAD  795 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~D  795 (969)
                      |+++++|.+++.....           ..+++..+..++.|++.|++|||+.   +++|+||+|+||++++++ .++++|
T Consensus        80 ~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d  145 (257)
T cd08225          80 YCDGGDLMKRINRQRG-----------VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGD  145 (257)
T ss_pred             cCCCCcHHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecc
Confidence            9999999999975432           2478999999999999999999988   999999999999999886 469999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||.+.......  .......|++.|+|||+..+..++.++||||||+++|||++|+.||........   ........  
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~--  218 (257)
T cd08225         146 FGIARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---VLKICQGY--  218 (257)
T ss_pred             cccchhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHhccc--
Confidence            99987654321  122234688999999999888899999999999999999999999875443222   21111110  


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .         .+.....+..+.+++.+||..+|++||++.|+++
T Consensus       219 ~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         219 F---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             C---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0         0111122357899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-37  Score=343.92  Aligned_cols=430  Identities=29%  Similarity=0.370  Sum_probs=290.7

Q ss_pred             eEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCC
Q 002085           75 VTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG  154 (969)
Q Consensus        75 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  154 (969)
                      +..|+++++.+. ..|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|+|.+|.+. ..|.++..+.+|++||++.
T Consensus        47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~  123 (1081)
T KOG0618|consen   47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF  123 (1081)
T ss_pred             eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence            444555544442 34445555555555555555554 44455555555555555555554 4555555555555555555


Q ss_pred             CCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccccc
Q 002085          155 NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGE  234 (969)
Q Consensus       155 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  234 (969)
                      |++. .+|..+..++.+..+..++|......    +... .+.+++..|.  ....++..+..++.  .|+|.+|+++  
T Consensus       124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l----g~~~-ik~~~l~~n~--l~~~~~~~i~~l~~--~ldLr~N~~~--  191 (1081)
T KOG0618|consen  124 NHFG-PIPLVIEVLTAEEELAASNNEKIQRL----GQTS-IKKLDLRLNV--LGGSFLIDIYNLTH--QLDLRYNEME--  191 (1081)
T ss_pred             hccC-CCchhHHhhhHHHHHhhhcchhhhhh----cccc-chhhhhhhhh--cccchhcchhhhhe--eeecccchhh--
Confidence            5554 45555555555555555555211111    1111 4444444443  22334444444444  5666666665  


Q ss_pred             CchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcc
Q 002085          235 IPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLK  314 (969)
Q Consensus       235 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~  314 (969)
                       --.+.++.+|+.|....|++...    --..++|+.|+.++|.++ .....+...+|+++|+++|+++ .+|++++.+.
T Consensus       192 -~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~-~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~  264 (1081)
T KOG0618|consen  192 -VLDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLT-TLDVHPVPLNLQYLDISHNNLS-NLPEWIGACA  264 (1081)
T ss_pred             -hhhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcce-eeccccccccceeeecchhhhh-cchHHHHhcc
Confidence             12355666677777777766522    113466777778888777 3444444557899999999998 5568889999


Q ss_pred             cchhhhhccccCcCcCCcccc------cccccCcccccCCCCCCCCccCcEEEcccccccCCCCccccccc--CCCcccc
Q 002085          315 NLQLLGLFSNHLSGEVPASIG------VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTF--NLSSLML  386 (969)
Q Consensus       315 ~L~~L~L~~N~l~~~~p~~~~------~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L  386 (969)
                      +|+.++..+|+|+ .+|..+.      .+....+-...+|.....+++|++|+|..|+|. ..|+.+....  .|..|+.
T Consensus       265 nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~  342 (1081)
T KOG0618|consen  265 NLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNV  342 (1081)
T ss_pred             cceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhh
Confidence            9999999999985 5554432      222344555578888888999999999999998 6666554432  3788888


Q ss_pred             CCCccccccCc--cccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCC
Q 002085          387 SDNTISGELPS--KTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGK  464 (969)
Q Consensus       387 s~N~l~~~~~~--~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  464 (969)
                      +.|.++.....  .....|+.|+|.+|.+++..-..+.+++.|++|+|++|++.......+.++..|++|+||||+|+ .
T Consensus       343 s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~  421 (1081)
T KOG0618|consen  343 SSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-T  421 (1081)
T ss_pred             hhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-h
Confidence            88888733211  22356999999999999998888999999999999999999555566788999999999999999 8


Q ss_pred             CCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccc-cCCCccccccccEEEeecCc
Q 002085          465 LPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSG-EIPPEIGQLKLNTFNLSSNK  531 (969)
Q Consensus       465 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~L~~l~ls~N~  531 (969)
                      +|+.+.++..|++|...+|+|. ..| .+..++.|+.+|+|.|+|+- .+|...-.-+|++|||++|.
T Consensus       422 Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  422 LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            9999999999999999999998 678 89999999999999999985 44444444569999999997

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=301.46  Aligned_cols=246  Identities=21%  Similarity=0.251  Sum_probs=193.7

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHh-ccccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILG-TIRHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      +.||+|+||.||+|....+++.||+|++.............+..|..++. ..+|||++++++++...+..|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999998889999999986543322333344556655544 45899999999999999999999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      ++|.+++....             .+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||+++
T Consensus        82 ~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  145 (260)
T cd05611          82 GDCASLIKTLG-------------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR  145 (260)
T ss_pred             CCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccce
Confidence            99999997543             378889999999999999999988   99999999999999999999999999987


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL  880 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  880 (969)
                      ....      .....++..|+|||.+.+..++.++||||+|+++|||++|..||...+..........   ....     
T Consensus       146 ~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-----  211 (260)
T cd05611         146 NGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS---RRIN-----  211 (260)
T ss_pred             eccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---cccC-----
Confidence            5422      2234578899999999888899999999999999999999999976544332221111   0000     


Q ss_pred             ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       881 ~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                         .........+..+.+++.+||+.+|++||++.++.+.
T Consensus       212 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         212 ---WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             ---CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence               0001111234778999999999999999987666543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=311.22  Aligned_cols=271  Identities=21%  Similarity=0.299  Sum_probs=200.6

Q ss_pred             CCCccceeeecCcEEEEEEEEcC--CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--CceE
Q 002085          637 SLTESNLIGSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--NSKL  712 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  712 (969)
                      .|+..++||+|+||.||+|....  +++.||+|.+.............+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            37778899999999999999987  7899999998664322233346678899999999999999999999887  7899


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC----C
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS----E  788 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~----~  788 (969)
                      +||||++ +++.+++......        ....+++..++.++.|++.|++|||+.   +|+||||||+||+++.    +
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~  148 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQA--------KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPER  148 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccC--------CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCcc
Confidence            9999997 4777776543321        012578899999999999999999988   9999999999999999    8


Q ss_pred             CcEEEeecccceecccCCC-CccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccc-----
Q 002085          789 FKAKIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTS-----  861 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~-----  861 (969)
                      +.+|++|||+++....... ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.....     
T Consensus       149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  228 (316)
T cd07842         149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP  228 (316)
T ss_pred             ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence            9999999999987643322 1222345678999999988764 57899999999999999999999997654322     


Q ss_pred             ----hHHHHHHHh-----------hccCCchhhhccCCCCccc---------H--HHHHHHHHHHHHccCCCCCCCCCHH
Q 002085          862 ----LAEWAWRHY-----------AEEKPITDALDKGIAEPCY---------L--EEMTTVYRLALICTSTLPSSRPSMK  915 (969)
Q Consensus       862 ----~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~---------~--~~~~~~~~l~~~cl~~dP~~RPs~~  915 (969)
                          ....+...+           ..........+........         .  .....+.+++.+|++.||++|||+.
T Consensus       229 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~  308 (316)
T cd07842         229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE  308 (316)
T ss_pred             hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH
Confidence                000000000           0000001100000000000         0  2235688999999999999999999


Q ss_pred             HHHH
Q 002085          916 EVLQ  919 (969)
Q Consensus       916 evl~  919 (969)
                      |+++
T Consensus       309 eil~  312 (316)
T cd07842         309 EALE  312 (316)
T ss_pred             HHhc
Confidence            9985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.1e-33  Score=308.76  Aligned_cols=274  Identities=21%  Similarity=0.314  Sum_probs=203.0

Q ss_pred             cchhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC
Q 002085          629 FTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE  708 (969)
Q Consensus       629 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  708 (969)
                      +...+.+++|+..++||+|+||.||+|....+++.||||.+..... .......+.+|++++++++||||+++++++...
T Consensus         5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865           5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             CcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            3344567789999999999999999999998999999998854322 122234567899999999999999999998765


Q ss_pred             C--------ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCC
Q 002085          709 N--------SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKS  780 (969)
Q Consensus       709 ~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  780 (969)
                      +        ..++||||++ ++|.+++....            ..+++.+++.++.|++.||+|||+.   +++|+||||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p  147 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN------------VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKA  147 (310)
T ss_pred             cccccCCCceEEEEEcCCC-cCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence            4        3499999996 58888876543            2488999999999999999999988   999999999


Q ss_pred             CcEEECCCCcEEEeecccceecccCCCC--ccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCC
Q 002085          781 SNILLDSEFKAKIADFGLAKMLAKQGEP--HTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD  857 (969)
Q Consensus       781 ~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~  857 (969)
                      +||+++.++.+||+|||++..+......  .......++..|+|||.+.+.. ++.++||||||+++|||++|..||.+.
T Consensus       148 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         148 ANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             HHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999866432211  1223445788999999887654 688999999999999999999998766


Q ss_pred             CccchHHHHHHHhhccC-Cc------hhhhcc-CCCCcc---------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          858 EHTSLAEWAWRHYAEEK-PI------TDALDK-GIAEPC---------YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       858 ~~~~~~~~~~~~~~~~~-~~------~~~~~~-~~~~~~---------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +.......+........ ..      .+..+. ......         .......+.+++.+||+.||++||+++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         228 TEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            54333222222110000 00      000000 000000         0001245678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.8e-33  Score=303.33  Aligned_cols=254  Identities=28%  Similarity=0.392  Sum_probs=207.1

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      +..+.|+..+.||+|+||.||+|.+..++..||+|++.....    ....+.+|+++++.++|+|++++++++......+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            345678888999999999999999988899999999864432    3567889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +|+||+++++|.+++....            ..+++..+..++.|++.||+|||..   +++|+||+|+||+++.++.++
T Consensus        92 lv~e~~~~~~L~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~  156 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF------------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVK  156 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEE
Confidence            9999999999999998653            2489999999999999999999987   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      |+|||.+.......  .......++..|+|||.+.+..++.++|||||||++|||++|..||...........+.   ..
T Consensus       157 l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~  231 (286)
T cd06614         157 LADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TK  231 (286)
T ss_pred             ECccchhhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc
Confidence            99999987553321  12223457889999999988889999999999999999999999987544332211111   00


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .  ...     .  ......+..+.+++.+||+.+|.+||++.++++
T Consensus       232 ~--~~~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         232 G--IPP-----L--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             C--CCC-----C--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0  000     0  111113467889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=303.09  Aligned_cols=255  Identities=24%  Similarity=0.336  Sum_probs=201.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCC----
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSEN----  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----  709 (969)
                      .++|+..+.||+|+||.||+|....+++.||+|++....    ...+.+.+|+++++++ +|+||+++++++.+..    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            468999999999999999999998889999999885432    2346789999999999 7999999999997644    


Q ss_pred             --ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          710 --SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       710 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                        ..++||||+++++|.+++.....         ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~  148 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRK---------KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTK  148 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEcc
Confidence              48999999999999999875331         013488999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCccch
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-----TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL  862 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  862 (969)
                      ++.++++|||.+......  ........|+..|+|||++..     ..++.++||||+||++|||++|..||........
T Consensus       149 ~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  226 (275)
T cd06608         149 NAEVKLVDFGVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA  226 (275)
T ss_pred             CCeEEECCCccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH
Confidence            999999999998765332  122234568899999998754     3467899999999999999999999975432221


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...+.    .. .     ....  ......+..+.+++.+||..||++|||+.|+++
T Consensus       227 ~~~~~----~~-~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         227 LFKIP----RN-P-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHHhh----cc-C-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11110    00 0     0001  112224567899999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.7e-33  Score=304.69  Aligned_cols=260  Identities=22%  Similarity=0.236  Sum_probs=198.2

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcC--CceEEE
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSE--NSKLLV  714 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  714 (969)
                      |+..++||+|+||.||+|....+++.||+|+++......  ......+|+.++.++. |||++++++++.++  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            567789999999999999998899999999986543211  1234457889999885 99999999999887  889999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++ ++|.+++....            ..++|..+..++.|++.||+|||+.   +++||||+|+||+++. +.+||+
T Consensus        79 ~e~~~-~~l~~~l~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~  141 (282)
T cd07831          79 FELMD-MNLYELIKGRK------------RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLA  141 (282)
T ss_pred             EecCC-ccHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEE
Confidence            99997 58888876543            2489999999999999999999988   9999999999999999 999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++......   ......++..|+|||.+.+ ..++.++||||+||++|||++|..||.+.+..+............
T Consensus       142 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~  218 (282)
T cd07831         142 DFGSCRGIYSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP  218 (282)
T ss_pred             ecccccccccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCC
Confidence            999998653321   1223457889999997654 557889999999999999999999997765544333332221111


Q ss_pred             CC----------chhhhccCCC----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KP----------ITDALDKGIA----EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~----------~~~~~~~~~~----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..          ......+...    .......+..+.+++.+||+.+|++||++.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         219 DAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00          0000000000    0001233578999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-33  Score=307.91  Aligned_cols=258  Identities=27%  Similarity=0.367  Sum_probs=197.5

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +|...+.||+|+||.||++.+..+++.||+|.+.....  ......+.+|+.++.++. ||||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            56667889999999999999999999999999864332  244567899999999996 999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||++ +++.++......        .....+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.++|+|
T Consensus        83 e~~~-~~l~~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~d  151 (288)
T cd06616          83 ELMD-ISLDKFYKYVYE--------VLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCD  151 (288)
T ss_pred             eccc-CCHHHHHHHHHH--------hhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEee
Confidence            9986 455554321100        0013488999999999999999999963  2899999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT---KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ||+++.+...   .......|+..|+|||.+.+.   .++.++||||+||++|||++|+.||....  .....+......
T Consensus       152 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~  226 (288)
T cd06616         152 FGISGQLVDS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKG  226 (288)
T ss_pred             cchhHHhccC---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCC
Confidence            9999765322   122334688899999998876   68999999999999999999999986543  111111111111


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..       +.+........+..+.+++.+||+.||++||++.||++
T Consensus       227 ~~-------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         227 DP-------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CC-------CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11       11111112234567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=333.42  Aligned_cols=268  Identities=26%  Similarity=0.396  Sum_probs=211.4

Q ss_pred             CCccceeeecCcEEEEEEEEcC-------CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCC
Q 002085          638 LTESNLIGSGGSGQVYRIDING-------AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSEN  709 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  709 (969)
                      ....+.+|+|.||.|++|....       ....||||.++....  ....+.+..|+++++.+ +|+||+.++|+|..++
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            3455699999999999987531       145799999866543  35568999999999999 6999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCc-CccccCCCCccc--ccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRK-RSLVSGSSSVHQ--HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                      ..++|+||++.|+|.++++..+ ............  ..+.....+.++.|||.||+||++.   ++|||||.++|||++
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence            9999999999999999999887 111111101111  3488899999999999999999988   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccc--cCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCC-C-ccch
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVA--GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD-E-HTSL  862 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~-~-~~~~  862 (969)
                      ++..+||+|||+|+...+...... ....  -...|||||.+....|+.++||||||++|||+++.+.+++.+ . ..++
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l  531 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL  531 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence            999999999999997655433322 2222  345699999999999999999999999999999955444433 1 2222


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .+              .+..+.+...+..+..+++++|+.||+.+|++||+++|+++.++...
T Consensus       532 ~~--------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  532 LE--------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             HH--------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            22              23334444556666789999999999999999999999999998853

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.7e-33  Score=296.00  Aligned_cols=250  Identities=27%  Similarity=0.373  Sum_probs=205.6

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|++|.||++....+++.|++|++.....   ...+.+.+|+++++.++||+++++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            47778999999999999999988899999999865432   345789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++....            ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+||
T Consensus        78 ~~~~~~L~~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~  142 (253)
T cd05122          78 FCSGGSLKDLLKSTN------------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDF  142 (253)
T ss_pred             cCCCCcHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeec
Confidence            999999999987653            2489999999999999999999987   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |.+........   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..........     ...
T Consensus       143 ~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~  214 (253)
T cd05122         143 GLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-----NGP  214 (253)
T ss_pred             ccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-----cCC
Confidence            99876643221   3345688999999999988899999999999999999999999876543221111110     000


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..     .  +.....+..+.+++.+||+.||++||++.|+++
T Consensus       215 ~~-----~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         215 PG-----L--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CC-----c--CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00     0  111112467899999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.4e-33  Score=313.09  Aligned_cols=269  Identities=29%  Similarity=0.390  Sum_probs=203.4

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC--C
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE--N  709 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~  709 (969)
                      .+.++|+..+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++ +||||+++++++...  .
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            456789999999999999999999988899999998854322 223345677899999999 999999999998653  4


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..|+||||++ ++|.+++...              .++|..+..++.|++.||+|||+.   +|+||||+|+||+++.++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~  144 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN--------------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDC  144 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCC
Confidence            6899999997 5999888643              378889999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCC---ccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          790 KAKIADFGLAKMLAKQGEP---HTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      .+||+|||+++........   .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.........
T Consensus       145 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~  224 (337)
T cd07852         145 RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK  224 (337)
T ss_pred             cEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9999999999866443222   22234568999999998765 4578899999999999999999999876543332222


Q ss_pred             HHHHhhccC---------Cc-hhhhc---cCCC---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          866 AWRHYAEEK---------PI-TDALD---KGIA---EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       866 ~~~~~~~~~---------~~-~~~~~---~~~~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .........         .. ...++   ....   .......+..+.+++.+||+.||++||++.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            111110000         00 00000   0000   00001134678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.7e-33  Score=297.86  Aligned_cols=254  Identities=28%  Similarity=0.384  Sum_probs=208.3

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--CceEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--NSKLLV  714 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  714 (969)
                      +|+..+.||+|++|.||+|....+++.|++|++..... .....+.+.+|++++++++||||+++++.+.+.  ...++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            46778999999999999999988899999999865432 234567899999999999999999999999888  889999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      +||+++++|.+++....             .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+
T Consensus        80 ~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~  143 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG-------------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLA  143 (260)
T ss_pred             EEecCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEc
Confidence            99999999999997643             389999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||.+................++..|+|||...+..++.++||||+|+++|+|++|..||...+..  ....+... .  
T Consensus       144 d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-~--  218 (260)
T cd06606         144 DFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIG-S--  218 (260)
T ss_pred             ccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhcc-c--
Confidence            999998765432211133456889999999999888999999999999999999999999765511  11111111 0  


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                             .......+...+..+.+++.+|+..||++||++.|+++
T Consensus       219 -------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         219 -------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                   00111122233578999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.3e-33  Score=302.74  Aligned_cols=265  Identities=25%  Similarity=0.378  Sum_probs=203.0

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..++||.|++|.||+|++..+|+.||||+++....  ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            47888999999999999999998999999999865432  2223567789999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |++ ++|.+++.....          ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++++||
T Consensus        79 ~~~-~~l~~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~  144 (284)
T cd07836          79 YMD-KDLKKYMDTHGV----------RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADF  144 (284)
T ss_pred             cCC-ccHHHHHHhcCC----------CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeec
Confidence            998 589888875432          13489999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      |+++.....  ........++..|++||.+.+. .++.++||||+||++|||++|..||.+.+.................
T Consensus       145 g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd07836         145 GLARAFGIP--VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE  222 (284)
T ss_pred             chhhhhcCC--ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence            999754321  1122334578899999988664 5688999999999999999999999776544333322221110000


Q ss_pred             --chhhh-----ccCCC-------CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 --ITDAL-----DKGIA-------EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 --~~~~~-----~~~~~-------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                        .....     .....       .......+..+.+++.+|++.||.+||++.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         223 STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              00000     00000       0001123467889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-33  Score=307.74  Aligned_cols=254  Identities=29%  Similarity=0.366  Sum_probs=214.8

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ..-+..|.+.+.||+|.|+.|..|++..++..||+|.+++... +....+.+.+|+++|..++|||||+++.+...+...
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            3445678889999999999999999999999999999977654 334445699999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      |+||||+.+|.+++|+....+             +....+..++.|+.+|++|||++   .|||||||++||+++.+.++
T Consensus       131 ylV~eya~~ge~~~yl~~~gr-------------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mni  194 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGR-------------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNI  194 (596)
T ss_pred             EEEEEeccCchhHHHHHhccc-------------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccce
Confidence            999999999999999998765             55578889999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||++..+..   .......+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||++..-.++...+    
T Consensus       195 kIaDfgfS~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv----  267 (596)
T KOG0586|consen  195 KIADFGFSTFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV----  267 (596)
T ss_pred             eeeccccceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh----
Confidence            9999999998843   344556789999999999999886 57899999999999999999999987654433221    


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                               +...++.+.+.  ..+..+++++++..+|.+|++.+++.+.
T Consensus       268 ---------l~gk~rIp~~m--s~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  268 ---------LRGKYRIPFYM--SCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ---------eeeeeccccee--echhHHHHHHhhccCccccCCHHHhhhh
Confidence                     12222222222  2466789999999999999999999763

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-35  Score=312.73  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=206.3

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      -|.++..||.|+||.||+|..+.++-..|.|++.   ....+...++.-|++||..++||+||++++.|.-.+..+|+.|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            3566778999999999999999888888889883   2345556889999999999999999999999888899999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      ||.||..+.++-+-++            ++...++.-+++|++.||.|||+.   .|+|||||+.|||++-+|.++++||
T Consensus       110 FC~GGAVDaimlEL~r------------~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADF  174 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGR------------VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADF  174 (1187)
T ss_pred             ecCCchHhHHHHHhcc------------ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecc
Confidence            9999999998887653            588999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |.+.....  .......+.|||.|||||+..     ..+|+.++||||||++|.||..+.+|.....+-   +.+.+.. 
T Consensus       175 GVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---RVllKia-  248 (1187)
T KOG0579|consen  175 GVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIA-  248 (1187)
T ss_pred             cccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---HHHHHHh-
Confidence            99864322  223345678999999999865     457999999999999999999999887654331   1111111 


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                            +.-.+.+.  .+...+..+.+++.+|+.+||..||+++++++
T Consensus       249 ------KSePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  249 ------KSEPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ------hcCCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                  11112222  34556688999999999999999999999975

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.2e-33  Score=303.17  Aligned_cols=261  Identities=20%  Similarity=0.236  Sum_probs=188.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhc--HH------HHHHHHHHHHHHhccccCceeeEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLN--QK------LEKEFIAEIEILGTIRHANIVKLWCC  704 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~--~~------~~~~~~~E~~~l~~l~h~niv~l~~~  704 (969)
                      ++|.+.++||+|+||.||+|....+   +..+|+|+........  +.      .......+...+..+.|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5799999999999999999998776   6677887643221110  00      01122333445566789999999987


Q ss_pred             EEcCC----ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCC
Q 002085          705 ISSEN----SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKS  780 (969)
Q Consensus       705 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  780 (969)
                      +....    ..++++|++. .++.+.+....             ..++..+..++.|++.||+|||+.   +|+||||||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp  154 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-------------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKP  154 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhc-------------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            65543    3467888774 46666665432             256788899999999999999988   999999999


Q ss_pred             CcEEECCCCcEEEeecccceecccCCCCc-----cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 002085          781 SNILLDSEFKAKIADFGLAKMLAKQGEPH-----TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY  855 (969)
Q Consensus       781 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~  855 (969)
                      +||+++.++.++|+|||+|+.+...+...     ......||+.|+|||+..+..++.++|||||||++|||++|+.||.
T Consensus       155 ~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~  234 (294)
T PHA02882        155 ENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWK  234 (294)
T ss_pred             HHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999998764322211     1123469999999999999999999999999999999999999997


Q ss_pred             CCCc-cchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          856 GDEH-TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       856 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      +... ..........+...     .......   ....+..+.+++..||..+|++||++.++.+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        235 GFGHNGNLIHAAKCDFIKR-----LHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             ccccchHHHHHhHHHHHHH-----hhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            6532 22222111111110     0000000   112246789999999999999999999999876

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5e-33  Score=303.95  Aligned_cols=265  Identities=25%  Similarity=0.321  Sum_probs=198.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|....+++.||+|++.....  ......+.+|+++++.++|+||+++.+++.+++..++|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            3578899999999999999999988899999999854422  22234567899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++ +++.+++....            ..+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+
T Consensus        82 ~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~  145 (291)
T cd07870          82 FEYMH-TDLAQYMIQHP------------GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLA  145 (291)
T ss_pred             Eeccc-CCHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEe
Confidence            99996 77777765432            2367888899999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHhhc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHT-SLAEWAWRHYAE  872 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~  872 (969)
                      |||+++......  .......+++.|+|||.+.+. .++.++||||+||++|||++|..||...... .....++.....
T Consensus       146 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~  223 (291)
T cd07870         146 DFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGV  223 (291)
T ss_pred             ccccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCC
Confidence            999987543221  122334578899999998764 5788999999999999999999999754321 111111111100


Q ss_pred             c-----------CCchhhhccCC-CCc-----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 E-----------KPITDALDKGI-AEP-----CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~-----------~~~~~~~~~~~-~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .           ....+...... ...     ........+.+++.+|+..||++|||+.|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         224 PTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             CChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0           00000000000 000     00011357789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.1e-33  Score=306.12  Aligned_cols=264  Identities=24%  Similarity=0.340  Sum_probs=200.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|++++++++||||+++++++.++...|+||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            578889999999999999999988999999998854322 2233467889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC-CCcEEEe
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-EFKAKIA  794 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~  794 (969)
                      ||++ ++|.+++.....           ..+++..+..++.|++.||+|||+.   +++||||+|+||+++. ++.+|++
T Consensus        81 e~~~-~~l~~~~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~  145 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPD-----------FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLA  145 (294)
T ss_pred             eccc-ccHHHHHHhCCC-----------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEc
Confidence            9996 588888764332           2357888889999999999999988   9999999999999985 4579999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||++......  ........+++.|+|||++.+. .++.++||||+||++|||++|+.||...+.............. 
T Consensus       146 dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~-  222 (294)
T PLN00009        146 DFGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT-  222 (294)
T ss_pred             ccccccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-
Confidence            99999754321  1222334678899999988764 5788999999999999999999999765443222221111110 


Q ss_pred             CCchhhhc------------cCCCCc----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPITDALD------------KGIAEP----CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~------------~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       +......            +.....    .....+..+.+++.+|++.+|++||++.++++
T Consensus       223 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        223 -PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             -CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0000000            000000    01122356889999999999999999999986

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.4e-33  Score=303.71  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             eeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCH
Q 002085          644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL  723 (969)
Q Consensus       644 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  723 (969)
                      ||+|+||.||++++..+|+.||+|++...........+.+.+|++++++++||||+++++.+..+...|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999988999999998665444445667899999999999999999999999999999999999999999


Q ss_pred             HHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecc
Q 002085          724 DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA  803 (969)
Q Consensus       724 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  803 (969)
                      .+++....             .+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++....
T Consensus        81 ~~~l~~~~-------------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~  144 (265)
T cd05579          81 ASLLENVG-------------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL  144 (265)
T ss_pred             HHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence            99997643             388999999999999999999988   99999999999999999999999999987543


Q ss_pred             cCCC------CccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          804 KQGE------PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       804 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      ....      ........++..|+|||...+..++.++||||||+++||+++|..||..............   ..    
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~----  217 (265)
T cd05579         145 VRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN---GK----  217 (265)
T ss_pred             cCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC----
Confidence            2211      1122344678899999999888899999999999999999999999976554332222111   00    


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                            ...+.....+..+.+++.+||+.+|++||++.++.+.|+
T Consensus       218 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         218 ------IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ------cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                  001111112477899999999999999999966665553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.2e-33  Score=304.06  Aligned_cols=248  Identities=21%  Similarity=0.360  Sum_probs=201.1

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |+...+||+|+||.||++....+++.||+|++...   .......+.+|+.+++.++|+|++++++++..++..++||||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            33346799999999999999889999999987432   223456799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++++|.+++...              .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||
T Consensus        99 ~~~~~L~~~~~~~--------------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg  161 (292)
T cd06657          99 LEGGALTDIVTHT--------------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  161 (292)
T ss_pred             CCCCcHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccc
Confidence            9999999987532              278899999999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      ++......  ........|++.|+|||.+.+..++.++|+||+||++|||++|..||.+.........+.....      
T Consensus       162 ~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~------  233 (292)
T cd06657         162 FCAQVSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------  233 (292)
T ss_pred             cceecccc--cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC------
Confidence            98765332  1222345688999999999888899999999999999999999999876544332222211111      


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                          ....  ........+.+++.+||+.||.+||++.++++
T Consensus       234 ----~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         234 ----PKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ----cccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence                0110  11122356789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=313.20  Aligned_cols=271  Identities=24%  Similarity=0.322  Sum_probs=203.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC-----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE-----  708 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  708 (969)
                      +.++|++.++||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.++++++||||+++++++...     
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            3468999999999999999999999899999999985321  223456788899999999999999999887544     


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      ...|+|+||++ ++|.+++...              .+++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~--------------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~  142 (336)
T cd07849          81 NDVYIVQELME-TDLYKLIKTQ--------------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTN  142 (336)
T ss_pred             ceEEEEehhcc-cCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCC
Confidence            35799999997 5888877542              388999999999999999999988   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCc-cccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      +.++|+|||+++......... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+.......+
T Consensus       143 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~  222 (336)
T cd07849         143 CDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI  222 (336)
T ss_pred             CCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999998654322211 2233568899999998654 46889999999999999999999999765432222222


Q ss_pred             HHHhhccC--Cchhhhc-----------cCCCCc---ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhc
Q 002085          867 WRHYAEEK--PITDALD-----------KGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI--LRRC  924 (969)
Q Consensus       867 ~~~~~~~~--~~~~~~~-----------~~~~~~---~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~  924 (969)
                      ...+....  .......           .....+   ........+.+++.+||+.||++||++.|+++.  +++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         223 LGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            11111100  0000000           000000   001224678899999999999999999999975  4444

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-33  Score=297.88  Aligned_cols=254  Identities=23%  Similarity=0.299  Sum_probs=201.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccc--hhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--Cce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNR--KLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--NSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  711 (969)
                      .+|+..+.||+|+||.||+|.+..+++.||+|.+....  .........+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            36888999999999999999999899999999875321  12334457899999999999999999999998764  457


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++|+||+++++|.+++....             .+++..+.+++.|++.|+.|||+.   +++|+||+|+||+++.++.+
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-------------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~  145 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-------------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNV  145 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCE
Confidence            89999999999999987543             378889999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCC-CccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      +|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++|+.||........   +.+..
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~  222 (264)
T cd06653         146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA---IFKIA  222 (264)
T ss_pred             EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH---HHHHH
Confidence            9999999986532111 1112235688999999999988899999999999999999999999875432211   11111


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..          ......+......+.+++.+||. +|.+||++.+++.
T Consensus       223 ~~----------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 TQ----------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             cC----------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            11          11111233344678999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=305.20  Aligned_cols=264  Identities=28%  Similarity=0.376  Sum_probs=202.7

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--CceEEEE
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--NSKLLVY  715 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  715 (969)
                      |++.+.||+|+||.||+|....+++.||+|++.... ........+.+|++++++++|||++++++++.+.  +..++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            567789999999999999999889999999997653 2233346788999999999999999999999887  8899999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||++ ++|.+++....            ..+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.++++|
T Consensus        80 e~~~-~~l~~~~~~~~------------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d  143 (287)
T cd07840          80 EYMD-HDLTGLLDSPE------------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLAD  143 (287)
T ss_pred             cccc-ccHHHHHhccC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcc
Confidence            9997 58988886542            2488999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|..||...........+........
T Consensus       144 ~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~  222 (287)
T cd07840         144 FGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT  222 (287)
T ss_pred             ccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            999987644321 12233457888999997765 4578999999999999999999999976654333332222111000


Q ss_pred             C-----chhh-----hccC------CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 P-----ITDA-----LDKG------IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~-----~~~~-----~~~~------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .     ..+.     ....      +........+..+.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         223 DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0     0000     0000      000000002567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.1e-33  Score=308.42  Aligned_cols=260  Identities=22%  Similarity=0.284  Sum_probs=197.1

Q ss_pred             ceeeec--CcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeecc
Q 002085          642 NLIGSG--GSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       642 ~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      ..||+|  +||+||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            356666  999999999998999999999865432 23445789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccc
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA  799 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  799 (969)
                      ++++.+++.....           ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+
T Consensus        83 ~~~l~~~l~~~~~-----------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~  148 (328)
T cd08226          83 YGSANSLLKTYFP-----------EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHL  148 (328)
T ss_pred             CCCHHHHHHhhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHH
Confidence            9999999886432           2478899999999999999999988   9999999999999999999999999865


Q ss_pred             eecccCCCCcc-----ccccccCcccCchhhcccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          800 KMLAKQGEPHT-----MSAVAGSFGYFAPEYAYTT--KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       800 ~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ......+....     .....++..|+|||++.+.  .++.++||||+||++|||++|..||............   ...
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~---~~~  225 (328)
T cd08226         149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK---LKG  225 (328)
T ss_pred             hhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH---hcC
Confidence            43322111111     1112356679999998764  4789999999999999999999998765432211110   000


Q ss_pred             cCC-------------------------ch----------hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002085          873 EKP-------------------------IT----------DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV  917 (969)
Q Consensus       873 ~~~-------------------------~~----------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev  917 (969)
                      ...                         +.          .........+........+.+++.+||+.||++|||+.|+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~  305 (328)
T cd08226         226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL  305 (328)
T ss_pred             CCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHH
Confidence            000                         00          0000111122233456789999999999999999999999


Q ss_pred             HH
Q 002085          918 LQ  919 (969)
Q Consensus       918 l~  919 (969)
                      ++
T Consensus       306 l~  307 (328)
T cd08226         306 LS  307 (328)
T ss_pred             hh
Confidence            85

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=305.42  Aligned_cols=264  Identities=27%  Similarity=0.366  Sum_probs=200.9

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |+..+.||+|++|.||+|.+..+|..||+|++..... .......+.+|+++++.++|||++++++++.+++..|+||||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            5677899999999999999988999999999864422 223345688899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      ++ ++|.+++.....           ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||
T Consensus        80 ~~-~~l~~~~~~~~~-----------~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~  144 (283)
T cd07835          80 LD-LDLKKYMDSSPL-----------TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFG  144 (283)
T ss_pred             cC-cCHHHHHhhCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecc
Confidence            95 799999876542           3489999999999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC--
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK--  874 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  874 (969)
                      .++.....  ........++..|+|||++.+. .++.++||||||+++|||++|+.||...+.......+.+......  
T Consensus       145 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd07835         145 LARAFGVP--VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDED  222 (283)
T ss_pred             cccccCCC--ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH
Confidence            99755322  1112234568899999987664 468899999999999999999999876543222111111110000  


Q ss_pred             ---------CchhhhccC---CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 ---------PITDALDKG---IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ---------~~~~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                               .........   .........+..+.+++.+||+.||++||++.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         223 VWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             HhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                     000000000   000011122367889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-33  Score=301.12  Aligned_cols=263  Identities=25%  Similarity=0.332  Sum_probs=201.4

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc---ccCceeeEEEEEEcCCc----
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI---RHANIVKLWCCISSENS----  710 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----  710 (969)
                      |++.+.||+|+||.||+|++..+++.||+|+++.... .......+.+|+.+++++   +|||++++++++.+.+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            5677899999999999999988899999999865433 223345667788777766   59999999999988776    


Q ss_pred             -eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          711 -KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       711 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                       .+++|||++ ++|.+++.....           ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++
T Consensus        80 ~~~l~~e~~~-~~l~~~l~~~~~-----------~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~  144 (287)
T cd07838          80 KLTLVFEHVD-QDLATYLSKCPK-----------PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDG  144 (287)
T ss_pred             eeEEEehhcc-cCHHHHHHHccC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCC
Confidence             899999997 589998875432           2488999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      .++|+|||.+..+....   ......++..|+|||.+.+..++.++|||||||++|||++|..||.+....+....+...
T Consensus       145 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~  221 (287)
T cd07838         145 QVKIADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDV  221 (287)
T ss_pred             CEEEeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHH
Confidence            99999999998764321   122335788999999999999999999999999999999999888765544333333222


Q ss_pred             hhccCCch---------hhhccCCC---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          870 YAEEKPIT---------DALDKGIA---EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       870 ~~~~~~~~---------~~~~~~~~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ........         ........   .....+....+.+++.+||+.||++||++.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         222 IGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            11100000         00000000   0111233467789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.1e-33  Score=305.99  Aligned_cols=267  Identities=28%  Similarity=0.344  Sum_probs=202.5

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--Cce
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--NSK  711 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  711 (969)
                      -.++|+..+.||+|+||.||+|.+..+|+.||+|+++..... ......+.+|++++++++|+|++++++++.+.  +..
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            356899999999999999999999989999999998643321 12223566899999999999999999998765  468


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||++ ++|.+++....            ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        84 ~lv~e~~~-~~l~~~l~~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~  147 (309)
T cd07845          84 FLVMEYCE-QDLASLLDNMP------------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCL  147 (309)
T ss_pred             EEEEecCC-CCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            99999997 58888887532            2488999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||.+.......  .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+.......+....
T Consensus       148 kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~  225 (309)
T cd07845         148 KIADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL  225 (309)
T ss_pred             EECccceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999998764322  12223346788999998865 457899999999999999999999997665544333322211


Q ss_pred             hccCC-c----------hhhhccCCCCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKP-I----------TDALDKGIAEPC----YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~-~----------~~~~~~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..... .          ............    .......+.+++.+|++.||++||++.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             CCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            11000 0          000000000000    0112467789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4e-33  Score=304.56  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=194.4

Q ss_pred             CCCccceeeecCcEEEEEEEEc---CCCcEEEEEEEeccchh-cHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCce
Q 002085          637 SLTESNLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSK  711 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  711 (969)
                      .|+..+.||+|+||.||+|...   .+|+.||+|++...... .....+.+.+|+++++++ +|++|+++.+++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            3677899999999999999874   47889999998654322 123346788999999999 599999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      |+||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~  144 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-------------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV  144 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCE
Confidence            99999999999999997543             377889999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT--KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      +|+|||+++...... ........|+..|+|||.+.+.  .++.++||||||+++|+|++|..||...........+...
T Consensus       145 kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~  223 (290)
T cd05613         145 VLTDFGLSKEFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR  223 (290)
T ss_pred             EEeeCccceeccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH
Confidence            999999997653321 1222235688999999998753  4678999999999999999999998643322211111111


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS  913 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs  913 (969)
                      .....           .+.+......+.+++.+||+.||++||+
T Consensus       224 ~~~~~-----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         224 ILKSE-----------PPYPQEMSALAKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             hhccC-----------CCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence            11100           0112223467889999999999999974

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-33  Score=325.41  Aligned_cols=274  Identities=20%  Similarity=0.234  Sum_probs=192.7

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCC-cEEEEEE--------------EeccchhcHHHHHHHHHHHHHHhccccCc
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAG-EFVAVKR--------------IWNNRKLNQKLEKEFIAEIEILGTIRHAN  697 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  697 (969)
                      .+.++|++.++||+|+||+||+|...... +.++.|.              +.+...........+.+|++++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            45678999999999999999998764322 2222221              11111112334567889999999999999


Q ss_pred             eeeEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecC
Q 002085          698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRD  777 (969)
Q Consensus       698 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  777 (969)
                      |+++++++.+.+..|+|+|++. ++|.+++......        .........+..++.|++.||+|||+.   +|+|||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~--------~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrD  292 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD--------WKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRD  292 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc--------ccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            9999999999999999999995 6788777643210        011233556778999999999999988   999999


Q ss_pred             CCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 002085          778 VKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD  857 (969)
Q Consensus       778 lkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~  857 (969)
                      |||+|||++.++.+||+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.++...
T Consensus       293 LKP~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~  371 (501)
T PHA03210        293 IKLENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD  371 (501)
T ss_pred             CCHHHEEECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence            99999999999999999999998764322 22223457999999999999999999999999999999999998765543


Q ss_pred             CccchHHHHHHHhhc----cCC-------chhhhccCC----CCcc-----cHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002085          858 EHTSLAEWAWRHYAE----EKP-------ITDALDKGI----AEPC-----YLEEMTTVYRLALICTSTLPSSRPSMKEV  917 (969)
Q Consensus       858 ~~~~~~~~~~~~~~~----~~~-------~~~~~~~~~----~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~ev  917 (969)
                      ........+......    ...       +.+.++...    ....     .......+.+++.+|++.||++||++.|+
T Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el  451 (501)
T PHA03210        372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL  451 (501)
T ss_pred             CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence            322211111111110    000       000000000    0000     00112456778999999999999999999


Q ss_pred             HH
Q 002085          918 LQ  919 (969)
Q Consensus       918 l~  919 (969)
                      ++
T Consensus       452 L~  453 (501)
T PHA03210        452 LA  453 (501)
T ss_pred             hh
Confidence            86

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.1e-34  Score=329.44  Aligned_cols=255  Identities=30%  Similarity=0.441  Sum_probs=189.2

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc-
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS-  710 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  710 (969)
                      .....+|.+.+.||+||||.||+++.+-+|+.||||++....  .+.....+.+|++++++++|||||+++..+.+... 
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~  552 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE  552 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence            345668888999999999999999999999999999996654  45667889999999999999999999865422111 


Q ss_pred             --------------------------------------------------------------------------------
Q 002085          711 --------------------------------------------------------------------------------  710 (969)
Q Consensus       711 --------------------------------------------------------------------------------  710 (969)
                                                                                                      
T Consensus       553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~  632 (1351)
T KOG1035|consen  553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN  632 (1351)
T ss_pred             cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHH
Q 002085          711 --------------------------------------KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL  752 (969)
Q Consensus       711 --------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~  752 (969)
                                                            .||-||||+..++.++++....            .-.-...+
T Consensus       633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~------------~~~~d~~w  700 (1351)
T KOG1035|consen  633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF------------NSQRDEAW  700 (1351)
T ss_pred             ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc------------chhhHHHH
Confidence                                                  1455555555555555543321            00245678


Q ss_pred             HHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecc------c----------CCCCcccccccc
Q 002085          753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA------K----------QGEPHTMSAVAG  816 (969)
Q Consensus       753 ~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~------~----------~~~~~~~~~~~g  816 (969)
                      +++.+|+.|++|+|+.   |||||||||.|||+|+++.|||+|||+|+...      .          .+.....+..+|
T Consensus       701 rLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VG  777 (1351)
T KOG1035|consen  701 RLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVG  777 (1351)
T ss_pred             HHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccc
Confidence            9999999999999998   99999999999999999999999999998721      0          111224466789


Q ss_pred             CcccCchhhcccCC---CCCccchhhHHHHHHHHHhCCCCCCCC-CccchHHHHHHHhhccCCchhhhccCCCCc--ccH
Q 002085          817 SFGYFAPEYAYTTK---VNEKIDIYSFGVVLLELVTGKEANYGD-EHTSLAEWAWRHYAEEKPITDALDKGIAEP--CYL  890 (969)
Q Consensus       817 t~~y~aPE~~~~~~---~~~~sDvwslG~il~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  890 (969)
                      |.-|+|||++.+..   |+.|+|+||+|+|++||+.   ||... +...    +....+         +..++.+  ...
T Consensus       778 TalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~----iL~~LR---------~g~iP~~~~f~~  841 (1351)
T KOG1035|consen  778 TALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS----ILTNLR---------KGSIPEPADFFD  841 (1351)
T ss_pred             eeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHH----HHHhcc---------cCCCCCCccccc
Confidence            99999999987654   9999999999999999985   45421 1111    111111         1111111  122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          891 EEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       891 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .....-..++.++++.||++||||.|++.
T Consensus       842 ~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  842 PEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            33345578999999999999999999985

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.2e-33  Score=297.78  Aligned_cols=252  Identities=27%  Similarity=0.347  Sum_probs=207.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|++.++||+|+||.||+++...+++.+|+|.+..... .......+.+|++++++++||||+++.+++.+....++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            47788999999999999999998999999999865432 23445678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++.....         ....+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.+|++||
T Consensus        80 ~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~  147 (256)
T cd08530          80 YAPFGDLSKAISKRKK---------KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDL  147 (256)
T ss_pred             hcCCCCHHHHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeec
Confidence            9999999999876321         123488999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |+++.....    ......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||...+...+...+..        
T Consensus       148 g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------  215 (256)
T cd08530         148 GISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR--------  215 (256)
T ss_pred             cchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------
Confidence            999876433    22234578899999999999999999999999999999999999976654332222111        


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                            +...+.......++.+++.+|+..+|++||++.|+++
T Consensus       216 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 ------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  1111122244577999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9e-34  Score=277.05  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=201.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      .++......||.|+.|+||+++.+.+|...|||.+...  .+.+..+++...+.++..- .+|+||+.+|||......++
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I  168 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI  168 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence            34566677899999999999999999999999998554  3455567888888877766 49999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      .||.|. ..++.+++...            .++++...-++...+..||.||.+++  +|+|||+||+|||+|+.|++|+
T Consensus       169 cMelMs-~C~ekLlkrik------------~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKl  233 (391)
T KOG0983|consen  169 CMELMS-TCAEKLLKRIK------------GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKL  233 (391)
T ss_pred             HHHHHH-HHHHHHHHHhc------------CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEe
Confidence            999994 55666665443            34777777799999999999998764  9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT---TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||||.+..+.   +....+..+|-+.|||||.+.-   ..|+-++||||||++++|++||+.||.+.+..-  +.+....
T Consensus       234 CDFGIsGrlv---dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~ltkvl  308 (391)
T KOG0983|consen  234 CDFGISGRLV---DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLTKVL  308 (391)
T ss_pred             ecccccceee---cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHHHHH
Confidence            9999997764   3445556789999999998864   368889999999999999999999998743221  1111111


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+ ++      +.++  .....+..+.+++..|+.+|+.+||...++++
T Consensus       309 n~-eP------P~L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  309 NE-EP------PLLP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             hc-CC------CCCC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            11 11      1111  12225678999999999999999999999886

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3e-34  Score=285.24  Aligned_cols=276  Identities=22%  Similarity=0.308  Sum_probs=204.7

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCC----cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAG----EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-  707 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  707 (969)
                      +.+..|+....||+|.||.||+|....+.    ..+|+|.++...+. ........+|+.+++.++|||++.+..++-. 
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            34568999999999999999999654332    26999999765432 2334567899999999999999999988866 


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      +...++++||.+ -+|++.++-++...        ...++..++..|+.||+.|+.|||+.   =|+||||||.|||+..
T Consensus       100 d~~v~l~fdYAE-hDL~~II~fHr~~~--------~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmg  167 (438)
T KOG0666|consen  100 DKKVWLLFDYAE-HDLWHIIKFHRASK--------AKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMG  167 (438)
T ss_pred             CceEEEEehhhh-hhHHHHHHHhccch--------hccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEec
Confidence            788999999997 68999998765421        24688899999999999999999998   6999999999999988


Q ss_pred             C----CcEEEeecccceecccCCCCc-cccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCcc-
Q 002085          788 E----FKAKIADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHT-  860 (969)
Q Consensus       788 ~----~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~-  860 (969)
                      +    |.|||+|||+++.+...-.+. .....+.|.+|+|||.+.+.+ |+++.||||.|||+.||++-.+.|.+.+.. 
T Consensus       168 dgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~  247 (438)
T KOG0666|consen  168 DGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKI  247 (438)
T ss_pred             cCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhc
Confidence            8    899999999999886543333 334567899999999998864 899999999999999999999888764321 


Q ss_pred             -----chH---HHHHHHhh-----------ccCCchhhhcc---CCCCcc----c----HHHHHHHHHHHHHccCCCCCC
Q 002085          861 -----SLA---EWAWRHYA-----------EEKPITDALDK---GIAEPC----Y----LEEMTTVYRLALICTSTLPSS  910 (969)
Q Consensus       861 -----~~~---~~~~~~~~-----------~~~~~~~~~~~---~~~~~~----~----~~~~~~~~~l~~~cl~~dP~~  910 (969)
                           ...   ..+...+.           ........+..   .....+    +    .......++++.+++..||-+
T Consensus       248 ~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~k  327 (438)
T KOG0666|consen  248 KTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIK  327 (438)
T ss_pred             ccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchh
Confidence                 111   11111110           00000000000   000000    0    001234789999999999999


Q ss_pred             CCCHHHHHHHH
Q 002085          911 RPSMKEVLQIL  921 (969)
Q Consensus       911 RPs~~evl~~L  921 (969)
                      |.|+.+.++..
T Consensus       328 RIta~qAleh~  338 (438)
T KOG0666|consen  328 RITAEQALEHP  338 (438)
T ss_pred             hccHHHHhccc
Confidence            99999998743

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.4e-33  Score=303.86  Aligned_cols=269  Identities=22%  Similarity=0.306  Sum_probs=199.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCc----
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENS----  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----  710 (969)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.++.... .......+.+|+.++++++ ||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            368888999999999999999998999999998754322 1223356888999999995 6999999999877655    


Q ss_pred             -eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC-C
Q 002085          711 -KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-E  788 (969)
Q Consensus       711 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~  788 (969)
                       .|+||||+++ +|.+++......        ....+++..++.++.||+.||+|||+.   +|+||||+|+||+++. +
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~  147 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRG--------PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQK  147 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhccc--------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCC
Confidence             8999999985 899988754321        013479999999999999999999988   9999999999999998 8


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      +.+||+|||+++.+...  ........+++.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+.
T Consensus       148 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~  225 (295)
T cd07837         148 GLLKIADLGLGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF  225 (295)
T ss_pred             CeEEEeecccceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            89999999999865322  112223456889999998865 457899999999999999999999997654432222111


Q ss_pred             HHhhccCC--------chhhhccCCCCc-----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          868 RHYAEEKP--------ITDALDKGIAEP-----CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       868 ~~~~~~~~--------~~~~~~~~~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ........        ...........+     ........+.+++.+||..||++||++.|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            11100000        000000000000     00123467889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.5e-33  Score=304.63  Aligned_cols=253  Identities=24%  Similarity=0.325  Sum_probs=207.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  714 (969)
                      ++|...+.||+|+||.||+|....+++.||+|++...........+.+.+|++++++++ ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999999899999999986644434455678899999999998 99999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....             .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++
T Consensus        81 ~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~  144 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-------------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKIT  144 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEec
Confidence            99999999999998653             389999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCC------------------ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 002085          795 DFGLAKMLAKQGEP------------------HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG  856 (969)
Q Consensus       795 Dfgla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~  856 (969)
                      |||++.........                  .......++..|+|||...+..++.++||||+|+++|++++|..||..
T Consensus       145 df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (280)
T cd05581         145 DFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG  224 (280)
T ss_pred             CCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999866432211                  122234578899999999888899999999999999999999999876


Q ss_pred             CCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 002085          857 DEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM----KEVLQ  919 (969)
Q Consensus       857 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~----~evl~  919 (969)
                      .+.........   ...            ...+...+..+.+++.+||+.+|++||++    .|+++
T Consensus       225 ~~~~~~~~~~~---~~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         225 SNEYLTFQKIL---KLE------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ccHHHHHHHHH---hcC------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            54322211111   110            01112224678999999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.8e-33  Score=305.29  Aligned_cols=268  Identities=27%  Similarity=0.351  Sum_probs=203.1

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN----  709 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  709 (969)
                      ..++|+..+.||+|+||.||+|....+++.||+|+++.... .......+.+|++++++++|||++++++++.+..    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45689999999999999999999998899999999864322 1223356788999999999999999999887654    


Q ss_pred             ------ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcE
Q 002085          710 ------SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI  783 (969)
Q Consensus       710 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Ni  783 (969)
                            ..++|+||+++ ++.+.+....            ..+++..+..++.|++.||+|||+.   +|+||||+|+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~ni  147 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL------------VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNI  147 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence                  78999999985 7777766432            2489999999999999999999988   999999999999


Q ss_pred             EECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccch
Q 002085          784 LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL  862 (969)
Q Consensus       784 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  862 (969)
                      ++++++.+||+|||.+........ .......++..|+|||.+.+. .++.++||||+||++|||++|+.||...+....
T Consensus       148 li~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~  226 (302)
T cd07864         148 LLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ  226 (302)
T ss_pred             EECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            999999999999999986643321 222233567889999987653 578899999999999999999999976654443


Q ss_pred             HHHHHHHhhccCC--chhhh--------ccCC-----CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          863 AEWAWRHYAEEKP--ITDAL--------DKGI-----AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       863 ~~~~~~~~~~~~~--~~~~~--------~~~~-----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...+.+......+  ..+..        +...     ........+..+.+++.+||+.||++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         227 LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            3333332211110  00000        0000     00001112467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.9e-33  Score=304.20  Aligned_cols=251  Identities=27%  Similarity=0.374  Sum_probs=200.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ..|+..+.||+|+||.||+|+...+++.||+|.+...........+.+.+|+++++.++|+|++++.+++.+....++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45777889999999999999998889999999886433333444567889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+. |++.+++....            ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|
T Consensus        95 e~~~-~~l~~~~~~~~------------~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~d  158 (308)
T cd06634          95 EYCL-GSASDLLEVHK------------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGD  158 (308)
T ss_pred             EccC-CCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECC
Confidence            9996 68888775432            2378899999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ||++.....      .....+++.|+|||.+.   ...++.++|||||||++|||++|+.||...+........   ...
T Consensus       159 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~  229 (308)
T cd06634         159 FGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQN  229 (308)
T ss_pred             cccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH---hhc
Confidence            999876532      12345788999999874   356788999999999999999999998764332211111   000


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      .          ............+.+++.+||+.+|++||++.++++.-
T Consensus       230 ~----------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         230 E----------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             C----------CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            0          01111123346788999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.8e-33  Score=295.84  Aligned_cols=254  Identities=27%  Similarity=0.391  Sum_probs=208.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||.|+||.||++.+..++..||+|++..... .....+.+.+|+++++.++|||++++.+.+.+++..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            47778899999999999999988899999999865432 33556788999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++.....         ....+++..+..++.+++.|++|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        80 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~  147 (258)
T cd08215          80 YADGGDLSQKIKKQKK---------EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDF  147 (258)
T ss_pred             ecCCCcHHHHHHHhhc---------cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCc
Confidence            9999999999986531         013589999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |.+.......  .......|++.|+|||...+..++.++||||+|+++|+|++|+.||...+.........    ...  
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----~~~--  219 (258)
T cd08215         148 GISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL----KGQ--  219 (258)
T ss_pred             cceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh----cCC--
Confidence            9998764432  12233468889999999998889999999999999999999999987655332222111    100  


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                              ..+.+......+.+++.+||..+|++||++.|+++
T Consensus       220 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 --------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    11112233467899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.4e-33  Score=302.14  Aligned_cols=259  Identities=23%  Similarity=0.284  Sum_probs=202.0

Q ss_pred             CCCccceeeecCcEEEEEEEEc---CCCcEEEEEEEeccchh-cHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCce
Q 002085          637 SLTESNLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSK  711 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  711 (969)
                      +|+..+.||+|+||.||+++..   .+++.||||.++..... .....+.+.+|++++.++ +||||+++.+.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3677889999999999998864   35788999998654322 223346788999999999 599999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++++|.+++....             .+++..+..++.|+++||.|||+.   +++||||+|+||+++.++.+
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~  144 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-------------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHV  144 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-------------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCE
Confidence            99999999999999987533             378889999999999999999987   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK--VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      +++|||+++....... .......|+..|+|||...+..  .+.++||||||+++|||++|..||.............+.
T Consensus       145 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  223 (288)
T cd05583         145 VLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR  223 (288)
T ss_pred             EEEECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH
Confidence            9999999876543221 1122345889999999987765  788999999999999999999998644322211111111


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      .....           .+.+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus       224 ~~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         224 ILKSK-----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHccC-----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            11100           11122233678899999999999999999888776543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=294.12  Aligned_cols=250  Identities=29%  Similarity=0.440  Sum_probs=205.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +|+..+.||+|++|.||+|....+++.||+|.+..... .+...+.+.+|++++++++|||++++++++.+++..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            47788999999999999999988899999999866533 23456789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++....             .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+||
T Consensus        80 ~~~~~~L~~~~~~~~-------------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~  143 (254)
T cd06627          80 YAENGSLRQIIKKFG-------------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADF  143 (254)
T ss_pred             cCCCCcHHHHHHhcc-------------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEecc
Confidence            999999999987543             388999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |.+........  ......++..|+|||...+..++.++||||+|+++|+|++|+.||........   .+.......  
T Consensus       144 ~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~--  216 (254)
T cd06627         144 GVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA---LFRIVQDDH--  216 (254)
T ss_pred             ccceecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHhccCC--
Confidence            99987644221  12345688999999999888889999999999999999999999875442111   111111100  


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                               ...+...+..+.+++.+|+..+|++||++.|++.
T Consensus       217 ---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 ---------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                     0111222467889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-35  Score=305.77  Aligned_cols=267  Identities=23%  Similarity=0.306  Sum_probs=220.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      ++++.++..||-||||.|-+++.......+|+|++++....+....+.+..|-.||...+.|.||+++-.|.+.++.|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            45677788899999999999988766666999999888888888889999999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      ||-|-||.|+..++.++.             ++..+...++..+.+|++|||++   +||+|||||+|.++|.+|.+||.
T Consensus       499 mEaClGGElWTiLrdRg~-------------Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLV  562 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGS-------------FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLV  562 (732)
T ss_pred             HHhhcCchhhhhhhhcCC-------------cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEe
Confidence            999999999999998764             88899999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+|+.+.....   +-..+|||.|.|||++.....+.++|.||+|+++||+++|.+||.+.++-.....+.+....- 
T Consensus       563 DFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-  638 (732)
T KOG0614|consen  563 DFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-  638 (732)
T ss_pred             ehhhHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-
Confidence            9999998855433   334789999999999999999999999999999999999999999887755554443332110 


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCcccc-cCCCCCCCCCcccce
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMG-RDVDSAPLLGTAGYL  951 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  951 (969)
                                  ..|.....                  ++.++++.|=+..|.|+.|+...+ ++++.|.+|...+|+
T Consensus       639 ------------~~Pr~I~k------------------~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  639 ------------EFPRRITK------------------TATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             ------------hcccccch------------------hHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence                        01111112                  456666666666666667766544 777888888744333

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=281.28  Aligned_cols=254  Identities=23%  Similarity=0.299  Sum_probs=202.4

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEeecc
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      .+.||+|+|+.|-.+....+|..||||++.+.   ....+.++.+|++++... .|+||+.++++|+++...|||||-|.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            36899999999999999999999999999553   456678999999999999 59999999999999999999999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC---cEEEeec
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF---KAKIADF  796 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Df  796 (969)
                      ||+|..++++++             .+.+.++.++..+||.||.+||.+   ||.|||+||+|||-.+..   -|||+||
T Consensus       160 GGplLshI~~~~-------------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  160 GGPLLSHIQKRK-------------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             CchHHHHHHHhh-------------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence            999999999865             489999999999999999999988   999999999999997765   4899999


Q ss_pred             ccceecccCCC-----CccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc------
Q 002085          797 GLAKMLAKQGE-----PHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT------  860 (969)
Q Consensus       797 gla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~------  860 (969)
                      .++.-+....+     ......++|+..|||||+..     ...|+.+.|.||+|||+|-|++|..||.+....      
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr  303 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR  303 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence            88764432211     12223567889999999753     345889999999999999999999999764321      


Q ss_pred             -chHHHHHHHhhccCCchhhhccC---CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          861 -SLAEWAWRHYAEEKPITDALDKG---IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       861 -~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       +.-+.....      +.+.+..+   ++...+...+.+..+++...+..|+.+|-++.+++.
T Consensus       304 Ge~Cr~CQ~~------LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  304 GEVCRVCQNK------LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCccHHHHHH------HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence             111111111      11112222   222334445677888999999999999999999987

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.1e-32  Score=301.92  Aligned_cols=247  Identities=28%  Similarity=0.415  Sum_probs=199.3

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |...+.||+|+||.||+|+...+++.||+|++...........+.+.+|+++++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            56667899999999999999889999999998654444444556788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +. +++.+++....            ..+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||
T Consensus       103 ~~-~~l~~~l~~~~------------~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg  166 (313)
T cd06633         103 CL-GSASDLLEVHK------------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG  166 (313)
T ss_pred             CC-CCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecC
Confidence            96 67888776433            2488999999999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ++....      ......|+..|+|||++.   ...++.++|||||||++|||++|..||...+..........   ...
T Consensus       167 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~  237 (313)
T cd06633         167 SASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NDS  237 (313)
T ss_pred             CCcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---cCC
Confidence            986421      122356888999999974   45688899999999999999999999876654332222111   110


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +       ..   .....+..+.+++.+||+.+|.+||++.+++.
T Consensus       238 ~-------~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         238 P-------TL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             C-------CC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0       00   11112356889999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.6e-33  Score=310.29  Aligned_cols=266  Identities=23%  Similarity=0.327  Sum_probs=202.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc----CCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS----ENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  711 (969)
                      ++|+..+.||+|+||.||+|....+|+.||+|++..... .....+.+.+|+.++++++||||+++.+++..    ....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            578888999999999999999999999999999865432 22335677889999999999999999987753    3568


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+. ++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~  146 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-------------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCEL  146 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence            99999996 68999886543             388999999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCC--ccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          792 KIADFGLAKMLAKQGEP--HTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      ||+|||++.........  .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus       147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~  226 (334)
T cd07855         147 RIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS  226 (334)
T ss_pred             EecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH
Confidence            99999999766433221  11234578899999998765 4688999999999999999999999976554322221111


Q ss_pred             Hhhcc----------CCchhhhcc-CCCCcc-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEE----------KPITDALDK-GIAEPC-----YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~----------~~~~~~~~~-~~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .....          ..+.+..+. ....+.     ....+..+.+++.+||+.||++||++++++.
T Consensus       227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            11000          000000000 000001     1223577999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.4e-32  Score=294.12  Aligned_cols=243  Identities=21%  Similarity=0.295  Sum_probs=191.5

Q ss_pred             hccCCCcccee--eecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCc
Q 002085          634 ILSSLTESNLI--GSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENS  710 (969)
Q Consensus       634 ~~~~~~~~~~l--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  710 (969)
                      +.+.|+..+.+  |+|+||.||++....+++.+|+|.+.......        .|+.....+ +|||++++++++..++.
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            34566666665  99999999999999999999999985432110        122222222 69999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-  789 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-  789 (969)
                      .++||||+++++|.+++....             .++|..+..++.|+++|+.|||+.   +++||||+|+||+++.++ 
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~  147 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEG-------------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKD  147 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCC
Confidence            999999999999999997543             389999999999999999999988   999999999999999998 


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccch--HHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL--AEWAW  867 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~--~~~~~  867 (969)
                      .++++|||+++.....      ....++..|+|||++.+..++.++||||+||++|||++|+.||........  ..+..
T Consensus       148 ~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  221 (267)
T PHA03390        148 RIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK  221 (267)
T ss_pred             eEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH
Confidence            9999999998765321      224688999999999998999999999999999999999999975443322  11111


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-MKEVLQ  919 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~  919 (969)
                      . ....            .......+..+.+++.+||+.||.+||+ ++|+++
T Consensus       222 ~-~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        222 R-QQKK------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             h-hccc------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            1 1100            0112234578899999999999999996 588774

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.9e-33  Score=308.63  Aligned_cols=270  Identities=24%  Similarity=0.309  Sum_probs=204.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC-----C
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE-----N  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  709 (969)
                      .++|...+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            4578899999999999999999998999999999865322 223345677899999999999999999987643     3


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..|+|+||+. ++|.+++....             .+++..+..++.|++.||.|||+.   +++||||||+||+++.++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~  145 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ-------------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANC  145 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence            4799999996 78998887543             388999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      .+||+|||+++......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus       146 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  223 (337)
T cd07858         146 DLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE  223 (337)
T ss_pred             CEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Confidence            99999999998654321  22234567889999998765 4688999999999999999999999976543322222211


Q ss_pred             Hhhcc----------CCchhhhccC---CC---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhc
Q 002085          869 HYAEE----------KPITDALDKG---IA---EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI--LRRC  924 (969)
Q Consensus       869 ~~~~~----------~~~~~~~~~~---~~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~  924 (969)
                      .....          ....+.....   ..   .......+..+.+++.+||+.||++||+++|+++.  ++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         224 LLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            11000          0000000000   00   00112234678899999999999999999999975  5554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=298.25  Aligned_cols=263  Identities=25%  Similarity=0.339  Sum_probs=204.8

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |+..+.||+|++|.||+|....+++.+|+|.+..... .......+.+|++++++++|+||+++++++.++...++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            5667899999999999999988899999999865432 223456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++ ++.+++....            ..+++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++.++|+|||
T Consensus        80 ~~~-~l~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~  143 (283)
T cd05118          80 MDT-DLYKLIKDRQ------------RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFG  143 (283)
T ss_pred             cCC-CHHHHHHhhc------------ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeee
Confidence            974 8888887542            2488999999999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC-
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP-  875 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  875 (969)
                      .+.......  .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+..+....+........+ 
T Consensus       144 ~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (283)
T cd05118         144 LARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPE  221 (283)
T ss_pred             eeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchH
Confidence            998764432  122335678899999998876 7899999999999999999999998766543332222211111000 


Q ss_pred             -chhhhc---------cCCC----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 -ITDALD---------KGIA----EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 -~~~~~~---------~~~~----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       ......         +...    .......+..+.+++.+||+.||.+||++.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             000000         0000    0011234578899999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=298.80  Aligned_cols=262  Identities=24%  Similarity=0.302  Sum_probs=199.6

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEEEEe
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      |+..+.||+|+||+||+|....+++.||+|++......  .......+|+..+++++ |||++++++++.+++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            56778999999999999999888999999998543221  22334567999999998 9999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+ +|+|.+++.....           ..+++..+..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+||
T Consensus        79 ~~-~~~l~~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~  143 (283)
T cd07830          79 YM-EGNLYQLMKDRKG-----------KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADF  143 (283)
T ss_pred             cC-CCCHHHHHHhccc-----------ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeec
Confidence            99 7899999876531           2489999999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC-
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK-  874 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  874 (969)
                      |.+.......   ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.................... 
T Consensus       144 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  220 (283)
T cd07830         144 GLAREIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK  220 (283)
T ss_pred             ccceeccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCCh
Confidence            9998653321   2233567889999998754 4578999999999999999999998876544332222211110000 


Q ss_pred             -------CchhhhccCCC-------CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 -------PITDALDKGIA-------EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 -------~~~~~~~~~~~-------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                             ...........       ..........+.+++.+||+.||++||++.|++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                   00000000000       0000111367899999999999999999999976

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.3e-32  Score=300.14  Aligned_cols=257  Identities=22%  Similarity=0.239  Sum_probs=191.5

Q ss_pred             CcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCHHHHh
Q 002085          648 GSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWL  727 (969)
Q Consensus       648 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l  727 (969)
                      ++|.||.++...+++.||||++.... ......+.+.+|+++++.++||||+++++++.+.+..+++|||+++++|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            44555666666689999999986542 23445678999999999999999999999999999999999999999999999


Q ss_pred             ccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCC
Q 002085          728 HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE  807 (969)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  807 (969)
                      .....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+..+...+.
T Consensus        91 ~~~~~-----------~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          91 KTHFP-----------EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             HHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            86432           2478889999999999999999988   999999999999999999999999999876543222


Q ss_pred             C-----ccccccccCcccCchhhcccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCccchH-HHHHHHhh---ccCC-
Q 002085          808 P-----HTMSAVAGSFGYFAPEYAYTT--KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA-EWAWRHYA---EEKP-  875 (969)
Q Consensus       808 ~-----~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~---~~~~-  875 (969)
                      .     .......++..|+|||++.+.  .++.++|||||||++|||++|..||......... +.......   .... 
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence            1     111234577889999998763  5788999999999999999999999765432211 11100000   0000 


Q ss_pred             ------chh----hhc----cCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ------ITD----ALD----KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ------~~~----~~~----~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                            ...    ..+    .............++.+++.+||+.||++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                  000    000    00111122334467889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.1e-32  Score=305.31  Aligned_cols=268  Identities=23%  Similarity=0.277  Sum_probs=201.5

Q ss_pred             ccCCCc-cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHH-----------HHHHHHHHHHHHhccccCceeeEE
Q 002085          635 LSSLTE-SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK-----------LEKEFIAEIEILGTIRHANIVKLW  702 (969)
Q Consensus       635 ~~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~  702 (969)
                      .++|.. .+.||+|+||.||+|.+..+++.||||.+.........           ....+.+|+++++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            345654 57799999999999999888999999998543221100           112578999999999999999999


Q ss_pred             EEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCc
Q 002085          703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSN  782 (969)
Q Consensus       703 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  782 (969)
                      +++..++..++||||++ ++|.+++....             .+++.....++.|++.||+|||+.   +++||||+|+|
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-------------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~n  149 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-------------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPAN  149 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHH
Confidence            99999999999999997 68999986533             378899999999999999999988   99999999999


Q ss_pred             EEECCCCcEEEeecccceecccCC------------CCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHh
Q 002085          783 ILLDSEFKAKIADFGLAKMLAKQG------------EPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVT  849 (969)
Q Consensus       783 ill~~~~~~kl~Dfgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ellt  849 (969)
                      |+++.++.++++|||.++.+....            .........++..|+|||.+.+. .++.++||||+||++|||++
T Consensus       150 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t  229 (335)
T PTZ00024        150 IFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT  229 (335)
T ss_pred             eEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh
Confidence            999999999999999998664111            01112234568889999998764 46889999999999999999


Q ss_pred             CCCCCCCCCccchHHHHHHHhhccCC--chhhhc--------cCCC---CcccHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002085          850 GKEANYGDEHTSLAEWAWRHYAEEKP--ITDALD--------KGIA---EPCYLEEMTTVYRLALICTSTLPSSRPSMKE  916 (969)
Q Consensus       850 g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--------~~~~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e  916 (969)
                      |..||.+.+.......+.........  ..+...        ....   .......+..+.+++.+|++.+|++||+++|
T Consensus       230 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  309 (335)
T PTZ00024        230 GKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE  309 (335)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence            99999876654433333222111100  000000        0000   0001122467889999999999999999999


Q ss_pred             HHH
Q 002085          917 VLQ  919 (969)
Q Consensus       917 vl~  919 (969)
                      ++.
T Consensus       310 ~l~  312 (335)
T PTZ00024        310 ALK  312 (335)
T ss_pred             Hhc
Confidence            986

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-33  Score=279.52  Aligned_cols=278  Identities=19%  Similarity=0.277  Sum_probs=219.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      +++|...++||+|+|+.|-.++...+.+.||+|+++++...+++..+-++.|..+..+- +||.+|.+..+|+.+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            56889999999999999999999999999999999888777777778889999999887 79999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      |.||++||+|--+++.+++             ++++.+..+...|..||.|||++   ||++||||..||++|.+|.+|+
T Consensus       329 vieyv~ggdlmfhmqrqrk-------------lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikl  392 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK-------------LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKL  392 (593)
T ss_pred             EEEEecCcceeeehhhhhc-------------CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceee
Confidence            9999999999888887664             89999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCC----CccchHHHHHHH
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD----EHTSLAEWAWRH  869 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~----~~~~~~~~~~~~  869 (969)
                      .|+|+++.-..  +....+..+|||.|.|||++++..|....|.|++||+++||+.|+.||+-.    ......+++.+.
T Consensus       393 tdygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv  470 (593)
T KOG0695|consen  393 TDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV  470 (593)
T ss_pred             cccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence            99999875322  333456689999999999999999999999999999999999999999631    122223333332


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCcccccCCCCCCCCCccc
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAG  949 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~  949 (969)
                      ..+.         -++.+  ...+.....+++.-+++||.+|.          .+.|      +..-.+++.|++|...+
T Consensus       471 ilek---------qirip--rslsvkas~vlkgflnkdp~erl----------gc~~------~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  471 ILEK---------QIRIP--RSLSVKASHVLKGFLNKDPKERL----------GCRP------QTGFSDIKSHAFFRSID  523 (593)
T ss_pred             Hhhh---------ccccc--ceeehhhHHHHHHhhcCCcHHhc----------CCCc------ccchhhhhcchhhhhCC
Confidence            2221         11111  11123344566666677776663          2222      12447889999999555


Q ss_pred             ceeccccc
Q 002085          950 YLFGFKRS  957 (969)
Q Consensus       950 ~~~~~~~~  957 (969)
                      |+.-..|+
T Consensus       524 wd~leqk~  531 (593)
T KOG0695|consen  524 WDLLEQKQ  531 (593)
T ss_pred             HHHHhhcc
Confidence            54433333

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.8e-32  Score=302.79  Aligned_cols=268  Identities=23%  Similarity=0.310  Sum_probs=199.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC-----
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN-----  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  709 (969)
                      .++|+..++||+|+||.||+|.+..+++.||+|++...... ......+.+|++++++++||||+++++++.+..     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            57899999999999999999999989999999988543221 122345678999999999999999998875433     


Q ss_pred             ---ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          710 ---SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       710 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                         ..++|+||++ +++.+.+....            ..+++..+..++.|+++||+|||+.   +|+||||||+||+++
T Consensus        86 ~~~~~~lv~~~~~-~~l~~~~~~~~------------~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~  149 (311)
T cd07866          86 KRGSVYMVTPYMD-HDLSGLLENPS------------VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILID  149 (311)
T ss_pred             cCceEEEEEecCC-cCHHHHHhccc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence               4699999997 46777766432            2489999999999999999999988   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCc---------cccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPH---------TMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYG  856 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~  856 (969)
                      +++.++|+|||+++.........         ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+
T Consensus       150 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         150 NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            99999999999998654322111         11234578889999987654 578999999999999999999999876


Q ss_pred             CCccchHHHHHHHhhccCC--------chhhhc----cCCCC---cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          857 DEHTSLAEWAWRHYAEEKP--------ITDALD----KGIAE---PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       857 ~~~~~~~~~~~~~~~~~~~--------~~~~~~----~~~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .......+.+........+        .....+    .....   .........+.+++.+|++.||++|||+.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         230 KSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            5544333332222111000        000000    00000   001112256889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-33  Score=307.53  Aligned_cols=202  Identities=30%  Similarity=0.422  Sum_probs=175.4

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC------Cce
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE------NSK  711 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  711 (969)
                      |...+.||+|+||.||+++++.+|+.||||.+....  .....+...+|++++++++|||||++++.-++.      ...
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            445678999999999999999999999999986543  345568899999999999999999999875543      356


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC--CCC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD--SEF  789 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~  789 (969)
                      .+|||||.||||+..+.....          ...+++.+.+.+..+++.||.|||++   +|+||||||.||++-  ++|
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN----------~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedg  159 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPEN----------AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDG  159 (732)
T ss_pred             eEEEeecCCCcHHHHhcCccc----------ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCC
Confidence            899999999999999997765          35699999999999999999999998   999999999999983  334


Q ss_pred             --cEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 002085          790 --KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGD  857 (969)
Q Consensus       790 --~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~  857 (969)
                        .-||+|||.|+.++++   ......+||..|.+||...+ +.|+..+|.|||||++||++||..||...
T Consensus       160 q~IyKLtDfG~Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  160 QSIYKLTDFGAARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ceEEeeecccccccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence              3699999999987543   36677899999999999985 78899999999999999999999999753

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.4e-32  Score=326.08  Aligned_cols=150  Identities=28%  Similarity=0.400  Sum_probs=136.6

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +++|++.++||+|+||.||+|.+..+++.||||+++............+.+|+.+++.++||||+++++++......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            46788999999999999999999989999999999765544555567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....             .+++..++.++.||+.||+|||..   +|+||||||+|||++.++.+||+
T Consensus        83 mEy~~g~~L~~li~~~~-------------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~  146 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-------------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLT  146 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEE
Confidence            99999999999997543             378889999999999999999988   99999999999999999999999


Q ss_pred             ecccce
Q 002085          795 DFGLAK  800 (969)
Q Consensus       795 Dfgla~  800 (969)
                      |||+++
T Consensus       147 DFGls~  152 (669)
T cd05610         147 DFGLSK  152 (669)
T ss_pred             eCCCCc
Confidence            999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-32  Score=290.31  Aligned_cols=240  Identities=28%  Similarity=0.353  Sum_probs=199.2

Q ss_pred             eeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCH
Q 002085          644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL  723 (969)
Q Consensus       644 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  723 (969)
                      ||.|+||.||++....+++.||+|++...........+.+..|++++++++|||++++++.+.++...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999888999999998765444444567899999999999999999999999999999999999999999


Q ss_pred             HHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecc
Q 002085          724 DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA  803 (969)
Q Consensus       724 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  803 (969)
                      .+++....             .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+....
T Consensus        81 ~~~l~~~~-------------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~  144 (250)
T cd05123          81 FSHLSKEG-------------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELS  144 (250)
T ss_pred             HHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecc
Confidence            99997543             378999999999999999999987   99999999999999999999999999997654


Q ss_pred             cCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccC
Q 002085          804 KQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG  883 (969)
Q Consensus       804 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  883 (969)
                      ...  .......++..|+|||...+...+.++|+||||+++||+++|..||...+.......+.   ....         
T Consensus       145 ~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---~~~~---------  210 (250)
T cd05123         145 SEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL---KDPL---------  210 (250)
T ss_pred             cCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh---cCCC---------
Confidence            321  22334568889999999988889999999999999999999999997655422222211   1110         


Q ss_pred             CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002085          884 IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKE  916 (969)
Q Consensus       884 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e  916 (969)
                         ..+...+..+.+++.+||..||++||++++
T Consensus       211 ---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 ---RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ---CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence               111222467889999999999999999955

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.5e-32  Score=297.08  Aligned_cols=255  Identities=26%  Similarity=0.403  Sum_probs=196.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      .++|+..+.||+|+||.||+|.+..+++.||||+++....  ......+.+|+.++.+. .||||+++++++.++...|+
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            4678899999999999999999988899999999864322  22345667777777666 59999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||++ +++.++.....            ..+++..+..++.|++.|++|||+.  .+|+||||+|+||++++++.++|
T Consensus        92 v~e~~~-~~l~~l~~~~~------------~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL  156 (296)
T cd06618          92 CMELMS-TCLDKLLKRIQ------------GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKL  156 (296)
T ss_pred             EeeccC-cCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEE
Confidence            999985 57777765432            2488999999999999999999962  28999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCC----CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK----VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      +|||++..+...   .......++..|+|||.+.+..    ++.++||||||+++|||++|+.||......  .+.....
T Consensus       157 ~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~  231 (296)
T cd06618         157 CDFGISGRLVDS---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKI  231 (296)
T ss_pred             CccccchhccCC---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHH
Confidence            999998765332   1222345788999999987654    788999999999999999999998653221  1111111


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ......       ...  .......++.+++.+||..||++||++.++++.
T Consensus       232 ~~~~~~-------~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         232 LQEEPP-------SLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             hcCCCC-------CCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111110       000  011233678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-32  Score=304.11  Aligned_cols=271  Identities=25%  Similarity=0.300  Sum_probs=209.5

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC-----ce
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN-----SK  711 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  711 (969)
                      +|++.+.||.|+||.||+|+...+++.||+|++..... .....+.+.+|+++++.++||||+++.+++.+..     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            47788999999999999999988899999999865322 2344577999999999999999999999987765     78


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      |+||||++ ++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~-------------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~  142 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQ-------------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDL  142 (330)
T ss_pred             EEEecchh-hhHHHHHhCCC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence            99999997 58998887543             488999999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCC-CccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      +|+|||.+........ ........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.........+...
T Consensus       143 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~  222 (330)
T cd07834         143 KICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV  222 (330)
T ss_pred             EEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHh
Confidence            9999999987644321 1123345678899999999887 7899999999999999999999999876644333332222


Q ss_pred             hhccC----------Cchhhhcc-CCCC-----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcC
Q 002085          870 YAEEK----------PITDALDK-GIAE-----PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRCC  925 (969)
Q Consensus       870 ~~~~~----------~~~~~~~~-~~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~~  925 (969)
                      .....          ...+.+.. ....     ......+..+.+++.+||+.+|++||++.++++  .+++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             cCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            11100          00000000 0000     001113467899999999999999999999997  365554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6e-32  Score=302.32  Aligned_cols=262  Identities=23%  Similarity=0.316  Sum_probs=198.4

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC-----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE-----  708 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  708 (969)
                      +.++|+..+.||+|+||.||+|....+++.||+|++..... .....+.+.+|++++++++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            45789999999999999999999988899999999865322 223346688899999999999999999987543     


Q ss_pred             -CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          709 -NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       709 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                       ...+++++++ +++|.+++...              .+++..+..++.|++.|++|||+.   +|+||||||+||+++.
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~  155 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKCQ--------------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE  155 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC
Confidence             3467888877 78998887642              378999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      ++.+||+|||+++....     ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+.......+
T Consensus       156 ~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (345)
T cd07877         156 DCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI  230 (345)
T ss_pred             CCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999875422     2234567889999998866 46888999999999999999999998655433222221


Q ss_pred             HHHhhccC-Cch---------hhhc--cCCCCcc----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEK-PIT---------DALD--KGIAEPC----YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~-~~~---------~~~~--~~~~~~~----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+...... ...         ....  .......    .......+.+++.+|++.||.+||++.|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            11110000 000         0000  0000000    0012456889999999999999999999986

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.7e-32  Score=301.18  Aligned_cols=268  Identities=21%  Similarity=0.301  Sum_probs=202.1

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC---
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN---  709 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  709 (969)
                      .+.++|+..+.||+|+||.||+|....+++.||||++.... ........+.+|++++++++||||+++++++....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            35678999999999999999999999899999999985432 22334567889999999999999999999887543   


Q ss_pred             ---ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          710 ---SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       710 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                         ..++||||+ +++|.+++...              .+++..+..++.|++.|++|||+.   +|+||||||+||+++
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~--------------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~  152 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE--------------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVN  152 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence               358999999 78998887632              378999999999999999999988   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      .++.++++|||++.....     ......+++.|+|||.+.+ ..++.++|+||+||++|++++|..||.+.+.......
T Consensus       153 ~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  227 (343)
T cd07880         153 EDCELKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME  227 (343)
T ss_pred             CCCCEEEeeccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999876432     1223467889999998876 4588899999999999999999999976543222111


Q ss_pred             HHHHhhcc----------CCchhhhc--cCCCC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhc
Q 002085          866 AWRHYAEE----------KPITDALD--KGIAE----PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRC  924 (969)
Q Consensus       866 ~~~~~~~~----------~~~~~~~~--~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~  924 (969)
                      ........          ........  +....    .........+.+++.+|++.||++||++.++++  .++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            11100000          00000000  00000    001122356889999999999999999999984  44444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-33  Score=297.32  Aligned_cols=210  Identities=23%  Similarity=0.346  Sum_probs=182.3

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      -|..++.||-|+||+|.+++-.++...||.|.+.+...........++.|..||..-+.+-||+++-.|+|++..|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            45567889999999999999988888999999977666666677889999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |++||++-.+|-+.+             .+.+..+..++.+++.|+++.|..   |+|||||||+|||||.+|.+||.||
T Consensus       710 YIPGGDmMSLLIrmg-------------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDF  773 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG-------------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  773 (1034)
T ss_pred             ccCCccHHHHHHHhc-------------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeec
Confidence            999999999998654             588888999999999999999998   9999999999999999999999999


Q ss_pred             ccceecc--------cCCCCcc--------------------------------ccccccCcccCchhhcccCCCCCccc
Q 002085          797 GLAKMLA--------KQGEPHT--------------------------------MSAVAGSFGYFAPEYAYTTKVNEKID  836 (969)
Q Consensus       797 gla~~~~--------~~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~sD  836 (969)
                      |+++-+.        ..++...                                .-..+||+.|+|||++....|+..+|
T Consensus       774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd  853 (1034)
T KOG0608|consen  774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD  853 (1034)
T ss_pred             cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence            9985321        0111100                                01246999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCccch
Q 002085          837 IYSFGVVLLELVTGKEANYGDEHTSL  862 (969)
Q Consensus       837 vwslG~il~elltg~~p~~~~~~~~~  862 (969)
                      .||.|||||||+.|+.||..+.+.+.
T Consensus       854 wws~gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  854 WWSVGVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             hhHhhHHHHHHhhCCCCccCCCCCcc
Confidence            99999999999999999987765443

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.8e-32  Score=299.46  Aligned_cols=263  Identities=27%  Similarity=0.327  Sum_probs=200.3

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-CCceE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-ENSKL  712 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  712 (969)
                      +.++|+..+.||+|+||.||+|....+++.||+|++..... .....+.+.+|+++++.++||||+++.+++.. ....+
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45679999999999999999999999999999998854322 22334678899999999999999999998865 56789


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +|+||+ +++|.+++...              .+++..+..++.|++.||+|||+.   +|+||||+|+||++++++.++
T Consensus        87 lv~e~~-~~~L~~~~~~~--------------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~  148 (328)
T cd07856          87 FVTELL-GTDLHRLLTSR--------------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLK  148 (328)
T ss_pred             EEeehh-ccCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEE
Confidence            999998 57899888642              367888889999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      ++|||.+.....     ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+.......+.+...
T Consensus       149 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~  223 (328)
T cd07856         149 ICDFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG  223 (328)
T ss_pred             eCccccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999875421     1223457889999998766 5689999999999999999999999976554222221111110


Q ss_pred             cc----------CCchhhh-ccCCCCcccH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          872 EE----------KPITDAL-DKGIAEPCYL-----EEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       872 ~~----------~~~~~~~-~~~~~~~~~~-----~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ..          ....+.. ......+.+.     .....+.+++.+|++.+|++||++.|++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00          0000000 0000011111     123678999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=4.7e-32  Score=302.90  Aligned_cols=268  Identities=23%  Similarity=0.304  Sum_probs=200.6

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC------
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE------  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  708 (969)
                      .++|...+.||+|+||.||+|.+..+|+.||||++..... .......+.+|++++++++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            3578888999999999999999988899999999865322 223345688999999999999999999988654      


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      ...++|+||+. .+|.++..               ..+++..+..++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        93 ~~~~lv~e~~~-~~l~~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~  153 (342)
T cd07879          93 QDFYLVMPYMQ-TDLQKIMG---------------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNED  153 (342)
T ss_pred             ceEEEEecccc-cCHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            24689999996 47776542               2378899999999999999999988   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      +.++++|||+++....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+.
T Consensus       154 ~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~  228 (342)
T cd07879         154 CELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL  228 (342)
T ss_pred             CCEEEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999875422     2223467889999999876 468899999999999999999999998755332222222


Q ss_pred             HHhhccC----------Cchhhhcc--CCCCc----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcCCC
Q 002085          868 RHYAEEK----------PITDALDK--GIAEP----CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRCCPT  927 (969)
Q Consensus       868 ~~~~~~~----------~~~~~~~~--~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~~~~  927 (969)
                      .......          ........  .....    ........+.+++.+||+.||++||+++|++.  .+++..+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            1110000          00000000  00000    00112356889999999999999999999994  46666543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=2.9e-32  Score=292.78  Aligned_cols=254  Identities=25%  Similarity=0.301  Sum_probs=200.3

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh--cHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL--NQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +|.+.+.||+|+||.||++.+...+..+++|+++.....  .......+.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            477789999999999999999877777777776542221  222345677899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++.....         ....+++..++.++.|++.|+.|||+.   +++|+||+|+||++++ +.++++
T Consensus        81 ~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~  147 (260)
T cd08222          81 TEYCEGRDLDCKLEELKH---------TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIG  147 (260)
T ss_pred             EEeCCCCCHHHHHHHHhh---------cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeec
Confidence            999999999999875322         123589999999999999999999988   9999999999999975 569999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||.++.+....  .......|++.|+|||...+..++.++|+||||+++|+|++|..||..........   ...... 
T Consensus       148 d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~---~~~~~~-  221 (260)
T cd08222         148 DFGVSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL---RIVEGP-  221 (260)
T ss_pred             ccCceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH---HHHcCC-
Confidence            999998764321  22234567889999999988889999999999999999999999986543222111   111110 


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                ....+...+..+.+++.+||+.+|++||++.|+++
T Consensus       222 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 ----------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ----------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                      11122344568899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=4.2e-32  Score=295.29  Aligned_cols=263  Identities=28%  Similarity=0.374  Sum_probs=203.5

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |+..+.||+|+||.||+|+...+++.||+|++.... ......+.+..|++++++++|+|++++++++.+.+..++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            456688999999999999999889999999986543 2233346778899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      ++ ++|.+++....            ..+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.++|+|||
T Consensus        80 ~~-~~l~~~i~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g  143 (282)
T cd07829          80 CD-MDLKKYLDKRP------------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFG  143 (282)
T ss_pred             cC-cCHHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCC
Confidence            97 59999998652            2488999999999999999999998   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC-
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP-  875 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  875 (969)
                      .++.......  ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+.+......+ 
T Consensus       144 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (282)
T cd07829         144 LARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE  221 (282)
T ss_pred             cccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHH
Confidence            9976543211  22234567889999998776 7899999999999999999999888766543333322221111000 


Q ss_pred             -------c---hhhhccCCCC---cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 -------I---TDALDKGIAE---PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 -------~---~~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                             .   ..........   .........+.+++.+||+.||++||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                   0   0000000000   001112467899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-32  Score=250.98  Aligned_cols=212  Identities=25%  Similarity=0.432  Sum_probs=177.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ..|...++||+|.||+||+|+...+++.||+|+++-+.. ++.......+|+-+++.++|.|||++++....+...-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            356778899999999999999999999999999965543 3333467889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |||. .+|..+.....            ..++.+.+..++.|+++|+.++|++   .+.|||+||.|.++..+|+.|++|
T Consensus        81 e~cd-qdlkkyfdsln------------g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelklad  144 (292)
T KOG0662|consen   81 EFCD-QDLKKYFDSLN------------GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLAD  144 (292)
T ss_pred             HHhh-HHHHHHHHhcC------------CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecc
Confidence            9995 78888887654            2478889999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCC-CCCccchHHHH
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWA  866 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~-~~~~~~~~~~~  866 (969)
                      ||+++.++-  .....+..+.|.+|++|.++.+.+ |+...|+||-||++.|+...+.|.. +.+..+....+
T Consensus       145 fglarafgi--pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkri  215 (292)
T KOG0662|consen  145 FGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI  215 (292)
T ss_pred             cchhhhcCC--ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH
Confidence            999987632  223455667899999999999876 7889999999999999999666544 44443333333

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.6e-32  Score=305.18  Aligned_cols=262  Identities=24%  Similarity=0.317  Sum_probs=200.9

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc---
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS---  710 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  710 (969)
                      +.++|+..+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.++++++|||++++.+++...+.   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            45689999999999999999999998899999998854322 22334667889999999999999999987765554   


Q ss_pred             ---eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          711 ---KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       711 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                         .++|+||+ +++|.+++...              .+++..+..++.|++.|++|||+.   +|+||||+|+||+++.
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--------------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~  153 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--------------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNE  153 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECC
Confidence               89999999 67999988742              388999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      ++.++|+|||++......     .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.........+
T Consensus       154 ~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i  228 (343)
T cd07851         154 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI  228 (343)
T ss_pred             CCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            999999999999765321     233467889999998865 36788999999999999999999999765543322222


Q ss_pred             HHHhhccC----------Cchhhhcc---CCCC---cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEK----------PITDALDK---GIAE---PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~----------~~~~~~~~---~~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ........          .....+..   ....   ......+..+.+++.+|++.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         229 MNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            11110000          00000000   0000   000112467899999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=4.7e-32  Score=302.91  Aligned_cols=264  Identities=23%  Similarity=0.316  Sum_probs=195.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC------
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE------  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  708 (969)
                      ..+|+..+.||.|+||.||+|....+++.||+|.+.....   ...+.+.+|++++++++||||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            4678999999999999999999998999999999854432   3346788999999999999999999776543      


Q ss_pred             --------CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCC
Q 002085          709 --------NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKS  780 (969)
Q Consensus       709 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  780 (969)
                              ...++||||++ ++|.+++...              .+++..+..++.|++.|+.|||+.   +|+||||||
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp  142 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQG--------------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKP  142 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCH
Confidence                    35789999997 5898887532              378899999999999999999988   999999999


Q ss_pred             CcEEECC-CCcEEEeecccceecccCCCCc-cccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 002085          781 SNILLDS-EFKAKIADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGD  857 (969)
Q Consensus       781 ~Nill~~-~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~  857 (969)
                      +||+++. ++.++++|||.++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       143 ~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         143 ANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             HHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999985 4578999999997653221111 1123357889999998654 46788999999999999999999999765


Q ss_pred             CccchHHHHHHHhhccC---------Cchhhhc-cCCCCcc-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          858 EHTSLAEWAWRHYAEEK---------PITDALD-KGIAEPC-----YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       858 ~~~~~~~~~~~~~~~~~---------~~~~~~~-~~~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .................         ....... .......     ......++.+++.+|++.||++||++.|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         223 HELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            43222211111100000         0000000 0000000     0122357889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=1.4e-31  Score=298.18  Aligned_cols=265  Identities=24%  Similarity=0.288  Sum_probs=196.3

Q ss_pred             CCCccceeeecCcEEEEEEEEcCC--CcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc----CC
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGA--GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS----EN  709 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~  709 (969)
                      +|+..+.||+|+||.||++.....  +..||+|++..... .....+.+.+|+++++++ .||||+++++++..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            367788999999999999999877  88999999854322 223356788899999999 59999999987532    24


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..|+++||++ ++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~  142 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ-------------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADC  142 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCC
Confidence            5788999986 68999886543             388999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCC--ccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEP--HTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      .++|+|||+++.+......  .......|+..|+|||+..+ ..++.++||||+||++|+|++|..||...+.......+
T Consensus       143 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~  222 (332)
T cd07857         143 ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQI  222 (332)
T ss_pred             CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHH
Confidence            9999999999865432211  11233568999999998765 46889999999999999999999998765533222221


Q ss_pred             HHHhhccC----------Cchhh---hccCCC---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEK----------PITDA---LDKGIA---EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~----------~~~~~---~~~~~~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ........          .....   ......   ..........+.+++.+|++.||++||++.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11110000          00000   000000   0000112367889999999999999999999974

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-32  Score=290.86  Aligned_cols=246  Identities=25%  Similarity=0.326  Sum_probs=201.3

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      .++||+|.||+||-|+++.+|+.||||++.+.+. ....+..+.+|+.|++.+.||.||.+-..|+.++..++|||-+. 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrF-p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRF-PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccC-CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-
Confidence            5889999999999999999999999999977654 34445889999999999999999999999999999999999996 


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC---CcEEEeecc
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE---FKAKIADFG  797 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg  797 (969)
                      |+..+.+-...+           ..++......+..||+.||.|||.+   +|||+||||+|||+.+.   -.+||||||
T Consensus       647 GDMLEMILSsEk-----------gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFG  712 (888)
T KOG4236|consen  647 GDMLEMILSSEK-----------GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFG  712 (888)
T ss_pred             chHHHHHHHhhc-----------ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccc
Confidence            555555443332           3588888899999999999999988   99999999999999754   369999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      +|+++..   ..-....+|||.|.|||++....|...-|+||.||++|--++|.-||..+++..  +++..        .
T Consensus       713 fARiIgE---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQN--------A  779 (888)
T KOG4236|consen  713 FARIIGE---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQN--------A  779 (888)
T ss_pred             ceeecch---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhc--------c
Confidence            9999854   333446789999999999999999999999999999999999999997665432  11110        1


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL  918 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl  918 (969)
                      .++.+   ...+.+.+...+++|...++..-.+|-+.++-+
T Consensus       780 aFMyP---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  780 AFMYP---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             ccccC---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            11211   122445567888999999999999998887764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-32  Score=277.93  Aligned_cols=263  Identities=19%  Similarity=0.238  Sum_probs=211.1

Q ss_pred             CCCccceeeecCcEEEEEEEEcCC-----CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEE-cCCc
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGA-----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCIS-SENS  710 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~  710 (969)
                      +++...++.+|.||.||.|.++..     .+.|-||.++..  .++-....+..|.-.+....|||+..+.+.+. +...
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            456667789999999999987643     234667766432  23444578889999999999999999999875 4567


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++++.++.-|+|+.++...+.....     ....+.-.+...+|.|++.|++|||.+   +|||.||.++|.++|+.-.
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~-----~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPS-----YAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCc-----cccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhee
Confidence            89999999999999999965532222     234466678889999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  869 (969)
                      ||++|=.+++.+.+.+..--....-....||+||.+....|+.++|||||||+||||+| |+.|+..-++.++...+.. 
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd-  513 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD-  513 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc-
Confidence            99999999998766433333333345678999999999999999999999999999999 7888877777665544433 


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                                   +.+..++..++.+++.+|.-||..+|++||++++++.-|.+
T Consensus       514 -------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  514 -------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             -------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                         33444556677899999999999999999999999987754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=282.83  Aligned_cols=261  Identities=26%  Similarity=0.345  Sum_probs=206.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHH----HHHHHHHHHHHHhccccCceeeEEEEEE-cCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK----LEKEFIAEIEILGTIRHANIVKLWCCIS-SENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~  710 (969)
                      ++|-...+||+|||++||+|.+....+.||||+-.....+.++    ..+...+|.+|-+.+.||.||++++++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            5677889999999999999999988999999987555544433    2456789999999999999999999996 4567


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC--
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE--  788 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--  788 (969)
                      .|-|+|||+|-+|+-|++..+.             +++.++..|++||+.||.||.+. +++|+|-||||.|||+-..  
T Consensus       543 FCTVLEYceGNDLDFYLKQhkl-------------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKL-------------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhh-------------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence            8899999999999999998764             88999999999999999999998 8899999999999999544  


Q ss_pred             -CcEEEeecccceecccCCCCcc-----ccccccCcccCchhhccc----CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002085          789 -FKAKIADFGLAKMLAKQGEPHT-----MSAVAGSFGYFAPEYAYT----TKVNEKIDIYSFGVVLLELVTGKEANYGDE  858 (969)
Q Consensus       789 -~~~kl~Dfgla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~il~elltg~~p~~~~~  858 (969)
                       |.+||.|||++++++++.....     .....||++|++||.+.-    .+.+.++||||+|||+|+++.|+.||..+.
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence             7899999999998876544322     245679999999997753    357889999999999999999999997543


Q ss_pred             ccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          859 HTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....       ..++..+....+-  ..+.-+..+.+..++|++|+...-++|....++..
T Consensus       689 sQQd-------ILqeNTIlkAtEV--qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  689 SQQD-------ILQENTILKATEV--QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hHHH-------HHhhhchhcceec--cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            2211       1111111111111  11222334467788999999999999988877753

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-32  Score=276.76  Aligned_cols=261  Identities=22%  Similarity=0.244  Sum_probs=204.6

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-c-C----ceeeEEEEEEc
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-H-A----NIVKLWCCISS  707 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~  707 (969)
                      +..+|.+...+|+|.||.|-++.+..++..||||+++..    ....++..-|+++++++. + |    -+|.+.+||.-
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            467899999999999999999999888999999998654    344567788999999993 2 2    37788889999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      .++.+||+|.+ |-|+++++....-           .+++...+..|+.|++++++|||+.   +++|-||||+||++.+
T Consensus       163 rghiCivfell-G~S~~dFlk~N~y-----------~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvs  227 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENNY-----------IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVS  227 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCCc-----------cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEec
Confidence            99999999998 6799999987542           4588899999999999999999998   9999999999999841


Q ss_pred             --------------------CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHH
Q 002085          788 --------------------EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL  847 (969)
Q Consensus       788 --------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el  847 (969)
                                          ...|+++|||.|++...     .....+.|..|+|||++.+-.++.++||||+||||+|+
T Consensus       228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             cceEEEeccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence                                23589999999986422     22556789999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCccchHHHHHHHhhccCCc----------------------------hhhhccCCC----CcccHHHHHH
Q 002085          848 VTGKEANYGDEHTSLAEWAWRHYAEEKPI----------------------------TDALDKGIA----EPCYLEEMTT  895 (969)
Q Consensus       848 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~----~~~~~~~~~~  895 (969)
                      ++|...|+..+..+....+.+ ..+.-+.                            ....+....    ......+...
T Consensus       303 ytG~~LFqtHen~EHLaMMer-IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~  381 (415)
T KOG0671|consen  303 YTGETLFQTHENLEHLAMMER-ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ  381 (415)
T ss_pred             eccceecccCCcHHHHHHHHH-hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence            999999987764432211111 1111000                            000000000    0112334567


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHH
Q 002085          896 VYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       896 ~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +++++++|+..||.+|+|++|++.
T Consensus       382 LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  382 LFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHHHHccCccccccHHHHhc
Confidence            999999999999999999999985

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-32  Score=294.86  Aligned_cols=242  Identities=23%  Similarity=0.226  Sum_probs=198.5

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKL  712 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  712 (969)
                      +.++|.....+|.|+|+.|-.+.+..+++..+||++.+.       .....+|+.++... +||||+++.+.+.++.+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc-------ccccccccchhhhhcCCCcceeecceecCCceee
Confidence            456788888899999999999999999999999999554       23445677777777 6999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE-CCCCcE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL-DSEFKA  791 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~  791 (969)
                      +|||++.|+-+.+.+...+.             +. ..+.+|+.+++.|+.|||++   |||||||||+|||+ ++.+.+
T Consensus       393 ~v~e~l~g~ell~ri~~~~~-------------~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~l  455 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPE-------------FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHL  455 (612)
T ss_pred             eeehhccccHHHHHHHhcch-------------hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcE
Confidence            99999999988887776542             22 67788999999999999998   99999999999999 588999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      +|+|||.++...+.     ....+-|..|.|||++....|++++|+||+|++||+|++|+.||......   ..+.....
T Consensus       456 rltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~  527 (612)
T KOG0603|consen  456 RLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQ  527 (612)
T ss_pred             EEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhc
Confidence            99999999875432     33456788999999999999999999999999999999999999765433   11111111


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .+             +.....+....+++.+|++.||.+||+|.++...
T Consensus       528 ~~-------------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  528 MP-------------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             CC-------------ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            11             1113345778899999999999999999999863

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-34  Score=322.11  Aligned_cols=419  Identities=28%  Similarity=0.358  Sum_probs=321.8

Q ss_pred             eEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCC
Q 002085           75 VTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG  154 (969)
Q Consensus        75 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  154 (969)
                      ++.|+++.|-+-...-+.+..--+|+.|||++|++. .+|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|.|.+
T Consensus        23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~  100 (1081)
T KOG0618|consen   23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKN  100 (1081)
T ss_pred             HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheecc
Confidence            677777777654433333434445999999999997 88999999999999999999998 7888999999999999999


Q ss_pred             CCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccccc
Q 002085          155 NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGE  234 (969)
Q Consensus       155 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  234 (969)
                      |.+. ..|.++..+.+|++|+++.|++. .+|..+..++.++.++.++|.  ....    ++... ++.+++..|.+.+.
T Consensus       101 n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~--~~~~----lg~~~-ik~~~l~~n~l~~~  171 (1081)
T KOG0618|consen  101 NRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNE--KIQR----LGQTS-IKKLDLRLNVLGGS  171 (1081)
T ss_pred             chhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcch--hhhh----hcccc-chhhhhhhhhcccc
Confidence            9998 89999999999999999999998 889999999999999999993  2222    22222 88889999999999


Q ss_pred             CchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcc
Q 002085          235 IPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLK  314 (969)
Q Consensus       235 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~  314 (969)
                      ++..+.++..  .|+|++|.++ .  ..+..+.+|+.|....|+++...   ....+++.|+.++|.++...+ .+ .-.
T Consensus       172 ~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~---~~g~~l~~L~a~~n~l~~~~~-~p-~p~  241 (1081)
T KOG0618|consen  172 FLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE---ISGPSLTALYADHNPLTTLDV-HP-VPL  241 (1081)
T ss_pred             hhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEE---ecCcchheeeeccCcceeecc-cc-ccc
Confidence            9988888877  7999999998 2  35678899999999999987322   234479999999999984332 22 246


Q ss_pred             cchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccc
Q 002085          315 NLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGE  394 (969)
Q Consensus       315 ~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  394 (969)
                      +|+++++++|+++                  .+|.+++.+.+|+.++..+|+|+ .+|..+..+.+|++|.+..|.++-.
T Consensus       242 nl~~~dis~n~l~------------------~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yi  302 (1081)
T KOG0618|consen  242 NLQYLDISHNNLS------------------NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYI  302 (1081)
T ss_pred             cceeeecchhhhh------------------cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhC
Confidence            8999999999998                  34445555666666666666664 5566666666666666666666544


Q ss_pred             cCccc-cccccEEEeeccccCCCcccc-------------------------cCCcccchhhcccCCccccccCccccCc
Q 002085          395 LPSKT-AWNLTRLEISNNRFSGQIQRG-------------------------VGSWKNLIVFKASNNLFSGEIPVELTSL  448 (969)
Q Consensus       395 ~~~~~-~~~L~~L~Ls~N~l~~~~~~~-------------------------~~~l~~L~~L~l~~N~l~~~~p~~~~~l  448 (969)
                      .|... ...|++|+|..|+|...++..                         =...+.|+.|.+.+|++++..-+.+.++
T Consensus       303 p~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~  382 (1081)
T KOG0618|consen  303 PPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNF  382 (1081)
T ss_pred             CCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccc
Confidence            43332 345566666666555322211                         1234558888999999998777788889


Q ss_pred             cccchhhccCcccCCCCC-cccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEE
Q 002085          449 SHLNTLLLDGNKLSGKLP-SQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFN  526 (969)
Q Consensus       449 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~  526 (969)
                      .+|+.|+|++|+|. .+| ..+.++..|+.|+||+|+|+ .+|..+.++..|++|..-+|++. ..| ++.+++ |+.+|
T Consensus       383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD  458 (1081)
T KOG0618|consen  383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD  458 (1081)
T ss_pred             cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence            99999999999998 455 45788889999999999998 78999999999999999999998 677 777785 99999


Q ss_pred             eecCcCCC-CCC
Q 002085          527 LSSNKLYG-NIP  537 (969)
Q Consensus       527 ls~N~l~~-~~p  537 (969)
                      ||.|+|+. .+|
T Consensus       459 lS~N~L~~~~l~  470 (1081)
T KOG0618|consen  459 LSCNNLSEVTLP  470 (1081)
T ss_pred             cccchhhhhhhh
Confidence            99999963 444

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=4.4e-31  Score=279.02  Aligned_cols=223  Identities=21%  Similarity=0.133  Sum_probs=178.5

Q ss_pred             cCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCHHHH
Q 002085          647 GGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRW  726 (969)
Q Consensus       647 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~  726 (969)
                      |.+|.||++++..+++.||+|++....        .+..|...+....|||++++++++.+.+..++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            899999999999999999999985532        233444555556799999999999999999999999999999999


Q ss_pred             hccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCC
Q 002085          727 LHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG  806 (969)
Q Consensus       727 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~  806 (969)
                      +....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+...... 
T Consensus        76 l~~~~-------------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-  138 (237)
T cd05576          76 ISKFL-------------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-  138 (237)
T ss_pred             HHHhc-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-
Confidence            87543             388999999999999999999988   9999999999999999999999999987654321 


Q ss_pred             CCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCC
Q 002085          807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAE  886 (969)
Q Consensus       807 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  886 (969)
                          .....++..|+|||...+..++.++||||+||++|||++|..|+.......         ..      ...    .
T Consensus       139 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------~~------~~~----~  195 (237)
T cd05576         139 ----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------NT------HTT----L  195 (237)
T ss_pred             ----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------cc------ccc----c
Confidence                223445778999999988889999999999999999999998764321100         00      000    0


Q ss_pred             cccHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002085          887 PCYLEEMTTVYRLALICTSTLPSSRPSMKEV  917 (969)
Q Consensus       887 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev  917 (969)
                      ..+......+.+++.+|++.||++||++.+.
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVA  226 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence            0111233678899999999999999997433

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-33  Score=270.35  Aligned_cols=259  Identities=27%  Similarity=0.373  Sum_probs=199.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +.+....||.|+||+|+|-.++..|+..|||++.....  ....+++..|.+...+- ++||||+++|++-.++..|+.|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            45556789999999999999999999999999965443  44557888888866555 7999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |.|+ .|+..+....-.        .....+++.-.-.|+.....||.||-+..  .|+|||+||+|||+|..|.+|+||
T Consensus       143 ELMd-~SlDklYk~vy~--------vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCD  211 (361)
T KOG1006|consen  143 ELMD-ISLDKLYKRVYS--------VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCD  211 (361)
T ss_pred             HHHh-hhHHHHHHHHHH--------HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeec
Confidence            9995 676554432110        11234777777788888899999998763  899999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT--KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      ||.+..+.   ++...+.-+|-..|||||.+...  .|+-+|||||+|++|||+.||..|+..=+  +..+++.......
T Consensus       212 FGIcGqLv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--svfeql~~Vv~gd  286 (361)
T KOG1006|consen  212 FGICGQLV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--SVFEQLCQVVIGD  286 (361)
T ss_pred             ccchHhHH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--HHHHHHHHHHcCC
Confidence            99987653   33344556788899999988643  48889999999999999999999986422  2344444444443


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .++...      .....+....+.+++.-|+.+|-+.||+..++.+
T Consensus       287 pp~l~~------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  287 PPILLF------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CCeecC------cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            332211      1112335678999999999999999999999876

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.4e-32  Score=265.51  Aligned_cols=270  Identities=22%  Similarity=0.343  Sum_probs=202.9

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-----
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-----  707 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  707 (969)
                      +....|....+||+|.||+||+|+...+|+.||+|++.-+.. ....-....+|++++..++|+|++.+++.|..     
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            345677888999999999999999999999999986532111 11122456789999999999999999877632     


Q ss_pred             ---CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          708 ---ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       708 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                         ....|+||++|+ -+|.-++....            ..++..++.+++.++..||.|+|+.   .|+|||+||.||+
T Consensus        93 ~r~r~t~ylVf~~ce-hDLaGlLsn~~------------vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvL  156 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCE-HDLAGLLSNRK------------VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVL  156 (376)
T ss_pred             ccccceeeeeHHHhh-hhHHHHhcCcc------------ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEE
Confidence               345799999997 68888887653            3488899999999999999999998   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCC--CCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccc
Q 002085          785 LDSEFKAKIADFGLAKMLAKQG--EPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTS  861 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~  861 (969)
                      ++.+|.+||+|||+++.+....  .....+..+.|.+|++||.+.+. .|+++.|||.-||++.||+||.+.+.++....
T Consensus       157 It~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq  236 (376)
T KOG0669|consen  157 ITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ  236 (376)
T ss_pred             EcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH
Confidence            9999999999999998664322  22234566789999999988775 58999999999999999999999998876554


Q ss_pred             hHHHHHHHhhcc----C------Cchhhhc-cCCCCcc---cHHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          862 LAEWAWRHYAEE----K------PITDALD-KGIAEPC---YLEE------MTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       862 ~~~~~~~~~~~~----~------~~~~~~~-~~~~~~~---~~~~------~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....+......-    +      ++.+.+. +.+....   ..+.      ..+..+++..++..||.+|+++++++.
T Consensus       237 ql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  237 QLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            433332211100    0      0111110 0011100   0111      136789999999999999999999985

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=4.4e-31  Score=251.73  Aligned_cols=274  Identities=22%  Similarity=0.267  Sum_probs=205.1

Q ss_pred             cCCCCCCcccccccccccchhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHh
Q 002085          612 RNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILG  691 (969)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~  691 (969)
                      ..++...|...+ ....++   -.++|++.+++|+|.|++||.|....+.+.++||+++...      .+.+.+|++|++
T Consensus        18 ~~rp~eYWdYE~-~~i~wg---~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~   87 (338)
T KOG0668|consen   18 EERPREYWDYES-LVIDWG---NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQ   87 (338)
T ss_pred             ccCchhhcchhh-eeeecc---ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHH
Confidence            344555666554 222222   2468999999999999999999998889999999996543      478999999999


Q ss_pred             ccc-cCceeeEEEEEEcC--CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhccc
Q 002085          692 TIR-HANIVKLWCCISSE--NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD  768 (969)
Q Consensus       692 ~l~-h~niv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~  768 (969)
                      .++ ||||+++++.+.++  ....+|+||+.+.+...+..                .+....+...+.+++.||.|+|+.
T Consensus        88 nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----------------tl~d~dIryY~~elLkALdyCHS~  151 (338)
T KOG0668|consen   88 NLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----------------TLTDYDIRYYIYELLKALDYCHSM  151 (338)
T ss_pred             hccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh----------------hhchhhHHHHHHHHHHHHhHHHhc
Confidence            996 99999999999875  45689999999988877654                366778889999999999999988


Q ss_pred             CCCCeEecCCCCCcEEECCC-CcEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHH
Q 002085          769 CTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLE  846 (969)
Q Consensus       769 ~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~e  846 (969)
                         ||.|||+||.||++|.. ..++++|+|+|.++.+..+..   ..+.+..|.-||.+..- .|+..-|+|||||++..
T Consensus       152 ---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~  225 (338)
T KOG0668|consen  152 ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS  225 (338)
T ss_pred             ---CcccccCCcceeeechhhceeeeeecchHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHH
Confidence               99999999999999976 479999999999987653332   34566778899988754 57889999999999999


Q ss_pred             HHhCCCCCCCCCcc--chHHHHHHHhhcc---------------CCchhhhccCCCCc--------ccHHHHHHHHHHHH
Q 002085          847 LVTGKEANYGDEHT--SLAEWAWRHYAEE---------------KPITDALDKGIAEP--------CYLEEMTTVYRLAL  901 (969)
Q Consensus       847 lltg~~p~~~~~~~--~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~  901 (969)
                      |+..+.||..+...  ++++.+  .....               ..+.+++....+.+        ...-..++..+++.
T Consensus       226 miFrkepFFhG~dN~DQLVkIa--kVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlld  303 (338)
T KOG0668|consen  226 MIFRKEPFFHGHDNYDQLVKIA--KVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLD  303 (338)
T ss_pred             HHhccCcccCCCCCHHHHHHHH--HHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHH
Confidence            99999999754432  222211  11111               11222222111110        00011367788899


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 002085          902 ICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       902 ~cl~~dP~~RPs~~evl~  919 (969)
                      +.++.|-.+|+|++|.+.
T Consensus       304 klLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  304 KLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHhhccccccchHHHhc
Confidence            999999999999888764

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.1e-30  Score=286.25  Aligned_cols=252  Identities=21%  Similarity=0.302  Sum_probs=205.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc-----CC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS-----EN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~  709 (969)
                      +.|.+.++||.|.+|.||+++...+++.+|+|+......    ..+++..|.++++.. .|||++.+++++..     ++
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            467788999999999999999999999999999855433    235677889999988 69999999998843     56


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..|||||||.+||..|+++....           ..+.|..+.-|++.++.|+.+||..   .++|||+|-.|||++.++
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g-----------~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~  160 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKG-----------NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENA  160 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcc-----------cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccC
Confidence            89999999999999999987652           4699999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-----KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                      .||++|||++..++.  .........|||.|||||++...     .|+.++|+||+|++..||.-|.+|+.+.-+.    
T Consensus       161 ~VKLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----  234 (953)
T KOG0587|consen  161 EVKLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----  234 (953)
T ss_pred             cEEEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh----
Confidence            999999999987643  33344567899999999998643     4777999999999999999999998654321    


Q ss_pred             HHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                        ...+.    +.....+.  ...+....+.+.++|..|+.+|-++||++.++++
T Consensus       235 --raLF~----IpRNPPPk--Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  235 --RALFL----IPRNPPPK--LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --hhhcc----CCCCCCcc--ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence              00110    01111111  1235667789999999999999999999998875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.3e-29  Score=268.66  Aligned_cols=239  Identities=33%  Similarity=0.445  Sum_probs=194.7

Q ss_pred             CcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCHHHHh
Q 002085          648 GSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWL  727 (969)
Q Consensus       648 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l  727 (969)
                      +||.||+|....+++.||+|++........  .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999988899999999865432211  578999999999999999999999999989999999999999999998


Q ss_pred             ccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCC
Q 002085          728 HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE  807 (969)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  807 (969)
                      .....             +++..++.++.+++.+++|||+.   +++|+||+|+||+++.++.++++|||.+....... 
T Consensus        79 ~~~~~-------------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-  141 (244)
T smart00220       79 KKRGR-------------LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-  141 (244)
T ss_pred             HhccC-------------CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence            75431             78899999999999999999988   99999999999999999999999999998764321 


Q ss_pred             CccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCC-CCccchHHHHHHHhhccCCchhhhccCCCC
Q 002085          808 PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG-DEHTSLAEWAWRHYAEEKPITDALDKGIAE  886 (969)
Q Consensus       808 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  886 (969)
                        ......++..|++||...+..++.++||||+|+++|++++|..||.. .+.....+...    ......        .
T Consensus       142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~----~~~~~~--------~  207 (244)
T smart00220      142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG----KPKPPF--------P  207 (244)
T ss_pred             --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----ccCCCC--------c
Confidence              33445688899999999988899999999999999999999999876 33222222211    110000        0


Q ss_pred             cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          887 PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       887 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ......+..+.+++.+|+..+|++||++.++++
T Consensus       208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            000003367899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=3.6e-29  Score=292.99  Aligned_cols=272  Identities=17%  Similarity=0.155  Sum_probs=170.9

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCC----CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEE-----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGA----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCC-----  704 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-----  704 (969)
                      ..++|...++||+|+||.||+|.+..+    +..||+|++......     +....|  .++...+.++..++..     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            356899999999999999999999888    899999987532211     111111  1111112222222111     


Q ss_pred             -EEcCCceEEEEeeccCCCHHHHhccCcCcccc-----C-CCCc-ccccCChHHHHHHHHHHHHhhhhhcccCCCCeEec
Q 002085          705 -ISSENSKLLVYEYMENQSLDRWLHGRKRSLVS-----G-SSSV-HQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHR  776 (969)
Q Consensus       705 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~-~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  776 (969)
                       ...+...++||||+++++|.+++.........     + .... .........+..++.|++.||+|||+.   +|+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence             24567889999999999999999754311000     0 0000 001122345668999999999999988   99999


Q ss_pred             CCCCCcEEECC-CCcEEEeecccceecccCCCCccccccccCcccCchhhcccC----------------------CCCC
Q 002085          777 DVKSSNILLDS-EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT----------------------KVNE  833 (969)
Q Consensus       777 Dlkp~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~  833 (969)
                      ||||+|||+++ ++.+||+|||+|+.+... .........+++.|+|||.+...                      .++.
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            99999999986 579999999999865332 22233456789999999965432                      2344


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchh---hhccCCCC------cccHHHHHHHHHHHHHcc
Q 002085          834 KIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD---ALDKGIAE------PCYLEEMTTVYRLALICT  904 (969)
Q Consensus       834 ~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~------~~~~~~~~~~~~l~~~cl  904 (969)
                      ++||||+||++|||+++..++... ...+...+.   ........   ........      ...........+++.+|+
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLK---RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHH---hcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            679999999999999976553321 101111000   00000000   00110000      000001134558999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 002085          905 STLPSSRPSMKEVLQI  920 (969)
Q Consensus       905 ~~dP~~RPs~~evl~~  920 (969)
                      +.||++|||++|+++.
T Consensus       435 ~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        435 RFKGRQRISAKAALAH  450 (566)
T ss_pred             cCCcccCCCHHHHhCC
Confidence            9999999999999973

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9e-31  Score=255.49  Aligned_cols=265  Identities=25%  Similarity=0.314  Sum_probs=203.1

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC-----ce
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN-----SK  711 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  711 (969)
                      +.+..+.||-|+||.||.+.+..+|+.||+|++.... ..-...+.+.+|++++...+|.|++..++..+-..     +.
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            4455688999999999999999999999999885432 23344678999999999999999999988765442     46


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      |+++|.|. .+|...+-..             ..++-..+.-+.+||++||+|||+.   +|.||||||.|.+++.+...
T Consensus       133 YV~TELmQ-SDLHKIIVSP-------------Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvL  195 (449)
T KOG0664|consen  133 YVLTELMQ-SDLHKIIVSP-------------QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCIL  195 (449)
T ss_pred             HHHHHHHH-hhhhheeccC-------------CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceE
Confidence            88999885 6777776543             3477788889999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+|+.-.. ++...++..+.|..|+|||++++. .|+.+.||||.||++.|++.++-.|....+.+..+.+....
T Consensus       196 KICDFGLARvee~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLL  274 (449)
T KOG0664|consen  196 KICDFGLARTWDQ-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLL  274 (449)
T ss_pred             Eecccccccccch-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHh
Confidence            9999999996543 344556667788999999999986 48999999999999999999998888766655544443222


Q ss_pred             -----------hccCCchhhhccCCCCcc---------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          871 -----------AEEKPITDALDKGIAEPC---------YLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       871 -----------~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                                 .++. -..++..+...+.         +.....+...+...++..||.+|.+..+.+...
T Consensus       275 GTPs~EaMr~ACEGA-k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  275 GTPSQEAMKYACEGA-KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             CCCcHHHHHHHhhhh-HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                       1111 1111111111110         112224567788899999999999999988654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=238.30  Aligned_cols=203  Identities=26%  Similarity=0.402  Sum_probs=168.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++.....||+|+||.|-+-++..+|...|+|++...  .+.+..++..+|+.+..+. .+|.+|.++|...+.+..++.|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            445567899999999999999999999999999543  3345567788899877765 7999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |.|+ -||..+-.+.-+         ....+++...-+||..|..||.|||++.  .++|||+||+|||++.+|.||+||
T Consensus       125 E~M~-tSldkfy~~v~~---------~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD  192 (282)
T KOG0984|consen  125 ELMD-TSLDKFYRKVLK---------KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD  192 (282)
T ss_pred             HHhh-hhHHHHHHHHHh---------cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence            9995 788776654321         1245788888899999999999999874  799999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhccc----CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT----TKVNEKIDIYSFGVVLLELVTGKEANYG  856 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~il~elltg~~p~~~  856 (969)
                      ||.+..+.+   +...+...|-..|||||.+..    ..|+-++||||+|+++.||.+++.||..
T Consensus       193 FGIsG~L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  193 FGISGYLVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             cccceeehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            999987633   333333567788999998754    3688999999999999999999999864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.9e-29  Score=262.22  Aligned_cols=154  Identities=22%  Similarity=0.330  Sum_probs=128.4

Q ss_pred             CCCCcccccccccccchhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc
Q 002085          615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR  694 (969)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~  694 (969)
                      ++..+...-+|.....+...-.+|-+.++||.|.|++||+|-+....+.||+|+.+..    +...+....|+++|++++
T Consensus        57 ~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~  132 (590)
T KOG1290|consen   57 DPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVR  132 (590)
T ss_pred             ChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHH
Confidence            3444555566766666554447899999999999999999999999999999999664    455677889999999984


Q ss_pred             -----c---CceeeEEEEEEc----CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhh
Q 002085          695 -----H---ANIVKLWCCISS----ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL  762 (969)
Q Consensus       695 -----h---~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L  762 (969)
                           |   .+||++++.|..    +.++++|+|++ |.+|..++....           ...++...+.+|++||+.||
T Consensus       133 ~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~-----------YrGlpl~~VK~I~~qvL~GL  200 (590)
T KOG1290|consen  133 EGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN-----------YRGLPLSCVKEICRQVLTGL  200 (590)
T ss_pred             hcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC-----------CCCCcHHHHHHHHHHHHHHH
Confidence                 2   379999999864    45889999999 789999998654           24589999999999999999


Q ss_pred             hhhcccCCCCeEecCCCCCcEEEC
Q 002085          763 CYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       763 ~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                      .|||+.|  ||+|-||||+|||+.
T Consensus       201 dYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  201 DYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             HHHHHhc--CccccCCCcceeeee
Confidence            9999998  999999999999984

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=7.3e-30  Score=273.41  Aligned_cols=201  Identities=27%  Similarity=0.377  Sum_probs=178.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHH-----HHHHHHHHHHhccc---cCceeeEEEEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-----KEFIAEIEILGTIR---HANIVKLWCCIS  706 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~---h~niv~l~~~~~  706 (969)
                      ..+|+..+.+|+|+||.|+.|.++.+...|+||.+.+++..-+.+.     ..+-.|++||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3568999999999999999999998888999999988765543332     34788999999997   999999999999


Q ss_pred             cCCceEEEEeec-cCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE
Q 002085          707 SENSKLLVYEYM-ENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL  785 (969)
Q Consensus       707 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill  785 (969)
                      +++.+||+||-. ++.+|.+++.-+++             +++..+.-|+.||+.|+++||+.   +|||||||-+||.+
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~-------------m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenviv  703 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPR-------------MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIV  703 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCc-------------cchHHHHHHHHHHHhcccccccc---CceecccccccEEE
Confidence            999999999986 56799999987764             88999999999999999999988   99999999999999


Q ss_pred             CCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCC-CccchhhHHHHHHHHHhCCCCCC
Q 002085          786 DSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANY  855 (969)
Q Consensus       786 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~  855 (969)
                      +.+|-+|++|||.|.+.    ........+||..|.|||++.+.+|- ..-|||++|++||.++....||+
T Consensus       704 d~~g~~klidfgsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  704 DSNGFVKLIDFGSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ecCCeEEEeeccchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999999999765    33344457899999999999998874 56899999999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.3e-28  Score=280.19  Aligned_cols=272  Identities=19%  Similarity=0.193  Sum_probs=183.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEc----------------CCCcEEEEEEEeccchhcH-----------HHHHHHHHHH
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDIN----------------GAGEFVAVKRIWNNRKLNQ-----------KLEKEFIAEI  687 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~  687 (969)
                      .++|.+.++||+|+||.||+|...                ..++.||||++........           ...+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            468999999999999999999652                2456799999854321110           0112344577


Q ss_pred             HHHhccccCce-----eeEEEEEEc--------CCceEEEEeeccCCCHHHHhccCcCccc-----------cCCCCccc
Q 002085          688 EILGTIRHANI-----VKLWCCISS--------ENSKLLVYEYMENQSLDRWLHGRKRSLV-----------SGSSSVHQ  743 (969)
Q Consensus       688 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----------~~~~~~~~  743 (969)
                      .++.+++|.++     ++++++|..        .+..++||||+++++|.++++.......           ........
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     677777643        3568999999999999999986432110           00011122


Q ss_pred             ccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCch
Q 002085          744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP  823 (969)
Q Consensus       744 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP  823 (969)
                      ..++|..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..... .........+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeCh
Confidence            3468889999999999999999988   9999999999999999999999999999765322 11112223457899999


Q ss_pred             hhcccCCC----------------------CCccchhhHHHHHHHHHhCCC-CCCCCCccc--hH-----HHHHHHhhcc
Q 002085          824 EYAYTTKV----------------------NEKIDIYSFGVVLLELVTGKE-ANYGDEHTS--LA-----EWAWRHYAEE  873 (969)
Q Consensus       824 E~~~~~~~----------------------~~~sDvwslG~il~elltg~~-p~~~~~~~~--~~-----~~~~~~~~~~  873 (969)
                      |.+.....                      ..+.||||+||++|||++|.. |+.......  ..     ...|+.....
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98764321                      124699999999999999876 543211100  00     0011111110


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLP---SSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP---~~RPs~~evl~  919 (969)
                               ....+..........+++.+++..+|   .+|+|++|+++
T Consensus       460 ---------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 ---------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ---------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                     11111122334678889999999876   68999999986

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=281.35  Aligned_cols=245  Identities=27%  Similarity=0.403  Sum_probs=186.5

Q ss_pred             ccceeeecCcEE-EEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEEee
Q 002085          640 ESNLIGSGGSGQ-VYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       640 ~~~~lG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      ..+++|.|+.|+ ||+|..  .|+.||||++-.      +..+...+|+..++.- +||||||+++.-+++...||..|.
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             cHHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            346789999985 899998  588999998843      3346788999999988 699999999998899999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC---C--CcEE
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS---E--FKAK  792 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~k  792 (969)
                      |. .+|.+++......         .....-...+.+..|++.|+++||+.   +||||||||.||||+.   +  .+++
T Consensus       585 C~-~sL~dlie~~~~d---------~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~  651 (903)
T KOG1027|consen  585 CA-CSLQDLIESSGLD---------VEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAK  651 (903)
T ss_pred             hh-hhHHHHHhccccc---------hhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEE
Confidence            95 8999999875110         01111144578899999999999998   9999999999999976   3  4789


Q ss_pred             EeecccceecccCCCCc-cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhC-CCCCCCCCccchHHHHHHHh
Q 002085          793 IADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG-KEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |+|||+++.+..+.... ......||.+|+|||++....-+.++||||+||++|+.++| .+||...-. .... +   .
T Consensus       652 iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-R~~N-I---l  726 (903)
T KOG1027|consen  652 ISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-RQAN-I---L  726 (903)
T ss_pred             ecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-hhhh-h---h
Confidence            99999999886543332 23566799999999999999999999999999999999997 567653211 0000 0   0


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .....+.. +     .+ ..++  +..++|.+|+..||..||++.+|+.
T Consensus       727 ~~~~~L~~-L-----~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  727 TGNYTLVH-L-----EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cCccceee-e-----cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            01111100 0     01 1111  7789999999999999999999963

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4e-28  Score=237.46  Aligned_cols=260  Identities=18%  Similarity=0.300  Sum_probs=196.7

Q ss_pred             cchhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEE-EE
Q 002085          629 FTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCC-IS  706 (969)
Q Consensus       629 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~  706 (969)
                      ...-++.+.|++.+.+|+|.||.+-+++++++...+++|.+....    ...++|.+|...--.+ .|.||+.-++. |+
T Consensus        17 l~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq   92 (378)
T KOG1345|consen   17 LKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ   92 (378)
T ss_pred             ccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence            334456789999999999999999999999999999999886543    3357788888765556 59999988754 67


Q ss_pred             cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       707 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                      ..+.+++++||+|.|+|..-+...              .+.+....+++.|+++|+.|||++   .+||||||.+|||+-
T Consensus        93 t~d~YvF~qE~aP~gdL~snv~~~--------------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif  155 (378)
T KOG1345|consen   93 TSDAYVFVQEFAPRGDLRSNVEAA--------------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIF  155 (378)
T ss_pred             cCceEEEeeccCccchhhhhcCcc--------------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEe
Confidence            778889999999999999877653              377888899999999999999988   999999999999993


Q ss_pred             -C-CCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCc
Q 002085          787 -S-EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-----KVNEKIDIYSFGVVLLELVTGKEANYGDEH  859 (969)
Q Consensus       787 -~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~elltg~~p~~~~~~  859 (969)
                       . ..+||+||||.++..+.     ......-+..|.+||.....     ...+.+|||.||+++|.++||+.||+....
T Consensus       156 ~~df~rvKlcDFG~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~  230 (378)
T KOG1345|consen  156 DADFYRVKLCDFGLTRKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI  230 (378)
T ss_pred             cCCccEEEeeecccccccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence             2 34899999999875422     22223356779999976532     356789999999999999999999985444


Q ss_pred             cchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      .+...|-|..+..++.. . +.     ......++...++.++-+..+|++|-...++.++.
T Consensus       231 ~d~~Y~~~~~w~~rk~~-~-~P-----~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  231 MDKPYWEWEQWLKRKNP-A-LP-----KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             cCchHHHHHHHhcccCc-c-Cc-----hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            34444444444443321 1 11     11122346778889999999999996555555443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.6e-26  Score=239.14  Aligned_cols=212  Identities=40%  Similarity=0.576  Sum_probs=184.9

Q ss_pred             eeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCH
Q 002085          644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL  723 (969)
Q Consensus       644 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  723 (969)
                      ||+|++|.||++....+++.+++|++.......  ..+.+.+|++.++.++|++++++++++......++++||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998779999999986543211  357899999999999999999999999998999999999999999


Q ss_pred             HHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC-CCcEEEeecccceec
Q 002085          724 DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-EFKAKIADFGLAKML  802 (969)
Q Consensus       724 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfgla~~~  802 (969)
                      .+++....            ..+++..+..++.+++++++|||+.   +++|+||+|.||+++. ++.++++|||.+...
T Consensus        79 ~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~  143 (215)
T cd00180          79 KDLLKENE------------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLL  143 (215)
T ss_pred             HHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence            99987642            2378899999999999999999988   9999999999999999 899999999999876


Q ss_pred             ccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhc
Q 002085          803 AKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD  881 (969)
Q Consensus       803 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  881 (969)
                      .....  ......+...|++||..... .++.++|+|++|++++++                                  
T Consensus       144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------  187 (215)
T cd00180         144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------  187 (215)
T ss_pred             cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence            43221  23345678899999998887 888999999999999999                                  


Q ss_pred             cCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       882 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                                  ..+.+++..|++.||++||++.++++.
T Consensus       188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                        457789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-27  Score=237.94  Aligned_cols=261  Identities=25%  Similarity=0.305  Sum_probs=198.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC------
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE------  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  708 (969)
                      ..+|...+.+|.|.- .|-.|-+.-.+++||+|..-.... .....++..+|..++..+.|+||++++.++.-.      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            356777888999998 676778877899999998866533 344457889999999999999999999998543      


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      ...|+|||||. ++|...++..               ++=.+...+..|++.|++|||+.   ||+||||||+||++..+
T Consensus        94 ~e~y~v~e~m~-~nl~~vi~~e---------------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~  154 (369)
T KOG0665|consen   94 QEVYLVMELMD-ANLCQVILME---------------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSD  154 (369)
T ss_pred             HhHHHHHHhhh-hHHHHHHHHh---------------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecch
Confidence            35699999995 7898888732               55578889999999999999998   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +.+||.|||+|+...   ....++..+.|..|.|||++-+..+.+.+||||.||++.||++|+..|.+.+..+....+.+
T Consensus       155 ~~lKi~dfg~ar~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~  231 (369)
T KOG0665|consen  155 CTLKILDFGLARTED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIE  231 (369)
T ss_pred             hheeeccchhhcccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHH
Confidence            999999999998642   22456778899999999999988899999999999999999999998876553322111111


Q ss_pred             H------------------hhccC------CchhhhccC-CCC--cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 H------------------YAEEK------PITDALDKG-IAE--PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~------------------~~~~~------~~~~~~~~~-~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .                  +.+..      ...+.+... ++.  ....-......+++.+|+..||++|-+++++++
T Consensus       232 ~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  232 QLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            0                  00000      000000000 000  001122345778999999999999999999986

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-28  Score=250.81  Aligned_cols=411  Identities=25%  Similarity=0.298  Sum_probs=245.4

Q ss_pred             cceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCC
Q 002085           67 EITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISG  146 (969)
Q Consensus        67 gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  146 (969)
                      +++|+...-..++.++.+++. +|..+-  +..+.++|..|+|+...|.+|..+++|+.||||+|+|+.+-|++|.++.+
T Consensus        40 pC~Cs~~~g~~VdCr~~GL~e-VP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~  116 (498)
T KOG4237|consen   40 PCTCSDVEGGIVDCRGKGLTE-VPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLAS  116 (498)
T ss_pred             CcccCCCCCceEEccCCCccc-CcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHh
Confidence            344544223344455544432 222211  24567888888888666778888888888888888888888888888887


Q ss_pred             CcEEecCC-CCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCc-cccccCCCcEE
Q 002085          147 LQCIDLGG-NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPI-EFGMLKKLKTL  224 (969)
Q Consensus       147 L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~-~~~~l~~L~~L  224 (969)
                      |..|-+-+ |+|+......|++|.+|+.|.+.-|++.-+..+.|..|++|..|.+..|.   ...++. +|..+..++.+
T Consensus       117 l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~---~q~i~~~tf~~l~~i~tl  193 (498)
T KOG4237|consen  117 LLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNK---IQSICKGTFQGLAAIKTL  193 (498)
T ss_pred             hhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchh---hhhhccccccchhccchH
Confidence            76665544 88885555578888888888888888887777888888888888888884   344444 67788888888


Q ss_pred             EccCCccc------------ccCchhhcCCCchhhhhccCCcCCCCCCchhhc-CcccchhhccCcccccCCCC-chhhc
Q 002085          225 WMTEANLI------------GEIPEAMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPS-SVEAL  290 (969)
Q Consensus       225 ~L~~n~l~------------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~-l~~L~~L~L~~N~l~~~~~~-~~~~~  290 (969)
                      ++..|.++            ...|..++...-..-..+.++++...-+..|.. +..+..=..+.+...+.-|. .|..+
T Consensus       194 hlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L  273 (498)
T KOG4237|consen  194 HLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKL  273 (498)
T ss_pred             hhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhc
Confidence            87777632            223334444444444455555554333333321 12221111222222223332 24444


Q ss_pred             -ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccC
Q 002085          291 -KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSG  369 (969)
Q Consensus       291 -~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~  369 (969)
                       +|+.|+|++|+++++-+.+|.+...+++|.|..|+|...                 -...|.++..|++|+|++|+|+.
T Consensus       274 ~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v-----------------~~~~f~~ls~L~tL~L~~N~it~  336 (498)
T KOG4237|consen  274 PNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFV-----------------SSGMFQGLSGLKTLSLYDNQITT  336 (498)
T ss_pred             ccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHH-----------------HHHhhhccccceeeeecCCeeEE
Confidence             688888888888877788888888888888888887621                 11346677788888888888887


Q ss_pred             CCCcccccccCCCccccCCCccc------------------cccCccccccccEEEeeccccCCC---cccccCCc----
Q 002085          370 ELPTGLWTTFNLSSLMLSDNTIS------------------GELPSKTAWNLTRLEISNNRFSGQ---IQRGVGSW----  424 (969)
Q Consensus       370 ~~p~~~~~l~~L~~L~Ls~N~l~------------------~~~~~~~~~~L~~L~Ls~N~l~~~---~~~~~~~l----  424 (969)
                      ..|..|..+..|..|+|-.|.+.                  |..|-..+..++.++++.+.+...   .|+..+-.    
T Consensus       337 ~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~  416 (498)
T KOG4237|consen  337 VAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSP  416 (498)
T ss_pred             EecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCC
Confidence            77888888888888888777654                  222222334566777776655422   22222211    


Q ss_pred             -----ccch-hhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccc
Q 002085          425 -----KNLI-VFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLV  498 (969)
Q Consensus       425 -----~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  498 (969)
                           +-+. +..-|++.++ .+|..+  -..-.+|+|.+|.++ .+|.+  .+.+| .+|||+|+++..--..|.+++.
T Consensus       417 cP~~c~c~~tVvRcSnk~lk-~lp~~i--P~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tq  489 (498)
T KOG4237|consen  417 CPPPCTCLDTVVRCSNKLLK-LLPRGI--PVDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQ  489 (498)
T ss_pred             CCCCcchhhhhHhhcccchh-hcCCCC--CchhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhh
Confidence                 1121 2233333333 333322  123345555555555 45544  34445 5555555555433445555555


Q ss_pred             cceEeccCc
Q 002085          499 MVSLDLSGN  507 (969)
Q Consensus       499 L~~L~ls~N  507 (969)
                      |.+|-||+|
T Consensus       490 l~tlilsyn  498 (498)
T KOG4237|consen  490 LSTLILSYN  498 (498)
T ss_pred             hheeEEecC
Confidence            555555554

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1e-27  Score=261.36  Aligned_cols=253  Identities=24%  Similarity=0.278  Sum_probs=201.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|....++|.|.||.||||++..+++..|+|+++-..   ......+++|+-+++..+||||+.+++.+-..+..+++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            357888999999999999999999999999999996543   23356788899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      ||||.+|+|.+.-+...             ++++.++..+++...+|++|||+.   +-+|||||-.||++++.|.+|++
T Consensus        91 MEycgggslQdiy~~Tg-------------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvkla  154 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTG-------------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLA  154 (829)
T ss_pred             EEecCCCcccceeeecc-------------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeec
Confidence            99999999999888654             488888899999999999999988   88999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |||.+..+..  .-.......||+.|||||+..   .+.|...+|||+.|+...|+-.-+.|.+..-+.      +..+.
T Consensus       155 Dfgvsaqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm------r~l~L  226 (829)
T KOG0576|consen  155 DFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM------RALFL  226 (829)
T ss_pred             ccCchhhhhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH------HHHHH
Confidence            9999876643  233445678999999999753   567889999999999999998877775432111      01111


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL  918 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl  918 (969)
                      ..+..   .++. .-.......+.+-++++.|+-++|.+||++..++
T Consensus       227 mTkS~---~qpp-~lkDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  227 MTKSG---FQPP-TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             hhccC---CCCC-cccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            11110   0000 0111233446788999999999999999987653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=5.3e-27  Score=248.25  Aligned_cols=264  Identities=23%  Similarity=0.250  Sum_probs=206.8

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc------cCceeeEEEEEEc
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR------HANIVKLWCCISS  707 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~  707 (969)
                      .-..|.+....|+|-|++|.+|.+...|..||||++....    ...+.=+.|++||++|.      -.|+++++-.|..
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            3457888888899999999999999889999999997654    34456678999999995      3489999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      ..+.|||||-+. .+|.++++..+.          ...+....+..++.|+..||..|-..   +|+|.||||.|||+.+
T Consensus       506 knHLClVFE~Ls-lNLRevLKKyG~----------nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE  571 (752)
T KOG0670|consen  506 KNHLCLVFEPLS-LNLREVLKKYGR----------NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE  571 (752)
T ss_pred             cceeEEEehhhh-chHHHHHHHhCc----------ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence            999999999884 899999998775          34578889999999999999999988   9999999999999998


Q ss_pred             CC-cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          788 EF-KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      .. .+||||||.|......    ..+.+..+..|.|||++.+..|+..-|+||.||+|||++||+..|.+.....+....
T Consensus       572 ~k~iLKLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~  647 (752)
T KOG0670|consen  572 SKNILKLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF  647 (752)
T ss_pred             CcceeeeccCccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence            74 6799999999876432    233345567899999999999999999999999999999999999887665555443


Q ss_pred             HHH------------------hhcc--------CC--------chhhhcc------CC-----CCcccHHHHHHHHHHHH
Q 002085          867 WRH------------------YAEE--------KP--------ITDALDK------GI-----AEPCYLEEMTTVYRLAL  901 (969)
Q Consensus       867 ~~~------------------~~~~--------~~--------~~~~~~~------~~-----~~~~~~~~~~~~~~l~~  901 (969)
                      ...                  |...        .+        +...+.+      .+     ...........+.+++.
T Consensus       648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd  727 (752)
T KOG0670|consen  648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD  727 (752)
T ss_pred             HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence            221                  1000        00        0000000      00     01112334567889999


Q ss_pred             HccCCCCCCCCCHHHHHH
Q 002085          902 ICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       902 ~cl~~dP~~RPs~~evl~  919 (969)
                      .|+..||++|.+..++++
T Consensus       728 kml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  728 KMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHhccChhhcCCHHHHhc
Confidence            999999999999988875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=2.9e-25  Score=232.44  Aligned_cols=201  Identities=35%  Similarity=0.495  Sum_probs=173.8

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |+..+.||+|++|.||++....+++.+|+|.+......  ...+.+.+|++.+++++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            45678899999999999999888899999998654322  2467899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++++|.+++.....            .+++..+..++.+++.++.|||+.   +++|+|++|.||+++.++.++++|||
T Consensus        79 ~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g  143 (225)
T smart00221       79 CEGGDLFDYLRKKGG------------KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFG  143 (225)
T ss_pred             cCCCCHHHHHHhccc------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCc
Confidence            999999999986432            178889999999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhc-ccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYA-YTTKVNEKIDIYSFGVVLLELVTGKEANYG  856 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~il~elltg~~p~~~  856 (969)
                      .+..+.... ........++..|++||.. ....++.++|||+||+++|||++|+.||..
T Consensus       144 ~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      144 LARFIHRDL-AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeeEecCcc-cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            998765432 1122345678889999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=5.3e-26  Score=237.74  Aligned_cols=201  Identities=27%  Similarity=0.436  Sum_probs=168.8

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcC---CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDING---AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS  707 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  707 (969)
                      ..+.+.|..+++||+|.|++||++.+..   ..+.||+|.+.....     ..++..|++++..+ .+.||+++.+++..
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            3456688999999999999999998876   678999999855433     35689999999999 59999999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      .+...+|+||++..+..++...                ++...+..++..+..||+++|..   |||||||||.|++.+.
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~----------------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~  167 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS----------------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNR  167 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc----------------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccc
Confidence            9999999999999998888764                66788899999999999999998   9999999999999986


Q ss_pred             C-CcEEEeecccceecccCC------------------------------------------CCccccccccCcccCchh
Q 002085          788 E-FKAKIADFGLAKMLAKQG------------------------------------------EPHTMSAVAGSFGYFAPE  824 (969)
Q Consensus       788 ~-~~~kl~Dfgla~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE  824 (969)
                      . +.-.|+|||+|..++...                                          .+.......||++|+|||
T Consensus       168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE  247 (418)
T KOG1167|consen  168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE  247 (418)
T ss_pred             ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence            4 678999999997321100                                          000112346999999999


Q ss_pred             hccc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 002085          825 YAYT-TKVNEKIDIYSFGVVLLELVTGKEANYG  856 (969)
Q Consensus       825 ~~~~-~~~~~~sDvwslG~il~elltg~~p~~~  856 (969)
                      ++.. +..+++.||||.||++..+++++.||..
T Consensus       248 vL~k~~~QttaiDiws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  248 VLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             HHhhccCcCCccceeeccceeehhhcccccccc
Confidence            8864 5678999999999999999999999974

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=7.8e-27  Score=240.18  Aligned_cols=388  Identities=23%  Similarity=0.240  Sum_probs=278.7

Q ss_pred             CeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccC-CcCCCCCCCCcccCCCCcEEec
Q 002085           74 SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQ-NYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        74 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      ..+.|+|..|+|+...|.+|+.+++|++||||.|+|+.+-|++|..|.+|..|-+.+ |+|+...-+.|++|.+|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            478899999999988888999999999999999999999999999999998887776 9999766778999999999999


Q ss_pred             CCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCC----------CCCCCCccccccCCCc
Q 002085          153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNF----------KPAMIPIEFGMLKKLK  222 (969)
Q Consensus       153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~----------~~~~~p~~~~~l~~L~  222 (969)
                      .-|++.-...+.|..|++|..|.+..|.+..+--..|..+.+++.+.+..|...          .....|.++++..-..
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~  227 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS  227 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence            999999777889999999999999999999444459999999999999998621          1223344444433222


Q ss_pred             E-------------------------EEccCCcccccCch-hhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccC
Q 002085          223 T-------------------------LWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYD  276 (969)
Q Consensus       223 ~-------------------------L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  276 (969)
                      .                         =..+.++..+..|. .|..+++|+.|+|++|+++++-+.+|..+..+++|.|..
T Consensus       228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~  307 (498)
T KOG4237|consen  228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR  307 (498)
T ss_pred             hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence            1                         12334445555554 688999999999999999999899999999999999999


Q ss_pred             cccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCC-cccccccccCcccccCCCCCCCC
Q 002085          277 NILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVP-ASIGVVAFENNLSGAVPKSLGNC  354 (969)
Q Consensus       277 N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~~n~l~~~~p~~l~~l  354 (969)
                      |+|...-...|..+ .|+.|+|.+|+|+...|.+|..+.+|..|+|-.|.+....- .+++.-.-.+. .+..|. -++.
T Consensus       308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~-~~~~~~-Cq~p  385 (498)
T KOG4237|consen  308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS-VVGNPR-CQSP  385 (498)
T ss_pred             chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCC-CCCCCC-CCCC
Confidence            99987777777777 69999999999999999999999999999999998875322 11111111122 222222 1233


Q ss_pred             ccCcEEEcccccccC---CCCcccccccCCCccccCCCccccccCccccccc-cEEEeeccccCCCcccccCCcccchhh
Q 002085          355 RTLRTVQLYSNRFSG---ELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNL-TRLEISNNRFSGQIQRGVGSWKNLIVF  430 (969)
Q Consensus       355 ~~L~~L~L~~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L  430 (969)
                      ..++.++++.+.+..   ..|++.+...            ++.-|.. .+-+ +....|++.++ .+|..+.  ..-..|
T Consensus       386 ~~~~~~~~~dv~~~~~~c~~~ee~~~~~------------s~~cP~~-c~c~~tVvRcSnk~lk-~lp~~iP--~d~tel  449 (498)
T KOG4237|consen  386 GFVRQIPISDVAFGDFRCGGPEELGCLT------------SSPCPPP-CTCLDTVVRCSNKLLK-LLPRGIP--VDVTEL  449 (498)
T ss_pred             chhccccchhccccccccCCccccCCCC------------CCCCCCC-cchhhhhHhhcccchh-hcCCCCC--chhHHH
Confidence            456667777666542   1232221110            0111111 1111 22234444444 3333332  235566


Q ss_pred             cccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCc
Q 002085          431 KASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARN  483 (969)
Q Consensus       431 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  483 (969)
                      .+.+|.++ .+|.+  .+.+| .+|||+|+++-.-...|.++++|.+|-||+|
T Consensus       450 yl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  450 YLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             hcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            77777777 66666  56677 7888888887555566788888888888876

>PLN03210 Resistant to P

Probab=99.91  E-value=3.1e-24  Score=272.87  Aligned_cols=346  Identities=18%  Similarity=0.234  Sum_probs=215.0

Q ss_pred             CcccCCCCCCCEEeccCCc------CCCCCCCCcccCC-CCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCC
Q 002085          114 PEFLYNCTKLQNLDLSQNY------FVGPIPSDIDRIS-GLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFP  186 (969)
Q Consensus       114 p~~~~~l~~L~~L~Ls~N~------l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  186 (969)
                      +.+|.++++|+.|.+..+.      +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|+.|+|.+|++. .++
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~  627 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW  627 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence            3446666666666665443      2234555565553 4777777777666 566665 3567777777777766 556


Q ss_pred             cccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcC
Q 002085          187 KEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLL  266 (969)
Q Consensus       187 ~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  266 (969)
                      ..+..+++|+.|+|+++.  ....+| .++.+++|+.|+|++|.....+|..+.++++|+.|++++|..-+.+|..+ .+
T Consensus       628 ~~~~~l~~Lk~L~Ls~~~--~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l  703 (1153)
T PLN03210        628 DGVHSLTGLRNIDLRGSK--NLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL  703 (1153)
T ss_pred             cccccCCCCCEEECCCCC--CcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence            666677777777777654  233444 36667777777777776667777777777777777777764444566544 56


Q ss_pred             cccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCccccc
Q 002085          267 NNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGA  346 (969)
Q Consensus       267 ~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~  346 (969)
                      ++|+.|+|++|.....+|...  .+|+.|++++|.+. .+|..+ .+++|+.|++.++... .++.         .+...
T Consensus       704 ~sL~~L~Lsgc~~L~~~p~~~--~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~-~l~~---------~~~~l  769 (1153)
T PLN03210        704 KSLYRLNLSGCSRLKSFPDIS--TNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSE-KLWE---------RVQPL  769 (1153)
T ss_pred             CCCCEEeCCCCCCcccccccc--CCcCeeecCCCccc-cccccc-cccccccccccccchh-hccc---------ccccc
Confidence            777777777776544555432  25777888888876 455544 5677887777664422 1111         01111


Q ss_pred             CCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCccc
Q 002085          347 VPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKN  426 (969)
Q Consensus       347 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~  426 (969)
                      .|.....+++|+.|+|++|...+.+|..+.++++|+.|++++|..-+.+|...                       ++++
T Consensus       770 ~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-----------------------~L~s  826 (1153)
T PLN03210        770 TPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-----------------------NLES  826 (1153)
T ss_pred             chhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-----------------------Cccc
Confidence            12223345678899999988877888888888888888888765433444322                       2334


Q ss_pred             chhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccC-ccccCCCCcccccccccceEecc
Q 002085          427 LIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLAR-NELSGEIPKAIGSLLVMVSLDLS  505 (969)
Q Consensus       427 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ls  505 (969)
                      |+.|++++|..-..+|..   ..+|+.|+|++|.++ .+|.++..+++|+.|+|++ |+|. .+|..+.++++|+.|+++
T Consensus       827 L~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~  901 (1153)
T PLN03210        827 LESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFS  901 (1153)
T ss_pred             cCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecC
Confidence            444444443322233322   245667777777776 5677777777777777776 4444 466667777777777777


Q ss_pred             Ccc
Q 002085          506 GNQ  508 (969)
Q Consensus       506 ~N~  508 (969)
                      ++.
T Consensus       902 ~C~  904 (1153)
T PLN03210        902 DCG  904 (1153)
T ss_pred             CCc
Confidence            664

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=4.3e-24  Score=271.59  Aligned_cols=355  Identities=23%  Similarity=0.257  Sum_probs=265.6

Q ss_pred             CeEEEEecCCCCCC--CCCccccCCCcccEEEccCCC------CCCCCCcccCCCC-CCCEEeccCCcCCCCCCCCcccC
Q 002085           74 SVTGISLRHKDITQ--KIPPIICDLKNLTTIDLSSNS------IPGEFPEFLYNCT-KLQNLDLSQNYFVGPIPSDIDRI  144 (969)
Q Consensus        74 ~v~~l~l~~~~l~~--~~~~~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l  144 (969)
                      .|.++.+.-..+..  .-+.+|..+++|+.|.+..+.      +...+|..|..++ +|+.|++.+|.+. .+|..| ..
T Consensus       533 ~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~  610 (1153)
T PLN03210        533 KVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RP  610 (1153)
T ss_pred             eeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-Cc
Confidence            46666665444432  123578899999999997654      3345777777764 6999999999987 788887 57


Q ss_pred             CCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEE
Q 002085          145 SGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTL  224 (969)
Q Consensus       145 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L  224 (969)
                      .+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.  ....+|..++.+++|+.|
T Consensus       611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~--~L~~lp~si~~L~~L~~L  686 (1153)
T PLN03210        611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCS--SLVELPSSIQYLNKLEDL  686 (1153)
T ss_pred             cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCC--CccccchhhhccCCCCEE
Confidence            89999999999998 7888899999999999998875557774 8899999999999986  456789999999999999


Q ss_pred             EccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCcccc-
Q 002085          225 WMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLT-  303 (969)
Q Consensus       225 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~-  303 (969)
                      ++++|+..+.+|..+ ++++|+.|+|++|...+.+|..   ..+|+.|+|++|.++ .+|..+...+|+.|++.++... 
T Consensus       687 ~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~  761 (1153)
T PLN03210        687 DMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEK  761 (1153)
T ss_pred             eCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhh
Confidence            999998888888766 7999999999999776666653   468999999999987 5666665557888888774422 


Q ss_pred             ------ccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCccccc
Q 002085          304 ------GSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWT  377 (969)
Q Consensus       304 ------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  377 (969)
                            ...+..+...++|+.|+|++|...+                 .+|..++++++|+.|++++|..-+.+|..+ .
T Consensus       762 l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~-----------------~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~  823 (1153)
T PLN03210        762 LWERVQPLTPLMTMLSPSLTRLFLSDIPSLV-----------------ELPSSIQNLHKLEHLEIENCINLETLPTGI-N  823 (1153)
T ss_pred             ccccccccchhhhhccccchheeCCCCCCcc-----------------ccChhhhCCCCCCEEECCCCCCcCeeCCCC-C
Confidence                  1222233345789999999887654                 456678899999999999987655788776 6


Q ss_pred             ccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhcc
Q 002085          378 TFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLD  457 (969)
Q Consensus       378 l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls  457 (969)
                      +++|+.|++++|..-..+|.. ..+                        |+.|+|++|.|+ .+|..+..+++|+.|+|+
T Consensus       824 L~sL~~L~Ls~c~~L~~~p~~-~~n------------------------L~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~  877 (1153)
T PLN03210        824 LESLESLDLSGCSRLRTFPDI-STN------------------------ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMN  877 (1153)
T ss_pred             ccccCEEECCCCCcccccccc-ccc------------------------cCEeECCCCCCc-cChHHHhcCCCCCEEECC
Confidence            788888888887544333321 234                        444555555554 456666666677777776


Q ss_pred             C-cccCCCCCcccccccCCCEEEccCcc
Q 002085          458 G-NKLSGKLPSQIVSWTSLNNLNLARNE  484 (969)
Q Consensus       458 ~-N~l~~~~p~~~~~l~~L~~L~Ls~N~  484 (969)
                      + |+|+ .+|..+..+++|+.|++++|.
T Consensus       878 ~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        878 GCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCcC-ccCcccccccCCCeeecCCCc
Confidence            6 4455 466666677777777777663

syringae 6; Provisional

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.2e-25  Score=217.85  Aligned_cols=255  Identities=21%  Similarity=0.303  Sum_probs=197.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      .++....+|.+...|+.|+|++.  |..+++|++.. +....+..++|..|.-.++-+.||||+.+++.|..+....++.
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~v-r~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNV-REVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--Ccchhhhhhhh-hhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            34455677899999999999996  55577887743 3334455578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      .||+.|+|+..+++...           ...+-.++.++|.++|+|++|||+. .+-|..--|..+.|++|++.+.+|+ 
T Consensus       267 q~mp~gslynvlhe~t~-----------vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-  333 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTS-----------VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-  333 (448)
T ss_pred             eeccchHHHHHHhcCcc-----------EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-
Confidence            99999999999998764           3466778999999999999999987 4445555799999999999887764 


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCC---CccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVN---EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      .+-+++.      .......-.|.||+||.++..+-+   .++|+|||++++||+.|+..||..-.+-+.          
T Consensus       334 mad~kfs------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----------  397 (448)
T KOG0195|consen  334 MADTKFS------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----------  397 (448)
T ss_pred             cccceee------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh----------
Confidence            1212211      111123346889999999876543   579999999999999999999975433211          


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                         -.++.-.+++...++..+..+.++|.-|+.+||.+||.++.|+-.|++..
T Consensus       398 ---gmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  398 ---GMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ---hhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence               11222334444455666789999999999999999999999999998763

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.91  E-value=8.5e-24  Score=250.65  Aligned_cols=313  Identities=21%  Similarity=0.351  Sum_probs=173.8

Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCC----CCCCCCCCCCCc----------------ceeeCCCeEEEEecCCCCCCC
Q 002085           29 PQSPNTEERTILLNLKQQLGNPPSLQS----WTSTSSPCDWPE----------------ITCTFNSVTGISLRHKDITQK   88 (969)
Q Consensus        29 ~~~~~~~~~~all~~k~~~~~~~~l~s----w~~~~~~c~w~g----------------v~C~~~~v~~l~l~~~~l~~~   88 (969)
                      +..+.++|.+.++.+.+.+.-|+.+.+    |..++|+|.-..                |.|..+.||.+...+......
T Consensus        57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~  136 (754)
T PRK15370         57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASS  136 (754)
T ss_pred             CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCccccccccccccccc
Confidence            556788999999999999988887666    999999996444                778888888877655322111


Q ss_pred             C--Cccc-------------------------------cCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCC
Q 002085           89 I--PPII-------------------------------CDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVG  135 (969)
Q Consensus        89 ~--~~~~-------------------------------~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  135 (969)
                      .  +...                               +-..+.+.|++++++++ .+|..+.  ++|+.|+|++|+|+ 
T Consensus       137 ~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-  212 (754)
T PRK15370        137 ASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-  212 (754)
T ss_pred             CCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-
Confidence            1  0000                               11123445555555554 3343332  34555555555555 


Q ss_pred             CCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccc
Q 002085          136 PIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEF  215 (969)
Q Consensus       136 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~  215 (969)
                      .+|..+.  .+|++|+|++|+|+ .+|..+.  .+|+.|+|++|+++ .+|..+.                         
T Consensus       213 sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~-------------------------  261 (754)
T PRK15370        213 SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP-------------------------  261 (754)
T ss_pred             cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh-------------------------
Confidence            3343332  24555555555554 3343332  24555555555554 3343332                         


Q ss_pred             cccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccc
Q 002085          216 GMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDI  295 (969)
Q Consensus       216 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L  295 (969)
                         ++|+.|++++|++. .+|+.+.  ++|+.|+|++|+|++ +|..+.  ++|+.|++++|+++. +|..+. .+|+.|
T Consensus       262 ---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~-~sL~~L  330 (754)
T PRK15370        262 ---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP-PGLKTL  330 (754)
T ss_pred             ---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc-ccceec
Confidence               24455555544444 2444332  356666666666653 343332  356666666666663 332221 256677


Q ss_pred             cccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCccc
Q 002085          296 DLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGL  375 (969)
Q Consensus       296 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  375 (969)
                      ++++|.+++ +|..+.  ++|+.|++++|+|+ .+|                 ..+  .++|+.|+|++|+|+ .+|..+
T Consensus       331 ~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP-----------------~~l--p~~L~~LdLs~N~Lt-~LP~~l  386 (754)
T PRK15370        331 EAGENALTS-LPASLP--PELQVLDVSKNQIT-VLP-----------------ETL--PPTITTLDVSRNALT-NLPENL  386 (754)
T ss_pred             cccCCcccc-CChhhc--CcccEEECCCCCCC-cCC-----------------hhh--cCCcCEEECCCCcCC-CCCHhH
Confidence            777777763 455443  57778888888776 233                 222  246888888888888 566655


Q ss_pred             ccccCCCccccCCCccccccCccc------cccccEEEeeccccC
Q 002085          376 WTTFNLSSLMLSDNTISGELPSKT------AWNLTRLEISNNRFS  414 (969)
Q Consensus       376 ~~l~~L~~L~Ls~N~l~~~~~~~~------~~~L~~L~Ls~N~l~  414 (969)
                      .  ..|+.|++++|+|+ .+|...      .+++..|+|.+|.|+
T Consensus       387 ~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        387 P--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             H--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            4  35777888888776 333311      123445555555544

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=3.7e-24  Score=251.66  Aligned_cols=264  Identities=25%  Similarity=0.386  Sum_probs=172.1

Q ss_pred             EEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccc
Q 002085          223 TLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNL  302 (969)
Q Consensus       223 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l  302 (969)
                      .|++++|+++ .+|..+.  ++|+.|++++|+|+ .+|.   .+++|++|+|++|+|+. +|...  .+|+.|++++|.+
T Consensus       205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lts-LP~lp--~sL~~L~Ls~N~L  274 (788)
T PRK15387        205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPVLP--PGLLELSIFSNPL  274 (788)
T ss_pred             EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCc-ccCcc--cccceeeccCCch
Confidence            3444444443 3444333  24555555555555 2332   13556666666666653 23221  2466666666666


Q ss_pred             cccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCC
Q 002085          303 TGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLS  382 (969)
Q Consensus       303 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  382 (969)
                      + .+|..+   ++|+.|++++|+++                  .+|.   ..++|+.|+|++|+|++ +|...   .+|+
T Consensus       275 ~-~Lp~lp---~~L~~L~Ls~N~Lt------------------~LP~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~  325 (788)
T PRK15387        275 T-HLPALP---SGLCKLWIFGNQLT------------------SLPV---LPPGLQELSVSDNQLAS-LPALP---SELC  325 (788)
T ss_pred             h-hhhhch---hhcCEEECcCCccc------------------cccc---cccccceeECCCCcccc-CCCCc---cccc
Confidence            6 333322   44566667777666                  2222   12457777777777773 44322   3566


Q ss_pred             ccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccC
Q 002085          383 SLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLS  462 (969)
Q Consensus       383 ~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  462 (969)
                      .|++++|+|++ +|. ...+|+.|+|++|+|++ +|..   ..+|+.|++++|+|+ .+|..   ..+|+.|+|++|+|+
T Consensus       326 ~L~Ls~N~L~~-LP~-lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt  395 (788)
T PRK15387        326 KLWAYNNQLTS-LPT-LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT  395 (788)
T ss_pred             ccccccCcccc-ccc-cccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCccc
Confidence            77777777764 443 33578888888888885 3432   246778888999988 46653   357899999999998


Q ss_pred             CCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecCcCCCCCCcccc
Q 002085          463 GKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFN  541 (969)
Q Consensus       463 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~~~  541 (969)
                       .+|...   ++|+.|++++|+|+ .+|..+   .+|+.|+|++|+|+ .+|..++.+. |+.|+|++|+|+|.+|..++
T Consensus       396 -~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~  466 (788)
T PRK15387        396 -SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR  466 (788)
T ss_pred             -CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHH
Confidence             466543   57999999999998 477643   46788999999998 7999998885 99999999999999988776


Q ss_pred             ccc
Q 002085          542 NLA  544 (969)
Q Consensus       542 ~~~  544 (969)
                      .+.
T Consensus       467 ~l~  469 (788)
T PRK15387        467 EIT  469 (788)
T ss_pred             HHh
Confidence            554

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=2e-24  Score=266.91  Aligned_cols=196  Identities=21%  Similarity=0.236  Sum_probs=138.5

Q ss_pred             cccc-CceeeEEEEE-------EcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhh
Q 002085          692 TIRH-ANIVKLWCCI-------SSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC  763 (969)
Q Consensus       692 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~  763 (969)
                      .++| +||.++++++       ...+..+.++||+ +++|.+++....            ..+++.+++.++.||++||+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~al~   94 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD------------RSVDAFECFHVFRQIVEIVN   94 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc------------ccccHHHHHHHHHHHHHHHH
Confidence            3445 5777788776       2234567889988 579999997532            24889999999999999999


Q ss_pred             hhcccCCCCeEecCCCCCcEEECCC-------------------CcEEEeecccceecccCCC--------------Ccc
Q 002085          764 YMHHDCTPQIIHRDVKSSNILLDSE-------------------FKAKIADFGLAKMLAKQGE--------------PHT  810 (969)
Q Consensus       764 ~LH~~~~~~ivH~Dlkp~Nill~~~-------------------~~~kl~Dfgla~~~~~~~~--------------~~~  810 (969)
                      |||++   +|+||||||+|||++..                   +.+|++|||+++.......              ...
T Consensus        95 ~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  171 (793)
T PLN00181         95 AAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMK  171 (793)
T ss_pred             HHHhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccc
Confidence            99988   99999999999999653                   4556666666653211000              000


Q ss_pred             ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccH
Q 002085          811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYL  890 (969)
Q Consensus       811 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  890 (969)
                      .....||+.|||||++.+..++.++|||||||++|||++|..|+.....  .........         ..     +...
T Consensus       172 ~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~---------~~-----~~~~  235 (793)
T PLN00181        172 QILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV---------LP-----PQIL  235 (793)
T ss_pred             ccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh---------cC-----hhhh
Confidence            1123578899999999999999999999999999999998877542211  000000000         00     1111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          891 EEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       891 ~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ........++.+||+.||.+||++.|+++
T Consensus       236 ~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        236 LNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            12244568889999999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=4.1e-23  Score=207.31  Aligned_cols=166  Identities=22%  Similarity=0.238  Sum_probs=126.6

Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.++++..+            ..++|..++.++.|++.||+|||+.   +      ||+||+++.++.+++  ||.++
T Consensus         1 GsL~~~l~~~~------------~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~   57 (176)
T smart00750        1 VSLADILEVRG------------RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVA   57 (176)
T ss_pred             CcHHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceE
Confidence            68899987543            2489999999999999999999987   5      999999999999999  99998


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHhhccCCchhh
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT-SLAEWAWRHYAEEKPITDA  879 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~  879 (969)
                      .....       ...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.........    
T Consensus        58 ~~~~~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  126 (176)
T smart00750       58 FKTPE-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP----  126 (176)
T ss_pred             eeccc-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc----
Confidence            65332       125889999999999999999999999999999999999998654322 111111111111100    


Q ss_pred             hccCCCCcccHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          880 LDKGIAEPCYLEEMT--TVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       880 ~~~~~~~~~~~~~~~--~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                         . ..+.......  .+.+++.+||..||++||++.|+++.+...
T Consensus       127 ---~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      127 ---R-DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ---c-ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence               0 0011122222  689999999999999999999999988665

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=2e-23  Score=245.45  Aligned_cols=66  Identities=29%  Similarity=0.502  Sum_probs=46.2

Q ss_pred             cccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccc
Q 002085          449 SHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQ  519 (969)
Q Consensus       449 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~  519 (969)
                      ++|+.|+|++|+|+ .+|...   .+|+.|+|++|+|+ .+|..++++++|+.|+|++|+|+|.+|..+..
T Consensus       402 s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~  467 (788)
T PRK15387        402 SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE  467 (788)
T ss_pred             cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence            45667777777776 355432   35677777777777 67777777788888888888888777766543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=6.1e-23  Score=224.10  Aligned_cols=179  Identities=20%  Similarity=0.202  Sum_probs=137.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcC-CCcEEEEEEEeccch--hcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDING-AGEFVAVKRIWNNRK--LNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      +..+|+..+.||+|+||+||+|.+.. +++.||||++.....  ......+.+.+|++++++++|+|++..+..   .+.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            45689999999999999999998875 677889998743211  123345679999999999999999853322   246


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCC-CCCcEEECCCC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDV-KSSNILLDSEF  789 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~  789 (969)
                      .|+||||++|++|... ...                .   ...++.|+++||+|||+.   ||+|||| ||+||+++.++
T Consensus        93 ~~LVmE~~~G~~L~~~-~~~----------------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~  149 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RPH----------------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDG  149 (365)
T ss_pred             cEEEEEccCCCCHHHh-Ccc----------------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCC
Confidence            8999999999999732 100                0   136788999999999988   9999999 99999999999


Q ss_pred             cEEEeecccceecccCCCCcc------ccccccCcccCchhhcccCC------CCCccchh
Q 002085          790 KAKIADFGLAKMLAKQGEPHT------MSAVAGSFGYFAPEYAYTTK------VNEKIDIY  838 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~sDvw  838 (969)
                      .+||+|||+|+.+...+....      .....+++.|+|||++...+      .+..+|-|
T Consensus       150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999999999998765432222      23556888999999886432      33446766

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.8e-22  Score=203.63  Aligned_cols=257  Identities=18%  Similarity=0.183  Sum_probs=199.4

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      .|+++++||+|+||++|.|+..-++++||||.-.....     .-.+..|.+.++.| ..+.|..++-+..++.+..||+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            68999999999999999999999999999997543322     24577788888888 5899999998888899999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-----c
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-----K  790 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~  790 (969)
                      |.+ |.||+|++.-.++            .++..++..||.|++.-++|+|++   ..|+|||||+|+||...+     .
T Consensus       104 dLL-GPSLEDLFD~CgR------------~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~  167 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGR------------RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANV  167 (449)
T ss_pred             hhh-CcCHHHHHHHhcC------------cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCce
Confidence            999 7999999987764            489999999999999999999998   999999999999997654     5


Q ss_pred             EEEeecccceecccCCC-----CccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          791 AKIADFGLAKMLAKQGE-----PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      +.++|||+|+.|.+...     ........||.+||+-....+.+.+.+.|+-|+|-++.+.+-|..||.+-.....-+.
T Consensus       168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k  247 (449)
T KOG1165|consen  168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK  247 (449)
T ss_pred             EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence            89999999998865322     1223456799999999999999999999999999999999999999998654332221


Q ss_pred             HHHHhhccC---CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          866 AWRHYAEEK---PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       866 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                       .+...+.+   ++.+.+.         ..+.++..-+.-.-+.+-.+-|..+-+...+..+
T Consensus       248 -YeKIGe~Kr~T~i~~Lc~---------g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv  299 (449)
T KOG1165|consen  248 -YEKIGETKRSTPIEVLCE---------GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV  299 (449)
T ss_pred             -HHHhccccccCCHHHHHh---------cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence             12222221   1222111         1234555555555567788888876665544333

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=8.4e-22  Score=217.00  Aligned_cols=262  Identities=21%  Similarity=0.216  Sum_probs=197.6

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCC-cEEEEEEEeccchhcHHHHHHHHHHHHHHhcccc----CceeeEEEEE-EcCCc
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAG-EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH----ANIVKLWCCI-SSENS  710 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~  710 (969)
                      +|++.++||+|+||.||.|....++ ..+|+|.........   ...+..|+.++..+..    +++..+++.. ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            7999999999999999999987664 679999875432211   1267788888888863    6899999988 57778


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC--
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE--  788 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--  788 (969)
                      .|+||+.+ |.+|.++......           ..++..++.+|+.|++.+|+++|+.   |++||||||.|+++...  
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~-----------~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~  160 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPP-----------GRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSR  160 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCC-----------CCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCC
Confidence            99999988 7999998865541           4589999999999999999999988   99999999999999865  


Q ss_pred             ---CcEEEeecccce--ecccCCC-----Ccc-ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 002085          789 ---FKAKIADFGLAK--MLAKQGE-----PHT-MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD  857 (969)
Q Consensus       789 ---~~~kl~Dfgla~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~  857 (969)
                         ..+.+.|||+++  .+.....     +.. .....||..|+++....+...+++.|+||++.++.|+..|..||...
T Consensus       161 ~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~  240 (322)
T KOG1164|consen  161 SEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL  240 (322)
T ss_pred             cccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence               369999999998  4322211     111 12456999999999999999999999999999999999999998665


Q ss_pred             CccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          858 EHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      ..........+......     ...     .....+..+.++...+-..+..++|....+...+++...
T Consensus       241 ~~~~~~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  241 EMTDLKSKFEKDPRKLL-----TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             cccchHHHHHHHhhhhc-----ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            43322221111111100     000     111122455666666666899999999999999887764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=5.1e-22  Score=191.64  Aligned_cols=259  Identities=21%  Similarity=0.216  Sum_probs=198.7

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKL  712 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  712 (969)
                      ....|..+++||+|+||.+|.|.....|+.||||+-.....     ...+..|.++++.++ ...|..+..+..+..+..
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            34679999999999999999999999999999998744332     245778999999996 467788888888999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC---C
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE---F  789 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~  789 (969)
                      +|||.. |.||.+++.-..+            .++..+++-.|-|++.-++|+|.+   +++||||||+|+|..-+   .
T Consensus        88 lVMdLL-GPsLEdLfnfC~R------------~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~  151 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCSR------------RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCN  151 (341)
T ss_pred             eeeecc-CccHHHHHHHHhh------------hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccc
Confidence            999998 7999999986653            488899999999999999999988   99999999999999654   4


Q ss_pred             cEEEeecccceecccCCC-----CccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          790 KAKIADFGLAKMLAKQGE-----PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                      .+.++|||+|+.+.+...     ........||.+|.+-....+...+.+.|+-|+|.+|.++-.|..||++-....-.+
T Consensus       152 kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q  231 (341)
T KOG1163|consen  152 KLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ  231 (341)
T ss_pred             eEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence            689999999998754322     122345679999999888888888999999999999999999999999865433222


Q ss_pred             HHHHHhhccC--CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          865 WAWRHYAEEK--PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       865 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                      ... ...+.+  ...+.+        ....+.++.-.+.-|-..--++-|...-+-+.+.
T Consensus       232 KyE-kI~EkK~s~~ie~L--------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  232 KYE-KISEKKMSTPIEVL--------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HHH-HHHHhhcCCCHHHH--------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            111 111110  001111        1112356667777888877888887665555443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=8.7e-20  Score=203.61  Aligned_cols=265  Identities=31%  Similarity=0.387  Sum_probs=201.3

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccC-ceeeEEEEEEcCCceEEEEe
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA-NIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e  716 (969)
                      |...+.||.|+||.||++.+.   ..+|+|.+.............+.+|+.+++.+.|+ +++++.+++......++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            566788999999999999986   77999998665544444578899999999999988 79999999977777899999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-cEEEee
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-KAKIAD  795 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~D  795 (969)
                      |+.++++.+++......          ..+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|
T Consensus        79 ~~~~~~l~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~d  145 (384)
T COG0515          79 YVDGGSLEDLLKKIGRK----------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLID  145 (384)
T ss_pred             cCCCCcHHHHHHhcccc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEec
Confidence            99999999777654310          2477889999999999999999988   999999999999999998 799999


Q ss_pred             cccceecccCCCCc----cccccccCcccCchhhccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          796 FGLAKMLAKQGEPH----TMSAVAGSFGYFAPEYAYT---TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       796 fgla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      ||.++.+.......    ......|+..|+|||...+   ..+....|+||+|++++++++|..|+..............
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~  225 (384)
T COG0515         146 FGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK  225 (384)
T ss_pred             cCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence            99998654432221    3456789999999999987   5788999999999999999999999765543101111111


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .......-  .................+.+++..|+..+|..|.+..+....
T Consensus       226 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         226 IILELPTP--SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHhcCCc--ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11111100  000000000001223567889999999999999998887764

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=1.3e-21  Score=232.21  Aligned_cols=291  Identities=23%  Similarity=0.356  Sum_probs=160.1

Q ss_pred             CCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEE
Q 002085          146 GLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLW  225 (969)
Q Consensus       146 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~  225 (969)
                      +...|++++++++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|++++|++.   .+|..+.  .+|+.|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt---sLP~~l~--~~L~~L~  247 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT---SIPATLP--DTIQEME  247 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc---cCChhhh--ccccEEE
Confidence            4455666666665 4554442  35666666666666 3444332  35666666655321   2232221  2445555


Q ss_pred             ccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCcccccc
Q 002085          226 MTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGS  305 (969)
Q Consensus       226 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~  305 (969)
                      |++|++. .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|++                        
T Consensus       248 Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~------------------------  297 (754)
T PRK15370        248 LSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT------------------------  297 (754)
T ss_pred             CcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc------------------------
Confidence            5555544 4444443  35666666666666 3454332  345555555555542                        


Q ss_pred             CCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccc
Q 002085          306 IPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLM  385 (969)
Q Consensus       306 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  385 (969)
                      +|..+.  ++|+.|++++|+++. +|                 ..+  .++|+.|++++|.++ .+|..+.  ++|+.|+
T Consensus       298 LP~~lp--~sL~~L~Ls~N~Lt~-LP-----------------~~l--~~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~  352 (754)
T PRK15370        298 LPAHLP--SGITHLNVQSNSLTA-LP-----------------ETL--PPGLKTLEAGENALT-SLPASLP--PELQVLD  352 (754)
T ss_pred             Ccccch--hhHHHHHhcCCcccc-CC-----------------ccc--cccceeccccCCccc-cCChhhc--CcccEEE
Confidence            222221  245555555555552 11                 111  134566666666665 3454442  4666666


Q ss_pred             cCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccc----cCccccchhhccCccc
Q 002085          386 LSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEL----TSLSHLNTLLLDGNKL  461 (969)
Q Consensus       386 Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l  461 (969)
                      |++|+|+ .+|.....+|+.|+|++|+|+. +|..+.  ..|+.|++++|+|+ .+|..+    ..++++..|+|.+|.+
T Consensus       353 Ls~N~L~-~LP~~lp~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npl  427 (754)
T PRK15370        353 VSKNQIT-VLPETLPPTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPF  427 (754)
T ss_pred             CCCCCCC-cCChhhcCCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCc
Confidence            6666665 3444444577888888888874 344343  36888888888887 555543    4457888999999998


Q ss_pred             CCCCCcccccccCCCEEEccCccccC-CCCcccccccccceEeccCccccccCC
Q 002085          462 SGKLPSQIVSWTSLNNLNLARNELSG-EIPKAIGSLLVMVSLDLSGNQFSGEIP  514 (969)
Q Consensus       462 ~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~g~~p  514 (969)
                      +.      ..+.+|+.| ++.+.+.| .++...+.+..++....-+|.+.+-++
T Consensus       428 s~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~~Wl~  474 (754)
T PRK15370        428 SE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQGWLT  474 (754)
T ss_pred             cH------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHhccCC
Confidence            72      344556666 45555554 345555555666655555555554443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=7.6e-22  Score=230.08  Aligned_cols=258  Identities=19%  Similarity=0.213  Sum_probs=192.7

Q ss_pred             CccceeeecCcEEEEEEEEcCCCcEEEEEEEec---cchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWN---NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ...+++|.|++|.|+.+......+.++.|.+..   ...........+..|+.+-..+.|||++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            456789999999888887766666666665431   11122222334778888888899999988877776666666669


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |||++ +|..++....             .+....+..++.|+..|++|+|..   ||.|||+|++|++++..|.+||+|
T Consensus       401 E~~~~-Dlf~~~~~~~-------------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~D  463 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG-------------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIID  463 (601)
T ss_pred             hcccH-HHHHHHhccc-------------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEee
Confidence            99998 9999998653             267778889999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCC--ccccccccCcccCchhhcccCCCCC-ccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          796 FGLAKMLAKQGEP--HTMSAVAGSFGYFAPEYAYTTKVNE-KIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       796 fgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ||.+....-..+.  .......|+-.|+|||++.+..|++ ..||||.|+++..|++|+.||......+... .......
T Consensus       464 fg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~~~~~  542 (601)
T KOG0590|consen  464 FGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTNNYSD  542 (601)
T ss_pred             cCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhhcccc
Confidence            9999876544443  4556778999999999999999987 5899999999999999999986433221110 0000000


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...     ...-........+.+...++.++++.||.+|-++.+|++
T Consensus       543 ~~~-----~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  543 QRN-----IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccc-----cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000     000001122334567788999999999999999999985

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2.2e-21  Score=213.70  Aligned_cols=189  Identities=26%  Similarity=0.317  Sum_probs=159.3

Q ss_pred             eeeecCcEEEEEEEE---cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEEEEeec
Q 002085          643 LIGSGGSGQVYRIDI---NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLLVYEYM  718 (969)
Q Consensus       643 ~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  718 (969)
                      ++|+|+||.|+.++-   ...|..+|.|+.++........ .....|..++..++ ||.++++..+++.+...+++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            369999999986433   3457789999887654433222 26677888999996 999999999999999999999999


Q ss_pred             cCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccc
Q 002085          719 ENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL  798 (969)
Q Consensus       719 ~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgl  798 (969)
                      .||.|...+.....             ++..........++-+++++|+.   +|+|||+|++||+++.+|.+++.|||+
T Consensus        80 rgg~lft~l~~~~~-------------f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfgl  143 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVM-------------FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGL  143 (612)
T ss_pred             ccchhhhccccCCc-------------hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchh
Confidence            99999988876543             66777778888899999999999   999999999999999999999999999


Q ss_pred             ceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 002085          799 AKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG  856 (969)
Q Consensus       799 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~  856 (969)
                      ++......      ..+||..|||||++.  ....++|.||||++++||+||..||.+
T Consensus       144 ske~v~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  144 SKEAVKEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hhHhHhhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            98654321      128999999999988  678899999999999999999999976

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=2e-20  Score=189.35  Aligned_cols=175  Identities=14%  Similarity=0.140  Sum_probs=135.3

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHH------HHHHHHHHhccccCceeeEEEEEE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIRHANIVKLWCCIS  706 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~niv~l~~~~~  706 (969)
                      -+..+|+..+++|.|+||.||.+..  ++..+|+|++.......+.....      +.+|++.+.++.||+|..+.+++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            3456899999999999999999766  46679999997554434443333      689999999999999999998865


Q ss_pred             cC--------CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCC
Q 002085          707 SE--------NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDV  778 (969)
Q Consensus       707 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  778 (969)
                      +.        +..++||||++|.+|.++..                 ++.    ....+++.++..+|+.   |++|||+
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------------~~~----~~~~~i~~~l~~lH~~---gi~H~Di  161 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-----------------ISE----DVKAKIKASIESLHQH---GMVSGDP  161 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh-----------------ccH----HHHHHHHHHHHHHHHc---CCccCCC
Confidence            43        35789999999999987732                 111    3456999999999998   9999999


Q ss_pred             CCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHH
Q 002085          779 KSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELV  848 (969)
Q Consensus       779 kp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell  848 (969)
                      +|+||+++.++ ++++|||..+......   .           ...+.....+..++|+|+||+++....
T Consensus       162 kp~Nili~~~g-i~liDfg~~~~~~e~~---a-----------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        162 HKGNFIVSKNG-LRIIDLSGKRCTAQRK---A-----------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ChHHEEEeCCC-EEEEECCCcccccchh---h-----------HHHHHHHhHhcccccccceeEeehHHH
Confidence            99999999988 9999999886542110   0           011334445667999999999887664

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=3.2e-20  Score=193.60  Aligned_cols=241  Identities=17%  Similarity=0.202  Sum_probs=158.4

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcccc----------CceeeEEEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH----------ANIVKLWCCIS  706 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~  706 (969)
                      .+...+.||.|+++.||.+++..+++.+|||++...........+.+++|.-....+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45567899999999999999999999999999876655555567788888766655322          12222222211


Q ss_pred             ---------c---CC-----ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC
Q 002085          707 ---------S---EN-----SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC  769 (969)
Q Consensus       707 ---------~---~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~  769 (969)
                               .   ..     ..+++|+-+. ++|.+++..-.....      ....+....++.+..|+++.+++||+. 
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~------~~~~l~~~arl~lT~Q~I~lvA~Lh~~-  164 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQ------THSPLAFAARLSLTVQMIRLVANLHSY-  164 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTT------TSHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhccc------ccchhHHHHHHHHHHHHHHHHHHHhhc-
Confidence                     1   11     2367888774 788887653221000      012244556778889999999999999 


Q ss_pred             CCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccC--------CCCCccchhhHH
Q 002085          770 TPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT--------KVNEKIDIYSFG  841 (969)
Q Consensus       770 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwslG  841 (969)
                        |+||+||+|+|++++++|.++|+||+.......   ... . ...+..|.+||.....        .++.+.|.|++|
T Consensus       165 --GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG  237 (288)
T PF14531_consen  165 --GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT---RYR-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG  237 (288)
T ss_dssp             --TEEEST-SGGGEEE-TTS-EEE--GGGEEETTE---EEE-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred             --ceEecccceeeEEEcCCCCEEEcChHHHeecCc---eee-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence              999999999999999999999999998765422   111 1 3455789999976542        478899999999


Q ss_pred             HHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCC
Q 002085          842 VVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSR  911 (969)
Q Consensus       842 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R  911 (969)
                      +++|.|+++..||..........+                  .-..|. +.++.+.++|..+++.+|.+|
T Consensus       238 ~~ly~lWC~~lPf~~~~~~~~~~~------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  238 ITLYSLWCGRLPFGLSSPEADPEW------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHSS-STCCCGGGSTSGG------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHccCCCCCCCccccccc------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999999999976533221111                  112344 666889999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=6.6e-20  Score=184.46  Aligned_cols=142  Identities=18%  Similarity=0.139  Sum_probs=107.9

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHH-----------------------HHHHHHHHHHHHhccccCc
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK-----------------------LEKEFIAEIEILGTIRHAN  697 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~n  697 (969)
                      ...||+|+||.||+|... +|+.||||+++........                       .......|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            357999999999999987 8999999999754321110                       0123345999999998777


Q ss_pred             eeeEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhh-cccCCCCeEec
Q 002085          698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYM-HHDCTPQIIHR  776 (969)
Q Consensus       698 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~  776 (969)
                      +.....+..  ...++||||++|+++.......             ..+++....+++.|++.+|.|+ |+.   +|+||
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-------------~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHr  142 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-------------APLSESKARELYLQVIQIMRILYQDC---RLVHA  142 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            643332222  2348999999988776543221             2378889999999999999999 677   99999


Q ss_pred             CCCCCcEEECCCCcEEEeecccceec
Q 002085          777 DVKSSNILLDSEFKAKIADFGLAKML  802 (969)
Q Consensus       777 Dlkp~Nill~~~~~~kl~Dfgla~~~  802 (969)
                      ||||+||+++ ++.++++|||+|...
T Consensus       143 DlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         143 DLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCCHHHEEEE-CCcEEEEEccccccC
Confidence            9999999998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.3e-19  Score=177.24  Aligned_cols=191  Identities=13%  Similarity=0.066  Sum_probs=142.3

Q ss_pred             CccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH-HHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEEEEe
Q 002085          639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ-KLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      .+...|++|+||+||.+..  .+.+++.+.+.....+.. -....+.+|+++++++. |+++++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999997766  577888777744332211 11236889999999995 5889999886    34799999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCC-CCCcEEECCCCcEEEee
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDV-KSSNILLDSEFKAKIAD  795 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~D  795 (969)
                      |++|.+|.+....                    ....++.|++.+++++|+.   ||+|||| ||.||+++.++.++|+|
T Consensus        79 yI~G~~L~~~~~~--------------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LID  135 (218)
T PRK12274         79 YLAGAAMYQRPPR--------------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVID  135 (218)
T ss_pred             eecCccHHhhhhh--------------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEE
Confidence            9999998754321                    1134678999999999998   9999999 79999999999999999


Q ss_pred             cccceecccCCCC------cc-----ccccccCcccCchhhcccC-CCC-CccchhhHHHHHHHHHhCCCCCCCCC
Q 002085          796 FGLAKMLAKQGEP------HT-----MSAVAGSFGYFAPEYAYTT-KVN-EKIDIYSFGVVLLELVTGKEANYGDE  858 (969)
Q Consensus       796 fgla~~~~~~~~~------~~-----~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwslG~il~elltg~~p~~~~~  858 (969)
                      ||+|......+..      .+     ......++.|++|+...-- ..+ .+.+.++-|+-+|.++|++.+.+++.
T Consensus       136 FG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        136 FQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            9999865443211      00     0122367888888754322 233 56799999999999999999987654

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.79  E-value=4e-21  Score=175.87  Aligned_cols=190  Identities=29%  Similarity=0.524  Sum_probs=142.7

Q ss_pred             CCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEc
Q 002085          283 IPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQL  362 (969)
Q Consensus       283 ~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L  362 (969)
                      +|..|....++.|.||+|+++ .+|..+..+.+|+.|++++|++.                  .+|..++.++.|+.|++
T Consensus        26 ~~gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie------------------~lp~~issl~klr~lnv   86 (264)
T KOG0617|consen   26 LPGLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE------------------ELPTSISSLPKLRILNV   86 (264)
T ss_pred             cccccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh------------------hcChhhhhchhhhheec
Confidence            344444445666667777776 56666777777777777777776                  45555555666666665


Q ss_pred             ccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCcccc-cc
Q 002085          363 YSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSG-EI  441 (969)
Q Consensus       363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~  441 (969)
                      +-|++.                                               ..|..|+.++.|++|||.+|++.. ..
T Consensus        87 gmnrl~-----------------------------------------------~lprgfgs~p~levldltynnl~e~~l  119 (264)
T KOG0617|consen   87 GMNRLN-----------------------------------------------ILPRGFGSFPALEVLDLTYNNLNENSL  119 (264)
T ss_pred             chhhhh-----------------------------------------------cCccccCCCchhhhhhccccccccccC
Confidence            555554                                               445555566666666666666553 57


Q ss_pred             CccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc
Q 002085          442 PVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK  521 (969)
Q Consensus       442 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~  521 (969)
                      |..|..|+.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|.+++.|+.|++|.+.+|+++ .+|++++.+.
T Consensus       120 pgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~  196 (264)
T KOG0617|consen  120 PGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLD  196 (264)
T ss_pred             CcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhh
Confidence            888888999999999999998 89999999999999999999998 79999999999999999999999 8999999884


Q ss_pred             ----ccEEEeecCcCCCCCCcccc
Q 002085          522 ----LNTFNLSSNKLYGNIPDEFN  541 (969)
Q Consensus       522 ----L~~l~ls~N~l~~~~p~~~~  541 (969)
                          -+.+.+.+|++-.+|-+.|+
T Consensus       197 l~~~k~v~r~E~NPwv~pIaeQf~  220 (264)
T KOG0617|consen  197 LVGNKQVMRMEENPWVNPIAEQFL  220 (264)
T ss_pred             hhhhHHHHhhhhCCCCChHHHHHH
Confidence                34567778888776666554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.79  E-value=8.8e-19  Score=177.31  Aligned_cols=142  Identities=19%  Similarity=0.144  Sum_probs=110.3

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc-----------------------HHHHHHHHHHHHHHhccccCc
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN-----------------------QKLEKEFIAEIEILGTIRHAN  697 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~h~n  697 (969)
                      ...||+|+||.||+|.+. +|+.||||+++......                       ......+.+|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 89999999987542110                       001233568999999999998


Q ss_pred             eeeEEEEEEcCCceEEEEeeccCCCHHHH-hccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEe
Q 002085          698 IVKLWCCISSENSKLLVYEYMENQSLDRW-LHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIH  775 (969)
Q Consensus       698 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH  775 (969)
                      +.....+...  ..++||||++|+++... +..              ..++.....+++.|++.++.++|+ .   ||+|
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--------------~~~~~~~~~~i~~~l~~~l~~lH~~~---givH  141 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--------------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVH  141 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhh--------------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEec
Confidence            7544443332  24899999998755433 322              126677889999999999999998 7   9999


Q ss_pred             cCCCCCcEEECCCCcEEEeecccceecc
Q 002085          776 RDVKSSNILLDSEFKAKIADFGLAKMLA  803 (969)
Q Consensus       776 ~Dlkp~Nill~~~~~~kl~Dfgla~~~~  803 (969)
                      |||||+||+++ ++.++++|||+++...
T Consensus       142 rDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         142 GDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCChhhEEEE-CCCEEEEEcccceecC
Confidence            99999999999 7899999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.78  E-value=7.4e-20  Score=210.78  Aligned_cols=254  Identities=22%  Similarity=0.227  Sum_probs=183.8

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccc-hhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNR-KLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++...+.||++.|=.|.+|++. .|. |+||++-+.. ..+-....+-..|++ ....+|||++++.-+-......|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            5666788999999999999886 454 9999985433 222233334444455 55568999999987777778889999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      +|+. -+|+|.+..++             .+...+...||.|++.|+..+|..   ||+|||||.+|||++.-..+.|+|
T Consensus       101 qyvk-hnLyDRlSTRP-------------FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtD  163 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTRP-------------FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTD  163 (1431)
T ss_pred             HHHh-hhhhhhhccch-------------HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhc
Confidence            9995 69999988654             367778899999999999999998   999999999999999999999999


Q ss_pred             ccccee-cccCCCCccccccccC----cccCchhhcccC-----------CCCCccchhhHHHHHHHHHhC-CCCCCCCC
Q 002085          796 FGLAKM-LAKQGEPHTMSAVAGS----FGYFAPEYAYTT-----------KVNEKIDIYSFGVVLLELVTG-KEANYGDE  858 (969)
Q Consensus       796 fgla~~-~~~~~~~~~~~~~~gt----~~y~aPE~~~~~-----------~~~~~sDvwslG~il~elltg-~~p~~~~~  858 (969)
                      |..-+. |-+.+++...+.+.-|    .+|.|||.+...           ..+++.||||.||++.|+++- +++|.-  
T Consensus       164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--  241 (1431)
T KOG1240|consen  164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--  241 (1431)
T ss_pred             ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--
Confidence            976653 3344455555444433    479999977542           156789999999999999995 555531  


Q ss_pred             ccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          859 HTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                           .+..+.-..+....+.+-..+..       ..+..++..|++.||++|.++.+.++.-.+.
T Consensus       242 -----SQL~aYr~~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  242 -----SQLLAYRSGNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             -----HHHHhHhccCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence                 11111111111122222222222       3577899999999999999999999874433

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=9.4e-19  Score=180.72  Aligned_cols=256  Identities=22%  Similarity=0.295  Sum_probs=171.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCc-----------------------------------EEEEEEEeccchh--cH
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGE-----------------------------------FVAVKRIWNNRKL--NQ  677 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----------------------------------~vavK~~~~~~~~--~~  677 (969)
                      +++|.+.+.||+|..+.||.|+...+|.                                   +.|+|.+..-...  +.
T Consensus       156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~  235 (598)
T KOG4158|consen  156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA  235 (598)
T ss_pred             hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence            5689999999999999999987642111                                   3567765432211  12


Q ss_pred             HHHHHHHHHH--------------HHHhc--------cccCceeeEEEEEEcC---------------------------
Q 002085          678 KLEKEFIAEI--------------EILGT--------IRHANIVKLWCCISSE---------------------------  708 (969)
Q Consensus       678 ~~~~~~~~E~--------------~~l~~--------l~h~niv~l~~~~~~~---------------------------  708 (969)
                      ...+.+.+|.              ...+.        -+|||||++.++|.+.                           
T Consensus       236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~  315 (598)
T KOG4158|consen  236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP  315 (598)
T ss_pred             HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence            2223333332              11111        1599999998776331                           


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE--C
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL--D  786 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill--~  786 (969)
                      ...|+||...+ .+|.+|+..+.              .+...+.-|..|+++|..|||++   ||.|||+|.+||++  |
T Consensus       316 ~tlylvMkrY~-~tLr~yl~~~~--------------~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~Eld  377 (598)
T KOG4158|consen  316 KTLYLVMKRYR-QTLREYLWTRH--------------RSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELD  377 (598)
T ss_pred             ceEEEehhcch-hhHHHHHhcCC--------------CchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEec
Confidence            24489998885 68999987654              34456777899999999999999   99999999999998  4


Q ss_pred             CCC--cEEEeecccceecccCC----CCccccccccCcccCchhhcccCC------CCCccchhhHHHHHHHHHhCCCCC
Q 002085          787 SEF--KAKIADFGLAKMLAKQG----EPHTMSAVAGSFGYFAPEYAYTTK------VNEKIDIYSFGVVLLELVTGKEAN  854 (969)
Q Consensus       787 ~~~--~~kl~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~elltg~~p~  854 (969)
                      +|+  ...++|||.+---...+    .........|.-..||||+....+      -..++|.|+.|.+.||++....||
T Consensus       378 dD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPF  457 (598)
T KOG4158|consen  378 DDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPF  457 (598)
T ss_pred             CCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcc
Confidence            444  47899999874321111    111122345778899999876432      235899999999999999999999


Q ss_pred             CCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002085          855 YGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL  921 (969)
Q Consensus       855 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L  921 (969)
                      +....-.+..         ..+.+.--+    ..+..++..+.+++...++.||++|++..-....|
T Consensus       458 Y~rGem~L~~---------r~Yqe~qLP----alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  458 YKRGEMLLDT---------RTYQESQLP----ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             cccchheech---------hhhhhhhCC----CCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence            9743222111         111111112    23344557788999999999999999866554443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=1.7e-20  Score=171.77  Aligned_cols=159  Identities=31%  Similarity=0.599  Sum_probs=78.9

Q ss_pred             eEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCC
Q 002085           75 VTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG  154 (969)
Q Consensus        75 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  154 (969)
                      +|.+.|+||.++ .+|+.+++|.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+.|||..
T Consensus        35 ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlty  111 (264)
T KOG0617|consen   35 ITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTY  111 (264)
T ss_pred             hhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccc
Confidence            444444444443 23444444444444444444444 44444444444444444444444 4444444444444444444


Q ss_pred             CCCCC-cCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccc
Q 002085          155 NNFSG-DIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIG  233 (969)
Q Consensus       155 N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~  233 (969)
                      |++.. .+|..|..|+.|+.|+|+.|.+. .+|..+++|++|+.|                          .+.+|++. 
T Consensus       112 nnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil--------------------------~lrdndll-  163 (264)
T KOG0617|consen  112 NNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQIL--------------------------SLRDNDLL-  163 (264)
T ss_pred             cccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEE--------------------------eeccCchh-
Confidence            44432 33444444444444444444444 444444444444444                          44444444 


Q ss_pred             cCchhhcCCCchhhhhccCCcCCCCCCchhhc
Q 002085          234 EIPEAMSNLSSLEILALNGNHLEGAIPSGLFL  265 (969)
Q Consensus       234 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  265 (969)
                      .+|..++.+++|++|.+.+|+++ .+|..++.
T Consensus       164 ~lpkeig~lt~lrelhiqgnrl~-vlppel~~  194 (264)
T KOG0617|consen  164 SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN  194 (264)
T ss_pred             hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence            45666777777777777777777 55655553

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=1.7e-18  Score=191.90  Aligned_cols=217  Identities=25%  Similarity=0.359  Sum_probs=163.5

Q ss_pred             HhccccCceeeEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC
Q 002085          690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC  769 (969)
Q Consensus       690 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~  769 (969)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+....            ..++|.....+..+++.||+|+|.. 
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~------------~~~d~~F~~s~~rdi~~Gl~ylh~s-   67 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED------------IKLDYFFILSFIRDISKGLAYLHNS-   67 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc------------cCccHHHHHHHHHHHHHHHHHHhcC-
Confidence            356789999999999999999999999999999999998743            3589999999999999999999976 


Q ss_pred             CCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCC-------CCCccchhhHHH
Q 002085          770 TPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-------VNEKIDIYSFGV  842 (969)
Q Consensus       770 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwslG~  842 (969)
                       +-..|+.++++|.++|....+|++|||+.................-..-|.|||.+....       .+.++||||||+
T Consensus        68 -~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~i  146 (484)
T KOG1023|consen   68 -PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGI  146 (484)
T ss_pred             -cceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHH
Confidence             233999999999999999999999999987653311122222223445799999987642       466799999999


Q ss_pred             HHHHHHhCCCCCCCCCccch-HHHHHHHhh-ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          843 VLLELVTGKEANYGDEHTSL-AEWAWRHYA-EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       843 il~elltg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      +++|+++.+.||........ .+.+..... .....+..+..    .  .+....+..++..||..+|++||++++|-..
T Consensus       147 i~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~----~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~  220 (484)
T KOG1023|consen  147 IMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL----L--NELPPELLLLVARCWEEIPEKRPSIEQIRSK  220 (484)
T ss_pred             HHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh----h--hhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence            99999999999976432222 122222111 11111111111    0  1333478999999999999999999999998


Q ss_pred             HhhcCC
Q 002085          921 LRRCCP  926 (969)
Q Consensus       921 L~~~~~  926 (969)
                      ++.+..
T Consensus       221 ~~~~~~  226 (484)
T KOG1023|consen  221 LLTINK  226 (484)
T ss_pred             hhhhcc
Confidence            887753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.74  E-value=2.5e-18  Score=198.48  Aligned_cols=229  Identities=22%  Similarity=0.284  Sum_probs=164.3

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      .+|..++.|-.|+||.||.+++..+.+++|.|+= +..        -+.+-  ++.....|.+|                
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~--------lilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN--------LILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhccc-ccc--------hhhhc--cccccCCccee----------------
Confidence            4788899999999999999999988999999643 211        11110  33333444444                


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                           |+=...++..+.             ++.        +.+.+++|+|+.   +|+|||+||+|.+|+.-|.+|+.|
T Consensus       136 -----gDc~tllk~~g~-------------lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTD  186 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGP-------------LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTD  186 (1205)
T ss_pred             -----chhhhhcccCCC-------------Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccc
Confidence                 333333333222             222        227889999988   999999999999999999999999


Q ss_pred             cccceecccCCC-----------C--ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccch
Q 002085          796 FGLAKMLAKQGE-----------P--HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL  862 (969)
Q Consensus       796 fgla~~~~~~~~-----------~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  862 (969)
                      ||++++......           .  -.....+||+.|.|||++....|...+|+|++|+++||.+.|+.||+++.++++
T Consensus       187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel  266 (1205)
T KOG0606|consen  187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL  266 (1205)
T ss_pred             hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence            999875321100           0  011345799999999999999999999999999999999999999999988776


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCcccccCCCCC
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSA  942 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~  942 (969)
                      ...+.....+-                              .+.|+.--|.++++++.|-+..+.++.+.. ++-++++|
T Consensus       267 fg~visd~i~w------------------------------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~-ga~evk~h  315 (1205)
T KOG0606|consen  267 FGQVISDDIEW------------------------------PEEDEALPPEAQDLIEQLLRQNPLCRLGTG-GALEVKQH  315 (1205)
T ss_pred             Hhhhhhhhccc------------------------------cccCcCCCHHHHHHHHHHHHhChHhhcccc-hhhhhhhc
Confidence            65543322110                              122344445677777777777777777777 66788999


Q ss_pred             CCCCcccceec
Q 002085          943 PLLGTAGYLFG  953 (969)
Q Consensus       943 ~~~~~~~~~~~  953 (969)
                      ++|+  +.+|.
T Consensus       316 ~ff~--~LDw~  324 (1205)
T KOG0606|consen  316 GFFQ--LLDWK  324 (1205)
T ss_pred             ccee--ecccc
Confidence            9999  66666

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=2.8e-17  Score=166.61  Aligned_cols=137  Identities=14%  Similarity=0.231  Sum_probs=105.9

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-----ccCceeeEEEEEEcCC---
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-----RHANIVKLWCCISSEN---  709 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---  709 (969)
                      +...+.||+|+||.||.  +..++.. +||++....   ....+.+.+|+++++.+     .||||++++++++++.   
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            45568899999999995  6555555 799885432   22346799999999999     5799999999998763   


Q ss_pred             ceE-EEEee--ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhh-hhhcccCCCCeEecCCCCCcEEE
Q 002085          710 SKL-LVYEY--MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL-CYMHHDCTPQIIHRDVKSSNILL  785 (969)
Q Consensus       710 ~~~-lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlkp~Nill  785 (969)
                      ..+ +|+||  +++++|.+++....              +++.  ..++.+++.++ +|||++   +|+||||||+||++
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~~--------------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl  138 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQCR--------------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILC  138 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHccc--------------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEE
Confidence            334 78999  56799999996532              3333  35677888777 999998   99999999999999


Q ss_pred             CCC----CcEEEeecccc
Q 002085          786 DSE----FKAKIADFGLA  799 (969)
Q Consensus       786 ~~~----~~~kl~Dfgla  799 (969)
                      +..    +.++|+||+.+
T Consensus       139 ~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        139 QRISESEVIPVVCDNIGE  156 (210)
T ss_pred             eccCCCCCcEEEEECCCC
Confidence            743    37999995443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=3.6e-17  Score=193.74  Aligned_cols=247  Identities=17%  Similarity=0.150  Sum_probs=179.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc---cCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR---HANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  712 (969)
                      +.|.+.+.||+|+||+||+|.... |+.||+|+-+....+.-.      -=.+++.+|+   -+-|+.+..++.-.+..+
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY------I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY------ICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee------ehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            467788899999999999999976 999999998666544322      2223344444   234444444455567789


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC-----
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-----  787 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----  787 (969)
                      +|+||.+.|+|.+++...             ..++|.-++.++.|++..+++||..   +|||+||||+|.++..     
T Consensus       771 lv~ey~~~Gtlld~~N~~-------------~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~  834 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTN-------------KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICAD  834 (974)
T ss_pred             eeeeccccccHHHhhccC-------------CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCC
Confidence            999999999999999843             4599999999999999999999998   9999999999999942     


Q ss_pred             --CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          788 --EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       788 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                        ...++|+|||.+-.+.-..+.......++|-.+-.+|...+..++.+.|-|.++.+++-|+.|+..-..++       
T Consensus       835 ~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g-------  907 (974)
T KOG1166|consen  835 SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNG-------  907 (974)
T ss_pred             CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCC-------
Confidence              24689999999976654434445667788999999999999999999999999999999999975321000       


Q ss_pred             HHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                ....++..++.....   ..+.++...+++.|=..=|...++...++++.
T Consensus       908 ----------~~~~~~~~~~Ry~~~---~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  908 ----------SSWMVKTNFPRYWKR---DMWNKFFDLLLNPDCDTLPNLQELRTELEEVL  954 (974)
T ss_pred             ----------cceeccccchhhhhH---HHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence                      000111111111111   23445566666633344478888888887765

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.71  E-value=6.6e-20  Score=203.20  Aligned_cols=251  Identities=25%  Similarity=0.287  Sum_probs=162.4

Q ss_pred             EEecCCCCC-CCCCccccCCCcccEEEccCCCCCCC----CCcccCCCCCCCEEeccCCcCCC------CCCCCcccCCC
Q 002085           78 ISLRHKDIT-QKIPPIICDLKNLTTIDLSSNSIPGE----FPEFLYNCTKLQNLDLSQNYFVG------PIPSDIDRISG  146 (969)
Q Consensus        78 l~l~~~~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~~  146 (969)
                      |+|..+.+. ......+..+.+|++|+++++.++..    ++..+...++|++|+++++.+.+      .++..+..+++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            556666665 33445566677788888888887532    55566677778888888887762      23345666778


Q ss_pred             CcEEecCCCCCCCcCCCcccCccc---ccceecccccccC----cCCcccCCC-CCcceeecccCCCCCC--CCCCcccc
Q 002085          147 LQCIDLGGNNFSGDIPRSIGRLSE---LQTLYLYMNEFNG----TFPKEIGDL-SNLEVLGLAYNSNFKP--AMIPIEFG  216 (969)
Q Consensus       147 L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~~~~~--~~~p~~~~  216 (969)
                      |+.|+|++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+...  ..++..+.
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~  162 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR  162 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence            888888888887656666655555   8888888888763    233345556 7788888888864421  12344566


Q ss_pred             ccCCCcEEEccCCccccc----CchhhcCCCchhhhhccCCcCCCCC----CchhhcCcccchhhccCcccccCCCCchh
Q 002085          217 MLKKLKTLWMTEANLIGE----IPEAMSNLSSLEILALNGNHLEGAI----PSGLFLLNNLTQLFLYDNILSGEIPSSVE  288 (969)
Q Consensus       217 ~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  288 (969)
                      .+++|++|++++|++.+.    ++..+..+++|++|+|++|.+++..    +..+..+++|++|++++|.+++.....+.
T Consensus       163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~  242 (319)
T cd00116         163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA  242 (319)
T ss_pred             hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence            677788888888777642    3344556678888888888876433    23344567788888888877642222221


Q ss_pred             -h-----cccccccccCccccc----cCCccccCcccchhhhhccccCcC
Q 002085          289 -A-----LKLTDIDLSMNNLTG----SIPEEFGKLKNLQLLGLFSNHLSG  328 (969)
Q Consensus       289 -~-----~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~  328 (969)
                       .     .+|+.|++++|.++.    .+...+..+++|+++++++|.++.
T Consensus       243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~  292 (319)
T cd00116         243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE  292 (319)
T ss_pred             HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence             1     257777777777751    233345556777777777777763

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=7.3e-17  Score=168.08  Aligned_cols=145  Identities=19%  Similarity=0.161  Sum_probs=111.5

Q ss_pred             CCCccceeeecCcEEEEEEE-EcCCCcEEEEEEEeccchh-------------------c--HHHHHHHHHHHHHHhccc
Q 002085          637 SLTESNLIGSGGSGQVYRID-INGAGEFVAVKRIWNNRKL-------------------N--QKLEKEFIAEIEILGTIR  694 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~-------------------~--~~~~~~~~~E~~~l~~l~  694 (969)
                      -|.+.+.||+|+||.||+|. +..+|+.||+|+++.....                   +  ......+.+|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            36677899999999999998 6668999999998643210                   0  012235678999999997


Q ss_pred             cC--ceeeEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCC
Q 002085          695 HA--NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQ  772 (969)
Q Consensus       695 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  772 (969)
                      +.  .+.+++++    ...++||||++|++|........             .....+...++.|++.++++||..   +
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~---g  168 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-------------EPEEEEEFELYDDILEEMRKLYKE---G  168 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-------------CcchHHHHHHHHHHHHHHHHHHhc---C
Confidence            53  34455543    23589999999988876542221             244556789999999999999988   8


Q ss_pred             -eEecCCCCCcEEECCCCcEEEeecccceec
Q 002085          773 -IIHRDVKSSNILLDSEFKAKIADFGLAKML  802 (969)
Q Consensus       773 -ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  802 (969)
                       |+||||||+||+++ ++.++++|||.+...
T Consensus       169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence             99999999999999 889999999998754

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.69  E-value=1.6e-19  Score=200.03  Aligned_cols=282  Identities=24%  Similarity=0.227  Sum_probs=164.3

Q ss_pred             EEEccCCCCC-CCCCcccCCCCCCCEEeccCCcCCCC----CCCCcccCCCCcEEecCCCCCCC------cCCCcccCcc
Q 002085          101 TIDLSSNSIP-GEFPEFLYNCTKLQNLDLSQNYFVGP----IPSDIDRISGLQCIDLGGNNFSG------DIPRSIGRLS  169 (969)
Q Consensus       101 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~------~~p~~~~~l~  169 (969)
                      .|+|+.+.++ +.....|..+.+|++|+|+++.+++.    ++..+...++|++|+++.+.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            5788888887 44556677788899999999998643    45556777889999999988862      2344567788


Q ss_pred             cccceecccccccCcCCcccCCCCC---cceeecccCCCCCC--CCCCcccccc-CCCcEEEccCCccccc----Cchhh
Q 002085          170 ELQTLYLYMNEFNGTFPKEIGDLSN---LEVLGLAYNSNFKP--AMIPIEFGML-KKLKTLWMTEANLIGE----IPEAM  239 (969)
Q Consensus       170 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~~~~~--~~~p~~~~~l-~~L~~L~L~~n~l~~~----~p~~~  239 (969)
                      +|+.|++++|.+.+..+..+..+.+   |++|++++|++...  ..+...+..+ ++|+.|++++|++++.    ++..+
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  161 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL  161 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence            8888899888887666666655555   88888888763311  1122334445 6667777777666632    23345


Q ss_pred             cCCCchhhhhccCCcCCCC----CCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCccc
Q 002085          240 SNLSSLEILALNGNHLEGA----IPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKN  315 (969)
Q Consensus       240 ~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~  315 (969)
                      ..+++|++|+|++|.+++.    ++..+..+++|+.|+|++|.+++....                   .++..+..+++
T Consensus       162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~-------------------~l~~~~~~~~~  222 (319)
T cd00116         162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS-------------------ALAETLASLKS  222 (319)
T ss_pred             HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH-------------------HHHHHhcccCC
Confidence            5556666666666666532    122233344566666666555422211                   12223444555


Q ss_pred             chhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccC----CCCcccccccCCCccccCCCcc
Q 002085          316 LQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSG----ELPTGLWTTFNLSSLMLSDNTI  391 (969)
Q Consensus       316 L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l  391 (969)
                      |++|++++|.+++.....+.         ..++   ...+.|+.|++++|.++.    .+...+..+++|+++++++|.+
T Consensus       223 L~~L~ls~n~l~~~~~~~l~---------~~~~---~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l  290 (319)
T cd00116         223 LEVLNLGDNNLTDAGAAALA---------SALL---SPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF  290 (319)
T ss_pred             CCEEecCCCcCchHHHHHHH---------HHHh---ccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCC
Confidence            66666666655531111100         0000   123566666666666651    2333444456677777777776


Q ss_pred             ccccCc----c---ccccccEEEeecccc
Q 002085          392 SGELPS----K---TAWNLTRLEISNNRF  413 (969)
Q Consensus       392 ~~~~~~----~---~~~~L~~L~Ls~N~l  413 (969)
                      +..-..    .   ..+.|+.|++.+|.+
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         291 GEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             cHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            643111    1   114677777766653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PLN03150 hypothetical protein; Provisional

Probab=99.67  E-value=1.9e-16  Score=188.09  Aligned_cols=148  Identities=32%  Similarity=0.562  Sum_probs=98.5

Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCCCCCCC----CCCcceeeCC------CeEEEEecCCCCCCCCCccccCCCccc
Q 002085           31 SPNTEERTILLNLKQQLGNPPSLQSWTSTSSPC----DWPEITCTFN------SVTGISLRHKDITQKIPPIICDLKNLT  100 (969)
Q Consensus        31 ~~~~~~~~all~~k~~~~~~~~l~sw~~~~~~c----~w~gv~C~~~------~v~~l~l~~~~l~~~~~~~~~~l~~L~  100 (969)
                      .+.++|..||+++|+++..+.. .+|.. +.||    .|.||.|+..      .|+.|+|+++++.|.+|+.++.+++|+
T Consensus       368 ~t~~~~~~aL~~~k~~~~~~~~-~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~  445 (623)
T PLN03150        368 KTLLEEVSALQTLKSSLGLPLR-FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ  445 (623)
T ss_pred             ccCchHHHHHHHHHHhcCCccc-CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCC
Confidence            4567899999999999976543 47863 3332    7999999632      266666666666666666666666666


Q ss_pred             EEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCc-ccccceecccc
Q 002085          101 TIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRL-SELQTLYLYMN  179 (969)
Q Consensus       101 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N  179 (969)
                      .|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++++++|++|+|++|+++|.+|..++.+ .++..+++.+|
T Consensus       446 ~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N  525 (623)
T PLN03150        446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN  525 (623)
T ss_pred             EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCC
Confidence            66666666666666666666666666666666666666666666666666666666666666665542 34445555555


Q ss_pred             c
Q 002085          180 E  180 (969)
Q Consensus       180 ~  180 (969)
                      .
T Consensus       526 ~  526 (623)
T PLN03150        526 A  526 (623)
T ss_pred             c
Confidence            4

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=6.7e-16  Score=159.85  Aligned_cols=137  Identities=23%  Similarity=0.331  Sum_probs=114.1

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc-----HHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN-----QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      +.||+|++|.||+|..  .|..|++|+........     ......+.+|++++..++|+++.....++.+....++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5789999999999988  57789999865432211     1223568899999999999998877777777788999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |++|++|.+++....                + .+..++.+++.+++++|+.   +++|||++|.||+++ ++.++++||
T Consensus        80 ~~~G~~L~~~~~~~~----------------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf  138 (211)
T PRK14879         80 YIEGEPLKDLINSNG----------------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDF  138 (211)
T ss_pred             EeCCcCHHHHHHhcc----------------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEEC
Confidence            999999999886421                2 7789999999999999988   999999999999999 789999999


Q ss_pred             cccee
Q 002085          797 GLAKM  801 (969)
Q Consensus       797 gla~~  801 (969)
                      |.++.
T Consensus       139 ~~a~~  143 (211)
T PRK14879        139 GLAEF  143 (211)
T ss_pred             CcccC
Confidence            98864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.65  E-value=4.7e-17  Score=176.38  Aligned_cols=176  Identities=30%  Similarity=0.448  Sum_probs=132.9

Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      .+.||.|++|+..+|.+|+...+..          ...+|.....++.|++.|+.|   +   +.+|||+||.||+...+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~----------e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d  392 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTG----------EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDD  392 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcc----------cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccc
Confidence            4578999999999999999866542          346788999999999999999   4   89999999999999999


Q ss_pred             CcEEEeecccceecccCC----CCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchH
Q 002085          789 FKAKIADFGLAKMLAKQG----EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLA  863 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~  863 (969)
                      ..+||+|||+........    .....+...||..||+||.+.+..|+.++||||+|++|+|++. -..++..       
T Consensus       393 ~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-------  465 (516)
T KOG1033|consen  393 DQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-------  465 (516)
T ss_pred             hhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-------
Confidence            999999999998765543    2334567789999999999999999999999999999999997 1112110       


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV  917 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev  917 (969)
                               .....++ +.+...+.....-+.-+.++.+++...|.+||++.+.
T Consensus       466 ---------~~t~~d~-r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  466 ---------IATLTDI-RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ---------HHhhhhh-hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence                     0001111 1111111111122344679999999999999955554

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=2.1e-15  Score=177.77  Aligned_cols=139  Identities=20%  Similarity=0.274  Sum_probs=112.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccch-----hcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-----LNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ..|...+.||+|+||.||+|.+..  ..+++|+......     ......+.+.+|+++++.++|++++....++.++..
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            445668999999999999998854  3345554321111     111234678999999999999999988878777778


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||++|++|.+++.                     ....++.+++.++.|||+.   +++|||+||+||++ +++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~  465 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDR  465 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCc
Confidence            899999999999998875                     2357899999999999988   99999999999999 6779


Q ss_pred             EEEeeccccee
Q 002085          791 AKIADFGLAKM  801 (969)
Q Consensus       791 ~kl~Dfgla~~  801 (969)
                      ++++|||+++.
T Consensus       466 ~~liDFGla~~  476 (535)
T PRK09605        466 LYLIDFGLGKY  476 (535)
T ss_pred             EEEEeCccccc
Confidence            99999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.63  E-value=1.3e-15  Score=156.03  Aligned_cols=133  Identities=23%  Similarity=0.298  Sum_probs=106.9

Q ss_pred             eeeecCcEEEEEEEEcCCCcEEEEEEEeccchh-----cHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL-----NQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       643 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      .||+|+||.||+|.+  +|..|++|+.......     .......+.+|++++..++|+++.....++.+....++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            479999999999986  5778999986432211     112236788999999999988765555555566678999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      ++|++|.+++....              .      .++.+++.+|+++|+.   +++|||++|.||+++ ++.++++|||
T Consensus        79 ~~g~~l~~~~~~~~--------------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg  134 (199)
T TIGR03724        79 IEGKPLKDVIEEGN--------------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFG  134 (199)
T ss_pred             ECCccHHHHHhhcH--------------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECC
Confidence            99999998875321              0      7899999999999988   999999999999999 7899999999


Q ss_pred             ccee
Q 002085          798 LAKM  801 (969)
Q Consensus       798 la~~  801 (969)
                      .++.
T Consensus       135 ~a~~  138 (199)
T TIGR03724       135 LGKY  138 (199)
T ss_pred             CCcC
Confidence            9865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.63  E-value=1.1e-15  Score=156.18  Aligned_cols=138  Identities=22%  Similarity=0.136  Sum_probs=107.8

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc-------------------HHHHHHHHHHHHHHhccccC--
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN-------------------QKLEKEFIAEIEILGTIRHA--  696 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~~~~E~~~l~~l~h~--  696 (969)
                      |...+.||+|+||.||++... +|+.||||++.......                   ......+..|..++..+.|+  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            666789999999999999875 79999999875432100                   01123467889999999877  


Q ss_pred             ceeeEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEec
Q 002085          697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHR  776 (969)
Q Consensus       697 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  776 (969)
                      .+...++    ....++||||++|++|.+....                   .....++.+++.++.++|+.   +|+||
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------------------~~~~~~~~~i~~~l~~lh~~---gi~H~  149 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-------------------EDPEEVLDEILEEIVKAYKH---GIIHG  149 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc-------------------ccHHHHHHHHHHHHHHHHHC---CCCcC
Confidence            4444443    2456899999999998765321                   23457889999999999988   99999


Q ss_pred             CCCCCcEEECCCCcEEEeecccceec
Q 002085          777 DVKSSNILLDSEFKAKIADFGLAKML  802 (969)
Q Consensus       777 Dlkp~Nill~~~~~~kl~Dfgla~~~  802 (969)
                      ||+|+||++++++.++|+|||.+...
T Consensus       150 Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         150 DLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCCcccEEEcCCCcEEEEECCccccC
Confidence            99999999999999999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.55  E-value=2.5e-14  Score=145.00  Aligned_cols=138  Identities=24%  Similarity=0.215  Sum_probs=98.5

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHH---------------------HHHHHHHHHhccccC--c
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEK---------------------EFIAEIEILGTIRHA--N  697 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~h~--n  697 (969)
                      .+.||+|+||+||+|... +++.||||++............                     ....|.+.+.++.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999886 7899999998654321111111                     114566666666443  2


Q ss_pred             eeeEEEEEEcCCceEEEEeeccCCCHHHH-hccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEe
Q 002085          698 IVKLWCCISSENSKLLVYEYMENQSLDRW-LHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIH  775 (969)
Q Consensus       698 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH  775 (969)
                      +.+.+++    ...++||||++++.+... +....              .. .....++.+++.++.++|. .   +|+|
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--------------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH  138 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--------------LL-EDPEELYDQILELMRKLYREA---GLVH  138 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh--------------hc-ccHHHHHHHHHHHHHHHhhcc---CcCc
Confidence            4444443    246899999998543211 11100              11 4677899999999999998 6   9999


Q ss_pred             cCCCCCcEEECCCCcEEEeecccceec
Q 002085          776 RDVKSSNILLDSEFKAKIADFGLAKML  802 (969)
Q Consensus       776 ~Dlkp~Nill~~~~~~kl~Dfgla~~~  802 (969)
                      |||||+||+++ ++.++++|||.+...
T Consensus       139 ~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         139 GDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCCChhhEEEE-CCcEEEEECcccccc
Confidence            99999999999 889999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=1.1e-15  Score=178.58  Aligned_cols=258  Identities=25%  Similarity=0.246  Sum_probs=194.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLL  713 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  713 (969)
                      ..|...+.||+|+|+.|-.+.... ....+|+|.+.... ...........|..+-..+. |+|++++++...+.+..++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            467778889999999998877643 34467777664432 22333455666888878886 9999999999999999999


Q ss_pred             EEeeccCCCHHHHhc-cCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhc-ccCCCCeEecCCCCCcEEECCCC-c
Q 002085          714 VYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMH-HDCTPQIIHRDVKSSNILLDSEF-K  790 (969)
Q Consensus       714 v~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~  790 (969)
                      ++||..|+++.+-+. ...            ...+....-....|+..++.|+| +.   ++.|||+||+|.+++..+ .
T Consensus        99 ~~~~s~g~~~f~~i~~~~~------------~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~  163 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS------------TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSA  163 (601)
T ss_pred             ccCcccccccccccccCCc------------cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCc
Confidence            999999999988873 221            12455567788999999999999 77   999999999999999999 9


Q ss_pred             EEEeecccceeccc-CCCCcccccccc-CcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          791 AKIADFGLAKMLAK-QGEPHTMSAVAG-SFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       791 ~kl~Dfgla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      .+++|||+|..+.. .+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............|
T Consensus       164 l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~  243 (601)
T KOG0590|consen  164 LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW  243 (601)
T ss_pred             ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee
Confidence            99999999998877 566666666778 9999999998885 44678999999999999999999987544332111100


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                         .+.+       ................++..+++..+|+.|.+..++..
T Consensus       244 ---~~~~-------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  244 ---KSNK-------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ---cccc-------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence               1100       00001112223356678888999999999999888754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=6.7e-14  Score=146.18  Aligned_cols=138  Identities=18%  Similarity=0.243  Sum_probs=106.0

Q ss_pred             cceee-ecCcEEEEEEEEcCCCcEEEEEEEeccch----------hcHHHHHHHHHHHHHHhccccCce--eeEEEEEEc
Q 002085          641 SNLIG-SGGSGQVYRIDINGAGEFVAVKRIWNNRK----------LNQKLEKEFIAEIEILGTIRHANI--VKLWCCISS  707 (969)
Q Consensus       641 ~~~lG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~  707 (969)
                      ...|| .||.|+||.+...  +..++||++.....          ........+.+|++++..++|+++  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45788 9999999998874  67899998853211          111234578899999999998774  667766433


Q ss_pred             C-Cc---eEEEEeeccC-CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCc
Q 002085          708 E-NS---KLLVYEYMEN-QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSN  782 (969)
Q Consensus       708 ~-~~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  782 (969)
                      . +.   .++||||++| .+|.+++....              ++.    ..+.+++.++++||+.   ||+||||||.|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~--------------l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~N  172 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEAP--------------LSE----EQWQAIGQLIARFHDA---GVYHADLNAHN  172 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcCC--------------CCH----HHHHHHHHHHHHHHHC---CCCCCCCCchh
Confidence            2 22   3599999997 69998876421              232    2367899999999998   99999999999


Q ss_pred             EEECCCCcEEEeeccccee
Q 002085          783 ILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       783 ill~~~~~~kl~Dfgla~~  801 (969)
                      ||++.++.++++|||.++.
T Consensus       173 ILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        173 ILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             EEEcCCCCEEEEECCCccc
Confidence            9999999999999999865

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.52  E-value=2.1e-15  Score=163.26  Aligned_cols=190  Identities=26%  Similarity=0.403  Sum_probs=152.4

Q ss_pred             cccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCC
Q 002085          292 LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGEL  371 (969)
Q Consensus       292 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  371 (969)
                      -...||+.|++. .+|..++.+..|+.+.|..|.+.                  .+|..++++..|++|||+.|+++ .+
T Consensus        77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r------------------~ip~~i~~L~~lt~l~ls~NqlS-~l  136 (722)
T KOG0532|consen   77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR------------------TIPEAICNLEALTFLDLSSNQLS-HL  136 (722)
T ss_pred             hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce------------------ecchhhhhhhHHHHhhhccchhh-cC
Confidence            345677777777 67777777778888888888777                  56666777777777777777777 66


Q ss_pred             CcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCcccc
Q 002085          372 PTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHL  451 (969)
Q Consensus       372 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  451 (969)
                      |..++.++                       |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|
T Consensus       137 p~~lC~lp-----------------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~sl  191 (722)
T KOG0532|consen  137 PDGLCDLP-----------------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSL  191 (722)
T ss_pred             ChhhhcCc-----------------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHH
Confidence            66665543                       666777777777 67888888899999999999998 889999999999


Q ss_pred             chhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCccccc---c-ccEEEe
Q 002085          452 NTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL---K-LNTFNL  527 (969)
Q Consensus       452 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l---~-L~~l~l  527 (969)
                      +.|.+..|++. .+|+++. .-.|..||+|.|+++ .||-.|.+|..|++|-|.+|+|. .-|..|+..   . .++|+.
T Consensus       192 r~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~  267 (722)
T KOG0532|consen  192 RDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLST  267 (722)
T ss_pred             HHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecc
Confidence            99999999999 6888888 456999999999998 89999999999999999999998 567776554   2 566776


Q ss_pred             ecC
Q 002085          528 SSN  530 (969)
Q Consensus       528 s~N  530 (969)
                      .-.
T Consensus       268 qA~  270 (722)
T KOG0532|consen  268 QAC  270 (722)
T ss_pred             hhc
Confidence            655

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.52  E-value=7.6e-14  Score=136.03  Aligned_cols=135  Identities=23%  Similarity=0.239  Sum_probs=113.0

Q ss_pred             ccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcccc--CceeeEEEEEEcCCceEEEEee
Q 002085          640 ESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH--ANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       640 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      +.+.||+|.++.||++...  +..+++|.......     ...+.+|+.+++.++|  .++++++++...++..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            3578999999999999985  36799998854322     4678899999999976  5899999988888889999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      ++++.+..+                    ++.....++.+++++++++|.....+++|+|++|+||++++.+.++++|||
T Consensus        75 ~~g~~~~~~--------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~  134 (155)
T cd05120          75 IEGETLDEV--------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWE  134 (155)
T ss_pred             cCCeecccC--------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecc
Confidence            988766532                    345667889999999999998644579999999999999998999999999


Q ss_pred             ccee
Q 002085          798 LAKM  801 (969)
Q Consensus       798 la~~  801 (969)
                      .++.
T Consensus       135 ~~~~  138 (155)
T cd05120         135 YAGY  138 (155)
T ss_pred             cccC
Confidence            9864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PLN03150 hypothetical protein; Provisional

Probab=99.49  E-value=3.6e-14  Score=168.79  Aligned_cols=116  Identities=35%  Similarity=0.613  Sum_probs=71.4

Q ss_pred             cchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeec
Q 002085          451 LNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSS  529 (969)
Q Consensus       451 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~  529 (969)
                      ++.|+|++|.++|.+|..+..+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..++.++ |+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            55566666666666666666666666666666666666666666666666666666666666666666664 66666666


Q ss_pred             CcCCCCCCcccccccc---cccccCCCCCCCCCCCCCCCCCCC
Q 002085          530 NKLYGNIPDEFNNLAY---DDSFLNNSNLCVKNPIINLPKCPS  569 (969)
Q Consensus       530 N~l~~~~p~~~~~~~~---~~~~~~n~~l~~~~~~~~l~~c~~  569 (969)
                      |+++|.+|..+.....   .-.+.+|+.+|+.+.   ++.|..
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~~  539 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACGP  539 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCCC---CCCCcc
Confidence            6666666665543211   123567777887432   456653

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.43  E-value=8.3e-15  Score=158.69  Aligned_cols=174  Identities=31%  Similarity=0.467  Sum_probs=111.8

Q ss_pred             CCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceee
Q 002085          120 CTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLG  199 (969)
Q Consensus       120 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  199 (969)
                      |+--...||+.|++. .+|..+..+..|+.|.|.+|.+. .+|..+++|..|++|||+.|+++ ..|..++.|+ |+.|-
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli  149 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI  149 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence            444445566666665 55666666666666666666665 56666666666666666666666 5555555554 55555


Q ss_pred             cccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCccc
Q 002085          200 LAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNIL  279 (969)
Q Consensus       200 L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  279 (969)
                      +++|+                           .+.+|+.++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++
T Consensus       150 ~sNNk---------------------------l~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l  201 (722)
T KOG0532|consen  150 VSNNK---------------------------LTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHL  201 (722)
T ss_pred             EecCc---------------------------cccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhh
Confidence            55553                           2344555555566666666666666 5566666666666666666666


Q ss_pred             ccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCc
Q 002085          280 SGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLS  327 (969)
Q Consensus       280 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  327 (969)
                      . .+|..+..+.|..||+|+|+++ .+|-.|.+|+.|++|-|.+|.+.
T Consensus       202 ~-~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  202 E-DLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             h-hCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence            6 3444444667777888888887 77888888888888888888887

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.39  E-value=2.6e-13  Score=154.76  Aligned_cols=180  Identities=37%  Similarity=0.529  Sum_probs=89.3

Q ss_pred             CCcccEEEccCCCCCCCCCcccCCCC-CCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccce
Q 002085           96 LKNLTTIDLSSNSIPGEFPEFLYNCT-KLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTL  174 (969)
Q Consensus        96 l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  174 (969)
                      ++.++.|++.+|.++ .+|.....++ +|++|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|
T Consensus       115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L  191 (394)
T COG4886         115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL  191 (394)
T ss_pred             ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence            344555555555555 4444444442 5555555555554 34444455555555555555555 444444444555555


Q ss_pred             ecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCc
Q 002085          175 YLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNH  254 (969)
Q Consensus       175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~  254 (969)
                      ++++|+++ .+|..+..+..|++|.+++|                          .. -..+..+.++.++..|.+.+|+
T Consensus       192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N--------------------------~~-~~~~~~~~~~~~l~~l~l~~n~  243 (394)
T COG4886         192 DLSGNKIS-DLPPEIELLSALEELDLSNN--------------------------SI-IELLSSLSNLKNLSGLELSNNK  243 (394)
T ss_pred             eccCCccc-cCchhhhhhhhhhhhhhcCC--------------------------cc-eecchhhhhcccccccccCCce
Confidence            55555554 44444334444555555544                          32 1233445555555555566665


Q ss_pred             CCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCc
Q 002085          255 LEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPE  308 (969)
Q Consensus       255 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~  308 (969)
                      +. .++..+..++++++|++++|+++. ++......+++.|++++|.+....|.
T Consensus       244 ~~-~~~~~~~~l~~l~~L~~s~n~i~~-i~~~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         244 LE-DLPESIGNLSNLETLDLSNNQISS-ISSLGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             ee-eccchhccccccceeccccccccc-cccccccCccCEEeccCccccccchh
Confidence            55 224455555556666666666652 22222222566666666666544443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.38  E-value=3.5e-13  Score=153.78  Aligned_cols=165  Identities=33%  Similarity=0.451  Sum_probs=108.2

Q ss_pred             CCCCCCCCc-cCcEEEcccccccCCCCcccccccCCCccccCCCccccccCcc-ccccccEEEeeccccCCCcccccCCc
Q 002085          347 VPKSLGNCR-TLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSK-TAWNLTRLEISNNRFSGQIQRGVGSW  424 (969)
Q Consensus       347 ~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~L~~L~Ls~N~l~~~~~~~~~~l  424 (969)
                      +|....... +|+.|++++|++. .+|..+..+++|+.|++++|+++...+.. ...+|+.|++++|+++ .+|..+...
T Consensus       131 i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~  208 (394)
T COG4886         131 IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL  208 (394)
T ss_pred             Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhh
Confidence            333333442 5666666666665 45555666666666666666666433333 4456666777777776 444444555


Q ss_pred             ccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEec
Q 002085          425 KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDL  504 (969)
Q Consensus       425 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  504 (969)
                      ..|++|.+++|.+. ..+..+..+.++..|.+++|++. .++..+..+++|++|++++|+++ .++. ++.+.+|+.||+
T Consensus       209 ~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~  284 (394)
T COG4886         209 SALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDL  284 (394)
T ss_pred             hhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEec
Confidence            66777777777544 55666777778888888888877 44677777777888888888887 4544 778888888888


Q ss_pred             cCccccccCCCcc
Q 002085          505 SGNQFSGEIPPEI  517 (969)
Q Consensus       505 s~N~l~g~~p~~~  517 (969)
                      ++|.++...|...
T Consensus       285 s~n~~~~~~~~~~  297 (394)
T COG4886         285 SGNSLSNALPLIA  297 (394)
T ss_pred             cCccccccchhhh
Confidence            8888875555443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.33  E-value=4.6e-12  Score=144.08  Aligned_cols=151  Identities=19%  Similarity=0.210  Sum_probs=103.2

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc-------------------------------HH---
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN-------------------------------QK---  678 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~---  678 (969)
                      +....|. .+.||+|++|+||+|+.. +|+.||||+.+......                               ++   
T Consensus       115 ~~F~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~  192 (437)
T TIGR01982       115 ELFAEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEK  192 (437)
T ss_pred             HHHhhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHH
Confidence            3444454 368999999999999986 68999999985431100                               00   


Q ss_pred             ---HHHHHHHHHHHHhccc----cCceeeEEEEE-EcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHH
Q 002085          679 ---LEKEFIAEIEILGTIR----HANIVKLWCCI-SSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT  750 (969)
Q Consensus       679 ---~~~~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~  750 (969)
                         .+-++.+|++.+.+++    |.+-+.+-..+ ......++||||++|++|.++......            ..   .
T Consensus       193 ~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~------------~~---~  257 (437)
T TIGR01982       193 TLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA------------GL---D  257 (437)
T ss_pred             HHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc------------CC---C
Confidence               0113556666666652    32223332222 234457999999999999887653211            11   2


Q ss_pred             HHHHHHHHHH-hhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecc
Q 002085          751 RLQIAIGAAQ-GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA  803 (969)
Q Consensus       751 ~~~i~~~ia~-~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~  803 (969)
                      +.+++..++. .+..+|..   |++|+|++|.||+++.++.++++|||++..+.
T Consensus       258 ~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       258 RKALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            3456666665 46778877   99999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=3.9e-12  Score=141.58  Aligned_cols=254  Identities=20%  Similarity=0.196  Sum_probs=184.7

Q ss_pred             hccCCCccceeee--cCcEEEEEEEE--cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC
Q 002085          634 ILSSLTESNLIGS--GGSGQVYRIDI--NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE  708 (969)
Q Consensus       634 ~~~~~~~~~~lG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  708 (969)
                      +...+.....+|+  |.+|.||.+..  ..++..+|+|.-+...... .....=.+|+...+.+ .|++.++....+.++
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p-~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP-LDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc-cccccccchhhcccccCccccccccCcccccC
Confidence            3456677788999  99999999988  8889999999854333211 2223445666666677 499999998999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHH----hhhhhcccCCCCeEecCCCCCcEE
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ----GLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                      +..|+-+|++. .+|..+.+....            .++....+.+..+..+    |+.++|..   .++|-|+||.||+
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~------------~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~  254 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCN------------FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIF  254 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccc------------cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhhee
Confidence            99999999994 888888776443            2455556666666666    99999988   9999999999999


Q ss_pred             ECCC-CcEEEeecccceecccCCCCccc---cccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 002085          785 LDSE-FKAKIADFGLAKMLAKQGEPHTM---SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT  860 (969)
Q Consensus       785 l~~~-~~~kl~Dfgla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~  860 (969)
                      ...+ ...+++|||+...+.........   ....|...|++||... +.++.++|+|++|.+..+..++..++..+...
T Consensus       255 ~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~  333 (524)
T KOG0601|consen  255 TTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS  333 (524)
T ss_pred             cccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence            9999 88999999999887665322221   2235778899999765 57899999999999999999998877654211


Q ss_pred             chHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          861 SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       861 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .     |.......         +...+......++...+..+++.+|-.|++++.+..
T Consensus       334 ~-----W~~~r~~~---------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  334 S-----WSQLRQGY---------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             C-----cccccccc---------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1     11111111         011111112244555889999999999999887754

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=1.8e-12  Score=131.82  Aligned_cols=202  Identities=22%  Similarity=0.301  Sum_probs=140.2

Q ss_pred             HhccccCceeeEEEEEEcC-----CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhh
Q 002085          690 LGTIRHANIVKLWCCISSE-----NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCY  764 (969)
Q Consensus       690 l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~  764 (969)
                      +-++-|.|+|++..|+.+.     .+..+++|||.-|++..+|++.++.         +..+......+|+.||..||.|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~---------~~a~~~~~wkkw~tqIlsal~y  191 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN---------QKALFQKAWKKWCTQILSALSY  191 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh---------hhhhhHHHHHHHHHHHHhhhhh
Confidence            3445699999999888654     3568999999999999999987653         2346666778999999999999


Q ss_pred             hcccCCCCeEecCCCCCcEEECCCCcEEEeeccccee--cccCCCCccccccccCcccCchhhcccCCCCCccchhhHHH
Q 002085          765 MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM--LAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGV  842 (969)
Q Consensus       765 LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~  842 (969)
                      ||+. +|.|+|+++.-+-|++..+|-+|++--.-...  ..............+-++|.+||+-.....+.++|||+||.
T Consensus       192 Lhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm  270 (458)
T KOG1266|consen  192 LHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM  270 (458)
T ss_pred             hhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence            9986 89999999999999999998888753211110  00001111122334678999999877777788999999999


Q ss_pred             HHHHHHhCCCCCCC-CCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          843 VLLELVTGKEANYG-DEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       843 il~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...||..+..-... .........+....           .++..       ..-..++.+|++..|..||+|.+++.
T Consensus       271 cAlemailEiq~tnseS~~~~ee~ia~~i-----------~~len-------~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  271 CALEMAILEIQSTNSESKVEVEENIANVI-----------IGLEN-------GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHHHHheeccCCCcceeehhhhhhhhe-----------eeccC-------ccccCcCcccccCCCCCCcchhhhhc
Confidence            99999988754322 22111111111100           00100       11134778999999999999999864

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.26  E-value=9.9e-12  Score=142.48  Aligned_cols=155  Identities=16%  Similarity=0.167  Sum_probs=101.2

Q ss_pred             chhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh--------------------------c-----HH
Q 002085          630 TESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL--------------------------N-----QK  678 (969)
Q Consensus       630 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~-----~~  678 (969)
                      ..++...+|.. +.||+|++|+||+|+...+|+.||||+.+.....                          +     ++
T Consensus       114 ~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e  192 (537)
T PRK04750        114 PVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE  192 (537)
T ss_pred             CHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence            34455667777 7999999999999999877999999998643210                          0     01


Q ss_pred             HHH------HHHHHHHHHhccc----cCceeeEEEEEEc-CCceEEEEeeccCCCHHHHh--ccCcCccccCCCCccccc
Q 002085          679 LEK------EFIAEIEILGTIR----HANIVKLWCCISS-ENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHV  745 (969)
Q Consensus       679 ~~~------~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~  745 (969)
                      ..+      ++.+|+.-+.+++    +...+.+-..+.+ ....+|||||++|+.+.++-  ...+.         ....
T Consensus       193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~---------d~~~  263 (537)
T PRK04750        193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT---------DMKL  263 (537)
T ss_pred             HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC---------CHHH
Confidence            112      2444554444442    3444444333333 45678999999999998752  21110         0111


Q ss_pred             CChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC----cEEEeecccceeccc
Q 002085          746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF----KAKIADFGLAKMLAK  804 (969)
Q Consensus       746 l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfgla~~~~~  804 (969)
                      +....+..++.|+.       ..   |++|+|++|.||+++.++    .++++|||++..+..
T Consensus       264 la~~~v~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        264 LAERGVEVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            22233334444443       34   999999999999999988    999999999987743

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.26  E-value=1.1e-10  Score=130.95  Aligned_cols=172  Identities=17%  Similarity=0.214  Sum_probs=130.8

Q ss_pred             EE-EEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccCCCHHHHhccC
Q 002085          652 VY-RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGR  730 (969)
Q Consensus       652 Vy-~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  730 (969)
                      +| .|..+.++.+|.|+..+....   .......+-++.++.+|||+|+++++.++..+..|||+|.+.  .|..++.+.
T Consensus        27 ~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l  101 (690)
T KOG1243|consen   27 LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL  101 (690)
T ss_pred             cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh
Confidence            44 466667888999988755432   334556677888999999999999999999999999999984  577777653


Q ss_pred             cCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCcc
Q 002085          731 KRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT  810 (969)
Q Consensus       731 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  810 (969)
                      .                ...+.-.+.||+.||.|||+.|  +++|++|....|+++..|..||++|.++......+.  .
T Consensus       102 ~----------------~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~  161 (690)
T KOG1243|consen  102 G----------------KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--P  161 (690)
T ss_pred             H----------------HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--c
Confidence            2                3456677899999999998664  899999999999999999999999998865433221  1


Q ss_pred             ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhC
Q 002085          811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG  850 (969)
Q Consensus       811 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg  850 (969)
                      .....--..|..|+.+....  -..|.|.|||++||++.|
T Consensus       162 ~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  162 AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            11222334566777543332  456999999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.16  E-value=1e-10  Score=116.36  Aligned_cols=131  Identities=21%  Similarity=0.198  Sum_probs=95.1

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCce-eeEEEEEEcCCceEEEEeecc
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI-VKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~  719 (969)
                      .+.++.|.++.||+++..  ++.|++|+......    ....+..|+++++.+.+.++ .+++.+.  ....++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence            356899999999999874  77899998744321    12346788999998865444 3444443  334589999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC--CCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC--TPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      |.++.+.    .              .   ....++.+++++++.||...  ..+++|+|++|.||+++ ++.++++|||
T Consensus        75 G~~l~~~----~--------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~  132 (170)
T cd05151          75 GSELLTE----D--------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWE  132 (170)
T ss_pred             CCccccc----c--------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecc
Confidence            9876532    0              0   11245678999999999872  12369999999999999 6689999999


Q ss_pred             ccee
Q 002085          798 LAKM  801 (969)
Q Consensus       798 la~~  801 (969)
                      .+..
T Consensus       133 ~a~~  136 (170)
T cd05151         133 YAGM  136 (170)
T ss_pred             cccC
Confidence            8753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.14  E-value=5e-12  Score=126.64  Aligned_cols=129  Identities=31%  Similarity=0.405  Sum_probs=105.0

Q ss_pred             cccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEcc
Q 002085          402 NLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLA  481 (969)
Q Consensus       402 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  481 (969)
                      .|++||||+|.|+ .+.+...-++.++.|++|+|.|... . .+..+++|+.||||+|.|+ .+-.+-..+-+.+.|.|+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceeee-h-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            5888888888888 4556677788899999999999833 2 3788999999999999998 677777788899999999


Q ss_pred             CccccCCCCcccccccccceEeccCccccc-cCCCcccccc-ccEEEeecCcCCCCC
Q 002085          482 RNELSGEIPKAIGSLLVMVSLDLSGNQFSG-EIPPEIGQLK-LNTFNLSSNKLYGNI  536 (969)
Q Consensus       482 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~-L~~l~ls~N~l~~~~  536 (969)
                      .|.|..  -..+++|-+|..||+++|+|.. .--..||.++ |+.+.|.+|++.+.+
T Consensus       361 ~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  361 QNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            999863  3568888999999999999974 1234688887 999999999998644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.14  E-value=5e-10  Score=111.42  Aligned_cols=139  Identities=13%  Similarity=0.094  Sum_probs=98.0

Q ss_pred             ceeeecCcEEEEEEEEcC------CCcEEEEEEEeccchh----------c---------HHHHHHH----HHHHHHHhc
Q 002085          642 NLIGSGGSGQVYRIDING------AGEFVAVKRIWNNRKL----------N---------QKLEKEF----IAEIEILGT  692 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~----------~---------~~~~~~~----~~E~~~l~~  692 (969)
                      ..||.|--+.||.|....      .+..+|||+.+.....          +         ....+.+    .+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997653      3578999987421100          0         1112233    389999999


Q ss_pred             ccc--CceeeEEEEEEcCCceEEEEeeccCCCHHH-HhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhh-ccc
Q 002085          693 IRH--ANIVKLWCCISSENSKLLVYEYMENQSLDR-WLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYM-HHD  768 (969)
Q Consensus       693 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~  768 (969)
                      +..  -++.+.+++    ...++||||+.++.+.. .++.              ..++......+..+++.+|..+ |+.
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--------------~~~~~~~~~~i~~~i~~~l~~l~H~~  144 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--------------AKLNDEEMKNAYYQVLSMMKQLYKEC  144 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--------------cccCHHHHHHHHHHHHHHHHHHHHhC
Confidence            842  456666654    46789999997653321 1111              1233445667889999999999 777


Q ss_pred             CCCCeEecCCCCCcEEECCCCcEEEeecccceec
Q 002085          769 CTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML  802 (969)
Q Consensus       769 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  802 (969)
                         ++||+||++.||+++ ++.+.++|||.+...
T Consensus       145 ---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         145 ---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             ---CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence               999999999999997 468999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.12  E-value=1.5e-11  Score=143.17  Aligned_cols=212  Identities=21%  Similarity=0.247  Sum_probs=152.3

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +.+.+.+-+-+|+++.++.++-...|...+.|+....-.......+...++-.+.-..++|.+++....+......++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            45556677889999999998877777666666553322111111233333333333345677777665555677889999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      +|..+++|...++..+.             .+..........+..+.+|||..   .+.|||++|.|.+...++..++.|
T Consensus       884 ~~~~~~~~~Skl~~~~~-------------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~  947 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGC-------------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD  947 (1205)
T ss_pred             HHhccCCchhhhhcCCC-------------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence            99999999999987552             23333344556677889999986   699999999999999999999999


Q ss_pred             cccceecccC---------------------C--------CCccccccccCcccCchhhcccCCCCCccchhhHHHHHHH
Q 002085          796 FGLAKMLAKQ---------------------G--------EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLE  846 (969)
Q Consensus       796 fgla~~~~~~---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~e  846 (969)
                      ||......-.                     .        +........||+.|.+||...+......+|+|+.|++++|
T Consensus       948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen  948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred             cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence            9843322100                     0        0011223468999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCccchH
Q 002085          847 LVTGKEANYGDEHTSLA  863 (969)
Q Consensus       847 lltg~~p~~~~~~~~~~  863 (969)
                      .++|..||.........
T Consensus      1028 ~l~g~pp~na~tpq~~f 1044 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQQIF 1044 (1205)
T ss_pred             hhcCCCCCCCcchhhhh
Confidence            99999999877665443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.09  E-value=1e-09  Score=104.65  Aligned_cols=134  Identities=25%  Similarity=0.312  Sum_probs=102.2

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH-----HHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ-----KLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      ..+++|+-+.+|.+.+.  |.++++|.-.+...-.+     -...+..+|++++.+++--.|....-+..+++...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            35789999999999774  55677775432222221     123568889999999875555554556668888999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |++|..|.+++....                    ..++..+-.-+.-||..   ||+|+||.++||++..++ +.++||
T Consensus        80 ~I~G~~lkd~l~~~~--------------------~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf  135 (204)
T COG3642          80 YIEGELLKDALEEAR--------------------PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF  135 (204)
T ss_pred             EeCChhHHHHHHhcc--------------------hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence            999999998887531                    35667777777889998   999999999999998875 999999


Q ss_pred             cccee
Q 002085          797 GLAKM  801 (969)
Q Consensus       797 gla~~  801 (969)
                      |++.+
T Consensus       136 GLg~~  140 (204)
T COG3642         136 GLGEF  140 (204)
T ss_pred             Ccccc
Confidence            99864

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.06  E-value=9e-11  Score=114.34  Aligned_cols=83  Identities=30%  Similarity=0.440  Sum_probs=18.0

Q ss_pred             CCCcccEEEccCCCCCCCCCcccC-CCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcc-cCccccc
Q 002085           95 DLKNLTTIDLSSNSIPGEFPEFLY-NCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSI-GRLSELQ  172 (969)
Q Consensus        95 ~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~  172 (969)
                      +...+++|+|++|+|+ .+. .++ .+.+|+.|+||+|.|+. ++ .+..+++|++|++++|.|+ .++..+ ..+++|+
T Consensus        17 n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~   91 (175)
T PF14580_consen   17 NPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ   91 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred             cccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence            3445566666666665 222 233 35566666666666652 22 3555556666666666665 333333 2455555


Q ss_pred             ceeccccccc
Q 002085          173 TLYLYMNEFN  182 (969)
Q Consensus       173 ~L~L~~N~l~  182 (969)
                      +|+|++|+|.
T Consensus        92 ~L~L~~N~I~  101 (175)
T PF14580_consen   92 ELYLSNNKIS  101 (175)
T ss_dssp             EEE-TTS---
T ss_pred             EEECcCCcCC
Confidence            5555555554

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.06  E-value=5.4e-11  Score=135.81  Aligned_cols=102  Identities=27%  Similarity=0.366  Sum_probs=45.6

Q ss_pred             CCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCccccccee
Q 002085           96 LKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLY  175 (969)
Q Consensus        96 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  175 (969)
                      +..++.+++..|.|. .+-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|.|+...  .+..++.|+.|+
T Consensus        71 l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~  146 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN  146 (414)
T ss_pred             hHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence            344444445555554 22233444555555555555554 22222444555555555555554222  233444455555


Q ss_pred             cccccccCcCCcccCCCCCcceeecccC
Q 002085          176 LYMNEFNGTFPKEIGDLSNLEVLGLAYN  203 (969)
Q Consensus       176 L~~N~l~~~~p~~~~~l~~L~~L~L~~N  203 (969)
                      +++|.|+..  ..+..++.|+.+++++|
T Consensus       147 l~~N~i~~~--~~~~~l~~L~~l~l~~n  172 (414)
T KOG0531|consen  147 LSGNLISDI--SGLESLKSLKLLDLSYN  172 (414)
T ss_pred             eccCcchhc--cCCccchhhhcccCCcc
Confidence            555555421  12333444444444444

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.05  E-value=1.6e-10  Score=128.86  Aligned_cols=249  Identities=20%  Similarity=0.178  Sum_probs=175.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEc-CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDIN-GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKL  712 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  712 (969)
                      ..+|..+..||.|.|+.||+.... .++..|++|.+......... ...-..|+.+...+ .|.+++++...+..-...|
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-DIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-hhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            446778899999999999987765 56778999987654432222 23344566666666 5999999888877777788


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC-CcE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKA  791 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~  791 (969)
                      +=-||++++++.....-             ...++...++++..|++.++.++|+.   .++|+|+||+||++..+ +..
T Consensus       343 ip~e~~~~~s~~l~~~~-------------~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~  406 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVT-------------SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFS  406 (524)
T ss_pred             CchhhhcCcchhhhhHH-------------HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhh
Confidence            99999999988766621             23477788899999999999999977   99999999999999886 788


Q ss_pred             EEeecccceecccCCCCccccccccCccc-CchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGY-FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      +++|||.++.+.-    ........+..| .+|+......+-.+.|++|||..+.|.+++.........     |.  ..
T Consensus       407 ~~~~~~~~t~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----~~--~i  475 (524)
T KOG0601|consen  407 KLGDFGCWTRLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----SL--TI  475 (524)
T ss_pred             hccccccccccce----ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----ce--ee
Confidence            9999998864211    111112233334 355666667788999999999999999998754322111     00  00


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR  922 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~  922 (969)
                      ..          +. .+........+..+.+.+...|+..||.+.++..+.+
T Consensus       476 ~~----------~~-~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  476 RS----------GD-TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ec----------cc-ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            00          00 0111112255667788888999999999988876443

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.05  E-value=2.8e-10  Score=138.23  Aligned_cols=105  Identities=30%  Similarity=0.397  Sum_probs=64.9

Q ss_pred             cccEEEccCCC--CCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCccccccee
Q 002085           98 NLTTIDLSSNS--IPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLY  175 (969)
Q Consensus        98 ~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  175 (969)
                      +|++|-+.+|.  +.....+.|..++.|++||||+|.=-+.+|..++.|-+|++|+|+++.++ .+|..+++|.+|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            46666666664  33233334556666666666666554566666666666666666666666 6666666666666666


Q ss_pred             cccccccCcCCcccCCCCCcceeecccC
Q 002085          176 LYMNEFNGTFPKEIGDLSNLEVLGLAYN  203 (969)
Q Consensus       176 L~~N~l~~~~p~~~~~l~~L~~L~L~~N  203 (969)
                      +..+.-...+|.....|++|++|.+...
T Consensus       625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  625 LEVTGRLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             cccccccccccchhhhcccccEEEeecc
Confidence            6666554455555555666666666544

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.05  E-value=7.6e-11  Score=114.86  Aligned_cols=127  Identities=24%  Similarity=0.335  Sum_probs=48.0

Q ss_pred             cCCCCCCCEEeccCCcCCCCCCCCcc-cCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCccc-CCCCC
Q 002085          117 LYNCTKLQNLDLSQNYFVGPIPSDID-RISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEI-GDLSN  194 (969)
Q Consensus       117 ~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~  194 (969)
                      +.+..++++|+|++|.|+. + +.++ .+.+|+.|||++|.|+ .++ .+..++.|++|++++|+|+. ++..+ ..+++
T Consensus        15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~   89 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN   89 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred             ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence            4556678888888888873 3 2455 5778888888888887 343 57778888888888888884 43334 35788


Q ss_pred             cceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCch----hhcCCCchhhhhc
Q 002085          195 LEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE----AMSNLSSLEILAL  250 (969)
Q Consensus       195 L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~----~~~~l~~L~~L~L  250 (969)
                      |++|++++|++.....+ ..+..+++|+.|+|.+|.+... +.    .+..+++|+.||-
T Consensus        90 L~~L~L~~N~I~~l~~l-~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   90 LQELYLSNNKISDLNEL-EPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             --EEE-TTS---SCCCC-GGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred             CCEEECcCCcCCChHHh-HHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence            88888888876555443 4567788888888888877644 32    4667888887774

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.04  E-value=2e-11  Score=122.45  Aligned_cols=109  Identities=29%  Similarity=0.332  Sum_probs=78.4

Q ss_pred             ccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEc
Q 002085          401 WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNL  480 (969)
Q Consensus       401 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  480 (969)
                      +.++.|++|+|.|+.+.  .+..+++|+.||||+|.++ .+-.+-..+.+.+.|.|++|.|..  -+.+..+-+|.+||+
T Consensus       307 Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl  381 (490)
T KOG1259|consen  307 PKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDL  381 (490)
T ss_pred             cceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccc
Confidence            45556666666665332  2666777777777777777 444444567788888888888862  245677888999999


Q ss_pred             cCccccCCC-CcccccccccceEeccCccccccCCC
Q 002085          481 ARNELSGEI-PKAIGSLLVMVSLDLSGNQFSGEIPP  515 (969)
Q Consensus       481 s~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p~  515 (969)
                      ++|+|...- -..+++|+-|+.|.|.+|++++ +|.
T Consensus       382 ~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~-~vd  416 (490)
T KOG1259|consen  382 SSNQIEELDEVNHIGNLPCLETLRLTGNPLAG-SVD  416 (490)
T ss_pred             cccchhhHHHhcccccccHHHHHhhcCCCccc-cch
Confidence            999997432 3578999999999999999984 443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.02  E-value=7.9e-11  Score=134.43  Aligned_cols=247  Identities=26%  Similarity=0.283  Sum_probs=124.0

Q ss_pred             CCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhh
Q 002085          242 LSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGL  321 (969)
Q Consensus       242 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  321 (969)
                      +..++.+++..|.+.. +-..+..+.+|+.|++.+|+|.......-...+|++|++++|.|+..  ..+..++.|+.|++
T Consensus        71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l  147 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNL  147 (414)
T ss_pred             hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccc--cchhhccchhhhee
Confidence            4455555566666552 22334555566666666666553222111122455555555555533  23444555666666


Q ss_pred             ccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccc
Q 002085          322 FSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAW  401 (969)
Q Consensus       322 ~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  401 (969)
                      ++|.|+..                   ..+..+..|+.+++++|++...-+.....+.+++.+++.+|.+...       
T Consensus       148 ~~N~i~~~-------------------~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i-------  201 (414)
T KOG0531|consen  148 SGNLISDI-------------------SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREI-------  201 (414)
T ss_pred             ccCcchhc-------------------cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcc-------
Confidence            66666521                   1233355566666666666522220024444555555555554422       


Q ss_pred             cccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEcc
Q 002085          402 NLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLA  481 (969)
Q Consensus       402 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  481 (969)
                                       ..+..+..+..+++..|.++..-+.....+.+|+.+++++|++. .++..+..+..+..|+++
T Consensus       202 -----------------~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~  263 (414)
T KOG0531|consen  202 -----------------EGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLS  263 (414)
T ss_pred             -----------------cchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccc-cccccccccccccccchh
Confidence                             22333344444455555555322211111113677777777776 344556666677777777


Q ss_pred             CccccCCCCcccccccccceEeccCccccc---cCCCc-cccc-cccEEEeecCcCCCCCC
Q 002085          482 RNELSGEIPKAIGSLLVMVSLDLSGNQFSG---EIPPE-IGQL-KLNTFNLSSNKLYGNIP  537 (969)
Q Consensus       482 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g---~~p~~-~~~l-~L~~l~ls~N~l~~~~p  537 (969)
                      +|++...  ..+.....+..+.++.|.+..   ..... .+.. .+..+.+..|......+
T Consensus       264 ~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  264 SNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             hcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            7777632  234455666667777777653   11111 2222 36666777776665444

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.01  E-value=2.1e-11  Score=125.68  Aligned_cols=244  Identities=24%  Similarity=0.314  Sum_probs=137.7

Q ss_pred             CCeEEEEecCCCCCCC----CCccccCCCcccEEEccCC---CCCCCCCcc-------cCCCCCCCEEeccCCcCCCCCC
Q 002085           73 NSVTGISLRHKDITQK----IPPIICDLKNLTTIDLSSN---SIPGEFPEF-------LYNCTKLQNLDLSQNYFVGPIP  138 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~----~~~~~~~l~~L~~L~L~~n---~l~~~~p~~-------~~~l~~L~~L~Ls~N~l~~~~p  138 (969)
                      .+++.|+|++|.+.-.    +.+.+.+.++|+..++|+-   ++...+|+.       +..+++|++||||.|-|.-.-+
T Consensus        30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~  109 (382)
T KOG1909|consen   30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI  109 (382)
T ss_pred             CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence            4678888888877433    4455667778888887763   233344433       3445677777777777764444


Q ss_pred             CCc----ccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCC--CC
Q 002085          139 SDI----DRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAM--IP  212 (969)
Q Consensus       139 ~~l----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~--~p  212 (969)
                      ..|    .++..|++|.|.+|.+...--..++.  .|..|.  .|+       -.+.-+.|+++..++|++...+.  +.
T Consensus       110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ga~~~A  178 (382)
T KOG1909|consen  110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENGGATALA  178 (382)
T ss_pred             HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccccHHHHH
Confidence            333    44566777777777665221111111  122221  111       11223456666666665332221  22


Q ss_pred             ccccccCCCcEEEccCCccccc----CchhhcCCCchhhhhccCCcCCCC----CCchhhcCcccchhhccCcccccCCC
Q 002085          213 IEFGMLKKLKTLWMTEANLIGE----IPEAMSNLSSLEILALNGNHLEGA----IPSGLFLLNNLTQLFLYDNILSGEIP  284 (969)
Q Consensus       213 ~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~  284 (969)
                      ..|...+.|+.+.+..|.+...    +...|..+++|+.|||.+|-++..    +...+..+++|+.|++++|.+...-.
T Consensus       179 ~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga  258 (382)
T KOG1909|consen  179 EAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGA  258 (382)
T ss_pred             HHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccH
Confidence            2355556666666665554322    233566777777777777777532    23344456677777777777764433


Q ss_pred             Cchh----h--cccccccccCccccc----cCCccccCcccchhhhhccccCc
Q 002085          285 SSVE----A--LKLTDIDLSMNNLTG----SIPEEFGKLKNLQLLGLFSNHLS  327 (969)
Q Consensus       285 ~~~~----~--~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~  327 (969)
                      ..+.    .  .+|+.|.+.+|.++.    .+.......+.|..|+|++|.+.
T Consensus       259 ~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  259 IAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            3332    1  257788888887763    22334556788999999999984

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.01  E-value=1.4e-10  Score=122.83  Aligned_cols=207  Identities=25%  Similarity=0.251  Sum_probs=98.4

Q ss_pred             cCCCCcEEecCCCCCCCcCC--CcccCcccccceecccccccCcCC--cccCCCCCcceeecccCCCCCCCCCCcccccc
Q 002085          143 RISGLQCIDLGGNNFSGDIP--RSIGRLSELQTLYLYMNEFNGTFP--KEIGDLSNLEVLGLAYNSNFKPAMIPIEFGML  218 (969)
Q Consensus       143 ~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l  218 (969)
                      ++.+|+...|.+.... ..+  .....|++++.||||+|-|....|  .-...|++|+.|+|+.|++.....- ..-..+
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s-~~~~~l  196 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISS-NTTLLL  196 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccc-cchhhh
Confidence            3444555555554443 222  133445555555555555542221  2234455555555555542211100 001144


Q ss_pred             CCCcEEEccCCccccc-CchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccc
Q 002085          219 KKLKTLWMTEANLIGE-IPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDL  297 (969)
Q Consensus       219 ~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L  297 (969)
                      +.|+.|.|+.|+++-. +-..+..+++|+.|+|..|...+.......-+..|+.|+|++|                    
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N--------------------  256 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNN--------------------  256 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCC--------------------
Confidence            5666666666666532 2223445666666666666422222222223444445554444                    


Q ss_pred             cCccccccCC--ccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCC-----CCCCccCcEEEcccccccCC
Q 002085          298 SMNNLTGSIP--EEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKS-----LGNCRTLRTVQLYSNRFSGE  370 (969)
Q Consensus       298 s~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~-----l~~l~~L~~L~L~~N~l~~~  370 (969)
                         ++-. .+  ...+.++.|+.|+++.+.+...                .+|+.     ...+++|++|+++.|++. .
T Consensus       257 ---~li~-~~~~~~~~~l~~L~~Lnls~tgi~si----------------~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~  315 (505)
T KOG3207|consen  257 ---NLID-FDQGYKVGTLPGLNQLNLSSTGIASI----------------AEPDVESLDKTHTFPKLEYLNISENNIR-D  315 (505)
T ss_pred             ---cccc-cccccccccccchhhhhccccCcchh----------------cCCCccchhhhcccccceeeecccCccc-c
Confidence               4431 22  2355677777788777777631                22222     344567777777777774 1


Q ss_pred             CC--cccccccCCCccccCCCccc
Q 002085          371 LP--TGLWTTFNLSSLMLSDNTIS  392 (969)
Q Consensus       371 ~p--~~~~~l~~L~~L~Ls~N~l~  392 (969)
                      .+  ..+..+.+|+.|....|.|+
T Consensus       316 w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  316 WRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             ccccchhhccchhhhhhccccccc
Confidence            11  22333444444444444443

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.01  E-value=1.9e-11  Score=125.98  Aligned_cols=224  Identities=23%  Similarity=0.264  Sum_probs=160.2

Q ss_pred             ccccCCCcccEEEccCCCCCC----CCCcccCCCCCCCEEeccCC---cCCCCCCCC-------cccCCCCcEEecCCCC
Q 002085           91 PIICDLKNLTTIDLSSNSIPG----EFPEFLYNCTKLQNLDLSQN---YFVGPIPSD-------IDRISGLQCIDLGGNN  156 (969)
Q Consensus        91 ~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N---~l~~~~p~~-------l~~l~~L~~L~L~~N~  156 (969)
                      +.+.....++.|+||+|.+..    .+.+.+.+.++|+.-++|+=   ++...+|+.       +...++|++||||+|.
T Consensus        24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA  103 (382)
T KOG1909|consen   24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA  103 (382)
T ss_pred             HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence            455677889999999999863    35566788889999999853   223345544       3455799999999999


Q ss_pred             CCCcCCCc----ccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccc
Q 002085          157 FSGDIPRS----IGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLI  232 (969)
Q Consensus       157 l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~  232 (969)
                      |...-++.    +.+++.|++|+|.+|-+...-...++.  .|..|.  .|.         ..+.-++|+.+...+|.+-
T Consensus       104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k---------k~~~~~~Lrv~i~~rNrle  170 (382)
T KOG1909|consen  104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK---------KAASKPKLRVFICGRNRLE  170 (382)
T ss_pred             cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh---------ccCCCcceEEEEeeccccc
Confidence            98655554    456788999999999876222222221  233333  221         2344578999999998875


Q ss_pred             ccC----chhhcCCCchhhhhccCCcCCC----CCCchhhcCcccchhhccCcccccCCCCchh----hc-ccccccccC
Q 002085          233 GEI----PEAMSNLSSLEILALNGNHLEG----AIPSGLFLLNNLTQLFLYDNILSGEIPSSVE----AL-KLTDIDLSM  299 (969)
Q Consensus       233 ~~~----p~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~----~~-~L~~L~Ls~  299 (969)
                      ...    ...|...+.|+.+.++.|.|..    .+...+..+++|+.|||.+|.++..-...+.    .. +|+.|++++
T Consensus       171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~d  250 (382)
T KOG1909|consen  171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGD  250 (382)
T ss_pred             cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccc
Confidence            443    3357778899999999999852    2344667899999999999999854333332    22 599999999


Q ss_pred             ccccccCCccc-----cCcccchhhhhccccCc
Q 002085          300 NNLTGSIPEEF-----GKLKNLQLLGLFSNHLS  327 (969)
Q Consensus       300 N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~  327 (969)
                      +.+......+|     ...++|+.|.+.+|.++
T Consensus       251 cll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  251 CLLENEGAIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             cccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence            99986544443     34789999999999987

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.99  E-value=6.9e-11  Score=125.14  Aligned_cols=181  Identities=20%  Similarity=0.179  Sum_probs=123.5

Q ss_pred             cCcccchhhhhccccCcCcCCcccccccccCcccccCC--CCCCCCccCcEEEcccccccCC--CCcccccccCCCcccc
Q 002085          311 GKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVP--KSLGNCRTLRTVQLYSNRFSGE--LPTGLWTTFNLSSLML  386 (969)
Q Consensus       311 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L  386 (969)
                      .++++|+.+.|.+.....                  .+  .....|+.++.||||.|-|..-  +-.-...+++|+.|+|
T Consensus       118 sn~kkL~~IsLdn~~V~~------------------~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNl  179 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVED------------------AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNL  179 (505)
T ss_pred             hhHHhhhheeecCccccc------------------cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhccc
Confidence            356677777777766552                  11  2455788899999999988732  3334456889999999


Q ss_pred             CCCccccccCcc---ccccccEEEeeccccCCC-cccccCCcccchhhcccCCccccccCccccCccccchhhccCcccC
Q 002085          387 SDNTISGELPSK---TAWNLTRLEISNNRFSGQ-IQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLS  462 (969)
Q Consensus       387 s~N~l~~~~~~~---~~~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  462 (969)
                      +.|++.-...+.   ....|+.|.|+.|.|+.. +......+++|..|+|..|..-++.......+..|+.|||++|++-
T Consensus       180 s~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li  259 (505)
T KOG3207|consen  180 SSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI  259 (505)
T ss_pred             ccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc
Confidence            999887544432   335788888888888732 2233456788888888888543344455556778888888888876


Q ss_pred             CCCC--cccccccCCCEEEccCccccCC-CCcc-----cccccccceEeccCcccc
Q 002085          463 GKLP--SQIVSWTSLNNLNLARNELSGE-IPKA-----IGSLLVMVSLDLSGNQFS  510 (969)
Q Consensus       463 ~~~p--~~~~~l~~L~~L~Ls~N~l~~~-~p~~-----~~~l~~L~~L~ls~N~l~  510 (969)
                       ..+  ...+.++.|+.|+++.+.++.. +|+.     ...+++|++|+++.|++.
T Consensus       260 -~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  260 -DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             -ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence             334  4466778888888888887643 3433     355678888888888875

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.98  E-value=5.3e-09  Score=98.95  Aligned_cols=146  Identities=21%  Similarity=0.283  Sum_probs=108.3

Q ss_pred             ccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh-----cHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          640 ESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL-----NQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       640 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      ....+-+|+-+.|+++.+  .|+...||.-.....-     .+-..++..+|++.+.+++--.|.--.-++.|...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            457789999999999988  4888888854333221     223356789999999998644444334456677778899


Q ss_pred             EeeccC-CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC---c
Q 002085          715 YEYMEN-QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF---K  790 (969)
Q Consensus       715 ~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~  790 (969)
                      |||++| .++.+++...-..           ..........+..|-+.+.-||..   +|+|+||..+||++..++   .
T Consensus        89 ME~~~g~~~vk~~i~~~~~~-----------~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~  154 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMED-----------ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQIT  154 (229)
T ss_pred             EEeccchhHHHHHHHHHccC-----------cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCc
Confidence            999986 5888888865431           122223367888999999999998   999999999999997665   4


Q ss_pred             EEEeeccccee
Q 002085          791 AKIADFGLAKM  801 (969)
Q Consensus       791 ~kl~Dfgla~~  801 (969)
                      +.++|||++..
T Consensus       155 ~~lIdfgls~~  165 (229)
T KOG3087|consen  155 PILIDFGLSSV  165 (229)
T ss_pred             eEEEeecchhc
Confidence            68999999853

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.95  E-value=2.2e-08  Score=106.01  Aligned_cols=264  Identities=13%  Similarity=0.120  Sum_probs=162.3

Q ss_pred             CccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEE------EEcC-Cc
Q 002085          639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCC------ISSE-NS  710 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~-~~  710 (969)
                      ..++.||+|+-+.+|...-.  + .-+-|+++......+      ...+..|... .||-+-.=+.|      ..++ ..
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchh--h-chhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            45678999999999964332  1 235577755432111      1223344554 57654432222      1122 23


Q ss_pred             eEEEEeeccCC-CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          711 KLLVYEYMENQ-SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       711 ~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++|+.+++. ....+...       .....+.....|.-.++++..+|.+.+.||+.   |.+-+|+.++|+|+++++
T Consensus        85 iGflmP~v~g~~pI~~~y~p-------~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~  154 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSP-------ATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDS  154 (637)
T ss_pred             eEEecccCCCccchhhhcCc-------hhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCc
Confidence            67888888764 22222221       11222345689999999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhC-CCCCCCC-----C
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTG-KEANYGD-----E  858 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg-~~p~~~~-----~  858 (969)
                      .|.+.|=..-...   .........+|...|.+||.-.     +..-+...|.|.+||++++++.| ++||.+-     .
T Consensus       155 ~V~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a  231 (637)
T COG4248         155 KVVLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA  231 (637)
T ss_pred             eEEEEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence            9999986543332   2223344567999999999654     33456789999999999999997 7888652     1


Q ss_pred             ccchH-HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHHhhc
Q 002085          859 HTSLA-EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTL--PSSRPSMKEVLQILRRC  924 (969)
Q Consensus       859 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d--P~~RPs~~evl~~L~~~  924 (969)
                      +.... ......+....+...-..+.-......-.+..+..+..+|+...  +.-||+++-++..|..+
T Consensus       232 p~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         232 PNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             CCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            11111 11111221111100000111111122223467777888888654  45799999888766544

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.95  E-value=3.4e-09  Score=110.61  Aligned_cols=143  Identities=19%  Similarity=0.266  Sum_probs=102.2

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcccc--CceeeEEEEEEcC---CceEEEEe
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH--ANIVKLWCCISSE---NSKLLVYE  716 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e  716 (969)
                      +.|+.|.++.||+++.. +|+.+++|+.......  .....+.+|+++++.+++  ..+.+++.+..+.   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            56899999999999875 3678999987543221  134578899999999965  3457777776653   36789999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhccc----------------------------
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD----------------------------  768 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------  768 (969)
                      |++|.++.+.+..              ..++......++.++++++++||+.                            
T Consensus        81 ~i~G~~l~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (223)
T cd05154          81 RVDGRVLRDRLLR--------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQY  146 (223)
T ss_pred             EeCCEecCCCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHH
Confidence            9999887765421              0134445555555666666555532                            


Q ss_pred             -------------------------CCCCeEecCCCCCcEEECC--CCcEEEeeccccee
Q 002085          769 -------------------------CTPQIIHRDVKSSNILLDS--EFKAKIADFGLAKM  801 (969)
Q Consensus       769 -------------------------~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgla~~  801 (969)
                                               ....++|+|+.+.||+++.  ++.+.++||+.+..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         147 DASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                     1346899999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.82  E-value=4e-09  Score=128.30  Aligned_cols=129  Identities=25%  Similarity=0.324  Sum_probs=95.7

Q ss_pred             CCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCc--CCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCccccc
Q 002085           95 DLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNY--FVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQ  172 (969)
Q Consensus        95 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  172 (969)
                      +....+...+.+|.+. .++.... .++|++|-+..|.  +....+..|..++.|++|||++|.=-+.+|..+++|-+|+
T Consensus       521 ~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr  598 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR  598 (889)
T ss_pred             chhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence            4467788888888876 4444433 3479999998886  5534444578899999999998866668999999999999


Q ss_pred             ceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccC
Q 002085          173 TLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTE  228 (969)
Q Consensus       173 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~  228 (969)
                      +|+|++..++ .+|..+++|..|.+|++.++.  ....+|.....|++|++|.+..
T Consensus       599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~--~l~~~~~i~~~L~~Lr~L~l~~  651 (889)
T KOG4658|consen  599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTG--RLESIPGILLELQSLRVLRLPR  651 (889)
T ss_pred             cccccCCCcc-ccchHHHHHHhhheecccccc--ccccccchhhhcccccEEEeec
Confidence            9999999998 888899999999999998775  2233344455566666666544

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.78  E-value=1.2e-07  Score=103.44  Aligned_cols=180  Identities=18%  Similarity=0.273  Sum_probs=134.1

Q ss_pred             cEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEE----cCCceEEEEeeccC-CCH
Q 002085          649 SGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCIS----SENSKLLVYEYMEN-QSL  723 (969)
Q Consensus       649 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL  723 (969)
                      ..+.||+....+|..|++|+++..+....   ..-..-+++++++.|+|+|++.+++.    .+-..++||+|.|+ ++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            35789999999999999999955443222   12233467899999999999998876    24467899999987 688


Q ss_pred             HHHhccCcCcc--ccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          724 DRWLHGRKRSL--VSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       724 ~~~l~~~~~~~--~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                      .++-.......  ............++...|.++.|++.||.++|+.   |..-+-|.+++|+++.+.+++|+..|....
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence            88766544321  0011122234577889999999999999999988   999999999999999999999999998876


Q ss_pred             cccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCC
Q 002085          802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEA  853 (969)
Q Consensus       802 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p  853 (969)
                      +..+.         +     +|  +   .--.+-|.=.+|.++..+.||..-
T Consensus       443 l~~d~---------~-----~~--l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  443 LQEDP---------T-----EP--L---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             ecCCC---------C-----cc--h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            64432         0     00  1   112356888999999999999754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=9.3e-08  Score=95.00  Aligned_cols=128  Identities=26%  Similarity=0.256  Sum_probs=83.5

Q ss_pred             EEEEEEEcCCCcEEEEEEEeccc-----------------------hhcHHHHHHHHHHHHHHhccccC--ceeeEEEEE
Q 002085          651 QVYRIDINGAGEFVAVKRIWNNR-----------------------KLNQKLEKEFIAEIEILGTIRHA--NIVKLWCCI  705 (969)
Q Consensus       651 ~Vy~~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~  705 (969)
                      .||.|... +|..+|||+.+...                       ...........+|.+.|.++..-  ++.+.+++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38988875 67899999874210                       11122345788999999999654  566666542


Q ss_pred             EcCCceEEEEeecc--CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhh-hcccCCCCeEecCCCCCc
Q 002085          706 SSENSKLLVYEYME--NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCY-MHHDCTPQIIHRDVKSSN  782 (969)
Q Consensus       706 ~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~Dlkp~N  782 (969)
                          ..+|||||++  |..+..+....               ++......++.+++..+.. +|..   |++|+|+.+.|
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~---------------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~N  137 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD---------------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYN  137 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG---------------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTS
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc---------------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhh
Confidence                4589999998  65554433321               1133456777788875555 4677   99999999999


Q ss_pred             EEECCCCcEEEeecccceec
Q 002085          783 ILLDSEFKAKIADFGLAKML  802 (969)
Q Consensus       783 ill~~~~~~kl~Dfgla~~~  802 (969)
                      |+++++ .+.++|||.+...
T Consensus       138 Ilv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  138 ILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             EEEETT-CEEE--GTTEEET
T ss_pred             EEeecc-eEEEEecCcceec
Confidence            999988 9999999998654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.75  E-value=3.5e-09  Score=84.78  Aligned_cols=61  Identities=33%  Similarity=0.465  Sum_probs=39.0

Q ss_pred             cccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccc
Q 002085          449 SHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQF  509 (969)
Q Consensus       449 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  509 (969)
                      ++|+.|+|++|+|+...+..|..+++|++|++++|+|+...|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566666666666644445666666666666666666655556666666666666666654

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.73  E-value=1.3e-07  Score=99.88  Aligned_cols=144  Identities=14%  Similarity=0.098  Sum_probs=98.6

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc---H-----HHHHHHHHHHHHHhccccC--ceeeEEEEEEc----
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN---Q-----KLEKEFIAEIEILGTIRHA--NIVKLWCCISS----  707 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~-----~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~----  707 (969)
                      +.+-+.....|+++..  .|+.|.||+........   .     .....+.+|.+.+.++...  .++..+++.+.    
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            3444334445667766  57789999773322100   0     1112478899988888432  23344445433    


Q ss_pred             -CCceEEEEeeccCC-CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE
Q 002085          708 -ENSKLLVYEYMENQ-SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL  785 (969)
Q Consensus       708 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill  785 (969)
                       ....++|||++++. +|.+++.....           ...+...+..++.+++..++-||..   ||+|+|++++|||+
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~-----------~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl  171 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWAT-----------NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLL  171 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEE
Confidence             23578999999986 89999853211           1234556778999999999999998   99999999999999


Q ss_pred             CC-------CCcEEEeeccccee
Q 002085          786 DS-------EFKAKIADFGLAKM  801 (969)
Q Consensus       786 ~~-------~~~~kl~Dfgla~~  801 (969)
                      +.       +..+.++||+.+..
T Consensus       172 ~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        172 HLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eccccCCCCCceEEEEECCcccc
Confidence            75       46899999998753

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.72  E-value=6.9e-09  Score=83.07  Aligned_cols=38  Identities=29%  Similarity=0.448  Sum_probs=13.7

Q ss_pred             ccCCCCcEEecCCCCCCCcCCCcccCcccccceecccc
Q 002085          142 DRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN  179 (969)
Q Consensus       142 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  179 (969)
                      .++++|++|++++|+++...|..|.++++|++|++++|
T Consensus        22 ~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N   59 (61)
T PF13855_consen   22 SNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN   59 (61)
T ss_dssp             TTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred             cCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence            33333333333333333333333333333333333333

...

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.67  E-value=2.2e-08  Score=73.20  Aligned_cols=38  Identities=42%  Similarity=0.997  Sum_probs=29.4

Q ss_pred             HHHHHHHHHHHHHcCCCC--CCCCCCCC--CCCCCCCcceee
Q 002085           34 TEERTILLNLKQQLGNPP--SLQSWTST--SSPCDWPEITCT   71 (969)
Q Consensus        34 ~~~~~all~~k~~~~~~~--~l~sw~~~--~~~c~w~gv~C~   71 (969)
                      ++|++||++||+++..++  .+.+|+.+  .+||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            579999999999999643  58999876  799999999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.64  E-value=1.5e-09  Score=121.25  Aligned_cols=177  Identities=28%  Similarity=0.360  Sum_probs=130.6

Q ss_pred             CCCCCCCccCcEEEcccccccCCCCcccccc-cCCCccccCCCccc----------cccCccccc-cccEEEeeccccCC
Q 002085          348 PKSLGNCRTLRTVQLYSNRFSGELPTGLWTT-FNLSSLMLSDNTIS----------GELPSKTAW-NLTRLEISNNRFSG  415 (969)
Q Consensus       348 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~----------~~~~~~~~~-~L~~L~Ls~N~l~~  415 (969)
                      |-.+..+++|+.|.|.++.|..  ..++..+ ..|+.|..+ |.+.          |.+.....| .|...+.++|++. 
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence            5567778899999999999873  2223332 245555433 2222          233333333 5888999999998 


Q ss_pred             CcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcc-cccccCCCEEEccCccccCCCCcccc
Q 002085          416 QIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQ-IVSWTSLNNLNLARNELSGEIPKAIG  494 (969)
Q Consensus       416 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~  494 (969)
                      .+...+.-++.|+.|+|++|+++...  .+..+++|+.|||+.|+|. .+|.. ...+. |+.|+|++|.++..  ..+.
T Consensus       178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie  251 (1096)
T KOG1859|consen  178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIE  251 (1096)
T ss_pred             hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHH
Confidence            56677888899999999999998544  7889999999999999999 56643 34444 99999999999843  5688


Q ss_pred             cccccceEeccCccccccCC-Cccccc-cccEEEeecCcCCC
Q 002085          495 SLLVMVSLDLSGNQFSGEIP-PEIGQL-KLNTFNLSSNKLYG  534 (969)
Q Consensus       495 ~l~~L~~L~ls~N~l~g~~p-~~~~~l-~L~~l~ls~N~l~~  534 (969)
                      +|.+|+.||||+|-|++.-- ..+..+ .|+.|+|.+|++..
T Consensus       252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            99999999999999987221 123444 48999999999974

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.60  E-value=2.5e-07  Score=93.83  Aligned_cols=138  Identities=22%  Similarity=0.148  Sum_probs=96.6

Q ss_pred             CccceeeecCcEEEEEEEEcCCCcEEEEEEEecc----------ch-------hc--HHHHHHHHHHHHHHhccccC--c
Q 002085          639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNN----------RK-------LN--QKLEKEFIAEIEILGTIRHA--N  697 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~-------~~--~~~~~~~~~E~~~l~~l~h~--n  697 (969)
                      .+++.||.|--+.||.|... .|.++|||.=+..          +.       .+  ...+....+|.++|.++.-.  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            35688999999999999886 6889999953211          00       01  22345688999999998644  6


Q ss_pred             eeeEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecC
Q 002085          698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRD  777 (969)
Q Consensus       698 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  777 (969)
                      |.+.++    .+...+||||++|-.|...--                  +....-.++..|+.-+.-.-..   ||||+|
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r~------------------~~en~~~il~~il~~~~~~~~~---GiVHGD  227 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLRL------------------DVENPDEILDKILEEVRKAYRR---GIVHGD  227 (304)
T ss_pred             CCCccc----cccceeeeehcccceeecccC------------------cccCHHHHHHHHHHHHHHHHHc---CccccC
Confidence            666654    356789999999876654321                  1222233444444444433345   899999


Q ss_pred             CCCCcEEECCCCcEEEeecccceec
Q 002085          778 VKSSNILLDSEFKAKIADFGLAKML  802 (969)
Q Consensus       778 lkp~Nill~~~~~~kl~Dfgla~~~  802 (969)
                      +++-||+++++|.+.++||-.+...
T Consensus       228 lSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         228 LSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             CchheEEEecCCCEEEEeCcccccC
Confidence            9999999999999999999877543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.57  E-value=2.3e-09  Score=119.98  Aligned_cols=136  Identities=29%  Similarity=0.323  Sum_probs=84.1

Q ss_pred             CCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEE
Q 002085          282 EIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQ  361 (969)
Q Consensus       282 ~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~  361 (969)
                      .+...+.-.+|...+.++|.+. .+..++.-++.|+.|||++|++...                   ..+..|+.|++||
T Consensus       156 d~~ns~~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v-------------------~~Lr~l~~LkhLD  215 (1096)
T KOG1859|consen  156 DISNSPVWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV-------------------DNLRRLPKLKHLD  215 (1096)
T ss_pred             ccccchhhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh-------------------HHHHhcccccccc
Confidence            3444444446778888888887 6667777788888888888887631                   2455677777777


Q ss_pred             cccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCcccccc
Q 002085          362 LYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEI  441 (969)
Q Consensus       362 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  441 (969)
                      |++|++. .+|..-..--                      .|+.|.|.+|.++..  ..+.++++|+.||++.|-|.+.-
T Consensus       216 lsyN~L~-~vp~l~~~gc----------------------~L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hs  270 (1096)
T KOG1859|consen  216 LSYNCLR-HVPQLSMVGC----------------------KLQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHS  270 (1096)
T ss_pred             cccchhc-cccccchhhh----------------------hheeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcch
Confidence            7777776 4443211111                      244455555544422  34556667777777777666421


Q ss_pred             -CccccCccccchhhccCcccC
Q 002085          442 -PVELTSLSHLNTLLLDGNKLS  462 (969)
Q Consensus       442 -p~~~~~l~~L~~L~Ls~N~l~  462 (969)
                       -..+..|..|+.|+|.||.+.
T Consensus       271 eL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  271 ELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             hhhHHHHHHHHHHHhhcCCccc
Confidence             223455677777888888776

>PRK09902 hypothetical protein; Provisional

Probab=98.54  E-value=7.4e-07  Score=88.80  Aligned_cols=141  Identities=19%  Similarity=0.159  Sum_probs=102.6

Q ss_pred             eecCcEEEEEEEEcCCCcEEEEEEEeccchhc---HHHHHHHHHHHHHHhcccc--CceeeEEEEE--EcC--CceEEEE
Q 002085          645 GSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN---QKLEKEFIAEIEILGTIRH--ANIVKLWCCI--SSE--NSKLLVY  715 (969)
Q Consensus       645 G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h--~niv~l~~~~--~~~--~~~~lv~  715 (969)
                      |+||.+.|++....  |..+-+|+-.......   +.....|.+|...+.++..  -.+.+.+.+.  ..+  ...+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            67899999998774  4578899763111111   2346789999999999852  2244444221  112  2458999


Q ss_pred             eeccC-CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc--EE
Q 002085          716 EYMEN-QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK--AK  792 (969)
Q Consensus       716 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~k  792 (969)
                      |-++| .+|.+++.....           ...+...+..+..+++..++-||+.   |+.|+|+.+.||+++.++.  ++
T Consensus       105 e~L~g~~~L~~~l~~~~~-----------~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~  170 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV-----------SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAG  170 (216)
T ss_pred             EeCCCCccHHHHHhcCCc-----------CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEE
Confidence            98865 699998865432           2345667789999999999999998   9999999999999986666  99


Q ss_pred             Eeeccccee
Q 002085          793 IADFGLAKM  801 (969)
Q Consensus       793 l~Dfgla~~  801 (969)
                      ++||.-++.
T Consensus       171 lIDlEk~r~  179 (216)
T PRK09902        171 FLDLEKSRR  179 (216)
T ss_pred             EEEhhccch
Confidence            999987653

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.54  E-value=5.3e-09  Score=93.53  Aligned_cols=115  Identities=25%  Similarity=0.345  Sum_probs=66.9

Q ss_pred             ccchhhcccCCccccccCcccc-CccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEe
Q 002085          425 KNLIVFKASNNLFSGEIPVELT-SLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLD  503 (969)
Q Consensus       425 ~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  503 (969)
                      ..|+..+|++|.|. ..|+.|. ..+.++.|+|++|+|+ .+|.++..++.|+.||++.|.|. ..|..+..|.+|..||
T Consensus        53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld  129 (177)
T KOG4579|consen   53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD  129 (177)
T ss_pred             ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence            33444455555555 3444443 2346666666666666 56666666777777777777776 5666666677777777


Q ss_pred             ccCccccccCCCcccccc-ccEEEeecCcCCCCCCcccccc
Q 002085          504 LSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNL  543 (969)
Q Consensus       504 ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~~~~~  543 (969)
                      ..+|.+. +||-.+---. ....++.+|.+.+.-|..+|.+
T Consensus       130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~  169 (177)
T KOG4579|consen  130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL  169 (177)
T ss_pred             CCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence            7777665 5554421111 2233556666776666655543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=4.9e-08  Score=110.49  Aligned_cols=152  Identities=16%  Similarity=0.217  Sum_probs=103.5

Q ss_pred             HHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCcc-------ccccccCcccCchhhcc
Q 002085          755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT-------MSAVAGSFGYFAPEYAY  827 (969)
Q Consensus       755 ~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~  827 (969)
                      +.+++.|+.|+|..  .++||++|.|++|.++..+..|++.|+.+...........       ..-......|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34556999999976  4899999999999999999999999998865432111110       01112345799999999


Q ss_pred             cCCCCCccchhhHHHHHHHHHhCCCCC-CCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCC
Q 002085          828 TTKVNEKIDIYSFGVVLLELVTGKEAN-YGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTST  906 (969)
Q Consensus       828 ~~~~~~~sDvwslG~il~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~  906 (969)
                      +...+.++|+||+||++|-+..|+.+. ...... ..... .....+..         ...+..+.+.++.+-+.+++..
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~-~~~~~~~~---------~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSF-SRNLLNAG---------AFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCc-chhhh-hhcccccc---------cccccccCcHHHHHHHHHHhcC
Confidence            988999999999999999999655543 332221 11111 11111000         1112234457788889999999


Q ss_pred             CCCCCCCHHHHHH
Q 002085          907 LPSSRPSMKEVLQ  919 (969)
Q Consensus       907 dP~~RPs~~evl~  919 (969)
                      ++..||++.++..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999998777654

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.46  E-value=3.6e-08  Score=99.58  Aligned_cols=46  Identities=20%  Similarity=0.184  Sum_probs=30.2

Q ss_pred             cccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCC
Q 002085          309 EFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGE  370 (969)
Q Consensus       309 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  370 (969)
                      .+..++.+-.|+|+.|+|..-                .--+.+..+++|+.|.+++|.+...
T Consensus       219 ~se~~p~~~~LnL~~~~idsw----------------asvD~Ln~f~~l~dlRv~~~Pl~d~  264 (418)
T KOG2982|consen  219 GSEPFPSLSCLNLGANNIDSW----------------ASVDALNGFPQLVDLRVSENPLSDP  264 (418)
T ss_pred             cCCCCCcchhhhhcccccccH----------------HHHHHHcCCchhheeeccCCccccc
Confidence            445566667888888887621                1113456677888888888887643

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.45  E-value=6.3e-09  Score=93.05  Aligned_cols=137  Identities=22%  Similarity=0.277  Sum_probs=79.9

Q ss_pred             CCCccccCCCccccccCcc-----ccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchh
Q 002085          380 NLSSLMLSDNTISGELPSK-----TAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTL  454 (969)
Q Consensus       380 ~L~~L~Ls~N~l~~~~~~~-----~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  454 (969)
                      .+..++|++++|. .++..     ....|+..+|++|.|....+..-..++-++.|+|++|.|+ .+|.++..++.|+.|
T Consensus        28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            4555666666554 12211     1234666677777776555554445556677777777776 666667777777777


Q ss_pred             hccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCccccc
Q 002085          455 LLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL  520 (969)
Q Consensus       455 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l  520 (969)
                      +++.|.+. ..|..+..+.+|-.|+..+|.+. .||-.+---...-..++.+|.+.+.-|..+..+
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~  169 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL  169 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence            77777776 55666666667777777777765 455443222222233446666666555444433

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	969
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-49
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-43
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-12
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		5e-43
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-12
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-35
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-34
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-33
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-33
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-31
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-24
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-23
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-13
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-22
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-16
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-15
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-15
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-15
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-15
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-15
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-15
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-15
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-15
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-15
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-15
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-15
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-11
3soa_A	444	Full-Length Human Camkii Length = 444		1e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		9e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-05
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		2e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-05
2z7x_A	549	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		5e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-05
2z80_A	353	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		6e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-05
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-04
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  192 bits (489), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 116/313 (37%), Positives = 174/313 (55%), Gaps = 21/313 (6%)
Query: 615 DPATWKLTSFHQLGFTESNILSS-LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNR 673
           DP    L    +    E  + S   +  N++G GG G+VY+  +   G  VAVKR+   R
Sbjct: 17  DPEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEER 74
Query: 674 KLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRS 733
              Q  E +F  E+E++    H N+++L     +   +LLVY YM N S+   L  R  S
Sbjct: 75  --XQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 132
Query: 734 LVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI 793
                    Q  L WP R +IA+G+A+GL Y+H  C P+IIHRDVK++NILLD EF+A +
Sbjct: 133 ---------QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 183
Query: 794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEA 853
            DFGLAK++  + + H   AV G+ G+ APEY  T K +EK D++ +GV+LLEL+TG+ A
Sbjct: 184 GDFGLAKLMDYK-DXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 242
Query: 854 N-----YGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLP 908
                   D+   L +W  +   +EK +   +D  +      EE+  + ++AL+CT + P
Sbjct: 243 FDLARLANDDDVMLLDWV-KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 301
Query: 909 SSRPSMKEVLQIL 921
             RP M EV+++L
Sbjct: 302 MERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  192 bits (488), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 111/286 (38%), Positives = 165/286 (57%), Gaps = 19/286 (6%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
            N++G GG G+VY+  +   G  VAVKR+   R   Q  E +F  E+E++    H N+++
Sbjct: 35  KNILGRGGFGKVYKGRL-ADGXLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLR 91
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L     +   +LLVY YM N S+   L  R  S         Q  L WP R +IA+G+A+
Sbjct: 92  LRGFCMTPTERLLVYPYMANGSVASCLRERPES---------QPPLDWPKRQRIALGSAR 142
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           GL Y+H  C P+IIHRDVK++NILLD EF+A + DFGLAK++  + + H   AV G  G+
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DXHVXXAVRGXIGH 201
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEAN-----YGDEHTSLAEWAWRHYAEEKP 875
            APEY  T K +EK D++ +GV+LLEL+TG+ A        D+   L +W  +   +EK 
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV-KGLLKEKK 260
Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           +   +D  +      EE+  + ++AL+CT + P  RP M EV+++L
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  174 bits (440), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 163/535 (30%), Positives = 248/535 (46%), Gaps = 55/535 (10%)
Query: 64  DWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYN-CTK 122
           D+     T   +  +++        IPP+   LK+L  + L+ N   GE P+FL   C  
Sbjct: 235 DFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDT 292
Query: 123 LQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPR-SIGRLSELQTLYLYMNEF 181
           L  LDLS N+F G +P      S L+ + L  NNFSG++P  ++ ++  L+ L L  NEF
Sbjct: 293 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 352
Query: 182 NGTFPKEIGDLS-NLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMS 240
           +G  P+ + +LS +L  L L+ N+   P +  +       L+ L++      G+IP  +S
Sbjct: 353 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 412
Query: 241 NLSSLEILALNGNHLEGAIPSGXXXXXXXXXXXXYDNILSGEIPSSVEALK-LTDIDLSM 299
           N S L  L L+ N+L G IPS             + N+L GEIP  +  +K L  + L  
Sbjct: 413 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 472
Query: 300 NNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIG------VVAFENN-LSGAVPKSLG 352
           N+LTG IP       NL  + L +N L+GE+P  IG      ++   NN  SG +P  LG
Sbjct: 473 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 532
Query: 353 NCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNR 412
           +CR+L  + L +N F+G +P  ++      S  ++ N I+G+           + I N+ 
Sbjct: 533 DCRSLIWLDLNTNLFNGTIPAAMFK----QSGKIAANFIAGK---------RYVYIKNDG 579
Query: 413 FSGQIQRGVGSWKNLIVFKA-----------------SNNLFSGEIPVEXXXXXXXXXXX 455
              +   G G   NL+ F+                  ++ ++ G                
Sbjct: 580 MKKECH-GAG---NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 635
Query: 456 XDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPP 515
              N LSG +P +I S   L  LNL  N++SG IP  +G L  +  LDLS N+  G IP 
Sbjct: 636 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 695
Query: 516 EIGQLKLNT-FNLSSNKLYGNIPD--EFNNLAYDDSFLNNSNLCVKNPIINLPKC 567
            +  L + T  +LS+N L G IP+  +F        FLNN  LC       LP+C
Sbjct: 696 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFP-PAKFLNNPGLCG----YPLPRC 745

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 130/308 (42%), Gaps = 73/308 (23%)
Query: 282 EIPSSVEALK----LTDIDLSMNNLTGSIPE--EFGKLKNLQLLGLFSNHLS--GEVPAS 333
            I  SV   K    LT +DLS N+L+G +      G    L+ L + SN L   G+V   
Sbjct: 85  HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 144
Query: 334 IGVVAFE------NNLSGA--VPKSLGN-CRTLRTVQLYSNRFSGELPTGLWTTFNLSSL 384
           + + + E      N++SGA  V   L + C  L+ + +  N+ SG++        NL  L
Sbjct: 145 LKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFL 202
Query: 385 MLSDNTISGELPS-KTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPV 443
            +S N  S  +P       L  L+IS N+ SG   R + +   L +   S+N F G IP 
Sbjct: 203 DVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP- 261
Query: 444 EXXXXXXXXXXXXDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAI-GSLLVMVSL 502
                                LP +     SL  L+LA N+ +GEIP  + G+   +  L
Sbjct: 262 --------------------PLPLK-----SLQYLSLAENKFTGEIPDFLSGACDTLTGL 296
Query: 503 DLSGNQFSGEIPPEIG-----------------QLKLNTF---------NLSSNKLYGNI 536
           DLSGN F G +PP  G                 +L ++T          +LS N+  G +
Sbjct: 297 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGEL 356
Query: 537 PDEFNNLA 544
           P+   NL+
Sbjct: 357 PESLTNLS 364

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  173 bits (438), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 163/535 (30%), Positives = 248/535 (46%), Gaps = 55/535 (10%)
Query: 64  DWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYN-CTK 122
           D+     T   +  +++        IPP+   LK+L  + L+ N   GE P+FL   C  
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDT 295
Query: 123 LQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPR-SIGRLSELQTLYLYMNEF 181
           L  LDLS N+F G +P      S L+ + L  NNFSG++P  ++ ++  L+ L L  NEF
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355
Query: 182 NGTFPKEIGDLS-NLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMS 240
           +G  P+ + +LS +L  L L+ N+   P +  +       L+ L++      G+IP  +S
Sbjct: 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415
Query: 241 NLSSLEILALNGNHLEGAIPSGXXXXXXXXXXXXYDNILSGEIPSSVEALK-LTDIDLSM 299
           N S L  L L+ N+L G IPS             + N+L GEIP  +  +K L  + L  
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 300 NNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIG------VVAFENN-LSGAVPKSLG 352
           N+LTG IP       NL  + L +N L+GE+P  IG      ++   NN  SG +P  LG
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535
Query: 353 NCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNR 412
           +CR+L  + L +N F+G +P  ++      S  ++ N I+G+           + I N+ 
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFK----QSGKIAANFIAGK---------RYVYIKNDG 582
Query: 413 FSGQIQRGVGSWKNLIVFKA-----------------SNNLFSGEIPVEXXXXXXXXXXX 455
              +   G G   NL+ F+                  ++ ++ G                
Sbjct: 583 MKKECH-GAG---NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 456 XDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPP 515
              N LSG +P +I S   L  LNL  N++SG IP  +G L  +  LDLS N+  G IP 
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 516 EIGQLKLNT-FNLSSNKLYGNIPD--EFNNLAYDDSFLNNSNLCVKNPIINLPKC 567
            +  L + T  +LS+N L G IP+  +F        FLNN  LC       LP+C
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFP-PAKFLNNPGLCG----YPLPRC 748

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 130/308 (42%), Gaps = 73/308 (23%)
Query: 282 EIPSSVEALK----LTDIDLSMNNLTGSIPE--EFGKLKNLQLLGLFSNHLS--GEVPAS 333
            I  SV   K    LT +DLS N+L+G +      G    L+ L + SN L   G+V   
Sbjct: 88  HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147
Query: 334 IGVVAFE------NNLSGA--VPKSLGN-CRTLRTVQLYSNRFSGELPTGLWTTFNLSSL 384
           + + + E      N++SGA  V   L + C  L+ + +  N+ SG++        NL  L
Sbjct: 148 LKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFL 205
Query: 385 MLSDNTISGELPS-KTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPV 443
            +S N  S  +P       L  L+IS N+ SG   R + +   L +   S+N F G IP 
Sbjct: 206 DVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP- 264
Query: 444 EXXXXXXXXXXXXDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAI-GSLLVMVSL 502
                                LP +     SL  L+LA N+ +GEIP  + G+   +  L
Sbjct: 265 --------------------PLPLK-----SLQYLSLAENKFTGEIPDFLSGACDTLTGL 299
Query: 503 DLSGNQFSGEIPPEIG-----------------QLKLNTF---------NLSSNKLYGNI 536
           DLSGN F G +PP  G                 +L ++T          +LS N+  G +
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGEL 359
Query: 537 PDEFNNLA 544
           P+   NL+
Sbjct: 360 PESLTNLS 367

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  147 bits (371), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 106/279 (37%), Positives = 147/279 (52%), Gaps = 20/279 (7%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           LIG G  G+VY+  +   G  VA+KR       + +  +EF  EIE L   RH ++V L 
Sbjct: 46  LIGHGVFGKVYK-GVLRDGAKVALKR---RTPESSQGIEEFETEIETLSFCRHPHLVSLI 101
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 N  +L+Y+YMEN +L R L+G     +S S         W  RL+I IGAA+GL
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS---------WEQRLEICIGAARGL 152
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   T  IIHRDVKS NILLD  F  KI DFG++K   + G+ H    V G+ GY  
Sbjct: 153 HYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEA---NYGDEHTSLAEWAWRHYAEEKPITDA 879
           PEY    ++ EK D+YSFGVVL E++  + A   +   E  +LAEWA   +   + +   
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ-LEQI 268
Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +D  +A+    E +      A+ C +     RPSM +VL
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  144 bits (364), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 105/279 (37%), Positives = 146/279 (52%), Gaps = 20/279 (7%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           LIG G  G+VY+  +   G  VA+KR       + +  +EF  EIE L   RH ++V L 
Sbjct: 46  LIGHGVFGKVYK-GVLRDGAKVALKR---RTPESSQGIEEFETEIETLSFCRHPHLVSLI 101
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 N  +L+Y+YMEN +L R L+G     +S S         W  RL+I IGAA+GL
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS---------WEQRLEICIGAARGL 152
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   T  IIHRDVKS NILLD  F  KI DFG++K   +  + H    V G+ GY  
Sbjct: 153 HYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEA---NYGDEHTSLAEWAWRHYAEEKPITDA 879
           PEY    ++ EK D+YSFGVVL E++  + A   +   E  +LAEWA   +   + +   
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ-LEQI 268
Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +D  +A+    E +      A+ C +     RPSM +VL
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  143 bits (360), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 116/316 (36%), Positives = 166/316 (52%), Gaps = 36/316 (11%)
Query: 622 TSFHQLGFTE-SNILSSLTE------SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK 674
           T FH   F E  N+ ++  E       N +G GG G VY+  +N     VAVK++     
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVD 67
Query: 675 LN-QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKR 732
           +  ++L+++F  EI+++   +H N+V+L    S  +   LVY YM N SL DR       
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL------ 121
Query: 733 SLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK 792
           S + G+       L W  R +IA GAA G+ ++H +     IHRD+KS+NILLD  F AK
Sbjct: 122 SCLDGTPP-----LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAK 173
Query: 793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE 852
           I+DFGLA+   K  +    S + G+  Y APE A   ++  K DIYSFGVVLLE++TG  
Sbjct: 174 ISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP 232
Query: 853 ANYGDEHTS---LAEWAWRHYAEEKPITDALDKGI--AEPCYLEEMTTVYRLALICTSTL 907
           A   DEH     L +       EEK I D +DK +  A+   +E M   Y +A  C    
Sbjct: 233 A--VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM---YSVASQCLHEK 287
Query: 908 PSSRPSMKEVLQILRR 923
            + RP +K+V Q+L+ 
Sbjct: 288 KNKRPDIKKVQQLLQE 303

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  141 bits (356), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 115/316 (36%), Positives = 165/316 (52%), Gaps = 36/316 (11%)
Query: 622 TSFHQLGFTE-SNILSSLTE------SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK 674
           T FH   F E  N+ ++  E       N +G GG G VY+  +N     VAVK++     
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVD 67
Query: 675 LN-QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKR 732
           +  ++L+++F  EI+++   +H N+V+L    S  +   LVY YM N SL DR       
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL------ 121
Query: 733 SLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK 792
           S + G+       L W  R +IA GAA G+ ++H +     IHRD+KS+NILLD  F AK
Sbjct: 122 SCLDGTPP-----LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAK 173
Query: 793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE 852
           I+DFGLA+   K  +      + G+  Y APE A   ++  K DIYSFGVVLLE++TG  
Sbjct: 174 ISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP 232
Query: 853 ANYGDEHTS---LAEWAWRHYAEEKPITDALDKGI--AEPCYLEEMTTVYRLALICTSTL 907
           A   DEH     L +       EEK I D +DK +  A+   +E M   Y +A  C    
Sbjct: 233 A--VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM---YSVASQCLHEK 287
Query: 908 PSSRPSMKEVLQILRR 923
            + RP +K+V Q+L+ 
Sbjct: 288 KNKRPDIKKVQQLLQE 303

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 115/315 (36%), Positives = 165/315 (52%), Gaps = 36/315 (11%)
Query: 622 TSFHQLGFTE-SNILSSLTE------SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK 674
           T FH   F E  N+ ++  E       N +G GG G VY+  +N     VAVK++     
Sbjct: 4   TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVD 61
Query: 675 LN-QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKR 732
           +  ++L+++F  EI+++   +H N+V+L    S  +   LVY YM N SL DR       
Sbjct: 62  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL------ 115
Query: 733 SLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK 792
           S + G+       L W  R +IA GAA G+ ++H +     IHRD+KS+NILLD  F AK
Sbjct: 116 SCLDGTPP-----LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAK 167
Query: 793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE 852
           I+DFGLA+   K  +      + G+  Y APE A   ++  K DIYSFGVVLLE++TG  
Sbjct: 168 ISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP 226
Query: 853 ANYGDEHTS---LAEWAWRHYAEEKPITDALDKGI--AEPCYLEEMTTVYRLALICTSTL 907
           A   DEH     L +       EEK I D +DK +  A+   +E M   Y +A  C    
Sbjct: 227 A--VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM---YSVASQCLHEK 281
Query: 908 PSSRPSMKEVLQILR 922
            + RP +K+V Q+L+
Sbjct: 282 KNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 114/315 (36%), Positives = 161/315 (51%), Gaps = 36/315 (11%)
Query: 622 TSFHQLGFTE-SNILSSLTE------SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK 674
           T FH   F E  N+ ++  E       N  G GG G VY+  +N     VAVK++     
Sbjct: 1   TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTT--VAVKKLAAMVD 58
Query: 675 LN-QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKR 732
           +  ++L+++F  EI++    +H N+V+L    S  +   LVY Y  N SL DR       
Sbjct: 59  ITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL------ 112
Query: 733 SLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK 792
           S + G+       L W  R +IA GAA G+ ++H +     IHRD+KS+NILLD  F AK
Sbjct: 113 SCLDGTPP-----LSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAK 164
Query: 793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE 852
           I+DFGLA+   K  +    S + G+  Y APE A   ++  K DIYSFGVVLLE++TG  
Sbjct: 165 ISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLP 223
Query: 853 ANYGDEHTS---LAEWAWRHYAEEKPITDALDKGI--AEPCYLEEMTTVYRLALICTSTL 907
           A   DEH     L +       EEK I D +DK    A+   +E     Y +A  C    
Sbjct: 224 A--VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVE---AXYSVASQCLHEK 278
Query: 908 PSSRPSMKEVLQILR 922
            + RP +K+V Q+L+
Sbjct: 279 KNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG+G  G V+R + +G+   VAVK I   +  + +   EF+ E+ I+  +RH NIV    
Sbjct: 45  IGAGSFGTVHRAEWHGSD--VAVK-ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++   +  +V EY+   SL R LH       SG+    +  L    RL +A   A+G+ 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHK------SGA----REQLDERRRLSMAYDVAKGMN 151
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H+   P I+HRD+KS N+L+D ++  K+ DFGL+++  K          AG+  + AP
Sbjct: 152 YLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAP 208
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVT 849
           E       NEK D+YSFGV+L EL T
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 113/206 (54%), Gaps = 16/206 (7%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG+G  G V+R + +G+   VAVK I   +  + +   EF+ E+ I+  +RH NIV    
Sbjct: 45  IGAGSFGTVHRAEWHGSD--VAVK-ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++   +  +V EY+   SL R LH       SG+    +  L    RL +A   A+G+ 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHK------SGA----REQLDERRRLSMAYDVAKGMN 151
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H+   P I+HR++KS N+L+D ++  K+ DFGL+++  K     +  + AG+  + AP
Sbjct: 152 YLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAP 208
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVT 849
           E       NEK D+YSFGV+L EL T
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  106 bits (264), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 101/381 (26%), Positives = 155/381 (40%), Gaps = 92/381 (24%)
Query: 33  NTEERTILLNLKQQLGNPPSLQSWTSTSSPCD--WPEITCTFNSVTGISLRHKDITQKIP 90
           N +++  LL +K+ LGNP +L SW  T+  C+  W  + C  ++ T              
Sbjct: 4   NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQT-------------- 49
Query: 91  PIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCI 150
                   +  +DLS  ++P  +P                      IPS +  +  L  +
Sbjct: 50  ------YRVNNLDLSGLNLPKPYP----------------------IPSSLANLPYLNFL 81
Query: 151 DLGG-NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPA 209
            +GG NN  G IP +I +L++L  LY+     +G  P  +  +  L  L  +YN+     
Sbjct: 82  YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA----- 136
Query: 210 MIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGXXXXXXX 269
                                L G +P ++S+L +L  +  +GN + GAIP         
Sbjct: 137 ---------------------LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175
Query: 270 XXXXXYD-NILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSG 328
                   N L+G+IP +   L L  +DLS N L G     FG  KN Q + L  N L+ 
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 329 EVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSD 388
           +    +G V    NL+G              + L +NR  G LP GL     L SL +S 
Sbjct: 236 D----LGKVGLSKNLNG--------------LDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 389 NTISGELPSKTAWNLTRLEIS 409
           N + GE+P     NL R ++S
Sbjct: 278 NNLCGEIPQ--GGNLQRFDVS 296

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 105/243 (43%), Gaps = 15/243 (6%)
Query: 285 SSVEALKLTDIDLSMNNLTGS--IPEEFGKLKNLQLLGLFS-NHLSGEVPASIG------ 335
           +  +  ++ ++DLS  NL     IP     L  L  L +   N+L G +P +I       
Sbjct: 45  TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 336 -VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGE 394
            +     N+SGA+P  L   +TL T+    N  SG LP  + +  NL  +    N ISG 
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 395 LPSKTAWN---LTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEXXXXXXX 451
           +P          T + IS NR +G+I     +  NL     S N+  G+  V        
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 452 XXXXXDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSG 511
                  N L+  L  ++    +LN L+L  N + G +P+ +  L  + SL++S N   G
Sbjct: 224 QKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 512 EIP 514
           EIP
Sbjct: 283 EIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 1/87 (1%)
Query: 459 NKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIG 518
           N L G +P  I   T L+ L +    +SG IP  +  +  +V+LD S N  SG +PP I 
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 519 QL-KLNTFNLSSNKLYGNIPDEFNNLA 544
            L  L       N++ G IPD + + +
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFS 173

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  105 bits (263), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 143/302 (47%), Gaps = 35/302 (11%)
Query: 627 LGFTESNILSSLTESNLIGSGGSGQVYRIDI---NGAGEF-VAVKRIWNNRKLNQKLEKE 682
           L FT     S +T   +IG+G  G+VY+  +   +G  E  VA+K +       Q+++  
Sbjct: 35  LKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-- 92
Query: 683 FIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
           F+ E  I+G   H NI++L   IS     +++ EYMEN +LD++L  +      G  SV 
Sbjct: 93  FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-----DGEFSVL 147
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
           Q V        +  G A G+ Y+        +HRD+ + NIL++S    K++DFGL+++L
Sbjct: 148 QLV-------GMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
Query: 803 AKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS 861
               E  +T S       + APE     K     D++SFG+V+ E++T  E  Y      
Sbjct: 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY------ 251
Query: 862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              W   ++   K I D    G   P  ++  + +Y+L + C     + RP   +++ IL
Sbjct: 252 ---WELSNHEVMKAIND----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304
Query: 922 RR 923
            +
Sbjct: 305 DK 306

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 137/292 (46%), Gaps = 34/292 (11%)
Query: 636 SSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           S +T   +IG+G  G+V   R+ + G  E  VA+K +       +K  ++F+ E  I+G 
Sbjct: 22  SCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTL--KVGYTEKQRRDFLGEASIMGQ 79
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H NI+ L   ++     ++V EYMEN SLD +L         G  +V Q V       
Sbjct: 80  FDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKN-----DGQFTVIQLV------- 127
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE-PHTM 811
            +  G + G+ Y+        +HRD+ + NIL++S    K++DFGL+++L    E  +T 
Sbjct: 128 GMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 184
Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA 871
                   + APE     K     D++S+G+V+ E+V+  E  Y           W    
Sbjct: 185 RGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY-----------WEMTN 233
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
           ++  +  A+++G   P  ++    +Y+L L C     +SRP   E++ +L +
Sbjct: 234 QD--VIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDK 283

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 148/313 (47%), Gaps = 34/313 (10%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    ++++   ++G+G  G+V   R+ +    E  VA+K +  
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-- 81
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F+ E  I+G   H NI++L   ++     ++V EYMEN SLD +L  RK
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                   +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 140 H---DAQFTVIQLV-------GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           K++DFGLA++L    E  +T         + +PE     K     D++S+G+VL E+++ 
Sbjct: 187 KVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 851 KEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS 910
            E  Y           W    ++  +  A+D+G   P  ++    +Y+L L C     ++
Sbjct: 247 GERPY-----------WEMSNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNN 293
Query: 911 RPSMKEVLQILRR 923
           RP  ++++ IL +
Sbjct: 294 RPKFEQIVSILDK 306

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 148/313 (47%), Gaps = 34/313 (10%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    ++++   ++G+G  G+V   R+ +    E  VA+K +  
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-- 81
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F+ E  I+G   H NI++L   ++     ++V EYMEN SLD +L  RK
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                   +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 140 H---DAQFTVIQLV-------GMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVC 186
Query: 792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           K++DFGL+++L    E  +T         + +PE     K     D++S+G+VL E+++ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 851 KEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS 910
            E  Y           W    ++  +  A+D+G   P  ++    +Y+L L C     ++
Sbjct: 247 GERPY-----------WEMSNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNN 293
Query: 911 RPSMKEVLQILRR 923
           RP  ++++ IL +
Sbjct: 294 RPKFEQIVSILDK 306

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 148/313 (47%), Gaps = 34/313 (10%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    ++++   ++G+G  G+V   R+ +    E  VA+K +  
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-- 81
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F+ E  I+G   H NI++L   ++     ++V EYMEN SLD +L  RK
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                   +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 140 H---DAQFTVIQLV-------GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           K++DFGL+++L    E  +T         + +PE     K     D++S+G+VL E+++ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 851 KEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS 910
            E  Y           W    ++  +  A+D+G   P  ++    +Y+L L C     ++
Sbjct: 247 GERPY-----------WEMSNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNN 293
Query: 911 RPSMKEVLQILRR 923
           RP  ++++ IL +
Sbjct: 294 RPKFEQIVSILDK 306

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 27/237 (11%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
            + LT   +IG GG G+VYR    G    V   R   +  ++Q +E     E ++   ++
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIEN-VRQEAKLFAMLK 64
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H NI+ L      E +  LV E+     L+R        ++SG       +++W      
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPLNR--------VLSGKRIPPDILVNW------ 110
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK--------AKIADFGLAKMLAKQG 806
           A+  A+G+ Y+H +    IIHRD+KSSNIL+  + +         KI DFGLA+   +  
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT- 169
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA 863
              T  + AG++ + APE    +  ++  D++S+GV+L EL+TG+    G +  ++A
Sbjct: 170 ---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 148/313 (47%), Gaps = 34/313 (10%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    ++++   ++G+G  G+V   R+ +    E  VA+K +  
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-- 81
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F+ E  I+G   H NI++L   ++     ++V EYMEN SLD +L  RK
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                   +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 140 H---DAQFTVIQLV-------GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           K++DFGL+++L    E  +T         + +PE     K     D++S+G+VL E+++ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 851 KEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS 910
            E  Y           W    ++  +  A+D+G   P  ++    +Y+L L C     ++
Sbjct: 247 GERPY-----------WEMSNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNN 293
Query: 911 RPSMKEVLQILRR 923
           RP  ++++ IL +
Sbjct: 294 RPKFEQIVSILDK 306

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/315 (25%), Positives = 149/315 (47%), Gaps = 38/315 (12%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    ++++   ++G+G  G+V   R+ +    E  VA+K +  
Sbjct: 22  DPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-- 79
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F+ E  I+G   H NI++L   ++     ++V EYMEN SLD +L  RK
Sbjct: 80  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 137
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                   +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 138 H---DAQFTVIQLV-------GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 184
Query: 792 KIADFGLAKMLAKQGEPHTMSAVAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELV 848
           K++DFGL+++L  + +P       G      + +PE     K     D++S+G+VL E++
Sbjct: 185 KVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 242
Query: 849 TGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLP 908
           +  E  Y           W    ++  +  A+D+G   P  ++    +Y+L L C     
Sbjct: 243 SYGERPY-----------WEMSNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDR 289
Query: 909 SSRPSMKEVLQILRR 923
           ++RP  ++++ IL +
Sbjct: 290 NNRPKFEQIVSILDK 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 148/313 (47%), Gaps = 34/313 (10%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    ++++   ++G+G  G+V   R+ +    E  VA+K +  
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-- 81
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F+ E  I+G   H NI++L   ++     ++V EYMEN SLD +L  RK
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                   +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 140 H---DAQFTVIQLV-------GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           K++DFGL+++L    E  +T         + +PE     K     D++S+G+VL E+++ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 851 KEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS 910
            E  Y           W    ++  +  A+D+G   P  ++    +Y+L L C     ++
Sbjct: 247 GERPY-----------WEMSNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNN 293
Query: 911 RPSMKEVLQILRR 923
           RP  ++++ IL +
Sbjct: 294 RPKFEQIVSILDK 306

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 146/315 (46%), Gaps = 36/315 (11%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGE-FVAVKRIWN 671
           DP T++  +     F +   +S +    +IG+G  G+V    + + G  E FVA+K +  
Sbjct: 12  DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-- 69
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F++E  I+G   H N++ L   ++     +++ E+MEN SLD +L    
Sbjct: 70  KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN- 128
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                G  +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 129 ----DGQFTVIQLV-------GMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVC 174
Query: 792 KIADFGLAKMLAKQ-GEPHTMSAVAGS--FGYFAPEYAYTTKVNEKIDIYSFGVVLLELV 848
           K++DFGL++ L     +P   SA+ G     + APE     K     D++S+G+V+ E++
Sbjct: 175 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234
Query: 849 TGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLP 908
           +  E  Y D                + + +A+++    P  ++  + +++L L C     
Sbjct: 235 SYGERPYWD-------------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDR 281
Query: 909 SSRPSMKEVLQILRR 923
           + RP   +++  L +
Sbjct: 282 NHRPKFGQIVNTLDK 296

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 148/313 (47%), Gaps = 34/313 (10%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    ++++   ++G+G  G+V   R+ +    E  VA+K +  
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-- 81
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F+ E  I+G   H NI++L   ++     ++V EYMEN SLD +L  RK
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                   +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 140 H---DAQFTVIQLV-------GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           K++DFGL+++L    E  +T         + +PE     K     D++S+G+VL E+++ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 851 KEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS 910
            E  Y           W    ++  +  A+D+G   P  ++    +Y+L L C     ++
Sbjct: 247 GERPY-----------WEMSNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNN 293
Query: 911 RPSMKEVLQILRR 923
           RP  ++++ IL +
Sbjct: 294 RPKFEQIVSILDK 306

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 147/313 (46%), Gaps = 34/313 (10%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    ++++   ++G+G  G+V   R+ +    E  VA+K +  
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-- 81
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F+ E  I+G   H NI++L   ++     ++V EYMEN SLD +L  RK
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                   +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 140 H---DAQFTVIQLV-------GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           K++DFGL ++L    E  +T         + +PE     K     D++S+G+VL E+++ 
Sbjct: 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 851 KEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS 910
            E  Y           W    ++  +  A+D+G   P  ++    +Y+L L C     ++
Sbjct: 247 GERPY-----------WEMSNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNN 293
Query: 911 RPSMKEVLQILRR 923
           RP  ++++ IL +
Sbjct: 294 RPKFEQIVSILDK 306

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH N
Sbjct: 15  ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVN 70
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           I+ L+   S++    +V ++ E  SL   LH            + +        + IA  
Sbjct: 71  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH------------IIETKFEMIKLIDIARQ 117
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            AQG+ Y+H      IIHRD+KS+NI L  +   KI DFGLA + ++    H    ++GS
Sbjct: 118 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 818 FGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
             + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH N
Sbjct: 37  ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVN 92
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           I+ L+   S++    +V ++ E  SL   LH            + +        + IA  
Sbjct: 93  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH------------IIETKFEMIKLIDIARQ 139
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            AQG+ Y+H      IIHRD+KS+NI L  +   KI DFGLA + ++    H    ++GS
Sbjct: 140 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 818 FGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
             + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G GG   VY  +       VA+K I+   +  ++  K F  E+     + H NIV +  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG-AAQGL 762
               ++   LV EY+E  +L  ++                   H P  +  AI    Q L
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIES-----------------HGPLSVDTAINFTNQIL 121
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
             + H    +I+HRD+K  NIL+DS    KI DFG+AK L++     T + V G+  YF+
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHVLGTVQYFS 180
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA 863
           PE A     +E  DIYS G+VL E++ G+    G+   S+A
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA 221

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH N
Sbjct: 38  ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVN 93
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           I+ L+   S++    +V ++ E  SL   LH            + +        + IA  
Sbjct: 94  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH------------IIETKFEMIKLIDIARQ 140
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            AQG+ Y+H      IIHRD+KS+NI L  +   KI DFGLA + ++    H    ++GS
Sbjct: 141 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 818 FGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
             + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 135/304 (44%), Gaps = 51/304 (16%)
Query: 623 SFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE 682
           S H + + E  +        ++G G  G V +         VA+K+I      ++   K 
Sbjct: 2   SLHMIDYKEIEV------EEVVGRGAFGVVCKAKWRAKD--VAIKQI-----ESESERKA 48
Query: 683 FIAEIEILGTIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSV 741
           FI E+  L  + H NIVKL+  C+   N   LV EY E  SL   LHG +      ++  
Sbjct: 49  FIVELRQLSRVNHPNIVKLYGACL---NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAA-- 103
Query: 742 HQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAK 800
             H + W       +  +QG+ Y+H      +IHRD+K  N+LL +     KI DFG A 
Sbjct: 104 --HAMSW------CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 155
Query: 801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT 860
            +        M+   GS  + APE    +  +EK D++S+G++L E++T ++    DE  
Sbjct: 156 DIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIG 208
Query: 861 SLA---EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
             A    WA  H     P+   L K I              L   C S  PS RPSM+E+
Sbjct: 209 GPAFRIMWA-VHNGTRPPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEI 255
Query: 918 LQIL 921
           ++I+
Sbjct: 256 VKIM 259

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
            +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHV 64
Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           NI+ L+   S++    +V ++ E  SL   LH            + +        + IA 
Sbjct: 65  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH------------IIETKFEMIKLIDIAR 111
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             AQG+ Y+H      IIHRD+KS+NI L  +   KI DFGLA + ++    H    ++G
Sbjct: 112 QTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 817 SFGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
           S  + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH N
Sbjct: 15  ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVN 70
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           I+ L+   S++    +V ++ E  SL   LH            + +        + IA  
Sbjct: 71  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH------------IIETKFEMIKLIDIARQ 117
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            AQG+ Y+H      IIHRD+KS+NI L  +   KI DFGLA + ++    H    ++GS
Sbjct: 118 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 818 FGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
             + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 135/304 (44%), Gaps = 51/304 (16%)
Query: 623 SFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE 682
           S H + + E  +        ++G G  G V +         VA+K+I      ++   K 
Sbjct: 1   SLHMIDYKEIEV------EEVVGRGAFGVVCKAKWRAKD--VAIKQI-----ESESERKA 47
Query: 683 FIAEIEILGTIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSV 741
           FI E+  L  + H NIVKL+  C+   N   LV EY E  SL   LHG +      ++  
Sbjct: 48  FIVELRQLSRVNHPNIVKLYGACL---NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAA-- 102
Query: 742 HQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAK 800
             H + W       +  +QG+ Y+H      +IHRD+K  N+LL +     KI DFG A 
Sbjct: 103 --HAMSW------CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154
Query: 801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT 860
            +        M+   GS  + APE    +  +EK D++S+G++L E++T ++    DE  
Sbjct: 155 DIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIG 207
Query: 861 SLA---EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
             A    WA  H     P+   L K I              L   C S  PS RPSM+E+
Sbjct: 208 GPAFRIMWA-VHNGTRPPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEI 254
Query: 918 LQIL 921
           ++I+
Sbjct: 255 VKIM 258

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH N
Sbjct: 12  ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVN 67
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           I+ L+   S++    +V ++ E  SL   LH            + +        + IA  
Sbjct: 68  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH------------IIETKFEMIKLIDIARQ 114
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            AQG+ Y+H      IIHRD+KS+NI L  +   KI DFGLA + ++    H    ++GS
Sbjct: 115 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 171
Query: 818 FGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
             + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 143/301 (47%), Gaps = 36/301 (11%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEFIA 685
           F +   +S +    +IG+G  G+V R  +   G+    VA+K +       Q+  +EF++
Sbjct: 9   FAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLS 66
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E  I+G   H NI++L   +++    +++ E+MEN +LD +L      L  G  +V Q V
Sbjct: 67  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR-----LNDGQFTVIQLV 121
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK- 804
                   +  G A G+ Y+        +HRD+ + NIL++S    K++DFGL++ L + 
Sbjct: 122 -------GMLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEEN 171
Query: 805 QGEPHTMSAVAGS--FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
             +P   S++ G     + APE     K     D +S+G+V+ E+++  E  Y D     
Sbjct: 172 SSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD----- 226
Query: 863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                      + + +A+++    P   +  T++++L L C     ++RP   +V+  L 
Sbjct: 227 --------MSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALD 278
Query: 923 R 923
           +
Sbjct: 279 K 279

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 141/313 (45%), Gaps = 38/313 (12%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           +P T++        FT     S +    +IGSG SG+V   R+ + G  +  VA+K +  
Sbjct: 28  EPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-- 85
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                ++  ++F++E  I+G   H NI++L   ++     ++V EYMEN SLD +L    
Sbjct: 86  KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH- 144
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                G  ++ Q V        +  G   G+ Y+        +HRD+ + N+L+DS    
Sbjct: 145 ----DGQFTIMQLV-------GMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVC 190
Query: 792 KIADFGLAKMLAKQGEPHTMSAVAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELV 848
           K++DFGL+++L  + +P       G      + APE       +   D++SFGVV+ E++
Sbjct: 191 KVSDFGLSRVL--EDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
Query: 849 TGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLP 908
              E  Y           W      + +  ++++G   P  +     +++L L C     
Sbjct: 249 AYGERPY-----------WN--MTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDR 295
Query: 909 SSRPSMKEVLQIL 921
           + RP   +++ +L
Sbjct: 296 AQRPRFSQIVSVL 308

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 143/301 (47%), Gaps = 36/301 (11%)
Query: 627 LGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEF 683
           + F +   +S +    +IG+G  G+V R  +   G+    VA+K +       Q+  +EF
Sbjct: 5   MEFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REF 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
           ++E  I+G   H NI++L   +++    +++ E+MEN +LD +L      L  G  +V Q
Sbjct: 63  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR-----LNDGQFTVIQ 117
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA 803
            V        +  G A G+ Y+        +HRD+ + NIL++S    K++DFGL++ L 
Sbjct: 118 LV-------GMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 167
Query: 804 K-QGEPHTMSAVAGS--FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT 860
           +   +P   S++ G     + APE     K     D +S+G+V+ E+++  E  Y D   
Sbjct: 168 ENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD--- 224
Query: 861 SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI 920
                        + + +A+++    P   +  T++++L L C     ++RP   +V+  
Sbjct: 225 ----------MSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSA 274
Query: 921 L 921
           L
Sbjct: 275 L 275

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 139/294 (47%), Gaps = 38/294 (12%)
Query: 636 SSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           ++++   ++G+G  G+V   R+ +    E  VA+K +       +K  ++F+ E  I+G 
Sbjct: 33  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQ 90
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H NI++L   ++     ++V EYMEN SLD +L            +V Q V       
Sbjct: 91  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLV------- 138
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
            +  G A G+ Y+        +HRD+ + NIL++S    K++DFGL+++L  + +P    
Sbjct: 139 GMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAY 193
Query: 813 AVAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
              G      + +PE     K     D++S+G+VL E+++  E  Y           W  
Sbjct: 194 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-----------WEM 242
Query: 870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
             ++  +  A+D+G   P  ++    +Y+L L C     ++RP  ++++ IL +
Sbjct: 243 SNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 294

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
            +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHV 64
Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           NI+ L+   S+     +V ++ E  SL   LH            + +        + IA 
Sbjct: 65  NIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLH------------IIETKFEMIKLIDIAR 111
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             AQG+ Y+H      IIHRD+KS+NI L  +   KI DFGLA + ++    H    ++G
Sbjct: 112 QTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 817 SFGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
           S  + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 139/294 (47%), Gaps = 38/294 (12%)
Query: 636 SSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           ++++   ++G+G  G+V   R+ +    E  VA+K +       +K  ++F+ E  I+G 
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQ 73
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H NI++L   ++     ++V EYMEN SLD +L            +V Q V       
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLV------- 121
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
            +  G A G+ Y+        +HRD+ + NIL++S    K++DFGL+++L  + +P    
Sbjct: 122 GMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAY 176
Query: 813 AVAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
              G      + +PE     K     D++S+G+VL E+++  E  Y           W  
Sbjct: 177 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-----------WEM 225
Query: 870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
             ++  +  A+D+G   P  ++    +Y+L L C     ++RP  ++++ IL +
Sbjct: 226 SNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 277

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH N
Sbjct: 38  ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVN 93
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           I+ L+   S++    +V ++ E  SL   LH            + +        + IA  
Sbjct: 94  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH------------IIETKFEMIKLIDIARQ 140
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            AQG+ Y+H      IIHRD+KS+NI L  +   KI DFGLA   ++    H    ++GS
Sbjct: 141 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 818 FGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
             + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 141/313 (45%), Gaps = 38/313 (12%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           +P T++        FT     S +    +IGSG SG+V   R+ + G  +  VA+K +  
Sbjct: 28  EPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-- 85
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                ++  ++F++E  I+G   H NI++L   ++     ++V EYMEN SLD +L    
Sbjct: 86  KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH- 144
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                G  ++ Q V        +  G   G+ Y+        +HRD+ + N+L+DS    
Sbjct: 145 ----DGQFTIMQLV-------GMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVC 190
Query: 792 KIADFGLAKMLAKQGEPHTMSAVAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELV 848
           K++DFGL+++L  + +P       G      + APE       +   D++SFGVV+ E++
Sbjct: 191 KVSDFGLSRVL--EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
Query: 849 TGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLP 908
              E  Y           W      + +  ++++G   P  +     +++L L C     
Sbjct: 249 AYGERPY-----------WN--MTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDR 295
Query: 909 SSRPSMKEVLQIL 921
           + RP   +++ +L
Sbjct: 296 AQRPRFSQIVSVL 308

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
            +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH 
Sbjct: 29  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHV 84
Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           NI+ L+   S++    +V ++ E  SL   LH            + +        + IA 
Sbjct: 85  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH------------IIETKFEMIKLIDIAR 131
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             AQG+ Y+H      IIHRD+KS+NI L  +   KI DFGLA   ++    H    ++G
Sbjct: 132 QTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSG 188
Query: 817 SFGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
           S  + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 189 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
            +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHV 64
Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           NI+ L+   S++    +V ++ E  SL   LH            + +        + IA 
Sbjct: 65  NIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH------------IIETKFEMIKLIDIAR 111
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             AQG+ Y+H      IIHRD+KS+NI L  +   KI DFGLA   ++    H    ++G
Sbjct: 112 QTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSG 168
Query: 817 SFGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
           S  + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S L    ++G G  GQ  ++     GE + +K +    + +++ ++ F+ E++++  + H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI---RFDEETQRTFLKEVKVMRCLEH 66
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N++K    +  +     + EY++  +L        R ++    S +     W  R+  A
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTL--------RGIIKSMDSQYP----WSQRVSFA 114
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQGEPHTMSA- 813
              A G+ Y+H   +  IIHRD+ S N L+       +ADFGLA+ M+ ++ +P  + + 
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 814 ----------VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELV 848
                     V G+  + APE       +EK+D++SFG+VL E++
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH N
Sbjct: 14  ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVN 69
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           I+ L+   S++    +V ++ E  SL   LH  +                    + IA  
Sbjct: 70  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKF------------EMKKLIDIARQ 116
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            A+G+ Y+H      IIHRD+KS+NI L  +   KI DFGLA + ++    H    ++GS
Sbjct: 117 TARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGS 173
Query: 818 FGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
             + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 174 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 147/313 (46%), Gaps = 34/313 (10%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    ++++   ++G+G  G+V   R+ +    E  VA+K +  
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-- 81
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F+ E  I+G   H NI++L   ++     ++V E MEN SLD +L  RK
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RK 139
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                   +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 140 H---DAQFTVIQLV-------GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVC 186
Query: 792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           K++DFGL+++L    E  +T         + +PE     K     D++S+G+VL E+++ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 851 KEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS 910
            E  Y           W    ++  +  A+D+G   P  ++    +Y+L L C     ++
Sbjct: 247 GERPY-----------WEMSNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNN 293
Query: 911 RPSMKEVLQILRR 923
           RP  ++++ IL +
Sbjct: 294 RPKFEQIVSILDK 306

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 147/313 (46%), Gaps = 34/313 (10%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    ++++   ++G+G  G+V   R+ +    E  VA+K +  
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-- 81
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F+ E  I+G   H NI++L   ++     ++V E MEN SLD +L  RK
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RK 139
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                   +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 140 H---DAQFTVIQLV-------GMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVC 186
Query: 792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           K++DFGL+++L    E  +T         + +PE     K     D++S+G+VL E+++ 
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 851 KEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS 910
            E  Y           W    ++  +  A+D+G   P  ++    +Y+L L C     ++
Sbjct: 247 GERPY-----------WEMSNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNN 293
Query: 911 RPSMKEVLQILRR 923
           RP  ++++ IL +
Sbjct: 294 RPKFEQIVSILDK 306

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH N
Sbjct: 26  ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVN 81
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           I+ L+   S++    +V ++ E  SL   LH  +                    + IA  
Sbjct: 82  IL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKF------------EMKKLIDIARQ 128
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            A+G+ Y+H      IIHRD+KS+NI L  +   KI DFGLA   ++    H    ++GS
Sbjct: 129 TARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 818 FGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
             + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 132/307 (42%), Gaps = 49/307 (15%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA---EIEILGT 692
           S +  S  IGSG  G VY+   +G    VAVK +    K+     ++F A   E+ +L  
Sbjct: 36  SEVMLSTRIGSGSFGTVYKGKWHGD---VAVKIL----KVVDPTPEQFQAFRNEVAVLRK 88
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
            RH NI+ L+    ++++  +V ++ E  SL + LH            V +        +
Sbjct: 89  TRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLH------------VQETKFQMFQLI 135
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
            IA   AQG+ Y+H      IIHRD+KS+NI L      KI DFGLA + ++      + 
Sbjct: 136 DIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192
Query: 813 AVAGSFGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
              GS  + APE       N    + D+YS+G+VL EL+TG             E  + H
Sbjct: 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG-------------ELPYSH 239
Query: 870 YAEEKPITDALDKGIAEP----CYLEEMTTVYRLALICTSTLPSSRPSMKEVL---QILR 922
                 I   + +G A P     Y      + RL   C   +   RP   ++L   ++L+
Sbjct: 240 INNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299
Query: 923 RCCPTEN 929
              P  N
Sbjct: 300 HSLPKIN 306

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 142/313 (45%), Gaps = 34/313 (10%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    S +    +IG G  G+V   R+ + G  E  VA+K +  
Sbjct: 8   DPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-- 65
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                 K  ++F++E  I+G   H NI+ L   ++     +++ EYMEN SLD +L  RK
Sbjct: 66  KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL--RK 123
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                G  +V Q V        +  G   G+ Y+        +HRD+ + NIL++S    
Sbjct: 124 N---DGRFTVIQLV-------GMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVC 170
Query: 792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           K++DFG++++L    E  +T         + APE     K     D++S+G+V+ E+++ 
Sbjct: 171 KVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 230
Query: 851 KEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS 910
            E  Y D                + +  A+++G   P  ++    +++L L C     S 
Sbjct: 231 GERPYWD-------------MSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSD 277
Query: 911 RPSMKEVLQILRR 923
           RP   +++ +L +
Sbjct: 278 RPKFGQIVNMLDK 290

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 52  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 156
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 157 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 213
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 41/281 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 330 VVS-EEPIYIVTEYMSKGSLLDFLKGET-----------GKYLRLPQLVDMAAQIASGMA 377
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 378 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 430
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 477
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           ++G   PC  E   +++ L   C    P  RP+  E LQ  
Sbjct: 478 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQAF 517

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 28  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 132
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 133 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 189
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 190 WYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 77  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 124
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 125 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 179
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 125
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 26  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 130
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 131 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 187
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 188 WYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 25  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 129
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 130 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 186
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 187 WYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 27  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 131
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 132 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 188
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 189 WYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 125
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 74  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 121
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 122 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 176
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 77  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 124
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 125 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 179
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 128
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 20  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 124
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 125 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 181
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 182 WYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 172
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    IGSG  G VY+   +G    VAVK +       Q+L+  F  E+ +L   RH N
Sbjct: 26  ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVN 81
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           I+ L+   S+     +V ++ E  SL   LH  +                    + IA  
Sbjct: 82  IL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKF------------EMKKLIDIARQ 128
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            A+G+ Y+H      IIHRD+KS+NI L  +   KI DFGLA   ++    H    ++GS
Sbjct: 129 TARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 818 FGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGK 851
             + APE       N    + D+Y+FG+VL EL+TG+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 172
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 19  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 123
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 124 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 180
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 172
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 116
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 171
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 116
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 171
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 173
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY+   +  G  VA+KRI  + + ++ +    I EI +L  + H NIV L  
Sbjct: 29  VGEGTYGVVYKAK-DSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I SE    LV+E+ME + L + L   K  L      ++ +        Q+  G A   C
Sbjct: 87  VIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLY--------QLLRGVAH--C 135
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H     +I+HRD+K  N+L++S+   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 136 HQH-----RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAP 188
Query: 824 EYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
           +    + K +  +DI+S G +  E++TGK
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 130/285 (45%), Gaps = 37/285 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
            SL     +G+G  G+V+    NG  + VA+K +    K      + F+ E +I+  ++H
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTK-VAIKTL----KPGTMSPESFLEEAQIMKKLKH 63
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQI 754
             +V+L+  +S E    +V EYM   SL  +L  G  R+L              P  + +
Sbjct: 64  DKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKDGEGRAL------------KLPNLVDM 110
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           A   A G+ Y+        IHRD++S+NIL+ +    KIADFGLA+++ +  E       
Sbjct: 111 AAQVAAGMAYIER---MNYIHRDLRSANILVGNGLICKIADFGLARLI-EDNEXTARQGA 166
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
                + APE A   +   K D++SFG++L ELVT     Y   +              +
Sbjct: 167 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------------R 213
Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
            + + +++G   PC  +   +++ L + C    P  RP+  E LQ
Sbjct: 214 EVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTF-EYLQ 257

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 39  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 143
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY+   +  G  VA+KRI  + + ++ +    I EI +L  + H NIV L  
Sbjct: 29  VGEGTYGVVYKAK-DSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I SE    LV+E+ME + L + L   K  L      ++ +        Q+  G A   C
Sbjct: 87  VIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLY--------QLLRGVAH--C 135
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H     +I+HRD+K  N+L++S+   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 136 HQH-----RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAP 188
Query: 824 EYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
           +    + K +  +DI+S G +  E++TGK
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 39  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 143
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 112/228 (49%), Gaps = 35/228 (15%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRI--WNNRKLNQKLEK--EFIAEIEILGTIRHANIV 699
           IG GG G V++  +      VA+K +   ++    + +EK  EF  E+ I+  + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           KL+  +   N   +V E++    L   L  +             H + W  +L++ +  A
Sbjct: 87  KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKA------------HPIKWSVKLRLMLDIA 132
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDS-----EFKAKIADFGLAKMLAKQGEPHTMSAV 814
            G+ YM +   P I+HRD++S NI L S        AK+ADFGL+     Q   H++S +
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGL 186
Query: 815 AGSFGYFAPEY--AYTTKVNEKIDIYSFGVVLLELVTGK----EANYG 856
            G+F + APE   A      EK D YSF ++L  ++TG+    E +YG
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 636 SSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           ++++   ++G+G  G+V   R+ +    E  VA+K +       +K  ++F+ E  I+G 
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQ 73
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H NI++L   ++     ++V E MEN SLD +L            +V Q V       
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF-----TVIQLV------- 121
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
            +  G A G+ Y+        +HRD+ + NIL++S    K++DFGL+++L  + +P    
Sbjct: 122 GMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAY 176
Query: 813 AVAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
              G      + +PE     K     D++S+G+VL E+++  E  Y           W  
Sbjct: 177 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-----------WEM 225
Query: 870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
             ++  +  A+D+G   P  ++    +Y+L L C     ++RP  ++++ IL +
Sbjct: 226 SNQD--VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 277

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLS 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 172
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  IRH  +V+L+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 81  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-----------LRLPQLVDMAAQIASGMA 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 181
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 228
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF-EYLQ 266

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 78/315 (24%), Positives = 147/315 (46%), Gaps = 38/315 (12%)
Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWN 671
           DP T++  +     F +    S +    +IG+G  G+V   R+ + G  +  VA+K +  
Sbjct: 22  DPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTL-- 79
Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F+ E  I+G   H N+V L   ++     ++V E+MEN +LD +L  RK
Sbjct: 80  KVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL--RK 137
Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                G  +V Q V        +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 138 H---DGQFTVIQLV-------GMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVC 184
Query: 792 KIADFGLAKMLAKQGEPHTMSAVAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELV 848
           K++DFGL++++  + +P  +    G      + APE     K     D++S+G+V+ E++
Sbjct: 185 KVSDFGLSRVI--EDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 242
Query: 849 TGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLP 908
           +  E  Y D                + +  A+++G   P  ++    +++L L C     
Sbjct: 243 SYGERPYWD-------------MSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKER 289
Query: 909 SSRPSMKEVLQILRR 923
           + RP  ++++ IL +
Sbjct: 290 AERPKFEQIVGILDK 304

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 137/295 (46%), Gaps = 36/295 (12%)
Query: 635 LSSLTESNLIGSGGSGQVY--RIDINGAGE-FVAVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +S +    +IG+G  G+V    + + G  E FVA+K +       +K  ++F++E  I+G
Sbjct: 6   ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMG 63
Query: 692 TIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
              H N++ L   ++     +++ E+MEN SLD +L         G  +V Q V      
Sbjct: 64  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-----DGQFTVIQLV------ 112
Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ-GEPHT 810
             +  G A G+ Y+        +HR + + NIL++S    K++DFGL++ L     +P  
Sbjct: 113 -GMLRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 168
Query: 811 MSAVAGS--FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
            SA+ G     + APE     K     D++S+G+V+ E+++  E  Y D           
Sbjct: 169 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD----------- 217
Query: 869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
                + + +A+++    P  ++  + +++L L C     + RP   +++  L +
Sbjct: 218 --MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 270

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 125
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 41/281 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 247 VVS-EEPIYIVTEYMSKGSLLDFLKGET-----------GKYLRLPQLVDMAAQIASGMA 294
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 347
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 394
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           ++G   PC  E   +++ L   C    P  RP+  E LQ  
Sbjct: 395 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQAF 434

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 86/288 (29%), Positives = 128/288 (44%), Gaps = 29/288 (10%)
Query: 644 IGSGGSGQV----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +G G  G+V    Y    +G GE VAVK +        +L   +  EIEIL T+ H +IV
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 700 KLWCCISS--ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           K   C     E S  LV EY+   SL  +L               +H +     L  A  
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP--------------RHCVGLAQLLLFAQQ 119
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +G+ Y+H       IHR + + N+LLD++   KI DFGLAK + +  E + +     S
Sbjct: 120 ICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 176
Query: 818 -FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK-- 874
              ++APE     K     D++SFGV L EL+T  ++N    HT   E       +    
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQ-SPHTKFTELIGHTQGQMTVL 235
Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            +T+ L++G   P        +Y L   C  T  S RP+ + ++ IL+
Sbjct: 236 RLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 86/288 (29%), Positives = 128/288 (44%), Gaps = 29/288 (10%)
Query: 644 IGSGGSGQV----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +G G  G+V    Y    +G GE VAVK +        +L   +  EIEIL T+ H +IV
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 700 KLWCCISS--ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           K   C     E S  LV EY+   SL  +L               +H +     L  A  
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP--------------RHCVGLAQLLLFAQQ 120
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +G+ Y+H       IHR + + N+LLD++   KI DFGLAK + +  E + +     S
Sbjct: 121 ICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 177
Query: 818 -FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK-- 874
              ++APE     K     D++SFGV L EL+T  ++N    HT   E       +    
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQ-SPHTKFTELIGHTQGQMTVL 236
Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            +T+ L++G   P        +Y L   C  T  S RP+ + ++ IL+
Sbjct: 237 RLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 284

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ E++   SL  +L   K  +       H  +L + +++       +
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERID------HIKLLQYTSQI------CK 128
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 41/281 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G      +G        L  P  + +A   A G+ 
Sbjct: 247 VVS-EEPIYIVTEYMSKGSLLDFLKGE-----TGK------YLRLPQLVDMAAQIASGMA 294
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 347
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 394
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           ++G   PC  E   +++ L   C    P  RP+  E LQ  
Sbjct: 395 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQAF 434

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L              H   +     LQ      +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQA------------HAERIDHIKLLQYTSQICK 128
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E   +     S   
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 41/281 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 247 VVS-EEPIYIVGEYMSKGSLLDFLKGET-----------GKYLRLPQLVDMAAQIASGMA 294
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 347
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 394
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           ++G   PC  E   +++ L   C    P  RP+  E LQ  
Sbjct: 395 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQAF 434

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 35/276 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 81  VVSEE-PIYIVIEYMSKGSLLDFLKGEMGKY-----------LRLPQLVDMAAQIASGMA 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+        +HRD++++NIL+      K+ADFGLA+++ +  E            + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAP 184
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG 883
           E A   +   K D++SFG++L EL T     Y                  + + D +++G
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQVERG 231
Query: 884 IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
              PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 232 YRMPCPPECPESLHDLMCQCWRKDPEERPTF-EYLQ 266

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 137/301 (45%), Gaps = 38/301 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIA 685
           F +    S +    +IG G  G+V   R+ + G  E  VA+K +        K  ++F++
Sbjct: 1   FAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL--KAGYTDKQRRDFLS 58
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E  I+G   H NI+ L   ++     +++ EYMEN SLD +L  RK     G  +V Q V
Sbjct: 59  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL--RKN---DGRFTVIQLV 113
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                   +  G   G+ Y+        +HRD+ + NIL++S    K++DFG++++L  +
Sbjct: 114 -------GMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVL--E 161
Query: 806 GEPHTMSAVAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
            +P       G      + APE     K     D++S+G+V+ E+++  E  Y D     
Sbjct: 162 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----- 216
Query: 863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                      + +  A+++G   P  ++    +++L L C     S RP   +++ +L 
Sbjct: 217 --------MSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 268
Query: 923 R 923
           +
Sbjct: 269 K 269

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 19  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 73
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 74  VVSEE-PIYIVTEYMSKGSLLDFLKGETGKY-----------LRLPQLVDMAAQIASGMA 121
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 122 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 174
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 221
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 222 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQ 259

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 35/276 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 16  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 71  VVSEE-PIXIVTEYMSKGSLLDFLKGETGKY-----------LRLPQLVDMAAQIASGMA 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+        +HRD++++NIL+      K+ADFGLA+++ +  E            + AP
Sbjct: 119 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAP 174
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG 883
           E A   +   K D++SFG++L EL T     Y                  + + D +++G
Sbjct: 175 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQVERG 221
Query: 884 IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
              PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 222 YRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQ 256

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 81  VVSEE-PIYIVIEYMSKGSLLDFLKGEMGKY-----------LRLPQLVDMAAQIASGMA 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 181
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 228
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF-EYLQ 266

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 114/210 (54%), Gaps = 23/210 (10%)
Query: 645 GSGGSGQVYRID--INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
           G+ GS ++ R D   +  GE VAVK++ ++    ++  ++F  EIEIL +++H NIVK  
Sbjct: 22  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
             C S+    L L+ EY+   SL  +L   K  +       H  +L + +++       +
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI------CK 126
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-FG 819
           G+ Y+    T + IHR++ + NIL+++E + KI DFGL K+L +  E + +     S   
Sbjct: 127 GMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 183
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
           ++APE    +K +   D++SFGVVL EL T
Sbjct: 184 WYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 81  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-----------LRLPQLVDMAAQIASGMA 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 181
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 228
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF-EYLQ 266

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 137/301 (45%), Gaps = 38/301 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIA 685
           F +    S +    +IG G  G+V   R+ + G  E  VA+K +        K  ++F++
Sbjct: 7   FAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL--KAGYTDKQRRDFLS 64
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E  I+G   H NI+ L   ++     +++ EYMEN SLD +L  RK     G  +V Q V
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL--RKN---DGRFTVIQLV 119
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                   +  G   G+ Y+        +HRD+ + NIL++S    K++DFG++++L  +
Sbjct: 120 -------GMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVL--E 167
Query: 806 GEPHTMSAVAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
            +P       G      + APE     K     D++S+G+V+ E+++  E  Y D     
Sbjct: 168 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----- 222
Query: 863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                      + +  A+++G   P  ++    +++L L C     S RP   +++ +L 
Sbjct: 223 --------MSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 274
Query: 923 R 923
           +
Sbjct: 275 K 275

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 17  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 72  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-----------LRLPQLVDMAAQIASGMA 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 120 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 172
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 219
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 220 ERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF-EYLQ 257

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 15  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 69
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 70  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-----------LRLPQLVDMAAQIASGMA 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 118 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 170
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 217
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 218 ERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF-EYLQ 255

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 81  VVSEE-PIYIVCEYMSKGSLLDFLKGEMGKY-----------LRLPQLVDMAAQIASGMA 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 181
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 228
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF-EYLQ 266

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 73  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 120
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 74  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 121
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 122 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 176
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 73  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 120
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+ +I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 172
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+ +I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 116
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 171
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 120 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 111/228 (48%), Gaps = 35/228 (15%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRI--WNNRKLNQKLEK--EFIAEIEILGTIRHANIV 699
           IG GG G V++  +      VA+K +   ++    + +EK  EF  E+ I+  + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           KL+  +   N   +V E++    L   L  +             H + W  +L++ +  A
Sbjct: 87  KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKA------------HPIKWSVKLRLMLDIA 132
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDS-----EFKAKIADFGLAKMLAKQGEPHTMSAV 814
            G+ YM +   P I+HRD++S NI L S        AK+ADFG +     Q   H++S +
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----QQSVHSVSGL 186
Query: 815 AGSFGYFAPEY--AYTTKVNEKIDIYSFGVVLLELVTGK----EANYG 856
            G+F + APE   A      EK D YSF ++L  ++TG+    E +YG
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 116
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 171
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 119 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 96  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 140
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQGEP-HTMSA 813
           +  A+G+ ++    + + +HRD+ + N +LD +F  K+ADFGLA+ ML K+ +  H  + 
Sbjct: 141 LQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTG 197
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 198 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 245
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 246 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 123/281 (43%), Gaps = 41/281 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGNMSPEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 248 VVS-EEPIYIVTEYMSKGSLLDFLKGE-----------MGKYLRLPQLVDMAAQIASGMA 295
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGL +++    E +  +A  G+     +
Sbjct: 296 YVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLI----EDNEYTARQGAKFPIKW 348
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 349 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 395
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           ++G   PC  E   +++ L   C    P  RP+  E LQ  
Sbjct: 396 ERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF-EYLQAF 435

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 116
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 171
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 111/228 (48%), Gaps = 35/228 (15%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIW--NNRKLNQKLEK--EFIAEIEILGTIRHANIV 699
           IG GG G V++  +      VA+K +   ++    + +EK  EF  E+ I+  + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           KL+  +   N   +V E++    L   L  +             H + W  +L++ +  A
Sbjct: 87  KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKA------------HPIKWSVKLRLMLDIA 132
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDS-----EFKAKIADFGLAKMLAKQGEPHTMSAV 814
            G+ YM +   P I+HRD++S NI L S        AK+ADF L+     Q   H++S +
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVHSVSGL 186
Query: 815 AGSFGYFAPEY--AYTTKVNEKIDIYSFGVVLLELVTGK----EANYG 856
            G+F + APE   A      EK D YSF ++L  ++TG+    E +YG
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L  ++     S ++G        +  P          QGL 
Sbjct: 69  VIHTENKLYLVFEHV-HQDLKTFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 116
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +T   V  +  Y AP
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 171
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + ++   A G+ 
Sbjct: 78  VVSEE-PIYIVTEYMNKGSLLDFLKGETGKY-----------LRLPQLVDMSAQIASGMA 125
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 126 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 178
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 225
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 226 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQ 263

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 75/279 (26%), Positives = 123/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + +A   A G+ 
Sbjct: 81  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKY-----------LRLPQLVDMAAQIASGMA 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD+ ++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 129 YVER---MNYVHRDLAAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 181
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 228
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF-EYLQ 266

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM    L  +L G                L  P  + +A   A G+ 
Sbjct: 81  VVSEE-PIYIVMEYMSKGCLLDFLKGEMGKY-----------LRLPQLVDMAAQIASGMA 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 181
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 228
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF-EYLQ 266

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM   SL  +L G                L  P  + ++   A G+ 
Sbjct: 78  VVSEE-PIYIVTEYMNKGSLLDFLKGETGKY-----------LRLPQLVDMSAQIASGMA 125
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 126 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEWTARQGAKFPIKW 178
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 225
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 226 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF-EYLQ 263

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L +++     S ++G        +  P          QGL 
Sbjct: 73  VIHTENKLYLVFEHV-DQDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 120
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 94  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 138
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQGEP-HTMSA 813
           +  A+G+ Y+    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+    H  + 
Sbjct: 139 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTG 195
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 196 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 243
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 244 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 41/279 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH  +V+L+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +S E    +V EYM    L  +L G                L  P  + +A   A G+ 
Sbjct: 81  VVSEE-PIYIVTEYMSKGCLLDFLKGEMGKY-----------LRLPQLVDMAAQIASGMA 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        +HRD++++NIL+      K+ADFGLA+++    E +  +A  G+     +
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKW 181
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE A   +   K D++SFG++L EL T     Y                  + + D +
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------MVNREVLDQV 228
Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           ++G   PC  E   +++ L   C    P  RP+  E LQ
Sbjct: 229 ERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF-EYLQ 266

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L  ++     S ++G        +  P          QGL 
Sbjct: 73  VIHTENKLYLVFEFL-HQDLKTFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 120
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 114 SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 158
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQ-GEPHTMSA 813
           +  A+G+ Y+    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+    H  + 
Sbjct: 159 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 215
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 216 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 263
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 264 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 307

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 113 SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 157
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQ-GEPHTMSA 813
           +  A+G+ Y+    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+    H  + 
Sbjct: 158 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 214
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 215 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 262
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 263 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 306

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 36/299 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEF-----VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           IG G  G+V++    G   +     VAVK +    + +  ++ +F  E  ++    + NI
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDNPNI 112
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSS----SVHQHV-------LH 747
           VKL    +      L++EYM    L+ +L       V   S    S    V       L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
              +L IA   A G+ Y+      + +HRD+ + N L+      KIADFGL++ +     
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 808 PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA 866
                  A    +  PE  +  +   + D++++GVVL E+ + G +  YG  H  +  + 
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY- 288
Query: 867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC 925
                    + D       E C LE    +Y L  +C S LP+ RPS   + +IL+R C
Sbjct: 289 ---------VRDGNILACPENCPLE----LYNLMRLCWSKLPADRPSFCSIHRILQRMC 334

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +Q L  ++     S ++G        +  P          QGL 
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKDFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 118 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+   N  GE  A+K+I    K ++ +    I EI IL  ++H+NIVKL+ 
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I ++   +LV+E++ +Q L + L             V +  L   T     +    G+ 
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLL------------DVCEGGLESVTAKSFLLQLLNGIA 114
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H     +++HRD+K  N+L++ E + KIADFGLA+        +T   V  +  Y AP
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAP 169
Query: 824 EYAY-TTKVNEKIDIYSFGVVLLELVTG 850
           +    + K +  IDI+S G +  E+V G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+   N  GE  A+K+I    K ++ +    I EI IL  ++H+NIVKL+ 
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I ++   +LV+E++ +Q L + L             V +  L   T     +    G+ 
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLL------------DVCEGGLESVTAKSFLLQLLNGIA 114
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H     +++HRD+K  N+L++ E + KIADFGLA+        +T   V  +  Y AP
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAP 169
Query: 824 EYAY-TTKVNEKIDIYSFGVVLLELVTG 850
           +    + K +  IDI+S G +  E+V G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 114/230 (49%), Gaps = 42/230 (18%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEI 689
           S   +   +G+G    VY+      G +VA+K +        KL+ E       I EI +
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV--------KLDSEEGTPSTAIREISL 56
Query: 690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
           +  ++H NIV+L+  I +EN   LV+E+M+N  L +++  R              V + P
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRT-------------VGNTP 102
Query: 750 TRLQIAI------GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA 803
             L++ +         QGL + H +   +I+HRD+K  N+L++   + K+ DFGLA+   
Sbjct: 103 RGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF- 158
Query: 804 KQGEP-HTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGK 851
             G P +T S+   +  Y AP+    ++  +  IDI+S G +L E++TGK
Sbjct: 159 --GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 139
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQ-GEPHTMSA 813
           +  A+G+ Y+    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+    H  + 
Sbjct: 140 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 196
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 244
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 245 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 87  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 131
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQ-GEPHTMSA 813
           +  A+G+ Y+    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+    H  + 
Sbjct: 132 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 188
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 189 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 236
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 237 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 280

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 130/287 (45%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 100 SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 144
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQGEP-HTMSA 813
           +  A+G+ ++    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+ +  H  + 
Sbjct: 145 LQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 201
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 202 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 249
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 250 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 293

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 94  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 138
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQ-GEPHTMSA 813
           +  A+G+ Y+    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+    H  + 
Sbjct: 139 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 195
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 196 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 243
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 244 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+   N  GE  A+K+I    K ++ +    I EI IL  ++H+NIVKL+ 
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I ++   +LV+E++ +Q L + L             V +  L   T     +    G+ 
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLL------------DVCEGGLESVTAKSFLLQLLNGIA 114
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H     +++HRD+K  N+L++ E + KIADFGLA+        +T   V  +  Y AP
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAP 169
Query: 824 EYAY-TTKVNEKIDIYSFGVVLLELVTG 850
           +    + K +  IDI+S G +  E+V G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 93  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 137
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQ-GEPHTMSA 813
           +  A+G+ Y+    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+    H  + 
Sbjct: 138 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 194
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 195 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 242
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 243 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 136
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQ-GEPHTMSA 813
           +  A+G+ Y+    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+    H  + 
Sbjct: 137 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 193
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 241
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 242 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 285

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 139
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQ-GEPHTMSA 813
           +  A+G+ Y+    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+    H  + 
Sbjct: 140 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 196
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 244
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 245 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 130/287 (45%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 93  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 137
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQGEP-HTMSA 813
           +  A+G+ ++    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+ +  H  + 
Sbjct: 138 LQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 194
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 195 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 242
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 243 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 130/287 (45%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 139
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQGEP-HTMSA 813
           +  A+G+ ++    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+ +  H  + 
Sbjct: 140 LQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 196
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 244
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 245 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 130/287 (45%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 96  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 140
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQGEP-HTMSA 813
           +  A+G+ ++    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+ +  H  + 
Sbjct: 141 LQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 197
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 198 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 245
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 246 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 134
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQ-GEPHTMSA 813
           +  A+G+ Y+    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+    H  + 
Sbjct: 135 LQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 239
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 240 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 283

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +  L +++     S ++G        +  P          QGL 
Sbjct: 73  VIHTENKLYLVFEFL-SMDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 120
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 121 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 59/301 (19%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
              E  LIGSGG GQV++      G+   +KR+  N   N+K E+E    ++ L  + H 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAERE----VKALAKLDHV 64
Query: 697 NIVKLWCC---------ISSENSK-------LLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
           NIV    C          SS+NS         +  E+ +  +L++W+  R+   +     
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD---- 120
Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK 800
               VL      QI     +G+ Y+H   + ++I+RD+K SNI L    + KI DFGL  
Sbjct: 121 ---KVLALELFEQIT----KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT 860
            L   G+        G+  Y +PE   +    +++D+Y+ G++L EL+            
Sbjct: 171 SLKNDGK---RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL------------ 215
Query: 861 SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI 920
            + + A   +   K  TD  D  I++    +E T + +L     S  P  RP+  E+L+ 
Sbjct: 216 HVCDTA---FETSKFFTDLRDGIISDIFDKKEKTLLQKLL----SKKPEDRPNTSEILRT 268
Query: 921 L 921
           L
Sbjct: 269 L 269

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 130/287 (45%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 198
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQGEP-HTMSA 813
           +  A+G+ ++    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+ +  H  + 
Sbjct: 199 LQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 303
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 304 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 347

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 130/287 (45%), Gaps = 46/287 (16%)
Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N++
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT---RLQIA 755
            L   C+ SE S L+V  YM+        HG  R+ +   +       H PT    +   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMK--------HGDLRNFIRNET-------HNPTVKDLIGFG 139
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK-MLAKQGEP-HTMSA 813
           +  A+G+ ++    + + +HRD+ + N +LD +F  K+ADFGLA+ M  K+ +  H  + 
Sbjct: 140 LQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 196
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + A E   T K   K D++SFGV+L EL+T     Y D +T             
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------ 244
Query: 874 KPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             IT  L +G  + +P Y  +   +Y + L C       RPS  E++
Sbjct: 245 -DITVYLLQGRRLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +  L +++     S ++G        +  P          QGL 
Sbjct: 71  VIHTENKLYLVFEFL-SMDLKKFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 119 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 115/231 (49%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73
Query: 697 NIVKL-WCCISSENSKLLVY-----EYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L +   SS   K +VY     +Y+      + R     K++L      ++ + L  
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 132
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 133 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 177
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 178 PN-VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           NL+G G    VYR +    G  VA+K I         + +    E++I   ++H +I++L
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +      N   LV E   N  ++R+L  R +     S +  +H +H     QI      G
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPF---SENEARHFMH-----QI----ITG 124
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           + Y+H   +  I+HRD+  SN+LL      KIADFGLA  L    E H    + G+  Y 
Sbjct: 125 MLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLCGTPNYI 179
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +PE A  +    + D++S G +   L+ G+
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 128/292 (43%), Gaps = 27/292 (9%)
Query: 633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           N L++      IG G   +VYR      G  VA+K++     ++ K   + I EI++L  
Sbjct: 29  NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWL-HGRKRSLVSGSSSVHQHVLHWPTR 751
           + H N++K +     +N   +V E  +   L R + H +K+  +    +V      W   
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV------WKYF 142
Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
           +Q+       L +MH   + +++HRD+K +N+ + +    K+ D GL +  + +      
Sbjct: 143 VQL----CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AA 193
Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA 871
            ++ G+  Y +PE  +    N K DI+S G +L E+   +   YGD+           Y+
Sbjct: 194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--------YS 245
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
             K I       +    Y EE+    +L  +C +  P  RP +  V  + +R
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEELR---QLVNMCINPDPEKRPDVTYVYDVAKR 294

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 92
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 151
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 152 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 196
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 197 PN-VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 245

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 74
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 133
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 134 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 178
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 179 PN-VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 227

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 107
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 166
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 167 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 211
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 212 PN-VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 132
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 133 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 177
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 178 PN-VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 81
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 140
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 141 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 185
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 186 PN-VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 234

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 85
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 144
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 145 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 189
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 190 PN-VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 238

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 85
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 144
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 145 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 189
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 190 PN-VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 238

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 25/284 (8%)
Query: 644 IGSGGSGQV----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +G G  G+V    Y  + +  GE VAVK +      N     +   EIEIL  + H NIV
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIV 74
Query: 700 KL--WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           K    C     N   L+ E++ + SL  +L   K  +            +   +L+ A+ 
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI------------NLKQQLKYAVQ 122
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +G+ Y+    + Q +HRD+ + N+L++SE + KI DFGL K +    E  T+     S
Sbjct: 123 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 179
Query: 818 -FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH-YAEEKP 875
              ++APE    +K     D++SFGV L EL+T  +++       L      H       
Sbjct: 180 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 239
Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           + + L +G   PC       VY+L   C    PS+R S + +++
Sbjct: 240 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 132
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 133 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 177
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 178 PN-VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 25/284 (8%)
Query: 644 IGSGGSGQV----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +G G  G+V    Y  + +  GE VAVK +      N     +   EIEIL  + H NIV
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIV 86
Query: 700 KL--WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           K    C     N   L+ E++ + SL  +L   K  +            +   +L+ A+ 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI------------NLKQQLKYAVQ 134
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +G+ Y+    + Q +HRD+ + N+L++SE + KI DFGL K +    E  T+     S
Sbjct: 135 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 191
Query: 818 -FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH-YAEEKP 875
              ++APE    +K     D++SFGV L EL+T  +++       L      H       
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           + + L +G   PC       VY+L   C    PS+R S + +++
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 86
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 145
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 146 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 190
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 191 PN-VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 239

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 77
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 136
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 137 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 181
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 182 PN-VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 230

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 37/291 (12%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V     Y +        VAVK +   +       K+F  E E+L  ++H +I
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHEHI 79
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRS-LVSGSSSVHQHVLHWPTRLQIA 755
           VK +      +  ++V+EYM++  L+++L  HG     LV G     +  L     L IA
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE----PHTM 811
              A G+ Y+    +   +HRD+ + N L+ +    KI DFG+++ +          HTM
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY 870
             +     +  PE     K   + D++SFGV+L E+ T GK+  +   +T + E   +  
Sbjct: 197 LPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             E+P            C  E    VY + L C    P  R ++KE+ +IL
Sbjct: 253 VLERP----------RVCPKE----VYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 78
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 137
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 138 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 182
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 183 PN-VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 231

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 107
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 166
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 167 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 211
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 212 PN-VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 109
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 168
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 169 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 213
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 214 PN-VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 262

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 101
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 160
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 161 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 205
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 206 PN-VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 254

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +  L  ++     S ++G        +  P          QGL 
Sbjct: 73  VIHTENKLYLVFEFL-SMDLKDFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 120
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 152
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 211
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 212 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 256
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 257 PN-VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 305

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 111
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 170
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 171 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 215
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 216 PN-VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 264

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 132
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 133 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 177
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 178 PN-VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY+      GE VA+K+I  + +  + +    I EI +L  + H NIVKL  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +EN   LV+E++ +  L  ++     S ++G        +  P          QGL 
Sbjct: 72  VIHTENKLYLVFEFL-SMDLKDFMDA---SALTG--------IPLPLIKSYLFQLLQGLA 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H   + +++HRD+K  N+L+++E   K+ADFGLA+        +    V  +  Y AP
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 824 EYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
           E     K  +  +DI+S G +  E+VT +    GD
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 132/314 (42%), Gaps = 72/314 (22%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
              E  LIGSGG GQV++      G+   ++R+  N   N+K E+E    ++ L  + H 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYN---NEKAERE----VKALAKLDHV 65
Query: 697 NIVKLWCC-------------------ISSENSK----------LLVYEYMENQSLDRWL 727
           NIV    C                      ENSK           +  E+ +  +L++W+
Sbjct: 66  NIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI 125
Query: 728 HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS 787
             R+              L     L++     +G+ Y+H   + ++IHRD+K SNI L  
Sbjct: 126 EKRR-----------GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVD 171
Query: 788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL 847
             + KI DFGL   L   G+    +   G+  Y +PE   +    +++D+Y+ G++L EL
Sbjct: 172 TKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 848 VTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTL 907
           +             + + A   +   K  TD  D  I++    +E T + +L     S  
Sbjct: 229 L------------HVCDTA---FETSKFFTDLRDGIISDIFDKKEKTLLQKLL----SKK 269
Query: 908 PSSRPSMKEVLQIL 921
           P  RP+  E+L+ L
Sbjct: 270 PEDRPNTSEILRTL 283

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 131/302 (43%), Gaps = 46/302 (15%)
Query: 633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRI-WNNRKLNQKLEKEFIAEIEILG 691
            + S L E   IG G  G VY        E VA+K++ ++ ++ N+K + + I E+  L 
Sbjct: 54  KLFSDLRE---IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQ 109
Query: 692 TIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
            +RH N ++   C   E++  LV EY    + D                VH+  L     
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL-------------EVHKKPLQEVEI 156
Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
             +  GA QGL Y+H   +  +IHRDVK+ NILL      K+ DFG A ++A        
Sbjct: 157 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PA 207
Query: 812 SAVAGSFGYFAPEYAYTT---KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
           +   G+  + APE        + + K+D++S G+  +EL   K   +     S    A  
Sbjct: 208 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALY 263
Query: 869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ---ILRRCC 925
           H A+ +  + AL  G     +   + +       C   +P  RP+ + +L+   +LR   
Sbjct: 264 HIAQNE--SPALQSGHWSEYFRNFVDS-------CLQKIPQDRPTSEVLLKHRFVLRERP 314
Query: 926 PT 927
           PT
Sbjct: 315 PT 316

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 25/228 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +V        G  VA+K I +  +LN    ++   E+ I+  + H NIVKL+ 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 704 CISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
            I +E +  L+ EY     +  +L  HGR +   + S            + +  + A Q 
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS------------KFRQIVSAVQ- 128
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
             Y H     +I+HRD+K+ N+LLD++   KIADFG +      G+   + A  G+  Y 
Sbjct: 129 --YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYA 180
Query: 822 APEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
           APE     K +  ++D++S GV+L  LV+G     G     L E   R
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ-KLEKEFIAEIEILGTIRHANIVK 700
           + +G G  G+V   +    G  VAVK I N +K+    +  +   EI+ L   RH +I+K
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           L+  IS+     +V EY+    L  ++  HGR   + +              RL   I +
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-------------RRLFQQILS 122
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A   C+ H      ++HRD+K  N+LLD+   AKIADFGL+ M++  GE   +    GS 
Sbjct: 123 AVDYCHRH-----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGE--FLRTSCGSP 174
Query: 819 GYFAPEY-AYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
            Y APE  +       ++DI+S GV+L  L+ G    + DEH
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT-LPFDDEH 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 71/262 (27%), Positives = 119/262 (45%), Gaps = 26/262 (9%)
Query: 630 TESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI 689
           T S++        ++G GG  +V+          VAVK +  +   +      F  E + 
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 65
Query: 690 LGTIRHANIVKLWCCISSENSK----LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
              + H  IV ++    +E        +V EY++  +L        R +V      H   
Sbjct: 66  AAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTL--------RDIV------HTEG 111
Query: 746 LHWPTR-LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
              P R +++   A Q L + H +    IIHRDVK +NI++ +    K+ DFG+A+ +A 
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168
Query: 805 QGEPHTMSA-VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA 863
            G   T +A V G+  Y +PE A    V+ + D+YS G VL E++TG+    GD   S+ 
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV- 227
Query: 864 EWAWRHYAEEKPITDALDKGIA 885
             A++H  E+     A  +G++
Sbjct: 228 --AYQHVREDPIPPSARHEGLS 247

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 31/294 (10%)
Query: 644 IGSGGSGQVYRIDINGA-----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V+  + +          VAVK +   ++ ++   ++F  E E+L  ++H +I
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTMLQHQHI 82
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           V+ +   +     L+V+EYM +  L+R+L  HG    L++G   V    L     L +A 
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A G+ Y+        +HRD+ + N L+      KI DFG+++ +              
Sbjct: 143 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKP 875
              +  PE     K   + D++SFGVVL E+ T GK+  Y   +T   +   +    E+P
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP 259
Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV---LQILRRCCP 926
                       C  E    VY +   C    P  R S+K+V   LQ L +  P
Sbjct: 260 ----------RACPPE----VYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 299

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 31/294 (10%)
Query: 644 IGSGGSGQVYRIDINGA-----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V+  + +          VAVK +   ++ ++   ++F  E E+L  ++H +I
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTMLQHQHI 76
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           V+ +   +     L+V+EYM +  L+R+L  HG    L++G   V    L     L +A 
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A G+ Y+        +HRD+ + N L+      KI DFG+++ +              
Sbjct: 137 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKP 875
              +  PE     K   + D++SFGVVL E+ T GK+  Y   +T   +   +    E+P
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP 253
Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV---LQILRRCCP 926
                       C  E    VY +   C    P  R S+K+V   LQ L +  P
Sbjct: 254 ----------RACPPE----VYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 293

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +V        G  VA+K I +  +LN    ++   E+ I+  + H NIVKL+ 
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 704 CISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
            I +E +  L+ EY     +  +L  HGR +   + S            + +  + A Q 
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS------------KFRQIVSAVQ- 125
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
             Y H     +I+HRD+K+ N+LLD++   KIADFG +      G+   +    GS  Y 
Sbjct: 126 --YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDTFCGSPPYA 177
Query: 822 APEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
           APE     K +  ++D++S GV+L  LV+G     G     L E   R
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 225

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 131/302 (43%), Gaps = 46/302 (15%)
Query: 633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRI-WNNRKLNQKLEKEFIAEIEILG 691
            + S L E   IG G  G VY        E VA+K++ ++ ++ N+K + + I E+  L 
Sbjct: 15  KLFSDLRE---IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQ 70
Query: 692 TIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
            +RH N ++   C   E++  LV EY    + D                VH+  L     
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL-------------EVHKKPLQEVEI 117
Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
             +  GA QGL Y+H   +  +IHRDVK+ NILL      K+ DFG A ++A        
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PA 168
Query: 812 SAVAGSFGYFAPEYAYTT---KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
           +   G+  + APE        + + K+D++S G+  +EL   K   +     S    A  
Sbjct: 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALY 224
Query: 869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ---ILRRCC 925
           H A+ +  + AL  G     +   + +       C   +P  RP+ + +L+   +LR   
Sbjct: 225 HIAQNE--SPALQSGHWSEYFRNFVDS-------CLQKIPQDRPTSEVLLKHRFVLRERP 275
Query: 926 PT 927
           PT
Sbjct: 276 PT 277

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ-KLEKEFIAEIEILGTIRHANIVK 700
           + +G G  G+V   +    G  VAVK I N +K+    +  +   EI+ L   RH +I+K
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           L+  IS+     +V EY+    L  ++  HGR   + +              RL   I +
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-------------RRLFQQILS 122
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A   C+ H      ++HRD+K  N+LLD+   AKIADFGL+ M++  GE   +    GS 
Sbjct: 123 AVDYCHRH-----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGE--FLRDSCGSP 174
Query: 819 GYFAPEY-AYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
            Y APE  +       ++DI+S GV+L  L+ G    + DEH
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT-LPFDDEH 215

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 127/295 (43%), Gaps = 31/295 (10%)
Query: 644 IGSGGSGQVYRIDINGA-----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V+  + +          VAVK +   ++ ++   ++F  E E+L  ++H +I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTMLQHQHI 105
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           V+ +   +     L+V+EYM +  L+R+L  HG    L++G   V    L     L +A 
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A G+ Y+        +HRD+ + N L+      KI DFG+++ +              
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKP 875
              +  PE     K   + D++SFGVVL E+ T GK+  Y   +T   +   +    E+P
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP 282
Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV---LQILRRCCPT 927
                       C  E    VY +   C    P  R S+K+V   LQ L +  P 
Sbjct: 283 ----------RACPPE----VYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 86/299 (28%), Positives = 135/299 (45%), Gaps = 31/299 (10%)
Query: 644 IGSGGSGQV----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +G G  G+V    Y    +G GE VAVK +  +     +    +  EI+IL T+ H +I+
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHEHII 96
Query: 700 KL-WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           K   CC  +  + L LV EY+   SL  +L               +H +     L  A  
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLP--------------RHSIGLAQLLLFAQQ 142
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +G+ Y+H       IHRD+ + N+LLD++   KI DFGLAK + +  E + +     S
Sbjct: 143 ICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDS 199
Query: 818 -FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK-- 874
              ++APE     K     D++SFGV L EL+T  +++     T   E       +    
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP-TKFLELIGIAQGQMTVL 258
Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGK 933
            +T+ L++G   P   +    VY L   C  T  S RP+ + ++ IL+     E Y G+
Sbjct: 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV--HEKYQGQ 315

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++   +    +       E++I+  + H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHC 73
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLF- 132
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 133 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 177
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 178 PN-VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++   +    +       E++I+  + H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHC 73
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 132
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 133 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 177
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 178 PN-VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 35/231 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++   +    +       E++I+  + H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHC 73
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQ--SLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIV+L     S   K       LV +Y+      + R     K++L      ++ + L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 132
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGE 807
                      + L Y+H   +  I HRD+K  N+LLD +    K+ DFG AK L + GE
Sbjct: 133 -----------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GE 177
Query: 808 PHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           P+ +S +   + Y APE  +  T     ID++S G VL EL+ G+    GD
Sbjct: 178 PN-VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 621 LTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE 680
           LT   ++G  + +    ++E   +G+G  G V ++    +G  +A K I  + ++   + 
Sbjct: 4   LTQKAKVGELKDDDFERISE---LGAGNGGVVTKVQHRPSGLIMARKLI--HLEIKPAIR 58
Query: 681 KEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
            + I E+++L       IV  +    S+    +  E+M+  SLD+ L   KR        
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-------- 110
Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK 800
           + + +L      +++I   +GL Y+      QI+HRDVK SNIL++S  + K+ DFG++ 
Sbjct: 111 IPEEILG-----KVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG 163
Query: 801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            L         ++  G+  Y APE    T  + + DI+S G+ L+EL  G+
Sbjct: 164 QLIDS----MANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 50/147 (34%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 741 VHQHVLHWPTR-LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
           VH      P R +++   A Q L + H +    IIHRDVK +NI++ +    K+ DFG+A
Sbjct: 107 VHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163
Query: 800 KMLAKQGEPHTMSA-VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
           + +A  G   T +A V G+  Y +PE A    V+ + D+YS G VL E++TG+    GD 
Sbjct: 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
Query: 859 HTSLAEWAWRHYAEEKPITDALDKGIA 885
             S+   A++H  E+     A  +G++
Sbjct: 224 PVSV---AYQHVREDPIPPSARHEGLS 247

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 50/147 (34%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 741 VHQHVLHWPTR-LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
           VH      P R +++   A Q L + H +    IIHRDVK +NI++ +    K+ DFG+A
Sbjct: 124 VHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 180
Query: 800 KMLAKQGEPHTMSA-VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
           + +A  G   T +A V G+  Y +PE A    V+ + D+YS G VL E++TG+    GD 
Sbjct: 181 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 240
Query: 859 HTSLAEWAWRHYAEEKPITDALDKGIA 885
             S+   A++H  E+     A  +G++
Sbjct: 241 PVSV---AYQHVREDPIPPSARHEGLS 264

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 50/147 (34%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 741 VHQHVLHWPTR-LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
           VH      P R +++   A Q L + H +    IIHRDVK +NI++ +    K+ DFG+A
Sbjct: 107 VHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163
Query: 800 KMLAKQGEPHTMSA-VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
           + +A  G   T +A V G+  Y +PE A    V+ + D+YS G VL E++TG+    GD 
Sbjct: 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
Query: 859 HTSLAEWAWRHYAEEKPITDALDKGIA 885
             S+   A++H  E+     A  +G++
Sbjct: 224 PVSV---AYQHVREDPIPPSARHEGLS 247

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G+   +     G    +K I N  +++ K  +E   E+ +L  ++H NIV+   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                 S  +V +Y E   L + ++ +K  L          +L W  ++ +A        
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ-----EDQILDWFVQICLA-------- 137
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            + H    +I+HRD+KS NI L  +   ++ DFG+A++L    E     A  G+  Y +P
Sbjct: 138 -LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSP 194
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEA 853
           E       N K DI++ G VL EL T K A
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHA 224

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 50/147 (34%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 741 VHQHVLHWPTR-LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
           VH      P R +++   A Q L + H +    IIHRDVK +NI++ +    K+ DFG+A
Sbjct: 107 VHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163
Query: 800 KMLAKQGEPHTMS-AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
           + +A  G   T + AV G+  Y +PE A    V+ + D+YS G VL E++TG+    GD 
Sbjct: 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
Query: 859 HTSLAEWAWRHYAEEKPITDALDKGIA 885
             S+   A++H  E+     A  +G++
Sbjct: 224 PDSV---AYQHVREDPIPPSARHEGLS 247

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 741 VHQHVLHWPTR-LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
           VH      P R +++   A Q L + H +    IIHRDVK +NIL+ +    K+ DFG+A
Sbjct: 107 VHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIA 163
Query: 800 KMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
           + +A  G      +AV G+  Y +PE A    V+ + D+YS G VL E++TG+    GD 
Sbjct: 164 RAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
Query: 859 HTSLAEWAWRHYAEEKPITDALDKGIA 885
             S+   A++H  E+     A  +G++
Sbjct: 224 PVSV---AYQHVREDPIPPSARHEGLS 247

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 25/228 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +V        G+ VAV RI +  +LN    ++   E+ I+  + H NIVKL+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 704 CISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
            I +E +  LV EY     +  +L  HGR +   + +            + +  + A Q 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA------------KFRQIVSAVQ- 127
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
             Y H      I+HRD+K+ N+LLD++   KIADFG +       +   +    GS  Y 
Sbjct: 128 --YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYA 179
Query: 822 APEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
           APE     K +  ++D++S GV+L  LV+G     G     L E   R
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 227

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +V        G+ VAVK I +  +LN    ++   E+ I+  + H NIVKL+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 704 CISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
            I +E +  LV EY     +  +L  HGR +   + +            + +  + A Q 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA------------KFRQIVSAVQ- 127
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
             Y H      I+HRD+K+ N+LLD++   KIADFG +       +   + A  G+  Y 
Sbjct: 128 --YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDAFCGAPPYA 179
Query: 822 APEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
           APE     K +  ++D++S GV+L  LV+G     G     L E   R
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 227

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 127/287 (44%), Gaps = 37/287 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           + L    ++GSG  G VY+      GE V    A+K +  N     K   EF+ E  I+ 
Sbjct: 38  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMA 95
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ H ++V+L   C+S   +  LV + M +  L  ++H  K ++ S      Q +L+W  
Sbjct: 96  SMDHPHLVRLLGVCLSP--TIQLVTQLMPHGCLLEYVHEHKDNIGS------QLLLNW-- 145
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ S    KI DFGLA++L    + + 
Sbjct: 146 ----CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 198
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E  +  K   + D++S+GV + EL+T     Y    T          
Sbjct: 199 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------- 248
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
              + I D L+KG   P        VY + + C      SRP  KE+
Sbjct: 249 ---REIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 292

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 127/287 (44%), Gaps = 37/287 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           + L    ++GSG  G VY+      GE V    A+K +  N     K   EF+ E  I+ 
Sbjct: 15  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMA 72
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ H ++V+L   C+S   +  LV + M +  L  ++H  K ++ S      Q +L+W  
Sbjct: 73  SMDHPHLVRLLGVCLSP--TIQLVTQLMPHGCLLEYVHEHKDNIGS------QLLLNW-- 122
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ S    KI DFGLA++L    + + 
Sbjct: 123 ----CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 175
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E  +  K   + D++S+GV + EL+T     Y    T          
Sbjct: 176 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------- 225
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
              + I D L+KG   P        VY + + C      SRP  KE+
Sbjct: 226 ---REIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 269

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 25/228 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +V        G+ VAV RI +  +LN    ++   E+ I+  + H NIVKL+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 704 CISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
            I +E +  LV EY     +  +L  HGR +   + +            + +  + A Q 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA------------KFRQIVSAVQ- 127
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
             Y H      I+HRD+K+ N+LLD++   KIADFG +       +   +    GS  Y 
Sbjct: 128 --YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYA 179
Query: 822 APEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
           APE     K +  ++D++S GV+L  LV+G     G     L E   R
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 227

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 25/228 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +V        G+ VAVK I +  +LN    ++   E+ I+  + H NIVKL+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 704 CISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
            I +E +  LV EY     +  +L  HGR +   + +            + +  + A Q 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA------------KFRQIVSAVQ- 127
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
             Y H      I+HRD+K+ N+LLD++   KIADFG +       +   +    GS  Y 
Sbjct: 128 --YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYA 179
Query: 822 APEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
           APE     K +  ++D++S GV+L  LV+G     G     L E   R
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 227

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+        +L+  T++  A
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSA 123
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
                    M +      IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 124 ---------MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 172
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 233 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 25/228 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +V        G+ VAVK I +  +LN    ++   E+ I+  + H NIVKL+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 704 CISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
            I +E +  LV EY     +  +L  HGR +   + +            + +  + A Q 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA------------KFRQIVSAVQ- 127
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
             Y H      I+HRD+K+ N+LLD++   KIADFG +       +   +    GS  Y 
Sbjct: 128 --YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYA 179
Query: 822 APEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
           APE     K +  ++D++S GV+L  LV+G     G     L E   R
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 227

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 82/288 (28%), Positives = 129/288 (44%), Gaps = 29/288 (10%)
Query: 644 IGSGGSGQV----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +G G  G+V    Y    +G GE VAVK +        +    +  EI+IL T+ H +I+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 700 KLWCCISS--ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           K   C     E S  LV EY+   SL  +L               +H +     L  A  
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP--------------RHSIGLAQLLLFAQQ 125
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +G+ Y+H   +   IHR++ + N+LLD++   KI DFGLAK + +  E + +     S
Sbjct: 126 ICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 818 -FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK-- 874
              ++APE     K     D++SFGV L EL+T  +++     T   E       +    
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP-TKFLELIGIAQGQMTVL 241
Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            +T+ L++G   P   +    VY L   C  T  S RP+ + ++ IL+
Sbjct: 242 RLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 35/234 (14%)
Query: 631 ESNILSSLTESNLIGSGGSGQVYRI-DINGAGEFVAVK----------RIWNNRKLNQKL 679
           E  I  S  +   +GSG  G+V    + NG  E  A+K          R  ++ K  +K 
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE-KAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 680 EKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSS 739
            +E   EI +L ++ H NI+KL+     +    LV E+ E   L   +  R +     ++
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 740 SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE---FKAKIADF 796
           ++ + +L              G+CY+H      I+HRD+K  NILL+++      KI DF
Sbjct: 150 NIMKQIL-------------SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           GL+   +K    + +    G+  Y APE     K NEK D++S GV++  L+ G
Sbjct: 194 GLSSFFSK---DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 36/279 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G +G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 21  LGAGQAGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 123
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           ++        IHRD++++NIL+      KIADFGLA+++ +  E            + AP
Sbjct: 124 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDAEXTAREGAKFPIKWTAP 179
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDALDK 882
           E         K D++SFG++L E+VT     Y G  +  + +   R Y   +P       
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP------- 232
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 233 ---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  VS               L +A
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV-----------VLLYMA 117
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 172
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 233 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  VS               L +A
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV-----------VLLYMA 122
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 123 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 177
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 178 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 237
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 238 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  VS               L +A
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV-----------VLLYMA 117
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 172
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 233 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+ I     G + A+K +     +  K  +    E  +L  + H  I+++W 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    ++ +Y+E         G   SL+  S      V  +      A      L 
Sbjct: 74  TFQDAQQIFMIMDYIEG--------GELFSLLRKSQRFPNPVAKF-----YAAEVCLALE 120
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H   +  II+RD+K  NILLD     KI DFG AK +     P     + G+  Y AP
Sbjct: 121 YLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYXLCGTPDYIAP 172
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANY 855
           E   T   N+ ID +SFG+++ E++ G    Y
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 66
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  VS               L +A
Sbjct: 67  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV-----------VLLYMA 115
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++       T +A A
Sbjct: 116 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TXTAHA 168
Query: 816 GS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
           G+     + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y 
Sbjct: 169 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYR 228
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
            E+P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 229 MERP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 128/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  VS        +L+  T++  A
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV-----LLYMATQISSA 123
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
                    M +      IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 124 ---------MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 172
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 233 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  VS               L +A
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV-----------VLLYMA 117
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 172
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 233 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 82/288 (28%), Positives = 128/288 (44%), Gaps = 29/288 (10%)
Query: 644 IGSGGSGQV----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
           +G G  G+V    Y    +G GE VAVK +        +    +  EI+IL T+ H +I+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 700 KLWCCISS--ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           K   C     E S  LV EY+   SL  +L               +H +     L  A  
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP--------------RHSIGLAQLLLFAQQ 125
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +G+ Y+H       IHR++ + N+LLD++   KI DFGLAK + +  E + +     S
Sbjct: 126 ICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 818 -FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK-- 874
              ++APE     K     D++SFGV L EL+T  +++     T   E       +    
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP-TKFLELIGIAQGQMTVL 241
Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            +T+ L++G   P   +    VY L   C  T  S RP+ + ++ IL+
Sbjct: 242 RLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 621 LTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE 680
           LT   ++G  + +    ++E   +G+G  G V+++    +G  +A K I  + ++   + 
Sbjct: 56  LTQKQKVGELKDDDFEKISE---LGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIR 110
Query: 681 KEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
            + I E+++L       IV  +    S+    +  E+M+  SLD+ L    R        
Sbjct: 111 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-------- 162
Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK 800
           + + +L      +++I   +GL Y+      +I+HRDVK SNIL++S  + K+ DFG++ 
Sbjct: 163 IPEQILG-----KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 215
Query: 801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            L         ++  G+  Y +PE    T  + + DI+S G+ L+E+  G+
Sbjct: 216 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ-KLEKEFIAEIEILGTIRHANIVK 700
           + +G G  G+V        G  VAVK I N +K+    +  +   EI+ L   RH +I+K
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+  IS+ +   +V EY+    L  ++    R     S  + Q +L           +  
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL-----------SGV 129
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
             C+ H      ++HRD+K  N+LLD+   AKIADFGL+ M++  GE   +    GS  Y
Sbjct: 130 DYCHRH-----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGE--FLRXSCGSPNY 181
Query: 821 FAPEY-AYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT 860
            APE  +       ++DI+S GV+L  L+ G    + D+H 
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGT-LPFDDDHV 221

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 74  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 122
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 123 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 177
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 178 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 237
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 238 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 66
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  VS               L +A
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV-----------VLLYMA 115
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++       T +A A
Sbjct: 116 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TFTAHA 168
Query: 816 GS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
           G+     + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y 
Sbjct: 169 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYR 228
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
            E+P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 229 MERP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 262

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +V        G+ VAVK I +  +LN    ++   E+ I   + H NIVKL+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 704 CISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
            I +E +  LV EY     +  +L  HGR +   + +            + +  + A Q 
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARA------------KFRQIVSAVQ- 127
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
             Y H      I+HRD+K+ N+LLD++   KIADFG +       +   + A  G+  Y 
Sbjct: 128 --YCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK---LDAFCGAPPYA 179
Query: 822 APEYAYTTKVN-EKIDIYSFGVVLLELVTG 850
           APE     K +  ++D++S GV+L  LV+G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 122
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 123 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 177
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 178 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 237
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 238 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 25/228 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +V        G  VAVK I +  +LN    ++   E+ I+  + H NIVKL+ 
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 704 CISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
            I +E +  LV EY     +  +L  HGR +   + +            + +  + A Q 
Sbjct: 82  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA------------KFRQIVSAVQ- 128
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
            C+  +     I+HRD+K+ N+LLD +   KIADFG +       +   +    GS  Y 
Sbjct: 129 YCHQKY-----IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK---LDTFCGSPPYA 180
Query: 822 APEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
           APE     K +  ++D++S GV+L  LV+G     G     L E   R
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 72
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 121
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 176
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 237 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 268

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 30  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 85  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 132
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           ++        IHRD++++NIL+      KIADFGLA+++ +  E            + AP
Sbjct: 133 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 188
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDALDK 882
           E         K D++SFG++L E+VT     Y G  +  + +   R Y   +P       
Sbjct: 189 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP------- 241
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 242 ---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 273

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 24/224 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 76  YFHDSTRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 122
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        +A+ G+  Y  P
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EAN-YGDEHTSLA 863
           E       +EK+D++S GV+  E + GK   EAN Y D +  ++
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRIS 219

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 66
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  VS               L +A
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV-----------VLLYMA 115
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++       T +A A
Sbjct: 116 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TXTAHA 168
Query: 816 GS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
           G+     + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y 
Sbjct: 169 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYR 228
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
            E+P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 229 MERP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 262

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW- 702
           IG+G  G+  +I     G+ +  K + +   + +  ++  ++E+ +L  ++H NIV+ + 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 703 CCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQH-----VLHWPTRLQIAI 756
             I   N+ L +V EY E   L         S+++  +   Q+     VL   T+L +A+
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLA--------SVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
                 C+   D    ++HRD+K +N+ LD +   K+ DFGLA++L    +     A  G
Sbjct: 125 KE----CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVG 178
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL 847
           +  Y +PE       NEK DI+S G +L EL
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 69
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 70  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 118
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 119 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAPAGA 173
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 174 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 233
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 234 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 265

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 128/288 (44%), Gaps = 36/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 275
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  VS        VL     L +A
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV------VL-----LYMA 324
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHR++ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 325 TQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 379
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 439
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           +P      +G  E         VY L   C    PS RPS  E+ Q  
Sbjct: 440 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQAF 473

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 23  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 77
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 78  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 125
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           ++        IHRD++++NIL+      KIADFGLA+++ +  E            + AP
Sbjct: 126 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 181
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDALDK 882
           E         K D++SFG++L E+VT     Y G  +  + +   R Y   +P       
Sbjct: 182 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP------- 234
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 235 ---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 266

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 29  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 83
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 84  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 131
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           ++        IHRD++++NIL+      KIADFGLA+++ +  E            + AP
Sbjct: 132 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 187
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDALDK 882
           E         K D++SFG++L E+VT     Y G  +  + +   R Y   +P       
Sbjct: 188 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP------- 240
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 241 ---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 272

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 122
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 123 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 177
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 178 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 237
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 238 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 82  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 129
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           ++        IHRD++++NIL+      KIADFGLA+++ +  E            + AP
Sbjct: 130 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 185
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDALDK 882
           E         K D++SFG++L E+VT     Y G  +  + +   R Y   +P       
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP------- 238
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 239 ---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 117
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 172
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 233 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 122
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++       T +A A
Sbjct: 123 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TXTAHA 175
Query: 816 GS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
           G+     + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y 
Sbjct: 176 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 235
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
            E+P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 236 MERP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 22  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 76
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 77  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 124
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           ++        IHRD++++NIL+      KIADFGLA+++ +  E            + AP
Sbjct: 125 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 180
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDALDK 882
           E         K D++SFG++L E+VT     Y G  +  + +   R Y   +P       
Sbjct: 181 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP------- 233
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 234 ---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 265

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 70
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 119
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 120 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAPAGA 174
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 175 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 234
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 235 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 69
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 70  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 118
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++       T +A A
Sbjct: 119 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TXTAHA 171
Query: 816 GS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
           G+     + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y 
Sbjct: 172 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 231
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
            E+P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 232 MERP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 265

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 123
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           ++        IHRD++++NIL+      KIADFGLA+++ +  E            + AP
Sbjct: 124 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 179
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDALDK 882
           E         K D++SFG++L E+VT     Y G  +  + +   R Y   +P       
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP------- 232
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 233 ---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G V   D  G    VAVK I N+        + F+AE  ++  +RH+N+V+L  
Sbjct: 14  IGKGEFGDVMLGDYRGNK--VAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 704 CISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
            I  E   L +V EYM   SL  +L  R RS++ G              L+ ++   + +
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD-----------CLLKFSLDVCEAM 115
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+  +     +HRD+ + N+L+  +  AK++DFGL K  +   +   +        + A
Sbjct: 116 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTA 167
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY 855
           PE     K + K D++SFG++L E+ +     Y
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 123
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           ++        IHRD++++NIL+      KIADFGLA+++ +  E            + AP
Sbjct: 124 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 179
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDALDK 882
           E         K D++SFG++L E+VT     Y G  +  + +   R Y   +P       
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP------- 232
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 233 ---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 81
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+        +L+  T++  A
Sbjct: 82  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV-----LLYMATQISSA 136
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
                    M +      IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 137 ---------MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 185
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 186 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 245
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 246 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 277

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 70
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 119
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 120 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 174
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 175 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 234
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 235 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 70
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+               L +A
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-----------VLLYMA 119
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 120 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 174
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 175 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 234
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P      +G  E         VY L   C    PS RPS  E+ Q
Sbjct: 235 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G V   D  G    VAVK I N+        + F+AE  ++  +RH+N+V+L  
Sbjct: 29  IGKGEFGDVMLGDYRGNK--VAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 704 CISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
            I  E   L +V EYM   SL  +L  R RS++ G              L+ ++   + +
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD-----------CLLKFSLDVCEAM 130
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+  +     +HRD+ + N+L+  +  AK++DFGL K  +   +   +        + A
Sbjct: 131 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTA 182
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVT 849
           PE     K + K D++SFG++L E+ +
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G V   D  G    VAVK I N+        + F+AE  ++  +RH+N+V+L  
Sbjct: 201 IGKGEFGDVMLGDYRGNK--VAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 704 CISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
            I  E   L +V EYM   SL  +L  R RS++ G              L+ ++   + +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC-----------LLKFSLDVCEAM 302
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+  +     +HRD+ + N+L+  +  AK++DFGL K  +   +   +        + A
Sbjct: 303 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTA 354
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVT 849
           PE     K + K D++SFG++L E+ +
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 42/282 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 82  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 129
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           ++        IHRD++++NIL+      KIADFGLA+++    E +  +A  G+     +
Sbjct: 130 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKW 182
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDA 879
            APE         K D++SFG++L E+VT     Y G  +  + +   R Y   +P    
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---- 238
Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                 + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 239 ------DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY+      G+ VA+K++     L     +E I EI I+      ++VK + 
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSPHVVKYYG 91
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS-SSVHQHVLHWPTRLQIAIGAAQGL 762
                    +V EY    S+   +  R ++L     +++ Q  L             +GL
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL-------------KGL 138
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H     + IHRD+K+ NILL++E  AK+ADFG+A  L         + V G+  + A
Sbjct: 139 EYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKR--NXVIGTPFWMA 193
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           PE       N   DI+S G+  +E+  GK   Y D H
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPP-YADIH 229

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 42/282 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 26  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 81  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           ++        IHRD++++NIL+      KIADFGLA+++    E +  +A  G+     +
Sbjct: 129 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKW 181
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDA 879
            APE         K D++SFG++L E+VT     Y G  +  + +   R Y   +P    
Sbjct: 182 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---- 237
Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                 + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 238 ------DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 269

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 42/282 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 16  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 70
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 71  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           ++        IHRD++++NIL+      KIADFGLA+++    E +  +A  G+     +
Sbjct: 119 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKW 171
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDA 879
            APE         K D++SFG++L E+VT     Y G  +  + +   R Y   +P    
Sbjct: 172 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---- 227
Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                 + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 228 ------DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 259

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 621 LTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE 680
           LT   ++G  + +    ++E   +G+G  G V+++    +G  +A K I  + ++   + 
Sbjct: 21  LTQKQKVGELKDDDFEKISE---LGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIR 75
Query: 681 KEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
            + I E+++L       IV  +    S+    +  E+M+  SLD+ L    R        
Sbjct: 76  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-------- 127
Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK 800
           + + +L      +++I   +GL Y+      +I+HRDVK SNIL++S  + K+ DFG++ 
Sbjct: 128 IPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            L         ++  G+  Y +PE    T  + + DI+S G+ L+E+  G+
Sbjct: 181 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 42/282 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 123
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           ++        IHRD++++NIL+      KIADFGLA+++    E +  +A  G+     +
Sbjct: 124 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKW 176
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDA 879
            APE         K D++SFG++L E+VT     Y G  +  + +   R Y   +P    
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---- 232
Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                 + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 233 ------DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 42/282 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 31  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 85
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 86  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 133
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           ++        IHRD++++NIL+      KIADFGLA+++    E +  +A  G+     +
Sbjct: 134 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKW 186
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDA 879
            APE         K D++SFG++L E+VT     Y G  +  + +   R Y   +P    
Sbjct: 187 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---- 242
Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                 + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 243 ------DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 274

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTIRHANIVK 700
            ++G G  G+V        G+  AVK I + R++ QK +KE  + E+++L  + H NI+K
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+     +    LV E      L   +  RKR     ++ + + VL              
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL-------------S 137
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAGS 817
           G+ YMH +   +I+HRD+K  N+LL+S+ K    +I DFGL+           M    G+
Sbjct: 138 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGT 191
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
             Y APE  + T  +EK D++S GV+L  L++G
Sbjct: 192 AYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 79  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 125
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        +A+ G+  Y  P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 23/223 (10%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKL 701
           ++G G  G+V+  +     +F A+K +  +  L     +  + E  +L     H  +  +
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 84
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +C   ++ +   V EY+    L           +    S H+  L   T     I    G
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDL-----------MYHIQSCHKFDLSRATFYAAEI--ILG 131
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK--MLAKQGEPHTMSAVAGSFG 819
           L ++H   +  I++RD+K  NILLD +   KIADFG+ K  ML   G+  T +   G+  
Sbjct: 132 LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML---GDAKT-NEFCGTPD 184
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
           Y APE     K N  +D +SFGV+L E++ G+   +G +   L
Sbjct: 185 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 227

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTIRHANIVK 700
            ++G G  G+V        G+  AVK I + R++ QK +KE  + E+++L  + H NI+K
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIMK 113
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+     +    LV E      L   +  RKR     ++ + + VL              
Sbjct: 114 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL-------------S 160
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAGS 817
           G+ YMH +   +I+HRD+K  N+LL+S+ K    +I DFGL+           M    G+
Sbjct: 161 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGT 214
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
             Y APE  + T  +EK D++S GV+L  L++G
Sbjct: 215 AYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 246

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 23/223 (10%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKL 701
           ++G G  G+V+  +     +F A+K +  +  L     +  + E  +L     H  +  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +C   ++ +   V EY+    L           +    S H+  L   T     I    G
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDL-----------MYHIQSCHKFDLSRATFYAAEI--ILG 130
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK--MLAKQGEPHTMSAVAGSFG 819
           L ++H   +  I++RD+K  NILLD +   KIADFG+ K  ML   G+  T +   G+  
Sbjct: 131 LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML---GDAKT-NXFCGTPD 183
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
           Y APE     K N  +D +SFGV+L E++ G+   +G +   L
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 45/239 (18%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S   E  ++G G  GQV +        + A+K+I   R   +KL    ++E+ +L ++ H
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLST-ILSEVMLLASLNH 61
Query: 696 ANIVKLWCC-------------ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
             +V+ +               +  +++  +  EY EN++L   +H    +         
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLN--------Q 113
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
           Q   +W    QI     + L Y+H   +  IIHRD+K  NI +D     KI DFGLAK +
Sbjct: 114 QRDEYWRLFRQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 803 AKQ------------GEPHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELV 848
            +             G    +++  G+  Y A E    T   NEKID+YS G++  E++
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTIRHANIVK 700
            ++G G  G+V        G+  AVK I + R++ QK +KE  + E+++L  + H NI+K
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIMK 114
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+     +    LV E      L   +  RKR     ++ + + VL              
Sbjct: 115 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL-------------S 161
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAGS 817
           G+ YMH +   +I+HRD+K  N+LL+S+ K    +I DFGL+           M    G+
Sbjct: 162 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGT 215
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
             Y APE  + T  +EK D++S GV+L  L++G
Sbjct: 216 AYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 247

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTIRHANIV 699
             ++G G  G+V        G+  AVK I + R++ QK +KE  + E+++L  + H NI+
Sbjct: 37  QRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIM 95
Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           KL+     +    LV E      L   +  RKR     ++ + + VL             
Sbjct: 96  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL------------- 142
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAG 816
            G+ YMH +   +I+HRD+K  N+LL+S+ K    +I DFGL+       +   M    G
Sbjct: 143 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIG 196
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           +  Y APE  + T  +EK D++S GV+L  L++G
Sbjct: 197 TAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 229

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 122
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        +A+ G+  Y  P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 36/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 259 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 314
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R  V+        VL     L +A
Sbjct: 315 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV------VL-----LYMA 363
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHR++ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 364 TQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGA 418
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE     K + K D+++FGV+L E+ T   + Y G + + + E   + Y  E
Sbjct: 419 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 478
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           +P      +G  E         VY L   C    PS RPS  E+ Q  
Sbjct: 479 RP------EGCPE--------KVYELMRACWQWNPSDRPSFAEIHQAF 512

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW- 702
           IG+G  G+  +I     G+ +  K + +   + +  ++  ++E+ +L  ++H NIV+ + 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 703 CCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQH-----VLHWPTRLQIAI 756
             I   N+ L +V EY E   L         S+++  +   Q+     VL   T+L +A+
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLA--------SVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
                 C+   D    ++HRD+K +N+ LD +   K+ DFGLA++L    +        G
Sbjct: 125 KE----CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVG 178
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL 847
           +  Y +PE       NEK DI+S G +L EL
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 128/291 (43%), Gaps = 46/291 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           SL     +G+G  G+V+    N   + VAVK +    K      + F+AE  ++ T++H 
Sbjct: 16  SLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTM----KPGSMSVEAFLAEANVMKTLQHD 70
Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWL---HGRKRSLVSGSSSVHQHVLHWPTRLQ 753
            +VKL   ++ E    ++ E+M   SL  +L    G K+ L              P  + 
Sbjct: 71  KLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--------------PKLID 115
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++        IHRD++++NIL+ +    KIADFGLA+++    E +  +A
Sbjct: 116 FSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI----EDNEYTA 168
Query: 814 VAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
             G+     + APE         K D++SFG++L+E+VT     Y               
Sbjct: 169 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------- 219
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                +  AL++G   P        +Y + + C    P  RP+ + +  +L
Sbjct: 220 ----EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW- 702
           IG+G  G+  +I     G+ +  K + +   + +  ++  ++E+ +L  ++H NIV+ + 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 703 CCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQH-----VLHWPTRLQIAI 756
             I   N+ L +V EY E   L         S+++  +   Q+     VL   T+L +A+
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLA--------SVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
                 C+   D    ++HRD+K +N+ LD +   K+ DFGLA++L    +        G
Sbjct: 125 KE----CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFVG 178
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL 847
           +  Y +PE       NEK DI+S G +L EL
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G V   D  G    VAVK I N+        + F+AE  ++  +RH+N+V+L  
Sbjct: 20  IGKGEFGDVMLGDYRGNK--VAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 704 CISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
            I  E   L +V EYM   SL  +L  R RS++ G              L+ ++   + +
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD-----------CLLKFSLDVCEAM 121
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+  +     +HRD+ + N+L+  +  AK++DFGL K  +   +   +        + A
Sbjct: 122 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTA 173
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY 855
           PE       + K D++SFG++L E+ +     Y
Sbjct: 174 PEALREAAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V+++    +G  +A K I  + ++   +  + I E+++L       IV  + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
              S+    +  E+M+  SLD+ L    R        + + +L      +++I   +GL 
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR--------IPEQILG-----KVSIAVIKGLT 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+      +I+HRDVK SNIL++S  + K+ DFG++  L         ++  G+  Y +P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 172
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           E    T  + + DI+S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V+++    +G  +A K I  + ++   +  + I E+++L       IV  + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
              S+    +  E+M+  SLD+ L    R        + + +L      +++I   +GL 
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR--------IPEQILG-----KVSIAVIKGLT 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+      +I+HRDVK SNIL++S  + K+ DFG++  L         ++  G+  Y +P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 172
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           E    T  + + DI+S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 102 YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 148
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 201
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 239

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 28/217 (12%)
Query: 644 IGSGGSGQVYRI-DINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILG---TIRHANIV 699
           IG G  G+V++  D+   G FVA+KR+   +   + +    I E+ +L    T  H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 700 KLW--CCISS---ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           +L+  C +S    E    LV+E++ +Q L  +L             V +  +   T   +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-----------DKVPEPGVPTETIKDM 125
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
                +GL ++H   + +++HRD+K  NIL+ S  + K+ADFGLA++ + Q     +++V
Sbjct: 126 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSV 179
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
             +  Y APE    +     +D++S G +  E+   K
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 44/293 (15%)
Query: 644 IGSGGSGQVY----RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G VY    R  I G  E  VAVK +  +  L +++E  F+ E  ++      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 82
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR------- 751
           V+L   +S     L+V E M +  L  +L            S+     + P R       
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLR-----------SLRPEAENNPGRPPPTLQE 131
Query: 752 -LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            +Q+A   A G+ Y++     + +HRD+ + N ++  +F  KI DFG+ + + +      
Sbjct: 132 MIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + APE           D++SFGVVL E+            TSLAE  ++  
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI------------TSLAEQPYQGL 236
Query: 871 AEEKPITDALDKG-IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           + E+ +   +D G + +P    E  T   L  +C    P+ RP+  E++ +L+
Sbjct: 237 SNEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK--LEKEFIAEIEILGTIRHANIV 699
           + +G G    VY+       + VA+K+I    +   K  + +  + EI++L  + H NI+
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
            L      +++  LV+++ME    D  +  +  SLV   S +  ++L             
Sbjct: 76  GLLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLM----------TL 122
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           QGL Y+H      I+HRD+K +N+LLD     K+ADFGLAK        +    V  +  
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRW 177
Query: 820 YFAPEYAYTTKV-NEKIDIYSFGVVLLELV 848
           Y APE  +  ++    +D+++ G +L EL+
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V+++    +G  +A K I  + ++   +  + I E+++L       IV  + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
              S+    +  E+M+  SLD+ L    R        + + +L      +++I   +GL 
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR--------IPEQILG-----KVSIAVIKGLT 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+      +I+HRDVK SNIL++S  + K+ DFG++  L         ++  G+  Y +P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 172
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           E    T  + + DI+S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V        G+ VA+K I         ++     EI  L  +RH +I+KL+ 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I S++  ++V EY  N+  D  +   K S         Q            I +A   C
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------------IISAVEYC 123
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H     +I+HRD+K  N+LLD     KIADFGL+ ++    + + +    GS  Y AP
Sbjct: 124 HRH-----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAP 175
Query: 824 EY-AYTTKVNEKIDIYSFGVVL 844
           E  +       ++D++S GV+L
Sbjct: 176 EVISGKLYAGPEVDVWSCGVIL 197

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 644 IGSGGSGQVY----RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G VY    R  I G  E  VAVK +  +  L +++E  F+ E  ++      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 82
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR------- 751
           V+L   +S     L+V E M +  L  +L            S+     + P R       
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLR-----------SLRPEAENNPGRPPPTLQE 131
Query: 752 -LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            +Q+A   A G+ Y++     + +HRD+ + N ++  +F  KI DFG+ + + +      
Sbjct: 132 MIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + APE           D++SFGVVL E+            TSLAE  ++  
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI------------TSLAEQPYQGL 236
Query: 871 AEEKPITDALDKG-IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           + E+ +   +D G + +P    E  T   L  +C    P  RP+  E++ +L+
Sbjct: 237 SNEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 50/264 (18%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    N + + VAVK +    K      + F+ E  ++ T++H  +V+L+ 
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-VAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYM   SL  +L           S     VL  P  +  +   A+G+ 
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFL----------KSDEGGKVLL-PKLIDFSAQIAEGMA 124
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        IHRD++++N+L+      KIADFGLA+++    E +  +A  G+     +
Sbjct: 125 YIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI----EDNEYTAREGAKFPIKW 177
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY------------------------G 856
            APE         K D++SFG++L E+VT  +  Y                         
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCP 237
Query: 857 DEHTSLAEWAWRHYAEEKPITDAL 880
           DE   + +  W+  AEE+P  D L
Sbjct: 238 DELYDIMKMCWKEKAEERPTFDYL 261

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +V        G+ VAVK I +  +LN    ++   E+ I+  + H NIVKL+ 
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH-WPTRLQIAIGAAQGL 762
            I +E +  LV EY                  SG       V H W    +      Q +
Sbjct: 74  VIETEKTLYLVMEY-----------------ASGGEVFDYLVAHGWMKEKEARAKFRQIV 116
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
             + +     I+HRD+K+ N+LLD++   KIADFG +       +   +    GS  Y A
Sbjct: 117 SAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAA 173
Query: 823 PEYAYTTKVN-EKIDIYSFGVVLLELVTG 850
           PE     K +  ++D++S GV+L  LV+G
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G V++      G+ VA+K+   +   +  ++K  + EI +L  ++H N+V L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 704 CISSENSKLLVYEYMEN---QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
               +    LV+EY ++     LDR+  G    LV   +        W T LQ     A 
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT--------WQT-LQ-----AV 115
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
             C+ H +C    IHRDVK  NIL+      K+ DFG A++L   G          +  Y
Sbjct: 116 NFCHKH-NC----IHRDVKPENILITKHSVIKLCDFGFARLLT--GPSDYYDDEVATRWY 168
Query: 821 FAPEYAY-TTKVNEKIDIYSFGVVLLELVTG 850
            +PE     T+    +D+++ G V  EL++G
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 128/291 (43%), Gaps = 46/291 (15%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           SL     +G+G  G+V+    N   + VAVK +    K      + F+AE  ++ T++H 
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTM----KPGSMSVEAFLAEANVMKTLQHD 243
Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWL---HGRKRSLVSGSSSVHQHVLHWPTRLQ 753
            +VKL   ++ E    ++ E+M   SL  +L    G K+ L              P  + 
Sbjct: 244 KLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--------------PKLID 288
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++        IHRD++++NIL+ +    KIADFGLA+++    E +  +A
Sbjct: 289 FSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI----EDNEYTA 341
Query: 814 VAGS---FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
             G+     + APE         K D++SFG++L+E+VT     Y               
Sbjct: 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG------------- 388
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                +  AL++G   P        +Y + + C    P  RP+ + +  +L
Sbjct: 389 MSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 644 IGSGGSGQVY----RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G VY    R  I G  E  VAVK +  +  L +++E  F+ E  ++      ++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 79
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR------- 751
           V+L   +S     L+V E M +  L  +L            S+     + P R       
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLR-----------SLRPEAENNPGRPPPTLQE 128
Query: 752 -LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            +Q+A   A G+ Y++     + +HRD+ + N ++  +F  KI DFG+ + + +      
Sbjct: 129 MIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 185
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + APE           D++SFGVVL E+            TSLAE  ++  
Sbjct: 186 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI------------TSLAEQPYQGL 233
Query: 871 AEEKPITDALDKG-IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           + E+ +   +D G + +P    E  T   L  +C    P  RP+  E++ +L+
Sbjct: 234 SNEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V        G+ VA+K I         ++     EI  L  +RH +I+KL+ 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I S++  ++V EY  N+  D  +   K S         Q            I +A   C
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------------IISAVEYC 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H     +I+HRD+K  N+LLD     KIADFGL+ ++    + + +    GS  Y AP
Sbjct: 120 HRH-----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAP 171
Query: 824 EY-AYTTKVNEKIDIYSFGVVL 844
           E  +       ++D++S GV+L
Sbjct: 172 EVISGKLYAGPEVDVWSCGVIL 193

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 621 LTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE 680
           LT   ++G  + +    ++E   +G+G  G V+++    +G  +A K I  + ++   + 
Sbjct: 13  LTQKQKVGELKDDDFEKISE---LGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIR 67
Query: 681 KEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
            + I E+++L       IV  +    S+    +  E+M+  SLD+ L    R        
Sbjct: 68  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-------- 119
Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK 800
           + + +L      +++I   +GL Y+      +I+HRDVK SNIL++S  + K+ DFG++ 
Sbjct: 120 IPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 172
Query: 801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            L         ++  G+  Y +PE    T  + + DI+S G+ L+E+  G+
Sbjct: 173 QLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 33/276 (11%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + + I      E  A K +  +  L     ++   EI I  ++ H ++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V E    +SL   LH R+++L    +  +          QI +G     
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR--------QIVLGCQ--- 155
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H +   ++IHRD+K  N+ L+ + + KI DFGLA  +   GE      + G+  Y A
Sbjct: 156 -YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIA 209
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDK 882
           PE       + ++D++S G ++  L+ GK      E + L E   R    E  I   ++ 
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEYSIPKHINP 266
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             A    +++M            T P++RP++ E+L
Sbjct: 267 VAAS--LIQKM----------LQTDPTARPTINELL 290

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V        G+ VA+K I         ++     EI  L  +RH +I+KL+ 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I S++  ++V EY  N+  D  +   K S         Q            I +A   C
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------------IISAVEYC 129
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H     +I+HRD+K  N+LLD     KIADFGL+ ++    + + +    GS  Y AP
Sbjct: 130 HRH-----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAP 181
Query: 824 EY-AYTTKVNEKIDIYSFGVVL 844
           E  +       ++D++S GV+L
Sbjct: 182 EVISGKLYAGPEVDVWSCGVIL 203

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V        G+ VA+K I         ++     EI  L  +RH +I+KL+ 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I S++  ++V EY  N+  D  +   K S         Q            I +A   C
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------------IISAVEYC 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           + H     +I+HRD+K  N+LLD     KIADFGL+ ++    + + +    GS  Y AP
Sbjct: 129 HRH-----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAP 180
Query: 824 EY-AYTTKVNEKIDIYSFGVVL 844
           E  +       ++D++S GV+L
Sbjct: 181 EVISGKLYAGPEVDVWSCGVIL 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V+++    +G  +A K I  + ++   +  + I E+++L       IV  + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
              S+    +  E+M+  SLD+ L    R        + + +L      +++I   +GL 
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR--------IPEQILG-----KVSIAVIKGLT 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+      +I+HRDVK SNIL++S  + K+ DFG++  L         ++  G+  Y +P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 172
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           E    T  + + DI+S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 129/282 (45%), Gaps = 42/282 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H  +V+L+ 
Sbjct: 17  LGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ EYMEN SL  +L        SG       +L       +A   A+G+ 
Sbjct: 72  VVTQE-PIYIITEYMENGSLVDFL-----KTPSGIKLTINKLL------DMAAQIAEGMA 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           ++        IHR+++++NIL+      KIADFGLA+++    E +  +A  G+     +
Sbjct: 120 FIEER---NYIHRNLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKW 172
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDA 879
            APE         K D++SFG++L E+VT     Y G  +  + +   R Y   +P    
Sbjct: 173 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---- 228
Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                 + C  E    +Y+L  +C    P  RP+   +  +L
Sbjct: 229 ------DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 260

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V+++    +G  +A K I  + ++   +  + I E+++L       IV  + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
              S+    +  E+M+  SLD+ L    R        + + +L      +++I   +GL 
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR--------IPEQILG-----KVSIAVIKGLT 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+      +I+HRDVK SNIL++S  + K+ DFG++  L         ++  G+  Y +P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 172
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           E    T  + + DI+S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V+++    +G  +A K I  + ++   +  + I E+++L       IV  + 
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
              S+    +  E+M+  SLD+ L    R        + + +L      +++I   +GL 
Sbjct: 75  AFYSDGEISICMEHMDGGSLDQVLKKAGR--------IPEQILG-----KVSIAVIKGLT 121
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+      +I+HRDVK SNIL++S  + K+ DFG++  L  +      +   G+  Y +P
Sbjct: 122 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSP 175
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           E    T  + + DI+S G+ L+E+  G+
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 123/285 (43%), Gaps = 23/285 (8%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
             +IGSG +  V         E VA+KRI N  K    ++ E + EI+ +    H NIV 
Sbjct: 20  QEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMD-ELLKEIQAMSQCHHPNIVS 77
Query: 701 LWCCISSENSKLLVYEYMENQS-LDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
            +     ++   LV + +   S LD   H      +         VL   T   I     
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKH------IVAKGEHKSGVLDESTIATILREVL 131
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE---PHTMSAVAG 816
           +GL Y+H +     IHRDVK+ NILL  +   +IADFG++  LA  G+           G
Sbjct: 132 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
           +  + APE     +  + K DI+SFG+  +EL TG  A Y   H            +  P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA-APY---HKYPPMKVLMLTLQNDP 244
Query: 876 ITDALDKGIAEPCYLEEMTTVYRLAL-ICTSTLPSSRPSMKEVLQ 919
              +L+ G+ +   L++    +R  + +C    P  RP+  E+L+
Sbjct: 245 --PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 33/276 (11%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + + I      E  A K +  +  L     ++   EI I  ++ H ++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V E    +SL   LH R+++L    +  +          QI +G     
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR--------QIVLGCQ--- 135
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H +   ++IHRD+K  N+ L+ + + KI DFGLA  +   GE      + G+  Y A
Sbjct: 136 -YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKTLCGTPNYIA 189
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDK 882
           PE       + ++D++S G ++  L+ GK      E + L E   R    E  I   ++ 
Sbjct: 190 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEYSIPKHINP 246
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             A    +++M            T P++RP++ E+L
Sbjct: 247 VAAS--LIQKM----------LQTDPTARPTINELL 270

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 93  YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 139
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 192
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 230

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 103/239 (43%), Gaps = 45/239 (18%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S   E  ++G G  GQV +        + A+K+I   R   +KL    ++E+ +L ++ H
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLST-ILSEVMLLASLNH 61
Query: 696 ANIVKLWCC-------------ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
             +V+ +               +  +++  +  EY EN +L   +H    +         
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN--------Q 113
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
           Q   +W    QI     + L Y+H   +  IIHRD+K  NI +D     KI DFGLAK +
Sbjct: 114 QRDEYWRLFRQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 803 AKQ------------GEPHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELV 848
            +             G    +++  G+  Y A E    T   NEKID+YS G++  E++
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 77  YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 123
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + ++G+  Y  P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 33/276 (11%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + + I      E  A K +  +  L     ++   EI I  ++ H ++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V E    +SL   LH R+++L    +  +          QI +G     
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR--------QIVLGCQ--- 131
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H +   ++IHRD+K  N+ L+ + + KI DFGLA  +   GE      + G+  Y A
Sbjct: 132 -YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKTLCGTPNYIA 185
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDK 882
           PE       + ++D++S G ++  L+ GK      E + L E   R    E  I   ++ 
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEYSIPKHINP 242
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             A    +++M            T P++RP++ E+L
Sbjct: 243 VAAS--LIQKM----------LQTDPTARPTINELL 266

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 76  YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 122
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 69/286 (24%), Positives = 126/286 (44%), Gaps = 45/286 (15%)
Query: 640 ESNLIGSGGSGQVYRIDING-AGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           E  L+   GSGQ   + +    G++ VAVK I    K     E EF  E + +  + H  
Sbjct: 9   EITLLKELGSGQFGVVKLGKWKGQYDVAVKMI----KEGSMSEDEFFQEAQTMMKLSHPK 64
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL-QIAI 756
           +VK +   S E    +V EY+ N  L  +L    + L              P++L ++  
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLE-------------PSQLLEMCY 111
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              +G+ ++    + Q IHRD+ + N L+D +   K++DFG+ + +    +   +S+V  
Sbjct: 112 DVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL---DDQYVSSVGT 165
Query: 817 SF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
            F   + APE  +  K + K D+++FG+++ E+             SL +  +  Y   +
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF------------SLGKMPYDLYTNSE 213
Query: 875 PITDALDKGIAEPCYLEEMT--TVYRLALICTSTLPSSRPSMKEVL 918
            +   L        Y   +   T+Y++   C   LP  RP+ +++L
Sbjct: 214 VV---LKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLL 256

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 33/276 (11%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + + I      E  A K +  +  L     ++   EI I  ++ H ++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V E    +SL   LH R+++L    +  +          QI +G     
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR--------QIVLGCQ--- 153
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H +   ++IHRD+K  N+ L+ + + KI DFGLA  +   GE      + G+  Y A
Sbjct: 154 -YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIA 207
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDK 882
           PE       + ++D++S G ++  L+ GK      E + L E   R    E  I   ++ 
Sbjct: 208 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEYSIPKHINP 264
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             A    +++M            T P++RP++ E+L
Sbjct: 265 VAAS--LIQKM----------LQTDPTARPTINELL 288

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           L+G G  G V +      G  VA+K+   +   ++ ++K  + EI++L  +RH N+V L 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                +    LV+E++++  LD         L    + +   V+      QI  G   G 
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILD--------DLELFPNGLDYQVVQ-KYLFQIINGI--GF 139
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
           C+ H+     IIHRD+K  NIL+      K+ DFG A+ LA  GE +    VA  + Y A
Sbjct: 140 CHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD-DEVATRW-YRA 192
Query: 823 PEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           PE      K  + +D+++ G ++ E+  G+    GD
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 123/285 (43%), Gaps = 23/285 (8%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
             +IGSG +  V         E VA+KRI  N +  Q    E + EI+ +    H NIV 
Sbjct: 15  QEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHHPNIVS 72
Query: 701 LWCCISSENSKLLVYEYMENQS-LDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
            +     ++   LV + +   S LD   H      +         VL   T   I     
Sbjct: 73  YYTSFVVKDELWLVMKLLSGGSVLDIIKH------IVAKGEHKSGVLDESTIATILREVL 126
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE---PHTMSAVAG 816
           +GL Y+H +     IHRDVK+ NILL  +   +IADFG++  LA  G+           G
Sbjct: 127 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
           +  + APE     +  + K DI+SFG+  +EL TG    +      +     ++   + P
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN---DPP 240
Query: 876 ITDALDKGIAEPCYLEEMTTVYRLAL-ICTSTLPSSRPSMKEVLQ 919
              +L+ G+ +   L++    +R  + +C    P  RP+  E+L+
Sbjct: 241 ---SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 282

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 33/276 (11%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + + I      E  A K +  +  L     ++   EI I  ++ H ++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V E    +SL   LH R+++L    +  +          QI +G     
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR--------QIVLGCQ--- 131
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H +   ++IHRD+K  N+ L+ + + KI DFGLA  +   GE      + G+  Y A
Sbjct: 132 -YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKTLCGTPNYIA 185
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDK 882
           PE       + ++D++S G ++  L+ GK      E + L E   R    E  I   ++ 
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEYSIPKHINP 242
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             A    +++M            T P++RP++ E+L
Sbjct: 243 VAAS--LIQKM----------LQTDPTARPTINELL 266

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 80  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 126
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 217

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 81  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 127
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 79  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 125
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G +G V    +  +G+ VAVK++   ++  ++L      E+ I+   +H N+V+++ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 215
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                +   +V E++E  +L          +V+ +    + +        + +   Q L 
Sbjct: 216 SYLVGDELWVVMEFLEGGALT--------DIVTHTRMNEEQIA------AVCLAVLQALS 261
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            +H      +IHRD+KS +ILL  + + K++DFG    ++K  E      + G+  + AP
Sbjct: 262 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAP 316
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           E         ++DI+S G++++E+V G+   + +
Sbjct: 317 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 75  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 121
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 212

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 81  YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 127
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 76  YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 122
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 79  YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 125
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 122
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 102 YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 148
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +          + G+  Y  P
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 201
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 239

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 77  YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 123
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +          + G+  Y  P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 122
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 77  YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 123
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 122
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 644 IGSGGSGQVY----RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G VY    R  I G  E  VAVK +  +  L +++E  F+ E  ++      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 82
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR------- 751
           V+L   +S     L+V E M +  L  +L            S+     + P R       
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLR-----------SLRPEAENNPGRPPPTLQE 131
Query: 752 -LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            +Q+A   A G+ Y++     + +HRD+ + N ++  +F  KI DFG+ + + +      
Sbjct: 132 MIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRK 188
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + APE           D++SFGVVL E+            TSLAE  ++  
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI------------TSLAEQPYQGL 236
Query: 871 AEEKPITDALDKG-IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           + E+ +   +D G + +P    E  T   L  +C    P  RP+  E++ +L+
Sbjct: 237 SNEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 81  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 127
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 28/213 (13%)
Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +G G    V R +      E+ A  +I N +KL+ +  ++   E  I   ++H NIV+L 
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAA--KIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 96
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKR-SLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
             IS E    LV++ +    L   +  R+  S    S  +HQ                + 
Sbjct: 97  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQ--------------ILES 142
Query: 762 LCYMH-HDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGS 817
           + ++H HD    I+HRD+K  N+LL S+ K    K+ADFGLA  +  QGE       AG+
Sbjct: 143 VNHIHQHD----IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGT 196
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            GY +PE        + +DI++ GV+L  L+ G
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 118/249 (47%), Gaps = 46/249 (18%)
Query: 628 GFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEI 687
           G  + ++L        +G G  G V++      GE VAVK+I++  + +   ++ F  EI
Sbjct: 1   GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REI 59
Query: 688 EILGTIR-HANIVKLWCCISSENSK--LLVYEYMENQSLDRWLHGRKRSLVSGSSSVH-Q 743
            IL  +  H NIV L   + ++N +   LV++YME       LH   R+ +     VH Q
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANIL--EPVHKQ 112
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA 803
           +V++   ++         + Y+H   +  ++HRD+K SNILL++E   K+ADFGL++   
Sbjct: 113 YVVYQLIKV---------IKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160
Query: 804 --------------------KQGEPHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGV 842
                                  +P     VA  + Y APE    +TK  + ID++S G 
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRW-YRAPEILLGSTKYTKGIDMWSLGC 219
Query: 843 VLLELVTGK 851
           +L E++ GK
Sbjct: 220 ILGEILCGK 228

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 644 IGSGGSGQVY----RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G VY    R  I G  E  VAVK +  +  L +++E  F+ E  ++      ++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 81
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR------- 751
           V+L   +S     L+V E M +  L  +L            S+     + P R       
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLR-----------SLRPEAENNPGRPPPTLQE 130
Query: 752 -LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            +Q+A   A G+ Y++     + +HRD+ + N ++  +F  KI DFG+ + + +      
Sbjct: 131 MIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 187
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + APE           D++SFGVVL E+            TSLAE  ++  
Sbjct: 188 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI------------TSLAEQPYQGL 235
Query: 871 AEEKPITDALDKG-IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           + E+ +   +D G + +P    E  T   L  +C    P  RP+  E++ +L+
Sbjct: 236 SNEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 113/251 (45%), Gaps = 25/251 (9%)
Query: 610 RKRNRDPATWKLTSFH---QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAV 666
           R   R+P       F    QL     +  S L     IG G +G V    +  +G+ VAV
Sbjct: 45  RSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAV 104
Query: 667 KRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRW 726
           K++   ++  ++L      E+ I+   +H N+V+++      +   +V E++E  +L   
Sbjct: 105 KKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-- 159
Query: 727 LHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD 786
                  +V+ +    + +        + +   Q L  +H      +IHRD+KS +ILL 
Sbjct: 160 ------DIVTHTRMNEEQIA------AVCLAVLQALSVLHAQG---VIHRDIKSDSILLT 204
Query: 787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLE 846
            + + K++DFG    ++K  E      + G+  + APE         ++DI+S G++++E
Sbjct: 205 HDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 262
Query: 847 LVTGKEANYGD 857
           +V G+   + +
Sbjct: 263 MVDGEPPYFNE 273

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 79  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 125
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +          + G+  Y  P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EAN 854
           E       +EK+D++S GV+  E + GK   EAN
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 644 IGSGGSGQVY----RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G VY    R  I G  E  VAVK +  +  L +++E  F+ E  ++      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 82
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR------- 751
           V+L   +S     L+V E M +  L  +L            S+     + P R       
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLR-----------SLRPEAENNPGRPPPTLQE 131
Query: 752 -LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            +Q+A   A G+ Y++     + +HRD+ + N ++  +F  KI DFG+ + + +      
Sbjct: 132 MIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + APE           D++SFGVVL E+            TSLAE  ++  
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI------------TSLAEQPYQGL 236
Query: 871 AEEKPITDALDKG-IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           + E+ +   +D G + +P    E  T   L  +C    P  RP+  E++ +L+
Sbjct: 237 SNEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY     +        + L   S    Q    + T L      A  L 
Sbjct: 81  YFHDATRVYLILEYAPRGEV-------YKELQKLSKFDEQRTATYITEL------ANALS 127
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY          +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 73  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 120 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 210

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G G  G+V +       +  AVK I N      K     + E+E+L  + H NI+KL+
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             +   +S  +V E      L   +  RKR     ++ + + V               G+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF-------------SGI 134
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            YMH      I+HRD+K  NILL+S+ K    KI DFGL+    +  +   M    G+  
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAY 188
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG-DEHTSLAEWAWRHYAEEKP 875
           Y APE    T  +EK D++S GV+L  L++G    YG +E+  L       YA + P
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 88/330 (26%), Positives = 138/330 (41%), Gaps = 60/330 (18%)
Query: 611 KRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEFVAVKR 668
           K N DP  + +  ++ + F            ++IG G  GQV   RI  +G     A+KR
Sbjct: 11  KNNPDPTIYPVLDWNDIKF-----------QDVIGEGNFGQVLKARIKKDGLRMDAAIKR 59
Query: 669 IWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWL 727
           +      ++   ++F  E+E+L  +  H NI+ L           L  EY  + +L  +L
Sbjct: 60  M--KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117
Query: 728 HGRKRSLV-----------SGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHR 776
             RK  ++           + S+   Q +LH+      A   A+G+ Y+      Q IHR
Sbjct: 118 --RKSRVLETDPAFAIANSTASTLSSQQLLHF------AADVARGMDYLSQ---KQFIHR 166
Query: 777 DVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF--GYFAPEYAYTTKVNEK 834
           D+ + NIL+   + AKIADFGL++     G+   +    G     + A E    +     
Sbjct: 167 DLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 221
Query: 835 IDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEM 893
            D++S+GV+L E+V+ G     G     L E   + Y  EKP+           C  E  
Sbjct: 222 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN----------CDDE-- 269
Query: 894 TTVYRLALICTSTLPSSRPSMKEVLQILRR 923
             VY L   C    P  RPS  ++L  L R
Sbjct: 270 --VYDLMRQCWREKPYERPSFAQILVSLNR 297

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 33/276 (11%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + + I      E  A K +  +  L     ++   EI I  ++ H ++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V E    +SL   LH R+++L    +  +          QI +G     
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR--------QIVLGCQ--- 129
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H +   ++IHRD+K  N+ L+ + + KI DFGLA  +   GE      + G+  Y A
Sbjct: 130 -YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIA 183
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDK 882
           PE       + ++D++S G ++  L+ GK      E + L E   R    E  I   ++ 
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEYSIPKHINP 240
Query: 883 GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             A    +++M            T P++RP++ E+L
Sbjct: 241 VAAS--LIQKM----------LQTDPTARPTINELL 264

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 122
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +          + G+  Y  P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 78  YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 124
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +          + G+  Y  P
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 123/288 (42%), Gaps = 50/288 (17%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           SL     +G+G  G+V+    N   + VAVK +    K      + F+AE  ++ T++H 
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTM----KPGSMSVEAFLAEANVMKTLQHD 237
Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWL---HGRKRSLVSGSSSVHQHVLHWPTRLQ 753
            +VKL   ++ E    ++ E+M   SL  +L    G K+ L              P  + 
Sbjct: 238 KLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--------------PKLID 282
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++        IHRD++++NIL+ +    KIADFGLA++ AK         
Sbjct: 283 FSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVGAK--------- 330
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE         K D++SFG++L+E+VT     Y                  
Sbjct: 331 --FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-------------MSN 375
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +  AL++G   P        +Y + + C    P  RP+ + +  +L
Sbjct: 376 PEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 88/330 (26%), Positives = 138/330 (41%), Gaps = 60/330 (18%)
Query: 611 KRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEFVAVKR 668
           K N DP  + +  ++ + F            ++IG G  GQV   RI  +G     A+KR
Sbjct: 1   KNNPDPTIYPVLDWNDIKF-----------QDVIGEGNFGQVLKARIKKDGLRMDAAIKR 49
Query: 669 IWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWL 727
           +      ++   ++F  E+E+L  +  H NI+ L           L  EY  + +L  +L
Sbjct: 50  M--KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 107
Query: 728 HGRKRSLV-----------SGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHR 776
             RK  ++           + S+   Q +LH+      A   A+G+ Y+      Q IHR
Sbjct: 108 --RKSRVLETDPAFAIANSTASTLSSQQLLHF------AADVARGMDYLSQ---KQFIHR 156
Query: 777 DVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF--GYFAPEYAYTTKVNEK 834
           D+ + NIL+   + AKIADFGL++     G+   +    G     + A E    +     
Sbjct: 157 DLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 211
Query: 835 IDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEM 893
            D++S+GV+L E+V+ G     G     L E   + Y  EKP+           C  E  
Sbjct: 212 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN----------CDDE-- 259
Query: 894 TTVYRLALICTSTLPSSRPSMKEVLQILRR 923
             VY L   C    P  RPS  ++L  L R
Sbjct: 260 --VYDLMRQCWREKPYERPSFAQILVSLNR 287

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G +G V    +  +G+ VAVK++   ++  ++L      E+ I+   +H N+V+++ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 95
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                +   +V E++E  +L          +V+ +    + +        + +   Q L 
Sbjct: 96  SYLVGDELWVVMEFLEGGALT--------DIVTHTRMNEEQIA------AVCLAVLQALS 141
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            +H      +IHRD+KS +ILL  + + K++DFG    ++K  E      + G+  + AP
Sbjct: 142 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAP 196
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           E         ++DI+S G++++E+V G+   + +
Sbjct: 197 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 230

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 99/226 (43%), Gaps = 47/226 (20%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+GG G V R      GE VA+K+    ++L+ K  + +  EI+I+  + H N+V    
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 704 C------ISSENSKLLVYEYMENQSLDRWLH----------GRKRSLVSGSSSVHQHVLH 747
                  ++  +  LL  EY E   L ++L+          G  R+L+S  SS       
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS------- 133
Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD---SEFKAKIADFGLAKMLAK 804
                         L Y+H +   +IIHRD+K  NI+L         KI D G AK L  
Sbjct: 134 -------------ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-D 176
Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           QGE    +   G+  Y APE     K    +D +SFG +  E +TG
Sbjct: 177 QGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 99/226 (43%), Gaps = 47/226 (20%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+GG G V R      GE VA+K+    ++L+ K  + +  EI+I+  + H N+V    
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 704 C------ISSENSKLLVYEYMENQSLDRWLH----------GRKRSLVSGSSSVHQHVLH 747
                  ++  +  LL  EY E   L ++L+          G  R+L+S  SS       
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS------- 132
Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD---SEFKAKIADFGLAKMLAK 804
                         L Y+H +   +IIHRD+K  NI+L         KI D G AK L  
Sbjct: 133 -------------ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-D 175
Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           QGE    +   G+  Y APE     K    +D +SFG +  E +TG
Sbjct: 176 QGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 44/312 (14%)
Query: 645 GSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           G+ GS ++ R D  G   G  VAVK++ ++    Q+   +F  EI+IL  + H++ +  +
Sbjct: 21  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKAL-HSDFIVKY 76
Query: 703 CCIS---SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
             +S      S  LV EY+ +  L  +L  R R+ +  S      +L + +++       
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDAS-----RLLLYSSQI------C 124
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-F 818
           +G+ Y+    + + +HRD+ + NIL++SE   KIADFGLAK+L    + + +     S  
Sbjct: 125 KGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 181
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            ++APE       + + D++SFGVVL EL T     Y D+  S +    R    E+ +  
Sbjct: 182 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT-----YCDKSCSPSAEFLRMMGSERDVP- 235
Query: 879 ALDK-------GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV---LQIL---RRCC 925
           AL +       G   P        V+ L  +C +  P  RPS   +   L +L    R C
Sbjct: 236 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 295
Query: 926 PTENYGGKKMGR 937
            T  +     G+
Sbjct: 296 ETHAFTAHPEGK 307

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 28/217 (12%)
Query: 644 IGSGGSGQVYRI-DINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL---GTIRHANIV 699
           IG G  G+V++  D+   G FVA+KR+   +   + +    I E+ +L    T  H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 700 KLW--CCISS---ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           +L+  C +S    E    LV+E+++ Q L  +L             V +  +   T   +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYL-----------DKVPEPGVPTETIKDM 125
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
                +GL ++H   + +++HRD+K  NIL+ S  + K+ADFGLA++ + Q     +++V
Sbjct: 126 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSV 179
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
             +  Y APE    +     +D++S G +  E+   K
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 28/217 (12%)
Query: 644 IGSGGSGQVYRI-DINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL---GTIRHANIV 699
           IG G  G+V++  D+   G FVA+KR+   +   + +    I E+ +L    T  H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 700 KLW--CCISS---ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           +L+  C +S    E    LV+E+++ Q L  +L             V +  +   T   +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYL-----------DKVPEPGVPTETIKDM 125
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
                +GL ++H   + +++HRD+K  NIL+ S  + K+ADFGLA++ + Q     +++V
Sbjct: 126 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSV 179
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
             +  Y APE    +     +D++S G +  E+   K
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 79  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 125
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +          + G+  Y  P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           IG G    V R + +    E+ A  +I N +KL+ +  ++   E  I   ++H+NIV+L 
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAA--KIINTKKLSARDHQKLEREARICRLLKHSNIVRLH 69
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             IS E    LV++ +    L   +  R+    + +S   Q +L             + +
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQIL-------------EAV 116
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            + H      ++HRD+K  N+LL S+ K    K+ADFGLA  +  QG+       AG+ G
Sbjct: 117 LHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y +PE        + +DI++ GV+L  L+ G
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 49/247 (19%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S   E  ++G G  GQV +        + A+K+I   R   +KL    ++E+ +L ++ H
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLST-ILSEVXLLASLNH 61
Query: 696 ANIVKLWCC-------------ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
             +V+ +               +  +++  +  EY EN++L   +H    +         
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLN--------Q 113
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
           Q   +W    QI     + L Y+H   +  IIHR++K  NI +D     KI DFGLAK +
Sbjct: 114 QRDEYWRLFRQIL----EALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNV 166
Query: 803 AKQ------------GEPHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELV- 848
            +             G    +++  G+  Y A E    T   NEKID YS G++  E + 
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY 226
Query: 849 ---TGKE 852
              TG E
Sbjct: 227 PFSTGXE 233

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +GSG  G V+ ++   +G    +K I  N+  +Q   ++  AEIE+L ++ H NI+K++ 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTI--NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 704 CISSENSKLLVYEYME-NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                ++  +V E  E  + L+R +  + R        V           ++       L
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV----------AELMKQMMNAL 137
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDS---EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            Y H   +  ++H+D+K  NIL          KI DFGLA++   + + H+ +A AG+  
Sbjct: 138 AYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNA-AGTAL 191
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y APE  +   V  K DI+S GVV+  L+TG
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 87
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    +V EYM   +L  +L    R  V+        +L+  T++  A
Sbjct: 88  PNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVV-----LLYMATQISSA 142
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
                    M +      IHRD+ + N L+      K+ADFGL++++   G+ +T  A A
Sbjct: 143 ---------MEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT--GDTYTAHAGA 191
Query: 816 G-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEE 873
                + APE       + K D+++FGV+L E+ T   + Y G + + + +   + Y  E
Sbjct: 192 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRME 251
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +P          E C       VY L   C    P+ RPS  E  Q
Sbjct: 252 QP----------EGC----PPKVYELMRACWKWSPADRPSFAETHQ 283

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 134/283 (47%), Gaps = 38/283 (13%)
Query: 645 GSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           G+ GS ++ R D  G   G  VAVK++ ++    Q+   +F  EI+IL  + H++ +  +
Sbjct: 34  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKAL-HSDFIVKY 89
Query: 703 CCIS---SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
             +S      S  LV EY+ +  L  +L  R R+ +  S      +L + +++       
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDAS-----RLLLYSSQI------C 137
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-F 818
           +G+ Y+    + + +HRD+ + NIL++SE   KIADFGLAK+L    + + +     S  
Sbjct: 138 KGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            ++APE       + + D++SFGVVL EL T     Y D+  S +    R    E+ +  
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT-----YCDKSCSPSAEFLRMMGCERDVP- 248
Query: 879 ALDK-------GIAEPCYLEEMTTVYRLALICTSTLPSSRPSM 914
           AL +       G   P        V+ L  +C +  P  RPS 
Sbjct: 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF 291

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G +G V    +  +G+ VAVK++ + RK  Q+  +    E+ I+   +H N+V+++ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM-DLRK--QQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                +   +V E++E  +L          +V+ +    + +        + +   Q L 
Sbjct: 89  SYLVGDELWVVMEFLEGGALT--------DIVTHTRMNEEQIA------AVCLAVLQALS 134
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            +H      +IHRD+KS +ILL  + + K++DFG    ++K  E      + G+  + AP
Sbjct: 135 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAP 189
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           E         ++DI+S G++++E+V G+   + +
Sbjct: 190 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 223

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G +G V    +  +G+ VAVK++ + RK  Q+  +    E+ I+   +H N+V+++ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM-DLRK--QQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                +   +V E++E  +L          +V+ +    + +        + +   Q L 
Sbjct: 85  SYLVGDELWVVMEFLEGGALT--------DIVTHTRMNEEQIA------AVCLAVLQALS 130
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            +H      +IHRD+KS +ILL  + + K++DFG    ++K  E      + G+  + AP
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAP 185
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           E         ++DI+S G++++E+V G+   + +
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 80  YFHDATRVYLILEYAPLGTV-------YRELQKLSRFDEQRTATYITEL------ANALS 126
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y  P
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTG 850
           E       +EK+D++S GV+  E + G
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY     +        + L   S    Q    + T L      A  L 
Sbjct: 81  YFHDATRVYLILEYAPRGEV-------YKELQKLSKFDEQRTATYITEL------ANALS 127
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +          + G+  Y  P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G G  G+V +       +  AVK I N      K     + E+E+L  + H NI+KL+
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             +   +S  +V E      L   +  RKR     ++ + + V               G+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF-------------SGI 134
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            YMH      I+HRD+K  NILL+S+ K    KI DFGL+    +  +   M    G+  
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAY 188
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG-DEHTSLAEWAWRHYAEEKP 875
           Y APE    T  +EK D++S GV+L  L++G    YG +E+  L       YA + P
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 79  YFHDATRVYLILEYAPLGTV-------YRELQKLSKFDEQRTATYITEL------ANALS 125
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIA+FG     +        + + G+  Y  P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 126/287 (43%), Gaps = 30/287 (10%)
Query: 644 IGSGGSGQVYRIDI-NGAGE----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V+  +  N   E     VAVK +   +  +    K+F  E E+L  ++H +I
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQHEHI 77
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           VK +      +  ++V+EYM++  L+++L  HG    L++  +   +  L     L IA 
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE--LTQSQMLHIAQ 135
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A G+ Y+    +   +HRD+ + N L+      KI DFG+++ +              
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 192
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKP 875
              +  PE     K   + D++S GVVL E+ T GK+  Y   +  + E   +    ++P
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 252
Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            T          C  E    VY L L C    P  R ++K +  +L+
Sbjct: 253 RT----------CPQE----VYELMLGCWQREPHMRKNIKGIHTLLQ 285

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 117/264 (44%), Gaps = 50/264 (18%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V+    N + + VAVK +    K      + F+ E  ++ T++H  +V+L+ 
Sbjct: 20  LGAGQFGEVWMGYYNNSTK-VAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 74
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            ++ E    ++ E+M   SL  +L   +   V             P  +  +   A+G+ 
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKV-----------LLPKLIDFSAQIAEGMA 123
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS---FGY 820
           Y+        IHRD++++N+L+      KIADFGLA+++    E +  +A  G+     +
Sbjct: 124 YIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI----EDNEYTAREGAKFPIKW 176
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY------------------------G 856
            APE         K +++SFG++L E+VT  +  Y                         
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCP 236
Query: 857 DEHTSLAEWAWRHYAEEKPITDAL 880
           DE   + +  W+  AEE+P  D L
Sbjct: 237 DELYDIMKMCWKEKAEERPTFDYL 260

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             LT    +G G  GQV       ID +   E V V          +K   + ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVL 746
             I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S   + V +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +    
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 272 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 315

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G G  G+V +       +  AVK I N      K     + E+E+L  + H NI+KL+
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             +   +S  +V E      L   +  RKR     ++ + + V               G+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF-------------SGI 134
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            YMH      I+HRD+K  NILL+S+ K    KI DFGL+    +  +   M    G+  
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAY 188
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG-DEHTSLAEWAWRHYAEEKP 875
           Y APE    T  +EK D++S GV+L  L++G    YG +E+  L       YA + P
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G    V R     AG+  A K I N +KL+ +  ++   E  I   ++H NIV+L  
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAK-IINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            IS E    L+++ +    L   +  R+    + +S   Q +L             + + 
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL-------------EAVL 135
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           + H      ++HRD+K  N+LL S+ K    K+ADFGLA  +  +GE       AG+ GY
Sbjct: 136 HCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGY 190
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +PE        + +D+++ GV+L  L+ G
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKLW 702
           IG G SG VY       G+ VA++++     L Q+ +KE I  EI ++   ++ NIV   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V EY+   SL              +  V +  +       +     Q L
Sbjct: 84  DSYLVGDELWVVMEYLAGGSL--------------TDVVTETCMDEGQIAAVCRECLQAL 129
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL-AKMLAKQGEPHTMSAVAGSFGYF 821
            ++H +   Q+IHRD+KS NILL  +   K+ DFG  A++  +Q +  TM    G+  + 
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWM 183
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           APE         K+DI+S G++ +E++ G+
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G+V+   +      VAVK       L   L+ +F+ E  IL    H NIV+L  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             + +    +V E ++      +L         G+       L   T LQ+   AA G+ 
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR------TEGAR------LRVKTLLQMVGDAAAGME 227
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF----- 818
           Y+   C    IHRD+ + N L+  +   KI+DFG+++      E   + A +G       
Sbjct: 228 YLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSRE-----EADGVXAASGGLRQVPV 279
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            + APE     + + + D++SFG++L E  +   + Y     +L+    R + E      
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY----PNLSNQQTREFVE------ 329
Query: 879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
              KG   PC       V+RL   C +  P  RPS   + Q L+
Sbjct: 330 ---KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V     Y+     A +F++ +++     ++ ++E+E    I  L  +RH +I
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVERE----ISYLKLLRHPHI 71
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           +KL+  I++    ++V EY   +  D  +  ++ +   G     Q            I  
Sbjct: 72  IKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQ------------IIC 119
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A   C+ H     +I+HRD+K  N+LLD     KIADFGL+ ++    + + +    GS 
Sbjct: 120 AIEYCHRH-----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTSCGSP 171
Query: 819 GYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
            Y APE          ++D++S G+VL  ++ G+
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY         L    R L   S    Q    + T L      A  L 
Sbjct: 78  YFHDATRVYLILEYAP-------LGTVYRELQKLSKFDEQRTATYITEL------ANALS 124
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIA+FG     +        + + G+  Y  P
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDE 858
           E       +EK+D++S GV+  E + GK   EAN   E
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L+ 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY    ++        R L   S    Q    + T L      A  L 
Sbjct: 80  YFHDATRVYLILEYAPLGTV-------YRELQKLSRFDEQRTATYITEL------ANALS 126
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H   + ++IHRD+K  N+LL S  + KIADFG     +          + G+  Y  P
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 179
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTG 850
           E       +EK+D++S GV+  E + G
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +G G    V R + I    E+ A  +I N +KL+ +  ++   E  I   ++H NIV+L 
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAA--KIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             IS E    LV++ +    L   +  R+    + +S   Q +L            +   
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-----------SVNH 118
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           C+++      I+HRD+K  N+LL S+ K    K+ADFGLA  +  QG+       AG+ G
Sbjct: 119 CHLN-----GIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y +PE        + +D+++ GV+L  L+ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G+V+   +      VAVK       L   L+ +F+ E  IL    H NIV+L  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             + +    +V E ++      +L         G+       L   T LQ+   AA G+ 
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR------TEGAR------LRVKTLLQMVGDAAAGME 227
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF----- 818
           Y+   C    IHRD+ + N L+  +   KI+DFG+++      E   + A +G       
Sbjct: 228 YLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSRE-----EADGVYAASGGLRQVPV 279
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            + APE     + + + D++SFG++L E  +   + Y     +L+    R + E      
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY----PNLSNQQTREFVE------ 329
Query: 879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
              KG   PC       V+RL   C +  P  RPS   + Q L+
Sbjct: 330 ---KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             LT    +G G  GQV       ID +   E V V          +K   + ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVL 746
             I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S   + V +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +    
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 272 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 315

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 126/293 (43%), Gaps = 44/293 (15%)
Query: 644 IGSGGSGQVY----RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G VY    R  I G  E  VAVK +  +  L +++E  F+ E  ++      ++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 83
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR------- 751
           V+L   +S     L+V E M +  L  +L            S+     + P R       
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLR-----------SLRPEAENNPGRPPPTLQE 132
Query: 752 -LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            +Q+A   A G+ Y++     + +HR++ + N ++  +F  KI DFG+ + + +      
Sbjct: 133 MIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 189
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + APE           D++SFGVVL E+            TSLAE  ++  
Sbjct: 190 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI------------TSLAEQPYQGL 237
Query: 871 AEEKPITDALDKG-IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           + E+ +   +D G + +P    E  T   L  +C    P+ RP+  E++ +L+
Sbjct: 238 SNEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 126/293 (43%), Gaps = 44/293 (15%)
Query: 644 IGSGGSGQVY----RIDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G VY    R  I G  E  VAVK +  +  L +++E  F+ E  ++      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 82
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR------- 751
           V+L   +S     L+V E M +  L  +L            S+     + P R       
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLR-----------SLRPEAENNPGRPPPTLQE 131
Query: 752 -LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            +Q+A   A G+ Y++     + +HR++ + N ++  +F  KI DFG+ + + +      
Sbjct: 132 MIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + APE           D++SFGVVL E+            TSLAE  ++  
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI------------TSLAEQPYQGL 236
Query: 871 AEEKPITDALDKG-IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           + E+ +   +D G + +P    E  T   L  +C    P+ RP+  E++ +L+
Sbjct: 237 SNEQVLKFVMDGGYLDQPDNCPERVT--DLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +G G    V R + I    E+ A  +I N +KL+ +  ++   E  I   ++H NIV+L 
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAA--KIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             IS E    LV++ +    L   +  R+    + +S   Q +L            +   
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-----------SVNH 118
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           C+++      I+HRD+K  N+LL S+ K    K+ADFGLA  +  QG+       AG+ G
Sbjct: 119 CHLN-----GIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y +PE        + +D+++ GV+L  L+ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 87/330 (26%), Positives = 138/330 (41%), Gaps = 60/330 (18%)
Query: 611 KRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVY--RIDINGAGEFVAVKR 668
           K N DP  + +  ++ + F            ++IG G  GQV   RI  +G     A+KR
Sbjct: 8   KNNPDPTIYPVLDWNDIKF-----------QDVIGEGNFGQVLKARIKKDGLRMDAAIKR 56
Query: 669 IWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWL 727
           +      ++   ++F  E+E+L  +  H NI+ L           L  EY  + +L  +L
Sbjct: 57  M--KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 114
Query: 728 HGRKRSLV-----------SGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHR 776
             RK  ++           + S+   Q +LH+      A   A+G+ Y+      Q IHR
Sbjct: 115 --RKSRVLETDPAFAIANSTASTLSSQQLLHF------AADVARGMDYLSQ---KQFIHR 163
Query: 777 DVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF--GYFAPEYAYTTKVNEK 834
           ++ + NIL+   + AKIADFGL++     G+   +    G     + A E    +     
Sbjct: 164 NLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 218
Query: 835 IDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEM 893
            D++S+GV+L E+V+ G     G     L E   + Y  EKP+           C  E  
Sbjct: 219 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN----------CDDE-- 266
Query: 894 TTVYRLALICTSTLPSSRPSMKEVLQILRR 923
             VY L   C    P  RPS  ++L  L R
Sbjct: 267 --VYDLMRQCWREKPYERPSFAQILVSLNR 294

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKLW 702
           IG G SG VY       G+ VA++++     L Q+ +KE I  EI ++   ++ NIV   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V EY+   SL              +  V +  +       +     Q L
Sbjct: 84  DSYLVGDELWVVMEYLAGGSL--------------TDVVTETCMDEGQIAAVCRECLQAL 129
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            ++H +   Q+IHRD+KS NILL  +   K+ DFG    +    E    S + G+  + A
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMVGTPYWMA 184
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE         K+DI+S G++ +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKLW 702
           IG G SG VY       G+ VA++++     L Q+ +KE I  EI ++   ++ NIV   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V EY+   SL              +  V +  +       +     Q L
Sbjct: 84  DSYLVGDELWVVMEYLAGGSL--------------TDVVTETCMDEGQIAAVCRECLQAL 129
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            ++H +   Q+IHRD+KS NILL  +   K+ DFG    +    E    S + G+  + A
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSEMVGTPYWMA 184
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE         K+DI+S G++ +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 19/209 (9%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL-GTIRHANIVKL 701
           +IG G  G+V          F AVK +     L +K EK  ++E  +L   ++H  +V L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                + +    V +Y+    L   L  R+R  +   +  +            A   A  
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFY------------AAEIASA 151
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  I++RD+K  NILLDS+    + DFGL K   +     T S   G+  Y 
Sbjct: 152 LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYL 206
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           APE  +    +  +D +  G VL E++ G
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKLW 702
           IG G SG VY       G+ VA++++     L Q+ +KE I  EI ++   ++ NIV   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V EY+   SL              +  V +  +       +     Q L
Sbjct: 85  DSYLVGDELWVVMEYLAGGSL--------------TDVVTETCMDEGQIAAVCRECLQAL 130
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            ++H +   Q+IHRD+KS NILL  +   K+ DFG    +    E    S + G+  + A
Sbjct: 131 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMVGTPYWMA 185
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE         K+DI+S G++ +E++ G+
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 85/311 (27%), Positives = 145/311 (46%), Gaps = 42/311 (13%)
Query: 645 GSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           G+ GS ++ R D  G   G  VAVK++ ++    Q+   +F  EI+IL  + H++ +  +
Sbjct: 22  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKAL-HSDFIVKY 77
Query: 703 CCIS---SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
             +S      S  LV EY+ +  L  +L  R R+ +  S      +L + +++       
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDAS-----RLLLYSSQI------C 125
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-F 818
           +G+ Y+    + + +HRD+ + NIL++SE   KIADFGLAK+L    + + +     S  
Sbjct: 126 KGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 182
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI-- 876
            ++APE       + + D++SFGVVL EL T     Y D+  S +    R    E+ +  
Sbjct: 183 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT-----YCDKSCSPSAEFLRMMGCERDVPA 237
Query: 877 ----TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV---LQIL---RRCCP 926
                + L++G   P        V+ L  +C +  P  RPS   +   L +L    R C 
Sbjct: 238 LCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 297
Query: 927 TENYGGKKMGR 937
           T  +     G+
Sbjct: 298 THAFTAHPEGK 308

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 38/288 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S LT    IGSG  G V+ +      + VA+K I    K     E +FI E E++  + H
Sbjct: 27  SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTI----KEGSMSEDDFIEEAEVMMKLSH 81
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+     +    LV+E+ME+  L  +L   +R L +             T L + 
Sbjct: 82  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAE-----------TLLGMC 129
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           +   +G+ Y+   C   +IHRD+ + N L+      K++DFG+ + +    +    S+  
Sbjct: 130 LDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTG 183
Query: 816 GSF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
             F   + +PE    ++ + K D++SFGV++ E+ +  +  Y +   S            
Sbjct: 184 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------------ 231
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             + + +  G          T VY++   C    P  RP+   +L+ L
Sbjct: 232 -EVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 38/231 (16%)
Query: 640 ESNLIGSGGSGQVYRIDIN-GAGEF----------VAVKRIW---NNRKLNQKLEKEFIA 685
           E+  +G    G+  + DI  G G F            V+  W    +RKL +   + F  
Sbjct: 15  ETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE 74
Query: 686 EIEILGTIRHANIVKLW----CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSV 741
           E E L  ++H NIV+ +      +  +   +LV E   + +L  +L   K   +    S 
Sbjct: 75  EAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW 134
Query: 742 HQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-KAKIADFGLAK 800
            + +L             +GL ++H   TP IIHRD+K  NI +       KI D GLA 
Sbjct: 135 CRQIL-------------KGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180
Query: 801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +           AV G+  + APE  Y  K +E +D+Y+FG   LE  T +
Sbjct: 181 L----KRASFAKAVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSE 226

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+VY+      G   A K I    K  ++LE ++I EIEIL T  H  IVKL  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELE-DYIVEIEILATCDHPYIVKLLG 75
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
               +    ++ E+    ++D  +    R L               T  QI +   Q L 
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGL---------------TEPQIQVVCRQMLE 120
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA----KMLAKQGEPHTMSAVAGSFG 819
            ++   + +IIHRD+K+ N+L+  E   ++ADFG++    K L K+       +  G+  
Sbjct: 121 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR------DSFIGTPY 174
Query: 820 YFAPEYAYT-----TKVNEKIDIYSFGVVLLEL 847
           + APE         T  + K DI+S G+ L+E+
Sbjct: 175 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             LT    +G G  GQV       ID +   E V V          +K   + ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH---QHVL 746
             I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S  ++   +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +    
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 272 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 315

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 31/292 (10%)
Query: 644 IGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RH 695
           +G G  GQV   +  G  +        VAVK + ++    +K   + I+E+E++  I +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKH 93
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRL 752
            NI+ L    + +    ++ EY    +L  +L  R+   +  S   S   +  L     +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +         +
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
                  + APE  +      + D++SFGV+L E+ T   + Y G     L +     + 
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 271 MDKPSN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 24/225 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G+V  +  N   +  A+K +   + + +   +    E++I+  + H  +V LW 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH-QHVLHWPTRLQIAIGAAQGL 762
               E    +V +                 L+ G    H Q  +H+     + +   + +
Sbjct: 83  SFQDEEDMFMVVDL----------------LLGGDLRYHLQQNVHFKEET-VKLFICELV 125
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
             + +    +IIHRD+K  NILLD      I DF +A ML ++ +  TM   AG+  Y A
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM---AGTKPYMA 182
Query: 823 PEYAYTTK---VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
           PE   + K    +  +D +S GV   EL+ G+   +    TS  E
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 39/237 (16%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTI 693
           L+       +G GG G V+           A+KRI   R  N++L +E  + E++ L  +
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI---RLPNRELAREKVMREVKALAKL 60
Query: 694 RHANIVKLWCCISSEN-------SKLLVYEYMENQ-----SLDRWLHGRKRSLVSGSSSV 741
            H  IV+ +     +N       S   VY Y++ Q     +L  W++GR  ++     SV
Sbjct: 61  EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSV 119
Query: 742 HQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM 801
             H+      LQIA    + + ++H   +  ++HRD+K SNI    +   K+ DFGL   
Sbjct: 120 CLHIF-----LQIA----EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167
Query: 802 LAKQGEPHT----MSAVAGSFG------YFAPEYAYTTKVNEKIDIYSFGVVLLELV 848
           + +  E  T    M A A   G      Y +PE  +    + K+DI+S G++L EL+
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 52/214 (24%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G +G V    +  +G+ VAVK++ + RK  Q+  +    E+ I+   +H N+V+++ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM-DLRK--QQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                +   +V E++E  +L          +V+ +    + +        + +   Q L 
Sbjct: 94  SYLVGDELWVVMEFLEGGALT--------DIVTHTRMNEEQIA------AVCLAVLQALS 139
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            +H      +IHRD+KS +ILL  + + K++DFG    ++K  E      + G+  + AP
Sbjct: 140 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAP 194
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           E         ++DI+S G++++E+V G+   + +
Sbjct: 195 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 228

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTIRHANIVKL 701
           ++G G  G+V        G+  AVK I + R++ QK +KE  + E+++L  + H NI KL
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +     +    LV E      L   +  RKR     ++ + + VL              G
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL-------------SG 138
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGSF 818
           + Y H +   +I+HRD+K  N+LL+S+ K    +I DFGL+       +        G+ 
Sbjct: 139 ITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IGTA 192
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            Y APE  + T  +EK D++S GV+L  L++G
Sbjct: 193 YYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+VY+      G   A K I    K  ++LE ++I EIEIL T  H  IVKL  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELE-DYIVEIEILATCDHPYIVKLLG 83
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
               +    ++ E+    ++D  +    R L               T  QI +   Q L 
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGL---------------TEPQIQVVCRQMLE 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA----KMLAKQGEPHTMSAVAGSFG 819
            ++   + +IIHRD+K+ N+L+  E   ++ADFG++    K L K+       +  G+  
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR------DSFIGTPY 182
Query: 820 YFAPEYAYT-----TKVNEKIDIYSFGVVLLEL 847
           + APE         T  + K DI+S G+ L+E+
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 20/224 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                + +    V EY     L  + H  R+R      +  +                  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY------------GAEIVS 116
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H   +  +++RD+K  N++LD +   KI DFGL K     G   TM    G+  Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEY 171
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 125/288 (43%), Gaps = 38/288 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S LT    IGSG  G V+ +      + VA+K I    +     E++FI E E++  + H
Sbjct: 10  SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSH 64
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+     +    LV+E+ME+  L  +L   +R L +             T L + 
Sbjct: 65  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAE-----------TLLGMC 112
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           +   +G+ Y+   C   +IHRD+ + N L+      K++DFG+ + +    +    S+  
Sbjct: 113 LDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTG 166
Query: 816 GSF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
             F   + +PE    ++ + K D++SFGV++ E+ +  +  Y +   S            
Sbjct: 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------------ 214
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             + + +  G          T VY++   C    P  RP+   +L+ L
Sbjct: 215 -EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 20/224 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                + +    V EY     L  + H  R+R      +  +                  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY------------GAEIVS 116
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H   +  +++RD+K  N++LD +   KI DFGL K     G   TM    G+  Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTPEY 171
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIRHAN 697
           +G G    VY+         VA+K I        +LE E       I E+ +L  ++HAN
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEI--------RLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV L   I +E S  LV+EY     LD+ L   K+ L    + ++ H +           
Sbjct: 62  IVTLHDIIHTEKSLTLVFEY-----LDKDL---KQYLDDCGNIINMHNVKL-----FLFQ 108
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +GL Y H     +++HRD+K  N+L++   + K+ADFGLA+  AK     T      +
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVT 163
Query: 818 FGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
             Y  P+    +T  + +ID++  G +  E+ TG+
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 125/288 (43%), Gaps = 38/288 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S LT    IGSG  G V+ +      + VA+K I    +     E++FI E E++  + H
Sbjct: 5   SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSH 59
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+     +    LV+E+ME+  L  +L   +R L +             T L + 
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAE-----------TLLGMC 107
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           +   +G+ Y+   C   +IHRD+ + N L+      K++DFG+ + +    +    S+  
Sbjct: 108 LDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTG 161
Query: 816 GSF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
             F   + +PE    ++ + K D++SFGV++ E+ +  +  Y +   S            
Sbjct: 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------------ 209
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             + + +  G          T VY++   C    P  RP+   +L+ L
Sbjct: 210 -EVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 20/224 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                + +    V EY     L  + H  R+R      +  +                  
Sbjct: 74  KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY------------GAEIVS 119
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H   +  +++RD+K  N++LD +   KI DFGL K     G   TM    G+  Y
Sbjct: 120 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEY 174
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 218

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 20/224 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                + +    V EY     L  + H  R+R      +  +                  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY------------GAEIVS 116
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H   +  +++RD+K  N++LD +   KI DFGL K     G   TM    G+  Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTPEY 171
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             LT    +G G  GQV       ID +   E V V          +K   + ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH---QHVL 746
             I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S  ++   +  +
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +    
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 272 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 315

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 125/288 (43%), Gaps = 38/288 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S LT    IGSG  G V+ +      + VA+K I    +     E++FI E E++  + H
Sbjct: 7   SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSH 61
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+     +    LV+E+ME+  L  +L   +R L +             T L + 
Sbjct: 62  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAE-----------TLLGMC 109
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           +   +G+ Y+   C   +IHRD+ + N L+      K++DFG+ + +    +    S+  
Sbjct: 110 LDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTG 163
Query: 816 GSF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
             F   + +PE    ++ + K D++SFGV++ E+ +  +  Y +   S            
Sbjct: 164 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------------ 211
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             + + +  G          T VY++   C    P  RP+   +L+ L
Sbjct: 212 -EVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 20/224 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                + +    V EY     L  + H  R+R      +  +                  
Sbjct: 76  KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY------------GAEIVS 121
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H   +  +++RD+K  N++LD +   KI DFGL K     G   TM    G+  Y
Sbjct: 122 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTPEY 176
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 220

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKLW 702
           IG G SG VY       G+ VA++++     L Q+ +KE I  EI ++   ++ NIV   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V EY+   SL              +  V +  +       +     Q L
Sbjct: 85  DSYLVGDELWVVMEYLAGGSL--------------TDVVTETCMDEGQIAAVCRECLQAL 130
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL-AKMLAKQGEPHTMSAVAGSFGYF 821
            ++H +   Q+IHR++KS NILL  +   K+ DFG  A++  +Q +  TM    G+  + 
Sbjct: 131 EFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWM 184
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           APE         K+DI+S G++ +E++ G+
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             LT    +G G  GQV       ID +   E V V          +K   + ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH---QHVL 746
             I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S  ++   +  +
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +    
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 272 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 315

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 20/224 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                + +    V EY     L  + H  R+R      +  +                  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY------------GAEIVS 116
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H   +  +++RD+K  N++LD +   KI DFGL K     G   TM    G+  Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTPEY 171
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 31/292 (10%)
Query: 644 IGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RH 695
           +G G  GQV   +  G  +        VAVK + ++    +K   + I+E+E++  I +H
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKH 134
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRL 752
            NI+ L    + +    ++ EY    +L  +L  R+   +  S   S   +  L     +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +         +
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
                  + APE  +      + D++SFGV+L E+ T   + Y G     L +     + 
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 311
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 312 MDKPSN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 349

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             LT    +G G  GQV       ID +   E V V          +K   + ++E+E++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVL 746
             I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S   + V +  +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +    
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317
Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 318 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 361

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +G G    V R + +    E+ A+  I N +KL+ +  ++   E  I   ++H NIV+L 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAM--IINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             IS E    L+++ +    L   +  R+    + +S   Q +L             + +
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL-------------EAV 123
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            + H      ++HR++K  N+LL S+ K    K+ADFGLA  +  +GE       AG+ G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPG 178
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y +PE        + +D+++ GV+L  L+ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 129/298 (43%), Gaps = 30/298 (10%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAG-----EFVAVKRIWNNRKLNQKLEKEFIAEIEI 689
           LS++     +G    G+VY+  + G       + VA+K +    K    L +EF  E  +
Sbjct: 25  LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAML 82
Query: 690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV---L 746
              ++H N+V L   ++ +    +++ Y  +  L  +L  R      GS+   + V   L
Sbjct: 83  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 142
Query: 747 HWPTRLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
             P  + +    A G+ Y+  HH     ++H+D+ + N+L+  +   KI+D GL + +  
Sbjct: 143 EPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197
Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
                 +        + APE     K +   DI+S+GVVL E+ +     YG +      
Sbjct: 198 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-----YGLQ------ 246
Query: 865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
             +  Y+ +  +    ++ +  PC  +    VY L + C +  PS RP  K++   LR
Sbjct: 247 -PYCGYSNQDVVEMIRNRQVL-PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             LT    +G G  GQV       ID +   E V V          +K   + ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVL 746
             I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S   + V +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      +IADFGLA+ +    
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 272 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 315

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             LT    +G G  GQV       ID +   E V V          +K   + ++E+E++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVL 746
             I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S   + V +  +
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +    
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 260
Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 261 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 304

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+VY+          A K I  + K  ++LE +++ EI+IL +  H NIVKL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELE-DYMVEIDILASCDHPNIVKLLD 101
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
               EN+  ++ E+    ++D  +   +R L               T  QI +   Q L 
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPL---------------TESQIQVVCKQTLD 146
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            +++    +IIHRD+K+ NIL   +   K+ADFG++    +  +     +  G+  + AP
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAP 204
Query: 824 EYAY--TTK---VNEKIDIYSFGVVLLEL 847
           E     T+K    + K D++S G+ L+E+
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 37/231 (16%)
Query: 650 GQVYRIDINGAGEFVAVKRIWNNRKLNQKL---------EKEFIAEIEILGT--IRHANI 698
           G +  ++I   G F  V   W  + +N  +         ++ + +E EI  T  ++H N+
Sbjct: 15  GSLQLLEIKARGRFGCV---WKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENL 71
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           ++    I++E           N  ++ WL        S +  +  +++ W     +A   
Sbjct: 72  LQF---IAAEKRG-------SNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETM 121
Query: 759 AQGLCYMHHDC--------TPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
           ++GL Y+H D          P I HRD KS N+LL S+  A +ADFGLA        P  
Sbjct: 122 SRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD 181
Query: 811 MSAVAGSFGYFAPEYA-----YTTKVNEKIDIYSFGVVLLELVTGKEANYG 856
                G+  Y APE       +      +ID+Y+ G+VL ELV+  +A  G
Sbjct: 182 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADG 232

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+VY+          A K I  + K  ++LE +++ EI+IL +  H NIVKL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELE-DYMVEIDILASCDHPNIVKLLD 101
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
               EN+  ++ E+    ++D  +   +R L               T  QI +   Q L 
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPL---------------TESQIQVVCKQTLD 146
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            +++    +IIHRD+K+ NIL   +   K+ADFG++    +  +     +  G+  + AP
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR--DSFIGTPYWMAP 204
Query: 824 EYAY--TTK---VNEKIDIYSFGVVLLEL 847
           E     T+K    + K D++S G+ L+E+
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + Y I      E  A K +  +  L    +++   EI I  ++ + ++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                ++   +V E    +SL   LH R++++              P          QG+
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTE------------PEARYFMRQTIQGV 155
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H++   ++IHRD+K  N+ L+ +   KI DFGLA  +   GE      + G+  Y A
Sbjct: 156 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKTLCGTPNYIA 210
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE       + ++DI+S G +L  L+ GK
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 28/201 (13%)
Query: 662 EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQ 721
           E+VAVK      K  Q  + E+  E+  L  ++H NI++    I +E     V       
Sbjct: 48  EYVAVKIFPIQDK--QSWQNEY--EVYSLPGMKHENILQF---IGAEKRGTSV------- 93
Query: 722 SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC-------TPQII 774
            +D WL        S S  +  +V+ W     IA   A+GL Y+H D         P I 
Sbjct: 94  DVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS 153
Query: 775 HRDVKSSNILLDSEFKAKIADFGLA-KMLAKQGEPHTMSAVAGSFGYFAPEYA-----YT 828
           HRD+KS N+LL +   A IADFGLA K  A +    T   V G+  Y APE       + 
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV-GTRRYMAPEVLEGAINFQ 212
Query: 829 TKVNEKIDIYSFGVVLLELVT 849
                +ID+Y+ G+VL EL +
Sbjct: 213 RDAFLRIDMYAMGLVLWELAS 233

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-----EI 687
           NI S     +L+G G  G V        GE VA+K+I       +  +K   A     EI
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-------EPFDKPLFALRTLREI 60
Query: 688 EILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
           +IL   +H NI+ ++     ++ +     Y+  + +   LH     ++S       H+ +
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLH----RVISTQMLSDDHIQY 116
Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ-- 805
           +  +   A+    G           +IHRD+K SN+L++S    K+ DFGLA+++ +   
Sbjct: 117 FIYQTLRAVKVLHG---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 806 ------GEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLEL 847
                 G+   M+    +  Y APE   T+ K +  +D++S G +L EL
Sbjct: 168 DNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 26/225 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G   +V   +    G+  AVK I   +K  +  E     EI +L  I+H NIV L  
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCI--PKKALKGKESSIENEIAVLRKIKHENIVALED 87
Query: 704 CISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              S N   LV + +    L DR +     +    S+ + Q                  +
Sbjct: 88  IYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ--------------VLDAV 133
Query: 763 CYMHHDCTPQIIHRDVKSSNILL---DSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            Y+H      I+HRD+K  N+L    D E K  I+DFGL+KM   +G+   MS   G+ G
Sbjct: 134 YYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPG 187
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
           Y APE       ++ +D +S GV+   L+ G    Y +  + L E
Sbjct: 188 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFE 232

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G +G V        G+ VAVK++ + RK  Q+  +    E+ I+    H N+V ++ 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM-DLRK--QQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                +   +V E++E  +L          +V+ +    + +        + +   + L 
Sbjct: 110 SYLVGDELWVVMEFLEGGALT--------DIVTHTRMNEEQIA------TVCLSVLRALS 155
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H+     +IHRD+KS +ILL S+ + K++DFG    ++K  E      + G+  + AP
Sbjct: 156 YLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKXLVGTPYWMAP 210
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           E         ++DI+S G++++E++ G+   + +
Sbjct: 211 EVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 244

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-----EI 687
           NI S     +L+G G  G V        GE VA+K+I       +  +K   A     EI
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-------EPFDKPLFALRTLREI 60
Query: 688 EILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
           +IL   +H NI+ ++     ++ +     Y+  + +   LH     ++S       H+ +
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLH----RVISTQMLSDDHIQY 116
Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ-- 805
           +  +   A+    G           +IHRD+K SN+L++S    K+ DFGLA+++ +   
Sbjct: 117 FIYQTLRAVKVLHG---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 806 ------GEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLEL 847
                 G+   M+    +  Y APE   T+ K +  +D++S G +L EL
Sbjct: 168 DNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             LT    +G G  GQV       ID +   E V V          ++   + ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVL 746
             I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S   + V +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +    
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 272 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 315

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + Y I      E  A K +  +  L    +++   EI I  ++ + ++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                ++   +V E    +SL   LH R++++              P          QG+
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTE------------PEARYFMRQTIQGV 155
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H++   ++IHRD+K  N+ L+ +   KI DFGLA  +   GE      + G+  Y A
Sbjct: 156 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKXLCGTPNYIA 210
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE       + ++DI+S G +L  L+ GK
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+VY+          A K I  + K  ++LE +++ EI+IL +  H NIVKL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELE-DYMVEIDILASCDHPNIVKLLD 101
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
               EN+  ++ E+    ++D  +   +R L               T  QI +   Q L 
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPL---------------TESQIQVVCKQTLD 146
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
            +++    +IIHRD+K+ NIL   +   K+ADFG++    +  +        G+  + AP
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR--DXFIGTPYWMAP 204
Query: 824 EYAY--TTK---VNEKIDIYSFGVVLLEL 847
           E     T+K    + K D++S G+ L+E+
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 682 EFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE-YMENQSLDRWLHGRKRSLVSGSSS 740
           + + E+ +L  + H NI+KL+     + +  LV E Y   +  D  +H  K + V  +  
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI 141
Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFG 797
           + Q                 G+ Y+H      I+HRD+K  N+LL+S+ K    KI DFG
Sbjct: 142 IKQ--------------VLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           L+ +   Q +   M    G+  Y APE     K +EK D++S GV+L  L+ G
Sbjct: 185 LSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 19/224 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                + +    V EY     L  + H  R+R      +  +                  
Sbjct: 76  KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFY------------GAEIVS 121
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H +    +++RD+K  N++LD +   KI DFGL K   K G   TM    G+  Y
Sbjct: 122 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEY 177
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 221

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + Y I      E  A K +  +  L    +++   EI I  ++ + ++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                ++   +V E    +SL   LH R++++              P          QG+
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTE------------PEARYFMRQTIQGV 155
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H++   ++IHRD+K  N+ L+ +   KI DFGLA  +   GE      + G+  Y A
Sbjct: 156 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDLCGTPNYIA 210
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE       + ++DI+S G +L  L+ GK
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + Y I      E  A K +  +  L    +++   EI I  ++ + ++V   
Sbjct: 33  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                ++   +V E    +SL   LH R++++              P          QG+
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTE------------PEARYFMRQTIQGV 139
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H++   ++IHRD+K  N+ L+ +   KI DFGLA  +   GE      + G+  Y A
Sbjct: 140 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDLCGTPNYIA 194
Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE       + ++DI+S G +L  L+ GK
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 31/292 (10%)
Query: 644 IGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RH 695
           +G G  GQV   +  G  +        VAVK + ++    +K   + I+E+E++  I +H
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKH 82
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRL 752
            NI+ L    + +    ++ EY    +L  +L  R+   +  S   S   +  L     +
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +         +
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
                  + APE  +      + D++SFGV+L E+ T   + Y G     L +     + 
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 259
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 260 MDKPSN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 297

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 19/224 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 73
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                + +    V EY     L  + H  R+R      +  +                  
Sbjct: 74  KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFY------------GAEIVS 119
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H +    +++RD+K  N++LD +   KI DFGL K   K G   TM    G+  Y
Sbjct: 120 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEY 175
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 219

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 31/292 (10%)
Query: 644 IGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RH 695
           +G G  GQV   +  G  +        VAVK + ++    +K   + I+E+E++  I +H
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKH 85
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRL 752
            NI+ L    + +    ++ EY    +L  +L  R+   +  S   S   +  L     +
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +         +
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
                  + APE  +      + D++SFGV+L E+ T   + Y G     L +     + 
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 262
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 263 MDKPSN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 300

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 19/224 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 74
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                + +    V EY     L  + H  R+R      +  +                  
Sbjct: 75  KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFY------------GAEIVS 120
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H +    +++RD+K  N++LD +   KI DFGL K   K G   TM    G+  Y
Sbjct: 121 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEY 176
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 220

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 31/292 (10%)
Query: 644 IGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RH 695
           +G G  GQV   +  G  +        VAVK + ++    +K   + I+E+E++  I +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKH 93
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRL 752
            NI+ L    + +    ++ EY    +L  +L  R+   +  S   S   +  L     +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +         +
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
                  + APE  +      + D++SFGV+L E+ T   + Y G     L +     + 
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 271 MDKPSN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 19/224 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                + +    V EY     L  + H  R+R      +  +                  
Sbjct: 214 KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFY------------GAEIVS 259
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H +    +++RD+K  N++LD +   KI DFGL K   K G   TM    G+  Y
Sbjct: 260 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEY 315
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 19/224 (8%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                + +    V EY     L  + H  R+R      +  +                  
Sbjct: 217 KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFY------------GAEIVS 262
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+H +    +++RD+K  N++LD +   KI DFGL K   K G   TM    G+  Y
Sbjct: 263 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEY 318
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 362

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 31/292 (10%)
Query: 644 IGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RH 695
           +G G  GQV   +  G  +        VAVK + ++    +K   + I+E+E++  I +H
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKH 86
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRL 752
            NI+ L    + +    ++ EY    +L  +L  R+   +  S   S   +  L     +
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +         +
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
                  + APE  +      + D++SFGV+L E+ T   + Y G     L +     + 
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 263
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 264 MDKPSN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 301

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 34/229 (14%)
Query: 633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-----EI 687
           NI S     +L+G G  G V        GE VA+K+I       +  +K   A     EI
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-------EPFDKPLFALRTLREI 60
Query: 688 EILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
           +IL   +H NI+ ++     ++ +     Y+  + +   LH     ++S       H+ +
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLH----RVISTQMLSDDHIQY 116
Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ-- 805
           +  +   A+    G           +IHRD+K SN+L++S    K+ DFGLA+++ +   
Sbjct: 117 FIYQTLRAVKVLHG---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 806 ------GEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLEL 847
                 G+   M     +  Y APE   T+ K +  +D++S G +L EL
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 78/281 (27%), Positives = 134/281 (47%), Gaps = 36/281 (12%)
Query: 645 GSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           G+ GS ++ R D  G   G  VAVK++ ++    Q+   +F  EI+IL  + H++ +  +
Sbjct: 18  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKAL-HSDFIVKY 73
Query: 703 CCISSENSK---LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
             +S    +    LV EY+ +  L  +L  R R+ +  S      +L + +++       
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQ-RHRARLDAS-----RLLLYSSQI------C 121
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS-F 818
           +G+ Y+    + + +HRD+ + NIL++SE   KIADFGLAK+L    +   +     S  
Sbjct: 122 KGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI 178
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI-- 876
            ++APE       + + D++SFGVVL EL T     Y D+  S +    R    E+ +  
Sbjct: 179 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT-----YCDKSCSPSAEFLRMMGCERDVPA 233
Query: 877 ----TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS 913
                + L++G   P        V+ L  +C +  P  RPS
Sbjct: 234 LCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS 274

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 38/288 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S LT    IGSG  G V+ +      + VA+K I    +     E++FI E E++  + H
Sbjct: 8   SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSH 62
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+     +    LV E+ME+  L  +L   +R L +             T L + 
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAE-----------TLLGMC 110
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           +   +G+ Y+   C   +IHRD+ + N L+      K++DFG+ + +    +    S+  
Sbjct: 111 LDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTG 164
Query: 816 GSF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
             F   + +PE    ++ + K D++SFGV++ E+ +  +  Y +   S            
Sbjct: 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------------ 212
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             + + +  G          T VY++   C    P  RP+   +L+ L
Sbjct: 213 -EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 31/292 (10%)
Query: 644 IGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RH 695
           +G G  GQV   +  G  +        VAVK + ++    +K   + I+E+E++  I +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKH 93
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKR---SLVSGSSSVHQHVLHWPTRL 752
            NI+ L    + +    ++ EY    +L  +L  R+          S   +  L     +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +         +
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
                  + APE  +      + D++SFGV+L E+ T   + Y G     L +     + 
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 271 MDKPSN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 27/298 (9%)
Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             LT    +G G  GQV       ID +   E V V          +K   + ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVL 746
             I +H NI+ L    + +    ++  Y    +L  +L  R+   +  S   + V +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +    
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 272 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 315

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 31/292 (10%)
Query: 644 IGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RH 695
           +G G  GQV   +  G  +        VAVK + ++    +K   + I+E+E++  I +H
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKH 78
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKR---SLVSGSSSVHQHVLHWPTRL 752
            NI+ L    + +    ++ EY    +L  +L  R+          S   +  L     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +         +
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
                  + APE  +      + D++SFGV+L E+ T   + Y G     L +     + 
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 256 MDKPSN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 31/292 (10%)
Query: 644 IGSGGSGQVYRIDINGAGE-------FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RH 695
           +G G  GQV   +  G  +        VAVK + ++    +K   + I+E+E++  I +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKH 93
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRL 752
            NI+ L    + +    ++ EY    +L  +L  R+   +  S   S   +  L     +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +         +
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
                  + APE  +      + D++SFGV+L E+ T   + Y G     L +     + 
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 270
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 271 MDKPSN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 66/294 (22%), Positives = 127/294 (43%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +  N   + +   EF+ E  ++  
Sbjct: 17  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKE 74
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   + ++ +        VL  P+  
Sbjct: 75  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP------VLAPPSLS 128
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +     
Sbjct: 129 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 185
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 233
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  ++ L  +C    P  RPS  E++  ++
Sbjct: 234 LSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 285

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 34/290 (11%)
Query: 644 IGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           +G G  G V R + +   G    VAVK +  +     +   +FI E+  + ++ H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+  + +   K++         LDR L   +   + G+ S            + A+  A+
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDR-LRKHQGHFLLGTLS------------RYAVQVAE 126
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG-SFG 819
           G+ Y+    + + IHRD+ + N+LL +    KI DFGL + L +  + + M       F 
Sbjct: 127 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 183
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           + APE   T   +   D + FGV L E+ T     YG E      W   + ++   I   
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFT-----YGQE-----PWIGLNGSQ---ILHK 230
Query: 880 LDK-GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTE 928
           +DK G   P   +    +Y + + C +  P  RP+   +   L    PT+
Sbjct: 231 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 280

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 70/298 (23%), Positives = 130/298 (43%), Gaps = 30/298 (10%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAG-----EFVAVKRIWNNRKLNQKLEKEFIAEIEI 689
           LS++     +G    G+VY+  + G       + VA+K + +  K    L +EF  E  +
Sbjct: 8   LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD--KAEGPLREEFRHEAML 65
Query: 690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV---L 746
              ++H N+V L   ++ +    +++ Y  +  L  +L  R      GS+   + V   L
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 747 HWPTRLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
             P  + +    A G+ Y+  HH     ++H+D+ + N+L+  +   KI+D GL + +  
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
                 +        + APE     K +   DI+S+GVVL E+ +     YG +      
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-----YGLQ------ 229
Query: 865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
             +  Y+ +  +    ++ +  PC  +    VY L + C +  PS RP  K++   LR
Sbjct: 230 -PYCGYSNQDVVEMIRNRQVL-PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 27/298 (9%)
Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             LT    +G G  GQV       ID +   E V V          +K   + ++E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH---QHVL 746
             I +H NI+ L    + +    ++  Y    +L  +L  R+   +  S  ++   +  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +    
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEW 865
                +       + APE  +      + D++SFGV++ E+ T   + Y G     L + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 272 LKEGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 315

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 33/234 (14%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE 688
             +  +   +T    +G G  G+V+R   +  GE VAVK I+++R      EK +  E E
Sbjct: 30  LVQRTVARQITLLECVGKGRYGEVWRG--SWQGENVAVK-IFSSRD-----EKSWFRETE 81
Query: 689 ILGTI--RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL 746
           +  T+  RH NI+     I+S+ +         + S   WL      + S    +    L
Sbjct: 82  LYNTVMLRHENILGF---IASDMTS-------RHSSTQLWLITHYHEMGSLYDYLQLTTL 131
Query: 747 HWPTRLQIAIGAAQGLCYMHHDC-----TPQIIHRDVKSSNILLDSEFKAKIADFGLAKM 801
              + L+I +  A GL ++H +       P I HRD+KS NIL+    +  IAD GLA M
Sbjct: 132 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 191
Query: 802 LAKQGEPHTM--SAVAGSFGYFAPEY-AYTTKVN-----EKIDIYSFGVVLLEL 847
            ++      +  +   G+  Y APE    T +V+     +++DI++FG+VL E+
Sbjct: 192 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 66/294 (22%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +  N   + +   EF+ E  ++  
Sbjct: 21  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKE 78
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   +  + +        VL  P+  
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP------VLAPPSLS 132
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +     
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 189
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 237
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  ++ L  +C    P  RPS  E++  ++
Sbjct: 238 LSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 134/293 (45%), Gaps = 38/293 (12%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G+G  G+V      G G+      VAVK + +    ++K  +  ++E++I+  + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 111
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSL-------VSGSSSVHQHVLHWPT 750
           IV L    +     L++ EY     L  +L  + R L       ++ S++  + +LH+ +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
           ++      AQG+ ++    +   IHRDV + N+LL +   AKI DFGLA+ +        
Sbjct: 172 QV------AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH 869
                    + APE  +      + D++S+G++L E+ + G     G    S      + 
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------KF 276
Query: 870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           Y   K + D     +A+P +  +   +Y +   C +  P+ RP+ +++   L+
Sbjct: 277 Y---KLVKDGYQ--MAQPAFAPK--NIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKL 701
           ++G G  G+V    +   G+  AVK +  +  L     +  + E  IL   R H  + +L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +CC  + +    V E++    L   +   +R   + +      ++               
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII-------------SA 136
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L ++H      II+RD+K  N+LLD E   K+ADFG+ K     G   T +   G+  Y 
Sbjct: 137 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDYI 191
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           APE          +D ++ GV+L E++ G
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVK--RIWNNRKLNQKLEKEFIAEIEILGTIR---HANI 698
           IG G  G VY+     +G FVA+K  R+ N       L    + E+ +L  +    H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 699 VKLW--CCISSENSKL---LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           V+L   C  S  + ++   LV+E+++ Q L  +L    ++   G        L   T   
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYL---DKAPPPG--------LPAETIKD 124
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
           +     +GL ++H +C   I+HRD+K  NIL+ S    K+ADFGLA++ + Q     ++ 
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTP 178
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           V  +  Y APE    +     +D++S G +  E+   K
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 115/268 (42%), Gaps = 32/268 (11%)
Query: 632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL-NQKLEKEFIAEIEIL 690
           +NI  +     ++GSG   +V+ +     G+  A+K I  +    +  LE E    I +L
Sbjct: 5   TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENE----IAVL 60
Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWP 749
             I+H NIV L     S     LV + +    L DR L  R       +S V Q VL   
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVL--- 116
Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL---DSEFKAKIADFGLAKMLAKQG 806
                       + Y+H +    I+HRD+K  N+L    +   K  I DFGL+KM  + G
Sbjct: 117 ----------SAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNG 162
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
               MS   G+ GY APE       ++ +D +S GV+   L+ G    Y +  + L E  
Sbjct: 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219
Query: 867 WRHYAE-EKPITDALDKGIAE-PCYLEE 892
              Y E E P  D + +   +  C+L E
Sbjct: 220 KEGYYEFESPFWDDISESAKDFICHLLE 247

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN---IVK 700
           IG G  G V ++    +G+ +AVKRI +   +++K +K+ + +++++  +R ++   IV+
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVV--MRSSDCPYIVQ 85
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
            +  +  E    +  E M + S D++             SV   V+      +I +   +
Sbjct: 86  FYGALFREGDCWICMELM-STSFDKFY--------KYVYSVLDDVIPEEILGKITLATVK 136
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L ++  +   +IIHRD+K SNILLD     K+ DFG++  L    +    +  AG   Y
Sbjct: 137 ALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPY 191
Query: 821 FAPEY----AYTTKVNEKIDIYSFGVVLLELVTGK 851
            APE     A     + + D++S G+ L EL TG+
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 66/294 (22%), Positives = 127/294 (43%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +  N   + +   EF+ E  ++  
Sbjct: 27  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKE 84
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   + ++ +        VL  P+  
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP------VLAPPSLS 138
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +     
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 243
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  ++ L  +C    P  RPS  E++  ++
Sbjct: 244 LSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 144
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+  A +     M+    +  Y 
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYR 196
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 144
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+  A +     M+    +  Y 
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYR 196
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 144
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+  A +     M+    +  Y 
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYR 196
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 130/297 (43%), Gaps = 36/297 (12%)
Query: 644 IGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V +     + G   +  VAVK +  N   ++   ++ ++E  +L  + H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL--RDLLSEFNVLKQVNHPHV 88
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKR---SLVSGSSSVHQHVLHWPTRLQIA 755
           +KL+   S +   LL+ EY +  SL  +L   ++     +    S +   L  P    + 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 756 IG--------AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
           +G         +QG+ Y+      +++HRD+ + NIL+    K KI+DFGL++ + ++  
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 808 PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA 866
               S       + A E  +      + D++SFGV+L E+VT G     G     L    
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265
Query: 867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
              +  E+P          + C  EEM   YRL L C    P  RP   ++ + L +
Sbjct: 266 KTGHRMERP----------DNCS-EEM---YRLMLQCWKQEPDKRPVFADISKDLEK 308

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 33/239 (13%)
Query: 631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           +  +   +T    +G G  G+V+R   +  GE VAVK I+++R      EK +  E E+ 
Sbjct: 3   QRTVARDITLLECVGKGRYGEVWRG--SWQGENVAVK-IFSSRD-----EKSWFRETELY 54
Query: 691 GTI--RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
            T+  RH NI+     I+S+ +         + S   WL      + S    +    L  
Sbjct: 55  NTVMLRHENILGF---IASDMTS-------RHSSTQLWLITHYHEMGSLYDYLQLTTLDT 104
Query: 749 PTRLQIAIGAAQGLCYMHHDC-----TPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA 803
            + L+I +  A GL ++H +       P I HRD+KS NIL+    +  IAD GLA M +
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 804 KQGEPHTM--SAVAGSFGYFAPEY-AYTTKVN-----EKIDIYSFGVVLLELVTGKEAN 854
           +      +  +   G+  Y APE    T +V+     +++DI++FG+VL E+     +N
Sbjct: 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 110/248 (44%), Gaps = 32/248 (12%)
Query: 616 PATWKLTSFHQLGFTESNILSSLTE-SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK 674
           P T  L   + +  +  + LS   E  + +G G +  VYR    G  +  A+K       
Sbjct: 32  PGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK------V 85
Query: 675 LNQKLEKEFI-AEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKR 732
           L + ++K+ +  EI +L  + H NI+KL     +     LV E +    L DR +     
Sbjct: 86  LKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY 145
Query: 733 SLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS---EF 789
           S    + +V Q +              + + Y+H +    I+HRD+K  N+L  +   + 
Sbjct: 146 SERDAADAVKQIL--------------EAVAYLHEN---GIVHRDLKPENLLYATPAPDA 188
Query: 790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
             KIADFGL+K++  Q     M  V G+ GY APE         ++D++S G++   L+ 
Sbjct: 189 PLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC 245
Query: 850 GKEANYGD 857
           G E  Y +
Sbjct: 246 GFEPFYDE 253

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 644 IGSGGSGQVYRIDINGAG-EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +G G    V R      G EF A  +I N +KL+ +  ++   E  I   ++H NIV+L 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAA--KIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             I  E+   LV++ +    L   +  R+    + +S   Q +L             + +
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-------------ESI 141
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            Y H +    I+HR++K  N+LL S+ K    K+ADFGLA    +  +       AG+ G
Sbjct: 142 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPG 195
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y +PE       ++ +DI++ GV+L  L+ G
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 33/239 (13%)
Query: 631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           +  +   +T    +G G  G+V+R   +  GE VAVK I+++R      EK +  E E+ 
Sbjct: 3   QRTVAHQITLLECVGKGRYGEVWRG--SWQGENVAVK-IFSSRD-----EKSWFRETELY 54
Query: 691 GTI--RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
            T+  RH NI+     I+S+ +         + S   WL      + S    +    L  
Sbjct: 55  NTVMLRHENILGF---IASDMTS-------RHSSTQLWLITHYHEMGSLYDYLQLTTLDT 104
Query: 749 PTRLQIAIGAAQGLCYMHHDC-----TPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA 803
            + L+I +  A GL ++H +       P I HRD+KS NIL+    +  IAD GLA M +
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 804 KQGEPHTM--SAVAGSFGYFAPEY-AYTTKVN-----EKIDIYSFGVVLLELVTGKEAN 854
           +      +  +   G+  Y APE    T +V+     +++DI++FG+VL E+     +N
Sbjct: 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 124/288 (43%), Gaps = 38/288 (13%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S LT    IGSG  G V+ +      + VA+K I    +     E++FI E E++  + H
Sbjct: 7   SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSH 61
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+     +    LV+E+ME+  L  +L   +R L +             T L + 
Sbjct: 62  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAE-----------TLLGMC 109
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           +   +G+ Y+       +IHRD+ + N L+      K++DFG+ + +    +    S+  
Sbjct: 110 LDVCEGMAYLEE---ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTG 163
Query: 816 GSF--GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
             F   + +PE    ++ + K D++SFGV++ E+ +  +  Y +   S            
Sbjct: 164 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------------ 211
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             + + +  G          T VY++   C    P  RP+   +L+ L
Sbjct: 212 -EVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYXQRTLREIKILLRFRHENI 87
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 137
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA++ A     HT  ++    
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVA 193
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 24/225 (10%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 703 CCISSENSKLLVYEYMENQSLDRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQIAIGA--A 759
               + +    V EY     L  + H  R+R      +  +              GA   
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY--------------GAEIV 115
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
             L Y+H   +  +++RD+K  N++LD +   KI DFGL K     G   TM    G+  
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPE 170
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
           Y APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 22/237 (9%)
Query: 637 SLTESN---LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
            LT+ N   ++G G  G+V   D  G  E  A+K +  +  +     +  + E  +L  +
Sbjct: 17  KLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALL 76
Query: 694 -RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
            +   + +L  C  + +    V EY+    L    H ++     G     Q V +     
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQ----VGKFKEPQAVFY----- 125
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   + GL ++H      II+RD+K  N++LDSE   KIADFG+ K     G   T  
Sbjct: 126 --AAEISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTR 178
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
              G+  Y APE        + +D +++GV+L E++ G+    G++   L +    H
Sbjct: 179 EFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 235

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V  +     HV       Q  I    +G
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHV-------QFLIYQILRG 133
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 185
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 25/286 (8%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 94
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS-GSSSVHQHVLHWPTRLQIA 755
           +V L   C       +++ E+ +  +L  +L  ++   V      +++  L     +  +
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +        
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E   
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEGTR 269
Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           +  A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 270 MR-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG-- 819
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+        HT   +AG     
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVATR 186
Query: 820 -YFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
            Y APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 133
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG-- 819
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+        HT   +AG     
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVATR 182
Query: 820 -YFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
            Y APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 36/297 (12%)
Query: 644 IGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V +     + G   +  VAVK +  N   ++   ++ ++E  +L  + H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL--RDLLSEFNVLKQVNHPHV 88
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKR---SLVSGSSSVHQHVLHWPTRLQIA 755
           +KL+   S +   LL+ EY +  SL  +L   ++     +    S +   L  P    + 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 756 IG--------AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
           +G         +QG+ Y+       ++HRD+ + NIL+    K KI+DFGL++ + ++  
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 808 PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA 866
               S       + A E  +      + D++SFGV+L E+VT G     G     L    
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265
Query: 867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
              +  E+P          + C  EEM   YRL L C    P  RP   ++ + L +
Sbjct: 266 KTGHRMERP----------DNCS-EEM---YRLMLQCWKQEPDKRPVFADISKDLEK 308

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 111/228 (48%), Gaps = 51/228 (22%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI--RHANIVKL 701
           +G G  G+V+R   +G  E VAVK I+++R      E+ +  E EI  T+  RH NI+  
Sbjct: 16  VGKGRYGEVWRGLWHG--ESVAVK-IFSSRD-----EQSWFRETEIYNTVLLRHDNILGF 67
Query: 702 WCC-ISSENSK---LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
               ++S NS     L+  Y E+ SL  +L            ++  H+      L++A+ 
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQ---------RQTLEPHLA-----LRLAVS 113
Query: 758 AAQGLCYMHHDC-----TPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM- 811
           AA GL ++H +       P I HRD KS N+L+ S  +  IAD GLA M ++  +   + 
Sbjct: 114 AACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIG 173
Query: 812 -SAVAGSFGYFAPEYAYTTKVNEKI-----------DIYSFGVVLLEL 847
            +   G+  Y APE      ++E+I           DI++FG+VL E+
Sbjct: 174 NNPRVGTKRYMAPEV-----LDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG-- 819
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+        HT   +AG     
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVATR 186
Query: 820 -YFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
            Y APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 130/297 (43%), Gaps = 36/297 (12%)
Query: 644 IGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+V +     + G   +  VAVK +  N   ++   ++ ++E  +L  + H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL--RDLLSEFNVLKQVNHPHV 88
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKR---SLVSGSSSVHQHVLHWPTRLQIA 755
           +KL+   S +   LL+ EY +  SL  +L   ++     +    S +   L  P    + 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 756 IG--------AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
           +G         +QG+ Y+      +++HRD+ + NIL+    K KI+DFGL++ + ++  
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 808 PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA 866
               S       + A E  +      + D++SFGV+L E+VT G     G     L    
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265
Query: 867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
              +  E+P          + C  EEM   YRL L C    P  RP   ++ + L +
Sbjct: 266 KTGHRMERP----------DNCS-EEM---YRLMLQCWKQEPDKRPVFADISKDLEK 308

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG+G  G    +    A E VAVK I    K+++ +++E I       ++RH NIV+   
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +     +V EY     L   +    R     +    Q ++              G+ 
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------------SGVS 129
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSE--FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           Y H     Q+ HRD+K  N LLD     + KIADFG +K      +P    +  G+  Y 
Sbjct: 130 YAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP---KSAVGTPAYI 183
Query: 822 APEYAYTTKVNEKI-DIYSFGVVLLELVTG 850
           APE     + + K+ D++S GV L  ++ G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/294 (22%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +     + +++E  F+ E  ++  
Sbjct: 12  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKE 69
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   +  + +        VL  P+  
Sbjct: 70  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP------VLAPPSLS 123
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +     
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 228
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  +  L  +C    P  RPS  E++  ++
Sbjct: 229 LSNEQVLRFVMEGGLLDKPDNCPDM--LLELMRMCWQYNPKMRPSFLEIISSIK 280

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 27/296 (9%)
Query: 638 LTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           LT    +G G  GQV       ID +   E V V          +K   + ++E+E++  
Sbjct: 24  LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 83
Query: 693 I-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHW 748
           I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S   + V +  + +
Sbjct: 84  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 143
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
              +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +      
Sbjct: 144 KDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYY 200
Query: 809 HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAW 867
              +       + APE  +      + D++SFGV++ E+ T   + Y G     L +   
Sbjct: 201 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 260
Query: 868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
             +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 261 EGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 302

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 27/296 (9%)
Query: 638 LTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           LT    +G G  GQV       ID +   E V V          +K   + ++E+E++  
Sbjct: 29  LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 88
Query: 693 I-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHW 748
           I +H NI+ L    + +    ++ EY    +L  +L  R+   +  S   + V +  + +
Sbjct: 89  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 148
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
              +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +      
Sbjct: 149 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 205
Query: 809 HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAW 867
              +       + APE  +      + D++SFGV++ E+ T   + Y G     L +   
Sbjct: 206 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 265
Query: 868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
             +  +KP            C  E    +Y +   C   +PS RP+ K++++ L R
Sbjct: 266 EGHRMDKPAN----------CTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 307

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 101/240 (42%), Gaps = 29/240 (12%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           Q+  +   +L    +   IGSG  G V        G  VAVK++    + NQ   K    
Sbjct: 12  QVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYR 70
Query: 686 EIEILGTIRHANIVKLWCCISSENS------KLLVYEYMENQSLDRWLHGRKRSLVSGSS 739
           E+ +L  + H NI+ L    + + +        LV E M+                +   
Sbjct: 71  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD---------------ANLCQ 115
Query: 740 SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
            +H  + H   R+   +   Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA
Sbjct: 116 VIHMELDH--ERMSYLL--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 171
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           +  +       M+    +  Y APE        E +DI+S G ++ ELV G     G +H
Sbjct: 172 RTASTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 228

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 133
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 185
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 644 IGSGGSGQVYRIDINGAG-EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +G G    V R      G EF A  +I N +KL+ +  ++   E  I   ++H NIV+L 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAA--KIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             I  E+   LV++ +    L   +  R+    + +S   Q +L             + +
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-------------ESI 118
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            Y H +    I+HR++K  N+LL S+ K    K+ADFGLA    +  +       AG+ G
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPG 172
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y +PE       ++ +DI++ GV+L  L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G V++       E VA+KR+  +   ++ +    + EI +L  ++H NIV+L  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            + S+    LV+E+  +Q L ++         S +  +   ++             +GL 
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKYFD-------SCNGDLDPEIVK-----SFLFQLLKGLG 115
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFA 822
           + H   +  ++HRD+K  N+L++   + K+ADFGLA+     G P    SA   +  Y  
Sbjct: 116 FCH---SRNVLHRDLKPQNLLINRNGELKLADFGLARAF---GIPVRCYSAEVVTLWYRP 169
Query: 823 PEYAYTTKV-NEKIDIYSFGVVLLELVTG 850
           P+  +  K+ +  ID++S G +  EL   
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANA 198

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 28  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLAFRHENI 85
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 135
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 136 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 191
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 26  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 83
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 133
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVA 189
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 66/294 (22%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +  N   + +   EF+ E  ++  
Sbjct: 20  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKE 77
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   +  + +        VL  P+  
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP------VLAPPSLS 131
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +     
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 236
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  ++ L  +C    P  RPS  E++  ++
Sbjct: 237 LSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG+G  G V        G+ VA+K+I N   +     K  + E++IL   +H NI+ +  
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN-AKRTLRELKILKHFKHDNIIAIKD 121
Query: 704 CISSE------NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
            +          S  +V + ME+  L + +H       S      +HV ++  +L     
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMES-DLHQIIH-------SSQPLTLEHVRYFLYQL----- 168
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVA 815
             +GL YMH   + Q+IHRD+K SN+L++   + KI DFG+A+ L      H   M+   
Sbjct: 169 -LRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 224
Query: 816 GSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKE 852
            +  Y APE   +  +  + ID++S G +  E++  ++
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI-LGTIRHANIVKLW 702
           +G G  G V ++    +G+ +AVKRI     +N + +K  + +++I + T+     V  +
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 116
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             +  E    +  E M+  SLD++     + ++    ++ + +L      +IA+   + L
Sbjct: 117 GALFREGDVWICMELMDT-SLDKFY----KQVIDKGQTIPEDILG-----KIAVSIVKAL 166
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            ++H   +  +IHRDVK SN+L+++  + K+ DFG++  L    +    +  AG   Y A
Sbjct: 167 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKTIDAGCKPYMA 221
Query: 823 PEYAYTTKVNE-----KIDIYSFGVVLLEL 847
           PE     ++N+     K DI+S G+ ++EL
Sbjct: 222 PE-RINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/294 (22%), Positives = 127/294 (43%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +     + +++E  F+ E  ++  
Sbjct: 49  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKE 106
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   +  + +        VL  P+  
Sbjct: 107 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP------VLAPPSLS 160
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +     
Sbjct: 161 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 217
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 265
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  ++ L  +C    P  RPS  E++  ++
Sbjct: 266 LSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 317

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 26  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 83
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 133
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVA 189
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 108 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 157
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 158 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 209
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 248

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 107 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 156
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 157 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 208
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 247

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           + T   +IG+G  G V++  +  + E VA+K++  +++   +       E++I+  ++H 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR-------ELQIMRIVKHP 92
Query: 697 NIVKLWCCISSENSKL------LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           N+V L     S   K       LV EY+         H  K         +  ++     
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL-- 150
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGEPH 809
                    + L Y+H   +  I HRD+K  N+LLD      K+ DFG AK+L   GEP+
Sbjct: 151 --------LRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPN 198
Query: 810 TMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGK 851
            +S +   + Y APE  +  T     IDI+S G V+ EL+ G+
Sbjct: 199 -VSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 66/294 (22%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +  N   + +   EF+ E  ++  
Sbjct: 18  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKE 75
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   +  + +        VL  P+  
Sbjct: 76  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP------VLAPPSLS 129
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +     
Sbjct: 130 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 186
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 234
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  ++ L  +C    P  RPS  E++  ++
Sbjct: 235 LSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 286

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 66/294 (22%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +  N   + +   EF+ E  ++  
Sbjct: 21  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKE 78
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   +  + +        VL  P+  
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP------VLAPPSLS 132
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +     
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 189
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 237
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  ++ L  +C    P  RPS  E++  ++
Sbjct: 238 LSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/234 (21%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 619 WKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK 678
           WK      +     ++L        +G+G  G V+R+     G   A K +    + +++
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 679 LEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS 738
             ++   EI+ +  +RH  +V L      +N  +++YE+M    L   +      +    
Sbjct: 200 TVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE 256
Query: 739 SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF--KAKIADF 796
           +            ++      +GLC+MH +     +H D+K  NI+  ++   + K+ DF
Sbjct: 257 A------------VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF 301
Query: 797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           GL   L  +    ++    G+  + APE A    V    D++S GV+   L++G
Sbjct: 302 GLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 97
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 98  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 147
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 148 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 199
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 238

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G +G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           IGSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 142
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYR 194
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 233

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 26  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 83
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 133
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 189
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 133/293 (45%), Gaps = 38/293 (12%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G+G  G+V      G G+      VAVK + +    ++K  +  ++E++I+  + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 111
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSL-------VSGSSSVHQHVLHWPT 750
           IV L    +     L++ EY     L  +L  + R L       ++ S+   + +LH+ +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
           ++      AQG+ ++    +   IHRDV + N+LL +   AKI DFGLA+ +        
Sbjct: 172 QV------AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH 869
                    + APE  +      + D++S+G++L E+ + G     G    S      + 
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------KF 276
Query: 870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           Y   K + D     +A+P +  +   +Y +   C +  P+ RP+ +++   L+
Sbjct: 277 Y---KLVKDGYQ--MAQPAFAPK--NIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG+G  G V        G+ VA+K+I N   +     K  + E++IL   +H NI+ +  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN-AKRTLRELKILKHFKHDNIIAIKD 120
Query: 704 CISSE------NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
            +          S  +V + ME+  L + +H       S      +HV ++  +L     
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMES-DLHQIIH-------SSQPLTLEHVRYFLYQL----- 167
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVA 815
             +GL YMH   + Q+IHRD+K SN+L++   + KI DFG+A+ L      H   M+   
Sbjct: 168 -LRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 223
Query: 816 GSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKE 852
            +  Y APE   +  +  + ID++S G +  E++  ++
Sbjct: 224 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 33/242 (13%)
Query: 618 TWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ 677
           T  LT   Q    E N L +L E   +GSG  GQV+++     G  +AVK++   R  N+
Sbjct: 10  TGYLTIGGQRYQAEINDLENLGE---MGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNK 64
Query: 678 KLEKEFIAEIEI-LGTIRHANIVKLWCCISSENSKLLVYEYMEN--QSLDRWLHGRKRSL 734
           +  K  + ++++ L +     IV+ +    +     +  E M    + L + + G     
Sbjct: 65  EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----- 119
Query: 735 VSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA 794
                 + + +L    ++ +AI   + L Y+       +IHRDVK SNILLD   + K+ 
Sbjct: 120 -----PIPERIL---GKMTVAI--VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLC 167
Query: 795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEY---AYTTKVNEKI--DIYSFGVVLLELVT 849
           DFG++  L    +       AG   Y APE       TK +  I  D++S G+ L+EL T
Sbjct: 168 DFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224
Query: 850 GK 851
           G+
Sbjct: 225 GQ 226

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 87
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 137
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA++ A     HT  ++    
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVA 193
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 66/294 (22%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +  N   + +   EF+ E  ++  
Sbjct: 14  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKE 71
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   +  + +        VL  P+  
Sbjct: 72  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP------VLAPPSLS 125
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +     
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 230
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  ++ L  +C    P  RPS  E++  ++
Sbjct: 231 LSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY         L  R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 644 IGSGGSGQVYRIDINGAG-EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +G G    V R      G EF A  +I N +KL+ +  ++   E  I   ++H NIV+L 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAA--KIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             I  E+   LV++ +    L   +  R+    + +S   Q +L             + +
Sbjct: 71  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-------------ESI 117
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            Y H +    I+HR++K  N+LL S+ K    K+ADFGLA    +  +       AG+ G
Sbjct: 118 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPG 171
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y +PE       ++ +DI++ GV+L  L+ G
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 28  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 85
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 135
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 136 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 191
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 66/294 (22%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +  N   + +   EF+ E  ++  
Sbjct: 20  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKE 77
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   +  + +        VL  P+  
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP------VLAPPSLS 131
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +     
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 236
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  ++ L  +C    P  RPS  E++  ++
Sbjct: 237 LSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 26/287 (9%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 93
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSS--SVHQHVLHWPTRLQI 754
           +V L   C       +++ E+ +  +L  +L  ++   V   +   +++  L     +  
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           +   A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +       
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
                + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E  
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEGT 268
Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            +  A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 269 RMR-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 122/285 (42%), Gaps = 25/285 (8%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 92
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           +V L   C       +++ E+ +  +L  +L  ++   V     +++  L     +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-YKDLYKDFLTLEHLIXYSF 151
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +         
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E    
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFXRRLKE---- 262
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                  +  P Y      +Y+  L C    PS RP+  E+++ L
Sbjct: 263 ----GTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 28  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLAFRHENI 85
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 135
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 136 LRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLAR-VADPDHDHTGFLTEYVA 191
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 34  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 91
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 92  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 141
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 142 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 197
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 26  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 83
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 133
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 189
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 644 IGSGGSGQVYRIDINGAG-EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +G G    V R      G EF A  +I N +KL+ +  ++   E  I   ++H NIV+L 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAA--KIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             I  E+   LV++ +    L   +  R+    + +S   Q +L             + +
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-------------ESI 118
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            Y H +    I+HR++K  N+LL S+ K    K+ADFGLA    +  +       AG+ G
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPG 172
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y +PE       ++ +DI++ GV+L  L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 46  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 103
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 153
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 154 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 209
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/234 (21%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 619 WKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK 678
           WK      +     ++L        +G+G  G V+R+     G   A K +    + +++
Sbjct: 34  WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 93
Query: 679 LEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS 738
             ++   EI+ +  +RH  +V L      +N  +++YE+M    L   +      +    
Sbjct: 94  TVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE 150
Query: 739 SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF--KAKIADF 796
           +            ++      +GLC+MH +     +H D+K  NI+  ++   + K+ DF
Sbjct: 151 A------------VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF 195
Query: 797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           GL   L  +    ++    G+  + APE A    V    D++S GV+   L++G
Sbjct: 196 GLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 26  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 83
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 133
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLAR-VADPDHDHTGFLTEYVA 189
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 66/294 (22%), Positives = 126/294 (42%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +  N   + +   EF+ E  ++  
Sbjct: 27  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKE 84
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   +  + +        VL  P+  
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP------VLAPPSLS 138
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N ++  +F  KI DFG+ + + +     
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 243
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  ++ L  +C    P  RPS  E++  ++
Sbjct: 244 LSNEQVLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 31  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 88
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 138
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 139 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 194
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 32  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 89
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 139
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 140 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 195
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 23  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 80
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 130
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 131 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 186
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 87
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 137
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 193
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLNHENVVKFYG 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY         L  R    +       Q   H             G+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFH---------QLMAGVV 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 24  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 81
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 131
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 132 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 187
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 27/288 (9%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 92
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQ 753
           +V L   C       +++ E+ +  +L  +L  ++   V        +++  L     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +      
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEG 267
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +  A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 268 TRMR-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 24  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 81
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 131
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 132 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 187
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY         L  R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 85  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 134
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 135 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 186
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 108 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 157
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M     +  Y 
Sbjct: 158 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYR 209
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 248

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 84  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 133
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 185
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 142
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 194
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 233

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 22/219 (10%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +IG G  G+V  +    + +  A+K +     + +     F  E +I+       +V+L+
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 141
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
           C    +    +V EYM    L         +L+S      +    +   + +A+ A   +
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDL--------VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 193
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
                     +IHRDVK  N+LLD     K+ADFG    + + G  H  +AV G+  Y +
Sbjct: 194 ---------GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYIS 243
Query: 823 PEYAYTT----KVNEKIDIYSFGVVLLELVTGKEANYGD 857
           PE   +         + D +S GV L E++ G    Y D
Sbjct: 244 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 282

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 34/290 (11%)
Query: 644 IGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           +G G  G V R + +   G    VAVK +  +     +   +FI E+  + ++ H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+  + +   K++         LDR    RK          HQ      T  + A+  A+
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRL---RK----------HQGHFLLGTLSRYAVQVAE 132
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG-SFG 819
           G+ Y+    + + IHRD+ + N+LL +    KI DFGL + L +  + + M       F 
Sbjct: 133 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           + APE   T   +   D + FGV L E+ T     YG E      W   + ++   I   
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT-----YGQE-----PWIGLNGSQ---ILHK 236
Query: 880 LDK-GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTE 928
           +DK G   P   +    +Y + + C +  P  RP+   +   L    PT+
Sbjct: 237 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T+   IG G  G V     +     VA+K+I      +Q   +  + EI+IL   RH N+
Sbjct: 46  TQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFE--HQTYCQRTLREIQILLRFRHENV 103
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   + +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLY----KLLKSQQLSNDHICYFLYQI------ 153
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+L+++    KI DFGLA+ +A     HT  ++    
Sbjct: 154 LRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTGFLTEXVA 209
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 34/290 (11%)
Query: 644 IGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           +G G  G V R + +   G    VAVK +  +     +   +FI E+  + ++ H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+  + +   K++         LDR    RK          HQ      T  + A+  A+
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRL---RK----------HQGHFLLGTLSRYAVQVAE 122
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG-SFG 819
           G+ Y+    + + IHRD+ + N+LL +    KI DFGL + L +  + + M       F 
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           + APE   T   +   D + FGV L E+ T     YG E      W   + ++   I   
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT-----YGQE-----PWIGLNGSQ---ILHK 226
Query: 880 LDK-GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTE 928
           +DK G   P   +    +Y + + C +  P  RP+   +   L    PT+
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 276

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 87
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKCQHLSNDHICYFLYQI------ 137
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 193
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 85  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 134
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 135 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 186
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 225

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 94  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 143
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 195
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 234

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 85
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 86  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 135
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 136 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 187
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 226

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + E+ +   +   +     ++V        HV        +     +GL
Sbjct: 90  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF------LIYQILRGL 140
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y A
Sbjct: 141 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 192
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           PE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 230

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVK--RIWNNRK-LNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G VY+     +G FVA+K  R+ N  + L     +E +A +  L    H N+V+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVRE-VALLRRLEAFEHPNVVR 70
Query: 701 LW--CCISSENSKL---LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           L   C  S  + ++   LV+E+++ Q L  +L    ++   G        L   T   + 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVD-QDLRTYL---DKAPPPG--------LPAETIKDLM 118
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               +GL ++H +C   I+HRD+K  NIL+ S    K+ADFGLA++ + Q     ++ V 
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVV 172
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            +  Y APE    +     +D++S G +  E+   K
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 131/328 (39%), Gaps = 53/328 (16%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +GSG  G+V        G   A+K I  +           + E+ +L  + H NI+KL+ 
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 704 CISSENSKLLVYE-YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               + +  LV E Y   +  D  +  +K S V  +  + Q                 G 
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQ--------------VLSGT 117
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            Y+H      I+HRD+K  N+LL+S+ +    KI DFGL+      G+   M    G+  
Sbjct: 118 TYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGTAY 171
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           Y APE     K +EK D++S GV+L  L+ G     G                ++ I   
Sbjct: 172 YIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFGG--------------QTDQEILKR 216
Query: 880 LDKG---IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ---ILRRCCPTENYGGK 933
           ++KG      P + +      +L  +  +  PS R S +E L    I++ C         
Sbjct: 217 VEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKFCSQKHT---- 272
Query: 934 KMGRDVDSAPLLGTAGYLFGFKRSKKVA 961
               DV    L G  G +  F+ S+K+A
Sbjct: 273 ----DVGKHALTGALGNMKKFQSSQKLA 296

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINAMLNHENVVKFYG 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY         L  R    +       Q   H             G+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFH---------QLMAGVV 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 142
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYR 194
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 233

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 25/285 (8%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 92
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           +V L   C       +++ E+ +  +L  +L  ++   V     +++  L     +  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-YKDLYKDFLTLEHLICYSF 151
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +         
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E   +
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEGTRM 266
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 267 R-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 111 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 160
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 161 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 212
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 251

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 99  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 148
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 149 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYR 200
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 239

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 46  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 103
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    +   L+     L+      + H+ ++  ++      
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLY----KLLKTQHLSNDHICYFLYQI------ 153
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 154 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVA 209
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 27/288 (9%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 92
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQ 753
           +V L   C       +++ E+ +  +L  +L  ++   V        +++  L     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +      
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEG 267
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +  A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 268 TRMR-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + E+ +   +   +     ++V        HV        +     +GL
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF------LIYQILRGL 138
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 190
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           PE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V      G  + VA+K I    K     E EFI E +++  + H  +V+L+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             + +    ++ EYM N  L  +L   +            H       L++     + + 
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMR------------HRFQTQQLLEMCKDVCEAME 134
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF--GYF 821
           Y+    + Q +HRD+ + N L++ +   K++DFGL++ +    E    S+V   F   + 
Sbjct: 135 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEET---SSVGSKFPVRWS 188
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVT 849
            PE    +K + K DI++FGV++ E+ +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + E+ +   +   +     ++V        HV        +     +GL
Sbjct: 90  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF------LIYQILRGL 140
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y A
Sbjct: 141 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 192
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           PE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 230

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 93  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 142
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 194
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 233

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 87  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 136
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 137 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 188
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + E+ +   +   +     ++V        HV        +     +GL
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF------LIYQILRGL 138
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 190
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           PE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 107 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 156
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 157 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 208
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 247

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 108 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 157
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 158 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 209
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 248

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + E+ +   +   +     ++V        HV        +     +GL
Sbjct: 100 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF------LIYQILRGL 150
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y A
Sbjct: 151 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 202
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           PE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 240

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 90  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 139
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 191
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + E+ +   +   +     ++V        HV        +     +GL
Sbjct: 100 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF------LIYQILRGL 150
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y A
Sbjct: 151 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 202
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           PE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 240

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 95  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 144
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 196
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 70
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 71  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 117
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 118 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 94  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 143
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 195
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 234

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + E+ +   +   +     ++V        HV        +     +GL
Sbjct: 99  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF------LIYQILRGL 149
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y A
Sbjct: 150 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 201
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           PE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 239

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 94  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 143
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYR 195
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 234

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 87
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 137
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA++ A     HT  +     
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVA 193
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+K+I      +Q   +  + EI+IL   RH NI
Sbjct: 31  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENI 88
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 138
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA++ A     HT  +     
Sbjct: 139 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVA 194
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           T  + IG G  G V     N     VA+++I      +Q   +  + EI+IL   RH NI
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFE--HQTYCQRTLREIKILLRFRHENI 87
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           + +   I +   + +   Y+    ++  L+     L+      + H+ ++  ++      
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQI------ 137
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAG 816
            +GL Y+H   +  ++HRD+K SN+LL++    KI DFGLA+ +A     HT  ++    
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVA 193
Query: 817 SFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +K   + IDI+S G +L E+++ +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 27/288 (9%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 94
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLV---SGSSSVHQHVLHWPTRLQ 753
           +V L   C       +++ E+ +  +L  +L  ++   V        +++  L     + 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +      
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E 
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEG 269
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +  A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 270 TRMR-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 72
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVK--RIWNNRK-LNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G VY+     +G FVA+K  R+ N  + L     +E +A +  L    H N+V+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVRE-VALLRRLEAFEHPNVVR 70
Query: 701 LW--CCISSENSKL---LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           L   C  S  + ++   LV+E+++ Q L  +L    ++   G        L   T   + 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVD-QDLRTYL---DKAPPPG--------LPAETIKDLM 118
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               +GL ++H +C   I+HRD+K  NIL+ S    K+ADFGLA++ + Q     +  V 
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVV 172
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            +  Y APE    +     +D++S G +  E+   K
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 90  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 139
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYR 191
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 230

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIR 694
           S  +GSG  G+V         + VA+ RI + RK      +E         EIEIL  + 
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAI-RIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  I+K+     +E+   +V E ME   L   + G KR L   +  ++ + +        
Sbjct: 199 HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQM-------- 248
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTM 811
            + A Q   Y+H +    IIHRD+K  N+LL S+ +    KI DFG +K+L   GE   M
Sbjct: 249 -LLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLM 298
Query: 812 SAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTG 850
             + G+  Y APE      T   N  +D +S GV+L   ++G
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 27/288 (9%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 92
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQ 753
           +V L   C       +++ E+ +  +L  +L  ++   V        +++  L     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +      
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEG 267
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +  A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 268 TRMR-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIR 694
           S  +GSG  G+V         + VA+K I + RK      +E         EIEIL  + 
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  I+K+     +E+   +V E ME   L   + G KR L   +  ++ +      ++ +
Sbjct: 74  HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFY------QMLL 125
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTM 811
           A+       Y+H +    IIHRD+K  N+LL S+ +    KI DFG +K+L   GE   M
Sbjct: 126 AVQ------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLM 173
Query: 812 SAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTG 850
             + G+  Y APE      T   N  +D +S GV+L   ++G
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIR 694
           S  +GSG  G+V         + VA+K I + RK      +E         EIEIL  + 
Sbjct: 21  SKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILKKLN 79
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  I+K+     +E+   +V E ME   L   + G KR L   +  ++ +      ++ +
Sbjct: 80  HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFY------QMLL 131
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTM 811
           A+       Y+H +    IIHRD+K  N+LL S+ +    KI DFG +K+L   GE   M
Sbjct: 132 AVQ------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLM 179
Query: 812 SAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTG 850
             + G+  Y APE      T   N  +D +S GV+L   ++G
Sbjct: 180 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 27/288 (9%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 129
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQ 753
           +V L   C       +++ E+ +  +L  +L  ++   V        +++  L     + 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +      
Sbjct: 190 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E 
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEG 304
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +  A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 305 TRMR-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIR 694
           S  +GSG  G+V         + VA+ RI + RK      +E         EIEIL  + 
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAI-RIISKRKFAIGSAREADPALNVETEIEILKKLN 212
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  I+K+     +E+   +V E ME   L   + G KR L   +  ++ +      ++ +
Sbjct: 213 HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFY------QMLL 264
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTM 811
           A+       Y+H +    IIHRD+K  N+LL S+ +    KI DFG +K+L   GE   M
Sbjct: 265 AVQ------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLM 312
Query: 812 SAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTG 850
             + G+  Y APE      T   N  +D +S GV+L   ++G
Sbjct: 313 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G +G V       +G  VAVK + + RK  Q+  +    E+ I+   +H N+V+++ 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM-DLRK--QQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    ++ E+++  +L              +  V Q  L+      +     Q L 
Sbjct: 110 SYLVGEELWVLMEFLQGGAL--------------TDIVSQVRLNEEQIATVCEAVLQALA 155
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      +IHRD+KS +ILL  + + K++DFG    ++K  +      + G+  + AP
Sbjct: 156 YLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKXLVGTPYWMAP 210
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
           E    +    ++DI+S G++++E+V G+   + D
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIR 694
           S  +GSG  G+V         + VA+K I + RK      +E         EIEIL  + 
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILKKLN 72
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  I+K+     +E+   +V E ME   L   + G KR L   +  ++ +      ++ +
Sbjct: 73  HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFY------QMLL 124
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTM 811
           A+       Y+H +    IIHRD+K  N+LL S+ +    KI DFG +K+L   GE   M
Sbjct: 125 AVQ------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLM 172
Query: 812 SAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTG 850
             + G+  Y APE      T   N  +D +S GV+L   ++G
Sbjct: 173 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 27/288 (9%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 83
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQ 753
           +V L   C       +++ E+ +  +L  +L  ++   V        +++  L     + 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +      
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEG 258
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +  A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 259 TRMR-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIR 694
           S  +GSG  G+V         + VA+K I + RK      +E         EIEIL  + 
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  I+K+     +E+   +V E ME   L   + G KR L   +  ++ +      ++ +
Sbjct: 74  HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFY------QMLL 125
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTM 811
           A+       Y+H +    IIHRD+K  N+LL S+ +    KI DFG +K+L   GE   M
Sbjct: 126 AVQ------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLM 173
Query: 812 SAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTG 850
             + G+  Y APE      T   N  +D +S GV+L   ++G
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +GSG  G+V        G   A+K I  +           + E+ +L  + H NI+KL+ 
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 704 CISSENSKLLVYE-YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               + +  LV E Y   +  D  +  +K S V  +  + Q                 G 
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQ--------------VLSGT 134
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            Y+H      I+HRD+K  N+LL+S+ +    KI DFGL+      G+   M    G+  
Sbjct: 135 TYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGTAY 188
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Y APE     K +EK D++S GV+L  L+ G
Sbjct: 189 YIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V         E VAVK +   R ++    +    EI I   + H N+VK + 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                N + L  EY     L      R    +       Q   H             G+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---------QLMAGVV 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 824 EYAYTTKVN-EKIDIYSFGVVLLELVTGK 851
           E     + + E +D++S G+VL  ++ G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIR 694
           S  +GSG  G+V         + VA+K I + RK      +E         EIEIL  + 
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  I+K+     +E+   +V E ME   L   + G KR L   +  ++ +      ++ +
Sbjct: 74  HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-LKEATCKLYFY------QMLL 125
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTM 811
           A+       Y+H +    IIHRD+K  N+LL S+ +    KI DFG +K+L   GE   M
Sbjct: 126 AVQ------YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLM 173
Query: 812 SAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTG 850
             + G+  Y APE      T   N  +D +S GV+L   ++G
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + E+ +   +   +     ++V        HV        +     +GL
Sbjct: 111 DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF------LIYQILRGL 161
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M     +  Y A
Sbjct: 162 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRWYRA 213
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           PE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 251

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI-LGTIRHANIVKLW 702
           +G G  G V ++    +G+ +AVKRI     +N + +K  + +++I + T+     V  +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             +  E    +  E M+  SLD++     + ++    ++ + +L      +IA+   + L
Sbjct: 73  GALFREGDVWICMELMDT-SLDKFY----KQVIDKGQTIPEDILG-----KIAVSIVKAL 122
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            ++H   +  +IHRDVK SN+L+++  + K+ DFG++  L    +       AG   Y A
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMA 177
Query: 823 PEYAYTTKVNE-----KIDIYSFGVVLLEL 847
           PE     ++N+     K DI+S G+ ++EL
Sbjct: 178 PE-RINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY      +   VA+K ++ ++   + +E +   EIEI   + H NI++L+ 
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ EY     L + L          ++++ + +             A  L 
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL-------------ADALM 137
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H     ++IHRD+K  N+LL  + + KIADFG + + A      TM    G+  Y  P
Sbjct: 138 YCH---GKKVIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLRRKTM---CGTLDYLPP 190
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTG 850
           E       NEK+D++  GV+  EL+ G
Sbjct: 191 EMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 49/293 (16%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEF----VAVKRIWNN--RKLNQKLEKEFIAEIEI 689
           + L +  ++GSG  G V++      GE     V +K I +   R+  Q +    +A    
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA---- 86
Query: 690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
           +G++ HA+IV+L   +   +S  LV +Y+   SL    H R+     G     Q +L+W 
Sbjct: 87  IGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLD--HVRQHRGALGP----QLLLNW- 138
Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
                 +  A+G+ Y+       ++HR++ + N+LL S  + ++ADFG+A +L    +  
Sbjct: 139 -----GVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 190
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR 868
             S       + A E  +  K   + D++S+GV + EL+T G E   G     LAE    
Sbjct: 191 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG---LRLAE---- 243
Query: 869 HYAEEKPITDALDKG--IAEP--CYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
                  + D L+KG  +A+P  C ++    VY + + C     + RP+ KE+
Sbjct: 244 -------VPDLLEKGERLAQPQICTID----VYMVMVKCWMIDENIRPTFKEL 285

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 47/231 (20%)
Query: 659 GAGEFVAVKR---------------IWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           G+G F  VK+               I  N   +  L+ E +AE  ++  + +  IV++  
Sbjct: 16  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 75
Query: 704 CISSENSKLLVYEYMENQSLDRWL----HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
              +E S +LV E  E   L+++L    H + ++++     VHQ               +
Sbjct: 76  ICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQ--------------VS 117
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF- 818
            G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L +  E +  +   G + 
Sbjct: 118 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWP 173
Query: 819 -GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY----GDEHTSLAE 864
             ++APE     K + K D++SFGV++ E  +  +  Y    G E T++ E
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 94  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 143
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 195
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 234

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 47/231 (20%)
Query: 659 GAGEFVAVKR---------------IWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           G+G F  VK+               I  N   +  L+ E +AE  ++  + +  IV++  
Sbjct: 26  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 704 CISSENSKLLVYEYMENQSLDRWL----HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
              +E S +LV E  E   L+++L    H + ++++     VHQ               +
Sbjct: 86  ICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQ--------------VS 127
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF- 818
            G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L +  E +  +   G + 
Sbjct: 128 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWP 183
Query: 819 -GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY----GDEHTSLAE 864
             ++APE     K + K D++SFGV++ E  +  +  Y    G E T++ E
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 47/231 (20%)
Query: 659 GAGEFVAVKR---------------IWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           G+G F  VK+               I  N   +  L+ E +AE  ++  + +  IV++  
Sbjct: 20  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 79
Query: 704 CISSENSKLLVYEYMENQSLDRWL----HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
              +E S +LV E  E   L+++L    H + ++++     VHQ               +
Sbjct: 80  ICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQ--------------VS 121
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF- 818
            G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L +  E +  +   G + 
Sbjct: 122 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWP 177
Query: 819 -GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY----GDEHTSLAE 864
             ++APE     K + K D++SFGV++ E  +  +  Y    G E T++ E
Sbjct: 178 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 73/290 (25%), Positives = 122/290 (42%), Gaps = 34/290 (11%)
Query: 644 IGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           +G G  G V R + +   G    VAVK +  +     +   +FI E+  + ++ H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+  + +   K++         LDR    RK          HQ      T  + A+  A+
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRL---RK----------HQGHFLLGTLSRYAVQVAE 132
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG-SFG 819
           G+ Y+    + + IHRD+ + N+LL +    KI DFGL + L +  +   M       F 
Sbjct: 133 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 189
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           + APE   T   +   D + FGV L E+ T     YG E      W   + ++   I   
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT-----YGQE-----PWIGLNGSQ---ILHK 236
Query: 880 LDK-GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTE 928
           +DK G   P   +    +Y + + C +  P  RP+   +   L    PT+
Sbjct: 237 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 27/288 (9%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 83
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQ 753
           +V L   C       +++ E+ +  +L  +L  ++   V        +++  L     + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +      
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEG 258
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +  A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 259 TRMR-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 47/231 (20%)
Query: 659 GAGEFVAVKR---------------IWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           G+G F  VK+               I  N   +  L+ E +AE  ++  + +  IV++  
Sbjct: 14  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 73
Query: 704 CISSENSKLLVYEYMENQSLDRWL----HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
              +E S +LV E  E   L+++L    H + ++++     VHQ               +
Sbjct: 74  ICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQ--------------VS 115
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF- 818
            G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L +  E +  +   G + 
Sbjct: 116 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWP 171
Query: 819 -GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY----GDEHTSLAE 864
             ++APE     K + K D++SFGV++ E  +  +  Y    G E T++ E
Sbjct: 172 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 222

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 47/231 (20%)
Query: 659 GAGEFVAVKR---------------IWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           G+G F  VK+               I  N   +  L+ E +AE  ++  + +  IV++  
Sbjct: 36  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 95
Query: 704 CISSENSKLLVYEYMENQSLDRWL----HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
              +E S +LV E  E   L+++L    H + ++++     VHQ               +
Sbjct: 96  ICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQ--------------VS 137
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF- 818
            G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L +  E +  +   G + 
Sbjct: 138 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWP 193
Query: 819 -GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY----GDEHTSLAE 864
             ++APE     K + K D++SFGV++ E  +  +  Y    G E T++ E
Sbjct: 194 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 47/231 (20%)
Query: 659 GAGEFVAVKR---------------IWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           G+G F  VK+               I  N   +  L+ E +AE  ++  + +  IV++  
Sbjct: 36  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 95
Query: 704 CISSENSKLLVYEYMENQSLDRWL----HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
              +E S +LV E  E   L+++L    H + ++++     VHQ               +
Sbjct: 96  ICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQ--------------VS 137
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF- 818
            G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L +  E +  +   G + 
Sbjct: 138 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWP 193
Query: 819 -GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY----GDEHTSLAE 864
             ++APE     K + K D++SFGV++ E  +  +  Y    G E T++ E
Sbjct: 194 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 47/231 (20%)
Query: 659 GAGEFVAVKR---------------IWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           G+G F  VK+               I  N   +  L+ E +AE  ++  + +  IV++  
Sbjct: 34  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 93
Query: 704 CISSENSKLLVYEYMENQSLDRWL----HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
              +E S +LV E  E   L+++L    H + ++++     VHQ               +
Sbjct: 94  ICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQ--------------VS 135
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF- 818
            G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L +  E +  +   G + 
Sbjct: 136 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWP 191
Query: 819 -GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY----GDEHTSLAE 864
             ++APE     K + K D++SFGV++ E  +  +  Y    G E T++ E
Sbjct: 192 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 242

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 49/293 (16%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEF----VAVKRIWNN--RKLNQKLEKEFIAEIEI 689
           + L +  ++GSG  G V++      GE     V +K I +   R+  Q +    +A    
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA---- 68
Query: 690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
           +G++ HA+IV+L   +   +S  LV +Y+   SL    H R+     G     Q +L+W 
Sbjct: 69  IGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLD--HVRQHRGALGP----QLLLNWG 121
Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
            ++      A+G+ Y+       ++HR++ + N+LL S  + ++ADFG+A +L    +  
Sbjct: 122 VQI------AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR 868
             S       + A E  +  K   + D++S+GV + EL+T G E   G     LAE    
Sbjct: 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG---LRLAE---- 225
Query: 869 HYAEEKPITDALDKG--IAEP--CYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
                  + D L+KG  +A+P  C ++    VY + + C     + RP+ KE+
Sbjct: 226 -------VPDLLEKGERLAQPQICTID----VYMVMVKCWMIDENIRPTFKEL 267

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G V++       E VA+KR+  +   ++ +    + EI +L  ++H NIV+L  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            + S+    LV+E+ + Q L ++         S +  +   ++             +GL 
Sbjct: 69  VLHSDKKLTLVFEFCD-QDLKKYFD-------SCNGDLDPEIVK-----SFLFQLLKGLG 115
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFA 822
           + H   +  ++HRD+K  N+L++   + K+A+FGLA+     G P    SA   +  Y  
Sbjct: 116 FCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF---GIPVRCYSAEVVTLWYRP 169
Query: 823 PEYAYTTKV-NEKIDIYSFGVVLLELVTG 850
           P+  +  K+ +  ID++S G +  EL   
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANA 198

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V      G  + VA+K I    K     E EFI E +++  + H  +V+L+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             + +    ++ EYM N  L  +L   +            H       L++     + + 
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMR------------HRFQTQQLLEMCKDVCEAME 134
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF--GYF 821
           Y+    + Q +HRD+ + N L++ +   K++DFGL++ +    +    S+V   F   + 
Sbjct: 135 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWS 188
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVT 849
            PE    +K + K DI++FGV++ E+ +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IGSG  G    +    + E VAVK I    K+++ +++E I       ++RH NIV+   
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 81
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +     +V EY     L   +    R     +    Q ++              G+ 
Sbjct: 82  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------------SGVS 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSE--FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           Y H     Q+ HRD+K  N LLD     + KI DFG +K      +P    +  G+  Y 
Sbjct: 129 YCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI 182
Query: 822 APEYAYTTKVNEKI-DIYSFGVVLLELVTG 850
           APE     + + K+ D++S GV L  ++ G
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  +V L  C  +E+    V EY+    L   +  R+R L        +H   +   + +
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPE------EHARFYSAEISL 164
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           A      L Y+H      II+RD+K  N+LLDSE   K+ D+G+ K   + G+  T S  
Sbjct: 165 A------LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTF 213
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            G+  Y APE          +D ++ GV++ E++ G+
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVK--RIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           IG G  G VY+     +G FVA+K  R+ N  +         +A +  L    H N+V+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 702 W--CCISSENSKL---LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
              C  S  + ++   LV+E+++ Q L  +L    ++   G        L   T   +  
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVD-QDLRTYL---DKAPPPG--------LPAETIKDLMR 119
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              +GL ++H +C   I+HRD+K  NIL+ S    K+ADFGLA++ + Q     +  V  
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALFPVVV 173
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +  Y APE    +     +D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 33/232 (14%)
Query: 633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           N   +++++ ++G G  GQV++ +    G  +A K I   R +  K  +E   EI ++  
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK-IIKTRGMKDK--EEVKNEISVMNQ 142
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
           + HAN+++L+    S+N  +LV EY++   L DR        ++  S ++        T 
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR--------IIDESYNL--------TE 186
Query: 752 LQIAIGAAQ---GLCYMHHDCTPQIIHRDVKSSNILL---DSEFKAKIADFGLAKMLAKQ 805
           L   +   Q   G+ +MH      I+H D+K  NIL    D++ + KI DFGLA+    +
Sbjct: 187 LDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPR 242
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
                +    G+  + APE      V+   D++S GV+   L++G     GD
Sbjct: 243 ---EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGL +    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + E+ +   +   +     ++V        HV        +     +GL
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF------LIYQILRGL 138
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + KI D+GLA+    +     M+    +  Y A
Sbjct: 139 KYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRA 190
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           PE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  +V L  C  +E+    V EY+    L  +   R+R L        +H   +   + +
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPE------EHARFYSAEISL 121
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           A      L Y+H      II+RD+K  N+LLDSE   K+ D+G+ K   + G+  T S  
Sbjct: 122 A------LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXF 170
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            G+  Y APE          +D ++ GV++ E++ G+
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 22/237 (9%)
Query: 637 SLTESN---LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
            LT+ N   ++G G  G+V   +  G  E  AVK +  +  +     +  + E  +L   
Sbjct: 18  KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 694 -RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
            +   + +L  C  + +    V EY+    L   +    R                P  +
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-------------FKEPHAV 124
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
             A   A GL ++    +  II+RD+K  N++LDSE   KIADFG+ K     G   T  
Sbjct: 125 FYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTK 179
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
              G+  Y APE        + +D ++FGV+L E++ G+    G++   L +    H
Sbjct: 180 XFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKL--EKEFIAEIEILGTIRHANIVKL 701
           +GSG  G V        G  VAVK++    K  Q +   K    E+ +L  ++H N++ L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL---SKPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
               +   S   + E+ +   +   +     ++V        HV        +     +G
Sbjct: 99  LDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF------LIYQILRG 149
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 150 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 201
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 240

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 73/289 (25%), Positives = 121/289 (41%), Gaps = 34/289 (11%)
Query: 644 IGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           +G G  G V R + +   G    VAVK +  +     +   +FI E+  + ++ H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+  + +   K++         LDR    RK          HQ      T  + A+  A+
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRL---RK----------HQGHFLLGTLSRYAVQVAE 122
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG-SFG 819
           G+ Y+    + + IHRD+ + N+LL +    KI DFGL + L +  +   M       F 
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 179
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           + APE   T   +   D + FGV L E+ T     YG E      W   + ++   I   
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT-----YGQE-----PWIGLNGSQ---ILHK 226
Query: 880 LDK-GIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPT 927
           +DK G   P   +    +Y + + C +  P  RP+   +   L    PT
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 275

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY          +A+K ++ ++   + +E +   EIEI   +RH NI++++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ E+     L + L    R     S++  + +             A  L 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL-------------ADALH 128
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H     ++IHRD+K  N+L+  + + KIADFG     +          + G+  Y  P
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPP 181
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT 860
           E       +EK+D++  GV+  E + G        HT
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IGSG  G    +      E VAVK I     +++ +++E I       ++RH NIV+   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH----RSLRHPNIVRFKE 83
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +     ++ EY     L   +    R     +    Q +L              G+ 
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL-------------SGVS 130
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSE--FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           Y H   + QI HRD+K  N LLD     + KI DFG +K      +P    +  G+  Y 
Sbjct: 131 YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI 184
Query: 822 APEYAYTTKVNEKI-DIYSFGVVLLELVTG 850
           APE     + + KI D++S GV L  ++ G
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G VY          +A+K ++ ++   + +E +   EIEI   +RH NI++++ 
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                    L+ E+     L + L    R     S++  + +             A  L 
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL-------------ADALH 129
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y H     ++IHRD+K  N+L+  + + KIADFG     +          + G+  Y  P
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPP 182
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT 860
           E       +EK+D++  GV+  E + G        HT
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 219

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 27/288 (9%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 83
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQ 753
           +V L   C       +++ E+ +  +L  +L  ++   V        +++  L     + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +      
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEG 258
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +  A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 259 TRMR-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V      G  + VA+K I    K     E EFI E +++  + H  +V+L+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             + +    ++ EYM N  L  +L   +            H       L++     + + 
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLREMR------------HRFQTQQLLEMCKDVCEAME 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF--GYF 821
           Y+    + Q +HRD+ + N L++ +   K++DFGL++ +    +    S+V   F   + 
Sbjct: 120 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWS 173
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVT 849
            PE    +K + K DI++FGV++ E+ +
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  +V L  C  +E+    V EY+    L  +   R+R L        +H   +   + +
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPE------EHARFYSAEISL 117
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           A      L Y+H      II+RD+K  N+LLDSE   K+ D+G+ K   + G+  T S  
Sbjct: 118 A------LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXF 166
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            G+  Y APE          +D ++ GV++ E++ G+
Sbjct: 167 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  +V L  C  +E+    V EY+    L  +   R+R L        +H   +   + +
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPE------EHARFYSAEISL 132
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           A      L Y+H      II+RD+K  N+LLDSE   K+ D+G+ K   + G+  T S  
Sbjct: 133 A------LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXF 181
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            G+  Y APE          +D ++ GV++ E++ G+
Sbjct: 182 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V      G  + VA+K I    K     E EFI E +++  + H  +V+L+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             + +    ++ EYM N  L  +L   +            H       L++     + + 
Sbjct: 71  VCTKQRPIFIITEYMANGCLLNYLREMR------------HRFQTQQLLEMCKDVCEAME 118
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF--GYF 821
           Y+    + Q +HRD+ + N L++ +   K++DFGL++ +    +    S+V   F   + 
Sbjct: 119 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWS 172
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVT 849
            PE    +K + K DI++FGV++ E+ +
Sbjct: 173 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 642 NLIGSGGSGQVYRI-DINGA--GEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTIRHAN 697
            ++G GG G+V+++  + GA  G+  A+K +     + N K      AE  IL  ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV L     +     L+ EY+    L   L  R+   +  ++        +   + +A+G
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACF------YLAEISMALG 135
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE-PHTMSAVAG 816
                 ++H      II+RD+K  NI+L+ +   K+ DFGL K     G   HT     G
Sbjct: 136 ------HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF---CG 183
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           +  Y APE    +  N  +D +S G ++ +++TG
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V      G  + VA+K I    K     E EFI E +++  + H  +V+L+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             + +    ++ EYM N  L  +L   +            H       L++     + + 
Sbjct: 78  VCTKQRPIFIITEYMANGCLLNYLREMR------------HRFQTQQLLEMCKDVCEAME 125
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF--GYF 821
           Y+    + Q +HRD+ + N L++ +   K++DFGL++ +    +    S+V   F   + 
Sbjct: 126 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWS 179
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVT 849
            PE    +K + K DI++FGV++ E+ +
Sbjct: 180 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V      G  + VA+K I    K     E EFI E +++  + H  +V+L+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             + +    ++ EYM N  L  +L   +            H       L++     + + 
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMR------------HRFQTQQLLEMCKDVCEAME 114
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF--GYF 821
           Y+    + Q +HRD+ + N L++ +   K++DFGL++ +    +    S+V   F   + 
Sbjct: 115 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWS 168
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVT 849
            PE    +K + K DI++FGV++ E+ +
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 27/288 (9%)
Query: 644 IGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G G  GQV     + ID       VAVK +      ++   +  ++E++IL  I  H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLN 83
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQ 753
           +V L   C       +++ E+ +  +L  +L  ++   V        +++  L     + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +      
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEG 258
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +  A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 259 TRMR-APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 19/228 (8%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKL 701
           ++G G  G+V   +  G  E  AVK +  +  +     +  + E  +L    +   + +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
             C  + +    V EY+    L   +    R                P  +  A   A G
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-------------FKEPHAVFYAAEIAIG 454
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L ++    +  II+RD+K  N++LDSE   KIADFG+ K     G   T     G+  Y 
Sbjct: 455 LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGTPDYI 509
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
           APE        + +D ++FGV+L E++ G+    G++   L +    H
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 642 NLIGSGGSGQVYRI-DINGA--GEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTIRHAN 697
            ++G GG G+V+++  + GA  G+  A+K +     + N K      AE  IL  ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV L     +     L+ EY+    L   L  R+   +  ++        +   + +A+G
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACF------YLAEISMALG 135
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
                 ++H      II+RD+K  NI+L+ +   K+ DFGL K     G         G+
Sbjct: 136 ------HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGT 184
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
             Y APE    +  N  +D +S G ++ +++TG
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 60/231 (25%), Positives = 106/231 (45%), Gaps = 47/231 (20%)
Query: 659 GAGEFVAVKR---------------IWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           G+G F  VK+               I  N   +  L+ E +AE  ++  + +  IV++  
Sbjct: 20  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 79
Query: 704 CISSENSKLLVYEYMENQSLDRWL----HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
              +E S +LV E  E   L+++L    H + ++++     VHQ               +
Sbjct: 80  ICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQ--------------VS 121
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF- 818
            G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L +  E    +   G + 
Sbjct: 122 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENXYKAQTHGKWP 177
Query: 819 -GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY----GDEHTSLAE 864
             ++APE     K + K D++SFGV++ E  +  +  Y    G E T++ E
Sbjct: 178 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DF LA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 66/294 (22%), Positives = 124/294 (42%), Gaps = 34/294 (11%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           +T S  +G G  G VY     G  +      VA+K +  N   + +   EF+ E  ++  
Sbjct: 14  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKE 71
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT-- 750
               ++V+L   +S     L++ E M    L  +L   +  + +        VL  P+  
Sbjct: 72  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP------VLAPPSLS 125
Query: 751 -RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             +Q+A   A G+ Y++ +   + +HRD+ + N  +  +F  KI DFG+ + + +     
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
                     + +PE           D++SFGVVL E+ T            LAE  ++ 
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------LAEQPYQG 230
Query: 870 YAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + E+ +   ++ G+ + P    +M  +  L  +C    P  RPS  E++  ++
Sbjct: 231 LSNEQVLRFVMEGGLLDKPDNCPDM--LLELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 644 IGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           +G G  G V R + +   G    VAVK +  +     +   +FI E+  + ++ H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+  + +   K++         LDR    RK          HQ      T  + A+  A+
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRL---RK----------HQGHFLLGTLSRYAVQVAE 126
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG-SFG 819
           G+ Y+    + + IHRD+ + N+LL +    KI DFGL + L +  + + M       F 
Sbjct: 127 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 183
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
           + APE   T   +   D + FGV L E+ T     YG E
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFT-----YGQE 217

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 644 IGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           +G G  G V R + +   G    VAVK +  +     +   +FI E+  + ++ H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+  + +   K++         LDR    RK          HQ      T  + A+  A+
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRL---RK----------HQGHFLLGTLSRYAVQVAE 122
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG-SFG 819
           G+ Y+    + + IHRD+ + N+LL +    KI DFGL + L +  + + M       F 
Sbjct: 123 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
           + APE   T   +   D + FGV L E+ T     YG E
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT-----YGQE 213

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ ++ + +
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 82
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           + +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W       +
Sbjct: 83  VCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIGS------QYLLNW------CV 128
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +       
Sbjct: 129 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 185
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + A E         + D++S+GV + EL+T     Y     S              I
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EI 232
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +  L+KG   P        VY + + C      SRP  +E++
Sbjct: 233 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 190
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + + G         
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 295
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 296 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +GSG  G V        G  VA+K+++   + ++   K    E+ +L  +RH N++ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSS--SVHQHVLHWPTRLQIAI-GAAQ 760
             +             +++LD +          G+    + +H      R+Q  +    +
Sbjct: 92  VFTP------------DETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK 139
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           GL Y+H      IIHRD+K  N+ ++ + + KI DFG    LA+Q +      V   + Y
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG----LARQADSEMXGXVVTRW-Y 191
Query: 821 FAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
            APE      +  + +DI+S G ++ E++TGK    G +H
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 19/240 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L     S V      H+  
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLSQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART---A 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           G    M+    +  Y APE        E +DI+S G ++ E++ G     G +H  + +W
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQW 234

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 167
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + + G         
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 272
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 273 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 320

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 128/296 (43%), Gaps = 35/296 (11%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G+G  G+V      G G+      VAVK + +    ++K  +  ++E++I+  + +H N
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 96
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ----------HVLH 747
           IV L    +     L++ EY     L  +L  +  +++  S +  Q            L 
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
               L  +   AQG+ ++    +   IHRDV + N+LL +   AKI DFGLA+ +     
Sbjct: 157 LRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213
Query: 808 PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA 866
                       + APE  +      + D++S+G++L E+ + G     G    S     
Sbjct: 214 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS----- 268
Query: 867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            + Y   K + D     +A+P +  +   +Y +   C +  P+ RP+ +++   L+
Sbjct: 269 -KFY---KLVKDGYQ--MAQPAFAPK--NIYSIMQACWALEPTHRPTFQQICSFLQ 316

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 19/240 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L     S V      H+  
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLSQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           G    M+    +  Y APE        E +DI+S G ++ E++ G     G +H  + +W
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQW 234

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 652 VYRI-DINGAGEFVAVKRIWNNRKLNQKLEKEFI-----------------AEIEILGTI 693
           VY + ++ G G F  V+R  N R+  Q+   + +                  E  I   +
Sbjct: 25  VYELCEVIGKGAFSVVRRCIN-RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           +H +IV+L    SS+    +V+E+M+   L   +  R  +    S +V  H +      Q
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-----Q 138
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHT 810
           I     + L Y H +    IIHRDVK  N+LL S+  +   K+ DFG+A  L + G    
Sbjct: 139 IL----EALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG--LV 189
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG 856
                G+  + APE        + +D++  GV+L  L++G    YG
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 56/285 (19%)
Query: 659 GAGEFVAVKR---------------IWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           G+G F  VK+               I  N   +  L+ E +AE  ++  + +  IV++  
Sbjct: 378 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM-I 436
Query: 704 CISSENSKLLVYEYMENQSLDRWL----HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
            I    S +LV E  E   L+++L    H + ++++     VHQ               +
Sbjct: 437 GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQ--------------VS 479
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF- 818
            G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L +  E +  +   G + 
Sbjct: 480 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWP 535
Query: 819 -GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             ++APE     K + K D++SFGV++ E  +  +  Y     S              +T
Sbjct: 536 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------------EVT 582
Query: 878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
             L+KG    C       +Y L  +C +    +RP    V   LR
Sbjct: 583 AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 627

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 75
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 76  SVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 125
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 126 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 229
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 230 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        IG+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EYM     D + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   K+ADFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        IG+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EYM     D + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   K+ADFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 642 NLIGSGGSGQVY---RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
            ++G G  G+V+   +I  + A +  A+K +     L  +       E +IL  + H  I
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMK-VLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           VKL     +E    L+ +++    L               + + + V+   T   +    
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDL--------------FTRLSKEVMF--TEEDVKFYL 132
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA--G 816
           A+    + H  +  II+RD+K  NILLD E   K+ DFG    L+K+   H   A +  G
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG----LSKESIDHEKKAYSFCG 188
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           +  Y APE        +  D +SFGV++ E++TG
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 73
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 74  SVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 123
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 124 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 176
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 177 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 227
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 228 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 72
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 73  SVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 122
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 123 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 226
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 227 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+ C   +        Y +N  L +++    R + S   +     
Sbjct: 87  ERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 138
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 139 ----TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 190
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 191 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 74
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 75  SVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 124
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 125 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 177
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 228
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 229 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 19/240 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L     S V      H+  
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLSQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART---A 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           G    M+    +  Y APE        E +DI+S G ++ E++ G     G +H  + +W
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQW 234

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 56/285 (19%)
Query: 659 GAGEFVAVKR---------------IWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           G+G F  VK+               I  N   +  L+ E +AE  ++  + +  IV++  
Sbjct: 379 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM-I 437
Query: 704 CISSENSKLLVYEYMENQSLDRWL----HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
            I    S +LV E  E   L+++L    H + ++++     VHQ               +
Sbjct: 438 GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE---LVHQ--------------VS 480
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF- 818
            G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L +  E +  +   G + 
Sbjct: 481 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWP 536
Query: 819 -GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             ++APE     K + K D++SFGV++ E  +  +  Y     S              +T
Sbjct: 537 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------------EVT 583
Query: 878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
             L+KG    C       +Y L  +C +    +RP    V   LR
Sbjct: 584 AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 628

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 97
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 98  SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 147
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 148 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 200
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 201 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 251
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 252 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW- 702
           IG G  G+V++      G+ VA+K++    +  +      + EI+IL  ++H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIE 84
Query: 703 CCISS-------ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            C +        + S  LV+++ E+       +   +  +S    V Q +L+        
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN-------- 136
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM--LAKQGEPHTMSA 813
                GL Y+H +   +I+HRD+K++N+L+  +   K+ADFGLA+   LAK  +P+    
Sbjct: 137 -----GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 814 VAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVT 849
              +  Y  PE     +     ID++  G ++ E+ T
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ ++ + +
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 79
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           + +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W       +
Sbjct: 80  VCRLLGICLTS--TVQLIMQLMPFGXLLDYVREHKDNIGS------QYLLNW------CV 125
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +       
Sbjct: 126 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + A E         + D++S+GV + EL+T     Y     S              I
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EI 229
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +  L+KG   P        VY + + C      SRP  +E++
Sbjct: 230 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ ++ + +
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 80
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           + +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W       +
Sbjct: 81  VCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW------CV 126
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +       
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + A E         + D++S+GV + EL+T     Y     S              I
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EI 230
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +  L+KG   P        VY + + C      SRP  +E++
Sbjct: 231 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ ++ + +
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 81
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           + +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W       +
Sbjct: 82  VCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW------CV 127
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +       
Sbjct: 128 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + A E         + D++S+GV + EL+T     Y     S              I
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EI 231
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +  L+KG   P        VY + + C      SRP  +E++
Sbjct: 232 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 26/210 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IGSG  G    +    + E VAVK I    K+   +++E I       ++RH NIV+   
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH----RSLRHPNIVRFKE 82
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +     +V EY     L   +    R     +    Q ++              G+ 
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------------SGVS 129
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSE--FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           Y H     Q+ HRD+K  N LLD     + KI DFG +K      +P    +  G+  Y 
Sbjct: 130 YCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI 183
Query: 822 APEYAYTTKVNEKI-DIYSFGVVLLELVTG 850
           APE     + + K+ D++S GV L  ++ G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 75
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 76  SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 125
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 126 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 229
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 230 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           ++  +  ++G GG G+V    +   G+  A K++   R   +K E   + E +IL  +  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V L     ++++  LV   M    L   ++   ++    + +V              
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV-------------- 289
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
             AA+  C +      +I++RD+K  NILLD     +I+D GLA  +    E  T+    
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRV 346
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G+ GY APE     +     D ++ G +L E++ G+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 72
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 73  SVDNPHVCRLLGICLTS--TVQLITQLMPFGXLLDYVREHKDNIGS------QYLLNW-- 122
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 123 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 226
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 227 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 72
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 73  SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 122
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 123 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 226
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 227 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ ++ + +
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 85
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           + +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W       +
Sbjct: 86  VCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW------CV 131
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +       
Sbjct: 132 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + A E         + D++S+GV + EL+T     Y     S              I
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EI 235
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +  L+KG   P        VY + + C      SRP  +E++
Sbjct: 236 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           ++  +  ++G GG G+V    +   G+  A K++   R   +K E   + E +IL  +  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V L     ++++  LV   M    L   ++   ++    + +V              
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV-------------- 289
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
             AA+  C +      +I++RD+K  NILLD     +I+D GLA  +    E  T+    
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRV 346
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G+ GY APE     +     D ++ G +L E++ G+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 96/233 (41%), Gaps = 29/233 (12%)
Query: 633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
            +L    +   IGSG  G V        G  VAVK++    + NQ   K    E+ +L  
Sbjct: 21  TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKC 79
Query: 693 IRHANIVKLWCCISSENS------KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL 746
           + H NI+ L    + + +        LV E M+                +    +H  + 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD---------------ANLCQVIHMELD 124
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
           H   R+   +   Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+      
Sbjct: 125 H--ERMSYLL--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN- 179
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
               M+    +  Y APE          +DI+S G ++ ELV G     G +H
Sbjct: 180 --FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDH 230

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI  FGLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 107/243 (44%), Gaps = 47/243 (19%)
Query: 628 GFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEI 687
           G   S I  ++     IG G  G+V+R    G  E VAVK I+++R+     E+ +  E 
Sbjct: 1   GAMGSTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVK-IFSSRE-----ERSWFREA 52
Query: 688 EILGTI--RHANIVKLWCCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSV 741
           EI  T+  RH NI+      + +N       LV +Y E+ SL  +L+ R    V G    
Sbjct: 53  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGM--- 108
Query: 742 HQHVLHWPTRLQIAIGAAQGLCYMHHDCT-----PQIIHRDVKSSNILLDSEFKAKIADF 796
                     +++A+  A GL ++H +       P I HRD+KS NIL+       IAD 
Sbjct: 109 ----------IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 158
Query: 797 GLAKMLAKQGEPHTMSAV----AGSFGYFAPEYAYTTKVN-------EKIDIYSFGVVLL 845
           GLA  +       T+        G+  Y APE      +N       ++ DIY+ G+V  
Sbjct: 159 GLA--VRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFW 215
Query: 846 ELV 848
           E+ 
Sbjct: 216 EIA 218

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ ++ + +
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 75
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           + +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W       +
Sbjct: 76  VCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW------CV 121
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +       
Sbjct: 122 QIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 178
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + A E         + D++S+GV + EL+T     Y     S              I
Sbjct: 179 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EI 225
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +  L+KG   P        VY + + C      SRP  +E++
Sbjct: 226 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW- 702
           IG G  G+V++      G+ VA+K++    +  +      + EI+IL  ++H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIE 84
Query: 703 CCISS-------ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            C +        + S  LV+++ E+       +   +  +S    V Q +L+        
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN-------- 136
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM--LAKQGEPHTMSA 813
                GL Y+H +   +I+HRD+K++N+L+  +   K+ADFGLA+   LAK  +P+    
Sbjct: 137 -----GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 814 VAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVT 849
              +  Y  PE     +     ID++  G ++ E+ T
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 106/242 (43%), Gaps = 47/242 (19%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE 688
             +  I  ++     IG G  G+V+R    G  E VAVK I+++R+     E+ +  E E
Sbjct: 35  LVQRTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVK-IFSSRE-----ERSWFREAE 86
Query: 689 ILGTI--RHANIVKLWCCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
           I  T+  RH NI+      + +N       LV +Y E+ SL  +L+ R    V G     
Sbjct: 87  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGM---- 141
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCT-----PQIIHRDVKSSNILLDSEFKAKIADFG 797
                    +++A+  A GL ++H +       P I HRD+KS NIL+       IAD G
Sbjct: 142 ---------IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192
Query: 798 LAKMLAKQGEPHTMSAV----AGSFGYFAPEYAYTTKVN-------EKIDIYSFGVVLLE 846
           LA  +       T+        G+  Y APE      +N       ++ DIY+ G+V  E
Sbjct: 193 LA--VRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE 249
Query: 847 LV 848
           + 
Sbjct: 250 IA 251

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ ++ + +
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 84
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           + +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W       +
Sbjct: 85  VCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW------CV 130
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +       
Sbjct: 131 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 187
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + A E         + D++S+GV + EL+T     Y     S              I
Sbjct: 188 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EI 234
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +  L+KG   P        VY + + C      SRP  +E++
Sbjct: 235 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G+V++      G+ VA+K++    +  +      + EI+IL  ++H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIE 84
Query: 704 CISSENSKL--------LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
              ++ S          LV+++ E+       +   +  +S    V Q +L+        
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN-------- 136
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM--LAKQGEPHTMSA 813
                GL Y+H +   +I+HRD+K++N+L+  +   K+ADFGLA+   LAK  +P+    
Sbjct: 137 -----GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 814 VAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVT 849
              +  Y  PE     +     ID++  G ++ E+ T
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V       +G  +AVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 116
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA-QG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 117 DVFTPATS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 166
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+    +     M+    +  Y 
Sbjct: 167 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 218
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N  +DI+S G ++ EL+TG+    G +H
Sbjct: 219 APEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDH 257

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G+G  G+V      G G+      VAVK + +    ++K  +  ++E++I+  + +H N
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 103
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQI 754
           IV L    +     L++ EY     L  +L  +  + +    G     + +LH+ +++  
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV-- 161
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
               AQG+ ++    +   IHRDV + N+LL +   AKI DFGLA+ +            
Sbjct: 162 ----AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEE 873
                + APE  +      + D++S+G++L E+ + G     G    S      + Y   
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------KFY--- 265
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           K + D     +A+P +  +   +Y +   C +  P+ RP+ +++   L+
Sbjct: 266 KLVKDGYQ--MAQPAFAPK--NIYSIMQACWALEPTHRPTFQQICSFLQ 310

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW- 702
           IG G  G+V++      G+ VA+K++    +  +      + EI+IL  ++H N+V L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIE 83
Query: 703 CCISS-------ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            C +        + S  LV+++ E+       +   +  +S    V Q +L+        
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN-------- 135
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM--LAKQGEPHTMSA 813
                GL Y+H +   +I+HRD+K++N+L+  +   K+ADFGLA+   LAK  +P+    
Sbjct: 136 -----GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 814 VAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVT 849
              +  Y  PE     +     ID++  G ++ E+ T
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 19/240 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L     S V      H+ +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
            +   ++ +      G+ ++H   +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 129 SYLLYQMLV------GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TA 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           G    M+    +  Y APE        E +DI+S GV++ E++ G     G +H  + +W
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDH--IDQW 234

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI D GLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 128/292 (43%), Gaps = 45/292 (15%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 66
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 67  SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 116
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 117 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 220
Query: 871 AEEKPITDALDKGIAEP----CYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P    C ++    VY + + C      SRP  +E++
Sbjct: 221 ----EISSILEKGERLPQPPICTID----VYMIMVKCWMIDADSRPKFRELI 264

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 126/289 (43%), Gaps = 28/289 (9%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G+G  G+V      G G+      VAVK + +    ++K  +  ++E++I+  + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 111
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKR--SLVSGSSSVHQHVLHWPTR--LQ 753
           IV L    +     L++ EY     L  +L  RKR   L    +  H       +R  L 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKRPPGLEYSYNPSHNPEEQLSSRDLLH 170
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            +   AQG+ ++    +   IHRDV + N+LL +   AKI DFGLA+ +           
Sbjct: 171 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 227
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE  +      + D++S+G++L E+ +     Y     +   +        
Sbjct: 228 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY-------- 279
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           K + D     +A+P +  +   +Y +   C +  P+ RP+ +++   L+
Sbjct: 280 KLVKDGYQ--MAQPAFAPK--NIYSIMQACWALEPTHRPTFQQICSFLQ 324

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI D GLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 19/240 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L       V      H+  
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           G    M+    +  Y APE        E +DI+S G ++ E++ G     G +H  + +W
Sbjct: 177 GTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQW 234

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 106/242 (43%), Gaps = 47/242 (19%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE 688
             +  I  ++     IG G  G+V+R    G  E VAVK I+++R+     E+ +  E E
Sbjct: 22  LVQRTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVK-IFSSRE-----ERSWFREAE 73
Query: 689 ILGTI--RHANIVKLWCCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
           I  T+  RH NI+      + +N       LV +Y E+ SL  +L+ R    V G     
Sbjct: 74  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGM---- 128
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCT-----PQIIHRDVKSSNILLDSEFKAKIADFG 797
                    +++A+  A GL ++H +       P I HRD+KS NIL+       IAD G
Sbjct: 129 ---------IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 179
Query: 798 LAKMLAKQGEPHTMSAV----AGSFGYFAPEYAYTTKVN-------EKIDIYSFGVVLLE 846
           LA  +       T+        G+  Y APE      +N       ++ DIY+ G+V  E
Sbjct: 180 LA--VRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE 236
Query: 847 LV 848
           + 
Sbjct: 237 IA 238

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 122/280 (43%), Gaps = 33/280 (11%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVK-RIWNNRKLNQ-KLEKEFIAEIEILGTIRHANIV 699
            ++GSG  G VY+      GE V +   I   R+    K  KE + E  ++ ++ + ++ 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W       +  
Sbjct: 115 RLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW------CVQI 160
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +         
Sbjct: 161 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            + A E         + D++S+GV + EL+T     Y     S              I+ 
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EISS 264
Query: 879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
            L+KG   P        VY + + C      SRP  +E++
Sbjct: 265 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IGSG  G    +    + E VAVK I    K+++ +++E I       ++RH NIV+   
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +     +V EY     L   +    R     +    Q ++              G+ 
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------------SGVS 129
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSE--FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           Y H     Q+ HRD+K  N LLD     + KI  FG +K      +P    +  G+  Y 
Sbjct: 130 YCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP---KSTVGTPAYI 183
Query: 822 APEYAYTTKVNEKI-DIYSFGVVLLELVTG 850
           APE     + + K+ D++S GV L  ++ G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 7   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 65
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLCQVIQMELDHE-- 119
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 120 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 169
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 13  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 71
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 72  ELVLMKCVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLCQVIQMELDHE-- 125
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 126 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---A 175
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 176 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 19/240 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L     S V      H+ +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
            +   ++ +      G+ ++H   +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 129 SYLLYQMLV------GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLART---A 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           G    M+    +  Y APE        E +DI+S GV++ E++ G     G +H  + +W
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDH--IDQW 234

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 8   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 66
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLCQVIQMELDHE-- 120
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 121 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 170
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 19/240 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L       V      H+  
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           G    M+    +  Y APE        E +DI+S G ++ E++ G     G +H  + +W
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQW 234

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V        G  VAVK++  +R     +  K    E+ +L  ++H N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI-GAAQG 761
              +   S   + E+ +   +   +     ++V        HV       Q  I    +G
Sbjct: 88  DVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-------QFLIYQILRG 137
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H   +  IIHRD+K SN+ ++ + + KI D GLA+    +     M+    +  Y 
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYR 189
Query: 822 APEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           APE        N+ +DI+S G ++ EL+TG+    G +H
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 19/240 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 15  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 73
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L       V      H+  
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHE-- 127
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 128 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---A 177
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           G    M+    +  Y APE        E +DI+S G ++ E++ G     G +H  + +W
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQW 235

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLCQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 15  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 73
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLCQVIQMELDHE-- 127
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 128 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 177
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 15  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 73
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLCQVIQMELDHE-- 127
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 128 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 177
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            ++G GG G+V+   +   G+  A K++   R   +K  +  + E +IL  +    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                ++    LV   M    +   ++      V   +   Q     P  +        G
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYN-----VDEDNPGFQE----PRAIFYTAQIVSG 301
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L ++H      II+RD+K  N+LLD +   +I+D GLA  L K G+  T    AG+ G+ 
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKT-KGYAGTPGFM 356
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           APE     + +  +D ++ GV L E++  +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLXQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TA 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 8   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 66
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLCQVIQMELDHE-- 120
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 121 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 170
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHAN 697
           +G+G  G+V      G G+      VAVK + +    ++K  +  ++E++I+  + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 111
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQI 754
           IV L    +     L++ EY     L  +L  +  + +    G     + +LH+ +++  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV-- 169
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
               AQG+ ++    +   IHRDV + N+LL +   AKI DFGLA+ +            
Sbjct: 170 ----AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEE 873
                + APE  +      + D++S+G++L E+ + G     G    S      + Y   
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------KFY--- 273
Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           K + D     +A+P +  +   +Y +   C +  P+ RP+ +++   L+
Sbjct: 274 KLVKDGYQ--MAQPAFAPK--NIYSIMQACWALEPTHRPTFQQICSFLQ 318

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLCQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---A 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            ++G GG G+V+   +   G+  A K++   R   +K  +  + E +IL  +    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                ++    LV   M    +   ++      V   +   Q     P  +        G
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYN-----VDEDNPGFQE----PRAIFYTAQIVSG 301
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L ++H      II+RD+K  N+LLD +   +I+D GLA  L K G+  T    AG+ G+ 
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKT-KGYAGTPGFM 356
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           APE     + +  +D ++ GV L E++  +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            ++G GG G+V+   +   G+  A K++   R   +K  +  + E +IL  +    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                ++    LV   M    +   ++      V   +   Q     P  +        G
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYN-----VDEDNPGFQE----PRAIFYTAQIVSG 301
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L ++H      II+RD+K  N+LLD +   +I+D GLA  L K G+  T    AG+ G+ 
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKT-KGYAGTPGFM 356
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           APE     + +  +D ++ GV L E++  +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            ++G GG G+V+   +   G+  A K++   R   +K  +  + E +IL  +    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                ++    LV   M    +   ++      V   +   Q     P  +        G
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYN-----VDEDNPGFQE----PRAIFYTAQIVSG 301
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L ++H      II+RD+K  N+LLD +   +I+D GLA  L K G+  T    AG+ G+ 
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKT-KGYAGTPGFM 356
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           APE     + +  +D ++ GV L E++  +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 111/292 (38%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+  + H NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 164
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 269
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 270 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 317

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 32/216 (14%)
Query: 643 LIGSGGSGQVY---RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE--ILGTIRHAN 697
           ++G G  G+V+   ++    +G   A+K +   +K   K+      ++E  IL  + H  
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVL---KKATLKVRDRVRTKMERDILADVNHPF 91
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           +VKL     +E    L+ +++    L               + + + V+     ++  + 
Sbjct: 92  VVKLHYAFQTEGKLYLILDFLRGGDL--------------FTRLSKEVMFTEEDVKFYLA 137
Query: 758 A-AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA- 815
             A GL ++H   +  II+RD+K  NILLD E   K+ DFG    L+K+   H   A + 
Sbjct: 138 ELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFG----LSKEAIDHEKKAYSF 190
Query: 816 -GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            G+  Y APE       +   D +S+GV++ E++TG
Sbjct: 191 CGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 19/240 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L       V      H+  
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           G    M+    +  Y APE        E +DI+S G ++ E++ G     G +H  + +W
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQW 234

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 124/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 75
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 76  SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 125
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 126 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 229
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY +   C      SRP  +E++
Sbjct: 230 ----EISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 52  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 110
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLCQVIQMELDHE-- 164
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 165 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---A 214
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 72
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 73  SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNWCV 124
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
           ++      A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 125 QI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 226
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY +   C      SRP  +E++
Sbjct: 227 ----EISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V      G  + VA+K I    K     E EFI E +++  + H  +V+L+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
             + +    ++ EYM N  L  +L   +            H       L++     + + 
Sbjct: 72  VCTKQRPIFIITEYMANGCLLNYLREMR------------HRFQTQQLLEMCKDVCEAME 119
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF--GYF 821
           Y+    + Q +HRD+ + N L++ +   K++DFGL++ +    +    S+    F   + 
Sbjct: 120 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSRGSKFPVRWS 173
Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVT 849
            PE    +K + K DI++FGV++ E+ +
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 124/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 82
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 83  SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 132
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + + 
Sbjct: 133 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 185
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 186 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 236
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY +   C      SRP  +E++
Sbjct: 237 ----EISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 111/292 (38%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+  + H NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 150
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 255
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 256 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 303

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 41/284 (14%)
Query: 641 SNLIGSGGSGQVYR-IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           + ++G G  G+VY  +  N  GE   VAVK    +  L+ K  ++F++E  I+  + H +
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHPH 86
Query: 698 IVKLWCCISSENSKLLV--YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           IVKL   I  E + +++  Y Y E   L  +L   K SL      V   VL+    LQI 
Sbjct: 87  IVKLIGIIEEEPTWIIMELYPYGE---LGHYLERNKNSL-----KVLTLVLY---SLQIC 135
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               + + Y+    +   +HRD+   NIL+ S    K+ DFGL++ +  + + +  S   
Sbjct: 136 ----KAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTR 187
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK 874
               + +PE     +     D++ F V + E+++ GK+  +              + E K
Sbjct: 188 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF--------------WLENK 233
Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
            +   L+KG   P        +Y L   C    PS RP   E++
Sbjct: 234 DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 277

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLCQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TA 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 643 LIGSGGSGQVY---RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE--ILGTIRHAN 697
           ++G G  G+V+   +I  + A +  A+K +   +K   K+      ++E  IL  + H  
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVL---KKATLKVRDRVRTKMERDILVEVNHPF 88
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IVKL     +E    L+ +++    L   L   K  + +      + V  +   L +A+ 
Sbjct: 89  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFT-----EEDVKFYLAELALALD 141
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA-- 815
               L          II+RD+K  NILLD E   K+ DFG    L+K+   H   A +  
Sbjct: 142 HLHSL---------GIIYRDLKPENILLDEEGHIKLTDFG----LSKESIDHEKKAYSFC 188
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           G+  Y APE        +  D +SFGV++ E++TG
Sbjct: 189 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 643 LIGSGGSGQVY---RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE--ILGTIRHAN 697
           ++G G  G+V+   +I  + A +  A+K +   +K   K+      ++E  IL  + H  
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVL---KKATLKVRDRVRTKMERDILVEVNHPF 87
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IVKL     +E    L+ +++    L   L   K  + +      + V  +   L +A+ 
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFT-----EEDVKFYLAELALALD 140
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA-- 815
               L          II+RD+K  NILLD E   K+ DFG    L+K+   H   A +  
Sbjct: 141 HLHSL---------GIIYRDLKPENILLDEEGHIKLTDFG----LSKESIDHEKKAYSFC 187
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           G+  Y APE        +  D +SFGV++ E++TG
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 52  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 110
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + +     E  ++  L   L       V      H+  
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKT----LEEFQDVYLVMELMDANLCQVIQMELDHE-- 164
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 165 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---A 214
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 164
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 269
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 270 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 317

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 659 GAGEFVAVKR-IWNNRK---------LNQKLEK----EFIAEIEILGTIRHANIVKLWCC 704
           G G F +V++ ++  RK         L Q  EK    E + E +I+  + +  IV+L   
Sbjct: 19  GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 705 ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCY 764
             +E + +LV E      L ++L G++  +   + +    +LH     Q+++G       
Sbjct: 79  CQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVA---ELLH-----QVSMG------- 122
Query: 765 MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM-SAVAGSFGYFAP 823
           M +      +HRD+ + N+LL +   AKI+DFGL+K L      +T  SA      ++AP
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANY 855
           E     K + + D++S+GV + E ++  +  Y
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVYSEQDELDFLMEALIISKFNHQNI 110
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 164
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 269
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 270 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 317

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 102/227 (44%), Gaps = 47/227 (20%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI--RHANIVKL 701
           IG G  G+V+R    G  E VAVK I+++R+     E+ +  E EI  T+  RH NI+  
Sbjct: 14  IGKGRFGEVWRGKWRG--EEVAVK-IFSSRE-----ERSWFREAEIYQTVMLRHENILGF 65
Query: 702 WCCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
               + +N       LV +Y E+ SL  +L+ R    V G              +++A+ 
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGM-------------IKLALS 111
Query: 758 AAQGLCYMHHDCT-----PQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
            A GL ++H +       P I HRD+KS NIL+       IAD GLA  +       T+ 
Sbjct: 112 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID 169
Query: 813 AV----AGSFGYFAPEYAYTTKVN-------EKIDIYSFGVVLLELV 848
                  G+  Y APE      +N       ++ DIY+ G+V  E+ 
Sbjct: 170 IAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 26/210 (12%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IGSG  G    +    + E VAVK I    K+++ +++E I       ++RH NIV+   
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I +     +V EY     L   +    R     +    Q ++              G+ 
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------------SGVS 129
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSE--FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           Y H     Q+ HRD+K  N LLD     + KI  FG +K      +P       G+  Y 
Sbjct: 130 YCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP---KDTVGTPAYI 183
Query: 822 APEYAYTTKVNEKI-DIYSFGVVLLELVTG 850
           APE     + + K+ D++S GV L  ++ G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 102/227 (44%), Gaps = 47/227 (20%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI--RHANIVKL 701
           IG G  G+V+R    G  E VAVK I+++R+     E+ +  E EI  T+  RH NI+  
Sbjct: 12  IGKGRFGEVWRGKWRG--EEVAVK-IFSSRE-----ERSWFREAEIYQTVMLRHENILGF 63
Query: 702 WCCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
               + +N       LV +Y E+ SL  +L+ R    V G              +++A+ 
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGM-------------IKLALS 109
Query: 758 AAQGLCYMHHDCT-----PQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
            A GL ++H +       P I HRD+KS NIL+       IAD GLA  +       T+ 
Sbjct: 110 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID 167
Query: 813 AV----AGSFGYFAPEYAYTTKVN-------EKIDIYSFGVVLLELV 848
                  G+  Y APE      +N       ++ DIY+ G+V  E+ 
Sbjct: 168 IAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 41/284 (14%)
Query: 641 SNLIGSGGSGQVYR-IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           + ++G G  G+VY  +  N  GE   VAVK    +  L+ K  ++F++E  I+  + H +
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHPH 74
Query: 698 IVKLWCCISSENSKLLV--YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           IVKL   I  E + +++  Y Y E   L  +L   K SL      V   VL+    LQI 
Sbjct: 75  IVKLIGIIEEEPTWIIMELYPYGE---LGHYLERNKNSL-----KVLTLVLY---SLQIC 123
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               + + Y+    +   +HRD+   NIL+ S    K+ DFGL++ +  + + +  S   
Sbjct: 124 ----KAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTR 175
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK 874
               + +PE     +     D++ F V + E+++ GK+  +              + E K
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF--------------WLENK 221
Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
            +   L+KG   P        +Y L   C    PS RP   E++
Sbjct: 222 DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 265

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 150
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 255
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 256 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 303

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 41/284 (14%)
Query: 641 SNLIGSGGSGQVYR-IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           + ++G G  G+VY  +  N  GE   VAVK    +  L+ K  ++F++E  I+  + H +
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHPH 70
Query: 698 IVKLWCCISSENSKLLV--YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           IVKL   I  E + +++  Y Y E   L  +L   K SL      V   VL+    LQI 
Sbjct: 71  IVKLIGIIEEEPTWIIMELYPYGE---LGHYLERNKNSL-----KVLTLVLY---SLQIC 119
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               + + Y+    +   +HRD+   NIL+ S    K+ DFGL++ +  + + +  S   
Sbjct: 120 ----KAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTR 171
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK 874
               + +PE     +     D++ F V + E+++ GK+  +              + E K
Sbjct: 172 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF--------------WLENK 217
Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
            +   L+KG   P        +Y L   C    PS RP   E++
Sbjct: 218 DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 261

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 34/203 (16%)
Query: 655 IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLL 713
           ID+ G G F A +         Q+L +  + E++IL  +  H NI++L     +     L
Sbjct: 50  IDVTGGGSFSAEE--------VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQI 773
           V++ M+   L  +L   K +L    +             +I     + +C +H      I
Sbjct: 102 VFDLMKKGELFDYL-TEKVTLSEKETR------------KIMRALLEVICALH---KLNI 145
Query: 774 IHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK--- 830
           +HRD+K  NILLD +   K+ DFG +  L   GE   + +V G+  Y APE    +    
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGE--KLRSVCGTPSYLAPEIIECSMNDN 202
Query: 831 ---VNEKIDIYSFGVVLLELVTG 850
                +++D++S GV++  L+ G
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 19/240 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 16  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 74
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L       V      H+  
Sbjct: 75  ELVLMKCVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHE-- 128
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 129 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---A 178
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           G    M     +  Y APE        E +DI+S G ++ E++ G     G +H  + +W
Sbjct: 179 GTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQW 236

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 131
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 132 ----TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +A  G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 184 SKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 141
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 246
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 247 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 294

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 124/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 74
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 75  SVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 124
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFG AK+L  + + + 
Sbjct: 125 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 228
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 229 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 149
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 254
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 255 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 124/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 76
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 77  SVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 126
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFG AK+L  + + + 
Sbjct: 127 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 179
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 180 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 230
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 231 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 102/227 (44%), Gaps = 47/227 (20%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI--RHANIVKL 701
           IG G  G+V+R    G  E VAVK I+++R+     E+ +  E EI  T+  RH NI+  
Sbjct: 11  IGKGRFGEVWRGKWRG--EEVAVK-IFSSRE-----ERSWFREAEIYQTVMLRHENILGF 62
Query: 702 WCCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
               + +N       LV +Y E+ SL  +L+ R    V G              +++A+ 
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGM-------------IKLALS 108
Query: 758 AAQGLCYMHHDCT-----PQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
            A GL ++H +       P I HRD+KS NIL+       IAD GLA  +       T+ 
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID 166
Query: 813 AV----AGSFGYFAPEYAYTTKVN-------EKIDIYSFGVVLLELV 848
                  G+  Y APE      +N       ++ DIY+ G+V  E+ 
Sbjct: 167 IAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 149
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 254
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 255 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-----EIEILGTIRHANI 698
           +GSG  G V       +GE VA+K      KL++  + E  A     E+ +L  ++H N+
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIK------KLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 699 VKLWCCISSENSKLLVYEY---MENQSLD-RWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           + L    +  +S    Y++   M     D + + G K S       V+Q +         
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML--------- 136
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
                +GL Y+H   +  ++HRD+K  N+ ++ + + KI DFGLA+    +     M+  
Sbjct: 137 -----KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGY 183
Query: 815 AGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
             +  Y APE   +    N+ +DI+S G ++ E++TGK    G ++
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 22/219 (10%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +IG G  G+V  +      +  A+K +     + +     F  E +I+       +V+L+
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                +    +V EYM    L         +L+S      +    +   + +A+ A   +
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDL--------VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            +         IHRDVK  N+LLD     K+ADFG    + K+G     +AV G+  Y +
Sbjct: 193 GF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 242
Query: 823 PEYAYTT----KVNEKIDIYSFGVVLLELVTGKEANYGD 857
           PE   +         + D +S GV L E++ G    Y D
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 281

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 156
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 214 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 261
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 262 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 309

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 22/219 (10%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +IG G  G+V  +      +  A+K +     + +     F  E +I+       +V+L+
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                +    +V EYM    L         +L+S      +    +   + +A+ A   +
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL--------VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            +         IHRDVK  N+LLD     K+ADFG    + K+G     +AV G+  Y +
Sbjct: 188 GF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 237
Query: 823 PEYAYTT----KVNEKIDIYSFGVVLLELVTGKEANYGD 857
           PE   +         + D +S GV L E++ G    Y D
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 122/282 (43%), Gaps = 37/282 (13%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            ++ SG  G VY+      GE V    A+K +      + K  KE + E  ++ ++ + +
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 85
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           + +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W       +
Sbjct: 86  VCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIGS------QYLLNW------CV 131
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +       
Sbjct: 132 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + A E         + D++S+GV + EL+T     Y     S              I
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EI 235
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +  L+KG   P        VY + + C      SRP  +E++
Sbjct: 236 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 124/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 72
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 73  SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 122
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFG AK+L  + + + 
Sbjct: 123 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 175
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 226
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 227 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 166
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 271
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 272 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 319

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI----RKIGSFDETC---- 133
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 134 ----TRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    ++  G+  Y +PE       ++  D+++ G ++ +LV G
Sbjct: 186 SKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 22/219 (10%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +IG G  G+V  +      +  A+K +     + +     F  E +I+       +V+L+
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                +    +V EYM    L         +L+S      +    +   + +A+ A   +
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDL--------VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            +         IHRDVK  N+LLD     K+ADFG    + K+G     +AV G+  Y +
Sbjct: 193 GF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 242
Query: 823 PEYAYTT----KVNEKIDIYSFGVVLLELVTGKEANYGD 857
           PE   +         + D +S GV L E++ G    Y D
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 281

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V         + VAVK++  +R     +  +    E+ +L  ++H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKL--SRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + ++ E   +   +     ++V   +   +HV     +L       +GL
Sbjct: 94  DVFTPATS---IEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQL------LRGL 144
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + +I DFGLA+   ++     M+    +  Y A
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRA 196
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGK 851
           PE        N+ +DI+S G ++ EL+ GK
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 150
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAM 207
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 255
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 256 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 303

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 122/282 (43%), Gaps = 37/282 (13%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            ++ SG  G VY+      GE V    A+K +      + K  KE + E  ++ ++ + +
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 85
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           + +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W       +
Sbjct: 86  VCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW------CV 131
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +       
Sbjct: 132 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + A E         + D++S+GV + EL+T     Y     S              I
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EI 235
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +  L+KG   P        VY + + C      SRP  +E++
Sbjct: 236 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        IG+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   K+ADFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 46/229 (20%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G GG+G V+    N   + VA+K+I      + +  K  + EI+I+  + H NIVK++ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFE 75
Query: 704 CISSENSKL--------------LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
            +    S+L              +V EYME    +    G    L+   + +  + L   
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG---PLLEEHARLFMYQL--- 129
Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEP 808
                     +GL Y+H   +  ++HRD+K +N+ +++E    KI DFGLA+++    +P
Sbjct: 130 ---------LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM----DP 173
Query: 809 HTMSAVAGSFG-----YFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGK 851
           H       S G     Y +P    +     + ID+++ G +  E++TGK
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 34/203 (16%)
Query: 655 IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLL 713
           ID+ G G F A +         Q+L +  + E++IL  +  H NI++L     +     L
Sbjct: 37  IDVTGGGSFSAEEV--------QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 88
Query: 714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQI 773
           V++ M+   L  +L   K +L    +             +I     + +C +H      I
Sbjct: 89  VFDLMKKGELFDYL-TEKVTLSEKETR------------KIMRALLEVICALH---KLNI 132
Query: 774 IHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK--- 830
           +HRD+K  NILLD +   K+ DFG +  L   GE   +  V G+  Y APE    +    
Sbjct: 133 VHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGE--KLREVCGTPSYLAPEIIECSMNDN 189
Query: 831 ---VNEKIDIYSFGVVLLELVTG 850
                +++D++S GV++  L+ G
Sbjct: 190 HPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 124/288 (43%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 79
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 80  SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 129
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFG AK+L  + + + 
Sbjct: 130 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 182
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 233
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY + + C      SRP  +E++
Sbjct: 234 ----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 34/203 (16%)
Query: 655 IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLL 713
           ID+ G G F A +         Q+L +  + E++IL  +  H NI++L     +     L
Sbjct: 50  IDVTGGGSFSAEE--------VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQI 773
           V++ M+   L  +L   K +L    +             +I     + +C +H      I
Sbjct: 102 VFDLMKKGELFDYL-TEKVTLSEKETR------------KIMRALLEVICALH---KLNI 145
Query: 774 IHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK--- 830
           +HRD+K  NILLD +   K+ DFG +  L   GE   +  V G+  Y APE    +    
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGE--KLREVCGTPSYLAPEIIECSMNDN 202
Query: 831 ---VNEKIDIYSFGVVLLELVTG 850
                +++D++S GV++  L+ G
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/301 (21%), Positives = 122/301 (40%), Gaps = 36/301 (11%)
Query: 638 LTESNLIGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           L+    +G+G  G+V     Y +  + A   VAVK +  +  L ++  +  ++E+++L  
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLSY 82
Query: 693 I-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS-----VHQHVL 746
           +  H NIV L    +     L++ EY     L  +L  ++ S +   +S       +  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
                L  +   A+G+ ++    +   IHRD+ + NILL      KI DFGLA+ +    
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
                        + APE  +      + D++S+G+ L EL +   + Y           
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----------- 248
Query: 867 WRHYAEEKPITDALDKGIAEPCYL----EEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                   P+     K I E   +         +Y +   C    P  RP+ K+++Q++ 
Sbjct: 249 -----PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 923 R 923
           +
Sbjct: 304 K 304

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/301 (21%), Positives = 122/301 (40%), Gaps = 36/301 (11%)
Query: 638 LTESNLIGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           L+    +G+G  G+V     Y +  + A   VAVK +  +  L ++  +  ++E+++L  
Sbjct: 48  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLSY 105
Query: 693 I-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS-----VHQHVL 746
           +  H NIV L    +     L++ EY     L  +L  ++ S +   +S       +  L
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
                L  +   A+G+ ++    +   IHRD+ + NILL      KI DFGLA+ +    
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
                        + APE  +      + D++S+G+ L EL +   + Y           
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--------- 273
Query: 867 WRHYAEEKPITDALDKGIAEPCYL----EEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                   P+     K I E   +         +Y +   C    P  RP+ K+++Q++ 
Sbjct: 274 -------MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326
Query: 923 R 923
           +
Sbjct: 327 K 327

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 122/282 (43%), Gaps = 37/282 (13%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            ++ SG  G VY+      GE V    A+K +      + K  KE + E  ++ ++ + +
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 78
Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           + +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W       +
Sbjct: 79  VCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW------CV 124
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +       
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              + A E         + D++S+GV + EL+T     Y     S              I
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EI 228
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +  L+KG   P        VY + + C      SRP  +E++
Sbjct: 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/301 (21%), Positives = 122/301 (40%), Gaps = 36/301 (11%)
Query: 638 LTESNLIGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           L+    +G+G  G+V     Y +  + A   VAVK +  +  L ++  +  ++E+++L  
Sbjct: 41  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLSY 98
Query: 693 I-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS-----VHQHVL 746
           +  H NIV L    +     L++ EY     L  +L  ++ S +   +S       +  L
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
                L  +   A+G+ ++    +   IHRD+ + NILL      KI DFGLA+ +    
Sbjct: 159 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
                        + APE  +      + D++S+G+ L EL +   + Y           
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--------- 266
Query: 867 WRHYAEEKPITDALDKGIAEPCYL----EEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                   P+     K I E   +         +Y +   C    P  RP+ K+++Q++ 
Sbjct: 267 -------MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319
Query: 923 R 923
           +
Sbjct: 320 K 320

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V         + VAVK++  +R     +  +    E+ +L  ++H N++ L 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKL--SRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + ++ E   +   +     ++V   +   +HV     +L       +GL
Sbjct: 86  DVFTPATS---IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL------LRGL 136
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + +I DFGLA+   ++     M+    +  Y A
Sbjct: 137 KYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGYVATRWYRA 188
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGK 851
           PE        N+ +DI+S G ++ EL+ GK
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 99/243 (40%), Gaps = 49/243 (20%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE 688
             +  I   +     IG G  G+V+       GE VAVK  +         E  +  E E
Sbjct: 30  LVQRTIAKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTTE------EASWFRETE 81
Query: 689 ILGTI--RHANIVKLWCC----ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
           I  T+  RH NI+           S     L+ +Y EN SL  +L   K + +   S   
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSM-- 136
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDC-----TPQIIHRDVKSSNILLDSEFKAKIADFG 797
                    L++A  +  GLC++H +       P I HRD+KS NIL+       IAD G
Sbjct: 137 ---------LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187
Query: 798 LA-KMLAKQGE----PHTMSAVAGSFGYFAPEYAYTTKVNEK-------IDIYSFGVVLL 845
           LA K ++   E    P+T     G+  Y  PE      +N          D+YSFG++L 
Sbjct: 188 LAVKFISDTNEVDIPPNTR---VGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILW 243
Query: 846 ELV 848
           E+ 
Sbjct: 244 EVA 246

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 19  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 77
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L       V      H+  
Sbjct: 78  ELVLMKCVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHE-- 131
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 132 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 181
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +D++S G ++ E+V  K
Sbjct: 182 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 104/240 (43%), Gaps = 19/240 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L     S V      H+ +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
            +   ++ +      G+ ++H   +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 129 SYLLYQMLV------GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TA 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
           G    M+    +  Y APE        E +DI+S G ++ E++ G     G +H  + +W
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQW 234

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVKLW 702
           +GSG  G V         + VAVK++  +R     +  +    E+ +L  ++H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKL--SRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
              +   S   + ++ E   +   +     ++V   +   +HV     +L       +GL
Sbjct: 94  DVFTPATS---IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL------LRGL 144
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y+H   +  IIHRD+K SN+ ++ + + +I DFGLA+   ++     M+    +  Y A
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRA 196
Query: 823 PEYAYT-TKVNEKIDIYSFGVVLLELVTGK 851
           PE        N+ +DI+S G ++ EL+ GK
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 133
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 134 ----TRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 186 SKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 123/288 (42%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 74
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 75  SVDNPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 124
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFG AK+L  + + + 
Sbjct: 125 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 228
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY +   C      SRP  +E++
Sbjct: 229 ----EISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/301 (21%), Positives = 122/301 (40%), Gaps = 36/301 (11%)
Query: 638 LTESNLIGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           L+    +G+G  G+V     Y +  + A   VAVK +  +  L ++  +  ++E+++L  
Sbjct: 43  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLSY 100
Query: 693 I-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS-----VHQHVL 746
           +  H NIV L    +     L++ EY     L  +L  ++ S +   +S       +  L
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
                L  +   A+G+ ++    +   IHRD+ + NILL      KI DFGLA+ +    
Sbjct: 161 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
                        + APE  +      + D++S+G+ L EL +   + Y           
Sbjct: 218 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--------- 268
Query: 867 WRHYAEEKPITDALDKGIAEPCYL----EEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                   P+     K I E   +         +Y +   C    P  RP+ K+++Q++ 
Sbjct: 269 -------MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321
Query: 923 R 923
           +
Sbjct: 322 K 322

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/301 (21%), Positives = 122/301 (40%), Gaps = 36/301 (11%)
Query: 638 LTESNLIGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           L+    +G+G  G+V     Y +  + A   VAVK +  +  L ++  +  ++E+++L  
Sbjct: 48  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLSY 105
Query: 693 I-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS-----VHQHVL 746
           +  H NIV L    +     L++ EY     L  +L  ++ S +   +S       +  L
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
                L  +   A+G+ ++    +   IHRD+ + NILL      KI DFGLA+ +    
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
                        + APE  +      + D++S+G+ L EL +   + Y           
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--------- 273
Query: 867 WRHYAEEKPITDALDKGIAEPCYL----EEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                   P+     K I E   +         +Y +   C    P  RP+ K+++Q++ 
Sbjct: 274 -------MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326
Query: 923 R 923
           +
Sbjct: 327 K 327

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 134
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 135 ----TRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    ++  G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 187 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 8   EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 66
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L       V      H+  
Sbjct: 67  ELVLMKCVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHE-- 120
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 121 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 170
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M+    +  Y APE        E +D++S G ++ E+V  K
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 110/292 (37%), Gaps = 38/292 (13%)
Query: 644 IGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +G G  G+VY   ++G         VAVK +      +++ E +F+ E  I+    H NI
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V+          + ++ E M    L  +L   +      SS     +LH      +A   
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH------VARDI 176
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAVA 815
           A G  Y+  +     IHRD+ + N LL        AKI DFG+A+ + +           
Sbjct: 177 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE         K D +SFGV+L E+             SL    +   + ++ 
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF------------SLGYMPYPSKSNQEV 281
Query: 876 ITDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           +      G  +P   C       VYR+   C    P  RP+   +L+ +  C
Sbjct: 282 LEFVTSGGRMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 329

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-----EIEILGTIRHANI 698
           +GSG  G V       +GE VA+K      KL++  + E  A     E+ +L  ++H N+
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIK------KLSRPFQSEIFAKRAYRELLLLKHMQHENV 103
Query: 699 VKLWCCISSENSKLLVYEY---MENQSLD-RWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           + L    +  +S    Y++   M     D + + G + S       V+Q +         
Sbjct: 104 IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQML--------- 154
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
                +GL Y+H   +  ++HRD+K  N+ ++ + + KI DFGLA+    +     M+  
Sbjct: 155 -----KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGY 201
Query: 815 AGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
             +  Y APE   +    N+ +DI+S G ++ E++TGK    G ++
Sbjct: 202 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 247

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 23/162 (14%)
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK-QGEPHTMSAVAGSF 818
           +GL Y+H +   + IHRD+K++N+LL  +   K+ADFG+A  L   Q + +T     G+ 
Sbjct: 131 KGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF---VGTP 184
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            + APE    +  + K DI+S G+  +EL  G+  N  D H     +      +  P   
Sbjct: 185 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN-SDMHPMRVLFL---IPKNNP--- 237
Query: 879 ALDKGIAEPCYLEEMTTVYRLAL-ICTSTLPSSRPSMKEVLQ 919
                   P  + + T  ++  +  C +  PS RP+ KE+L+
Sbjct: 238 --------PTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLK 271

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 111
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 112 ----TRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 163
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 164 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 123/288 (42%), Gaps = 37/288 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+      GE V    A+K +      + K  KE + E  ++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 74
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           ++ + ++ +L   C++S  +  L+ + M    L  ++   K ++ S      Q++L+W  
Sbjct: 75  SVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGS------QYLLNW-- 124
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                +  A+G+ Y+      +++HRD+ + N+L+ +    KI DFG AK+L  + + + 
Sbjct: 125 ----CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E         + D++S+GV + EL+T     Y     S         
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------- 228
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                I+  L+KG   P        VY +   C      SRP  +E++
Sbjct: 229 ----EISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 98/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
           AG+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 26/227 (11%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +++G+G   +V   +     + VA+K I   ++  +  E     EI +L  I+H NIV L
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCI--AKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 702 WCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                S     L+ + +    L DR +     +    S  + Q                 
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------------VLD 127
Query: 761 GLCYMHHDCTPQIIHRDVKSSNIL---LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            + Y+H      I+HRD+K  N+L   LD + K  I+DFGL+KM   +     +S   G+
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 181
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            GY APE       ++ +D +S GV+   L+ G    Y +    L E
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 228

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 26/227 (11%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +++G+G   +V   +     + VA+K I   ++  +  E     EI +L  I+H NIV L
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCI--AKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 702 WCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                S     L+ + +    L DR +     +    S  + Q                 
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------------VLD 127
Query: 761 GLCYMHHDCTPQIIHRDVKSSNIL---LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            + Y+H      I+HRD+K  N+L   LD + K  I+DFGL+KM   +     +S   G+
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 181
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            GY APE       ++ +D +S GV+   L+ G    Y +    L E
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 228

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 26/227 (11%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +++G+G   +V   +     + VA+K I   ++  +  E     EI +L  I+H NIV L
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCI--AKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 702 WCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                S     L+ + +    L DR +     +    S  + Q                 
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------------VLD 127
Query: 761 GLCYMHHDCTPQIIHRDVKSSNIL---LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            + Y+H      I+HRD+K  N+L   LD + K  I+DFGL+KM   +     +S   G+
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 181
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            GY APE       ++ +D +S GV+   L+ G    Y +    L E
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 228

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L       V      H+  
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---A 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M     +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 177 GTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 110
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 111 ----TRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 162
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 163 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 133
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 134 ----TRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 186 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 26/227 (11%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +++G+G   +V   +     + VA+K I   +K  +  E     EI +L  I+H NIV L
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCI--AKKALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 702 WCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                S     L+ + +    L DR +     +    S  + Q                 
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------------VLD 127
Query: 761 GLCYMHHDCTPQIIHRDVKSSNIL---LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            + Y+H      I+HRD+K  N+L   LD + K  I+DFGL+KM   +     +S   G+
Sbjct: 128 AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 181
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            GY APE       ++ +D +S GV+   L+ G    Y +    L E
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 228

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 108
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 109 ----TRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 160
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 161 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 131
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 132 ----TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 184 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 109
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 110 ----TRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 162 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 136
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 137 ----TRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 188
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 189 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 167
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +G   T+   
Sbjct: 168 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGATWTL--- 219
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 269

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 131
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 132 ----TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 184 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 134
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 135 ----TRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 187 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 131
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 132 ----TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 184 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 130
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 131 ----TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    ++  G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 183 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 133
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 134 ----TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 186 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 133
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 134 ----TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 186 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 37/293 (12%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILG 691
           + L +  ++GSG  G VY+      GE V    A+K +  N   + K  KE + E  ++ 
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMA 74
Query: 692 TIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
            +    + +L   C++S  +  LV + M    L    H R+     GS    Q +L+W  
Sbjct: 75  GVGSPYVSRLLGICLTS--TVQLVTQLMPYGCL--LDHVRENRGRLGS----QDLLNWCM 126
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
           ++      A+G+ Y+      +++HRD+ + N+L+ S    KI DFGLA++L      + 
Sbjct: 127 QI------AKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 177
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + A E     +   + D++S+GV + EL+T     Y               
Sbjct: 178 ADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDG------------- 224
Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
              + I D L+KG   P        VY + + C       RP  +E++    R
Sbjct: 225 IPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSR 277

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + DE   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYE 248

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 133
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 134 ----TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 186 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 620 KLTSFHQLGFTESNI---LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN 676
           K T F Q    E NI   ++  +   +IG GG G+VY       G+  A+K + + +++ 
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIK 228
Query: 677 QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS 736
            K  +       I+ ++          C+S        Y +     L   L      L++
Sbjct: 229 MKQGETLALNERIMLSLVSTGDCPFIVCMS--------YAFHTPDKLSFIL-----DLMN 275
Query: 737 GSSSVHQHVLHWP--TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA 794
           G   +H H+      +   +   AA+ +  + H     +++RD+K +NILLD     +I+
Sbjct: 276 G-GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 334
Query: 795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTG 850
           D GLA   +K+ +PH   A  G+ GY APE        +   D +S G +L +L+ G
Sbjct: 335 DLGLACDFSKK-KPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 620 KLTSFHQLGFTESNI---LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN 676
           K T F Q    E NI   ++  +   +IG GG G+VY       G+  A+K + + +++ 
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIK 228
Query: 677 QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS 736
            K  +       I+ ++          C+S        Y +     L   L      L++
Sbjct: 229 MKQGETLALNERIMLSLVSTGDCPFIVCMS--------YAFHTPDKLSFIL-----DLMN 275
Query: 737 GSSSVHQHVLHWP--TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA 794
           G   +H H+      +   +   AA+ +  + H     +++RD+K +NILLD     +I+
Sbjct: 276 G-GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 334
Query: 795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTG 850
           D GLA   +K+ +PH   A  G+ GY APE        +   D +S G +L +L+ G
Sbjct: 335 DLGLACDFSKK-KPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 52/241 (21%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRI-WNNRKLNQKLEKEFIAEIEILGT- 692
           L +L    LIG G  G VY+  ++     VAVK   + NR+        FI E  I    
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANRQ-------NFINEKNIYRVP 62
Query: 693 -IRHANIVKL-----WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL 746
            + H NI +                LLV EY  N SL ++L     SL         H  
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SL---------HTS 108
Query: 747 HWPTRLQIAIGAAQGLCYMHHDC------TPQIIHRDVKSSNILLDSEFKAKIADFGLA- 799
            W +  ++A    +GL Y+H +        P I HRD+ S N+L+ ++    I+DFGL+ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 800 ----KMLAKQGEPHTMS-AVAGSFGYFAPEYAYTTKVN--------EKIDIYSFGVVLLE 846
                 L + GE    + +  G+  Y APE      VN        +++D+Y+ G++  E
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 847 L 847
           +
Sbjct: 228 I 228

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 659 GAGEFVAVKR-IWNNRK---------LNQKLEK----EFIAEIEILGTIRHANIVKLWCC 704
           G G F +V++ ++  RK         L Q  EK    E + E +I+  + +  IV+L   
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 705 ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCY 764
             +E + +LV E      L ++L G++  +   + +    +LH     Q+++G       
Sbjct: 405 CQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVA---ELLH-----QVSMG------- 448
Query: 765 MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM-SAVAGSFGYFAP 823
           M +      +HR++ + N+LL +   AKI+DFGL+K L      +T  SA      ++AP
Sbjct: 449 MKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANY 855
           E     K + + D++S+GV + E ++  +  Y
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 620 KLTSFHQLGFTESNI---LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN 676
           K T F Q    E NI   ++  +   +IG GG G+VY       G+  A+K   + +++ 
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIK 228
Query: 677 QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS 736
            K  +       I+ ++          C+S        Y +     L   L      L++
Sbjct: 229 MKQGETLALNERIMLSLVSTGDCPFIVCMS--------YAFHTPDKLSFIL-----DLMN 275
Query: 737 GSSSVHQHVLHWP--TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA 794
           G   +H H+      +   +   AA+ +  + H     +++RD+K +NILLD     +I+
Sbjct: 276 G-GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 334
Query: 795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTG 850
           D GLA   +K+ +PH   A  G+ GY APE        +   D +S G +L +L+ G
Sbjct: 335 DLGLACDFSKK-KPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 620 KLTSFHQLGFTESNI---LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN 676
           K T F Q    E NI   ++  +   +IG GG G+VY       G+  A+K   + +++ 
Sbjct: 169 KFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIK 227
Query: 677 QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS 736
            K  +       I+ ++          C+S        Y +     L   L      L++
Sbjct: 228 MKQGETLALNERIMLSLVSTGDCPFIVCMS--------YAFHTPDKLSFIL-----DLMN 274
Query: 737 GSSSVHQHVLHWP--TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA 794
           G   +H H+      +   +   AA+ +  + H     +++RD+K +NILLD     +I+
Sbjct: 275 G-GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 333
Query: 795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTG 850
           D GLA   +K+ +PH   A  G+ GY APE        +   D +S G +L +L+ G
Sbjct: 334 DLGLACDFSKK-KPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 115
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 116 ----TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 167
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 168 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            T+ + IG G  G+VY+   N   E VA+K I  + +  +   ++   EI +L       
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 698 IVKLWCCISSENSKLLVYEYMENQS-LDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           I + +          ++ EY+   S LD    G      +  +++ + +L          
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEE--TYIATILREIL---------- 126
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              +GL Y+H +   + IHRD+K++N+LL  +   K+ADFG+A  L         +   G
Sbjct: 127 ---KGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NXFVG 178
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEAN 854
           +  + APE    +  + K DI+S G+  +EL  G+  N
Sbjct: 179 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 216

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E +++  + H   VKL+     +        Y +N  L +++    R + S   +     
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETC---- 130
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               TR   A      L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ +
Sbjct: 131 ----TRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +    +   G+  Y +PE        +  D+++ G ++ +LV G
Sbjct: 183 SKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 132
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +G   T+   
Sbjct: 133 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTL--- 184
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 185 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 234

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 17/226 (7%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ ++  + H NI+ L    + + S     E  ++  +   L       V      H+  
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHE-- 126
Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                  +++    Q LC + H  +  IIHRD+K SNI++ S+   KI DFGLA+     
Sbjct: 127 -------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---A 176
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G    M     +  Y APE        E +D++S G ++ E+V  K
Sbjct: 177 GTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT- 810
           L I I  A+ + ++H   +  ++HRD+K SNI    +   K+ DFGL   + +  E  T 
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 811 ---MSAVAGSFG------YFAPEYAYTTKVNEKIDIYSFGVVLLELV 848
              M A A   G      Y +PE  +    + K+DI+S G++L EL+
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 642 NLIGSGGSGQVY---RIDINGAGEFVAVKRIWNNRKLNQKLEKEFI-AEIEILGTIRHAN 697
            ++G+G  G+V+   +I  +  G+  A+K +     + +    E    E ++L  IR + 
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 698 -IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
            +V L     +E    L+ +Y+    L   L  R+R                 T  ++ I
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF----------------TEHEVQI 163
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              + +  + H     II+RD+K  NILLDS     + DFGL+K      E        G
Sbjct: 164 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCG 222
Query: 817 SFGYFAPEYAY--TTKVNEKIDIYSFGVVLLELVTGKEANYGD-EHTSLAEWAWRHYAEE 873
           +  Y AP+      +  ++ +D +S GV++ EL+TG      D E  S AE + R    E
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
Query: 874 KP 875
            P
Sbjct: 283 PP 284

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 86
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 133
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 134 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR-----TWXL 185
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 186 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 235

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 24/172 (13%)
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK-QGEPHTMSAVAGSF 818
           +GL Y+H +   + IHRD+K++N+LL    + K+ADFG+A  L   Q + +T     G+ 
Sbjct: 135 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF---VGTP 188
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            + APE    +  + K DI+S G+  +EL  G E  + + H     +      +  P T 
Sbjct: 189 FWMAPEVIKQSAYDSKADIWSLGITAIELARG-EPPHSELHPMKVLFL---IPKNNPPT- 243
Query: 879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ---ILRRCCPT 927
            L+   ++P  L+E          C +  PS RP+ KE+L+   ILR    T
Sbjct: 244 -LEGNYSKP--LKEFVEA------CLNKEPSFRPTAKELLKHKFILRNAKKT 286

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +G   T+   
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTL--- 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 29/232 (12%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 7   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 65
Query: 686 EIEILGTIRHANIVKLWCCISSENS------KLLVYEYMENQSLDRWLHGRKRSLVSGSS 739
           E+ ++  + H NI+ L    + + +        LV E M+                +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----------------ANLX 109
Query: 740 SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
            V Q  L       +      G+ ++H   +  IIHRD+K SNI++ S+   KI DFGLA
Sbjct: 110 QVIQMELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLA 166
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +     G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 167 R---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 22/171 (12%)
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           +GL Y+H +   + IHRD+K++N+LL    + K+ADFG+A  L         +   G+  
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNXFVGTPF 184
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           + APE    +  + K DI+S G+  +EL  G E  + + H     +      +  P T  
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARG-EPPHSELHPMKVLFL---IPKNNPPT-- 238
Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ---ILRRCCPT 927
           L+   ++P  L+E          C +  PS RP+ KE+L+   ILR    T
Sbjct: 239 LEGNYSKP--LKEFVEA------CLNKEPSFRPTAKELLKHKFILRNAKKT 281

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVK--RIWNNRKLNQKLEKEFIA---EIEILGTIR-H 695
           ++IG G S  V R      G   AVK   +   R   ++LE+   A   E  IL  +  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            +I+ L     S +   LV++ M    L  +L  +       + S+ + +L         
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL--------- 210
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               + + ++H +    I+HRD+K  NILLD   + +++DFG +  L + GE   +  + 
Sbjct: 211 ----EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGE--KLRELC 260
Query: 816 GSFGYFAPEYAYTTK------VNEKIDIYSFGVVLLELVTG 850
           G+ GY APE    +         +++D+++ GV+L  L+ G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 24/172 (13%)
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK-QGEPHTMSAVAGSF 818
           +GL Y+H +   + IHRD+K++N+LL    + K+ADFG+A  L   Q + +T     G+ 
Sbjct: 115 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF---VGTP 168
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            + APE    +  + K DI+S G+  +EL  G E  + + H     +      +  P T 
Sbjct: 169 FWMAPEVIKQSAYDSKADIWSLGITAIELARG-EPPHSELHPMKVLFL---IPKNNPPT- 223
Query: 879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ---ILRRCCPT 927
            L+   ++P  L+E          C +  PS RP+ KE+L+   ILR    T
Sbjct: 224 -LEGNYSKP--LKEFVEA------CLNKEPSFRPTAKELLKHKFILRNAKKT 266

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 652 VYRI-DINGAGEFVAVKRIWNNRKLNQKLEKEFI-----------------AEIEILGTI 693
           VY + ++ G G F  V+R  N R+  Q+   + +                  E  I   +
Sbjct: 27  VYELCEVIGKGPFSVVRRCIN-RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           +H +IV+L    SS+    +V+E+M+   L   +  R  +    S +V  H +      Q
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-----Q 140
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE---FKAKIADFGLAKMLAKQGEPHT 810
           I     + L Y H +    IIHRDVK   +LL S+      K+  FG+A  L + G    
Sbjct: 141 I----LEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--V 191
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG 856
                G+  + APE        + +D++  GV+L  L++G    YG
Sbjct: 192 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 139
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 140 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 191
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 241

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 29/232 (12%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENS------KLLVYEYMENQSLDRWLHGRKRSLVSGSS 739
           E+ ++  + H NI+ L    + + +        LV E M+                +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----------------ANLX 116
Query: 740 SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
            V Q  L       +      G+ ++H   +  IIHRD+K SNI++ S+   KI DFGLA
Sbjct: 117 QVIQMELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLA 173
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +     G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 174 R---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 22/171 (12%)
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           +GL Y+H +   + IHRD+K++N+LL    + K+ADFG+A  L         +   G+  
Sbjct: 115 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNXFVGTPF 169
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           + APE    +  + K DI+S G+  +EL  G E  + + H     +      +  P T  
Sbjct: 170 WMAPEVIKQSAYDSKADIWSLGITAIELARG-EPPHSELHPMKVLFL---IPKNNPPT-- 223
Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ---ILRRCCPT 927
           L+   ++P  L+E          C +  PS RP+ KE+L+   ILR    T
Sbjct: 224 LEGNYSKP--LKEFVEA------CLNKEPSFRPTAKELLKHKFILRNAKKT 266

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 29/232 (12%)
Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++    + NQ   K    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYR 72
Query: 686 EIEILGTIRHANIVKLWCCISSENS------KLLVYEYMENQSLDRWLHGRKRSLVSGSS 739
           E+ ++  + H NI+ L    + + +        LV E M+                +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----------------ANLX 116
Query: 740 SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
            V Q  L       +      G+ ++H   +  IIHRD+K SNI++ S+   KI DFGLA
Sbjct: 117 QVIQMELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLA 173
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +     G    M+    +  Y APE        E +DI+S G ++ E+V  K
Sbjct: 174 R---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI-LGTIRHANIVKLW 702
           +G G  G V +     +G+  AVKRI     +N + +K  + +++I   T+     V  +
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI--RATVNSQEQKRLLXDLDISXRTVDCPFTVTFY 99
Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             +  E    +  E + + SLD++     + ++    ++ + +L      +IA+   + L
Sbjct: 100 GALFREGDVWICXE-LXDTSLDKFY----KQVIDKGQTIPEDILG-----KIAVSIVKAL 149
Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            ++H   +  +IHRDVK SN+L+++  + K  DFG++  L    +       AG   Y A
Sbjct: 150 EHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLV---DDVAKDIDAGCKPYXA 204
Query: 823 PEYAYTTKVNE-----KIDIYSFGVVLLEL 847
           PE     ++N+     K DI+S G+  +EL
Sbjct: 205 PE-RINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 167
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 168 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 219
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 269

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 652 VYRI-DINGAGEFVAVKRIWNNRKLNQKLEKEFI-----------------AEIEILGTI 693
           VY + ++ G G F  V+R  N R+  Q+   + +                  E  I   +
Sbjct: 25  VYELCEVIGKGPFSVVRRCIN-RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           +H +IV+L    SS+    +V+E+M+   L   +  R  +    S +V  H +      Q
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-----Q 138
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE---FKAKIADFGLAKMLAKQGEPHT 810
           I     + L Y H +    IIHRDVK   +LL S+      K+  FG+A  L + G    
Sbjct: 139 I----LEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--V 189
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG 856
                G+  + APE        + +D++  GV+L  L++G    YG
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 106/259 (40%), Gaps = 35/259 (13%)
Query: 627 LGFTESNILSSLTESNLIGSGGSGQ--VYRIDINGAGEFVAVKRIWNN---RKLNQKLEK 681
           L F   ++L    + +L G+ G G   V R+ I      +   +I N    R++N K  +
Sbjct: 14  LYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE 73
Query: 682 EFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLH-------GR---- 730
               E+ ++  + H NI +L+     E    LV E      L   L+       G+    
Sbjct: 74  RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133
Query: 731 ------------KRSLVSGSSSVHQHVLHWPTRLQ-IAIGAAQGLCYMHHDCTPQIIHRD 777
                           ++GS    +  L +  R + I+    Q    +H+     I HRD
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRD 193
Query: 778 VKSSNILL--DSEFKAKIADFGLAKMLAK--QGEPHTMSAVAGSFGYFAPEYAYTTK--V 831
           +K  N L   +  F+ K+ DFGL+K   K   GE + M+  AG+  + APE   TT    
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253
Query: 832 NEKIDIYSFGVVLLELVTG 850
             K D +S GV+L  L+ G
Sbjct: 254 GPKCDAWSAGVLLHLLLMG 272

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY     +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+++D +   K+ DFGLAK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 671 NNRKLNQKLE-KEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL---DRW 726
           NN K++ K +  +F  E++I+  I++   +     I++ +   ++YEYMEN S+   D +
Sbjct: 77  NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY 136
Query: 727 LHGRKRSLVSGSSSVHQHVLHWPTRLQIAI--GAAQGLCYMHHDCTPQIIHRDVKSSNIL 784
                ++          +    P ++   I         Y+H++    I HRDVK SNIL
Sbjct: 137 FFVLDKN----------YTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNIL 184
Query: 785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYA--YTTKVNEKIDIYSFGV 842
           +D   + K++DFG ++ +  +     +    G++ +  PE+    ++    K+DI+S G+
Sbjct: 185 MDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240
Query: 843 VL 844
            L
Sbjct: 241 CL 242

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 95/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY     +  + H R+   +   S  H            
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR---IGRFSEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+++D +   K+ DFG AK +  +        +
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 628 GFTESNILSSLTESN------LIGSGGSGQVYRIDINGAGEFVAVKRI-WNNRKLNQKLE 680
           G  ES++L    E +      ++G G  G VY          +A+K I   + + +Q L 
Sbjct: 8   GDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH 67
Query: 681 KEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
           +E    I +   ++H NIV+     S      +  E +   SL   L  +      G   
Sbjct: 68  EE----IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK-----WGPLK 118
Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLA 799
            ++  + + T+ QI     +GL Y+H +   QI+HRD+K  N+L+++     KI+DFG +
Sbjct: 119 DNEQTIGFYTK-QIL----EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTS 170
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYT--TKVNEKIDIYSFGVVLLELVTGKEANY 855
           K LA  G         G+  Y APE          +  DI+S G  ++E+ TGK   Y
Sbjct: 171 KRLA--GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 34/182 (18%)
Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML------AKQ 805
           +   +  A+G+ Y+      + +HRD+ + N +LD  F  K+ADFGLA+ +      + Q
Sbjct: 127 ISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183
Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
              H    V     + A E   T +   K D++SFGV+L EL+T     Y          
Sbjct: 184 QHRHARLPVK----WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY---------- 229
Query: 866 AWRHYAEEKPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMK----EVLQ 919
             RH  +   +T  L +G  + +P Y  +  ++Y++   C    P+ RP+ +    EV Q
Sbjct: 230 --RH-IDPFDLTHFLAQGRRLPQPEYCPD--SLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284
Query: 920 IL 921
           I+
Sbjct: 285 IV 286

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 95/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  I   + 
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY     +  + H R+   +   S  H            
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEM--FSHLRR---IGRFSEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   K+ADFG AK +  +        +
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXL 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   +  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFAEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+++D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ ++  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYE 248

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/230 (20%), Positives = 92/230 (40%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY                +  G    H   +        
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEY----------------VAGGEMFSHLRRIGRFXEPHA 138
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 139 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 193
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 194 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 243

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    +G G  G+V+R+     G   AVK++        +LE   + E+     +    
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRVEELVACAGLSSPR 111
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV L+  +       +  E +E  SL +        L+     + +       R    +G
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQ--------LIKQMGCLPE------DRALYYLG 157
Query: 758 AA-QGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEPHTM---S 812
            A +GL Y+H   T +I+H DVK+ N+LL S+  +A + DFG A  L   G   ++    
Sbjct: 158 QALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            + G+  + APE       + K+DI+S   ++L ++ G
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/230 (20%), Positives = 92/230 (40%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY                +  G    H   +        
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEY----------------VAGGEMFSHLRRIGRFXEPHA 143
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/230 (20%), Positives = 92/230 (40%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY                +  G    H   +        
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEY----------------VAGGEMFSHLRRIGRFXEPHA 143
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/230 (20%), Positives = 92/230 (40%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY                +  G    H   +        
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEY----------------VAGGEMFSHLRRIGRFXEPHA 164
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 219
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 269

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 95/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY     +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+++D +   K+ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/230 (20%), Positives = 92/230 (40%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY                +  G    H   +        
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEY----------------VAGGEMFSHLRRIGRFXEPHA 143
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRI-WNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           ++G G  G VY          +A+K I   + + +Q L +E    I +   ++H NIV+ 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE----IALHKHLKHKNIVQY 70
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
               S      +  E +   SL   L  +      G    ++  + + T+ QI     +G
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSK-----WGPLKDNEQTIGFYTK-QIL----EG 120
Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           L Y+H +   QI+HRD+K  N+L+++     KI+DFG +K LA  G         G+  Y
Sbjct: 121 LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGTLQY 175
Query: 821 FAPEYAYT--TKVNEKIDIYSFGVVLLELVTGKEANY 855
            APE          +  DI+S G  ++E+ TGK   Y
Sbjct: 176 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 212

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    +G G  G+V+R+     G   AVK++        +LE   + E+     +    
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRVEELVACAGLSSPR 127
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV L+  +       +  E +E  SL +        L+     + +       R    +G
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQ--------LIKQMGCLPE------DRALYYLG 173
Query: 758 AA-QGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEPHTM---S 812
            A +GL Y+H   T +I+H DVK+ N+LL S+  +A + DFG A  L   G   ++    
Sbjct: 174 QALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 230
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            + G+  + APE       + K+DI+S   ++L ++ G
Sbjct: 231 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +      H            
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFXEPHARFY-------- 139
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 140 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 191
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 241

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY     +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+++D +   ++ DFGLAK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           +T    +G G  G+V+R+     G   AVK++        +LE   + E+     +    
Sbjct: 74  MTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRVEELVACAGLSSPR 125
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV L+  +       +  E +E  SL +        L+     + +       R    +G
Sbjct: 126 IVPLYGAVREGPWVNIFMELLEGGSLGQ--------LIKQMGCLPE------DRALYYLG 171
Query: 758 AA-QGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEPHTM---S 812
            A +GL Y+H   T +I+H DVK+ N+LL S+  +A + DFG A  L   G   ++    
Sbjct: 172 QALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 228
Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            + G+  + APE       + K+DI+S   ++L ++ G
Sbjct: 229 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 642 NLIGSGGSGQVYRIDI---NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
            ++G G  G V   ++   +G    VAVK +  +    +++E EF++E   +    H N+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE-EFLSEAACMKDFSHPNV 98
Query: 699 VKLW-CCISSENS----KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           ++L   CI   +      +++  +M+   L  +L      L S   +  +H+    T L+
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL------LYSRLETGPKHI-PLQTLLK 151
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
             +  A G+ Y+ +      +HRD+ + N +L  +    +ADFGL+K +   G+ +    
Sbjct: 152 FMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIY-SGDYYRQGR 207
Query: 814 VAG-SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYA 871
           +A     + A E         K D+++FGV + E+ T     Y G ++  + ++    + 
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS 913
            ++P  D LD+             +Y +   C  T P  RP+
Sbjct: 268 LKQP-EDCLDE-------------LYEIMYSCWRTDPLDRPT 295

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y AP    +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY     +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+++D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +      H            
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFXEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +      H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFXEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 31/207 (14%)
Query: 648 GSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS 707
           G+G+ Y      A +F+  +R+ ++R+   + E E   E+ IL  IRH NI+ L     +
Sbjct: 49  GTGKEY------AAKFIKKRRLXSSRRGVSREEIE--REVNILREIRHPNIITLHDIFEN 100
Query: 708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH 767
           +   +L+ E +    L  +L   K SL    ++            Q       G+ Y+H 
Sbjct: 101 KTDVVLILELVSGGELFDFL-AEKESLTEDEAT------------QFLKQILDGVHYLH- 146
Query: 768 DCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
             + +I H D+K  NI LLD      + K+ DFG+A  +    E      + G+  + AP
Sbjct: 147 --SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAP 201
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTG 850
           E      +  + D++S GV+   L++G
Sbjct: 202 EIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +      H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRR---IGRFXEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 94/230 (40%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY     +  + H R+   +      H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR---IGRFXEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+++D +   K+ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 94/230 (40%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              + KL       ++  +V EY     +  + H R+   +   S  H            
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR---IGRFSEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+++D +   K+ DFG AK +  +        +
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 94/230 (40%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              + KL       ++  +V EY     +  + H R+   +   S  H            
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR---IGRFSEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+++D +   K+ DFG AK +  +        +
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 31/207 (14%)
Query: 648 GSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS 707
           G+G+ Y      A +F+  +R+ ++R+   + E E   E+ IL  IRH NI+ L     +
Sbjct: 35  GTGKEY------AAKFIKKRRLSSSRRGVSREEIE--REVNILREIRHPNIITLHDIFEN 86
Query: 708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH 767
           +   +L+ E +    L  +L   K SL    ++            Q       G+ Y+H 
Sbjct: 87  KTDVVLILELVSGGELFDFL-AEKESLTEDEAT------------QFLKQILDGVHYLH- 132
Query: 768 DCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
             + +I H D+K  NI LLD      + K+ DFG+A  +    E      + G+  + AP
Sbjct: 133 --SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAP 187
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTG 850
           E      +  + D++S GV+   L++G
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTIRHANIVKL 701
           +IG G  G+V  + +  A +  A+K I N  ++ ++ E   F  E ++L       I  L
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSV--HQHVLHWPTRLQIAIGAA 759
                 +N+  LV +Y        ++ G   +L+S        +    +   + IAI + 
Sbjct: 140 HYAFQDDNNLYLVMDY--------YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
             L Y         +HRD+K  NIL+D     ++ADFG    L + G   +  AV G+  
Sbjct: 192 HQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPD 241
Query: 820 YFAPEYAYTT-----KVNEKIDIYSFGVVLLELVTGKEANYGD 857
           Y +PE          +   + D +S GV + E++ G+   Y +
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 84/184 (45%), Gaps = 40/184 (21%)
Query: 681 KEFIAEIEILGTIRHANIVKLWCCIS--SENSKLLVYEYMENQSLDRWLHGRKRSLVSGS 738
           ++   EI IL  + H N+VKL   +   +E+   +V+E + NQ                 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV-NQG---------------- 123
Query: 739 SSVHQHVLHWPTRLQIAIGAA--------QGLCYMHHDCTPQIIHRDVKSSNILLDSEFK 790
                 V+  PT   ++   A        +G+ Y+H+    +IIHRD+K SN+L+  +  
Sbjct: 124 -----PVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGH 175
Query: 791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK---VNEKIDIYSFGVVLLEL 847
            KIADFG++     +G    +S   G+  + APE    T+     + +D+++ GV L   
Sbjct: 176 IKIADFGVSNEF--KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 848 VTGK 851
           V G+
Sbjct: 234 VFGQ 237

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 31/207 (14%)
Query: 648 GSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS 707
           G+G+ Y      A +F+  +R+ ++R+   + E E   E+ IL  IRH NI+ L     +
Sbjct: 28  GTGKEY------AAKFIKKRRLSSSRRGVSREEIE--REVNILREIRHPNIITLHDIFEN 79
Query: 708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH 767
           +   +L+ E +    L  +L   K SL    ++            Q       G+ Y+H 
Sbjct: 80  KTDVVLILELVSGGELFDFL-AEKESLTEDEAT------------QFLKQILDGVHYLH- 125
Query: 768 DCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
             + +I H D+K  NI LLD      + K+ DFG+A  +    E      + G+  + AP
Sbjct: 126 --SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAP 180
Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTG 850
           E      +  + D++S GV+   L++G
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL------NQKLEKEFIAEIEILGTIRHAN 697
           +GSG  G V+        + V VK I   + L      + KL K    EI IL  + HAN
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK-VTLEIAILSRVEHAN 90
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQH-VLHWPTRLQIAI 756
           I+K             V +  ENQ   + +  +  S +   + + +H  L  P    I  
Sbjct: 91  IIK-------------VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
                + Y+       IIHRD+K  NI++  +F  K+ DFG A  L +    +T     G
Sbjct: 138 QLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CG 191
Query: 817 SFGYFAPEYAYTTKVN-EKIDIYSFGVVLLELV 848
           +  Y APE          +++++S GV L  LV
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 96/230 (41%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              +VKL       ++  +V EY+    +  + H R+   +   S  H            
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRR---IGRFSEPHARFY-------- 146
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+L+D +   ++ DFG AK +  +        +
Sbjct: 147 ---AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+    APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 21/223 (9%)
Query: 643 LIGSGGSGQV-----YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHA 696
           ++GSG  G+V     Y I   G    VAVK +    K +    +  ++E++++  +  H 
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKMMTQLGSHE 109
Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQH----------VL 746
           NIV L    +      L++EY     L  +L  ++                       VL
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   L  A   A+G+ ++        +HRD+ + N+L+      KI DFGLA+ +    
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT 849
                        + APE  +      K D++S+G++L E+ +
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+R++    G   AVK++        +LE     E+     +    IV L+ 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV--------RLEVFRAEELMACAGLTSPRIVPLYG 152
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +       +  E +E  SL             G     Q  L     L     A +GL 
Sbjct: 153 AVREGPWVNIFMELLEGGSL-------------GQLVKEQGCLPEDRALYYLGQALEGLE 199
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEPHTM---SAVAGSFG 819
           Y+H   + +I+H DVK+ N+LL S+   A + DFG A  L   G   ++     + G+  
Sbjct: 200 YLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET 256
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           + APE       + K+D++S   ++L ++ G
Sbjct: 257 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 137/316 (43%), Gaps = 61/316 (19%)
Query: 631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           E ++ + +    ++G G SG V     +  G  VAVKR+  +      +E + + E +  
Sbjct: 28  EQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD-- 84
Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
               H N+++ +C   SE +   +Y  +E  +L+  L     S      ++     + P 
Sbjct: 85  ---DHPNVIRYYC---SETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPI 136
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL--DSEFKAK-----------IADFG 797
            L   I  A G+ ++H   + +IIHRD+K  NIL+   S F A            I+DFG
Sbjct: 137 SLLRQI--ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 798 LAKML--AKQGEPHTMSAVAGSFGYFAPEY---AYTTKVNEKIDIYSFGVVLLELVTGKE 852
           L K L   +      ++  +G+ G+ APE    +   ++   IDI+S G V   +++  +
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 853 ANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTST------ 906
             +GD+           Y+ E  I     +GI     L+EM  ++  +LI  +T      
Sbjct: 252 HPFGDK-----------YSRESNII----RGIFS---LDEMKCLHDRSLIAEATDLISQM 293
Query: 907 ---LPSSRPSMKEVLQ 919
               P  RP+  +VL+
Sbjct: 294 IDHDPLKRPTAMKVLR 309

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+V+R++    G   AVK++        +LE     E+     +    IV L+ 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV--------RLEVFRAEELMACAGLTSPRIVPLYG 133
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            +       +  E +E  SL             G     Q  L     L     A +GL 
Sbjct: 134 AVREGPWVNIFMELLEGGSL-------------GQLVKEQGCLPEDRALYYLGQALEGLE 180
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQG---EPHTMSAVAGSFG 819
           Y+H   + +I+H DVK+ N+LL S+   A + DFG A  L   G   +  T   + G+  
Sbjct: 181 YLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET 237
Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           + APE       + K+D++S   ++L ++ G
Sbjct: 238 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 26/179 (14%)
Query: 686 EIEILGTIRHANIVKLW-CCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
           EI +L  ++H N++ L    +S  + K+ L+++Y E+   D W H  K    S ++    
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH---DLW-HIIKFHRASKANK--- 120
Query: 744 HVLHWPTRLQIAIGAAQGLCY-----MHHDCTPQIIHRDVKSSNILLDSE----FKAKIA 794
                   +Q+  G  + L Y     +H+     ++HRD+K +NIL+  E     + KIA
Sbjct: 121 ------KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174
Query: 795 DFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEK-IDIYSFGVVLLELVTGK 851
           D G A++     +P   +  V  +F Y APE     +   K IDI++ G +  EL+T +
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 137/316 (43%), Gaps = 61/316 (19%)
Query: 631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           E ++ + +    ++G G SG V     +  G  VAVKR+  +      +E + + E +  
Sbjct: 28  EQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD-- 84
Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
               H N+++ +C   SE +   +Y  +E  +L+  L     S      ++     + P 
Sbjct: 85  ---DHPNVIRYYC---SETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPI 136
Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL--DSEFKAK-----------IADFG 797
            L   I  A G+ ++H   + +IIHRD+K  NIL+   S F A            I+DFG
Sbjct: 137 SLLRQI--ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 798 LAKML--AKQGEPHTMSAVAGSFGYFAPEY---AYTTKVNEKIDIYSFGVVLLELVTGKE 852
           L K L   +      ++  +G+ G+ APE    +   ++   IDI+S G V   +++  +
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 853 ANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTST------ 906
             +GD+           Y+ E  I     +GI     L+EM  ++  +LI  +T      
Sbjct: 252 HPFGDK-----------YSRESNII----RGIFS---LDEMKCLHDRSLIAEATDLISQM 293
Query: 907 ---LPSSRPSMKEVLQ 919
               P  RP+  +VL+
Sbjct: 294 IDHDPLKRPTAMKVLR 309

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 40/231 (17%)
Query: 656 DINGAGEFVAVKRIWNNRKLNQKL---------------EKEFIAEIEILGTIRHANIVK 700
           D+ G G +  VK + ++  L ++                E     EI++L  +RH N+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 701 LWCCISSENSK--LLVYEYM---ENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           L   + +E  +   +V EY      + LD      KR  V  +      ++         
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLI--------- 119
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
                GL Y+H   +  I+H+D+K  N+LL +    KI+  G+A+ L       T     
Sbjct: 120 ----DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 816 GSFGYFAPEYA--YTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
           GS  +  PE A    T    K+DI+S GV L  + TG     GD    L E
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE 223

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/230 (20%), Positives = 93/230 (40%), Gaps = 21/230 (9%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           L        +G+G  G+V  +     G   A+K +   + +  K  +  + E  IL  + 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              + KL       ++  +V EY     +  + H R+   +      H            
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRR---IGRFXEPHARFY-------- 147
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
              AAQ +    +  +  +I+RD+K  N+++D +   K+ DFG AK +  +        +
Sbjct: 148 ---AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXL 199
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
            G+  Y APE   +   N+ +D ++ GV++ E+  G    + D+   + E
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 249

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G  G+VY+       E VA+KRI    +  + +    I E+ +L  ++H NI++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
            I   +   L++EY EN            S+    S ++Q +               G+ 
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLI--------------NGVN 146
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKA-----KIADFGLAKMLAKQGEPHTMSAVAGSF 818
           + H   + + +HRD+K  N+LL     +     KI DFGLA+         T   +  + 
Sbjct: 147 FCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TL 201
Query: 819 GYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
            Y  PE    ++  +  +DI+S   +  E++       GD
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 34/217 (15%)
Query: 651 QVYRIDIN----GAGEFVAVKRIWNNRK--------LNQKLEKEFIAEIEILGTIR-HAN 697
           Q Y +D+     G G F   ++  + +         +++++E     EI  L     H N
Sbjct: 8   QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPN 67
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IVKL      +    LV E +    L   +  +K    + +S + + ++           
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV----------- 116
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSE---FKAKIADFGLAKMLAKQGEPHTMSAV 814
               + +MH      ++HRD+K  N+L   E    + KI DFG A++     +P  +   
Sbjct: 117 --SAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTP 169
Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
             +  Y APE       +E  D++S GV+L  +++G+
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 92/240 (38%), Gaps = 54/240 (22%)
Query: 628 GFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI--- 684
           G T+ +I    T  N IG G  G+V           +AV++    R+  +K+ K F+   
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVK----------IAVQKGTRIRRAAKKIPKYFVEDV 50
Query: 685 ----AEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
                EIEI+ ++ H NI++L+          LV E      L                 
Sbjct: 51  DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL-------------FERV 97
Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL--DS-EFKAKIADFG 797
           VH+ V       +I       + Y H      + HRD+K  N L   DS +   K+ DFG
Sbjct: 98  VHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFG 154
Query: 798 LAK-------MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           LA        M  K G P+ +S      G + PE           D +S GV++  L+ G
Sbjct: 155 LAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPE----------CDEWSAGVMMYVLLCG 203

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 35/257 (13%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTIRHANIVK 700
            +IG G   +V  + +   G+  A+K I N   + ++ E   F  E ++L       I +
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMK-IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS--GSSSVHQHVLHWPTRLQIAIGA 758
           L      EN   LV EY        ++ G   +L+S  G     +    +   + +AI +
Sbjct: 126 LHFAFQDENYLYLVMEY--------YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
              L Y         +HRD+K  NILLD     ++ADFG    L   G   ++ AV G+ 
Sbjct: 178 VHRLGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTP 227
Query: 819 GYFAPEYAYTTKVNE-------KIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR--H 869
            Y +PE                + D ++ GV   E+  G+   Y D   S AE   +  H
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD---STAETYGKIVH 284
Query: 870 YAEEKPITDALDKGIAE 886
           Y E   +   +D+G+ E
Sbjct: 285 YKEHLSLP-LVDEGVPE 300

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 81/322 (25%), Positives = 140/322 (43%), Gaps = 69/322 (21%)
Query: 631 ESNILSSLTESNLIGSGGSGQVYRIDINGA--GEFVAVKRIWNNRKLNQKLEKEFIAEIE 688
           E ++ + +    ++G G SG V      G+  G  VAVKR+  +      +E + + E +
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVV---FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 689 ILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
                 H N+++ +C   SE +   +Y  +E  +L+  L     S      ++     + 
Sbjct: 67  -----DHPNVIRYYC---SETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYN 116
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL--DSEFKAK-----------IAD 795
           P  L   I  A G+ ++H   + +IIHRD+K  NIL+   S F A            I+D
Sbjct: 117 PISLLRQI--ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 796 FGLAKML-AKQGEPHT-MSAVAGSFGYFAPEYAYTT-------KVNEKIDIYSFGVVLLE 846
           FGL K L + Q    T ++  +G+ G+ APE    +       ++   IDI+S G V   
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 847 LVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTST 906
           +++  +  +GD+           Y+ E  I     +GI     L+EM  ++  +LI  +T
Sbjct: 232 ILSKGKHPFGDK-----------YSRESNII----RGIFS---LDEMKCLHDRSLIAEAT 273
Query: 907 ---------LPSSRPSMKEVLQ 919
                     P  RP+  +VL+
Sbjct: 274 DLISQMIDHDPLKRPTAMKVLR 295

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 92/240 (38%), Gaps = 54/240 (22%)
Query: 628 GFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI--- 684
           G T+ +I    T  N IG G  G+V           +AV++    R+  +K+ K F+   
Sbjct: 18  GSTKGDINQYYTLENTIGRGSWGEVK----------IAVQKGTRIRRAAKKIPKYFVEDV 67
Query: 685 ----AEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
                EIEI+ ++ H NI++L+          LV E      L                 
Sbjct: 68  DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL-------------FERV 114
Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL--DS-EFKAKIADFG 797
           VH+ V       +I       + Y H      + HRD+K  N L   DS +   K+ DFG
Sbjct: 115 VHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFG 171
Query: 798 LAK-------MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           LA        M  K G P+ +S      G + PE           D +S GV++  L+ G
Sbjct: 172 LAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPE----------CDEWSAGVMMYVLLCG 220

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 127/305 (41%), Gaps = 52/305 (17%)
Query: 627 LGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRI--WNNRKLNQKLEKEFI 684
           + F + N L+ L E++      SG++++    G    V V ++  W+ RK      ++F 
Sbjct: 7   IDFKQLNFLTKLNENH------SGELWKGRWQGNDIVVKVLKVRDWSTRK-----SRDFN 55
Query: 685 AEIEILGTIRHANIVKLW--CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
            E   L    H N++ +   C         L+  +M   SL   LH     +V  S +V 
Sbjct: 56  EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV- 114
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
                     + A+  A+G+ ++H    P I    + S ++++D +  A+I+   +A + 
Sbjct: 115 ----------KFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARIS---MADVK 160
Query: 803 AKQGEPHTMSAVAGSFGYFAPEYAYTTKVNE----KIDIYSFGVVLLELVTGKEANYGDE 858
                P  M A A    + APE A   K  +      D++SF V+L ELVT +E  + D 
Sbjct: 161 FSFQSPGRMYAPA----WVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVT-REVPFAD- 213
Query: 859 HTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
             S  E   +   E   +   +  GI+          V +L  IC +  P+ RP    ++
Sbjct: 214 -LSNMEIGMKVALEG--LRPTIPPGIS--------PHVSKLMKICMNEDPAKRPKFDMIV 262
Query: 919 QILRR 923
            IL +
Sbjct: 263 PILEK 267

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 40/241 (16%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIV 699
            +LIG G  G VY        + VA+K++  NR     ++ K  + EI IL  ++   I+
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYII 88
Query: 700 KLWCCISSENSKLLVYE--YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           +L+  I  ++  LL ++  Y+  +  D  L   K+   +      +H+        I   
Sbjct: 89  RLYDLIIPDD--LLKFDELYIVLEIADSDL---KKLFKTPIFLTEEHIK------TILYN 137
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE---------- 807
              G  ++H      IIHRD+K +N LL+ +   K+ DFGLA+ +  + +          
Sbjct: 138 LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 808 ----PHT------MSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYG 856
               PH       +++   +  Y APE     +   + IDI+S G +  EL+   +++  
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
Query: 857 D 857
           D
Sbjct: 255 D 255

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIV 699
            +LIG G  G VY      A + VA+K++  NR     ++ K  + EI IL  ++   I+
Sbjct: 33  KHLIGRGSYGYVYLAYDKNANKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYII 90
Query: 700 KLWCCISSENSKLLVYE--YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           +L   I  E+  LL ++  Y+  +  D  L   K+   +      QHV        I   
Sbjct: 91  RLHDLIIPED--LLKFDELYIVLEIADSDL---KKLFKTPIFLTEQHVK------TILYN 139
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
              G  ++H      IIHRD+K +N LL+ +   KI DFGLA+ +    + H ++
Sbjct: 140 LLLGEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVN 191

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G V++   +        VA+K   N    +  + ++F+ E   +    H +IVK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   I+ EN   ++ E      L  +L  RK SL   S  ++ + L            + 
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL------------ST 122
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+    + + +HRD+ + N+L+ S    K+ DFGL++ + +    +  S       +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 178
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELV 848
            APE     +     D++ FGV + E++
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 79/322 (24%), Positives = 138/322 (42%), Gaps = 69/322 (21%)
Query: 631 ESNILSSLTESNLIGSGGSGQVYRIDINGA--GEFVAVKRIWNNRKLNQKLEKEFIAEIE 688
           E ++ + +    ++G G SG V      G+  G  VAVKR+  +      +E + + E +
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVV---FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 689 ILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
                 H N+++ +C   SE +   +Y  +E  +L+  L     S      ++     + 
Sbjct: 67  -----DHPNVIRYYC---SETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYN 116
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL--DSEFKAK-----------IAD 795
           P  L   I  A G+ ++H   + +IIHRD+K  NIL+   S F A            I+D
Sbjct: 117 PISLLRQI--ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 796 FGLAKML--AKQGEPHTMSAVAGSFGYFAPEYAYTT-------KVNEKIDIYSFGVVLLE 846
           FGL K L   +      ++  +G+ G+ APE    +       ++   IDI+S G V   
Sbjct: 172 FGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 847 LVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTST 906
           +++  +  +GD+           Y+ E  I     +GI     L+EM  ++  +LI  +T
Sbjct: 232 ILSKGKHPFGDK-----------YSRESNII----RGIFS---LDEMKCLHDRSLIAEAT 273
Query: 907 ---------LPSSRPSMKEVLQ 919
                     P  RP+  +VL+
Sbjct: 274 DLISQMIDHDPLKRPTAMKVLR 295

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 61
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 62  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 120
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 121 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 32/224 (14%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           S+++G G +  V+R      G+  A+K ++NN    + ++ + + E E+L  + H NIVK
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIK-VFNNISFLRPVDVQ-MREFEVLKKLNHKNIVK 71
Query: 701 LWCC--ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           L+     ++   K+L+ E+    SL   L     +     S        +   L+  +G 
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE-------FLIVLRDVVGG 124
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILL----DSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
                 M+H     I+HR++K  NI+     D +   K+ DFG A+ L    +     ++
Sbjct: 125 ------MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSL 175
Query: 815 AGSFGYFAP---EYAYTTKVNEK-----IDIYSFGVVLLELVTG 850
            G+  Y  P   E A   K ++K     +D++S GV      TG
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 61
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 62  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 120
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 121 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G V++   +        VA+K   N    +  + ++F+ E   +    H +IVK
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   I+ EN   ++ E      L  +L  RK SL   S  ++ + L            + 
Sbjct: 104 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL------------ST 150
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+    + + +HRD+ + N+L+ S    K+ DFGL++ + +    +  S       +
Sbjct: 151 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 206
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELV 848
            APE     +     D++ FGV + E++
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 59/236 (25%), Positives = 90/236 (38%), Gaps = 36/236 (15%)
Query: 631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           ES    S    + +G G  G+V+++     G   AVKR  +  +   K     +AE+   
Sbjct: 52  ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVG-- 108
Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSG--SSSVHQHVLHW 748
               H  + +  CC+  E +               W  G    L +     S+ QH   W
Sbjct: 109 ---SHEKVGQHPCCVRLEQA---------------WEEGGILYLQTELCGPSLQQHCEAW 150
Query: 749 PTRL---QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
              L   Q+       L  + H  +  ++H DVK +NI L    + K+ DFGL   L   
Sbjct: 151 GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210
Query: 806 GEPHTMSAVAGSFGYFAPEY---AYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
           G         G   Y APE    +Y T      D++S G+ +LE+    E  +G E
Sbjct: 211 GAGEVQE---GDPRYMAPELLQGSYGTAA----DVFSLGLTILEVACNMELPHGGE 259

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G V++   +        VA+K   N    +  + ++F+ E   +    H +IVK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   I+ EN   ++ E      L  +L  RK SL   S  ++ + L            + 
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL------------ST 122
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+    + + +HRD+ + N+L+ S    K+ DFGL++ + +    +  S       +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 178
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELV 848
            APE     +     D++ FGV + E++
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 3/85 (3%)
Query: 775 HRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT-MSAVAGSFGYFAPEYAYTTKVNE 833
           HRDVK  NIL+ ++  A + DFG+A   A   E  T +    G+  Y APE    +    
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 834 KIDIYSFGVVLLELVTGKEANYGDE 858
           + DIY+   VL E +TG     GD+
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQ 239

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 34/225 (15%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           S+++G G +  V+R      G+  A+K ++NN    + ++ + + E E+L  + H NIVK
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIK-VFNNISFLRPVDVQ-MREFEVLKKLNHKNIVK 71
Query: 701 LWCCISSENS---KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           L+  I  E +   K+L+ E+    SL   L     +     S        +   L+  +G
Sbjct: 72  LF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE-------FLIVLRDVVG 123
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILL----DSEFKAKIADFGLAKMLAKQGEPHTMSA 813
                  M+H     I+HR++K  NI+     D +   K+ DFG A+ L    +      
Sbjct: 124 G------MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVX 174
Query: 814 VAGSFGYFAP---EYAYTTKVNEK-----IDIYSFGVVLLELVTG 850
           + G+  Y  P   E A   K ++K     +D++S GV      TG
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 15/170 (8%)
Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
           +  +   A+G+ ++    + + IHRD+ + NILL      KI DFGLA+ + K  +    
Sbjct: 202 ISYSFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRK 258
Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA 871
                   + APE  +    + K D++S+GV+L E+             SL    +    
Sbjct: 259 GDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIF------------SLGGSPYPGVQ 306
Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            ++     L +G+           +Y++ L C    P  RP   E+++ L
Sbjct: 307 MDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G V++   +        VA+K   N    +  + ++F+ E   +    H +IVK
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   I+ EN   ++ E      L  +L  RK SL   S  ++ + L            + 
Sbjct: 81  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL------------ST 127
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+    + + +HRD+ + N+L+ S    K+ DFGL++ + +    +  S       +
Sbjct: 128 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 183
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELV 848
            APE     +     D++ FGV + E++
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G V++   +        VA+K   N    +  + ++F+ E   +    H +IVK
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   I+ EN   ++ E      L  +L  RK SL   S  ++ + L            + 
Sbjct: 79  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL------------ST 125
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+    + + +HRD+ + N+L+ S    K+ DFGL++ + +    +  S       +
Sbjct: 126 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 181
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELV 848
            APE     +     D++ FGV + E++
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G V++   +        VA+K   N    +  + ++F+ E   +    H +IVK
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   I+ EN   ++ E      L  +L  RK SL   S  ++ + L            + 
Sbjct: 78  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL------------ST 124
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+    + + +HRD+ + N+L+ S    K+ DFGL++ + +    +  S       +
Sbjct: 125 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 180
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELV 848
            APE     +     D++ FGV + E++
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G V++   +        VA+K   N    +  + ++F+ E   +    H +IVK
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   I+ EN   ++ E      L  +L  RK SL   S  ++ + L            + 
Sbjct: 73  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL------------ST 119
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+    + + +HRD+ + N+L+ S    K+ DFGL++ + +    +  S       +
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 175
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELV 848
            APE     +     D++ FGV + E++
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G V++   +        VA+K   N    +  + ++F+ E   +    H +IVK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   I+ EN   ++ E      L  +L  RK SL   S  ++ + L            + 
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL------------ST 122
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF-- 818
            L Y+    + + +HRD+ + N+L+ S    K+ DFGL++ +    +     A  G    
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME---DSTXXKASKGKLPI 176
Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELV 848
            + APE     +     D++ FGV + E++
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 60/234 (25%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKL 701
           L+G+G  GQVY+      G+  A+K +     +    E+E   EI +L     H NI   
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVM----DVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 702 WCCISSENSK------LLVYEYMENQSL-------------DRWLHGRKRSLVSGSSSVH 742
           +     +N         LV E+    S+             + W+    R ++ G S +H
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
           QH                           ++IHRD+K  N+LL    + K+ DFG++  L
Sbjct: 147 QH---------------------------KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 803 AKQ-GEPHTMSAVAGSFGYFAPEYAYTTK-----VNEKIDIYSFGVVLLELVTG 850
            +  G  +T     G+  + APE     +      + K D++S G+  +E+  G
Sbjct: 180 DRTVGRRNTF---IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 15/164 (9%)
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +          
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E   + 
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEGTRMR 321
Query: 878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 322 -APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 15/164 (9%)
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +          
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E   + 
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEGTRMR 316
Query: 878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 317 -APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 15/164 (9%)
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +          
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E   + 
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEGTRMR 314
Query: 878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 315 -APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 15/164 (9%)
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            A+G+ ++    + + IHRD+ + NILL  +   KI DFGLA+ + K  +          
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             + APE  +      + D++SFGV+L E+ +   + Y      + E   R   E   + 
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--VKIDEEFCRRLKEGTRMR 323
Query: 878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            A D    E         +Y+  L C    PS RP+  E+++ L
Sbjct: 324 -APDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 629 FTESNILSSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           F + N+         +GSG    V +       +  A +F+  +R  ++R+   + + E 
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE- 62
Query: 684 IAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ 743
             E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++      ++   +
Sbjct: 63  -REVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 744 HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADFGLA 799
            +L+             G+ Y+H   + QI H D+K  NI LLD      + KI DFGLA
Sbjct: 122 QILN-------------GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             +    E      + G+  + APE      +  + D++S GV+   L++G     GD
Sbjct: 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G V++   +        VA+K   N    +  + ++F+ E   +    H +IVK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   I+ EN   ++ E      L  +L  RK SL   S  ++ + L            + 
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL------------ST 122
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+    + + +HRD+ + N+L+ +    K+ DFGL++ + +    +  S       +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 178
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELV 848
            APE     +     D++ FGV + E++
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA----- 696
            +IG G  GQV +   +   + VA+K + N ++ +    ++   EI IL  +R       
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQDKDNT 158
Query: 697 -NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N++ +    +  N   + +E + + +L   +   K++   G S         P   + A
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELI---KKNKFQGFS--------LPLVRKFA 206
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA--KIADFGLAKMLAKQGEPHTMSA 813
               Q L  +H +   +IIH D+K  NILL  + ++  K+ DFG +       E   +  
Sbjct: 207 HSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQRVYT 258
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
              S  Y APE     +    ID++S G +L EL+TG
Sbjct: 259 XIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G V++   +        VA+K   N    +  + ++F+ E   +    H +IVK
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   I+ EN   ++ E      L  +L  RK SL   S  ++ + L            + 
Sbjct: 456 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL------------ST 502
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+    + + +HRD+ + N+L+ S    K+ DFGL++ + +    +  S       +
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 558
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELV 848
            APE     +     D++ FGV + E++
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA----- 696
            +IG G  GQV +   +   + VA+K + N ++ +    ++   EI IL  +R       
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQDKDNT 158
Query: 697 -NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N++ +    +  N   + +E + + +L   +   K++   G S         P   + A
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELI---KKNKFQGFS--------LPLVRKFA 206
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA--KIADFGLAKMLAKQGEPHTMSA 813
               Q L  +H +   +IIH D+K  NILL  + ++  K+ DFG     +   E   +  
Sbjct: 207 HSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG-----SSCYEHQRVYT 258
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
              S  Y APE     +    ID++S G +L EL+TG
Sbjct: 259 XIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 54/113 (47%), Gaps = 14/113 (12%)
Query: 144 ISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYN 203
           +S LQ  ++  N F  D          L  LYL  N      P EI +LSNL VL L++N
Sbjct: 231 LSNLQIFNISANIFKYDF---------LTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHN 280
Query: 204 SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLE 256
              +   +P E G   +LK  +  + N++  +P    NL +L+ L + GN LE
Sbjct: 281 ---RLTSLPAELGSCFQLKYFYFFD-NMVTTLPWEFGNLCNLQFLGVEGNPLE 329

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA----- 696
            +IG G  GQV +   +   + VA+K + N ++ +    ++   EI IL  +R       
Sbjct: 103 KVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQDKDNT 158
Query: 697 -NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N++ +    +  N   + +E + + +L   +   K++   G S         P   + A
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELI---KKNKFQGFS--------LPLVRKFA 206
Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA--KIADFGLAKMLAKQGEPHTMSA 813
               Q L  +H +   +IIH D+K  NILL  + ++  K+ DFG +       E   +  
Sbjct: 207 HSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQRVYX 258
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
              S  Y APE     +    ID++S G +L EL+TG
Sbjct: 259 XIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           IG G  G V++   +        VA+K   N    +  + ++F+ E   +    H +IVK
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L   I+ EN   ++ E      L  +L  RK SL   S  ++ + L            + 
Sbjct: 456 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL------------ST 502
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y+    + + +HRD+ + N+L+ +    K+ DFGL++ + +    +  S       +
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 558
Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELV 848
            APE     +     D++ FGV + E++
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 32/205 (15%)
Query: 659 GAGEFVAVKRIWNNR-------KLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENS 710
           G G +   KR  +         K+  K +++   EIEIL    +H NI+ L         
Sbjct: 36  GVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKH 95
Query: 711 KLLVYEYMEN-QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC 769
             LV E M   + LD+ L  R++      +S    VLH        IG    + Y+H   
Sbjct: 96  VYLVTELMRGGELLDKIL--RQKFFSEREASF---VLH-------TIGKT--VEYLH--- 138
Query: 770 TPQIIHRDVKSSNILLDSEFK----AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEY 825
           +  ++HRD+K SNIL   E       +I DFG AK L  + E   +     +  + APE 
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQL--RAENGLLMTPCYTANFVAPEV 196
Query: 826 AYTTKVNEKIDIYSFGVVLLELVTG 850
                 +E  DI+S G++L  ++ G
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 23/222 (10%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTIRHANIVK 700
            +IG G  G+V  + +       A+K I N  ++ ++ E   F  E ++L       I  
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMK-ILNKWEMLKRAETACFREERDVLVNGDCQWITA 154
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L      EN   LV +Y     L   L   +  L    +        +   + +AI +  
Sbjct: 155 LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF------YIGEMVLAIDSIH 208
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y         +HRD+K  N+LLD     ++ADFG    +   G   +  AV G+  Y
Sbjct: 209 QLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDY 258
Query: 821 FAPEYAYTT-----KVNEKIDIYSFGVVLLELVTGKEANYGD 857
            +PE          K   + D +S GV + E++ G+   Y +
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 300

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 23/222 (10%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTIRHANIVK 700
            +IG G  G+V  + +       A+K I N  ++ ++ E   F  E ++L       I  
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMK-ILNKWEMLKRAETACFREERDVLVNGDCQWITA 138
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L      EN   LV +Y     L   L   +  L    +        +   + +AI +  
Sbjct: 139 LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF------YIGEMVLAIDSIH 192
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            L Y         +HRD+K  N+LLD     ++ADFG    +   G   +  AV G+  Y
Sbjct: 193 QLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDY 242
Query: 821 FAPEYAYTT-----KVNEKIDIYSFGVVLLELVTGKEANYGD 857
            +PE          K   + D +S GV + E++ G+   Y +
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 284

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 32/205 (15%)
Query: 659 GAGEFVAVKRIWNNR-------KLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENS 710
           G G +   KR  +         K+  K +++   EIEIL    +H NI+ L         
Sbjct: 36  GVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKH 95
Query: 711 KLLVYEYMEN-QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC 769
             LV E M   + LD+ L  R++      +S    VLH        IG    + Y+H   
Sbjct: 96  VYLVTELMRGGELLDKIL--RQKFFSEREASF---VLH-------TIGKT--VEYLH--- 138
Query: 770 TPQIIHRDVKSSNILLDSEFK----AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEY 825
           +  ++HRD+K SNIL   E       +I DFG AK L  + E   +     +  + APE 
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQL--RAENGLLMTPCYTANFVAPEV 196
Query: 826 AYTTKVNEKIDIYSFGVVLLELVTG 850
                 +E  DI+S G++L  ++ G
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 64/291 (21%), Positives = 115/291 (39%), Gaps = 41/291 (14%)
Query: 636 SSLTESNLIGSGGSGQVYRIDI---NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
              T   ++G G  G V    +   +G+   VAVK +  +   +  +E EF+ E   +  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFLREAACMKE 81
Query: 693 IRHANIVKLWCCISSENSK------LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL 746
             H ++ KL        +K      +++  +M++  L  +L          +S + ++  
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---------ASRIGENPF 132
Query: 747 HWP--TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
           + P  T ++  +  A G+ Y+    +   IHRD+ + N +L  +    +ADFGL++ +  
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
                   A      + A E           D+++FGV + E++T  +  Y         
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG------- 242
Query: 865 WAWRHYAEEKPITDALDKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPS 913
                  E   I + L  G  + +P   E M  VY L   C S  P  RPS
Sbjct: 243 ------IENAEIYNYLIGGNRLKQPP--ECMEEVYDLMYQCWSADPKQRPS 285

>pdb|2Z7X|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 549

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 20/203 (9%)
Query: 105 SSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL---GGNNFSGDI 161
           S NSIP    E       +++LDLS N       SD+ R   LQ + L   G N    D 
Sbjct: 16  SLNSIPSGLTE------AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS 69
Query: 162 PRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKL 221
             S+G L  L   Y Y++  + ++ K +  L+ L +LG  Y +  + ++    F  L KL
Sbjct: 70  FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSL----FSHLTKL 125
Query: 222 KTLWMTEANLIGEIPEA-MSNLSSLEILALNGNHLEGAIPSGXXXXXXXXXXXXY--DNI 278
           + L +   +   +I     + L+ LE L ++ + L+   P              +   +I
Sbjct: 126 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 185
Query: 279 LSGEI----PSSVEALKLTDIDL 297
           L  EI     SSVE L+L D DL
Sbjct: 186 LLLEIFVDVTSSVECLELRDTDL 208

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 37/232 (15%)
Query: 637 SLTESNLIGSGGSGQ-VYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S    +++G G  G  VYR   +     VAVKRI          E + + E +      H
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRD--VAVKRILPECFSFADREVQLLRESD-----EH 77
Query: 696 ANIVKLWCCISSENSKLLVYEYME--NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
            N+++ +C   +E  +   Y  +E    +L  ++  +  + +          L   T LQ
Sbjct: 78  PNVIRYFC---TEKDRQFQYIAIELCAATLQEYVEQKDFAHLG---------LEPITLLQ 125
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL-----DSEFKAKIADFGLAKMLAKQGEP 808
                  GL ++H   +  I+HRD+K  NIL+       + KA I+DFGL K LA     
Sbjct: 126 ---QTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 809 HT-MSAVAGSFGYFAPEY-AYTTKVNE--KIDIYSFGVVLLELVTGKEANYG 856
            +  S V G+ G+ APE  +   K N    +DI+S G V   +++     +G
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 640 ESNLIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HAN 697
           + +++G G   +V   I++  + E+ AVK I    K    +      E+E+L   + H N
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEY-AVKII---EKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           +++L      E+   LV+E M   S+   +H R+      +S V Q V            
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV------------ 120
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMS-- 812
            A  L ++H+     I HRD+K  NIL +   +    KI DFGL   +   G+   +S  
Sbjct: 121 -ASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 813 ---AVAGSFGYFAPEY--AYTTKV---NEKIDIYSFGVVLLELVTG 850
                 GS  Y APE   A++ +    +++ D++S GV+L  L++G
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 67/238 (28%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HAN-IVKL 701
           IGSGGS +V+++ +N   +  A+K +      NQ L+  +  EI  L  ++ H++ I++L
Sbjct: 20  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRL 77
Query: 702 WCCISSENSKLLVYEYME--NQSLDRWLHGRK-----------RSLVSGSSSVHQHVLHW 748
           +     E +   +Y  ME  N  L+ WL  +K           ++++    ++HQH    
Sbjct: 78  Y---DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---- 130
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
                                   I+H D+K +N L+  +   K+ DFG    +A Q +P
Sbjct: 131 -----------------------GIVHSDLKPANFLI-VDGMLKLIDFG----IANQMQP 162
Query: 809 HTMSAV----AGSFGYFAPEYAYTTKVNEK-----------IDIYSFGVVLLELVTGK 851
            T S V     G+  Y  PE       + +            D++S G +L  +  GK
Sbjct: 163 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|2Z80|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 20/203 (9%)
Query: 105 SSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL---GGNNFSGDI 161
           S NSIP    E       +++LDLS N       SD+ R   LQ + L   G N    D 
Sbjct: 42  SLNSIPSGLTE------AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS 95
Query: 162 PRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKL 221
             S+G L  L   Y Y++  + ++ K +  L+ L +LG  Y +  + ++    F  L KL
Sbjct: 96  FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSL----FSHLTKL 151
Query: 222 KTLWMTEANLIGEIPEA-MSNLSSLEILALNGNHLEGAIPSGXXXXXXXXXXXXY--DNI 278
           + L +   +   +I     + L+ LE L ++ + L+   P              +   +I
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
Query: 279 LSGEI----PSSVEALKLTDIDL 297
           L  EI     SSVE L+L D DL
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDL 234

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 66/310 (21%), Positives = 112/310 (36%), Gaps = 62/310 (20%)
Query: 627 LGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRI--WNNRKLNQKLEKEFI 684
           + F + N L+ L E++      SG++++    G    V V ++  W+ RK      ++F 
Sbjct: 7   IDFKQLNFLTKLNENH------SGELWKGRWQGNDIVVKVLKVRDWSTRK-----SRDFN 55
Query: 685 AEIEILGTIRHANIVKLW--CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
            E   L    H N++ +   C         L+  +    SL   LH     +V  S +V 
Sbjct: 56  EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAV- 114
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
                     + A+  A+G  ++H    P I    + S ++ +D +  A+I+   +    
Sbjct: 115 ----------KFALDXARGXAFLH-TLEPLIPRHALNSRSVXIDEDXTARISXADVKFSF 163
Query: 803 AKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
              G  +  + VA       PE           D +SF V+L ELVT             
Sbjct: 164 QSPGRXYAPAWVAPEALQKKPEDTN----RRSADXWSFAVLLWELVT------------- 206
Query: 863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTT---------VYRLALICTSTLPSSRPS 913
                     E P  D  +  I     LE +           V +L  IC +  P+ RP 
Sbjct: 207 ---------REVPFADLSNXEIGXKVALEGLRPTIPPGISPHVSKLXKICXNEDPAKRPK 257
Query: 914 MKEVLQILRR 923
              ++ IL +
Sbjct: 258 FDXIVPILEK 267

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 67/238 (28%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HAN-IVKL 701
           IGSGGS +V+++ +N   +  A+K +      NQ L+  +  EI  L  ++ H++ I++L
Sbjct: 64  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRL 121
Query: 702 WCCISSENSKLLVYEYME--NQSLDRWLHGRK-----------RSLVSGSSSVHQHVLHW 748
           +     E +   +Y  ME  N  L+ WL  +K           ++++    ++HQH    
Sbjct: 122 Y---DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---- 174
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
                                   I+H D+K +N L+  +   K+ DFG    +A Q +P
Sbjct: 175 -----------------------GIVHSDLKPANFLI-VDGMLKLIDFG----IANQMQP 206
Query: 809 HTMSAV----AGSFGYFAPEYAYTTKVNEK-----------IDIYSFGVVLLELVTGK 851
            T S V     G+  Y  PE       + +            D++S G +L  +  GK
Sbjct: 207 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 9/102 (8%)
Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEF---KAKIADFGLAKMLAKQGEPHTMSAVAG 816
           +G+ Y+H +    I+H D+K  NILL S +     KI DFG+++   K G    +  + G
Sbjct: 142 EGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIMG 195
Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
           +  Y APE      +    D+++ G++   L+T      G++
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +GSG  G V+R      G     K I     L++   K    EI I+  + H  ++ L  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINLHD 115
Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
               +   +L+ E++    L   +      +          V+++  +      A +GL 
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE------VINYMRQ------ACEGLK 163
Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKA--KIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           +MH      I+H D+K  NI+ +++  +  KI DFGLA  L     P  +  V  +   F
Sbjct: 164 HMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVTTATAEF 216
Query: 822 -APEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            APE      V    D+++ GV+   L++G
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 41/234 (17%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE-KEFIAEIEILGTIRHANIVK 700
           +LIG+G  G V           VA+K+I   R     ++ K  + EI IL  + H ++VK
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKIL--RVFEDLIDCKRILREIAILNRLNHDHVVK 116
Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           +   +  ++ +     Y+  +  D       R+ V  +       LH  T L        
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE------LHIKTLL---YNLLV 167
Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML-------------AKQGE 807
           G+ Y+H   +  I+HRD+K +N L++ +   K+ DFGLA+ +              ++ +
Sbjct: 168 GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 808 ------PHT------MSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELV 848
                 PHT      ++    +  Y APE     +   E ID++S G +  EL+
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNN-RKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           + G G  G V        G  VA+K++  + R  N++L+      ++ L  + H NIV+L
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-----MQDLAVLHHPNIVQL 84
Query: 702 WCCISS--ENSKLLVY-----EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
                +  E  +  +Y     EY+ + +L R      R  V+    + +  L    R   
Sbjct: 85  QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR--- 140
Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILL-DSEFKAKIADFGLAKMLAKQGEPHTMSA 813
           +IG         H  +  + HRD+K  N+L+ +++   K+ DFG AK L+   EP+   A
Sbjct: 141 SIGCL-------HLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP-SEPNV--A 190
Query: 814 VAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGD 857
              S  Y APE  +  +     +DI+S G +  E++ G+    GD
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 67/238 (28%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HAN-IVKL 701
           IGSGGS +V+++ +N   +  A+K +      NQ L+  +  EI  L  ++ H++ I++L
Sbjct: 36  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRL 93
Query: 702 WCCISSENSKLLVYEYME--NQSLDRWLHGRK-----------RSLVSGSSSVHQHVLHW 748
           +     E +   +Y  ME  N  L+ WL  +K           ++++    ++HQH    
Sbjct: 94  Y---DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---- 146
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
                                   I+H D+K +N L+  +   K+ DFG    +A Q +P
Sbjct: 147 -----------------------GIVHSDLKPANFLI-VDGMLKLIDFG----IANQMQP 178
Query: 809 HTMSAV----AGSFGYFAPEYAYTTKVNEK-----------IDIYSFGVVLLELVTGK 851
            T S V     G+  Y  PE       + +            D++S G +L  +  GK
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 67/238 (28%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HAN-IVKL 701
           IGSGGS +V+++ +N   +  A+K +      NQ L+  +  EI  L  ++ H++ I++L
Sbjct: 16  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRL 73
Query: 702 WCCISSENSKLLVYEYME--NQSLDRWLHGRK-----------RSLVSGSSSVHQHVLHW 748
           +     E +   +Y  ME  N  L+ WL  +K           ++++    ++HQH    
Sbjct: 74  Y---DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---- 126
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
                                   I+H D+K +N L+  +   K+ DFG    +A Q +P
Sbjct: 127 -----------------------GIVHSDLKPANFLI-VDGMLKLIDFG----IANQMQP 158
Query: 809 HTMSAV----AGSFGYFAPEYAYTTKVNEK-----------IDIYSFGVVLLELVTGK 851
            T S V     G+  Y  PE       + +            D++S G +L  +  GK
Sbjct: 159 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 103/244 (42%), Gaps = 55/244 (22%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V  +    +G+  A+K++  + +   +       E++I+  + H NI+KL  
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-------ELDIMKVLDHVNIIKLVD 67
Query: 704 CISS--------------------------ENSKLLVYEYMENQSLD-------RWLHGR 730
              +                           + K ++    +N+ L+         LH  
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 731 KRSLVSGSSSVHQHVLH-WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF 789
            +S +    S+  +++  +  +L  A+G    L          I HRD+K  N+L++S+ 
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---------ICHRDIKPQNLLVNSKD 178
Query: 790 KA-KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-TTKVNEKIDIYSFGVVLLEL 847
              K+ DFG AK L    EP +++ +   F Y APE     T+    ID++S G V  EL
Sbjct: 179 NTLKLCDFGSAKKLIP-SEP-SVAXICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 848 VTGK 851
           + GK
Sbjct: 236 ILGK 239

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 67/238 (28%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HAN-IVKL 701
           IGSGGS +V+++ +N   +  A+K +      NQ L+  +  EI  L  ++ H++ I++L
Sbjct: 64  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRL 121
Query: 702 WCCISSENSKLLVYEYME--NQSLDRWLHGRK-----------RSLVSGSSSVHQHVLHW 748
           +     E +   +Y  ME  N  L+ WL  +K           ++++    ++HQH    
Sbjct: 122 Y---DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---- 174
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
                                   I+H D+K +N L+  +   K+ DFG    +A Q +P
Sbjct: 175 -----------------------GIVHSDLKPANFLI-VDGMLKLIDFG----IANQMQP 206
Query: 809 HTMSAV----AGSFGYFAPEYAYTTKVNEK-----------IDIYSFGVVLLELVTGK 851
            T S V     G+  Y  PE       + +            D++S G +L  +  GK
Sbjct: 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 12/165 (7%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVK 700
            ++  GG   VY     G+G   A+KR+ +N    ++  +  I E+  +  +  H NIV+
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 701 LWCC--ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
                 I  E S     E++    L     G+    +    S  +  L   T L+I    
Sbjct: 91  FCSAASIGKEESDTGQAEFL---LLTELCKGQLVEFLKKMES--RGPLSCDTVLKIFYQT 145
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA 803
            + + +MH    P IIHRD+K  N+LL ++   K+ DFG A  ++
Sbjct: 146 CRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 67/238 (28%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HAN-IVKL 701
           IGSGGS +V+++ +N   +  A+K +      NQ L+  +  EI  L  ++ H++ I++L
Sbjct: 17  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRL 74
Query: 702 WCCISSENSKLLVYEYME--NQSLDRWLHGRK-----------RSLVSGSSSVHQHVLHW 748
           +     E +   +Y  ME  N  L+ WL  +K           ++++    ++HQH    
Sbjct: 75  Y---DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---- 127
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
                                   I+H D+K +N L+  +   K+ DFG    +A Q +P
Sbjct: 128 -----------------------GIVHSDLKPANFLI-VDGMLKLIDFG----IANQMQP 159
Query: 809 HTMSAV----AGSFGYFAPEYAYTTKVNEK-----------IDIYSFGVVLLELVTGK 851
            T S V     G+  Y  PE       + +            D++S G +L  +  GK
Sbjct: 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 67/238 (28%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HAN-IVKL 701
           IGSGGS +V+++ +N   +  A+K +      NQ L+  +  EI  L  ++ H++ I++L
Sbjct: 64  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRL 121
Query: 702 WCCISSENSKLLVYEYME--NQSLDRWLHGRK-----------RSLVSGSSSVHQHVLHW 748
           +     E +   +Y  ME  N  L+ WL  +K           ++++    ++HQH    
Sbjct: 122 Y---DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---- 174
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
                                   I+H D+K +N L+  +   K+ DFG    +A Q +P
Sbjct: 175 -----------------------GIVHSDLKPANFLI-VDGMLKLIDFG----IANQMQP 206
Query: 809 HTMSAV----AGSFGYFAPEYAYTTKVNEK-----------IDIYSFGVVLLELVTGK 851
            T S V     G+  Y  PE       + +            D++S G +L  +  GK
Sbjct: 207 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 32/205 (15%)
Query: 659 GAGEFVAVKRIWNNR-------KLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENS 710
           G G +   KR  +         K+  K +++   EIEIL    +H NI+ L         
Sbjct: 31  GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKY 90
Query: 711 KLLVYEYMEN-QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC 769
             +V E M+  + LD+ L  +  S    S+              +     + + Y+H   
Sbjct: 91  VYVVTELMKGGELLDKILRQKFFSEREASA--------------VLFTITKTVEYLH--- 133
Query: 770 TPQIIHRDVKSSNILLDSEF----KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEY 825
              ++HRD+K SNIL   E       +I DFG AK L  + E   +     +  + APE 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL--RAENGLLMTPCYTANFVAPEV 191
Query: 826 AYTTKVNEKIDIYSFGVVLLELVTG 850
                 +   DI+S GV+L  ++TG
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 99/235 (42%), Gaps = 32/235 (13%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-LNQ-KLEKEFIAEIEILGTIRHANI 698
            +LIG G  GQV +       E+VA+K I N +  LNQ ++E   +  +    T     I
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V L       N   LV+E +     D   +   R +                 L +    
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV----------------SLNLTRKF 162
Query: 759 AQGLC-YMHHDCTPQ--IIHRDVKSSNILLDSEFKA--KIADFGLAKMLAKQGEPHTMSA 813
           AQ +C  +    TP+  IIH D+K  NILL +  ++  KI DFG +  L ++        
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQX 218
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE----ANYGDEHTSLAE 864
           +   F Y +PE       +  ID++S G +L+E+ TG+     AN  D+   + E
Sbjct: 219 IQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 95/234 (40%), Gaps = 59/234 (25%)
Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HAN-IVKL 701
           IGSGGS +V+++ +N   +  A+K +      NQ L+  +  EI  L  ++ H++ I++L
Sbjct: 36  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRL 93
Query: 702 WCCISSENSKLLVYEYME--NQSLDRWLHGRK-----------RSLVSGSSSVHQHVLHW 748
           +     E +   +Y  ME  N  L+ WL  +K           ++++    ++HQH    
Sbjct: 94  Y---DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---- 146
Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
                                   I+H D+K +N L+  +   K+ DFG+A  +      
Sbjct: 147 -----------------------GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXX 182
Query: 809 HTMSAVAGSFGYFAPEYAYTTKVNEK-----------IDIYSFGVVLLELVTGK 851
               +  G+  Y  PE       + +            D++S G +L  +  GK
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 99/235 (42%), Gaps = 32/235 (13%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-LNQ-KLEKEFIAEIEILGTIRHANI 698
            +LIG G  GQV +       E+VA+K I N +  LNQ ++E   +  +    T     I
Sbjct: 40  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 99
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V L       N   LV+E +     D   +   R +                 L +    
Sbjct: 100 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV----------------SLNLTRKF 143
Query: 759 AQGLC-YMHHDCTPQ--IIHRDVKSSNILLDSEFKA--KIADFGLAKMLAKQGEPHTMSA 813
           AQ +C  +    TP+  IIH D+K  NILL +  ++  KI DFG +  L ++        
Sbjct: 144 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQX 199
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE----ANYGDEHTSLAE 864
           +   F Y +PE       +  ID++S G +L+E+ TG+     AN  D+   + E
Sbjct: 200 IQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 253

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 96/235 (40%), Gaps = 32/235 (13%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-LNQ-KLEKEFIAEIEILGTIRHANI 698
            +LIG G  GQV +       E+VA+K I N +  LNQ ++E   +  +    T     I
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V L       N   LV+E +     D   +   R +                 L +    
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV----------------SLNLTRKF 162
Query: 759 AQGLC-YMHHDCTPQ--IIHRDVKSSNILL--DSEFKAKIADFGLAKMLAKQGEPHTMSA 813
           AQ +C  +    TP+  IIH D+K  NILL        KI DFG +  L ++        
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQR----IYQX 218
Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE----ANYGDEHTSLAE 864
           +   F Y +PE       +  ID++S G +L+E+ TG+     AN  D+   + E
Sbjct: 219 IQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 31/164 (18%)
Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK-AKIADFGLAKMLAKQGEPHTMSAVAGS 817
            Q +  + H  +  ++HRD+K  NIL+D     AK+ DFG   +L    EP+T     G+
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYT--DFDGT 201
Query: 818 FGYFAPEYAYTTKVNE-KIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
             Y  PE+    + +     ++S G++L ++V G      D+    AE    H+      
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL---HFPAH--- 255
Query: 877 TDALDKGIAEPCYLEEMTTVYRLALI--CTSTLPSSRPSMKEVL 918
                  ++  C           ALI  C +  PSSRPS++E+L
Sbjct: 256 -------VSPDC----------CALIRRCLAPKPSSRPSLEEIL 282

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 640 ESNLIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HAN 697
           + +++G G   +V   I++  + E+ AVK I    K    +      E+E+L   + H N
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEY-AVKII---EKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           +++L      E+   LV+E M   S+   +H R+      +S V Q V            
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV------------ 120
Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMS-- 812
            A  L ++H+     I HRD+K  NIL +   +    KI DF L   +   G+   +S  
Sbjct: 121 -ASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 813 ---AVAGSFGYFAPEY--AYTTKV---NEKIDIYSFGVVLLELVTG 850
                 GS  Y APE   A++ +    +++ D++S GV+L  L++G
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 25/202 (12%)
Query: 660 AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYME 719
           A +F+  ++   +R+   + E E   E+ IL  + H N++ L     +    +L+ E + 
Sbjct: 41  AAKFIKKRQSRASRRGVSREEIE--REVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK 779
              L  +L  ++      ++S  + +L              G+ Y+H   T +I H D+K
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQIL-------------DGVNYLH---TKKIAHFDLK 142
Query: 780 SSNI-LLDSEF---KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKI 835
             NI LLD        K+ DFGLA  +    E      + G+  + APE      +  + 
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 836 DIYSFGVVLLELVTGKEANYGD 857
           D++S GV+   L++G     GD
Sbjct: 200 DMWSIGVITYILLSGASPFLGD 221

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 40/221 (18%)
Query: 641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAE--------IEILGT 692
             ++G G +G+V        G+  A+K ++++ K  Q+++  + A         +++   
Sbjct: 15  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYEN 74
Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
           + H        C+      L++ E ME   L   +  R     +   +           +
Sbjct: 75  MHHGKR-----CL------LIIMECMEGGELFSRIQERGDQAFTEREAA---------EI 114
Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPH 809
              IG A    + H+     I HRDVK  N+L  S+ K    K+ DFG AK   +     
Sbjct: 115 MRDIGTAIQFLHSHN-----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--- 166
Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            +     +  Y APE     K ++  D++S GV++  L+ G
Sbjct: 167 -LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 206

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 89/220 (40%), Gaps = 40/220 (18%)
Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAE--------IEILGTI 693
            ++G G +G+V        G+  A+K ++++ K  Q+++  + A         +++   +
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENM 94
Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
            H        C+      L++ E ME   L   +  R     +   +           + 
Sbjct: 95  HHGKR-----CL------LIIMECMEGGELFSRIQERGDQAFTEREAA---------EIM 134
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHT 810
             IG A    + H+     I HRDVK  N+L  S+ K    K+ DFG AK   +      
Sbjct: 135 RDIGTAIQFLHSHN-----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---- 185
Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           +     +  Y APE     K ++  D++S GV++  L+ G
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 25/202 (12%)
Query: 660 AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYME 719
           A +F+  ++   +R+   + E E   E+ IL  + H N++ L     +    +L+ E + 
Sbjct: 41  AAKFIKKRQSRASRRGVSREEIE--REVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK 779
              L  +L  ++      ++S  + +L              G+ Y+H   T +I H D+K
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQIL-------------DGVNYLH---TKKIAHFDLK 142
Query: 780 SSNI-LLDSEF---KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKI 835
             NI LLD        K+ DFGLA  +    E      + G+  + APE      +  + 
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 836 DIYSFGVVLLELVTGKEANYGD 857
           D++S GV+   L++G     GD
Sbjct: 200 DMWSIGVITYILLSGASPFLGD 221

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 25/202 (12%)
Query: 660 AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYME 719
           A +F+  ++   +R+   + E E   E+ IL  + H N++ L     +    +L+ E + 
Sbjct: 41  AAKFIKKRQSRASRRGVSREEIE--REVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK 779
              L  +L  ++      ++S  + +L              G+ Y+H   T +I H D+K
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQIL-------------DGVNYLH---TKKIAHFDLK 142
Query: 780 SSNI-LLDSEF---KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKI 835
             NI LLD        K+ DFGLA  +    E      + G+  + APE      +  + 
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 836 DIYSFGVVLLELVTGKEANYGD 857
           D++S GV+   L++G     GD
Sbjct: 200 DMWSIGVITYILLSGASPFLGD 221

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 98/231 (42%), Gaps = 36/231 (15%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNN----RKLN----QKLEKEFIAEI 687
           S  T    I SG  G V    ++  G  VA+KR++N     R +N      L K  + EI
Sbjct: 22  SPYTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 688 EILGTIRHANIVKLW-CCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
            +L    H NI+ L    +  E   +    LV E M    L + +H  +R ++S      
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD-QRIVISP----- 133
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM- 801
           QH+ ++   + +      GL  +H      ++HRD+   NILL       I DF LA+  
Sbjct: 134 QHIQYFMYHILL------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
            A   + H ++       Y APE     K   + +D++S G V+ E+   K
Sbjct: 185 TADANKTHYVT----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 98/231 (42%), Gaps = 36/231 (15%)
Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNN----RKLN----QKLEKEFIAEI 687
           S  T    I SG  G V    ++  G  VA+KR++N     R +N      L K  + EI
Sbjct: 22  SPYTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 688 EILGTIRHANIVKLW-CCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVH 742
            +L    H NI+ L    +  E   +    LV E M    L + +H  +R ++S      
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD-QRIVISP----- 133
Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM- 801
           QH+ ++   + +      GL  +H      ++HRD+   NILL       I DF LA+  
Sbjct: 134 QHIQYFMYHILL------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGK 851
            A   + H ++       Y APE     K   + +D++S G V+ E+   K
Sbjct: 185 TADANKTHYVT----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 77/181 (42%), Gaps = 23/181 (12%)
Query: 681 KEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
           +E   E+ IL  + H NI+ L     +    +L+ E +    L  +L  ++      ++S
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 741 VHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI-LLDSEF---KAKIADF 796
             + +L              G+ Y+H   T +I H D+K  NI LLD        K+ DF
Sbjct: 120 FIKQIL-------------DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG 856
           GLA  +    E      + G+  + APE      +  + D++S GV+   L++G     G
Sbjct: 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 857 D 857
           D
Sbjct: 221 D 221

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 25/202 (12%)
Query: 660 AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYME 719
           A +F+  ++   +R+   + E E   E+ IL  + H N++ L     +    +L+ E + 
Sbjct: 41  AAKFIKKRQSRASRRGVSREEIE--REVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK 779
              L  +L  ++      ++S  + +L              G+ Y+H   T +I H D+K
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQIL-------------DGVNYLH---TKKIAHFDLK 142
Query: 780 SSNI-LLDSEF---KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKI 835
             NI LLD        K+ DFGLA  +    E      + G+  + APE      +  + 
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 836 DIYSFGVVLLELVTGKEANYGD 857
           D++S GV+   L++G     GD
Sbjct: 200 DMWSIGVITYILLSGASPFLGD 221

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 22/165 (13%)
Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
              L    LIG G  GQVY    +G    VA++ I +  + N+   K F  E+      R
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLI-DIERDNEDQLKAFKREVMAYRQTR 87
Query: 695 HANIVK-LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           H N+V  +  C+S  +  ++        SL +   GR    V   + +   VL      Q
Sbjct: 88  HENVVLFMGACMSPPHLAIIT-------SLCK---GRTLYSVVRDAKI---VLDVNKTRQ 134
Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGL 798
           IA    +G+ Y+H      I+H+D+KS N+  D+  K  I DFGL
Sbjct: 135 IAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGL 175

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 25/202 (12%)
Query: 660 AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYME 719
           A +F+  ++   +R+   + E E   E+ IL  + H N++ L     +    +L+ E + 
Sbjct: 41  AAKFIKKRQSRASRRGVSREEIE--REVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK 779
              L  +L  ++      ++S  + +L              G+ Y+H   T +I H D+K
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQIL-------------DGVNYLH---TKKIAHFDLK 142
Query: 780 SSNI-LLDSEF---KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKI 835
             NI LLD        K+ DFGLA  +    E      + G+  + APE      +  + 
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 836 DIYSFGVVLLELVTGKEANYGD 857
           D++S GV+   L++G     GD
Sbjct: 200 DMWSIGVITYILLSGASPFLGD 221

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	969
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-143
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-132
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-121
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-08
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-106
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-99
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-97
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-84
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-64
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-47
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-78
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-76
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-34
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-78
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-68
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-67
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-54
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-43
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-11
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-74
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-66
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-64
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-30
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-63
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-60
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-08
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-60
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-60
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-59
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-55
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-08
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-56
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-56
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-08
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-55
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-51
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-49
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-48
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-45
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-26
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-45
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-40
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-34
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-31
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-43
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-37
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-28
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-34
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-31
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-42
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-23
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-41
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-40
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-33
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-26
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-36
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-36
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-34
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-17
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-32
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-04
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-33
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-33
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-17
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-32
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-31
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-31
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-31
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-30
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-14
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-30
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-30
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-30
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-30
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-30
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-30
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-29
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-29
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-29
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-29
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-29
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-29
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-29
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-29
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-29
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-29
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-28
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-28
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-20
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-06
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-27
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-20
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-27
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-26
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-26
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-26
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-23
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-07
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-26
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-26
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-08
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-16
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-04
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-21
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-05
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-17
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-10
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-04
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	9e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	9e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	9e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	9e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	6e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	4e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	4e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  443 bits (1142), Expect = e-143
 Identities = 158/535 (29%), Positives = 237/535 (44%), Gaps = 31/535 (5%)

Query: 33  NTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDIT---QKI 89
              E   L++ K  L +   L  W+S  +PC +  +TC  + VT I L  K +      +
Sbjct: 10  LYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAV 69

Query: 90  PPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSD--IDRISGL 147
              +  L  L ++ LS++ I G    F      L +LDLS+N   GP+ +   +   SGL
Sbjct: 70  SSSLLSLTGLESLFLSNSHINGSVSGFK-CSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128

Query: 148 QCIDLGGNNFSGDIPRSIG-RLSELQTLYLYMNEFNGTFPKEI---GDLSNLEVLGLAYN 203
           + +++  N        S G +L+ L+ L L  N  +G              L+ L ++ N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188

Query: 204 SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGL 263
                    ++      L+ L ++  N    IP  + + S+L+ L ++GN L G     +
Sbjct: 189 -KISG---DVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAI 243

Query: 264 FLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLF 322
                L  L +  N   G IP       L  + L+ N  TG IP+   G    L  L L 
Sbjct: 244 STCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302

Query: 323 SNHLSGEVPASIG-------VVAFENNLSGAVPK-SLGNCRTLRTVQLYSNRFSGELPTG 374
            NH  G VP   G       +    NN SG +P  +L   R L+ + L  N FSGELP  
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362

Query: 375 LW-TTFNLSSLMLSDNTISGELPS----KTAWNLTRLEISNNRFSGQIQRGVGSWKNLIV 429
           L   + +L +L LS N  SG +           L  L + NN F+G+I   + +   L+ 
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422

Query: 430 FKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEI 489
              S N  SG IP  L SLS L  L L  N L G++P +++   +L  L L  N+L+GEI
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482

Query: 490 PKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNKLYGNIPDEFNNL 543
           P  + +   +  + LS N+ +GEIP  IG+L  L    LS+N   GNIP E  + 
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  415 bits (1070), Expect = e-132
 Identities = 152/489 (31%), Positives = 238/489 (48%), Gaps = 25/489 (5%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
             ++  + +   + +  IP  + D   L  +D+S N + G+F   +  CT+L+ L++S N
Sbjct: 199 CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEFNGTFPKEIG 190
            FVGPIP     +  LQ + L  N F+G+IP  + G    L  L L  N F G  P   G
Sbjct: 258 QFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315

Query: 191 DLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLS-SLEILA 249
             S LE L L+ N NF   +       ++ LK L ++     GE+PE+++NLS SL  L 
Sbjct: 316 SCSLLESLALSSN-NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374

Query: 250 LNGNHLEGAIPSGLF--LLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSI 306
           L+ N+  G I   L     N L +L+L +N  +G+IP ++     L  + LS N L+G+I
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434

Query: 307 PEEFGKLKNLQLLGLFSNHLSGEVPASIG-------VVAFENNLSGAVPKSLGNCRTLRT 359
           P   G L  L+ L L+ N L GE+P  +        ++   N+L+G +P  L NC  L  
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494

Query: 360 VQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAW--NLTRLEISNNRFSGQI 417
           + L +NR +GE+P  +    NL+ L LS+N+ SG +P++     +L  L+++ N F+G I
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554

Query: 418 QRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGN--KLSGKLPSQIVSWTSL 475
              +      I    + N  +G+  V + +          GN  +  G    Q+   ++ 
Sbjct: 555 PAAMFKQSGKI----AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR 610

Query: 476 NNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYG 534
           N  N+      G       +   M+ LD+S N  SG IP EIG +  L   NL  N + G
Sbjct: 611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISG 670

Query: 535 NIPDEFNNL 543
           +IPDE  +L
Sbjct: 671 SIPDEVGDL 679

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  386 bits (995), Expect = e-121
 Identities = 156/526 (29%), Positives = 230/526 (43%), Gaps = 44/526 (8%)

Query: 72  FNSVTGISLRHKDITQKIPP-IICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQ 130
             S+  +SL     T +IP  +      LT +DLS N   G  P F  +C+ L++L LS 
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327

Query: 131 NYFVGPIPSD-IDRISGLQCIDLGGNNFSGDIPRSIGRLS-ELQTLYLYMNEFNGTFPKE 188
           N F G +P D + ++ GL+ +DL  N FSG++P S+  LS  L TL L  N F+G     
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387

Query: 189 IGD--LSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLE 246
           +     + L+ L L  N                             G+IP  +SN S L 
Sbjct: 388 LCQNPKNTLQELYLQNN--------------------------GFTGKIPPTLSNCSELV 421

Query: 247 ILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTGS 305
            L L+ N+L G IPS L  L+ L  L L+ N+L GEIP  +  +K L  + L  N+LTG 
Sbjct: 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481

Query: 306 IPEEFGKLKNLQLLGLFSNHLSGEVPASIG-------VVAFENNLSGAVPKSLGNCRTLR 358
           IP       NL  + L +N L+GE+P  IG       +    N+ SG +P  LG+CR+L 
Sbjct: 482 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI 541

Query: 359 TVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQ 418
            + L +N F+G +P  ++      +           + +           +   F G   
Sbjct: 542 WLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS 601

Query: 419 RGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNL 478
             +           ++ ++ G       +   +  L +  N LSG +P +I S   L  L
Sbjct: 602 EQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFIL 661

Query: 479 NLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIP 537
           NL  N++SG IP  +G L  +  LDLS N+  G IP  +  L  L   +LS+N L G IP
Sbjct: 662 NLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

Query: 538 DE--FNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKH 581
           +   F        FLNN  LC   P+       +      + S  H
Sbjct: 722 EMGQFETFP-PAKFLNNPGLC-GYPLPRCDPSNADGYAHHQRSHHH 765

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  116 bits (292), Expect = 1e-26
 Identities = 32/157 (20%), Positives = 56/157 (35%)

Query: 47  LGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSS 106
           +       +    +                  +    +        +  L      +++S
Sbjct: 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS 617

Query: 107 NSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIG 166
               G       N   +  LD+S N   G IP +I  +  L  ++LG N+ SG IP  +G
Sbjct: 618 RVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG 677

Query: 167 RLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYN 203
            L  L  L L  N+ +G  P+ +  L+ L  + L+ N
Sbjct: 678 DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 57.6 bits (140), Expect = 1e-08
 Identities = 20/102 (19%), Positives = 41/102 (40%), Gaps = 7/102 (6%)

Query: 473 TSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKL 532
           TS++  +   N     +  ++ SL  + SL LS +  +G +        L + +LS N L
Sbjct: 53  TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSL 112

Query: 533 YGNIPDEFN-----NLAYDDSFLNNSNLCVKNPIINLPKCPS 569
            G +    +      L + +  ++++ L     +    K  S
Sbjct: 113 SGPVTTLTSLGSCSGLKFLN--VSSNTLDFPGKVSGGLKLNS 152

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  333 bits (856), Expect = e-106
 Identities = 114/291 (39%), Positives = 166/291 (57%), Gaps = 27/291 (9%)

Query: 640 ESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
             N++G GG G+VY+    G    G  VAVKR+   R   Q  E +F  E+E++    H 
Sbjct: 34  NKNILGRGGFGKVYK----GRLADGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHR 87

Query: 697 NIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           N+++L   C++    +LLVY YM N S+   L  R  S         Q  L WP R +IA
Sbjct: 88  NLLRLRGFCMTP-TERLLVYPYMANGSVASCLRERPES---------QPPLDWPKRQRIA 137

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           +G+A+GL Y+H  C P+IIHRDVK++NILLD EF+A + DFGLAK L    + H  +AV 
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVR 196

Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEA-----NYGDEHTSLAEWAWRHY 870
           G+ G+ APEY  T K +EK D++ +GV+LLEL+TG+ A        D+   L +W     
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
            +EK +   +D  +      EE+  + ++AL+CT + P  RP M EV+++L
Sbjct: 257 -KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  312 bits (801), Expect = 6e-99
 Identities = 104/307 (33%), Positives = 153/307 (49%), Gaps = 29/307 (9%)

Query: 623 SFHQL-----GFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN- 676
           SF++L      F E          N +G GG G VY+  +N     VAVK++     +  
Sbjct: 16  SFYELKNVTNNFDER---PISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITT 70

Query: 677 QKLEKEFIAEIEILGTIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLV 735
           ++L+++F  EI+++   +H N+V+L       ++   LVY YM N SL   L        
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRLSCLDG--- 126

Query: 736 SGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD 795
                     L W  R +IA GAA G+ ++H +     IHRD+KS+NILLD  F AKI+D
Sbjct: 127 -------TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176

Query: 796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEA-N 854
           FGLA+   K  +    S + G+  Y APE     ++  K DIYSFGVVLLE++TG  A +
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD 235

Query: 855 YGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM 914
              E   L +       EEK I D +DK + +      +  +Y +A  C     + RP +
Sbjct: 236 EHREPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDI 294

Query: 915 KEVLQIL 921
           K+V Q+L
Sbjct: 295 KKVQQLL 301

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  307 bits (790), Expect = 3e-97
 Identities = 105/294 (35%), Positives = 146/294 (49%), Gaps = 22/294 (7%)

Query: 640 ESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
              LIG G  G+VY+  +   G  VA+KR     + +Q   +EF  EIE L   RH ++V
Sbjct: 43  HKFLIGHGVFGKVYKGVLRD-GAKVALKRR--TPESSQG-IEEFETEIETLSFCRHPHLV 98

Query: 700 KLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
            L   C    N  +L+Y+YMEN +L R L+G                + W  RL+I IGA
Sbjct: 99  SLIGFCDE-RNEMILIYKYMENGNLKRHLYGSDL---------PTMSMSWEQRLEICIGA 148

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A+GL Y+H      IIHRDVKS NILLD  F  KI DFG++K   +  + H  + V G+ 
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEA---NYGDEHTSLAEWAWRHYAEEKP 875
           GY  PEY    ++ EK D+YSFGVVL E++  + A   +   E  +LAEWA         
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-VESHNNGQ 264

Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTEN 929
           +   +D  +A+    E +      A+ C +     RPSM +VL  L      + 
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  273 bits (700), Expect = 2e-84
 Identities = 87/339 (25%), Positives = 140/339 (41%), Gaps = 47/339 (13%)

Query: 33  NTEERTILLNLKQQLGNPPSLQSWTSTSSPCD--WPEITCT----FNSVTGISLRHKDI- 85
           N +++  LL +K+ LGNP +L SW  T+  C+  W  + C        V  + L   ++ 
Sbjct: 4   NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63

Query: 86  -TQKIPPIICDLKNLTTIDLSS-NSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDR 143
               IP  + +L  L  + +   N++ G  P  +   T+L  L ++     G IP  + +
Sbjct: 64  KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123

Query: 144 ISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNL-EVLGLAY 202
           I  L  +D   N  SG +P SI  L  L  +    N  +G  P   G  S L   + ++ 
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183

Query: 203 NSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSG 262
           N                           L G+IP   +NL +L  + L+ N LEG     
Sbjct: 184 N--------------------------RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVL 216

Query: 263 LFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLF 322
                N  ++ L  N L+ ++     +  L  +DL  N + G++P+   +LK L  L + 
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276

Query: 323 SNHLSGEVPAS-----IGVVAFENN--LSGAVPKSLGNC 354
            N+L GE+P         V A+ NN  L G+    L  C
Sbjct: 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGS---PLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  219 bits (561), Expect = 1e-64
 Identities = 77/306 (25%), Positives = 126/306 (41%), Gaps = 44/306 (14%)

Query: 230 NLIGEIPEAMSNLSSLEILALNGNHLEG--AIPSGLFLLNNLTQLFLYD-NILSGEIPSS 286
             +G + +  +    +  L L+G +L     IPS L  L  L  L++   N L G IP +
Sbjct: 37  TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96

Query: 287 VEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSG 345
           +  L +L  + ++  N++G+IP+   ++K L  L    N LSG +P SI           
Sbjct: 97  IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS---------- 146

Query: 346 AVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTR 405
                  +   L  +    NR SG +P       + S L                   T 
Sbjct: 147 -------SLPNLVGITFDGNRISGAIPDSY---GSFSKL------------------FTS 178

Query: 406 LEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKL 465
           + IS NR +G+I     +  NL     S N+  G+  V   S  +   + L  N L+  L
Sbjct: 179 MTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237

Query: 466 PSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTF 525
              +    +LN L+L  N + G +P+ +  L  + SL++S N   GEIP      + +  
Sbjct: 238 GK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVS 296

Query: 526 NLSSNK 531
             ++NK
Sbjct: 297 AYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  169 bits (431), Expect = 5e-47
 Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 10/208 (4%)

Query: 346 AVPKSLGNCRTLR----TVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELP-SKTA 400
            + K LGN  TL     T    +  + G L      T+ +++L LS   +    P   + 
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 401 WNLTRLEI----SNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLL 456
            NL  L        N   G I   +     L     ++   SG IP  L+ +  L TL  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 457 DGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLL-VMVSLDLSGNQFSGEIPP 515
             N LSG LP  I S  +L  +    N +SG IP + GS   +  S+ +S N+ +G+IPP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

Query: 516 EIGQLKLNTFNLSSNKLYGNIPDEFNNL 543
               L L   +LS N L G+    F + 
Sbjct: 193 TFANLNLAFVDLSRNMLEGDASVLFGSD 220

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  267 bits (685), Expect = 2e-78
 Identities = 73/525 (13%), Positives = 155/525 (29%), Gaps = 72/525 (13%)

Query: 70  CTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLS 129
             F+ +    +      + I          T I   SN+I     + +   TKL+   + 
Sbjct: 156 EDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMG 214

Query: 130 QNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEI 189
            + FV             +  +                L +L  + +Y        P  +
Sbjct: 215 NSPFVAENIC-----EAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269

Query: 190 GDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILA 249
             L  ++++ +A N       +                      +          ++I+ 
Sbjct: 270 KALPEMQLINVACNRGISGEQLK------------------DDWQALADAPVGEKIQIIY 311

Query: 250 LNGNHL-EGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPE 308
           +  N+L    + + L  +  L  L    N L G++P+    +KL  ++L+ N +T     
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPAN 371

Query: 309 EFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS 368
             G  + ++ L    N L   +P                     +   +  +    N   
Sbjct: 372 FCGFTEQVENLSFAHNKLK-YIPNIFD---------------AKSVSVMSAIDFSYNEIG 415

Query: 369 G-------ELPTGLWTTFNLSSLMLSDNTISGELPS--KTAWNLTRLEISNNRFSG---- 415
                    L    +   N+SS+ LS+N IS        T   L+ + +  N  +     
Sbjct: 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475

Query: 416 ---QIQRGVGSWKNLIVFKASNNLFSGEIPVEL--TSLSHLNTLLLDGNKLSGKLPSQIV 470
                     +   L       N  +  +  +   T+L +L  + L  N  S   P+Q +
Sbjct: 476 SLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL 533

Query: 471 SWTSL------NNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNT 524
           + ++L      N  +   N    E P+ I     +  L +  N     +  +I    ++ 
Sbjct: 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP-NISV 591

Query: 525 FNLSSNKLYGNIPDEFNN---LAYDDSFLNNSNLCVKNPIINLPK 566
            ++  N                     F + +        +++ +
Sbjct: 592 LDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIKR 636

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  261 bits (668), Expect = 6e-76
 Identities = 77/541 (14%), Positives = 165/541 (30%), Gaps = 72/541 (13%)

Query: 22  SIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEIT--CTFNSVTGIS 79
            +P ++   +   ++   L  +   L      Q    T    +W        + +  G+S
Sbjct: 17  IVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVS 76

Query: 80  LRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPS 139
           L                  +T + L      G  P+ +   T+L+ L L  +        
Sbjct: 77  LN-------------SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL 123

Query: 140 DIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLG 199
                                 P+ I      +        +  TF          +++ 
Sbjct: 124 --------------------FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163

Query: 200 LAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAI 259
              NS+ +   I     +  K   +     N I  + +A+  L+ L    +  +      
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLS-NNITFVSKAVMRLTKLRQFYMGNSPFVAEN 222

Query: 260 PSGLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSIPEEFGKLKNLQL 318
               +   N      Y            + LK LTD+++        +P     L  +QL
Sbjct: 223 ICEAWENENSEYAQQY-----KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277

Query: 319 LGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRF-SGELPTGLWT 377
           + +  N               +                ++ + +  N   +  + T L  
Sbjct: 278 INVACNRGIS---------GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK 328

Query: 378 TFNLSSLMLSDNTISGELPS-KTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNL 436
              L  L    N + G+LP+  +   L  L ++ N+ +       G  + +     ++N 
Sbjct: 329 MKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK 388

Query: 437 FSGEIP--VELTSLSHLNTLLLDGNKLSG-------KLPSQIVSWTSLNNLNLARNELSG 487
               IP   +  S+S ++ +    N++          L        +++++NL+ N++S 
Sbjct: 389 LK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK 447

Query: 488 EIPKAIGSLLVMVSLDLSGNQFSG-------EIPPEIGQLK-LNTFNLSSNKLYGNIPDE 539
              +   +   + S++L GN  +        +          L + +L  NKL   + D+
Sbjct: 448 FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDD 506

Query: 540 F 540
           F
Sbjct: 507 F 507

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  140 bits (354), Expect = 1e-34
 Identities = 30/267 (11%), Positives = 79/267 (29%), Gaps = 33/267 (12%)

Query: 291 KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKS 350
           ++T + L     +G +P+  G+L  L++L L S+                       PK 
Sbjct: 82  RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG-------------PKG 128

Query: 351 LGNCRTLRTVQLYSNRFSGELPTGL--WTTFNLSSLMLSDNTISGELPSKTAW--NLTRL 406
           +    +    Q     +              +L    ++ +     +   +      T++
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188

Query: 407 EISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLP 466
              +N  +  + + V     L  F   N+ F  E   E            +  +      
Sbjct: 189 GQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA-----WENENSEYAQQYKTED 242

Query: 467 SQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQF--------SGEIPPEIG 518
            +  +   L ++ +       ++P  + +L  M  ++++ N+           +   +  
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302

Query: 519 QLK-LNTFNLSSNKL-YGNIPDEFNNL 543
             + +    +  N L    +      +
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKM 329

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.8 bits (135), Expect = 5e-08
 Identities = 23/113 (20%), Positives = 36/113 (31%), Gaps = 9/113 (7%)

Query: 460 KLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQ 519
              G       +W    N N   +    +   ++ S   +  L L G   SG +P  IGQ
Sbjct: 48  SQQGFGTQPGANW----NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103

Query: 520 L-KLNTFNLSSNKLYGN----IPDEFNNLAYDDSFLNNSNLCVKNPIINLPKC 567
           L +L    L S+    N     P   +    D+          K  +   P+ 
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRE 156

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  268 bits (687), Expect = 3e-78
 Identities = 106/516 (20%), Positives = 168/516 (32%), Gaps = 33/516 (6%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
             ++T ++L H  + +           LT++D+  N+I    PE       L+ L+L  N
Sbjct: 24  PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGD 191
                        + L  + L  N+          +   L TL L  N  + T       
Sbjct: 84  ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143

Query: 192 LSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALN 251
           L NL+ L L+ N         ++      LK L ++   +    P     +  L  L LN
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203

Query: 252 GNHLEGAIPSGLFL---LNNLTQLFLYDNILSGEIPSSVEALK---LTDIDLSMNNLTGS 305
              L  ++   L L     ++  L L ++ LS    ++   LK   LT +DLS NNL   
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263

Query: 306 IPEEFGKLKNLQLLGLFSNHLSGEVPASIG----------------VVAFENNLSGAVPK 349
             + F  L  L+   L  N++      S+                       +L      
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323

Query: 350 SLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAW------NL 403
           S    + L  + +  N   G          NL  L LS++  S    +   +       L
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383

Query: 404 TRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPV-ELTSLSHLNTLLLDGNKLS 462
             L ++ N+ S           +L V     N    E+   E   L ++  + L  NK  
Sbjct: 384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYL 443

Query: 463 GKLPSQIVSWTSLNNLNLARNELSG--EIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL 520
               +      SL  L L R  L      P     L  +  LDLS N  +      +  L
Sbjct: 444 QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL 503

Query: 521 -KLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNL 555
            KL   +L  N L   +    N           S+L
Sbjct: 504 EKLEILDLQHNNL-ARLWKHANPGGPIYFLKGLSHL 538

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  241 bits (616), Expect = 2e-68
 Identities = 91/506 (17%), Positives = 170/506 (33%), Gaps = 61/506 (12%)

Query: 78  ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFL---YNCTKLQNLDLSQNYFV 134
           + L    I +  P     +  L  + L++  +     E L      T ++NL LS +   
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235

Query: 135 GPIPSDID--RISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDL 192
               +     + + L  +DL  NN +     S   L +L+  +L  N     F   +  L
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295

Query: 193 SNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNG 252
            N+  L L  +                      ++ A+L      +   L  LE L +  
Sbjct: 296 FNVRYLNLKRS-----------------FTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338

Query: 253 NHLEGAIPSGLFLLNNLTQLFLYDNILS-----GEIPSSVEALKLTDIDLSMNNLTGSIP 307
           N + G   +    L NL  L L ++  S      E   S+    L  ++L+ N ++    
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398

Query: 308 EEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRF 367
           + F  L +L++L L  N +  E+                  +       +  + L  N++
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELT----------------GQEWRGLENIFEIYLSYNKY 442

Query: 368 SGELPTGLWTTFNLSSLMLSDNTISGELPSKTAW----NLTRLEISNNRFSGQIQRGVGS 423
                       +L  LML    +     S + +    NLT L++SNN  +      +  
Sbjct: 443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502

Query: 424 WKNLIVFKASNN--------LFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSL 475
            + L +    +N           G     L  LSHL+ L L+ N               L
Sbjct: 503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562

Query: 476 NNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL--KLNTFNLSSNKLY 533
             ++L  N L+        + + + SL+L  N  +       G     L   ++  N   
Sbjct: 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622

Query: 534 GNIPDEFNNLAYDDSFLNNSNLCVKN 559
                   ++A+  +++N ++  +  
Sbjct: 623 CTCE----SIAWFVNWINETHTNIPE 644

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  237 bits (608), Expect = 2e-67
 Identities = 104/483 (21%), Positives = 164/483 (33%), Gaps = 45/483 (9%)

Query: 98  NLTTIDLSSN---SIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG 154
           +    D S      +P + P      T +  L+L+ N       ++  R S L  +D+G 
Sbjct: 5   SHEVADCSHLKLTQVPDDLP------TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58

Query: 155 NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE 214
           N  S   P    +L  L+ L L  NE +    K     +NL  L L  NS  K       
Sbjct: 59  NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKI--KNNP 116

Query: 215 FGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNN--LTQL 272
           F   K L TL ++   L          L +L+ L L+ N ++      L +  N  L +L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176

Query: 273 FLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFG---KLKNLQLLGLFSNHLSG 328
            L  N +    P    A+ +L  + L+   L  S+ E+        +++ L L ++ LS 
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236

Query: 329 EVPASIGVVAF---------ENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTF 379
               +   + +          NNL+     S      L    L  N         L   F
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296

Query: 380 NLSSLMLSDNTISG--------ELPSKTAWNLTRLE---ISNNRFSGQIQRGVGSWKNLI 428
           N+  L L  +            ++   +   L  LE   + +N   G          NL 
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356

Query: 429 VFKASNNLFSGEIPVELT----SLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNE 484
               SN+  S       T    + S L+ L L  NK+S            L  L+L  NE
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNE 416

Query: 485 LSGEIP-KAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNKLYG--NIPDEF 540
           +  E+  +    L  +  + LS N++          +  L    L    L    + P  F
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476

Query: 541 NNL 543
             L
Sbjct: 477 QPL 479

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  199 bits (508), Expect = 6e-54
 Identities = 78/448 (17%), Positives = 134/448 (29%), Gaps = 69/448 (15%)

Query: 70  CTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLS 129
             + ++T + L + ++          L  L    L  N+I   F   L+    ++ L+L 
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304

Query: 130 QNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEI 189
           ++                    +   +       S   L  L+ L +  N+  G      
Sbjct: 305 RS---------------FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349

Query: 190 GDLSNLEVLGLAYNSNFKPAMIPIEFGML--KKLKTLWMTEANLIGEIPEAMSNLSSLEI 247
             L NL+ L L+ +      +    F  L    L  L +T+  +     +A S L  LE+
Sbjct: 350 TGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409

Query: 248 LALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIP 307
           L L  N +   +    +    L                      + +I LS N       
Sbjct: 410 LDLGLNEIGQELTGQEW--RGLE--------------------NIFEIYLSYNKYLQLTR 447

Query: 308 EEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRF 367
             F  + +LQ L L    L                   + P      R L  + L +N  
Sbjct: 448 NSFALVPSLQRLMLRRVALKN---------------VDSSPSPFQPLRNLTILDLSNNNI 492

Query: 368 SGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNL 427
           +      L     L  L L  N ++               +  +   G     +    +L
Sbjct: 493 ANINDDMLEGLEKLEILDLQHNNLA--------------RLWKHANPGGPIYFLKGLSHL 538

Query: 428 IVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSG 487
            +    +N F          L  L  + L  N L+    S   +  SL +LNL +N ++ 
Sbjct: 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598

Query: 488 EIPKAIGSLLV-MVSLDLSGNQFSGEIP 514
              K  G     +  LD+  N F     
Sbjct: 599 VEKKVFGPAFRNLTELDMRFNPFDCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  167 bits (426), Expect = 2e-43
 Identities = 70/361 (19%), Positives = 117/361 (32%), Gaps = 29/361 (8%)

Query: 213 IEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQL 272
           +   +   +  L +T   L        +  S L  L +  N +    P     L  L  L
Sbjct: 19  VPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVL 78

Query: 273 FLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVP 331
            L  N LS     +      LT++ L  N++       F K KNL  L L  N LS    
Sbjct: 79  NLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL 138

Query: 332 ASIG-------VVAFENNLSGAVPKSLG--NCRTLRTVQLYSNRFSGELPTGLWTTFNLS 382
            +         ++   N +     + L      +L+ ++L SN+     P        L 
Sbjct: 139 GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLF 198

Query: 383 SLMLSDNTISGELPSKTAW-----NLTRLEISNNRFSGQIQRGVGS--WKNLIVFKASNN 435
            L L++  +   L  K        ++  L +SN++ S           W NL +   S N
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258

Query: 436 LFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARN---------ELS 486
             +         L  L    L+ N +       +    ++  LNL R+          L 
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318

Query: 487 GEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNKLYGN--IPDEFNNL 543
                +   L  +  L++  N   G        L  L   +LS++         + F +L
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378

Query: 544 A 544
           A
Sbjct: 379 A 379

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  101 bits (254), Expect = 3e-22
 Identities = 37/167 (22%), Positives = 59/167 (35%), Gaps = 2/167 (1%)

Query: 378 TFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLF 437
           T +      S   ++ ++P     N+T L +++N+           +  L       N  
Sbjct: 3   TVSHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 438 SGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLL 497
           S   P     L  L  L L  N+LS          T+L  L+L  N +            
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 498 VMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNKLYGNIPDEFNNL 543
            +++LDLS N  S        QL  L    LS+NK+     +E +  
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 85.8 bits (213), Expect = 3e-17
 Identities = 36/239 (15%), Positives = 69/239 (28%), Gaps = 49/239 (20%)

Query: 66  PEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQN 125
           P       ++T + L + +I      ++  L+ L  +DL  N++                
Sbjct: 473 PSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL---------------- 516

Query: 126 LDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTF 185
             L ++   G     +  +S L  ++L  N F          L EL+ + L +N  N   
Sbjct: 517 ARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLP 576

Query: 186 PKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMS-NLSS 244
                +  +L+ L L  N                           +     +       +
Sbjct: 577 ASVFNNQVSLKSLNLQKN--------------------------LITSVEKKVFGPAFRN 610

Query: 245 LEILALNGNHLEGAIPSGLFLLN-----NLTQLFLYDNILSGEIPSSVEALKLTDIDLS 298
           L  L +  N  +    S  + +N     +     L  + L    P       +   D S
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT-PPHYHGFPVRLFDTS 668

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 65.8 bits (161), Expect = 4e-11
 Identities = 19/112 (16%), Positives = 36/112 (32%), Gaps = 1/112 (0%)

Query: 52  SLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPG 111
           +L      ++P          + +  ++L      +    +  DL  L  IDL  N++  
Sbjct: 515 NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT 574

Query: 112 EFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRI-SGLQCIDLGGNNFSGDIP 162
                  N   L++L+L +N                L  +D+  N F     
Sbjct: 575 LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  245 bits (626), Expect = 9e-74
 Identities = 72/308 (23%), Positives = 112/308 (36%), Gaps = 44/308 (14%)

Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           L    +   G  G V++  +    E+VAVK       +  K   +   E+  L  ++H N
Sbjct: 26  LQLLEVKARGRFGCVWKAQLLN--EYVAVKIF----PIQDKQSWQNEYEVYSLPGMKHEN 79

Query: 698 IVKLW-CCISSENSK---LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           I++         +      L+  + E  SL  +L                +V+ W     
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--------------NVVSWNELCH 125

Query: 754 IAIGAAQGLCYMHHD-------CTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
           IA   A+GL Y+H D         P I HRD+KS N+LL +   A IADFGLA       
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 807 EPHTMSAVAGSFGYFAPEYA-----YTTKVNEKIDIYSFGVVLLELVTGKEANYG---DE 858
                    G+  Y APE       +      +ID+Y+ G+VL EL +   A  G   + 
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 859 HTSLAEWAWRHYAEEKPITDALDKG----IAEPCYLEE-MTTVYRLALICTSTLPSSRPS 913
                E   +H + E      + K     + +       M  +      C      +R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 914 MKEVLQIL 921
              V + +
Sbjct: 306 AGCVGERI 313

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  234 bits (598), Expect = 1e-66
 Identities = 96/483 (19%), Positives = 161/483 (33%), Gaps = 42/483 (8%)

Query: 74  SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPG-EFPEFLYNCTKLQNLDLSQNY 132
           S+  +     ++       I  LK L  ++++ N I   + PE+  N T L++LDLS N 
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160

Query: 133 FVGPIPSDIDRISGLQC----IDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKE 188
                 +D+  +  +      +DL  N  +  I     +   L  L L  N  +    K 
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKT 219

Query: 189 -IGDLSNLEVLGLAYNSNF-KPAMIPIEFGMLKKLKTLWMTEANL------IGEIPEAMS 240
            I  L+ LEV  L       +  +   +   L+ L  L + E  L      + +I +  +
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279

Query: 241 NLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMN 300
            L+++   +L    +E               L L +          +++LK     L+  
Sbjct: 280 CLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLK----RLTFT 333

Query: 301 NLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTV 360
           +  G        L +L+ L L  N LS                 G   +S     +L+ +
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLS---------------FKGCCSQSDFGTTSLKYL 378

Query: 361 QLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPS---KTAWNLTRLEISNNRFSGQI 417
            L  N     + +       L  L    + +          +  NL  L+IS+       
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 418 QRGVGSWKNLIVFKASNNLFSGEI-PVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLN 476
                   +L V K + N F     P   T L +L  L L   +L    P+   S +SL 
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497

Query: 477 NLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL--KLNTFNLSSNKLYG 534
            LN++ N            L  +  LD S N        E+      L   NL+ N    
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

Query: 535 NIP 537
              
Sbjct: 558 TCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  228 bits (584), Expect = 1e-64
 Identities = 93/499 (18%), Positives = 155/499 (31%), Gaps = 48/499 (9%)

Query: 62  PCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCT 121
           PC          ++T       +  + IP  +    +   +DLS N +        ++  
Sbjct: 2   PCV-----EVVPNIT-YQCMELNFYK-IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFP 52

Query: 122 KLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF 181
           +LQ LDLS+             +S L  + L GN        +   LS LQ L       
Sbjct: 53  ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112

Query: 182 NGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSN 241
                  IG L  L+ L +A+N   +   +P  F  L  L+ L ++   +       +  
Sbjct: 113 ASLENFPIGHLKTLKELNVAHN-LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171

Query: 242 LSSLEI----LALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSV----EALKLT 293
           L  + +    L L+ N +   I  G F    L +L L +N  S  +  +       L++ 
Sbjct: 172 LHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230

Query: 294 DIDL----SMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPK 349
            + L    +  NL          L NL +      +L              +     +  
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL--------------DYYLDDIID 276

Query: 350 SLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEIS 409
                  + +  L S              F    L L +       P+    +L RL  +
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQ-FPTLKLKSLKRLTFT 333

Query: 410 NNRFSGQIQRGVGSWKNLIVFKASNN--LFSGEIPVELTSLSHLNTLLLDGNKLSGKLPS 467
           +N+             +L     S N   F G         + L  L L  N +   + S
Sbjct: 334 SNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSS 390

Query: 468 QIVSWTSLNNLNLARNELSGEIPK-AIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTF 525
             +    L +L+   + L          SL  ++ LD+S              L  L   
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450

Query: 526 NLSSNKLYGNI-PDEFNNL 543
            ++ N    N  PD F  L
Sbjct: 451 KMAGNSFQENFLPDIFTEL 469

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  125 bits (317), Expect = 5e-30
 Identities = 41/217 (18%), Positives = 85/217 (39%), Gaps = 7/217 (3%)

Query: 87  QKIPPIICDLKNLTTIDLSSNSIPGEFP-EFLYNCTKLQNLDLSQNYFVGPIPSDIDRIS 145
             +      L+ L  +D   +++          +   L  LD+S  +         + +S
Sbjct: 386 ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445

Query: 146 GLQCIDLGGNNFSGDI-PRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNS 204
            L+ + + GN+F  +  P     L  L  L L   +     P     LS+L+VL +++N 
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN- 504

Query: 205 NFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNL-SSLEILALNGNHLEGAIPSGL 263
           NF  ++    +  L  L+ L  +  +++    + + +  SSL  L L  N          
Sbjct: 505 NFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS 563

Query: 264 FL--LNNLTQLFLYDNILSGEIPSSVEALKLTDIDLS 298
           FL  + +  QL +    +    PS  + + +  ++++
Sbjct: 564 FLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  114 bits (287), Expect = 2e-26
 Identities = 45/253 (17%), Positives = 82/253 (32%), Gaps = 12/253 (4%)

Query: 340 ENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKT 399
           E N    +P +L    + + + L  N          ++   L  L LS   I   +    
Sbjct: 16  ELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGA 71

Query: 400 AWNLTRLEI---SNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLL 456
             +L+ L     + N              +L    A     +      +  L  L  L +
Sbjct: 72  YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131

Query: 457 DGNKL-SGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSL----LVMVSLDLSGNQFSG 511
             N + S KLP    + T+L +L+L+ N++       +  L    L+ +SLDLS N  + 
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191

Query: 512 EIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRF 571
             P    +++L+   L +N    N+                     +N         S  
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251

Query: 572 RNSDKISSKHLAL 584
                ++ +   L
Sbjct: 252 EGLCNLTIEEFRL 264

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 75.1 bits (185), Expect = 6e-14
 Identities = 23/131 (17%), Positives = 49/131 (37%), Gaps = 3/131 (2%)

Query: 66  PEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQN 125
           P+I     ++T + L    + Q  P     L +L  +++S N+              LQ 
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 522

Query: 126 LDLSQNYFVGPIPSDIDRI-SGLQCIDLGGNNFSGDIPRS--IGRLSELQTLYLYMNEFN 182
           LD S N+ +     ++    S L  ++L  N+F+        +  + + + L + +    
Sbjct: 523 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERME 582

Query: 183 GTFPKEIGDLS 193
              P +   + 
Sbjct: 583 CATPSDKQGMP 593

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  230 bits (589), Expect = 1e-63
 Identities = 83/564 (14%), Positives = 178/564 (31%), Gaps = 82/564 (14%)

Query: 38  TILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFN-SVTGISLRHKDITQ-----KIPP 91
           T+   L       P +           + ++   ++  +    L    I +      I  
Sbjct: 360 TVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419

Query: 92  IICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCID 151
                   T I   +N I     + +   TKLQ +  + + F     +        +  +
Sbjct: 420 DSRISLKDTQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDAN 473

Query: 152 LGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMI 211
                   +   S   L +L  + LY        P  + DL  L+ L +A N        
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN-------- 525

Query: 212 PIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPS-GLFLLNNLT 270
                   +  +    +A+    + +       ++I  +  N+LE    S  L  +  L 
Sbjct: 526 --------RGISAAQLKADW-TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLG 576

Query: 271 QLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGK-LKNLQLLGLFSNHLSGE 329
            L    N +   + +    +KLTD+ L  N +   IPE+F      ++ LG   N L   
Sbjct: 577 LLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-Y 633

Query: 330 VPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPT-----GLWTTFNLSSL 384
           +P                  +  +   + +V    N+   E          +   N S++
Sbjct: 634 IPNIF---------------NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678

Query: 385 MLSDNTISGELPSKTAWNLTRLEI---SNNRFS-------GQIQRGVGSWKNLIVFKASN 434
            LS N I    P++     + +     SNN  +               +   L       
Sbjct: 679 TLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRF 737

Query: 435 NLFSGEIPVEL--TSLSHLNTLLLDGNKLSGKLPSQIVSWTSL------NNLNLARNELS 486
           N  +  +  +   T+L +L+ + +  N  S   P+Q ++ + L      +  +   N + 
Sbjct: 738 NKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRIL 795

Query: 487 GEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKL----YGNIPDEFNN 542
            + P  I +   ++ L +  N    ++  ++   +L   +++ N        ++      
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTP-QLYILDIADNPNISIDVTSVCPYIEA 853

Query: 543 LAYDDSFLNNSNLCVKNPIINLPK 566
             Y   +    ++      + + +
Sbjct: 854 GMYVLLYDKTQDIR-GCDALGIER 876

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  221 bits (565), Expect = 2e-60
 Identities = 85/542 (15%), Positives = 169/542 (31%), Gaps = 73/542 (13%)

Query: 22  SIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLR 81
           ++P ++   +   ++   L  + + L       +W   S   +    +  +N    + + 
Sbjct: 256 NVPIQLKETAEYIKDYKALKAIWEALDGK----NWRYYSGTINNTIHSLNWNFNKELDMW 311

Query: 82  HKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI 141
                   P +  D                       N  ++  L L+     G +P  I
Sbjct: 312 GD-----QPGVDLD-----------------------NNGRVTGLSLAGFGAKGRVPDAI 343

Query: 142 DRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGD-LSNLEVLGL 200
            +++ L+ +  G ++ +                    +     + K   D    L +  L
Sbjct: 344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403

Query: 201 AYNS-NFKPAMIPIEFGMLKKLKTLWMTEA-NLIGEIPEAMSNLSSLEILALNGNHLEGA 258
             ++ N  P M PI+      LK   +    N I  I +A+  L+ L+I+    +     
Sbjct: 404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYD 463

Query: 259 IPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSIPEEFGKLKNLQ 317
             +  +   N                 S   LK LTD++L        +P+    L  LQ
Sbjct: 464 NIAVDWEDANSDY-----AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518

Query: 318 LLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELP--TGL 375
            L +  N             A        +         ++   +  N    E P    L
Sbjct: 519 SLNIACNRGIS--------AAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL 569

Query: 376 WTTFNLSSLMLSDNTISGELPS-KTAWNLTRLEISNNRFSGQIQRGVGSW-KNLIVFKAS 433
                L  L    N +   L +  T   LT L++  N+   +I     ++   +     S
Sbjct: 570 QKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFS 627

Query: 434 NNLFSGEIP--VELTSLSHLNTLLLDGNKLSGKLPSQIVS-----WTSLNNLNLARNELS 486
           +N     IP      S+  + ++    NK+  +  +   S       + + + L+ NE+ 
Sbjct: 628 HNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686

Query: 487 GEIPKAIGSLLVMVSLDLSGNQFS-------GEIPPEIGQL-KLNTFNLSSNKLYGNIPD 538
               +   +   + ++ LS N  +                   L T +L  NKL  ++ D
Sbjct: 687 KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSD 745

Query: 539 EF 540
           +F
Sbjct: 746 DF 747

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  124 bits (312), Expect = 4e-29
 Identities = 63/482 (13%), Positives = 134/482 (27%), Gaps = 66/482 (13%)

Query: 116 FLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLY 175
           F    T+L+ + ++         +  +       I +   + +  +P    ++    T  
Sbjct: 166 FNRVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTT-- 223

Query: 176 LYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEI 235
            Y          E   +   E   +  N   K A +PI+                    I
Sbjct: 224 -YSQSGIKRSELETQSVRG-ESFTVIDNKLTKDANVPIQLKETA-------------EYI 268

Query: 236 PEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDI 295
            +  +  +  E L            +      N       D              ++T +
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328

Query: 296 DLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCR 355
            L+     G +P+  G+L  L++L   ++  +       G           +   +   R
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV-SGRLFG--------DEELTPDMSEER 379

Query: 356 TLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEI--SNNRF 413
             R    Y   F            +L    ++ N     +   +  +L   +I    NR 
Sbjct: 380 KHRIRMHYKKMFLDYDQ--RLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437

Query: 414 SGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWT 473
           +  I + +     L +   +N+ F+ +                D  K          +  
Sbjct: 438 TF-ISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNLK 491

Query: 474 SLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSG---------EIPPEIGQL-KLN 523
            L ++ L       ++P  +  L  + SL+++ N+             +  +     K+ 
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551

Query: 524 TFNLSSNKLYGNIPDE---------------FNNLAYDDSFLNNSNLCV----KNPIINL 564
            F +  N L    P                  N + + ++F  N  L       N I  +
Sbjct: 552 IFYMGYNNL-EEFPASASLQKMVKLGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIEEI 610

Query: 565 PK 566
           P+
Sbjct: 611 PE 612

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 56.8 bits (137), Expect = 3e-08
 Identities = 22/122 (18%), Positives = 38/122 (31%), Gaps = 2/122 (1%)

Query: 456 LDGNKLSGKLPSQIVSWTSLN-NLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIP 514
           LDG        +   +  SLN N N   +    +    + +   +  L L+G    G +P
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340

Query: 515 PEIGQLK-LNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRN 573
             IGQL  L   +  ++    +     +     D      +    +          R   
Sbjct: 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400

Query: 574 SD 575
           SD
Sbjct: 401 SD 402

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  209 bits (533), Expect = 4e-61
 Identities = 73/305 (23%), Positives = 123/305 (40%), Gaps = 52/305 (17%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRI----WNNRKLNQKLEKEFIAEIEIL 690
            + +     IG GG G V++  +      VA+K +            +  +EF  E+ I+
Sbjct: 18  DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 691 GTIRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
             + H NIVKL+       N   +V E++    L   L  +   +             W 
Sbjct: 78  SNLNHPNIVKLYGLMH---NPPRMVMEFVPCGDLYHRLLDKAHPI------------KWS 122

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-----EFKAKIADFGLAKMLAK 804
            +L++ +  A G+ YM +   P I+HRD++S NI L S        AK+ADFGL++    
Sbjct: 123 VKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--- 178

Query: 805 QGEPHTMSAVAGSFGYFAPE--YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
               H++S + G+F + APE   A      EK D YSF ++L  ++TG+   + +     
Sbjct: 179 --SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGK 235

Query: 863 AEWAWRHYAEEK--PITDALDKGIAEPCYLEEMTTVYRLALI--CTSTLPSSRPSMKEVL 918
            ++      E     I +     +                +I  C S  P  RP    ++
Sbjct: 236 IKFINMIREEGLRPTIPEDCPPRLRN--------------VIELCWSGDPKKRPHFSYIV 281

Query: 919 QILRR 923
           + L  
Sbjct: 282 KELSE 286

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  208 bits (531), Expect = 1e-60
 Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 45/294 (15%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
              +    ++G G  G V +       + VA+K+I      ++   K FI E+  L  + 
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQI-----ESESERKAFIVELRQLSRVN 59

Query: 695 HANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           H NIVKL+  C+   N   LV EY E  SL   LHG +                    + 
Sbjct: 60  HPNIVKLYGACL---NPVCLVMEYAEGGSLYNVLHGAEP----------LPYYTAAHAMS 106

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK-AKIADFGLAKMLAKQGEPHTMS 812
             +  +QG+ Y+H      +IHRD+K  N+LL +     KI DFG A  +        M+
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-----THMT 161

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE 872
              GS  + APE    +  +EK D++S+G++L E++T ++  + +         W  +  
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP-FDEIGGPAFRIMWAVHNG 220

Query: 873 EKP-ITDALDKGIAEPCYLEEMTTVYRLALI--CTSTLPSSRPSMKEVLQILRR 923
            +P +   L K I                L+  C S  PS RPSM+E+++I+  
Sbjct: 221 TRPPLIKNLPKPIES--------------LMTRCWSKDPSQRPSMEEIVKIMTH 260

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  216 bits (551), Expect = 3e-60
 Identities = 91/479 (18%), Positives = 152/479 (31%), Gaps = 31/479 (6%)

Query: 78  ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPI 137
           + L    +       +   K L  +      I       L+N   L++L L  N+     
Sbjct: 86  LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK 145

Query: 138 PSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNE-FNGTFPKEIGDLSNLE 196
                    L+ +D   N         +  L +   L L +N            D +  +
Sbjct: 146 LPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQ 205

Query: 197 VLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLS--SLEILALNGNH 254
            L      N       ++   ++ L      + +     P     L   S+E + L  ++
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265

Query: 255 LEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKL 313
                 +     + L +L L    LS E+PS +  L  L  + LS N             
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324

Query: 314 KNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNR--FSGEL 371
            +L  L +  N    E+                    L N   LR + L  +    S   
Sbjct: 325 PSLTHLSIKGNTKRLELG----------------TGCLENLENLRELDLSHDDIETSDCC 368

Query: 372 PTGLWTTFNLSSLMLSDNTISGELPSKT---AWNLTRLEISNNRFSGQIQRGV-GSWKNL 427
              L    +L SL LS N     L ++       L  L+++  R   +  +    +   L
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLS-LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427

Query: 428 IVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSG---KLPSQIVSWTSLNNLNLARNE 484
            V   S++L           L  L  L L GN       +  + + +   L  L L+  +
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487

Query: 485 LSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNL 543
           LS     A  SL +M  +DLS N+ +      +  LK    NL+SN +   +P     L
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPIL 546

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  214 bits (547), Expect = 1e-59
 Identities = 94/491 (19%), Positives = 149/491 (30%), Gaps = 42/491 (8%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
            NS   +      +          L NLT +DL+   I     +   +  +L  L L+ N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGD 191
             +    + +     L+ +       S      +     L++LYL  N  +     +   
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 192 LSNLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWM-TEANLIGEIPEAMSNLSSLEIL 248
              L+VL    N            +   L++   L +    N I  I     + +  + L
Sbjct: 152 TEKLKVLDFQNNAIHYLSKE----DMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSL 207

Query: 249 ALNGNHLEGAIPSGLFL--LNNLTQLFLYDNILSGEIPSSVEALK---LTDIDLSMNNLT 303
              G      I  GL    + +L      D       P+  E L    +  I+L  +   
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267

Query: 304 GSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLY 363
                 F     LQ L L + HLS                   +P  L    TL+ + L 
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLS------------------ELPSGLVGLSTLKKLVLS 309

Query: 364 SNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEI---SNNRFSGQIQRG 420
           +N+F            +L+ L +  NT   EL +    NL  L     S++         
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE-TSDCC 368

Query: 421 VGSWKNLI---VFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLP-SQIVSWTSLN 476
               +NL        S N               L  L L   +L  K   S   +   L 
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK 428

Query: 477 NLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK----LNTFNLSSNKL 532
            LNL+ + L     +    L  +  L+L GN F      +   L+    L    LS   L
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488

Query: 533 YGNIPDEFNNL 543
                  F +L
Sbjct: 489 SSIDQHAFTSL 499

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  201 bits (514), Expect = 2e-55
 Identities = 80/450 (17%), Positives = 141/450 (31%), Gaps = 28/450 (6%)

Query: 85  ITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRI 144
           I+      + + K L ++ L SN I        +   KL+ LD   N        D+  +
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSL 176

Query: 145 SGLQCIDLG-GNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIG--DLSNLEVLGLA 201
                + L    N    I       +  Q+L     +      K +    + +L +    
Sbjct: 177 QQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFE 236

Query: 202 YNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPS 261
              +   +    E      ++++ + +              S L+ L L   HL   +PS
Sbjct: 237 DMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPS 295

Query: 262 GLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSIPEE-FGKLKNLQLL 319
           GL  L+ L +L L  N        S      LT + +  N     +       L+NL+ L
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLREL 355

Query: 320 GLFSNHLSGEVPASIGVVAFE------------NNLSGAVPKSLGNCRTLRTVQLYSNRF 367
            L  + +     +    +               N       ++   C  L  + L   R 
Sbjct: 356 DLSHDDIET---SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412

Query: 368 SGELPTGLWTTF-NLSSLMLSDNTISGELPSKTAW--NLTRLEISNNRFSGQIQRGVGSW 424
             +     +     L  L LS + +             L  L +  N F     +   S 
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472

Query: 425 KN---LIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLA 481
           +    L +   S    S       TSL  +N + L  N+L+     + +S      LNLA
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGIYLNLA 531

Query: 482 RNELSGEIPKAIGSLLVMVSLDLSGNQFSG 511
            N +S  +P  +  L    +++L  N    
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 63.5 bits (155), Expect = 2e-10
 Identities = 19/102 (18%), Positives = 39/102 (38%), Gaps = 1/102 (0%)

Query: 83  KDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDID 142
                +    +  L  L  + LS   +         +   + ++DLS N         + 
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521

Query: 143 RISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGT 184
            + G+  ++L  N+ S  +P  +  LS+ +T+ L  N  + T
Sbjct: 522 HLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 55.8 bits (135), Expect = 5e-08
 Identities = 19/82 (23%), Positives = 34/82 (41%), Gaps = 1/82 (1%)

Query: 79  SLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIP 138
            L   D++         LK +  +DLS N +     E L +   +  L+L+ N+    +P
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILP 540

Query: 139 SDIDRISGLQCIDLGGNNFSGD 160
           S +  +S  + I+L  N     
Sbjct: 541 SLLPILSQQRTINLRQNPLDCT 562

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  207 bits (528), Expect = 3e-60
 Identities = 87/321 (27%), Positives = 141/321 (43%), Gaps = 42/321 (13%)

Query: 610 RKRNRDPATWKLTSFHQLGFTESNI-LSSLTESNLIGSGGSGQVYRIDINGA--GEFVAV 666
                 P T  L     +   + +I    L     IG+G  G V+R        G  VAV
Sbjct: 10  MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHR----AEWHGSDVAV 65

Query: 667 KRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL--WCCISSENSKLLVYEYMENQSLD 724
           K +   +  + +   EF+ E+ I+  +RH NIV        +   +  +V EY+   SL 
Sbjct: 66  KIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV--TQPPNLSIVTEYLSRGSLY 122

Query: 725 RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL 784
           R LH              +  L    RL +A   A+G+ Y+H+   P I+HR++KS N+L
Sbjct: 123 RLLHKSGA----------REQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLL 171

Query: 785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVL 844
           +D ++  K+ DFGL+++  K     +  + AG+  + APE       NEK D+YSFGV+L
Sbjct: 172 VDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIL 229

Query: 845 LELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALI-- 902
            EL T ++  +G+ + +    A     +   I   L+  +A               +I  
Sbjct: 230 WELATLQQP-WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA--------------IIEG 274

Query: 903 CTSTLPSSRPSMKEVLQILRR 923
           C +  P  RPS   ++ +LR 
Sbjct: 275 CWTNEPWKRPSFATIMDLLRP 295

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  199 bits (508), Expect = 1e-57
 Identities = 76/295 (25%), Positives = 121/295 (41%), Gaps = 40/295 (13%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
             +T    IGSG  G VY+   +G    VAVK + N      +  + F  E+ +L   RH
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRH 79

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            NI+      ++     +V ++ E  SL   LH  +                    + IA
Sbjct: 80  VNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKF------------EMKKLIDIA 126

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              A+G+ Y+H      IIHRD+KS+NI L  +   KI DFGLA   ++    H    ++
Sbjct: 127 RQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183

Query: 816 GSFGYFAPE---YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE 872
           GS  + APE      +   + + D+Y+FG+VL EL+TG             +  + +   
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG-------------QLPYSNINN 230

Query: 873 EKPITDALDKGIAEPCYLEEMTT----VYRLALICTSTLPSSRPSMKEVLQILRR 923
              I + + +G   P   +  +     + RL   C       RPS   +L  +  
Sbjct: 231 RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  198 bits (505), Expect = 2e-57
 Identities = 78/297 (26%), Positives = 128/297 (43%), Gaps = 42/297 (14%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRI-WNNRKLNQKLEKEFIAEIEILGTI 693
            + LT   +IG GG G+VYR    G  + VAVK    +  +   +  +    E ++   +
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           +H NI+ L      E +  LV E+     L+R L G++              +     + 
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--------------IPPDILVN 109

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK--------AKIADFGLAKMLAKQ 805
            A+  A+G+ Y+H +    IIHRD+KSSNIL+  + +         KI DFGLA+   + 
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR- 168

Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
               T  + AG++ + APE    +  ++  D++S+GV+L EL+TG+   +         +
Sbjct: 169 ---TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP-FRGIDGLAVAY 224

Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                    PI     +  A+            L   C +  P SRPS   +L  L 
Sbjct: 225 GVAMNKLALPIPSTCPEPFAK------------LMEDCWNPDPHSRPSFTNILDQLT 269

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  198 bits (505), Expect = 2e-57
 Identities = 56/301 (18%), Positives = 105/301 (34%), Gaps = 45/301 (14%)

Query: 631 ESNI-LSSLTESNLIGSGGSGQVYRIDINGA--GEFVAVKRIWNNRKLNQKLEKEFIAEI 687
            S I    L     +    SG++++    G   G  + VK +   R  + +  ++F  E 
Sbjct: 4   HSGIDFKQLNFLTKLNENHSGELWK----GRWQGNDIVVKVL-KVRDWSTRKSRDFNEEC 58

Query: 688 EILGTIRHANIVKLW-CCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
             L    H N++ +   C S       L+  +M   SL   LH                V
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-----------FV 107

Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
           +     ++ A+  A+G+ ++H    P I    + S ++++D +  A+I+   +       
Sbjct: 108 VDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF--- 163

Query: 806 GEPHTMSAVAGSFGYFAPE---YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
                      +  + APE              D++SF V+L ELVT +   + D     
Sbjct: 164 ----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP-FADLSNME 218

Query: 863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                        I   +   +++            L  IC +  P+ RP    ++ IL 
Sbjct: 219 IGMKVALEGLRPTIPPGISPHVSK------------LMKICMNEDPAKRPKFDMIVPILE 266

Query: 923 R 923
           +
Sbjct: 267 K 267

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  204 bits (521), Expect = 3e-56
 Identities = 84/491 (17%), Positives = 146/491 (29%), Gaps = 44/491 (8%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
            +S   I L    +         +   L  +DLS   I     +  +    L NL L+ N
Sbjct: 31  PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNG-TFPKEIG 190
                 P     ++ L+ +       +      IG+L  L+ L +  N  +    P    
Sbjct: 91  PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150

Query: 191 DLSNLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEIL 248
           +L+NL  + L+YN         +       +   +L M+  N I  I +       L  L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL-NPIDFIQDQAFQGIKLHEL 209

Query: 249 ALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSV---------EALKLTDIDLS 298
            L GN     I       L  L    L       E    +           + + +  L+
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269

Query: 299 MNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLR 358
             N       +F  L N+  + L    +                      + +      +
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKY-------------------LEDVPKHFKWQ 310

Query: 359 TVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQ 418
           ++ +   +        L     L SL L+ N  S         +L+ L++S N  S    
Sbjct: 311 SLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSF-SG 366

Query: 419 RGVGSW---KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLP-SQIVSWTS 474
               S     +L     S N     +      L  L  L    + L      S  +S   
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425

Query: 475 LNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL--KLNTFNLSSNKL 532
           L  L+++      +       L  + +L ++GN F       +      L   +LS  +L
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485

Query: 533 YGNIPDEFNNL 543
                  F+ L
Sbjct: 486 EQISWGVFDTL 496

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  189 bits (481), Expect = 6e-51
 Identities = 85/467 (18%), Positives = 154/467 (32%), Gaps = 44/467 (9%)

Query: 85  ITQKIPPIICDLKNLTTIDLSSNSIPG-EFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDR 143
           +       I  L  L  ++++ N I   + P +  N T L ++DLS NY      +D+  
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175

Query: 144 ISGLQC----IDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKE-IGDLSNLEVL 198
           +         +D+  N     I     +  +L  L L  N  +    K  + +L+ L V 
Sbjct: 176 LRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234

Query: 199 GLAYNSNFKPAMIP-IEFGMLKKLKTLWMTEANL-----IGEIPEAMSNLSSLEILALNG 252
            L          +   E  +++ L  + + E  L       +       L+++  ++L G
Sbjct: 235 RLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294

Query: 253 NHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGK 312
             ++  +            L +    L       +    L  + L+MN    SI  +   
Sbjct: 295 VSIKY-LEDVPKH-FKWQSLSIIRCQLKQFPTLDLP--FLKSLTLTMNKG--SISFKKVA 348

Query: 313 LKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELP 372
           L +L  L L  N LS       G  ++ +              +LR + L  N     + 
Sbjct: 349 LPSLSYLDLSRNALS-----FSGCCSYSD----------LGTNSLRHLDLSFNGAI-IMS 392

Query: 373 TGLWTTFNLSSLMLSDNTISGELPSKTAW----NLTRLEISNNRFSGQIQRGVGSWKNLI 428
                   L  L    +T+   +   +A+     L  L+IS                +L 
Sbjct: 393 ANFMGLEELQHLDFQHSTLKR-VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451

Query: 429 VFKASNNLFSGEIPVE-LTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSG 487
             K + N F          + ++L  L L   +L         +   L  LN++ N L  
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511

Query: 488 EIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL--KLNTFNLSSNKL 532
                   L  + +LD S N+        +      L  FNL++N +
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  130 bits (328), Expect = 2e-31
 Identities = 67/481 (13%), Positives = 117/481 (24%), Gaps = 136/481 (28%)

Query: 89  IPPIICDLKNLTTIDLSSN---SIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRIS 145
           + P I  + N+T           +P + P      +  +N+DLS N             S
Sbjct: 4   LNPCIEVVPNIT-YQCMDQKLSKVPDDIP------SSTKNIDLSFNPLKILKSYSFSNFS 56

Query: 146 GLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSN 205
            LQ +DL          ++   L  L  L L  N      P     L++LE L       
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET-- 114

Query: 206 FKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFL 265
                                    L       +  L +L+ L +  N +        F 
Sbjct: 115 ------------------------KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF- 149

Query: 266 LNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNH 325
            +NLT                     L  +DLS N +      +   L+    +   S  
Sbjct: 150 -SNLT--------------------NLVHVDLSYNYIQTITVNDLQFLRENPQV-NLSLD 187

Query: 326 LSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLM 385
           +S             N +     ++                              L  L 
Sbjct: 188 MSL------------NPIDFIQDQAFQG-------------------------IKLHELT 210

Query: 386 LSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEL 445
           L  N  S  +      NL  L +                            F  E  +E+
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRL---------------------ILGEFKDERNLEI 249

Query: 446 TSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLS 505
              S +  L                   +++   L       +       L  + ++ L+
Sbjct: 250 FEPSIMEGL----------------CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA 293

Query: 506 GNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLP 565
           G      +       K  + ++   +L      +   L      L  +   +    + LP
Sbjct: 294 GVSIK-YLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLT--LTMNKGSISFKKVALP 350

Query: 566 K 566
            
Sbjct: 351 S 351

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 79.3 bits (196), Expect = 3e-15
 Identities = 26/131 (19%), Positives = 43/131 (32%), Gaps = 1/131 (0%)

Query: 74  SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFP-EFLYNCTKLQNLDLSQNY 132
            +  + + + +       I   L +L T+ ++ NS           N T L  LDLS+  
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484

Query: 133 FVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDL 192
                    D +  LQ +++  NN          +L  L TL    N    +        
Sbjct: 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFP 544

Query: 193 SNLEVLGLAYN 203
            +L    L  N
Sbjct: 545 KSLAFFNLTNN 555

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 65.1 bits (159), Expect = 7e-11
 Identities = 18/98 (18%), Positives = 31/98 (31%)

Query: 85  ITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRI 144
               +  +  +  NLT +DLS   +            +LQ L++S N  +    S  +++
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520

Query: 145 SGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFN 182
             L  +D   N               L    L  N   
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 57.0 bits (138), Expect = 2e-08
 Identities = 14/81 (17%), Positives = 25/81 (30%)

Query: 78  ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPI 137
           + L    + Q    +   L  L  +++S N++             L  LD S N      
Sbjct: 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSK 537

Query: 138 PSDIDRISGLQCIDLGGNNFS 158
                    L   +L  N+ +
Sbjct: 538 GILQHFPKSLAFFNLTNNSVA 558

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  194 bits (495), Expect = 1e-55
 Identities = 64/299 (21%), Positives = 123/299 (41%), Gaps = 42/299 (14%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S L    ++G G  GQ  ++     GE + +K +    + +++ ++ F+ E++++  + H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL---IRFDEETQRTFLKEVKVMRCLEH 66

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N++K    +  +     + EY++  +L   +                    W  R+  A
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY------------PWSQRVSFA 114

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML------------A 803
              A G+ Y+H   +  IIHRD+ S N L+       +ADFGLA+++             
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171

Query: 804 KQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA 863
           K+ +      V G+  + APE       +EK+D++SFG+VL E++    A+         
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD------- 224

Query: 864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
            +  R       +   LD+     C      + + + + C    P  RPS  ++   L 
Sbjct: 225 -YLPRTMDFGLNVRGFLDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  194 bits (495), Expect = 2e-55
 Identities = 69/334 (20%), Positives = 122/334 (36%), Gaps = 60/334 (17%)

Query: 626 QLGFTESNI-LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI 684
           +   +E ++ L +L    LIG G  G VY+  ++     VAVK        +    + FI
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVK------VFSFANRQNFI 53

Query: 685 AEIEI--LGTIRHANIVKL-----WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSG 737
            E  I  +  + H NI +                LLV EY  N SL ++L          
Sbjct: 54  NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--------- 104

Query: 738 SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD------CTPQIIHRDVKSSNILLDSEFKA 791
                 H   W +  ++A    +GL Y+H +        P I HRD+ S N+L+ ++   
Sbjct: 105 -----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159

Query: 792 KIADFGLAKMLA------KQGEPHTMSAVAGSFGYFAPEYAYTT-------KVNEKIDIY 838
            I+DFGL+  L          E +   +  G+  Y APE               +++D+Y
Sbjct: 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219

Query: 839 SFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAE--------PCYL 890
           + G++  E+       +  E     + A++      P  + +   ++           + 
Sbjct: 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK 279

Query: 891 EEMTTVYRLALI---CTSTLPSSRPSMKEVLQIL 921
           E    V  L      C      +R + +   + +
Sbjct: 280 ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  185 bits (472), Expect = 1e-52
 Identities = 76/313 (24%), Positives = 122/313 (38%), Gaps = 50/313 (15%)

Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI--RH 695
           +T    +G G  G+V+R    G  E VAVK        + + EK +  E E+  T+  RH
Sbjct: 10  ITLLECVGKGRYGEVWRGSWQG--ENVAVK------IFSSRDEKSWFRETELYNTVMLRH 61

Query: 696 ANIVKLW-CCISSENSK---LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
            NI+      ++S +S     L+  Y E  SL  +L                  L   + 
Sbjct: 62  ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--------------LTTLDTVSC 107

Query: 752 LQIAIGAAQGLCYMHHD-----CTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
           L+I +  A GL ++H +       P I HRD+KS NIL+    +  IAD GLA M ++  
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167

Query: 807 EPH--TMSAVAGSFGYFAPE------YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
                  +   G+  Y APE              +++DI++FG+VL E+     +N   E
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

Query: 859 HTSLA--EWAWRHYAEEKPITDALDKG----IAEPCYLEEMTTVYRLALI--CTSTLPSS 910
                  +      + E              I    + +   T     L+  C    PS+
Sbjct: 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLA-KLMKECWYQNPSA 286

Query: 911 RPSMKEVLQILRR 923
           R +   + + L +
Sbjct: 287 RLTALRIKKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  186 bits (474), Expect = 1e-52
 Identities = 76/317 (23%), Positives = 110/317 (34%), Gaps = 50/317 (15%)

Query: 634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT- 692
           I   +     IG G  G+V+     G  E VAVK            E  +  E EI  T 
Sbjct: 35  IAKQIQMVKQIGKGRYGEVWMGKWRG--EKVAVK------VFFTTEEASWFRETEIYQTV 86

Query: 693 -IRHANIVKLW-CCISSENSK---LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
            +RH NI+      I    S     L+ +Y EN SL  +L                  L 
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK--------------STTLD 132

Query: 748 WPTRLQIAIGAAQGLCYMH-----HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
             + L++A  +  GLC++H         P I HRD+KS NIL+       IAD GLA   
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192

Query: 803 AKQGEPHT--MSAVAGSFGYFAPE------YAYTTKVNEKIDIYSFGVVLLELVTGKEAN 854
                      +   G+  Y  PE           +     D+YSFG++L E+     + 
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252

Query: 855 YGDEHTSLA--EWAWRHYAEEKPITDALDKG----IAEPCYLEEMTTVYRLALI--CTST 906
              E   L   +      + E        K            +E        L+  C + 
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG-KLMTECWAH 311

Query: 907 LPSSRPSMKEVLQILRR 923
            P+SR +   V + L +
Sbjct: 312 NPASRLTALRVKKTLAK 328

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  185 bits (472), Expect = 2e-52
 Identities = 61/302 (20%), Positives = 108/302 (35%), Gaps = 47/302 (15%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
              L    LIG G  GQVY    +G    VA++ I +  + N+   K F  E+      R
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLI-DIERDNEDQLKAFKREVMAYRQTR 87

Query: 695 HANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           H N+V     C+S  +   ++    + ++L   +   K  L                  Q
Sbjct: 88  HENVVLFMGACMSPPH-LAIITSLCKGRTLYSVVRDAKIVL------------DVNKTRQ 134

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK---QGEPHT 810
           IA    +G+ Y+H      I+H+D+KS N+  D   K  I DFGL  +            
Sbjct: 135 IAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190

Query: 811 MSAVAGSFGYFAPE---------YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS 861
           +    G   + APE                ++  D+++ G +  EL   +   +  +   
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-FKTQPAE 249

Query: 862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
              W      +       + K I++            + L C +     RP+  +++ +L
Sbjct: 250 AIIWQMGTGMKPNLSQIGMGKEISD------------ILLFCWAFEQEERPTFTKLMDML 297

Query: 922 RR 923
            +
Sbjct: 298 EK 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  182 bits (463), Expect = 5e-51
 Identities = 69/317 (21%), Positives = 118/317 (37%), Gaps = 50/317 (15%)

Query: 634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI--LG 691
           I  ++     IG G  G+V+R    G  E VAVK        + + E+ +  E EI    
Sbjct: 40  IARTIVLQESIGKGRFGEVWRGKWRG--EEVAVK------IFSSREERSWFREAEIYQTV 91

Query: 692 TIRHANIVKLW-CCISSENSK---LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
            +RH NI+           +     LV +Y E+ SL  +L+              ++ + 
Sbjct: 92  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--------------RYTVT 137

Query: 748 WPTRLQIAIGAAQGLCYMHHD-----CTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
               +++A+  A GL ++H +       P I HRD+KS NIL+       IAD GLA   
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197

Query: 803 AKQGEPHT--MSAVAGSFGYFAPE------YAYTTKVNEKIDIYSFGVVLLELVTGKEAN 854
               +      +   G+  Y APE           +  ++ DIY+ G+V  E+       
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257

Query: 855 YGDEHTSLA--EWAWRHYAEEKPITDALDKG----IAEPCYLEEMTTVYRLALI--CTST 906
              E   L   +      + E+      ++     I       E   V    ++  C   
Sbjct: 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA-KIMRECWYA 316

Query: 907 LPSSRPSMKEVLQILRR 923
             ++R +   + + L +
Sbjct: 317 NGAARLTALRIKKTLSQ 333

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  179 bits (457), Expect = 7e-49
 Identities = 85/458 (18%), Positives = 153/458 (33%), Gaps = 54/458 (11%)

Query: 100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSG 159
           +        I   F        +     L +      +      +  +  +         
Sbjct: 5   SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK- 59

Query: 160 DIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLK 219
                +  L+ L  +    N+        + +L+ L  + +  N              L 
Sbjct: 60  -SIDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADI----TPLANLT 112

Query: 220 KLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNIL 279
            L  L +   N I +I   + NL++L  L L+ N +     S L  L +L QL   + + 
Sbjct: 113 NLTGLTLFN-NQITDID-PLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVT 168

Query: 280 SGEIPSSVEALK-LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVA 338
                  +  L  L  +D+S N ++        KL NL+ L   +N +S   P       
Sbjct: 169 D---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP------- 216

Query: 339 FENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSK 398
                       LG    L  + L  N+        L +  NL+ L L++N IS   P  
Sbjct: 217 ------------LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 262

Query: 399 TAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDG 458
               LT L++  N+ S      +     L   + + N      P  +++L +L  L L  
Sbjct: 263 GLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF 318

Query: 459 NKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIG 518
           N +S   P  + S T L  L    N++S     ++ +L  +  L    NQ S   P  + 
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LA 372

Query: 519 QL-KLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNL 555
            L ++    L+         +   N++  ++  N +  
Sbjct: 373 NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  178 bits (453), Expect = 2e-48
 Identities = 95/448 (21%), Positives = 164/448 (36%), Gaps = 36/448 (8%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
            + VT +      I   I  +   L NLT I+ S+N +       L N TKL ++ ++ N
Sbjct: 45  LDQVTTLQADRLGIK-SIDGV-EYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNN 100

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGD 191
                 P  +  ++ L  + L  N  + DI   +  L+ L  L L  N  +      +  
Sbjct: 101 QIADITP--LANLTNLTGLTLFNNQIT-DID-PLKNLTNLNRLELSSNTISD--ISALSG 154

Query: 192 LSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALN 251
           L++L+ L                   L  L+ L ++   +       ++ L++LE L   
Sbjct: 155 LTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIAT 207

Query: 252 GNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFG 311
            N +    P  L +L NL +L L  N L  +I +      LTD+DL+ N ++   P    
Sbjct: 208 NNQISDITP--LGILTNLDELSLNGNQLK-DIGTLASLTNLTDLDLANNQISNLAP--LS 262

Query: 312 KLKNLQLLGLFSNHLSGEVPAS-----IGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNR 366
            L  L  L L +N +S   P +       +   EN L       + N + L  + LY N 
Sbjct: 263 GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNN 320

Query: 367 FSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKN 426
            S   P    T   L  L   +N +S         N+  L   +N+ S      + +   
Sbjct: 321 ISDISPVSSLT--KLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLT--PLANLTR 376

Query: 427 LIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELS 486
           +     ++  ++        ++S  NT+      L    P+ I    S    ++  N  S
Sbjct: 377 ITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS 434

Query: 487 GEIPKAIGSLLVMVSLDLSGNQFSGEIP 514
               +   +    V++      FSG + 
Sbjct: 435 -YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  170 bits (433), Expect = 1e-45
 Identities = 92/469 (19%), Positives = 164/469 (34%), Gaps = 52/469 (11%)

Query: 96  LKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGN 155
           L       L   ++         +  ++  L   +          ++ ++ L  I+   N
Sbjct: 23  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 78

Query: 156 NFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEF 215
             +   P  +  L++L  + +  N+        + +L+NL  L L  N            
Sbjct: 79  QLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDI----DPL 130

Query: 216 GMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLY 275
             L  L  L ++  N I +I  A+S L+SL+ L+      +      L  L  L +L + 
Sbjct: 131 KNLTNLNRLELSS-NTISDIS-ALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDIS 185

Query: 276 DNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASI 334
            N +S    S +  L  L  +  + N ++   P   G L NL  L L  N L        
Sbjct: 186 SNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD------ 235

Query: 335 GVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGE 394
                          +L +   L  + L +N+ S   P    T   L+ L L  N IS  
Sbjct: 236 -------------IGTLASLTNLTDLDLANNQISNLAPLSGLT--KLTELKLGANQISNI 280

Query: 395 LPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTL 454
            P      LT LE++ N+        + + KNL       N  S   P  ++SL+ L  L
Sbjct: 281 SPLAGLTALTNLELNENQLEDIS--PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336

Query: 455 LLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIP 514
               NK+S    S + + T++N L+   N++S   P  + +L  +  L L+   ++    
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPV 392

Query: 515 PEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIIN 563
                + +     +        P   ++           NL      ++
Sbjct: 393 NYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEVS 440

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  112 bits (282), Expect = 3e-26
 Identities = 62/286 (21%), Positives = 112/286 (39%), Gaps = 29/286 (10%)

Query: 74  SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYF 133
           ++  +   +  I+  I P+   L NL  + L+ N +  +    L + T L +LDL+ N  
Sbjct: 200 NLESLIATNNQIS-DITPL-GILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQI 255

Query: 134 VGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLS 193
               P  +  ++ L  + LG N  S +I   +  L+ L  L L  N+        I +L 
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQIS-NIS-PLAGLTALTNLELNENQL--EDISPISNLK 309

Query: 194 NLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALN 251
           NL  L L +N  S+  P         L KL+ L+    N + ++   ++NL+++  L+  
Sbjct: 310 NLTYLTLYFNNISDISP------VSSLTKLQRLFFYN-NKVSDVSS-LANLTNINWLSAG 361

Query: 252 GNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFG 311
            N +    P  L  L  +TQL L D   +    +    + + +   ++       P    
Sbjct: 362 HNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL-IAPATIS 418

Query: 312 KLKNLQLLGLFSNHLS--GEVPAS----IGVVAFENNLSGAVPKSL 351
              +     +  N  S   EV  +    + +       SG V + L
Sbjct: 419 DGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  169 bits (430), Expect = 2e-45
 Identities = 100/498 (20%), Positives = 170/498 (34%), Gaps = 93/498 (18%)

Query: 89  IPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI------- 141
           I P       L      S+++  E P    N         + + +    P          
Sbjct: 3   INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 142 ------DRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNL 195
                         ++L     S  +P        L++L    N      P+    L +L
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSL 116

Query: 196 EVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHL 255
            V      +      +     +   L+ L ++  N + ++PE + N S L+I+ ++ N L
Sbjct: 117 LVDNNNLKA------LS---DLPPLLEYLGVSN-NQLEKLPE-LQNSSFLKIIDVDNNSL 165

Query: 256 EGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKN 315
           +  +P    L  +L  +   +N L  E+P       LT I    N+L   +P+    L++
Sbjct: 166 K-KLPD---LPPSLEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSLK-KLPDLPLSLES 219

Query: 316 LQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGL 375
           +                        N L       L N   L T+   +N     LP   
Sbjct: 220 IVAGN--------------------NILE--ELPELQNLPFLTTIYADNNLLK-TLPDLP 256

Query: 376 WTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNN 435
               +L +L + DN ++ +LP     +LT L++S N FS  +        NL    AS+N
Sbjct: 257 ---PSLEALNVRDNYLT-DLPELPQ-SLTFLDVSENIFS-GLSELPP---NLYYLNASSN 307

Query: 436 LFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGS 495
                +     SL  LN   +  NKL  +LP+       L  L  + N L+ E+P+   +
Sbjct: 308 EIR-SLCDLPPSLEELN---VSNNKLI-ELPALP---PRLERLIASFNHLA-EVPELPQN 358

Query: 496 LLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNL 555
           L     L +  N    E P     ++    +L  N     +P+   NL      L+    
Sbjct: 359 L---KQLHVEYNPLR-EFPDIPESVE----DLRMNSHLAEVPELPQNLKQ----LHVET- 405

Query: 556 CVKNPIINLPKCPSRFRN 573
              NP+   P  P    +
Sbjct: 406 ---NPLREFPDIPESVED 420

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  157 bits (400), Expect = 2e-41
 Identities = 82/441 (18%), Positives = 163/441 (36%), Gaps = 55/441 (12%)

Query: 70  CTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLS 129
           C       + L +  ++  +P +     +L ++  S NS+  E PE   +   L   + +
Sbjct: 68  CLDRQAHELELNNLGLSS-LPELP---PHLESLVASCNSL-TELPELPQSLKSLLVDNNN 122

Query: 130 QNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEI 189
                   P        L+ + +  N     +P  +   S L+ + +  N      P   
Sbjct: 123 LKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP 172

Query: 190 GDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILA 249
               +LE +    N   +   +P E   L  L  ++    N + ++P+      SLE + 
Sbjct: 173 P---SLEFIAAGNNQLEE---LP-ELQNLPFLTAIYADN-NSLKKLPD---LPLSLESIV 221

Query: 250 LNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEE 309
              N LE      L  L  LT ++  +N+L   +P       L  +++  N LT  +PE 
Sbjct: 222 AGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPP--SLEALNVRDNYLT-DLPEL 275

Query: 310 FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSG 369
              L  L +     + LS E+P ++  +   +N   ++     +   L  + + +N+   
Sbjct: 276 PQSLTFLDVSENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPS---LEELNVSNNKLI- 330

Query: 370 ELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIV 429
           ELP        L  L+ S N ++ E+P     NL +L +  N    +      S ++L  
Sbjct: 331 ELPALP---PRLERLIASFNHLA-EVPELPQ-NLKQLHVEYNPLR-EFPDIPESVEDL-- 382

Query: 430 FKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEI 489
            + +++L   E+P    +L  L+   ++ N L  + P       S+ +L +    +    
Sbjct: 383 -RMNSHL--AEVPELPQNLKQLH---VETNPLR-EFPDIP---ESVEDLRMNSERVVDPY 432

Query: 490 PKAIGSLLVMVSLDLSGNQFS 510
             A  +   +       +   
Sbjct: 433 EFAHETTDKLEDDVFEHHHHH 453

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  160 bits (406), Expect = 3e-43
 Identities = 79/388 (20%), Positives = 141/388 (36%), Gaps = 44/388 (11%)

Query: 146 GLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSN 205
           G   +       +   P     L+E     L              +L ++  L +A    
Sbjct: 1   GAATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGE-- 54

Query: 206 FKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFL 265
            K A I      L  L+ L +   N I +I   +SNL  L  L +  N +     S L  
Sbjct: 55  -KVASIQ-GIEYLTNLEYLNLNG-NQITDIS-PLSNLVKLTNLYIGTNKIT--DISALQN 108

Query: 266 LNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNH 325
           L NL +L+L ++ +S  I       K+  ++L  N+   S       +  L  L +  + 
Sbjct: 109 LTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESK 166

Query: 326 LSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLM 385
           +                        + N   L ++ L  N+      + L +  +L    
Sbjct: 167 VKD-------------------VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFT 205

Query: 386 LSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEL 445
              N I+   P      L  L+I NN+ +      + +   L   +   N  S  I   +
Sbjct: 206 AYVNQITDITPVANMTRLNSLKIGNNKITDLS--PLANLSQLTWLEIGTNQISD-IN-AV 261

Query: 446 TSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLS 505
             L+ L  L +  N++S    S + + + LN+L L  N+L  E  + IG L  + +L LS
Sbjct: 262 KDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319

Query: 506 GNQFSGEIPPEIGQL-KLNTFNLSSNKL 532
            N  +   P  +  L K+++ + ++  +
Sbjct: 320 QNHITDIRP--LASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  157 bits (400), Expect = 2e-42
 Identities = 78/413 (18%), Positives = 144/413 (34%), Gaps = 69/413 (16%)

Query: 99  LTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFS 158
             T+      I   FP    +  +     L +      +    + +  +  + + G   +
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 159 GDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGML 218
             I   I  L+ L+ L L  N+        + +L  L  L +  N              L
Sbjct: 58  -SIQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNK----ITDISALQNL 109

Query: 219 KKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNI 278
             L+ L++ E + I +I   ++NL+ +  L L  NH      S L  +  L  L + ++ 
Sbjct: 110 TNLRELYLNE-DNISDIS-PLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESK 166

Query: 279 LSGEIPSSVEALK-LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVV 337
           +    P  +  L  L  + L+ N +    P     L +L     + N ++          
Sbjct: 167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--------- 213

Query: 338 AFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPS 397
                        + N   L ++++ +N+ +    + L     L+ L +  N IS     
Sbjct: 214 ----------ITPVANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISDINAV 261

Query: 398 KTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLD 457
           K    L  L + +N+ S                         +I   L +LS LN+L L+
Sbjct: 262 KDLTKLKMLNVGSNQIS-------------------------DIS-VLNNLSQLNSLFLN 295

Query: 458 GNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFS 510
            N+L  +    I   T+L  L L++N ++   P  + SL  M S D +     
Sbjct: 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  152 bits (387), Expect = 1e-40
 Identities = 73/389 (18%), Positives = 132/389 (33%), Gaps = 47/389 (12%)

Query: 76  TGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVG 135
             ++     I Q  P    DL       L   S+             +  L ++      
Sbjct: 3   ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS 58

Query: 136 PIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNL 195
                I+ ++ L+ ++L GN  +   P  +  L +L  LY+  N+   T    + +L+NL
Sbjct: 59  --IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNL 112

Query: 196 EVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGN 253
             L L  +  S+  P         L K+ +L +   N        +SN++ L  L +  +
Sbjct: 113 RELYLNEDNISDISP------LANLTKMYSLNLGA-NHNLSDLSPLSNMTGLNYLTVTES 165

Query: 254 HLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKL 313
            ++   P  +  L +L  L L  N +   I        L      +N +T   P     +
Sbjct: 166 KVKDVTP--IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITP--VANM 220

Query: 314 KNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPT 373
             L  L + +N ++                       L N   L  +++ +N+ S     
Sbjct: 221 TRLNSLKIGNNKITD-------------------LSPLANLSQLTWLEIGTNQISD--IN 259

Query: 374 GLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKAS 433
            +     L  L +  N IS          L  L ++NN+   +    +G   NL     S
Sbjct: 260 AVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319

Query: 434 NNLFSGEIPVELTSLSHLNTLLLDGNKLS 462
            N  +   P  L SLS +++       + 
Sbjct: 320 QNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  133 bits (338), Expect = 3e-34
 Identities = 74/375 (19%), Positives = 134/375 (35%), Gaps = 68/375 (18%)

Query: 171 LQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEAN 230
             TL       N  FP    DL+      L   S        +    L+ +  L +    
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDV----VTQEELESITKLVVAG-E 54

Query: 231 LIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL 290
            +  I   +  L++LE L LNGN +    P  L  L  LT L++  N ++    S+++ L
Sbjct: 55  KVASIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNL 109

Query: 291 K-LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPK 349
             L ++ L+ +N++   P     L  +  L L +NH                        
Sbjct: 110 TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS------------------DLS 149

Query: 350 SLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEIS 409
            L N   L  + +  ++      T +    +L SL L+ N I    P  +  +L      
Sbjct: 150 PLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAY 207

Query: 410 NNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQI 469
            N+ +                              + +++ LN+L +  NK++   P  +
Sbjct: 208 VNQITDIT--------------------------PVANMTRLNSLKIGNNKITDLSP--L 239

Query: 470 VSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLS 528
            + + L  L +  N++S     A+  L  +  L++  NQ S      +  L  LN+  L+
Sbjct: 240 ANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLN 295

Query: 529 SNKLYGNIPDEFNNL 543
           +N+L     +    L
Sbjct: 296 NNQLGNEDMEVIGGL 310

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  126 bits (318), Expect = 1e-31
 Identities = 61/300 (20%), Positives = 113/300 (37%), Gaps = 43/300 (14%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
              +T + +    IT      + +L NL  + L+ ++I       L N TK+ +L+L  N
Sbjct: 87  LVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGAN 142

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGD 191
           + +    S +  ++GL  + +  +      P  I  L++L +L L  N+        +  
Sbjct: 143 HNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI--EDISPLAS 197

Query: 192 LSNLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILA 249
           L++L       N  ++  P         + +L +L +   N I ++   ++NLS L  L 
Sbjct: 198 LTSLHYFTAYVNQITDITP------VANMTRLNSLKIGN-NKITDLS-PLANLSQLTWLE 249

Query: 250 LNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSIPE 308
           +  N +     + +  L  L  L +  N +S    S +  L  L  + L+ N L     E
Sbjct: 250 IGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305

Query: 309 EFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS 368
             G L NL  L L  NH++   P                   L +   + +    +    
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRP-------------------LASLSKMDSADFANQVIK 346

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  163 bits (415), Expect = 8e-43
 Identities = 83/460 (18%), Positives = 154/460 (33%), Gaps = 28/460 (6%)

Query: 99  LTTIDLSSN---SIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGN 155
               D  S    SIP            +++LDLS N        D+   + LQ + L  +
Sbjct: 7   SGVCDGRSRSFTSIPSGLT------AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60

Query: 156 NFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEF 215
             +     +   L  L+ L L  N  +       G LS+L+ L L  N  ++   +   F
Sbjct: 61  RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN-PYQTLGVTSLF 119

Query: 216 GMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLF 273
             L  L+TL +       EI     + L+SL  L +    L     S     + ++  L 
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLT 178

Query: 274 LYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPA 332
           L+ +  +  +    + L  +  ++L   NL           +    +   +   S     
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238

Query: 333 SI-GVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTI 391
           S   ++     +         +C          +        G   T  +  L +    +
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298

Query: 392 SGELPSKTAW--NLTRLEISNNRFSGQIQRGVGSW-KNLIVFKASNNLFSGEI---PVEL 445
             +L +  +    + R+ + N++    +        K+L     S NL   E        
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357

Query: 446 TSLSHLNTLLLDGNKLS--GKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLD 503
            +   L TL+L  N L    K    +++  +L +L+++RN     +P +      M  L+
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416

Query: 504 LSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNL 543
           LS       +   I Q  L   ++S+N L  +       L
Sbjct: 417 LSSTGIR-VVKTCIPQ-TLEVLDVSNNNL-DSFSLFLPRL 453

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  145 bits (368), Expect = 9e-37
 Identities = 73/480 (15%), Positives = 155/480 (32%), Gaps = 65/480 (13%)

Query: 87  QKIPPIICD-LKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVG-PIPSDIDRI 144
             I       L +L  +DLS N +      +    + L+ L+L  N +    + S    +
Sbjct: 63  NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122

Query: 145 SGLQCIDLGGNNFSGDIPR-SIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYN 203
           + LQ + +G      +I R     L+ L  L +          + +  + ++  L L  +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182

Query: 204 SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLE------- 256
            +    ++ I   +L  ++ L + + NL       +        +               
Sbjct: 183 ES--AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240

Query: 257 GAIPSGLFLLNNLTQLFLYDNILSGEI------------PSSVEALKLTDIDLSMNNLTG 304
             +   L  +  L+++   D  L+G                 VE + +  + +    L  
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300

Query: 305 SIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYS 364
            +   +  L+ ++ + + ++ +       +     ++             ++L  + L  
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVF-----LVPCSFSQH------------LKSLEFLDLSE 343

Query: 365 NRFSGELPTGLWTTF----NLSSLMLSDNTISGELPSKTAW-----NLTRLEISNNRFSG 415
           N    E             +L +L+LS N +   +           NLT L+IS N F  
Sbjct: 344 NLMV-EEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH- 400

Query: 416 QIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSL 475
            +       + +     S+      +   +     L  L +  N L       +     L
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFL---PRL 453

Query: 476 NNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL--KLNTFNLSSNKLY 533
             L ++RN+L   +P       V++ + +S NQ    +P  I      L    L +N   
Sbjct: 454 QELYISRNKLK-TLP-DASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  119 bits (301), Expect = 3e-28
 Identities = 65/438 (14%), Positives = 145/438 (33%), Gaps = 62/438 (14%)

Query: 78  ISLRHKDITQKIPP-IICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGP 136
           + + + +   +I       L +L  +++ + S+     + L +   + +L L  +     
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 137 IPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLE 196
           +    D +S ++ ++L   N +      +        +       +    +   +L  L 
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

Query: 197 VLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLE 256
              L  +       +  +   L  L     +E++++ E+ +      ++  L +   +L 
Sbjct: 248 RYILELSE------VEFDDCTLNGLGDFNPSESDVVSELGK--VETVTIRRLHIPQFYLF 299

Query: 257 GAIPSGLFLLNNLTQLFLYDNILSGEIPSSV--EALKLTDIDLSMNNLTGSIPEE---FG 311
             + +   LL  + ++ + ++ +   +P S       L  +DLS N +     +     G
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358

Query: 312 KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGEL 371
              +LQ L L  NHL   +  +  ++                 + L ++ +  N F   +
Sbjct: 359 AWPSLQTLVLSQNHLR-SMQKTGEILL--------------TLKNLTSLDISRNTFH-PM 402

Query: 372 PTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFK 431
           P        +  L LS   I   + +     L  L++SNN                    
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLD----------------- 444

Query: 432 ASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPK 491
                      + L  L  L    +  NKL   LP   +    L  + ++RN+L      
Sbjct: 445 --------SFSLFLPRLQELY---ISRNKLK-TLPDASLF-PVLLVMKISRNQLKSVPDG 491

Query: 492 AIGSLLVMVSLDLSGNQF 509
               L  +  + L  N +
Sbjct: 492 IFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  102 bits (255), Expect = 1e-22
 Identities = 56/320 (17%), Positives = 107/320 (33%), Gaps = 46/320 (14%)

Query: 14  TLILLVLLSIPFEVIPQSPN----TEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEIT 69
                VL    F  + +         E          LG+    +S   +          
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV----- 283

Query: 70  CTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLS 129
               ++  + +    +   +  +   L+ +  I + ++ +      F  +   L+ LDLS
Sbjct: 284 -ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLS 342

Query: 130 QNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEI 189
           +N            +      +              G    LQTL L  N    +  K  
Sbjct: 343 EN-----------LMVEEYLKN----------SACKGAWPSLQTLVLSQNHLR-SMQKTG 380

Query: 190 G---DLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLE 246
                L NL  L ++ N  F P  +P      +K++ L ++    I  +        +LE
Sbjct: 381 EILLTLKNLTSLDISRN-TFHP--MPDSCQWPEKMRFLNLSS-TGIRVVKT--CIPQTLE 434

Query: 247 ILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSI 306
           +L ++ N+L+ +       L  L +L++  N L   +P +     L  + +S N L    
Sbjct: 435 VLDVSNNNLD-SFSLF---LPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVP 489

Query: 307 PEEFGKLKNLQLLGLFSNHL 326
              F +L +LQ + L +N  
Sbjct: 490 DGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 74.4 bits (183), Expect = 8e-14
 Identities = 42/225 (18%), Positives = 80/225 (35%), Gaps = 29/225 (12%)

Query: 66  PEITCTFNSVTGISLRHKDITQKIPPIICD-LKNLTTIDLSSN---SIPGEFPEFLYNCT 121
             +      V  I++ +  +   +P      LK+L  +DLS N       +         
Sbjct: 303 STVYSLLEKVKRITVENSKV-FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361

Query: 122 KLQNLDLSQNYF--VGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN 179
            LQ L LSQN+   +      +  +  L  +D+  N F   +P S     +++ L L   
Sbjct: 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST 420

Query: 180 EFNGTFPKEIGDLSNLEVLGLAYNS-NFKPAMIP---------------IEFGMLKKLKT 223
                    I     LEVL ++ N+ +     +P                +  +   L  
Sbjct: 421 GIR-VVKTCI--PQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVLLV 477

Query: 224 LWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFLLN 267
           + +   N +  +P+     L+SL+ + L+ N  + + P   +L  
Sbjct: 478 MKI-SRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 521

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 74.0 bits (182), Expect = 9e-14
 Identities = 50/327 (15%), Positives = 97/327 (29%), Gaps = 50/327 (15%)

Query: 267 NNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL 326
            + T +          + +++++L     DLS N +T     +     NLQ+L L S+ +
Sbjct: 15  RSFTSIP-------SGLTAAMKSL-----DLSFNKITYIGHGDLRACANLQVLILKSSRI 62

Query: 327 SGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLML 386
           +     +I   AF +  S            L  + L  N  S    +      +L  L L
Sbjct: 63  N-----TIEGDAFYSLGS------------LEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105

Query: 387 SDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELT 446
             N       +    NLT L+                     +   +   FS    ++  
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQT--------------------LRIGNVETFSEIRRIDFA 145

Query: 447 SLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSG 506
            L+ LN L +    L       + S   +++L L  +E +  +      L  +  L+L  
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205

Query: 507 NQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPK 566
              +         +   +  +      G++  + +             L           
Sbjct: 206 TNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264

Query: 567 CPSRFRNSDKISSKHLALILVLAILVL 593
               F  S+      L  +  + I  L
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRL 291

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  160 bits (406), Expect = 4e-42
 Identities = 64/451 (14%), Positives = 132/451 (29%), Gaps = 40/451 (8%)

Query: 89  IPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQ 148
           I  I  +        ++ +S+         +   ++ LDLS N       +D+   + L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 149 CIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKP 208
            ++L  N         +  LS L+TL L  N       +E+    ++E L  A N+    
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN---- 110

Query: 209 AMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLF-LL 266
            +  +     +  K +++   N I  + +      S ++ L L  N ++    + L    
Sbjct: 111 -ISRVSCSRGQGKKNIYLAN-NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 267 NNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL 326
           + L  L L  N +  ++   V   KL  +DLS N L   +  EF     +  + L +N L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

Query: 327 SGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS-GELPTGLWTTFNLSSLM 385
                               + K+L   + L    L  N F  G L         + ++ 
Sbjct: 227 V------------------LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA 268

Query: 386 LSDNTISGELPSKTAWNLTRLEISNNRFS----GQIQRGVGSWKNLIVFKASNNLFSGEI 441
                       +     T                  R +   +      +     +  +
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERL 328

Query: 442 PVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVS 501
             E  + +    +     +    +    +   +   L   +  L  ++     +   +  
Sbjct: 329 ECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG 388

Query: 502 LDLSGNQFSGEIPPEIGQLKLNTFNLSSNKL 532
                            Q  L        + 
Sbjct: 389 TLQQAVGQIELQHATEEQSPLQLLRAIVKRY 419

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  135 bits (341), Expect = 9e-34
 Identities = 61/364 (16%), Positives = 113/364 (31%), Gaps = 37/364 (10%)

Query: 235 IPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLT 293
           I E   N +  +I  +  + L+ A+ S      N+ +L L  N LS    + +    KL 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 294 DIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGN 353
            ++LS N L      +   L  L+ L L +N++                        L  
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ----------------------ELLV 97

Query: 354 CRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLE---ISN 410
             ++ T+   +N  S  +           ++ L++N I+  L        +R++   +  
Sbjct: 98  GPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKL 153

Query: 411 NRFSG-QIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQI 469
           N            S   L       N    ++       + L TL L  NKL+  +  + 
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEF 210

Query: 470 VSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSS 529
            S   +  ++L  N+L   I KA+     +   DL GN F      +          ++ 
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269

Query: 530 NKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLA 589
             +                    +  C   P     +  +  R    + S   +    L 
Sbjct: 270 QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329

Query: 590 ILVL 593
               
Sbjct: 330 CERE 333

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  129 bits (325), Expect = 1e-31
 Identities = 62/436 (14%), Positives = 131/436 (30%), Gaps = 32/436 (7%)

Query: 66  PEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQN 125
             +  +  +V  + L    ++Q     +     L  ++LSSN +  E  +   + + L+ 
Sbjct: 27  ASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL-YETLDL-ESLSTLRT 84

Query: 126 LDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTF 185
           LDL+ NY       ++     ++ +    NN S  +  S       + +YL  N+     
Sbjct: 85  LDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLR 136

Query: 186 PKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSL 245
             + G  S ++ L L  N                 L+ L +   N I ++       + L
Sbjct: 137 DLDEGCRSRVQYLDLKLN-EIDTVNFAELAASSDTLEHLNLQY-NFIYDVKGQ-VVFAKL 193

Query: 246 EILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNL-T 303
           + L L+ N L   +         +T + L +N L   I  ++   + L   DL  N    
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251

Query: 304 GSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKS-----LGNCRTLR 358
           G++ + F K + +Q +   +             V    +      +            L+
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK 311

Query: 359 TVQLYSNRFSG----ELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLE---ISNN 411
             +       G     L            +          +  +                
Sbjct: 312 RKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQVTLRKQAKITLEQKKK 370

Query: 412 RFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKL-PSQIV 470
               Q+  G  +   L        +   E+       S L  L     +        Q V
Sbjct: 371 ALDEQVSNGRRAHAELDG-TLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSV 429

Query: 471 SWTSLNNLNLARNELS 486
              ++ + ++ +++ +
Sbjct: 430 QNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 96.1 bits (239), Expect = 8e-21
 Identities = 51/249 (20%), Positives = 91/249 (36%), Gaps = 23/249 (9%)

Query: 305 SIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFE--------NNLSGAVPKSLGNCRT 356
           +I E        ++  +  + L  +  AS+   A+         N LS      L     
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

Query: 357 LRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQ 416
           L  + L SN    E    L +   L +L L++N +  EL      ++  L  +NN  S +
Sbjct: 60  LELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLVGP--SIETLHAANNNIS-R 113

Query: 417 IQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSG-KLPSQIVSWTSL 475
           +    G          +NN  +    ++    S +  L L  N++          S  +L
Sbjct: 114 VSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 476 NNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNKLYG 534
            +LNL  N +  ++   +     + +LDLS N+ +  + PE      +   +L +NKL  
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-V 227

Query: 535 NIPDEFNNL 543
            I       
Sbjct: 228 LIEKALRFS 236

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  161 bits (410), Expect = 5e-42
 Identities = 89/482 (18%), Positives = 153/482 (31%), Gaps = 44/482 (9%)

Query: 80  LRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPS 139
               +  + IP  +    +   +DLS N +        ++  +LQ LDLS+         
Sbjct: 14  CMELNFYK-IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 140 DIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLG 199
               +S L  + L GN        +   LS LQ L              IG L  L+ L 
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 200 LAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEI----LALNGNHL 255
           +A+N   +   +P  F  L  L+ L ++   +       +  L  + +    L L+ N +
Sbjct: 131 VAHN-LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 256 EGAIPSGLFLLNNLTQLFLYDNILSGEIPSSV----EALKLTDIDL----SMNNLTGSIP 307
              I  G F    L +L L +N  S  +  +       L++  + L    +  NL     
Sbjct: 190 NF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 308 EEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRF 367
                L NL +      +L              +     +         + +  L S   
Sbjct: 249 SALEGLCNLTIEEFRLAYL--------------DYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 368 SGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNL 427
              +    +       L L +     + P+    +L RL  ++N+        V    +L
Sbjct: 295 E-RVKDFSYNF-GWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGN-AFSEVD-LPSL 349

Query: 428 IVFKASNNL--FSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNEL 485
                S N   F G         + L  L L  N +   + S  +    L +L+   + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 408

Query: 486 SGEIP-KAIGSLLVMVSLDLSGNQFSGEIPPEI--GQLKLNTFNLSSNKLYGNIPDE-FN 541
                     SL  ++ LD+S           I  G   L    ++ N    N   + F 
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467

Query: 542 NL 543
            L
Sbjct: 468 EL 469

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  159 bits (403), Expect = 4e-41
 Identities = 89/483 (18%), Positives = 160/483 (33%), Gaps = 25/483 (5%)

Query: 78  ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPI 137
           + L   +I          L +L+T+ L+ N I           + LQ L   +       
Sbjct: 57  LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 138 PSDIDRISGLQCIDLGGNNF-SGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLE 196
              I  +  L+ +++  N   S  +P     L+ L+ L L  N+    +  ++  L  + 
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176

Query: 197 VLGLAYN-SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNH 254
           +L L+ + S      I        +L  L +        + +  +  L+ LE+  L    
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236

Query: 255 LEG-----AIPSGLFL-LNNLTQLFLYDNILSGEIPSSVEAL----KLTDIDLSMNNLTG 304
                            L NLT        L   +   ++       ++   L    +  
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296

Query: 305 SIPEEF-GKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLY 363
                +    ++L+L+             S+  + F +N  G    S  +  +L  + L 
Sbjct: 297 VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF-SEVDLPSLEFLDLS 355

Query: 364 SNR--FSGELPTGLWTTFNLSSLMLSDNTISGELPS--KTAWNLTRLEISNNRFSGQIQR 419
            N   F G      + T +L  L LS N +   + S       L  L+  ++      + 
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 414

Query: 420 GV-GSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQI-VSWTSLNN 477
            V  S +NLI    S+             LS L  L + GN         I     +L  
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474

Query: 478 LNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEI--GQLKLNTFNLSSNKLYGN 535
           L+L++ +L    P A  SL  +  L+++ NQ    +P  I      L    L +N    +
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 533

Query: 536 IPD 538
            P 
Sbjct: 534 CPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  104 bits (261), Expect = 2e-23
 Identities = 66/367 (17%), Positives = 127/367 (34%), Gaps = 46/367 (12%)

Query: 18  LVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTG 77
              L++    I      E   ++L   +  GN                  +T     +  
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG----LCNLTIEEFRLAY 266

Query: 78  ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPE-FLYNCTKLQNLDLSQNYFVGP 136
           +     DI      +   L N+++  L S +I       + +    L+ ++     F   
Sbjct: 267 LDYYLDDI----IDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF--- 319

Query: 137 IPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFN--GTFPKEIGDLSN 194
                 ++  L+ +    N    +    +  L  L+ L L  N  +  G   +     ++
Sbjct: 320 ---PTLKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374

Query: 195 LEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE--AMSNLSSLEILALNG 252
           L+ L L++N       +   F  L++L+ L     + + ++ E     +L +L  L ++ 
Sbjct: 375 LKYLDLSFN---GVITMSSNFLGLEQLEHLDFQH-SNLKQMSEFSVFLSLRNLIYLDISH 430

Query: 253 NHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSV--EALKLTDIDLSMNNLTGSIPEE 309
            H      +G+F  L++L  L +  N         +  E   LT +DLS   L    P  
Sbjct: 431 THTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

Query: 310 FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSG 369
           F  L +LQ+L + SN L   VP  I                     +L+ + L++N +  
Sbjct: 490 FNSLSSLQVLNMASNQLK-SVPDGI----------------FDRLTSLQKIWLHTNPWDC 532

Query: 370 ELPTGLW 376
             P   +
Sbjct: 533 SCPRIDY 539

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  152 bits (385), Expect = 4e-41
 Identities = 73/287 (25%), Positives = 113/287 (39%), Gaps = 47/287 (16%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL- 701
            IG G    VY+         VA   +  +RKL +   + F  E E+L  ++H NIV+  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 702 --WCCISSENSKLLVY-EYMENQSLDRWL--HGR-KRSLVSGSSSVHQHVLHWPTRLQIA 755
             W         +++  E M + +L  +L      K  ++            W  R QI 
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR----------SW-CR-QIL 139

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-KAKIADFGLAKMLAKQGEPHTMSAV 814
               +GL ++H   TP IIHRD+K  NI +       KI D GLA +           AV
Sbjct: 140 ----KGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAV 190

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
            G+  + APE  Y  K +E +D+Y+FG+ +LE+ T  E  Y +   +   +         
Sbjct: 191 IGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATS-EYPYSECQNAAQIY---RRVTSG 245

Query: 875 PITDALDKGIAEPC--YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
               + DK         +E           C       R S+K++L 
Sbjct: 246 VKPASFDKVAIPEVKEIIEG----------CIRQNKDERYSIKDLLN 282

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  158 bits (401), Expect = 6e-40
 Identities = 90/525 (17%), Positives = 175/525 (33%), Gaps = 62/525 (11%)

Query: 78  ISLRHKDITQKIPPIIC-DLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGP 136
           + L  +     I      +L NL  +DL S+ I    P+       L  L L        
Sbjct: 53  LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112

Query: 137 I--PSDIDRISGLQCIDLGGNNFSG-DIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLS 193
           +        +  L  +DL  N      +  S G+L+ L+++    N+       E+  L 
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172

Query: 194 NLEVLGLAYNSNFKPAMIPIEF-GMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNG 252
              +   +  +N   + + +++   +   + + +   ++ G       N  +++I     
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFS 225

Query: 253 NHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSV----EALKLTDIDLSMNNLTGSIPE 308
           N +  +    L L +++       + +  +   +         +  +DLS   +      
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSR 284

Query: 309 EFGKLKNLQLLGLFSNHLSGEVPASIGVVAFE------------NNLSGAVPKSLGNCRT 356
            F  LK+L++L L  N ++      I   AF             N L      +      
Sbjct: 285 VFETLKDLKVLNLAYNKIN-----KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPK 339

Query: 357 LRTVQLYSNRFSGELPTGLWTTF-NLSSLMLSDNTIS--GELPS---------------K 398
           +  + L  N  +  +    +     L +L L DN ++    +PS               K
Sbjct: 340 VAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPK 398

Query: 399 TAWNLTRLEISNNRFSG-QIQRGVGSWKNLIVFKASNNLFSG-EIPVELTSLSHLNTLLL 456
                  + +S NR     I   +    +L +   + N FS        +    L  L L
Sbjct: 399 INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458

Query: 457 DGNKLSGKLPSQIVSW-----TSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSG 511
             N L     +++        + L  L L  N L+   P     L  +  L L+ N+ + 
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT- 517

Query: 512 EIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLC 556
            +        L   ++S N+L    PD F +L+  D   +N  +C
Sbjct: 518 VLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLD-ITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  137 bits (347), Expect = 2e-33
 Identities = 102/555 (18%), Positives = 179/555 (32%), Gaps = 83/555 (14%)

Query: 88  KIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCT--KLQNLDLSQNYFVGPIPSDIDRIS 145
            + P    L +L +ID SSN I       L       L    L+ N     +  D  +  
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198

Query: 146 G------LQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLG 199
                  L+ +D+ GN ++ DI               + N  + +    +    ++   G
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITG------------NFSNAISKSQAFSLILAHHIMGAG 246

Query: 200 LAYNSNFKPAMIPIEFGMLKKLKTLWMTE----ANLIGEI-PEAMSNLSSLEILALNGNH 254
             +++     +   +      L    +         +  +       L  L++L L  N 
Sbjct: 247 FGFHN-----IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301

Query: 255 LEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGK 312
           +   I    F  L+NL  L L  N+L     S+   L K+  IDL  N++     + F  
Sbjct: 302 INK-IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360

Query: 313 LKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELP 372
           L+ LQ L L  N L+                      ++    ++  + L  N+    LP
Sbjct: 361 LEKLQTLDLRDNALT----------------------TIHFIPSIPDIFLSGNKLV-TLP 397

Query: 373 TGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLE---ISNNRFSGQIQRGVGSW-KNLI 428
                    + + LS+N +           +  L+   ++ NRFS        S   +L 
Sbjct: 398 KI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE 454

Query: 429 VFKASNNLFSGEIPVEL-----TSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARN 483
                 N+       EL       LSHL  L L+ N L+   P      T+L  L+L  N
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514

Query: 484 ELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIP-DEFNN 542
            L+      + + L    LD+S NQ     P     + L+  +++ NK         F N
Sbjct: 515 RLTVLSHNDLPANL--EILDISRNQLL--APNPDVFVSLSVLDITHNKFICECELSTFIN 570

Query: 543 LA--YDDSFLNNSNLCV--------KNPIINLPKCPSRFRNSDKISSKHLALILVLAILV 592
                + +                    + +L           K     L ++  + + +
Sbjct: 571 WLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTL 630

Query: 593 LLVTVSLSWFVVRDC 607
            L+T+         C
Sbjct: 631 FLMTILTVTKFRGFC 645

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  127 bits (320), Expect = 5e-30
 Identities = 80/445 (17%), Positives = 139/445 (31%), Gaps = 78/445 (17%)

Query: 94  CDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLG 153
           C             ++  + P+ L      + L LS NY      S    +  LQ ++LG
Sbjct: 2   CSFDG-RIAFYRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELG 56

Query: 154 GNNFSGDI-PRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIP 212
                  I   +   L  L+ L L  ++     P     L +L  L L +       +  
Sbjct: 57  SQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKD 116

Query: 213 IEFGMLKKLKTLWMTEANLIGEIPE--AMSNLSSLEILALNGNHLEGAIPSGLFLLNNLT 270
             F  LK L  L +++ N I  +    +   L+SL+ +  + N +   +           
Sbjct: 117 GYFRNLKALTRLDLSK-NQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHEL------ 168

Query: 271 QLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKN-LQLLGLFSNHLSGE 329
                           ++   L+   L+ N+L   +  ++GK  N  + + L    +SG 
Sbjct: 169 --------------EPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214

Query: 330 VPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDN 389
                    F N +S +   SL     +       +                       N
Sbjct: 215 GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK----------------DPDQN 258

Query: 390 TISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLS 449
           T +G   S    ++  L++S+                   F  ++ +F          L 
Sbjct: 259 TFAGLARS----SVRHLDLSHGFV----------------FSLNSRVFET--------LK 290

Query: 450 HLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQF 509
            L  L L  NK++           +L  LNL+ N L          L  +  +DL  N  
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350

Query: 510 SGEIPPEI--GQLKLNTFNLSSNKL 532
           +  I  +      KL T +L  N L
Sbjct: 351 A-IIQDQTFKFLEKLQTLDLRDNAL 374

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  116 bits (291), Expect = 1e-26
 Identities = 80/441 (18%), Positives = 152/441 (34%), Gaps = 47/441 (10%)

Query: 79  SLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTK--LQNLDLSQNYFVGP 136
                 I++     +    ++       ++I            +  +++LDLS  +    
Sbjct: 222 GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSL 281

Query: 137 IPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLE 196
                + +  L+ ++L  N  +     +   L  LQ L L  N     +      L  + 
Sbjct: 282 NSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341

Query: 197 VLGLAYNS-NFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHL 255
            + L  N            F  L+KL+TL + + N +  I      + S+  + L+GN L
Sbjct: 342 YIDLQKNHIAIIQDQT---FKFLEKLQTLDLRD-NALTTIH----FIPSIPDIFLSGNKL 393

Query: 256 EGAIPSGLFLLNNLTQLFLYDNILSG-EIPSSVEALK-LTDIDLSMNNLTGSIPEE-FGK 312
              +P      N    + L +N L   +I   +  +  L  + L+ N  +    ++   +
Sbjct: 394 VT-LPKINLTAN---LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449

Query: 313 LKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELP 372
             +L+ L L  N L       +    FE                L+ + L  N  +  LP
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGL------------SHLQVLYLNHNYLN-SLP 496

Query: 373 TGLWTTF-NLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFK 431
            G+++    L  L L+ N ++    +    NL  L+IS N+           + +L V  
Sbjct: 497 PGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPD---VFVSLSVLD 553

Query: 432 ASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSW-------TSLNNLNLARNE 484
            ++N F  E       LS     L   N      P+ I           SL +L+    +
Sbjct: 554 ITHNKFICEC-----ELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCD 608

Query: 485 LSGEIPKAIGSLLVMVSLDLS 505
               +     SL ++ ++ L+
Sbjct: 609 EEEVLKSLKFSLFIVCTVTLT 629

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 97.2 bits (242), Expect = 1e-20
 Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 35/276 (12%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
              +  ++L +  I +        L NL  ++LS N +   +    Y   K+  +DL +N
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF----NGTFPK 187
           +           +  LQ +DL  N  +     +I  +  +  ++L  N+           
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTA 403

Query: 188 EIGDLS-----------------NLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEAN 230
            +  LS                 +L++L L  N  F              L+ L++ E  
Sbjct: 404 NLIHLSENRLENLDILYFLLRVPHLQILILNQN-RFSSCSGDQTPSENPSLEQLFLGENM 462

Query: 231 LIGEI-----PEAMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIP 284
           L          +    LS L++L LN N+L  ++P G+F  L  L  L L  N L+  + 
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VLS 520

Query: 285 SSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLG 320
            +     L  +D+S N L    P+ F  L  L +  
Sbjct: 521 HNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITH 556

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  141 bits (357), Expect = 4e-37
 Identities = 58/331 (17%), Positives = 109/331 (32%), Gaps = 38/331 (11%)

Query: 235 IPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLT 293
           I E   N +  +I  +  + L+ A+ S      N+ +L L  N LS    + +    KL 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 294 DIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGN 353
            ++LS N L     +    L  L+ L L +N++                        L  
Sbjct: 62  LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ----------------------ELLV 97

Query: 354 CRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLE---ISN 410
             ++ T+   +N  S  +           ++ L++N I+  L        +R++   +  
Sbjct: 98  GPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKL 153

Query: 411 NRFSG-QIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQI 469
           N            S   L       N    ++       + L TL L  NKL+  +  + 
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEF 210

Query: 470 VSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSS 529
            S   +  ++L  N+L   I KA+     +   DL GN F           K       +
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVA 268

Query: 530 NKLYGNIPDEFNNLAYDDSFLNNSNLCVKNP 560
            +    +  +        +  +    C ++ 
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  140 bits (356), Expect = 6e-37
 Identities = 55/327 (16%), Positives = 109/327 (33%), Gaps = 39/327 (11%)

Query: 89  IPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQ 148
           I  I  +        ++ +S+         +   ++ LDLS N       +D+   + L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 149 CIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKP 208
            ++L  N    +    +  LS L+TL L  N       +E+    ++E L  A N+    
Sbjct: 62  LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN---- 110

Query: 209 AMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFL-- 265
            +  +     +  K +++   N I  + +      S ++ L L  N ++  +        
Sbjct: 111 -ISRVSCSRGQGKKNIYLAN-NKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167

Query: 266 LNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNH 325
            + L  L L  N +  ++   V   KL  +DLS N L   +  EF     +  + L +N 
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 326 LSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFN-LSSL 384
           L                    + K+L   + L    L  N F        ++    + ++
Sbjct: 226 LV------------------LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267

Query: 385 MLSDNTISGELPSKTAWNLTRLEISNN 411
                        +    +  L     
Sbjct: 268 AKQTVKKLTGQNEE-ECTVPTLGHYGA 293

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  117 bits (295), Expect = 6e-29
 Identities = 54/305 (17%), Positives = 107/305 (35%), Gaps = 17/305 (5%)

Query: 66  PEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQN 125
             +  +  +V  + L    ++Q     +     L  ++LSSN +  E  +   + + L+ 
Sbjct: 27  ASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL-YETLDL-ESLSTLRT 84

Query: 126 LDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTF 185
           LDL+ NY       ++     ++ +    NN S  +  S G+    + +YL  N+     
Sbjct: 85  LDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRGQG--KKNIYLANNKITMLR 136

Query: 186 PKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSL 245
             + G  S ++ L L  N                 L+ L +   N I ++       + L
Sbjct: 137 DLDEGCRSRVQYLDLKLN-EIDTVNFAELAASSDTLEHLNLQY-NFIYDVK-GQVVFAKL 193

Query: 246 EILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLT- 303
           + L L+ N L   +         +T + L +N L   I  ++   + L   DL  N    
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251

Query: 304 GSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLY 363
           G++ + F K + +Q +   +             V    +      + L      R + L 
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALG 311

Query: 364 SNRFS 368
            +   
Sbjct: 312 HHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 45/263 (17%), Positives = 79/263 (30%), Gaps = 74/263 (28%)

Query: 305 SIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYS 364
           +I E        ++  +  + L  +  AS+                  +   ++ + L  
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLK-QALASL----------------RQSAWNVKELDLSG 43

Query: 365 NRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSW 424
           N  S      L     L  L LS N +   L  ++   L  L+++NN             
Sbjct: 44  NPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ---------- 93

Query: 425 KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNE 484
                              EL     + TL    N +S ++           N+ LA N+
Sbjct: 94  -------------------ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNK 131

Query: 485 LSGEIPKAIGSLLVMVSLDLSGNQFSG------------------------EIPPEIGQL 520
           ++       G    +  LDL  N+                           ++  ++   
Sbjct: 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFA 191

Query: 521 KLNTFNLSSNKLYGNIPDEFNNL 543
           KL T +LSSNKL   +  EF + 
Sbjct: 192 KLKTLDLSSNKL-AFMGPEFQSA 213

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  140 bits (355), Expect = 1e-36
 Identities = 55/363 (15%), Positives = 102/363 (28%), Gaps = 59/363 (16%)

Query: 214 EFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLF 273
                   + L+   +  +    + +S          N  H      +     NN     
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIET 62

Query: 274 LYDNILSGEIPSSVEALK---LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEV 330
                L       +E         ++L    L    P++  +L +LQ + + +  L    
Sbjct: 63  RTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM--- 117

Query: 331 PASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNT 390
                           +P ++     L T+ L  N     LP  + +   L  L +    
Sbjct: 118 ---------------ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161

Query: 391 ISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSH 450
              ELP           +++   SG+         NL   +         +P  + +L +
Sbjct: 162 ELTELPE---------PLASTDASGEH----QGLVNLQSLRLEWTGIR-SLPASIANLQN 207

Query: 451 LNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSG-NQF 509
           L +L +  + LS  L   I     L  L+L         P   G    +  L L   +  
Sbjct: 208 LKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266

Query: 510 SGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCV----KNPIINL 564
              +P +I +L  L   +L        +P     L            C+     +    L
Sbjct: 267 L-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL---------PANCIILVPPHLQAQL 316

Query: 565 PKC 567
            + 
Sbjct: 317 DQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  140 bits (355), Expect = 1e-36
 Identities = 48/263 (18%), Positives = 93/263 (35%), Gaps = 24/263 (9%)

Query: 70  CTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLS 129
            T      + LR   +  + P     L +L  + + +  +  E P+ +     L+ L L+
Sbjct: 78  ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLA 135

Query: 130 QNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEI 189
           +N     +P+ I  ++ L+ + +       ++P  +                      E 
Sbjct: 136 RNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTD---------------ASGEH 179

Query: 190 GDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILA 249
             L NL+ L L +        +P     L+ LK+L +   + +  +  A+ +L  LE L 
Sbjct: 180 QGLVNLQSLRLEWT---GIRSLPASIANLQNLKSLKIRN-SPLSALGPAIHHLPKLEELD 235

Query: 250 LNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSIPE 308
           L G       P        L +L L D      +P  +  L  L  +DL        +P 
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295

Query: 309 EFGKLKNLQLLGLFSNHLSGEVP 331
              +L    ++ +   HL  ++ 
Sbjct: 296 LIAQLPANCIILV-PPHLQAQLD 317

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  137 bits (348), Expect = 1e-35
 Identities = 65/351 (18%), Positives = 101/351 (28%), Gaps = 45/351 (12%)

Query: 192 LSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALN 251
            S  E L    ++  +P          ++         +          N ++ +I    
Sbjct: 11  SSGRENLYFQGSTALRP--YHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRT 64

Query: 252 GNHLEGAIPSGLFLLN--NLTQLFLYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSIPE 308
           G  L+ A    L          L L    L  + P     L  L  + +    L   +P+
Sbjct: 65  GRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPD 121

Query: 309 EFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS 368
              +   L+ L L  N L                   A+P S+ +   LR + + +    
Sbjct: 122 TMQQFAGLETLTLARNPLR------------------ALPASIASLNRLRELSIRACPEL 163

Query: 369 GELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLI 428
            ELP  L +T                L      NL  L +        +   + + +NL 
Sbjct: 164 TELPEPLASTDASGEH--------QGLV-----NLQSLRLEWTGIR-SLPASIANLQNLK 209

Query: 429 VFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGE 488
             K  N+  S  +   +  L  L  L L G       P        L  L L        
Sbjct: 210 SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268

Query: 489 IPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDE 539
           +P  I  L  +  LDL G      +P  I QL  N   L    L   +   
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  136 bits (344), Expect = 3e-35
 Identities = 51/383 (13%), Positives = 114/383 (29%), Gaps = 69/383 (18%)

Query: 96  LKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGN 155
                 +    ++    + + L    +  N D ++ +      +     +  Q     G 
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRTGR 66

Query: 156 NFSGDIPRSIGRLSE--LQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPI 213
                    +   ++     L L        FP +   LS+L+ + +      +   +P 
Sbjct: 67  ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME---LPD 121

Query: 214 EFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLF 273
                  L+TL +   N +  +P ++++L+ L  L++                  LT+L 
Sbjct: 122 TMQQFAGLETLTLAR-NPLRALPASIASLNRLRELSIRAC-------------PELTEL- 166

Query: 274 LYDNILSGEIPSSVEALK-LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPA 332
             + + S +     + L  L  + L    +  S+P     L+NL+ L + ++ LS     
Sbjct: 167 -PEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS----- 219

Query: 333 SIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTIS 392
                        A+  ++ +   L  + L         P        L  L+L D +  
Sbjct: 220 -------------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266

Query: 393 GELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLN 452
             LP                        +     L        +    +P  +  L    
Sbjct: 267 LTLPL----------------------DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304

Query: 453 TLLLDGNKLSGKLPSQIVSWTSL 475
            +L+  +  +     + V+  + 
Sbjct: 305 IILVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  132 bits (334), Expect = 6e-34
 Identities = 54/329 (16%), Positives = 102/329 (31%), Gaps = 37/329 (11%)

Query: 114 PEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQT 173
               ++ +  +NL    +  + P    + +       D        +   S  R +    
Sbjct: 5   HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR-------NRWHSAWRQANSNN 57

Query: 174 LYLYMNEFNG--TFPKEIGDLS--NLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEA 229
             +              + D +      L L           P +   L  L+ + + +A
Sbjct: 58  PQIETRTGRALKATADLLEDATQPGRVALELRSV---PLPQFPDQAFRLSHLQHMTI-DA 113

Query: 230 NLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEA 289
             + E+P+ M   + LE L L  N L  A+P+ +  LN L +L +       E+P  + +
Sbjct: 114 AGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 290 LK----------LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIG---- 335
                       L  + L    +  S+P     L+NL+ L + ++ LS  +  +I     
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK 230

Query: 336 ---VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTIS 392
              +           P   G    L+ + L        LP  +     L  L L      
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290

Query: 393 GELPS--KTAWNLTRLEISNNRFSGQIQR 419
             LPS          + +  +  +   Q 
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 29/229 (12%), Positives = 56/229 (24%), Gaps = 37/229 (16%)

Query: 345 GAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLT 404
           G+      +      +    +         L           +D         +   N  
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLS---QWQRHYNADRNRWHSAWRQANSNNP 58

Query: 405 RLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLN--TLLLDGNKLS 462
           ++E                            L        L   +      L L    L 
Sbjct: 59  QIETRTG----------------------RAL--KATADLLEDATQPGRVALELRSVPLP 94

Query: 463 GKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK- 521
            + P Q    + L ++ +    L  E+P  +     + +L L+ N     +P  I  L  
Sbjct: 95  -QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNR 151

Query: 522 LNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCV----KNPIINLPK 566
           L   ++ +      +P+   +           NL         I +LP 
Sbjct: 152 LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPA 200

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  138 bits (351), Expect = 1e-36
 Identities = 69/309 (22%), Positives = 119/309 (38%), Gaps = 65/309 (21%)

Query: 630 TESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI 689
            +        E  LIGSGG GQV++      G+   +KR+   +  N+K E+E    ++ 
Sbjct: 5   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAERE----VKA 57

Query: 690 LGTIRHANIVKLWCCISSENSKL----------------LVYEYMENQSLDRWLHGRKRS 733
           L  + H NIV    C    +                   +  E+ +  +L++W+  R+  
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117

Query: 734 LVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI 793
            +          L      QI     +G+ Y+H   + ++I+RD+K SNI L    + KI
Sbjct: 118 KLD-----KVLALELFE--QIT----KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKI 163

Query: 794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEA 853
            DFGL   L   G+        G+  Y +PE   +    +++D+Y+ G++L EL+     
Sbjct: 164 GDFGLVTSLKNDGKRTRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC-- 218

Query: 854 NYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTL---PSS 910
                             E       L  GI    + ++         +    L   P  
Sbjct: 219 --------------DTAFETSKFFTDLRDGIISDIFDKK------EKTLLQKLLSKKPED 258

Query: 911 RPSMKEVLQ 919
           RP+  E+L+
Sbjct: 259 RPNTSEILR 267

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  139 bits (351), Expect = 2e-36
 Identities = 59/299 (19%), Positives = 111/299 (37%), Gaps = 53/299 (17%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG G V+           A+KRI       +   ++ + E++ L  + H  IV+ +
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEHPGIVRYF 69

Query: 703 CCISSENS---------KLLVY---EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
                +N+         K+ +Y   +    ++L  W++GR               LH   
Sbjct: 70  NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI----EERERSVCLHIFL 125

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
             QIA    + + ++H   +  ++HRD+K SNI    +   K+ DFGL   + +  E  T
Sbjct: 126 --QIA----EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 811 MSAVAGSFG----------YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT 860
           +     ++           Y +PE  +    + K+DI+S G++L EL+            
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQM----- 231

Query: 861 SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
                      E       +      P + ++    Y +     S  P  RP    +++
Sbjct: 232 -----------ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  135 bits (343), Expect = 1e-35
 Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 40/286 (13%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            IG+G  G+  +I     G+ +  K + +   + +  ++  ++E+ +L  ++H NIV+ +
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 703 CCISSENSKLL--VYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
             I    +  L  V EY E   L   +    ++R  +       + VL   T  Q+    
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD-----EEFVLRVMT--QLT--- 121

Query: 759 AQGLCYMH--HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              L   H   D    ++HRD+K +N+ LD +   K+ DFGLA++L         + V G
Sbjct: 122 -LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-G 178

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
           +  Y +PE       NEK DI+S G +L EL              LA            I
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA----------GKI 228

Query: 877 TDALDKGIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
                +G        Y +E+  +    L   +     RPS++E+L+
Sbjct: 229 R----EGKFRRIPYRYSDELNEIITRML---NLKDYHRPSVEEILE 267

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  138 bits (349), Expect = 2e-35
 Identities = 72/379 (18%), Positives = 136/379 (35%), Gaps = 47/379 (12%)

Query: 161 IPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE-FGMLK 219
           I  ++        +++ M   +  F  E   L+N +++    +       +P       +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNS---TMRKLPAALLDSFR 69

Query: 220 KLKTLWMTEANLIGEIP-EAMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDN 277
           +++ L + +   I EI   A +   +++ L +  N +   +P  +F  +  LT L L  N
Sbjct: 70  QVELLNLND-LQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN 127

Query: 278 ILSGEIPSSV--EALKLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSNHLSGEVPASI 334
            LS  +P  +     KLT + +S NNL   I ++ F    +LQ L L SN L+      +
Sbjct: 128 DLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-----HV 180

Query: 335 GVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGE 394
            +    +               L    +  N       + L     +  L  S N+I+  
Sbjct: 181 DLSLIPS---------------LFHANVSYNLL-----STLAIPIAVEELDASHNSIN-V 219

Query: 395 LPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVE-LTSLSHLNT 453
           +       LT L++ +N  +      + ++  L+    S N    +I       +  L  
Sbjct: 220 VRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLER 276

Query: 454 LLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEI 513
           L +  N+L   L        +L  L+L+ N L   + +       + +L L  N     +
Sbjct: 277 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TL 333

Query: 514 PPEIGQLKLNTFNLSSNKL 532
                   L    LS N  
Sbjct: 334 KLSTHH-TLKNLTLSHNDW 351

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  127 bits (321), Expect = 9e-32
 Identities = 66/349 (18%), Positives = 129/349 (36%), Gaps = 44/349 (12%)

Query: 71  TFNSVTGISLRHKDITQKIPP-IICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLS 129
           T N+   ++ ++  +  K+P  ++   + +  ++L+   I             +Q L + 
Sbjct: 43  TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 101

Query: 130 QNYFVGPIPSDI-DRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEFNGTFPK 187
            N     +P  +   +  L  + L  N+ S  +PR I     +L TL +  N        
Sbjct: 102 FNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIED 158

Query: 188 EI-GDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLE 246
           +     ++L+ L L+ N      +  ++  ++  L    ++  NL+  +        ++E
Sbjct: 159 DTFQATTSLQNLQLSSNR-----LTHVDLSLIPSLFHANVSY-NLLSTLA----IPIAVE 208

Query: 247 ILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSI 306
            L  + N +   +   +     LT L L  N L+ +    +    L ++DLS N L   I
Sbjct: 209 ELDASHNSIN-VVRGPVN--VELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KI 263

Query: 307 PEE-FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSN 365
               F K++ L+ L + +N L                   A+        TL+ + L  N
Sbjct: 264 MYHPFVKMQRLERLYISNNRLV------------------ALNLYGQPIPTLKVLDLSHN 305

Query: 366 RFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFS 414
                +         L +L L  N+I   L   T   L  L +S+N + 
Sbjct: 306 HLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  126 bits (319), Expect = 2e-31
 Identities = 63/391 (16%), Positives = 120/391 (30%), Gaps = 52/391 (13%)

Query: 103 DLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIP 162
                 I               ++ +           +   ++  + +    +       
Sbjct: 7   QPEYKCIDSNLQYDCV----FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 62

Query: 163 RSIGRLSELQTLYLYMNEFNGTFPKEI-GDLSNLEVLGLAYNSNFKPAMIPIE-FGMLKK 220
             +    +++ L L   +               ++ L + +N       +P   F  +  
Sbjct: 63  ALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN---AIRYLPPHVFQNVPL 118

Query: 221 LKTLWMTEANLIGEIPEAM-SNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNI 278
           L  L + E N +  +P  +  N   L  L+++ N+LE  I    F    +L  L L  N 
Sbjct: 119 LTVLVL-ERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 176

Query: 279 LSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVA 338
           L+  +  S+    L   ++S N L+            ++ L    N ++      +    
Sbjct: 177 LT-HVDLSLIP-SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-----VVRGPV 224

Query: 339 FENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSK 398
                             L  ++L  N  + +    L     L  + LS N +  ++   
Sbjct: 225 NVE---------------LTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYH 266

Query: 399 TAWNLTRLE---ISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLL 455
               + RLE   ISNNR    +         L V   S+N     +         L  L 
Sbjct: 267 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324

Query: 456 LDGNKLSGKLPSQIVSWTSLNNLNLARNELS 486
           LD N +   L     +  +L NL L+ N+  
Sbjct: 325 LDHNSIV-TLKLS--THHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 48.1 bits (115), Expect = 1e-05
 Identities = 15/107 (14%), Positives = 37/107 (34%), Gaps = 7/107 (6%)

Query: 76  TGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVG 135
             + + +  +   +      +  L  +DLS N +            +L+NL L  N  V 
Sbjct: 275 ERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV- 331

Query: 136 PIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFN 182
            +         L+ + L  N++  +  R++     +    +   + +
Sbjct: 332 TLKLST--HHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQH 374

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.3 bits (100), Expect = 5e-04
 Identities = 13/106 (12%), Positives = 31/106 (29%), Gaps = 5/106 (4%)

Query: 441 IPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMV 500
           I   L        + +D          + ++  +   +    + +       + S   + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 501 SLDLSGNQFSGEIPPEI--GQLKLNTFNLSSNKLYGNIPDE-FNNL 543
            L+L+  Q   EI          +    +  N +   +P   F N+
Sbjct: 73  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNV 116

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  136 bits (345), Expect = 4e-35
 Identities = 69/280 (24%), Positives = 113/280 (40%), Gaps = 37/280 (13%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            IG G  G+   +     G    +K I N  +++ K  +E   E+ +L  ++H NIV+  
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                  S  +V +Y E   L + ++ +K  L          +L W    QI       L
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ-----EDQILDWFV--QIC----LAL 138

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            ++H     +I+HRD+KS NI L  +   ++ DFG+A++L         + + G+  Y +
Sbjct: 139 KHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLS 193

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDK 882
           PE       N K DI++ G VL EL T K A       +L             I      
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV----------LKII----S 239

Query: 883 GIAEP---CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           G   P    Y  ++ ++           P  RPS+  +L+
Sbjct: 240 GSFPPVSLHYSYDLRSLVSQ---LFKRNPRDRPSVNSILE 276

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  134 bits (340), Expect = 7e-35
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 31/284 (10%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            IG G   +VYR      G  VA+K++     ++ K   + I EI++L  + H N++K +
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 703 CCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                +N   +V E  +   L R +    +++ L+       + V  +    Q+      
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP-----ERTVWKYFV--QLC----S 147

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML-AKQGEPHTMSAVAGSFG 819
            L +MH     +++HRD+K +N+ + +    K+ D GL +   +K    H+   + G+  
Sbjct: 148 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS---LVGTPY 201

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           Y +PE  +    N K DI+S G +L E+   +   +  +  +L     +       I   
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP-FYGDKMNLYSLCKK-------IEQC 253

Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
               +    Y EE+  +  +   C +  P  RP +  V  + +R
Sbjct: 254 DYPPLPSDHYSEELRQLVNM---CINPDPEKRPDVTYVYDVAKR 294

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  133 bits (338), Expect = 9e-35
 Identities = 78/285 (27%), Positives = 124/285 (43%), Gaps = 32/285 (11%)

Query: 643 LIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            +G GG   VY   D       VA+K I+   +  ++  K F  E+     + H NIV +
Sbjct: 18  KLGGGGMSTVYLAEDTI-LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                 ++   LV EY+E  +L  ++                  L   T +        G
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-------------LSVDTAINFTNQILDG 123

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           + + H     +I+HRD+K  NIL+DS    KI DFG+AK L++     T + V G+  YF
Sbjct: 124 IKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHVLGTVQYF 179

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP-ITDAL 880
           +PE A     +E  DIYS G+VL E++ G+    G+   S+   A +H  +  P +T  +
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI---AIKHIQDSVPNVTTDV 236

Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-SMKEVLQILRRC 924
            K I  P  L        + L  T    ++R  +++E+   L   
Sbjct: 237 RKDI--PQSLSN------VILRATEKDKANRYKTIQEMKDDLSSV 273

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  132 bits (335), Expect = 2e-34
 Identities = 78/305 (25%), Positives = 129/305 (42%), Gaps = 43/305 (14%)

Query: 636 SSLTESNLIGSGGSGQVYR----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILG 691
             L     +G G  G+V       + +  GE VAVK +    +       +   EIEIL 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILR 78

Query: 692 TIRHANIVKLWCCISSENSK--LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
            + H NIVK     + +      L+ E++ + SL  +L   K  +               
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL------------K 126

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
            +L+ A+   +G+ Y+    + Q +HRD+ + N+L++SE + KI DFGL K +    E +
Sbjct: 127 QQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 183

Query: 810 TMSAVAGS-FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
           T+     S   ++APE    +K     D++SFGV L EL+T     Y D  +S      +
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-----YCDSDSSPMALFLK 238

Query: 869 HYAEEKP------ITDALDKG--IAEP--CYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                        + + L +G  +  P  C  E    VY+L   C    PS+R S + ++
Sbjct: 239 MIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDE----VYQLMRKCWEFQPSNRTSFQNLI 294

Query: 919 QILRR 923
           +    
Sbjct: 295 EGFEA 299

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  134 bits (340), Expect = 3e-34
 Identities = 72/318 (22%), Positives = 118/318 (37%), Gaps = 37/318 (11%)

Query: 611 KRNRDPATWKLTSFHQLGFTESNIL---SSLTESNLIGSGGSGQVYRIDINGAGEFVAVK 667
              + P T K          +   +     L     IG G  G+V+   +      VAVK
Sbjct: 86  LSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145

Query: 668 RIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWL 727
                  L   L+ +F+ E  IL    H NIV+L    + +    +V E ++      +L
Sbjct: 146 SC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 203

Query: 728 HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS 787
                             L   T LQ+   AA G+ Y+        IHRD+ + N L+  
Sbjct: 204 RTEGAR------------LRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTE 248

Query: 788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY--FAPEYAYTTKVNEKIDIYSFGVVLL 845
           +   KI+DFG+++        +  S           APE     + + + D++SFG++L 
Sbjct: 249 KNVLKISDFGMSREE--ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306

Query: 846 ELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTS 905
           E  +   + Y +   S  +             + ++KG   PC       V+RL   C +
Sbjct: 307 ETFSLGASPYPN--LSNQQ-----------TREFVEKGGRLPCPELCPDAVFRLMEQCWA 353

Query: 906 TLPSSRPSMKEVLQILRR 923
             P  RPS   + Q L+ 
Sbjct: 354 YEPGQRPSFSTIYQELQS 371

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  131 bits (332), Expect = 1e-33
 Identities = 82/301 (27%), Positives = 127/301 (42%), Gaps = 37/301 (12%)

Query: 636 SSLTESNLIGSGGSGQVYR----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILG 691
             L +   +G G  G+V         +G GE VAVK +        +    +  EI+IL 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILR 88

Query: 692 TIRHANIVKLW--CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
           T+ H +I+K    C  +   S  LV EY+   SL  +L               +H +   
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP--------------RHSIGLA 134

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             L  A    +G+ Y+H       IHRD+ + N+LLD++   KI DFGLAK + +  E +
Sbjct: 135 QLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191

Query: 810 TMSAVAGS-FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
            +     S   ++APE     K     D++SFGV L EL+T     + D   S       
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-----HCDSSQSPPTKFLE 246

Query: 869 HYAEEKP------ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
                +       +T+ L++G   P   +    VY L   C  T  S RP+ + ++ IL+
Sbjct: 247 LIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

Query: 923 R 923
            
Sbjct: 307 T 307

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (330), Expect = 1e-33
 Identities = 79/313 (25%), Positives = 134/313 (42%), Gaps = 35/313 (11%)

Query: 643 LIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           ++G GG  +V+   D+      VAVK +  +   +      F  E +    + H  IV +
Sbjct: 19  ILGFGGMSEVHLARDLR-DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 702 --WCCISSENSKL--LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
                  +    L  +V EY++  +L   +H                 +     +++   
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------------MTPKRAIEVIAD 124

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM-SAVAG 816
           A Q L + H +    IIHRDVK +NI++ +    K+ DFG+A+ +A  G   T  +AV G
Sbjct: 125 ACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
           +  Y +PE A    V+ + D+YS G VL E++TG+    GD   S+   A++H  E+   
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---AYQHVREDPIP 238

Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-SMKEVLQILRRCCPTENYGGKKM 935
             A  +G+     L+       + L   +  P +R  +  E+   L R    E     K+
Sbjct: 239 PSARHEGL--SADLDA------VVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290

Query: 936 GRDVDSAPLLGTA 948
             D +   LL +A
Sbjct: 291 LTDAERTSLLSSA 303

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  130 bits (330), Expect = 2e-33
 Identities = 79/312 (25%), Positives = 128/312 (41%), Gaps = 44/312 (14%)

Query: 636 SSLTESNLIGSGGSGQVYR----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILG 691
             L   + +G G  G V         +  G  VAVK++   +      +++F  EI+IL 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILK 79

Query: 692 TIRHANIVKLW--CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
            +    IVK           S  LV EY+ +  L  +L   +  L +             
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA------------S 127

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             L  +    +G+ Y+    + + +HRD+ + NIL++SE   KIADFGLAK+L    + +
Sbjct: 128 RLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY 184

Query: 810 TMSAVAGS-FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
            +     S   ++APE       + + D++SFGVVL EL T     Y D+  S +    R
Sbjct: 185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-----YCDKSCSPSAEFLR 239

Query: 869 HYAEEKP------ITDALDKG--IAEP--CYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
               E+       + + L++G  +  P  C  E    V+ L  +C +  P  RPS   + 
Sbjct: 240 MMGCERDVPALSRLLELLEEGQRLPAPPACPAE----VHELMKLCWAPSPQDRPSFSALG 295

Query: 919 QILRRCCPTENY 930
             L         
Sbjct: 296 PQLDMLWSGSRG 307

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  133 bits (336), Expect = 2e-33
 Identities = 63/289 (21%), Positives = 107/289 (37%), Gaps = 48/289 (16%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKL 701
           ++G G  G +    +      VAVKRI    +     ++E    +++L     H N+++ 
Sbjct: 31  VLGHGAEGTIVYRGMFD-NRDVAVKRI--LPECFSFADRE----VQLLRESDEHPNVIRY 83

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +C       + +  E     +L  ++  +  +           +L      Q       G
Sbjct: 84  FCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAH---LGLEPITLLQ-----QTT----SG 130

Query: 762 LCYMHHDCTPQIIHRDVKSSNILL-----DSEFKAKIADFGLAKML-AKQGEPHTMSAVA 815
           L ++H      I+HRD+K  NIL+       + KA I+DFGL K L   +      S V 
Sbjct: 131 LAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187

Query: 816 GSFGYFAPEY---AYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE 872
           G+ G+ APE             +DI+S G V   +++     +G      A       + 
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL 247

Query: 873 EKPITDALDKGIAEPCYLEEMTTVYRLALI--CTSTLPSSRPSMKEVLQ 919
           +    +  +  IA               LI    +  P  RPS K VL+
Sbjct: 248 DCLHPEKHEDVIAR-------------ELIEKMIAMDPQKRPSAKHVLK 283

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  134 bits (339), Expect = 2e-33
 Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 38/289 (13%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 275

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R             +     L +A
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-----------QEVSAVVLLYMA 324

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHR++ + N L+      K+ADFGL++++   G+ +T  A  
Sbjct: 325 TQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHA-G 378

Query: 816 GSFGYF--APEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAE 872
             F     APE     K + K D+++FGV+L E+ T G     G + + + E   + Y  
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438

Query: 873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           E+P          E C  +    VY L   C    PS RPS  E+ Q  
Sbjct: 439 ERP----------EGCPEK----VYELMRACWQWNPSDRPSFAEIHQAF 473

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  129 bits (326), Expect = 3e-33
 Identities = 77/301 (25%), Positives = 130/301 (43%), Gaps = 35/301 (11%)

Query: 636 SSLTESNLIGSGGSGQVYR----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILG 691
             L     +G G  G V         +  GE VAVK++   +   ++  ++F  EIEIL 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILK 66

Query: 692 TIRHANIVKLW--CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
           +++H NIVK    C  +   +  L+ EY+   SL  +L              H+  +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK------------HKERIDHI 114

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             LQ      +G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E  
Sbjct: 115 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF 171

Query: 810 TMSAVAGS-FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
            +     S   ++APE    +K +   D++SFGVVL EL T  E +       +      
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231

Query: 869 HYAE--EKPITDALDKG--IAEP--CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
              +     + + L     +  P  C  E    +Y +   C +   + RPS +++   + 
Sbjct: 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRVD 287

Query: 923 R 923
           +
Sbjct: 288 Q 288

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  128 bits (325), Expect = 6e-33
 Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 33/223 (14%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH--ANIV 699
             IGSGGS +V+++ +N   +  A+K + N  + + +    +  EI  L  ++     I+
Sbjct: 34  KQIGSGGSSKVFQV-LNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           +L+    ++    +V E   N  L+ WL  +K+S+        +          +     
Sbjct: 92  RLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSI---DPWERKSYWK-----NML---- 137

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           + +  +H      I+H D+K +N L+      K+ DFG+A  +          +  G+  
Sbjct: 138 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193

Query: 820 YFAPE-----------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y  PE               +K++ K D++S G +L  +  GK
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  129 bits (326), Expect = 7e-33
 Identities = 77/301 (25%), Positives = 131/301 (43%), Gaps = 35/301 (11%)

Query: 636 SSLTESNLIGSGGSGQVYR----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILG 691
             L     +G G  G V         +  GE VAVK++   +   ++  ++F  EIEIL 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILK 97

Query: 692 TIRHANIVKLW--CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
           +++H NIVK    C  +   +  L+ EY+   SL  +L              H+  +   
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK------------HKERIDHI 145

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             LQ      +G+ Y+    T + IHRD+ + NIL+++E + KI DFGL K+L +  E +
Sbjct: 146 KLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY 202

Query: 810 TMSAVAGS-FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
            +     S   ++APE    +K +   D++SFGVVL EL T  E +       +      
Sbjct: 203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262

Query: 869 HYAEEKP--ITDALDKG--IAEP--CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
              +     + + L     +  P  C  E    +Y +   C +   + RPS +++   + 
Sbjct: 263 KQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRVD 318

Query: 923 R 923
           +
Sbjct: 319 Q 319

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  134 bits (339), Expect = 8e-33
 Identities = 73/360 (20%), Positives = 138/360 (38%), Gaps = 47/360 (13%)

Query: 227 TEANLIGEIPEAMSN--LSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIP 284
            E+     + + M     +   +L +  + L   +P  L    ++T L + DN L+  +P
Sbjct: 22  EESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLP 77

Query: 285 SSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLS 344
           +     +L  +++S N LT S+P     L  L +      HL   +P+ +  +    N  
Sbjct: 78  ALPP--ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQL 133

Query: 345 GAVPKSLGNCRTL-----------------RTVQLYSNRFSGELPTGLWTTFNLSSLMLS 387
            ++P      + L                   +  Y+N+ +  LP        L  L +S
Sbjct: 134 TSLPVLPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLT-SLPMLP---SGLQELSVS 189

Query: 388 DNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTS 447
           DN ++  LP+     L +L   NNR +  +       K LIV   S N  +  +PV  + 
Sbjct: 190 DNQLA-SLPT-LPSELYKLWAYNNRLT-SLPALPSGLKELIV---SGNRLT-SLPVLPSE 242

Query: 448 LSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGN 507
           L  L    + GN+L+  LP      + L +L++ RN+L+  +P+++  L    +++L GN
Sbjct: 243 LKELM---VSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294

Query: 508 QFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKC 567
             S E   +  +   +    S   +  ++             L  ++  V          
Sbjct: 295 PLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  130 bits (327), Expect = 3e-31
 Identities = 76/461 (16%), Positives = 146/461 (31%), Gaps = 117/461 (25%)

Query: 93  ICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL 152
            C       +++  + +    P+ L     +  L +  N     +P        L+ +++
Sbjct: 36  ACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LP---ALPPELRTLEV 88

Query: 153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIP 212
            GN  +  +P     L EL      +       P     L  L + G             
Sbjct: 89  SGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKLWIFG------------- 130

Query: 213 IEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQL 272
                            N +  +P     L  L    ++ N L  ++P+   L + L +L
Sbjct: 131 -----------------NQLTSLPVLPPGLQELS---VSDNQLA-SLPA---LPSELCKL 166

Query: 273 FLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPA 332
           + Y+N L+  +P       L ++ +S N L  S+P    +L  L      +N L+     
Sbjct: 167 WAYNNQLT-SLPMLPS--GLQELSVSDNQLA-SLPTLPSELYKLWAY---NNRLT----- 214

Query: 333 SIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTIS 392
                        ++P      + L    +  NR +  LP        L  LM+S N ++
Sbjct: 215 -------------SLPALPSGLKELI---VSGNRLT-SLPVLP---SELKELMVSGNRLT 254

Query: 393 GELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLN 452
             LP      L  L +  N+ +                          +P  L  LS   
Sbjct: 255 -SLPM-LPSGLLSLSVYRNQLT-------------------------RLPESLIHLSSET 287

Query: 453 TLLLDGNKLSGKLPSQIVSWTSL---NNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQF 509
           T+ L+GN LS +    +   TS    +   +  +      P+   +L +  +  L   + 
Sbjct: 288 TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPARE 347

Query: 510 SGEIPPEI-----GQLKLNTFNLSSNKLYGNIPDEFNNLAY 545
               P +       +   + F+L  ++L     +   +  +
Sbjct: 348 GEPAPADRWHMFGQEDNADAFSLFLDRLS-ETENFIKDAGF 387

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  118 bits (296), Expect = 2e-27
 Identities = 63/333 (18%), Positives = 111/333 (33%), Gaps = 52/333 (15%)

Query: 87  QKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISG 146
             +P +   L  L+        +P          + L  L +  N     +P       G
Sbjct: 94  TSLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLTS-LPVL---PPG 142

Query: 147 LQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNF 206
           LQ + +  N  +  +P        L  L+ Y N+   + P        L+ L ++ N   
Sbjct: 143 LQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQL- 193

Query: 207 KPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLL 266
             A +P     L KL        N +  +P      S L+ L ++GN L  ++P    L 
Sbjct: 194 --ASLPTLPSELYKLWAY----NNRLTSLPA---LPSGLKELIVSGNRLT-SLPV---LP 240

Query: 267 NNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL 326
           + L +L +  N L+  +P       L  + +  N LT  +PE    L +   + L  N L
Sbjct: 241 SELKELMVSGNRLT-SLPMLPS--GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296

Query: 327 SGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLML 386
           S     ++  +      SG                +     +G          +L++   
Sbjct: 297 SERTLQALREITSAPGYSG---------------PIIRFDMAGASAPRETRALHLAAADW 341

Query: 387 SDNTISGELPSKTAWNLTRLEISNNRFSGQIQR 419
                 GE      W++   E + + FS  + R
Sbjct: 342 LVPAREGEPAPADRWHMFGQEDNADAFSLFLDR 374

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  129 bits (326), Expect = 9e-33
 Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 33/223 (14%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH--ANIV 699
             IGSGGS +V+++ +N   +  A+K + N  + + +    +  EI  L  ++     I+
Sbjct: 15  KQIGSGGSSKVFQV-LNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           +L+    ++    +V E   N  L+ WL  +K+S+        +          +     
Sbjct: 73  RLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSI---DPWERKSYWK-----NML---- 118

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           + +  +H      I+H D+K +N L+      K+ DFG+A  +          +  G+  
Sbjct: 119 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174

Query: 820 YFAPE-----------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y  PE               +K++ K D++S G +L  +  GK
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  129 bits (325), Expect = 3e-32
 Identities = 47/223 (21%), Positives = 90/223 (40%), Gaps = 33/223 (14%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH--ANIV 699
             IGSGGS +V+++ +N   +  A+K + N  + + +    +  EI  L  ++     I+
Sbjct: 62  KQIGSGGSSKVFQV-LNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           +L+    ++    +V E   N  L+ WL  +K           +          +     
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI----DPWERKSYWK-----NML---- 165

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           + +  +H      I+H D+K +N L+      K+ DFG+A  +          +  G+  
Sbjct: 166 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221

Query: 820 YFAPE-----------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y  PE               +K++ K D++S G +L  +  GK
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  126 bits (319), Expect = 3e-32
 Identities = 78/300 (26%), Positives = 125/300 (41%), Gaps = 39/300 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IGSG +  V         E VA+KRI N  K    ++ E + EI+ +    H NIV  + 
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYYT 80

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI---GAAQ 760
               ++   LV + +   S+          ++    +  +H         IA       +
Sbjct: 81  SFVVKDELWLVMKLLSGGSV--------LDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA---VAGS 817
           GL Y+H +     IHRDVK+ NILL  +   +IADFG++  LA  G+           G+
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 818 FGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE 872
             + APE       Y    + K DI+SFG+  +EL TG  A Y                +
Sbjct: 190 PCWMAPEVMEQVRGY----DFKADIWSFGITAIELATG-AAPYHKYPPM---KVLMLTLQ 241

Query: 873 EKPITDALDKGIAEPCYLEEMTTVYR--LALICTSTLPSSRPSMKEVLQ--ILRRCCPTE 928
             P +  L+ G+ +   L++    +R  ++L C    P  RP+  E+L+    ++    E
Sbjct: 242 NDPPS--LETGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  130 bits (329), Expect = 3e-32
 Identities = 74/473 (15%), Positives = 152/473 (32%), Gaps = 64/473 (13%)

Query: 97  KNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNN 156
            N  +   ++  +             L +LD   +       + I++++GL  +    NN
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNN 75

Query: 157 FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFG 216
            +  +   + + + L  L    N+       ++  L+ L  L    N      +  ++  
Sbjct: 76  IT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNK-----LTKLDVS 124

Query: 217 MLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYD 276
               L  L     N + EI   +S+ + L  L  + N     +   +     LT L    
Sbjct: 125 QNPLLTYLNCAR-NTLTEID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179

Query: 277 NILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGV 336
           N ++    S  +   L  ++   NN+T  +     +   L  L   SN L+      I  
Sbjct: 180 NKITELDVSQNK--LLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-----EI-- 227

Query: 337 VAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELP 396
                         +     L       N  + EL     +   L++L      +  E+ 
Sbjct: 228 -------------DVTPLTQLTYFDCSVNPLT-ELDVSTLS--KLTTLHCIQTDLL-EID 270

Query: 397 SKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLL 456
                 L   +    R   ++   V     L +        +    ++L+    L  L L
Sbjct: 271 LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYL 325

Query: 457 DGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPE 516
           +  +L+ +L   +   T L +L+     +  +   ++G +  + +   +  Q    +P E
Sbjct: 326 NNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKE 379

Query: 517 IGQLKLNTFNLSSNKL--YGNI----PDEFNNLAYDDSFLNNSNLCVKNPIIN 563
                  T  +S + L  +GN     P +        + +   NL   NP + 
Sbjct: 380 TLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVT 432

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 85.9 bits (213), Expect = 1e-17
 Identities = 53/305 (17%), Positives = 96/305 (31%), Gaps = 30/305 (9%)

Query: 79  SLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIP 138
            L      +     +     LTT+D S N I  E    +     L  L+   N       
Sbjct: 152 ELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL-- 206

Query: 139 SDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVL 198
            D+++   L  +D   N  + +I   +  L++L      +N         +  LS L  L
Sbjct: 207 -DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTL 259

Query: 199 GLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGA 258
                      ++ I+     +L          I E+   +++ + L +L      +   
Sbjct: 260 HCIQTD-----LLEIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-E 311

Query: 259 IPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQL 318
           +   L     L  L+L +  L+ E+  S    KL  +     ++        GK+  L  
Sbjct: 312 LD--LSQNPKLVYLYLNNTELT-ELDVS-HNTKLKSLSCVNAHIQ-DFS-SVGKIPALNN 365

Query: 319 LGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTT 378
                      +P         N+L+ AV   L +           +    +  T   T 
Sbjct: 366 NFEAEGQTI-TMPKETLT---NNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITW 421

Query: 379 FNLSS 383
            NLS+
Sbjct: 422 ENLST 426

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 84.0 bits (208), Expect = 5e-17
 Identities = 59/351 (16%), Positives = 110/351 (31%), Gaps = 59/351 (16%)

Query: 219 KKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNI 278
               +       +      +   L++L  L  + + +     +G+  L  LT+L    N 
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75

Query: 279 LSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVA 338
           ++  +  S +   LT +    N LT ++      L  L  L   +N L+           
Sbjct: 76  IT-TLDLS-QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT----------- 119

Query: 339 FENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSK 398
                       +     L  +    N  + E+     T   L+ L    N    +L   
Sbjct: 120 ---------KLDVSQNPLLTYLNCARNTLT-EIDVSHNT--QLTELDCHLNKKITKLDVT 167

Query: 399 TAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDG 458
               LT L+ S N+ + ++   V   K L       N  +    ++L     L  L    
Sbjct: 168 PQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSS 221

Query: 459 NKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIG 518
           NKL+ ++   +   T L   + + N L+ E+   + +L  + +L                
Sbjct: 222 NKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTD---------- 265

Query: 519 QLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNL----CVKNPIINLP 565
              L   +L+ N        E      +    +N+ L    C    I  L 
Sbjct: 266 ---LLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELD 313

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  125 bits (317), Expect = 8e-32
 Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 31/224 (13%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG   V  ++    G F A+KRI       Q+  +E   E ++     H NI++L 
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLV 92

Query: 703 CCISSENSK----LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
                E        L+  + +  +L   +   K            + L     L + +G 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKD---------KGNFLTEDQILWLLLGI 143

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA--- 815
            +GL  +H        HRD+K +NILL  E +  + D G         E    +      
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 816 ----GSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
                +  Y APE     ++   ++E+ D++S G VL  ++ G+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGE 243

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  128 bits (323), Expect = 2e-31
 Identities = 77/348 (22%), Positives = 130/348 (37%), Gaps = 41/348 (11%)

Query: 150 IDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPA 209
           +      F   +P  I   +E + L L  N        E     +LE L L  N     +
Sbjct: 16  VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN---IVS 69

Query: 210 MIPIE-FGMLKKLKTLWMTEANLIGEIPEAM-SNLSSLEILALNGNHLEGAIPSGLFL-L 266
            +    F  L  L+TL +  +N +  IP  + + LS+L  L ++ N +   +   +F  L
Sbjct: 70  AVEPGAFNNLFNLRTLGL-RSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDL 127

Query: 267 NNLTQLFLYDNILSGEIPSSV-EAL-KLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFS 323
            NL  L + DN L   I       L  L  + L   NLT SIP E    L  L +L L  
Sbjct: 128 YNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRH 185

Query: 324 NHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSS 383
            +++     +I   +F+                L+ +++    +   +        NL+S
Sbjct: 186 LNIN-----AIRDYSFKR------------LYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228

Query: 384 LMLSDNTISGELPSKT---AWNLTRLEISNNRFSGQIQRGV-GSWKNLIVFKASNNLFSG 439
           L ++   ++  +P         L  L +S N  S  I+  +      L   +      + 
Sbjct: 229 LSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA- 285

Query: 440 EIPVE-LTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELS 486
            +       L++L  L + GN+L+    S   S  +L  L L  N L+
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  125 bits (315), Expect = 2e-30
 Identities = 81/408 (19%), Positives = 137/408 (33%), Gaps = 96/408 (23%)

Query: 69  TCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDL 128
            C+      +    K     +P  I        +DL  N I     +   +   L+ L+L
Sbjct: 8   ECSAQDRA-VLCHRKRFVA-VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELEL 63

Query: 129 SQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF----NGT 184
           ++N            +S      +    F+         L  L+TL L  N       G 
Sbjct: 64  NEN-----------IVS-----AVEPGAFNN--------LFNLRTLGLRSNRLKLIPLGV 99

Query: 185 FPKEIGDLSNLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSN 241
           F      LSNL  L ++ N        M    F  L  LK+L + + N +  I   A S 
Sbjct: 100 FT----GLSNLTKLDISENKIVILLDYM----FQDLYNLKSLEVGD-NDLVYISHRAFSG 150

Query: 242 LSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSV-EAL-KLTDIDLS 298
           L+SLE L L   +L  +IP+     L+ L  L L    ++  I     + L +L  +++S
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEIS 208

Query: 299 MNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLR 358
                 ++        NL  L +   +L+  VP                  ++ +   LR
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP----------------YLAVRHLVYLR 251

Query: 359 TVQLYSNRFSGELPTGLWTTF-NLSSLMLSDNTISGELPSKTAWNLTRLEI---SNNRFS 414
            + L  N  S  +   +      L  + L    ++  +       L  L +   S N+ +
Sbjct: 252 FLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309

Query: 415 GQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLS 462
             ++  V                         S+ +L TL+LD N L+
Sbjct: 310 -TLEESV-----------------------FHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  102 bits (257), Expect = 5e-23
 Identities = 57/305 (18%), Positives = 102/305 (33%), Gaps = 38/305 (12%)

Query: 250 LNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPE 308
            +      A+P G+        L L  N +         +   L +++L+ N ++ ++  
Sbjct: 18  CHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEP 73

Query: 309 E-FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRF 367
             F  L NL+ LGL SN L   +P                         L  + +  N+ 
Sbjct: 74  GAFNNLFNLRTLGLRSNRLK-LIP----------------LGVFTGLSNLTKLDISENKI 116

Query: 368 SGELPTGLWTTF-NLSSLMLSDNTISGELPSKTAWNLTRLEI---SNNRFSGQIQRGV-G 422
              L   ++    NL SL + DN +   +  +    L  LE         +  I      
Sbjct: 117 V-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALS 173

Query: 423 SWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLAR 482
               LIV +  +   +         L  L  L +        +    +   +L +L++  
Sbjct: 174 HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233

Query: 483 NELSGEIP-KAIGSLLVMVSLDLSGNQFSGEIPPEI--GQLKLNTFNLSSNKLYGNIPDE 539
             L+  +P  A+  L+ +  L+LS N  S  I   +    L+L    L   +L   +   
Sbjct: 234 CNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQL-AVVEPY 290

Query: 540 -FNNL 543
            F  L
Sbjct: 291 AFRGL 295

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  123 bits (312), Expect = 2e-31
 Identities = 57/246 (23%), Positives = 98/246 (39%), Gaps = 47/246 (19%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G G  GQV +        + A+K+I    +  ++     ++E+ +L ++ H  +V+ +
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68

Query: 703 CCISSENSKL-------------LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
                  + +             +  EY EN +L   +H    +                
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ------RDEYWRLF 122

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML------- 802
              QI     + L Y+H      IIHRD+K  NI +D     KI DFGLAK +       
Sbjct: 123 R--QIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 803 -----AKQGEPHTMSAVAGSFGYFAPE-YAYTTKVNEKIDIYSFGVVLLELVTGKEANYG 856
                   G    +++  G+  Y A E    T   NEKID+YS G++  E++     + G
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTG 231

Query: 857 DEHTSL 862
            E  ++
Sbjct: 232 MERVNI 237

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  123 bits (310), Expect = 3e-31
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           L+G G    VYR +    G  VA+K I         + +    E++I   ++H +I++L+
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 N   LV E   N  ++R+L  R +     S +  +H +H     QI      G+
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPF---SENEARHFMH-----QI----ITGM 125

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HTMSAVAGSFGYF 821
            Y+H      I+HRD+  SN+LL      KIADFGLA  L    E  +T+    G+  Y 
Sbjct: 126 LYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL---CGTPNYI 179

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +PE A  +    + D++S G +   L+ G+
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  123 bits (310), Expect = 4e-31
 Identities = 70/291 (24%), Positives = 118/291 (40%), Gaps = 42/291 (14%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            N+V+L    + E    ++ E+M   +L  +L    R             +     L +A
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-----------QEVSAVVLLYMA 117

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              +  + Y+        IHRD+ + N L+      K+ADFGL++++   G+ +T    A
Sbjct: 118 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYT----A 168

Query: 816 GSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
            +   F     APE     K + K D+++FGV+L E+ T   + Y               
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------PGID 217

Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             +  + + L+K             VY L   C    PS RPS  E+ Q  
Sbjct: 218 LSQ--VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (311), Expect = 5e-31
 Identities = 58/294 (19%), Positives = 92/294 (31%), Gaps = 52/294 (17%)

Query: 643 LIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV-- 699
           L+G GG G VY   D       VA+K +      +         E    G ++  ++V  
Sbjct: 41  LVGRGGMGDVYEAEDTV-RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 700 --------KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
                   +L+          +    +    L   L  +               L  P  
Sbjct: 100 HDFGEIDGQLY----------VDMRLINGVDLAAMLRRQGP-------------LAPPRA 136

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
           + I       L   H        HRDVK  NIL+ ++  A + DFG+A     +      
Sbjct: 137 VAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL- 192

Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA 871
               G+  Y APE    +    + DIY+   VL E +TG     GD    L+     H  
Sbjct: 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD---QLSV-MGAHIN 248

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSR-PSMKEVLQILRRC 924
           +  P    +  GI  P   +       +     +  P  R  +  ++       
Sbjct: 249 QAIPRPSTVRPGI--PVAFDA------VIARGMAKNPEDRYVTCGDLSAAAHAA 294

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  123 bits (311), Expect = 5e-31
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 36/225 (16%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G G +  V+R      G+  A+K   NN    + ++ +   E E+L  + H NIVKL+
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQM-REFEVLKKLNHKNIVKLF 73

Query: 703 CCISSENSKL--LVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
                  ++   L+ E+    SL   L        L     S    VL       +    
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL---PESEFLIVLR-----DV---- 121

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILL----DSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
             G+ ++  +    I+HR++K  NI+     D +   K+ DFG A+ L    +     ++
Sbjct: 122 VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSL 175

Query: 815 AGSFGYFAPE--------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
            G+  Y  P+          +  K    +D++S GV      TG 
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  122 bits (308), Expect = 7e-31
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 31/217 (14%)

Query: 643 LIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           ++G G  G VY   D++     +A+K I    + + +  +    EI +   ++H NIV+ 
Sbjct: 29  VLGKGTYGIVYAGRDLS-NQVRIAIKEI---PERDSRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
               S      +  E +   SL   L  +   L     ++  +        QI     +G
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT------KQI----LEG 134

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEF-KAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           L Y+H +   QI+HRD+K  N+L+++     KI+DFG +K LA    P T +   G+  Y
Sbjct: 135 LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTET-FTGTLQY 189

Query: 821 FAPE------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
            APE        Y        DI+S G  ++E+ TGK
Sbjct: 190 MAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATGK 222

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  123 bits (311), Expect = 7e-31
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 34/217 (15%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             +G G  G+V+R+     G   AVK++        +LE   + E+     +    IV L
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRVEELVACAGLSSPRIVPL 115

Query: 702 WCCISSENSKLLVYEYMENQSLDRWL--HGR-KRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           +  +       +  E +E  SL + +   G                 L            
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL---YYLGQAL------------ 160

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEPHTMSA---V 814
            +GL Y+H     +I+H DVK+ N+LL S+  +A + DFG A  L   G   ++     +
Sbjct: 161 -EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            G+  + APE       + K+DI+S   ++L ++ G 
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  126 bits (317), Expect = 8e-31
 Identities = 74/288 (25%), Positives = 122/288 (42%), Gaps = 38/288 (13%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
            SL     +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRH 238

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+  +S E    +V EYM   SL  +L G                L  P  + +A
Sbjct: 239 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETG-----------KYLRLPQLVDMA 286

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              A G+ Y+        +HRD++++NIL+      K+ADFGLA+++    +    +   
Sbjct: 287 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQG 340

Query: 816 GSFGYF--APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
             F     APE A   +   K D++SFG++L EL T     Y        E         
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNRE--------- 389

Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             + D +++G   PC  E   +++ L   C    P  RP+ + +   L
Sbjct: 390 --VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  127 bits (320), Expect = 1e-30
 Identities = 66/348 (18%), Positives = 129/348 (37%), Gaps = 42/348 (12%)

Query: 71  TFNSVTGISLRHKDITQKIPP-IICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLS 129
           T N+   ++ ++  +  K+P  ++   + +  ++L+   I             +Q L + 
Sbjct: 49  TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107

Query: 130 QNYFVGPIPSDI-DRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEFNGTFPK 187
            N     +P  +   +  L  + L  N+ S  +PR I     +L TL +  N        
Sbjct: 108 FNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDD 165

Query: 188 EIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEI 247
                ++L+ L L+ N      +  ++  ++  L    ++  NL+  +        ++E 
Sbjct: 166 TFQATTSLQNLQLSSNR-----LTHVDLSLIPSLFHANVSY-NLLSTLA----IPIAVEE 215

Query: 248 LALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIP 307
           L  + N +   +   + +   LT L L  N L+ +    +    L ++DLS N L   I 
Sbjct: 216 LDASHNSIN-VVRGPVNV--ELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIM 270

Query: 308 EE-FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNR 366
              F K++ L+ L + +N L                   A+        TL+ + L  N 
Sbjct: 271 YHPFVKMQRLERLYISNNRLV------------------ALNLYGQPIPTLKVLDLSHNH 312

Query: 367 FSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFS 414
               +         L +L L  N+I   L   T   L  L +S+N + 
Sbjct: 313 LL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 76.5 bits (188), Expect = 2e-14
 Identities = 47/271 (17%), Positives = 95/271 (35%), Gaps = 37/271 (13%)

Query: 290 LKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFE--------- 340
               D+ + M         E   L N +++   ++ +  ++PA+      +         
Sbjct: 27  CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAA----LLDSFRQVELLN 81

Query: 341 ---NNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTG-LWTTFNLSSLMLSDNTISGELP 396
                +      +     T++ + +  N     LP         L+ L+L  N +S  LP
Sbjct: 82  LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLP 139

Query: 397 SKTAWNLTRLE---ISNNRFSGQIQRGVGSW-KNLIVFKASNNLFSGEIPVELTSLSHLN 452
                N  +L    +SNN    +I+        +L   + S+N  +    V+L+ +  L 
Sbjct: 140 RGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLF 195

Query: 453 TLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGE 512
              +  N LS  L   I    ++  L+ + N ++  +   +   L    L L  N  + +
Sbjct: 196 HANVSYNLLS-TLAIPI----AVEELDASHNSIN-VVRGPVNVEL--TILKLQHNNLT-D 246

Query: 513 IPPEIGQLKLNTFNLSSNKLYGNIPDEFNNL 543
               +    L   +LS N+L   +   F  +
Sbjct: 247 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM 277

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  122 bits (308), Expect = 2e-30
 Identities = 49/302 (16%), Positives = 98/302 (32%), Gaps = 41/302 (13%)

Query: 630 TESNILSSLTESNLIGSGGSGQV--YRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEI 687
            E   L+ L    ++    +              E        +    +         +I
Sbjct: 53  REVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKI 112

Query: 688 EILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
             +      N V      S +    +  +    ++L  W++ R           H   LH
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL----EDREHGVCLH 168

Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE 807
               +QIA    + + ++H      ++HRD+K SNI    +   K+ DFGL   + +  E
Sbjct: 169 I--FIQIA----EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219

Query: 808 PHTMSAVA----------GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD 857
             T+              G+  Y +PE  +    + K+DI+S G++L EL+         
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QM 277

Query: 858 EHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
           E   +                 +        + ++    + +     S  P+ RP   ++
Sbjct: 278 ERVRIIT--------------DVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323

Query: 918 LQ 919
           ++
Sbjct: 324 IE 325

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  121 bits (306), Expect = 2e-30
 Identities = 64/229 (27%), Positives = 96/229 (41%), Gaps = 45/229 (19%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             +G G  G VY+      G+ VA+K++     +   L+ E I EI I+      ++VK 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQ-EIIKEISIMQQCDSPHVVKY 89

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI---GA 758
           +          +V EY    S+   +  R ++L               T  +IA      
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL---------------TEDEIATILQST 134

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ--------GEPHT 810
            +GL Y+H     + IHRD+K+ NILL++E  AK+ADFG+A  L           G P  
Sbjct: 135 LKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFW 191

Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           M          APE       N   DI+S G+  +E+  G +  Y D H
Sbjct: 192 M----------APEVIQEIGYNCVADIWSLGITAIEMAEG-KPPYADIH 229

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  121 bits (306), Expect = 2e-30
 Identities = 71/315 (22%), Positives = 116/315 (36%), Gaps = 68/315 (21%)

Query: 628 GFTESNILSSLTES----NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEF 683
           G+  S   S   +S    + +G G  G+V+++     G   AVKR   +     K     
Sbjct: 45  GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARK 103

Query: 684 IAEIEILGTI-RHANIVKLWCCISS--ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS 740
           +AE+     + +H   V+L     +  E   L  Y   E              L   S  
Sbjct: 104 LAEVGSHEKVGQHPCCVRL---EQAWEEGGIL--YLQTE--------------LCGPS-- 142

Query: 741 VHQHVLHWPTRL---QIAIGAAQ---GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA 794
           + QH   W   L   Q+          L ++H      ++H DVK +NI L    + K+ 
Sbjct: 143 LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLG 199

Query: 795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEY---AYTTKVNEKIDIYSFGVVLLELVTGK 851
           DFGL   L   G         G   Y APE    +Y T      D++S G+ +LE+    
Sbjct: 200 DFGLLVELGTAGAGEVQ---EGDPRYMAPELLQGSYGTAA----DVFSLGLTILEVACNM 252

Query: 852 EANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYR-LALICTSTLPSS 910
           E  +G E        W+           L +G   P +   +++  R + ++     P  
Sbjct: 253 ELPHGGE-------GWQQ----------LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKL 295

Query: 911 RPSMKEVLQ--ILRR 923
           R + + +L   +LR+
Sbjct: 296 RATAEALLALPVLRQ 310

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  127 bits (320), Expect = 2e-30
 Identities = 59/289 (20%), Positives = 101/289 (34%), Gaps = 56/289 (19%)

Query: 643 LIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            I  GG G +Y  +D N  G  V +K + ++   + + +   +AE + L  + H +IV++
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 702 WCCISSENSKL-----LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           +  +   +        +V EY+  QSL R    +               L     +   +
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---------------LPVAEAIAYLL 189

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
                L Y+H      +++ D+K  NI+L  E + K+ D G    +   G       + G
Sbjct: 190 EILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------YLYG 239

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
           + G+ APE    T      DIY+ G  L  L        G               E+ P+
Sbjct: 240 TPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGR--------YVDGLPEDDPV 290

Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-SMKEVLQILRRC 924
               D             +  RL        P  R  + +E+   L   
Sbjct: 291 LKTYD-------------SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  120 bits (303), Expect = 3e-30
 Identities = 71/303 (23%), Positives = 119/303 (39%), Gaps = 44/303 (14%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
             L     +G G  G V R      +G    VAVK +  +     +   +FI E+  + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
           + H N+++L+  +       +V E     SL   L   +   +              T  
Sbjct: 78  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLL------------GTLS 124

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
           + A+  A+G+ Y+      + IHRD+ + N+LL +    KI DFGL + L  Q + H + 
Sbjct: 125 RYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVM 180

Query: 813 AVAGSFGY--FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                  +   APE   T   +   D + FGV L E+ T     YG E      W   + 
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT-----YGQE-----PWIGLNG 230

Query: 871 AEEKPITDALDKG---IAEP--CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC 925
           ++   I   +DK    +  P  C  +    +Y + + C +  P  RP+   +   L    
Sbjct: 231 SQ---ILHKIDKEGERLPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283

Query: 926 PTE 928
           PT+
Sbjct: 284 PTD 286

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  120 bits (303), Expect = 4e-30
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 20/210 (9%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + + I      E  A K +  +  L     ++   EI I  ++ H ++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V E    +SL      RK      +    ++ L      QI      G 
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKAL----TEPEARYYLR-----QIV----LGC 128

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HTMSAVAGSFGYF 821
            Y+H +   ++IHRD+K  N+ L+ + + KI DFGLA  +   GE    +    G+  Y 
Sbjct: 129 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYI 182

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           APE       + ++D++S G ++  L+ GK
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  121 bits (305), Expect = 4e-30
 Identities = 67/294 (22%), Positives = 124/294 (42%), Gaps = 42/294 (14%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           S +    +IGSG SG+V              VA+K +       Q+  ++F++E  I+G 
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQ 106

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H NI++L   ++     ++V EYMEN SLD +L                        +
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI------------MQLV 154

Query: 753 QIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS 812
            +  G   G+ Y+        +HRD+ + N+L+DS    K++DFGL+++L    +    +
Sbjct: 155 GMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211

Query: 813 AVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW 867
                 G       APE       +   D++SFGVV+ E++   E  Y +   +  +   
Sbjct: 212 TG----GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN--MTNRD--- 262

Query: 868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                   +  ++++G   P  +     +++L L C     + RP   +++ +L
Sbjct: 263 --------VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  126 bits (318), Expect = 4e-30
 Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 31/219 (14%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+GG G V R      GE VA+K+    ++L+ K  + +  EI+I+  + H N+V    
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 704 CISSENS------KLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
                         LL  EY E   L ++L        L        + +L       I+
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL---KEGPIRTLLS-----DIS 131

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMS 812
                 L Y+H +   +IIHRD+K  NI+L    +    KI D G AK L  QGE    +
Sbjct: 132 ----SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGEL--CT 181

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
              G+  Y APE     K    +D +SFG +  E +TG 
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  121 bits (305), Expect = 5e-30
 Identities = 64/305 (20%), Positives = 123/305 (40%), Gaps = 59/305 (19%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+   I      +  VA+K +      + K  KE + E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 72

Query: 692 TIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
           ++ + ++ +L     +  +  L+ + M    L  ++   K ++ S               
Sbjct: 73  SVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGS------------QYL 119

Query: 752 LQIAIGAAQGLCY---MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
           L   +  A+G+ Y           ++HRD+ + N+L+ +    KI DFGLAK+L    E 
Sbjct: 120 LNWCVQIAKGMNYLEDRR------LVHRDLAARNVLVKTPQHVKITDFGLAKLL-GAEEK 172

Query: 809 HTMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA 863
              +      G       A E         + D++S+GV + EL+T     +G +     
Sbjct: 173 EYHA----EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT-----FGSK----- 218

Query: 864 EWAWRHYAEEKPITDALDKG--IAEP--CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
            +     +E   I+  L+KG  + +P  C ++    VY +   C      SRP  +E++ 
Sbjct: 219 PYDGIPASE---ISSILEKGERLPQPPICTID----VYMIMRKCWMIDADSRPKFRELII 271

Query: 920 ILRRC 924
              + 
Sbjct: 272 EFSKM 276

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  124 bits (314), Expect = 5e-30
 Identities = 74/288 (25%), Positives = 122/288 (42%), Gaps = 38/288 (13%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
            SL     +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTL----KPGTMSPEAFLQEAQVMKKLRH 321

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+  +S E    +V EYM   SL  +L G                L  P  + +A
Sbjct: 322 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETG-----------KYLRLPQLVDMA 369

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              A G+ Y+        +HRD++++NIL+      K+ADFGLA+++    +    +   
Sbjct: 370 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQG 423

Query: 816 GSFGYF--APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
             F     APE A   +   K D++SFG++L EL T     Y        E         
Sbjct: 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNRE--------- 472

Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             + D +++G   PC  E   +++ L   C    P  RP+ + +   L
Sbjct: 473 --VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  120 bits (302), Expect = 6e-30
 Identities = 74/311 (23%), Positives = 124/311 (39%), Gaps = 55/311 (17%)

Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             +     +G G  G+V+      +        VAVK +   +       K+F  E E+L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELL 71

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK---RSLVSGSSSVHQHVLH 747
             ++H +IVK +      +  ++V+EYM++  L+++L         LV G     +  L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 748 WPTRLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML--- 802
               L IA   A G+ Y+   H      +HRD+ + N L+ +    KI DFG+++ +   
Sbjct: 132 LSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186

Query: 803 ---AKQGEPHTMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVT-GKEA 853
                 G                     PE     K   + D++SFGV+L E+ T GK+ 
Sbjct: 187 DYYRVGGH-----------TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

Query: 854 NYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS 913
            +   +T + E   +    E+P            C  E    VY + L C    P  R +
Sbjct: 236 WFQLSNTEVIECITQGRVLERP----------RVCPKE----VYDVMLGCWQREPQQRLN 281

Query: 914 MKEVLQILRRC 924
           +KE+ +IL   
Sbjct: 282 IKEIYKILHAL 292

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  122 bits (307), Expect = 6e-30
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 36/225 (16%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G G +  V+R      G+  A+K   NN    + ++ +   E E+L  + H NIVKL+
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQM-REFEVLKKLNHKNIVKLF 73

Query: 703 CCISSENSKL--LVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
                  ++   L+ E+    SL   L        L     S    VL       +    
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL---PESEFLIVLR-----DV---- 121

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILL----DSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
             G+ ++  +    I+HR++K  NI+     D +   K+ DFG A+ L    +     ++
Sbjct: 122 VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSL 175

Query: 815 AGSFGYFAPE--------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
            G+  Y  P+          +  K    +D++S GV      TG 
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  119 bits (301), Expect = 6e-30
 Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 48/300 (16%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
             +  + +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+  
Sbjct: 25  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKD 82

Query: 693 IRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
             H N++ L   C+ SE S L+V  YM++  L  ++     +      +V   +      
Sbjct: 83  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLI------ 131

Query: 752 LQIAIGAAQGLCY---MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
               +  A+G+ Y            +HRD+ + N +LD +F  K+ADFGLA+ +    + 
Sbjct: 132 -GFGLQVAKGMKYLASKK------FVHRDLAARNCMLDEKFTVKVADFGLARDMY---DK 181

Query: 809 HTMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA 863
              S    +         A E   T K   K D++SFGV+L EL+T     Y        
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-------- 233

Query: 864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
                    +  IT  L +G            +Y + L C       RPS  E++  +  
Sbjct: 234 ---PDVNTFD--ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  121 bits (306), Expect = 7e-30
 Identities = 72/300 (24%), Positives = 118/300 (39%), Gaps = 48/300 (16%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
             +  + +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+  
Sbjct: 89  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKD 146

Query: 693 IRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
             H N++ L   C+ SE S L+V  YM++  L  ++     +      +V   +      
Sbjct: 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLI------ 195

Query: 752 LQIAIGAAQGLCY---MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
               +  A+G+ +            +HRD+ + N +LD +F  K+ADFGLA+ +  +   
Sbjct: 196 -GFGLQVAKGMKFLASKK------FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248

Query: 809 HTMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA 863
              S    +         A E   T K   K D++SFGV+L EL+T     Y        
Sbjct: 249 ---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-------- 297

Query: 864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
                    +  IT  L +G            +Y + L C       RPS  E++  +  
Sbjct: 298 ---PDVNTFD--ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  118 bits (298), Expect = 8e-30
 Identities = 66/291 (22%), Positives = 122/291 (41%), Gaps = 44/291 (15%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
           S LT    IGSG  G V+        + VA+K I    +     E++FI E E++  + H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTI----REGAMSEEDFIEEAEVMMKLSH 62

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+     +    LV E+ME+  L  +L  ++    +             T L + 
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA------------ETLLGMC 110

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           +   +G+ Y+       +IHRD+ + N L+      K++DFG+ + +         ++  
Sbjct: 111 LDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSST 163

Query: 816 GSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
           G    F     +PE    ++ + K D++SFGV++ E+ +  +  Y +   S +E      
Sbjct: 164 G--TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSE------ 213

Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                + + +  G          T VY++   C    P  RP+   +L+ L
Sbjct: 214 -----VVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  121 bits (305), Expect = 9e-30
 Identities = 71/297 (23%), Positives = 131/297 (44%), Gaps = 48/297 (16%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           ++++   ++G+G  G+V    +    +    VA+K +       Q+  ++F+ E  I+G 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQ 102

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H NI++L   ++     ++V EYMEN SLD +L                        +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------------FTVIQLV 150

Query: 753 QIAIGAAQGLCY---MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
            +  G A G+ Y   M        +HRD+ + NIL++S    K++DFGL ++L    E  
Sbjct: 151 GMLRGIASGMKYLSDMG------YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE-- 202

Query: 810 TMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
             +A     G       +PE     K     D++S+G+VL E+++  E  Y +   S  +
Sbjct: 203 --AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE--MSNQD 258

Query: 865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                      +  A+D+G   P  ++    +Y+L L C     ++RP  ++++ IL
Sbjct: 259 -----------VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  121 bits (304), Expect = 9e-30
 Identities = 64/312 (20%), Positives = 125/312 (40%), Gaps = 52/312 (16%)

Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
             + + +G+G  G V+++    +G  +A K I  + ++   +  + I E+++L       
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV  +    S+    +  E+M+  SLD+ L    R        + + +L      +++I 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--------IPEQILG-----KVSIA 139

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA-VAG 816
             +GL Y+      +I+HRDVK SNIL++S  + K+ DFG++  L       +M+    G
Sbjct: 140 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVG 192

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
           +  Y +PE    T  + + DI+S G+ L+E+  G+      +   L          +   
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

Query: 877 TDALDKGIAEPCYLEEMTTVYRLALI-----------------------------CTSTL 907
           T    +    P     M +   +A+                              C    
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312

Query: 908 PSSRPSMKEVLQ 919
           P+ R  +K+++ 
Sbjct: 313 PAERADLKQLMV 324

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (299), Expect = 1e-29
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 47/228 (20%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKLW 702
           IG G SG VY       G+ VA++++     L Q+ +KE I  EI ++   ++ NIV   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI---GAA 759
                 +   +V EY+   SL              +  V +  +      QIA       
Sbjct: 84  DSYLVGDELWVVMEYLAGGSL--------------TDVVTETCM---DEGQIAAVCRECL 126

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ--------GEPHTM 811
           Q L ++H +   Q+IHRD+KS NILL  +   K+ DFG    +  +        G P+ M
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
                     APE         K+DI+S G++ +E++ G E  Y +E+
Sbjct: 184 ----------APEVVTRKAYGPKVDIWSLGIMAIEMIEG-EPPYLNEN 220

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  120 bits (302), Expect = 1e-29
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 20/210 (9%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G GG  + + I      E  A K +  +  L     ++   EI I  ++ H ++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                 +   +V E    +SL      RK      +    ++ L      QI      G 
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKAL----TEPEARYYLR-----QIV----LGC 154

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HTMSAVAGSFGYF 821
            Y+H +   ++IHRD+K  N+ L+ + + KI DFGLA  +   GE    +    G+  Y 
Sbjct: 155 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYI 208

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           APE       + ++D++S G ++  L+ GK
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  119 bits (301), Expect = 1e-29
 Identities = 81/306 (26%), Positives = 121/306 (39%), Gaps = 47/306 (15%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
           + +   ++IG G  GQV +  I   G     A+KR+      ++   ++F  E+E+L  +
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKL 82

Query: 694 -RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ---HVLHWP 749
             H NI+ L           L  EY  + +L  +L   +      + ++       L   
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
             L  A   A+G   M +    Q IHRD+ + NIL+   + AKIADFGL++         
Sbjct: 143 QLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--------G 191

Query: 810 TMSAVAGSFGYF-----APE----YAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEH 859
               V  + G       A E      YTT      D++S+GV+L E+V+ G     G   
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNS----DVWSYGVLLWEIVSLGGTPYCGMTC 247

Query: 860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
             L E   + Y  EKP            C  E    VY L   C    P  RPS  ++L 
Sbjct: 248 AELYEKLPQGYRLEKP----------LNCDDE----VYDLMRQCWREKPYERPSFAQILV 293

Query: 920 ILRRCC 925
            L R  
Sbjct: 294 SLNRML 299

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  118 bits (299), Expect = 1e-29
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 50/230 (21%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G+V++   N   + VA+K I +  +   ++E +   EI +L       + K + 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 87

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL---QIAI---G 757
               +    ++ EY+   S                      +L  P  L   QIA     
Sbjct: 88  SYLKDTKLWIIMEYLGGGSA-------------------LDLLE-PGPLDETQIATILRE 127

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ--------GEPH 809
             +GL Y+H +   + IHRD+K++N+LL    + K+ADFG+A  L           G P 
Sbjct: 128 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 184

Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
            M          APE    +  + K DI+S G+  +EL  G E  + + H
Sbjct: 185 WM----------APEVIKQSAYDSKADIWSLGITAIELARG-EPPHSELH 223

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (304), Expect = 1e-29
 Identities = 51/235 (21%), Positives = 83/235 (35%), Gaps = 45/235 (19%)

Query: 644 IGSGGS--GQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           IG G      V        GE+V V+RI N    + ++      E+ +     H NIV  
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL---QIAI-- 756
                ++N   +V  +M   S         + L+           H+   +    IA   
Sbjct: 92  RATFIADNELWVVTSFMAYGSA--------KDLIC---------THFMDGMNELAIAYIL 134

Query: 757 -GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGE-PHTMSAV 814
            G  + L Y+HH      +HR VK+S+IL+  + K  ++       +   G+    +   
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 815 AGSF-G---YFAPE------YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
                    + +PE        Y    + K DIYS G+   EL  G    + D  
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGY----DAKSDIYSVGITACELANG-HVPFKDMP 241

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  118 bits (297), Expect = 2e-29
 Identities = 63/299 (21%), Positives = 118/299 (39%), Gaps = 44/299 (14%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
             LT    +G+G  G V      G  + VA+K I    K     E EFI E +++  + H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMI----KEGSMSEDEFIEEAKVMMNLSH 78

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+   + +    ++ EYM N  L  +L               +H       L++ 
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE------------MRHRFQTQQLLEMC 126

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               + + Y+      Q +HRD+ + N L++ +   K++DFGL++ +         ++  
Sbjct: 127 KDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSV 179

Query: 816 GSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
           G    F      PE    +K + K DI++FGV++ E+ +  +  Y     + +E      
Sbjct: 180 G--SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER--FTNSE------ 229

Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTEN 929
                  + + +G+           VY +   C       RP+ K +L  +      E+
Sbjct: 230 -----TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  117 bits (296), Expect = 2e-29
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 20/210 (9%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +          L+ EY    ++ R L    +     +++            ++A      
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------ELA----NA 121

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y H     ++IHRD+K  N+LL S  + KIADFG +   A       +    G+  Y 
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDL---CGTLDYL 174

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            PE       +EK+D++S GV+  E + GK
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  118 bits (297), Expect = 2e-29
 Identities = 65/303 (21%), Positives = 116/303 (38%), Gaps = 42/303 (13%)

Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           S++     +G    G+VY+            + VA+K +    K    L +EF  E  + 
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLR 66

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK---RSLVSGSSSVHQHVLH 747
             ++H N+V L   ++ +    +++ Y  +  L  +L  R        +      +  L 
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 748 WPTRLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
            P  + +    A G+ Y+  HH     ++H+D+ + N+L+  +   KI+D GL + +   
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181

Query: 806 GEPHTMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEH 859
                                APE     K +   DI+S+GVVL E+ + G +   G  +
Sbjct: 182 DY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236

Query: 860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
             + E          P          + C       VY L + C +  PS RP  K++  
Sbjct: 237 QDVVEMIRNRQVLPCP----------DDC----PAWVYALMIECWNEFPSRRPRFKDIHS 282

Query: 920 ILR 922
            LR
Sbjct: 283 RLR 285

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  121 bits (306), Expect = 2e-29
 Identities = 73/297 (24%), Positives = 127/297 (42%), Gaps = 56/297 (18%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
            SL     +G+G  G+V+    N   + VAVK +    K      + F+AE  ++ T++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTM----KPGSMSVEAFLAEANVMKTLQH 242

Query: 696 ANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
             +VKL      ++    ++ E+M   SL  +L   + S               P  +  
Sbjct: 243 DKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGS-----------KQPLPKLIDF 289

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           +   A+G+ ++        IHRD++++NIL+ +    KIADFGLA+++    E +  +A 
Sbjct: 290 SAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI----EDNEYTAR 342

Query: 815 AGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
            G    F     APE         K D++SFG++L+E+VT     Y     S  E     
Sbjct: 343 EG--AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG--MSNPE----- 393

Query: 870 YAEEKPITDALDKGIAEPCY-LEEM----TTVYRLALICTSTLPSSRPSMKEVLQIL 921
                 +  AL++G     Y +         +Y + + C    P  RP+ + +  +L
Sbjct: 394 ------VIRALERG-----YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  120 bits (304), Expect = 3e-29
 Identities = 71/257 (27%), Positives = 119/257 (46%), Gaps = 41/257 (15%)

Query: 608 LRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVK 667
           ++  R++D +             +     S T++ +IG+G  G VY+  +  +GE VA+K
Sbjct: 26  MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85

Query: 668 RIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKLWCCISSENSKL------LVYEYMEN 720
           ++          +K F   E++I+  + H NIV+L     S   K       LV +Y+  
Sbjct: 86  KV--------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP- 136

Query: 721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKS 780
           +++ R      R+  +      +  ++     Q+     + L Y+H   +  I HRD+K 
Sbjct: 137 ETVYRVARHYSRAKQTLPVIYVKLYMY-----QLF----RSLAYIH---SFGICHRDIKP 184

Query: 781 SNILLDSE-FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPE-----YAYTTKVNEK 834
            N+LLD +    K+ DFG AK L + GEP+  S +  S  Y APE       YT+     
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVR-GEPNV-SYIC-SRYYRAPELIFGATDYTS----S 237

Query: 835 IDIYSFGVVLLELVTGK 851
           ID++S G VL EL+ G+
Sbjct: 238 IDVWSAGCVLAELLLGQ 254

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  117 bits (295), Expect = 3e-29
 Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 56/297 (18%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
            +L     +G+G  G+V+    NG  + VAVK +    K        F+AE  ++  ++H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSL----KQGSMSPDAFLAEANLMKQLQH 67

Query: 696 ANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
             +V+L+     ++    ++ EYMEN SL  +L                  L     L +
Sbjct: 68  QRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI-----------KLTINKLLDM 114

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           A   A+G+ ++        IHRD++++NIL+      KIADFGLA+++    E +  +A 
Sbjct: 115 AAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAR 167

Query: 815 AGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
            G    F     APE         K D++SFG++L E+VT     Y     +  E     
Sbjct: 168 EG--AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPE----- 218

Query: 870 YAEEKPITDALDKGIAEPCY-LEEM----TTVYRLALICTSTLPSSRPSMKEVLQIL 921
                 +   L++G     Y +         +Y+L  +C    P  RP+   +  +L
Sbjct: 219 ------VIQNLERG-----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  117 bits (295), Expect = 4e-29
 Identities = 62/300 (20%), Positives = 115/300 (38%), Gaps = 48/300 (16%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
                  +IG G  G VY    ID        A+K +  +R    +  + F+ E  ++  
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRG 78

Query: 693 IRHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
           + H N++ L    +  E    ++  YM +  L +++   +R+                  
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV------------KDL 126

Query: 752 LQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
           +   +  A+G+ Y+          +HRD+ + N +LD  F  K+ADFGLA+ +    +  
Sbjct: 127 ISFGLQVARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDIL---DRE 178

Query: 810 TMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLA 863
             S              A E   T +   K D++SFGV+L EL+T G       +   L 
Sbjct: 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT 238

Query: 864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +  +     +P          E C       +Y++   C    P+ RP+ + ++  + +
Sbjct: 239 HFLAQGRRLPQP----------EYCPDS----LYQVMQQCWEADPAVRPTFRVLVGEVEQ 284

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  118 bits (297), Expect = 5e-29
 Identities = 82/339 (24%), Positives = 145/339 (42%), Gaps = 74/339 (21%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILG 691
           S +T   +IG+G  G+VY+      +G  E  VA+K +       Q+   +F+ E  I+G
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMG 101

Query: 692 TIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
              H NI++L   IS     +++ EYMEN +LD++L  +                     
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE------------FSVLQL 149

Query: 752 LQIAIGAAQGLCY---MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
           + +  G A G+ Y   M++      +HRD+ + NIL++S    K++DFGL+++L    E 
Sbjct: 150 VGMLRGIAAGMKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203

Query: 809 HTMSAVAGSFGYF-----APEYA----YTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
              +    S G       APE      +T+      D++SFG+V+ E++T     YG   
Sbjct: 204 TYTT----SGGKIPIRWTAPEAISYRKFTSAS----DVWSFGIVMWEVMT-----YG--- 247

Query: 860 TSLAEWAWRHYAEEKP--------ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSR 911
                        E+P        +  A++ G   P  ++  + +Y+L + C     + R
Sbjct: 248 -------------ERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 294

Query: 912 PSMKEVLQILRRCC-PTENYGGKKMGRDVDSAPLLGTAG 949
           P   +++ IL +     ++           S  L  T+G
Sbjct: 295 PKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG 333

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  116 bits (293), Expect = 6e-29
 Identities = 72/306 (23%), Positives = 121/306 (39%), Gaps = 60/306 (19%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
             L     IG G  G V   D  G    VAVK I N+        + F+AE  ++  +RH
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKND-----ATAQAFLAEASVMTQLRH 73

Query: 696 ANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           +N+V+L    +  +    +V EYM   SL  +L  R R            VL     L+ 
Sbjct: 74  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-----------SVLGGDCLLKF 122

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           ++   + + Y+  +     +HRD+ + N+L+  +  AK++DFGL K  +           
Sbjct: 123 SLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---------- 169

Query: 815 AGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
               G       APE     K + K D++SFG++L E+ +     Y            R 
Sbjct: 170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-----------PRI 218

Query: 870 YAEEKPITDALDKGIAEPCY-LEEM----TTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
             ++  +   ++KG     Y ++        VY +   C     + RPS  ++ + L   
Sbjct: 219 PLKD--VVPRVEKG-----YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

Query: 925 CPTENY 930
              E +
Sbjct: 272 KTHELH 277

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  120 bits (303), Expect = 6e-29
 Identities = 70/296 (23%), Positives = 119/296 (40%), Gaps = 58/296 (19%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
             L     IG G  G V   D  G    VAVK I    K +    + F+AE  ++  +RH
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCI----KNDAT-AQAFLAEASVMTQLRH 245

Query: 696 ANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           +N+V+L    +  +    +V EYM   SL  +L  R R            VL     L+ 
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-----------SVLGGDCLLKF 294

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           ++   + + Y+  +     +HRD+ + N+L+  +  AK++DFGL K  +           
Sbjct: 295 SLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---------- 341

Query: 815 AGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
               G       APE     K + K D++SFG++L E+ +     Y            R 
Sbjct: 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-----------PRI 390

Query: 870 YAEEKPITDALDKG----IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
             ++  +   ++KG      + C       VY +   C     ++RP+  ++ + L
Sbjct: 391 PLKD--VVPRVEKGYKMDAPDGCPPA----VYDVMKNCWHLDAATRPTFLQLREQL 440

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  118 bits (297), Expect = 7e-29
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 40/226 (17%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G  G VY        E VA+K++  + K + +  ++ I E+  L  +RH N ++   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI---GAAQ 760
           C   E++  LV EY    + D  L   K+ L                 ++IA    GA Q
Sbjct: 122 CYLREHTAWLVMEYCLGSASD-LLEVHKKPL---------------QEVEIAAVTHGALQ 165

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ----GEPHTMSAVAG 816
           GL Y+H      +IHRDVK+ NILL      K+ DFG A ++A      G P+ M     
Sbjct: 166 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWM----- 217

Query: 817 SFGYFAPEYAYTTKV---NEKIDIYSFGVVLLELVTGKEANYGDEH 859
                APE          + K+D++S G+  +EL    +    + +
Sbjct: 218 -----APEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPLFNMN 257

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  117 bits (294), Expect = 1e-28
 Identities = 74/311 (23%), Positives = 124/311 (39%), Gaps = 54/311 (17%)

Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             +     +G G  G+V+      +        VAVK +   ++ ++   ++F  E E+L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELL 97

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWL--HGRKRSLVSGSSSVHQHVLHW 748
             ++H +IV+ +   +     L+V+EYM +  L+R+L  HG    L++G   V    L  
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157

Query: 749 PTRLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML---- 802
              L +A   A G+ Y+   H      +HRD+ + N L+      KI DFG+++ +    
Sbjct: 158 GQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212

Query: 803 --AKQGEPHTMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVT-GKEAN 854
                G                     PE     K   + D++SFGVVL E+ T GK+  
Sbjct: 213 YYRVGGR-----------TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261

Query: 855 YGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM 914
           Y   +T   +   +    E+P            C       VY +   C    P  R S+
Sbjct: 262 YQLSNTEAIDCITQGRELERP----------RAC----PPEVYAIMRGCWQREPQQRHSI 307

Query: 915 KEVLQILRRCC 925
           K+V   L+   
Sbjct: 308 KDVHARLQALA 318

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  115 bits (290), Expect = 1e-28
 Identities = 65/291 (22%), Positives = 117/291 (40%), Gaps = 44/291 (15%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
             +T    +GSG  G V      G  + VAVK I    K     E EF  E + +  + H
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMI----KEGSMSEDEFFQEAQTMMKLSH 62

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +VK +   S E    +V EY+ N  L  +L    +             L     L++ 
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG------------LEPSQLLEMC 110

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               +G+ ++      Q IHRD+ + N L+D +   K++DFG+ + +          +  
Sbjct: 111 YDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSV 163

Query: 816 GSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
           G    F     APE  +  K + K D+++FG+++ E+ +  +  Y     + +E      
Sbjct: 164 G--TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL--YTNSE------ 213

Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                +   + +G           T+Y++   C   LP  RP+ +++L  +
Sbjct: 214 -----VVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  116 bits (292), Expect = 2e-28
 Identities = 62/309 (20%), Positives = 117/309 (37%), Gaps = 48/309 (15%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
           + L    ++G G  G V        +G    VAVK +      +Q+  +EF++E   +  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKD 92

Query: 693 IRHANIVKLW-CCISSE----NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
             H N+++L   CI          +++  +M+   L  +L      L +G   +    L 
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL--LYSRLETGPKHIPLQTL- 149

Query: 748 WPTRLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               L+  +  A G+ Y+   +      +HRD+ + N +L  +    +ADFGL+K +   
Sbjct: 150 ----LKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200

Query: 806 GEPHTMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEH 859
                     G          A E         K D+++FGV + E+ T G     G ++
Sbjct: 201 DY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255

Query: 860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
             + ++    +  ++P          E C    +  +Y +   C  T P  RP+   +  
Sbjct: 256 HEMYDYLLHGHRLKQP----------EDC----LDELYEIMYSCWRTDPLDRPTFSVLRL 301

Query: 920 ILRRCCPTE 928
            L +   + 
Sbjct: 302 QLEKLLESL 310

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  116 bits (292), Expect = 2e-28
 Identities = 66/301 (21%), Positives = 115/301 (38%), Gaps = 41/301 (13%)

Query: 137 IPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLE 196
           +P D+        +DL  N  +         L  L TL L  N+ +   P     L  LE
Sbjct: 46  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103

Query: 197 VLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHL 255
            L L+ N      +  +   M K L+ L +   N I ++ +   + L+ + ++ L  N L
Sbjct: 104 RLYLSKNQ-----LKELPEKMPKTLQELRV-HENEITKVRKSVFNGLNQMIVVELGTNPL 157

Query: 256 -EGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEE-FGK 312
               I +G F  +  L+ + + D  ++  IP  +    LT++ L  N +T  +       
Sbjct: 158 KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP-SLTELHLDGNKIT-KVDAASLKG 214

Query: 313 LKNLQLLGLFSNHLSGEVPASIGVVAFEN-------NLSG----AVPKSLGNCRTLRTVQ 361
           L NL  LGL  N +S     ++   +  N       +L+      VP  L + + ++ V 
Sbjct: 215 LNNLAKLGLSFNSIS-----AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVY 269

Query: 362 LYSNRFS-----GELPTGLWTTF-NLSSLMLSDNTIS-GELPSKTAWNLTRLEI---SNN 411
           L++N  S        P G  T   + S + L  N +   E+   T   +         N 
Sbjct: 270 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

Query: 412 R 412
           +
Sbjct: 330 K 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  107 bits (269), Expect = 2e-25
 Identities = 67/329 (20%), Positives = 123/329 (37%), Gaps = 61/329 (18%)

Query: 72  FNSVTGISLRHKDITQKIPP-IICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQ 130
                 + L++  IT +I      +LKNL T+ L +N I    P       KL+ L LS+
Sbjct: 51  PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109

Query: 131 NYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEF------NG 183
           N     +P  +     LQ + +  N  +  + +S+   L+++  + L  N        NG
Sbjct: 110 NQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165

Query: 184 TFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNL 242
            F      +  L  + +A         IP   G+   L  L + + N I ++   ++  L
Sbjct: 166 AF----QGMKKLSYIRIADT---NITTIP--QGLPPSLTELHL-DGNKITKVDAASLKGL 215

Query: 243 SSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNL 302
           ++L  L L+ N +  A+ +G     N                       L ++ L+ N L
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSL--ANTPH--------------------LRELHLNNNKL 252

Query: 303 TGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQL 362
              +P      K +Q++ L +N++S     +IG   F        P       +   V L
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNIS-----AIGSNDF------CPPGYNTKKASYSGVSL 300

Query: 363 YSNRFS-GELPTGLWTTF-NLSSLMLSDN 389
           +SN     E+    +      +++ L + 
Sbjct: 301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  102 bits (257), Expect = 9e-24
 Identities = 65/328 (19%), Positives = 113/328 (34%), Gaps = 85/328 (25%)

Query: 230 NLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSV 287
           N I EI +    NL +L  L L  N +   I  G F  L  L +L+L  N L  E+P   
Sbjct: 62  NKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPE-- 117

Query: 288 EALK-LTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSG 345
           +  K L ++ +  N +T  + +  F  L  + ++ L +N L     + I   AF+     
Sbjct: 118 KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK---SSGIENGAFQG---- 169

Query: 346 AVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTR 405
                                    +         LS + ++D  I+  +P     +LT 
Sbjct: 170 -------------------------MK-------KLSYIRIADTNIT-TIPQGLPPSLTE 196

Query: 406 LEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKL 465
           L +  N+ + ++                           L  L++L  L L  N +S   
Sbjct: 197 LHLDGNKIT-KVDAAS-----------------------LKGLNNLAKLGLSFNSISAVD 232

Query: 466 PSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEI-------- 517
              + +   L  L+L  N+L  ++P  +     +  + L  N  S  I            
Sbjct: 233 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNT 290

Query: 518 GQLKLNTFNLSSNKL-YGNIPDE-FNNL 543
            +   +  +L SN + Y  I    F  +
Sbjct: 291 KKASYSGVSLFSNPVQYWEIQPSTFRCV 318

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  115 bits (290), Expect = 2e-28
 Identities = 63/296 (21%), Positives = 115/296 (38%), Gaps = 58/296 (19%)

Query: 644 IGSGGSGQVYRIDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +G G  G V +       +   VA+K +    +      +E + E +I+  + +  IV+L
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
              +    + +LV E      L ++L G++  +                  ++    + G
Sbjct: 76  IG-VCQAEALMLVMEMAGGGPLHKFLVGKREEI------------PVSNVAELLHQVSMG 122

Query: 762 LCY---MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           + Y    +       +HRD+ + N+LL +   AKI+DFGL+K L    + +  +  AG +
Sbjct: 123 MKYLEEKN------FVHRDLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKW 175

Query: 819 GYF--APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP- 875
                APE     K + + D++S+GV + E ++     YG                +KP 
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALS-----YG----------------QKPY 214

Query: 876 -------ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
                  +   +++G    C  E    +Y L   C       RP    V Q +R C
Sbjct: 215 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  116 bits (292), Expect = 2e-28
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 47/228 (20%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI-AEIEILGTIRHANIVKLW 702
           IG G +G V       +G  VAVK +     L ++  +E +  E+ I+   +H N+V+++
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM----DLRKQQRRELLFNEVVIMRDYQHFNVVEMY 108

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI---GAA 759
                     ++ E+++  +L              +  V Q  L      QIA       
Sbjct: 109 KSYLVGEELWVLMEFLQGGAL--------------TDIVSQVRL---NEEQIATVCEAVL 151

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ--------GEPHTM 811
           Q L Y+H      +IHRD+KS +ILL  + + K++DFG    ++K         G P+ M
Sbjct: 152 QALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 208

Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
                     APE    +    ++DI+S G++++E+V G E  Y  + 
Sbjct: 209 ----------APEVISRSLYATEVDIWSLGIMVIEMVDG-EPPYFSDS 245

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  116 bits (292), Expect = 2e-28
 Identities = 65/305 (21%), Positives = 121/305 (39%), Gaps = 61/305 (20%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILG 691
           + L +  ++GSG  G V++   I    + +  V +K I    K  ++  +     +  +G
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIG 70

Query: 692 TIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
           ++ HA+IV+L        S  LV +Y+   SL   +   + +L                 
Sbjct: 71  SLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGP------------QLL 117

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
           L   +  A+G+ Y+       ++HR++ + N+LL S  + ++ADFG+A +L    +    
Sbjct: 118 LNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK---- 170

Query: 812 SAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
             +  S         A E  +  K   + D++S+GV + EL+T     +G          
Sbjct: 171 -QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT-----FG---------- 214

Query: 867 WRHYAEEKP--------ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
                  +P        + D L+KG            VY + + C     + RP+ KE+ 
Sbjct: 215 ------AEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELA 268

Query: 919 QILRR 923
               R
Sbjct: 269 NEFTR 273

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  115 bits (290), Expect = 2e-28
 Identities = 60/233 (25%), Positives = 96/233 (41%), Gaps = 50/233 (21%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-FIAEIEILGTIRHANIVKLW 702
           +G G  G+VY+      G   A K I    +   + E E +I EIEIL T  H  IVKL 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVI----ETKSEEELEDYIVEIEILATCDHPYIVKLL 82

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI---GAA 759
                +    ++ E+    ++D  +    R L               T  QI +      
Sbjct: 83  GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL---------------TEPQIQVVCRQML 127

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ--------GEPHTM 811
           + L ++H     +IIHRD+K+ N+L+  E   ++ADFG++    K         G P+ M
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 184

Query: 812 SAVAGSFGYFAPEYAYTTKV-----NEKIDIYSFGVVLLELVTGKEANYGDEH 859
                     APE      +     + K DI+S G+ L+E+    E  + + +
Sbjct: 185 ----------APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-EPPHHELN 226

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  115 bits (290), Expect = 3e-28
 Identities = 71/325 (21%), Positives = 115/325 (35%), Gaps = 50/325 (15%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEIL 690
            ++T    +G G  G+VY      +        VAVK +      +++ E +F+ E  I+
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALII 87

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
               H NIV+          + ++ E M    L  +L   +      SS      L    
Sbjct: 88  SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS------LAMLD 141

Query: 751 RLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSE---FKAKIADFGLAKMLAKQ 805
            L +A   A G  Y+  +H      IHRD+ + N LL        AKI DFG+A+ + + 
Sbjct: 142 LLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196

Query: 806 GEPHTMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEH 859
                     G           PE         K D +SFGV+L E+ + G        +
Sbjct: 197 SY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251

Query: 860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
             + E+       + P          + C       VYR+   C    P  RP+   +L+
Sbjct: 252 QEVLEFVTSGGRMDPP----------KNCPGP----VYRIMTQCWQHQPEDRPNFAIILE 297

Query: 920 ILRRCCPTENYGGKKMGRDVDSAPL 944
            +  C    +         ++  PL
Sbjct: 298 RIEYCTQDPDV--INTALPIEYGPL 320

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  117 bits (295), Expect = 5e-28
 Identities = 64/327 (19%), Positives = 118/327 (36%), Gaps = 79/327 (24%)

Query: 631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           E ++ + +    ++G G SG V        G  VAVKR+            E    I++L
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRM--LIDFCDIALME----IKLL 62

Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
                H N+++ +C  +++    +  E     +L   +  +        S  +  +    
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESK------NVSDENLKLQKEY 115

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-------------FKAKIADF 796
             + +    A G+ ++H     +IIHRD+K  NIL+ +               +  I+DF
Sbjct: 116 NPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172

Query: 797 GLAKMLA--KQGEPHTMSAVAGSFGYFAPE-------YAYTTKVNEKIDIYSFGVVLLEL 847
           GL K L   +      ++  +G+ G+ APE            ++   IDI+S G V   +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

Query: 848 VTGKEANYGDEHT-------------SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMT 894
           ++  +  +GD+++              +     R    E     A D             
Sbjct: 233 LSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAE-----ATD------------- 274

Query: 895 TVYRLALI--CTSTLPSSRPSMKEVLQ 919
                 LI       P  RP+  +VL+
Sbjct: 275 ------LISQMIDHDPLKRPTAMKVLR 295

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  115 bits (291), Expect = 6e-28
 Identities = 74/312 (23%), Positives = 125/312 (40%), Gaps = 53/312 (16%)

Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIE 688
             LT    +G G  GQV       ID +   E   VAVK +       +K   + ++E+E
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEME 138

Query: 689 ILGTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK---RSLVSGSSSVHQH 744
           ++  I +H NI+ L    + +    ++ EY    +L  +L  R+          + V + 
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 745 VLHWPTRLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML 802
            + +   +      A+G+ Y+          IHRD+ + N+L+      KIADFGLA+ +
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 803 AKQGEPHTMSAVAGSFGYF-----APE----YAYTTKVNEKIDIYSFGVVLLELVT-GKE 852
                         + G       APE      YT +     D++SFGV++ E+ T G  
Sbjct: 254 NNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQS----DVWSFGVLMWEIFTLGGS 304

Query: 853 ANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP 912
              G     L +     +  +KP            C  E    +Y +   C   +PS RP
Sbjct: 305 PYPGIPVEELFKLLKEGHRMDKP----------ANCTNE----LYMMMRDCWHAVPSQRP 350

Query: 913 SMKEVLQILRRC 924
           + K++++ L R 
Sbjct: 351 TFKQLVEDLDRI 362

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  113 bits (286), Expect = 7e-28
 Identities = 70/302 (23%), Positives = 119/302 (39%), Gaps = 64/302 (21%)

Query: 644 IGSGGSGQVYRIDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +GSG  G V +           VAVK + N    +  L+ E +AE  ++  + +  IV++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                +E S +LV E  E   L+++L   +              +     +++    + G
Sbjct: 84  IGICEAE-SWMLVMEMAELGPLNKYLQQNRH-------------VKDKNIIELVHQVSMG 129

Query: 762 LCY---MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           + Y    +       +HRD+ + N+LL ++  AKI+DFGL+K L      +       + 
Sbjct: 130 MKYLEESN------FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----TH 179

Query: 819 GYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
           G +     APE     K + K D++SFGV++ E  +     YG                +
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS-----YG----------------Q 218

Query: 874 KP--------ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC 925
           KP        +T  L+KG    C       +Y L  +C +    +RP    V   LR   
Sbjct: 219 KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278

Query: 926 PT 927
             
Sbjct: 279 YD 280

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  117 bits (294), Expect = 7e-28
 Identities = 82/401 (20%), Positives = 144/401 (35%), Gaps = 50/401 (12%)

Query: 160 DIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE-FGML 218
           ++P  +        + L +N            L +L+ L +         +I    F  L
Sbjct: 27  ELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKV--EQQTPGLVIRNNTFRGL 78

Query: 219 KKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGA-IPSGLFL-LNNLTQLFLY 275
             L  L +   N   ++   A + L++LE+L L   +L+GA +    F  L +L  L L 
Sbjct: 79  SSLIILKLDY-NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137

Query: 276 DNILSGEIPSSV--EALKLTDIDLSMNNLTGSIPEEFGKLKNLQL--LGLFSNHLSGEVP 331
           DN +    P+S      +   +DL+ N +     E+    +      L L S  L     
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQD--- 194

Query: 332 ASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFN---LSSLMLSD 388
                   E  L      +     ++ T+ L  N F   +    +       + SL+LS+
Sbjct: 195 ------MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248

Query: 389 NTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEL-TS 447
           +   G     T +     +  N  F G           +     S +     +   + + 
Sbjct: 249 SYNMGSSFGHTNFK----DPDNFTFKGL------EASGVKTCDLSKSKIF-ALLKSVFSH 297

Query: 448 LSHLNTLLLDGNKLSGKLPSQI-VSWTSLNNLNLARNELSGEIPKAI-GSLLVMVSLDLS 505
            + L  L L  N+++ K+        T L  LNL++N L   I   +  +L  +  LDLS
Sbjct: 298 FTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLS 355

Query: 506 GNQFSGEIPPEI--GQLKLNTFNLSSNKLYGNIPDE-FNNL 543
            N     +  +   G   L    L +N+L  ++PD  F+ L
Sbjct: 356 YNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRL 394

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 98.7 bits (246), Expect = 1e-21
 Identities = 67/302 (22%), Positives = 119/302 (39%), Gaps = 50/302 (16%)

Query: 95  DLKNLTTIDLSSNSIPGEFPE-FLYNCTKLQNLDLSQN----------YFVGPIPSDIDR 143
            L +L  + L  N+I    P  F  N  +   LDL+ N                   + R
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186

Query: 144 ISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDL---SNLEVLGL 200
           +S +   D+       +   +  + + + TL L  N F  +  K   D    + ++ L L
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246

Query: 201 AYNSNFKPAMIPIEFGMLKK----------LKTLWMTEANLIGEIPEAM-SNLSSLEILA 249
           + + N   +     F               +KT  +++ + I  + +++ S+ + LE L 
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSK-SKIFALLKSVFSHFTDLEQLT 305

Query: 250 LNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSV-EAL-KLTDIDLSMNNLTGSI 306
           L  N +   I    F  L +L +L L  N L   I S + E L KL  +DLS N++  ++
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-AL 362

Query: 307 PEE-FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSN 365
            ++ F  L NL+ L L +N L      S+    F+   S            L+ + L++N
Sbjct: 363 GDQSFLGLPNLKELALDTNQLK-----SVPDGIFDRLTS------------LQKIWLHTN 405

Query: 366 RF 367
            +
Sbjct: 406 PW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 93.7 bits (233), Expect = 4e-20
 Identities = 77/479 (16%), Positives = 130/479 (27%), Gaps = 126/479 (26%)

Query: 74  SVTGISLRHKDITQKIPP-IICDLKNLTTIDLSSNSIPGEFPE-FLYNCTKLQNLDLSQN 131
            V  + L    I  ++       L++L  + +   +             + L  L L  N
Sbjct: 31  HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF------NGTF 185
                      +   L+               +   L+ L+ L L              F
Sbjct: 90  -----------QFLQLE-------------TGAFNGLANLEVLTLTQCNLDGAVLSGNFF 125

Query: 186 PKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAM-SNLSS 244
                 L++LE+L L  N                 +K +           P +   N+  
Sbjct: 126 KP----LTSLEMLVLRDN----------------NIKKI----------QPASFFLNMRR 155

Query: 245 LEILALNGNHLEGAIPSGLFL---LNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNN 301
             +L L  N ++ +I     L     + T L L    L                D++   
Sbjct: 156 FHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQ---------------DMNEYW 199

Query: 302 LTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLG-NCRTLRTV 360
           L         K  ++  L L  N              F + ++G   +SL  +       
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFK-----ESMAKRFFDAIAGTKIQSLILSNSYNMGS 254

Query: 361 QLYSNRFSGELPTGLW--TTFNLSSLMLSDNTISGELPSKTAWNLTRLEI---SNNRFSG 415
                 F               + +  LS + I   L      + T LE    + N  + 
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN- 312

Query: 416 QIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSW-TS 474
           +I                   F G        L+HL  L L  N L   + S++      
Sbjct: 313 KIDDNA---------------FWG--------LTHLLKLNLSQNFLG-SIDSRMFENLDK 348

Query: 475 LNNLNLARNELSGEIPKAIGSLLVMV-SLDLSGNQFSGEIPPEI--GQLKLNTFNLSSN 530
           L  L+L+ N +   +       L  +  L L  NQ    +P  I      L    L +N
Sbjct: 349 LEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 49.0 bits (117), Expect = 6e-06
 Identities = 27/100 (27%), Positives = 45/100 (45%), Gaps = 7/100 (7%)

Query: 87  QKIPPIICD-LKNLTTIDLSSNSIPGEFPEFL-YNCTKLQNLDLSQNYFVGPIPSDI-DR 143
            KI       L +L  ++LS N + G     +  N  KL+ LDLS N+    +       
Sbjct: 312 NKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLG 369

Query: 144 ISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEFN 182
           +  L+ + L  N     +P  I  RL+ LQ ++L+ N ++
Sbjct: 370 LPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  113 bits (286), Expect = 8e-28
 Identities = 66/318 (20%), Positives = 120/318 (37%), Gaps = 51/318 (16%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           + L+    +G+G  G+V       +  +     VAVK +      +    +  ++E+++L
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVL 80

Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLV-----SGSSSVHQH 744
             +  H NIV L    +     L++ EY     L  +L  ++ S +            + 
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 745 VLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
            L     L  +   A+G+ ++    +   IHRD+ + NILL      KI DFGLA+ +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 805 QGEPHTMSAVAGSFGYF-----APE----YAYTTKVNEKIDIYSFGVVLLELVT-GKEAN 854
                    V            APE      YT +     D++S+G+ L EL + G    
Sbjct: 198 DSN-----YVVKGNARLPVKWMAPESIFNCVYTFES----DVWSYGIFLWELFSLGSSPY 248

Query: 855 YG-DEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS 913
            G    +   +     +    P          E    E    +Y +   C    P  RP+
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSP----------EHAPAE----MYDIMKTCWDADPLKRPT 294

Query: 914 MKEVLQILRRCC-PTENY 930
            K+++Q++ +    + N+
Sbjct: 295 FKQIVQLIEKQISESTNH 312

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  115 bits (291), Expect = 9e-28
 Identities = 70/256 (27%), Positives = 113/256 (44%), Gaps = 43/256 (16%)

Query: 609 RRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKR 668
           +     DP    +      G T      + T   +IG+G  G V++  +  + E VA+K+
Sbjct: 14  KLNPLDDPNKV-IKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKK 71

Query: 669 IWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKLWCCISSENSKL------LVYEYMENQ 721
           +          +K F   E++I+  ++H N+V L     S   K       LV EY+  +
Sbjct: 72  V--------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-E 122

Query: 722 SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSS 781
           ++ R      +   +    + +  ++     Q+     + L Y+H   +  I HRD+K  
Sbjct: 123 TVYRASRHYAKLKQTMPMLLIKLYMY-----QLL----RSLAYIH---SIGICHRDIKPQ 170

Query: 782 NILLDSE-FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPE-----YAYTTKVNEKI 835
           N+LLD      K+ DFG AK+L   GEP+  S +  S  Y APE       YTT     I
Sbjct: 171 NLLLDPPSGVLKLIDFGSAKILIA-GEPNV-SYIC-SRYYRAPELIFGATNYTT----NI 223

Query: 836 DIYSFGVVLLELVTGK 851
           DI+S G V+ EL+ G+
Sbjct: 224 DIWSTGCVMAELMQGQ 239

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  113 bits (286), Expect = 1e-27
 Identities = 63/298 (21%), Positives = 120/298 (40%), Gaps = 45/298 (15%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF-VAVKRIWNNRKLNQKLEKEFIAEIEILG 691
           +   +  ++GSG  G VY+   I      +  VA+K +      + K  KE + E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 72

Query: 692 TIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
           ++ + ++ +L     +  +  L+ + M    L  ++   K ++ S               
Sbjct: 73  SVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGS------------QYL 119

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
           L   +  A+G+ Y+       ++HRD+ + N+L+ +    KI DFGLAK+L    E    
Sbjct: 120 LNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL-GAEEKEYH 175

Query: 812 SAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
           +      G       A E         + D++S+GV + EL+T     +G +      + 
Sbjct: 176 A----EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT-----FGSK-----PYD 221

Query: 867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
               +E   I+  L+KG   P        VY + + C      SRP  +E++    + 
Sbjct: 222 GIPASE---ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  112 bits (283), Expect = 1e-27
 Identities = 63/311 (20%), Positives = 112/311 (36%), Gaps = 65/311 (20%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
             +  + ++G G  G+VY     +  G    VAVK     +      +++F++E  I+  
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKN 69

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
           + H +IVKL   I  E    ++ E      L  +L   K SL               T +
Sbjct: 70  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKV------------LTLV 116

Query: 753 QIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
             ++   + + Y+   +      +HRD+   NIL+ S    K+ DFGL++ +  +     
Sbjct: 117 LYSLQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----- 166

Query: 811 MSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
                 S         +PE     +     D++ F V + E+++     +G         
Sbjct: 167 -DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS-----FG--------- 211

Query: 866 AWRHYAEEKP--------ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEV 917
                  ++P        +   L+KG   P        +Y L   C    PS RP   E+
Sbjct: 212 -------KQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTEL 264

Query: 918 LQILRRCCPTE 928
           +  L      E
Sbjct: 265 VCSLSDVYQME 275

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  112 bits (283), Expect = 1e-27
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 30/217 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI-LGTIRHANIVKLW 702
           +G G  G V ++    +G+ +AVKRI     +N + +K  + +++I + T+     V  +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             +  E    +  E M + SLD++     + ++    ++ + +L      +IA+   + L
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILG-----KIAVSIVKAL 122

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            ++H      +IHRDVK SN+L+++  + K+ DFG++  L            AG   Y A
Sbjct: 123 EHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI---DAGCKPYMA 177

Query: 823 PE--------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE          Y+ K     DI+S G+ ++EL   +
Sbjct: 178 PERINPELNQKGYSVKS----DIWSLGITMIELAILR 210

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (285), Expect = 2e-27
 Identities = 63/306 (20%), Positives = 115/306 (37%), Gaps = 42/306 (13%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             +T S  +G G  G VY      +        VA+K +  N   + +   EF+ E  ++
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVM 82

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
                 ++V+L   +S     L++ E M    L  +L  R       ++ V         
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPAMANNPVLA-PPSLSK 139

Query: 751 RLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
            +Q+A   A G+ Y+  +       +HRD+ + N ++  +F  KI DFG+ + + +    
Sbjct: 140 MIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY- 193

Query: 809 HTMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSL 862
                  G  G       +PE           D++SFGVVL E+ T  ++   G  +  +
Sbjct: 194 ----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249

Query: 863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
             +       +KP          + C       ++ L  +C    P  RPS  E++  ++
Sbjct: 250 LRFVMEGGLLDKP----------DNCPDM----LFELMRMCWQYNPKMRPSFLEIISSIK 295

Query: 923 RCCPTE 928
                 
Sbjct: 296 EEMEPG 301

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  113 bits (285), Expect = 2e-27
 Identities = 74/309 (23%), Positives = 127/309 (41%), Gaps = 49/309 (15%)

Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIE 688
             LT    +G G  GQV       ID +   E   VAVK +       +K   + ++E+E
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEME 92

Query: 689 ILGTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK---RSLVSGSSSVHQH 744
           ++  I +H NI+ L    + +    ++ EY    +L  +L  R+          + V + 
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 745 VLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
            + +   +      A+G+ Y+    + + IHRD+ + N+L+      KIADFGLA+ +  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 805 QGEPHTMSAVAGSFGYF-----APE----YAYTTKVNEKIDIYSFGVVLLELVT-GKEAN 854
                       + G       APE      YT +     D++SFGV++ E+ T G    
Sbjct: 210 IDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQS----DVWSFGVLMWEIFTLGGSPY 260

Query: 855 YGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM 914
            G     L +     +  +KP            C  E    +Y +   C   +PS RP+ 
Sbjct: 261 PGIPVEELFKLLKEGHRMDKP----------ANCTNE----LYMMMRDCWHAVPSQRPTF 306

Query: 915 KEVLQILRR 923
           K++++ L R
Sbjct: 307 KQLVEDLDR 315

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  117 bits (294), Expect = 2e-27
 Identities = 103/518 (19%), Positives = 202/518 (38%), Gaps = 63/518 (12%)

Query: 64  DWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSN---SIPGEFPEFLYNC 120
           D   I  +F+ V  ++L    +T          +  + +D S+     +P + P      
Sbjct: 4   DRKPIVGSFHFVCALALIVGSMTP------FSNELESMVDYSNRNLTHVPKDLP------ 51

Query: 121 TKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMN 179
            + + L LSQN        DI  +S L+ + L  N     +   +     +L+ L +  N
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110

Query: 180 EFNGTFPKEI--GDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE 237
                  + I    +++L  L L++N +F    +  EFG L KL  L ++ A    ++  
Sbjct: 111 RL-----QNISCCPMASLRHLDLSFN-DFDVLPVCKEFGNLTKLTFLGLS-AAKFRQLDL 163

Query: 238 AMSNLSSLEILALN--GNHLEGAIPSGLFLLN-NLTQLFLYDNILSGEIP----SSVEAL 290
                  L  + L+    H++G     L + N  +  L  + N L         +++  L
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHL 223

Query: 291 KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAF----------- 339
           +L++I L+  N    +       +   LL +   H+      S+ +  F           
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283

Query: 340 -ENNLSGAVPK-----SLGNCRTLRTVQLYSNRFSGELPTGLWTTF-NLSSLMLSDNTIS 392
               ++  + +     S    ++L    + +  F       L++ F  ++  MLS +   
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDTP 342

Query: 393 G--ELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFS--GEIPVELTSL 448
               +   +  + T L  + N F+  + +G  + K L       N      ++ +   ++
Sbjct: 343 FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNM 402

Query: 449 SHLNTLLLDGNKLSGKLPSQIVSW-TSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGN 507
           S L TL +  N L+     +  +W  S+  LNL+ N L+G + + +   +    LDL  N
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVK--VLDLHNN 460

Query: 508 QFSGEIPPEIGQL-KLNTFNLSSNKLYGNIPDE-FNNL 543
           +    IP ++  L  L   N++SN+L  ++PD  F+ L
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQL-KSVPDGVFDRL 496

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 96.1 bits (239), Expect = 1e-20
 Identities = 84/472 (17%), Positives = 158/472 (33%), Gaps = 51/472 (10%)

Query: 74  SVTGISLRHKDITQKIPPIICD-LKNLTTIDLSSNSI----PGEFPEFLYNCTKLQNLDL 128
               +SL    I+ ++       L  L  + LS N I       F         L+ LD+
Sbjct: 53  RTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVF----LFNQDLEYLDV 107

Query: 129 SQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRS--IGRLSELQTLYLYMNEFNGTFP 186
           S N     I      ++ L+ +DL  N+F   +P     G L++L  L L   +F     
Sbjct: 108 SHNRLQN-ISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDL 163

Query: 187 KEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLE 246
             +  L +L  + L   S            +        +   N +  +   MS +++L 
Sbjct: 164 LPVAHL-HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS-VNALG 221

Query: 247 ILALNGNHLEGA-------IPSGLFLLNNLTQLFLYDNILSG----EIPSSVEALKLTDI 295
            L L+   L            S L     L  + L     +     ++        +  +
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281

Query: 296 DLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFEN-------NLSGAVP 348
           ++    +T  I  E        L  L   H+  +V        +          LS +  
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341

Query: 349 KSL-----GNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTI-SGELPSKTAWN 402
             +      +  +   +    N F+  +  G  T   L +L+L  N + +    +    N
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKN 401

Query: 403 LTRLEISNNRF----SGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDG 458
           ++ LE  +       S    R     ++++V   S+N+ +G +   L     +  L L  
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHN 459

Query: 459 NKLSGKLPSQIVSWTSLNNLNLARNELSGEIPK-AIGSLLVMVSLDLSGNQF 509
           N++   +P  +    +L  LN+A N+L   +P      L  +  + L  N +
Sbjct: 460 NRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 83.0 bits (205), Expect = 2e-16
 Identities = 49/331 (14%), Positives = 108/331 (32%), Gaps = 38/331 (11%)

Query: 52  SLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPG 111
                +  S   +          ++ I L  ++  + +  +    +  T ++++   I  
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261

Query: 112 EFPEF-----LYNCTKLQNLDLSQNYFVGPIPSDIDRISG-----LQCIDLGGNNFSGDI 161
            +         +    ++ L++        I  +    S      L    +    F    
Sbjct: 262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSK 321

Query: 162 PRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKL 221
                  +E+    L +++            S+   L    N       +      LK+L
Sbjct: 322 EALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF--TDSVFQGCSTLKRL 379

Query: 222 KTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLF-----LLNNLTQLFLYD 276
           +TL + + N +    +      ++  L      L  ++ S  +        ++  L L  
Sbjct: 380 QTLIL-QRNGLKNFFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSS 437

Query: 277 NILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGV 336
           N+L+G +   +   K+  +DL  N +  SIP++   L+ LQ L + SN L   VP     
Sbjct: 438 NMLTGSVFRCL-PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDG--- 491

Query: 337 VAFENNLSGAVPKSLGNCRTLRTVQLYSNRF 367
             F+               +L+ + L+ N +
Sbjct: 492 -VFD------------RLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 46.4 bits (110), Expect = 4e-05
 Identities = 39/174 (22%), Positives = 62/174 (35%), Gaps = 9/174 (5%)

Query: 433 SNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQI-VSWTSLNNLNLARNELSGEIPK 491
           S N  S     +++ LS L  L L  N++   L   + +    L  L+++ N L   I  
Sbjct: 60  SQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS- 116

Query: 492 AIGSLLVMVSLDLSGNQFSGEIPP--EIGQL-KLNTFNLSSNKLYGNIPDEFNNLAYDDS 548
               +  +  LDLS N F   +P   E G L KL    LS+ K          +L     
Sbjct: 117 -CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCI 174

Query: 549 FLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWF 602
            L+  +  +K       + P+            L  + V   +  L  + LS  
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  112 bits (283), Expect = 3e-27
 Identities = 59/301 (19%), Positives = 107/301 (35%), Gaps = 42/301 (13%)

Query: 137 IPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLE 196
           +P +I        +DL  N+ S         L  L  L L  N+ +    K    L  L+
Sbjct: 48  VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105

Query: 197 VLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHL 255
            L ++ N      ++ I   +   L  L +   N I ++P+   S L ++  + + GN L
Sbjct: 106 KLYISKNH-----LVEIPPNLPSSLVELRI-HDNRIRKVPKGVFSGLRNMNCIEMGGNPL 159

Query: 256 -EGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEE-FGKL 313
                  G F    L  L + +  L+  IP  +    L ++ L  N +  +I  E   + 
Sbjct: 160 ENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPE-TLNELHLDHNKIQ-AIELEDLLRY 216

Query: 314 KNLQLLGLFSNHLSGEVPASIGVVAFEN-------NLSG----AVPKSLGNCRTLRTVQL 362
             L  LGL  N +       I   +          +L       VP  L + + L+ V L
Sbjct: 217 SKLYRLGLGHNQIR-----MIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYL 271

Query: 363 YSNRFSGELPTGLWTTF-------NLSSLMLSDNTIS-GELPSKTAWNLTRLE---ISNN 411
           ++N  + ++    +            + + L +N +   E+   T   +T        N 
Sbjct: 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

Query: 412 R 412
           +
Sbjct: 331 K 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  103 bits (258), Expect = 6e-24
 Identities = 64/324 (19%), Positives = 114/324 (35%), Gaps = 56/324 (17%)

Query: 74  SVTGISLRHKDITQKIPP-IICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNY 132
             T + L++ DI+ ++       L++L  + L +N I     +      KLQ L +S+N+
Sbjct: 55  DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113

Query: 133 FVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF-NGTFPKEIGD 191
            V  IP ++   S L  + +  N            L  +  + +  N   N  F     D
Sbjct: 114 LVE-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 192 LSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILAL 250
              L  L ++     K   IP    + + L  L + + N I  I    +   S L  L L
Sbjct: 171 GLKLNYLRISEA---KLTGIP--KDLPETLNELHL-DHNKIQAIELEDLLRYSKLYRLGL 224

Query: 251 NGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEF 310
             N +   I +G    + L                      L ++ L  N L+  +P   
Sbjct: 225 GHNQIR-MIENGSL--SFLPT--------------------LRELHLDNNKLS-RVPAGL 260

Query: 311 GKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS-G 369
             LK LQ++ L +N+++      +GV  F     G              + L++N     
Sbjct: 261 PDLKLLQVVYLHTNNIT-----KVGVNDFCPVGFGVKRAY------YNGISLFNNPVPYW 309

Query: 370 ELPTGLWTTF----NLSSLMLSDN 389
           E+      TF    +  ++   + 
Sbjct: 310 EVQPA---TFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 93.9 bits (234), Expect = 7e-21
 Identities = 67/324 (20%), Positives = 125/324 (38%), Gaps = 37/324 (11%)

Query: 268 NLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSNHL 326
           +L  +   D  L   +P  +     T +DL  N+++  + ++ F  L++L  L L +N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISP-DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90

Query: 327 SGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLML 386
           S      I   AF           L     L+ + +  N    E+P  L +  +L  L +
Sbjct: 91  S-----KIHEKAFSP---------LRK---LQKLYISKNHLV-EIPPNLPS--SLVELRI 130

Query: 387 SDNTISGELPSKT---AWNLTRLEISNNRF-SGQIQRGVGSWKNLIVFKASNNLFSGEIP 442
            DN I  ++P        N+  +E+  N   +   + G      L   + S    +  IP
Sbjct: 131 HDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIP 188

Query: 443 VELTSLSHLNTLLLDGNKLSGKLPSQI-VSWTSLNNLNLARNELSGEIPKAIGSLLVMVS 501
            +L     LN L LD NK+   +  +  + ++ L  L L  N++      ++  L  +  
Sbjct: 189 KDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245

Query: 502 LDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCV-KN 559
           L L  N+ S  +P  +  LK L    L +N +     ++F  + +       + + +  N
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNN 304

Query: 560 PIINLPKCPSRFRNSDKISSKHLA 583
           P+      P+ FR      +    
Sbjct: 305 PVPYWEVQPATFRCVTDRLAIQFG 328

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  114 bits (287), Expect = 3e-27
 Identities = 38/270 (14%), Positives = 72/270 (26%), Gaps = 36/270 (13%)

Query: 638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA- 696
           L    ++G               GE   V   +   +      K+   E+  L  +R   
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 697 ---------------------NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLV 735
                                   K+      E    ++  +     +   L      L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 736 SGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD 795
           S SS+     L    RLQ+ +   + L  +HH     ++H  ++  +I+LD      +  
Sbjct: 200 SHSST--HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254

Query: 796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTG 850
           F                         A           T +    D ++ G+ +  +   
Sbjct: 255 FEHLVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

Query: 851 KEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
              N  D     +EW    +   K I   +
Sbjct: 314 DLPNTDDAALGGSEW---IFRSCKNIPQPV 340

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  112 bits (283), Expect = 3e-27
 Identities = 65/313 (20%), Positives = 110/313 (35%), Gaps = 62/313 (19%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKL 701
           ++  GG   VY     G+G   A+KR+       ++  +  I E+  +  +  H NIV+ 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91

Query: 702 WCCISSENSK--------LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
               S    +        LL+ E  + Q ++       R             L   T L+
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-----------LSCDTVLK 140

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
           I     + + +MH    P IIHRD+K  N+LL ++   K+ DFG A  ++   +    + 
Sbjct: 141 IFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199

Query: 814 VA----------GSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
                        +  Y  PE    Y+    + EK DI++ G +L  L   +     ++ 
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHPF--EDG 256

Query: 860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTL---PSSRPSMKE 916
             L             I +                +     LI  + L   P  R S+ E
Sbjct: 257 AKLR------------IVNGKYSIPPHDTQYTVFHS-----LI-RAMLQVNPEERLSIAE 298

Query: 917 VLQILRRCCPTEN 929
           V+  L+      N
Sbjct: 299 VVHQLQEIAAARN 311

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  111 bits (280), Expect = 3e-27
 Identities = 66/315 (20%), Positives = 111/315 (35%), Gaps = 71/315 (22%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
             +     IG G  G V++   +        VA+K   N    +  + ++F+ E   +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQ 72

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H +IVKL   + +EN   ++ E      L  +L  RK SL               + +
Sbjct: 73  FDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDL------------ASLI 119

Query: 753 QIAIGAAQGLCYM-HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
             A   +  L Y+         +HRD+ + N+L+ S    K+ DFGL++ +         
Sbjct: 120 LYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------ 169

Query: 812 SAVAGSFGYF-----APEYA----YTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
           +    S G       APE      +T+      D++ FGV + E++      +G      
Sbjct: 170 TYYKASKGKLPIKWMAPESINFRRFTSAS----DVWMFGVCMWEILM-----HG------ 214

Query: 863 AEWAWRHYAEEKP--------ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM 914
                      KP        +   ++ G   P       T+Y L   C +  PS RP  
Sbjct: 215 ----------VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRF 264

Query: 915 KEVLQILRRCCPTEN 929
            E+   L      E 
Sbjct: 265 TELKAQLSTILEEEK 279

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  113 bits (285), Expect = 3e-27
 Identities = 72/325 (22%), Positives = 116/325 (35%), Gaps = 50/325 (15%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEIL 690
            ++T    +G G  G+VY      +        VAVK +      +++ E +F+ E  I+
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALII 128

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
               H NIV+          + ++ E M    L  +L   +      SS      L    
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS------LAMLD 182

Query: 751 RLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSE---FKAKIADFGLAKMLAKQ 805
            L +A   A G  Y+  +H      IHRD+ + N LL        AKI DFG+A+ + + 
Sbjct: 183 LLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237

Query: 806 GEPHTMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEH 859
           G         G           PE         K D +SFGV+L E+ + G        +
Sbjct: 238 GY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292

Query: 860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
             + E+       + P          + C       VYR+   C    P  RP+   +L+
Sbjct: 293 QEVLEFVTSGGRMDPP----------KNCPGP----VYRIMTQCWQHQPEDRPNFAIILE 338

Query: 920 ILRRCCPTENYGGKKMGRDVDSAPL 944
            +  C    +         ++  PL
Sbjct: 339 RIEYCTQDPDV--INTALPIEYGPL 361

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  111 bits (280), Expect = 3e-27
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 20/209 (9%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G G  G VY          +A+K ++ ++   + +E +   EIEI   +RH NI++++
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                     L+ E+     L + L    R     S++  +         ++A      L
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME---------ELA----DAL 127

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
            Y H     ++IHRD+K  N+L+  + + KIADFG +   A      TM    G+  Y  
Sbjct: 128 HYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRTM---CGTLDYLP 180

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           PE       +EK+D++  GV+  E + G 
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  111 bits (281), Expect = 4e-27
 Identities = 68/315 (21%), Positives = 113/315 (35%), Gaps = 59/315 (18%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             L     +G G  GQV       I+       VAVK +           +  ++E++IL
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKIL 84

Query: 691 GTI-RHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRK---RSLVSGSSSVHQHV 745
             I  H N+V L   C       +++ E+ +  +L  +L  ++            +++  
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
           L     +  +   A+G   M    + + IHRD+ + NILL  +   KI DFGLA+ + K 
Sbjct: 145 LTLEHLICYSFQVAKG---MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201

Query: 806 GEPHTMSAVAGSFGYF-----APE----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYG 856
            +      V            APE      YT +     D++SFGV+L E+ +      G
Sbjct: 202 PD-----YVRKGDARLPLKWMAPETIFDRVYTIQS----DVWSFGVLLWEIFS-----LG 247

Query: 857 -------DEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPS 909
                                    P          +    E    +Y+  L C    PS
Sbjct: 248 ASPYPGVKIDEEFCRRLKEGTRMRAP----------DYTTPE----MYQTMLDCWHGEPS 293

Query: 910 SRPSMKEVLQILRRC 924
            RP+  E+++ L   
Sbjct: 294 QRPTFSELVEHLGNL 308

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  116 bits (293), Expect = 4e-27
 Identities = 62/303 (20%), Positives = 107/303 (35%), Gaps = 47/303 (15%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
             +     IG G  G V++   +        VA+K   N    +  + ++F+ E   +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQ 447

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
             H +IVKL   + +EN   ++ E      L  +L  RK SL               + +
Sbjct: 448 FDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDL------------ASLI 494

Query: 753 QIAIGAAQGLCYMH-HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
             A   +  L Y+         +HRD+ + N+L+ S    K+ DFGL++ +         
Sbjct: 495 LYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------ 544

Query: 812 SAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
           +    S G       APE     +     D++ FGV + E++      +           
Sbjct: 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF----------- 593

Query: 867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP 926
                 +  +   ++ G   P       T+Y L   C +  PS RP   E+   L     
Sbjct: 594 QGVKNND--VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651

Query: 927 TEN 929
            E 
Sbjct: 652 EEK 654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (281), Expect = 4e-27
 Identities = 55/239 (23%), Positives = 92/239 (38%), Gaps = 55/239 (23%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVK-- 700
           +G+G  GQVY+      G+  A+K +     +    E+E   EI +L     H NI    
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVM----DVTGDEEEEIKQEINMLKKYSHHRNIATYY 87

Query: 701 ---LWCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
              +       + +L LV E+    S+   +   K + +                  IA 
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL--------------KEEWIAY 133

Query: 757 ---GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ-------- 805
                 +GL ++H     ++IHRD+K  N+LL    + K+ DFG++  L +         
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 190

Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKV-----NEKIDIYSFGVVLLELVTGKEANYGDEH 859
           G P+ M          APE     +      + K D++S G+  +E+  G      D H
Sbjct: 191 GTPYWM----------APEVIACDENPDATYDFKSDLWSLGITAIEMAEG-APPLCDMH 238

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  112 bits (281), Expect = 5e-27
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 33/219 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI-LGTIRHANIVKLW 702
           IG G  G V ++    +G+ +AVKRI     +++K +K+ + ++++ + +     IV+ +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
             +  E    +  E M + S D++    K         + + +L      +I +   + L
Sbjct: 88  GALFREGDCWICMELM-STSFDKFY---KYVYSVLDDVIPEEILG-----KITLATVKAL 138

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA--VAGSFGY 820
            ++  +   +IIHRD+K SNILLD     K+ DFG++  L       +++    AG   Y
Sbjct: 139 NHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-----DSIAKTRDAGCRPY 191

Query: 821 FAPE--------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
            APE          Y  +     D++S G+ L EL TG+
Sbjct: 192 MAPERIDPSASRQGYDVRS----DVWSLGITLYELATGR 226

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  112 bits (281), Expect = 6e-27
 Identities = 57/244 (23%), Positives = 84/244 (34%), Gaps = 40/244 (16%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE---FIAEIEILGTIRHANIVK 700
           IG G  G V     N      A+K + N  K+ Q   K+      E+ ++  + H NI +
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIM-NKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 701 LWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           L+     E    LV E      L D+       S    +  V +  +             
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 760 --------------------------QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-- 791
                                       L Y+H+     I HRD+K  N L  +      
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209

Query: 792 KIADFGLAKML--AKQGEPHTMSAVAGSFGYFAPE--YAYTTKVNEKIDIYSFGVVLLEL 847
           K+ DFGL+K       GE + M+  AG+  + APE           K D +S GV+L  L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269

Query: 848 VTGK 851
           + G 
Sbjct: 270 LMGA 273

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  110 bits (277), Expect = 7e-27
 Identities = 56/317 (17%), Positives = 109/317 (34%), Gaps = 71/317 (22%)

Query: 631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           +S   +   E   IGSG  G V++      G   A+KR           E+  + E+   
Sbjct: 6   KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAH 64

Query: 691 GTI-RHANIVKLWCCISSENSKLLVY-EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
             + +H+++V+ +   + E+  +L+  EY    SL   +    R +     +  + +L  
Sbjct: 65  AVLGQHSHVVRYFSAWA-EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL-- 121

Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD-------------------SEF 789
              LQ+     +GL Y+H      ++H D+K SNI +                    ++ 
Sbjct: 122 ---LQVG----RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171

Query: 790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVL 844
             KI D G    ++    P       G   + A E     Y +  K     DI++  + +
Sbjct: 172 MFKIGDLGHVTRISS---PQVE---EGDSRFLANEVLQENYTHLPKA----DIFALALTV 221

Query: 845 LELVTGKEANYGDEHTSLAEWAWRHYAEEK--PITDALDKGIAEPCYLEEMTTVYRLALI 902
           +     +      +        W    + +   I              +E T + ++   
Sbjct: 222 VCAAGAEPLPRNGDQ-------WHEIRQGRLPRIPQ---------VLSQEFTELLKV--- 262

Query: 903 CTSTLPSSRPSMKEVLQ 919
                P  RPS   +++
Sbjct: 263 MIHPDPERRPSAMALVK 279

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  111 bits (280), Expect = 7e-27
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 41/219 (18%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIRHAN 697
           +G G    VY+         VA+K I        +LE E       I E+ +L  ++HAN
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEI--------RLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV L   I +E S  LV+EY++ + L ++L      +   +    +  L      Q+   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNII---NMHNVKLFLF-----QLL-- 110

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +GL Y H     +++HRD+K  N+L++   + K+ADFGLA+  AK     T      +
Sbjct: 111 --RGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVT 163

Query: 818 FGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTGK 851
             Y  P+       Y+T++    D++  G +  E+ TG+
Sbjct: 164 LWYRPPDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  110 bits (277), Expect = 1e-26
 Identities = 50/317 (15%), Positives = 104/317 (32%), Gaps = 81/317 (25%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF----VAVKRIWNNRKLNQKLEKEFIAEIE 688
             L  +  +G G   ++++    ++   G+     V +K +    K ++   + F     
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAAS 64

Query: 689 ILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           ++  + H ++V  +      +  +LV E+++  SLD +L   K  +              
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI------------ 112

Query: 749 PTRLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFK--------AKIADFGL 798
             +L++A   A  + ++  +      +IH +V + NILL  E           K++D G+
Sbjct: 113 LWKLEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167

Query: 799 AKMLAKQGEPHTMSAVAGSFGYF-----APE-----YAYTTKVNEKIDIYSFGVVLLELV 848
           +  +  +                      PE                D +SFG  L E+ 
Sbjct: 168 SITVLPK-----------DILQERIPWVPPECIENPKNLNLAT----DKWSFGTTLWEIC 212

Query: 849 TGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG--IAEPCYLEEMTTVYRLALICTST 906
           +G +                            +    +  P   E    +  L   C   
Sbjct: 213 SGGDKPLSA--LDSQR-----------KLQFYEDRHQLPAPKAAE----LANLINNCMDY 255

Query: 907 LPSSRPSMKEVLQILRR 923
            P  RPS + +++ L  
Sbjct: 256 EPDHRPSFRAIIRDLNS 272

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  111 bits (280), Expect = 1e-26
 Identities = 44/224 (19%), Positives = 94/224 (41%), Gaps = 29/224 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVK--------------RIWNNRKLNQKLEKEFIAEIEI 689
           +  G   ++   + +   +F A+K              +  N++   +    +F  E++I
Sbjct: 39  LNQGKFNKIILCEKDN--KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
           +  I++   +     I++ +   ++YEYMEN S+ ++         + +  +   V+   
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
            +  +         Y+H++    I HRDVK SNIL+D   + K++DFG ++      +  
Sbjct: 157 IK-SVL----NSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEY-MVDKKIK 208

Query: 810 TMSAVAGSFGYFAPEYAYTTKV--NEKIDIYSFGVVLLELVTGK 851
                 G++ +  PE+          K+DI+S G+ L  +    
Sbjct: 209 GS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  110 bits (278), Expect = 1e-26
 Identities = 60/306 (19%), Positives = 109/306 (35%), Gaps = 49/306 (16%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
              T   ++G G  G V        +G+   VAVK +     +     +EF+ E   +  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKE 81

Query: 693 IRHANIVKLW-CCISSENSK-----LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL 746
             H ++ KL    + S         +++  +M++  L  +L      +     ++    L
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL--LASRIGENPFNLPLQTL 139

Query: 747 HWPTRLQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
                ++  +  A G+ Y+   +      IHRD+ + N +L  +    +ADFGL++ +  
Sbjct: 140 -----VRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189

Query: 805 QGEPHTMSAVAGSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDE 858
                      G          A E           D+++FGV + E++T G+    G E
Sbjct: 190 GDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244

Query: 859 HTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL 918
           +  +  +       ++P            C  E    VY L   C S  P  RPS   + 
Sbjct: 245 NAEIYNYLIGGNRLKQP----------PECMEE----VYDLMYQCWSADPKQRPSFTCLR 290

Query: 919 QILRRC 924
             L   
Sbjct: 291 MELENI 296

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  114 bits (287), Expect = 1e-26
 Identities = 89/480 (18%), Positives = 173/480 (36%), Gaps = 44/480 (9%)

Query: 74  SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYF 133
             T +++    I++     I  L  L  + +S N I            +L+ LDLS N  
Sbjct: 22  KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81

Query: 134 VGPIPSDIDRISGLQCIDLGGNNFSGDIPRS--IGRLSELQTLYLYMNEFNGTFPKEIGD 191
           V  I         L+ +DL  N F   +P     G +S+L+ L L       +    I  
Sbjct: 82  VK-ISC--HPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137

Query: 192 LSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALN 251
           L+  +VL +   +  +      +   L+   T  +       +    + ++S   +  L 
Sbjct: 138 LNISKVLLVLGETYGE----KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193

Query: 252 GNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFG 311
            ++++        +L +    +    +   +    +  L L +I+ + N+    +  +  
Sbjct: 194 LSNIK-------CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL--QLV 244

Query: 312 KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGEL 371
               +    + +  L G                     S  + + L   Q+ S+ F    
Sbjct: 245 WHTTVWYFSISNVKLQG------------QLDFRDFDYSGTSLKALSIHQVVSDVFG-FP 291

Query: 372 PTGLWTTF---NLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLI 428
            + ++  F   N+ +  +S   +   L          L+ SNN  +  +    G    L 
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE 351

Query: 429 VFKASNNLFS--GEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSW-TSLNNLNLARNEL 485
                 N      +I    T +  L  L +  N +S        SW  SL +LN++ N L
Sbjct: 352 TLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411

Query: 486 SGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNKLYGNIPDE-FNNL 543
           +  I + +   + +  LDL  N+    IP ++ +L  L   N++SN+L  ++PD  F+ L
Sbjct: 412 TDTIFRCLPPRIKV--LDLHSNKIK-SIPKQVVKLEALQELNVASNQL-KSVPDGIFDRL 467

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  113 bits (283), Expect = 3e-26
 Identities = 82/459 (17%), Positives = 143/459 (31%), Gaps = 56/459 (12%)

Query: 98  NLTTIDLSSN---SIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG 154
           +   +D S N    +P +         K   L++SQNY      SDI  +S L+ + +  
Sbjct: 1   SEFLVDRSKNGLIHVPKDLS------QKTTILNISQNYISELWTSDILSLSKLRILIISH 54

Query: 155 NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE 214
           N              EL+ L L  N+             NL+ L L++N  F    I  E
Sbjct: 55  NRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFN-AFDALPICKE 110

Query: 215 FGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFL 274
           FG + +LK L ++  +L       +++L+  ++L + G                      
Sbjct: 111 FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGL---------- 160

Query: 275 YDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASI 334
                            L  +  +       +      + NL+L  +             
Sbjct: 161 ----------QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV------LEDN 204

Query: 335 GVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGE 394
               F + L+        +  TL  ++   N F   +   +W T  +    +S+  + G+
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI-RILQLVWHT-TVWYFSISNVKLQGQ 262

Query: 395 LPSKTAW----NLTRLEISNNRFSGQIQRGVGSWKNLIVFK----ASNNLFSGEIPVELT 446
           L  +       +L  L I               ++            +      +    +
Sbjct: 263 LDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC-PS 321

Query: 447 SLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVS---LD 503
            +S    L    N L+  +       T L  L L  N+L  E+ K       M S   LD
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLD 380

Query: 504 LSGNQFSGEIPPEI--GQLKLNTFNLSSNKLYGNIPDEF 540
           +S N  S +           L + N+SSN L   I    
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  102 bits (255), Expect = 9e-23
 Identities = 65/375 (17%), Positives = 121/375 (32%), Gaps = 48/375 (12%)

Query: 20  LLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTS------------SPCDWPE 67
           L       I     ++   +L     +  +P  LQ + + S               D   
Sbjct: 127 LEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186

Query: 68  ITCTFNSVTGIS--LRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEF-----LYNC 120
            T     ++ I   L     +  +  +     N    +L+ N+I   +  F     L   
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246

Query: 121 TKLQNLDLSQNYFVGPIPSDIDRISG-----LQCIDLGGNNFSGDIPRSIGRLSELQTLY 175
           T +    +S     G +       SG     L    +  + F           S +    
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306

Query: 176 LYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANL--IG 233
             ++            +S    L  + N       +    G L +L+TL +    L  + 
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLL--TDTVFENCGHLTELETLILQMNQLKELS 364

Query: 234 EIPEAMSNLSSLEILALNGNHLEGAIPSGLF-LLNNLTQLFLYDNILSGEIPSSVEALKL 292
           +I E  + + SL+ L ++ N +      G      +L  L +  NIL+ +        ++
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT-DTIFRCLPPRI 423

Query: 293 TDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLG 352
             +DL  N +  SIP++  KL+ LQ L + SN L   VP                     
Sbjct: 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDG----------------IFD 465

Query: 353 NCRTLRTVQLYSNRF 367
              +L+ + L++N +
Sbjct: 466 RLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 92.2 bits (229), Expect = 1e-19
 Identities = 58/405 (14%), Positives = 128/405 (31%), Gaps = 57/405 (14%)

Query: 96  LKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRI---SGLQCIDL 152
           +  L  + LS+  +       + +    + L +    +      +  +      L  +  
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173

Query: 153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMI- 211
               F   +  S+  ++ L+   +     +      +  L+ L+      N         
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233

Query: 212 ------PIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLE----GAIPS 261
                  ++      +    ++   L G++     + S   + AL+ + +     G   S
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQS 293

Query: 262 GLFL-LNNLTQLFLYDNIL-SGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLL 319
            ++   +N+       +      +    +      +D S N LT ++ E  G L  L+ L
Sbjct: 294 YIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353

Query: 320 GLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWT-T 378
            L  N L  E+     +      +            +L+ + +  N  S +   G  + T
Sbjct: 354 ILQMNQLK-ELSKIAEMTT---QMK-----------SLQQLDISQNSVSYDEKKGDCSWT 398

Query: 379 FNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFS 438
            +L SL +S N ++  +       +  L++ +N    +I+                    
Sbjct: 399 KSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSN----KIKS------------------- 435

Query: 439 GEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARN 483
             IP ++  L  L  L +  N+L           TSL  + L  N
Sbjct: 436 --IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.9 bits (127), Expect = 4e-07
 Identities = 41/208 (19%), Positives = 74/208 (35%), Gaps = 6/208 (2%)

Query: 433 SNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKA 492
           S N  S     ++ SLS L  L++  N++     S       L  L+L+ N+L  +I   
Sbjct: 29  SQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS-- 85

Query: 493 IGSLLVMVSLDLSGNQF-SGEIPPEIGQL-KLNTFNLSSNKLYGNIPDEFNNLAYDDSFL 550
               + +  LDLS N F +  I  E G + +L    LS+  L  +      +L      L
Sbjct: 86  CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLL 145

Query: 551 N-NSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLR 609
                   K     L    +   +    ++K    IL +++  +      +   V +  +
Sbjct: 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205

Query: 610 RKRNRDPATWKLTSFHQLGFTESNILSS 637
                       T+      T +NI ++
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETT 233

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 51.8 bits (124), Expect = 8e-07
 Identities = 25/112 (22%), Positives = 52/112 (46%), Gaps = 8/112 (7%)

Query: 74  SVTGISLRHKDITQKIPPIICD-LKNLTTIDLSSNSIP-GEFPEFLYNCTKLQNLDLSQN 131
           S+  + +    ++       C   K+L ++++SSN +    F        +++ LDL  N
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP---PRIKVLDLHSN 431

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEFN 182
                IP  + ++  LQ +++  N     +P  I  RL+ LQ ++L+ N ++
Sbjct: 432 KIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  111 bits (280), Expect = 1e-26
 Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 37/236 (15%)

Query: 630 TESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL-NQKLEKEFIAEIE 688
                +       + G G  G V        G  VA+K++  + +  N++L+      ++
Sbjct: 17  RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-----IMQ 71

Query: 689 ILGTIRHANIVKLWCCISSENSK-------LLVYEYMENQSLDRWLHGRKRSLVSGSSSV 741
            L  + H NIV+L     +   +        +V EY+   +L R      R  V+    +
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPIL 130

Query: 742 HQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD-SEFKAKIADFGLAK 800
            +  L      Q+     + +  +H   +  + HRD+K  N+L++ ++   K+ DFG AK
Sbjct: 131 IKVFLF-----QLI----RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180

Query: 801 MLAKQGEPHTMSAVAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
            L+   EP+  + +  S  Y APE       YTT     +DI+S G +  E++ G+
Sbjct: 181 KLSP-SEPNV-AYIC-SRYYRAPELIFGNQHYTT----AVDIWSVGCIFAEMMLGE 229

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  111 bits (279), Expect = 1e-26
 Identities = 77/318 (24%), Positives = 124/318 (38%), Gaps = 58/318 (18%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           +++     IG G  G+V++     +     F  VAVK +    + +  ++ +F  E  ++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALM 104

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
               + NIVKL    +      L++EYM    L+ +L       V   S          +
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164

Query: 751 R-----------LQIAIGAAQGLCYM--HHDCTPQIIHRDVKSSNILLDSEFKAKIADFG 797
                       L IA   A G+ Y+          +HRD+ + N L+      KIADFG
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFG 219

Query: 798 LAKMLAKQGEPHTMSAVAGSFGYF-----APE----YAYTTKVNEKIDIYSFGVVLLELV 848
           L++ +            A            PE      YTT+     D++++GVVL E+ 
Sbjct: 220 LSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTES----DVWAYGVVLWEIF 270

Query: 849 T-GKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTL 907
           + G +  YG  H  +  +         P          E C LE    +Y L  +C S L
Sbjct: 271 SYGLQPYYGMAHEEVIYYVRDGNILACP----------ENCPLE----LYNLMRLCWSKL 316

Query: 908 PSSRPSMKEVLQILRRCC 925
           P+ RPS   + +IL+R C
Sbjct: 317 PADRPSFCSIHRILQRMC 334

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  115 bits (288), Expect = 1e-26
 Identities = 61/288 (21%), Positives = 115/288 (39%), Gaps = 42/288 (14%)

Query: 644 IGSGGSGQVYR--IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +G G  G V +    +      VA+K +    +      +E + E +I+  + +  IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 401

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                +E + +LV E      L ++L G++  +                  ++    + G
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEI------------PVSNVAELLHQVSMG 448

Query: 762 LCY---MHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           + Y    +       +HR++ + N+LL +   AKI+DFGL+K L    + +  +  AG +
Sbjct: 449 MKYLEEKN------FVHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKW 501

Query: 819 GY--FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
               +APE     K + + D++S+GV + E ++  +  Y        E           +
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK--MKGPE-----------V 548

Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
              +++G    C  E    +Y L   C       RP    V Q +R C
Sbjct: 549 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  110 bits (278), Expect = 1e-26
 Identities = 63/312 (20%), Positives = 120/312 (38%), Gaps = 56/312 (17%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           ++L     +G+G  G+V       +        VAVK +      +   ++  ++E++I+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIM 103

Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS-GSSSVHQHVLHW 748
             + +H NIV L    +     L++ EY     L  +L  + R L +  + ++       
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163

Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
              L  +   AQG+ ++    +   IHRDV + N+LL +   AKI DFGLA+ +      
Sbjct: 164 RDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN- 219

Query: 809 HTMSAVAGSFGYF-----APE----YAYTTKVNEKIDIYSFGVVLLELVT-------GKE 852
                +            APE      YT +     D++S+G++L E+ +       G  
Sbjct: 220 ----YIVKGNARLPVKWMAPESIFDCVYTVQS----DVWSYGILLWEIFSLGLNPYPGIL 271

Query: 853 ANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP 912
            N     +   +     Y   +P                    +Y +   C +  P+ RP
Sbjct: 272 VN-----SKFYKLVKDGYQMAQP----------AFAPKN----IYSIMQACWALEPTHRP 312

Query: 913 SMKEVLQILRRC 924
           + +++   L+  
Sbjct: 313 TFQQICSFLQEQ 324

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  109 bits (275), Expect = 2e-26
 Identities = 56/273 (20%), Positives = 91/273 (33%), Gaps = 31/273 (11%)

Query: 150 IDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPA 209
           I       +  +P  I   S    L L  N+           L+ L  L L+ N      
Sbjct: 12  IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68

Query: 210 MIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFL-LNN 268
                      LK L ++  N +  +      L  LE L    ++L+      +FL L N
Sbjct: 69  CCSQSDFGTTSLKYLDLSF-NGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127

Query: 269 LTQLFLYDNILSGEIPSSV-EAL-KLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSNH 325
           L  L +          + +   L  L  + ++ N+   +   + F +L+NL  L L    
Sbjct: 128 LIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186

Query: 326 LSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTG-LWTTFNLSSL 384
           L       +   AF N+LS            L+ + +  N F   L T       +L  L
Sbjct: 187 LE-----QLSPTAF-NSLSS-----------LQVLNMSHNNFF-SLDTFPYKCLNSLQVL 228

Query: 385 MLSDN---TISGELPSKTAWNLTRLEISNNRFS 414
             S N   T   +       +L  L ++ N F+
Sbjct: 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  107 bits (270), Expect = 9e-26
 Identities = 56/272 (20%), Positives = 95/272 (34%), Gaps = 29/272 (10%)

Query: 69  TCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDL 128
           +C+   +       K +T  +P  I    + T ++L SN +           T+L  L L
Sbjct: 6   SCSGTEI---RCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSL 59

Query: 129 SQN--YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF----- 181
           S N   F G         + L+ +DL  N     +  +   L +L+ L    +       
Sbjct: 60  SSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 118

Query: 182 NGTFPKEIGDLSNLEVLGLAYNS-NFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AM 239
              F      L NL  L +++         I   F  L  L+ L M   +          
Sbjct: 119 FSVF----LSLRNLIYLDISHTHTRVAFNGI---FNGLSSLEVLKMAGNSFQENFLPDIF 171

Query: 240 SNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSV--EALKLTDID 296
           + L +L  L L+   LE  +    F  L++L  L +  N     + +        L  +D
Sbjct: 172 TELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLD 229

Query: 297 LSMNNLTGSIPEEFGKL-KNLQLLGLFSNHLS 327
            S+N++  S  +E      +L  L L  N  +
Sbjct: 230 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 87.0 bits (216), Expect = 9e-19
 Identities = 56/275 (20%), Positives = 94/275 (34%), Gaps = 32/275 (11%)

Query: 268 NLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLS 327
           + T++      L+  +P+ + +   T ++L  N L       F KL  L  L L SN LS
Sbjct: 8   SGTEIRCNSKGLT-SVPTGIPS-SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65

Query: 328 GEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLS 387
            +        +              +   L+ + L  N     + +       L  L   
Sbjct: 66  FK---GCCSQSDFG---------TTS---LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 109

Query: 388 DNTISGELPSKTAW----NLTRLEISNNRFSGQIQRGV-GSWKNLIVFKASNNLFSGEIP 442
            + +  ++   + +    NL  L+IS+         G+     +L V K + N F     
Sbjct: 110 HSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL 167

Query: 443 VE-LTSLSHLNTLLLDGNKLSGKLPSQI-VSWTSLNNLNLARNELSGEIPKAIGSLLVMV 500
            +  T L +L  L L   +L  +L      S +SL  LN++ N            L  + 
Sbjct: 168 PDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 226

Query: 501 SLDLSGNQFSGEIPPEIGQ---LKLNTFNLSSNKL 532
            LD S N        +  Q     L   NL+ N  
Sbjct: 227 VLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 37/199 (18%), Positives = 66/199 (33%), Gaps = 38/199 (19%)

Query: 354 CR-TLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEI---S 409
           C  +   ++  S   +  +PTG+ +  + + L L  N +   LP      LT+L     S
Sbjct: 5   CSCSGTEIRCNSKGLT-SVPTGIPS--SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLS 60

Query: 410 NNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQI 469
           +N  S                   +    G         + L  L L  N +   + S  
Sbjct: 61  SNGLS--------------FKGCCSQSDFG--------TTSLKYLDLSFNGVI-TMSSNF 97

Query: 470 VSWTSLNNLNLARNELSGEIPK--AIGSLLVMVSLDLSGNQFSGEIPPEI--GQLKLNTF 525
           +    L +L+   + L  ++ +     SL  ++ LD+S           I  G   L   
Sbjct: 98  LGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVL 155

Query: 526 NLSSNKLYGNIPDE-FNNL 543
            ++ N    N   + F  L
Sbjct: 156 KMAGNSFQENFLPDIFTEL 174

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  111 bits (278), Expect = 2e-26
 Identities = 33/308 (10%), Positives = 74/308 (24%), Gaps = 55/308 (17%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +  G    V+ +      E  A+K      + ++   +           +   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 703 CCI--------------------------SSENSKLLVYEYMENQSLDRWLHGRKRSLVS 736
                                         +  + LL+        L+          V 
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187

Query: 737 GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF 796
                            +     +    +       ++H      N+ +  + +  + D 
Sbjct: 188 RGDEGILA------LHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDV 238

Query: 797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEY--AYTTKVNEKIDIYSFGVVLLELVTGKEAN 854
                  K G      A +    Y   E+  A T      ++ +  G+ +  +       
Sbjct: 239 SALW---KVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293

Query: 855 YGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTL---PSSR 911
                T   + +W+  +   P TD+L  G   P      T + R        L      R
Sbjct: 294 --GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF-------LNFDRRRR 344

Query: 912 PSMKEVLQ 919
               E ++
Sbjct: 345 LLPLEAME 352

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  109 bits (274), Expect = 2e-26
 Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 43/220 (19%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEF-------IAEIEILGTIRHA 696
           IG G  G VY+   N  GE  A+K+I        +LEKE        I EI IL  ++H+
Sbjct: 10  IGEGTYGVVYK-AQNNYGETFALKKI--------RLEKEDEGIPSTTIREISILKELKHS 60

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           NIVKL+  I ++   +LV+E+++ Q L + L   +  L    S   +  L      Q+  
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGL---ESVTAKSFLL-----QLL- 110

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
               G+ Y H     +++HRD+K  N+L++ E + KIADFGLA+  A        +    
Sbjct: 111 ---NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEIV 162

Query: 817 SFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +  Y AP+       Y+T +    DI+S G +  E+V G 
Sbjct: 163 TLWYRAPDVLMGSKKYSTTI----DIWSVGCIFAEMVNGT 198

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  113 bits (284), Expect = 3e-26
 Identities = 63/423 (14%), Positives = 137/423 (32%), Gaps = 49/423 (11%)

Query: 91  PIICDLKNLTTI--DLSSNSIPGEFPEFLYNCTKLQNLDLSQNYF--VGPIPSDIDRISG 146
            I+  + N  ++  +   N+I G + ++     K +   L          +  +   I+ 
Sbjct: 2   SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LINQ 60

Query: 147 LQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNF 206
              + L   N S  +P ++    ++  L +  N    + P+    L  L+      ++  
Sbjct: 61  FSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASLEYLDACDNRLST-- 114

Query: 207 KPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLL 266
               +P     LK L      + N +  +PE  + L   E +  + N L   +P    L 
Sbjct: 115 ----LPELPASLKHLDV----DNNQLTMLPELPALL---EYINADNNQLT-MLPE---LP 159

Query: 267 NNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL 326
            +L  L + +N L+  +P   E   L  +D+S N L  S+P    +  + +   +F    
Sbjct: 160 TSLEVLSVRNNQLT-FLPELPE--SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFR-C 214

Query: 327 SGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLML 386
                        EN ++  +P+++ +     T+ L  N  S  +   L           
Sbjct: 215 R------------ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHG 261

Query: 387 SDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELT 446
                S     +   +    +     F    Q  V    +    +   N FS      L+
Sbjct: 262 PRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLS 320

Query: 447 SLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSG 506
                        +++  L  ++ +   L         ++ +  ++    + +   +L  
Sbjct: 321 DTVSARNTSGFREQVAAWLE-KLSASAELRQQ---SFAVAADATESCEDRVALTWNNLRK 376

Query: 507 NQF 509
              
Sbjct: 377 TLL 379

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  112 bits (282), Expect = 7e-26
 Identities = 56/330 (16%), Positives = 103/330 (31%), Gaps = 69/330 (20%)

Query: 230 NLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEA 289
               +   A        +   N N     +   L  +N  ++L L    LS  +P ++  
Sbjct: 24  GTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNL-P 79

Query: 290 LKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPK 349
            ++T ++++ N L  S+PE    L+ L       N LS                   +P+
Sbjct: 80  PQITVLEITQNALI-SLPELPASLEYLDACD---NRLS------------------TLPE 117

Query: 350 SLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEIS 409
              + + L    + +N+ +  LP        L  +   +N ++  LP     +L  L + 
Sbjct: 118 LPASLKHLD---VDNNQLT-MLPELP---ALLEYINADNNQLT-MLPELPT-SLEVLSVR 168

Query: 410 NNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQI 469
           NN+ +                          +P    SL  L+   +  N L   LP+  
Sbjct: 169 NNQLT-------------------------FLPELPESLEALD---VSTNLLES-LPAVP 199

Query: 470 VSWTSLNN----LNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTF 525
           V                N ++  IP+ I SL    ++ L  N  S  I   + Q      
Sbjct: 200 VRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPD 258

Query: 526 NLSSNKLYGNIPDEFNNLAYDDSFLNNSNL 555
                  +     + N L    +    +  
Sbjct: 259 YHGPRIYFSMSDGQQNTLHRPLADAVTAWF 288

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 85.4 bits (211), Expect = 3e-17
 Identities = 41/264 (15%), Positives = 82/264 (31%), Gaps = 40/264 (15%)

Query: 70  CTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLS 129
           C  N  + + L   +++  +P  +     +T ++++ N++    PE       L+ LD  
Sbjct: 56  CLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNAL-ISLPELP---ASLEYLDAC 108

Query: 130 QNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRL-----------------SELQ 172
            N     +P   +  + L+ +D+  N  +  +P     L                 + L+
Sbjct: 109 DNRLST-LP---ELPASLKHLDVDNNQLT-MLPELPALLEYINADNNQLTMLPELPTSLE 163

Query: 173 TLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMT---EA 229
            L +  N+     P+      +LE L ++ N       +P         +   +      
Sbjct: 164 VLSVRNNQLT-FLPELPE---SLEALDVSTN---LLESLPAVPVRNHHSEETEIFFRCRE 216

Query: 230 NLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEA 289
           N I  IPE + +L     + L  N L   I   L                S         
Sbjct: 217 NRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMS-DGQQNT 275

Query: 290 LKLTDIDLSMNNLTGSIPEEFGKL 313
           L     D        +   +  ++
Sbjct: 276 LHRPLADAVTAWFPENKQSDVSQI 299

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  109 bits (274), Expect = 3e-26
 Identities = 70/221 (31%), Positives = 105/221 (47%), Gaps = 45/221 (20%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEF-------IAEIEILGTIRH 695
           +G G  G VY+  D  G    VA+KRI        +L+ E        I EI +L  + H
Sbjct: 29  VGEGTYGVVYKAKDSQG--RIVALKRI--------RLDAEDEGIPSTAIREISLLKELHH 78

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            NIV L   I SE    LV+E+ME + L + L   K  L     S  +  L+     Q+ 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGL---QDSQIKIYLY-----QLL 129

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               +G+ + H     +I+HRD+K  N+L++S+   K+ADFGLA+  A      + +   
Sbjct: 130 ----RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEV 180

Query: 816 GSFGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTGK 851
            +  Y AP+       Y+T V    DI+S G +  E++TGK
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  109 bits (274), Expect = 6e-26
 Identities = 64/326 (19%), Positives = 111/326 (34%), Gaps = 65/326 (19%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEIL 690
            +L    ++GSG  G+V       I+  G    VAVK +    K +    +  ++E++++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKMM 102

Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQ------ 743
             +  H NIV L    +      L++EY     L  +L  ++                  
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 744 ----HVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
               +VL +   L  A   A+G   M        +HRD+ + N+L+      KI DFGLA
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKG---MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219

Query: 800 KMLAKQGEPHTMSAVAGSFGYF-----APE----YAYTTKVNEKIDIYSFGVVLLELVTG 850
           + +           V            APE      YT K     D++S+G++L E+ + 
Sbjct: 220 RDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKS----DVWSYGILLWEIFS- 269

Query: 851 KEANYG-------DEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALIC 903
                G           +  +     +  ++P               E    +Y +   C
Sbjct: 270 ----LGVNPYPGIPVDANFYKLIQNGFKMDQP----------FYATEE----IYIIMQSC 311

Query: 904 TSTLPSSRPSMKEVLQILRRCCPTEN 929
            +     RPS   +   L        
Sbjct: 312 WAFDSRKRPSFPNLTSFLGCQLADAE 337

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  108 bits (271), Expect = 9e-26
 Identities = 74/314 (23%), Positives = 127/314 (40%), Gaps = 54/314 (17%)

Query: 636 SSLTESNLIGSGGSGQVYR---IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIEIL 690
            +L     +G G  G+V +     + G   +  VAVK +      +    ++ ++E  +L
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVL 80

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
             + H +++KL+   S +   LL+ EY +  SL  +L   ++       S          
Sbjct: 81  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 751 R-----------LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
                       +  A   +QG   M +    +++HRD+ + NIL+    K KI+DFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQG---MQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 800 KMLAKQGEPHTMSAVAGSFGYF-----APE----YAYTTKVNEKIDIYSFGVVLLELVT- 849
           + + ++        V  S G       A E    + YTT+     D++SFGV+L E+VT 
Sbjct: 198 RDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQS----DVWSFGVLLWEIVTL 248

Query: 850 GKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPS 909
           G     G     L       +  E+P          + C  E    +YRL L C    P 
Sbjct: 249 GGNPYPGIPPERLFNLLKTGHRMERP----------DNCSEE----MYRLMLQCWKQEPD 294

Query: 910 SRPSMKEVLQILRR 923
            RP   ++ + L +
Sbjct: 295 KRPVFADISKDLEK 308

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  109 bits (273), Expect = 9e-26
 Identities = 39/236 (16%), Positives = 76/236 (32%), Gaps = 36/236 (15%)

Query: 642 NLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEF---IAEIEILGTI 693
           +L+G G   QVY      ++     +   +K              EF      +E L   
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLK------VQKPANPWEFYIGTQLMERLKPS 124

Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
                +K +     +N  +LV E     +L   ++  K +         + V+     + 
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT--------PEKVMPQGLVIS 176

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL-----------DSEFKAKIADFGLAKML 802
            A+     +  +H     +IIH D+K  N +L           D      + D G +  +
Sbjct: 177 FAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 803 AKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
               +    +A   + G+   E       N +ID +     +  ++ G      +E
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  107 bits (269), Expect = 1e-25
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 44/223 (19%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEF-------IAEIEILGTIRH 695
           IG G  G V++  +     E VA+KR+        +L+ +        + EI +L  ++H
Sbjct: 10  IGEGTYGTVFKAKNRET-HEIVALKRV--------RLDDDDEGVPSSALREICLLKELKH 60

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
            NIV+L   + S+    LV+E+ + Q L ++       L      + +  L      Q+ 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDL---DPEIVKSFLF-----QLL 111

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               +GL + H      ++HRD+K  N+L++   + K+A+FGLA+  A        SA  
Sbjct: 112 ----KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR--AFGIPVRCYSAEV 162

Query: 816 GSFGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTGKEA 853
            +  Y  P+       Y+T +    D++S G +  EL      
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSI----DMWSAGCIFAELANAGRP 201

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (269), Expect = 1e-25
 Identities = 55/241 (22%), Positives = 102/241 (42%), Gaps = 31/241 (12%)

Query: 620 KLTSFHQLGFTESNI-LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK 678
           K T +  +G       ++ L     +GSG  GQV+++     G  +AVK++   R  N++
Sbjct: 8   KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKE 65

Query: 679 LEKEFIAEIEIL-GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSG 737
             K  + +++++  +     IV+ +    +     +  E M   +       +       
Sbjct: 66  ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP----- 120

Query: 738 SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG 797
              + + +L      ++ +   + L Y+       +IHRDVK SNILLD   + K+ DFG
Sbjct: 121 ---IPERILG-----KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFG 170

Query: 798 LAKMLAKQGEPHTMSA--VAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTG 850
           ++  L         +    AG   Y APE            + + D++S G+ L+EL TG
Sbjct: 171 ISGRLVD-----DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

Query: 851 K 851
           +
Sbjct: 226 Q 226

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  107 bits (269), Expect = 2e-25
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 36/219 (16%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIRHAN 697
           +G+G    VY+      G +VA+K +        KL+ E       I EI ++  ++H N
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV--------KLDSEEGTPSTAIREISLMKELKHEN 64

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV+L+  I +EN   LV+E+M+   L +++  R          ++  V ++  +L     
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELN-LVKYFQWQLL---- 118

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             QGL + H +   +I+HRD+K  N+L++   + K+ DFGLA+  A     +T S+   +
Sbjct: 119 --QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR--AFGIPVNTFSSEVVT 171

Query: 818 FGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTGK 851
             Y AP+       Y+T +    DI+S G +L E++TGK
Sbjct: 172 LWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  108 bits (271), Expect = 2e-25
 Identities = 75/311 (24%), Positives = 125/311 (40%), Gaps = 49/311 (15%)

Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEF--VAVKRIWNNRKLNQKLEKEFIAEIE 688
             L     +G G  GQV       +D +       VAVK +       +K   + I+E+E
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEME 126

Query: 689 ILGTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK---RSLVSGSSSVHQH 744
           ++  I +H NI+ L    + +    ++ EY    +L  +L  R+          S   + 
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 745 VLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
            L     +  A   A+G+ Y+    + + IHRD+ + N+L+  +   KIADFGLA+ +  
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243

Query: 805 QGEPHTMSAVAGSFGYF-----APE----YAYTTKVNEKIDIYSFGVVLLELVT-GKEAN 854
                       + G       APE      YT +     D++SFGV+L E+ T G    
Sbjct: 244 IDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQS----DVWSFGVLLWEIFTLGGSPY 294

Query: 855 YGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM 914
            G     L +     +  +KP            C  E    +Y +   C   +PS RP+ 
Sbjct: 295 PGVPVEELFKLLKEGHRMDKP----------SNCTNE----LYMMMRDCWHAVPSQRPTF 340

Query: 915 KEVLQILRRCC 925
           K++++ L R  
Sbjct: 341 KQLVEDLDRIV 351

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  106 bits (267), Expect = 5e-25
 Identities = 58/330 (17%), Positives = 115/330 (34%), Gaps = 49/330 (14%)

Query: 53  LQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGE 112
            +  +S  +               G S     I   +         + ++DLS+N I   
Sbjct: 18  SKEESSNQASLSCD----RNGICKGSSGSLNSIPSGLTE------AVKSLDLSNNRITYI 67

Query: 113 FPEFLYNCTKLQNLDLSQNYFVGPIPSDI-DRISGLQCIDLGGNNFSGDIPRSI-GRLSE 170
               L  C  LQ L L+ N  +  I  D    +  L+ +DL  N  S ++  S    LS 
Sbjct: 68  SNSDLQRCVNLQALVLTSNG-INTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSS 125

Query: 171 LQTLYLYMNEFNGTFPKEI-GDLSNLEVLGLAYNSNFKPAMIPIE-FGMLKKLKTLWMTE 228
           L  L L  N +       +   L+ L++L +     F    I  + F  L  L+ L + +
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT--KIQRKDFAGLTFLEELEI-D 182

Query: 229 ANLIGEIP-EAMSNLSSLEILALNGNHLEGAIPSGLF-LLNNLTQLFLYDNILSGEIPSS 286
           A+ +     +++ ++ ++  L L+       +      + +++  L L D  L     S 
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSE 241

Query: 287 VEA---------LKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVV 337
           +               ++ ++  +L   + +   ++  L  L    N L      S+   
Sbjct: 242 LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-----SVPDG 295

Query: 338 AFENNLSGAVPKSLGNCRTLRTVQLYSNRF 367
            F+   S            L+ + L++N +
Sbjct: 296 IFDRLTS------------LQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 92.1 bits (229), Expect = 4e-20
 Identities = 53/297 (17%), Positives = 97/297 (32%), Gaps = 49/297 (16%)

Query: 221 LKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNI 278
           +K+L ++  N I  I    +    +L+ L L  N +   I    F  L +L  L L  N 
Sbjct: 54  VKSLDLSN-NRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111

Query: 279 LSGEIPSSV-EAL-KLTDIDLSMNNLTGSIPEE--FGKLKNLQLLGLFSNHLSGEVPASI 334
           LS  + SS  + L  LT ++L  N    ++ E   F  L  LQ+L + +     ++    
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQ--- 166

Query: 335 GVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTF-NLSSLMLSDNTISG 393
                         K       L  +++ ++            +  N+S L+L       
Sbjct: 167 -------------RKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI- 211

Query: 394 ELPSKTAW---NLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSH 450
            L         ++  LE+ +                       + L +GE    L     
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDT---------------FHFSELSTGETNS-LIKKFT 255

Query: 451 LNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGN 507
              + +    L  ++   +   + L  L  +RN+L          L  +  + L  N
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 79.4 bits (196), Expect = 6e-16
 Identities = 55/302 (18%), Positives = 105/302 (34%), Gaps = 62/302 (20%)

Query: 258 AIPSGLFLLNNLTQLFLYDNILSGEIPSSV--EALKLTDIDLSMNNLTGSIPEE-FGKLK 314
           +IPSGL     +  L L +N ++  I +S     + L  + L+ N +  +I E+ F  L 
Sbjct: 45  SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100

Query: 315 NLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTG 374
           +L+ L L  N+LS     ++    F+          L +   L  + L  N +     T 
Sbjct: 101 SLEHLDLSYNYLS-----NLSSSWFKP---------LSS---LTFLNLLGNPYKTLGETS 143

Query: 375 LWT-TFNLSSLMLSDNTISGELPSKTAWNLTRLE---ISNNRFSGQIQRGVGSWKNLIVF 430
           L++    L  L + +     ++  K    LT LE   I  +      +            
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKS--------- 193

Query: 431 KASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIP 490
                         L S+ +++ L+L   +    L   +   +S+  L L   +L     
Sbjct: 194 --------------LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239

Query: 491 KAIGS--------LLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDE-FN 541
             + +             ++ ++       +        L     S N+L  ++PD  F+
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFD 298

Query: 542 NL 543
            L
Sbjct: 299 RL 300

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  106 bits (267), Expect = 5e-25
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 25/209 (11%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKL---EKEFIAEIEILGTIRHANIVK 700
           IG G    V R      G+  AVK + +  K         ++   E  I   ++H +IV+
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 701 LWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           L    SS+    +V+E+M+   L    +  R  +    S +V  H +      QI     
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFE-IVKRADAGFVYSEAVASHYMR-----QI----L 140

Query: 760 QGLCYMH-HDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVA 815
           + L Y H ++    IIHRDVK   +LL S+  +   K+  FG+A  L + G         
Sbjct: 141 EALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRV 194

Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVL 844
           G+  + APE        + +D++  GV+L
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  107 bits (267), Expect = 6e-25
 Identities = 40/263 (15%), Positives = 75/263 (28%), Gaps = 50/263 (19%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-------- 694
           ++G               GE   V   +   +      K+   E+  L  +R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 695 -----------------HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSG 737
                               ++++             + Y   QS  +       S  S 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 738 SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG 797
             S+  H      RLQ+ +   + L  +HH     ++H  ++  +I+LD      +  F 
Sbjct: 200 HKSLVHHA-----RLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 798 LAKMLAKQGEPHTMSAVAGSFGYFAPEY-----------AYTTKVNEKIDIYSFGVVLLE 846
                 + G     S    S G+  PE               T +    D ++ G+V+  
Sbjct: 252 HLV---RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 847 LVTGKEANYGDEHTSLAEWAWRH 869
           +         D     +EW +R 
Sbjct: 306 IWCADLPITKDAALGGSEWIFRS 328

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  105 bits (265), Expect = 8e-25
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 31/214 (14%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IG G   +V        G  VA+K I +  +LN    ++   E+ I+  + H NIVKL+ 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81

Query: 704 CISSENSKLLVYEYMENQSL-DRWL-HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
            I +E +  L+ EY     + D  + HGR            +         QI       
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRM------KEKEARSKFR-----QI----VSA 126

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           + Y H      I+HRD+K+ N+LLD++   KIADFG +      G+        G+  Y 
Sbjct: 127 VQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAPPYA 180

Query: 822 APEY----AYTTKVNEKIDIYSFGVVLLELVTGK 851
           APE      Y      ++D++S GV+L  LV+G 
Sbjct: 181 APELFQGKKYDGP---EVDVWSLGVILYTLVSGS 211

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (263), Expect = 9e-25
 Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 42/220 (19%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-----FIA--EIEILGTIRHA 696
           IG G  G V++      G+ VA+K+            ++      IA  EI +L  ++H 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKF--------LESEDDPVIKKIALREIRMLKQLKHP 62

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           N+V L      +    LV+EY +  ++   L   +R +      + + +       Q   
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCD-HTVLHELDRYQRGV---PEHLVKSITW-----QTL- 112

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              Q + + H       IHRDVK  NIL+      K+ DFG A++L    + +       
Sbjct: 113 ---QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT- 165

Query: 817 SFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
              Y +PE       Y   V    D+++ G V  EL++G 
Sbjct: 166 -RWYRSPELLVGDTQYGPPV----DVWAIGCVFAELLSGV 200

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  108 bits (271), Expect = 9e-25
 Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 26/236 (11%)

Query: 620 KLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKL 679
           + T    +   + ++         +GSG  G+V            A+K I     ++   
Sbjct: 21  QATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII-RKTSVSTSS 79

Query: 680 EKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGS 738
             + + E+ +L  + H NI+KL+     + +  LV E  +   L D  +  R +     +
Sbjct: 80  NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE-IIHRMKFNEVDA 138

Query: 739 SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS---EFKAKIAD 795
           + + + VL              G+ Y+H      I+HRD+K  N+LL+S   +   KI D
Sbjct: 139 AVIIKQVL-------------SGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVD 182

Query: 796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           FGL+ +  +  +   M    G+  Y APE     K +EK D++S GV+L  L+ G 
Sbjct: 183 FGLSAVF-ENQKK--MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  105 bits (264), Expect = 9e-25
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 42/226 (18%)

Query: 642 NLIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEF-------IAEIEIL--- 690
             IG G  G+V++  D+   G FVA+KR+        +++          I E+ +L   
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRV--------RVQTGEEGMPLSTIREVAVLRHL 68

Query: 691 GTIRHANIVKLWCCI-----SSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
            T  H N+V+L+          E    LV+E+++ Q L  +L       V   +   + +
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVP--TETIKDM 125

Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
           +      Q+     +GL ++H      ++HRD+K  NIL+ S  + K+ADFGLA++    
Sbjct: 126 MF-----QLL----RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--- 170

Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
                +++V  +  Y APE    +     +D++S G +  E+   K
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  105 bits (264), Expect = 1e-24
 Identities = 59/222 (26%), Positives = 89/222 (40%), Gaps = 42/222 (18%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE-----FIA--EIEILGTIR 694
            L+G G  G V +      G  VA+K+             +      IA  EI++L  +R
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKF--------LESDDDKMVKKIAMREIKLLKQLR 82

Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H N+V L      +    LV+E+++  ++   L      L      V Q  L      QI
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVD-HTILDDLELFPNGL---DYQVVQKYLF-----QI 133

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
                 G+ + H      IIHRD+K  NIL+      K+ DFG A+ LA  GE +     
Sbjct: 134 I----NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA 186

Query: 815 AGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
                Y APE       Y   V    D+++ G ++ E+  G+
Sbjct: 187 T--RWYRAPELLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  105 bits (263), Expect = 1e-24
 Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 48/225 (21%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEF-------IAEIEILGTIRHA 696
           +G G  G+VY+       E VA+KRI        +LE E        I E+ +L  ++H 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRI--------RLEHEEEGVPGTAIREVSLLKELQHR 93

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           NI++L   I   +   L++EY E   L +++          S  V +  L+     Q+  
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAE-NDLKKYMD----KNPDVSMRVIKSFLY-----QL-- 141

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-----KIADFGLAKMLAKQGEPHTM 811
               G+ + H     + +HRD+K  N+LL     +     KI DFGLA+  A        
Sbjct: 142 --INGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--AFGIPIRQF 194

Query: 812 SAVAGSFGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTGK 851
           +    +  Y  PE       Y+T V    DI+S   +  E++   
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  106 bits (267), Expect = 3e-24
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 27/229 (11%)

Query: 627 LGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA- 685
           +  + +          ++G G  G+V        G+  AVK I + R++ QK +KE +  
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLR 75

Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQH 744
           E+++L  + H NI+KL+     +    LV E      L D  +  RKR     ++ + + 
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE-IISRKRFSEVDAARIIRQ 134

Query: 745 VLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS---EFKAKIADFGLAKM 801
           VL              G+ YMH +   +I+HRD+K  N+LL+S   +   +I DFGL+  
Sbjct: 135 VL-------------SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178

Query: 802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
             +  +   M    G+  Y APE       +EK D++S GV+L  L++G
Sbjct: 179 F-EASKK--MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (265), Expect = 5e-24
 Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 26/226 (11%)

Query: 629 FTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE 688
           + +           ++G G  G+V +       +  AVK I N      K     + E+E
Sbjct: 15  YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVE 73

Query: 689 ILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLH 747
           +L  + H NI+KL+  +   +S  +V E      L D  +  RKR     ++ + + V  
Sbjct: 74  LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDE-IIKRKRFSEHDAARIIKQVF- 131

Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS---EFKAKIADFGLAKMLAK 804
                        G+ YMH      I+HRD+K  NILL+S   +   KI DFGL+    +
Sbjct: 132 ------------SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-Q 175

Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           Q     M    G+  Y APE       +EK D++S GV+L  L++G
Sbjct: 176 QNTK--MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  101 bits (255), Expect = 6e-24
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G    V R      G   A K I N +KL+ +  ++   E  I   ++H NIV+L  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 704 CISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
            I  E+   LV++ +    L +  +  R+    + +S   Q +L             + +
Sbjct: 73  SIQEESFHYLVFDLVTGGELFED-IVAREFYSEADASHCIQQIL-------------ESI 118

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            Y H +    I+HR++K  N+LL S+ K    K+ADFGLA  +    +       AG+ G
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPG 172

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVL 844
           Y +PE       ++ +DI++ GV+L
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  101 bits (255), Expect = 7e-24
 Identities = 60/222 (27%), Positives = 91/222 (40%), Gaps = 32/222 (14%)

Query: 630 TESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI 689
            +           ++G G  G+V +       +  AVK I N      K     + E+E+
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVEL 74

Query: 690 LGTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHW 748
           L  + H NI+KL+  +   +S  +V E      L D  +  RKR     ++ + + V   
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDE-IIKRKRFSEHDAARIIKQVF-- 131

Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS---EFKAKIADFGLAKMLAKQ 805
                       G+ YMH      I+HRD+K  NILL+S   +   KI DFGL+      
Sbjct: 132 -----------SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--- 174

Query: 806 GEPHTMSAVAGSFGYFAPE---YAYTTKVNEKIDIYSFGVVL 844
            +   M    G+  Y APE     Y  K     D++S GV+L
Sbjct: 175 QQNTKMKDRIGTAYYIAPEVLRGTYDEKC----DVWSAGVIL 212

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  102 bits (256), Expect = 7e-24
 Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 28/206 (13%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++GSG   +V+ +     G+  A+K I   +K     +     EI +L  I+H NIV L 
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCI---KKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 703 CCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
               S     LV + +    L DR L     +    S  + Q VL               
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ-VL-------------SA 118

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEF---KAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           + Y+H +    I+HRD+K  N+L  +     K  I DFGL+KM     +   MS   G+ 
Sbjct: 119 VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTP 171

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVL 844
           GY APE       ++ +D +S GV+ 
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (262), Expect = 8e-24
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 24/205 (11%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G    V R     AG+  A   I N +KL+ +  ++   E  I   ++H NIV+L  
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMII-NTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 704 CISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
            IS E    L+++ +    L +  +     S    S  + Q +              + +
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL--------------EAV 123

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            + H      ++HR++K  N+LL S+ K    K+ADFGLA  +  +GE       AG+ G
Sbjct: 124 LHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFGFAGTPG 178

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVL 844
           Y +PE        + +D+++ GV+L
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (258), Expect = 1e-23
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G G    V R      G   A K I N +KL+ +  ++   E  I   ++H NIV+L  
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 704 CISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
            I  E+   LV++ +    L +  +   +      S +   H +      QI     + +
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIV--AREFY---SEADASHCIQ-----QIL----ESI 141

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            Y H +    I+HR++K  N+LL S+ K    K+ADFGLA  +    +       AG+ G
Sbjct: 142 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPG 195

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVL 844
           Y +PE       ++ +DI++ GV+L
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVIL 220

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  101 bits (253), Expect = 1e-23
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 33/216 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +GSG  G V+ ++   +G    +K I N  +    +E+   AEIE+L ++ H NI+K++ 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQ-IEAEIEVLKSLDHPNIIKIFE 87

Query: 704 CISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQ--HVLHWPTRLQIAIGAAQ 760
                ++  +V E  E   L +R +          + S      ++      Q+      
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIV---SAQARGKALSEGYVAELMK-----QMM----N 135

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGS 817
            L Y H      ++H+D+K  NIL          KI DFGLA++          +  AG+
Sbjct: 136 ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF---KSDEHSTNAAGT 189

Query: 818 FGYFAPE---YAYTTKVNEKIDIYSFGVVLLELVTG 850
             Y APE            K DI+S GVV+  L+TG
Sbjct: 190 ALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTG 221

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  102 bits (257), Expect = 1e-23
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 39/220 (17%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEF------IAEIEILGTIRHA 696
           +G G    VY+  D N   + VA+K+I    KL  + E +       + EI++L  + H 
Sbjct: 18  LGEGQFATVYKARDKN-TNQIVAIKKI----KLGHRSEAKDGINRTALREIKLLQELSHP 72

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           NI+ L      +++  LV+++ME   L+  +      L         H+  +   L    
Sbjct: 73  NIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPS------HIKAY--MLMTL- 122

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              QGL Y+H      I+HRD+K +N+LLD     K+ADFGLAK  +        +    
Sbjct: 123 ---QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVV 174

Query: 817 SFGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTGK 851
           +  Y APE       Y   V    D+++ G +L EL+   
Sbjct: 175 TRWYRAPELLFGARMYGVGV----DMWAVGCILAELLLRV 210

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  101 bits (255), Expect = 1e-23
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 35/214 (16%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIRHAN 697
           +GSG  G+V         + VA+K I + RK      +E         EIEIL  + H  
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKII-SKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 698 IVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           I+K+     +E+   +V E ME   L D+ + G KR   +        +L          
Sbjct: 77  IIKIKNFFDAED-YYIVLELMEGGELFDK-VVGNKRLKEATCKLYFYQML---------- 124

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDS---EFKAKIADFGLAKMLAKQGEPHTMSA 813
                + Y+H +    IIHRD+K  N+LL S   +   KI DFG +K+L   GE   M  
Sbjct: 125 ---LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRT 175

Query: 814 VAGSFGYFAPE---YAYTTKVNEKIDIYSFGVVL 844
           + G+  Y APE      T   N  +D +S GV+L
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  104 bits (260), Expect = 1e-23
 Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 33/219 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKE------FIAEIEILGTIRHAN 697
           +GSG  G+V         + VA++ I + RK      +E         EIEIL  + H  
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRII-SKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           I+K+     +E+   +V E ME   L   + G KR   +        +L           
Sbjct: 202 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML----------- 249

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDS---EFKAKIADFGLAKMLAKQGEPHTMSAV 814
               + Y+H +    IIHRD+K  N+LL S   +   KI DFG +K+L   GE   M  +
Sbjct: 250 --LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTL 301

Query: 815 AGSFGYFAPE---YAYTTKVNEKIDIYSFGVVLLELVTG 850
            G+  Y APE      T   N  +D +S GV+L   ++G
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  100 bits (252), Expect = 1e-23
 Identities = 54/226 (23%), Positives = 86/226 (38%), Gaps = 38/226 (16%)

Query: 628 GFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEI 687
           G T+ +I    T  N IG G  G+V      G     A K+I     +       F  EI
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI-PKYFVEDV--DRFKQEI 57

Query: 688 EILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVL 746
           EI+ ++ H NI++L+          LV E      L +R +  ++    S ++ + + VL
Sbjct: 58  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFER-VVHKRVFRESDAARIMKDVL 116

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS---EFKAKIADFGLAKMLA 803
                          + Y H      + HRD+K  N L  +   +   K+ DFGLA    
Sbjct: 117 -------------SAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF- 159

Query: 804 KQGEPHTMSAVAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVL 844
                  M    G+  Y +P+     Y        + D +S GV++
Sbjct: 160 --KPGKMMRTKVGTPYYVSPQVLEGLY------GPECDEWSAGVMM 197

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (251), Expect = 2e-23
 Identities = 63/276 (22%), Positives = 99/276 (35%), Gaps = 54/276 (19%)

Query: 62  PCDWPEI-TCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNC 120
           PC  P    C        S   + +   +P  I        I L  N I          C
Sbjct: 1   PC--PGACVCYNEPKVTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRAC 55

Query: 121 TKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNE 180
             L  L L  N            ++ +         F+G        L+ L+ L L  N 
Sbjct: 56  RNLTILWLHSN-----------VLARID-----AAAFTG--------LALLEQLDLSDNA 91

Query: 181 F-----NGTFPKEIGDLSNLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIG 233
                   TF      L  L  L L         P +    F  L  L+ L++ + N + 
Sbjct: 92  QLRSVDPATF----HGLGRLHTLHLDRCGLQELGPGL----FRGLAALQYLYLQD-NALQ 142

Query: 234 EIPE-AMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSV-EAL 290
            +P+    +L +L  L L+GN +  ++P   F  L++L +L L+ N ++  +       L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDL 200

Query: 291 -KLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSN 324
            +L  + L  NNL+ ++P E    L+ LQ L L  N
Sbjct: 201 GRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 51/254 (20%), Positives = 81/254 (31%), Gaps = 54/254 (21%)

Query: 283 IPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENN 342
           IP++ + +      L  N ++      F   +NL +L L SN L+      I   AF   
Sbjct: 30  IPAASQRI-----FLHGNRISHVPAASFRACRNLTILWLHSNVLA-----RIDAAAFTG- 78

Query: 343 LSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWT-TFNLSSLMLSDNTISGELPSKTAW 401
                   L     L  + L  N     +    +     L +L L    +  EL      
Sbjct: 79  --------LAL---LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126

Query: 402 NLTRLE---ISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDG 458
            L  L+   + +N     +                              L +L  L L G
Sbjct: 127 GLAALQYLYLQDNALQ-ALPDDT-----------------------FRDLGNLTHLFLHG 162

Query: 459 NKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEI- 517
           N++S           SL+ L L +N ++   P A   L  +++L L  N  S  +P E  
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEAL 221

Query: 518 -GQLKLNTFNLSSN 530
                L    L+ N
Sbjct: 222 APLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 26/106 (24%), Positives = 40/106 (37%), Gaps = 10/106 (9%)

Query: 441 IPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMV 500
           IP     +       L GN++S    +   +  +L  L L  N L+     A   L ++ 
Sbjct: 30  IPAASQRIF------LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 501 SLDLSGNQFSGEIPPEI--GQLKLNTFNLSSNKLYGNIPDE-FNNL 543
            LDLS N     + P    G  +L+T +L    L   +    F  L
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGL 128

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  102 bits (256), Expect = 2e-23
 Identities = 51/242 (21%), Positives = 92/242 (38%), Gaps = 51/242 (21%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G V  +    +G+  A+K++  + +   +       E++I+  + H NI+KL  
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-------ELDIMKVLDHVNIIKLVD 67

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSS-------------------VHQH 744
              +   +        +            +    S                     +H+ 
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127

Query: 745 VLHWPTRLQ-IAIGAAQ--------GLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIA 794
           +  +    + I +             + ++H   +  I HRD+K  N+L++S+    K+ 
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLC 184

Query: 795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVT 849
           DFG AK L    EP   + +  S  Y APE       YT      ID++S G V  EL+ 
Sbjct: 185 DFGSAKKLIP-SEPSV-AYIC-SRFYRAPELMLGATEYTP----SIDLWSIGCVFGELIL 237

Query: 850 GK 851
           GK
Sbjct: 238 GK 239

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  102 bits (257), Expect = 3e-23
 Identities = 74/264 (28%), Positives = 104/264 (39%), Gaps = 43/264 (16%)

Query: 137 IPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF----NGTFPKEIGDL 192
           +P  I   +  + ++L  N        S   L  L+ L L  N       G F      L
Sbjct: 58  VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAF----NGL 111

Query: 193 SNLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAM-SNLSSLEILA 249
           +NL  L L  N  +          F  L KLK LW+   N I  IP    + + SL  L 
Sbjct: 112 ANLNTLELFDNRLTTIPNGA----FVYLSKLKELWL-RNNPIESIPSYAFNRIPSLRRLD 166

Query: 250 L-NGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIP 307
           L     L   I  G F  L+NL  L L    L  EIP+    +KL ++DLS N+L+ +I 
Sbjct: 167 LGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLS-AIR 223

Query: 308 EE-FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNR 366
              F  L +LQ L +  + +       I   AF+N         L +   L  + L  N 
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQ-----VIERNAFDN---------LQS---LVEINLAHNN 266

Query: 367 FSGELPTGLWTTF-NLSSLMLSDN 389
            +  LP  L+T   +L  + L  N
Sbjct: 267 LT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 99.4 bits (248), Expect = 4e-22
 Identities = 74/328 (22%), Positives = 115/328 (35%), Gaps = 70/328 (21%)

Query: 47  LGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSS 106
           +G      S  +  S C     +C  N  + +    K++ + +P  I    N   ++L  
Sbjct: 23  MGCVAETGSAQTCPSVC-----SC-SNQFSKVICVRKNLRE-VPDGI--STNTRLLNLHE 73

Query: 107 NSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIG 166
           N I         +   L+ L LS+N            I  ++        F+G       
Sbjct: 74  NQIQIIKVNSFKHLRHLEILQLSRN-----------HIRTIE-----IGAFNG------- 110

Query: 167 RLSELQTLYLYMNEF----NGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE-FGMLKKL 221
            L+ L TL L+ N      NG F      LS L+ L L  N       IP   F  +  L
Sbjct: 111 -LANLNTLELFDNRLTTIPNGAF----VYLSKLKELWLRNN---PIESIPSYAFNRIPSL 162

Query: 222 KTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILS 280
           + L + E   +  I E A   LS+L  L L   +L   IP+ L  L  L +L L  N LS
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS 220

Query: 281 GEIPSSVEA--LKLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSNHLSGEVPASIGVV 337
             I        + L  + +  + +   I    F  L++L  + L  N+L+      +   
Sbjct: 221 -AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-----LLPHD 273

Query: 338 AFENNLSGAVPKSLGNCRTLRTVQLYSN 365
            F                 L  + L+ N
Sbjct: 274 LFTPLHH------------LERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 94.4 bits (235), Expect = 2e-20
 Identities = 64/263 (24%), Positives = 94/263 (35%), Gaps = 56/263 (21%)

Query: 230 NLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSV 287
           N I  I   +  +L  LEIL L+ NH+   I  G F  L NL  L L+DN L+  IP+  
Sbjct: 74  NQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGA 131

Query: 288 --EALKLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLS 344
                KL ++ L  N +  SIP   F ++ +L+ L L                     LS
Sbjct: 132 FVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGEL----------------KRLS 174

Query: 345 GAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLT 404
                +      LR + L       E+P  L     L  L LS N +S  +   +   L 
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLM 231

Query: 405 RLE---ISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKL 461
            L+   +  ++    I+R                 F          L  L  + L  N L
Sbjct: 232 HLQKLWMIQSQIQ-VIERNA---------------FDN--------LQSLVEINLAHNNL 267

Query: 462 SGKLPSQIV-SWTSLNNLNLARN 483
           +  LP  +      L  ++L  N
Sbjct: 268 T-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 87.9 bits (218), Expect = 2e-18
 Identities = 65/275 (23%), Positives = 105/275 (38%), Gaps = 39/275 (14%)

Query: 267 NNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL 326
           N  +++      L  E+P  +       ++L  N +       F  L++L++L L  NH+
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIST-NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 327 SGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTF----NLS 382
                 +I + AF           L N   L T++L+ NR +  +P G    F     L 
Sbjct: 101 R-----TIEIGAFNG---------LAN---LNTLELFDNRLT-TIPNG---AFVYLSKLK 139

Query: 383 SLMLSDNTISGELPSKTAWNLTRLEI----SNNRFSGQIQRGV-GSWKNLIVFKASNNLF 437
            L L +N I   +PS     +  L         R S  I  G      NL     +    
Sbjct: 140 ELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNL 197

Query: 438 SGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLL 497
             EIP  LT L  L+ L L GN LS   P        L  L + ++++      A  +L 
Sbjct: 198 R-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255

Query: 498 VMVSLDLSGNQFSGEIPPEIGQL--KLNTFNLSSN 530
            +V ++L+ N  +  +P ++      L   +L  N
Sbjct: 256 SLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 24/106 (22%), Positives = 39/106 (36%), Gaps = 11/106 (10%)

Query: 441 IPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMV 500
           I      L+      L  N++     +       L  L L+RN +      A   L  + 
Sbjct: 62  ISTNTRLLN------LHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN 115

Query: 501 SLDLSGNQFSGEIPPEI--GQLKLNTFNLSSNKLYGNIPDE-FNNL 543
           +L+L  N+ +  IP        KL    L +N +  +IP   FN +
Sbjct: 116 TLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRI 159

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  103 bits (258), Expect = 4e-23
 Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 35/254 (13%)

Query: 611 KRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRI- 669
           + N       +     +   E  I  S  +   +GSG  G+V            A+K I 
Sbjct: 11  RENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIK 70

Query: 670 ---------WNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMEN 720
                     ++ K  +K  +E   EI +L ++ H NI+KL+     +    LV E+ E 
Sbjct: 71  KSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG 130

Query: 721 QSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK 779
             L ++ +  R +     ++++ + +L              G+CY+H      I+HRD+K
Sbjct: 131 GELFEQ-IINRHKFDECDAANIMKQIL-------------SGICYLHKH---NIVHRDIK 173

Query: 780 SSNILLDS---EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKID 836
             NILL++       KI DFGL+     +     +    G+  Y APE     K NEK D
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFF-SKDYK--LRDRLGTAYYIAPE-VLKKKYNEKCD 229

Query: 837 IYSFGVVLLELVTG 850
           ++S GV++  L+ G
Sbjct: 230 VWSCGVIMYILLCG 243

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 34/215 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRI------WNNRKLNQKLEKEFIAEIEILGTI-RHA 696
           +G G S  V R       +  AVK I        + +  Q+L +  + E++IL  +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           NI++L     +     LV++ M+   L D  L  +       +  + + +L         
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDY-LTEKVTLSEKETRKIMRALL--------- 134

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               + +C +H      I+HRD+K  NILLD +   K+ DFG +  L        +  V 
Sbjct: 135 ----EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVC 184

Query: 816 GSFGYFAPE------YAYTTKVNEKIDIYSFGVVL 844
           G+  Y APE              +++D++S GV++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 65/246 (26%), Positives = 92/246 (37%), Gaps = 40/246 (16%)

Query: 94  CDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLG 153
           C   N          IP   P         +NLDLS N               LQ +DL 
Sbjct: 14  CMELNFY-------KIPDNLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60

Query: 154 GNNFSGDIPRSI-GRLSELQTLYLYMNEF----NGTFPKEIGDLSNLEVLGLAYNSNFKP 208
                  I       LS L TL L  N       G F      LS+L+ L          
Sbjct: 61  RCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG----LSSLQKLVAVET---NL 112

Query: 209 AMIPIE-FGMLKKLKTLWMTEANLIGEIPE--AMSNLSSLEILALNGNHLEGAIPSGLFL 265
           A +     G LK LK L +   NLI         SNL++LE L L+ N ++ +I      
Sbjct: 113 ASLENFPIGHLKTLKELNVAH-NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR 170

Query: 266 -LNNLT----QLFLYDNILSGEIPSSV-EALKLTDIDLSMNNLTGSIPEE-FGKLKNLQL 318
            L+ +      L L  N ++  I     + ++L ++ L  N L  S+P+  F +L +LQ 
Sbjct: 171 VLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQK 228

Query: 319 LGLFSN 324
           + L +N
Sbjct: 229 IWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 54/259 (20%), Positives = 87/259 (33%), Gaps = 61/259 (23%)

Query: 283 IPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENN 342
           +P S + L     DLS N L       F     LQ+L L    +                
Sbjct: 26  LPFSTKNL-----DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ--------------T 66

Query: 343 LSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWT-TFNLSSLMLSDNTISGELPSKTAW 401
           +     +SL +   L T+ L  N     L  G ++   +L  L+  +  ++  L +    
Sbjct: 67  IEDGAYQSLSH---LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIG 121

Query: 402 ---NLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDG 458
               L  L +++N     IQ       +          FS      LT+L HL+   L  
Sbjct: 122 HLKTLKELNVAHN----LIQ-------SFK----LPEYFSN-----LTNLEHLD---LSS 158

Query: 459 NKLSGKLPSQI----VSWTSLN-NLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEI 513
           NK+   +             LN +L+L+ N ++  I       + +  L L  NQ    +
Sbjct: 159 NKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SV 215

Query: 514 PPEI--GQLKLNTFNLSSN 530
           P  I      L    L +N
Sbjct: 216 PDGIFDRLTSLQKIWLHTN 234

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 98.4 bits (246), Expect = 2e-22
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 52/232 (22%)

Query: 642 NLIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEF----------IAEIEIL 690
             IG G  G VY+  D + +G FVA+K +        ++              + E+ +L
Sbjct: 15  AEIGVGAYGTVYKARDPH-SGHFVALKSV--------RVPNGGGGGGGLPISTVREVALL 65

Query: 691 ---GTIRHANIVKLWCCISSENSKL-----LVYEYMENQSLDRWLHGRKRSLVSGS---S 739
                  H N+V+L    ++  +       LV+E+++ Q L  +L       +       
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKD 124

Query: 740 SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
            + Q  L             +GL ++H +    I+HRD+K  NIL+ S    K+ADFGLA
Sbjct: 125 LMRQ-FL-------------RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167

Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           ++         ++ V  +  Y APE    +     +D++S G +  E+   K
Sbjct: 168 RIY---SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 96.9 bits (242), Expect = 4e-22
 Identities = 58/227 (25%), Positives = 88/227 (38%), Gaps = 46/227 (20%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK--LEKEFIAEIEILGTIRHANIVK 700
           L+G G  G+V  +  +      AVK I   +KL +    E     EI++L  +RH N+++
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 701 LWCCISSENSK--LLVYEYMENQS---LDRWLHGRK---------RSLVSGSSSVHQHVL 746
           L   + +E  +   +V EY        LD     R            L+ G         
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG--------- 121

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
                          L Y+H      I+H+D+K  N+LL +    KI+  G+A+ L    
Sbjct: 122 ---------------LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163

Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNE--KIDIYSFGVVLLELVTGK 851
              T     GS  +  PE A         K+DI+S GV L  + TG 
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 98.1 bits (245), Expect = 4e-22
 Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 52/231 (22%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEF-------IAEIEILGTIRH 695
           IG G  G+V++       G+ VA+K++         +E E        + EI+IL  ++H
Sbjct: 25  IGQGTFGEVFKARHRK-TGQKVALKKV--------LMENEKEGFPITALREIKILQLLKH 75

Query: 696 ANIVKLWCCISSENSKL--------LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
            N+V L     ++ S          LV+++ E   L   L          + S  + V+ 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKF---TLSEIKRVMQ 131

Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM--LAKQ 805
                 +      GL Y+H +   +I+HRD+K++N+L+  +   K+ADFGLA+   LAK 
Sbjct: 132 -----MLL----NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 806 GEPHTMSAVAGSFGYFAPEY-----AYTTKVNEKIDIYSFGVVLLELVTGK 851
            +P+  +    +  Y  PE       Y   +    D++  G ++ E+ T  
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 97.3 bits (243), Expect = 5e-22
 Identities = 45/214 (21%), Positives = 85/214 (39%), Gaps = 28/214 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA-NIVKLW 702
           +G G    V +      G+  A K +   R+  Q    E + EI +L   +    ++ L 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFL-KKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 703 CCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVS--GSSSVHQHVLHWPTRLQIAIGAA 759
               + +  +L+ EY     +           +VS      + + +L             
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSL-CLPELAEMVSENDVIRLIKQIL------------- 141

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAG 816
           +G+ Y+H +    I+H D+K  NILL S +     KI DFG+++ +        +  + G
Sbjct: 142 EGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACE--LREIMG 195

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           +  Y APE      +    D+++ G++   L+T 
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 97.9 bits (244), Expect = 5e-22
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 35/215 (16%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN------QKLEKEFIAEIEILGTIR-HA 696
           IG G S  V R      G   AVK +             +++ +    E  IL  +  H 
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIM-EVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
           +I+ L     S +   LV++ M    L D  L  +       + S+ + +L         
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDY-LTEKVALSEKETRSIMRSLL--------- 210

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               + + ++H +    I+HRD+K  NILLD   + +++DFG +  L        +  + 
Sbjct: 211 ----EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL---EPGEKLRELC 260

Query: 816 GSFGYFAPE------YAYTTKVNEKIDIYSFGVVL 844
           G+ GY APE              +++D+++ GV+L
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 98.7 bits (246), Expect = 9e-22
 Identities = 64/283 (22%), Positives = 123/283 (43%), Gaps = 29/283 (10%)

Query: 53  LQSWTSTSSPCDWPEI-TCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPG 111
             + ++    C  P + +C+      +    + +++ +P  I    N   ++L  N+I  
Sbjct: 36  AAAASAGPQNC--PSVCSCSNQFSK-VVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQM 89

Query: 112 EFPEFLYNCTKLQNLDLSQNYFVGPIPSDI-DRISGLQCIDLGGNNFSGDIPRSIGRLSE 170
              +   +   L+ L L +N  +  I     + ++ L  ++L  N  +     +   LS+
Sbjct: 90  IQADTFRHLHHLEVLQLGRNS-IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSK 148

Query: 171 LQTLYLYMNEF----NGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE-FGMLKKLKTLW 225
           L+ L+L  N      +  F      + +L  L L      +   I    F  L  LK L 
Sbjct: 149 LRELWLRNNPIESIPSYAF----NRVPSLMRLDLGELKKLE--YISEGAFEGLFNLKYLN 202

Query: 226 MTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIP 284
           +     I ++P  ++ L  LE L ++GNH    I  G F  L++L +L++ ++ +S  I 
Sbjct: 203 LGM-CNIKDMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIE 258

Query: 285 SSV-EAL-KLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSN 324
            +  + L  L +++L+ NNL+ S+P + F  L+ L  L L  N
Sbjct: 259 RNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 89.0 bits (221), Expect = 1e-18
 Identities = 62/275 (22%), Positives = 102/275 (37%), Gaps = 39/275 (14%)

Query: 267 NNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL 326
           N  +++      LS E+P  + +     ++L  NN+     + F  L +L++L L  N +
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIPS-NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 327 SGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTF----NLS 382
                  I V AF           L +   L T++L+ N  +  +P+G    F     L 
Sbjct: 112 R-----QIEVGAFNG---------LAS---LNTLELFDNWLT-VIPSG---AFEYLSKLR 150

Query: 383 SLMLSDNTISGELPSKTAWNLTRLEI----SNNRFSGQIQRGV-GSWKNLIVFKASNNLF 437
            L L +N I   +PS     +  L         +    I  G      NL          
Sbjct: 151 ELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNI 208

Query: 438 SGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLL 497
             ++P  LT L  L  L + GN      P      +SL  L +  +++S     A   L 
Sbjct: 209 K-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA 266

Query: 498 VMVSLDLSGNQFSGEIPPEI--GQLKLNTFNLSSN 530
            +V L+L+ N  S  +P ++      L   +L  N
Sbjct: 267 SLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 86.0 bits (213), Expect = 1e-17
 Identities = 71/282 (25%), Positives = 106/282 (37%), Gaps = 53/282 (18%)

Query: 234 EIPEAMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSV-EAL- 290
           E+P+ +   S+   L L  N+++  I +  F  L++L  L L  N +  +I       L 
Sbjct: 68  EVPQGIP--SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLA 123

Query: 291 KLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPK 349
            L  ++L  N LT  IP   F  L  L+ L L +N +      SI   AF          
Sbjct: 124 SLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-----SIPSYAFNR-------- 169

Query: 350 SLGNCRTLRTVQLYSNRFSGELPTGLWT-TFNLSSLMLSDNTISGELPS-KTAWNLTRLE 407
                 +L  + L   +    +  G +   FNL  L L    I  ++P+      L  LE
Sbjct: 170 ----VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELE 224

Query: 408 ISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPS 467
           +S N F  +I+ G                F G        LS L  L +  +++S    +
Sbjct: 225 MSGNHFP-EIRPGS---------------FHG--------LSSLKKLWVMNSQVSLIERN 260

Query: 468 QIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQF 509
                 SL  LNLA N LS         L  +V L L  N +
Sbjct: 261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 57/226 (25%), Positives = 84/226 (37%), Gaps = 53/226 (23%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKL 701
            +G G  G+V         E VAVK I + ++     E   I  EI I   + H N+VK 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 70

Query: 702 WCCISSENSKLLVYEYMENQSL-DRWL-HGRK---------RSLVSGSSSVHQHVLHWPT 750
           +      N + L  EY     L DR                  L++G   +H        
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI------ 124

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                                 I HRD+K  N+LLD     KI+DFGLA +         
Sbjct: 125 ---------------------GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163

Query: 811 MSAVAGSFGYFAPE------YAYTTKVNEKIDIYSFGVVLLELVTG 850
           ++ + G+  Y APE      +       E +D++S G+VL  ++ G
Sbjct: 164 LNKMCGTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAG 204

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 29/206 (14%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G G +  VYR    G  +  A+K +       + +  E    I +L  + H NI+KL 
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDKKIVRTE----IGVLLRLSHPNIIKLK 114

Query: 703 CCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
               +     LV E +    L DR +     S    + +V Q +L             + 
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ-IL-------------EA 160

Query: 762 LCYMHHDCTPQIIHRDVKSSNILL---DSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           + Y+H +    I+HRD+K  N+L      +   KIADFGL+K++        M  V G+ 
Sbjct: 161 VAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTP 214

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVL 844
           GY APE         ++D++S G++ 
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIIT 240

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 95.8 bits (239), Expect = 3e-21
 Identities = 56/228 (24%), Positives = 87/228 (38%), Gaps = 46/228 (20%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKL---EKEFIA-----EIEILGTIRH 695
           I SG  G V    ++  G  VA+KR++N     + +      F+      EI +L    H
Sbjct: 30  ISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 696 ANIVKLWCCISSENSKL-----LVYEYMENQSLDRWLHGRKRSLVSGSSSVH-QHVLHWP 749
            NI+ L                LV E M    L + +H ++  +    S  H Q+ ++  
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVI----SPQHIQYFMY-- 141

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
               I      GL  +H      ++HRD+   NILL       I DF LA+         
Sbjct: 142 ---HIL----LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-- 189

Query: 810 TMSA-VAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
             +  V   + Y APE       +T      +D++S G V+ E+   K
Sbjct: 190 -KTHYVTHRW-YRAPELVMQFKGFTK----LVDMWSAGCVMAEMFNRK 231

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 47/221 (21%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLW 702
           +G G   +V+        E V VK       L    +K+   EI+IL  +R   NI+ L 
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGGPNIITLA 97

Query: 703 CCISSENSK--LLVYEYMENQSLDRWLHGRKRSLVSGSSSVH-QHVLHWPTRLQIAIGAA 759
             +    S+   LV+E++ N           + L    +    +  ++     +I     
Sbjct: 98  DIVKDPVSRTPALVFEHVNNTDF--------KQLYQTLTDYDIRFYMY-----EIL---- 140

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA-KIADFGLAKMLAKQGEPHTMSAVAGSF 818
           + L Y H   +  I+HRDVK  N+++D E +  ++ D+GLA+     G+ + +  VA  +
Sbjct: 141 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVR-VASRY 195

Query: 819 GYFAPE-------YAYTTKVNEKIDIYSFGVVLLELVTGKE 852
            +  PE       Y Y+      +D++S G +L  ++  KE
Sbjct: 196 -FKGPELLVDYQMYDYS------LDMWSLGCMLASMIFRKE 229

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 95.5 bits (238), Expect = 4e-21
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 29/214 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IGSG  G V           VA+K++    + NQ   K    E+ ++  + H NI+ L  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLN 91

Query: 704 CISSENSKL------LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
             + + S        +V E M+  +L + +                  L +    Q+   
Sbjct: 92  VFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLY----QML-- 137

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
              G+ ++H   +  IIHRD+K SNI++ S+   KI DFGLA+     G    M+    +
Sbjct: 138 --CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVT 189

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
             Y APE        E +DI+S G ++ E++ G 
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 95.5 bits (238), Expect = 4e-21
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 27/218 (12%)

Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           +++++ ++G G  GQV++ +    G  +A K I   +    K ++E   EI ++  + HA
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKII---KTRGMKDKEEVKNEISVMNQLDHA 146

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSL-DRWLH-GRKRSLVSGSSSVHQHVLHWPTRLQI 754
           N+++L+    S+N  +LV EY++   L DR +      + +     + Q +         
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ-IC-------- 197

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA--KIADFGLAKMLAKQGEPHTMS 812
                +G+ +MH      I+H D+K  NIL  +      KI DFGLA+   K  E   + 
Sbjct: 198 -----EGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREK--LK 246

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
              G+  + APE      V+   D++S GV+   L++G
Sbjct: 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 94.3 bits (235), Expect = 5e-21
 Identities = 55/225 (24%), Positives = 82/225 (36%), Gaps = 51/225 (22%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G G  G+V         E VAVK +  + K      +    EI I   + H N+VK +
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 703 CCISSENSKLLVYEYMENQSL-DRWL-HGRK---------RSLVSGSSSVHQHVLHWPTR 751
                 N + L  EY     L DR                  L++G   +H         
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI------- 124

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
                                I HRD+K  N+LLD     KI+DFGLA +         +
Sbjct: 125 --------------------GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164

Query: 812 SAVAGSFGYFAPE------YAYTTKVNEKIDIYSFGVVLLELVTG 850
           + + G+  Y APE      +       E +D++S G+VL  ++ G
Sbjct: 165 NKMCGTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAG 204

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 94.8 bits (236), Expect = 8e-21
 Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 27/211 (12%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +GSG  G V+R      G     K I N      K       EI I+  + H  ++ L  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDK--YTVKNEISIMNQLHHPKLINLHD 115

Query: 704 CISSENSKLLVYEYMENQSL-DRWL-HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
               +   +L+ E++    L DR      K S     + + Q                +G
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ-AC-------------EG 161

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKA--KIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           L +MH      I+H D+K  NI+ +++  +  KI DFGLA  L    E   +     +  
Sbjct: 162 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEI--VKVTTATAE 215

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
           + APE      V    D+++ GV+   L++G
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.9 bits (236), Expect = 9e-21
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 39/226 (17%)

Query: 644 IGSGGSGQVY--RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +G G  G VY  +       +  A+K+I         +      EI +L  ++H N++ L
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTG--ISMSACREIALLRELKHPNVISL 83

Query: 702 W-CCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR----LQIA 755
               +S  + K+ L+++Y E   L   +        +  ++     L          QI 
Sbjct: 84  QKVFLSHADRKVWLLFDYAE-HDLWHIIK----FHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA----KIADFGLAKMLAKQGEPHT- 810
                G+ Y+H +    ++HRD+K +NIL+  E       KIAD G A++     +P   
Sbjct: 139 ----DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 811 MSAVAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +  V  +F Y APE       YT  +    DI++ G +  EL+T +
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 49/216 (22%), Positives = 82/216 (37%), Gaps = 30/216 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA----EIEILGTIRHANIV 699
           +GSG    V +      G   A K I   R+               E+ IL  + H N++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFI-KKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 700 KLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
            L     +    +L+ E +    L D        S    +S + Q +             
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL------------- 125

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA----KIADFGLAKMLAKQGEPHTMSAV 814
             G+ Y+H     +I H D+K  NI+L  +       K+ DFGLA  + + G       +
Sbjct: 126 -DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVE--FKNI 178

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            G+  + APE      +  + D++S GV+   L++G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 68/227 (29%), Positives = 97/227 (42%), Gaps = 54/227 (23%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKL 701
            +G G  G+V   +    G  VAVK I N +K+        I  EI+ L   RH +I+KL
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 702 WCCISSENSKLLVYEYMENQSL-DRWL-HGRK---------RSLVSGSSSVHQHVLHWPT 750
           +  IS+     +V EY+    L D    HGR          + ++S     H+H      
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH------ 130

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                                 ++HRD+K  N+LLD+   AKIADFGL+ M++      T
Sbjct: 131 ---------------------MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169

Query: 811 MSAVAGSFGYFAPE------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
                GS  Y APE      YA       ++DI+S GV+L  L+ G 
Sbjct: 170 ---SCGSPNYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCGT 208

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 95.7 bits (238), Expect = 1e-20
 Identities = 52/243 (21%), Positives = 96/243 (39%), Gaps = 25/243 (10%)

Query: 611 KRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIW 670
             N     WK      +     ++L        +G+G  G V+R+     G   A K + 
Sbjct: 132 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV- 190

Query: 671 NNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSL-DRWLHG 729
                ++  ++    EI+ +  +RH  +V L      +N  +++YE+M    L ++    
Sbjct: 191 --MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 248

Query: 730 RKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF 789
             +     +    + V              +GLC+MH +     +H D+K  NI+  ++ 
Sbjct: 249 HNKMSEDEAVEYMRQVC-------------KGLCHMHEN---NYVHLDLKPENIMFTTKR 292

Query: 790 KA--KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL 847
               K+ DFGL   L    +   +    G+  + APE A    V    D++S GV+   L
Sbjct: 293 SNELKLIDFGLTAHL-DPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 349

Query: 848 VTG 850
           ++G
Sbjct: 350 LSG 352

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 50/216 (23%), Positives = 82/216 (37%), Gaps = 30/216 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA----EIEILGTIRHANIV 699
           +GSG    V +      G   A K I   R+               E+ IL  + H NI+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFI-KKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 700 KLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
            L     +    +L+ E +    L D        S    +S + Q +             
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL------------- 125

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSE----FKAKIADFGLAKMLAKQGEPHTMSAV 814
             G+ Y+H     +I H D+K  NI+L  +       K+ DFGLA  + + G       +
Sbjct: 126 -DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVE--FKNI 178

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            G+  + APE      +  + D++S GV+   L++G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 53/226 (23%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKL 701
            +G G  G+V         + VA+K   + + L +      +  EI  L  +RH +I+KL
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALK-FISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 702 WCCISSENSKLLVYEYMENQSLDRWL-HGRK---------RSLVSGSSSVHQHVLHWPTR 751
           +  I++    ++V EY   +  D  +   R          + ++      H+H       
Sbjct: 75  YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH------- 127

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
                               +I+HRD+K  N+LLD     KIADFGL+ ++       T 
Sbjct: 128 --------------------KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT- 166

Query: 812 SAVAGSFGYFAPE------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
               GS  Y APE      YA       ++D++S G+VL  ++ G+
Sbjct: 167 --SCGSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGR 205

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 52/253 (20%), Positives = 97/253 (38%), Gaps = 29/253 (11%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
             +   I+    ++T  +     DL  +TT+      +     E +     L  L+L  N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDN 73

Query: 132 YFVGPIPSDIDRISG---LQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKE 188
                  +D+  +     +  ++L GN    ++  +I  L  ++TL L   +     P  
Sbjct: 74  QI-----TDLAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP-- 124

Query: 189 IGDLSNLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLE 246
           +  LSNL+VL L  N  +N  P         L  L+ L +     + ++   ++NLS L 
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP------LAGLTNLQYLSIGN-AQVSDL-TPLANLSKLT 176

Query: 247 ILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSI 306
            L  + N +     S L  L NL ++ L +N +S ++        L  + L+   +T   
Sbjct: 177 TLKADDNKISDI--SPLASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLTNQTITNQP 233

Query: 307 PEEFGKLKNLQLL 319
                 L    ++
Sbjct: 234 VFYNNNLVVPNVV 246

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 34/287 (11%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
            + +T +S     +T  I  +   L NL  ++L  N I       L N TK+  L+LS N
Sbjct: 40  LDGITTLSAFGTGVT-TIEGV-QYLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGN 95

Query: 132 YFVGPIPSDIDRISG---LQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKE 188
                   ++  I+G   ++ +DL     + D+   +  LS LQ LYL +N+   T    
Sbjct: 96  PL-----KNVSAIAGLQSIKTLDLTSTQIT-DVT-PLAGLSNLQVLYLDLNQI--TNISP 146

Query: 189 IGDLSNLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLE 246
           +  L+NL+ L +     S+  P         L KL TL   + N I +I   +++L +L 
Sbjct: 147 LAGLTNLQYLSIGNAQVSDLTP------LANLSKLTTLKADD-NKISDIS-PLASLPNLI 198

Query: 247 ILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSI 306
            + L  N +     S L   +NL  + L +  ++   P       +    +   +     
Sbjct: 199 EVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPSGAPIA 255

Query: 307 PEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGN 353
           P               S +L+  + + I  V++  N S     +   
Sbjct: 256 PATISDNGTYA-----SPNLTWNLTSFINNVSYTFNQSVTFKNTTVP 297

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 46/272 (16%), Positives = 94/272 (34%), Gaps = 32/272 (11%)

Query: 291 KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKS 350
               I    +N+T ++      L  +  L  F   ++               + G     
Sbjct: 20  NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT--------------TIEG----- 58

Query: 351 LGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISN 410
           +     L  ++L  N+ +      L     ++ L LS N +          ++  L++++
Sbjct: 59  VQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTS 116

Query: 411 NRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIV 470
            + +      +    NL V     N  +  I   L  L++L  L +   ++S  L   + 
Sbjct: 117 TQITDVT--PLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS-DLTP-LA 170

Query: 471 SWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSN 530
           + + L  L    N++S +I   + SL  ++ + L  NQ S ++ P      L    L++ 
Sbjct: 171 NLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLTNQ 227

Query: 531 KLYGNIPDEFNNLAYDDSFLNNSNLCVKNPII 562
            +        NNL   +     S   +    I
Sbjct: 228 TITNQPVFYNNNLVVPNVVKGPSGAPIAPATI 259

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 64/321 (19%), Positives = 115/321 (35%), Gaps = 43/321 (13%)

Query: 168 LSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMT 227
           L+    +    +           DL  +  L            I      L  L  L + 
Sbjct: 18  LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGT---GVTTIE-GVQYLNNLIGLELK 71

Query: 228 EANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSV 287
           + N I ++   + NL+ +  L L+GN L+    S +  L ++  L L    ++ ++    
Sbjct: 72  D-NQITDLAP-LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQIT-DVTPLA 126

Query: 288 EALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAV 347
               L  + L +N +T +I      L NLQ L + +  +S              +L+   
Sbjct: 127 GLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVS--------------DLTP-- 168

Query: 348 PKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLE 407
              L N   L T++   N+ S ++   L +  NL  + L +N IS   P     NL  + 
Sbjct: 169 ---LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223

Query: 408 ISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPS 467
           ++N   + Q    V    NL+V     N+  G     +   +  +        L+  L S
Sbjct: 224 LTNQTITNQP---VFYNNNLVV----PNVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276

Query: 468 QI--VSWTSLNNLNLARNELS 486
            I  VS+T   ++      + 
Sbjct: 277 FINNVSYTFNQSVTFKNTTVP 297

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 93.8 bits (233), Expect = 4e-20
 Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 29/214 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           IGSG  G V           VA+K++    + NQ   K    E+ ++  + H NI+ L  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLN 128

Query: 704 CISSENSKL------LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
             + + +        LV E M+       L    + +           L +    Q+   
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMDAN-----LC---QVIQMELDHERMSYLLY----QML-- 174

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
              G+ ++H   +  IIHRD+K SNI++ S+   KI DFGLA+     G    M+    +
Sbjct: 175 --CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVT 226

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
             Y APE        E +DI+S G ++ E+V  K
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 30/206 (14%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLW 702
           +G G      +     + +  AVK I  ++++    +KE    I  L     H NIVKL 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKE----ITALKLCEGHPNIVKLH 72

Query: 703 CCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                +    LV E +    L +R    +  S    S  + + V                
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV--------------SA 118

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAVAGSF 818
           + +MH      ++HRD+K  N+L   E      KI DFG A++     +P  +     + 
Sbjct: 119 VSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTL 173

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVL 844
            Y APE       +E  D++S GV+L
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVIL 199

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.7 bits (228), Expect = 5e-20
 Identities = 55/231 (23%), Positives = 83/231 (35%), Gaps = 60/231 (25%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVK-----RIWNNRKLNQKLEKEFIAEIEILGTIRHANI 698
           +GSG  G V+        + V VK     ++  +  +      +   EI IL  + HANI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 699 VKLWCCISSENSKLLVYEY-----------MENQSLDRWLHGRK--RSLVSGSSSVHQHV 745
           +K+     ++    LV E              +  LD  L      R LVS    +    
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL-ASYIFRQLVSAVGYLRLK- 149

Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
                                      IIHRD+K  NI++  +F  K+ DFG A  L + 
Sbjct: 150 --------------------------DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183

Query: 806 GEPHTMSAVAGSFGYFAPE------YAYTTKVNEKIDIYSFGVVLLELVTG 850
              +T     G+  Y APE      Y        +++++S GV L  LV  
Sbjct: 184 KLFYT---FCGTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFE 226

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 91.1 bits (227), Expect = 5e-20
 Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 30/212 (14%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKLW 702
           +G G  G V+R     + +    K +   +   +  ++  +  EI IL   RH NI+ L 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFV---KV--KGTDQVLVKKEISILNIARHRNILHLH 67

Query: 703 CCISSENSKLLVYEYMENQSL-DRWL-HGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
               S    ++++E++    + +R      + +     S VHQ V              +
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ-VC-------------E 113

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKA--KIADFGLAKMLAKQGEPHTMSAVAGSF 818
            L ++H      I H D++  NI+  +   +  KI +FG A+ L K G+      +  + 
Sbjct: 114 ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDN--FRLLFTAP 167

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            Y+APE      V+   D++S G ++  L++G
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 90.7 bits (226), Expect = 6e-20
 Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 18/210 (8%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G G    V            A+K +     + +        E +++  + H   VKL+
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA-IGAAQG 761
                +        Y +N  L +++  RK     GS           TR   A I +A  
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI--RK----IGSFDETC------TRFYTAEIVSA-- 142

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H      IIHRD+K  NILL+ +   +I DFG AK+L+ + +    ++  G+  Y 
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
           +PE        +  D+++ G ++ +LV G 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 94.0 bits (233), Expect = 6e-20
 Identities = 51/272 (18%), Positives = 93/272 (34%), Gaps = 34/272 (12%)

Query: 87  QKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISG 146
           ++I P           +L   S+             +  +  + +        DI  + G
Sbjct: 12  KQIFPD-DAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNS--------DIKSVQG 60

Query: 147 LQC------IDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGL 200
           +Q       + L GN  + DI   +  L  L  L+L  N+        + DL  L+ L L
Sbjct: 61  IQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSL 116

Query: 201 AYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGA 258
            +N  S+            L +L++L++   N I +I   +S L+ L+ L+L  N +   
Sbjct: 117 EHNGISDING------LVHLPQLESLYLGN-NKITDI-TVLSRLTKLDTLSLEDNQISDI 168

Query: 259 IPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQL 318
               L  L  L  L+L  N +S ++ +      L  ++L               L     
Sbjct: 169 --VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 225

Query: 319 LGLFSNHLSGEVPASIGVVAFENNLSGAVPKS 350
           +      L      S      + N+   +P+ 
Sbjct: 226 VKNTDGSLVTPEIISDDGDYEKPNVKWHLPEF 257

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 80.9 bits (199), Expect = 7e-16
 Identities = 60/322 (18%), Positives = 122/322 (37%), Gaps = 39/322 (12%)

Query: 218 LKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDN 277
             +     + +   + +     + L+S++ +  N + ++     G+  L N+T+LFL  N
Sbjct: 20  FAETIKDNLKK-KSVTDA-VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGN 75

Query: 278 ILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVV 337
            L+ +I        L  + L  N +   +      LK L+ L L  N +S          
Sbjct: 76  KLT-DIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS---------- 122

Query: 338 AFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPS 397
               +++G     L +   L ++ L +N+ +    T L     L +L L DN IS  +P 
Sbjct: 123 ----DING-----LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPL 171

Query: 398 KTAWNLTRLEISNNRFSGQIQ--RGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTL- 454
                L  L +S N     I   R +   KNL V +  +     +     ++L   NT+ 
Sbjct: 172 AGLTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 227

Query: 455 LLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIP 514
             DG+ ++   P  I         N+  + L     +        V++  +  +F G + 
Sbjct: 228 NTDGSLVT---PEIISDDGDYEKPNVKWH-LPEFTNEVSFIFYQPVTIGKAKARFHGRVT 283

Query: 515 PEIGQLKLNTFNLSSNKLYGNI 536
             + ++   ++++    +   +
Sbjct: 284 QPLKEVYTVSYDVDGTVIKTKV 305

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 70.1 bits (171), Expect = 2e-12
 Identities = 48/271 (17%), Positives = 94/271 (34%), Gaps = 32/271 (11%)

Query: 292 LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSL 351
           + +       +    P++           L    ++  V                     
Sbjct: 1   MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT-------------------Q 39

Query: 352 GNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNN 411
               ++  +   ++     +  G+    N++ L L+ N ++   P     NL  L +  N
Sbjct: 40  NELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDEN 97

Query: 412 RFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVS 471
           +    +   +   K L      +N  S +I   L  L  L +L L  NK++    + +  
Sbjct: 98  KIK-DLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSR 151

Query: 472 WTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNK 531
            T L+ L+L  N++S +I   +  L  + +L LS N  S ++    G   L+   L S +
Sbjct: 152 LTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQE 208

Query: 532 LYGNIPDEFNNLAYDDSFLNNSNLCVKNPII 562
                 +  +NL   ++  N     V   II
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSLVTPEII 239

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.6 bits (228), Expect = 1e-19
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 36/232 (15%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI-AEIEILGTIRHANIVKL 701
            IG G  G+V  +  N   +  A+K + N +K  ++ E   +  E++I+  + H  +V L
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYM-NKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 702 WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA-IGAA 759
           W     E   + +V + +    L R+   +       +            +L I  +  A
Sbjct: 81  WYSFQDE-EDMFMVVDLLLGGDL-RYHLQQNVHFKEET-----------VKLFICELVMA 127

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
             L Y+ +    +IIHRD+K  NILLD      I DF +A ML ++ +  TM+   G+  
Sbjct: 128 --LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKP 179

Query: 820 YFAPE-------YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
           Y APE         Y+  V    D +S GV   EL+ G+   +    TS  E
Sbjct: 180 YMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRPYHIRSSTSSKE 227

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 90.9 bits (226), Expect = 1e-19
 Identities = 58/227 (25%), Positives = 84/227 (37%), Gaps = 58/227 (25%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            IGSG  G    +      E VAVK I     +++ +++E    I    ++RH NIV+  
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFK 82

Query: 703 CCISSENSKLLVYEYMENQSLDRWL--HGRK---------RSLVSGSSSVHQHVLHWPTR 751
             I +     ++ EY     L   +   GR          + L+SG S  H         
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM------- 135

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA--KIADFGLAKMLAKQGEPH 809
                               QI HRD+K  N LLD       KI DFG +K      +P 
Sbjct: 136 --------------------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175

Query: 810 TMSAVAGSFGYFAPE------YAYTTKVNEKIDIYSFGVVLLELVTG 850
           +     G+  Y APE      Y       +  D++S GV L  ++ G
Sbjct: 176 S---TVGTPAYIAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVG 214

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 30/216 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA----EIEILGTIRHANIV 699
           +GSG    V +    G G+  A K I   R+L+             E+ IL  IRH NI+
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFI-KKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 700 KLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
            L     ++   +L+ E +    L D        +    +  + Q +L            
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ-IL------------ 118

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA----KIADFGLAKMLAKQGEPHTMSAV 814
             G+ Y+H     +I H D+K  NI+L  +       K+ DFG+A  + + G       +
Sbjct: 119 -DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNE--FKNI 171

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            G+  + APE      +  + D++S GV+   L++G
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 50/216 (23%), Positives = 81/216 (37%), Gaps = 30/216 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA----EIEILGTIRHANIV 699
           +GSG    V +      G   A K I   R+               E+ IL  I+H N++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 700 KLWCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
            L     ++   +L+ E +    L D        +    +  + Q +             
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL------------- 124

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA----KIADFGLAKMLAKQGEPHTMSAV 814
             G+ Y+H     QI H D+K  NI+L          KI DFGLA  +   G       +
Sbjct: 125 -NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNE--FKNI 177

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG 850
            G+  + APE      +  + D++S GV+   L++G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 33/282 (11%), Positives = 70/282 (24%), Gaps = 58/282 (20%)

Query: 643 LIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             G     Q ++ +D       VA+  +     L   + +E ++    L  I    + ++
Sbjct: 38  FHGGVPPLQFWQALDTA-LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
              + +    L+V E++   SL                            ++     A  
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS---------------PSPVGAIRAMQSLAAA 141

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
               H      +       S + +  +    +A                           
Sbjct: 142 ADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TM 176

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
                         DI   G  L  L+  +         S    A R  A +      +D
Sbjct: 177 PDANPQD-------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID 229

Query: 882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
           + I  P  +        +A          R +   +L ++++
Sbjct: 230 RDI--PFQISA------VAARSVQGDGGIRSAS-TLLNLMQQ 262

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 55/252 (21%), Positives = 94/252 (37%), Gaps = 77/252 (30%)

Query: 643 LIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIA---------------- 685
            IG G  G V    + N    + A+K + + +KL ++                       
Sbjct: 20  EIGKGSYGVVKLAYNEND-NTYYAMK-VLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 686 --------EIEILGTIRHANIVKLWCCISSEN-SKL-LVYEYMENQSL-DRWLHGRK--- 731
                   EI IL  + H N+VKL   +   N   L +V+E +    + +          
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137

Query: 732 ------RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL 785
                 + L+ G                        + Y+H+    +IIHRD+K SN+L+
Sbjct: 138 QARFYFQDLIKG------------------------IEYLHYQ---KIIHRDIKPSNLLV 170

Query: 786 DSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPE------YAYTTKVNEKIDIYS 839
             +   KIADFG++     +G    +S   G+  + APE        ++ K    +D+++
Sbjct: 171 GEDGHIKIADFGVSNEF--KGSDALLSNTVGTPAFMAPESLSETRKIFSGK---ALDVWA 225

Query: 840 FGVVLLELVTGK 851
            GV L   V G+
Sbjct: 226 MGVTLYCFVFGQ 237

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 89.3 bits (222), Expect = 3e-19
 Identities = 57/207 (27%), Positives = 80/207 (38%), Gaps = 32/207 (15%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT-IRHANIVKLW 702
           IG G      R          AVK I +  K +         EIEIL    +H NI+ L 
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKII-DKSKRDPT------EEIEILLRYGQHPNIITLK 82

Query: 703 CCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                     +V E M+   L D+ L  R++     S      VL       I     + 
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDKIL--RQKFF---SEREASAVLF-----TIT----KT 128

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKA----KIADFGLAKMLAKQGEPHTMSAVAGS 817
           + Y+H      ++HRD+K SNIL   E       +I DFG AK L  + E   +     +
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL--RAENGLLMTPCYT 183

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVL 844
             + APE       +   DI+S GV+L
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLL 210

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 89.7 bits (223), Expect = 3e-19
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 45/222 (20%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +GSG  G V        G  VA+K+++   + ++   K    E+ +L  +RH N++ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLD 91

Query: 704 CISSENSKL------LVYEYMENQSLDRWLHG--RKRSLVSGSSSVH-QHVLHWPTRLQI 754
             + + +        LV  +M     D  L    +   L         Q +++     Q+
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGT---D--LGKLMKHEKL----GEDRIQFLVY-----QM 137

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
                +GL Y+H      IIHRD+K  N+ ++ + + KI DFGLA+      +      V
Sbjct: 138 L----KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYV 186

Query: 815 AGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
              + Y APE       YT      +DI+S G ++ E++TGK
Sbjct: 187 VTRW-YRAPEVILNWMRYTQ----TVDIWSVGCIMAEMITGK 223

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 44/225 (19%)

Query: 643 LIGSGGSGQVY----RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA----EIEILGTIR 694
           L+GSGG G VY      D       VA+K +    +++   E         E+ +L  + 
Sbjct: 50  LLGSGGFGSVYSGIRVSD----NLPVAIKHV-EKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 695 HA--NIVKLWCCISSENSKLLVYEYMEN-QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
                +++L       +S +L+ E  E  Q L  ++  R   L      + +        
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-L---QEELARSFFW---- 156

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEPHT 810
            Q+     + + + H+     ++HRD+K  NIL+D    + K+ DFG   +L K      
Sbjct: 157 -QVL----EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTD 207

Query: 811 MSAVAGSFGYFAPEY----AYTTKVNEKIDIYSFGVVLLELVTGK 851
                G+  Y  PE+     Y  +      ++S G++L ++V G 
Sbjct: 208 ---FDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGD 246

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 90.6 bits (225), Expect = 4e-19
 Identities = 68/227 (29%), Positives = 98/227 (43%), Gaps = 54/227 (23%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA-EIEILGTIRHANIVKL 701
            +G G  G+V        G  VAVK I N +K+        I  EI+ L   RH +I+KL
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 702 WCCISSENSKLLVYEYMENQSL-DRWL-HGRK---------RSLVSGSSSVHQHVLHWPT 750
           +  IS+ +   +V EY+    L D    +GR          + ++SG    H+H      
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH------ 135

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                                 ++HRD+K  N+LLD+   AKIADFGL+ M++      T
Sbjct: 136 ---------------------MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174

Query: 811 MSAVAGSFGYFAPE------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
                GS  Y APE      YA       ++DI+S GV+L  L+ G 
Sbjct: 175 ---SCGSPNYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGT 213

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 88.8 bits (220), Expect = 5e-19
 Identities = 73/356 (20%), Positives = 119/356 (33%), Gaps = 91/356 (25%)

Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             L     +G G  GQV       ID       VAVK +           +  ++E++IL
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKIL 79

Query: 691 GTI-RHANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGR------------------ 730
             I  H N+V L   C       +++ E+ +  +L  +L  +                  
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGK 139

Query: 731 ----------KRSLVSGSSS-------------------------VHQHVLHWPTRLQIA 755
                     KR L S +SS                         +++  L     +  +
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              A+G   M    + + IHRD+ + NILL  +   KI DFGLA+ + K  +      V 
Sbjct: 200 FQVAKG---MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-----YVR 251

Query: 816 GSFGYF-----APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY--GDEHTSLAEWAWR 868
                      APE  +      + D++SFGV+L E+ +   + Y               
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311

Query: 869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
                 P          +    E    +Y+  L C    PS RP+  E+++ L   
Sbjct: 312 GTRMRAP----------DYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 51/217 (23%), Positives = 84/217 (38%), Gaps = 35/217 (16%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKL 701
           ++G G   +V         +  AVK I   +  + +       E+E+L   + H N+++L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKII-EKQPGHIR--SRVFREVEMLYQCQGHRNVLEL 76

Query: 702 WCCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                 E+   LV+E M   S+    +H R+      +S V Q V               
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSH-IHKRRHFNELEASVVVQDVA-------------S 122

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKML-----AKQGEPHTMS 812
            L ++H      I HRD+K  NIL +   +    KI DF L   +             + 
Sbjct: 123 ALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 813 AVAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVL 844
              GS  Y APE         +  +++ D++S GV+L
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 88.1 bits (219), Expect = 8e-19
 Identities = 57/242 (23%), Positives = 104/242 (42%), Gaps = 42/242 (17%)

Query: 623 SFHQLGF--TESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE 680
            F++     T   +  +      +GSG  G V       +GE VA+K++    + ++   
Sbjct: 9   GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFA 67

Query: 681 KEFIAEIEILGTIRHANIVKLWCCISSENSKL------LVYEYMENQSLDRWLHGRKRSL 734
           K    E+ +L  ++H N++ L    +  +S        LV  +M+    D  L       
Sbjct: 68  KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---D--LQKIMGL- 121

Query: 735 VSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA 794
              S    Q++++     Q+     +GL Y+H   +  ++HRD+K  N+ ++ + + KI 
Sbjct: 122 -KFSEEKIQYLVY-----QML----KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKIL 168

Query: 795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVT 849
           DFGLA+      +      V   + Y APE       Y       +DI+S G ++ E++T
Sbjct: 169 DFGLARHA----DAEMTGYVVTRW-YRAPEVILSWMHYNQ----TVDIWSVGCIMAEMLT 219

Query: 850 GK 851
           GK
Sbjct: 220 GK 221

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 86.7 bits (215), Expect = 9e-19
 Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 24/217 (11%)

Query: 70  CTFN---SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNL 126
           C  +   S   ++   +++T  +PP +   K+ T + LS N +       L   T+L  L
Sbjct: 4   CEVSKVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 127 DLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF----N 182
           +L +   +  +  D   +  L  +DL  N     +P     L  L  L +  N       
Sbjct: 61  NLDRAE-LTKLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 183 GTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE-FGMLKKLKTLWMTEANLIGEIPEAM-S 240
           G        L  L+ L L  N   +   +P        KL+ L +   N + E+P  + +
Sbjct: 118 GALRG----LGELQELYLKGN---ELKTLPPGLLTPTPKLEKLSLAN-NNLTELPAGLLN 169

Query: 241 NLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDN 277
            L +L+ L L  N L   IP G F  + L   FL+ N
Sbjct: 170 GLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 52/272 (19%), Positives = 80/272 (29%), Gaps = 77/272 (28%)

Query: 240 SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSM 299
           S ++S   +  +  +L  A+P                      +P     L      LS 
Sbjct: 7   SKVASHLEVNCDKRNL-TALPPD--------------------LPKDTTIL-----HLSE 40

Query: 300 NNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRT 359
           N L             L  L L    L+ ++     +                    L T
Sbjct: 41  NLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPV------------------LGT 81

Query: 360 VQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAW---NLTRLEISNNRFSGQ 416
           + L  N+    LP    T   L+ L +S N ++  LP         L  L +  N     
Sbjct: 82  LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-T 138

Query: 417 IQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQI-VSWTSL 475
           +  G+                       LT    L  L L  N L+ +LP+ +     +L
Sbjct: 139 LPPGL-----------------------LTPTPKLEKLSLANNNLT-ELPAGLLNGLENL 174

Query: 476 NNLNLARNELSGEIPKAIGSLLVMVSLDLSGN 507
           + L L  N L   IPK      ++    L GN
Sbjct: 175 DTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 48/205 (23%), Positives = 74/205 (36%), Gaps = 21/205 (10%)

Query: 357 LRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEI---SNNRF 413
              V       +  LP  L    + + L LS+N +       T    TRL          
Sbjct: 12  HLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRA-- 65

Query: 414 SGQIQR--GVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQI-V 470
             ++ +    G+   L     S+N     +P+   +L  L  L +  N+L+  LP     
Sbjct: 66  --ELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121

Query: 471 SWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEI--GQLKLNTFNLS 528
               L  L L  NEL    P  +     +  L L+ N  + E+P  +  G   L+T  L 
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180

Query: 529 SNKLYGNIPDE-FNNLAYDDSFLNN 552
            N LY  IP   F +     +FL+ 
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHG 204

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 88.1 bits (219), Expect = 1e-18
 Identities = 59/243 (24%), Positives = 100/243 (41%), Gaps = 48/243 (19%)

Query: 630 TESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI 689
              NI S     +L+G G  G V        GE VA+K+I              + EI+I
Sbjct: 5   IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKI 62

Query: 690 LGTIRHANIVKLWCCISSENSKL-----LVYEYMENQSLDRWLHG--RKRSLVSGSSSVH 742
           L   +H NI+ ++     ++ +      ++ E M+    D  LH     + L    S  H
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT---D--LHRVISTQML----SDDH 113

Query: 743 -QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM 801
            Q+ ++     Q      + +  +H      +IHRD+K SN+L++S    K+ DFGLA++
Sbjct: 114 IQYFIY-----QTL----RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161

Query: 802 LAKQGEPHTMSAVAGSFG--------YFAPE-----YAYTTKVNEKIDIYSFGVVLLELV 848
           + +    ++      S          Y APE       Y+      +D++S G +L EL 
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSR----AMDVWSCGCILAELF 217

Query: 849 TGK 851
             +
Sbjct: 218 LRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 89.0 bits (221), Expect = 1e-18
 Identities = 55/269 (20%), Positives = 108/269 (40%), Gaps = 52/269 (19%)

Query: 622 TSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEK 681
            + +  G    ++  +    +LIG G  G VY        + VA+K++    + +    K
Sbjct: 12  ENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCK 70

Query: 682 EFIAEIEILGTIRHANIVKLWCCISSENSKL-----LVYEYMENQSLDRWLHGRKRSLVS 736
             + EI IL  ++   I++L+  I  ++        +V E  ++   D  L    ++ + 
Sbjct: 71  RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS---D--LKKLFKTPIF 125

Query: 737 GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF 796
            +    + +L+      +      G  ++H      IIHRD+K +N LL+ +   K+ DF
Sbjct: 126 LTEEHIKTILY-----NLL----LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDF 173

Query: 797 GLAKMLAKQGEPHTMSAVAGSFG--------------------YFAPE-----YAYTTKV 831
           GLA+ +  + + + ++ +  +                      Y APE       YT   
Sbjct: 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK-- 231

Query: 832 NEKIDIYSFGVVLLELVTGKEANYGDEHT 860
              IDI+S G +  EL+   +++  D   
Sbjct: 232 --SIDIWSTGCIFAELLNMLQSHINDPTN 258

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 88.0 bits (218), Expect = 2e-18
 Identities = 56/285 (19%), Positives = 107/285 (37%), Gaps = 57/285 (20%)

Query: 609 RRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKR 668
             ++ +   + K T+      ++  I       +LIG+G  G V           VA+K+
Sbjct: 26  EGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK 85

Query: 669 IWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL-----LVYEYMENQSL 723
           I    + +    K  + EI IL  + H ++VK+   +  ++ +      +V E  +    
Sbjct: 86  ILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---S 141

Query: 724 DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI 783
           D       R+ V  +    + +L+      +      G+ Y+H   +  I+HRD+K +N 
Sbjct: 142 D--FKKLFRTPVYLTELHIKTLLY-----NLL----VGVKYVH---SAGILHRDLKPANC 187

Query: 784 LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG------------------------ 819
           L++ +   K+ DFGLA+ +      ++   ++                            
Sbjct: 188 LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTR 247

Query: 820 -YFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE 858
            Y APE       YT      ID++S G +  EL+   + N    
Sbjct: 248 WYRAPELILLQENYTE----AIDVWSIGCIFAELLNMIKENVAYH 288

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 86.6 bits (215), Expect = 3e-18
 Identities = 64/241 (26%), Positives = 107/241 (44%), Gaps = 41/241 (17%)

Query: 625 HQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI 684
             +     ++    T  + IG G  G V     N     VA+K+I  +   +Q   +  +
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTL 73

Query: 685 AEIEILGTIRHANIVKLWCCISSENSKL-----LVYEYMENQSLDRWLHG--RKRSLVSG 737
            EI+IL   RH NI+ +   I +   +      +V + ME    D  L+   + + L   
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET---D--LYKLLKTQHL--- 125

Query: 738 SSSVH-QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF 796
            S+ H  + L+     QI     +GL Y+H   +  ++HRD+K SN+LL++    KI DF
Sbjct: 126 -SNDHICYFLY-----QIL----RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDF 172

Query: 797 GLAKMLAKQ-GEPHTMSAVAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTG 850
           GLA++          ++    +  Y APE       YT      IDI+S G +L E+++ 
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK----SIDIWSVGCILAEMLSN 228

Query: 851 K 851
           +
Sbjct: 229 R 229

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.5 bits (212), Expect = 5e-18
 Identities = 44/211 (20%), Positives = 81/211 (38%), Gaps = 36/211 (17%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKL 701
           ++G G +G+V        G+  A+K +  +    ++       E++         +IV +
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLL-YDSPKARQ-------EVDHHWQASGGPHIVCI 87

Query: 702 W----CCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
                     +   L++ E ME   L  R     +R   + +      ++       I  
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQ---ERGDQAFTEREAAEIMR-----DIG- 138

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSA 813
                + ++H      I HRDVK  N+L  S+ K    K+ DFG AK        + +  
Sbjct: 139 ---TAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQT 188

Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVL 844
              +  Y APE     K ++  D++S GV++
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 87.9 bits (218), Expect = 5e-18
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 31/216 (14%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G GG G+V    +   G+  A K++   R   +K E   + E +IL  +    +V L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ-- 760
               ++++  LV   M    L   ++   ++    + +V                AA+  
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--------------AAEIC 296

Query: 761 -GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            GL  +H +   +I++RD+K  NILLD     +I+D GLA  + +           G+ G
Sbjct: 297 CGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVG 350

Query: 820 YFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           Y APE      YT       D ++ G +L E++ G+
Sbjct: 351 YMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQ 382

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 85.8 bits (213), Expect = 5e-18
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 41/220 (18%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +GSG  G V        G  VAVK++    + +    K    E+ +L  ++H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLD 95

Query: 704 CISSENSKL------LVYEYMENQSLDRWLHGRKRSLVSGSSSVH-QHVLHWPTRLQIAI 756
             +   S        LV   M    L+  +  +K  L    +  H Q +++     QI  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK--L----TDDHVQFLIY-----QI-- 141

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              +GL Y+H   +  IIHRD+K SN+ ++ + + KI DFGLA+  A          VA 
Sbjct: 142 --LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVAT 192

Query: 817 SFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
            + Y APE       Y       +DI+S G ++ EL+TG+
Sbjct: 193 RW-YRAPEIMLNWMHYNQ----TVDIWSVGCIMAELLTGR 227

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 83.5 bits (207), Expect = 9e-18
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 32/211 (15%)

Query: 161 IPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE-FGMLK 219
           IP +I   ++ + L L  N+ +    K    L+ L +L L  N   K   +P   F  LK
Sbjct: 31  IPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDN---KLQTLPAGIFKELK 85

Query: 220 KLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDN 277
            L+TLW+T+ N +  +P      L +L  L L+ N L+ ++P  +F  L  LT L L  N
Sbjct: 86  NLETLWVTD-NKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN 143

Query: 278 ILSGEIPSSV-EAL-KLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSNHLSGEVPASI 334
            L   +P  V + L  L ++ L  N L   +PE  F KL  L+ L L +N L       +
Sbjct: 144 ELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-----RV 196

Query: 335 GVVAFENNLSGAVPKSLGNCRTLRTVQLYSN 365
              AF++               L+ +QL  N
Sbjct: 197 PEGAFDSLEK------------LKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 56/204 (27%), Positives = 83/204 (40%), Gaps = 31/204 (15%)

Query: 94  CDLKNLTTI-----------DLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI- 141
           C  K LT I           DL SN +     +  +  TKL+ L L+ N     +P+ I 
Sbjct: 23  CSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIF 81

Query: 142 DRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEF----NGTFPKEIGDLSNLE 196
             +  L+ + +  N     +P  +  +L  L  L L  N+        F      L+ L 
Sbjct: 82  KELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDS----LTKLT 136

Query: 197 VLGLAYNSNFKPAMIPIE-FGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNH 254
            L L YN   +   +P   F  L  LK L +   N +  +PE A   L+ L+ L L+ N 
Sbjct: 137 YLSLGYN---ELQSLPKGVFDKLTSLKELRLYN-NQLKRVPEGAFDKLTELKTLKLDNNQ 192

Query: 255 LEGAIPSGLF-LLNNLTQLFLYDN 277
           L+  +P G F  L  L  L L +N
Sbjct: 193 LK-RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 59/251 (23%), Positives = 84/251 (33%), Gaps = 73/251 (29%)

Query: 283 IPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENN 342
           IP+  + L     DL  N L+    + F +L  L+LL L  N L                
Sbjct: 35  IPADTKKL-----DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ--------------T 75

Query: 343 LSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWN 402
           L   + K L N   L T+ +  N+    LP G++    L                    N
Sbjct: 76  LPAGIFKELKN---LETLWVTDNKLQ-ALPIGVFD--QLV-------------------N 110

Query: 403 LTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLS 462
           L  L +  N    Q++                 +F       LT L++L+   L  N+L 
Sbjct: 111 LAELRLDRN----QLK------------SLPPRVFDS-----LTKLTYLS---LGYNELQ 146

Query: 463 GKLPSQI-VSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEI--GQ 519
             LP  +    TSL  L L  N+L      A   L  + +L L  NQ    +P       
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSL 204

Query: 520 LKLNTFNLSSN 530
            KL    L  N
Sbjct: 205 EKLKMLQLQEN 215

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 29/191 (15%), Positives = 72/191 (37%), Gaps = 39/191 (20%)

Query: 95  DLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISG---LQCID 151
            + +LT I L++ ++       +     +++L ++  +      ++ + ISG   L+ + 
Sbjct: 42  QMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHA-----TNYNPISGLSNLERLR 94

Query: 152 LGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMI 211
           + G + + D   ++  L+ L  L +  +  + +   +I  L  +  + L+YN        
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN-------- 146

Query: 212 PIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQ 271
                               I +I   +  L  L+ L +  + +      G+     L Q
Sbjct: 147 ------------------GAITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQ 185

Query: 272 LFLYDNILSGE 282
           L+ +   + G+
Sbjct: 186 LYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 78.8 bits (195), Expect = 8e-17
 Identities = 28/178 (15%), Positives = 67/178 (37%), Gaps = 14/178 (7%)

Query: 154 GNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYN--SNFKPAMI 211
           G + + +I  +  +++ L  + L            I    N++ L +     +N+ P   
Sbjct: 31  GQSSTANI--TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP--- 83

Query: 212 PIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQ 271
                 L  L+ L +   ++  +    +S L+SL +L ++ +  + +I + +  L  +  
Sbjct: 84  ---ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140

Query: 272 LFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGE 329
           + L  N    +I       +L  +++  + +             L  L  FS  + G+
Sbjct: 141 IDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 27/189 (14%), Positives = 66/189 (34%), Gaps = 25/189 (13%)

Query: 207 KPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLL 266
           + +   I    +  L  + +     + ++   +    +++ L +N  H      + +  L
Sbjct: 32  QSSTANITEAQMNSLTYITLAN-INVTDL-TGIEYAHNIKDLTINNIHATNY--NPISGL 87

Query: 267 NNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNH 325
           +NL +L +    ++ +   ++  L  LT +D+S +    SI  +   L  +  + L  N 
Sbjct: 88  SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147

Query: 326 LSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLM 385
              ++                    L     L+++ +  +        G+     L+ L 
Sbjct: 148 AITDI------------------MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLY 187

Query: 386 LSDNTISGE 394
               TI G+
Sbjct: 188 AFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 26/111 (23%), Positives = 42/111 (37%), Gaps = 3/111 (2%)

Query: 93  ICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL 152
           I  L NL  + +    +  +    L   T L  LD+S +     I + I+ +  +  IDL
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYN 203
             N    DI   +  L EL++L +  +  +      I D   L  L     
Sbjct: 144 SYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 64.6 bits (158), Expect = 7e-12
 Identities = 26/199 (13%), Positives = 65/199 (32%), Gaps = 26/199 (13%)

Query: 218 LKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDN 277
            K      + + +    I E  + ++SL  + L   ++     +G+   +N+  L + + 
Sbjct: 22  FKAYLNGLLGQ-SSTANITE--AQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76

Query: 278 ILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGV 336
             +    + +  L  L  + +   ++T         L +L LL +               
Sbjct: 77  HATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH------------- 121

Query: 337 VAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELP 396
               +    ++   +     + ++ L  N    ++   L T   L SL +  + +     
Sbjct: 122 ----SAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG 176

Query: 397 SKTAWNLTRLEISNNRFSG 415
            +    L +L   +    G
Sbjct: 177 IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 58.8 bits (143), Expect = 7e-10
 Identities = 29/153 (18%), Positives = 66/153 (43%), Gaps = 5/153 (3%)

Query: 380 NLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSG 439
              + +L  ++ +    ++   +LT + ++N   +  +  G+    N+     +N   + 
Sbjct: 24  AYLNGLLGQSSTANITEAQMN-SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN 80

Query: 440 EIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVM 499
             P  ++ LS+L  L + G  ++      +   TSL  L+++ +     I   I +L  +
Sbjct: 81  YNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKV 138

Query: 500 VSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKL 532
            S+DLS N    +I P     +L + N+  + +
Sbjct: 139 NSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 58.8 bits (143), Expect = 7e-10
 Identities = 27/177 (15%), Positives = 61/177 (34%), Gaps = 5/177 (2%)

Query: 336 VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGEL 395
            +      S     +     +L  + L +   + +L TG+    N+  L +++   +   
Sbjct: 25  YLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYN 82

Query: 396 PSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLL 455
           P     NL RL I     +      +    +L +   S++     I  ++ +L  +N++ 
Sbjct: 83  PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142

Query: 456 LDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGE 512
           L  N     +   + +   L +LN+  + +       I     +  L        G+
Sbjct: 143 LSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 26/225 (11%), Positives = 61/225 (27%), Gaps = 52/225 (23%)

Query: 266 LNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNH 325
                   L  +  S    +  +   LT I L+  N+T  +        N++ L + + H
Sbjct: 22  FKAYLNGLLGQS--STANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH 77

Query: 326 LSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLM 385
            +              N +      +     L  +++     + +    L    +L+ L 
Sbjct: 78  AT--------------NYNP-----ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118

Query: 386 LSDNTISGELPSKTAW--NLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPV 443
           +S +     + +K      +  +++S N     I   + +   L       +        
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFD-------- 169

Query: 444 ELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGE 488
            +     +                       LN L      + G+
Sbjct: 170 GVHDYRGIEDF------------------PKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 18/120 (15%), Positives = 44/120 (36%), Gaps = 8/120 (6%)

Query: 425 KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNE 484
           K  +      +  +     ++ SL+++    L    ++  L + I    ++ +L +    
Sbjct: 23  KAYLNGLLGQSSTANITEAQMNSLTYIT---LANINVT-DL-TGIEYAHNIKDLTINNIH 77

Query: 485 LSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNKLYGNIPDEFNNL 543
            +      I  L  +  L + G   + +  P +  L  L   ++S +    +I  + N L
Sbjct: 78  ATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 46/226 (20%), Positives = 81/226 (35%), Gaps = 46/226 (20%)

Query: 643 LIGSGGSGQVY----RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA----EIEILGTIR 694
           L+G GG G V+      D       VA+K I    ++              E+ +L  + 
Sbjct: 38  LLGKGGFGTVFAGHRLTD----RLQVAIKVI-PRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 695 ----HANIVKLWCCISSENSKLLVYEYMEN-QSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
               H  +++L     ++   +LV E     Q L  ++  +            +      
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPL----GEGPSRCFFG-- 146

Query: 750 TRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEP 808
              Q+       + + H      ++HRD+K  NIL+D     AK+ DFG   +L      
Sbjct: 147 ---QVV----AAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPY 195

Query: 809 HTMSAVAGSFGYFAPEY----AYTTKVNEKIDIYSFGVVLLELVTG 850
                  G+  Y  PE+     Y         ++S G++L ++V G
Sbjct: 196 TD---FDGTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCG 235

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 54/318 (16%), Positives = 100/318 (31%), Gaps = 40/318 (12%)

Query: 230 NLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEA 289
           N     P+  S  + L    +       ++   L  ++    L  + +I+      S++ 
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSL---SLKR 72

Query: 290 LKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPK 349
           L +    +    L G++      +  LQ L L +  ++G  P  +      +        
Sbjct: 73  LTVRAARIPSRILFGAL--RVLGISGLQELTLENLEVTGTAPPPLLEATGPD-------- 122

Query: 350 SLGNCRTLRTVQLYSNRFSGELP----TGLWTTFNLSSLMLSDNTISGELPSKTAWNLTR 405
                  L  + L +  ++           W    L  L ++          +       
Sbjct: 123 -------LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFSCEQVRVFPA 174

Query: 406 LE---ISNNRFSGQI----QRGVGSWKNLIVFKASNNLF---SGEIPVELTSLSHLNTLL 455
           L    +S+N   G+           +  L V    N      SG       +   L  L 
Sbjct: 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLD 234

Query: 456 LDGNKLSGKLPSQIVSW-TSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIP 514
           L  N L     +    W + LN+LNL+   L  ++PK + + L    LDLS N+     P
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLS--VLDLSYNRLD-RNP 290

Query: 515 PEIGQLKLNTFNLSSNKL 532
                 ++   +L  N  
Sbjct: 291 SPDELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 75.7 bits (186), Expect = 6e-15
 Identities = 54/287 (18%), Positives = 90/287 (31%), Gaps = 32/287 (11%)

Query: 240 SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL----KLTDI 295
              S   +L       +    + +    +L +L +    +   I      +     L ++
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 296 DLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCR 355
            L    +TG+ P    +     L  L   ++S          A+   L   +   L    
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVS-----WATRDAWLAELQQWLKPGL---- 151

Query: 356 TLRTVQLYSNRFSGELPTGLWTTF-NLSSLMLSDNTISGELPSKTAW------NLTRLEI 408
             + + +                F  LS+L LSDN   GE    +A        L  L +
Sbjct: 152 --KVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208

Query: 409 SNNRF---SGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTS-LSHLNTLLLDGNKLSGK 464
            N      SG       +   L     S+N              S LN+L L    L  +
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-Q 267

Query: 465 LPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSG 511
           +P  + +   L+ L+L+ N L    P     L  + +L L GN F  
Sbjct: 268 VPKGLPA--KLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 45/248 (18%), Positives = 81/248 (32%), Gaps = 42/248 (16%)

Query: 71  TFNSVTGISLRHKDITQKIPPII--CDLKNLTTIDLSSNSIPGEFPE----FLYNCTKLQ 124
             + +  ++L + ++T   PP +      +L  ++L + S             +    L+
Sbjct: 93  GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152

Query: 125 NLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSI----GRLSELQTLYLYMNE 180
            L ++Q + +      +     L  +DL  N   G+          +   LQ L L    
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212

Query: 181 FN---GTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE 237
                G           L+ L L++N + + A          +L +L             
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHN-SLRDAAGAPSCDWPSQLNSL------------- 258

Query: 238 AMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDL 297
              NLS           L+  +P GL     L+ L L  N L    PS  E  ++ ++ L
Sbjct: 259 ---NLSF--------TGLK-QVPKGLP--AKLSVLDLSYNRLD-RNPSPDELPQVGNLSL 303

Query: 298 SMNNLTGS 305
             N    S
Sbjct: 304 KGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 72.2 bits (177), Expect = 9e-14
 Identities = 51/295 (17%), Positives = 95/295 (32%), Gaps = 31/295 (10%)

Query: 58  STSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDL----KNLTTIDLSSNSI--PG 111
           +   PC+  E +C+ N  +            +     +L    ++L  +    ++    G
Sbjct: 1   ADPEPCELDEESCSCN-FSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLG 59

Query: 112 EFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRI---SGLQCIDLGGNNFSGDIPRSIGRL 168
           +F + +     L+ L +        I     R+   SGLQ + L     +G  P  +   
Sbjct: 60  QFTDII-KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA 118

Query: 169 SELQTLYLYMNEFN-GTFPKEIGDLSN-----LEVLGLAYNSNFKPAMIPIEFGMLKKLK 222
           +      L +   +  T    + +L       L+VL +A   +        +  +   L 
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL--NFSCEQVRVFPALS 176

Query: 223 TLWMTEANLIGEI-------PEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLY 275
           TL +++   +GE        P     L  L +         G   +       L  L L 
Sbjct: 177 TLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS 236

Query: 276 DNILSGEIPSSVEAL--KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSG 328
            N L     +       +L  ++LS   L   +P+       L +L L  N L  
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR 288

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 61/362 (16%), Positives = 101/362 (27%), Gaps = 85/362 (23%)

Query: 107 NSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIP-SDIDRISGLQCIDLGGNNFSGDIPRSI 165
           N +     E       L+ L    +        +DI +   L+ + +        I    
Sbjct: 29  NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88

Query: 166 GRL---SELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLK 222
            R+   S LQ L L   E  GT P  + + +  ++  L    N   A        L++  
Sbjct: 89  LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL-NLRNVSWATRDAWLAELQQWL 147

Query: 223 TLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGE 282
                                 L++L++   H        + +   L+ L L DN   GE
Sbjct: 148 -------------------KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 283 IPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENN 342
                              L  ++     K   LQ+L L +  +                
Sbjct: 189 RG-----------------LISALCP--LKFPTLQVLALRNAGM--------------ET 215

Query: 343 LSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWT-TFNLSSLMLSDNTISGELPSKTAW 401
            SG           L+ + L  N                L+SL LS   +  ++P     
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA 274

Query: 402 NLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKL 461
            L+ L++S NR                             P EL  + +L+   L GN  
Sbjct: 275 KLSVLDLSYNRLD-----------------------RNPSPDELPQVGNLS---LKGNPF 308

Query: 462 SG 463
             
Sbjct: 309 LD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 69.5 bits (170), Expect = 8e-13
 Identities = 37/208 (17%), Positives = 65/208 (31%), Gaps = 20/208 (9%)

Query: 356 TLRTVQLYSNRFSGELPTGLWTTFNLSS---LMLSDNTISGELP----SKTAWNLTRLEI 408
           +L+ + + + R    +  G      +S    L L +  ++G  P      T  +L  L +
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 409 SNNRFSGQIQR----GVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGK 464
            N  ++ +              L V   +          ++     L+TL L  N   G+
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 465 LP----SQIVSWTSLNNLNLARNE---LSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEI 517
                    + + +L  L L        SG       + + +  LDLS N          
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

Query: 518 GQL--KLNTFNLSSNKLYGNIPDEFNNL 543
                +LN+ NLS   L          L
Sbjct: 249 CDWPSQLNSLNLSFTGLKQVPKGLPAKL 276

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 86.0 bits (213), Expect = 2e-17
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 28/216 (12%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G GG G+V+   +   G+  A K++   R   +K  +  + E +IL  +    IV L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ-- 760
               ++    LV   M    +    H       +      + + +           AQ  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFY----------TAQIV 299

Query: 761 -GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
            GL ++H      II+RD+K  N+LLD +   +I+D GLA  L            AG+ G
Sbjct: 300 SGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPG 354

Query: 820 YFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           + APE      Y   V    D ++ GV L E++  +
Sbjct: 355 FMAPELLLGEEYDFSV----DYFALGVTLYEMIAAR 386

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 47/210 (22%), Positives = 82/210 (39%), Gaps = 35/210 (16%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLW 702
           +G G +G+V +I      E  A+K +       Q   K    E+E+     +  +IV++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKAR-REVELHWRASQCPHIVRIV 121

Query: 703 C----CISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
                  +     L+V E ++   L  R      R   + +      ++       I   
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMK-----SIG-- 171

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAV 814
             + + Y+H      I HRDVK  N+L  S+      K+ DFG AK          ++  
Sbjct: 172 --EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNS--LTTP 223

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVL 844
             +  Y APE     K ++  D++S GV++
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 55/229 (24%), Positives = 85/229 (37%), Gaps = 32/229 (13%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +IG G  G+V  +      +  A+K +     + +     F  E +I+       +V+L+
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA-IGAAQG 761
                +    +V EYM    L   +      +                R   A +  A  
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDV---PEKW--------ARFYTAEVVLA-- 180

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L  +H       IHRDVK  N+LLD     K+ADFG    + K+G     +AV G+  Y 
Sbjct: 181 LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYI 236

Query: 822 APE--------YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
           +PE          Y  +     D +S GV L E++ G    Y D     
Sbjct: 237 SPEVLKSQGGDGYYGREC----DWWSVGVFLYEMLVGDTPFYADSLVGT 281

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 56/254 (22%)

Query: 628 GFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEI 687
           G  + ++L        +G G  G V++      GE VAVK+I++  + N    +    EI
Sbjct: 1   GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREI 59

Query: 688 EILGTIR-HANIVKLWCCISSENSK--LLVYEYMENQSLDRWLHG--RKRSLVSGSSSVH 742
            IL  +  H NIV L   + ++N +   LV++YME    D  LH   R   L      VH
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET---D--LHAVIRANIL----EPVH 110

Query: 743 -QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM 801
            Q+V++     Q+     + + Y+H   +  ++HRD+K SNILL++E   K+ADFGL++ 
Sbjct: 111 KQYVVY-----QLI----KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158

Query: 802 LAKQGEPHTMSAVAGSFG-------------------YFAPE-----YAYTTKVNEKIDI 837
                       ++ +                     Y APE       YT      ID+
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTK----GIDM 214

Query: 838 YSFGVVLLELVTGK 851
           +S G +L E++ GK
Sbjct: 215 WSLGCILGEILCGK 228

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 54/233 (23%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G GG+G V+    N   + VA+K+I      + +  K  + EI+I+  + H NIVK++ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFE 75

Query: 704 CISSENSKL--------------LVYEYMENQSLDRWLHG--RKRSLVSGSSSVH-QHVL 746
            +    S+L              +V EYME    D  L     +  L       H +  +
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMET---D--LANVLEQGPL----LEEHARLFM 126

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-KAKIADFGLAKMLAKQ 805
           +     Q+     +GL Y+H   +  ++HRD+K +N+ +++E    KI DFGLA+++   
Sbjct: 127 Y-----QLL----RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174

Query: 806 -GEPHTMSA-VAGSFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
                 +S  +   + Y +P        YT      ID+++ G +  E++TGK
Sbjct: 175 YSHKGHLSEGLVTKW-YRSPRLLLSPNNYTK----AIDMWAAGCIFAEMLTGK 222

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 57/260 (21%), Positives = 92/260 (35%), Gaps = 46/260 (17%)

Query: 87  QKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISG 146
           ++I             +L   S+             +  +  + +        DI  + G
Sbjct: 15  KQIFSD-DAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNS--------DIKSVQG 63

Query: 147 LQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYN--S 204
           +Q                   L  +  L+L  N+     P  + +L NL  L L  N   
Sbjct: 64  IQY------------------LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK 103

Query: 205 NFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLF 264
           +            LKKLK+L + E N I +I   + +L  LE L L  N +     + L 
Sbjct: 104 DLSS------LKDLKKLKSLSL-EHNGISDI-NGLVHLPQLESLYLGNNKIT--DITVLS 153

Query: 265 LLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSN 324
            L  L  L L DN +S +I       KL ++ LS N+++  +      LKNL +L LFS 
Sbjct: 154 RLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQ 210

Query: 325 HLSGEVPASIGVVAFENNLS 344
               +       +   N + 
Sbjct: 211 ECLNKPINHQSNLVVPNTVK 230

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 47/257 (18%), Positives = 88/257 (34%), Gaps = 45/257 (17%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
           F      +L+ K +T  +     +L ++  I  +++ I  +  + +     +  L L+ N
Sbjct: 23  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGN 78

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGD 191
                    +  I  L                    L  L  L+L  N+        + D
Sbjct: 79  K--------LTDIKPL------------------ANLKNLGWLFLDENKVKDLSS--LKD 110

Query: 192 LSNLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILA 249
           L  L+ L L +N  S+            L +L++L++   N I +I   +S L+ L+ L+
Sbjct: 111 LKKLKSLSLEHNGISDING------LVHLPQLESLYLGN-NKITDI-TVLSRLTKLDTLS 162

Query: 250 LNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEE 309
           L  N +       L  L  L  L+L  N +S ++ +      L  ++L            
Sbjct: 163 LEDNQISDI--VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINH 219

Query: 310 FGKLKNLQLLGLFSNHL 326
              L     +      L
Sbjct: 220 QSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 57/251 (22%), Positives = 102/251 (40%), Gaps = 27/251 (10%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
            NS+  I   + DI   +  I   L N+T + L+ N +    P  L N   L  L L +N
Sbjct: 45  LNSIDQIIANNSDIK-SVQGI-QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100

Query: 132 YFVGPIPSDIDRISG---LQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKE 188
                +  D+  +     L+ + L  N  S DI   +  L +L++LYL  N    T    
Sbjct: 101 ----KV-KDLSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNN--KITDITV 151

Query: 189 IGDLSNLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLE 246
           +  L+ L+ L L  N  S+  P         L KL+ L++++ N I ++  A++ L +L+
Sbjct: 152 LSRLTKLDTLSLEDNQISDIVP------LAGLTKLQNLYLSK-NHISDL-RALAGLKNLD 203

Query: 247 ILALNGNHLEGAIPSGLFLLNNLTQLFLYDN-ILSGEIPSSVEALKLTDIDLSMNNLTGS 305
           +L L          +    L     +   D  +++ EI S     +  ++   +   T  
Sbjct: 204 VLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNE 263

Query: 306 IPEEFGKLKNL 316
           +   F +   +
Sbjct: 264 VSFIFYQPVTI 274

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 54/287 (18%), Positives = 98/287 (34%), Gaps = 31/287 (10%)

Query: 227 TEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSS 286
           T    I +I  +    +      L    +          LN++ Q+   ++ +   +   
Sbjct: 9   TVPTPIKQI-FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQGI 64

Query: 287 VEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGA 346
                +T + L+ N LT  I +    LKNL  L L  N +               +LS  
Sbjct: 65  QYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK--------------DLSS- 107

Query: 347 VPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRL 406
               L + + L+++ L  N  S ++  GL     L SL L +N I+          L  L
Sbjct: 108 ----LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTL 161

Query: 407 EISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLP 466
            + +N+ S  I   +     L     S N  S ++   L  L +L+ L L   +   K  
Sbjct: 162 SLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPI 217

Query: 467 SQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEI 513
           +   +    N +      L      +        ++     +F+ E+
Sbjct: 218 NHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 47/252 (18%), Positives = 89/252 (35%), Gaps = 30/252 (11%)

Query: 312 KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGEL 371
                    L    ++  V                         ++  +   ++     +
Sbjct: 22  AFAETIKDNLKKKSVTDAVT-------------------QNELNSIDQIIANNSDIK-SV 61

Query: 372 PTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFK 431
             G+    N++ L L+ N ++   P     NL  L +  N+    +   +   K L    
Sbjct: 62  -QGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLS 118

Query: 432 ASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPK 491
             +N  S +I   L  L  L +L L  NK++    + +   T L+ L+L  N++S +I  
Sbjct: 119 LEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV- 172

Query: 492 AIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLN 551
            +  L  + +L LS N  S ++    G   L+   L S +      +  +NL   ++  N
Sbjct: 173 PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231

Query: 552 NSNLCVKNPIIN 563
                V   II+
Sbjct: 232 TDGSLVTPEIIS 243

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 83.0 bits (205), Expect = 2e-16
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 38/220 (17%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN---IV 699
           +IG GG G+VY       G+  A+K +   R   ++ E   + E  +L  +   +   IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
            +     + +    + + M    L    H  +  + S +                   AA
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMR--------------FYAA 299

Query: 760 Q---GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
           +   GL +MH+     +++RD+K +NILLD     +I+D GLA   +K  +PH      G
Sbjct: 300 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VG 352

Query: 817 SFGYFAPE-----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           + GY APE      AY +      D +S G +L +L+ G 
Sbjct: 353 THGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGH 388

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 31/230 (13%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +IG G  G+V  + +  A +  A+K +     L +     F  E ++L       I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA-IGAAQG 761
                +N+  LV +Y     L   L           S     +     R  +A +  A  
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLL-----------SKFEDRLPEEMARFYLAEMVIA-- 187

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           +  +H       +HRD+K  NIL+D     ++ADFG    L + G   +  AV G+  Y 
Sbjct: 188 IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 243

Query: 822 APE---------YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
           +PE           Y  +     D +S GV + E++ G+   Y +     
Sbjct: 244 SPEILQAMEGGKGRYGPEC----DWWSLGVCMYEMLYGETPFYAESLVET 289

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.5 bits (199), Expect = 5e-16
 Identities = 55/243 (22%), Positives = 83/243 (34%), Gaps = 55/243 (22%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           +IG G   +V  + +   G+  A+K +     L +     F  E ++L       I +L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 703 CCISSENSKLLVYEYMENQSLDRWL--HGRKRS----------LVSGSSSVHQHVLHWPT 750
                EN   LV EY     L   L   G +            +V    SVH+       
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL------ 181

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
                                  +HRD+K  NILLD     ++ADFG    L   G   +
Sbjct: 182 ---------------------GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220

Query: 811 MSAVAGSFGYFAPE-----------YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
           + AV G+  Y +PE            +Y  +     D ++ GV   E+  G+   Y D  
Sbjct: 221 LVAV-GTPDYLSPEILQAVGGGPGTGSYGPEC----DWWALGVFAYEMFYGQTPFYADST 275

Query: 860 TSL 862
              
Sbjct: 276 AET 278

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 37/247 (14%)

Query: 605 RDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFV 664
            D L++       T +L  F ++                +G+G  G+V  +    +G   
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRI--------------KTLGTGSFGRVMLVKHKESGNHY 69

Query: 665 AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLD 724
           A+K +   + +  K  +  + E  IL  +    +VKL       ++  +V EY+    + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM- 128

Query: 725 RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA-IGAAQGLCYMHHDCTPQIIHRDVKSSNI 783
            + H R+    S              R   A I       Y+H      +I+RD+K  N+
Sbjct: 129 -FSHLRRIGRFSEPH----------ARFYAAQIVLT--FEYLHSL---DLIYRDLKPENL 172

Query: 784 LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVV 843
           L+D +   ++ DFG AK +  +G   T+    G+    APE   +   N+ +D ++ GV+
Sbjct: 173 LIDQQGYIQVTDFGFAKRV--KGRTWTL---CGTPEALAPEIILSKGYNKAVDWWALGVL 227

Query: 844 LLELVTG 850
           + E+  G
Sbjct: 228 IYEMAAG 234

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 78.5 bits (194), Expect = 3e-15
 Identities = 74/486 (15%), Positives = 146/486 (30%), Gaps = 94/486 (19%)

Query: 97  KNLTTIDLSSNSI-PGEFPEFLYNCTKLQNLDLSQNYF----VGPIPSDIDRISGLQCID 151
            ++ ++D+    +    + E L    + Q + L            I S +     L  ++
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 152 LGGNNFSGDIPRSIGRL-----SELQTLYLYMNEFNGTFPKEIGDL----SNLEVLGLAY 202
           L  N         + +       ++Q L L      G     +         L+ L L+ 
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 203 NSNFKPAMIPIEFGMLK---KLKTLWMTEANLIGE-----IPEAMSNLSSLEILALNGNH 254
           N      +  +  G+L    +L+ L +     +       +   +      + L ++ N 
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEY-CSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 255 L--EGAIPSGLFLLNN---LTQLFLYDNILSGE-IPSSVEALK----LTDIDLSMNNLTG 304
           +   G       L ++   L  L L    ++ +        +     L ++ L  N L  
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241

Query: 305 SIPEEFGK-----LKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRT 359
               E           L+ L ++   ++ +    +              + L    +L+ 
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC-------------RVLRAKESLKE 288

Query: 360 VQLYSNRFSGE----LPTGLW-TTFNLSSLMLSDNTISGE--------LPSKTAWNLTRL 406
           + L  N    E    L   L      L SL +   + +          L       L  L
Sbjct: 289 LSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR--FLLEL 346

Query: 407 EISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGK-- 464
           +ISNNR       GV   + L                     S L  L L    +S    
Sbjct: 347 QISNNRLEDA---GV---RELCQGLGQPG-------------SVLRVLWLADCDVSDSSC 387

Query: 465 --LPSQIVSWTSLNNLNLARNELSGEIPKAIGSLL-----VMVSLDLSGNQFSGEIPPEI 517
             L + +++  SL  L+L+ N L       +   +     ++  L L    +S E+   +
Sbjct: 388 SSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 447

Query: 518 GQLKLN 523
             L+ +
Sbjct: 448 QALEKD 453

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 78.5 bits (194), Expect = 3e-15
 Identities = 72/367 (19%), Positives = 119/367 (32%), Gaps = 69/367 (18%)

Query: 219 KKLKTLWMTEANLIGE--IPEAMSNLSSLEILALNGNHL--EGA--IPSGLFLLNNLTQL 272
             +++L +     + +    E +  L   +++ L+   L       I S L +   L +L
Sbjct: 3   LDIQSLDIQC-EELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 273 FLYDNILSGEIPSSVEAL---------KLTDIDLSMNNLT----GSIPEEFGKLKNLQLL 319
            L  N L       V  +         K+  + L    LT    G +      L  LQ L
Sbjct: 62  NLRSNELG---DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118

Query: 320 GLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGE----LPTGL 375
            L  N L        G+      L       L     L  +QL     S      L + L
Sbjct: 119 HLSDNLLGDA-----GLQLLCEGL-------LDPQCRLEKLQLEYCSLSAASCEPLASVL 166

Query: 376 WTTFNLSSLMLSDNTIS-------GELPSKTAWNLTRLEISNNRFSGQ----IQRGVGSW 424
               +   L +S+N I+        +    +   L  L++ +   +      +   V S 
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226

Query: 425 KNLIVFKASNNLFSGE-----IPVELTSLSHLNTLLLDGNKLSGK----LPSQIVSWTSL 475
            +L      +N           P  L   S L TL +    ++ K    L   + +  SL
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286

Query: 476 NNLNLARNELSGEIPKAIGSLLVMV-----SLDLSGNQFSGEIPPEIGQ-LKLNTF---- 525
             L+LA NEL  E  + +   L+       SL +    F+          L  N F    
Sbjct: 287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346

Query: 526 NLSSNKL 532
            +S+N+L
Sbjct: 347 QISNNRL 353

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 66.1 bits (162), Expect = 3e-11
 Identities = 68/371 (18%), Positives = 125/371 (33%), Gaps = 64/371 (17%)

Query: 74  SVTGISLRHKDIT----QKIPPIICDLKNLTTIDLSSNSIPGE-----FPEFLYNCTKLQ 124
            +  +SL++  +T      +   +  L  L  + LS N +            L    +L+
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145

Query: 125 NLDLSQNYF----VGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRL-----SELQTLY 175
            L L           P+ S +      + + +  N+ +    R + +       +L+ L 
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

Query: 176 LYMNEFNGTFPKEIGDL----SNLEVLGLAYNSNFKPAMIPIEFGMLK---KLKTLWMTE 228
           L          +++  +    ++L  L L  N      M  +  G+L    +L+TLW+ E
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265

Query: 229 ANLIGE-----IPEAMSNLSSLEILALNGNHL--EGA--IPSGLFLLN-NLTQLFLYDNI 278
              I       +   +    SL+ L+L GN L  EGA  +   L      L  L++    
Sbjct: 266 -CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCS 324

Query: 279 LSGE-IPSSVEALK----LTDIDLSMNNLTGSIPEEFGKL-----KNLQLLGLFSNHLSG 328
            +          L     L ++ +S N L  +   E  +        L++L L    +S 
Sbjct: 325 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384

Query: 329 EVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGE----LPTGLWT-TFNLSS 383
              +S+               +L    +LR + L +N         L   +      L  
Sbjct: 385 SSCSSLA-------------ATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 431

Query: 384 LMLSDNTISGE 394
           L+L D   S E
Sbjct: 432 LVLYDIYWSEE 442

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 42.6 bits (101), Expect = 6e-04
 Identities = 37/231 (16%), Positives = 70/231 (30%), Gaps = 61/231 (26%)

Query: 92  IICDLKNLTTIDLSSNSIPGE----FPEFLYNCTKLQNLDLSQNYFVGPIPSD------- 140
           ++     L T+ +    I  +        L     L+ L L+ N        D       
Sbjct: 251 LLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL-----GDEGARLLC 305

Query: 141 ---IDRISGLQCIDLGGNNFSGD----IPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLS 193
              ++    L+ + +   +F+          + +   L  L +  N         + D +
Sbjct: 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNN--------RLED-A 356

Query: 194 NLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGE-----IPEAMSNLSSLEIL 248
            +  L                      L+ LW+     + +     +   +    SL  L
Sbjct: 357 GVRELCQGLGQP------------GSVLRVLWL-ADCDVSDSSCSSLAATLLANHSLREL 403

Query: 249 ALNGNHLEGAIPSGLFLL--------NNLTQLFLYDNILSGEIPSSVEALK 291
            L+ N L     +G+  L          L QL LYD   S E+   ++AL+
Sbjct: 404 DLSNNCLG---DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 451

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 77.8 bits (192), Expect = 4e-15
 Identities = 59/233 (25%), Positives = 90/233 (38%), Gaps = 43/233 (18%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI----------AEIEILGT 692
           L+G G  G+V  +     G + A+K           L+KE I           E  +L  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMK----------ILKKEVIVAKDEVAHTLTENRVLQN 204

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRL 752
            RH  +  L     + +    V EY     L   L  R+R                 +  
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVF---------------SED 248

Query: 753 QIAIGAAQ---GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPH 809
           +     A+    L Y+H +    +++RD+K  N++LD +   KI DFGL K   K G   
Sbjct: 249 RARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 304

Query: 810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
           TM    G+  Y APE          +D +  GVV+ E++ G+   Y  +H  L
Sbjct: 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 77.1 bits (190), Expect = 7e-15
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 50/226 (22%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-LNQKLEKEFIAEIEILGTIRHA----- 696
           +IG G  GQV +   +   + VA+K + N ++   Q  E     EI IL  +R       
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EIRILEHLRKQDKDNT 158

Query: 697 -NIVKLWC--------CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
            N++ +          C++ E   + +YE ++         G    LV       +   H
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF----QGFSLPLV-------RKFAH 207

Query: 748 WPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA--KIADFGLAKMLAKQ 805
                 I     Q L  +H     +IIH D+K  NILL  + ++  K+ DFG +      
Sbjct: 208 -----SIL----QCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---- 251

Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
            E   +     S  Y APE     +    ID++S G +L EL+TG 
Sbjct: 252 -EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 39/163 (23%), Positives = 63/163 (38%), Gaps = 32/163 (19%)

Query: 208 PAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFL- 265
           P  +P        +  + + E N I  IP  A S    L  + L+ N +   +    F  
Sbjct: 27  PTNLPET------ITEIRL-EQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG 78

Query: 266 LNNLTQLFLYDNILSGEIPSSV--EALKLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLF 322
           L +L  L LY N ++ E+P S+      L  + L+ N +   +  + F  L NL LL L+
Sbjct: 79  LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136

Query: 323 SNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSN 365
            N L      +I    F    +            ++T+ L  N
Sbjct: 137 DNKLQ-----TIAKGTFSPLRA------------IQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 38/138 (27%), Positives = 53/138 (38%), Gaps = 16/138 (11%)

Query: 74  SVTGISLRHKDITQKIPPIICD-LKNLTTIDLSSNSI----PGEFPEFLYNCTKLQNLDL 128
           ++T I L    I   IPP      K L  IDLS+N I    P  F         L +L L
Sbjct: 33  TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAF----QGLRSLNSLVL 87

Query: 129 SQNYFVGPIPSDI-DRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEFNGTFP 186
             N     +P  + + +  LQ + L  N  +  +       L  L  L LY N+   T  
Sbjct: 88  YGNKITE-LPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQ-TIA 144

Query: 187 KEIGD-LSNLEVLGLAYN 203
           K     L  ++ + LA N
Sbjct: 145 KGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 43.9 bits (104), Expect = 9e-05
 Identities = 37/162 (22%), Positives = 61/162 (37%), Gaps = 38/162 (23%)

Query: 356 TLRTVQLYSNRFSGELPTGLWTTF----NLSSLMLSDNTISGELPSKT---AWNLTRLEI 408
           T+  ++L  N     +P G    F     L  + LS+N IS EL         +L  L +
Sbjct: 33  TITEIRLEQNTIK-VIPPG---AFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVL 87

Query: 409 SNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQ 468
             N+ + ++ + +               F G        L  L  LLL+ NK++  L   
Sbjct: 88  YGNKIT-ELPKSL---------------FEG--------LFSLQLLLLNANKIN-CLRVD 122

Query: 469 I-VSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQF 509
                 +LN L+L  N+L          L  + ++ L+ N F
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 75.5 bits (186), Expect = 2e-14
 Identities = 62/339 (18%), Positives = 114/339 (33%), Gaps = 71/339 (20%)

Query: 74  SVTGISLRHKDIT----QKIPPIICDLKNLTTIDLSSNSIPGE----FPEFLYNCTKLQN 125
           S+ G SL+   IT    + +  ++ +  ++  I LS N+I  E      E + +   L+ 
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 126 LDLSQNYFVGPIPSDIDRI-----------SGLQCIDLGGNNFSGDIPRSIGRL----SE 170
            + S   F G +  +I                L  + L  N F       +       + 
Sbjct: 65  AEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 171 LQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEAN 230
           L+ LYL+ N         +G  +    +  A            +      L+++     N
Sbjct: 124 LEHLYLHNN--------GLGPQA-GAKIARALQELAVNK----KAKNAPPLRSIICGR-N 169

Query: 231 LIGE-----IPEAMSNLSSLEILALNGNHL-----EGAIPSGLFLLNNLTQLFLYDNILS 280
            +         +   +   L  + +  N +     E  +  GL     L  L L DN  +
Sbjct: 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229

Query: 281 GE-IPSSVEALK----LTDIDLSMNNLTG----SIPEEFGKLKNLQL--LGLFSNHLSGE 329
                +   ALK    L ++ L+   L+     ++ + F KL+N+ L  L L  N +  +
Sbjct: 230 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD 289

Query: 330 VPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS 368
                 V   +  +             L  ++L  NRFS
Sbjct: 290 -----AVRTLKTVID-------EKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 73.2 bits (180), Expect = 9e-14
 Identities = 65/378 (17%), Positives = 123/378 (32%), Gaps = 77/378 (20%)

Query: 221 LKTLWMTEANLIGE-----IPEAMSNLSSLEILALNGNHL--EGA--IPSGLFLLNNLTQ 271
           ++   +   + I       +   +    S++ + L+GN +  E A  +   +    +L  
Sbjct: 6   IEGKSLKL-DAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 272 LFLYDNI---LSGEIPSSVEAL--------KLTDIDLSMNNLTGSIPEEFGKL----KNL 316
               D     +  EIP ++  L        KL  + LS N    +  E           L
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 317 QLLGLFSNHLSGEVPASIGVVAFENNLS-GAVPKSLGNCRTLRTVQLYSNRFSGE----L 371
           + L L +N L  +             L   AV K   N   LR++    NR         
Sbjct: 125 EHLYLHNNGLGPQ-----AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179

Query: 372 PTGLWTTFNLSSLMLSDNTISGE---------LPSKTAWNLTRLEISNNRFSGQ----IQ 418
                +   L ++ +  N I  E         L       L  L++ +N F+      + 
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ--ELKVLDLQDNTFTHLGSSALA 237

Query: 419 RGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNL 478
             + SW NL     ++ L S      +     ++      N               L  L
Sbjct: 238 IALKSWPNLRELGLNDCLLSARGAAAV-----VDAFSKLEN-------------IGLQTL 279

Query: 479 NLARNELSGEIPKAIGSLLV-----MVSLDLSGNQFS--GEIPPEIGQL--KLNTFNLSS 529
            L  NE+  +  + + +++      ++ L+L+GN+FS   ++  EI ++        L  
Sbjct: 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE 339

Query: 530 NKLYGNIPDEFNNLAYDD 547
                 + DE      ++
Sbjct: 340 LDDMEELTDEEEEDEEEE 357

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 56/308 (18%), Positives = 97/308 (31%), Gaps = 76/308 (24%)

Query: 73  NSVTGISLRHKDIT----QKIPPIICDLKNLTTIDLSSNSIPGEFPEF----------LY 118
           +SV  I L    I     + +   I   K+L   + S         E           L 
Sbjct: 32  DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALL 91

Query: 119 NCTKLQNLDLSQNYF----VGPIPSDIDRISGLQCIDLGGNNFS-------------GDI 161
            C KL  + LS N F      P+   + + + L+ + L  N                  +
Sbjct: 92  KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151

Query: 162 PRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKL 221
            +       L+++    N         + + S ++     + S+             + L
Sbjct: 152 NKKAKNAPPLRSIICGRN--------RLENGS-MKEWAKTFQSH-------------RLL 189

Query: 222 KTLWMTEANLIGE------IPEAMSNLSSLEILALNGNHL--EGA--IPSGLFLLNNLTQ 271
            T+ M + N I        + E ++    L++L L  N     G+  +   L    NL +
Sbjct: 190 HTVKMVQ-NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 248

Query: 272 LFLYDNILSGE-IPSSVEALK------LTDIDLSMNNLTGSIPEEFG-----KLKNLQLL 319
           L L D +LS     + V+A        L  + L  N +              K+ +L  L
Sbjct: 249 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 308

Query: 320 GLFSNHLS 327
            L  N  S
Sbjct: 309 ELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.0 bits (99), Expect = 8e-04
 Identities = 32/176 (18%), Positives = 50/176 (28%), Gaps = 54/176 (30%)

Query: 97  KNLTTIDLSSNSIPGE-----FPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCID 151
           + L T+ +  N I  E       E L  C +L+ LDL  N             + L    
Sbjct: 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN-----------TFTHLGSSA 235

Query: 152 LGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMI 211
           L           ++     L+ L L     +      + D         +   N      
Sbjct: 236 LA---------IALKSWPNLRELGLNDCLLSARGAAAVVD-------AFSKLEN------ 273

Query: 212 PIEFGMLKKLKTLWMTEANLIGE-----IPEAM-SNLSSLEILALNGNHL--EGAI 259
                    L+TL +   N I       +   +   +  L  L LNGN    E  +
Sbjct: 274 -------IGLQTLRLQY-NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDV 321

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.7 bits (182), Expect = 4e-14
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 34/218 (15%)

Query: 643 LIGSGGSGQVY---RIDINGAGEFVAVKRIWNNRK--LNQKLEKEFIAEIEILGTIRHAN 697
           ++G G  G+V+   +I  + A +  A+K +   +K  L  +       E +IL  + H  
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVL---KKATLKVRDRVRTKMERDILVEVNHPF 87

Query: 698 IVKLWCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           IVKL     +E  KL L+ +++    L   L                          +  
Sbjct: 88  IVKLHYAFQTE-GKLYLILDFLRGGDLFTRLSKEVMFTEE----------------DVKF 130

Query: 757 GAAQ---GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
             A+    L ++H      II+RD+K  NILLD E   K+ DFGL+K      +     +
Sbjct: 131 YLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYS 185

Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
             G+  Y APE        +  D +SFGV++ E++TG 
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 70.5 bits (173), Expect = 9e-14
 Identities = 33/137 (24%), Positives = 54/137 (39%), Gaps = 10/137 (7%)

Query: 193 SNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALN 251
                L L  N  F        F  L +L+ +  +  N I +I E A    S +  + L 
Sbjct: 32  QYTAELRLNNNE-FTVLEATGIFKKLPQLRKINFSN-NKITDIEEGAFEGASGVNEILLT 89

Query: 252 GNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSV-EAL-KLTDIDLSMNNLTGSIPE 308
            N LE  +   +F  L +L  L L  N ++  + +     L  +  + L  N +T ++  
Sbjct: 90  SNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAP 146

Query: 309 E-FGKLKNLQLLGLFSN 324
             F  L +L  L L +N
Sbjct: 147 GAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 32/164 (19%), Positives = 59/164 (35%), Gaps = 33/164 (20%)

Query: 208 PAMIPIEFGMLKKLKTLWMTEANLIGEIPE--AMSNLSSLEILALNGNHLEGAIPSGLFL 265
           P  IP           L +   N    +        L  L  +  + N +   I  G F 
Sbjct: 27  PEHIPQY------TAELRL-NNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFE 78

Query: 266 -LNNLTQLFLYDNILSGEIPSSV-EAL-KLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGL 321
             + + ++ L  N L   +   + + L  L  + L  N +T  +  + F  L +++LL L
Sbjct: 79  GASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSL 136

Query: 322 FSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSN 365
           + N ++     ++   AF+   S            L T+ L +N
Sbjct: 137 YDNQIT-----TVAPGAFDTLHS------------LSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 32/164 (19%), Positives = 56/164 (34%), Gaps = 34/164 (20%)

Query: 63  CDWPEITCTFNSVTGI-----------SLRHKDITQKIPP--IICDLKNLTTIDLSSNSI 109
           C+   + C+   +  I            L + + T  +    I   L  L  I+ S+N I
Sbjct: 11  CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTV-LEATGIFKKLPQLRKINFSNNKI 69

Query: 110 ----PGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI-DRISGLQCIDLGGNNFSGDIPRS 164
                G F       + +  + L+ N     +   +   +  L+ + L  N  +  +   
Sbjct: 70  TDIEEGAF----EGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGND 123

Query: 165 I-GRLSELQTLYLYMNEF----NGTFPKEIGDLSNLEVLGLAYN 203
               LS ++ L LY N+      G F      L +L  L L  N
Sbjct: 124 SFIGLSSVRLLSLYDNQITTVAPGAFDT----LHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 23/116 (19%), Positives = 41/116 (35%), Gaps = 12/116 (10%)

Query: 73  NSVTGISLRHKDITQKIPPIICD-LKNLTTIDLSSN---SIPGEFPEFLYNCTKLQNLDL 128
             +  I+  +  I   I     +    +  I L+SN   ++     +       L+ L L
Sbjct: 57  PQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLENVQ---HKMFKGLESLKTLML 112

Query: 129 SQNYFVGPIPSDI-DRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEFN 182
             N     + +D    +S ++ + L  N  +  +       L  L TL L  N FN
Sbjct: 113 RSNRITC-VGNDSFIGLSSVRLLSLYDNQITT-VAPGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 34/159 (21%), Positives = 56/159 (35%), Gaps = 36/159 (22%)

Query: 380 NLSSLMLSDNTISGELPSKTAW----NLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNN 435
             + L L++N  +  L +   +     L ++  SNN    +I                  
Sbjct: 33  YTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNN----KIT------------DIEEG 75

Query: 436 LFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQI-VSWTSLNNLNLARNELSGEIPKAIG 494
            F G         S +N +LL  N+L   +  ++     SL  L L  N ++  +     
Sbjct: 76  AFEG--------ASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSF 125

Query: 495 SLLVMV-SLDLSGNQFSGEIPPEI--GQLKLNTFNLSSN 530
             L  V  L L  NQ +  + P        L+T NL +N
Sbjct: 126 IGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 71.8 bits (177), Expect = 1e-13
 Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 37/216 (17%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK---LNQKLEKEFIAEIEILGTIRHANIV 699
            +G+G  G+V+ I     G + A+K +   +K   +  K  +    E  +L  + H  I+
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVL---KKEIVVRLKQVEHTNDERLMLSIVTHPFII 69

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA-IGA 758
           ++W          ++ +Y+E   L  +   RK    S              +   A +  
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGEL--FSLLRK----SQRFPNPV------AKFYAAEVCL 117

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A  L Y+H      II+RD+K  NILLD     KI DFG AK       P     + G+ 
Sbjct: 118 A--LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYTLCGTP 167

Query: 819 GYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTG 850
            Y APE      Y   +    D +SFG+++ E++ G
Sbjct: 168 DYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAG 199

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 55/227 (24%), Positives = 86/227 (37%), Gaps = 48/227 (21%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-LNQKLEKEFIAEIEILGTIRHA---- 696
           +LIG G  GQV +       E+VA+K I N +  LNQ        E+ +L  +       
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----EVRLLELMNKHDTEM 114

Query: 697 --NIVKLWC--------CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL 746
              IV L          C+  E     +Y+ + N +      G   +L            
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTN----FRGVSLNLTR---------- 160

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA--KIADFGLAKMLAK 804
                 + A      L ++       IIH D+K  NILL +  ++  KI DFG +     
Sbjct: 161 ------KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--- 210

Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGK 851
                 +     S  Y +PE       +  ID++S G +L+E+ TG+
Sbjct: 211 --LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 51/235 (21%), Positives = 88/235 (37%), Gaps = 54/235 (22%)

Query: 643 LIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA----- 696
            +G G    V+   D+      VA+K +  ++   +  E E    I++L  +  A     
Sbjct: 26  KLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKE 80

Query: 697 ------NIVKLWCCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL 746
                 +I+KL    + +        +V+E +  ++L   +   K+    G   ++    
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI---KKYEHRGIPLIYVK-- 134

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA------KIADFGLAK 800
                 QI+     GL YMH  C   IIH D+K  N+L++           KIAD G A 
Sbjct: 135 ------QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186

Query: 801 MLAKQGEPHTMSAVAGSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
                      +    +  Y +PE      +        DI+S   ++ EL+TG 
Sbjct: 187 W-----YDEHYTNSIQTREYRSPEVLLGAPWGCG----ADIWSTACLIFELITGD 232

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 62/236 (26%), Positives = 88/236 (37%), Gaps = 50/236 (21%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI----------AEIEILGT 692
           L+G G  G+V  +     G + A+K           L KE I           E  +L  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMK----------ILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 693 IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP-TR 751
            RH  +  L     + +    V EY     L   L               + V      R
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-------------RERVFTEERAR 108

Query: 752 LQIA-IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
              A I +A  L Y+H      +++RD+K  N++LD +   KI DFGL K     G   T
Sbjct: 109 FYGAEIVSA--LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 161

Query: 811 MSAVAGSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
           M    G+  Y APE      Y   V    D +  GVV+ E++ G+   Y  +H  L
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLPFYNQDHERL 213

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 35/209 (16%), Positives = 74/209 (35%), Gaps = 28/209 (13%)

Query: 216 GMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLF 273
            +    +TL + E   +  IP  A SNL ++  + ++ +     + S  F  L+ +T + 
Sbjct: 28  SLPPSTQTLKLIE-THLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86

Query: 274 LYDNILSGEIPSSV-EAL-KLTDIDLSMNNLTGSIPEE--FGKLKNLQLLGLFSNHLSGE 329
           + +      I     + L  L  + +    L    P+           +L +  N     
Sbjct: 87  IRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS 145

Query: 330 VPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDN 389
           +P +    AF+           G C    T++LY+N F+  +    +    L ++ L+ N
Sbjct: 146 IPVN----AFQ-----------GLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189

Query: 390 TISGELPSKT----AWNLTRLEISNNRFS 414
                +            + L++S    +
Sbjct: 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 36/238 (15%), Positives = 71/238 (29%), Gaps = 63/238 (26%)

Query: 96  LKNLTTIDLSSN----SIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCID 151
           L N++ I +S +     +        YN +K+ ++++     +  I  D           
Sbjct: 54  LPNISRIYVSIDVTLQQLE---SHSFYNLSKVTHIEIRNTRNLTYIDPDA---------- 100

Query: 152 LGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMI 211
                           L  L+ L ++         K   DL+                  
Sbjct: 101 -----LKE--------LPLLKFLGIFNTGL-----KMFPDLTK----------------- 125

Query: 212 PIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSS-LEILALNGNHLEGAIPSGLFLLNNL 269
                       L +T+   +  IP  A   L +    L L  N    ++    F    L
Sbjct: 126 ---VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181

Query: 270 TQLFLYDNILSGEIPSSV-EALK--LTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFS 323
             ++L  N     I       +    + +D+S  ++T ++P +    LK L     ++
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 42/224 (18%), Positives = 73/224 (32%), Gaps = 46/224 (20%)

Query: 355 RTLRTVQLYSNRFSGELPTGLWTTF----NLSSLMLSDNTISGELPSKTAWNLTRLE--- 407
            + +T++L        +P+     F    N+S + +S +    +L S + +NL+++    
Sbjct: 31  PSTQTLKLIETHLR-TIPSH---AFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86

Query: 408 ISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLP- 466
           I N R    I                              L  L  L +    L    P 
Sbjct: 87  IRNTRNLTYIDPDA---------------LKE--------LPLLKFLGIFNTGLK-MFPD 122

Query: 467 -SQIVSWTSLNNLNLARNELSGEIPKAIGSLLV--MVSLDLSGNQFSGEIPPEI-GQLKL 522
            +++ S      L +  N     IP      L    ++L L  N F+  +        KL
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181

Query: 523 NTFNLSSNKLYGNIPDE-FNNLAYDDSFLNNSNLCVKNPIINLP 565
           +   L+ NK    I  + F  +    S L+ S       +  LP
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQ----TSVTALP 221

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 37/230 (16%), Positives = 78/230 (33%), Gaps = 46/230 (20%)

Query: 93  ICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISG---LQC 149
              L N    +L   S+           + +QN +   +         +  +     L+ 
Sbjct: 15  DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNI-----QSLAGMQFFTNLKE 67

Query: 150 IDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPA 209
           + L  N  S D+   +  L++L+ L +  N         + +L+ +              
Sbjct: 68  LHLSHNQIS-DLS-PLKDLTKLEELSVNRN--------RLKNLNGIP------------- 104

Query: 210 MIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNL 269
                      L  L++   N + +  +++ +L +LEIL++  N L+      L  L+ L
Sbjct: 105 --------SACLSRLFLDN-NELRDT-DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKL 152

Query: 270 TQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLL 319
             L L+ N ++          K+  IDL+         +   +L     +
Sbjct: 153 EVLDLHGNEIT-NTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 38/234 (16%), Positives = 68/234 (29%), Gaps = 44/234 (18%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
            + V   +  + +I   +  +     NL  + LS N I       L + TKL+ L +++N
Sbjct: 40  LSGVQNFNGDNSNIQ-SLAGM-QFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRN 95

Query: 132 YFVGPIPSDIDRISG--LQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEI 189
                   +++ I    L  + L  N    D   S+  L  L+ L +  N        ++
Sbjct: 96  RL-----KNLNGIPSACLSRLFLDNNELR-DTD-SLIHLKNLEILSIRNN--------KL 140

Query: 190 GDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILA 249
             +  L                      L KL+ L +   N I      ++ L  +  + 
Sbjct: 141 KSIVMLG--------------------FLSKLEVLDLHG-NEITNT-GGLTRLKKVNWID 178

Query: 250 LNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLT 303
           L G             L     +   D         S       D  +      
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS-NGGSYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 36/214 (16%), Positives = 67/214 (31%), Gaps = 16/214 (7%)

Query: 351 LGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISN 410
                      L     +  +     +   + +    ++ I      +   NL  L +S+
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVSQKELS--GVQNFNGDNSNIQSLAGMQFFTNLKELHLSH 72

Query: 411 NRFSGQIQR--GVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQ 468
           N    QI     +     L     + N       +    LS L    LD N+L       
Sbjct: 73  N----QISDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD--TDS 123

Query: 469 IVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLS 528
           ++   +L  L++  N+L   I   +G L  +  LDL GN+ +          K+N  +L+
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDLT 180

Query: 529 SNKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPII 562
             K           L   ++  +     +    I
Sbjct: 181 GQKCVNEPVKYQPELYITNTVKDPDGRWISPYYI 214

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 45/250 (18%), Positives = 75/250 (30%), Gaps = 34/250 (13%)

Query: 312 KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGEL 371
            L N     L    ++  V                          ++     ++      
Sbjct: 17  GLANAVKQNLGKQSVTDLVS-------------------QKELSGVQNFNGDNSNIQS-- 55

Query: 372 PTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFK 431
             G+    NL  L LS N IS   P K    L  L ++ NR    +         L    
Sbjct: 56  LAGMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLK-NLN--GIPSACLSRLF 112

Query: 432 ASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPK 491
             NN         L  L +L  L +  NKL   +   +   + L  L+L  NE++     
Sbjct: 113 LDNNELRDTDS--LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGG- 167

Query: 492 AIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEF--NNLAYDDSF 549
            +  L  +  +DL+G +   E      +L +   N   +     I   +  N  +Y D  
Sbjct: 168 -LTRLKKVNWIDLTGQKCVNEPVKYQPELYIT--NTVKDPDGRWISPYYISNGGSYVDGC 224

Query: 550 LNNSNLCVKN 559
           +        +
Sbjct: 225 VLWELPVYTD 234

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 13/159 (8%)

Query: 172 QTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFK-PAMIPIEFGMLKKLKTLWMTEAN 230
           + L L               L+ L  L L YN      A +   F  L +L TL +   N
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV---FDDLTELGTLGLAN-N 93

Query: 231 LIGEIPEAM-SNLSSLEILALNGNHLEGAIPSGLF-LLNNLTQLFLYDNILSGEIPSSV- 287
            +  +P  +  +L+ L+ L L GN L+ ++PSG+F  L  L +L L  N L   IP+   
Sbjct: 94  QLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151

Query: 288 EAL-KLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSN 324
           + L  L  + LS N L  S+P   F +L  LQ + LF N
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 22/170 (12%)

Query: 208 PAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLF-LL 266
           P+ IP +       + L +    L          L+ L  L L+ N L+  + +G+F  L
Sbjct: 30  PSGIPAD------TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDL 82

Query: 267 NNLTQLFLYDNILSGEIPSSV--EALKLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFS 323
             L  L L +N L+  +P  V     +L  + L  N L  S+P   F +L  L+ L L +
Sbjct: 83  TELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNT 140

Query: 324 NHLSGEVPA-------SIGVVAFENNLSGAVPK-SLGNCRTLRTVQLYSN 365
           N L   +PA       ++  ++   N   +VP  +      L+T+ L+ N
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 51/202 (25%), Positives = 77/202 (38%), Gaps = 51/202 (25%)

Query: 94  CDLKNLTTI-----------DLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDID 142
           C  K+L ++           DL S  +           TKL  L+L  N     + + + 
Sbjct: 21  CQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGV- 78

Query: 143 RISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF----NGTFPKEIGDLSNLEVL 198
                         F          L+EL TL L  N+      G F      L+ L+ L
Sbjct: 79  --------------FDD--------LTELGTLGLANNQLASLPLGVFDH----LTQLDKL 112

Query: 199 GLAYNSNFKPAMIPIE-FGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLE 256
            L  N   +   +P   F  L KLK L +   N +  IP  A   L++L+ L+L+ N L+
Sbjct: 113 YLGGN---QLKSLPSGVFDRLTKLKELRL-NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168

Query: 257 GAIPSGLF-LLNNLTQLFLYDN 277
            ++P G F  L  L  + L+ N
Sbjct: 169 -SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 24/157 (15%)

Query: 80  LRHKDITQKIPPIICDLKNLTTIDLSSNSI----PGEFPEFLYNCTKLQNLDLSQNYFVG 135
           L+   +          L  LT ++L  N +     G F +     T+L  L L+ N    
Sbjct: 42  LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDL----TELGTLGLANNQLAS 97

Query: 136 PIPSDI-DRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEF----NGTFPKEI 189
            +P  + D ++ L  + LGGN     +P  +  RL++L+ L L  N+      G F K  
Sbjct: 98  -LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDK-- 153

Query: 190 GDLSNLEVLGLAYNSNFKPAMIPIE-FGMLKKLKTLW 225
             L+NL+ L L+ N   +   +P   F  L KL+T+ 
Sbjct: 154 --LTNLQTLSLSTN---QLQSVPHGAFDRLGKLQTIT 185

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 31/100 (31%), Positives = 46/100 (46%), Gaps = 13/100 (13%)

Query: 87  QKIPPIICD-LKNLTTIDLSSN---SIP-GEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI 141
             +P  + D L  L  + L  N   S+P G F       TKL+ L L+ N     IP+  
Sbjct: 96  ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVF----DRLTKLKELRLNTNQLQS-IPAGA 150

Query: 142 -DRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMN 179
            D+++ LQ + L  N     +P     RL +LQT+ L+ N
Sbjct: 151 FDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 71.8 bits (175), Expect = 7e-13
 Identities = 80/511 (15%), Positives = 147/511 (28%), Gaps = 154/511 (30%)

Query: 445 LTSLSHLNTLLLDGNKLSGK--LPSQI-------------VSWTSLNNLNLARNELSGEI 489
           L  L     +L+DG   SGK  +   +             + W     LNL        +
Sbjct: 144 LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW-----LNLKNCNSPETV 198

Query: 490 PKAIGSLLVMVSLDL-SGNQFSGEIPPEIGQLKLNTFNLSSNKLYGN---IPDEFNNLAY 545
            + +  LL  +  +  S +  S  I   I  ++     L  +K Y N   +      L  
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV------L-- 250

Query: 546 DDSFLNNSNLCVKNP-IINLPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVV 604
            +         V+N    N       F     +S K           +LL T       V
Sbjct: 251 LN---------VQNAKAWNA------F----NLSCK-----------ILLTTRFKQ---V 277

Query: 605 RDCLRRKRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSG---QVYRID---IN 658
            D L        +       H +  T   + S L     +         +V   +   ++
Sbjct: 278 TDFLSAATTTHISL----DHHSMTLTPDEVKSLL--LKYLDCRPQDLPREVLTTNPRRLS 331

Query: 659 GAGEFVAVKRI-WNN-RKLNQ-KLEKEFIAEIEIL--GTIRH-----------ANI---- 698
              E +      W+N + +N  KL     + + +L     R            A+I    
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL 391

Query: 699 -VKLWCCISSENSKLLVYEYMENQSL-DRW-------LHG---RKRSLVSGSSSVHQHVL 746
              +W  +   +  ++V + +   SL ++        +       +  +    ++H+ ++
Sbjct: 392 LSLIWFDVIKSDVMVVVNK-LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV 450

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQII----------H--------RDVKSSNILLDSE 788
                  I         +   D  P  +          H        R      + LD  
Sbjct: 451 ---DHYNIP------KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR 501

Query: 789 F-KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP-EYAYTTKVNEKIDIYSFGVVLLE 846
           F + KI     A   A     +T+  +     Y    +  Y   VN           +L+
Sbjct: 502 FLEQKIRHDSTA-WNASGSILNTLQQLKFYKPYICDNDPKYERLVNA----------ILD 550

Query: 847 LVTGKEAN-YGDEHTSLAEWAWRHYAEEKPI 876
            +   E N    ++T L   A     E++ I
Sbjct: 551 FLPKIEENLICSKYTDLLRIALMA--EDEAI 579

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.2 bits (137), Expect = 2e-08
 Identities = 94/719 (13%), Positives = 208/719 (28%), Gaps = 214/719 (29%)

Query: 78  ISLRHKDITQK-IPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGP 136
              ++KDI        + +       D+  + +  E  + +          +S    +  
Sbjct: 14  HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIM----SKDAVSGTLRL-- 67

Query: 137 IPSDIDRISGLQCIDLGGNN----FSGDIPRSIGRLSELQTLYLYM-----NEFNGTFPK 187
                        +          F  ++         L+  Y ++      E       
Sbjct: 68  ----------FWTLLSKQEEMVQKFVEEV---------LRINYKFLMSPIKTEQRQPSMM 108

Query: 188 EIGDLSNLEVLGLAYNSN--FKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEA------M 239
               +   + L   YN N  F    +        KL+   + E       P        +
Sbjct: 109 TRMYIEQRDRL---YNDNQVFAKYNVSRL-QPYLKLRQ-ALLELR-----PAKNVLIDGV 158

Query: 240 --SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDL 297
             S  + + +       ++  +   +F L NL      + +L  E+   ++ L L  ID 
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIFWL-NLKNCNSPETVL--EM---LQKL-LYQIDP 211

Query: 298 SMNNL---TGSIPEEF----GKLKNLQLLGLFSNHL-------SGEVPASIGVVAFENNL 343
           +  +    + +I         +L+ L     + N L       + +        AF    
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA-----WNAFN--- 263

Query: 344 SGAVPKSLGNCRTLRT-----------VQLYSNRFSGELPTGLWTTFNLSSLMLSDNTIS 392
                    +C+ L T               ++         L      S L+   +   
Sbjct: 264 --------LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315

Query: 393 GELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNL--IVFKASNNLFSGEIPVELTSLSH 450
            +LP +         +S    +  I+ G+ +W N   +       +         +SL+ 
Sbjct: 316 QDLPRE-VLTTNPRRLS--IIAESIRDGLATWDNWKHVNCDKLTTIIE-------SSLNV 365

Query: 451 LNTLLLDGN--KLS-----GKLPSQIVS--WTSLNNLNLARNELSGEIPKAIGSLLVMVS 501
           L          +LS       +P+ ++S  W           ++       + + L   S
Sbjct: 366 LEPAEYRKMFDRLSVFPPSAHIPTILLSLIW----------FDVIKSDVMVVVNKLHKYS 415

Query: 502 L-DLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNL-AYDDSFLNNSNLCVKN 559
           L +    + +  I P I  L+L     +   L+ +I D +N    +D      S+  +  
Sbjct: 416 LVEKQPKESTISI-PSI-YLELKVKLENEYALHRSIVDHYNIPKTFD------SDDLIPP 467

Query: 560 PIIN---------LPKCPSRFRNSDKISSKHLALILVLAILVLLVTVSLSWFVVRDCLRR 610
            +           L        + ++++            L  +V +   +      L +
Sbjct: 468 YLDQYFYSHIGHHLKNI----EHPERMT------------LFRMVFLDFRF------LEQ 505

Query: 611 KRNRDPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIW 670
           K   D   W  +       +  N L  L            + Y+              I 
Sbjct: 506 KIRHDSTAWNASG------SILNTLQQL------------KFYK------------PYIC 535

Query: 671 NNRKLNQKLEK---EFIAEIE-ILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDR 725
           +N    ++L     +F+ +IE  L   ++ +++++   + +E+    ++E    Q + R
Sbjct: 536 DNDPKYERLVNAILDFLPKIEENLICSKYTDLLRI--ALMAEDEA--IFEEAHKQ-VQR 589

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 69.9 bits (171), Expect = 9e-13
 Identities = 41/178 (23%), Positives = 65/178 (36%), Gaps = 25/178 (14%)

Query: 137 IPSDIDRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEF----NGTFPKEIGD 191
           +P  +   S    +DL  NN S         RL+ L +L L  N      +  F      
Sbjct: 33  VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF----VP 86

Query: 192 LSNLEVLGLAYN--SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEIL 248
           + NL  L L+ N        +    F  L+ L+ L +   N I  +   A  +++ L+ L
Sbjct: 87  VPNLRYLDLSSNHLHTLDEFL----FSDLQALEVLLLYN-NHIVVVDRNAFEDMAQLQKL 141

Query: 249 ALNGNHLEGAIPSGLFL----LNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNN 301
            L+ N +    P  L      L  L  L L  N L     + ++ L       L ++N
Sbjct: 142 YLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 51/237 (21%), Positives = 83/237 (35%), Gaps = 57/237 (24%)

Query: 54  QSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEF 113
           +S  S  + C      C  N ++    +  ++ Q +P           +DLS N++    
Sbjct: 7   RSVVSCPANC-----LCASNILSCSKQQLPNVPQSLPS------YTALLDLSHNNLSRLR 55

Query: 114 PE-FLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQ 172
            E      T L +L LS N               L  I      F          +  L+
Sbjct: 56  AEWTPTRLTNLHSLLLSHN--------------HLNFISSEA--FVP--------VPNLR 91

Query: 173 TLYLYMNEF----NGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE-FGMLKKLKTLWMT 227
            L L  N         F     DL  LEVL L  N      ++    F  + +L+ L+++
Sbjct: 92  YLDLSSNHLHTLDEFLFS----DLQALEVLLLYNN---HIVVVDRNAFEDMAQLQKLYLS 144

Query: 228 EANLIGEIPE----AMSNLSSLEILALNGNHLEGAIPSGLF-LLNNLTQ--LFLYDN 277
           + N I   P       + L  L +L L+ N L+  +P      L    +  L+L++N
Sbjct: 145 Q-NQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 37/169 (21%), Positives = 61/169 (36%), Gaps = 27/169 (15%)

Query: 230 NLIGEIP--EAMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSS 286
           N +  +      + L++L  L L+ NHL   I S  F+ + NL  L L  N L   +   
Sbjct: 49  NNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEF 106

Query: 287 V--EALKLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNL 343
           +  +   L  + L  N++   +    F  +  LQ L L  N +S        V   ++  
Sbjct: 107 LFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-----RFPVELIKD-- 158

Query: 344 SGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTF---NLSSLMLSDN 389
                        L  + L SN+   +LP            + L L +N
Sbjct: 159 -------GNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 41/188 (21%), Positives = 67/188 (35%), Gaps = 24/188 (12%)

Query: 358 RTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTA----WNLTRLEISNNRF 413
             +     +    +P  L +    + L LS N +S  L ++       NL  L +S+N  
Sbjct: 21  NILSCSKQQLP-NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL 76

Query: 414 SGQIQRGV-GSWKNLIVFKASNNLFSGEIPVE-LTSLSHLNTLLLDGNKLSGKLPSQI-V 470
           +  I         NL     S+N     +     + L  L  LLL  N +   +      
Sbjct: 77  N-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE 133

Query: 471 SWTSLNNLNLARNELSGEIP----KAIGSLLVMVSLDLSGNQFSGEIPPEI----GQLKL 522
               L  L L++N++S   P    K    L  ++ LDLS N+   ++P            
Sbjct: 134 DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVK 191

Query: 523 NTFNLSSN 530
           N   L +N
Sbjct: 192 NGLYLHNN 199

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 69.9 bits (171), Expect = 9e-13
 Identities = 35/234 (14%), Positives = 73/234 (31%), Gaps = 15/234 (6%)

Query: 72  FNSVTGISLRHKDITQKIPP-IICDLKNLTTIDLSSNSIPGEFPEF-LYNCTKLQNLDLS 129
             +   +      +   I         +L  I++S N +          N  KL  + + 
Sbjct: 29  PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87

Query: 130 QNYFVGPIPSDI-DRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKE 188
           +   +  I  +    +  LQ + +                 +   L +  N    T  + 
Sbjct: 88  KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN 147

Query: 189 I--GDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSL 245
              G      +L L  N       I        +L  L +++ N + E+P       S  
Sbjct: 148 SFVGLSFESVILWLNKN---GIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGP 204

Query: 246 EILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPSSVEALKLTDIDLS 298
            IL ++   +  ++PS     L  L     Y+     ++P+  + + L +  L+
Sbjct: 205 VILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLT 254

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 51/276 (18%), Positives = 84/276 (30%), Gaps = 35/276 (12%)

Query: 221 LKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNI 278
              L       +  I + A S    LE + ++ N +   I + +F  L  L ++ +    
Sbjct: 32  AIELRFVL-TKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 279 LSGEIPSSV-EAL-KLTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSNHLSGEVPASIG 335
               I     + L  L  + +S   +   +P+          LL +  N     +  +  
Sbjct: 91  NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERN-- 147

Query: 336 VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGEL 395
             +F            G       + L  N    E+    +    L  L LSDN    EL
Sbjct: 148 --SFV-----------GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEEL 193

Query: 396 PS---KTAWNLTRLEISNNRFSGQIQRGV-GSWKNLIVFKASNNLFSGEIPVELTSLSHL 451
           P+     A     L+IS  R    +      + K L      N     ++P  L  L  L
Sbjct: 194 PNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNL---KKLPT-LEKLVAL 248

Query: 452 NTLLLDGNK---LSGKLPSQIVSWTSLNNLNLARNE 484
               L              QI     + N ++ R E
Sbjct: 249 MEASLTYPSHCCAFANWRRQISELHPICNKSILRQE 284

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 42/247 (17%), Positives = 86/247 (34%), Gaps = 30/247 (12%)

Query: 292 LTDIDLSMNNLTGSIPEE-FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKS 350
             ++   +  L   I +  F    +L+ + +  N +   + A      F N         
Sbjct: 32  AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEAD----VFSN--------- 77

Query: 351 LGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTR---LE 407
           L     +R     +N      P       NL  L++S+  I   LP     +  +   L+
Sbjct: 78  LPKLHEIRI--EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLD 134

Query: 408 ISNNRFSGQIQRGV--GSWKNLIVFKASNNLFSGEIPVELTSLSHLNTL-LLDGNKLSGK 464
           I +N     I+R    G     ++   + N    EI     + + L+ L L D N L  +
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-E 192

Query: 465 LPSQI-VSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLN 523
           LP+ +    +    L+++R  +       + +L  + +      +   ++P     + L 
Sbjct: 193 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALM 249

Query: 524 TFNLSSN 530
             +L+  
Sbjct: 250 EASLTYP 256

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 68.5 bits (168), Expect = 9e-13
 Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 36/234 (15%)

Query: 137 IPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLE 196
            P D    +     +L   + + D       L+ +  +    ++      + I  L N+ 
Sbjct: 13  FPDDAF--AETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDI--KSVQGIQYLPNVR 66

Query: 197 VLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHL 255
            L L  N   K   I      L  L  L +   N +  +P      L++L+ L L  N L
Sbjct: 67  YLALGGN---KLHDISA-LKELTNLTYLIL-TGNQLQSLPNGVFDKLTNLKELVLVENQL 121

Query: 256 EGAIPSGLF-LLNNLTQLFLYDNILSGEIPSSV-EAL-KLTDIDLSMNNLTGSIPEE-FG 311
           + ++P G+F  L NLT L L  N L   +P  V + L  LT++DLS N L  S+PE  F 
Sbjct: 122 Q-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD 178

Query: 312 KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSN 365
           KL  L+ L L+ N L      S+    F+          L +   L+ + L+ N
Sbjct: 179 KLTQLKDLRLYQNQLK-----SVPDGVFDR---------LTS---LQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 35/194 (18%), Positives = 66/194 (34%), Gaps = 30/194 (15%)

Query: 5   ASVFPKIPVTLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCD 64
                      I   L                   ++     + +   +Q   +      
Sbjct: 11  QIFPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVR---- 66

Query: 65  WPEITCTFNSVTGISLRHK--DIT---------QKIPPIICD-LKNLTTIDLSSNSI--- 109
              +    N +  IS   +  ++T         Q +P  + D L NL  + L  N +   
Sbjct: 67  --YLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSL 124

Query: 110 -PGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI-DRISGLQCIDLGGNNFSGDIPRSI-G 166
             G F +     T L  L+L+ N     +P  + D+++ L  +DL  N     +P  +  
Sbjct: 125 PDGVFDKL----TNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQS-LPEGVFD 178

Query: 167 RLSELQTLYLYMNE 180
           +L++L+ L LY N+
Sbjct: 179 KLTQLKDLRLYQNQ 192

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 69.7 bits (170), Expect = 3e-12
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 33/225 (14%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK--LNQKLEKEFI-AEIEILGTI-RHANI 698
           ++G G  G+V   +  G  E  AVK +   +K  + Q  + E    E  +L    +   +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKIL---KKDVVIQDDDVECTMVEKRVLALPGKPPFL 404

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
            +L  C  + +    V EY+    L   +                     P  +  A   
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-------------QVGRFKEPHAVFYAAEI 451

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           A GL ++       II+RD+K  N++LDSE   KIADFG+ K     G   T     G+ 
Sbjct: 452 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTP 506

Query: 819 GYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH 859
            Y APE      Y   V    D ++FGV+L E++ G+    G++ 
Sbjct: 507 DYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAPFEGEDE 547

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 56/232 (24%)

Query: 643 LIGSGGSGQVY---RIDINGAGEFVAVKRIWNNRKLNQKLEKEFI-----------AEIE 688
           ++G+G  G+V+   +I  +  G+  A+K           L+K  I            E +
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMK----------VLKKATIVQKAKTTEHTRTERQ 110

Query: 689 ILGTIRHAN-IVKLWCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL 746
           +L  IR +  +V L     +E +KL L+ +Y+    L  + H  +R       + H+   
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGEL--FTHLSQR----ERFTEHE--- 160

Query: 747 HWPTRLQIA-IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
               ++ +  I  A  L ++H      II+RD+K  NILLDS     + DFGL+K     
Sbjct: 161 ---VQIYVGEIVLA--LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVA 211

Query: 806 GEPHTMSAVAGSFGYFAPE------YAYTTKVNEKIDIYSFGVVLLELVTGK 851
            E        G+  Y AP+        +   V    D +S GV++ EL+TG 
Sbjct: 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGA 259

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 67.2 bits (165), Expect = 5e-12
 Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 54/229 (23%)

Query: 643 LIGSGGSGQVY---RIDINGAGEFVAVKRIWNNRKLNQKLEKEFI-----------AEIE 688
           ++G GG G+V+   ++     G+  A+K           L+K  I           AE  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMK----------VLKKAMIVRNAKDTAHTKAERN 73

Query: 689 ILGTIRHANIVKLWCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLH 747
           IL  ++H  IV L     +   KL L+ EY+    L   L      +             
Sbjct: 74  ILEEVKHPFIVDLIYAFQTG-GKLYLILEYLSGGELFMQLEREGIFMEDT---------- 122

Query: 748 WPTRLQIA-IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
                 +A I  A  L ++H      II+RD+K  NI+L+ +   K+ DFGL K     G
Sbjct: 123 --ACFYLAEISMA--LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175

Query: 807 EPHTMSAVAGSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
                    G+  Y APE      +   V    D +S G ++ +++TG 
Sbjct: 176 T--VTHTFCGTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGA 218

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 29/161 (18%)

Query: 208 PAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLF-LL 266
           PA IP         + L++ +  +    P    +L +L+ L L  N L  A+P G+F  L
Sbjct: 35  PAGIPTN------AQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSL 87

Query: 267 NNLTQLFLYDNILSGEIPSSV-EAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSN 324
             LT L L  N L+  +PS+V + L  L ++ +  N LT  +P    +L +L  L L  N
Sbjct: 88  TQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145

Query: 325 HLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSN 365
            L      SI   AF+          L +   L    L+ N
Sbjct: 146 QLK-----SIPHGAFDR---------LSS---LTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.4 bits (113), Expect = 8e-06
 Identities = 48/214 (22%), Positives = 76/214 (35%), Gaps = 67/214 (31%)

Query: 69  TCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDL 128
           +C+  +V   S RH  +   IP       N   + L  N I    P    +   L+ L L
Sbjct: 18  SCSGTTVDCRSKRHASVPAGIPT------NAQILYLHDNQITKLEPGVFDSLINLKELYL 71

Query: 129 SQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF----NGT 184
             N               L  + +G       +      L++L  L L  N+     +  
Sbjct: 72  GSN--------------QLGALPVG-------VF---DSLTQLTVLDLGTNQLTVLPSAV 107

Query: 185 FPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSS 244
           F +    L +L+ L +  N                KL            E+P  +  L+ 
Sbjct: 108 FDR----LVHLKELFMCCN----------------KLT-----------ELPRGIERLTH 136

Query: 245 LEILALNGNHLEGAIPSGLF-LLNNLTQLFLYDN 277
           L  LAL+ N L+ +IP G F  L++LT  +L+ N
Sbjct: 137 LTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.5 bits (164), Expect = 1e-11
 Identities = 45/231 (19%), Positives = 86/231 (37%), Gaps = 18/231 (7%)

Query: 90  PPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQC 149
                  + L   +LS           L +C +LQ L+    + +  I   +  +  L  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 150 IDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPA 209
                  FS        R + L  L    ++F         + +++ VL LA+       
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDL---RSKFLLENSVLKMEYADVRVLHLAHKDLTVLC 457

Query: 210 MIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNL 269
            +      L  +  L ++  N +  +P A++ L  LE+L  + N LE  +  G+  L  L
Sbjct: 458 HL----EQLLLVTHLDLSH-NRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRL 510

Query: 270 TQLFLYDNILSGEIPSSVEAL----KLTDIDLSMNNLTGSIPEEFGKLKNL 316
            +L L +N L     ++++ L    +L  ++L  N+L         +L  +
Sbjct: 511 QELLLCNNRLQQ--SAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.1 bits (150), Expect = 6e-10
 Identities = 33/245 (13%), Positives = 76/245 (31%), Gaps = 31/245 (12%)

Query: 42  NLKQQLGNPPSLQSW-TSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLT 100
              +       L     S            +   +  +   +K     I   I  ++ L 
Sbjct: 340 CWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTI---ILLMRALD 396

Query: 101 TIDLSSNSIPGEFPEFLYNCTKLQNLDLS-----QNYFVGPIPSDIDRISGLQCIDLGGN 155
            +     ++     ++      +  +  +     ++ F+          + ++ + L   
Sbjct: 397 PLLYEKETL-----QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK 451

Query: 156 NFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYN--SNFKPAMIPI 213
           + +  +   + +L  +  L L  N      P  +  L  LEVL  + N   N        
Sbjct: 452 DLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG----- 503

Query: 214 EFGMLKKLKTLWMTEANLIGEIPE--AMSNLSSLEILALNGNHL---EGAIPSGLFLLNN 268
               L +L+ L +   N + +      + +   L +L L GN L   EG       +L +
Sbjct: 504 -VANLPRLQELLLCN-NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 561

Query: 269 LTQLF 273
           ++ + 
Sbjct: 562 VSSIL 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 61.7 bits (149), Expect = 8e-10
 Identities = 53/325 (16%), Positives = 100/325 (30%), Gaps = 48/325 (14%)

Query: 95  DLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPI----PSDIDRISGLQCI 150
           D+     +      +   F   L   +++  L L  +     +    P   +R S +   
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302

Query: 151 DLGGNNFSGDIPRSIGR-LSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPA 209
           DL   + +  +P+   R +                      D +  E L     S  K  
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362

Query: 210 MIPIEFGMLKKLKTLW-------------MTEANLIGEIPEAMSNLSSLEIL-------- 248
           ++  E    K+L+ L              M   + +    E +   S+L+ +        
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422

Query: 249 ALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPE 308
               +              ++  L L    L+  +    + L +T +DLS N L  ++P 
Sbjct: 423 DDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLR-ALPP 480

Query: 309 EFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS 368
               L+ L++L    N L               N+ G     + N   L+ + L +NR  
Sbjct: 481 ALAALRCLEVLQASDNALE--------------NVDG-----VANLPRLQELLLCNNRLQ 521

Query: 369 G-ELPTGLWTTFNLSSLMLSDNTIS 392
                  L +   L  L L  N++ 
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 56.7 bits (136), Expect = 3e-08
 Identities = 45/284 (15%), Positives = 84/284 (29%), Gaps = 36/284 (12%)

Query: 245 LEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTG 304
           L   +LN    +          ++  +  L  +        S    +L   +LS+   T 
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST- 362

Query: 305 SIPEEFGKLKNLQLLGLFSNHL---SGEVPASIGVVAFENNLSGAVPK--SLGNCRTLRT 359
            +  E    K LQ L   +         +  ++  + +E           ++   R    
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422

Query: 360 VQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQR 419
             L S     E         ++  L L+   ++     +    +T L++S+NR       
Sbjct: 423 DDLRSKFLL-ENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR----- 476

Query: 420 GVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLN 479
                                +P  L +L  L  L    N L   +   + +   L  L 
Sbjct: 477 --------------------ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELL 514

Query: 480 LARNELSG-EIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKL 522
           L  N L      + + S   +V L+L GN    +      +L  
Sbjct: 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 557

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 50.9 bits (121), Expect = 1e-06
 Identities = 32/183 (17%), Positives = 58/183 (31%), Gaps = 31/183 (16%)

Query: 14  TLILLVLLSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFN 73
              LL ++ +   + P     E       LK       +      +    +   +   + 
Sbjct: 382 KWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYA 441

Query: 74  SVTGISLRHKDIT---------------------QKIPPIICDLKNLTTIDLSSN---SI 109
            V  + L HKD+T                     + +PP +  L+ L  +  S N   ++
Sbjct: 442 DVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 501

Query: 110 PGEFPEFLYNCTKLQNLDLSQNYFVG-PIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRL 168
            G     + N  +LQ L L  N          +     L  ++L GN+          RL
Sbjct: 502 DG-----VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERL 555

Query: 169 SEL 171
           +E+
Sbjct: 556 AEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 49.4 bits (117), Expect = 5e-06
 Identities = 39/305 (12%), Positives = 82/305 (26%), Gaps = 61/305 (20%)

Query: 267 NNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL 326
            +L    L D +                  + + +       +    + L    L     
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKS 361

Query: 327 SGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLML 386
           +                   +   L +C+ L+ ++  +      L T +     L  L+ 
Sbjct: 362 T------------------VLQSELESCKELQELEPENKWC---LLTIILLMRALDPLLY 400

Query: 387 SDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELT 446
              T+            + L+  +                        + F  E  V   
Sbjct: 401 EKETLQ---------YFSTLKAVDP-------------MRAAYLDDLRSKFLLENSVLKM 438

Query: 447 SLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSG 506
             + +  L L    L+  L   +     + +L+L+ N L   +P A+ +L  +  L  S 
Sbjct: 439 EYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASD 495

Query: 507 NQFSGEIPPEIGQL-KLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCV----KNPI 561
           N     +   +  L +L    L +N+L           A     ++   L +     N +
Sbjct: 496 NALE-NVDG-VANLPRLQELLLCNNRL--------QQSAAIQPLVSCPRLVLLNLQGNSL 545

Query: 562 INLPK 566
                
Sbjct: 546 CQEEG 550

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 42/210 (20%), Positives = 77/210 (36%), Gaps = 56/210 (26%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLW 702
           +G G +G+V +I      E  A+K + +  K  +        E+E+     +  +IV++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVRIV 77

Query: 703 ----CCISSENSKLLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
                  +     L+V E ++   L  R      R   + +      ++       I   
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMK-----SIG-- 127

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA---KIADFGLAKMLAKQGEPHTMSAV 814
             + + Y+H      I HRDVK  N+L  S+      K+ DFG AK    +         
Sbjct: 128 --EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE--------- 173

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVL 844
                Y           ++  D++S GV++
Sbjct: 174 ----KY-----------DKSCDMWSLGVIM 188

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 53/238 (22%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI----------AEIEILGT 692
           ++G G  G+V+  +     +F A+K           L+K+ +           E  +L  
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIK----------ALKKDVVLMDDDVECTMVEKRVLSL 73

Query: 693 -IRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
              H  +  ++C   ++ +   V EY+    L   +             + +   +    
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKF-----DLSRATFY---- 123

Query: 752 LQIAIGAAQ---GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
                 AA+   GL ++H      I++RD+K  NILLD +   KIADFG+ K        
Sbjct: 124 ------AAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 173

Query: 809 HTMSAVAGSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
              +   G+  Y APE      Y   V    D +SFGV+L E++ G+   +G +   L
Sbjct: 174 -KTNTFCGTPDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSPFHGQDEEEL 226

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 65.4 bits (160), Expect = 3e-11
 Identities = 48/248 (19%), Positives = 82/248 (33%), Gaps = 76/248 (30%)

Query: 643 LIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRK-LNQKLEKEFIAEIEILGTIRHA---- 696
            +G G  G+V   +D       VA+K I N  K            EI +L  I+      
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-----EINVLKKIKEKDKEN 80

Query: 697 --NIVKLWC--------CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL 746
               V +          CI+ E      +E++           ++ +         +H+ 
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL-----------KENNFQPYPLPHVRHMA 129

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL-DSEFKA-------------- 791
           +     Q+       L ++H     Q+ H D+K  NIL  +SEF+               
Sbjct: 130 Y-----QLC----HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177

Query: 792 ----KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPE----YAYTTKVNEKIDIYSFGVV 843
               ++ADFG A       +    + +  +  Y  PE      +        D++S G +
Sbjct: 178 NTSIRVADFGSATF-----DHEHHTTIVATRHYRPPEVILELGWAQP----CDVWSIGCI 228

Query: 844 LLELVTGK 851
           L E   G 
Sbjct: 229 LFEYYRGF 236

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.9 bits (159), Expect = 4e-11
 Identities = 60/236 (25%), Positives = 93/236 (39%), Gaps = 49/236 (20%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI----------AEIEILGT 692
           ++G G  G+V    +   G+  AVK           L+K+ I           E  IL  
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVK----------VLKKDVILQDDDVECTMTEKRILSL 79

Query: 693 I-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
              H  + +L+CC  + +    V E++    L   +   +R   +              R
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------------RAR 127

Query: 752 LQIA-IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
              A I +A  L ++H      II+RD+K  N+LLD E   K+ADFG+ K     G   T
Sbjct: 128 FYAAEIISA--LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--T 180

Query: 811 MSAVAGSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
            +   G+  Y APE      Y   V    D ++ GV+L E++ G      +    L
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAPFEAENEDDL 232

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 63.8 bits (156), Expect = 7e-11
 Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 39/220 (17%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK--LNQKLEKEFI-AEIEILGTI-RHANI 698
           +IG G   +V  + +       A+K +   +K  +N   + +++  E  +      H  +
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVV---KKELVNDDEDIDWVQTEKHVFEQASNHPFL 72

Query: 699 VKLWCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP-TRLQIA- 755
           V L  C  +E S+L  V EY+    L   +               Q  L     R   A 
Sbjct: 73  VGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQ-------------RQRKLPEEHARFYSAE 118

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           I  A  L Y+H      II+RD+K  N+LLDSE   K+ D+G+ K   + G+  T S   
Sbjct: 119 ISLA--LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFC 171

Query: 816 GSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G+  Y APE      Y   V    D ++ GV++ E++ G+
Sbjct: 172 GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGR 207

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 64.2 bits (157), Expect = 8e-11
 Identities = 64/220 (29%), Positives = 93/220 (42%), Gaps = 39/220 (17%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK---LNQKLEKEFIAEIEILG-TIRHANI 698
           +IG G  G+V          F AVK +   +K   L +K EK  ++E  +L   ++H  +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVL---QKKAILKKKEEKHIMSERNVLLKNVKHPFL 101

Query: 699 VKLWCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA-I 756
           V L     +   KL  V +Y+    L   L  R+R          +       R   A I
Sbjct: 102 VGLHFSFQTA-DKLYFVLDYINGGELFYHLQ-RERCF-----LEPR------ARFYAAEI 148

Query: 757 GAAQGLCYMH-HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
            +A  L Y+H  +    I++RD+K  NILLDS+    + DFGL K   +     T S   
Sbjct: 149 ASA--LGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFC 200

Query: 816 GSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G+  Y APE      Y   V    D +  G VL E++ G 
Sbjct: 201 GTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGL 236

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.0 bits (154), Expect = 2e-10
 Identities = 58/236 (24%), Positives = 89/236 (37%), Gaps = 49/236 (20%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI----------AEIEILGT 692
           ++G G  G+V   +  G  E  AVK           L+K+ +           E  +L  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVK----------ILKKDVVIQDDDVECTMVEKRVLAL 76

Query: 693 I-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
             +   + +L  C  + +    V EY+    L   +    R                   
Sbjct: 77  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------------HAV 124

Query: 752 LQIA-IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
              A I     L ++       II+RD+K  N++LDSE   KIADFG+ K     G   T
Sbjct: 125 FYAAEIAIG--LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--T 177

Query: 811 MSAVAGSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL 862
                G+  Y APE      Y   V    D ++FGV+L E++ G+    G++   L
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 47/248 (18%), Positives = 84/248 (33%), Gaps = 76/248 (30%)

Query: 643 LIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRK-LNQKLEKEFIAEIEILGTIRHA---- 696
            +G G  G+V   ID    G  VAVK + N  +            EI++L  +       
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-----EIQVLEHLNTTDPNS 75

Query: 697 --NIVKLWC--------CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVL 746
               V++          CI  E   L  Y+++           ++   +       + + 
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLGLSTYDFI-----------KENGFLPFRLDHIRKMA 124

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL-DSEFKA-------------- 791
           +     QI     + + ++H     ++ H D+K  NIL   S++                
Sbjct: 125 Y-----QIC----KSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172

Query: 792 ----KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPE----YAYTTKVNEKIDIYSFGVV 843
               K+ DFG A       +    S +  +  Y APE      ++       D++S G +
Sbjct: 173 NPDIKVVDFGSATY-----DDEHHSTLVSTRHYRAPEVILALGWSQP----CDVWSIGCI 223

Query: 844 LLELVTGK 851
           L+E   G 
Sbjct: 224 LIEYYLGF 231

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 39/220 (17%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK--LNQKLEKEFI-AEIEILGTI-RHANI 698
           +IG G   +V  + +       A++ +   +K  +N   + +++  E  +      H  +
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVV---KKELVNDDEDIDWVQTEKHVFEQASNHPFL 115

Query: 699 VKLWCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP-TRLQIA- 755
           V L  C  +E S+L  V EY+    L   +               Q  L     R   A 
Sbjct: 116 VGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQ-------------RQRKLPEEHARFYSAE 161

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
           I  A  L Y+H      II+RD+K  N+LLDSE   K+ D+G+ K   + G+  T S   
Sbjct: 162 ISLA--LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFC 214

Query: 816 GSFGYFAPE----YAYTTKVNEKIDIYSFGVVLLELVTGK 851
           G+  Y APE      Y   V    D ++ GV++ E++ G+
Sbjct: 215 GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGR 250

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 61.8 bits (149), Expect = 3e-10
 Identities = 34/187 (18%), Positives = 53/187 (28%), Gaps = 34/187 (18%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVK--RIWNNRKLN---QKLEKEFIAEIEIL-------- 690
           IG G  G+V++   +     VA+K   I     +N   QK  +E + EI I         
Sbjct: 28  IGEGVFGEVFQTIADH--TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 691 -GTIRHANIVKL--WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS--------- 738
               R    + L    C+      LL+  +    S     + R                 
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 739 -----SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI 793
                  +   +    T   I       L         +  HRD+   N+LL      K+
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKL 203

Query: 794 ADFGLAK 800
                 K
Sbjct: 204 HYTLNGK 210

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 51/252 (20%), Positives = 80/252 (31%), Gaps = 80/252 (31%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-LNQKLEKEFIAEIEILGTIRHA----- 696
            +G G  G+V         ++ AVK + N +K            E +IL  I++      
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-----EADILKKIQNDDINNN 96

Query: 697 NIVKLWC--------CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
           NIVK           C+  E     +YE +            + +         +     
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLGPSLYEII-----------TRNNYNGFHIEDIKLYCI- 144

Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA----------------- 791
               +I     + L Y+       + H D+K  NILLD  +                   
Sbjct: 145 ----EIL----KALNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193

Query: 792 --------KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPE----YAYTTKVNEKIDIYS 839
                   K+ DFG A       +     ++  +  Y APE      +        D++S
Sbjct: 194 YRTKSTGIKLIDFGCATF-----KSDYHGSIINTRQYRAPEVILNLGWDVS----SDMWS 244

Query: 840 FGVVLLELVTGK 851
           FG VL EL TG 
Sbjct: 245 FGCVLAELYTGS 256

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 42/209 (20%), Positives = 65/209 (31%), Gaps = 66/209 (31%)

Query: 79  SLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIP 138
                 I  K+   +  LK    + LS+N+I  E    L     L+ L L +N       
Sbjct: 31  HGMIPPIE-KMDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGRNL------ 81

Query: 139 SDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVL 198
             I +I  L  +                    L+ L++  N        +I  LS +E  
Sbjct: 82  --IKKIENLDAV-----------------ADTLEELWISYN--------QIASLSGIEK- 113

Query: 199 GLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE--AMSNLSSLEILALNGNHLE 256
                              L  L+ L+M+  N I    E   ++ L  LE L L GN L 
Sbjct: 114 -------------------LVNLRVLYMSN-NKITNWGEIDKLAALDKLEDLLLAGNPLY 153

Query: 257 GAIPSG-------LFLLNNLTQLFLYDNI 278
                        + ++  L  L   D +
Sbjct: 154 NDYKENNATSEYRIEVVKRLPNLKKLDGM 182

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 34/198 (17%), Positives = 63/198 (31%), Gaps = 46/198 (23%)

Query: 225 WMTEANLIGEIPEAMS-NLSSLEILALNGNHLE-GAIPSGLFLLNNLTQLFLYDNILSGE 282
             T  + I    E  S   +  E + L+G       + + L  L     L L  N +   
Sbjct: 4   ATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI--- 60

Query: 283 IPSSVEAL----KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVA 338
               + +L     L  + L  N +   I         L+ L +  N ++           
Sbjct: 61  --EKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA----------- 106

Query: 339 FENNLSGAVPKSLGNCRTLRTVQLYSNRFS--------GELPTGLWTTFNLSSLMLSDNT 390
              +LSG     +     LR + + +N+ +          L         L  L+L+ N 
Sbjct: 107 ---SLSG-----IEKLVNLRVLYMSNNKITNWGEIDKLAALD-------KLEDLLLAGNP 151

Query: 391 ISGELPSKTAWNLTRLEI 408
           +  +     A +  R+E+
Sbjct: 152 LYNDYKENNATSEYRIEV 169

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 74/372 (19%), Positives = 120/372 (32%), Gaps = 121/372 (32%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN------ 697
           +G G    V+        +FVA+K +  +    +   +  + EI +L ++R+++      
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMK-VVKS---AEHYTETALDEIRLLKSVRNSDPNDPNR 100

Query: 698 --IVKLWCC--ISSENSK--LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
             +V+L     IS  N     +V+E +    L +W+    +S        +   L  P  
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWI---IKS--------NYQGLPLPCV 148

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE----------------------- 788
            +I     QGL Y+H  C  +IIH D+K  NILL                          
Sbjct: 149 KKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206

Query: 789 --------------------------FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA 822
                                      K KIAD G A       +  T      +  Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDIQ--TRQYRS 261

Query: 823 PEYAYTTKVNEKIDIYSFGVVLLELVTGK---EANYGDEHTS----LA-----------E 864
            E    +  N   DI+S   +  EL TG    E + G+E+T     +A           +
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321

Query: 865 WA---------------WRHYAEEKPITDALDKGIAEPCYL--EEMTTVYRLALICTSTL 907
                             +H  + KP    L + + E      EE        L     +
Sbjct: 322 LIVAGKYSKEFFTKKGDLKHITKLKPWG--LFEVLVEKYEWSQEEAAGFTDFLLPMLELI 379

Query: 908 PSSRPSMKEVLQ 919
           P  R +  E L+
Sbjct: 380 PEKRATAAECLR 391

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 32/135 (23%), Positives = 50/135 (37%), Gaps = 32/135 (23%)

Query: 193 SNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALN 251
            ++  L L  N   +  ++P E    K L  + +   N I  +   + SN++ L  L L+
Sbjct: 31  RDVTELYLDGN---QFTLVPKELSNYKHLTLIDL-SNNRISTLSNQSFSNMTQLLTLILS 86

Query: 252 GNHLEGAIPSGLF-LLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEE- 309
            N L   IP   F  L +L  L L+ N +S                         +PE  
Sbjct: 87  YNRLR-CIPPRTFDGLKSLRLLSLHGNDIS------------------------VVPEGA 121

Query: 310 FGKLKNLQLLGLFSN 324
           F  L  L  L + +N
Sbjct: 122 FNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 36/123 (29%), Positives = 55/123 (44%), Gaps = 21/123 (17%)

Query: 137 IPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF----NGTFPKEIGDL 192
           IP D+  +       L GN F+  +P+ +     L  + L  N      N +F      +
Sbjct: 29  IPRDVTEL------YLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSN----M 77

Query: 193 SNLEVLGLAYNSNFKPAMIPIE-FGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILAL 250
           + L  L L+YN   +   IP   F  LK L+ L +   N I  +PE A ++LS+L  LA+
Sbjct: 78  TQLLTLILSYN---RLRCIPPRTFDGLKSLRLLSL-HGNDISVVPEGAFNDLSALSHLAI 133

Query: 251 NGN 253
             N
Sbjct: 134 GAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 36/112 (32%), Positives = 49/112 (43%), Gaps = 13/112 (11%)

Query: 74  SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSI----PGEFPEFLYNCTKLQNLDLS 129
            VT + L     T  +P  + + K+LT IDLS+N I       F     N T+L  L LS
Sbjct: 32  DVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFS----NMTQLLTLILS 86

Query: 130 QNYFVGPIPSDI-DRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMN 179
            N     IP    D +  L+ + L GN+ S  +P      LS L  L +  N
Sbjct: 87  YNRL-RCIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 48/352 (13%), Positives = 108/352 (30%), Gaps = 70/352 (19%)

Query: 115 EFLYNCTKLQNLDLSQNYFVGPIPSDIDRIS--------GLQCIDLGGNNFSGDIPRSIG 166
           EF      + +LDLS N            +          +  ++L GN+        + 
Sbjct: 16  EFTSIPHGVTSLDLSLNNL---YSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELV 72

Query: 167 RL-----SELQTLYLYMNEFNGTFPKEIGDL-----SNLEVLGLAYNSNFKPAMIPIEFG 216
           ++     + + +L L  N  +     E+          + VL L +N +F          
Sbjct: 73  QILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWN-DFSSKSSSEFKQ 131

Query: 217 MLKK----LKTLWMTEANLIGE-----IPEAMSNL-SSLEILALNGNHL--EGA--IPSG 262
                   + +L +   N +G      + + ++ + +++  L L GN+L  +    +   
Sbjct: 132 AFSNLPASITSLNLRG-NDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKF 190

Query: 263 LFLLN-NLTQLFLYDNILSGE-IPSSVEALK-----LTDIDLSMNNLTGS----IPEEFG 311
           L  +  ++T L L  N+L  +               +  ++L +N L G     +     
Sbjct: 191 LASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKD 250

Query: 312 KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGEL 371
            LK+LQ + L  + +      ++     +     A+  +  N + +  V           
Sbjct: 251 SLKHLQTVYLDYDIVK-----NMSKEQCK-----ALGAAFPNIQKIILVDKNGKEIHPSH 300

Query: 372 PTGLW-----TTFNLSSLMLSDNTISGELPSKTAWN-------LTRLEISNN 411
              +       +       L +  +      +T          L     +  
Sbjct: 301 SIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCK 352

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 54/330 (16%), Positives = 105/330 (31%), Gaps = 73/330 (22%)

Query: 240 SNLSSLEILALNGNHL--EGA--IPSGLFLLN-NLTQLFLYDNILSGEIPSSVEAL---- 290
           +  +S+  L L+GN L  + +  +   L  +  N+T L L  N LS +   S + L    
Sbjct: 48  NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYK---SSDELVKTL 104

Query: 291 -----KLTDIDLSMNNLTGSIPEEFGKL-----KNLQLLGLFSNHLSGEVPASIGVVAFE 340
                 +T +DL  N+ +     EF +       ++  L L  N L  +           
Sbjct: 105 AAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK-----SSDELI 159

Query: 341 NNLSGAVPKSLGNCRTLRTVQLYSNRFSGE----LPTGLWTT-FNLSSLMLSDNTIS--- 392
             L+            + ++ L  N  + +    L   L +   +++SL LS N +    
Sbjct: 160 QILAAI------PA-NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKS 212

Query: 393 ----GELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSL 448
                 + S    ++  L +  N   G     +                         SL
Sbjct: 213 YAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL--------------------KDSL 252

Query: 449 SHLNTLLLDGNKLSGKLPSQIVSW-------TSLNNLNLARNELSGEIPKAIGSLLVMVS 501
            HL T+ LD + +      Q  +          +  ++    E+       I +L+  +S
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELS 312

Query: 502 LDLSGNQFSGEIPPEIGQLKLNTFNLSSNK 531
                     +      + + N  +L+   
Sbjct: 313 GKADVPSLLNQCLIFAQKHQTNIEDLNIPD 342

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 58/339 (17%), Positives = 105/339 (30%), Gaps = 84/339 (24%)

Query: 248 LALNGNHLEGAIPSGLFLLNN--LTQLFLYDNILSGEIPSSVEAL---------KLTDID 296
           +        G+ P   F      +T L L  N L      S   L          +T ++
Sbjct: 1   MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLY---SISTVELIQAFANTPASVTSLN 57

Query: 297 LSMNNLTGSIPEEFGKL-----KNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSL 351
           LS N+L     +E  ++      N+  L L  N LS +             L+       
Sbjct: 58  LSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYK-----SSDELVKTLAA------ 106

Query: 352 GNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNN 411
               T+  + L  N FS +      ++        +              ++T L +  N
Sbjct: 107 -IPFTITVLDLGWNDFSSK------SSSEFKQAFSNLPA-----------SITSLNLRGN 148

Query: 412 RFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGK----LPS 467
               +    +       +  A                +++N+L L GN L+ K    L  
Sbjct: 149 DLGIKSSDELIQ-----ILAAIP--------------ANVNSLNLRGNNLASKNCAELAK 189

Query: 468 QIVSW-TSLNNLNLARNELSGEIPKAIGSLLVMV-----SLDLSGNQFSGEIPPEIGQL- 520
            + S   S+ +L+L+ N L  +    +  +   +     SL+L  N   G     +  L 
Sbjct: 190 FLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLK 249

Query: 521 ----KLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNL 555
                L T  L  + +     ++   L    +F N   +
Sbjct: 250 DSLKHLQTVYLDYDIVKNMSKEQCKALG--AAFPNIQKI 286

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 32/270 (11%), Positives = 77/270 (28%), Gaps = 45/270 (16%)

Query: 97  KNLTTIDLSSNSIPGEFPEFL-----YNCTKLQNLDLSQNYF----VGPIPSDIDRI-SG 146
            N+T+++LS N +  +  + L          +  LDL  N F              + + 
Sbjct: 80  ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139

Query: 147 LQCIDLGGNNFSGDIPRSIGRLSE--------LQTLYLYMNEFNGTFPKEIGDL-----S 193
           +  ++L GN+      +S   L +        + +L L  N        E+        +
Sbjct: 140 ITSLNLRGNDLG---IKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196

Query: 194 NLEVLGLAYNSNFKPAMIPIEFGMLK----KLKTLWMTEANLIGE-----IPEAMSNLSS 244
           ++  L L+ N             +       + +L +   N +       +     +L  
Sbjct: 197 SVTSLDLSAN-LLGLKSYAELAYIFSSIPNHVVSLNLCL-NCLHGPSLENLKLLKDSLKH 254

Query: 245 LEILALNGNHLEGAIPSGLFLL-------NNLTQLFLYDNILSGE-IPSSVEALKLTDID 296
           L+ + L+ + ++         L         +  +      +           ++     
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGK 314

Query: 297 LSMNNLTGSIPEEFGKLKNLQLLGLFSNHL 326
             + +L         K +         + L
Sbjct: 315 ADVPSLLNQCLIFAQKHQTNIEDLNIPDEL 344

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 41.6 bits (98), Expect = 9e-04
 Identities = 29/236 (12%), Positives = 72/236 (30%), Gaps = 49/236 (20%)

Query: 97  KNLTTIDLSSNSIPGE----FPEFLYNC-TKLQNLDLSQNYF----VGPIPSDIDRI-SG 146
            ++T+++L  N +  +      + L      + +L+L  N         +   +  I + 
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 147 LQCIDLGGNNFSGDIPRSIGRL-----SELQTLYLYMNEFNGTFPKEIGDL----SNLEV 197
           +  +DL  N         +  +     + + +L L +N  +G   + +  L     +L+ 
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257

Query: 198 LGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHL-- 255
           + L Y+     +                         +  A  N+  + ++  NG  +  
Sbjct: 258 VYLDYDIVKNMS-------------------KEQCKALGAAFPNIQKIILVDKNGKEIHP 298

Query: 256 EGA--IPSGLFLLN-NLTQLFLYDNILSGEIPSSVEALK------LTDIDLSMNNL 302
             +  I + +  L+       L +  L                  L +   +   L
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 40/165 (24%), Positives = 61/165 (36%), Gaps = 31/165 (18%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           IG G  G++    ++    E+VA+K      +  Q L  E+    ++        I +++
Sbjct: 17  IGCGNFGELRLGKNLYT-NEYVAIKLEPMKSRAPQ-LHLEYRFYKQLGSGD---GIPQVY 71

Query: 703 CCISSENSKLLVYEYMENQSLD--RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                     +V E +   SL+    L  R  SL               T L IAI    
Sbjct: 72  YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL--------------KTVLMIAIQLIS 116

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK-----IADFGLAK 800
            + Y+H      +I+RDVK  N L+            I DF LAK
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 48/165 (29%), Positives = 64/165 (38%), Gaps = 31/165 (18%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA-NIVKL 701
           IGSG  G +Y   DI   GE VA+K      K  Q L      E +I   ++    I  +
Sbjct: 17  IGSGSFGDIYLGTDIAA-GEEVAIKLECVKTKHPQ-LHI----ESKIYKMMQGGVGIPTI 70

Query: 702 WCCISSENSKLLVYEYMENQSLD--RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
             C +  +  ++V E +   SL+       RK SL               T L +A    
Sbjct: 71  RWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL--------------KTVLLLADQMI 115

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILL---DSEFKAKIADFGLAKM 801
             + Y+H       IHRDVK  N L+          I DFGLAK 
Sbjct: 116 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 33/166 (19%), Positives = 57/166 (34%), Gaps = 31/166 (18%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           IG G  G ++   ++    + VA+K         Q L  E+     + G      I  ++
Sbjct: 18  IGEGSFGVIFEGTNLLN-NQQVAIKFEPRRSDAPQ-LRDEYRTYKLLAGCT---GIPNVY 72

Query: 703 CCISSENSKLLVYEYMENQSLD--RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
                    +LV + +   SL+    L GRK S+               T    A     
Sbjct: 73  YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV--------------KTVAMAAKQMLA 117

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK-----IADFGLAKM 801
            +  +H      +++RD+K  N L+            + DFG+ K 
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 29/87 (33%), Positives = 52/87 (59%), Gaps = 7/87 (8%)

Query: 242 LSSLEILALNGNHLEGAIPSGLF-LLNNLTQLFLYDNILSGEIPSSV--EALKLTDIDLS 298
           L+ L  L+L+ N ++ ++P G+F  L  LT L+L++N L   +P+ V  +  +L ++ L 
Sbjct: 51  LTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALD 108

Query: 299 MNNLTGSIPEE-FGKLKNLQLLGLFSN 324
            N L  S+P+  F +L +LQ + L +N
Sbjct: 109 TNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 52.3 bits (126), Expect = 7e-08
 Identities = 39/127 (30%), Positives = 57/127 (44%), Gaps = 24/127 (18%)

Query: 243 SSLEILALNGNHLEGAIPSGLF-LLNNLTQLFLYDNILSGEIPSSV--EALKLTDIDLSM 299
           SS   L L  N L+ ++P G+F  L  LT+L L  N +   +P  V  +  KLT + L  
Sbjct: 28  SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHE 85

Query: 300 NNLTGSIPEE-FGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLR 358
           N L  S+P   F KL  L+ L L +N L      S+    F+   S            L+
Sbjct: 86  NKLQ-SLPNGVFDKLTQLKELALDTNQLK-----SVPDGIFDRLTS------------LQ 127

Query: 359 TVQLYSN 365
            + L++N
Sbjct: 128 KIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 44/147 (29%)

Query: 137 IPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF----NGTFPKEIGDL 192
           IPS   R+      +L  N           +L++L  L L  N+     +G F K    L
Sbjct: 26  IPSSATRL------ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDK----L 75

Query: 193 SNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALN 251
           + L +L L  N                KL++L           P      L+ L+ LAL+
Sbjct: 76  TKLTILYLHEN----------------KLQSL-----------PNGVFDKLTQLKELALD 108

Query: 252 GNHLEGAIPSGLF-LLNNLTQLFLYDN 277
            N L+ ++P G+F  L +L +++L+ N
Sbjct: 109 TNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 13/100 (13%)

Query: 87  QKIPPIICD-LKNLTTIDLSSNSI----PGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI 141
           Q +P  + D L  LT + LS N I     G F +     TKL  L L +N     +P+ +
Sbjct: 41  QSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKL----TKLTILYLHENKLQS-LPNGV 95

Query: 142 -DRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMN 179
            D+++ L+ + L  N     +P  I  RL+ LQ ++L+ N
Sbjct: 96  FDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 24/88 (27%), Positives = 39/88 (44%), Gaps = 7/88 (7%)

Query: 241 NLSSLEILALNGNHLEGAIPSGLF-LLNNLTQLFLYDNILSGEIPSSV-EAL-KLTDIDL 297
            L  L  L L  N L   I    F   +++ +L L +N +  EI + +   L +L  ++L
Sbjct: 52  RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNL 109

Query: 298 SMNNLTGSIPEE-FGKLKNLQLLGLFSN 324
             N ++  +    F  L +L  L L SN
Sbjct: 110 YDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 23/104 (22%), Positives = 41/104 (39%), Gaps = 14/104 (13%)

Query: 87  QKIPP--IICDLKNLTTIDLSSNSI----PGEFPEFLYNCTKLQNLDLSQNYFVGPIPSD 140
            +I    +   L +L  ++L  N +    P  F       + +Q L L +N     I + 
Sbjct: 42  GRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF----EGASHIQELQLGENKI-KEISNK 96

Query: 141 I-DRISGLQCIDLGGNNFSGDIPRSI-GRLSELQTLYLYMNEFN 182
           +   +  L+ ++L  N  S  +       L+ L +L L  N FN
Sbjct: 97  MFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFN 139

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.0 bits (129), Expect = 1e-07
 Identities = 19/95 (20%), Positives = 34/95 (35%), Gaps = 3/95 (3%)

Query: 211 IPIEFGMLKKLKTLWMTEANLIGEIP-EAMSNLSSLEILALNGNHLEGAIPSGLFL-LNN 268
                   + L  L++     +  +    +  L  L  L +  + L   +    F     
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 269 LTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLT 303
           L++L L  N L      +V+ L L ++ LS N L 
Sbjct: 82  LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 5e-07
 Identities = 24/134 (17%), Positives = 42/134 (31%), Gaps = 32/134 (23%)

Query: 145 SGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNS 204
           SGL+C   G    + D    +     L  LY+   +                        
Sbjct: 11  SGLRCTRDG----ALDSLHHLPGAENLTELYIENQQHLQHLELRD--------------- 51

Query: 205 NFKPAMIPIEFGMLKKLKTLWMTEANLIGEI-PEAMSNLSSLEILALNGNHLEGAIPSGL 263
                        L +L+ L + + + +  + P+A      L  L L+ N LE ++    
Sbjct: 52  ----------LRGLGELRNLTIVK-SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKT 99

Query: 264 FLLNNLTQLFLYDN 277
               +L +L L  N
Sbjct: 100 VQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 20/102 (19%), Positives = 37/102 (36%), Gaps = 4/102 (3%)

Query: 227 TEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFL-LNNLTQLFLYDNILSGEIPS 285
           T    + +    +    +L  L +        +       L  L  L +  + L    P 
Sbjct: 16  TRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74

Query: 286 SVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL 326
           +     +L+ ++LS N L  S+  +  +  +LQ L L  N L
Sbjct: 75  AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.2 bits (114), Expect = 8e-06
 Identities = 20/94 (21%), Positives = 33/94 (35%), Gaps = 1/94 (1%)

Query: 440 EIPVELTSLSHLNTLLLDGNKLSGKLPSQIVS-WTSLNNLNLARNELSGEIPKAIGSLLV 498
           +    L    +L  L ++  +    L  + +     L NL + ++ L    P A      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 499 MVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKL 532
           +  L+LS N         +  L L    LS N L
Sbjct: 82  LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 24/135 (17%), Positives = 36/135 (26%), Gaps = 29/135 (21%)

Query: 354 CRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKT---AWNLTRLEISN 410
                 +   +   + +    L    NL+ L + +      L  +       L  L I  
Sbjct: 7   PHGSSGL-RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 411 NRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIV 470
           +     +                   F          LS LN   L  N L   L  + V
Sbjct: 66  SGLR-FVAPDA---------------FHF-----TPRLSRLN---LSFNALE-SLSWKTV 100

Query: 471 SWTSLNNLNLARNEL 485
              SL  L L+ N L
Sbjct: 101 QGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.0 bits (103), Expect = 2e-04
 Identities = 20/117 (17%), Positives = 40/117 (34%), Gaps = 9/117 (7%)

Query: 70  CTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSN----SIPGEFPEFLYNCTKLQN 125
           C  +  +G+              +   +NLT + + +      +       L    +L+N
Sbjct: 5   CCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLE---LRDLRGLGELRN 60

Query: 126 LDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFN 182
           L + ++      P        L  ++L  N       +++  LS LQ L L  N  +
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 14/75 (18%), Positives = 26/75 (34%), Gaps = 8/75 (10%)

Query: 258 AIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK----LTDIDLSMNNLTGSIPEE-FGK 312
                L    NLT+L++ +      +      L+    L ++ +  + L   +  + F  
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLEL--RDLRGLGELRNLTIVKSGLR-FVAPDAFHF 78

Query: 313 LKNLQLLGLFSNHLS 327
              L  L L  N L 
Sbjct: 79  TPRLSRLNLSFNALE 93

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 58/367 (15%), Positives = 115/367 (31%), Gaps = 51/367 (13%)

Query: 97  KNLTTIDLSSNSIPGE----FPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRI----SGLQ 148
           + + T+ +  +S   +      E   + T L+ L+     F    P D++ I      L 
Sbjct: 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223

Query: 149 CIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKP 208
            + +G       +       + L+         +   P++  +L     L     S   P
Sbjct: 224 SVKVGDFEILELV-GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP 282

Query: 209 AMIPIEFGMLKKLKTLWMTEANLIGE-IPEAMSNLSSLEILALNGNHLEGAIPSGLFLLN 267
             +PI F    +++ L +  A L  E     +    +LE+L       +  +        
Sbjct: 283 NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCK 342

Query: 268 NLTQLFLYDNILSGEIPSSVEAL-------------KLTDIDLSMNNLT----GSIPEEF 310
            L +L +        +      +             +L  + + ++++T     SI    
Sbjct: 343 QLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYL 402

Query: 311 GKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSN----- 365
             L + +L+ L       ++P   GV +            L  C+ LR    Y       
Sbjct: 403 KNLCDFRLVLLDREERITDLPLDNGVRSL-----------LIGCKKLRRFAFYLRQGGLT 451

Query: 366 ----RFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQ-IQRG 420
                + G+    +     L  +  SD  +          NL +LE+    FS + I   
Sbjct: 452 DLGLSYIGQYSPNV-RWMLLGYVGESDEGLMEFSRGCP--NLQKLEMRGCCFSERAIAAA 508

Query: 421 VGSWKNL 427
           V    +L
Sbjct: 509 VTKLPSL 515

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 34/174 (19%), Positives = 65/174 (37%), Gaps = 31/174 (17%)

Query: 644 IGSGGSGQVY--------RIDINGAGEFVAVK------RIWNNRKLNQKLEKEF-IAEIE 688
                 G +Y          D     +  ++K      R++N +   Q+  K   + + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 689 ILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHW 748
            L +     I         ++     Y ++   SL R       SL S      +HVL  
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGR-------SLQSALDVSPKHVLSE 158

Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI--ADFGLAK 800
            + LQ+A      L ++H +     +H +V + NI +D E ++++  A +G A 
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 43/164 (26%), Positives = 64/164 (39%), Gaps = 31/164 (18%)

Query: 644 IGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA-NIVKL 701
           IGSG  G++Y   +I    E VA+K      K  Q L      E +I   ++    I  +
Sbjct: 15  IGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHPQ-LLY----ESKIYRILQGGTGIPNV 68

Query: 702 WCCISSENSKLLVYEYMENQSLD--RWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
                  +  +LV + +   SL+       RK SL               T L +A    
Sbjct: 69  RWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL--------------KTVLMLADQMI 113

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK---IADFGLAK 800
             + ++H       +HRD+K  N L+    +A    I DFGLAK
Sbjct: 114 NRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 32/86 (37%), Positives = 49/86 (56%), Gaps = 7/86 (8%)

Query: 243 SSLEILALNGNHLEGAIPSGLF-LLNNLTQLFLYDNILSGEIPSSV-EAL-KLTDIDLSM 299
           +  + L LN N +   +  G+F  L NL QL+   N L+  IP+ V + L +LT +DL+ 
Sbjct: 33  TDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLND 90

Query: 300 NNLTGSIPE-EFGKLKNLQLLGLFSN 324
           N+L  SIP   F  LK+L  + L++N
Sbjct: 91  NHLK-SIPRGAFDNLKSLTHIYLYNN 115

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 47/189 (24%), Positives = 74/189 (39%), Gaps = 47/189 (24%)

Query: 98  NLTTIDLSS---NSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG 154
           + TT++  S    S+P   P       +   LDL  N          D ++ L  + LGG
Sbjct: 8   SGTTVECYSQGRTSVPTGIP------AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGG 61

Query: 155 NNFSGDIPRSIGRLSELQTLYLYMNEF----NGTFPKEIGDLSNLEVLGLAYNSNFKPAM 210
           N           +L+ L  L L  N+     NG F K    L+ L+ L L  N       
Sbjct: 62  NKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDK----LTQLKELALNTN------- 110

Query: 211 IPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLF-LLNN 268
                    +L++L           P+     L+ L+ L L  N L+ ++P G+F  L +
Sbjct: 111 ---------QLQSL-----------PDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTS 149

Query: 269 LTQLFLYDN 277
           L  ++L+DN
Sbjct: 150 LQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 40/139 (28%), Positives = 59/139 (42%), Gaps = 24/139 (17%)

Query: 243 SSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSV--EALKLTDIDLSMN 300
           +    L L  N L+         L +LTQL+L  N L   +P+ V  +   LT ++LS N
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86

Query: 301 NLTGSIPEE-FGKLKNLQLLGLFSNHLSGEVPASIGV---------VAFENNLSGAVPK- 349
            L  S+P   F KL  L+ L L +N L   +P   GV         +    N   +VP  
Sbjct: 87  QLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPD--GVFDKLTQLKDLRLYQNQLKSVPDG 142

Query: 350 ---SLGNCRTLRTVQLYSN 365
               L +   L+ + L+ N
Sbjct: 143 VFDRLTS---LQYIWLHDN 158

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 49.5 bits (119), Expect = 6e-07
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 7/86 (8%)

Query: 243 SSLEILALNGNHLEGAIPSGLF-LLNNLTQLFLYDNILSGEIPSSV-EAL-KLTDIDLSM 299
           ++ ++L L  N +   +  G+F  L  LT+L L +N L+  +P+ V + L +LT + L+ 
Sbjct: 30  TTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLND 87

Query: 300 NNLTGSIPEE-FGKLKNLQLLGLFSN 324
           N L  SIP   F  LK+L  + L +N
Sbjct: 88  NQLK-SIPRGAFDNLKSLTHIWLLNN 112

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 35/176 (19%), Positives = 58/176 (32%), Gaps = 36/176 (20%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEF-----------IAEIEILG 691
            IGSGG G +Y        E  A   +    + N  L  E            I +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 692 TIRHANIVKLWCCISSENSK----LLVYEYMENQSL-DRWLHGRKRSLVSGSSSVHQHVL 746
            + +  I   +    +E        +V E +    L                        
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKK------------ 150

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI--ADFGLAK 800
              T LQ+ I     L Y+H +     +H D+K++N+LL  +   ++  AD+GL+ 
Sbjct: 151 --STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 22/104 (21%), Positives = 35/104 (33%), Gaps = 6/104 (5%)

Query: 78  ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPI 137
           + LR   I   I  +   L     ID S N I     +      +L+ L ++ N      
Sbjct: 24  LDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRICRIG 80

Query: 138 PSDIDRISGLQCIDLGGNNFS--GDIPRSIGRLSELQTLYLYMN 179
                 +  L  + L  N+    GD+   +  L  L  L +  N
Sbjct: 81  EGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 24/134 (17%), Positives = 37/134 (27%), Gaps = 28/134 (20%)

Query: 95  DLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG 154
           +      +DL    IP           +   +D S N        +I ++ G        
Sbjct: 17  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN--------EIRKLDGFPL----- 62

Query: 155 NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE 214
                        L  L+TL +  N            L +L  L L  NS  +   +   
Sbjct: 63  -------------LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DP 108

Query: 215 FGMLKKLKTLWMTE 228
              LK L  L +  
Sbjct: 109 LASLKSLTYLCILR 122

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 11/104 (10%)

Query: 228 EANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSV 287
            A LI +  +  +N      L L G  +   I +    L+    +   DN +       +
Sbjct: 5   TAELIEQAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KL 57

Query: 288 EAL----KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLS 327
           +      +L  + ++ N +          L +L  L L +N L 
Sbjct: 58  DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 24/117 (20%), Positives = 44/117 (37%), Gaps = 11/117 (9%)

Query: 191 DLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILAL 250
           +      L L      K  +I      L +   +  ++ N I ++ +    L  L+ L +
Sbjct: 17  NAVRDRELDLRGY---KIPVIENLGATLDQFDAIDFSD-NEIRKL-DGFPLLRRLKTLLV 71

Query: 251 NGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK----LTDIDLSMNNLT 303
           N N +          L +LT+L L +N L       ++ L     LT + +  N +T
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.5 bits (103), Expect = 7e-05
 Identities = 36/177 (20%), Positives = 49/177 (27%), Gaps = 58/177 (32%)

Query: 103 DLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIP 162
            L++  I  E      N  + + LDL            I  I  L               
Sbjct: 3   KLTAELI--EQAAQYTNAVRDRELDLRGY--------KIPVIENLGA------------- 39

Query: 163 RSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLK 222
                L +   +    N        EI  L                        +L++LK
Sbjct: 40  ----TLDQFDAIDFSDN--------EIRKLDGFP--------------------LLRRLK 67

Query: 223 TLWMTEANLIGEIPEAM-SNLSSLEILALNGNHLEG-AIPSGLFLLNNLTQLFLYDN 277
           TL +   N I  I E +   L  L  L L  N L        L  L +LT L +  N
Sbjct: 68  TLLV-NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.2 bits (116), Expect = 4e-06
 Identities = 41/304 (13%), Positives = 87/304 (28%), Gaps = 35/304 (11%)

Query: 30  QSPNTEERTILLNLKQQLGNPPSL----QSWTSTSSPCDWPEITCTFNSVTGISLRHKDI 85
           ++ ++         K                 +     +  +   +++           I
Sbjct: 41  KNFSSAGEAEKAAGKLIAEKTKKGYVETLEEVAKEMKVEAKKYALSYDEAEEGVNLMDKI 100

Query: 86  TQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRIS 145
            +           +                 + N  K  +    +  F G I  +   IS
Sbjct: 101 LKDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHF---EGLFWGDIDFEEQEIS 157

Query: 146 GLQCIDLGGN------------NFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIG--D 191
            ++ +DL                 + ++         L++L +       +  ++I   D
Sbjct: 158 WIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217

Query: 192 LSNLEVLGLAYNSNFKPAMIPIEF-------GMLKKLKTLWMTEANLIGEIPEAMSN--- 241
           L NLE L L            +              LK L + +A     + E       
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277

Query: 242 LSSLEILALNGNHL--EGA--IPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDL 297
           L  LE + ++   L  EGA  +   +  + +L  + +  N LS E+   ++      ID+
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDV 337

Query: 298 SMNN 301
           S + 
Sbjct: 338 SDSQ 341

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.9 bits (105), Expect = 7e-05
 Identities = 31/184 (16%), Positives = 60/184 (32%), Gaps = 24/184 (13%)

Query: 345 GAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAW--- 401
             +   L     L  +++   + +  L  G     NL SL +    +   +         
Sbjct: 162 VDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 402 -NLTRLEI----SNNRFSGQIQR-----GVGSWKNLIVFKASNNLFSGEIPVELTS---L 448
            NL +L +     +  F G +           + NL      +      +         L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 449 SHLNTLLLDGNKLSGK----LPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDL 504
             L T+ +    L+ +    L   +     L  +N+  N LS E+ K +   L  + +D+
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL-PMKIDV 337

Query: 505 SGNQ 508
           S +Q
Sbjct: 338 SDSQ 341

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.0 bits (100), Expect = 4e-04
 Identities = 23/188 (12%), Positives = 61/188 (32%), Gaps = 19/188 (10%)

Query: 364 SNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGS 423
           S     +L   L     L++L +     +  +  K   NL  LEI +      +   +  
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTN-NLSIGKKPRPNLKSLEIISGGLPDSVVEDILG 215

Query: 424 W-----KNLIVFKASNNLFSGEIPVEL------TSLSHLNTLLLDGNKLSGKLPSQIVS- 471
                 + L+++    +                    +L  L +   +    +    +  
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275

Query: 472 --WTSLNNLNLARNELSGE----IPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTF 525
                L  ++++   L+ E    +   +  +  +  +++  N  S E+  E+ +      
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKI 335

Query: 526 NLSSNKLY 533
           ++S ++ Y
Sbjct: 336 DVSDSQEY 343

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 37/180 (20%), Positives = 63/180 (35%), Gaps = 41/180 (22%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKR---IWNNRKLNQKLEKEF-----------IAEIE 688
            IG GG G +Y  D+N   E V       +      N  L  E            I +  
Sbjct: 42  PIGQGGFGCIYLADMNS-SESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 689 ILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWL------HGRKRSLVSGSSSVH 742
               +++  + K W      +     Y +M        L      + ++ S         
Sbjct: 101 RTRKLKYLGVPKYWGS-GLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSR-------- 151

Query: 743 QHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI--ADFGLAK 800
                  T LQ+++     L Y+H       +H D+K+SN+LL+ +   ++   D+GLA 
Sbjct: 152 ------KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.7 bits (111), Expect = 5e-06
 Identities = 22/105 (20%), Positives = 44/105 (41%), Gaps = 6/105 (5%)

Query: 78  ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPI 137
           +     +   KI  +  +  NL  + L +  +       L    KL+ L+LS+N   G +
Sbjct: 31  LDNCKSNDG-KIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELSENRIFGGL 87

Query: 138 PSDIDRISGLQCIDLGGNNFS--GDIPRSIGRLSELQTLYLYMNE 180
               +++  L  ++L GN       +   + +L  L++L L+  E
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCE 131

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.0 bits (104), Expect = 4e-05
 Identities = 31/136 (22%), Positives = 48/136 (35%), Gaps = 12/136 (8%)

Query: 191 DLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILAL 250
             + +  L L    +    +  +       L+ L +     +  +   +  L  L+ L L
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGL-TAEFVNLEFLSLIN-VGLISV-SNLPKLPKLKKLEL 78

Query: 251 NGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK----LTDIDLSMN---NLT 303
           + N + G +      L NLT L L  N L     S++E LK    L  +DL      NL 
Sbjct: 79  SENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEVTNLN 136

Query: 304 GSIPEEFGKLKNLQLL 319
                 F  L  L  L
Sbjct: 137 DYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 27/180 (15%), Positives = 55/180 (30%), Gaps = 34/180 (18%)

Query: 73  NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNY 132
           +  +G+ ++ +   +        ++ L  +D   ++   +          L+ L L    
Sbjct: 3   SGSSGMDMKRRIHLELRNRTPAAVRELV-LDNCKSNDG-KIEGLTAEFVNLEFLSLINV- 59

Query: 133 FVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDL 192
                   +  +S L                   +L +L+ L L  N   G        L
Sbjct: 60  -------GLISVSNLP------------------KLPKLKKLELSENRIFGGLDMLAEKL 94

Query: 193 SNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE----AMSNLSSLEIL 248
            NL  L L+ N     + +      L+ LK+L +     +  + +        L  L  L
Sbjct: 95  PNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFN-CEVTNLNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 20/93 (21%), Positives = 37/93 (39%), Gaps = 7/93 (7%)

Query: 66  PEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQN 125
             +T  F ++  +SL +  +   +   +  L  L  ++LS N I G           L +
Sbjct: 42  EGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99

Query: 126 LDLSQNYFVGPIPSDIDRISG---LQCIDLGGN 155
           L+LS N       S ++ +     L+ +DL   
Sbjct: 100 LNLSGNKLKD--ISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 26/92 (28%), Positives = 36/92 (39%), Gaps = 10/92 (10%)

Query: 241 NLSSLEILALNGNHL-EGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL----KLTDI 295
             +++  L L+     +G I        NL  L L +  L      SV  L    KL  +
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKL 76

Query: 296 DLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLS 327
           +LS N + G +     KL NL  L L  N L 
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 26/117 (22%), Positives = 49/117 (41%), Gaps = 9/117 (7%)

Query: 191 DLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILAL 250
             S+++ L L  + + +  +  +     ++L+ L       +  I   +  L+ L+ L L
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGL-TDEFEELEFLSTIN-VGLTSI-ANLPKLNKLKKLEL 71

Query: 251 NGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK----LTDIDLSMNNLT 303
           + N + G +        NLT L L  N +     S++E LK    L  +DL    +T
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.7 bits (101), Expect = 9e-05
 Identities = 22/135 (16%), Positives = 41/135 (30%), Gaps = 28/135 (20%)

Query: 95  DLKNLTTIDLSSNSIP-GEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLG 153
              ++  + L ++    G+         +L+ L              +  I+ L      
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV--------GLTSIANLP----- 61

Query: 154 GNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPI 213
                        +L++L+ L L  N  +G          NL  L L+ N   K      
Sbjct: 62  -------------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN-KIKDLSTIE 107

Query: 214 EFGMLKKLKTLWMTE 228
               L+ LK+L +  
Sbjct: 108 PLKKLENLKSLDLFN 122

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 22/92 (23%), Positives = 36/92 (39%), Gaps = 10/92 (10%)

Query: 241 NLSSLEILALNGNHL-EGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL----KLTDI 295
             S ++ L L+ +   EG +         L  L   +  L+     S+  L    KL  +
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69

Query: 296 DLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLS 327
           +LS N ++G +     K  NL  L L  N + 
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 7/93 (7%)

Query: 66  PEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQN 125
             +T  F  +  +S  +  +T  I   +  L  L  ++LS N + G        C  L +
Sbjct: 35  EGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92

Query: 126 LDLSQNYFVGPIPSDIDRISG---LQCIDLGGN 155
           L+LS N       S I+ +     L+ +DL   
Sbjct: 93  LNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 38/226 (16%), Positives = 73/226 (32%), Gaps = 15/226 (6%)

Query: 68  ITCTFNSVTGISLRHKDIT-QKIPPIICDLKNLTTIDLSSNSIPGE--FPEFLYNCTKLQ 124
           ++ ++  +  I L+   +T   +  I    KN   + LSS               C  L+
Sbjct: 100 MSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLK 159

Query: 125 NLDLSQNYFVGPIPSDIDRIS----GLQCIDLGG--NNFSGDIPRSIG-RLSELQTLYLY 177
            LDL ++         +         L  +++    +  S      +  R   L++L L 
Sbjct: 160 ELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLN 219

Query: 178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNF----KPAMIPIEFGMLKKLKTLWMTEANLIG 233
                      +     LE LG    +        + + +     K+L+ L      +  
Sbjct: 220 RAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPA 279

Query: 234 EIPEAMSNLSSLEILALNGNHL-EGAIPSGLFLLNNLTQLFLYDNI 278
            +P   S  S L  L L+   +    +   L     L +L++ D I
Sbjct: 280 YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYI 325

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 42/314 (13%), Positives = 76/314 (24%), Gaps = 74/314 (23%)

Query: 237 EAMSNLSSLEILALNGNHL--EGAIPSGLFLLNN---LTQLFLYDNILSGEIPSSVEAL- 290
           E +S+L  L    L G  +           L +    L ++ L    L       +  L 
Sbjct: 69  EVLSSLRQLN---LAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPA---GLRTLL 122

Query: 291 ----KLTDIDLSMNNLTGSIPEEFGK-LK----NLQLLGLFSNHLSGEVPASIGVVAFEN 341
               +   + L +N+L     ++    L      +  L L +N L+       GV     
Sbjct: 123 PVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAA-----GVAV--- 174

Query: 342 NLSGAVPKSLGNCRTLRTVQLYSNRFSGE----LPTGLWTTFNLSSLMLSDNTISGE--- 394
            L       L    ++  + L       E    L   L     L  L ++ N        
Sbjct: 175 -LMEG----LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL 229

Query: 395 -----LPSKTAWNLTRLEISNNRFS-------GQIQRGVGSWKNLIVFKASNNLFSGEIP 442
                       +L  L +  N  S         +         ++V        S    
Sbjct: 230 ALARAAREHP--SLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWS 287

Query: 443 VELTS-LSHLNTLLLDGNKLSGKLPSQIVSW------------------TSLNNLNLARN 483
           V L+    +LN+      +   +L  + +                      +  L     
Sbjct: 288 VILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLG 347

Query: 484 ELSGEIPKAIGSLL 497
                         
Sbjct: 348 SSGSPSGSWSHPQF 361

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	969
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.98
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.94
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.92
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.92
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.91
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.89
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.87
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.86
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.86
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.84
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.84
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.79
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.78
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.78
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.78
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.78
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.77
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.77
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.75
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.72
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.72
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.7
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.69
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.62
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.58
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.57
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.57
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.53
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.52
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.51
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.5
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.48
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.48
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.45
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.45
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.45
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.45
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.43
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.41
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.4
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.31
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.29
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.22
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.21
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.15
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.14
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.07
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.99
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.9
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.89
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.79
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.78
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.76
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.65
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.59
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.53
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.5
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.48
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.31
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.28
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.25
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.12
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.11
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.94
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.82
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.77
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.61
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.6
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.46
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.33
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.96
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.96
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.95
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.82
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.76
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.75
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.71
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.52
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.46
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.39
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.26
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.19
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.94
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.56
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.5
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.5
3mes_A	424	Choline kinase; malaria, structural genomics, stru	92.84
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.47
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	84.1
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	83.82

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.1e-72  Score=697.44  Aligned_cols=535  Identities=34%  Similarity=0.511  Sum_probs=421.2

Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCCCcceeeCCCeEEEEecCCCCCCC---CC-----------------
Q 002085           31 SPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQK---IP-----------------   90 (969)
Q Consensus        31 ~~~~~~~~all~~k~~~~~~~~l~sw~~~~~~c~w~gv~C~~~~v~~l~l~~~~l~~~---~~-----------------   90 (969)
                      ...++|++||++||+++.++..+++|+.++|||+|.||+|+.++|+.|+|+++.+.|.   +|                 
T Consensus         8 ~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~   87 (768)
T 3rgz_A            8 QSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNS   87 (768)
T ss_dssp             CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTS
T ss_pred             cCCHHHHHHHHHHHhhCCCcccccCCCCCCCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCC
Confidence            3467899999999999987667899998899999999999988999999999998886   33                 


Q ss_pred             ------ccccCCCcccEEEccCCCCCCCCCc--ccCCCCCCCEEeccCCcCCCCCCCCc-c-------------------
Q 002085           91 ------PIICDLKNLTTIDLSSNSIPGEFPE--FLYNCTKLQNLDLSQNYFVGPIPSDI-D-------------------  142 (969)
Q Consensus        91 ------~~~~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~l-~-------------------  142 (969)
                            +.|+.+++|++|||++|.++|.+|.  .++++++|++|+|++|.+++.+|..+ .                   
T Consensus        88 ~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  167 (768)
T 3rgz_A           88 HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN  167 (768)
T ss_dssp             CEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEET
T ss_pred             CcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcC
Confidence                  5778888999999999999888887  88888888888888888777666543 3                   


Q ss_pred             ------------------------------cCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCC
Q 002085          143 ------------------------------RISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDL  192 (969)
Q Consensus       143 ------------------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  192 (969)
                                                    .+++|++|+|++|++++.+|. ++++++|++|+|++|++++.+|..|+++
T Consensus       168 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l  246 (768)
T 3rgz_A          168 VVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTC  246 (768)
T ss_dssp             HHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTC
T ss_pred             ChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcC
Confidence                                          334455555555555554554 6777777777777777777777777777


Q ss_pred             CCcceeecccCCCCC--------------------CCCCCcccccc-CCCcEEEccCCcccccCchhhcCCCchhhhhcc
Q 002085          193 SNLEVLGLAYNSNFK--------------------PAMIPIEFGML-KKLKTLWMTEANLIGEIPEAMSNLSSLEILALN  251 (969)
Q Consensus       193 ~~L~~L~L~~N~~~~--------------------~~~~p~~~~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  251 (969)
                      ++|++|++++|.+..                    .+.+|..+..+ ++|++|+|++|++.+.+|..|+++++|++|+|+
T Consensus       247 ~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~  326 (768)
T 3rgz_A          247 TELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS  326 (768)
T ss_dssp             SSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECC
T ss_pred             CCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECC
Confidence            777777777775321                    01445555443 777777777777777777777777777777777


Q ss_pred             CCcCCCCCCch-hhcCcccchhhccCcccccCCCCchhhc----------------------------ccccccccCccc
Q 002085          252 GNHLEGAIPSG-LFLLNNLTQLFLYDNILSGEIPSSVEAL----------------------------KLTDIDLSMNNL  302 (969)
Q Consensus       252 ~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~~----------------------------~L~~L~Ls~N~l  302 (969)
                      +|+++|.+|.. +..+++|++|+|++|++++.+|..+...                            +|+.|++++|++
T Consensus       327 ~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l  406 (768)
T 3rgz_A          327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF  406 (768)
T ss_dssp             SSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEE
T ss_pred             CCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcc
Confidence            77777666654 6667777777777777766666555432                            355556666666


Q ss_pred             cccCCccccCcccchhhhhccccCcCcCCcccccc------c-ccCcccccCCCCCCCCccCcEEEcccccccCCCCccc
Q 002085          303 TGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVV------A-FENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGL  375 (969)
Q Consensus       303 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l------~-~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  375 (969)
                      ++.+|..|+.+++|+.|++++|++++.+|..++.+      . ..|++.+.+|..+..+++|++|++++|++++.+|..+
T Consensus       407 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l  486 (768)
T 3rgz_A          407 TGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL  486 (768)
T ss_dssp             EEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred             ccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHH
Confidence            66677777777788888888888877777665532      2 2466777888888888888888888888888888888


Q ss_pred             ccccCCCccccCCCccccccCccc--cccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccc--------
Q 002085          376 WTTFNLSSLMLSDNTISGELPSKT--AWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEL--------  445 (969)
Q Consensus       376 ~~l~~L~~L~Ls~N~l~~~~~~~~--~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~--------  445 (969)
                      ..+++|+.|+|++|++++.+|...  .++|++|+|++|++++.+|..++.+++|++|++++|.++|.+|..+        
T Consensus       487 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~  566 (768)
T 3rgz_A          487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA  566 (768)
T ss_dssp             GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBC
T ss_pred             hcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhh
Confidence            888889999999999888888754  3689999999999998899999999999999999998887777544        


Q ss_pred             --------------------------------------------------------------cCccccchhhccCcccCC
Q 002085          446 --------------------------------------------------------------TSLSHLNTLLLDGNKLSG  463 (969)
Q Consensus       446 --------------------------------------------------------------~~l~~L~~L~Ls~N~l~~  463 (969)
                                                                                    ..+++|+.|||++|+++|
T Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g  646 (768)
T 3rgz_A          567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG  646 (768)
T ss_dssp             CSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBS
T ss_pred             hhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccc
Confidence                                                                          335778999999999999


Q ss_pred             CCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecCcCCCCCCccccc
Q 002085          464 KLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNN  542 (969)
Q Consensus       464 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~~~~  542 (969)
                      .+|..++.+++|+.|+|++|+++|.+|..|+++++|+.||||+|+++|.+|..++.++ |++||||+|+|+|.||...+.
T Consensus       647 ~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~  726 (768)
T 3rgz_A          647 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF  726 (768)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSG
T ss_pred             cCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhh
Confidence            9999999999999999999999999999999999999999999999999999999996 999999999999999987655


Q ss_pred             cccc-ccccCCCCCCCCCCCCCCCCCCCC
Q 002085          543 LAYD-DSFLNNSNLCVKNPIINLPKCPSR  570 (969)
Q Consensus       543 ~~~~-~~~~~n~~l~~~~~~~~l~~c~~~  570 (969)
                      .++. .+|.+|+++||.+    ++.|...
T Consensus       727 ~~~~~~~~~gN~~Lcg~~----l~~C~~~  751 (768)
T 3rgz_A          727 ETFPPAKFLNNPGLCGYP----LPRCDPS  751 (768)
T ss_dssp             GGSCGGGGCSCTEEESTT----SCCCCSC
T ss_pred             ccCCHHHhcCCchhcCCC----CcCCCCC
Confidence            5543 5799999999963    3467543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2e-57  Score=561.16  Aligned_cols=457  Identities=34%  Similarity=0.575  Sum_probs=392.8

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      .+++.|++++|.+.+.+|. ++++++|++|+|++|.+++.+|..|+++++|++|+|++|.+++.+|..  .+++|++|+|
T Consensus       200 ~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L  276 (768)
T 3rgz_A          200 VNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL  276 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEEC
T ss_pred             CcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEEC
Confidence            4678888888888887776 888888888888888888888888888888888888888888777765  7888888888


Q ss_pred             CCCCCCCcCCCcccCc-ccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCcc-ccccCCCcEEEccCCc
Q 002085          153 GGNNFSGDIPRSIGRL-SELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIE-FGMLKKLKTLWMTEAN  230 (969)
Q Consensus       153 ~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~-~~~l~~L~~L~L~~n~  230 (969)
                      ++|++++.+|..+..+ ++|++|+|++|++++.+|..|+++++|++|++++|.+  .+.+|.. ++.+++|++|++++|+
T Consensus       277 ~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l--~~~ip~~~l~~l~~L~~L~Ls~n~  354 (768)
T 3rgz_A          277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF--SGELPMDTLLKMRGLKVLDLSFNE  354 (768)
T ss_dssp             CSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEE--EEECCHHHHTTCTTCCEEECCSSE
T ss_pred             cCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcc--cCcCCHHHHhcCCCCCEEeCcCCc
Confidence            8888888888888765 8888888888888888888888888888888888863  2356655 8888888888888888


Q ss_pred             ccccCchhhcCCC-chhhhhccCCcCCCCCCchhhc--CcccchhhccCcccccCCCCchhhc-ccccccccCccccccC
Q 002085          231 LIGEIPEAMSNLS-SLEILALNGNHLEGAIPSGLFL--LNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSI  306 (969)
Q Consensus       231 l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~--l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~  306 (969)
                      +.+.+|..+.+++ +|++|+|++|++++.+|..+..  +++|++|++++|++++.+|..+... +|+.|++++|++++.+
T Consensus       355 l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~  434 (768)
T 3rgz_A          355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI  434 (768)
T ss_dssp             EEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCC
T ss_pred             cCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcc
Confidence            8888888888877 8888888888888888877776  7889999999999998888888776 6999999999999999


Q ss_pred             CccccCcccchhhhhccccCcCcCCcccccc------c-ccCcccccCCCCCCCCccCcEEEcccccccCCCCccccccc
Q 002085          307 PEEFGKLKNLQLLGLFSNHLSGEVPASIGVV------A-FENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTF  379 (969)
Q Consensus       307 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l------~-~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  379 (969)
                      |..|+.+++|+.|++++|++++.+|..+..+      . ..|++.+.+|..+.++++|++|+|++|++++.+|.++..++
T Consensus       435 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  514 (768)
T 3rgz_A          435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE  514 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred             cHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCC
Confidence            9999999999999999999999888876532      2 25678888999999999999999999999999999999999


Q ss_pred             CCCccccCCCccccccCcccc--ccccEEEeeccccCCCccccc------------------------------------
Q 002085          380 NLSSLMLSDNTISGELPSKTA--WNLTRLEISNNRFSGQIQRGV------------------------------------  421 (969)
Q Consensus       380 ~L~~L~Ls~N~l~~~~~~~~~--~~L~~L~Ls~N~l~~~~~~~~------------------------------------  421 (969)
                      +|+.|+|++|++++.+|....  ++|+.|+|++|+++|.+|..+                                    
T Consensus       515 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (768)
T 3rgz_A          515 NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL  594 (768)
T ss_dssp             TCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEE
T ss_pred             CCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccc
Confidence            999999999999998887543  689999999999987777543                                    


Q ss_pred             ----------------------------------CCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCc
Q 002085          422 ----------------------------------GSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPS  467 (969)
Q Consensus       422 ----------------------------------~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  467 (969)
                                                        +.+++|+.|++++|+++|.+|.+|+++++|+.|+|++|+++|.+|.
T Consensus       595 ~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~  674 (768)
T 3rgz_A          595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD  674 (768)
T ss_dssp             ECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred             ccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCCh
Confidence                                              3457789999999999999999999999999999999999999999


Q ss_pred             ccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCccccc-cccEEEeecCc-CCCC
Q 002085          468 QIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNK-LYGN  535 (969)
Q Consensus       468 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~-l~~~  535 (969)
                      .++++++|+.|||++|+++|.+|..++++++|++||||+|+|+|.||.. +++ .+....+.+|+ |+|.
T Consensus       675 ~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~  743 (768)
T 3rgz_A          675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY  743 (768)
T ss_dssp             GGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred             HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence            9999999999999999999999999999999999999999999999975 333 35555677775 6663

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=5.6e-58  Score=553.02  Aligned_cols=470  Identities=19%  Similarity=0.299  Sum_probs=395.2

Q ss_pred             CHHHHHHHHHHHHHcCCCCC---------CCCCCCCCCCCCC---CcceeeC-CCeEEEEecCCCCCCCCCccccCCCcc
Q 002085           33 NTEERTILLNLKQQLGNPPS---------LQSWTSTSSPCDW---PEITCTF-NSVTGISLRHKDITQKIPPIICDLKNL   99 (969)
Q Consensus        33 ~~~~~~all~~k~~~~~~~~---------l~sw~~~~~~c~w---~gv~C~~-~~v~~l~l~~~~l~~~~~~~~~~l~~L   99 (969)
                      ...|++||.+||+++.++.+         ..+|+.++|||.|   .||+|+. ++|+.|+|+++++.|.+|+++++|++|
T Consensus        28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L  107 (636)
T 4eco_A           28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL  107 (636)
T ss_dssp             HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred             HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccc
Confidence            45699999999999976643         2379999999999   9999965 689999999999999999999999999


Q ss_pred             cEEEccCCCC------CC------CCCcccCCCCCCCEEeccCCcCCCCCCCCcccC-------------------CCCc
Q 002085          100 TTIDLSSNSI------PG------EFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRI-------------------SGLQ  148 (969)
Q Consensus       100 ~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-------------------~~L~  148 (969)
                      ++|||++|.+      .|      .+|...  +..|+ +++++|.+.+.+|..+..+                   ..++
T Consensus       108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~  184 (636)
T 4eco_A          108 EVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK  184 (636)
T ss_dssp             CEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred             eEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence            9999999976      23      344433  55677 8888888887777666521                   1222


Q ss_pred             EEecC--CCCCCCcCCCcccCcccccceecccccccCc-----------------CCcccC--CCCCcceeecccCCCCC
Q 002085          149 CIDLG--GNNFSGDIPRSIGRLSELQTLYLYMNEFNGT-----------------FPKEIG--DLSNLEVLGLAYNSNFK  207 (969)
Q Consensus       149 ~L~L~--~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~~~~  207 (969)
                      .+.+.  .|++++ +|..|+++++|++|+|++|++++.                 +|..++  ++++|++|+|++|+  .
T Consensus       185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~--l  261 (636)
T 4eco_A          185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP--N  261 (636)
T ss_dssp             TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCT--T
T ss_pred             hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCc--C
Confidence            22232  678887 898999999999999999999985                 899988  99999999999987  4


Q ss_pred             CCCCCccccccCCCcEEEccCCc-ccc-cCchhhcCC------CchhhhhccCCcCCCCCCc--hhhcCcccchhhccCc
Q 002085          208 PAMIPIEFGMLKKLKTLWMTEAN-LIG-EIPEAMSNL------SSLEILALNGNHLEGAIPS--GLFLLNNLTQLFLYDN  277 (969)
Q Consensus       208 ~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N  277 (969)
                      .+.+|..|+++++|++|++++|+ +.+ .+|..++++      ++|++|+|++|+++ .+|.  .+..+++|++|+|++|
T Consensus       262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N  340 (636)
T 4eco_A          262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYN  340 (636)
T ss_dssp             CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSC
T ss_pred             CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCC
Confidence            56788899999999999999998 888 889888876      89999999999999 7888  8999999999999999


Q ss_pred             ccccCCCCchhhc-ccccccccCccccccCCccccCccc-chhhhhccccCcCcCCcccccccccCcccccCCCCCCCC-
Q 002085          278 ILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKN-LQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNC-  354 (969)
Q Consensus       278 ~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l-  354 (969)
                      +++|.+| .+..+ +|+.|++++|+++ .+|..+..+++ |+.|++++|+++ .+                 |..+..+ 
T Consensus       341 ~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~l-----------------p~~~~~~~  400 (636)
T 4eco_A          341 QLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YI-----------------PNIFDAKS  400 (636)
T ss_dssp             CCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SC-----------------CSCCCTTC
T ss_pred             cCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-cc-----------------chhhhhcc
Confidence            9998888 66554 7999999999999 78888999999 999999999988 33                 4444444 


Q ss_pred             -ccCcEEEcccccccCCCCcccc-------cccCCCccccCCCccccccCccc---cccccEEEeeccccCCCcccccCC
Q 002085          355 -RTLRTVQLYSNRFSGELPTGLW-------TTFNLSSLMLSDNTISGELPSKT---AWNLTRLEISNNRFSGQIQRGVGS  423 (969)
Q Consensus       355 -~~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~---~~~L~~L~Ls~N~l~~~~~~~~~~  423 (969)
                       ++|+.|++++|++++.+|..+.       .+.+|+.|+|++|+++ .+|...   .++|++|+|++|+++...+..+..
T Consensus       401 l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~  479 (636)
T 4eco_A          401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD  479 (636)
T ss_dssp             SSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEE
T ss_pred             cCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhcc
Confidence             4899999999999999998888       7789999999999998 455432   468999999999999444444433


Q ss_pred             c-------ccchhhcccCCccccccCcccc--CccccchhhccCcccCCCCCcccccccCCCEEEc------cCccccCC
Q 002085          424 W-------KNLIVFKASNNLFSGEIPVELT--SLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNL------ARNELSGE  488 (969)
Q Consensus       424 l-------~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~  488 (969)
                      .       ++|++|++++|+|+ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|      ++|++.+.
T Consensus       480 ~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~  557 (636)
T 4eco_A          480 ENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE  557 (636)
T ss_dssp             TTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCC
T ss_pred             ccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCccccc
Confidence            3       39999999999999 7888887  99999999999999997 8999999999999999      56889999


Q ss_pred             CCcccccccccceEeccCccccccCCCccccccccEEEeecCcCCC
Q 002085          489 IPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYG  534 (969)
Q Consensus       489 ~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~~  534 (969)
                      +|..++++++|+.|||++|+| +.+|..+. -.|++|||++|++..
T Consensus       558 ~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~-~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          558 WPEGITLCPSLTQLQIGSNDI-RKVNEKIT-PNISVLDIKDNPNIS  601 (636)
T ss_dssp             CCTTGGGCSSCCEEECCSSCC-CBCCSCCC-TTCCEEECCSCTTCE
T ss_pred             ChHHHhcCCCCCEEECCCCcC-CccCHhHh-CcCCEEECcCCCCcc
Confidence            999999999999999999999 68998876 359999999998863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=2.3e-56  Score=546.38  Aligned_cols=455  Identities=20%  Similarity=0.280  Sum_probs=266.4

Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCCCC-----CC--CCC------------CcceeeC-CCeEEEEecCCCCCCCCC
Q 002085           31 SPNTEERTILLNLKQQLGNPPSLQSWTSTS-----SP--CDW------------PEITCTF-NSVTGISLRHKDITQKIP   90 (969)
Q Consensus        31 ~~~~~~~~all~~k~~~~~~~~l~sw~~~~-----~~--c~w------------~gv~C~~-~~v~~l~l~~~~l~~~~~   90 (969)
                      .+..+|++||++||+++.++    +|+.+.     +|  |.|            .||+|+. ++|+.|+|+++++.|.+|
T Consensus       265 ~~~~~d~~ALl~~k~~l~~~----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip  340 (876)
T 4ecn_A          265 AEYIKDYKALKAIWEALDGK----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP  340 (876)
T ss_dssp             CHHHHHHHHHHHHHHHTTGG----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEEC
T ss_pred             ccchHHHHHHHHHHHHcCCC----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCc
Confidence            34567999999999999766    776443     66  999            9999984 789999999999999999


Q ss_pred             ccccCCCcccEEEc-cCCCCCCCCCccc---------------------------------------------------C
Q 002085           91 PIICDLKNLTTIDL-SSNSIPGEFPEFL---------------------------------------------------Y  118 (969)
Q Consensus        91 ~~~~~l~~L~~L~L-~~n~l~~~~p~~~---------------------------------------------------~  118 (969)
                      ++|++|++|++||| ++|.++|..|-..                                                   .
T Consensus       341 ~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~  420 (876)
T 4ecn_A          341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD  420 (876)
T ss_dssp             GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred             hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence            99999999999999 8888876643221                                                   1


Q ss_pred             CCCCCCEEeccC--CcCCCCCCCCcccCCCCcEEecCCCCCCC-----------------cCCCccc--Ccccccceecc
Q 002085          119 NCTKLQNLDLSQ--NYFVGPIPSDIDRISGLQCIDLGGNNFSG-----------------DIPRSIG--RLSELQTLYLY  177 (969)
Q Consensus       119 ~l~~L~~L~Ls~--N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~L~  177 (969)
                      ....++.+.++.  |++++ +|..|+++++|++|+|++|+|++                 .+|..++  ++++|++|+|+
T Consensus       421 ~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls  499 (876)
T 4ecn_A          421 SRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY  499 (876)
T ss_dssp             CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred             cccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence            112223333332  55555 56666666666666666666665                 2555544  55555555555


Q ss_pred             cccccCcCCcccCCCCCcceeecccCCCCCCC-CCCccccccC-------CCcEEEccCCcccccCch--hhcCCCchhh
Q 002085          178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPA-MIPIEFGMLK-------KLKTLWMTEANLIGEIPE--AMSNLSSLEI  247 (969)
Q Consensus       178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~-~~p~~~~~l~-------~L~~L~L~~n~l~~~~p~--~~~~l~~L~~  247 (969)
                      +|++.+.+|..|+++++|++|+|++|+.. .+ .+|..++.++       +|+.|+|++|++. .+|.  .|+++++|+.
T Consensus       500 ~N~l~~~iP~~l~~L~~L~~L~Ls~N~~l-sg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~  577 (876)
T 4ecn_A          500 NCPNMTQLPDFLYDLPELQSLNIACNRGI-SAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGL  577 (876)
T ss_dssp             SCTTCCSCCGGGGGCSSCCEEECTTCTTS-CHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCE
T ss_pred             CCCCCccChHHHhCCCCCCEEECcCCCCc-ccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCE
Confidence            55555555555555555555555555310 11 2444444333       5555555555554 4444  4555555555


Q ss_pred             hhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-c-cccccccCccccccCCccccCccc--chhhhhcc
Q 002085          248 LALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-K-LTDIDLSMNNLTGSIPEEFGKLKN--LQLLGLFS  323 (969)
Q Consensus       248 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~  323 (969)
                      |+|++|+++ .+| .+..+++|+.|+|++|+++ .+|..+..+ + |+.|+|++|+++ .+|..+..++.  |+.|+|++
T Consensus       578 L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~  653 (876)
T 4ecn_A          578 LDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSY  653 (876)
T ss_dssp             EECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCS
T ss_pred             EECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcC
Confidence            555555555 444 4445555555555555555 344333333 3 555555555555 44444444332  55555555


Q ss_pred             ccCcCcCCcccccccccCcccccCCCCCC--CCccCcEEEcccccccCCCCcccc-cccCCCccccCCCccccccCcccc
Q 002085          324 NHLSGEVPASIGVVAFENNLSGAVPKSLG--NCRTLRTVQLYSNRFSGELPTGLW-TTFNLSSLMLSDNTISGELPSKTA  400 (969)
Q Consensus       324 N~l~~~~p~~~~~l~~~n~l~~~~p~~l~--~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~  400 (969)
                      |++++.+|.              +|..+.  .+++|+.|+|++|+++ .+|..+. .+++                    
T Consensus       654 N~l~g~ip~--------------l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~--------------------  698 (876)
T 4ecn_A          654 NKIGSEGRN--------------ISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSP--------------------  698 (876)
T ss_dssp             SCTTTTSSS--------------CSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCC--------------------
T ss_pred             CcCCCcccc--------------chhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCC--------------------
Confidence            555443331              111111  2234455555555554 3333332 3444                    


Q ss_pred             ccccEEEeeccccCCCcccccC-------CcccchhhcccCCccccccCcccc--CccccchhhccCcccCCCCCccccc
Q 002085          401 WNLTRLEISNNRFSGQIQRGVG-------SWKNLIVFKASNNLFSGEIPVELT--SLSHLNTLLLDGNKLSGKLPSQIVS  471 (969)
Q Consensus       401 ~~L~~L~Ls~N~l~~~~~~~~~-------~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~  471 (969)
                        |+.|+|++|+|+...+..+.       ++++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+..
T Consensus       699 --L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~  774 (876)
T 4ecn_A          699 --ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLN  774 (876)
T ss_dssp             --CSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGG
T ss_pred             --CCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhc
Confidence              55555555555522222221       2236666666666666 5666665  66667777777777664 5666666


Q ss_pred             ccCCCEEEccC------ccccCCCCcccccccccceEeccCccccccCCCccccccccEEEeecCcCCCCCC
Q 002085          472 WTSLNNLNLAR------NELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIP  537 (969)
Q Consensus       472 l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~~~~p  537 (969)
                      +++|+.|+|++      |++.+.+|..|+++++|+.|+|++|+| +.+|..+.. .|+.|||++|++...-+
T Consensus       775 L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~-~L~~LdLs~N~l~~i~~  844 (876)
T 4ecn_A          775 SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTP-QLYILDIADNPNISIDV  844 (876)
T ss_dssp             CTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCS-SSCEEECCSCTTCEEEC
T ss_pred             CCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhcC-CCCEEECCCCCCCccCh
Confidence            66777776654      667777777777777777777777777 577776552 47777777777754333

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.1e-54  Score=460.83  Aligned_cols=277  Identities=17%  Similarity=0.240  Sum_probs=234.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|++++++++|||||++++++++++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999999999999999997654434444578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |||+||+|.+++...+             .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       112 Ey~~gG~L~~~i~~~~-------------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~D  175 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-------------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITD  175 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             ecCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEE
Confidence            9999999999998654             389999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+|+.+............+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+...+...+..   ..-.
T Consensus       176 FGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~  252 (311)
T 4aw0_A          176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK---LEYD  252 (311)
T ss_dssp             CTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TCCC
T ss_pred             cCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---CCCC
Confidence            9999987654444455567899999999999999999999999999999999999999987765544443322   1111


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCcccccCCCCCCCCCcccceeccc
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGFK  955 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  955 (969)
                                  .+...+.++.+++.+|++.||++|||++|++..                ..+..||||+  +++|+..
T Consensus       253 ------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~----------------~~i~~Hp~F~--~idw~~l  302 (311)
T 4aw0_A          253 ------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY----------------GPLKAHPFFE--SVTWENL  302 (311)
T ss_dssp             ------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH----------------HHHHTSGGGT--TCCCTTG
T ss_pred             ------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC----------------HHHHCCCCcC--CCCHHHh
Confidence                        112234678899999999999999999886432                2346799999  6677777


Q ss_pred             cccchh
Q 002085          956 RSKKVA  961 (969)
Q Consensus       956 ~~~~~~  961 (969)
                      +++++|
T Consensus       303 ~~~~pP  308 (311)
T 4aw0_A          303 HQQTPP  308 (311)
T ss_dssp             GGSCCC
T ss_pred             cCCCCC
Confidence            766654

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2e-52  Score=504.88  Aligned_cols=450  Identities=21%  Similarity=0.188  Sum_probs=312.9

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      ..++.|+++++.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  112 (606)
T 3t6q_A           33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF  112 (606)
T ss_dssp             TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred             CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence            35889999999999888889999999999999999999888999999999999999999999888999999999999999


Q ss_pred             CCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCc--EEEccCCc
Q 002085          153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLK--TLWMTEAN  230 (969)
Q Consensus       153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~--~L~L~~n~  230 (969)
                      ++|++++..|..|+++++|++|+|++|++++..+..+..+++|++|++++|.+  ....|..|+.+++|+  .|++++|.
T Consensus       113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l--~~~~~~~~~~l~~L~~l~L~l~~n~  190 (606)
T 3t6q_A          113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI--HYLSKEDMSSLQQATNLSLNLNGND  190 (606)
T ss_dssp             TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCC--CEECHHHHHTTTTCCSEEEECTTCC
T ss_pred             cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcc--cccChhhhhhhcccceeEEecCCCc
Confidence            99999977788899999999999999999975545555699999999999963  345577789999999  89999999


Q ss_pred             ccccCchhhcCC---------------------------------------------------CchhhhhccCCcCCCCC
Q 002085          231 LIGEIPEAMSNL---------------------------------------------------SSLEILALNGNHLEGAI  259 (969)
Q Consensus       231 l~~~~p~~~~~l---------------------------------------------------~~L~~L~L~~N~l~~~~  259 (969)
                      +.+..|..|...                                                   .+|+.|++++|.+++..
T Consensus       191 l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~  270 (606)
T 3t6q_A          191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS  270 (606)
T ss_dssp             CCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCC
T ss_pred             cCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccC
Confidence            988877765432                                                   04555666666666555


Q ss_pred             CchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCCccccccc
Q 002085          260 PSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVA  338 (969)
Q Consensus       260 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  338 (969)
                      +..|..+++|++|++++|+++ .+|..+..+ +|++|++++|++++..|..+..+++|++|++++|.+.+.+|.      
T Consensus       271 ~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~------  343 (606)
T 3t6q_A          271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT------  343 (606)
T ss_dssp             TTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCS------
T ss_pred             HHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccch------
Confidence            555666666666666666666 344444433 566666666666655556666666666666666666544432      


Q ss_pred             ccCcccccCCCCCCCCccCcEEEcccccccCCC--CcccccccCCCccccCCCccccccCccc--cccccEEEeeccccC
Q 002085          339 FENNLSGAVPKSLGNCRTLRTVQLYSNRFSGEL--PTGLWTTFNLSSLMLSDNTISGELPSKT--AWNLTRLEISNNRFS  414 (969)
Q Consensus       339 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~--~~~L~~L~Ls~N~l~  414 (969)
                                ..+.++++|++|++++|++++..  |..+..+++|+.|++++|.+++..|...  .++|++|++++|+++
T Consensus       344 ----------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  413 (606)
T 3t6q_A          344 ----------GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK  413 (606)
T ss_dssp             ----------STTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred             ----------hhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence                      23556666666666666665443  5556666666666666666665544432  245666666666666


Q ss_pred             CCcccc-cCCcccchhhcccCCccccccCccccCccccchhhccCcccCCC---CCcccccccCCCEEEccCccccCCCC
Q 002085          415 GQIQRG-VGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGK---LPSQIVSWTSLNNLNLARNELSGEIP  490 (969)
Q Consensus       415 ~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p  490 (969)
                      +..+.. +..+++|++|++++|.+++..|..+..+++|++|+|++|++++.   .+..+..+++|+.|+|++|++++..|
T Consensus       414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  493 (606)
T 3t6q_A          414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ  493 (606)
T ss_dssp             CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECT
T ss_pred             CcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccCh
Confidence            554433 56666666666666666666666666666666666666666541   22445666666666666666666556


Q ss_pred             cccccccccceEeccCccccccCCCcccccc-ccEEEeecCcCCCCCCccccc
Q 002085          491 KAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNN  542 (969)
Q Consensus       491 ~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~~~~  542 (969)
                      ..|+++++|+.|||++|++++.+|..+..++ | +|++++|++++.+|..+..
T Consensus       494 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~  545 (606)
T 3t6q_A          494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPI  545 (606)
T ss_dssp             TTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHH
T ss_pred             hhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhccc
Confidence            6666666666666666666666666666664 5 6666666666555554443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-51  Score=513.67  Aligned_cols=472  Identities=21%  Similarity=0.229  Sum_probs=340.1

Q ss_pred             CCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCC-CcccCCCCCCCEEeccCCcCCCCCCCCc
Q 002085           63 CDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEF-PEFLYNCTKLQNLDLSQNYFVGPIPSDI  141 (969)
Q Consensus        63 c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  141 (969)
                      |.|..|.+-..+++.|+|++|.+++..|..|.++++|++|||++|.+.+.+ |..|.++++|++|+|++|.+++..|..|
T Consensus        14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~   93 (844)
T 3j0a_A           14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF   93 (844)
T ss_dssp             CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred             CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence            567888774478999999999999988999999999999999999776666 7889999999999999999998889999


Q ss_pred             ccCCCCcEEecCCCCCCCcCCCc--ccCcccccceecccccccCcCC-cccCCCCCcceeecccCCCCCCCCCCcccccc
Q 002085          142 DRISGLQCIDLGGNNFSGDIPRS--IGRLSELQTLYLYMNEFNGTFP-KEIGDLSNLEVLGLAYNSNFKPAMIPIEFGML  218 (969)
Q Consensus       142 ~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l  218 (969)
                      .++++|++|+|++|.+++.+|..  |+++++|++|+|++|++++..+ ..|+++++|++|+|++|.+  ....|..++.+
T Consensus        94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i--~~~~~~~l~~l  171 (844)
T 3j0a_A           94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI--FLVCEHELEPL  171 (844)
T ss_dssp             CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCC--CCCCSGGGHHH
T ss_pred             cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcC--CeeCHHHcccc
Confidence            99999999999999999877665  8999999999999999987765 5799999999999999973  45577788887


Q ss_pred             --CCCcEEEccCCcccccCchhhcCCCc------hhhhhccCCcCCCCCCchhhcC------------------------
Q 002085          219 --KKLKTLWMTEANLIGEIPEAMSNLSS------LEILALNGNHLEGAIPSGLFLL------------------------  266 (969)
Q Consensus       219 --~~L~~L~L~~n~l~~~~p~~~~~l~~------L~~L~L~~N~l~~~~p~~l~~l------------------------  266 (969)
                        ++|+.|++++|++.+..|..++.+++      |+.|+|++|++++..+..+...                        
T Consensus       172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~  251 (844)
T 3j0a_A          172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN  251 (844)
T ss_dssp             HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred             cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence              89999999999999988887777665      9999999998887776655432                        


Q ss_pred             --------------cccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCC
Q 002085          267 --------------NNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVP  331 (969)
Q Consensus       267 --------------~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  331 (969)
                                    ++|+.|+|++|.+++..+..+..+ +|+.|+|++|++++..|..|..+++|++|+|++|++++..|
T Consensus       252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  331 (844)
T 3j0a_A          252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS  331 (844)
T ss_dssp             STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCS
T ss_pred             cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCH
Confidence                          467777777777776666666655 57777777777777777777777777777777777765544


Q ss_pred             ccccc------ccc-cCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCcccccccc
Q 002085          332 ASIGV------VAF-ENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLT  404 (969)
Q Consensus       332 ~~~~~------l~~-~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~  404 (969)
                      ..+..      +.+ .|++.+..+..+.++++|++|+|++|.+++ ++    .+++|+.|++++|+++ .+|.. ..+++
T Consensus       332 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~L~~L~l~~N~l~-~l~~~-~~~l~  404 (844)
T 3j0a_A          332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPSIPDIFLSGNKLV-TLPKI-NLTAN  404 (844)
T ss_dssp             CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCSCSEEEEESCCCC-CCCCC-CTTCC
T ss_pred             HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCCcchhccCCCCcc-ccccc-ccccc
Confidence            43321      222 233333334445556666666666666552 21    1445555555555554 22221 23455


Q ss_pred             EEEeeccccCCCc-ccccCCcccchhhcccCCccccccCc-cccCccccchhhccCcccC-----CCCCcccccccCCCE
Q 002085          405 RLEISNNRFSGQI-QRGVGSWKNLIVFKASNNLFSGEIPV-ELTSLSHLNTLLLDGNKLS-----GKLPSQIVSWTSLNN  477 (969)
Q Consensus       405 ~L~Ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~  477 (969)
                      .|++++|++++.. +..+.++++|++|++++|++++..+. .+..+++|+.|+|++|+++     +..|..+..+++|+.
T Consensus       405 ~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~  484 (844)
T 3j0a_A          405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV  484 (844)
T ss_dssp             EEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEEC
T ss_pred             eeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccE
Confidence            5566666655432 12344667777777777777754333 3455677777777777776     334455667777777


Q ss_pred             EEccCccccCCCCcccccccccceEeccCccccccCCCccccccccEEEeecCcCCCCCCccccccc
Q 002085          478 LNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLA  544 (969)
Q Consensus       478 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~~~~p~~~~~~~  544 (969)
                      |+|++|+|++..|..|..+++|+.|||++|+|++..|..+. -.|+.|||++|+|++.+|..+..+.
T Consensus       485 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~~~~L~  550 (844)
T 3j0a_A          485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDVFVSLS  550 (844)
T ss_dssp             CCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCCCSSCC
T ss_pred             EECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhHhCCcC
Confidence            77777777776677777777777777777777754443333 3477777777777777776665443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.3e-53  Score=455.58  Aligned_cols=270  Identities=24%  Similarity=0.372  Sum_probs=218.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEc-----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDIN-----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ++|...+.||+|+||+||+|++.     .+++.||||+++..   .....+.|.+|++++++++|||||+++++|.+++.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            46778899999999999999875     35788999999643   34556789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .|||||||++|+|.++++..+..............++|..++.|+.|||.||+|||++   +|+||||||+|||+++++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence            9999999999999999987542111111111234699999999999999999999988   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  869 (969)
                      +||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....++...+...
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~  246 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  246 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999987654433333445579999999999999999999999999999999999 89999876655444333221


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .              ..+.+..++.++.+++.+||+.||++|||++||++.|+++.
T Consensus       247 ~--------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          247 R--------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             C--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C--------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1              11223334578999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.9e-52  Score=451.82  Aligned_cols=271  Identities=24%  Similarity=0.380  Sum_probs=220.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEc-----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDIN-----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      .+++..++||+|+||+||+|++.     .+++.||||+++...  .....+.|.+|++++++++|||||+++|+|.+++.
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            34566789999999999999874     356789999986543  23345789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCC---CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      .+||||||++|+|.++++........+.   .......++|..+++|+.|||.||+|||+.   +||||||||+|||+++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence            9999999999999999976543211111   111234699999999999999999999988   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~  866 (969)
                      ++.+||+|||+|+.+.........+...||++|||||++.++.|+.++|||||||++|||+| |..||.+....++...+
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i  260 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI  260 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999999999987755444444556789999999999999999999999999999999999 78898876654443333


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..              +...+.+.+++..+.+++.+||+.||++||||+||++.|+...
T Consensus       261 ~~--------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          261 RN--------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             Hc--------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            21              1112233445578999999999999999999999999998763

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7e-52  Score=453.23  Aligned_cols=270  Identities=24%  Similarity=0.371  Sum_probs=210.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEc-----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDIN-----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ++|...++||+|+||+||+|++.     .+++.||||+++..   .....+.|.+|++++++++|||||+++++|.+++.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            35667789999999999999875     35789999999643   34556789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccc--cCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLV--SGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      .|||||||++|+|.++++.......  ..........++|.+++.|+.|||.||+|||+.   +|+||||||+|||++++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence            9999999999999999987643211  111122235699999999999999999999988   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  867 (969)
                      +.+||+|||+|+...........+...||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+....+.
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  274 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT  274 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999997655444444456789999999999999999999999999999999999 899998766544443332


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..    .          +.+.+..++.++.+++.+||+.||++||||+||+++|+.+.
T Consensus       275 ~g----~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          275 QG----R----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             HT----C----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             cC----C----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            21    1          11223334578999999999999999999999999998875

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=6.7e-51  Score=491.62  Aligned_cols=463  Identities=20%  Similarity=0.160  Sum_probs=389.5

Q ss_pred             EEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCC
Q 002085           77 GISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNN  156 (969)
Q Consensus        77 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  156 (969)
                      .+++++.+++ .+|..+.  +.+++|||++|.|++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus        16 ~~~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   92 (606)
T 3t6q_A           16 TYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP   92 (606)
T ss_dssp             EEECTTSCCS-SCCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEECCCCCcc-cCcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence            3455555554 3555554  378999999999998889999999999999999999999899999999999999999999


Q ss_pred             CCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCc
Q 002085          157 FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIP  236 (969)
Q Consensus       157 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  236 (969)
                      +++..|..|+++++|++|+|++|++++..|..|+++++|++|++++|++.  ...+..+..+++|++|++++|++.+..|
T Consensus        93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~  170 (606)
T 3t6q_A           93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS--SIKLPKGFPTEKLKVLDFQNNAIHYLSK  170 (606)
T ss_dssp             CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCC--CCCCCTTCCCTTCCEEECCSSCCCEECH
T ss_pred             ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCccc--ccCcccccCCcccCEEEcccCcccccCh
Confidence            99889999999999999999999999887889999999999999999743  2222344559999999999999999999


Q ss_pred             hhhcCCCchh--hhhccCCcCCCCCCchhhcCcccchhhccCcccc--------------------------cCCCCchh
Q 002085          237 EAMSNLSSLE--ILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILS--------------------------GEIPSSVE  288 (969)
Q Consensus       237 ~~~~~l~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--------------------------~~~~~~~~  288 (969)
                      ..|+.+++|+  .|++++|++++..|..+. ..+|+.|++++|...                          ...+..+.
T Consensus       171 ~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~  249 (606)
T 3t6q_A          171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE  249 (606)
T ss_dssp             HHHHTTTTCCSEEEECTTCCCCEECTTTTT-TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGG
T ss_pred             hhhhhhcccceeEEecCCCccCccChhHhh-hccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhc
Confidence            9999999999  899999999987666544 457777777766410                          01111222


Q ss_pred             ---hcccccccccCccccccCCccccCcccchhhhhccccCcCcCCccccc------ccc-cCcccccCCCCCCCCccCc
Q 002085          289 ---ALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGV------VAF-ENNLSGAVPKSLGNCRTLR  358 (969)
Q Consensus       289 ---~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~-~n~l~~~~p~~l~~l~~L~  358 (969)
                         ..+++.|++++|.+++..+..|..+++|++|++++|+++ .+|..+..      +.+ .|.+.+..|..+.++++|+
T Consensus       250 ~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  328 (606)
T 3t6q_A          250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT  328 (606)
T ss_dssp             GGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCS
T ss_pred             hhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCC
Confidence               225778888888888777777888888888888888887 56655432      233 3455666677899999999


Q ss_pred             EEEcccccccCCCCcc-cccccCCCccccCCCcccccc--Cc--cccccccEEEeeccccCCCcccccCCcccchhhccc
Q 002085          359 TVQLYSNRFSGELPTG-LWTTFNLSSLMLSDNTISGEL--PS--KTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKAS  433 (969)
Q Consensus       359 ~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~--~~--~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  433 (969)
                      +|++++|.+.+.+|.. +..+++|+.|++++|.+++..  +.  ...++|++|++++|++++..|..+..+++|++|+++
T Consensus       329 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  408 (606)
T 3t6q_A          329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA  408 (606)
T ss_dssp             EEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECT
T ss_pred             EEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECC
Confidence            9999999999777665 889999999999999998765  33  334789999999999999999999999999999999


Q ss_pred             CCccccccCcc-ccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCC---CCcccccccccceEeccCccc
Q 002085          434 NNLFSGEIPVE-LTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGE---IPKAIGSLLVMVSLDLSGNQF  509 (969)
Q Consensus       434 ~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~ls~N~l  509 (969)
                      +|.+++..|.. +..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++.   .+..+..+++|+.|+|++|++
T Consensus       409 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l  488 (606)
T 3t6q_A          409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL  488 (606)
T ss_dssp             TCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCC
T ss_pred             CCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCcc
Confidence            99999876654 89999999999999999999999999999999999999999873   346799999999999999999


Q ss_pred             cccCCCcccccc-ccEEEeecCcCCCCCCccccccccc
Q 002085          510 SGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNLAYD  546 (969)
Q Consensus       510 ~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~~~~~~~~  546 (969)
                      ++..|..++.++ |++|+|++|++++.+|..+..+...
T Consensus       489 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L  526 (606)
T 3t6q_A          489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI  526 (606)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC
T ss_pred             CccChhhhccccCCCEEECCCCccCcCChhHhCccccc
Confidence            998899999995 9999999999999999888776644

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.2e-50  Score=496.14  Aligned_cols=467  Identities=21%  Similarity=0.195  Sum_probs=310.1

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      .+++.|+++++.+++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            36889999999998877778999999999999999999888888999999999999999998655567899999999999


Q ss_pred             CCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCcccc--ccCCCcEEEccCCc
Q 002085          153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFG--MLKKLKTLWMTEAN  230 (969)
Q Consensus       153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~--~l~~L~~L~L~~n~  230 (969)
                      ++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|.+.  ...+..++  .+++|++|++++|+
T Consensus       105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~~~~~~L~~L~L~~n~  182 (680)
T 1ziw_A          105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ--ALKSEELDIFANSSLKKLELSSNQ  182 (680)
T ss_dssp             CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCC--CBCHHHHGGGTTCEESEEECTTCC
T ss_pred             CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccc--ccCHHHhhccccccccEEECCCCc
Confidence            999998777788899999999999999998888888888999999999888632  23333332  34566666666666


Q ss_pred             ccccCchhhc---------------------------------------------------CCCc--hhhhhccCCcCCC
Q 002085          231 LIGEIPEAMS---------------------------------------------------NLSS--LEILALNGNHLEG  257 (969)
Q Consensus       231 l~~~~p~~~~---------------------------------------------------~l~~--L~~L~L~~N~l~~  257 (969)
                      +.+..|..|.                                                   +++.  |+.|+|++|++++
T Consensus       183 l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~  262 (680)
T 1ziw_A          183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV  262 (680)
T ss_dssp             CCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCE
T ss_pred             ccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCc
Confidence            6555554443                                                   3322  5555555555554


Q ss_pred             CCCchhhcCcccchhhccCcccccCCCCchhhc----------------------------------ccccccccCcccc
Q 002085          258 AIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL----------------------------------KLTDIDLSMNNLT  303 (969)
Q Consensus       258 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~----------------------------------~L~~L~Ls~N~l~  303 (969)
                      ..|..+..+++|++|+|++|++++..|..+...                                  +|+.|++++|+++
T Consensus       263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~  342 (680)
T 1ziw_A          263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP  342 (680)
T ss_dssp             ECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBC
T ss_pred             cCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccC
Confidence            444555555555555555555554443322211                                  2333333334444


Q ss_pred             ccCCccccCcccchhhhhccccCcCcC-C---------cccccccc-cCcccccCCCCCCCCccCcEEEcccccccCCCC
Q 002085          304 GSIPEEFGKLKNLQLLGLFSNHLSGEV-P---------ASIGVVAF-ENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELP  372 (969)
Q Consensus       304 ~~~p~~~~~l~~L~~L~L~~N~l~~~~-p---------~~~~~l~~-~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  372 (969)
                      +..+..|..+++|++|++++|.+.+.. +         ..+..+.+ .|++.+..|..+..+++|+.|++++|++++.+|
T Consensus       343 ~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  422 (680)
T 1ziw_A          343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT  422 (680)
T ss_dssp             CCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECC
T ss_pred             CCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccC
Confidence            333333444444444444444332110 0         01111111 244555556666666666666666666665444


Q ss_pred             -cccccccCCCccccCCCccccccCccc--cccccEEEeeccccC--CCcccccCCcccchhhcccCCccccccCccccC
Q 002085          373 -TGLWTTFNLSSLMLSDNTISGELPSKT--AWNLTRLEISNNRFS--GQIQRGVGSWKNLIVFKASNNLFSGEIPVELTS  447 (969)
Q Consensus       373 -~~~~~l~~L~~L~Ls~N~l~~~~~~~~--~~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  447 (969)
                       ..+..+++|+.|++++|++++..+...  .++|+.|++++|.++  +.+|..+..+++|++|++++|+|++..+..|..
T Consensus       423 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~  502 (680)
T 1ziw_A          423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG  502 (680)
T ss_dssp             SGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             cccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcc
Confidence             456666666666666666665444332  356777777777665  456777778888888888888888777777788


Q ss_pred             ccccchhhccCcccCCCCC--------cccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccc
Q 002085          448 LSHLNTLLLDGNKLSGKLP--------SQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQ  519 (969)
Q Consensus       448 l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~  519 (969)
                      +++|++|+|++|++++..+        ..+..+++|+.|+|++|+|+...+..|.++++|+.|||++|+|++..+..+..
T Consensus       503 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~  582 (680)
T 1ziw_A          503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN  582 (680)
T ss_dssp             CTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             ccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCC
Confidence            8888888888888774321        23677788888888888887433346788888888888888888443344566


Q ss_pred             cc-ccEEEeecCcCCCCCCcccc
Q 002085          520 LK-LNTFNLSSNKLYGNIPDEFN  541 (969)
Q Consensus       520 l~-L~~l~ls~N~l~~~~p~~~~  541 (969)
                      +. |++|+|++|++++..|..+.
T Consensus       583 l~~L~~L~L~~N~l~~~~~~~~~  605 (680)
T 1ziw_A          583 QVSLKSLNLQKNLITSVEKKVFG  605 (680)
T ss_dssp             CTTCCEEECTTSCCCBCCHHHHH
T ss_pred             CCCCCEEECCCCcCCccChhHhc
Confidence            64 88888888888876665443

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-51  Score=442.58  Aligned_cols=261  Identities=28%  Similarity=0.383  Sum_probs=205.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++++..++||+|+||+||+|++.   ..||||+++... ......+.|.+|++++++++|||||++++++.+ +..||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            56788899999999999999874   259999986433 344556889999999999999999999998865 5689999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |||+||+|.++++...            ..++|..+..|+.|||.||+|||+.   +||||||||+|||+++++.+||+|
T Consensus       111 Ey~~gGsL~~~l~~~~------------~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~D  175 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQE------------TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGD  175 (307)
T ss_dssp             ECCSSCBHHHHHHTSC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECC
T ss_pred             EcCCCCCHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEee
Confidence            9999999999997653            2489999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT---TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ||+|+...............||+.|||||++.+   +.|+.++|||||||++|||+||+.||.+..........   ...
T Consensus       176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~---~~~  252 (307)
T 3omv_A          176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM---VGR  252 (307)
T ss_dssp             CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---HHT
T ss_pred             ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH---Hhc
Confidence            999987654444444556789999999999864   46899999999999999999999999865543322221   111


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ...     .+. ....+..++..+.+++.+||+.||++||||+||++.|+.+.
T Consensus       253 ~~~-----~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          253 GYA-----SPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             TCC-----CCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             CCC-----CCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            110     000 01122334578899999999999999999999999887763

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1e-50  Score=490.03  Aligned_cols=461  Identities=20%  Similarity=0.175  Sum_probs=365.2

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      .+++.|+++++.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            35888899998888887888888999999999999888777888888999999999999888877888888999999999


Q ss_pred             CCCCCCCcCCCcccCcccccceecccccccC-cCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCc----EEEcc
Q 002085          153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNG-TFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLK----TLWMT  227 (969)
Q Consensus       153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~----~L~L~  227 (969)
                      ++|.+++..|..|+++++|++|+|++|++++ .+|..|+++++|++|++++|++  ....|..|+.+++|+    .|+++
T Consensus       112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l--~~~~~~~~~~l~~L~~~l~~L~l~  189 (606)
T 3vq2_A          112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI--QTITVNDLQFLRENPQVNLSLDMS  189 (606)
T ss_dssp             TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCC--CEECTTTTHHHHHCTTCCCEEECT
T ss_pred             cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcc--eecChhhhhhhhccccccceeecc
Confidence            9998887777788888999999999998876 5688888899999999988863  344566677776665    78888


Q ss_pred             CCcccccCchhhcCCCchhhhhccCCcCC-CCCCchhhcCcccchhhc--------------------------------
Q 002085          228 EANLIGEIPEAMSNLSSLEILALNGNHLE-GAIPSGLFLLNNLTQLFL--------------------------------  274 (969)
Q Consensus       228 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L--------------------------------  274 (969)
                      +|++.+..+..+... +|+.|++++|.++ +..|..+..+++|+.+++                                
T Consensus       190 ~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l  268 (606)
T 3vq2_A          190 LNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL  268 (606)
T ss_dssp             TCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred             CCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence            888887766666655 8888888888876 234445555555554444                                


Q ss_pred             -cCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcc----cccccccCc-ccccC
Q 002085          275 -YDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPAS----IGVVAFENN-LSGAV  347 (969)
Q Consensus       275 -~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~~n~-l~~~~  347 (969)
                       ..|.+++.+|. +... +|+.|++++|.+. .+| .+..+++|+.|++++|.+ +.+|..    +..+.+.++ ..+.+
T Consensus       269 ~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~  344 (606)
T 3vq2_A          269 TYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISF  344 (606)
T ss_dssp             CCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEEC
T ss_pred             cccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccccCCCCccceeeccCCcCccch
Confidence             55566666666 3333 6888888888886 455 778888888888888888 567732    122233333 44433


Q ss_pred             CCCCCCCccCcEEEcccccccCC--CCcccccccCCCccccCCCccccccCc-cccccccEEEeeccccCCCcc-cccCC
Q 002085          348 PKSLGNCRTLRTVQLYSNRFSGE--LPTGLWTTFNLSSLMLSDNTISGELPS-KTAWNLTRLEISNNRFSGQIQ-RGVGS  423 (969)
Q Consensus       348 p~~l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~L~~L~Ls~N~l~~~~~-~~~~~  423 (969)
                        .+..+++|++|++++|++++.  +|..+..+++|+.|++++|.+++.... ...++|+.|++++|++++..+ ..+..
T Consensus       345 --~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  422 (606)
T 3vq2_A          345 --KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS  422 (606)
T ss_dssp             --CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTT
T ss_pred             --hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhc
Confidence              567888999999999998865  488888889999999999998864322 233689999999999998877 68888


Q ss_pred             cccchhhcccCCccccccCccccCccccchhhccCcccCC-CCCcccccccCCCEEEccCccccCCCCcccccccccceE
Q 002085          424 WKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSG-KLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSL  502 (969)
Q Consensus       424 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  502 (969)
                      +++|++|++++|.+++..|..+..+++|+.|+|++|++++ .+|..+..+++|+.|+|++|++++..|..|+++++|+.|
T Consensus       423 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  502 (606)
T 3vq2_A          423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL  502 (606)
T ss_dssp             CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             cccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEE
Confidence            9999999999999998888889999999999999999987 478888899999999999999998888889999999999


Q ss_pred             eccCccccccCCCcccccc-ccEEEeecCcCCCCCCcccccc
Q 002085          503 DLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNL  543 (969)
Q Consensus       503 ~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~~~~~  543 (969)
                      +|++|++++.+|..++.++ |++|+|++|+++ .+|..+..+
T Consensus       503 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l  543 (606)
T 3vq2_A          503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHF  543 (606)
T ss_dssp             ECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGS
T ss_pred             ECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhh
Confidence            9999999988888888885 999999999988 677666554

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-50  Score=440.36  Aligned_cols=267  Identities=23%  Similarity=0.241  Sum_probs=218.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .+.|+..++||+|+||+||+|++..+|+.||||+++....        ..+|++++++++|||||++++++.+++..|||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3567788899999999999999999999999999965422        24699999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-cEEE
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-KAKI  793 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl  793 (969)
                      ||||+||+|.++++..+             .+++..+..++.||+.||+|||++   +|+||||||+|||++.+| .+||
T Consensus       129 mEy~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl  192 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMG-------------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAAL  192 (336)
T ss_dssp             ECCCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEE
T ss_pred             EeccCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEE
Confidence            99999999999998654             389999999999999999999988   999999999999999998 6999


Q ss_pred             eecccceecccCCCCc---cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          794 ADFGLAKMLAKQGEPH---TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      +|||+|+.+...+...   .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.....+...+... 
T Consensus       193 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-  271 (336)
T 4g3f_A          193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE-  271 (336)
T ss_dssp             CCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-
T ss_pred             eeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-
Confidence            9999999875433222   223457999999999999999999999999999999999999999887666555443221 


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCcccccCCCCCCCCC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLG  946 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~  946 (969)
                        ..+..         ..+...+..+.+++.+||+.||++|||+.|+++.|.++..         ......||+++
T Consensus       272 --~~~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~---------~~~~l~hPw~~  327 (336)
T 4g3f_A          272 --PPPIR---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ---------EVGGLKSPWKG  327 (336)
T ss_dssp             --CCGGG---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH---------HTTSSCSCSSS
T ss_pred             --CCCch---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh---------hhhhccCCCcC
Confidence              11111         1122334678999999999999999999999999887752         22345677765

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.4e-51  Score=446.99  Aligned_cols=254  Identities=26%  Similarity=0.348  Sum_probs=210.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +++|++.+.||+|+||+||+|++..+|+.||||++..... .....+.+.+|++++++++|||||++++++.+++..|||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4689999999999999999999999999999999976543 344567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      ||||+||+|.+++...+.           ..+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+
T Consensus       102 mEy~~gg~L~~~i~~~~~-----------~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~  167 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKG-----------VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLG  167 (350)
T ss_dssp             EECCTTCBHHHHHHHTTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEEC
T ss_pred             EeCCCCCcHHHHHHHcCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEc
Confidence            999999999999976542           3478889999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+|+.+...  .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+...+...+..   ...
T Consensus       168 DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~---~~~  242 (350)
T 4b9d_A          168 DFGIARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS---GSF  242 (350)
T ss_dssp             STTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---TCC
T ss_pred             ccccceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCC
Confidence            99999876321  1123456799999999999999999999999999999999999999987765444333322   111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                 .+.+...+.++.+++.+||+.||++|||++|+++
T Consensus       243 -----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 -----------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       0112233467899999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.9e-50  Score=438.91  Aligned_cols=250  Identities=21%  Similarity=0.350  Sum_probs=212.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +.|+..++||+|+||+||+|++..+|+.||||++.....   ...+.+.+|++++++++|||||++++++.+++..||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            468888999999999999999999999999999965432   22356889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |||+||+|.+++...              .+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|
T Consensus       151 Ey~~gg~L~~~l~~~--------------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D  213 (346)
T 4fih_A          151 EFLEGGALTDIVTHT--------------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSD  213 (346)
T ss_dssp             CCCTTEEHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             eCCCCCcHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEec
Confidence            999999999999753              389999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+|+.+....  ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.........+......   
T Consensus       214 FGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~---  288 (346)
T 4fih_A          214 FGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP---  288 (346)
T ss_dssp             CTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC---
T ss_pred             CcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---
Confidence            99999775432  2334578999999999999999999999999999999999999999877654444333221110   


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                             .  .+.+...+.++.+++.+||+.||++|||++|+++
T Consensus       289 -------~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 -------R--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -------C--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------C--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   1  1112234478899999999999999999999875

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.3e-48  Score=475.95  Aligned_cols=453  Identities=22%  Similarity=0.227  Sum_probs=368.6

Q ss_pred             EEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCC
Q 002085           77 GISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNN  156 (969)
Q Consensus        77 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  156 (969)
                      .+++++++++. +|..+.  +++++|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+
T Consensus         8 ~~~cs~~~L~~-ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~   84 (680)
T 1ziw_A            8 VADCSHLKLTQ-VPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE   84 (680)
T ss_dssp             EEECCSSCCSS-CCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred             eeECCCCCccc-cccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence            45666666653 665554  789999999999998888889999999999999999999999999999999999999999


Q ss_pred             CCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCc
Q 002085          157 FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIP  236 (969)
Q Consensus       157 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  236 (969)
                      +++..+..|+++++|++|+|++|++++..|..|+++++|++|++++|.+  ....|..++.+++|++|++++|++.+..+
T Consensus        85 l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l--~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  162 (680)
T 1ziw_A           85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGL--SSTKLGTQVQLENLQELLLSNNKIQALKS  162 (680)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCC--SCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred             cCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcc--cccCchhhcccccCCEEEccCCcccccCH
Confidence            9966556799999999999999999988889999999999999999974  45567889999999999999999999888


Q ss_pred             hhhc--CCCchhhhhccCCcCCCCCCchhhcC---------------------------cccchhhccCcccccCCCCch
Q 002085          237 EAMS--NLSSLEILALNGNHLEGAIPSGLFLL---------------------------NNLTQLFLYDNILSGEIPSSV  287 (969)
Q Consensus       237 ~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l---------------------------~~L~~L~L~~N~l~~~~~~~~  287 (969)
                      ..+.  .+++|+.|++++|++++..|..+..+                           ++|+.|++++|.+++..|..+
T Consensus       163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~  242 (680)
T 1ziw_A          163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF  242 (680)
T ss_dssp             HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred             HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence            8765  56899999999999998888777654                           457788888999998888888


Q ss_pred             hhc---ccccccccCccccccCCccccCcccchhhhhccccCcCcCCccccc------ccccCcccc------cCCC---
Q 002085          288 EAL---KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGV------VAFENNLSG------AVPK---  349 (969)
Q Consensus       288 ~~~---~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~~n~l~~------~~p~---  349 (969)
                      ...   +|+.|++++|++++..|..|+.+++|++|++++|++.+..|..+..      +.+.++..+      .+|.   
T Consensus       243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~  322 (680)
T 1ziw_A          243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD  322 (680)
T ss_dssp             GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred             hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence            765   3999999999999998999999999999999999999887765543      333443332      3443   


Q ss_pred             -CCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCcccccc-Cccc-----cccccEEEeeccccCCCcccccC
Q 002085          350 -SLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGEL-PSKT-----AWNLTRLEISNNRFSGQIQRGVG  422 (969)
Q Consensus       350 -~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~-----~~~L~~L~Ls~N~l~~~~~~~~~  422 (969)
                       .+..+++|++|++++|++++..|..|..+++|++|++++|.++... +...     ..+|+.|++++|++++..|..+.
T Consensus       323 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~  402 (680)
T 1ziw_A          323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS  402 (680)
T ss_dssp             TTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTT
T ss_pred             hhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhh
Confidence             7888999999999999999988889999999999999999865322 2111     14788888888888888888888


Q ss_pred             CcccchhhcccCCccccccC-ccccCccccchhhccCcccCCCCCcccccccCCCEEEccCcccc--CCCCccccccccc
Q 002085          423 SWKNLIVFKASNNLFSGEIP-VELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELS--GEIPKAIGSLLVM  499 (969)
Q Consensus       423 ~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L  499 (969)
                      .+++|++|++++|.+++.+| ..|..+++|++|+|++|++++..+..+..+++|+.|++++|.++  +.+|..|+++++|
T Consensus       403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L  482 (680)
T 1ziw_A          403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL  482 (680)
T ss_dssp             TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred             CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence            88888888888888887665 67788888888888888887666666666777777777777665  4566667777777


Q ss_pred             ceEeccCccccccCCCcccccc-ccEEEeecCcCCC
Q 002085          500 VSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYG  534 (969)
Q Consensus       500 ~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~  534 (969)
                      +.|||++|++++..|..++.++ |++|++++|++++
T Consensus       483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~  518 (680)
T 1ziw_A          483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR  518 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGG
T ss_pred             CEEECCCCCCCcCChhhhccccccCEEeCCCCCccc
Confidence            7777777777654445566663 6777777776654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.7e-50  Score=424.43  Aligned_cols=251  Identities=24%  Similarity=0.311  Sum_probs=197.3

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      .+.+|+..+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|++++++++|||||++++++.+++..|+
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            35789999999999999999999999999999999976554444556789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+ +|+|.+++....             .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||
T Consensus        91 vmEy~-~g~L~~~l~~~~-------------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl  153 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQRD-------------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKI  153 (275)
T ss_dssp             EEECC-CEEHHHHHHHSC-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEE
T ss_pred             EEeCC-CCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEE
Confidence            99999 689999998654             389999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||+|+.....   .......||+.|||||++.+..+ +.++||||+||++|||++|+.||.+.+...+.+.+...   
T Consensus       154 ~DFGla~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~---  227 (275)
T 3hyh_A          154 ADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG---  227 (275)
T ss_dssp             CCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---
T ss_pred             eecCCCeecCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC---
Confidence            999999876432   23345689999999999998876 57999999999999999999999876544433332211   


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..+            .+...+.++.+++.+||+.||++|||++|+++
T Consensus       228 ~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          228 VYT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111            11123467889999999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-49  Score=424.10  Aligned_cols=249  Identities=26%  Similarity=0.352  Sum_probs=201.2

Q ss_pred             CccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc----CCceEEE
Q 002085          639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS----ENSKLLV  714 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  714 (969)
                      +..++||+|+||+||+|.+..+++.||+|++..... .....+.|.+|++++++++|||||++++++.+    ++..|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            556789999999999999999999999999965433 34456789999999999999999999999865    3457999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC-CCcEEE
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-EFKAKI  793 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl  793 (969)
                      ||||+||+|.+++....             .+++..+..++.||+.||+|||++ .++|+||||||+|||++. ++.+||
T Consensus       108 mEy~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl  173 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK-------------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKI  173 (290)
T ss_dssp             EECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEE
T ss_pred             EeCCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEE
Confidence            99999999999998654             389999999999999999999987 223999999999999985 789999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+|+...    ........||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.....   .+.......
T Consensus       174 ~DFGla~~~~----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~---~~~~~i~~~  245 (290)
T 3fpq_A          174 GDLGLATLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYRRVTSG  245 (290)
T ss_dssp             CCTTGGGGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHHHHTTT
T ss_pred             EeCcCCEeCC----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH---HHHHHHHcC
Confidence            9999998542    223345689999999998865 69999999999999999999999997644321   111222221


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ... .        ..+...+.++.+++.+||+.||++|||++|+++
T Consensus       246 ~~~-~--------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 VKP-A--------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCC-G--------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCC-C--------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110 0        111112356889999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-49  Score=438.29  Aligned_cols=273  Identities=24%  Similarity=0.361  Sum_probs=218.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCC-----CcEEEEEEEeccchhcHHHHHHHHHHHHHHhcccc-CceeeEEEEEEcC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGA-----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH-ANIVKLWCCISSE  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~  708 (969)
                      .++|+..+.||+|+||+||+|++...     ++.||||+++...  .....+.|.+|++++.+++| ||||+++++|.++
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            35788899999999999999998643     3689999996543  23445789999999999965 8999999999764


Q ss_pred             -CceEEEEeeccCCCHHHHhccCcCcccc---CCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          709 -NSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       709 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                       +..|||||||++|+|.++++........   .........++|..+..++.|||.||+|||++   +||||||||+|||
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL  217 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence             5689999999999999999875432111   11122345689999999999999999999998   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchH
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLA  863 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~  863 (969)
                      +++++.+||+|||+|+.+.........+...||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.......
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999997765544445556789999999999999999999999999999999998 89998765433221


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                         ......+          .+.+.+...+.++++++.+||+.||++||||+||++.|+.+.
T Consensus       298 ---~~~i~~g----------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          298 ---CRRLKEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             ---HHHHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHcC----------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence               1111111          111223334578999999999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.2e-50  Score=432.31  Aligned_cols=246  Identities=23%  Similarity=0.272  Sum_probs=199.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEc---CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++|++.+.||+|+||+||+|+..   .+++.||||+++....... ....+.+|++++++++|||||++++++.+++..|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            57999999999999999999874   3578999999965432221 1246888999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +|||||+||+|.+++...+             .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+|
T Consensus       103 ivmEy~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vK  166 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEV-------------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIK  166 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEE
T ss_pred             EEEEcCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEE
Confidence            9999999999999998654             389999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      |+|||+|+.....  ........||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..++...+..   .
T Consensus       167 l~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~---~  241 (304)
T 3ubd_A          167 LTDFGLSKESIDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK---A  241 (304)
T ss_dssp             EESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C
T ss_pred             ecccccceeccCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc---C
Confidence            9999999865432  2223456899999999999999999999999999999999999999988765544433322   1


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK  915 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~  915 (969)
                      ..+            .+...+.++.+++.+||+.||++|||+.
T Consensus       242 ~~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~  272 (304)
T 3ubd_A          242 KLG------------MPQFLSPEAQSLLRMLFKRNPANRLGAG  272 (304)
T ss_dssp             CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred             CCC------------CCCcCCHHHHHHHHHHcccCHHHCCCCC
Confidence            111            1222346789999999999999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.6e-49  Score=440.13  Aligned_cols=251  Identities=21%  Similarity=0.353  Sum_probs=212.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .+.|+..++||+|+||.||+|++..+|+.||||++.....   ...+.+.+|++++++++|||||++++++.+++..|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            4579999999999999999999999999999999965432   2235688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      ||||+||+|.+++...              .+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+
T Consensus       227 mEy~~gG~L~~~i~~~--------------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~  289 (423)
T 4fie_A          227 MEFLEGGALTDIVTHT--------------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS  289 (423)
T ss_dssp             EECCTTEEHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEEC
T ss_pred             EeCCCCCcHHHHHhcc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEe
Confidence            9999999999999743              388999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+|+.+....  ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.........+......  
T Consensus       290 DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--  365 (423)
T 4fie_A          290 DFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP--  365 (423)
T ss_dssp             CCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--
T ss_pred             cCccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--
Confidence            999998775432  2334568999999999999999999999999999999999999999877655444333221110  


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                              ..  ..+...+.++.+++.+||+.||++|||+.|+++
T Consensus       366 --------~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          366 --------RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --------CC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------CC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                    01  111223467899999999999999999999875

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=483.88  Aligned_cols=452  Identities=21%  Similarity=0.219  Sum_probs=369.2

Q ss_pred             CCCeEEEEecCCCCCCCC-CccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCC--cccCCCCc
Q 002085           72 FNSVTGISLRHKDITQKI-PPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSD--IDRISGLQ  148 (969)
Q Consensus        72 ~~~v~~l~l~~~~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--l~~l~~L~  148 (969)
                      ..+++.|+|+++...+.+ |..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.+++.+|..  |.++++|+
T Consensus        47 l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~  126 (844)
T 3j0a_A           47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT  126 (844)
T ss_dssp             CCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCC
T ss_pred             cccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCC
Confidence            356889999999777777 678999999999999999999888999999999999999999999877665  89999999


Q ss_pred             EEecCCCCCCCcCC-CcccCcccccceecccccccCcCCcccCCC--CCcceeecccCCCCCCCCCCccccccCC-----
Q 002085          149 CIDLGGNNFSGDIP-RSIGRLSELQTLYLYMNEFNGTFPKEIGDL--SNLEVLGLAYNSNFKPAMIPIEFGMLKK-----  220 (969)
Q Consensus       149 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~~~~~~~~p~~~~~l~~-----  220 (969)
                      +|+|++|.+++..+ ..|+++++|++|+|++|++++..|..+..+  ++|+.|+++.|.+.  ...|..++.+++     
T Consensus       127 ~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~--~~~~~~~~~~~~~~~~~  204 (844)
T 3j0a_A          127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY--SRVSVDWGKCMNPFRNM  204 (844)
T ss_dssp             EEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSC--CCCCCCCCSSSCTTTTC
T ss_pred             EEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccc--cccccchhhcCCccccC
Confidence            99999999987655 578999999999999999998888888877  88889999888743  445555555554     


Q ss_pred             -CcEEEccCCcccccCchhhcC--------------------------------------CCchhhhhccCCcCCCCCCc
Q 002085          221 -LKTLWMTEANLIGEIPEAMSN--------------------------------------LSSLEILALNGNHLEGAIPS  261 (969)
Q Consensus       221 -L~~L~L~~n~l~~~~p~~~~~--------------------------------------l~~L~~L~L~~N~l~~~~p~  261 (969)
                       |+.|++++|++.+.+|..+..                                      .++|+.|+|++|.+++..|.
T Consensus       205 ~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~  284 (844)
T 3j0a_A          205 VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR  284 (844)
T ss_dssp             CBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSC
T ss_pred             ceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChh
Confidence             888888888776665544432                                      15688888888888877777


Q ss_pred             hhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccc-----
Q 002085          262 GLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIG-----  335 (969)
Q Consensus       262 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----  335 (969)
                      .+..+++|+.|+|++|++++..|..+..+ +|+.|+|++|++++..|..|..+++|+.|++++|++.+..+..+.     
T Consensus       285 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  364 (844)
T 3j0a_A          285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL  364 (844)
T ss_dssp             CSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCC
T ss_pred             hhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCC
Confidence            88888888888888888888777777665 688888888888877788888888888888888888765554433     


Q ss_pred             -cccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCcc---ccccccEEEeecc
Q 002085          336 -VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSK---TAWNLTRLEISNN  411 (969)
Q Consensus       336 -~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~~L~~L~Ls~N  411 (969)
                       .+.+.+|-...+    ..+++|+.|++++|+++ .+|..   ..+++.|++++|++++.....   ..++|+.|+|++|
T Consensus       365 ~~L~Ls~N~l~~i----~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N  436 (844)
T 3j0a_A          365 QTLDLRDNALTTI----HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQN  436 (844)
T ss_dssp             CEEEEETCCSCCC----SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESC
T ss_pred             CEEECCCCCCCcc----cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCC
Confidence             333444433333    33789999999999999 66654   468999999999998643321   3478999999999


Q ss_pred             ccCCCccc-ccCCcccchhhcccCCccc-----cccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccc
Q 002085          412 RFSGQIQR-GVGSWKNLIVFKASNNLFS-----GEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNEL  485 (969)
Q Consensus       412 ~l~~~~~~-~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  485 (969)
                      ++++..+. .+..+++|+.|++++|.++     +..+..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|
T Consensus       437 ~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  516 (844)
T 3j0a_A          437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL  516 (844)
T ss_dssp             CCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCC
T ss_pred             cccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCC
Confidence            99976554 4667899999999999997     45567789999999999999999998899999999999999999999


Q ss_pred             cCCCCcccccccccceEeccCccccccCCCccccccccEEEeecCcCCCCCC
Q 002085          486 SGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIP  537 (969)
Q Consensus       486 ~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~~~~p  537 (969)
                      ++..|..+.  ++|+.|||++|+|+|.+|..+.  .|+.|++++|++.+..+
T Consensus       517 ~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~--~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          517 TVLSHNDLP--ANLEILDISRNQLLAPNPDVFV--SLSVLDITHNKFICECE  564 (844)
T ss_dssp             SSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS--SCCEEEEEEECCCCSSS
T ss_pred             CccChhhhh--ccccEEECCCCcCCCCChhHhC--CcCEEEecCCCcccccc
Confidence            987777666  8999999999999999887765  58899999999988776

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-48  Score=464.69  Aligned_cols=459  Identities=20%  Similarity=0.183  Sum_probs=358.1

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      .+++.|+++++.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence            35888999999988887888889999999999999988777788889999999999999988777788899999999999


Q ss_pred             CCCCCCCcCCCcccCcccccceecccccccC-cCCcccCCCCCcceeecccCCCCCCCCCCccccccCCC----cEEEcc
Q 002085          153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNG-TFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKL----KTLWMT  227 (969)
Q Consensus       153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L----~~L~L~  227 (969)
                      ++|++++..+..|+++++|++|+|++|++++ .+|..|+++++|++|++++|++  ....|..++.+++|    +.|+++
T Consensus       108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l--~~~~~~~~~~l~~L~~~~~~L~l~  185 (570)
T 2z63_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI--QSIYCTDLRVLHQMPLLNLSLDLS  185 (570)
T ss_dssp             TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCC--CEECGGGGHHHHTCTTCCCEEECT
T ss_pred             cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcc--ceecHHHccchhccchhhhhcccC
Confidence            9999886655578889999999999998886 4688888999999999998863  34456778888888    888999


Q ss_pred             CCcccccCchhhcCCCchhhhhccCCcCCCC-CCch------------------------------hhcCc--ccchhhc
Q 002085          228 EANLIGEIPEAMSNLSSLEILALNGNHLEGA-IPSG------------------------------LFLLN--NLTQLFL  274 (969)
Q Consensus       228 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~------------------------------l~~l~--~L~~L~L  274 (969)
                      +|.+.+..|..|..+ +|+.|++++|..... ++..                              +..+.  .++.+++
T Consensus       186 ~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l  264 (570)
T 2z63_A          186 LNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL  264 (570)
T ss_dssp             TCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred             CCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence            988888888877766 788888887732210 0111                              11111  1233334


Q ss_pred             cCc-ccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcc----ccccccc-CcccccC
Q 002085          275 YDN-ILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPAS----IGVVAFE-NNLSGAV  347 (969)
Q Consensus       275 ~~N-~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~~-n~l~~~~  347 (969)
                      ++| .+.+.+|..+... +|+.|++++|.++ .+|..+..+ +|+.|++++|.+. .+|..    +..+.+. |.+.+.+
T Consensus       265 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~~l~~L~~L~l~~n~~~~~~  341 (570)
T 2z63_A          265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGNAF  341 (570)
T ss_dssp             EETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBCBCSSCCEEEEESCBSCCBC
T ss_pred             hcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCcccccccCEEeCcCCcccccc
Confidence            444 4444555555544 4666666666666 455556656 6666666666665 33321    1122222 2233333


Q ss_pred             CCCCCCCccCcEEEcccccccCCC--CcccccccCCCccccCCCccccccCc-cccccccEEEeeccccCCCcc-cccCC
Q 002085          348 PKSLGNCRTLRTVQLYSNRFSGEL--PTGLWTTFNLSSLMLSDNTISGELPS-KTAWNLTRLEISNNRFSGQIQ-RGVGS  423 (969)
Q Consensus       348 p~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~L~~L~Ls~N~l~~~~~-~~~~~  423 (969)
                      +.  ..+++|+.|++++|++++..  |..+..+++|+.|++++|.+++..+. ...++|++|++++|.+++..+ ..+..
T Consensus       342 ~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  419 (570)
T 2z63_A          342 SE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS  419 (570)
T ss_dssp             CC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTT
T ss_pred             cc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhc
Confidence            33  67899999999999998554  77888999999999999999875554 234689999999999998776 57889


Q ss_pred             cccchhhcccCCccccccCccccCccccchhhccCcccC-CCCCcccccccCCCEEEccCccccCCCCcccccccccceE
Q 002085          424 WKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLS-GKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSL  502 (969)
Q Consensus       424 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  502 (969)
                      +++|++|++++|.+++..|..|..+++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++..|..|.++++|+.|
T Consensus       420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  499 (570)
T 2z63_A          420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  499 (570)
T ss_dssp             CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence            999999999999999999999999999999999999998 6789999999999999999999998889999999999999


Q ss_pred             eccCccccccCCCcccccc-ccEEEeecCcCCCCCCcc
Q 002085          503 DLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDE  539 (969)
Q Consensus       503 ~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~  539 (969)
                      +|++|++++..|..+..++ |++|++++|+++|.+|..
T Consensus       500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence            9999999987777788885 999999999999998853

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-48  Score=424.57  Aligned_cols=266  Identities=26%  Similarity=0.300  Sum_probs=201.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC----ce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN----SK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  711 (969)
                      ++|...++||+|+||+||+|++  +|+.||||++....    .....+..|+..+.+++|||||++++++.+++    ..
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4677889999999999999998  58899999985432    11223345666667889999999999997654    57


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC-----CCCeEecCCCCCcEEEC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC-----TPQIIHRDVKSSNILLD  786 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~Nill~  786 (969)
                      |||||||++|+|.++++..              .++|..+.+++.|+|.||+|||+++     .++|+||||||+|||++
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~--------------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~  142 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY--------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  142 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             EEEecCCCCCcHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC
Confidence            9999999999999999753              3899999999999999999999752     45899999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCc--cccccccCcccCchhhcccC------CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPH--TMSAVAGSFGYFAPEYAYTT------KVNEKIDIYSFGVVLLELVTGKEANYGDE  858 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~il~elltg~~p~~~~~  858 (969)
                      .++.+||+|||+|+.........  ......||+.|||||++.+.      .++.++|||||||++|||+||+.|+....
T Consensus       143 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~  222 (303)
T 3hmm_A          143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  222 (303)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred             CCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccc
Confidence            99999999999998775443322  22345799999999998764      36779999999999999999987764322


Q ss_pred             ccc-----------hHHHHHHHhhccCCchhhhccCCCC-cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          859 HTS-----------LAEWAWRHYAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       859 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      ...           ....+........     ..+.+.. ....+.+..+.+++.+||+.||++||||.||++.|+++..
T Consensus       223 ~~~~p~~~~~~~~~~~~~~~~~~~~~~-----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          223 DYQLPYYDLVPSDPSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccccchhcccccchHHHHHHHHhccc-----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            110           1111111111110     1111111 1233566789999999999999999999999999998863

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.4e-48  Score=471.21  Aligned_cols=455  Identities=19%  Similarity=0.148  Sum_probs=373.8

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      .+++.|++++|.+++..|.+|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus        56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  135 (606)
T 3vq2_A           56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV  135 (606)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred             ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence            57999999999999988999999999999999999999888999999999999999999999888789999999999999


Q ss_pred             CCCCCCC-cCCCcccCcccccceecccccccCcCCcccCCCCCcc----eeecccCCCCCCCCCCccccccCCCcEEEcc
Q 002085          153 GGNNFSG-DIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLE----VLGLAYNSNFKPAMIPIEFGMLKKLKTLWMT  227 (969)
Q Consensus       153 ~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~  227 (969)
                      ++|.+++ .+|..|+++++|++|+|++|++++..|..|+.+++|+    +|++++|.+   ..+|.......+|+.|+++
T Consensus       136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l---~~~~~~~~~~~~L~~L~L~  212 (606)
T 3vq2_A          136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI---DFIQDQAFQGIKLHELTLR  212 (606)
T ss_dssp             CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCC---CEECTTTTTTCEEEEEEEE
T ss_pred             CCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCc---ceeCcccccCceeeeeecc
Confidence            9999986 6799999999999999999999998888888887765    899999963   3344444444489999999


Q ss_pred             CCccc-ccCchhhcCCCchhhhhc---------------------------------cCCcCCCCCCchhhcCcccchhh
Q 002085          228 EANLI-GEIPEAMSNLSSLEILAL---------------------------------NGNHLEGAIPSGLFLLNNLTQLF  273 (969)
Q Consensus       228 ~n~l~-~~~p~~~~~l~~L~~L~L---------------------------------~~N~l~~~~p~~l~~l~~L~~L~  273 (969)
                      +|.+. +.+|..+.++++|+.+++                                 ..|.+++.+|. +..+++|+.|+
T Consensus       213 ~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~  291 (606)
T 3vq2_A          213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMS  291 (606)
T ss_dssp             SCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEE
T ss_pred             CCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEE
Confidence            98776 344555666665555444                                 45555555554 66667777777


Q ss_pred             ccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCC----ccccccccc-Cccccc-
Q 002085          274 LYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVP----ASIGVVAFE-NNLSGA-  346 (969)
Q Consensus       274 L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~~-n~l~~~-  346 (969)
                      +++|.++ .+| .+... +|+.|++++|.+ +.+| .+ .+++|+.|++++|+..+.++    ..+..+.+. |++.+. 
T Consensus       292 l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~  366 (606)
T 3vq2_A          292 LAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSG  366 (606)
T ss_dssp             EESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEE
T ss_pred             ecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCc
Confidence            7777765 334 33332 577777777777 3555 33 66677777777764443322    112223333 333333 


Q ss_pred             -CCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCc-c--ccccccEEEeeccccCCCcccccC
Q 002085          347 -VPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPS-K--TAWNLTRLEISNNRFSGQIQRGVG  422 (969)
Q Consensus       347 -~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~--~~~~L~~L~Ls~N~l~~~~~~~~~  422 (969)
                       +|..+..+++|++|++++|.++ .+|..+..+++|+.|++++|++++..+. .  ..++|++|++++|++++..|..+.
T Consensus       367 ~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  445 (606)
T 3vq2_A          367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL  445 (606)
T ss_dssp             ECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             chhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhc
Confidence             3777889999999999999998 4778899999999999999999988773 2  347899999999999999999999


Q ss_pred             CcccchhhcccCCcccc-ccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccce
Q 002085          423 SWKNLIVFKASNNLFSG-EIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVS  501 (969)
Q Consensus       423 ~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  501 (969)
                      .+++|++|++++|.+++ .+|..|+.+++|+.|+|++|++++..|..+..+++|+.|+|++|++++.+|..|+++++|+.
T Consensus       446 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  525 (606)
T 3vq2_A          446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST  525 (606)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCE
T ss_pred             CCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCE
Confidence            99999999999999998 48999999999999999999999988999999999999999999999988999999999999


Q ss_pred             EeccCccccccCCCccccc-c-ccEEEeecCcCCCCCCc
Q 002085          502 LDLSGNQFSGEIPPEIGQL-K-LNTFNLSSNKLYGNIPD  538 (969)
Q Consensus       502 L~ls~N~l~g~~p~~~~~l-~-L~~l~ls~N~l~~~~p~  538 (969)
                      |||++|+|+ .+|..+..+ + |++|++++|++.+..+-
T Consensus       526 L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          526 LDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             EECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             EECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            999999999 788888888 4 99999999999987763

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=9.1e-49  Score=467.21  Aligned_cols=455  Identities=20%  Similarity=0.219  Sum_probs=220.2

Q ss_pred             CCCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCc
Q 002085           62 PCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI  141 (969)
Q Consensus        62 ~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  141 (969)
                      .|.|.|+ |+.        ++++++ .+|+.+.  ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|
T Consensus         3 ~C~~~~~-c~~--------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~   70 (549)
T 2z81_A            3 SCDASGV-CDG--------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF   70 (549)
T ss_dssp             EECTTSE-EEC--------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTT
T ss_pred             cCCCCce-EEC--------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhc
Confidence            4999998 853        233333 2333332  455566666665555555555556666666666665555555555


Q ss_pred             ccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccC-cCCcccCCCCCcceeecccCCCCCCCCCC-ccccccC
Q 002085          142 DRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNG-TFPKEIGDLSNLEVLGLAYNSNFKPAMIP-IEFGMLK  219 (969)
Q Consensus       142 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~~~~~~~~p-~~~~~l~  219 (969)
                      .++++|++|+|++|++++..|..|+++++|++|+|++|++++ ..|..++++++|++|++++|.  ..+.+| ..|++++
T Consensus        71 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~--~~~~~~~~~~~~l~  148 (549)
T 2z81_A           71 YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE--TFSEIRRIDFAGLT  148 (549)
T ss_dssp             TTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS--SCCEECTTTTTTCC
T ss_pred             cccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc--cccccCHhhhhccc
Confidence            555666666666666554444445555666666666665554 234455555666666665553  112222 3455555


Q ss_pred             CCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchh-hcCcccchhhccCcccccCC--CCchh--hccccc
Q 002085          220 KLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGL-FLLNNLTQLFLYDNILSGEI--PSSVE--ALKLTD  294 (969)
Q Consensus       220 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~--~~~~~--~~~L~~  294 (969)
                      +|++|++++|++.+.+|..+.++++|++|++++|.+. .+|..+ ..+++|++|++++|++++..  |..+.  ..+|+.
T Consensus       149 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~  227 (549)
T 2z81_A          149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK  227 (549)
T ss_dssp             EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred             ccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence            6666666655555555555555555666666555554 233332 23555555666665555431  11111  114555


Q ss_pred             ccccCccccccCCc----cccCcccchhhhhccccCcCcCC---------cccc---cccccCc-cc-----ccCCCCCC
Q 002085          295 IDLSMNNLTGSIPE----EFGKLKNLQLLGLFSNHLSGEVP---------ASIG---VVAFENN-LS-----GAVPKSLG  352 (969)
Q Consensus       295 L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p---------~~~~---~l~~~n~-l~-----~~~p~~l~  352 (969)
                      |++++|.+++..+.    .+..+++|+.+++++|.+.+...         ..++   .+...++ +.     ..++..+.
T Consensus       228 L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~  307 (549)
T 2z81_A          228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS  307 (549)
T ss_dssp             EEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHH
T ss_pred             eeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhh
Confidence            55555555433222    22334445555555554443100         0000   0000000 00     00011111


Q ss_pred             CCccCcEEEcccccccCCCCccc-ccccCCCccccCCCccccccCc-----cccccccEEEeeccccCCCcc--cccCCc
Q 002085          353 NCRTLRTVQLYSNRFSGELPTGL-WTTFNLSSLMLSDNTISGELPS-----KTAWNLTRLEISNNRFSGQIQ--RGVGSW  424 (969)
Q Consensus       353 ~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~-----~~~~~L~~L~Ls~N~l~~~~~--~~~~~l  424 (969)
                      ...+|+.|++++|++. .+|..+ ..+++|+.|+|++|++++.+|.     ...++|++|+|++|++++..+  ..+..+
T Consensus       308 ~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l  386 (549)
T 2z81_A          308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL  386 (549)
T ss_dssp             HSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred             hcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence            2334555555555554 444444 2455555555555555544321     122455555555555554322  334555


Q ss_pred             ccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEec
Q 002085          425 KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDL  504 (969)
Q Consensus       425 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  504 (969)
                      ++|++|++++|+|+ .+|..+..+++|++|+|++|+++ .+|..+.  ++|+.|+|++|+|++.+    ..+++|++|||
T Consensus       387 ~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~L  458 (549)
T 2z81_A          387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYI  458 (549)
T ss_dssp             TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEEC
T ss_pred             CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEEC
Confidence            55555555555555 44555555555555555555555 2333221  34555555555554321    24445555555


Q ss_pred             cCccccccCCCccccc-cccEEEeecCcCCCCCCccccc
Q 002085          505 SGNQFSGEIPPEIGQL-KLNTFNLSSNKLYGNIPDEFNN  542 (969)
Q Consensus       505 s~N~l~g~~p~~~~~l-~L~~l~ls~N~l~~~~p~~~~~  542 (969)
                      ++|+|+ .+|. .+.+ .|++|+|++|++++.+|..+..
T Consensus       459 s~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~  495 (549)
T 2z81_A          459 SRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDR  495 (549)
T ss_dssp             CSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGG
T ss_pred             CCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhc
Confidence            555554 4444 2233 2555555555555444444433

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.1e-48  Score=471.80  Aligned_cols=463  Identities=18%  Similarity=0.255  Sum_probs=386.2

Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCCCCCC----CCCCc-c-eeeC---CCeEEEEecCCCCCCCCCccccCCCcccE
Q 002085           31 SPNTEERTILLNLKQQLGNPPSLQSWTSTSSP----CDWPE-I-TCTF---NSVTGISLRHKDITQKIPPIICDLKNLTT  101 (969)
Q Consensus        31 ~~~~~~~~all~~k~~~~~~~~l~sw~~~~~~----c~w~g-v-~C~~---~~v~~l~l~~~~l~~~~~~~~~~l~~L~~  101 (969)
                      +..+++.+.-.++++-+..-. -.+|....+.    |.|.. . .|.-   ..|++   ...             .+++.
T Consensus        23 ~~~~~~~~d~~aL~~~~~~~~-~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C---~~~-------------~~V~~   85 (636)
T 4eco_A           23 SRTAEYIKDYLALKEIWDALN-GKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL---NSN-------------GRVTG   85 (636)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTT-GGGCCCCC------CCCCCSSCGGGTTCCTTEEE---CTT-------------CCEEE
T ss_pred             hhhhhHHHHHHHHHHHHHHcC-CCCcccCCcCCccCCCCCCCCCcccccCCCCeEE---cCC-------------CCEEE
Confidence            345666677777777765433 3579744433    47963 2 2443   34543   211             47899


Q ss_pred             EEccCCCCCCCCCcccCCCCCCCEEeccCCcC------CC------CCCCCcccCCCCcEEecCCCCCCCcCCCcccC-c
Q 002085          102 IDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYF------VG------PIPSDIDRISGLQCIDLGGNNFSGDIPRSIGR-L  168 (969)
Q Consensus       102 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l------~~------~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l  168 (969)
                      |+|++|+++|.+|++|++|++|++|+|++|.+      .|      .+|...  +..|+ ++++.|.+.+.+|..++. +
T Consensus        86 L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~  162 (636)
T 4eco_A           86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLI  162 (636)
T ss_dssp             EECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHH
T ss_pred             EEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHH
Confidence            99999999999999999999999999999976      22      334333  55677 899999999888877762 2


Q ss_pred             cc------------------ccceecc--cccccCcCCcccCCCCCcceeecccCCCCCCCC-----------------C
Q 002085          169 SE------------------LQTLYLY--MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAM-----------------I  211 (969)
Q Consensus       169 ~~------------------L~~L~L~--~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~-----------------~  211 (969)
                      ..                  ++.+++.  +|++++ +|..|+++++|++|+|++|++.  +.                 +
T Consensus       163 ~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~--~~~~~~~~~~~~~~~~~~~i  239 (636)
T 4eco_A          163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFV--AENICEAWENENSEYAQQYK  239 (636)
T ss_dssp             HHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCC--GGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccc--cccccccccccccchhcccC
Confidence            22                  2233332  789998 8999999999999999999743  32                 8


Q ss_pred             Ccccc--ccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCc-CCC-CCCchhhcC------cccchhhccCccccc
Q 002085          212 PIEFG--MLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNH-LEG-AIPSGLFLL------NNLTQLFLYDNILSG  281 (969)
Q Consensus       212 p~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l------~~L~~L~L~~N~l~~  281 (969)
                      |..++  ++++|++|+|++|++.+.+|+.|+++++|++|+|++|+ ++| .+|..++.+      ++|++|+|++|+++ 
T Consensus       240 p~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-  318 (636)
T 4eco_A          240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-  318 (636)
T ss_dssp             TSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-
T ss_pred             chhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-
Confidence            99999  99999999999999999999999999999999999999 998 899999887      99999999999999 


Q ss_pred             CCCC--chhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCcc-C
Q 002085          282 EIPS--SVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRT-L  357 (969)
Q Consensus       282 ~~~~--~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~-L  357 (969)
                      .+|.  .+..+ +|+.|++++|+++|.+| .|+.+++|+.|++++|+++                  .+|..+.++++ |
T Consensus       319 ~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~------------------~lp~~l~~l~~~L  379 (636)
T 4eco_A          319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT------------------EIPANFCGFTEQV  379 (636)
T ss_dssp             SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE------------------ECCTTSEEECTTC
T ss_pred             ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc------------------cccHhhhhhcccC
Confidence            7888  77776 79999999999999999 9999999999999999988                  56677888999 9


Q ss_pred             cEEEcccccccCCCCccccccc--CCCccccCCCccccccCcccc---------ccccEEEeeccccCCCcccccCCccc
Q 002085          358 RTVQLYSNRFSGELPTGLWTTF--NLSSLMLSDNTISGELPSKTA---------WNLTRLEISNNRFSGQIQRGVGSWKN  426 (969)
Q Consensus       358 ~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~---------~~L~~L~Ls~N~l~~~~~~~~~~l~~  426 (969)
                      ++|++++|+++ .+|..+..+.  +|+.|++++|.+++.+|....         .+|++|+|++|++++..+..+..+++
T Consensus       380 ~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~  458 (636)
T 4eco_A          380 ENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP  458 (636)
T ss_dssp             CEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCC
T ss_pred             cEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCC
Confidence            99999999999 8898887765  899999999999998876443         48999999999999666566777999


Q ss_pred             chhhcccCCccccccCccccC--------ccccchhhccCcccCCCCCcccc--cccCCCEEEccCccccCCCCcccccc
Q 002085          427 LIVFKASNNLFSGEIPVELTS--------LSHLNTLLLDGNKLSGKLPSQIV--SWTSLNNLNLARNELSGEIPKAIGSL  496 (969)
Q Consensus       427 L~~L~l~~N~l~~~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l  496 (969)
                      |++|++++|+|+ .+|..+..        +++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+|++ +|..++++
T Consensus       459 L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l  535 (636)
T 4eco_A          459 LSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS  535 (636)
T ss_dssp             CSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGC
T ss_pred             CCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcC
Confidence            999999999999 66654432        239999999999999 7998887  99999999999999997 99999999


Q ss_pred             cccceEec------cCccccccCCCcccccc-ccEEEeecCcCCCCCCcccc
Q 002085          497 LVMVSLDL------SGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFN  541 (969)
Q Consensus       497 ~~L~~L~l------s~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~~~  541 (969)
                      ++|+.|+|      ++|++.+.+|..++.++ |++|+|++|++ +.||..+.
T Consensus       536 ~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~  586 (636)
T 4eco_A          536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT  586 (636)
T ss_dssp             SSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC
T ss_pred             CCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh
Confidence            99999999      56889999999999996 99999999999 78997654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-47  Score=414.85  Aligned_cols=254  Identities=22%  Similarity=0.367  Sum_probs=193.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC-----
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN-----  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  709 (969)
                      +++|+..+.||+|+||+||+|++..+|+.||||+++...  .+...+.+.+|++++++++|||||++++++.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            457899999999999999999999999999999986543  3445578999999999999999999999987544     


Q ss_pred             -------ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCc
Q 002085          710 -------SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSN  782 (969)
Q Consensus       710 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  782 (969)
                             ..|+|||||++|+|.+++.....          ....++..++.++.||+.||+|||++   +|+||||||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~----------~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~N  148 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCT----------IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSN  148 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCS----------GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCC----------CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHH
Confidence                   36899999999999999986543          12356777899999999999999998   99999999999


Q ss_pred             EEECCCCcEEEeecccceecccCCCCc----------cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCC
Q 002085          783 ILLDSEFKAKIADFGLAKMLAKQGEPH----------TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE  852 (969)
Q Consensus       783 ill~~~~~~kl~Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~  852 (969)
                      ||++.++.+||+|||+|+.+.......          ..+..+||+.|||||++.+..|+.++||||+||++|||++   
T Consensus       149 ILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---  225 (299)
T 4g31_A          149 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---  225 (299)
T ss_dssp             EEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---
T ss_pred             eEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---
Confidence            999999999999999998765432211          2234579999999999999999999999999999999996   


Q ss_pred             CCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          853 ANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       853 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ||.+..  +....+ ......         . ..+...+..+...+++.+||+.||++|||+.|+++
T Consensus       226 Pf~~~~--~~~~~~-~~~~~~---------~-~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          226 PFSTQM--ERVRTL-TDVRNL---------K-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             CCSSHH--HHHHHH-HHHHTT---------C-CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCcc--HHHHHH-HHHhcC---------C-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            665321  111111 111110         0 11222334456788999999999999999999874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.6e-47  Score=468.22  Aligned_cols=418  Identities=19%  Similarity=0.235  Sum_probs=318.8

Q ss_pred             CcccEEEccCCCCCCCCCcccCCCCCCCEEec-cCCcCCCCCCCCcccCC-CCc--------E------Eec-CCCCCCC
Q 002085           97 KNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDL-SQNYFVGPIPSDIDRIS-GLQ--------C------IDL-GGNNFSG  159 (969)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~l~~l~-~L~--------~------L~L-~~N~l~~  159 (969)
                      .+++.|+|++|+++|.+|++|++|++|++|+| ++|.++|..|....... .+.        .      ++. ....+++
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57999999999999999999999999999999 99988877543211110 000        0      000 0000000


Q ss_pred             -----------cCCCcccCcccccceeccc--ccccCcCCcccCCCCCcceeecccCCCCCC---------------CCC
Q 002085          160 -----------DIPRSIGRLSELQTLYLYM--NEFNGTFPKEIGDLSNLEVLGLAYNSNFKP---------------AMI  211 (969)
Q Consensus       160 -----------~~p~~~~~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~---------------~~~  211 (969)
                                 ..+........++.+.+..  |++++ +|..|+++++|++|+|++|++...               +.+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                       0111112233444454543  66766 666777777777777777753320               026


Q ss_pred             Ccccc--ccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCc-CCC-CCCchhhcCc-------ccchhhccCcccc
Q 002085          212 PIEFG--MLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNH-LEG-AIPSGLFLLN-------NLTQLFLYDNILS  280 (969)
Q Consensus       212 p~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~  280 (969)
                      |..++  ++++|+.|+|++|++.+.+|..|+++++|+.|+|++|+ ++| .+|..++.++       +|++|+|++|+++
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~  561 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE  561 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred             ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence            77766  78888888888888888888888888888888888887 777 6777776665       8888888888888


Q ss_pred             cCCCC--chhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCcc-
Q 002085          281 GEIPS--SVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRT-  356 (969)
Q Consensus       281 ~~~~~--~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~-  356 (969)
                       .+|.  .+..+ +|+.|+|++|+++ .+| .|+.+++|+.|+|++|+++                  .+|..+.++++ 
T Consensus       562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~------------------~lp~~l~~l~~~  620 (876)
T 4ecn_A          562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE------------------EIPEDFCAFTDQ  620 (876)
T ss_dssp             -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS------------------CCCTTSCEECTT
T ss_pred             -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc------------------cchHHHhhcccc
Confidence             6776  66655 6888888888888 677 7888888888888888887                  45556777888 


Q ss_pred             CcEEEcccccccCCCCcccccccC--CCccccCCCccccccCccc-------cccccEEEeeccccCCCcccccCCcccc
Q 002085          357 LRTVQLYSNRFSGELPTGLWTTFN--LSSLMLSDNTISGELPSKT-------AWNLTRLEISNNRFSGQIQRGVGSWKNL  427 (969)
Q Consensus       357 L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~~~~~-------~~~L~~L~Ls~N~l~~~~~~~~~~l~~L  427 (969)
                      |+.|+|++|+++ .+|..+..+..  |+.|+|++|++++.+|...       ..+|+.|+|++|+++...+..+..+++|
T Consensus       621 L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L  699 (876)
T 4ecn_A          621 VEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI  699 (876)
T ss_dssp             CCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCC
T ss_pred             CCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCC
Confidence            888888888888 77877776654  8889999998888766432       2479999999999996555555689999


Q ss_pred             hhhcccCCccccccCccccC--------ccccchhhccCcccCCCCCcccc--cccCCCEEEccCccccCCCCccccccc
Q 002085          428 IVFKASNNLFSGEIPVELTS--------LSHLNTLLLDGNKLSGKLPSQIV--SWTSLNNLNLARNELSGEIPKAIGSLL  497 (969)
Q Consensus       428 ~~L~l~~N~l~~~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~  497 (969)
                      +.|+|++|+|+ .+|..+..        +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+++++
T Consensus       700 ~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~  776 (876)
T 4ecn_A          700 STIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSS  776 (876)
T ss_dssp             SEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCT
T ss_pred             CEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCC
Confidence            99999999999 66665543        349999999999999 7899887  99999999999999997 899999999


Q ss_pred             ccceEeccC------ccccccCCCcccccc-ccEEEeecCcCCCCCCcccc
Q 002085          498 VMVSLDLSG------NQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFN  541 (969)
Q Consensus       498 ~L~~L~ls~------N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~~~  541 (969)
                      +|+.|+|++      |++.+.+|..++.++ |+.|+|++|++ +.||..+.
T Consensus       777 ~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~  826 (876)
T 4ecn_A          777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT  826 (876)
T ss_dssp             TCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC
T ss_pred             CCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc
Confidence            999999976      889999999999996 99999999999 89998654

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=448.84  Aligned_cols=458  Identities=21%  Similarity=0.169  Sum_probs=383.6

Q ss_pred             EEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCC
Q 002085           77 GISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNN  156 (969)
Q Consensus        77 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  156 (969)
                      .++.++.+++. +|..+.  +++++|||++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus        11 ~~~c~~~~l~~-ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~   87 (570)
T 2z63_A           11 TYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (570)
T ss_dssp             EEECCSSCCSS-CCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EEEeCCCCccc-cCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCc
Confidence            35555555543 555442  579999999999998888899999999999999999998888899999999999999999


Q ss_pred             CCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCc
Q 002085          157 FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIP  236 (969)
Q Consensus       157 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  236 (969)
                      +++..|..|+++++|++|++++|++++..+..|+++++|++|++++|.+.. ..+|..|+++++|++|++++|++.+..|
T Consensus        88 l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~-~~lp~~~~~l~~L~~L~l~~n~l~~~~~  166 (570)
T 2z63_A           88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (570)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCC-CCCCGGGGGCTTCCEEECTTSCCCEECG
T ss_pred             CCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccce-ecChhhhcccCCCCEEeCcCCccceecH
Confidence            998888999999999999999999997776689999999999999997432 1368899999999999999999999999


Q ss_pred             hhhcCCCch----hhhhccCCcCCCCCCchhhcCcccchhhccCccccc-------------------------------
Q 002085          237 EAMSNLSSL----EILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSG-------------------------------  281 (969)
Q Consensus       237 ~~~~~l~~L----~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-------------------------------  281 (969)
                      ..++.+++|    +.|++++|.+++..|..+... +|+.|++++|....                               
T Consensus       167 ~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~  245 (570)
T 2z63_A          167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK  245 (570)
T ss_dssp             GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEE
T ss_pred             HHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhh
Confidence            999988888    889999999998877776655 89999999884321                               


Q ss_pred             CCCCchh---hcccccccccCc-cccccCCccccCcccchhhhhccccCcCcCCcccc-----cccccCcccccCCCCCC
Q 002085          282 EIPSSVE---ALKLTDIDLSMN-NLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIG-----VVAFENNLSGAVPKSLG  352 (969)
Q Consensus       282 ~~~~~~~---~~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~~n~l~~~~p~~l~  352 (969)
                      .....+.   .+.++.+++++| .+.+..|..|..+++|+.|++++|.+. .+|..+.     .+.+.++....+|.  .
T Consensus       246 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~--~  322 (570)
T 2z63_A          246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPT--L  322 (570)
T ss_dssp             CCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCB--C
T ss_pred             cchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccCCccEEeeccCcccccCc--c
Confidence            1111222   235677888888 788889999999999999999999998 4665443     23344444446665  4


Q ss_pred             CCccCcEEEcccccccCCCCcccccccCCCccccCCCcccccc--Cc--cccccccEEEeeccccCCCcccccCCcccch
Q 002085          353 NCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGEL--PS--KTAWNLTRLEISNNRFSGQIQRGVGSWKNLI  428 (969)
Q Consensus       353 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~--~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  428 (969)
                      .+++|+.|++++|.+.+..+.  ..+++|+.|++++|++++..  +.  ...++|++|++++|.+++..+. +..+++|+
T Consensus       323 ~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~  399 (570)
T 2z63_A          323 KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLE  399 (570)
T ss_dssp             BCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCC
T ss_pred             cccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCC
Confidence            788899999999998877665  67889999999999998653  22  2346899999999999976665 89999999


Q ss_pred             hhcccCCccccccC-ccccCccccchhhccCcccCCCCCcccccccCCCEEEccCcccc-CCCCcccccccccceEeccC
Q 002085          429 VFKASNNLFSGEIP-VELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELS-GEIPKAIGSLLVMVSLDLSG  506 (969)
Q Consensus       429 ~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~  506 (969)
                      .|++++|.+++..| ..+..+++|++|+|++|++++..|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+|++
T Consensus       400 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~  479 (570)
T 2z63_A          400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ  479 (570)
T ss_dssp             EEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred             EEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCC
Confidence            99999999997766 57889999999999999999888999999999999999999998 57899999999999999999


Q ss_pred             ccccccCCCcccccc-ccEEEeecCcCCCCCCcccccccc
Q 002085          507 NQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNLAY  545 (969)
Q Consensus       507 N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~~~~~~~  545 (969)
                      |++++..|..++.++ |++|++++|++++.+|..+..+..
T Consensus       480 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  519 (570)
T 2z63_A          480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS  519 (570)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred             CccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccC
Confidence            999988899999885 999999999999887776765543

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=444.38  Aligned_cols=430  Identities=20%  Similarity=0.197  Sum_probs=251.0

Q ss_pred             EEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCC
Q 002085           76 TGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGN  155 (969)
Q Consensus        76 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N  155 (969)
                      +.+++++++++ .+|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            35777777777 4666554  77777777777777766677777777777777777777666777777777777777777


Q ss_pred             CCCCcCCCcccCcccccceecccccccC-cCCcccCCCCCcceeecccCCCCCCCCCCccccccCCC--cEEEccCCcc-
Q 002085          156 NFSGDIPRSIGRLSELQTLYLYMNEFNG-TFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKL--KTLWMTEANL-  231 (969)
Q Consensus       156 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L--~~L~L~~n~l-  231 (969)
                      +|+ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|.+..     ..+..+++|  +.|++++|++ 
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~-----~~~~~l~~L~L~~L~l~~n~l~  151 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK-----SSVLPIAHLNISKVLLVLGETY  151 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG-----GGGGGGTTSCEEEEEEEECTTT
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch-----hhccccccceeeEEEeeccccc
Confidence            777 45555  67777777777777776 366777777777777777775322     456667777  7777777777 


Q ss_pred             -cccCchhhcCCC-chhhhhccCCcCCCCCCc-hhhcCcccchhhccCcc-------cccCCCCchhhcccccccccCcc
Q 002085          232 -IGEIPEAMSNLS-SLEILALNGNHLEGAIPS-GLFLLNNLTQLFLYDNI-------LSGEIPSSVEALKLTDIDLSMNN  301 (969)
Q Consensus       232 -~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~-------l~~~~~~~~~~~~L~~L~Ls~N~  301 (969)
                       .+..|..+..+. +...+++++|++.+.+++ .+..+++|+.|++++|.       +.+.+|......+|+.|++++|.
T Consensus       152 ~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~  231 (520)
T 2z7x_B          152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE  231 (520)
T ss_dssp             TSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEE
T ss_pred             ccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccc
Confidence             666676666654 233456666666554443 34456666666666665       44444422222246666666665


Q ss_pred             ccccCCcccc---CcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCC-ccccc
Q 002085          302 LTGSIPEEFG---KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELP-TGLWT  377 (969)
Q Consensus       302 l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~  377 (969)
                      +++..+..+.   ..++|++|++++|+++|.+|..+..            ...+++++|+.+++++|.+  .+| ..+..
T Consensus       232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~------------~~~~~l~~L~~l~l~~n~~--~~p~~~~~~  297 (520)
T 2z7x_B          232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFD------------YSGTSLKALSIHQVVSDVF--GFPQSYIYE  297 (520)
T ss_dssp             EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCC------------CCSCCCCEEEEEEEEECCC--CSCTHHHHH
T ss_pred             cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhh------------cccccCceeEeccccccce--ecchhhhhc
Confidence            5543222111   1235666666666665544432200            0014455555555555555  333 33333


Q ss_pred             c---cCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCcccc--ccCccccCccccc
Q 002085          378 T---FNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSG--EIPVELTSLSHLN  452 (969)
Q Consensus       378 l---~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~  452 (969)
                      +   .+|+.|++++|.+.+.......++|++|+|++|++++.+|..++.+++|++|++++|++++  .+|..+..+++|+
T Consensus       298 ~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~  377 (520)
T 2z7x_B          298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQ  377 (520)
T ss_dssp             HHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCC
T ss_pred             ccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCC
Confidence            3   4455555555555432211233455555555555555555555555555555555555554  3444555555555


Q ss_pred             hhhccCcccCCCCCcc-cccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecC
Q 002085          453 TLLLDGNKLSGKLPSQ-IVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSN  530 (969)
Q Consensus       453 ~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N  530 (969)
                      +|+|++|++++.+|.. +..+++|+.|+|++|++++.+|..+.  ++|+.|||++|+|+ .+|..+..++ |++|++++|
T Consensus       378 ~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N  454 (520)
T 2z7x_B          378 QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN  454 (520)
T ss_dssp             EEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSS
T ss_pred             EEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCC
Confidence            5555555555434432 44555555555555555555544443  45555555555555 5555554443 555555555


Q ss_pred             cCC
Q 002085          531 KLY  533 (969)
Q Consensus       531 ~l~  533 (969)
                      +++
T Consensus       455 ~l~  457 (520)
T 2z7x_B          455 QLK  457 (520)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            555

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=4.9e-46  Score=443.61  Aligned_cols=463  Identities=20%  Similarity=0.191  Sum_probs=385.2

Q ss_pred             CCCCcceee----CCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCC
Q 002085           63 CDWPEITCT----FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIP  138 (969)
Q Consensus        63 c~w~gv~C~----~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  138 (969)
                      |++.+++.-    ..+++.|+++++.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|
T Consensus        12 ~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~   91 (549)
T 2z81_A           12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS   91 (549)
T ss_dssp             CTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred             CCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence            445554431    2579999999999999889999999999999999999998888999999999999999999998877


Q ss_pred             CCcccCCCCcEEecCCCCCCC-cCCCcccCcccccceecccccccCcCC-cccCCCCCcceeecccCCCCCCCCCCcccc
Q 002085          139 SDIDRISGLQCIDLGGNNFSG-DIPRSIGRLSELQTLYLYMNEFNGTFP-KEIGDLSNLEVLGLAYNSNFKPAMIPIEFG  216 (969)
Q Consensus       139 ~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~  216 (969)
                      ..|+++++|++|+|++|.+++ ..|..|+++++|++|++++|++.+.+| ..|+++++|++|++++|+  ..+..|..++
T Consensus        92 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~--l~~~~~~~l~  169 (549)
T 2z81_A           92 SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS--LRNYQSQSLK  169 (549)
T ss_dssp             HHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT--CCEECTTTTT
T ss_pred             HHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCc--ccccChhhhh
Confidence            779999999999999999986 467889999999999999999544554 689999999999999997  4456889999


Q ss_pred             ccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCC--Cc-hhhcCcccchhhccCcccccCCCCchhh----
Q 002085          217 MLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAI--PS-GLFLLNNLTQLFLYDNILSGEIPSSVEA----  289 (969)
Q Consensus       217 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~-~l~~l~~L~~L~L~~N~l~~~~~~~~~~----  289 (969)
                      .+++|++|++++|.+....+..+..+++|++|++++|++++..  |. ....+++|+.|++++|.+++..+..+..    
T Consensus       170 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~  249 (549)
T 2z81_A          170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY  249 (549)
T ss_dssp             TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGG
T ss_pred             ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhh
Confidence            9999999999999875443334567999999999999999742  22 2335789999999999998765544432    


Q ss_pred             c-ccccccccCccccccC------CccccCcccchhhhhccccCcCcC-----------CcccccccccCcccccCCCCC
Q 002085          290 L-KLTDIDLSMNNLTGSI------PEEFGKLKNLQLLGLFSNHLSGEV-----------PASIGVVAFENNLSGAVPKSL  351 (969)
Q Consensus       290 ~-~L~~L~Ls~N~l~~~~------p~~~~~l~~L~~L~L~~N~l~~~~-----------p~~~~~l~~~n~l~~~~p~~l  351 (969)
                      . +|+.+++++|.+.+..      ...+..+.+|+.|++.++.+....           ...+..+.+.++..+.+|..+
T Consensus       250 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~  329 (549)
T 2z81_A          250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF  329 (549)
T ss_dssp             CTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHH
T ss_pred             hccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHH
Confidence            2 6999999999988642      234567788999999988775321           123444555666667888776


Q ss_pred             -CCCccCcEEEcccccccCCCCc---ccccccCCCccccCCCccccccC----ccccccccEEEeeccccCCCcccccCC
Q 002085          352 -GNCRTLRTVQLYSNRFSGELPT---GLWTTFNLSSLMLSDNTISGELP----SKTAWNLTRLEISNNRFSGQIQRGVGS  423 (969)
Q Consensus       352 -~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~~L~~L~Ls~N~l~~~~~~~~~~  423 (969)
                       .++++|++|++++|++++.+|.   .+..+++|+.|+|++|++++..+    ....++|++|+|++|+++ .+|..+..
T Consensus       330 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~  408 (549)
T 2z81_A          330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW  408 (549)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCC
T ss_pred             HhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcc
Confidence             5799999999999999987653   37788999999999999986543    234578999999999999 67888999


Q ss_pred             cccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEe
Q 002085          424 WKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLD  503 (969)
Q Consensus       424 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  503 (969)
                      +++|++|++++|.|+ .+|..+  .++|+.|+|++|+|++.+    ..+++|++|+|++|+|+ .+|. ...+++|+.||
T Consensus       409 ~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~  479 (549)
T 2z81_A          409 PEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMK  479 (549)
T ss_dssp             CTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEE
T ss_pred             cccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEe
Confidence            999999999999998 455444  368999999999999643    57899999999999998 7887 57899999999


Q ss_pred             ccCccccccCCCcccccc-ccEEEeecCcCCCCCC
Q 002085          504 LSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIP  537 (969)
Q Consensus       504 ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p  537 (969)
                      |++|+|++.+|..++.++ |+.|++++|++.+.+|
T Consensus       480 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          480 ISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             CCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             cCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            999999988888899885 9999999999999887

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.4e-46  Score=433.70  Aligned_cols=248  Identities=22%  Similarity=0.242  Sum_probs=203.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHH---HHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEF---IAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      +++|++.++||+|+||+||+|++..+|+.||||++.+...........+   ..++++++.++|||||++++++++++..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            4679999999999999999999999999999999976543222222333   3446677788999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      |+|||||+||+|.+++...+             .+++..+..++.||+.||+|||++   +||||||||+|||++.+|.+
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-------------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~v  331 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-------------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  331 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEEEecCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCE
Confidence            99999999999999998654             389999999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+|+.+...    .....+||+.|||||++.+ ..|+.++||||+||++|||++|..||.+..............
T Consensus       332 KL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~  407 (689)
T 3v5w_A          332 RISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL  407 (689)
T ss_dssp             EECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH
T ss_pred             EecccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Confidence            99999999876432    2334689999999999975 579999999999999999999999998755444333222222


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                      .....            .+...+.++.+++.+|++.||++|++.
T Consensus       408 ~~~~~------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          408 TMAVE------------LPDSFSPELRSLLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             HCCCC------------CCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred             CCCCC------------CCccCCHHHHHHHHHHccCCHhHCCCC
Confidence            21111            122234678999999999999999873

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=443.45  Aligned_cols=436  Identities=18%  Similarity=0.182  Sum_probs=372.2

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      .+++.|++++|.+.+..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+|+ .+|..  .+++|++|+|
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L   97 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL   97 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence            57999999999999988889999999999999999999888999999999999999999999 67766  8999999999


Q ss_pred             CCCCCCC-cCCCcccCcccccceecccccccCcCCcccCCCCCc--ceeecccCCCCCCCCCCccccccC-CCcEEEccC
Q 002085          153 GGNNFSG-DIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNL--EVLGLAYNSNFKPAMIPIEFGMLK-KLKTLWMTE  228 (969)
Q Consensus       153 ~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~~~~~~~~p~~~~~l~-~L~~L~L~~  228 (969)
                      ++|++++ .+|..|+++++|++|+|++|++++   ..+..+++|  ++|++++|.+......|..+..+. +...+++++
T Consensus        98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~  174 (520)
T 2z7x_B           98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT  174 (520)
T ss_dssp             CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred             cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence            9999997 578999999999999999999986   457778888  999999998644567788887776 345678899


Q ss_pred             CcccccCch-hhcCCCchhhhhccCCc-------CCCCCCchhhcCcccchhhccCcccccCCCCchh----hccccccc
Q 002085          229 ANLIGEIPE-AMSNLSSLEILALNGNH-------LEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVE----ALKLTDID  296 (969)
Q Consensus       229 n~l~~~~p~-~~~~l~~L~~L~L~~N~-------l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~----~~~L~~L~  296 (969)
                      |++.+.+++ .+.++++|+.|++++|.       +.+.+| .+..+++|+.|++++|.+++..+..+.    ..+|+.|+
T Consensus       175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~  253 (520)
T 2z7x_B          175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS  253 (520)
T ss_dssp             SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEE
T ss_pred             Ccchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEE
Confidence            998887765 68899999999999998       776665 788999999999999998864433322    23799999


Q ss_pred             ccCccccccCCccc-----cCcccchhhhhccccCcCcCCc-ccccccccCcccccCCCCCCCCccCcEEEcccccccCC
Q 002085          297 LSMNNLTGSIPEEF-----GKLKNLQLLGLFSNHLSGEVPA-SIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGE  370 (969)
Q Consensus       297 Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  370 (969)
                      +++|+++|.+|..+     +.+++|+.+++++|.+  .+|. .+..              +....+|+.|++++|.+.+.
T Consensus       254 l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~--------------~~~~~~L~~L~l~~n~l~~~  317 (520)
T 2z7x_B          254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYE--------------IFSNMNIKNFTVSGTRMVHM  317 (520)
T ss_dssp             EEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHH--------------HHHTCCCSEEEEESSCCCCC
T ss_pred             eecccccCccccchhhcccccCceeEeccccccce--ecchhhhhc--------------ccccCceeEEEcCCCccccc
Confidence            99999999999998     9999999999999998  4552 2211              00125689999999998743


Q ss_pred             CCcccccccCCCccccCCCccccccCccc--cccccEEEeeccccCC--CcccccCCcccchhhcccCCccccccCcc-c
Q 002085          371 LPTGLWTTFNLSSLMLSDNTISGELPSKT--AWNLTRLEISNNRFSG--QIQRGVGSWKNLIVFKASNNLFSGEIPVE-L  445 (969)
Q Consensus       371 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~--~~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~  445 (969)
                      .  .+..+++|++|++++|++++.+|...  .++|++|+|++|++++  .+|..+..+++|++|++++|.+++.+|.. +
T Consensus       318 ~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~  395 (520)
T 2z7x_B          318 L--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC  395 (520)
T ss_dssp             C--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSC
T ss_pred             c--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchh
Confidence            2  12578899999999999998777643  4689999999999997  56678999999999999999999856654 8


Q ss_pred             cCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCc-ccccc-cc
Q 002085          446 TSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPE-IGQLK-LN  523 (969)
Q Consensus       446 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~-L~  523 (969)
                      ..+++|+.|+|++|++++.+|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +..++ |+
T Consensus       396 ~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~  471 (520)
T 2z7x_B          396 SWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQ  471 (520)
T ss_dssp             CCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred             ccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCccc
Confidence            8899999999999999988887765  79999999999999 89998889999999999999999 68876 77775 99


Q ss_pred             EEEeecCcCCCCCC
Q 002085          524 TFNLSSNKLYGNIP  537 (969)
Q Consensus       524 ~l~ls~N~l~~~~p  537 (969)
                      +|++++|++++..+
T Consensus       472 ~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          472 KIWLHTNPWDCSCP  485 (520)
T ss_dssp             EEECCSSCBCCCHH
T ss_pred             EEECcCCCCcccCC
Confidence            99999999998776

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=409.70  Aligned_cols=266  Identities=24%  Similarity=0.310  Sum_probs=210.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc------CC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS------EN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  709 (969)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.... .....+.+.+|+++|+.++|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            579999999999999999999999999999999965433 33445778899999999999999999998764      36


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..|||||||+ |+|.+++....             .+++..+..++.||+.||+|||++   +|+||||||+|||++.++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~-------------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~  195 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ-------------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENC  195 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCC
Confidence            7899999996 68999997644             489999999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCC--CCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          790 KAKIADFGLAKMLAKQG--EPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      .+||+|||+|+.+....  ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I  275 (398)
T 4b99_A          196 ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI  275 (398)
T ss_dssp             CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred             CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999998764322  12234567899999999998875 4689999999999999999999999987766555544


Q ss_pred             HHHhhccCC----------chhhhcc-CCCCccc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEKP----------ITDALDK-GIAEPCY-----LEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~~----------~~~~~~~-~~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .........          ....... ....+.+     ...+.++.+++.+||..||++|||+.|+++
T Consensus       276 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          276 MMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            433221110          0000000 0000111     112367889999999999999999999986

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.6e-43  Score=429.98  Aligned_cols=481  Identities=21%  Similarity=0.196  Sum_probs=302.0

Q ss_pred             CCCCCCCCCCCCCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCC
Q 002085           52 SLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN  131 (969)
Q Consensus        52 ~l~sw~~~~~~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N  131 (969)
                      .+++|..+ -|..|..+.|..... .++.++.+++. +|+.+.  +++++|||++|+|++..+.+|.++++|++|+|++|
T Consensus        12 ~~~~~~~~-~p~~~~~c~~~~~~~-~~~c~~~~l~~-vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N   86 (635)
T 4g8a_A           12 KLAAANSS-IPESWEPCVEVVPNI-TYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC   86 (635)
T ss_dssp             --------------CCSEEEETTT-EEECTTSCCSS-CCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             hhhcccCC-CCCCCCCccccCCCC-EEECCCCCcCc-cCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCC
Confidence            35666432 344577666654332 34667766663 555432  46889999999999777788999999999999999


Q ss_pred             cCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCC
Q 002085          132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMI  211 (969)
Q Consensus       132 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~  211 (969)
                      +|++..|.+|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|.+.. ...
T Consensus        87 ~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~-~~~  165 (635)
T 4g8a_A           87 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKL  165 (635)
T ss_dssp             CCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC-CCC
T ss_pred             cCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCcccc-CCC
Confidence            9987778889999999999999999987666788999999999999999997777789999999999999997432 235


Q ss_pred             CccccccCCCcEEEccCCcccccCchhhcCCCchh----hhhccCCcCCCCCCchhhcCcccchhhccCcccccC-----
Q 002085          212 PIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLE----ILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGE-----  282 (969)
Q Consensus       212 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-----  282 (969)
                      |..++.+++|++|++++|++.+..|..|..+.+++    .++++.|.++...+. ......+..+++.+|..+..     
T Consensus       166 ~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~-~~~~~~~~~l~l~~n~~~~~~~~~~  244 (635)
T 4g8a_A          166 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLHKLTLRNNFDSLNVMKTC  244 (635)
T ss_dssp             CGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTT-TTTTCEEEEEEEESCCSSHHHHHHH
T ss_pred             chhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcc-cccchhhhhhhhhcccccccccchh
Confidence            77888899999999999999888888777665554    467788887744333 33333344444444422110     


Q ss_pred             -----------------------------------------------------CCCchhhc-ccccccccCccccccCCc
Q 002085          283 -----------------------------------------------------IPSSVEAL-KLTDIDLSMNNLTGSIPE  308 (969)
Q Consensus       283 -----------------------------------------------------~~~~~~~~-~L~~L~Ls~N~l~~~~p~  308 (969)
                                                                           .+..+... +++.+++.+|.+...  .
T Consensus       245 ~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~  322 (635)
T 4g8a_A          245 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--K  322 (635)
T ss_dssp             HHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--G
T ss_pred             hcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--c
Confidence                                                                 00111111 355566666666533  2


Q ss_pred             cccCcccchhhhhccccCcCcCCccccc---ccccCcccccCCCCCCCCccCcEEEccccccc--CCCCcccccccCCCc
Q 002085          309 EFGKLKNLQLLGLFSNHLSGEVPASIGV---VAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS--GELPTGLWTTFNLSS  383 (969)
Q Consensus       309 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~---l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~  383 (969)
                      .+....+|+.|++.+|.+.+..+..+..   +.+..+..+. +.....+++|+.|++++|.+.  +..+..+..+.+|+.
T Consensus       323 ~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~  401 (635)
T 4g8a_A          323 DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKY  401 (635)
T ss_dssp             GGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCC-BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCE
T ss_pred             ccccchhhhhhhcccccccCcCcccchhhhhcccccccCCC-Ccccccccccccchhhccccccccccccchhhhhhhhh
Confidence            3556678888888888877544433322   2222232222 233456788888888888875  345556666667777


Q ss_pred             cccCCCccccccCcc-ccccccEEEeeccccCCCcc-cccCCcccchhhcccCCccccccCccccCccccchhhccCccc
Q 002085          384 LMLSDNTISGELPSK-TAWNLTRLEISNNRFSGQIQ-RGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKL  461 (969)
Q Consensus       384 L~Ls~N~l~~~~~~~-~~~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  461 (969)
                      |+++.|.+....+.. ...+|+.++++.|++....+ ..+..+++++.+++++|.+++..+..+..+++|+.|+|++|++
T Consensus       402 L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~  481 (635)
T 4g8a_A          402 LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF  481 (635)
T ss_dssp             EECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEE
T ss_pred             hhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhccc
Confidence            777777665433322 22456666666555544333 3455556666666666666655555556666666666666653


Q ss_pred             -CCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecCcCCCCCCcc
Q 002085          462 -SGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDE  539 (969)
Q Consensus       462 -~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~  539 (969)
                       .+.+|..+..+++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..++.++ |++|||++|+|++.+|..
T Consensus       482 ~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  561 (635)
T 4g8a_A          482 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE  561 (635)
T ss_dssp             GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSC
T ss_pred             ccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHH
Confidence             234455556666666666666666655555666666666666666666655555555553 666666666666655555


Q ss_pred             ccc
Q 002085          540 FNN  542 (969)
Q Consensus       540 ~~~  542 (969)
                      ++.
T Consensus       562 l~~  564 (635)
T 4g8a_A          562 LQH  564 (635)
T ss_dssp             TTC
T ss_pred             HHh
Confidence            543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.1e-44  Score=395.97  Aligned_cols=202  Identities=25%  Similarity=0.398  Sum_probs=172.0

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEc---CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE  708 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  708 (969)
                      .+.+.|++.++||+|+||+||+|++.   .+++.||+|++.....     ...+.+|+++++.+ +||||+++++++.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            34568999999999999999999874   4578999999855422     35678999999998 699999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      +..|+||||++||+|.+++..                +++.++..++.|++.||+|||++   +|+||||||+|||++.+
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~~----------------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~  153 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILNS----------------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRR  153 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHTT----------------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT
T ss_pred             CEEEEEEeCCCcccHHHHHcC----------------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCC
Confidence            999999999999999999842                78899999999999999999998   99999999999999877


Q ss_pred             -CcEEEeecccceecccCCC--------------------------CccccccccCcccCchhhcccC-CCCCccchhhH
Q 002085          789 -FKAKIADFGLAKMLAKQGE--------------------------PHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSF  840 (969)
Q Consensus       789 -~~~kl~Dfgla~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwsl  840 (969)
                       +.+||+|||+|+.......                          .......+||+.|||||++.+. .++.++||||+
T Consensus       154 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSl  233 (361)
T 4f9c_A          154 LKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA  233 (361)
T ss_dssp             TTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred             CCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhh
Confidence             7999999999986543211                          0112345799999999999875 58999999999


Q ss_pred             HHHHHHHHhCCCCCCCCC
Q 002085          841 GVVLLELVTGKEANYGDE  858 (969)
Q Consensus       841 G~il~elltg~~p~~~~~  858 (969)
                      ||++|||++|+.||....
T Consensus       234 G~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          234 GVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             HHHHHHHHHTCSSSSCCS
T ss_pred             HHHHHHHHHCCCCCCCCC
Confidence            999999999999997654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.3e-43  Score=415.95  Aligned_cols=256  Identities=20%  Similarity=0.332  Sum_probs=215.8

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ..++++|++.+.||+|+||.||+|++..+|+.||+|++....   ....+.+.+|+++|+.++|||||++++++.+++..
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            445688999999999999999999999999999999986543   33356789999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC--C
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE--F  789 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~  789 (969)
                      |+|||||+||+|.+++....            ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~------------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~  294 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEH------------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSN  294 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTT------------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCC
T ss_pred             EEEEeecCCCcHHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCC
Confidence            99999999999999997543            2488999999999999999999998   99999999999999864  8


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      .+||+|||+|+.+...   ......+||+.|||||++.+..|+.++||||+||++|||++|..||.+.........+...
T Consensus       295 ~vKl~DFG~a~~~~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~  371 (573)
T 3uto_A          295 ELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC  371 (573)
T ss_dssp             CEEECCCSSCEECCTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred             CEEEeeccceeEccCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC
Confidence            9999999999987432   3334568999999999999999999999999999999999999999877655444333211


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                         ...        .....+...+..+.+|+.+||+.||++||++.|+++
T Consensus       372 ---~~~--------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          372 ---DWN--------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ---CCC--------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CCC--------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               111        111122233467889999999999999999999987

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=2.3e-43  Score=420.94  Aligned_cols=441  Identities=17%  Similarity=0.186  Sum_probs=277.4

Q ss_pred             EEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCC
Q 002085           76 TGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGN  155 (969)
Q Consensus        76 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N  155 (969)
                      +.++++++++++ +|..+.  ++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            788899999886 676554  78999999999999888889999999999999999999888889999999999999999


Q ss_pred             CCCCcCCCcccCcccccceecccccccCc-CCcccCCCCCcceeecccCCCCCCCCCCccccccCCC--cEEEccCCcc-
Q 002085          156 NFSGDIPRSIGRLSELQTLYLYMNEFNGT-FPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKL--KTLWMTEANL-  231 (969)
Q Consensus       156 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L--~~L~L~~n~l-  231 (969)
                      +|+ .+|..  .+++|++|+|++|++++. +|..|+++++|++|++++|++..     ..+..+++|  +.|++++|.+ 
T Consensus       111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~-----~~~~~l~~L~L~~L~L~~n~l~  182 (562)
T 3a79_B          111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ-----LDLLPVAHLHLSCILLDLVSYH  182 (562)
T ss_dssp             CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT-----TTTGGGTTSCEEEEEEEESSCC
T ss_pred             cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc-----CchhhhhhceeeEEEeeccccc
Confidence            998 67766  799999999999999863 46889999999999999997532     346666666  9999999998 


Q ss_pred             -cccCchhhcCCC--chhhhhccCCcCCCCCCc-hhhcCcccchhhccCcc-----cccCCCCchhhcccccccccCccc
Q 002085          232 -IGEIPEAMSNLS--SLEILALNGNHLEGAIPS-GLFLLNNLTQLFLYDNI-----LSGEIPSSVEALKLTDIDLSMNNL  302 (969)
Q Consensus       232 -~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~-----l~~~~~~~~~~~~L~~L~Ls~N~l  302 (969)
                       .+..|..|..+.  .| .+++++|.+.+.++. .+..+++|+.|++++|+     +.+.++......+++.|+++++.+
T Consensus       183 ~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l  261 (562)
T 3a79_B          183 IKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET  261 (562)
T ss_dssp             CCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEE
T ss_pred             ccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcC
Confidence             888888887765  33 457788888776654 34467788888888874     111111111111344444444444


Q ss_pred             ccc----CCccccCcccchhhhhccccCcCcCCcccc-----cc---c---cc-CcccccCCC-CCC---CCccCcEEEc
Q 002085          303 TGS----IPEEFGKLKNLQLLGLFSNHLSGEVPASIG-----VV---A---FE-NNLSGAVPK-SLG---NCRTLRTVQL  362 (969)
Q Consensus       303 ~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l---~---~~-n~l~~~~p~-~l~---~l~~L~~L~L  362 (969)
                      ++.    ++..+ ..++|++|++++|.++|.+|..+-     .+   .   .. +.+  .+|. .+.   ...+|+.|++
T Consensus       262 ~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l  338 (562)
T 3a79_B          262 TWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSI  338 (562)
T ss_dssp             CHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEE
T ss_pred             cHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEc
Confidence            321    11111 123666666666666665554320     00   0   00 000  1110 000   1134556666


Q ss_pred             ccccccCCCCcccccccCCCccccCCCccccccCccc--cccccEEEeeccccCCC--cccccCCcccchhhcccCCccc
Q 002085          363 YSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKT--AWNLTRLEISNNRFSGQ--IQRGVGSWKNLIVFKASNNLFS  438 (969)
Q Consensus       363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~--~~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~l~~N~l~  438 (969)
                      ++|.+....  ....+++|++|++++|++++.+|...  .++|++|+|++|++++.  +|..+..+++|++|++++|.++
T Consensus       339 ~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~  416 (562)
T 3a79_B          339 SDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN  416 (562)
T ss_dssp             ESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCB
T ss_pred             cCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCC
Confidence            666554211  01345556666666666665444332  24566666666666642  2344556666666666666666


Q ss_pred             cccCc-cccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCc-
Q 002085          439 GEIPV-ELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPE-  516 (969)
Q Consensus       439 ~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-  516 (969)
                      +.+|. .+..+++|+.|+|++|++++.+|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|||++|+|+ .+|+. 
T Consensus       417 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~  492 (562)
T 3a79_B          417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGV  492 (562)
T ss_dssp             SCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTS
T ss_pred             CccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHH
Confidence            53333 355556666666666666555554443  45666666666665 45555556666666666666666 45554 


Q ss_pred             ccccc-ccEEEeecCcCCCCCC
Q 002085          517 IGQLK-LNTFNLSSNKLYGNIP  537 (969)
Q Consensus       517 ~~~l~-L~~l~ls~N~l~~~~p  537 (969)
                      +..++ |+.|++++|++.+..|
T Consensus       493 ~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          493 FDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             TTTCTTCCCEECCSCCBCCCHH
T ss_pred             HhcCCCCCEEEecCCCcCCCcc
Confidence            55553 6666666666655544

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=4.6e-43  Score=385.07  Aligned_cols=293  Identities=27%  Similarity=0.464  Sum_probs=275.3

Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCCCCCCCC--CCcceeeC----CCeEEEEecCCCCCC--CCCccccCCCcccEE
Q 002085           31 SPNTEERTILLNLKQQLGNPPSLQSWTSTSSPCD--WPEITCTF----NSVTGISLRHKDITQ--KIPPIICDLKNLTTI  102 (969)
Q Consensus        31 ~~~~~~~~all~~k~~~~~~~~l~sw~~~~~~c~--w~gv~C~~----~~v~~l~l~~~~l~~--~~~~~~~~l~~L~~L  102 (969)
                      .|.++|++||++||+++.++..+++|+.++|||.  |.||+|+.    ++|+.|+|+++++.+  .+|+.|+++++|++|
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L   81 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL   81 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred             CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence            4789999999999999987767899998889998  99999975    689999999999999  899999999999999


Q ss_pred             EccC-CCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccc
Q 002085          103 DLSS-NSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF  181 (969)
Q Consensus       103 ~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  181 (969)
                      +|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|.+++.+|..|+++++|++|+|++|++
T Consensus        82 ~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  161 (313)
T 1ogq_A           82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI  161 (313)
T ss_dssp             EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred             eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcc
Confidence            9995 999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCCcccCCCC-CcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCC
Q 002085          182 NGTFPKEIGDLS-NLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIP  260 (969)
Q Consensus       182 ~~~~p~~~~~l~-~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  260 (969)
                      ++.+|..++.++ +|++|++++|++  .+.+|..++.++ |+.|++++|++.+.+|..|..+++|+.|+|++|++++.+|
T Consensus       162 ~~~~p~~l~~l~~~L~~L~L~~N~l--~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  238 (313)
T 1ogq_A          162 SGAIPDSYGSFSKLFTSMTISRNRL--TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG  238 (313)
T ss_dssp             EEECCGGGGCCCTTCCEEECCSSEE--EEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred             cCcCCHHHhhhhhcCcEEECcCCee--eccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecC
Confidence            999999999998 999999999973  357888999998 9999999999999999999999999999999999997766


Q ss_pred             chhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhcccc-CcC
Q 002085          261 SGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNH-LSG  328 (969)
Q Consensus       261 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~  328 (969)
                      . +..+++|++|+|++|++++.+|..+..+ +|+.|+|++|++++.+|.. +.+++|+.+++++|. ++|
T Consensus       239 ~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          239 K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             G-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred             c-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence            5 7889999999999999999999998876 7999999999999999986 889999999999998 554

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=5.9e-43  Score=406.76  Aligned_cols=377  Identities=18%  Similarity=0.122  Sum_probs=259.4

Q ss_pred             CcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCC-CCCcccCCCCcEEecCCCCCCCcCCCcccCccccccee
Q 002085           97 KNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPI-PSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLY  175 (969)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  175 (969)
                      ++|++|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            67889999999988877888888999999999988887555 56688888888888888888877788888888888888


Q ss_pred             cccccccCcCCcc--cCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchh-hcCCCchhhhhccC
Q 002085          176 LYMNEFNGTFPKE--IGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEA-MSNLSSLEILALNG  252 (969)
Q Consensus       176 L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~  252 (969)
                      |++|++++..|..  |+.+++|++|+|++|+                          +.+..|.. +.++++|++|+|++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~--------------------------l~~~~~~~~~~~l~~L~~L~L~~  163 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN--------------------------IKKIQPASFFLNMRRFHVLDLTF  163 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSB--------------------------CCSCCCCGGGGGCTTCCEEECTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCc--------------------------cCccCcccccCCCCcccEEeCCC
Confidence            8888888655544  6777777777777664                          33333433 45555555555555


Q ss_pred             CcCCCCCCchhhcC--cccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcC
Q 002085          253 NHLEGAIPSGLFLL--NNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEV  330 (969)
Q Consensus       253 N~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  330 (969)
                      |++++..|..+..+  .+|+.|++++|.+.+..+..+..               .....+..+++|+.|++++|++++.+
T Consensus       164 n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~---------------~~~~~~~~~~~L~~L~Ls~n~l~~~~  228 (455)
T 3v47_A          164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW---------------EKCGNPFKNTSITTLDLSGNGFKESM  228 (455)
T ss_dssp             CCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH---------------HHHCCTTTTCEEEEEECTTSCCCHHH
T ss_pred             CcccccChhhhhccccccccccccccCcccccchhhccc---------------cccccccccceeeeEecCCCcccccc
Confidence            55555555444433  34555555555554333222110               00011223344444444444444333


Q ss_pred             CcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeec
Q 002085          331 PASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISN  410 (969)
Q Consensus       331 p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~  410 (969)
                      |..+...              ...++|+.|++++|.+.+.... ...+..+..     ..+.    .....+|+.|++++
T Consensus       229 ~~~~~~~--------------~~~~~L~~L~l~~~~~~~~~~~-~~~~~~~~~-----~~~~----~~~~~~L~~L~l~~  284 (455)
T 3v47_A          229 AKRFFDA--------------IAGTKIQSLILSNSYNMGSSFG-HTNFKDPDN-----FTFK----GLEASGVKTCDLSK  284 (455)
T ss_dssp             HHHHHHH--------------TTTCCEEEEECTTCTTTSCCTT-CCSSCCCCT-----TTTG----GGTTSCCCEEECCS
T ss_pred             hhhhhcc--------------ccccceeeEeeccccccccccc-hhhhccCcc-----cccc----cccccCceEEEecC
Confidence            3222110              0124555666666655432110 000111110     0010    11124788999999


Q ss_pred             cccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCC
Q 002085          411 NRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIP  490 (969)
Q Consensus       411 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  490 (969)
                      |++++.+|..+..+++|++|++++|++++..|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..|
T Consensus       285 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  364 (455)
T 3v47_A          285 SKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGD  364 (455)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECT
T ss_pred             ccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccCh
Confidence            99998888999999999999999999998888899999999999999999987778889999999999999999998889


Q ss_pred             cccccccccceEeccCccccccCCCcccccc-ccEEEeecCcCCCCCCc
Q 002085          491 KAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPD  538 (969)
Q Consensus       491 ~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~  538 (969)
                      ..|..+++|++|+|++|+|++..+..++.++ |++|++++|++++.+|.
T Consensus       365 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          365 QSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             hhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence            9999999999999999999965555567775 99999999999999884

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=9.4e-43  Score=401.66  Aligned_cols=396  Identities=23%  Similarity=0.282  Sum_probs=263.9

Q ss_pred             CCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCC-------------CEEeccCCcCCCCCC
Q 002085           72 FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKL-------------QNLDLSQNYFVGPIP  138 (969)
Q Consensus        72 ~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~~~~p  138 (969)
                      ..+++.++++++++ +.+|++++++++|++|++++|.++|.+|..++++++|             ++|++++|.+++ +|
T Consensus        10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp   87 (454)
T 1jl5_A           10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP   87 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred             cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence            34688899999999 8899999999999999999999999999999998875             999999999885 45


Q ss_pred             CCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCcccccc
Q 002085          139 SDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGML  218 (969)
Q Consensus       139 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l  218 (969)
                      ..   .++|++|++++|.+++ +|..   +++|++|++++|++++ +|..   .++|++|++++|++.   .+| .|+.+
T Consensus        88 ~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~---~lp-~~~~l  152 (454)
T 1jl5_A           88 EL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLE---KLP-ELQNS  152 (454)
T ss_dssp             SC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCS---SCC-CCTTC
T ss_pred             CC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCC---CCc-ccCCC
Confidence            42   3689999999999996 6754   3789999999999985 3332   268999999999644   366 59999


Q ss_pred             CCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhccccccccc
Q 002085          219 KKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLS  298 (969)
Q Consensus       219 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls  298 (969)
                      ++|++|++++|++.+ +|..+   .+|++|++++|++++ +| .+..+++|++|++++|++++ +|...  .+|+.|+++
T Consensus       153 ~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~  223 (454)
T 1jl5_A          153 SFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP--LSLESIVAG  223 (454)
T ss_dssp             TTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--TTCCEEECC
T ss_pred             CCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--CcccEEECc
Confidence            999999999998876 56543   588999999999986 56 58889999999999999986 44332  378999999


Q ss_pred             CccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccc
Q 002085          299 MNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTT  378 (969)
Q Consensus       299 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l  378 (969)
                      +|+++ .+| .++.+++|++|++++|++++                  +|..   +++|+.|++++|++++ +|..   .
T Consensus       224 ~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~------------------l~~~---~~~L~~L~l~~N~l~~-l~~~---~  276 (454)
T 1jl5_A          224 NNILE-ELP-ELQNLPFLTTIYADNNLLKT------------------LPDL---PPSLEALNVRDNYLTD-LPEL---P  276 (454)
T ss_dssp             SSCCS-SCC-CCTTCTTCCEEECCSSCCSS------------------CCSC---CTTCCEEECCSSCCSC-CCCC---C
T ss_pred             CCcCC-ccc-ccCCCCCCCEEECCCCcCCc------------------cccc---ccccCEEECCCCcccc-cCcc---c
Confidence            99998 666 48889999999999998873                  2221   3678999999999985 5654   3


Q ss_pred             cCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCc-ccchhhcccCCccccccCccccCccccchhhcc
Q 002085          379 FNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSW-KNLIVFKASNNLFSGEIPVELTSLSHLNTLLLD  457 (969)
Q Consensus       379 ~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls  457 (969)
                      ++|+.|++++|++++. |. ...+|++|++++|++++. +    .+ ++|++|++++|++++ +|..   +++|+.|+|+
T Consensus       277 ~~L~~L~ls~N~l~~l-~~-~~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~  345 (454)
T 1jl5_A          277 QSLTFLDVSENIFSGL-SE-LPPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIAS  345 (454)
T ss_dssp             TTCCEEECCSSCCSEE-SC-CCTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred             CcCCEEECcCCccCcc-cC-cCCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECC
Confidence            7889999999998862 21 235789999999988852 2    23 578889999999885 5554   5788899999


Q ss_pred             CcccCCCCCcccccccCCCEEEccCccccC--CCCcccccccccceEeccCccccccCCCccccccccEEEeecCcCCC-
Q 002085          458 GNKLSGKLPSQIVSWTSLNNLNLARNELSG--EIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYG-  534 (969)
Q Consensus       458 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~l~~-  534 (969)
                      +|+++ .+|.   .+++|+.|+|++|++++  .+|.+++.+        +.|++.|.+|..+  -.|++|++++|+++| 
T Consensus       346 ~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~~--~~L~~L~ls~N~l~~~  411 (454)
T 1jl5_A          346 FNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPELP--QNLKQLHVETNPLREF  411 (454)
T ss_dssp             SSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC---------------------------
T ss_pred             CCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhccccccccccc--CcCCEEECCCCcCCcc
Confidence            99988 5666   46789999999999987  677776543        3466666666532  137788888888877 


Q ss_pred             -CCCcccccccc
Q 002085          535 -NIPDEFNNLAY  545 (969)
Q Consensus       535 -~~p~~~~~~~~  545 (969)
                       .+|.+++.+..
T Consensus       412 ~~iP~sl~~L~~  423 (454)
T 1jl5_A          412 PDIPESVEDLRM  423 (454)
T ss_dssp             ------------
T ss_pred             ccchhhHhheeC
Confidence             77777766654

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.3e-42  Score=400.40  Aligned_cols=375  Identities=25%  Similarity=0.277  Sum_probs=265.7

Q ss_pred             cCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCC-------------cEEecCCCCCCCc
Q 002085           94 CDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGL-------------QCIDLGGNNFSGD  160 (969)
Q Consensus        94 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L-------------~~L~L~~N~l~~~  160 (969)
                      ...++|++|++++|++ |.+|++|+++++|++|+|++|.++|.+|..++.+.+|             ++|++++|++++ 
T Consensus         8 ~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-   85 (454)
T 1jl5_A            8 VSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-   85 (454)
T ss_dssp             ---------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-
T ss_pred             cccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-
Confidence            3568999999999999 7999999999999999999999999999999998875             999999999984 


Q ss_pred             CCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhc
Q 002085          161 IPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMS  240 (969)
Q Consensus       161 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~  240 (969)
                      +|..   .++|++|++++|++++ +|..   +++|++|++++|++......|      ++|++|++++|++.+ +| .|+
T Consensus        86 lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~~------~~L~~L~L~~n~l~~-lp-~~~  150 (454)
T 1jl5_A           86 LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDLP------PLLEYLGVSNNQLEK-LP-ELQ  150 (454)
T ss_dssp             CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSCC------TTCCEEECCSSCCSS-CC-CCT
T ss_pred             CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCCC------CCCCEEECcCCCCCC-Cc-ccC
Confidence            5552   3689999999999996 6654   478999999999755432222      689999999998886 67 588


Q ss_pred             CCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhh
Q 002085          241 NLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLL  319 (969)
Q Consensus       241 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  319 (969)
                      ++++|++|++++|++++ +|..+   .+|++|++++|++++ +|. +..+ +|+.|++++|++++ +|...   ++|++|
T Consensus       151 ~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~~-~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L  220 (454)
T 1jl5_A          151 NSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LPE-LQNLPFLTAIYADNNSLKK-LPDLP---LSLESI  220 (454)
T ss_dssp             TCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CCC-CTTCTTCCEEECCSSCCSS-CCCCC---TTCCEE
T ss_pred             CCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Ccc-ccCCCCCCEEECCCCcCCc-CCCCc---CcccEE
Confidence            99999999999999985 55533   588899999998886 554 4444 78889999998885 44432   578888


Q ss_pred             hhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccc
Q 002085          320 GLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKT  399 (969)
Q Consensus       320 ~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~  399 (969)
                      ++++|+++                  .+| .++.+++|++|++++|++++ +|..   ..+|+.|++++|++++ +|.. 
T Consensus       221 ~l~~n~l~------------------~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~-  275 (454)
T 1jl5_A          221 VAGNNILE------------------ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL-  275 (454)
T ss_dssp             ECCSSCCS------------------SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC-
T ss_pred             ECcCCcCC------------------ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc-
Confidence            88888887                  345 37788999999999999984 5543   3789999999999986 4443 


Q ss_pred             cccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCc-cccchhhccCcccCCCCCcccccccCCCEE
Q 002085          400 AWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSL-SHLNTLLLDGNKLSGKLPSQIVSWTSLNNL  478 (969)
Q Consensus       400 ~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  478 (969)
                      ..+|++|++++|++++.. ..   .++|+.|++++|++++ ++    .+ ++|+.|+|++|++++ +|..   +++|+.|
T Consensus       276 ~~~L~~L~ls~N~l~~l~-~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L  342 (454)
T 1jl5_A          276 PQSLTFLDVSENIFSGLS-EL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERL  342 (454)
T ss_dssp             CTTCCEEECCSSCCSEES-CC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred             cCcCCEEECcCCccCccc-Cc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEE
Confidence            378999999999998732 11   2678999999999985 22    23 589999999999995 6654   5789999


Q ss_pred             EccCccccCCCCcccccccccceEeccCccccc--cCCCccccccccEEEeecCcCCCCCCccccccc
Q 002085          479 NLARNELSGEIPKAIGSLLVMVSLDLSGNQFSG--EIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLA  544 (969)
Q Consensus       479 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~L~~l~ls~N~l~~~~p~~~~~~~  544 (969)
                      +|++|+++ .+|.   .+++|+.|++++|++++  .+|..++.       ++.|++.|.+|..+..+.
T Consensus       343 ~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~-------L~~n~~~~~i~~~~~~L~  399 (454)
T 1jl5_A          343 IASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED-------LRMNSHLAEVPELPQNLK  399 (454)
T ss_dssp             ECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE-------EECCC-------------
T ss_pred             ECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh-------hhhcccccccccccCcCC
Confidence            99999998 5777   47899999999999998  77877653       456888888887655544

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3.2e-42  Score=411.11  Aligned_cols=428  Identities=19%  Similarity=0.211  Sum_probs=350.8

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      .+++.|++++|.+++..|..|+++++|++|+|++|+|++..|+.|.++++|++|+|++|+|+ .+|..  .+++|++|+|
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L  128 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL  128 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence            57999999999999988889999999999999999999888999999999999999999999 67776  8999999999


Q ss_pred             CCCCCCC-cCCCcccCcccccceecccccccCcCCcccCCCCCc--ceeecccCCCCCCCCCCccccccC-CCcEEEccC
Q 002085          153 GGNNFSG-DIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNL--EVLGLAYNSNFKPAMIPIEFGMLK-KLKTLWMTE  228 (969)
Q Consensus       153 ~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~~~~~~~~p~~~~~l~-~L~~L~L~~  228 (969)
                      ++|++++ .+|..|+++++|++|+|++|++++.   .+..+++|  ++|++++|.+......|..+..+. +.-.+++++
T Consensus       129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~  205 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP  205 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECS
T ss_pred             CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecC
Confidence            9999996 3568999999999999999999864   45555555  999999998643567788887765 222568888


Q ss_pred             CcccccCch-hhcCCCchhhhhccCCc-----CCCCCCchhhcCcccchhhccCcccccCC----CCchhhccccccccc
Q 002085          229 ANLIGEIPE-AMSNLSSLEILALNGNH-----LEGAIPSGLFLLNNLTQLFLYDNILSGEI----PSSVEALKLTDIDLS  298 (969)
Q Consensus       229 n~l~~~~p~-~~~~l~~L~~L~L~~N~-----l~~~~p~~l~~l~~L~~L~L~~N~l~~~~----~~~~~~~~L~~L~Ls  298 (969)
                      |.+.+.+++ .+.++++|+.|++++|+     +.+ ....+..+++|+.|+++++.+++..    +......+|++|+++
T Consensus       206 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~  284 (562)
T 3a79_B          206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY  284 (562)
T ss_dssp             SSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEE
T ss_pred             ccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEe
Confidence            888887765 57788999999999985     222 2345677888888888888776432    122222379999999


Q ss_pred             CccccccCCccc-----cCcccchhhhhccccCcCcCCcc----------cccccccCcccccCCCCCCCCccCcEEEcc
Q 002085          299 MNNLTGSIPEEF-----GKLKNLQLLGLFSNHLSGEVPAS----------IGVVAFENNLSGAVPKSLGNCRTLRTVQLY  363 (969)
Q Consensus       299 ~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~  363 (969)
                      +|.++|.+|..+     ..++.|+.+++..|.+  .+|..          +..+.+.++-...++ ....+++|++|+++
T Consensus       285 ~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~l~  361 (562)
T 3a79_B          285 NLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV-CPPSPSSFTFLNFT  361 (562)
T ss_dssp             EEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC-CCSSCCCCCEEECC
T ss_pred             ccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc-CccCCCCceEEECC
Confidence            999998888877     7788888888888877  45521          233333333221111 12688999999999


Q ss_pred             cccccCCCCcccccccCCCccccCCCccccc--cCc--cccccccEEEeeccccCCCcc-cccCCcccchhhcccCCccc
Q 002085          364 SNRFSGELPTGLWTTFNLSSLMLSDNTISGE--LPS--KTAWNLTRLEISNNRFSGQIQ-RGVGSWKNLIVFKASNNLFS  438 (969)
Q Consensus       364 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~--~~~~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~  438 (969)
                      +|++++.+|..+..+++|+.|+|++|++++.  +|.  ...++|++|+|++|++++.+| ..+..+++|++|++++|+++
T Consensus       362 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~  441 (562)
T 3a79_B          362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT  441 (562)
T ss_dssp             SSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCC
T ss_pred             CCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCC
Confidence            9999999999999999999999999999963  232  344789999999999998444 56889999999999999999


Q ss_pred             cccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcc-cccccccceEeccCccccccCC
Q 002085          439 GEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKA-IGSLLVMVSLDLSGNQFSGEIP  514 (969)
Q Consensus       439 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~g~~p  514 (969)
                      +.+|..+.  ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|.. |..+++|+.|+|++|++++..|
T Consensus       442 ~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          442 GSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             GGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             cchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            88877664  79999999999999 78888889999999999999999 57766 9999999999999999998655

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-41  Score=376.91  Aligned_cols=283  Identities=40%  Similarity=0.689  Sum_probs=233.9

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ..++|+..+.||+|+||.||+|+.. +++.||||++.....  ......+.+|+++++.++||||+++++++.+++..++
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC--chHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            4578999999999999999999864 688999999865432  1122368999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++|+|.+++......         ...++|..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||
T Consensus       105 v~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPES---------QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTT---------CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EEEeccCCCHHHHHHhcccc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            99999999999999875431         245899999999999999999999876779999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCC-----CCCccchHHHHHH
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-----GDEHTSLAEWAWR  868 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~-----~~~~~~~~~~~~~  868 (969)
                      +|||+++..... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.     .........++. 
T Consensus       176 ~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  253 (326)
T 3uim_A          176 GDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-  253 (326)
T ss_dssp             CCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-
T ss_pred             ccCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-
Confidence            999999876433 2333445569999999999999999999999999999999999999995     223333444432 


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCC
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENY  930 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  930 (969)
                      ............+.........+.+..+.+++.+||+.||++|||+.|++++|++....+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~  315 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW  315 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence            23334445566666666677888889999999999999999999999999999987765544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.1e-41  Score=367.09  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=211.7

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      +..++|+..+.||+|+||+||+|.+..+++.||||++......   ..+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence            3457899999999999999999999999999999998654322   2466889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++|+|.+++...              .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        94 lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~k  156 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK  156 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred             EEEECCCCCCHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEE
Confidence            999999999999999753              378899999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      |+|||+++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+......
T Consensus       157 l~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  234 (297)
T 3fxz_A          157 LTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP  234 (297)
T ss_dssp             ECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC
T ss_pred             EeeCCCceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            99999998764322  2334567999999999999999999999999999999999999999876543322222111110


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                  ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 ------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                        01112233467889999999999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.9e-41  Score=373.13  Aligned_cols=276  Identities=37%  Similarity=0.569  Sum_probs=229.1

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ...++|+..+.||+|+||.||+|++. +++.||||++....   ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            35678999999999999999999975 68899999885432   233567999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++|+|.+++.....         ....++|..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       112 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDL---------PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCC---------CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEE
T ss_pred             EEEEcCCCCcHHHHHhccCC---------CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEE
Confidence            99999999999999976432         123589999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc---chHHHHHHH
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT---SLAEWAWRH  869 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~---~~~~~~~~~  869 (969)
                      |+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.+....   ....|....
T Consensus       180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  259 (321)
T 2qkw_B          180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES  259 (321)
T ss_dssp             ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred             EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence            99999998754433333344556899999999999999999999999999999999999999765433   223332222


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                       .....+...+++........+.+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       260 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          260 -HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             -HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence             2222344455555555667788899999999999999999999999999998875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.6e-41  Score=373.06  Aligned_cols=252  Identities=25%  Similarity=0.348  Sum_probs=213.8

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ....+|+..+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..|
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            346789999999999999999999999999999999966433 3445678899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        91 lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~k  154 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHG-------------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIK  154 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             EEEECCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEE
Confidence            9999999999999997654             388999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |+|||+++.+...   .......||+.|+|||++.+..++ .++||||+||++|||++|+.||.+.+.......+...  
T Consensus       155 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--  229 (328)
T 3fe3_A          155 IADFGFSNEFTVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--  229 (328)
T ss_dssp             ECSTTCCGGGSSS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--
T ss_pred             EeeccCceecCCC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Confidence            9999999866432   234456799999999999988875 7899999999999999999999876654443332211  


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       ...            .+...+..+.+++.+||+.||++|||+.|+++
T Consensus       230 -~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          230 -KYR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -CCC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -CCC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             110            11122367889999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.6e-41  Score=375.60  Aligned_cols=252  Identities=24%  Similarity=0.330  Sum_probs=212.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|+...+|+.||+|++++...........+.+|+++++.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            45788999999999999999999999999999999765433333456788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||+|.+++....             .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        84 ~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~  147 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-------------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EeCCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEe
Confidence            99999999999997643             388999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+++.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+..   ...
T Consensus       148 DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---~~~  222 (337)
T 1o6l_A          148 DFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---EEI  222 (337)
T ss_dssp             CCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCC
T ss_pred             eccchhhcccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc---CCC
Confidence            99999864322  2233456799999999999999999999999999999999999999987654433332211   111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                      .            .+...+..+.+++.+||+.||++||     ++.|+++
T Consensus       223 ~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 R------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             C------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            1            1122346789999999999999999     8999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-41  Score=379.88  Aligned_cols=272  Identities=24%  Similarity=0.353  Sum_probs=219.6

Q ss_pred             ccCCCccceeeecCcEEEEEEEEc-------CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDIN-------GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCIS  706 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  706 (969)
                      .++|+..+.||+|+||.||+|++.       .++..||||+++...  .....+.+.+|+++++++ +||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            357889999999999999999874       345689999986542  345567899999999999 8999999999999


Q ss_pred             cCCceEEEEeeccCCCHHHHhccCcCccccCC---CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcE
Q 002085          707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI  783 (969)
Q Consensus       707 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Ni  783 (969)
                      +++..|+||||+++|+|.+++...........   .......+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence            99999999999999999999987643110000   011124589999999999999999999998   999999999999


Q ss_pred             EECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccch
Q 002085          784 LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSL  862 (969)
Q Consensus       784 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~  862 (969)
                      +++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.....+
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999999999999987655433334445567899999999999999999999999999999999 8888877655544


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ...+...              .....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       315 ~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          315 FKLLKEG--------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             HHHHHTT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcC--------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            3332211              111122234467899999999999999999999999998874

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.1e-42  Score=387.50  Aligned_cols=256  Identities=21%  Similarity=0.260  Sum_probs=210.6

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||.||+|++..+++.||+|++.+.........+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            46899999999999999999999999999999999654322222234588999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||+|.++++..              .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       148 ~E~~~gg~L~~~l~~~--------------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~  210 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSNY--------------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA  210 (410)
T ss_dssp             ECCCTTEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EeCCCCCcHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEe
Confidence            9999999999999753              278899999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCC----CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK----VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |||+++.....+ ........||+.|+|||++.+..    ++.++||||+||++|||++|+.||.+.+.......+....
T Consensus       211 DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  289 (410)
T 3v8s_A          211 DFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK  289 (410)
T ss_dssp             CCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             ccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence            999998764321 22234567999999999998765    7889999999999999999999998876555444332211


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS--RPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~  919 (969)
                      ..           ...+.....+..+.+++.+|+..+|.+  ||++.||++
T Consensus       290 ~~-----------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          290 NS-----------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HH-----------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             cc-----------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            00           000111122367889999999999988  999999886

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.6e-41  Score=367.07  Aligned_cols=266  Identities=27%  Similarity=0.383  Sum_probs=216.1

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +.++|+..+.||+|+||.||+|++..+++.||+|++...........+.+.+|++++++++||||+++++++.+++..|+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            34679999999999999999999999999999999876655566667889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++++|.+++....             .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        89 v~e~~~g~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl  152 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHG-------------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKI  152 (294)
T ss_dssp             EEECCCSCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEeCCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence            999999999999997643             389999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+++..... .........||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.......   .......
T Consensus       153 ~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~---~~~~~~~  228 (294)
T 4eqm_A          153 FDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA---IKHIQDS  228 (294)
T ss_dssp             CCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH---HHHHSSC
T ss_pred             EeCCCccccccc-cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHhhcc
Confidence            999999865432 122233456999999999999999999999999999999999999999776543221   1111111


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcCC
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-SMKEVLQILRRCCP  926 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~  926 (969)
                      .+..   ..    ......+..+.+++.+||+.||++|| ++.++.+.|+++..
T Consensus       229 ~~~~---~~----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          229 VPNV---TT----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             CCCH---HH----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             CCCc---ch----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            1100   00    01112336789999999999999998 99999999998864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=379.79  Aligned_cols=247  Identities=22%  Similarity=0.317  Sum_probs=205.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      .++|+..++||+|+||.||+|++..+++.||||+++..........+.+.+|.++++.+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            56899999999999999999999999999999999765443444457788999999988 79999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||++||+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       102 v~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL  165 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-------------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKL  165 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEeCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEE
Confidence            999999999999998654             389999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+++....  .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...+...+..   ..
T Consensus       166 ~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~~  240 (353)
T 3txo_A          166 ADFGMCKEGIC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN---DE  240 (353)
T ss_dssp             CCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CC
T ss_pred             ccccceeeccc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc---CC
Confidence            99999975422  22233456799999999999998999999999999999999999999987765544433322   11


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                      ..            .+...+..+.+++.+|++.||++||++
T Consensus       241 ~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          241 VV------------YPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             CC------------CCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CC------------CCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence            10            111233678899999999999999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.1e-41  Score=378.25  Aligned_cols=251  Identities=20%  Similarity=0.281  Sum_probs=205.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      .++|+..++||+|+||.||+|+...+++.||+|++++.........+.+.+|..++.++ +||||+++++++.+++..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            46799999999999999999999999999999999776554455556788999999887 89999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++|+|.+++....             .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       131 V~E~~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL  194 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-------------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL  194 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEcCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEE
Confidence            999999999999998654             389999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc-----chHHHHHH
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT-----SLAEWAWR  868 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~-----~~~~~~~~  868 (969)
                      +|||+++....  .........||+.|+|||++.+..++.++||||+||++|||++|+.||......     .....+..
T Consensus       195 ~DFGla~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~  272 (396)
T 4dc2_A          195 TDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  272 (396)
T ss_dssp             CCCTTCBCCCC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH
T ss_pred             eecceeeeccc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH
Confidence            99999985322  222344568999999999999999999999999999999999999999753221     11111222


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                      ......         .  ..+...+..+.+++.+||+.||++||++
T Consensus       273 ~i~~~~---------~--~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          273 VILEKQ---------I--RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHCC---------C--CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHhccc---------c--CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            111111         1  1122234678899999999999999996

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-41  Score=375.60  Aligned_cols=248  Identities=23%  Similarity=0.345  Sum_probs=208.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      .++|+..+.||+|+||.||+|++..+|+.||+|+++..........+.+..|.+++..+ +||||+++++++.+.+..|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            56899999999999999999999999999999999765433333456788899999887 89999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||++||+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        96 v~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL  159 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCH-------------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI  159 (345)
T ss_dssp             EEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEeCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEE
Confidence            999999999999998643             388999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+++.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+..   ..
T Consensus       160 ~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---~~  234 (345)
T 1xjd_A          160 ADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM---DN  234 (345)
T ss_dssp             CCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CC
T ss_pred             eEChhhhhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh---CC
Confidence            999999754322  1223456799999999999999999999999999999999999999987665444333221   11


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK  915 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~  915 (969)
                      ..            .+...+..+.+++.+||+.||++||++.
T Consensus       235 ~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~  264 (345)
T 1xjd_A          235 PF------------YPRWLEKEAKDLLVKLFVREPEKRLGVR  264 (345)
T ss_dssp             CC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred             CC------------CCcccCHHHHHHHHHHhcCCHhHcCCCh
Confidence            10            1112236788999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=365.09  Aligned_cols=260  Identities=23%  Similarity=0.429  Sum_probs=212.3

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||+||+|.+..+++.||+|++...   +....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            5788899999999999999999999999999988442   3455678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....            ..++|..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        87 e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D  151 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMD------------SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVAD  151 (310)
T ss_dssp             ECCTTCBHHHHHHHCC------------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECC
T ss_pred             EecCCCcHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEee
Confidence            9999999999998643            2489999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCc------------cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          796 FGLAKMLAKQGEPH------------TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       796 fgla~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                      ||+++.+.......            ......||+.|+|||++.+..++.++|||||||++|||++|..|+.........
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~  231 (310)
T 3s95_A          152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD  231 (310)
T ss_dssp             CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred             cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence            99998764432211            111457999999999999999999999999999999999999988653221110


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .        ........+...    +...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       232 ~--------~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          232 F--------GLNVRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             S--------SBCHHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H--------hhhhhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0        000111111111    1122356889999999999999999999999998885

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.7e-41  Score=374.15  Aligned_cols=259  Identities=20%  Similarity=0.259  Sum_probs=213.9

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH---HHHHHHHHHHHHHhccccCceeeEEEEEEc
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ---KLEKEFIAEIEILGTIRHANIVKLWCCISS  707 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  707 (969)
                      ...+.+.|+..+.||+|+||.||+|++..+|+.||+|+++.......   ...+.+.+|++++++++||||+++++++.+
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            34566789999999999999999999999999999999976433211   124678999999999999999999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      +...|+||||++||+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~  150 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKE-------------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLD  150 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCS-------------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeC
Confidence            999999999999999999997543             388999999999999999999998   9999999999999988


Q ss_pred             CC----cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          788 EF----KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       788 ~~----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                      ++    .+||+|||+++.+...   .......||+.|+|||++.+..++.++||||+||++|||++|..||.+.......
T Consensus       151 ~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~  227 (361)
T 2yab_A          151 KNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL  227 (361)
T ss_dssp             TTSSSCCEEECCCSSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             CCCCccCEEEEecCCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            77    7999999999876432   2234567999999999999999999999999999999999999999876554433


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..+..   ......        ...+...+..+.+++.+||..||++|||+.|+++
T Consensus       228 ~~i~~---~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          228 ANITA---VSYDFD--------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHT---TCCCCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHh---cCCCCC--------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            32211   111100        0111122467889999999999999999999985

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-41  Score=384.37  Aligned_cols=259  Identities=26%  Similarity=0.357  Sum_probs=214.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|++..+++.||||+++..  ......+.+.+|++++++++||||+++++++.+++..++||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            5788899999999999999999988999999998643  23444567999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.++++...            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       192 e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~D  256 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEG------------ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISD  256 (377)
T ss_dssp             ECCTTCBHHHHHHHHG------------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             EcCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECc
Confidence            9999999999998643            2488999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.    .  
T Consensus       257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~----~--  330 (377)
T 3cbl_A          257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----K--  330 (377)
T ss_dssp             GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH----T--
T ss_pred             CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----c--
Confidence            999986532211111122345778999999999999999999999999999998 888887655433322221    1  


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                              +...+.+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       331 --------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          331 --------GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                    1111223334467899999999999999999999999998874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.7e-41  Score=367.84  Aligned_cols=260  Identities=30%  Similarity=0.422  Sum_probs=207.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      ..+|++.+.||+|+||.||+|++  +|+.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            46788999999999999999987  588899999865432 344567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCC--eEecCCCCCcEEECCCCcEE
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQ--IIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~k  792 (969)
                      |||+++|+|.+++.....          ...+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+|
T Consensus       113 ~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~k  179 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGA----------REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVK  179 (309)
T ss_dssp             EECCTTCBHHHHHHSTTH----------HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEE
T ss_pred             EecCCCCcHHHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEE
Confidence            999999999999986432          13488999999999999999999988   7  99999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      |+|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..   .
T Consensus       180 L~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~---~  254 (309)
T 3p86_A          180 VCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF---K  254 (309)
T ss_dssp             ECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH---S
T ss_pred             ECCCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---c
Confidence            9999999754321  2223446799999999999999999999999999999999999999987654433222211   1


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..          ....+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       255 ~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          255 CK----------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             CC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            00          11112233467899999999999999999999999998885

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.7e-41  Score=373.74  Aligned_cols=251  Identities=21%  Similarity=0.282  Sum_probs=207.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      .++|+..+.||+|+||.||+|++..+++.||+|++...........+.+.+|+++++++ +||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            45789999999999999999999999999999999776555556677899999999988 89999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        88 v~e~~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL  151 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-------------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL  151 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEeCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEE
Confidence            999999999999997643             388999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc-----chHHHHHH
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT-----SLAEWAWR  868 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~-----~~~~~~~~  868 (969)
                      +|||+++.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||......     .....+..
T Consensus       152 ~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  229 (345)
T 3a8x_A          152 TDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  229 (345)
T ss_dssp             CCGGGCBCSCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH
T ss_pred             EeccccccccCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH
Confidence            999999864322  22334567999999999999999999999999999999999999999753211     11111212


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                      ......         .  ..+...+..+.+++.+||+.||++||++
T Consensus       230 ~i~~~~---------~--~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          230 VILEKQ---------I--RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHHCC---------C--CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HHHcCC---------C--CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            111111         1  1122234678899999999999999996

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.6e-41  Score=371.58  Aligned_cols=261  Identities=25%  Similarity=0.410  Sum_probs=214.4

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCc---EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ..++|++.+.||+|+||.||+|++..+++   .||||+++...  .....+.+.+|++++++++||||+++++++.+++.
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            35678999999999999999999975544   59999996432  34456789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||+++|+|.++++...            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~  189 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHD------------GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLV  189 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT------------TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             cEEEeeCCCCCcHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCC
Confidence            999999999999999997543            2489999999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCC-ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  868 (969)
                      +||+|||+++.+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus       190 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  269 (325)
T 3kul_A          190 CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE  269 (325)
T ss_dssp             EEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence            999999999876543222 22334456889999999999999999999999999999999 9999877655443332211


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .              ...+.+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       270 ~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          270 G--------------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             T--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C--------------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1              111222334478899999999999999999999999999885

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=366.04  Aligned_cols=249  Identities=25%  Similarity=0.338  Sum_probs=209.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|+...+|+.||+|+++..........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            46789999999999999999999999999999999664433333456788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        85 ~e~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  148 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-------------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT  148 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-------------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             EeCCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEe
Confidence            99999999999998644             388999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+++....     ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+..   ...
T Consensus       149 Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~  220 (318)
T 1fot_A          149 DFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---AEL  220 (318)
T ss_dssp             CCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---CCC
T ss_pred             ecCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCC
Confidence            9999987532     22345799999999999999999999999999999999999999987654433322211   111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                      .            .+...+..+.+++.+|++.||++||     ++.|+++
T Consensus       221 ~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 R------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             C------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             C------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            1            1112236788999999999999999     7777764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=369.39  Aligned_cols=254  Identities=23%  Similarity=0.327  Sum_probs=212.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++..+++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            56899999999999999999999999999999999765433444457889999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        94 ~e~~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~  157 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV-------------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHIT  157 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EecCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEe
Confidence            99999999999998643             388999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT---TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |||+++.+...   .......||+.|+|||++.+   ..++.++||||+||++|||++|+.||.................
T Consensus       158 DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~  234 (384)
T 4fr4_A          158 DFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET  234 (384)
T ss_dssp             CCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH
T ss_pred             ccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh
Confidence            99999876432   23345679999999999874   4589999999999999999999999986655444333222211


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-MKEVLQ  919 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~  919 (969)
                      ...            ..+...+..+.+++.+||+.||++||+ +.++.+
T Consensus       235 ~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 TVV------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ccc------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            111            112223467899999999999999998 666654

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.2e-40  Score=400.79  Aligned_cols=437  Identities=21%  Similarity=0.180  Sum_probs=344.2

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN  179 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  179 (969)
                      .+.+-++.+++ .+|..+.  +++++|||++|+|++..|.+|.++++|++|||++|+|++..|.+|.+|++|++|+|++|
T Consensus        34 ~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N  110 (635)
T 4g8a_A           34 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN  110 (635)
T ss_dssp             TEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             CEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCC
Confidence            45677787888 7786553  57999999999999877889999999999999999999888889999999999999999


Q ss_pred             cccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccc-cCchhhcCCCchhhhhccCCcCCCC
Q 002085          180 EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIG-EIPEAMSNLSSLEILALNGNHLEGA  258 (969)
Q Consensus       180 ~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~  258 (969)
                      +|++..+..|.++++|++|+|++|++.  ...+..|+++++|++|+|++|.+.+ .+|..++++++|++|+|++|++++.
T Consensus       111 ~l~~l~~~~f~~L~~L~~L~Ls~N~l~--~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~  188 (635)
T 4g8a_A          111 PIQSLALGAFSGLSSLQKLVAVETNLA--SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI  188 (635)
T ss_dssp             CCCEECGGGGTTCTTCCEEECTTSCCC--CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred             cCCCCCHHHhcCCCCCCEEECCCCcCC--CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccc
Confidence            999888889999999999999999743  4455679999999999999999976 4688999999999999999999988


Q ss_pred             CCchhhcCcccc----hhhccCcccccCCCCchhhcccccccccCccccccC-CccccCcc-------------------
Q 002085          259 IPSGLFLLNNLT----QLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSI-PEEFGKLK-------------------  314 (969)
Q Consensus       259 ~p~~l~~l~~L~----~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~-------------------  314 (969)
                      .+..+..+.+++    .++++.|.++...+..+....+..+++++|..+..+ +..+..+.                   
T Consensus       189 ~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~  268 (635)
T 4g8a_A          189 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE  268 (635)
T ss_dssp             CGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred             ccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccc
Confidence            888888776654    577899999988887777777777777777543211 11122222                   


Q ss_pred             --------------------------------------cchhhhhccccCcCcCC----cccccccccCcccccCCCCCC
Q 002085          315 --------------------------------------NLQLLGLFSNHLSGEVP----ASIGVVAFENNLSGAVPKSLG  352 (969)
Q Consensus       315 --------------------------------------~L~~L~L~~N~l~~~~p----~~~~~l~~~n~l~~~~p~~l~  352 (969)
                                                            +++.+++.+|.+....+    ..+..+...++-.+.++.  .
T Consensus       269 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--~  346 (635)
T 4g8a_A          269 KFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT--L  346 (635)
T ss_dssp             CCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCC--C
T ss_pred             cccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCc--c
Confidence                                                  22222222222221100    011112222222222222  3


Q ss_pred             CCccCcEEEcccccccCCCCcccccccCCCccccCCCcccccc--Ccc--ccccccEEEeeccccCCCcccccCCcccch
Q 002085          353 NCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGEL--PSK--TAWNLTRLEISNNRFSGQIQRGVGSWKNLI  428 (969)
Q Consensus       353 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~--~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  428 (969)
                      .+..|+.++++.|.+....  ....+++|+.|++++|.+....  +..  ...+|+.|+++.|.+.. .+..+..+++|+
T Consensus       347 ~l~~L~~l~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~  423 (635)
T 4g8a_A          347 KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLE  423 (635)
T ss_dssp             BCTTCCEEEEESCCSCCBC--CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCC
T ss_pred             cchhhhhcccccccCCCCc--ccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-cccccccccccc
Confidence            5678999999999987433  3457899999999999987432  222  23589999999999885 456788899999


Q ss_pred             hhcccCCccccccC-ccccCccccchhhccCcccCCCCCcccccccCCCEEEccCcccc-CCCCcccccccccceEeccC
Q 002085          429 VFKASNNLFSGEIP-VELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELS-GEIPKAIGSLLVMVSLDLSG  506 (969)
Q Consensus       429 ~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~  506 (969)
                      .++++.|.+....+ ..|..+.+|+.+++++|++++..|..+..+++|+.|+|++|++. +.+|..|..+++|+.|||++
T Consensus       424 ~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~  503 (635)
T 4g8a_A          424 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ  503 (635)
T ss_dssp             EEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred             chhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCC
Confidence            99999998876544 56788999999999999999989999999999999999999854 45789999999999999999


Q ss_pred             ccccccCCCcccccc-ccEEEeecCcCCCCCCccccccccc
Q 002085          507 NQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIPDEFNNLAYD  546 (969)
Q Consensus       507 N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p~~~~~~~~~  546 (969)
                      |+|++..|..++.++ |++|+|++|+|++..|..|..+...
T Consensus       504 N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L  544 (635)
T 4g8a_A          504 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL  544 (635)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTC
T ss_pred             CccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCC
Confidence            999998899999995 9999999999999888777766543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.7e-40  Score=360.39  Aligned_cols=271  Identities=36%  Similarity=0.525  Sum_probs=221.6

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccch-hcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEe
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-LNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      |...++||+|+||.||+|..  +++.||||++..... ......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            33448999999999999987  578999999865432 223446789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      |+++++|.+++.....          ...++|..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       111 ~~~~~~L~~~l~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df  177 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDG----------TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDF  177 (307)
T ss_dssp             CCTTCBHHHHHHTGGG----------CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCCcHHHHHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence            9999999999975432          23589999999999999999999998   9999999999999999999999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh-hccCC
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY-AEEKP  875 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~  875 (969)
                      |+++...............||+.|+|||.+.+ .++.++||||||+++|||++|..||...........+.... .....
T Consensus       178 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  256 (307)
T 2nru_A          178 GLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT  256 (307)
T ss_dssp             TTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC
T ss_pred             ccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh
Confidence            99987654333333445679999999998865 58999999999999999999999998765444333333322 23333


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      +.+.++... ...+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       257 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          257 IEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             hhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            444444443 3345677789999999999999999999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-40  Score=368.06  Aligned_cols=257  Identities=24%  Similarity=0.309  Sum_probs=210.2

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            56789999999999999999999999999999999864432  2234678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        83 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl  146 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDI-------------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI  146 (323)
T ss_dssp             EEECCTTEEGGGGSBTTT-------------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEcCCCCcHHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEE
Confidence            999999999999997543             389999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||+++.+.............||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+.   .
T Consensus       147 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---~  223 (323)
T 3tki_A          147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---E  223 (323)
T ss_dssp             CCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH---T
T ss_pred             EEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---c
Confidence            99999987654433334456689999999999988776 7789999999999999999999976554322221111   1


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ..         .........+..+.+++.+||+.||++|||+.|+++.
T Consensus       224 ~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          224 KK---------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TC---------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cc---------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            11         0111112234678899999999999999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.8e-41  Score=371.98  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=207.9

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKL  712 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  712 (969)
                      ..++|+..+.||+|+||.||+|++..+++.||+|+++..........+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            356899999999999999999999988999999999765433334456788999999988 7999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||++||+|.+++....             .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        98 lv~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vk  161 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-------------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK  161 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEeCCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEE
Confidence            9999999999999998643             388999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      |+|||+++.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...+.+.+..   .
T Consensus       162 L~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~  236 (353)
T 2i0e_A          162 IADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---H  236 (353)
T ss_dssp             ECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---C
T ss_pred             EEeCCcccccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh---C
Confidence            9999999854322  2233456799999999999999999999999999999999999999987665444333321   1


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                      ...            .+...+..+.+++.+||+.||++||++
T Consensus       237 ~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          237 NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             CCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            111            112234678999999999999999964

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7e-41  Score=372.87  Aligned_cols=249  Identities=20%  Similarity=0.267  Sum_probs=211.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            46899999999999999999999999999999999665433333456789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       120 ~e~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  183 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-------------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVT  183 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EcCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEc
Confidence            99999999999998643             388999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+++.....     .....||+.|+|||++.+..++.++||||+||++|||++|..||.+.........+..   ...
T Consensus       184 DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---~~~  255 (350)
T 1rdq_E          184 DFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---GKV  255 (350)
T ss_dssp             CCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCC
T ss_pred             ccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc---CCC
Confidence            99999876321     2345799999999999999999999999999999999999999987655443332221   111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-----MKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~  919 (969)
                      .            .+...+..+.+++.+||+.||++||+     +.|+++
T Consensus       256 ~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 R------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            0            11223467899999999999999998     777764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.7e-41  Score=377.55  Aligned_cols=261  Identities=25%  Similarity=0.415  Sum_probs=204.1

Q ss_pred             hccCCCccceeeecCcEEEEEEEEc---CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ..++|+..+.||+|+||.||+|++.   .++..||||+++...  .....+.+.+|++++++++||||+++++++.+.+.
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            3568999999999999999999886   457789999986432  34556789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||+++|+|.++++...            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  185 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHD------------AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLV  185 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT------------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred             eEEEEeCCCCCcHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCC
Confidence            999999999999999998643            2489999999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCC-ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  868 (969)
                      +||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...........+..
T Consensus       186 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~  265 (373)
T 2qol_A          186 CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE  265 (373)
T ss_dssp             EEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT
T ss_pred             EEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999876443221 12223346788999999999999999999999999999998 9999877654433332211


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .              ...+.+...+..+.+++.+||+.||++||++.|++++|+++.
T Consensus       266 ~--------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          266 G--------------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             T--------------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C--------------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence            1              111122234467899999999999999999999999998874

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.9e-41  Score=383.47  Aligned_cols=259  Identities=19%  Similarity=0.222  Sum_probs=211.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+++..|+|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            46899999999999999999999999999999999654332222234588999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||+|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       153 ~Ey~~gg~L~~~l~~~~------------~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFE------------DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             ECCCTTCBHHHHHHTTT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EecCCCCcHHHHHHHcc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEc
Confidence            99999999999998643            2489999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      |||+|+..... .........||+.|+|||++.     ...++.++||||+||++|||++|+.||.+.+..+....+...
T Consensus       218 DFGla~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~  296 (437)
T 4aw2_A          218 DFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  296 (437)
T ss_dssp             CCTTCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             chhhhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence            99999876432 222334467999999999987     567899999999999999999999999887655444433221


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSS--RPSMKEVLQ  919 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~evl~  919 (969)
                      ... ...     +    ......+..+.+++.+|+..+|++  ||++.|+++
T Consensus       297 ~~~-~~~-----p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          297 KER-FQF-----P----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHH-CCC-----C----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ccc-ccC-----C----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            100 000     0    001123367889999999998888  999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-40  Score=367.49  Aligned_cols=254  Identities=19%  Similarity=0.255  Sum_probs=212.0

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++.++|+..+.||+|+||.||+|.+..+++.||+|++...    ......+.+|+++++.++||||+++++++.+.+..+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   77 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence            3567899999999999999999999999999999998543    233467889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC--CCc
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS--EFK  790 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~  790 (969)
                      +||||+++|+|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.  ++.
T Consensus        78 lv~e~~~g~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~  142 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSA------------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSST  142 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCC
T ss_pred             EEEEeCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCC
Confidence            9999999999999997543            2488999999999999999999998   9999999999999997  789


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      +||+|||+++.+...   .......||+.|+|||++.+..++.++||||+||++|||++|..||.+.........+..  
T Consensus       143 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--  217 (321)
T 1tki_A          143 IKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN--  217 (321)
T ss_dssp             EEECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--
T ss_pred             EEEEECCCCeECCCC---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHc--
Confidence            999999999876432   233446789999999999988899999999999999999999999987655443332221  


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       .......        ......+..+.+++.+||..||++|||+.|+++
T Consensus       218 -~~~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          218 -AEYTFDE--------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -TCCCCCH--------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCCCCCh--------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1111110        011122467899999999999999999999997

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.4e-40  Score=367.44  Aligned_cols=270  Identities=26%  Similarity=0.324  Sum_probs=208.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc----
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS----  710 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  710 (969)
                      .++|+..++||+|+||.||+|++.  ++.||||++....    .......+|+.++++++||||+++++++.+...    
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            357999999999999999999885  7899999985432    223456679999999999999999999987543    


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhccc-------CCCCeEecCCCCCcE
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD-------CTPQIIHRDVKSSNI  783 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------~~~~ivH~Dlkp~Ni  783 (969)
                      .++||||+++|+|.++++..              .++|..++.++.|++.||+|||+.       .+++|+||||||+||
T Consensus        97 ~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Ni  162 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKAN--------------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV  162 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGE
T ss_pred             EEEEEecCCCCCHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhE
Confidence            69999999999999999753              388999999999999999999965       134899999999999


Q ss_pred             EECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002085          784 LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-----KVNEKIDIYSFGVVLLELVTGKEANYGDE  858 (969)
Q Consensus       784 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~elltg~~p~~~~~  858 (969)
                      +++.++.+||+|||+++.+.............||+.|+|||++.+.     .++.++|||||||++|||++|+.||.+..
T Consensus       163 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             EECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             EECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999999877654444444556799999999998873     45668899999999999999999997653


Q ss_pred             ccchHHHHHHHhhccCCch---hhh-----ccCCCC-cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          859 HTSLAEWAWRHYAEEKPIT---DAL-----DKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~---~~~-----~~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ......+... ........   +..     .+.... ......+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       243 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          243 DEYMLPFEEE-IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             CCCCCTTHHH-HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhccchhhh-hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            3211111100 00000000   000     011111 112345677999999999999999999999999998874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=367.73  Aligned_cols=258  Identities=22%  Similarity=0.290  Sum_probs=212.8

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH---HHHHHHHHHHHHHhccccCceeeEEEEEEcC
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ---KLEKEFIAEIEILGTIRHANIVKLWCCISSE  708 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  708 (969)
                      .++.+.|+..+.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|++++++++||||+++++++.++
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4456779999999999999999999999999999999865432211   1246789999999999999999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      ...++||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~  150 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKE-------------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR  150 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSS-------------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCS
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC-------------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecC
Confidence            99999999999999999997543             388999999999999999999998   99999999999999988


Q ss_pred             C----cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          789 F----KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       789 ~----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                      +    .+||+|||+++.+...   .......||+.|+|||++.+..++.++||||+||++|||++|..||.+........
T Consensus       151 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  227 (326)
T 2y0a_A          151 NVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  227 (326)
T ss_dssp             SSSSCCEEECCCTTCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             CCCCCCEEEEECCCCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence            7    7999999999876432   22334679999999999999999999999999999999999999998765443332


Q ss_pred             HHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+...   ......        ......+..+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~---~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          228 NVSAV---NYEFED--------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHT---CCCCCH--------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhc---CCCcCc--------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22111   111110        111122367889999999999999999999987

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=378.80  Aligned_cols=258  Identities=21%  Similarity=0.270  Sum_probs=214.2

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ..+.++|+..+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+++..
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            4566789999999999999999999999999999999865443 334467899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC---CC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD---SE  788 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~  788 (969)
                      |+||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++   .+
T Consensus        86 ~lv~E~~~gg~L~~~i~~~~-------------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~  149 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVARE-------------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKG  149 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHCS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTT
T ss_pred             EEEEEeCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCC
Confidence            99999999999999998654             388999999999999999999998   999999999999998   45


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +.+||+|||+++.....  ........||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.......+..
T Consensus       150 ~~vkL~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  227 (444)
T 3soa_A          150 AAVKLADFGLAIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA  227 (444)
T ss_dssp             CCEEECCCSSCBCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CcEEEccCceeEEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence            78999999999866432  2233456799999999999999999999999999999999999999987765444433322


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....           ...+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~-----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          228 GAYD-----------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TCCC-----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCC-----------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1110           011111223467899999999999999999999987

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.3e-40  Score=371.05  Aligned_cols=257  Identities=22%  Similarity=0.297  Sum_probs=213.7

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      .+.++|+..+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|++++++++||||+++++++.+++..|
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            345689999999999999999999999999999999965433 3444578999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC---
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF---  789 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---  789 (969)
                      +||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++   
T Consensus       105 lv~e~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~  168 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVARE-------------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA  168 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTC
T ss_pred             EEEecCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence            9999999999999997543             388999999999999999999998   999999999999998654   


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      .+||+|||+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.......+...
T Consensus       169 ~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~  245 (362)
T 2bdw_A          169 AVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG  245 (362)
T ss_dssp             CEEECCCTTCBCCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             CEEEeecCcceEecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence            5999999999876432   2234467999999999999999999999999999999999999999876654443333221


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ..   .        ...+.....+..+.+++.+||+.||++||++.|+++.
T Consensus       246 ~~---~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          246 AY---D--------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CC---C--------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CC---C--------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            10   0        0111122334678999999999999999999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=359.88  Aligned_cols=273  Identities=20%  Similarity=0.235  Sum_probs=216.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC--ceE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN--SKL  712 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  712 (969)
                      -++|+..++||+|+||+||+|++..+++.||||++......  ...+.+.+|++++++++||||+++++++.+..  ..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            35789999999999999999999999999999999654322  22467789999999999999999999998755  779


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE----CCC
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL----DSE  788 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~  788 (969)
                      +||||+++++|.+++.....          ...+++..++.++.|++.||+|||+.   +|+||||||+||++    +.+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~  152 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSN----------AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQ  152 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGG----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSC
T ss_pred             EEEeCCCCCCHHHHHHHhcc----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCC
Confidence            99999999999999986543          13389999999999999999999998   99999999999999    788


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcc--------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY--------TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT  860 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslG~il~elltg~~p~~~~~~~  860 (969)
                      +.+||+|||+++.+...   .......||+.|+|||++.        +..++.++|||||||++|||++|+.||......
T Consensus       153 ~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  229 (319)
T 4euu_A          153 SVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP  229 (319)
T ss_dssp             EEEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred             ceEEEccCCCceecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence            88999999999876432   2233457999999999886        578899999999999999999999999754432


Q ss_pred             chHHHHHHHhhccCCch--hhh------------ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          861 SLAEWAWRHYAEEKPIT--DAL------------DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       861 ~~~~~~~~~~~~~~~~~--~~~------------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..............+..  ...            ...............+.+++.+||+.||++|||++|+++......
T Consensus       230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            22222222222111100  000            001112334667788999999999999999999999999887664

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.9e-40  Score=381.22  Aligned_cols=362  Identities=19%  Similarity=0.178  Sum_probs=267.9

Q ss_pred             CCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccC
Q 002085           88 KIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGR  167 (969)
Q Consensus        88 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  167 (969)
                      ..+..++++++|++|+|++|.+++. | .+..+++|++|+|++|++++. |  ++.+++|++|+|++|++++. |  +++
T Consensus        33 ~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~  104 (457)
T 3bz5_A           33 TDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTP  104 (457)
T ss_dssp             TSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred             ccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCC
Confidence            3344566777777777777777753 4 577777777777777777753 3  77777777777777777753 3  777


Q ss_pred             cccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhh
Q 002085          168 LSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEI  247 (969)
Q Consensus       168 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  247 (969)
                      +++|++|+|++|++++ +|  ++.+++|++|++++|++..   +  .++.+++|++|++++|+..+.+  .+..+++|++
T Consensus       105 l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~---l--~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~  174 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE---I--DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTT  174 (457)
T ss_dssp             CTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC---C--CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCE
T ss_pred             CCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce---e--ccccCCcCCEEECCCCCccccc--ccccCCcCCE
Confidence            7777777777777775 33  7777777777777776443   2  2677777777777777666666  3777788888


Q ss_pred             hhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccC
Q 002085          248 LALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL  326 (969)
Q Consensus       248 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  326 (969)
                      |++++|++++ +|  +..+++|+.|++++|++++. +  +... +|+.|++++|++++ +|  ++.+++|+.|++++|++
T Consensus       175 L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l  245 (457)
T 3bz5_A          175 LDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPL  245 (457)
T ss_dssp             EECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCC
T ss_pred             EECCCCccce-ec--cccCCCCCEEECcCCcCCee-c--cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcC
Confidence            8888888886 34  67778888888888888764 1  3333 67888888888886 45  77788888888888888


Q ss_pred             cCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEE
Q 002085          327 SGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRL  406 (969)
Q Consensus       327 ~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L  406 (969)
                      ++.                  |  ++.+++|+.|++++|+              |+.|++++|.+.+.+|....++|+.|
T Consensus       246 ~~~------------------~--~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~~~~l~~L~~L  291 (457)
T 3bz5_A          246 TEL------------------D--VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQAEGCRKIKEL  291 (457)
T ss_dssp             SCC------------------C--CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEECTTCTTCCCC
T ss_pred             CCc------------------C--HHHCCCCCEEeccCCC--------------CCEEECCCCccCCcccccccccCCEE
Confidence            742                  1  3456677778777663              45678888888877776666788888


Q ss_pred             EeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCcccc
Q 002085          407 EISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELS  486 (969)
Q Consensus       407 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  486 (969)
                      +|++|.+.+.+|.   ...+|+.|++++|             ++|+.|+|++|+|++ ++  +..+++|+.|++++|+|+
T Consensus       292 ~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~  352 (457)
T 3bz5_A          292 DVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ  352 (457)
T ss_dssp             CCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCC
T ss_pred             ECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCC
Confidence            8888887777774   3455666666554             689999999999997 43  889999999999999998


Q ss_pred             CCCCcccccccccceEeccCccccccCCCccccc-cccEEEeecCcCCCCCCccccc
Q 002085          487 GEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNKLYGNIPDEFNN  542 (969)
Q Consensus       487 ~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~L~~l~ls~N~l~~~~p~~~~~  542 (969)
                      +        ++.|..|++++|.++|.     +.+ .+..+++++|+++|.||..+..
T Consensus       353 ~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~  396 (457)
T 3bz5_A          353 D--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLD  396 (457)
T ss_dssp             B--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred             C--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhc
Confidence            6        35677889999999986     244 4888999999999999976543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.3e-40  Score=384.86  Aligned_cols=376  Identities=17%  Similarity=0.189  Sum_probs=280.4

Q ss_pred             CCCCCCc--ceeeC----------CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCC-CcccCCCCCCCEEe
Q 002085           61 SPCDWPE--ITCTF----------NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEF-PEFLYNCTKLQNLD  127 (969)
Q Consensus        61 ~~c~w~g--v~C~~----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~  127 (969)
                      +.|.|.+  |.|+.          .+++.|+|+++.+.+..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+
T Consensus         6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~   85 (455)
T 3v47_A            6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK   85 (455)
T ss_dssp             -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred             ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence            3455555  77754          35899999999999988999999999999999999998666 56799999999999


Q ss_pred             ccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCc--ccCcccccceecccccccCcCCcc-cCCCCCcceeecccCC
Q 002085          128 LSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRS--IGRLSELQTLYLYMNEFNGTFPKE-IGDLSNLEVLGLAYNS  204 (969)
Q Consensus       128 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~  204 (969)
                      |++|++++..|..|+++++|++|+|++|++++.+|..  |+.+++|++|+|++|++++..|.. ++++++|++|++++|+
T Consensus        86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~  165 (455)
T 3v47_A           86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK  165 (455)
T ss_dssp             CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred             CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence            9999999888999999999999999999999865554  999999999999999999887876 7888888888888875


Q ss_pred             CCCCCCCCccccccCCCcEEEccCCcccccCchhhcCC--CchhhhhccCCcCCCCCCch--------hhcCcccchhhc
Q 002085          205 NFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNL--SSLEILALNGNHLEGAIPSG--------LFLLNNLTQLFL  274 (969)
Q Consensus       205 ~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~--------l~~l~~L~~L~L  274 (969)
                                                +.+..|..+..+  .+|+.|++++|.+++..+..        +..+++|++|++
T Consensus       166 --------------------------l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~L  219 (455)
T 3v47_A          166 --------------------------VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDL  219 (455)
T ss_dssp             --------------------------BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEEC
T ss_pred             --------------------------ccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEec
Confidence                                      333344444433  45666666666666433322        223455555555


Q ss_pred             cCcccccCCCCchhh----cccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCC
Q 002085          275 YDNILSGEIPSSVEA----LKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKS  350 (969)
Q Consensus       275 ~~N~l~~~~~~~~~~----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~  350 (969)
                      ++|++++..|..+..    .+|+.|++++|.+.+...              ..+.+.+                 ..+..
T Consensus       220 s~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~-----------------~~~~~  268 (455)
T 3v47_A          220 SGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF--------------GHTNFKD-----------------PDNFT  268 (455)
T ss_dssp             TTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT--------------TCCSSCC-----------------CCTTT
T ss_pred             CCCcccccchhhhhccccccceeeEeecccccccccc--------------chhhhcc-----------------Ccccc
Confidence            555555544444332    235555555554432210              0111111                 11111


Q ss_pred             CC--CCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccch
Q 002085          351 LG--NCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLI  428 (969)
Q Consensus       351 l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  428 (969)
                      +.  ..++|+.|++++|++++..|..+..+++|+                      +|+|++|++++..|..|.++++|+
T Consensus       269 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~----------------------~L~Ls~n~l~~~~~~~~~~l~~L~  326 (455)
T 3v47_A          269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLE----------------------QLTLAQNEINKIDDNAFWGLTHLL  326 (455)
T ss_dssp             TGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCC----------------------EEECTTSCCCEECTTTTTTCTTCC
T ss_pred             cccccccCceEEEecCccccccchhhcccCCCCC----------------------EEECCCCcccccChhHhcCcccCC
Confidence            21  235677777777777766666666555544                      455555555556677788888999


Q ss_pred             hhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCcc
Q 002085          429 VFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQ  508 (969)
Q Consensus       429 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~  508 (969)
                      +|++++|.+++..|..|..+++|+.|+|++|++++..|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus       327 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  406 (455)
T 3v47_A          327 KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  406 (455)
T ss_dssp             EEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCC
Confidence            99999999988888899999999999999999998889999999999999999999997666778999999999999999


Q ss_pred             ccccCCC
Q 002085          509 FSGEIPP  515 (969)
Q Consensus       509 l~g~~p~  515 (969)
                      +++.+|.
T Consensus       407 l~~~~~~  413 (455)
T 3v47_A          407 WDCSCPR  413 (455)
T ss_dssp             BCCCTTT
T ss_pred             cccCCCc
Confidence            9988773

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.9e-41  Score=374.17  Aligned_cols=256  Identities=24%  Similarity=0.310  Sum_probs=202.6

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHH-HhccccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI-LGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      .++|+..+.||+|+||.||+|++..+++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4678999999999999999999999999999999976654444555677778877 567899999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||++||+|.+++....             .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       117 v~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL  180 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-------------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVL  180 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEeCCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEE
Confidence            999999999999998643             388899999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+++.....  ........||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.......+..   ..
T Consensus       181 ~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~~  255 (373)
T 2r5t_A          181 TDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN---KP  255 (373)
T ss_dssp             CCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH---SC
T ss_pred             eeCccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---cc
Confidence            999999864322  2233456799999999999999999999999999999999999999987655443333221   11


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      ..            .+...+..+.+++.+||+.||++||++.+.++.+.+
T Consensus       256 ~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~  293 (373)
T 2r5t_A          256 LQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS  293 (373)
T ss_dssp             CC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred             cC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence            10            111223678899999999999999998655444433

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2e-40  Score=386.71  Aligned_cols=257  Identities=23%  Similarity=0.296  Sum_probs=212.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||.||+|++..+|+.||||++.............+.+|+++++.++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            35688899999999999999999999999999999665433333456788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||+|.+++.....           ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       263 mEy~~gg~L~~~l~~~~~-----------~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~  328 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ-----------AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRIS  328 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEcCCCCcHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEE
Confidence            999999999999986542           3489999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+++.+...   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+........
T Consensus       329 DFGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~  405 (576)
T 2acx_A          329 DLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP  405 (576)
T ss_dssp             CCTTCEECCTT---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC
T ss_pred             ecccceecccC---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc
Confidence            99999876432   223345899999999999999999999999999999999999999987654332222222222111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                      .           ..+...+..+.+++.+||+.||++||     +++|+++
T Consensus       406 ~-----------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 E-----------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             C-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             c-----------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            0           11122346789999999999999999     6777764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.2e-40  Score=368.73  Aligned_cols=259  Identities=22%  Similarity=0.350  Sum_probs=206.3

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcE----EEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEF----VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ++|+..++||+|+||+||+|++..+++.    ||+|.+....  .....+.+.+|++++++++||||+++++++.++. .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            5788999999999999999998777765    4777664322  2334578999999999999999999999998754 7


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++|+||+++|+|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~  156 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV  156 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHST------------TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred             EEEEEecCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCE
Confidence            89999999999999998754            2488999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+..  
T Consensus       157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--  234 (327)
T 3poz_A          157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--  234 (327)
T ss_dssp             EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--
T ss_pred             EEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc--
Confidence            9999999987755444444445567889999999999999999999999999999999 9999987665544333221  


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                                  ....+.+...+..+.+++.+||+.||++||++.|+++.|+++..
T Consensus       235 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          235 ------------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ------------TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ------------CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                        11112223344678999999999999999999999999988753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-41  Score=375.87  Aligned_cols=266  Identities=24%  Similarity=0.333  Sum_probs=216.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEE-----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDI-----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      .++|+..+.||+|+||.||+|++     ..+++.||||+++...  .......+.+|+.++++++||||+++++++.++.
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            45788999999999999999994     4467789999985432  3444567899999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++|+|.+++.......      .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  218 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRP------SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG  218 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCS------SSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred             CCEEEEEeCCCCCHHHHHHhhcccc------CccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCC
Confidence            9999999999999999998754311      1123589999999999999999999998   999999999999999655


Q ss_pred             ---cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHH
Q 002085          790 ---KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEW  865 (969)
Q Consensus       790 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~  865 (969)
                         .+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........
T Consensus       219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~  298 (367)
T 3l9p_A          219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF  298 (367)
T ss_dssp             TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence               599999999986654444444445678999999999999999999999999999999998 8888877655443332


Q ss_pred             HHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      +...    .          ....+...+..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus       299 i~~~----~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          299 VTSG----G----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             HHTT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcC----C----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            2111    1          11112233467899999999999999999999999998885

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=377.49  Aligned_cols=258  Identities=20%  Similarity=0.191  Sum_probs=209.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||.||+|+...+|+.||+|++.+.........+.+.+|.+++..++||||+++++++.+++..|+|
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            46899999999999999999999999999999999654332233345688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||+|.+++...+            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       140 mE~~~gg~L~~~l~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKFG------------ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             ECCCCSCBHHHHHHHHS------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EcCCCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence            99999999999998643            2488999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcc-------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-------TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      |||+++...... ........||+.|+|||++.       +..++.++||||+||++|||++|+.||.+.+.......+.
T Consensus       205 DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  283 (412)
T 2vd5_A          205 DFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV  283 (412)
T ss_dssp             CCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             echhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999998764322 22233467999999999987       3568999999999999999999999998876554433332


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSR---PSMKEVLQ  919 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R---Ps~~evl~  919 (969)
                      ..... ...     +    ......+..+.+++.+||. +|++|   |++.|+++
T Consensus       284 ~~~~~-~~~-----p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          284 HYKEH-LSL-----P----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             THHHH-CCC-----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             hcccC-cCC-----C----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            11100 000     0    0011233678999999999 99998   58888865

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.2e-40  Score=361.91  Aligned_cols=268  Identities=26%  Similarity=0.359  Sum_probs=208.4

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ...+.++|+..+.||+|+||.||+|++..+++.||||++.............+.+|++++++++||||+++++++.....
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            34456789999999999999999999998999999999977655556667889999999999999999999999876544


Q ss_pred             e----EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          711 K----LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       711 ~----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                      .    |+||||+++++|.++++...             .+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~  150 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEG-------------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMIS  150 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEc
Confidence            3    99999999999999997643             388999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCC-ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      .++.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+........ 
T Consensus       151 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-  229 (311)
T 3ork_A          151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-  229 (311)
T ss_dssp             TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-
T ss_pred             CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-
Confidence            9999999999999876543222 22334568999999999999999999999999999999999999998765433222 


Q ss_pred             HHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH-HHHhhcC
Q 002085          866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL-QILRRCC  925 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl-~~L~~~~  925 (969)
                        .............        ....+..+.+++.+||+.||++||++.+++ +.+.+..
T Consensus       230 --~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          230 --QHVREDPIPPSAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             --HHHHCCCCCHHHH--------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --HHhcCCCCCcccc--------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence              2222211111111        111236788999999999999999666554 5555553

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.4e-40  Score=367.99  Aligned_cols=259  Identities=24%  Similarity=0.319  Sum_probs=209.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcE----EEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEF----VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ++|+..++||+|+||.||+|.+..+++.    ||+|.+....  .....+.+.+|+.++++++||||+++++++. ++..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            5788999999999999999999877765    7777764322  1222356778999999999999999999986 5678


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++|+|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~  154 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR------------GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQV  154 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG------------GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCE
T ss_pred             EEEEEeCCCCCHHHHHHHcc------------ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeE
Confidence            99999999999999998653            2488999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+....
T Consensus       155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  234 (325)
T 3kex_A          155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE  234 (325)
T ss_dssp             EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC
T ss_pred             EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence            9999999988755444444455678889999999999999999999999999999999 999998766554443332111


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                                    ....+...+..+.+++.+||+.||++||++.|+++.|+++..
T Consensus       235 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          235 --------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             --------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             --------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                          011111223467889999999999999999999999998864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.8e-41  Score=368.94  Aligned_cols=251  Identities=23%  Similarity=0.306  Sum_probs=207.8

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+++++.++||||+++++++.+++..++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            35689999999999999999999999999999999865433222334678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+ +|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||
T Consensus        87 v~E~~-~g~l~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl  149 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKK-------------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKI  149 (336)
T ss_dssp             EECCC-CEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEE
T ss_pred             EEECC-CCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEE
Confidence            99999 689999987644             388999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||++......   .......||+.|+|||++.+..+ ++++||||+||++|||++|+.||.+........        
T Consensus       150 ~DFG~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------  218 (336)
T 3h4j_B          150 ADFGLSNIMTDG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------  218 (336)
T ss_dssp             CCSSCTBTTTTS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------
T ss_pred             EEeccceeccCC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------
Confidence            999999865332   23345679999999999988776 689999999999999999999997654322111        


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                            ...... ...+...+..+.+++.+||+.||.+|||++|+++
T Consensus       219 ------~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          219 ------KVNSCV-YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ------CCCSSC-CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ------HHHcCC-CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                  000000 0112223467889999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.1e-40  Score=386.11  Aligned_cols=255  Identities=20%  Similarity=0.281  Sum_probs=209.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|...++||+|+||.||+|++..+|+.||+|++...........+.+.+|++++++++||||+++++++.+....|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            35788899999999999999999999999999999665433333456789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||+|.+++.....         ....+++..+..++.||+.||+|||+.   +|+||||||+||+++.+|.+||+
T Consensus       264 mE~~~gg~L~~~l~~~~~---------~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDE---------DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             ECCCTTCBHHHHHHTSST---------TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEeccCCCHHHHHHHhhc---------ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEe
Confidence            999999999999976532         123589999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+++.+....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+........
T Consensus       332 DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~  409 (543)
T 3c4z_A          332 DLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA  409 (543)
T ss_dssp             CCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC
T ss_pred             ecceeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc
Confidence            999998764322  122345899999999999999999999999999999999999999987643322222222221111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                      .           ..+...+..+.+++.+||+.||++||++
T Consensus       410 ~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 V-----------TYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             C-----------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             c-----------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence            0           1122234678899999999999999975

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-39  Score=359.63  Aligned_cols=248  Identities=21%  Similarity=0.327  Sum_probs=206.5

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      |...++||+|+||.||+|+...+|+.||||++.....   ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            5566789999999999999998999999999864332   2246788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      +++++|.+++...              .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       124 ~~~~~L~~~l~~~--------------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  186 (321)
T 2c30_A          124 LQGGALTDIVSQV--------------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFG  186 (321)
T ss_dssp             CCSCBHHHHHTTC--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCCHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeee
Confidence            9999999998742              388999999999999999999998   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      +++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....   .   
T Consensus       187 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---~---  258 (321)
T 2c30_A          187 FCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---P---  258 (321)
T ss_dssp             TCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---C---
T ss_pred             eeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---C---
Confidence            998764322  22345679999999999999999999999999999999999999998765443332221110   0   


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                          +..  ......+..+.+++.+||+.||++|||+.|+++
T Consensus       259 ----~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          259 ----PKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ----CCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----CCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                000  011123367889999999999999999999987

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.5e-40  Score=371.94  Aligned_cols=273  Identities=23%  Similarity=0.349  Sum_probs=216.2

Q ss_pred             ccCCCccceeeecCcEEEEEEE-----EcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC
Q 002085          635 LSSLTESNLIGSGGSGQVYRID-----INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  708 (969)
                      .++|+..+.||+|+||.||+|+     ...+++.||||+++...  .....+.+.+|+++++++ +||||+++++++.+.
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            4679999999999999999998     45567899999996542  334457899999999999 799999999999875


Q ss_pred             C-ceEEEEeeccCCCHHHHhccCcCcccc---------------------------------------------------
Q 002085          709 N-SKLLVYEYMENQSLDRWLHGRKRSLVS---------------------------------------------------  736 (969)
Q Consensus       709 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~~---------------------------------------------------  736 (969)
                      + ..++||||+++|+|.++++.......+                                                   
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            5 489999999999999999876431100                                                   


Q ss_pred             --CCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCcccccc
Q 002085          737 --GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV  814 (969)
Q Consensus       737 --~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  814 (969)
                        .........+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+............
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence              00111123489999999999999999999998   9999999999999999999999999999876554444445566


Q ss_pred             ccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHH
Q 002085          815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEM  893 (969)
Q Consensus       815 ~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  893 (969)
                      .||+.|+|||++.+..++.++|||||||++|||++ |..||.+..........   .....          ....+...+
T Consensus       256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---~~~~~----------~~~~~~~~~  322 (359)
T 3vhe_A          256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---LKEGT----------RMRAPDYTT  322 (359)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH---HHHTC----------CCCCCTTCC
T ss_pred             CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH---HHcCC----------CCCCCCCCC
Confidence            78999999999999999999999999999999998 99998765543222111   11111          111122233


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          894 TTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       894 ~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..+.+++.+||+.||++||++.|++++|+++.
T Consensus       323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            67899999999999999999999999998874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-40  Score=369.33  Aligned_cols=273  Identities=26%  Similarity=0.434  Sum_probs=217.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEc-----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDIN-----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      .++|+..+.||+|+||.||+|++.     .+++.||||+++...  .....+.+.+|++++++++||||+++++++.+++
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            467899999999999999999986     345899999986543  3445678999999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccC-----------CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSG-----------SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDV  778 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~-----------~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  778 (969)
                      ..++||||+++|+|.+++..........           ........+++..++.++.|++.||+|||+.   +|+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            9999999999999999998753211000           0000124689999999999999999999998   9999999


Q ss_pred             CCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 002085          779 KSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGD  857 (969)
Q Consensus       779 kp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~  857 (969)
                      ||+||+++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999987644333333445678999999999999999999999999999999999 88898776


Q ss_pred             CccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          858 EHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      ........+.    ...          ....+...+..+.+++.+||+.||++||++.|+++.|+++..
T Consensus       281 ~~~~~~~~~~----~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          281 AHEEVIYYVR----DGN----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             CHHHHHHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ChHHHHHHHh----CCC----------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            5443332221    111          011122334678999999999999999999999999999863

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.1e-40  Score=352.05  Aligned_cols=258  Identities=23%  Similarity=0.330  Sum_probs=212.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++. ++..||+|++......    .+.+.+|++++++++||||+++++++.+++..++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            357889999999999999999886 5678999998654321    35688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+
T Consensus        82 ~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~  146 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHG------------KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVS  146 (268)
T ss_dssp             EECCTTCBHHHHHHHHG------------GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEEC
T ss_pred             EEccCCCcHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEc
Confidence            99999999999997643            2489999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++..... .........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...........+.    ..
T Consensus       147 Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~----~~  221 (268)
T 3sxs_A          147 DFGMTRYVLDD-QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS----QG  221 (268)
T ss_dssp             CTTCEEECCTT-CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH----TT
T ss_pred             cCccceecchh-hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH----cC
Confidence            99999876432 2223334557788999999999899999999999999999999 888987655433222211    11


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPT  927 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  927 (969)
                      .          ....+...+..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       222 ~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          222 H----------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             C----------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             C----------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            1          0111112236789999999999999999999999999999754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-40  Score=368.33  Aligned_cols=259  Identities=20%  Similarity=0.263  Sum_probs=213.7

Q ss_pred             chhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          630 TESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       630 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      ....+.+.|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+
T Consensus        45 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  121 (387)
T 1kob_A           45 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY  121 (387)
T ss_dssp             BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             cCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence            33456678999999999999999999999999999999986543   233467899999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC--
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS--  787 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~--  787 (969)
                      ..++||||+++|+|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.  
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~  186 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAED------------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKK  186 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTT------------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTT
T ss_pred             EEEEEEEcCCCCcHHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCC
Confidence            9999999999999999997543            2488999999999999999999998   9999999999999974  


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      ++.+||+|||+++.+...   .......||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.......+.
T Consensus       187 ~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~  263 (387)
T 1kob_A          187 ASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK  263 (387)
T ss_dssp             CCCEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             CCceEEEecccceecCCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            467999999999876432   22334579999999999999999999999999999999999999998765443333221


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .   ....        .........+..+.+++.+||+.||++|||+.|+++.
T Consensus       264 ~---~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          264 R---CDWE--------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             H---CCCC--------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             h---CCCC--------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1   1111        0111112234678999999999999999999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.2e-40  Score=358.06  Aligned_cols=261  Identities=28%  Similarity=0.363  Sum_probs=202.9

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhc--cccCceeeEEEEEEc----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT--IRHANIVKLWCCISS----  707 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----  707 (969)
                      +.++|+..+.||+|+||+||+|++  +++.||||++....      ...+.+|.+++..  ++||||+++++++.+    
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            456899999999999999999988  58899999985432      2455667777666  799999999998654    


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhc--------ccCCCCeEecCCC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMH--------HDCTPQIIHRDVK  779 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlk  779 (969)
                      ....++||||+++|+|.++++..              .+++..++.++.|++.||+|||        +.   +|+|||||
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlk  140 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQLT--------------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLK  140 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTTC--------------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCC
T ss_pred             CceeEEehhhccCCCHHHHHhhc--------------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCC
Confidence            34579999999999999999643              3889999999999999999999        66   99999999


Q ss_pred             CCcEEECCCCcEEEeecccceecccCCCCcc--ccccccCcccCchhhcccC------CCCCccchhhHHHHHHHHHhC-
Q 002085          780 SSNILLDSEFKAKIADFGLAKMLAKQGEPHT--MSAVAGSFGYFAPEYAYTT------KVNEKIDIYSFGVVLLELVTG-  850 (969)
Q Consensus       780 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~il~elltg-  850 (969)
                      |+||+++.++.+||+|||+++..........  .....||+.|+|||++.+.      .++.++|||||||++|||++| 
T Consensus       141 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~  220 (301)
T 3q4u_A          141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM  220 (301)
T ss_dssp             GGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             hHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhh
Confidence            9999999999999999999987654322211  2334799999999999876      455789999999999999999 


Q ss_pred             ---------CCCCCCCCccc-hHHHHHHHhhccCCchhhhccCCC-CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          851 ---------KEANYGDEHTS-LAEWAWRHYAEEKPITDALDKGIA-EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       851 ---------~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                               +.||....... ...............     +... .......+..+.+++.+||+.||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR-----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-----CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCccccccccccccccCCCCcchhhhhHHHhccCCC-----CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                     77876543221 111121211111110     1111 1123346688999999999999999999999999


Q ss_pred             HHhhc
Q 002085          920 ILRRC  924 (969)
Q Consensus       920 ~L~~~  924 (969)
                      .|+++
T Consensus       296 ~L~~i  300 (301)
T 3q4u_A          296 TLTKI  300 (301)
T ss_dssp             HHHHH
T ss_pred             HHhcc
Confidence            99875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8.9e-40  Score=359.00  Aligned_cols=270  Identities=25%  Similarity=0.338  Sum_probs=210.5

Q ss_pred             chhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          630 TESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       630 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      ..+.+.++|+..++||+|+||+||+|++. +|+.||+|++..... .....+.+.+|++++++++||||+++++++.+++
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            34456789999999999999999999986 589999999865432 2334567889999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||++ ++|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        93 ~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~  156 (311)
T 3niz_A           93 CLTLVFEFME-KDLKKVLDENK------------TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDG  156 (311)
T ss_dssp             CEEEEEECCS-EEHHHHHHTCT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTC
T ss_pred             EEEEEEcCCC-CCHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCC
Confidence            9999999998 58888887543            2488999999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      .+||+|||+++.....  ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.........+..
T Consensus       157 ~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  234 (311)
T 3niz_A          157 ALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS  234 (311)
T ss_dssp             CEEECCCTTCEETTSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH
T ss_pred             CEEEccCcCceecCCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            9999999999876432  223344578999999999876 5689999999999999999999999987766655555444


Q ss_pred             HhhccCCc--------hhhhccCCC--Cc-----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKPI--------TDALDKGIA--EP-----CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~~--------~~~~~~~~~--~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ......+.        .........  ..     .......++.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          235 ILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            33221110        000000000  00     01112357889999999999999999999985

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=359.09  Aligned_cols=266  Identities=22%  Similarity=0.343  Sum_probs=206.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++..+|+.||||++.... ......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            468999999999999999999999999999999986543 2344567889999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        81 ~e~~~~~~l~~~~~~~~-------------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  144 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQR-------------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLC  144 (311)
T ss_dssp             EECCSEEHHHHHHHTSS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEeCCCchHHHHHhhhc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEe
Confidence            99999999999887543             388999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++.....  ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.........+.......
T Consensus       145 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  222 (311)
T 4agu_A          145 DFGFARLLTGP--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL  222 (311)
T ss_dssp             CCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             eCCCchhccCc--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccc
Confidence            99999876432  222334578999999999876 568999999999999999999999998766554443333222111


Q ss_pred             CCch-------hhh-ccCCCCc--------ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPIT-------DAL-DKGIAEP--------CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~-------~~~-~~~~~~~--------~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+..       ... ......+        .....+..+.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000       000 0000000        00123466889999999999999999999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.4e-39  Score=354.35  Aligned_cols=265  Identities=22%  Similarity=0.326  Sum_probs=206.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||+||+|++..+++.||||++..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            578999999999999999999999999999999965443 3344577889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++ ++.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 e~~~~-~l~~~~~~~~------------~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~D  144 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCN------------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLAN  144 (292)
T ss_dssp             ECCSE-EHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             ecCCC-CHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            99985 6666655432            2489999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCc-cchHHHHHHHhhcc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEH-TSLAEWAWRHYAEE  873 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~  873 (969)
                      ||+++....  .........||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ......+.+.....
T Consensus       145 fg~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~  222 (292)
T 3o0g_A          145 FGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             CTTCEECCS--CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cccceecCC--ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            999987642  222334567899999999998766 79999999999999999999998765433 23333332222111


Q ss_pred             CC--chhhhc------------cCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KP--ITDALD------------KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~--~~~~~~------------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..  ......            ...........+..+.+++.+|++.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00  000000            00000111233467889999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.8e-40  Score=354.38  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=211.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|++++++++||||+++++++.+++..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            57888999999999999999987 5778999999654321    256899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        85 e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D  149 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQR------------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD  149 (269)
T ss_dssp             ECCTTCBHHHHHHTTT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC
T ss_pred             EeCCCCcHHHHHHhcC------------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecc
Confidence            9999999999997643            2488999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++..... .........+|+.|+|||.+.+..++.++||||+|+++|||++ |..||...........+...     
T Consensus       150 fg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-----  223 (269)
T 4hcu_A          150 FGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----  223 (269)
T ss_dssp             TTGGGGBCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----
T ss_pred             cccccccccc-ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-----
Confidence            9999865321 1112234457788999999999999999999999999999999 88888765544333322111     


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                               .....+...+..+.+++.+||+.||++||+++|+++.|+++.
T Consensus       224 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          224 ---------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence                     111112222467899999999999999999999999998874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.7e-40  Score=367.49  Aligned_cols=260  Identities=23%  Similarity=0.276  Sum_probs=208.8

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc--HHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN--QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      +.+.|+..+.||+|+||.||+|.+..+++.||||++.......  ....+.+.+|+++++.++||||+++++++.+++..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4567999999999999999999999999999999986432211  11246789999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc-
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK-  790 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-  790 (969)
                      |+||||+++++|.+++......         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++. 
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~  169 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADA---------GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENS  169 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHT---------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTT
T ss_pred             EEEEeCCCCCCHHHHHHHhccc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCC
Confidence            9999999999999888754321         13478999999999999999999998   9999999999999987654 


Q ss_pred             --EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          791 --AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       791 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                        +||+|||+++.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+... .....+  
T Consensus       170 ~~vkl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i--  244 (351)
T 3c0i_A          170 APVKLGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGI--  244 (351)
T ss_dssp             CCEEECCCTTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHH--
T ss_pred             CcEEEecCcceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHH--
Confidence              999999999876432  2223456799999999999999999999999999999999999999986432 111111  


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       .........        ......+..+.+++.+||+.||++||++.|+++
T Consensus       245 -~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          245 -IKGKYKMNP--------RQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             -HHTCCCCCH--------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HcCCCCCCc--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             111111000        001122467899999999999999999999985

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6e-40  Score=363.94  Aligned_cols=261  Identities=17%  Similarity=0.186  Sum_probs=213.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      -++|+..+.||+|+||.||+|++..+++.||||++.....     .+.+.+|+++++++ +||||+++++++.+++..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            3578999999999999999999988999999999865432     24588999999999 99999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc---
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---  790 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---  790 (969)
                      ||||+ +++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   
T Consensus        83 v~e~~-~~~L~~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~  146 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCD------------RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQ  146 (330)
T ss_dssp             EEECC-CCBHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCT
T ss_pred             EEEeC-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCC
Confidence            99999 999999998643            2489999999999999999999998   9999999999999999887   


Q ss_pred             --EEEeecccceecccCCCCc-----cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          791 --AKIADFGLAKMLAKQGEPH-----TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       791 --~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                        +||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......
T Consensus       147 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~  226 (330)
T 2izr_A          147 QVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK  226 (330)
T ss_dssp             TSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH
T ss_pred             ceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH
Confidence              9999999998765432211     124567999999999999999999999999999999999999999876554443


Q ss_pred             HHHHHHhhccCC-chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          864 EWAWRHYAEEKP-ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       864 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      +........... ..+..        .... ..+.+++..||+.||.+||+++++.+.|+++.
T Consensus       227 ~~~~~i~~~~~~~~~~~~--------~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          227 ERYQKIGDTKRATPIEVL--------CENF-PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHHHHHHHHHHHSCHHHH--------TTTC-HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhhhccCCHHHH--------hccC-hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            332221111000 00000        0011 27899999999999999999999999998765

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-40  Score=370.19  Aligned_cols=271  Identities=25%  Similarity=0.363  Sum_probs=219.3

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-------CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-------AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS  707 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  707 (969)
                      ++|...++||+|+||.||+|++..       .+..||||+++...  .....+.+.+|+++++++ +||||+++++++.+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            578889999999999999999753       34579999996542  345567899999999999 89999999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCcccc---CCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                      ++..++||||+++|+|.+++.........   .........+++..++.++.|++.||+|||+.   +|+||||||+||+
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence            99999999999999999999876531110   00011124589999999999999999999998   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchH
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLA  863 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~  863 (969)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.......
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987654433344455668899999999999999999999999999999999 88898766544333


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..+..    ..          ....+...+..+.+++.+||+.||++||+++|+++.|+++.
T Consensus       304 ~~~~~----~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          304 KLLKE----GH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             HHHHT----TC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHc----CC----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            32211    11          11112223467899999999999999999999999998885

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.4e-40  Score=382.51  Aligned_cols=252  Identities=24%  Similarity=0.323  Sum_probs=202.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..++||+|+||.||+|++..+|+.||||++.............+.+|+++++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999999999999999999765444445556788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      |||+++|+|.+++....             .+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.+||
T Consensus       227 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl  290 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-------------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKI  290 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEE
T ss_pred             EeeCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEE
Confidence            99999999999997643             38899999999999999999997 7   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..   ..
T Consensus       291 ~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---~~  365 (446)
T 4ejn_A          291 TDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---EE  365 (446)
T ss_dssp             CCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CC
T ss_pred             ccCCCceeccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh---CC
Confidence            999999754322  2233456899999999999999999999999999999999999999987665444333221   11


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                      ..            .+...+..+.+++.+||+.||++||     ++.|+++
T Consensus       366 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 IR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            11            1112336789999999999999999     8988875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.5e-40  Score=361.16  Aligned_cols=272  Identities=24%  Similarity=0.336  Sum_probs=219.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEc-----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDIN-----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      .++|...+.||+|+||.||+|.+.     .+++.||||+++...  .....+.+.+|++++++++||||+++++++.+.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            357889999999999999999873     455899999986432  3445678999999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCcccc-----------CCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVS-----------GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDV  778 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~-----------~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  778 (969)
                      ..++||||+++++|.+++.........           .........+++..++.++.|++.||+|||+.   +|+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence            999999999999999999875431000           00001123488999999999999999999998   9999999


Q ss_pred             CCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 002085          779 KSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGD  857 (969)
Q Consensus       779 kp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~  857 (969)
                      ||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+||++|||++ |+.||.+.
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987654433333445567899999999999899999999999999999999 99998876


Q ss_pred             CccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          858 EHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ........+....              ....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       257 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          257 PPERLFNLLKTGH--------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             CGGGHHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHhhcCC--------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            6554443322111              11112233467899999999999999999999999998874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-40  Score=363.11  Aligned_cols=268  Identities=28%  Similarity=0.387  Sum_probs=208.8

Q ss_pred             ccCCCccceeeecCcEEEEEEE----EcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc--C
Q 002085          635 LSSLTESNLIGSGGSGQVYRID----INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS--E  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  708 (969)
                      .++|+..+.||+|+||.||+|+    ...+++.||||++...   .....+.+.+|++++++++||||+++++++..  .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            4678999999999999999998    4567899999998543   34455789999999999999999999999865  4


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      ...++||||+++|+|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~  150 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK------------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENE  150 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG------------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc------------cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCC
Confidence            56899999999999999998654            2488999999999999999999988   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCC-ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      +.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..    
T Consensus       151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~----  225 (295)
T 3ugc_A          151 NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-FM----  225 (295)
T ss_dssp             TEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-HH----
T ss_pred             CeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH-HH----
Confidence            99999999999876443222 2223445778899999999999999999999999999999999987642110 00    


Q ss_pred             HHhhccC-------CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          868 RHYAEEK-------PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       868 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .......       ...+.+......+.+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          226 RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            0000000       011111222222333445578999999999999999999999999998874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.4e-39  Score=351.97  Aligned_cols=250  Identities=26%  Similarity=0.353  Sum_probs=207.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            46789999999999999999999999999999998654433333456799999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+
T Consensus        88 ~e~~~~~~l~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~  151 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-------------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA  151 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEEC
T ss_pred             EecCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEE
Confidence            99999999999997654             388999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||++.....    .......|++.|+|||.+.+..++.++||||+|+++|||++|..||...........+...   ..
T Consensus       152 Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~  224 (279)
T 3fdn_A          152 DFGWSVHAPS----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---EF  224 (279)
T ss_dssp             SCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---CC
T ss_pred             eccccccCCc----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC---CC
Confidence            9999865422    2233457899999999999999999999999999999999999999866543333222111   00


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                  ..+...+..+.+++.+||+.||++||++.|+++
T Consensus       225 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          225 ------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                        111122367889999999999999999999996

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.9e-39  Score=350.55  Aligned_cols=255  Identities=23%  Similarity=0.304  Sum_probs=212.9

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +.++|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            45789999999999999999999999999999999865433 34445789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc---
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---  790 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---  790 (969)
                      ||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   
T Consensus        83 v~e~~~~~~l~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~  146 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVARE-------------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA  146 (284)
T ss_dssp             EECCCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCC
T ss_pred             EEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCc
Confidence            999999999999987643             388999999999999999999998   9999999999999987655   


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      +||+|||++.....   ........||+.|+|||.+.+..++.++||||+|+++|||++|+.||.+.........+....
T Consensus       147 ~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  223 (284)
T 3kk8_A          147 VKLADFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA  223 (284)
T ss_dssp             EEECCCTTCEECCS---SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             EEEeeceeeEEccc---CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc
Confidence            99999999976633   223345679999999999999999999999999999999999999998765544333322211


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..           ...+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       224 ~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          224 YD-----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CC-----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc-----------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            10           011111223467889999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.4e-40  Score=356.95  Aligned_cols=254  Identities=23%  Similarity=0.300  Sum_probs=201.2

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc-----------------------HHHHHHHHHHHHHH
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN-----------------------QKLEKEFIAEIEIL  690 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l  690 (969)
                      ..++|+..+.||+|+||.||+|++..+++.||||++.......                       ....+.+.+|++++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3578999999999999999999999999999999986543211                       11235689999999


Q ss_pred             hccccCceeeEEEEEEc--CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhccc
Q 002085          691 GTIRHANIVKLWCCISS--ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD  768 (969)
Q Consensus       691 ~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~  768 (969)
                      ++++||||+++++++.+  .+..++||||+++++|.+++..              ..+++..+..++.|++.||+|||+.
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~  156 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--------------KPLSEDQARFYFQDLIKGIEYLHYQ  156 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--------------SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            99999999999999987  5678999999999999876542              2489999999999999999999998


Q ss_pred             CCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCC---CCCccchhhHHHHHH
Q 002085          769 CTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK---VNEKIDIYSFGVVLL  845 (969)
Q Consensus       769 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~  845 (969)
                         +|+||||||+||+++.++.+||+|||+++.+...  ........||+.|+|||.+.+..   ++.++||||+||++|
T Consensus       157 ---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~  231 (298)
T 2zv2_A          157 ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY  231 (298)
T ss_dssp             ---TEECCCCCGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHH
T ss_pred             ---CeeccCCCHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHH
Confidence               9999999999999999999999999999876432  22234567999999999988765   377899999999999


Q ss_pred             HHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          846 ELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       846 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ||++|+.||.+.........+..   ..          ...+.....+..+.+++.+||+.||++||++.|+++
T Consensus       232 ~l~~g~~pf~~~~~~~~~~~~~~---~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          232 CFVFGQCPFMDERIMCLHSKIKS---QA----------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHH---CC----------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHCCCCCCCccHHHHHHHHhc---cc----------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            99999999976544332222211   10          011111123367899999999999999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-39  Score=375.28  Aligned_cols=256  Identities=25%  Similarity=0.330  Sum_probs=214.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      ..+|...+.||+|+||.||+|++..+|+.||||++.............+.+|+++++.++||||+++++++.+++..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            56899999999999999999999999999999999654332333456799999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        95 ~E~~~gg~L~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~  158 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-------------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIA  158 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-------------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             EeCCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEE
Confidence            99999999999997543             388999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++.....   .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.........+...    
T Consensus       159 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----  231 (476)
T 2y94_A          159 DFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG----  231 (476)
T ss_dssp             CCSSCEECCTT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT----
T ss_pred             eccchhhcccc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC----
Confidence            99999876432   22344679999999999988776 68999999999999999999999876554433322111    


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhc
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRC  924 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~  924 (969)
                      .         .  ..+...+..+.+++.+||+.||++|||+.|+++  .+++.
T Consensus       232 ~---------~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          232 I---------F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             C---------C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             C---------c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            0         0  011122367889999999999999999999996  45544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5e-40  Score=383.85  Aligned_cols=257  Identities=25%  Similarity=0.349  Sum_probs=216.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||.||+|.+..++..||||+++....    ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            468888999999999999999988899999999865422    2467999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++.....           ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       296 E~~~~g~L~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D  361 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNR-----------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVAD  361 (495)
T ss_dssp             ECCTTCBHHHHHHHSCT-----------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred             EccCCCCHHHHHHhcCc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEee
Confidence            99999999999986432           3488999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++..... .........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.....+.+..      
T Consensus       362 FG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~------  434 (495)
T 1opk_A          362 FGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------  434 (495)
T ss_dssp             TTCEECCTTC-CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT------
T ss_pred             cccceeccCC-ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------
Confidence            9999876432 2222234456789999999999999999999999999999999 8888877665544333221      


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                              +...+.+...+..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus       435 --------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          435 --------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                    1111223334478899999999999999999999999999885

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.2e-40  Score=352.65  Aligned_cols=257  Identities=31%  Similarity=0.435  Sum_probs=197.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc-HHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN-QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      .++|+..+.||+|+||.||+|.+.  ++.||||++....... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            357889999999999999999984  8899999986543222 2234678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC------
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS------  787 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~------  787 (969)
                      ||||+++++|.+++...              .+++..++.++.|++.||+|||+....+|+||||||+||+++.      
T Consensus        84 v~e~~~~~~L~~~~~~~--------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~  149 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGK--------------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD  149 (271)
T ss_dssp             EEECCTTEEHHHHHTSS--------------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred             EEEcCCCCCHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence            99999999999998643              3889999999999999999999981112999999999999986      


Q ss_pred             --CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          788 --EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       788 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                        ++.+||+|||+++.+...    ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.+.+.......
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  225 (271)
T 3dtc_A          150 LSNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG  225 (271)
T ss_dssp             CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred             ccCcceEEccCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Confidence              678999999999865332    22245789999999999999999999999999999999999999986554322211


Q ss_pred             HHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      .   ...          ....+.+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       226 ~---~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          226 V---AMN----------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             H---HTS----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             h---hcC----------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1   111          111112233346789999999999999999999999999763

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.5e-40  Score=362.70  Aligned_cols=267  Identities=22%  Similarity=0.301  Sum_probs=199.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCc---EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .++|+..+.||+|+||.||+|++..++.   .||||+++.... .....+.+.+|++++++++||||+++++++.+....
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            3579999999999999999999876664   899999865432 234467899999999999999999999999877655


Q ss_pred             ------EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE
Q 002085          712 ------LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL  785 (969)
Q Consensus       712 ------~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill  785 (969)
                            ++||||+++|+|.+++.......       ....+++..++.++.|++.||+|||+.   +|+||||||+||++
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli  170 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGE-------NPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCML  170 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC----------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccc-------cccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEE
Confidence                  99999999999999997543210       112488999999999999999999998   99999999999999


Q ss_pred             CCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHH
Q 002085          786 DSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAE  864 (969)
Q Consensus       786 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~  864 (969)
                      +.++.+||+|||+++...............+++.|+|||.+.+..++.++||||+||++|||++ |..||.+........
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~  250 (323)
T 3qup_A          171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN  250 (323)
T ss_dssp             CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence            9999999999999987654433333445567889999999999999999999999999999999 888887766554443


Q ss_pred             HHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      .+....              ....+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       251 ~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          251 YLIGGN--------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HHHTTC--------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcCC--------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            322111              111222334678999999999999999999999999998853

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-39  Score=352.82  Aligned_cols=257  Identities=27%  Similarity=0.417  Sum_probs=207.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHH----HHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE----KEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      .++|+..+.||+|+||.||+|++..+++.||+|++...........    +.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            3578899999999999999999999999999999865433222221    67999999999999999999999987654 


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCC--eEecCCCCCcEEECCC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQ--IIHRDVKSSNILLDSE  788 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~  788 (969)
                       ++||||+++|+|.+++....            ..+++..++.++.|++.||+|||+.   +  |+||||||+||+++.+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~  160 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA------------HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSL  160 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT------------SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCC
T ss_pred             -eEEEEecCCCCHHHHHhccc------------CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEecc
Confidence             79999999999999987643            2489999999999999999999988   7  9999999999999888


Q ss_pred             Cc-----EEEeecccceecccCCCCccccccccCcccCchhhcc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccc
Q 002085          789 FK-----AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY--TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS  861 (969)
Q Consensus       789 ~~-----~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~  861 (969)
                      +.     +||+|||+++...     .......||+.|+|||.+.  ...++.++||||+||++|||++|+.||.......
T Consensus       161 ~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  235 (287)
T 4f0f_A          161 DENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK  235 (287)
T ss_dssp             CTTCSCCEEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred             CCCCceeEEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence            76     9999999997532     2234467999999999984  4557889999999999999999999997655443


Q ss_pred             hHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      ..... ....          .......+...+..+.+++.+||+.||++||++.|+++.|+++
T Consensus       236 ~~~~~-~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          236 IKFIN-MIRE----------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHH-HHHH----------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHH-HHhc----------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            22111 1111          1111112223346889999999999999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=364.19  Aligned_cols=274  Identities=21%  Similarity=0.325  Sum_probs=215.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEE-----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDI-----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  708 (969)
                      .++|+..+.||+|+||.||+|++     ..+++.||||+++...  .....+.+.+|+++++++ +||||+++++++.+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            46788999999999999999997     3456789999996432  233457899999999999 899999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccC----------CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSG----------SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDV  778 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----------~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  778 (969)
                      +..++||||+++|+|.+++..........          ........+++..++.++.|++.||+|||+.   +|+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence            99999999999999999998754311000          0001123489999999999999999999998   9999999


Q ss_pred             CCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 002085          779 KSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGD  857 (969)
Q Consensus       779 kp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~  857 (969)
                      ||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999987765444444455668899999999999999999999999999999998 98898765


Q ss_pred             CccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          858 EHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      .........   ...          +...+.+...+..+.+++.+||+.||++||++.|+++.|+.+..
T Consensus       279 ~~~~~~~~~---~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          279 PVDANFYKL---IQN----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CCSHHHHHH---HHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CcHHHHHHH---Hhc----------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            443222111   111          11111222234678999999999999999999999999998863

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.1e-40  Score=359.04  Aligned_cols=249  Identities=21%  Similarity=0.287  Sum_probs=198.8

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKL  712 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  712 (969)
                      +.++|+..++||+|+||+||+|++..+++.||||++...... .........|+..+.++ +||||+++++++.+++..+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            446799999999999999999999989999999998654332 23334555566655555 8999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+ +++|.+++....            ..++|..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       134 lv~e~~-~~~L~~~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~k  197 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWG------------ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK  197 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHC------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEE
T ss_pred             EEEecc-CCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEE
Confidence            999999 679999987653            2489999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      |+|||+++....   ........||+.|+|||++.+ .++.++|||||||++|||++|..|+.+.+.       +.....
T Consensus       198 l~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-------~~~~~~  266 (311)
T 3p1a_A          198 LGDFGLLVELGT---AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-------WQQLRQ  266 (311)
T ss_dssp             ECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------HHHHTT
T ss_pred             Eccceeeeeccc---CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHhc
Confidence            999999987633   223344569999999998876 799999999999999999999888765321       111111


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .. ...        ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       267 ~~-~~~--------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          267 GY-LPP--------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TC-CCH--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cC-CCc--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11 011        111123467899999999999999999999986

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.5e-39  Score=361.40  Aligned_cols=255  Identities=21%  Similarity=0.338  Sum_probs=203.1

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN----  709 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  709 (969)
                      +.++|+..+.||+|+||.||+|++..+|+.||||++....  .....+.+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            5678999999999999999999999899999999996543  2334578999999999999999999999986543    


Q ss_pred             -----------------------------------------------------ceEEEEeeccCCCHHHHhccCcCcccc
Q 002085          710 -----------------------------------------------------SKLLVYEYMENQSLDRWLHGRKRSLVS  736 (969)
Q Consensus       710 -----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~  736 (969)
                                                                           ..++||||+++++|.+++.....    
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----  157 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS----  157 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS----
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC----
Confidence                                                                 27999999999999999987553    


Q ss_pred             CCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCC--------
Q 002085          737 GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP--------  808 (969)
Q Consensus       737 ~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~--------  808 (969)
                            ....++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........        
T Consensus       158 ------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~  228 (332)
T 3qd2_B          158 ------LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP  228 (332)
T ss_dssp             ------GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-----------
T ss_pred             ------ccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccc
Confidence                  23457778999999999999999998   9999999999999999999999999999877543211        


Q ss_pred             --ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCC
Q 002085          809 --HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAE  886 (969)
Q Consensus       809 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  886 (969)
                        .......||+.|+|||++.+..++.++||||+||++|||++|..|+...     .. .......          ....
T Consensus       229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~-~~~~~~~----------~~~~  292 (332)
T 3qd2_B          229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VR-IITDVRN----------LKFP  292 (332)
T ss_dssp             ---CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HH-HHHHHHT----------TCCC
T ss_pred             ccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HH-HHHHhhc----------cCCC
Confidence              2223457999999999999999999999999999999999987653210     01 1111111          1111


Q ss_pred             cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          887 PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       887 ~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .........+.+++.+||+.||++||++.|+++
T Consensus       293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            122334467789999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2e-39  Score=374.53  Aligned_cols=251  Identities=27%  Similarity=0.390  Sum_probs=209.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC-ceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN-SKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~l  713 (969)
                      .++|+..+.||+|+||.||+|.+.  ++.||||+++...     ..+.+.+|++++++++||||+++++++.+.+ ..|+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            357888999999999999999985  7799999996543     2467899999999999999999999987655 7899


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++|+|.+++.....           ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       265 v~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl  330 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGR-----------SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV  330 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCT-----------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEE
T ss_pred             EEEecCCCcHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEE
Confidence            9999999999999986542           2478899999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||+++.....     .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+....+....+..    
T Consensus       331 ~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~----  401 (450)
T 1k9a_A          331 SDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----  401 (450)
T ss_dssp             CCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT----
T ss_pred             eeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----
Confidence            999999854221     122357889999999999999999999999999999998 9999877655544433221    


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                +...+.+...+..+.++|.+||+.||++|||+.|+++.|+.+.
T Consensus       402 ----------~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          402 ----------GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                      1111223334578999999999999999999999999998875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.5e-40  Score=378.36  Aligned_cols=256  Identities=26%  Similarity=0.429  Sum_probs=211.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|.+. ++..||||+++....    ..+.+.+|++++++++||||+++++++. .+..++||
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            46888899999999999999986 467899999965332    2467999999999999999999999986 56789999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.++++....           ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       262 e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEG-----------SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             CCCTTCBHHHHHHSHHH-----------HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECS
T ss_pred             eecCCCcHHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEee
Confidence            99999999999985431           2478899999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++..... .........+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+....    
T Consensus       328 FG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~----  402 (454)
T 1qcf_A          328 FGLARVIEDN-EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY----  402 (454)
T ss_dssp             TTGGGGBCCH-HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC----
T ss_pred             CCCceEcCCC-ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----
Confidence            9999875321 1111233456789999999999999999999999999999999 999987765544433332211    


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                                ..+.+...+..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       403 ----------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 ----------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                      112223345789999999999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-39  Score=358.93  Aligned_cols=273  Identities=23%  Similarity=0.341  Sum_probs=217.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEE-----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDI-----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  708 (969)
                      .++|+..+.||+|+||.||+|++     ..+++.||||+++...  .....+.+.+|+++++++ +||||+++++++.++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            35788999999999999999985     4467899999996543  234457899999999999 899999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccC-----CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcE
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSG-----SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI  783 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Ni  783 (969)
                      +..++||||+++|+|.+++..........     ........+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence            99999999999999999998754311000     0001123589999999999999999999998   999999999999


Q ss_pred             EECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccch
Q 002085          784 LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSL  862 (969)
Q Consensus       784 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~  862 (969)
                      +++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+......
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            999999999999999987755433333445567889999999999999999999999999999999 8888876544332


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ......   ..          .....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       257 ~~~~~~---~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          257 FYKMIK---EG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             HHHHHH---HT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhc---cC----------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            221111   11          111112223467899999999999999999999999998874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.3e-39  Score=351.78  Aligned_cols=261  Identities=14%  Similarity=0.153  Sum_probs=214.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      .++|+..+.||+|+||.||+|.+..+++.||||++.....     .+.+.+|+++++.+ +|++++++++++.+....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            4579999999999999999999988999999999864332     24578899999999 79999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc---
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---  790 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---  790 (969)
                      ||||+ +++|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   
T Consensus        84 v~e~~-~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~  147 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCG------------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNA  147 (298)
T ss_dssp             EEECC-CCBHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTT
T ss_pred             EEEec-CCCHHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCC
Confidence            99999 999999998653            2489999999999999999999988   9999999999999988776   


Q ss_pred             --EEEeecccceecccCCCC-----ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          791 --AKIADFGLAKMLAKQGEP-----HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       791 --~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                        +||+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.......
T Consensus       148 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  227 (298)
T 1csn_A          148 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK  227 (298)
T ss_dssp             TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH
T ss_pred             CeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH
Confidence              999999999877543222     1234567999999999999999999999999999999999999999875544333


Q ss_pred             HHHHHHhhc--cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          864 EWAWRHYAE--EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       864 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .........  ..+....         ....+..+.+++.+||+.||++||++++|++.|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          228 QKYERIGEKKQSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             HHHHHHHHHHHHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhhccCccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            222111111  0111110         1122367899999999999999999999999998885

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-39  Score=353.48  Aligned_cols=266  Identities=20%  Similarity=0.259  Sum_probs=208.7

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ....++|+..+.||+|+||.||+|++..+++.||+|++...........+.+.+|++++++++||||+++++++.+++..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            34567899999999999999999999989999999999766555556678899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++++|.+++....             .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~  173 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQG-------------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFA  173 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred             EEEEEecCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCE
Confidence            99999999999999998643             388999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      ||+|||++...... .........|++.|+|||.+.+..++.++||||||+++|||++|+.||.+......    .....
T Consensus       174 kl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~  248 (309)
T 2h34_A          174 YLVDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM----GAHIN  248 (309)
T ss_dssp             EECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH----HHHHH
T ss_pred             EEecCccCcccccc-ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH----HHHhc
Confidence            99999999765432 12223345789999999999999999999999999999999999999976543221    11111


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcCC
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-SMKEVLQILRRCCP  926 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~  926 (969)
                      ........        .+...+..+.+++.+||+.||++|| ++.++++.|+++..
T Consensus       249 ~~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          249 QAIPRPST--------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             SCCCCGGG--------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             cCCCCccc--------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            11111111        1122235788999999999999999 99999999998864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.9e-39  Score=365.96  Aligned_cols=271  Identities=20%  Similarity=0.235  Sum_probs=211.0

Q ss_pred             ccCCCccceeeec--CcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          635 LSSLTESNLIGSG--GSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       635 ~~~~~~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ..+|++.++||+|  +||.||+|++..+++.||||++..... .....+.+.+|+++++.++||||+++++++.+++..|
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            3579999999999  999999999999999999999976432 3455678999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++|+|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       103 lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~k  168 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM-----------DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVY  168 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred             EEEEccCCCCHHHHHhhhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            99999999999999986532           3488999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCC-----ccccccccCcccCchhhccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          793 IADFGLAKMLAKQGEP-----HTMSAVAGSFGYFAPEYAYT--TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      |+|||.+......+..     .......||+.|+|||++.+  ..++.++||||+||++|||++|+.||.+.........
T Consensus       169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  248 (389)
T 3gni_B          169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE  248 (389)
T ss_dssp             ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred             EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999998765332211     11223478999999999987  5799999999999999999999999987654433322


Q ss_pred             HHHHhhcc---------C-------------Cchhhhcc---------CCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          866 AWRHYAEE---------K-------------PITDALDK---------GIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       866 ~~~~~~~~---------~-------------~~~~~~~~---------~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                      ........         .             ...+....         ....+.+...+..+.+++.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta  328 (389)
T 3gni_B          249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA  328 (389)
T ss_dssp             C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred             HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence            11100000         0             00000000         00001222334678999999999999999999


Q ss_pred             HHHHHH
Q 002085          915 KEVLQI  920 (969)
Q Consensus       915 ~evl~~  920 (969)
                      .|+++.
T Consensus       329 ~ell~h  334 (389)
T 3gni_B          329 STLLNH  334 (389)
T ss_dssp             HHHTTS
T ss_pred             HHHhcC
Confidence            999853

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=361.82  Aligned_cols=252  Identities=25%  Similarity=0.330  Sum_probs=193.7

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +.+.|+..+.||+|+||.||+|++..+++.||||+++...     ..+.+.+|++++++++||||+++++++.+++..++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            4567999999999999999999999899999999986532     24668899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC---CCc
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS---EFK  790 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~  790 (969)
                      ||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.   ++.
T Consensus       126 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~  189 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKG-------------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAP  189 (349)
T ss_dssp             EECCCCSCBHHHHHTTCS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCC
T ss_pred             EEEeCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCC
Confidence            999999999999997643             388999999999999999999998   9999999999999975   789


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      +||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|..||........   .....
T Consensus       190 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~i  263 (349)
T 2w4o_A          190 LKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRI  263 (349)
T ss_dssp             EEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---HHHHH
T ss_pred             EEEccCccccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---HHHHH
Confidence            999999999865332   223346799999999999999999999999999999999999999976544321   11111


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .....       ....+.....+..+.+++.+||+.||++||++.|+++
T Consensus       264 ~~~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          264 LNCEY-------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HTTCC-------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhCCC-------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11110       0011112233467899999999999999999999987

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-39  Score=364.79  Aligned_cols=254  Identities=24%  Similarity=0.240  Sum_probs=198.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++..+++.||||++......    .+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            46899999999999999999999999999999999654322    25678999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc--EE
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK--AK  792 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~k  792 (969)
                      |||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.  +|
T Consensus        95 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~k  158 (361)
T 3uc3_A           95 MEYASGGELYERICNAG-------------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLK  158 (361)
T ss_dssp             EECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEE
T ss_pred             EEeCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEE
Confidence            99999999999997643             389999999999999999999988   9999999999999987765  99


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCc-cchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEK-IDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |+|||+++....   ........||+.|+|||++.+..++.+ +||||+||++|||++|+.||.+...............
T Consensus       159 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~  235 (361)
T 3uc3_A          159 ICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL  235 (361)
T ss_dssp             ECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH
T ss_pred             EeecCccccccc---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence            999999975322   222334579999999999988887665 8999999999999999999987554333332222221


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ...         ...+.....+..+.+++.+||+.||++|||+.|+++.
T Consensus       236 ~~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          236 SVK---------YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             TTC---------CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cCC---------CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            111         1111111223678899999999999999999999963

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.7e-39  Score=355.18  Aligned_cols=266  Identities=25%  Similarity=0.371  Sum_probs=197.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|.+..+|+.||+|+++....  ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            3579999999999999999999998999999999865432  22235688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++ ++|.+++.......       ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~  150 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGN-------TPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLG  150 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSS-------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEecC-CCHHHHHHhccccc-------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEEC
Confidence            99998 69999987643210       113488999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++.....  ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.........+.......
T Consensus       151 Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  228 (317)
T 2pmi_A          151 DFGLARAFGIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP  228 (317)
T ss_dssp             CCSSCEETTSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cCccceecCCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999876432  2223445789999999998764 68999999999999999999999998776555444443322111


Q ss_pred             C-Cc----------------------hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 K-PI----------------------TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~-~~----------------------~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      . ..                      .+.+.+..    ....+..+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ChhHhhhhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0 00                      00000000    0112357899999999999999999999885

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.4e-39  Score=357.65  Aligned_cols=258  Identities=20%  Similarity=0.253  Sum_probs=212.1

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH---HHHHHHHHHHHHHhccccCceeeEEEEEEcC
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ---KLEKEFIAEIEILGTIRHANIVKLWCCISSE  708 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  708 (969)
                      ..+.+.|+..+.||+|+||.||+|++..+|+.||+|++........   ...+.+.+|++++++++||||+++++++.++
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            3456789999999999999999999999999999999865432211   1246789999999999999999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      +..++||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~  151 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKE-------------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK  151 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCS-------------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecC
Confidence            99999999999999999997543             378999999999999999999998   99999999999999988


Q ss_pred             C----cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          789 F----KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       789 ~----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                      +    .+||+|||+++.....   .......||+.|+|||.+.+..++.++||||+||++|||++|..||.+........
T Consensus       152 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  228 (321)
T 2a2a_A          152 NIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  228 (321)
T ss_dssp             TSSSCCEEECCCTTCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             CCCcCCEEEccCccceecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            8    7999999999876432   22344579999999999999999999999999999999999999998765433322


Q ss_pred             HHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+..   ........        .....+..+.+++.+||+.||++|||+.|+++
T Consensus       229 ~i~~---~~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          229 NITS---VSYDFDEE--------FFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHT---TCCCCCHH--------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHh---cccccChh--------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            2211   11111100        01122367889999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.4e-39  Score=347.25  Aligned_cols=254  Identities=20%  Similarity=0.286  Sum_probs=209.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--CceE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--NSKL  712 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  712 (969)
                      .++|+..+.||+|+||.||+|++.  ++.||||++.... ......+.+.+|++++++++||||+++++++.+.  +..+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            457899999999999999999984  8889999986543 2344567899999999999999999999999887  7889


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCC--eEecCCCCCcEEECCCCc
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQ--IIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~  790 (969)
                      +||||+++|+|.+++.....           ..+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.
T Consensus        86 lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~  151 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTN-----------FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMT  151 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSS-----------CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSC
T ss_pred             eeecccCCCcHHHHHhhccc-----------CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcc
Confidence            99999999999999986542           3589999999999999999999987   7  999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCC---ccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNE---KIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      ++++|||++...       ......||+.|+|||.+.+..++.   ++||||+||++|||++|+.||.+.......... 
T Consensus       152 ~~l~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-  223 (271)
T 3kmu_A          152 ARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-  223 (271)
T ss_dssp             EEEEGGGSCCTT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH-
T ss_pred             eeEEeccceeee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH-
Confidence            999999987542       122356899999999998766554   799999999999999999999765543322211 


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                        ...          ......+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       224 --~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          224 --ALE----------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             --HHS----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             --Hhc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence              111          1111122233467899999999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.6e-39  Score=351.57  Aligned_cols=264  Identities=26%  Similarity=0.376  Sum_probs=203.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|++ .+|+.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            5788999999999999999998 5789999999865432 2222467889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++ +|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  143 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCE------------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIAD  143 (288)
T ss_dssp             ECCSE-EHHHHHHTST------------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             EecCC-CHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeE
Confidence            99985 9999987643            2488999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++.....  ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.........+.+......
T Consensus       144 fg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (288)
T 1ob3_A          144 FGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN  221 (288)
T ss_dssp             TTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             CccccccCcc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCC
Confidence            9999865321  2223345789999999998764 589999999999999999999999987655444433333221110


Q ss_pred             C--chhh-----hccCCC-------CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 P--ITDA-----LDKGIA-------EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~--~~~~-----~~~~~~-------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .  ....     .++...       .......+..+.+++.+||+.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0  0000     000000       0011123467889999999999999999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=360.38  Aligned_cols=260  Identities=22%  Similarity=0.330  Sum_probs=205.6

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEE----EEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFV----AVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      .++|+..++||+|+||.||+|.+..+++.|    |+|.+....  .....+.+.+|++++++++||||+++++++.++. 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            357899999999999999999998777654    666664322  2233578899999999999999999999998754 


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++|+||+++|+|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~  155 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred             ceEEEEecCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCC
Confidence            889999999999999998654            2488999999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  869 (969)
                      +||+|||+++.+.............+|+.|+|||.+.+..++.++||||+||++|||++ |..||.+.........+...
T Consensus       156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  235 (327)
T 3lzb_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG  235 (327)
T ss_dssp             EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999987755444444445567889999999999999999999999999999999 99999876655544333211


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                                    ...+.+...+..+.+++.+||+.||++||++.|+++.|+++..
T Consensus       236 --------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          236 --------------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             --------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                          1111222334678999999999999999999999999988863

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.5e-39  Score=359.60  Aligned_cols=272  Identities=24%  Similarity=0.356  Sum_probs=216.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEc-------CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDIN-------GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCIS  706 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  706 (969)
                      .++|+..+.||+|+||.||+|++.       .+++.||||+++...  .....+.+.+|+++++++ +||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            357889999999999999999975       356789999986542  344567899999999999 8999999999999


Q ss_pred             cCCceEEEEeeccCCCHHHHhccCcCccccCC---CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcE
Q 002085          707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI  783 (969)
Q Consensus       707 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Ni  783 (969)
                      +.+..++||||+++|+|.+++...........   .......+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence            99999999999999999999987543111100   011123589999999999999999999998   999999999999


Q ss_pred             EECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccch
Q 002085          784 LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSL  862 (969)
Q Consensus       784 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~  862 (969)
                      +++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+......
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence            999999999999999987654333233344567889999999999899999999999999999999 8889876654433


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ...+....              ....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       269 ~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          269 FKLLKEGH--------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             HHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcCC--------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            33222111              11112223467899999999999999999999999998885

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.5e-39  Score=364.00  Aligned_cols=270  Identities=17%  Similarity=0.225  Sum_probs=207.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCC-----CcEEEEEEEeccchhcHH--------HHHHHHHHHHHHhccccCceeeE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGA-----GEFVAVKRIWNNRKLNQK--------LEKEFIAEIEILGTIRHANIVKL  701 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l  701 (969)
                      .++|++.+.||+|+||.||+|.+..+     ++.||||++.........        ....+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            44899999999999999999998654     578999998654321111        01234556667788899999999


Q ss_pred             EEEEEcC----CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecC
Q 002085          702 WCCISSE----NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRD  777 (969)
Q Consensus       702 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  777 (969)
                      ++++...    ...++||||+ +++|.+++....            ..+++..++.++.|++.||+|||+.   +|+|||
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~------------~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrD  177 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA------------KRFSRKTVLQLSLRILDILEYIHEH---EYVHGD  177 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEec
Confidence            9998764    4579999999 999999998643            2489999999999999999999998   999999


Q ss_pred             CCCCcEEEC--CCCcEEEeecccceecccCCCCcc-----ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhC
Q 002085          778 VKSSNILLD--SEFKAKIADFGLAKMLAKQGEPHT-----MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG  850 (969)
Q Consensus       778 lkp~Nill~--~~~~~kl~Dfgla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg  850 (969)
                      |||+||+++  .++.+||+|||+++.+........     .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       178 lkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g  257 (364)
T 3op5_A          178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG  257 (364)
T ss_dssp             CCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence            999999999  889999999999987654322211     1334599999999999999999999999999999999999


Q ss_pred             CCCCCCCCc-cchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          851 KEANYGDEH-TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       851 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      +.||.+... ..........+.  ..+.+.++..+..   ...+..+.+++..||+.||++||++.++++.|+++.
T Consensus       258 ~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          258 HLPWEDNLKDPKYVRDSKIRYR--ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             CCTTGGGTTCHHHHHHHHHHHH--HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCCccccccCHHHHHHHHHHhh--hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            999985322 222222222221  1233333332211   112367899999999999999999999999998775

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-39  Score=351.88  Aligned_cols=258  Identities=24%  Similarity=0.318  Sum_probs=201.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .++|+..+.||+|+||.||+|.+..+   +..||+|++...  ......+.+.+|+.++++++||||+++++++. ++..
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            45789999999999999999998643   457999988543  23455678999999999999999999999984 4678


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  155 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRK------------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV  155 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTT------------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred             EEEEecCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCE
Confidence            99999999999999998643            2488999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+++..... .........+++.|+|||.+.+..++.++||||+||++|||++ |..||.+.........+... 
T Consensus       156 kl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-  233 (281)
T 1mp8_A          156 KLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-  233 (281)
T ss_dssp             EECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred             EECccccccccCcc-cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-
Confidence            99999999876432 2222234457889999999999999999999999999999997 88898776655443332111 


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                         .          ..+.+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       234 ---~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          234 ---E----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             ---C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---C----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               1          11122233467899999999999999999999999998874

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.7e-39  Score=365.23  Aligned_cols=258  Identities=22%  Similarity=0.286  Sum_probs=198.4

Q ss_pred             hhhhccCCCcc-ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhc-cccCceeeEEEEEEc-
Q 002085          631 ESNILSSLTES-NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT-IRHANIVKLWCCISS-  707 (969)
Q Consensus       631 ~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~-  707 (969)
                      ...+.++|... ++||+|+||.||+|.+..+++.||||++...        ..+.+|++++.+ .+||||+++++++.. 
T Consensus        56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            34456778776 7899999999999999999999999998532        356778888755 489999999998865 


Q ss_pred             ---CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          708 ---ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       708 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                         .+..|+||||++||+|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nil  193 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGD-----------QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLL  193 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC--------------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEE
Confidence               5678999999999999999986532           3489999999999999999999998   9999999999999


Q ss_pred             ECC---CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccc
Q 002085          785 LDS---EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS  861 (969)
Q Consensus       785 l~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~  861 (969)
                      ++.   ++.+||+|||+++....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....
T Consensus       194 l~~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  270 (400)
T 1nxk_A          194 YTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  270 (400)
T ss_dssp             ESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS
T ss_pred             EecCCCCccEEEEecccccccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc
Confidence            998   78899999999986532   222345678999999999999999999999999999999999999998654332


Q ss_pred             hHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ..............       ....+.....+..+.+++.+||+.||++|||+.|+++.
T Consensus       271 ~~~~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          271 ISPGMKTRIRMGQY-------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             SCCSHHHHHHHTCC-------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccHHHHHHHHcCcc-------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11111111111100       00111112334678999999999999999999999973

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.4e-39  Score=359.57  Aligned_cols=255  Identities=23%  Similarity=0.241  Sum_probs=206.1

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCc
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENS  710 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  710 (969)
                      ..+.++|+..+.||+|+||.||+|.+..+++.||||++.....       ...+|++++.++ +||||+++++++.+++.
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            3456789999999999999999999999999999999965432       245688888888 79999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC--
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE--  788 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--  788 (969)
                      .|+||||++||+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||++.++  
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~-------------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~  154 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQK-------------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESG  154 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCT-------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCC
Confidence            999999999999999997643             388999999999999999999998   99999999999998543  


Q ss_pred             --CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          789 --FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       789 --~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                        +.+||+|||+++......  .......||+.|+|||++.+..++.++||||+||++|||++|..||.+.......+..
T Consensus       155 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~  232 (342)
T 2qr7_A          155 NPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL  232 (342)
T ss_dssp             SGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH
T ss_pred             CcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH
Confidence              359999999998764432  2234467899999999998888999999999999999999999999864433332222


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .........        .....+...+..+.+++.+||..||++||++.|+++
T Consensus       233 ~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          233 ARIGSGKFS--------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHCCCC--------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHccCCcc--------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            221111111        111112233467899999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.4e-39  Score=348.61  Aligned_cols=262  Identities=27%  Similarity=0.365  Sum_probs=198.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      -.+|+..++||+|+||.||+|++.   ..||||+++.... .....+.+.+|++++++++||||+++++++ .....++|
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            357999999999999999999874   3599999865432 345567899999999999999999999965 55678999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        98 ~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~  162 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASE------------TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIG  162 (289)
T ss_dssp             EECCCEEEHHHHHTTC---------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred             EEecCCCcHHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEc
Confidence            99999999999997543            3489999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |||+++...............||+.|+|||.+.   +..++.++||||+||++|||++|+.||.................
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  242 (289)
T 3og7_A          163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS  242 (289)
T ss_dssp             CCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS
T ss_pred             cceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc
Confidence            999998664433333444567999999999986   56788899999999999999999999976544322211111110


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .....         .......+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       243 ~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          243 LSPDL---------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCCCT---------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cCcch---------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            00000         0111223467899999999999999999999999999885

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2e-39  Score=351.50  Aligned_cols=256  Identities=23%  Similarity=0.331  Sum_probs=208.6

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++. ++..||+|++......    .+.+.+|++++++++||||+++++++.+++..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            457889999999999999999886 5778999999654321    35688999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        98 ~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~  162 (283)
T 3gen_A           98 TEYMANGCLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVS  162 (283)
T ss_dssp             ECCCTTCBHHHHHHCGG------------GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEEC
T ss_pred             EeccCCCcHHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEc
Confidence            99999999999998643            2489999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++..... .........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...........+...    
T Consensus       163 Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----  237 (283)
T 3gen_A          163 DFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG----  237 (283)
T ss_dssp             STTGGGGBCCH-HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT----
T ss_pred             ccccccccccc-ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc----
Confidence            99999865322 1112233457788999999999999999999999999999998 99998766544333322111    


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                .....+...+..+.+++.+||+.||++||+++|+++.|+++.
T Consensus       238 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          238 ----------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence                      111111222367889999999999999999999999998875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=363.06  Aligned_cols=249  Identities=24%  Similarity=0.308  Sum_probs=201.6

Q ss_pred             CccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeec
Q 002085          639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYM  718 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  718 (969)
                      ...+.||+|+||.||+|.+..+|+.||+|+++...   ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            33578999999999999999899999999986543   234568999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE--CCCCcEEEeec
Q 002085          719 ENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL--DSEFKAKIADF  796 (969)
Q Consensus       719 ~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill--~~~~~~kl~Df  796 (969)
                      ++++|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||++  +.++.+||+||
T Consensus       169 ~~~~L~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DF  233 (373)
T 2x4f_A          169 DGGELFDRIIDES------------YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDF  233 (373)
T ss_dssp             TTCEEHHHHHHTG------------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCC
T ss_pred             CCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeC
Confidence            9999999987543            2488999999999999999999998   99999999999999  66789999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI  876 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  876 (969)
                      |+++.+...   .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+..   .....
T Consensus       234 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~---~~~~~  307 (373)
T 2x4f_A          234 GLARRYKPR---EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA---CRWDL  307 (373)
T ss_dssp             SSCEECCTT---CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---TCCCS
T ss_pred             CCceecCCc---cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---ccCCC
Confidence            999876432   223345799999999999998999999999999999999999999987655433332221   11111


Q ss_pred             hhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       877 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                              ........+..+.+++.+||+.||++||++.|+++
T Consensus       308 --------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          308 --------EDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             --------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                    11111223467899999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.3e-39  Score=347.06  Aligned_cols=254  Identities=22%  Similarity=0.254  Sum_probs=209.1

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .++.++|+..+.||+|+||.||+|.+..++..||+|++......   ..+.+.+|++++++++||||+++++++.+++..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence            34567899999999999999999999999999999998654322   246789999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE---CCC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL---DSE  788 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~  788 (969)
                      ++||||+++++|.+++....             .+++..++.++.|++.||+|||+.   +|+||||||+||++   +.+
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  145 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHKR-------------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPD  145 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTT
T ss_pred             EEEEeccCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCC
Confidence            99999999999999987643             388999999999999999999998   99999999999999   788


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +.++|+|||++..+...   .......||+.|+|||.+.+ .++.++||||+|+++|||++|+.||...........+..
T Consensus       146 ~~~~l~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  221 (277)
T 3f3z_A          146 SPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE  221 (277)
T ss_dssp             CCEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CcEEEEecccceeccCc---cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            89999999999876432   23344579999999998865 499999999999999999999999987654433322211


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                         ........        .....+..+.+++.+||+.||++||++.|+++
T Consensus       222 ---~~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          222 ---GTFTFPEK--------DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ---CCCCCCHH--------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---CCCCCCch--------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               11111000        00122467899999999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-39  Score=365.21  Aligned_cols=273  Identities=21%  Similarity=0.243  Sum_probs=216.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC--ceE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN--SKL  712 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  712 (969)
                      -++|+..++||+|+||.||+|++..+|+.||||++......  ...+.+.+|++++++++||||+++++++.+.+  ..+
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            35789999999999999999999999999999999654322  22467789999999999999999999998755  679


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE----CCC
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL----DSE  788 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~  788 (969)
                      +||||+++|+|.+++.....          ...+++..++.++.|++.||+|||+.   +|+||||||+||++    +.+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~  152 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSN----------AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQ  152 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGG----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSC
T ss_pred             EEEecCCCCCHHHHHHhhhc----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCc
Confidence            99999999999999986543          12389999999999999999999998   99999999999999    777


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhccc--------CCCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT--------TKVNEKIDIYSFGVVLLELVTGKEANYGDEHT  860 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~il~elltg~~p~~~~~~~  860 (969)
                      +.+||+|||+++.....   .......||+.|+|||++.+        ..++.++|||||||++|||++|+.||......
T Consensus       153 ~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~  229 (396)
T 4eut_A          153 SVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP  229 (396)
T ss_dssp             EEEEECCGGGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred             eeEEEecCCCceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence            88999999999876432   23344679999999999865        46778999999999999999999999754332


Q ss_pred             c-hHHHHHHHhhccCCchhh--h------------ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          861 S-LAEWAWRHYAEEKPITDA--L------------DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       861 ~-~~~~~~~~~~~~~~~~~~--~------------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      . ..+.+.... ...+....  .            ...............+.+++.+||+.||++||+++|+++.++.+.
T Consensus       230 ~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          230 RRNKEVMYKII-TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             TTCHHHHHHHH-HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             cchHHHHHHHh-cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            2 222222222 21111000  0            001112234667788999999999999999999999999998876


Q ss_pred             C
Q 002085          926 P  926 (969)
Q Consensus       926 ~  926 (969)
                      .
T Consensus       309 ~  309 (396)
T 4eut_A          309 H  309 (396)
T ss_dssp             T
T ss_pred             h
Confidence            4

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-39  Score=360.34  Aligned_cols=273  Identities=23%  Similarity=0.350  Sum_probs=216.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCc-----EEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  708 (969)
                      .++|+..+.||+|+||.||+|.+..+++     .||+|++....  .....+.+.+|+++++++ +||||+++++++.++
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            4678899999999999999999876554     79999986543  334457899999999999 899999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccC-CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSG-SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      +..++||||+++|+|.+++.......... ........+++..++.++.|++.||+|||+.   +|+||||||+||+++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence            99999999999999999998643211000 0011123578999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~  866 (969)
                      ++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+..........
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            99999999999987655444434445667889999999999999999999999999999999 88888765443322211


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..   ..          .....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       280 ~~---~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          280 VK---DG----------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HH---HT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Hh---cC----------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            11   11          111111222367899999999999999999999999998874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.4e-39  Score=360.65  Aligned_cols=251  Identities=27%  Similarity=0.387  Sum_probs=207.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .+.|+..+.||+|+||.||+|++..+++.||||++...........+.+.+|++++++++||||+++++++.+++..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            34588889999999999999999889999999999765444455567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++ |+|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       133 ~e~~~-g~l~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~  196 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK------------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG  196 (348)
T ss_dssp             EECCS-EEHHHHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEEC
T ss_pred             EecCC-CCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEe
Confidence            99997 68888886433            2489999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |||+++....      .....||+.|+|||++.   +..++.++|||||||++|||++|+.||.+.........+   ..
T Consensus       197 DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---~~  267 (348)
T 1u5q_A          197 DFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQ  267 (348)
T ss_dssp             CCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH
T ss_pred             eccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---Hh
Confidence            9999976532      23457999999999984   567899999999999999999999999765543222211   11


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ...+          .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       268 ~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          268 NESP----------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             SCCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             cCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1111          00111223678899999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.4e-39  Score=356.44  Aligned_cols=247  Identities=22%  Similarity=0.278  Sum_probs=182.1

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEEEEeecc
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      .+.||+|+||.||+|.+..+++.||||++....      ...+.+|+++++.+. ||||+++++++.++...|+||||++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~   89 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN   89 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence            478999999999999999999999999985432      356788999999996 9999999999999999999999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC---cEEEeec
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF---KAKIADF  796 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Df  796 (969)
                      +|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++   .+||+||
T Consensus        90 ~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Df  153 (325)
T 3kn6_A           90 GGELFERIKKKK-------------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDF  153 (325)
T ss_dssp             SCBHHHHHHHCS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCC
T ss_pred             CCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecc
Confidence            999999998654             389999999999999999999998   999999999999998766   8999999


Q ss_pred             ccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc----chHHHHHHHhhc
Q 002085          797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT----SLAEWAWRHYAE  872 (969)
Q Consensus       797 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~----~~~~~~~~~~~~  872 (969)
                      |+++.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..    ...+ +......
T Consensus       154 g~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~  230 (325)
T 3kn6_A          154 GFARLKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKK  230 (325)
T ss_dssp             TTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTT
T ss_pred             ccceecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHc
Confidence            999865432  22234457899999999999999999999999999999999999999764431    1111 1111111


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...       ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          231 GDF-------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TCC-------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCC-------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            110       0111111233578899999999999999999998874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.7e-39  Score=344.81  Aligned_cols=256  Identities=23%  Similarity=0.301  Sum_probs=210.2

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +.++|+..+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            45689999999999999999999998999999999865432  2345788999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        83 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  146 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDI-------------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI  146 (276)
T ss_dssp             EEECCTTEEGGGGSBTTT-------------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEecCCCcHHHHHhhcc-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEE
Confidence            999999999999987543             388999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||.+..+.............||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||............   ...
T Consensus       147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~  223 (276)
T 2yex_A          147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKE  223 (276)
T ss_dssp             CCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---HHT
T ss_pred             eeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---hhh
Confidence            99999987654333333445679999999999987765 67899999999999999999999765443221111   111


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....         .......+..+.+++.+||+.||++|||+.|+++
T Consensus       224 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          224 KKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TCTT---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccc---------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            1100         0111223467889999999999999999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-39  Score=359.51  Aligned_cols=280  Identities=23%  Similarity=0.218  Sum_probs=213.4

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh--cHHHHHHHHHHHHHHhccccCceeeEEEEEEcC
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL--NQKLEKEFIAEIEILGTIRHANIVKLWCCISSE  708 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  708 (969)
                      ..++.++|+..+.||+|+||.||+|.+..+++.||+|++......  .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            345678899999999999999999999999999999998654321  234457899999999999999999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCcccc---------------------------CCCCcccccCChHHHHHHHHHHHHh
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVS---------------------------GSSSVHQHVLHWPTRLQIAIGAAQG  761 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------------------------~~~~~~~~~l~~~~~~~i~~~ia~~  761 (969)
                      +..++||||+++|+|.+++.........                           .........+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999999642211000                           0000001234667788999999999


Q ss_pred             hhhhcccCCCCeEecCCCCCcEEECCCC--cEEEeecccceecccCCCC--ccccccccCcccCchhhccc--CCCCCcc
Q 002085          762 LCYMHHDCTPQIIHRDVKSSNILLDSEF--KAKIADFGLAKMLAKQGEP--HTMSAVAGSFGYFAPEYAYT--TKVNEKI  835 (969)
Q Consensus       762 L~~LH~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~s  835 (969)
                      |+|||+.   +|+||||||+||+++.++  .+||+|||+++.+......  .......||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999998   999999999999998776  8999999999876443222  23345679999999999875  6789999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002085          836 DIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK  915 (969)
Q Consensus       836 DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~  915 (969)
                      |||||||++|||++|+.||.+.........+..   ....        ...+.....+..+.+++.+||+.||++||++.
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  326 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN---KKLC--------FENPNYNVLSPLARDLLSNLLNRNVDERFDAM  326 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCCC--------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHh---cccc--------cCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence            999999999999999999987654433322221   1111        11111222346789999999999999999999


Q ss_pred             HHHH--HHhhc
Q 002085          916 EVLQ--ILRRC  924 (969)
Q Consensus       916 evl~--~L~~~  924 (969)
                      |+++  .+++.
T Consensus       327 ~~l~hp~~~~~  337 (345)
T 3hko_A          327 RALQHPWISQF  337 (345)
T ss_dssp             HHHHSHHHHTT
T ss_pred             HHhcChhhccC
Confidence            9987  44444

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5e-39  Score=353.33  Aligned_cols=268  Identities=23%  Similarity=0.358  Sum_probs=206.2

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ..++|+..+.||+|+||.||+|....+|+.||||++......+......+.+|++++++++||||+++++++.+.+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            45689999999999999999999988999999999976444455667889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++++|.+++......         ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus       110 v~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl  177 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQ---------KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL  177 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHT---------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEecCCCCCHHHHHHHhccc---------ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEE
Confidence            99999999999999753210         23488999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+++......  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.+.... ....... ....
T Consensus       178 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-~~~~  253 (310)
T 2wqm_A          178 GDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK-IEQC  253 (310)
T ss_dssp             CCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHH-HHTT
T ss_pred             EeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHH-hhcc
Confidence            9999998654321  2223456899999999999999999999999999999999999999765332 1111111 1110


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      .         .........+..+.+++.+||+.||++||++.|+++.|+++.+
T Consensus       254 ~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          254 D---------YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             C---------SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c---------CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            0         0000111233678999999999999999999999999998853

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.6e-39  Score=353.34  Aligned_cols=258  Identities=25%  Similarity=0.348  Sum_probs=217.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            457888999999999999999999889999999986432    2356789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++.....           ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+
T Consensus        88 ~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~  153 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNR-----------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA  153 (288)
T ss_dssp             EECCTTEEHHHHHHHCCT-----------TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEcCCCCcHHHHHHhccc-----------CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEc
Confidence            999999999999986542           3589999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||+++..... .........+|+.|+|||.+.+..++.++||||+|+++|||++ |..||.+.+.......+...    
T Consensus       154 Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~----  228 (288)
T 3kfa_A          154 DFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----  228 (288)
T ss_dssp             CCCGGGTSCSS-SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----
T ss_pred             cCccceeccCC-ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc----
Confidence            99999866432 2233344567889999999999999999999999999999999 88888776655444333221    


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                .....+...+..+.+++.+|++.||++||++.|+++.|+++.
T Consensus       229 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          229 ----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence                      111122233467899999999999999999999999998875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=348.61  Aligned_cols=254  Identities=24%  Similarity=0.332  Sum_probs=188.9

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ..++|+..+.||+|+||.||+|++..+|+.||||++...........+.+.+|++++++++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            34679999999999999999999988999999999965433233334779999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        89 v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl  153 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRV------------KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKI  153 (278)
T ss_dssp             EEECCTTEEHHHHHHTCS------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEE
T ss_pred             EEecCCCCcHHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence            999999999999998643            2488999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||++.......  .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...........   .    
T Consensus       154 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~----  224 (278)
T 3cok_A          154 ADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK---V----  224 (278)
T ss_dssp             CCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------C----
T ss_pred             EeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH---H----
Confidence            9999998764321  122345689999999999998999999999999999999999999976543322110   0    


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                            .....  ..+...+..+.+++.+||+.||++||+++|+++
T Consensus       225 ------~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          225 ------VLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ------CSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ------hhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                  00000  111223367889999999999999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.9e-39  Score=353.95  Aligned_cols=252  Identities=23%  Similarity=0.303  Sum_probs=198.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEc---CCCcEEEEEEEeccchh-cHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      .++|+..+.||+|+||.||+|+..   .+++.||+|+++..... .......+.+|+++++.++||||+++++++.+++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            467999999999999999999985   57899999999654322 22334668899999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .|+||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~  159 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-------------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGH  159 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCc
Confidence            999999999999999997643             378899999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      +||+|||+++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+..  
T Consensus       160 ~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--  235 (327)
T 3a62_A          160 VKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--  235 (327)
T ss_dssp             EEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--
T ss_pred             EEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--
Confidence            9999999997643221  223345799999999999999999999999999999999999999987654433332221  


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                       ....            .+...+..+.+++.+||+.||++||     ++.|+++
T Consensus       236 -~~~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          236 -CKLN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -TCCC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -CCCC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence             1111            1112336789999999999999999     6777765

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.5e-39  Score=373.92  Aligned_cols=257  Identities=28%  Similarity=0.455  Sum_probs=206.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||.||+|.+.. +..||||+++....    ..+.+.+|++++++++||||+++++++.+ +..++||
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence            467888999999999999999974 56799999865432    13578999999999999999999999876 6789999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       258 e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D  323 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGETG-----------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD  323 (452)
T ss_dssp             CCCTTCBHHHHHSHHHH-----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             hhhcCCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECC
Confidence            99999999999975321           3488999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++..... .........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+....+....+..      
T Consensus       324 fG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~------  396 (452)
T 1fmk_A          324 FGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------  396 (452)
T ss_dssp             CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------
T ss_pred             CccceecCCC-ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------
Confidence            9999876432 1222234457889999999999999999999999999999999 8888876654433322211      


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPT  927 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  927 (969)
                              +...+.+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       397 --------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          397 --------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             --------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                    111222334457889999999999999999999999999998643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.5e-39  Score=346.79  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=209.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++..+++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            46799999999999999999999989999999998654332333356789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        93 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  156 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-------------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIA  156 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred             EEeCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEe
Confidence            99999999999998643             388999999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||++.....    .......|++.|+|||.+.+..++.++||||+|+++|||++|..||...........+.   ....
T Consensus       157 Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~  229 (284)
T 2vgo_A          157 DFGWSVHAPS----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV---NVDL  229 (284)
T ss_dssp             CCTTCEECSS----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---TTCC
T ss_pred             cccccccCcc----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh---cccc
Confidence            9999876532    12234578999999999999999999999999999999999999997655433222111   1110


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                  ..+...+..+.+++.+|++.||++||++.|+++
T Consensus       230 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 ------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                        111223367889999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-39  Score=367.47  Aligned_cols=268  Identities=26%  Similarity=0.360  Sum_probs=201.2

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCC-
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSEN-  709 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-  709 (969)
                      ..+.++|+..+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++...+ 
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            456789999999999999999999999999999999986442 23444677889999999997 999999999997543 


Q ss_pred             -ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          710 -SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       710 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                       ..|+||||++ ++|.+++...              .+++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~  145 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRAN--------------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAE  145 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHT--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT
T ss_pred             CEEEEEecccC-cCHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCC
Confidence             6899999997 6899998753              388899999999999999999998   99999999999999999


Q ss_pred             CcEEEeecccceecccCC-------------------CCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQG-------------------EPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELV  848 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell  848 (969)
                      +.+||+|||+|+.+....                   .........||+.|+|||++.+ ..++.++||||+||++|||+
T Consensus       146 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  225 (388)
T 3oz6_A          146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL  225 (388)
T ss_dssp             CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence            999999999998764311                   1122344679999999999886 67899999999999999999


Q ss_pred             hCCCCCCCCCccchHHHHHHHhhccCCchhhhcc----------------------CCCCcc------------cHHHHH
Q 002085          849 TGKEANYGDEHTSLAEWAWRHYAEEKPITDALDK----------------------GIAEPC------------YLEEMT  894 (969)
Q Consensus       849 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~------------~~~~~~  894 (969)
                      +|+.||.+.+.......+.......  ..+.+..                      ......            ....+.
T Consensus       226 ~g~~pf~~~~~~~~~~~i~~~~~~p--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (388)
T 3oz6_A          226 CGKPIFPGSSTMNQLERIIGVIDFP--SNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE  303 (388)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCC--CHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCH
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCC--CHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCH
Confidence            9999998876554444333221111  0000000                      000000            001235


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          895 TVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       895 ~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .+.+++.+||+.||++|||++|+++.
T Consensus       304 ~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          304 EALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHhhccCcccCCCHHHHhCC
Confidence            78899999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.6e-39  Score=357.77  Aligned_cols=270  Identities=21%  Similarity=0.325  Sum_probs=216.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEc-----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDIN-----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      .++|+..+.||+|+||.||+|.+.     .+++.||||++....  .......+.+|+++++.++||||+++++++.+++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            467999999999999999999875     357789999986432  3344567999999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++|+|.+++.........   ......+++..++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMAN---NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHH---CTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhcc---CCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence            999999999999999999864321000   00013468999999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  868 (969)
                      .+||+|||+++...............+|+.|+|||.+.+..++.++||||+||++|||++ |..||.+.........+. 
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-  254 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-  254 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH-
Confidence            999999999987654333333344567899999999999999999999999999999999 778887654433322221 


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                         ...          ....+...+..+.+++.+||+.||++||++.|+++.|++...
T Consensus       255 ---~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          255 ---EGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ---TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---cCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence               111          011122334678999999999999999999999999998853

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-39  Score=356.18  Aligned_cols=260  Identities=27%  Similarity=0.454  Sum_probs=206.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCC----CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGA----GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      .++|+..+.||+|+||.||+|.+..+    +..||||+++...  .......+.+|++++++++||||+++++++.+.+.
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            45788889999999999999988644    3469999986432  34445689999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~  185 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKD------------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLV  185 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT------------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred             cEEEEeCCCCCcHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCc
Confidence            999999999999999997643            2488999999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCC-ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  868 (969)
                      +||+|||+++........ .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.........+. 
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-  264 (333)
T 1mqb_A          186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-  264 (333)
T ss_dssp             EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-
T ss_pred             EEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-
Confidence            999999999876443211 12223456889999999999999999999999999999999 999987665433322221 


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                         ..          ...+.+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       265 ---~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          265 ---DG----------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             ---TT----------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---CC----------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               11          111122233467899999999999999999999999998875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.3e-39  Score=390.62  Aligned_cols=247  Identities=23%  Similarity=0.319  Sum_probs=209.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  713 (969)
                      .++|+..++||+|+||.||+|++..+++.||||+++..........+.+..|.+++..+ +||+|+++++++.+.+..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            56899999999999999999999999999999999765433344456788999999988 79999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||++||+|.++++...             .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       420 V~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL  483 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG-------------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI  483 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEE
T ss_pred             EEeCcCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEE
Confidence            999999999999998654             389999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+|+.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+..   ..
T Consensus       484 ~DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~---~~  558 (674)
T 3pfq_A          484 ADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---HN  558 (674)
T ss_dssp             CCCTTCEECCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS---SC
T ss_pred             eecceeeccccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh---CC
Confidence            999999864332  2234456899999999999999999999999999999999999999988765444433321   11


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                      .            ..+...+.++.+++.+||+.||++||++
T Consensus       559 ~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          559 V------------AYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             C------------CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             C------------CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence            1            1122334678999999999999999987

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-38  Score=347.61  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=213.4

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            34679999999999999999999999999999999976654555667889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        93 v~e~~~~~~L~~~~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  156 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK-------------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKI  156 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred             EEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEE
Confidence            999999999999987543             388999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+++......  .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...........+   ....
T Consensus       157 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~  231 (294)
T 2rku_A          157 GDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI---KKNE  231 (294)
T ss_dssp             CCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTTC
T ss_pred             EeccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hhcc
Confidence            9999998764322  2233457899999999999989999999999999999999999999765433222111   1111


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .            ..+......+.+++.+||+.||++||++.|+++
T Consensus       232 ~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          232 Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             C------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            0            011122367889999999999999999999996

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-39  Score=356.61  Aligned_cols=270  Identities=22%  Similarity=0.306  Sum_probs=204.7

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc--HHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN--QKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ...++|+..+.||+|+||.||+|++..+|+.||||++.......  ....+.+.+|+++++.++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999999899999999986432211  1223568899999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||+++ +|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~  150 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS------------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGV  150 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC------------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             eEEEEEcCCC-CHHHHHHhcC------------cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCC
Confidence            9999999985 8998887543            2478899999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      +||+|||+++.+...  ........||+.|+|||++.+. .++.++||||+||++|||++|..||.+.........+...
T Consensus       151 ~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~  228 (346)
T 1ua2_A          151 LKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET  228 (346)
T ss_dssp             EEECCCGGGSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEEEecccceeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence            999999999876432  2233456789999999998764 4889999999999999999999998876655444444332


Q ss_pred             hhccCC--ch------hhhccCCCCccc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          870 YAEEKP--IT------DALDKGIAEPCY-----LEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       870 ~~~~~~--~~------~~~~~~~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ......  ..      +..........+     ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            211110  00      000000000001     2234678999999999999999999999974

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-38  Score=368.33  Aligned_cols=264  Identities=24%  Similarity=0.269  Sum_probs=203.9

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC---
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN---  709 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  709 (969)
                      .+.++|+..++||+|+||.||+|.+..+++.||||++.... ......+.+.+|+++++.++||||+++++++...+   
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence            34678999999999999999999999999999999996542 24455678999999999999999999999996553   


Q ss_pred             ---ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          710 ---SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       710 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                         ..|+||||+++ +|.+.+..               .+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus       138 ~~~~~~lv~E~~~~-~l~~~~~~---------------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~  198 (464)
T 3ttj_A          138 EFQDVYLVMELMDA-NLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK  198 (464)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHTS---------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred             cCCeEEEEEeCCCC-CHHHHHhh---------------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEe
Confidence               56999999975 46666642               278899999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      .++.+||+|||+|+....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+
T Consensus       199 ~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i  275 (464)
T 3ttj_A          199 SDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV  275 (464)
T ss_dssp             TTSCEEECCCCCC--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCEEEEEEEeeeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999987633   22344568999999999999999999999999999999999999999877654443333


Q ss_pred             HHHhhccC------------------------CchhhhccCCC---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEK------------------------PITDALDKGIA---EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~------------------------~~~~~~~~~~~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ........                        ...........   ..........+.+++.+||+.||++|||++|+++
T Consensus       276 ~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          276 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            22211100                        00000000000   0011122567899999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-38  Score=354.10  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=213.8

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ..++|...+.||+|+||.||+|++..+++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            35679999999999999999999999999999999976655555667889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++++|.+++....             .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       119 v~e~~~~~~L~~~~~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl  182 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK-------------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKI  182 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred             EEecCCCCCHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEE
Confidence            999999999999987543             388999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..   ..
T Consensus       183 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~  257 (335)
T 2owb_A          183 GDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---NE  257 (335)
T ss_dssp             CCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---TC
T ss_pred             eeccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc---CC
Confidence            9999998764322  223345799999999999999999999999999999999999999976543332221111   11


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..            .+......+.+++.+||+.||++||++.|+++
T Consensus       258 ~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 YS------------IPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11            11122357889999999999999999999996

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.8e-39  Score=350.57  Aligned_cols=252  Identities=19%  Similarity=0.328  Sum_probs=205.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCC-------cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAG-------EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE  708 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  708 (969)
                      ++|+..+.||+|+||.||+|++..++       ..||+|++....   ....+.+.+|++++++++||||+++++++.++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            57888999999999999999987666       479999985432   23356799999999999999999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      +..++||||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  149 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNK------------NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIRE  149 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTG------------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEEC
T ss_pred             CCCEEEEECCCCCCHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecC
Confidence            99999999999999999998654            2488999999999999999999998   99999999999999988


Q ss_pred             Cc--------EEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCc
Q 002085          789 FK--------AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEH  859 (969)
Q Consensus       789 ~~--------~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~  859 (969)
                      +.        +||+|||++.....      .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.|+.....
T Consensus       150 ~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~  223 (289)
T 4fvq_A          150 EDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD  223 (289)
T ss_dssp             CBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             CcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence            87        99999999865421      123457899999999987 6789999999999999999997776665433


Q ss_pred             cchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      .......   .......        ..    ..+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       224 ~~~~~~~---~~~~~~~--------~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          224 SQRKLQF---YEDRHQL--------PA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHHHHH---HHTTCCC--------CC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hHHHHHH---hhccCCC--------CC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2221111   1111110        11    112467899999999999999999999999999974

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6e-39  Score=352.33  Aligned_cols=268  Identities=25%  Similarity=0.305  Sum_probs=206.5

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh--cHHHHHHHHHHHHHHhccc---cCceeeEEEEEEcC
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL--NQKLEKEFIAEIEILGTIR---HANIVKLWCCISSE  708 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  708 (969)
                      +.++|+..++||+|+||+||+|++..+++.||||++......  .......+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            356899999999999999999999889999999998643211  1111245667777777764   99999999999775


Q ss_pred             C-----ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcE
Q 002085          709 N-----SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI  783 (969)
Q Consensus       709 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Ni  783 (969)
                      .     ..++||||++ ++|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Ni  151 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-----------PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENI  151 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            5     4799999997 699999986542           3489999999999999999999998   999999999999


Q ss_pred             EECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          784 LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       784 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                      +++.++.+||+|||+++....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.......
T Consensus       152 l~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  228 (308)
T 3g33_A          152 LVTSGGTVKLADFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL  228 (308)
T ss_dssp             EECTTSCEEECSCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEeeCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999986532   22334567899999999999999999999999999999999999999877665554


Q ss_pred             HHHHHHhhccCC--chh-------hhccCCCC---cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          864 EWAWRHYAEEKP--ITD-------ALDKGIAE---PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       864 ~~~~~~~~~~~~--~~~-------~~~~~~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..+.........  ...       ........   ....+.+..+.+++.+|++.||++|||+.|+++
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            444333221110  000       00000000   001123467889999999999999999999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=359.46  Aligned_cols=250  Identities=24%  Similarity=0.316  Sum_probs=208.3

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc-----HHHHHHHHHHHHHHhccccCceeeEEEEE
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN-----QKLEKEFIAEIEILGTIRHANIVKLWCCI  705 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~  705 (969)
                      ...+.++|+..+.||+|+||.||+|++..+++.||||++.......     ....+.+.+|++++++++||||+++++++
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~   98 (335)
T 3dls_A           19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF   98 (335)
T ss_dssp             TTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456788999999999999999999999999999999997543211     11234677899999999999999999999


Q ss_pred             EcCCceEEEEeeccCC-CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          706 SSENSKLLVYEYMENQ-SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       706 ~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                      .+.+..++||||+.+| +|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~-------------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  162 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHP-------------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIV  162 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEE
Confidence            9999999999999776 9999998654             389999999999999999999998   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                      ++.++.+||+|||+++.....   .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......   
T Consensus       163 l~~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---  236 (335)
T 3dls_A          163 IAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---  236 (335)
T ss_dssp             ECTTSCEEECCCTTCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---
T ss_pred             EcCCCcEEEeecccceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---
Confidence            999999999999999876432   22334579999999999988877 78999999999999999999999652110   


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                                      ......  .+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       237 ----------------~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ----------------VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----------------TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----------------HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                            001111  111123678999999999999999999999984

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.1e-39  Score=359.23  Aligned_cols=273  Identities=27%  Similarity=0.357  Sum_probs=214.3

Q ss_pred             cCCCccceeeecCcEEEEEEE----EcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEE--cCC
Q 002085          636 SSLTESNLIGSGGSGQVYRID----INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCIS--SEN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~  709 (969)
                      ++|+..+.||+|+||.||+|+    ...+++.||||++...   .....+.+.+|++++++++||||+++++++.  +..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            578999999999999999999    4567899999998653   3344577999999999999999999999886  455


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~  164 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR------------ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEA  164 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG------------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             eEEEEEeecCCCCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCC
Confidence            6899999999999999998643            2489999999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCc-cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH-
Q 002085          790 KAKIADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW-  867 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~-  867 (969)
                      .+||+|||+++......... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||............. 
T Consensus       165 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  244 (327)
T 3lxl_A          165 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE  244 (327)
T ss_dssp             EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred             CEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence            99999999998765432222 2234568889999999999999999999999999999999999986532211000000 


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      ..........+....+...+.+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             --CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             cccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            00000001112222222333344455789999999999999999999999999999863

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-39  Score=349.36  Aligned_cols=258  Identities=21%  Similarity=0.329  Sum_probs=207.6

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCc---EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce-E
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK-L  712 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~  712 (969)
                      .|...++||+|+||+||+|.+..+++   .||+|++...  ......+.+.+|++++++++||||+++++++.+.+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            45567899999999999999755444   7999998543  2344567899999999999999999999999876655 9


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+.+++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       100 ~v~e~~~~~~L~~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~k  164 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQ------------RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVK  164 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTT------------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEE
T ss_pred             EEEecccCCCHHHHHhccc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence            9999999999999998643            2478999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCC--CCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCC-CccchHHHHHHH
Q 002085          793 IADFGLAKMLAKQG--EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD-EHTSLAEWAWRH  869 (969)
Q Consensus       793 l~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~-~~~~~~~~~~~~  869 (969)
                      |+|||+++.+....  .........+++.|+|||.+.+..++.++||||+||++|||++|+.|++.. +.......+...
T Consensus       165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~  244 (298)
T 3pls_A          165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG  244 (298)
T ss_dssp             ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT
T ss_pred             eCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC
Confidence            99999998653321  112233456789999999999999999999999999999999977776544 333332222111


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                    ...+.+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       245 --------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          245 --------------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             --------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------------CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                          111112223467899999999999999999999999998875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.4e-39  Score=346.47  Aligned_cols=258  Identities=26%  Similarity=0.328  Sum_probs=204.4

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .++.+.|...++||+|+||.||+|+...+++.||+|++.....  ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            3456789999999999999999999999999999999865432  22346789999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE---CCC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL---DSE  788 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~  788 (969)
                      ++||||+++|+|.+++.....         ....+++..++.++.|++.||+|||+.   +|+||||||+||++   +.+
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~  163 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQA---------RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPH  163 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHH---------HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTT
T ss_pred             EEEEEeCCCCcHHHHHHhhhh---------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCC
Confidence            999999999999999865421         013488999999999999999999998   99999999999999   455


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +.+||+|||+++.+...   .......||+.|+|||.+. ..++.++||||+||++|||++|+.||.+............
T Consensus       164 ~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~  239 (285)
T 3is5_A          164 SPIKIIDFGLAELFKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY  239 (285)
T ss_dssp             CCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCEEEEeeecceecCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc
Confidence            78999999999865432   2234457899999999875 5689999999999999999999999987654433322211


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                         ...... .        .....+..+.+++.+||+.||++|||+.|+++
T Consensus       240 ---~~~~~~-~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          240 ---KEPNYA-V--------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---CCCCCC-C----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---CCcccc-c--------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               111000 0        00012367889999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.7e-39  Score=349.45  Aligned_cols=258  Identities=25%  Similarity=0.354  Sum_probs=207.6

Q ss_pred             cCCCccc-eeeecCcEEEEEEEE--cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESN-LIGSGGSGQVYRIDI--NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~-~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++|+..+ .||+|+||.||+|.+  ..+++.||||+++... ......+.+.+|+++++.++||||+++++++ +.+..+
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            4677777 999999999999954  5567899999986543 2334467899999999999999999999999 567789


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++++|.+++....             .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        94 lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~k  157 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-------------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAK  157 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred             EEEEeCCCCCHHHHHHhCc-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEE
Confidence            9999999999999998643             388999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCCc-cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          793 IADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |+|||+++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.........+.   
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---  234 (291)
T 1xbb_A          158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---  234 (291)
T ss_dssp             ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---
T ss_pred             EccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---
Confidence            99999998764432221 1223456789999999998889999999999999999999 999987765443322221   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                       ...          ....+...+..+.+++.+||+.||++||++.|+++.|+++-
T Consensus       235 -~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          235 -KGE----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             -TTC----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             111          11122233467999999999999999999999999998874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.6e-39  Score=345.51  Aligned_cols=255  Identities=25%  Similarity=0.359  Sum_probs=210.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|++++++++||||+++++++.+++..++||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            57888999999999999999986 5778999999654321    357899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++....            ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        83 e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d  147 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQR------------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD  147 (267)
T ss_dssp             CCCTTCBHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECC
T ss_pred             eCCCCCcHHHHHhhCc------------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcc
Confidence            9999999999998653            2488999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++..... .........+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...........+..    ..
T Consensus       148 fg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~----~~  222 (267)
T 3t9t_A          148 FGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GF  222 (267)
T ss_dssp             TTGGGGBCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----TC
T ss_pred             cccccccccc-cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc----CC
Confidence            9999865321 1112234457889999999999999999999999999999999 7888876554333322211    10


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                ....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       223 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          223 ----------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                      01111222467899999999999999999999999998874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-38  Score=357.47  Aligned_cols=257  Identities=23%  Similarity=0.364  Sum_probs=209.9

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccch-----hcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-----LNQKLEKEFIAEIEILGTI-RHANIVKLWCCIS  706 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  706 (969)
                      .+.++|+..+.||+|+||.||+|.+..+|+.||||++.....     ......+.+.+|+++++++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            456789999999999999999999988899999999865431     1123356789999999999 7999999999999


Q ss_pred             cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       707 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                      .....|+||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~-------------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~  234 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKV-------------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLD  234 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            9999999999999999999997543             388999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT------TKVNEKIDIYSFGVVLLELVTGKEANYGDEHT  860 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~il~elltg~~p~~~~~~~  860 (969)
                      .++.+||+|||++..+...   .......||+.|+|||++.+      ..++.++|||||||++|||++|+.||......
T Consensus       235 ~~~~ikl~DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  311 (365)
T 2y7j_A          235 DNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI  311 (365)
T ss_dssp             TTCCEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCCCEEEEecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence            9999999999999876432   22345679999999999863      35888999999999999999999999875543


Q ss_pred             chHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          861 SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       861 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .....+...   ....        ..+.....+..+.+++.+||+.||++||++.|+++
T Consensus       312 ~~~~~i~~~---~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          312 LMLRMIMEG---QYQF--------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHHHHT---CCCC--------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhC---CCCC--------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            333222111   0000        00001122367899999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.1e-39  Score=346.38  Aligned_cols=260  Identities=22%  Similarity=0.298  Sum_probs=208.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH---HHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ---KLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .++|+..+.||+|+||.||+|++..+++.||+|+++.......   ...+.+.+|++++++++||||+++++++.++...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            3568899999999999999999998999999999865432211   1256799999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC--
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF--  789 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~--  789 (969)
                      ++||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++  
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  147 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-------------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVP  147 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSS
T ss_pred             EEEEeecCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCC
Confidence            99999999999999997543             388999999999999999999998   999999999999999887  


Q ss_pred             --cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          790 --KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       790 --~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                        .+||+|||++......   .......|++.|+|||.+.+..++.++||||+|+++|||++|+.||.+.........+.
T Consensus       148 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  224 (283)
T 3bhy_A          148 NPRIKLIDFGIAHKIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS  224 (283)
T ss_dssp             SCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             CCceEEEecccceeccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH
Confidence              8999999999876432   22334568999999999999999999999999999999999999998765433222111


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhc
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRC  924 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~  924 (969)
                         .......        .......+..+.+++.+||+.||++||++.|+++  .++..
T Consensus       225 ---~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          225 ---AVNYDFD--------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             ---TTCCCCC--------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             ---hcccCCc--------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence               1111000        0011122367889999999999999999999997  44444

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-38  Score=356.69  Aligned_cols=262  Identities=24%  Similarity=0.261  Sum_probs=208.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-----cCceeeEEEEEEcC
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-----HANIVKLWCCISSE  708 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~  708 (969)
                      +.++|++.++||+|+||.||+|++..+++.||||++...    ....+.+..|+++++.++     ||||+++++++...
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~  108 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY  108 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence            346899999999999999999999989999999998532    234566788999999986     99999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC-
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-  787 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~-  787 (969)
                      +..++||||+ +++|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++. 
T Consensus       109 ~~~~lv~e~~-~~~L~~~~~~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          109 DHMCLIFEPL-GPSLYEIITRNNY-----------NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP  173 (360)
T ss_dssp             TEEEEEECCC-CCBHHHHHHHTTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred             CeeEEEEcCC-CCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence            9999999999 8999999986542           3488999999999999999999988   9999999999999986 


Q ss_pred             ------------------------CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHH
Q 002085          788 ------------------------EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVV  843 (969)
Q Consensus       788 ------------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~i  843 (969)
                                              ++.+||+|||+++....     ......||+.|+|||++.+..++.++||||+||+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                                    78999999999986432     2234578999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCccchHHHHHHHhhccCC----------chhhhcc-----CCCCc----------------ccHHH
Q 002085          844 LLELVTGKEANYGDEHTSLAEWAWRHYAEEKP----------ITDALDK-----GIAEP----------------CYLEE  892 (969)
Q Consensus       844 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~-----~~~~~----------------~~~~~  892 (969)
                      +|||++|+.||.+.+.......+.........          .......     .....                .....
T Consensus       249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (360)
T 3llt_A          249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK  328 (360)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred             HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence            99999999999876654443333222111000          0000000     00000                00001


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          893 MTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       893 ~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...+.+++.+||+.||++|||++|+++
T Consensus       329 ~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          329 HELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            256789999999999999999999975

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.1e-39  Score=352.22  Aligned_cols=266  Identities=20%  Similarity=0.308  Sum_probs=203.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcC---CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC--
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDING---AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN--  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  709 (969)
                      .++|...+.||+|+||.||+|....   +++.||+|+++.... .....+.+.+|++++++++||||+++++++.+..  
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3578889999999999999998764   456899999865432 3444678999999999999999999999997754  


Q ss_pred             ---ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          710 ---SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       710 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                         ..++||||+++++|.+++......       .....+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~  181 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLE-------TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLR  181 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBT-------TSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEEC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhh-------cCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEc
Confidence               359999999999999999643211       0124589999999999999999999988   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEW  865 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~  865 (969)
                      .++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.........
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  261 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY  261 (313)
T ss_dssp             TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence            999999999999987654333333344567889999999999999999999999999999999 7788876655544433


Q ss_pred             HHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      +....              ....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       262 ~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          262 LLHGH--------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             HHTTC--------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCC--------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            22111              11122233467899999999999999999999999998874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=354.84  Aligned_cols=269  Identities=17%  Similarity=0.192  Sum_probs=204.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcC---CCcEEEEEEEeccchhcH--------HHHHHHHHHHHHHhccccCceeeEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDING---AGEFVAVKRIWNNRKLNQ--------KLEKEFIAEIEILGTIRHANIVKLWC  703 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~  703 (969)
                      .++|+..+.||+|+||.||+|.+..   ++..||||++........        .....+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3579999999999999999999986   778999999865432111        11234778889999999999999999


Q ss_pred             EEEc----CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCC
Q 002085          704 CISS----ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK  779 (969)
Q Consensus       704 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  779 (969)
                      ++.+    ....|+||||+ +++|.+++....             .+++..++.++.|++.||+|||+.   +|+|||||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk  178 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-------------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIK  178 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-------------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcC
Confidence            9887    67889999999 999999998643             389999999999999999999998   99999999


Q ss_pred             CCcEEECCCC--cEEEeecccceecccCCCC-----ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCC
Q 002085          780 SSNILLDSEF--KAKIADFGLAKMLAKQGEP-----HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE  852 (969)
Q Consensus       780 p~Nill~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~  852 (969)
                      |+||+++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       179 p~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~  258 (345)
T 2v62_A          179 AANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKL  258 (345)
T ss_dssp             GGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             HHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999887  9999999999876543221     11244579999999999999999999999999999999999999


Q ss_pred             CCCCCCcc-chHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          853 ANYGDEHT-SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       853 p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ||.+.... ..............  .........   ....+..+.+++.+||+.||++||++.++++.|++..
T Consensus       259 pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          259 PWEQNLKDPVAVQTAKTNLLDEL--PQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             TTGGGTTCHHHHHHHHHHHHHTT--THHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             CccccccccHHHHHHHHhhcccc--cHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            99653222 11122222221111  111111000   0022367899999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-38  Score=348.58  Aligned_cols=267  Identities=27%  Similarity=0.394  Sum_probs=208.8

Q ss_pred             cCCCccceeeecCcEEEEEEE----EcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--C
Q 002085          636 SSLTESNLIGSGGSGQVYRID----INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--N  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  709 (969)
                      +.|+..+.||+|+||.||+|+    ...+++.||||++.....  ....+.+.+|++++++++||||+++++++.+.  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            458889999999999999999    456789999999865432  22346789999999999999999999999876  6


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~  163 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNK------------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH  163 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHT------------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             eEEEEEEeCCCCcHHHHHHhcc------------ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCC
Confidence            6899999999999999996543            2488999999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCCC-ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      .+||+|||+++.+...... .......||..|+|||.+.+..++.++||||+||++|||++|+.|+.....     ....
T Consensus       164 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~  238 (302)
T 4e5w_A          164 QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA-----LFLK  238 (302)
T ss_dssp             EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHH
T ss_pred             CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh-----HHhh
Confidence            9999999999877543222 223345688899999999999999999999999999999999988542110     0000


Q ss_pred             Hhhc------cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          869 HYAE------EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       869 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      ....      ..............+.+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          239 MIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            0000      0001111122222233334457899999999999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.7e-38  Score=372.89  Aligned_cols=264  Identities=26%  Similarity=0.349  Sum_probs=212.0

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH----------HHHHHHHHHHHHHhccccCceee
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ----------KLEKEFIAEIEILGTIRHANIVK  700 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~  700 (969)
                      ...+.++|++.++||+|+||+||+|++..+++.||||++........          ...+.+.+|++++++++||||++
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            34567889999999999999999999999999999999965432211          23467999999999999999999


Q ss_pred             EEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCC
Q 002085          701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKS  780 (969)
Q Consensus       701 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  780 (969)
                      +++++.+++..|+||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp  174 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRH-------------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKP  174 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcH
Confidence            9999999999999999999999999997643             389999999999999999999998   999999999


Q ss_pred             CcEEECCCC---cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 002085          781 SNILLDSEF---KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD  857 (969)
Q Consensus       781 ~Nill~~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~  857 (969)
                      +||+++.++   .+||+|||+++.+...   .......||+.|+|||++. +.++.++||||+||++|+|++|..||.+.
T Consensus       175 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  250 (504)
T 3q5i_A          175 ENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ  250 (504)
T ss_dssp             GGEEESSTTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEEecCCCCccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999876   6999999999876432   2334567999999999987 46999999999999999999999999876


Q ss_pred             CccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcC
Q 002085          858 EHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRCC  925 (969)
Q Consensus       858 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~~  925 (969)
                      ........+...   ....        ..+.....+..+.+++.+||+.||++|||+.|+++  .+++..
T Consensus       251 ~~~~~~~~i~~~---~~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          251 NDQDIIKKVEKG---KYYF--------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             SHHHHHHHHHHC---CCCC--------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CHHHHHHHHHcC---CCCC--------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            654443333221   0000        00011122467899999999999999999999985  455543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5e-39  Score=375.93  Aligned_cols=261  Identities=24%  Similarity=0.328  Sum_probs=215.9

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      .+.++|+..++||+|+||.||+|++..+|+.||||++...........+.+.+|++++++++||||+++++++.+.+..|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45568999999999999999999999999999999996554333344578999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE---CCCC
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL---DSEF  789 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~  789 (969)
                      +||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++
T Consensus       103 lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  166 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRK-------------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDA  166 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCS-------------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTC
T ss_pred             EEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCC
Confidence            9999999999999997654             388999999999999999999998   99999999999999   5678


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      .+||+|||+++.+...   .......||+.|+|||++.+ .++.++||||+||++|||++|..||.+.........+...
T Consensus       167 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  242 (484)
T 3nyv_A          167 NIRIIDFGLSTHFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG  242 (484)
T ss_dssp             CEEECCTTHHHHBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             cEEEEeeeeeEEcccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence            9999999999876432   23344579999999999876 6999999999999999999999999876654443333221


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhc
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRC  924 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~  924 (969)
                      .   .        ....+.+...+..+.+++.+||+.||++|||+.|+++  .++..
T Consensus       243 ~---~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          243 K---Y--------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             C---C--------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             C---C--------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            0   0        0111222334577899999999999999999999995  45444

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-38  Score=349.84  Aligned_cols=268  Identities=27%  Similarity=0.347  Sum_probs=203.7

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc--ccCceeeEEEEEEcC-
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI--RHANIVKLWCCISSE-  708 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~-  708 (969)
                      ..+.++|+..+.||+|+||.||+|++.  ++.||||++....      ...+.+|.+++...  +||||+++++++.+. 
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            345678999999999999999999985  8899999985432      23445566666655  899999999999876 


Q ss_pred             ---CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC-----CCCeEecCCCC
Q 002085          709 ---NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC-----TPQIIHRDVKS  780 (969)
Q Consensus       709 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp  780 (969)
                         ...++||||+++|+|.++++..              .+++..++.++.|++.||+|||+.+     .++|+||||||
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp  170 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST--------------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS  170 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCG
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccch
Confidence               6789999999999999999753              3889999999999999999999652     33899999999


Q ss_pred             CcEEECCCCcEEEeecccceecccCCCCc--cccccccCcccCchhhcccCCCCCc------cchhhHHHHHHHHHhC--
Q 002085          781 SNILLDSEFKAKIADFGLAKMLAKQGEPH--TMSAVAGSFGYFAPEYAYTTKVNEK------IDIYSFGVVLLELVTG--  850 (969)
Q Consensus       781 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslG~il~elltg--  850 (969)
                      +||+++.++.+||+|||+++.+.......  ......||+.|+|||++.+...+.+      +|||||||++|||++|  
T Consensus       171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~  250 (337)
T 3mdy_A          171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV  250 (337)
T ss_dssp             GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence            99999999999999999998764432221  1234579999999999988777665      9999999999999999  


Q ss_pred             --------CCCCCCCCccch-HHHHHHHhhccCCchhhhccCCCC-cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          851 --------KEANYGDEHTSL-AEWAWRHYAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       851 --------~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                              ..||........ ........ .....    .+.... ....+.+..+.+++.+||+.||++||++.|+++.
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          251 SGGIVEEYQLPYHDLVPSDPSYEDMREIV-CIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             BTTBCCCCCCTTTTTSCSSCCHHHHHHHH-TTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccccccccccHhhhcCCCCchhhhHHHH-hhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                    556544322111 11111111 11110    111111 1123667889999999999999999999999999


Q ss_pred             HhhcCC
Q 002085          921 LRRCCP  926 (969)
Q Consensus       921 L~~~~~  926 (969)
                      |+++..
T Consensus       326 L~~l~~  331 (337)
T 3mdy_A          326 LAKMSE  331 (337)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            998863

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.8e-39  Score=355.07  Aligned_cols=269  Identities=20%  Similarity=0.264  Sum_probs=200.4

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      .....++|+..++||+|+||+||+|.+..+++.||||++..... .....+.+.+|++++++++||||+++++++.+++.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            34557789999999999999999999999999999999865432 33345678899999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC----
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD----  786 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~----  786 (969)
                      .++||||++ |+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++    
T Consensus       108 ~~lv~e~~~-~~L~~~~~~~~-------------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~  170 (329)
T 3gbz_A          108 LHLIFEYAE-NDLKKYMDKNP-------------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA  170 (329)
T ss_dssp             EEEEEECCS-EEHHHHHHHCT-------------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC---
T ss_pred             EEEEEecCC-CCHHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC
Confidence            999999998 59999998654             388999999999999999999998   999999999999994    


Q ss_pred             -CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          787 -SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       787 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                       +++.+||+|||+++.+...  ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+........
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  248 (329)
T 3gbz_A          171 SETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF  248 (329)
T ss_dssp             --CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CccceEEECcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH
Confidence             4556999999999876432  2223445689999999999875 48999999999999999999999998766544433


Q ss_pred             HHHHHhhccCC--chhhh--------ccCCCCcc-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          865 WAWRHYAEEKP--ITDAL--------DKGIAEPC-----YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       865 ~~~~~~~~~~~--~~~~~--------~~~~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+.........  .....        .+......     .......+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          249 KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            33322211100  00000        00000000     0112367889999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-38  Score=343.40  Aligned_cols=251  Identities=25%  Similarity=0.317  Sum_probs=201.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|++.+.||+|+||.||+|++..+++.||||++...........+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            46899999999999999999999989999999998654332333456889999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        90 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~  153 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-------------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIA  153 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEEC
T ss_pred             EeccCCCcHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEe
Confidence            99999999999997643             388999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      |||++......   .......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||...........+..    .
T Consensus       154 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~  226 (276)
T 2h6d_A          154 DFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG----G  226 (276)
T ss_dssp             CCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----C
T ss_pred             ecccccccCCC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc----C
Confidence            99999865332   22234568999999999987765 5899999999999999999999976544333222211    1


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..           ..+...+..+.+++.+||+.||++||++.|+++
T Consensus       227 ~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          227 VF-----------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cc-----------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            10           011122367889999999999999999999997

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.5e-38  Score=366.98  Aligned_cols=356  Identities=20%  Similarity=0.201  Sum_probs=279.2

Q ss_pred             CCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEe
Q 002085           72 FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCID  151 (969)
Q Consensus        72 ~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  151 (969)
                      ..+++.|+++++.+++. | .++.+++|++|+|++|++++. |  ++.+++|++|+|++|.+++. |  ++.+++|++|+
T Consensus        41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~  112 (457)
T 3bz5_A           41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLN  112 (457)
T ss_dssp             HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEE
T ss_pred             cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEE
Confidence            35799999999999975 4 799999999999999999974 4  89999999999999999974 4  89999999999


Q ss_pred             cCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcc
Q 002085          152 LGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANL  231 (969)
Q Consensus       152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l  231 (969)
                      |++|++++ +|  ++.+++|++|++++|++++. +  ++.+++|++|++++|+.  .+.+  .++.+++|+.|++++|++
T Consensus       113 L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~--~~~~--~~~~l~~L~~L~ls~n~l  182 (457)
T 3bz5_A          113 CDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKK--ITKL--DVTPQTQLTTLDCSFNKI  182 (457)
T ss_dssp             CCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSC--CCCC--CCTTCTTCCEEECCSSCC
T ss_pred             CCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCc--cccc--ccccCCcCCEEECCCCcc
Confidence            99999996 55  89999999999999999974 3  89999999999999962  2233  588999999999999999


Q ss_pred             cccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhh-cccccccccCccccccCCccc
Q 002085          232 IGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEA-LKLTDIDLSMNNLTGSIPEEF  310 (969)
Q Consensus       232 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~Ls~N~l~~~~p~~~  310 (969)
                      .+ +|  +..+++|+.|++++|++++.   .+..+++|++|++++|++++ +|  +.. .+|+.|++++|++++..   +
T Consensus       183 ~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~  250 (457)
T 3bz5_A          183 TE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---V  250 (457)
T ss_dssp             CC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---C
T ss_pred             ce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---H
Confidence            88 45  88999999999999999975   38889999999999999997 45  444 37999999999999764   4


Q ss_pred             cCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCc
Q 002085          311 GKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNT  390 (969)
Q Consensus       311 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  390 (969)
                      +.+++|+.|++++|++                               +.|++++|++.+.+|  +..+++|+.|++++|.
T Consensus       251 ~~l~~L~~L~l~~n~L-------------------------------~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~  297 (457)
T 3bz5_A          251 STLSKLTTLHCIQTDL-------------------------------LEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNT  297 (457)
T ss_dssp             TTCTTCCEEECTTCCC-------------------------------SCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCT
T ss_pred             HHCCCCCEEeccCCCC-------------------------------CEEECCCCccCCccc--ccccccCCEEECCCCc
Confidence            5567777777766544                               345566666555554  3455666666666666


Q ss_pred             cccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccc
Q 002085          391 ISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIV  470 (969)
Q Consensus       391 l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  470 (969)
                      +.+.+|. ...+|+.|++++|             ++|++|++++|+|++. +  ++.+++|+.|++++|+|++       
T Consensus       298 ~l~~l~~-~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-------  353 (457)
T 3bz5_A          298 QLYLLDC-QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD-------  353 (457)
T ss_dssp             TCCEEEC-TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB-------
T ss_pred             ccceecc-CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC-------
Confidence            6555553 2234444444433             5677777777777763 2  7777788888888888774       


Q ss_pred             cccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCccccc
Q 002085          471 SWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL  520 (969)
Q Consensus       471 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l  520 (969)
                       ++.|..|++++|+++|.     +++..|..+|+++|+|+|.||+.+...
T Consensus       354 -l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~~  397 (457)
T 3bz5_A          354 -FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLDQ  397 (457)
T ss_dssp             -CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBCT
T ss_pred             -ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhcc
Confidence             24566667888888765     456777888888888888888776443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.6e-38  Score=371.96  Aligned_cols=256  Identities=24%  Similarity=0.311  Sum_probs=206.5

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ..+.+.|+..++||+|+||+||+|++..+++.||+|++...... ......+.+|+++++.++||||+++++++.+.+..
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            34566899999999999999999999999999999998654322 22246789999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC---
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE---  788 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---  788 (969)
                      |+||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++..   
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  175 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRM-------------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKD  175 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTT
T ss_pred             EEEEecCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCC
Confidence            99999999999999987643             388999999999999999999998   99999999999999764   


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +.+||+|||+++.+...   .......||+.|+|||++. ..++.++||||+||++|||++|..||.+.........+..
T Consensus       176 ~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  251 (494)
T 3lij_A          176 ALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK  251 (494)
T ss_dssp             CCEEECCCTTCEECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CcEEEEECCCCeECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            45999999999876432   2334567999999999886 5699999999999999999999999987665444433322


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....           ...+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       252 ~~~~-----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          252 GKYT-----------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             TCCC-----------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCC-----------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            1100           011112233467889999999999999999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.8e-39  Score=352.92  Aligned_cols=273  Identities=24%  Similarity=0.360  Sum_probs=215.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEE-----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDI-----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  708 (969)
                      .++|+..+.||+|+||.||+|++     ..+++.||||++....  .....+.+.+|+++++++ +||||+++++++...
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            46899999999999999999985     3467899999996543  334457899999999999 799999999998775


Q ss_pred             C-ceEEEEeeccCCCHHHHhccCcCcccc---CCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          709 N-SKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       709 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                      + ..++||||+++++|.+++.........   .........+++..++.++.|++.||+|||+.   +|+||||||+||+
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil  180 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL  180 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEE
Confidence            4 589999999999999999875532110   00111223488999999999999999999998   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchH
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLA  863 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~  863 (969)
                      ++.++.+||+|||+++.+.............||+.|+|||++.+..++.++||||+||++|||++ |..||.+.......
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  260 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  260 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence            99999999999999987655444444455678899999999999999999999999999999998 88888765433211


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .   ........          ...+...+..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus       261 ~---~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          261 C---RRLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             H---HHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H---HHhccCcc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1   11111110          1111223367899999999999999999999999998875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-38  Score=345.47  Aligned_cols=258  Identities=24%  Similarity=0.345  Sum_probs=210.2

Q ss_pred             cCCCccc-eeeecCcEEEEEEEEc--CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESN-LIGSGGSGQVYRIDIN--GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++|.+.+ .||+|+||.||+|.+.  .++..||||+++...  .....+.+.+|++++++++||||+++++++ ..+..+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            3455555 8999999999999864  467889999996542  345567899999999999999999999999 456789


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        86 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~k  150 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR------------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK  150 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT------------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred             EEEEeCCCCCHHHHHHhCC------------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEE
Confidence            9999999999999997543            3488999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCCc-cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          793 IADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |+|||+++......... ......+|+.|+|||.+.+..++.++||||+||++|||++ |+.||...........+..  
T Consensus       151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~--  228 (287)
T 1u59_A          151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--  228 (287)
T ss_dssp             ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT--
T ss_pred             ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc--
Confidence            99999998764432221 2233457899999999998899999999999999999998 9999977655443332211  


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                        ..          ....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       229 --~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          229 --GK----------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             --TC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CC----------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              11          11122234478999999999999999999999999998885

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.8e-39  Score=345.72  Aligned_cols=258  Identities=22%  Similarity=0.309  Sum_probs=208.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcC---CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDING---AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .++|+..+.||+|+||.||+|.+..   ++..||+|++....  .....+.+.+|++++++++||||+++++++.+ +..
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   87 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence            3578899999999999999998753   34569999986542  33446789999999999999999999999865 457


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++++|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  152 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNK------------NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECV  152 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHT------------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEE
T ss_pred             EEEEecCCCCCHHHHHHhcc------------ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcE
Confidence            89999999999999997643            2488999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+++..... .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+....
T Consensus       153 kl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~  231 (281)
T 3cc6_A          153 KLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD  231 (281)
T ss_dssp             EECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC
T ss_pred             EeCccCCCcccccc-cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC
Confidence            99999999876432 2222334567889999999999999999999999999999998 999998766555443332211


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .              .+.+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       232 ~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          232 R--------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             C--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C--------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            0              1111223367899999999999999999999999998874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=347.07  Aligned_cols=254  Identities=29%  Similarity=0.427  Sum_probs=199.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|++.  ++.||||++...     ...+.+.+|++++++++||||+++++++.+  ..++||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~   78 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM   78 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence            57888999999999999999984  788999998543     234678999999999999999999998764  489999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc-EEEe
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK-AKIA  794 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~  794 (969)
                      ||+++|+|.+++.....          ...+++..++.++.|++.||+|||+....+|+||||||+||+++.++. +||+
T Consensus        79 e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~  148 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEP----------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC  148 (307)
T ss_dssp             ECCTTCBHHHHHHCSSS----------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred             EcCCCCCHHHHHhccCC----------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence            99999999999986542          134788899999999999999999842239999999999999998886 7999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||++.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...... 
T Consensus       149 Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~-  221 (307)
T 2eva_A          149 DFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMWAVHNGT-  221 (307)
T ss_dssp             CCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHHHHHTTC-
T ss_pred             cccccccccc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHHHHhcCC-
Confidence            9999976532     12234689999999999999999999999999999999999999975433221 1111111110 


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                ..+.....+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       222 ----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          222 ----------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             ----------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             ----------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence                      11112223467889999999999999999999999998875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.3e-38  Score=347.90  Aligned_cols=259  Identities=25%  Similarity=0.349  Sum_probs=204.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEE-cCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCIS-SENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~  711 (969)
                      ..|+..++||+|+||.||+|.+..+   +..||+|.+...  ......+.+.+|++++++++||||+++++++. .++..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            4688889999999999999997543   336899988543  23455678999999999999999999999864 56678


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++|+|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~  167 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNET------------HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTV  167 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTT------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCE
T ss_pred             EEEEeCCCCCCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCE
Confidence            99999999999999997543            2478999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCC--CccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCC-CCCccchHHHHHH
Q 002085          792 KIADFGLAKMLAKQGE--PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWR  868 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~-~~~~~~~~~~~~~  868 (969)
                      ||+|||+++.......  ........+|+.|+|||.+.+..++.++||||+|+++|||++|+.|++ .............
T Consensus       168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~  247 (298)
T 3f66_A          168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ  247 (298)
T ss_dssp             EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT
T ss_pred             EECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc
Confidence            9999999986643221  122334567889999999999999999999999999999999655544 4443333322211


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .    .          ....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       248 ~----~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          248 G----R----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             T----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----C----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1    0          11111222367899999999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.8e-39  Score=355.06  Aligned_cols=266  Identities=24%  Similarity=0.321  Sum_probs=209.5

Q ss_pred             ccCCCccceeeecCcEEEEEEE-----EcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC
Q 002085          635 LSSLTESNLIGSGGSGQVYRID-----INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  709 (969)
                      .++|+..+.||+|+||.||+|+     ...+++.||||++....  .......+.+|+.++++++||||+++++++.+.+
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            4689999999999999999998     44567899999985432  3444568999999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC-
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-  788 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-  788 (969)
                      ..|+||||+++++|.+++.......      .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.+ 
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~  177 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRP------SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG  177 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCS------SSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccc------cccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCC
Confidence            9999999999999999998764311      1123588999999999999999999998   99999999999999954 


Q ss_pred             --CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHH
Q 002085          789 --FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEW  865 (969)
Q Consensus       789 --~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~  865 (969)
                        ..+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||...........
T Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  257 (327)
T 2yfx_A          178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF  257 (327)
T ss_dssp             TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH
Confidence              4699999999986644333333445568999999999999999999999999999999998 8888876554333322


Q ss_pred             HHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      +..    ..          ....+...+..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus       258 ~~~----~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          258 VTS----GG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHT----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Hhc----CC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            211    11          01112223467899999999999999999999999998875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.4e-38  Score=360.34  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=199.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc--cCceeeEEEEEEcCCceEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR--HANIVKLWCCISSENSKLL  713 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  713 (969)
                      +.|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|++++++++  ||||+++++++..++..|+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            459999999999999999999864 88999999865432 4455678999999999996  5999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||| +.+++|.+++....             .+++..+..++.||+.||+|||+.   +|+||||||+||+++ ++.+||
T Consensus       134 v~E-~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl  195 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKK-------------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKL  195 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCS-------------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEE
T ss_pred             EEe-cCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEE
Confidence            999 56899999998654             378889999999999999999988   999999999999996 579999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCccch
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-----------TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL  862 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  862 (969)
                      +|||+++.+.............||+.|+|||++.+           ..++.++|||||||++|||++|+.||......  
T Consensus       196 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--  273 (390)
T 2zmd_A          196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--  273 (390)
T ss_dssp             CCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--
T ss_pred             EecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--
Confidence            99999987654333333445679999999999875           46889999999999999999999999754321  


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ...+....          +.......+...+..+.+++.+||+.||++||++.|+++.
T Consensus       274 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          274 ISKLHAII----------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHHHHH----------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHh----------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            11111111          1111111111123678899999999999999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.4e-38  Score=353.14  Aligned_cols=265  Identities=27%  Similarity=0.347  Sum_probs=208.9

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhc--cccCceeeEEEEEEcCC
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT--IRHANIVKLWCCISSEN  709 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~  709 (969)
                      ..+.++|+..+.||+|+||.||+|++  +++.||||++....      .+.+.+|++++..  ++||||+++++++....
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            34567899999999999999999998  58899999985432      3567788888887  68999999999998875


Q ss_pred             ----ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhc--------ccCCCCeEecC
Q 002085          710 ----SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMH--------HDCTPQIIHRD  777 (969)
Q Consensus       710 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~D  777 (969)
                          ..++||||+++|+|.+++...              .+++..++.++.|++.||+|||        +.   +|+|||
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~D  172 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRY--------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRD  172 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSC
T ss_pred             CccceeEEEEeecCCCcHHHHHhcc--------------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCC
Confidence                789999999999999999753              3889999999999999999999        66   999999


Q ss_pred             CCCCcEEECCCCcEEEeecccceecccCCCCc--cccccccCcccCchhhcccCC------CCCccchhhHHHHHHHHHh
Q 002085          778 VKSSNILLDSEFKAKIADFGLAKMLAKQGEPH--TMSAVAGSFGYFAPEYAYTTK------VNEKIDIYSFGVVLLELVT  849 (969)
Q Consensus       778 lkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~ellt  849 (969)
                      |||+||+++.++.+||+|||+++.........  ......||+.|+|||++.+..      ++.++|||||||++|||++
T Consensus       173 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t  252 (342)
T 1b6c_B          173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR  252 (342)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence            99999999999999999999998765433221  234457999999999988763      3368999999999999999


Q ss_pred             C----------CCCCCCCCccc-hHHHHHHHhhccCCchhhhccCCCC-cccHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002085          850 G----------KEANYGDEHTS-LAEWAWRHYAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEV  917 (969)
Q Consensus       850 g----------~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev  917 (969)
                      |          ..||....... ....+........     ..+.... ....+....+.+++.+||+.||++||++.|+
T Consensus       253 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             ccCcCCcccccccCccccCcCcccHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence            9          67776543221 1111212111111     0111111 1123566789999999999999999999999


Q ss_pred             HHHHhhcCC
Q 002085          918 LQILRRCCP  926 (969)
Q Consensus       918 l~~L~~~~~  926 (969)
                      ++.|+++..
T Consensus       328 ~~~L~~i~~  336 (342)
T 1b6c_B          328 KKTLSQLSQ  336 (342)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999998863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.3e-38  Score=372.38  Aligned_cols=262  Identities=25%  Similarity=0.335  Sum_probs=213.3

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ..+.++|++.++||+|+||+||+|++..+++.||||++...... ......+.+|++++++++||||+++++++.+....
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            45677899999999999999999999989999999998654322 22346789999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC---CC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD---SE  788 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~  788 (969)
                      |+||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++   .+
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~  160 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRK-------------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKD  160 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTT
T ss_pred             EEEEEcCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCC
Confidence            99999999999999987644             388999999999999999999998   999999999999995   45


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +.+||+|||+++.+...   .......||+.|+|||++.+ .++.++||||+||++|||++|..||.+.........+..
T Consensus       161 ~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  236 (486)
T 3mwu_A          161 CDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET  236 (486)
T ss_dssp             CCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCEEEEECCcCeECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            67999999999865332   23345679999999999876 599999999999999999999999987665444333222


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcC
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRCC  925 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~~  925 (969)
                      ..   .        ....+.....+..+.+++.+||+.||++|||+.|+++  .+++..
T Consensus       237 ~~---~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          237 GK---Y--------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             TC---C--------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CC---C--------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            10   0        0111222334467899999999999999999999997  355543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.6e-39  Score=348.81  Aligned_cols=262  Identities=23%  Similarity=0.305  Sum_probs=211.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEE--cCCceE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCIS--SENSKL  712 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  712 (969)
                      .++|+..+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|++++++++||||+++++++.  .....+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            4678999999999999999999999999999999965432 3445678999999999999999999999874  366889


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCC-----eEecCCCCCcEEECC
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQ-----IIHRDVKSSNILLDS  787 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlkp~Nill~~  787 (969)
                      +||||+++++|.+++.....         ....+++..++.++.|++.||+|||+.   +     |+||||||+||+++.
T Consensus        84 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~  151 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTK---------ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDG  151 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECS
T ss_pred             EEEeCCCCCCHHHHHHhhcc---------cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcC
Confidence            99999999999999986432         123489999999999999999999998   7     999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      ++.+||+|||.++.....  ........|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+.
T Consensus       152 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~  229 (279)
T 2w5a_A          152 KQNVKLGDFGLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR  229 (279)
T ss_dssp             SSCEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCEEEecCchheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh
Confidence            999999999999865332  122234568999999999999999999999999999999999999998765433332221


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..    .          ....+...+..+.+++.+||+.||++||++.|+++.+....
T Consensus       230 ~~----~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          230 EG----K----------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             HT----C----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             hc----c----------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            11    1          00111223467899999999999999999999998765443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=355.86  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=197.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcccc--CceeeEEEEEEcCCceEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH--ANIVKLWCCISSENSKLL  713 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l  713 (969)
                      +.|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+.+|++++++++|  |||+++++++.+++..++
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            46889999999999999999885 68899999986543 344556789999999999976  999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      |||| .+++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++ ++.+||
T Consensus        87 v~e~-~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl  148 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKKKK-------------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKL  148 (343)
T ss_dssp             EECC-CSEEHHHHHHHSC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEE
T ss_pred             EEeC-CCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEE
Confidence            9994 5789999998654             388999999999999999999998   999999999999997 578999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCccch
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-----------TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL  862 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  862 (969)
                      +|||+++.+.............||+.|+|||++.+           ..++.++|||||||++|||++|+.||......  
T Consensus       149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--  226 (343)
T 3dbq_A          149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--  226 (343)
T ss_dssp             CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--
T ss_pred             eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--
Confidence            99999987654433333445679999999999865           67889999999999999999999999754321  


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .......          .+.......+......+.+++.+||+.||++|||+.|+++.
T Consensus       227 ~~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          227 ISKLHAI----------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHHHH----------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHH----------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1111111          11111111122223578899999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-39  Score=360.82  Aligned_cols=258  Identities=24%  Similarity=0.332  Sum_probs=197.0

Q ss_pred             CCCccceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-CCceE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-ENSKL  712 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  712 (969)
                      .|+..+.||+|+||.||+|.+..+   +..||||.++..  ......+.+.+|++++++++||||+++++++.+ ++..+
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            456678999999999999987533   346899988543  234456789999999999999999999998754 56789


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++|+|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       168 lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~k  232 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNET------------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVK  232 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTT------------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred             EEEECCCCCCHHHHHhhcc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEE
Confidence            9999999999999997643            2478899999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCC--ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhC-CCCCCCCCccchHHHHHHH
Q 002085          793 IADFGLAKMLAKQGEP--HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTG-KEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~  869 (969)
                      |+|||+++.+......  .......+|+.|+|||.+.+..++.++|||||||++|||++| ..||...........+...
T Consensus       233 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~  312 (373)
T 3c1x_A          233 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG  312 (373)
T ss_dssp             ECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT
T ss_pred             EeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC
Confidence            9999999866433211  122345678899999999999999999999999999999995 5555554444433322111


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                          .          ....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       313 ----~----------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          313 ----R----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             ----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----C----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                1          11112223467899999999999999999999999999885

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.6e-38  Score=351.81  Aligned_cols=259  Identities=19%  Similarity=0.267  Sum_probs=208.1

Q ss_pred             hhhccCCCcc-ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCC
Q 002085          632 SNILSSLTES-NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSEN  709 (969)
Q Consensus       632 ~~~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  709 (969)
                      +++.+.|.+. +.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.+ .||||+++++++.+.+
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            3455667776 88999999999999999999999999987644322 2346789999999999 5799999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC--
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS--  787 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~--  787 (969)
                      ..++||||+++|+|.+++.....           ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.  
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~  168 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELA-----------EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIY  168 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBT
T ss_pred             eEEEEEEecCCCcHHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCC
Confidence            99999999999999999865432           3589999999999999999999998   9999999999999998  


Q ss_pred             -CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          788 -EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 -~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                       ++.+||+|||+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+
T Consensus       169 ~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  245 (327)
T 3lm5_A          169 PLGDIKIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI  245 (327)
T ss_dssp             TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCcEEEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence             789999999999876432   2233467999999999999999999999999999999999999999876544333222


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....   .        ..........+..+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~---~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          246 SQVN---V--------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHTC---C--------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             Hhcc---c--------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            1111   0        1111112233467889999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.3e-38  Score=347.82  Aligned_cols=260  Identities=23%  Similarity=0.286  Sum_probs=199.7

Q ss_pred             hccCCCcc-ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCce
Q 002085          634 ILSSLTES-NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSK  711 (969)
Q Consensus       634 ~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  711 (969)
                      +.+.|++. ++||+|+||.||+|.+..+++.||||++....   ....+.+.+|++++.++ +||||+++++++.+++..
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~   86 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF   86 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            44578774 78999999999999998899999999986542   22346788999999985 799999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc-
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK-  790 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-  790 (969)
                      ++||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++. 
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~  150 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKRR-------------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQV  150 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSS
T ss_pred             EEEEEcCCCCcHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCc
Confidence            99999999999999998643             388999999999999999999998   9999999999999998876 


Q ss_pred             --EEEeecccceecccCCCC-----ccccccccCcccCchhhccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002085          791 --AKIADFGLAKMLAKQGEP-----HTMSAVAGSFGYFAPEYAYT-----TKVNEKIDIYSFGVVLLELVTGKEANYGDE  858 (969)
Q Consensus       791 --~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~  858 (969)
                        +||+|||+++.....+..     .......||+.|+|||++.+     ..++.++||||+||++|||++|+.||.+..
T Consensus       151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          151 SPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             CSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             CceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence              999999999865432211     11223469999999999875     568899999999999999999999997654


Q ss_pred             ccch-----------HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          859 HTSL-----------AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       859 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....           .............       ..........+..+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          231 GSDCGWDRGEACPACQNMLFESIQEGKY-------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CSCSCC----CCHHHHHHHHHHHHHCCC-------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccccccccchhHHHHHHHHHhccCc-------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            3210           0111111111100       0000000112467899999999999999999999987

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.5e-39  Score=355.64  Aligned_cols=273  Identities=29%  Similarity=0.388  Sum_probs=211.4

Q ss_pred             hccCC-CccceeeecCcEEEEEEEE----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC
Q 002085          634 ILSSL-TESNLIGSGGSGQVYRIDI----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE  708 (969)
Q Consensus       634 ~~~~~-~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  708 (969)
                      +.++| +..++||+|+||.||++.+    ..+++.||||+++...  .....+.+.+|++++++++||||+++++++.+.
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            34455 8899999999999988764    3468899999996542  345567899999999999999999999999874


Q ss_pred             --CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          709 --NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       709 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                        ...++||||+++++|.+++...              .+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~  168 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRH--------------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLD  168 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGS--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             CCceEEEEEecccCCcHHHHHhhC--------------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEc
Confidence              5679999999999999999753              288999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCC-ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      .++.+||+|||+++.+...... .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||...........
T Consensus       169 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~  248 (318)
T 3lxp_A          169 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI  248 (318)
T ss_dssp             TTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred             CCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh
Confidence            9999999999999877543222 123345688899999999999999999999999999999999999864321100000


Q ss_pred             HH-HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          866 AW-RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       866 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .. ..........+.+......+.+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          249 GIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             CSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            00 0000000112222233333334445578999999999999999999999999998874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6e-39  Score=356.06  Aligned_cols=266  Identities=24%  Similarity=0.362  Sum_probs=206.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++..+|+.||||++.... ......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            568999999999999999999999999999999986543 3445567788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.++.....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       103 ~e~~~~~~l~~~~~~~~-------------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~  166 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPN-------------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLC  166 (331)
T ss_dssp             EECCSEEHHHHHHHSTT-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EecCCcchHHHHHhhcc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEE
Confidence            99999999998876443             388999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc-
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE-  872 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-  872 (969)
                      |||+++.+...  ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.........+...... 
T Consensus       167 Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (331)
T 4aaa_A          167 DFGFARTLAAP--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNL  244 (331)
T ss_dssp             CCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             eCCCceeecCC--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            99999865432  2223345789999999998875 7899999999999999999999999876554333322221110 


Q ss_pred             ----------cCCchhhhccCCCCcc-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 ----------EKPITDALDKGIAEPC-----YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ----------~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                .........+......     ....+..+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                      0000000001111111     1123467999999999999999999998875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.7e-39  Score=353.80  Aligned_cols=269  Identities=26%  Similarity=0.364  Sum_probs=209.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEE--EEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFV--AVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  711 (969)
                      .++|+..+.||+|+||.||+|++..++..+  |+|.+....  .....+.+.+|+++++++ +||||+++++++.+.+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            468999999999999999999998888755  999886432  233456789999999999 899999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccC---CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSG---SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      ++||||+++++|.+++..........   ........+++..++.++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence            99999999999999998653100000   0000123589999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  867 (969)
                      +.+||+|||+++....   ........+++.|+|||.+.+..++.++||||+||++|||++ |+.||.+.........  
T Consensus       179 ~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~--  253 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK--  253 (327)
T ss_dssp             GCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--
T ss_pred             CeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH--
Confidence            9999999999874322   112233457889999999998889999999999999999998 9999977654332221  


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                        ....          .....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       254 --~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          254 --LPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             --GGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --hhcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              1111          111122233467899999999999999999999999998875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-38  Score=348.82  Aligned_cols=258  Identities=25%  Similarity=0.335  Sum_probs=210.5

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      .+.++|...+.||+|+||.||+|++..+|+.||+|++.....   ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            456789999999999999999999998999999999965322   22457889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE---CCCC
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL---DSEF  789 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~  789 (969)
                      +||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++
T Consensus        83 lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~  146 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERG-------------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENS  146 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTC
T ss_pred             EEEEcCCCccHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCC
Confidence            9999999999999987543             388999999999999999999998   99999999999999   7788


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      .++|+|||+++....    .......||+.|+|||.+.+..++.++||||+||++|||++|..||...........+...
T Consensus       147 ~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~  222 (304)
T 2jam_A          147 KIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG  222 (304)
T ss_dssp             CEEBCSCSTTCCCCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC
T ss_pred             CEEEccCCcceecCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence            999999999875422    2223456899999999999999999999999999999999999999876544333332221


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhc
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRC  924 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~  924 (969)
                      ..   .        ...+.....+..+.+++.+||+.||++||++.|+++  .++..
T Consensus       223 ~~---~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          223 YY---E--------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             CC---C--------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             CC---C--------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            10   0        011112233467899999999999999999999996  44443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.9e-38  Score=343.39  Aligned_cols=258  Identities=24%  Similarity=0.344  Sum_probs=210.7

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccch------hcHHHHHHHHHHHHHHhccc-cCceeeEEEE
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK------LNQKLEKEFIAEIEILGTIR-HANIVKLWCC  704 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~  704 (969)
                      ..+.++|+..+.||+|+||.||+|.+..+++.||||++.....      ......+.+.+|+++++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            3456789999999999999999999999999999999865431      12334577899999999995 9999999999


Q ss_pred             EEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          705 ISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       705 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                      +.+.+..++||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil  156 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKV-------------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENIL  156 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEE
Confidence            999999999999999999999998643             388999999999999999999998   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY------TTKVNEKIDIYSFGVVLLELVTGKEANYGDE  858 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~il~elltg~~p~~~~~  858 (969)
                      ++.++.+||+|||++......   .......|++.|+|||++.      ...++.++||||+|+++|||++|+.||....
T Consensus       157 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  233 (298)
T 1phk_A          157 LDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  233 (298)
T ss_dssp             ECTTCCEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EcCCCcEEEecccchhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence            999999999999999876432   2233457899999999885      4568899999999999999999999997765


Q ss_pred             ccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          859 HTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .......+...   ...        ...+.....+..+.+++.+||+.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~---~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          234 QMLMLRMIMSG---NYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHHHHT---CCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhcC---Ccc--------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            43333222111   100        011112233467899999999999999999999876

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3e-38  Score=344.67  Aligned_cols=261  Identities=22%  Similarity=0.232  Sum_probs=205.1

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEE-EcCCceE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCI-SSENSKL  712 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~  712 (969)
                      +.++|+..+.||+|+||.||+|++..+++.||||++.....     .+.+.+|+++++.++|++++..+.++ .+++..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            45689999999999999999999988999999998754322     24578899999999887766665554 6677889


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE---CCCC
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL---DSEF  789 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~  789 (969)
                      +||||+ +++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||++   +.++
T Consensus        82 lv~e~~-~~~L~~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~  145 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCS------------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGN  145 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTT
T ss_pred             EEEEcc-CCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCC
Confidence            999999 999999998543            2489999999999999999999998   99999999999999   7889


Q ss_pred             cEEEeecccceecccCCCC-----ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH-
Q 002085          790 KAKIADFGLAKMLAKQGEP-----HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA-  863 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~-  863 (969)
                      .+||+|||+++........     .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+....... 
T Consensus       146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  225 (296)
T 4hgt_A          146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ  225 (296)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred             eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence            9999999999877543321     1223567999999999999999999999999999999999999999764433211 


Q ss_pred             --HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          864 --EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       864 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                        ..+...... .+. ....        ...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       226 ~~~~~~~~~~~-~~~-~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          226 KYERISEKKMS-TPI-EVLC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HHHHHHHHHHH-SCH-HHHT--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             hhhhhhccccc-chh-hhhh--------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence              111111100 000 0000        112367899999999999999999999999998885

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=350.32  Aligned_cols=262  Identities=23%  Similarity=0.304  Sum_probs=207.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEE----cCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCIS----SENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~  711 (969)
                      ++|+..+.||+|+||.||+|+...+++.||||++...   .....+.+.+|+++++.++||||+++++++.    .....
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            5799999999999999999999889999999988543   3345678999999999999999999999986    34478


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++|+|.+++.....         ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~  173 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKD---------KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQP  173 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHT---------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCE
Confidence            999999999999999986422         123589999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCCc-------cccccccCcccCchhhcccCC---CCCccchhhHHHHHHHHHhCCCCCCCC--Cc
Q 002085          792 KIADFGLAKMLAKQGEPH-------TMSAVAGSFGYFAPEYAYTTK---VNEKIDIYSFGVVLLELVTGKEANYGD--EH  859 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~elltg~~p~~~~--~~  859 (969)
                      ||+|||+++.........       ......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||...  ..
T Consensus       174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  253 (317)
T 2buj_A          174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG  253 (317)
T ss_dssp             EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred             EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence            999999987653211110       112345799999999987654   688999999999999999999998531  11


Q ss_pred             cchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      .....              ........+.....+..+.+++.+||+.||++||++.|+++.|+++.+
T Consensus       254 ~~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          254 DSVAL--------------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             SCHHH--------------HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             chhhH--------------HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            11111              111111111222334679999999999999999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.4e-38  Score=340.51  Aligned_cols=250  Identities=26%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc----CCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS----ENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  711 (969)
                      +.|+..+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|++++++++||||+++++++..    ....
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            457788899999999999999999999999999865432 44556789999999999999999999999865    3558


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCC--eEecCCCCCcEEEC-CC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQ--IIHRDVKSSNILLD-SE  788 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~Nill~-~~  788 (969)
                      ++||||+++++|.+++....             .+++..++.++.|++.||+|||+.   +  |+||||||+||+++ .+
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~  168 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFK-------------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPT  168 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTT
T ss_pred             EEEEEecCCCCHHHHHHHcc-------------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCC
Confidence            99999999999999997643             388999999999999999999988   7  99999999999998 78


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +.+||+|||++.....    .......||+.|+|||.+. +.++.++||||+||++|||++|+.||........   ...
T Consensus       169 ~~~kl~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~  240 (290)
T 1t4h_A          169 GSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYR  240 (290)
T ss_dssp             SCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHH
T ss_pred             CCEEEeeCCCcccccc----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH---HHH
Confidence            8999999999975422    2233457999999999876 4689999999999999999999999976433211   111


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ........         ...+...+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          241 RVTSGVKP---------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHTTTCCC---------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhccCCc---------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11111110         0111112257899999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.1e-38  Score=342.74  Aligned_cols=255  Identities=26%  Similarity=0.405  Sum_probs=208.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|... ++..||||++.....    ..+.+.+|++++++++||||+++++++.+ +..++||
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   86 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence            57889999999999999999986 567899999865432    23678999999999999999999999864 5689999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++++|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        87 e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D  152 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSG-----------IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD  152 (279)
T ss_dssp             ECCTTCBHHHHTTSHHH-----------HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             ecCCCCCHHHHHhcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECC
Confidence            99999999999975431           2488999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++..... .........+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.+.........+...     
T Consensus       153 fg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----  226 (279)
T 1qpc_A          153 FGLARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-----  226 (279)
T ss_dssp             CTTCEECSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----
T ss_pred             CcccccccCc-ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-----
Confidence            9999876432 1222234457889999999998899999999999999999999 88888765543333222111     


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                               .....+...+..+.+++.+||+.||++||++.++++.|++..
T Consensus       227 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          227 ---------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence                     011112223467899999999999999999999999998874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.1e-39  Score=354.65  Aligned_cols=264  Identities=22%  Similarity=0.338  Sum_probs=202.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||.||+|++..+++.||||++.....  ......+.+|++++++++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            578999999999999999999998999999999854321  122234568999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||++ |+|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  143 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDCG------------NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLAD  143 (324)
T ss_dssp             ECCS-EEHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECS
T ss_pred             cccc-cCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEcc
Confidence            9997 59999987654            2488999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++.....  ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.........+.+......
T Consensus       144 fg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  221 (324)
T 3mtl_A          144 FGLARAKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT  221 (324)
T ss_dssp             SSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             CcccccccCC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999865322  223334578999999999876 5689999999999999999999999988766555544444322211


Q ss_pred             C--chhhhc---------cCCCC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 P--ITDALD---------KGIAE----PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~--~~~~~~---------~~~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .  ......         +....    ......+..+.+++.+|++.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            1  000000         00000    001122367889999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=354.53  Aligned_cols=266  Identities=24%  Similarity=0.335  Sum_probs=198.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHH--HhccccCceeeEEEEEEc-----
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI--LGTIRHANIVKLWCCISS-----  707 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----  707 (969)
                      .++|+..+.||+|+||.||+|+.  +++.||||++....      ...+..|.++  +..++||||+++++++..     
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            56899999999999999999987  68999999985432      2334444444  445899999999986532     


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC------CCCeEecCCCCC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC------TPQIIHRDVKSS  781 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~  781 (969)
                      ....++||||+++|+|.+++....              .++..++.++.|++.||+|||+.+      .++|+||||||+
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~  149 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLHT--------------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR  149 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHCC--------------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGG
T ss_pred             CceEEEEEecCCCCcHHHHHhhcc--------------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccc
Confidence            235689999999999999997543              588999999999999999999652      238999999999


Q ss_pred             cEEECCCCcEEEeecccceecccCCC------CccccccccCcccCchhhccc-------CCCCCccchhhHHHHHHHHH
Q 002085          782 NILLDSEFKAKIADFGLAKMLAKQGE------PHTMSAVAGSFGYFAPEYAYT-------TKVNEKIDIYSFGVVLLELV  848 (969)
Q Consensus       782 Nill~~~~~~kl~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~ell  848 (969)
                      ||+++.++.+||+|||+++.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||+
T Consensus       150 Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell  229 (336)
T 3g2f_A          150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF  229 (336)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH
Confidence            99999999999999999987643221      122234569999999999887       35667899999999999999


Q ss_pred             hCCCCCCCCCccchH--------------HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCH
Q 002085          849 TGKEANYGDEHTSLA--------------EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSM  914 (969)
Q Consensus       849 tg~~p~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~  914 (969)
                      +|+.||.........              ........... .......  ........+..+.+++.+||+.||++|||+
T Consensus       230 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (336)
T 3g2f_A          230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK-QRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTA  306 (336)
T ss_dssp             TTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccc-cCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcch
Confidence            998887653321110              00000000000 0000000  011233456789999999999999999999


Q ss_pred             HHHHHHHhhcC
Q 002085          915 KEVLQILRRCC  925 (969)
Q Consensus       915 ~evl~~L~~~~  925 (969)
                      +|+++.|+++.
T Consensus       307 ~e~l~~L~~ll  317 (336)
T 3g2f_A          307 QXAEERMAELM  317 (336)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-38  Score=358.05  Aligned_cols=264  Identities=22%  Similarity=0.316  Sum_probs=208.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            357899999999999999999999999999999986542  345567899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....             .+++..+..++.|++.||+|||+.+  +|+||||||+||+++.++.+||+
T Consensus       110 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~  174 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAG-------------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC  174 (360)
T ss_dssp             ECCCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EECCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEE
Confidence            99999999999998643             3889999999999999999999731  79999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc--
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE--  872 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--  872 (969)
                      |||+++.....    ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..............  
T Consensus       175 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  250 (360)
T 3eqc_A          175 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA  250 (360)
T ss_dssp             CCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred             ECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence            99999765322    223457899999999999999999999999999999999999999765543322211000000  


Q ss_pred             -----------------------cCCchhh----hccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 -----------------------EKPITDA----LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 -----------------------~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                             .....+.    .............+..+.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                                   0000000    0000000111122467899999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.5e-38  Score=359.16  Aligned_cols=206  Identities=25%  Similarity=0.371  Sum_probs=172.6

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC--
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE--  708 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  708 (969)
                      ...+.++|+..+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|++++++++||||+++++++...  
T Consensus        21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            3345678999999999999999999999999999999996542 2445567899999999999999999999998766  


Q ss_pred             ---CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE
Q 002085          709 ---NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL  785 (969)
Q Consensus       709 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill  785 (969)
                         ...|+||||++ ++|.+++....             .+++..+..++.||+.||+|||+.   +|+||||||+||++
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~~~-------------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl  162 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKTPI-------------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLL  162 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHSSC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEE
Confidence               57899999996 69999997543             389999999999999999999998   99999999999999


Q ss_pred             CCCCcEEEeecccceecccCCCC--------------------ccccccccCcccCchhhc-ccCCCCCccchhhHHHHH
Q 002085          786 DSEFKAKIADFGLAKMLAKQGEP--------------------HTMSAVAGSFGYFAPEYA-YTTKVNEKIDIYSFGVVL  844 (969)
Q Consensus       786 ~~~~~~kl~Dfgla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~il  844 (969)
                      +.++.+||+|||+|+........                    .......||+.|+|||++ .+..++.++||||+||++
T Consensus       163 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il  242 (432)
T 3n9x_A          163 NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF  242 (432)
T ss_dssp             CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHH
Confidence            99999999999999876543221                    123567899999999986 566799999999999999


Q ss_pred             HHHHhCCCCC
Q 002085          845 LELVTGKEAN  854 (969)
Q Consensus       845 ~elltg~~p~  854 (969)
                      |||++|..||
T Consensus       243 ~ell~g~~p~  252 (432)
T 3n9x_A          243 AELLNMLQSH  252 (432)
T ss_dssp             HHHHTTCTTT
T ss_pred             HHHHhccccc
Confidence            9999854443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.8e-39  Score=347.55  Aligned_cols=251  Identities=26%  Similarity=0.433  Sum_probs=208.0

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-----
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-----  707 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  707 (969)
                      .+..+|+..+.||+|+||.||+|++..+++.||+|++....       +.+.+|++++++++||||+++++++..     
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            45568999999999999999999999899999999986542       356789999999999999999998854     


Q ss_pred             -----------CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEec
Q 002085          708 -----------ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHR  776 (969)
Q Consensus       708 -----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  776 (969)
                                 ....++||||+++++|.+++.....           ..+++..++.++.|++.||+|||+.   +|+||
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~  146 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-----------EKLDKVLALELFEQITKGVDYIHSK---KLINR  146 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGG-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence                       4457999999999999999976432           3488999999999999999999998   99999


Q ss_pred             CCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 002085          777 DVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG  856 (969)
Q Consensus       777 Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~  856 (969)
                      ||||+||+++.++.+||+|||+++......   ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus       147 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  223 (284)
T 2a19_B          147 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE  223 (284)
T ss_dssp             CCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred             cCCHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence            999999999999999999999998764322   23345689999999999999999999999999999999999988642


Q ss_pred             CCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          857 DEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       857 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      ..      ........         .....    ..+..+.+++.+||+.||++||++.|+++.|+....
T Consensus       224 ~~------~~~~~~~~---------~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          224 TS------KFFTDLRD---------GIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HH------HHHHHHHT---------TCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             HH------HHHHHhhc---------ccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            11      11111111         11111    122567899999999999999999999999998864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9e-38  Score=342.53  Aligned_cols=262  Identities=23%  Similarity=0.258  Sum_probs=208.1

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc-HHHHHHHHHHHHHHhccccCceeeEEEEEE--cCCc
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN-QKLEKEFIAEIEILGTIRHANIVKLWCCIS--SENS  710 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~  710 (969)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|++++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4578999999999999999999999899999999996543211 234578999999999999999999999984  4567


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||++++ |.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~  147 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPE-----------KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGT  147 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTT-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             EEEEehhccCC-HHHHHHhCcc-----------cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCc
Confidence            89999999876 7777765432           3588999999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK--VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +||+|||++................||+.|+|||++.+..  ++.++||||+|+++|||++|+.||.+.........+..
T Consensus       148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~  227 (305)
T 2wtk_C          148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK  227 (305)
T ss_dssp             EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc
Confidence            9999999998765433334445567999999999987654  37799999999999999999999987654333222211


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcC
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRCC  925 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~~  925 (969)
                          ...           ..+...+..+.+++.+||+.||++||++.|+++  .+++..
T Consensus       228 ----~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          228 ----GSY-----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             ----CCC-----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             ----CCC-----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence                110           011123367889999999999999999999996  455443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-38  Score=354.96  Aligned_cols=261  Identities=23%  Similarity=0.338  Sum_probs=203.9

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC---
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN---  709 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  709 (969)
                      .+.++|+..+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+++++.++||||+++++++...+   
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  100 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD  100 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence            45678999999999999999999999999999999985543 23455678999999999999999999999997653   


Q ss_pred             ---ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          710 ---SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       710 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                         ..|+||||+ +++|.+++...              .+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~~~--------------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~  162 (367)
T 1cm8_A          101 DFTDFYLVMPFM-GTDLGKLMKHE--------------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVN  162 (367)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC
T ss_pred             cCceEEEEEecC-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEc
Confidence               459999999 78999998753              378899999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      .++.+||+|||+++....     ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.......
T Consensus       163 ~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~  237 (367)
T 1cm8_A          163 EDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE  237 (367)
T ss_dssp             TTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCCEEEEeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999987532     2344678999999999887 6799999999999999999999999987765444333


Q ss_pred             HHHHhhccCCchhhhcc--------------CC----CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          866 AWRHYAEEKPITDALDK--------------GI----AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~--------------~~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +......  +..+....              ..    ........+..+.+++.+|+..||++|||+.|+++
T Consensus       238 i~~~~g~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          238 IMKVTGT--PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHCC--CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCC--CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            3222111  00000000              00    00011223467899999999999999999999997

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.4e-38  Score=347.85  Aligned_cols=256  Identities=20%  Similarity=0.237  Sum_probs=202.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEc--CCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISS--ENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~  711 (969)
                      .++|+..++||+|+||.||+|.+..+++.||||+++...      .+.+.+|++++++++ ||||+++++++.+  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            467999999999999999999999999999999986432      367889999999997 9999999999988  6678


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-c
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-K  790 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~  790 (969)
                      ++||||+++++|.+++..                +++..+..++.|++.||+|||+.   +|+||||||+||+++.++ .
T Consensus       109 ~lv~e~~~~~~l~~~~~~----------------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~  169 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT----------------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRK  169 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG----------------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred             EEEEeccCchhHHHHHHh----------------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCE
Confidence            999999999999998852                77889999999999999999998   999999999999999776 8


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCcc-chHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHT-SLAEWAWR  868 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~-~~~~~~~~  868 (969)
                      +||+|||+++.+....   ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+..
T Consensus       170 ~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~  246 (330)
T 3nsz_A          170 LRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  246 (330)
T ss_dssp             EEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred             EEEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence            9999999998764322   2344578999999999877 67899999999999999999999999654322 11111111


Q ss_pred             HhhccCCchhhhc-----------------------cCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKPITDALD-----------------------KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .. ......+.++                       ...........+..+.+++.+||+.||++|||++|+++
T Consensus       247 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          247 VL-GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HH-CHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hc-CCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00 0000000000                       00011111223478899999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.9e-38  Score=343.03  Aligned_cols=261  Identities=22%  Similarity=0.232  Sum_probs=208.1

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEE-EcCCceE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCI-SSENSKL  712 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~  712 (969)
                      +.++|+..+.||+|+||.||+|++..+++.||||++.....     .+.+.+|+++++.++|++++..+.++ .+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            45689999999999999999999988999999999865432     24588999999999988766555554 6677889


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC---CCC
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD---SEF  789 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~  789 (969)
                      +||||+ +++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++   .++
T Consensus        82 lv~e~~-~~~L~~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~  145 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCS------------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGN  145 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTT
T ss_pred             EEEEec-CCCHHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCC
Confidence            999999 899999997543            2489999999999999999999998   999999999999994   788


Q ss_pred             cEEEeecccceecccCCCCc-----cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc---c
Q 002085          790 KAKIADFGLAKMLAKQGEPH-----TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT---S  861 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~---~  861 (969)
                      .+||+|||+++.........     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....   .
T Consensus       146 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  225 (296)
T 3uzp_A          146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ  225 (296)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred             eEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh
Confidence            99999999998765433211     224567999999999999999999999999999999999999999864322   2


Q ss_pred             hHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ....+...... .+. ...        ....+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       226 ~~~~~~~~~~~-~~~-~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  279 (296)
T 3uzp_A          226 KYERISEKKMS-TPI-EVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HHHHHHHHHHH-SCH-HHH--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             hhhhhcccccC-Cch-HHH--------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence            22222111111 000 000        0112367899999999999999999999999998885

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-38  Score=380.92  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=202.9

Q ss_pred             ceeeecCcEEEEEEEE--cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeecc
Q 002085          642 NLIGSGGSGQVYRIDI--NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      ++||+|+||.||+|.+  ..+++.||||+++... .+....+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            5799999999999965  4557899999996543 233445789999999999999999999999965 56899999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccc
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA  799 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  799 (969)
                      +|+|.+++....             .+++..++.|+.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus       453 ~g~L~~~l~~~~-------------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla  516 (635)
T 4fl3_A          453 LGPLNKYLQQNR-------------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS  516 (635)
T ss_dssp             TEEHHHHHHHCT-------------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred             CCCHHHHHhhCC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence            999999997643             388999999999999999999998   9999999999999999999999999999


Q ss_pred             eecccCCCC-ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          800 KMLAKQGEP-HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       800 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      +.+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+..         
T Consensus       517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---------  587 (635)
T 4fl3_A          517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------  587 (635)
T ss_dssp             HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------
T ss_pred             cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------
Confidence            876543222 22334457889999999999999999999999999999998 9999987665443332221         


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                           +.....+...+..+.+++..||+.||++||++++|++.|++.
T Consensus       588 -----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          588 -----GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 111122333457899999999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=378.83  Aligned_cols=251  Identities=24%  Similarity=0.350  Sum_probs=202.5

Q ss_pred             eeeecCcEEEEEEEEc--CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeeccC
Q 002085          643 LIGSGGSGQVYRIDIN--GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMEN  720 (969)
Q Consensus       643 ~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  720 (969)
                      .||+|+||.||+|.+.  .++..||||+++...  .....+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            7999999999999875  356679999986542  22335789999999999999999999999976 569999999999


Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      |+|.+++....            ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       420 g~L~~~l~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          420 GPLHKFLVGKR------------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             CBHHHHHTTCT------------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             CcHHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            99999997543            3489999999999999999999998   99999999999999999999999999998


Q ss_pred             ecccCCCCc-cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCchh
Q 002085          801 MLAKQGEPH-TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITD  878 (969)
Q Consensus       801 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  878 (969)
                      .+....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+..          
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~----------  554 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----------  554 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT----------
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----------
Confidence            764332211 1223346789999999999999999999999999999998 9999987665444333221          


Q ss_pred             hhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       879 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                          +...+.+...+..+.++|.+||+.||++||++.++++.|+...
T Consensus       555 ----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          555 ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                1111223334578999999999999999999999999998874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.2e-39  Score=366.12  Aligned_cols=250  Identities=14%  Similarity=0.143  Sum_probs=195.6

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHH---HHhccccCceeeEE-------EE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE---ILGTIRHANIVKLW-------CC  704 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~  704 (969)
                      .++|+..+.||+|+||.||+|++..+|+.||||++...........+.+.+|++   ++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467888999999999999999998889999999997554444455678999994   55555899999998       77


Q ss_pred             EEcCCc-----------------eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc
Q 002085          705 ISSENS-----------------KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH  767 (969)
Q Consensus       705 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~  767 (969)
                      +.+++.                 .|+||||+ +|+|.+++.......      .....++|..++.|+.|++.||+|||+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS------STHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT------TTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc------cccccccHHHHHHHHHHHHHHHHHHHh
Confidence            776543                 78999999 689999998653210      011235568899999999999999999


Q ss_pred             cCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-----------CCCCccc
Q 002085          768 DCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-----------KVNEKID  836 (969)
Q Consensus       768 ~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sD  836 (969)
                      .   +|+||||||+|||++.++.+||+|||+++...     .......| +.|+|||++.+.           .++.++|
T Consensus       225 ~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  295 (377)
T 3byv_A          225 Y---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD  295 (377)
T ss_dssp             T---TEECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred             C---CeecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence            8   99999999999999999999999999998532     12334567 999999999887           8999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002085          837 IYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKE  916 (969)
Q Consensus       837 vwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e  916 (969)
                      ||||||++|||++|+.||.+........             .... ..     ...+..+.+++.+||+.||++||++.|
T Consensus       296 vwSlG~il~elltg~~Pf~~~~~~~~~~-------------~~~~-~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          296 AWALGLVIYWIWCADLPITKDAALGGSE-------------WIFR-SC-----KNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHHHHHHHSSCCC------CCSG-------------GGGS-SC-----CCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHHHHHHHCCCCCcccccccchh-------------hhhh-hc-----cCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            9999999999999999997644322111             1111 00     112367889999999999999999999


Q ss_pred             HHH
Q 002085          917 VLQ  919 (969)
Q Consensus       917 vl~  919 (969)
                      +++
T Consensus       357 ~l~  359 (377)
T 3byv_A          357 AME  359 (377)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.7e-39  Score=376.37  Aligned_cols=256  Identities=28%  Similarity=0.455  Sum_probs=209.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||.||+|.+.. +..||||+++....    ..+.+.+|++++++++||||+++++++.+ +..|+||
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            467888999999999999999974 56799999965432    13578999999999999999999999876 6789999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.++++....           ..+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       341 e~~~~gsL~~~l~~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D  406 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGETG-----------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD  406 (535)
T ss_dssp             CCCTTEEHHHHHSHHHH-----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             ehhcCCcHHHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcc
Confidence            99999999999975421           3488999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++.+... .........++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....+....+..      
T Consensus       407 FG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~------  479 (535)
T 2h8h_A          407 FGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------  479 (535)
T ss_dssp             TTSTTTCCCH-HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT------
T ss_pred             cccceecCCC-ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------
Confidence            9999865321 1111223456789999999999999999999999999999999 8888876654433332211      


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                              +...+.+...+..+.++|.+||+.||++||++.+|+++|+.+..
T Consensus       480 --------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          480 --------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                    11112233345788999999999999999999999999999864

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4e-38  Score=366.39  Aligned_cols=342  Identities=27%  Similarity=0.355  Sum_probs=175.6

Q ss_pred             CeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecC
Q 002085           74 SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLG  153 (969)
Q Consensus        74 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  153 (969)
                      +++.|++.++++.. +| .+..+++|++|+|++|.+++..+  +.++++|++|+|++|.+++..|  ++++++|++|+|+
T Consensus        47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~  120 (466)
T 1o6v_A           47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF  120 (466)
T ss_dssp             TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECC
Confidence            45555555555543 22 25555555666665555553322  5555555555555555553332  5555555555555


Q ss_pred             CCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccc
Q 002085          154 GNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIG  233 (969)
Q Consensus       154 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~  233 (969)
                      +|++++. |. +.++++|++|++++|++++ ++ .++.+++|++|++++                           ++.+
T Consensus       121 ~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~~---------------------------~~~~  169 (466)
T 1o6v_A          121 NNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFGN---------------------------QVTD  169 (466)
T ss_dssp             SSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEEE---------------------------SCCC
T ss_pred             CCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecCC---------------------------cccC
Confidence            5555532 21 5555555555555555553 22 244445555544432                           2222


Q ss_pred             cCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccC
Q 002085          234 EIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGK  312 (969)
Q Consensus       234 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~  312 (969)
                      ..  .+.++++|++|++++|.+++.  ..+..+++|++|++++|.+++..|  +... +|+.|++++|++++.  ..+. 
T Consensus       170 ~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~-  240 (466)
T 1o6v_A          170 LK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA-  240 (466)
T ss_dssp             CG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGG-
T ss_pred             ch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhh-
Confidence            22  277778888888888888743  346667777777777776664433  2111 344444444444421  1233 


Q ss_pred             cccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccc
Q 002085          313 LKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTIS  392 (969)
Q Consensus       313 l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  392 (969)
                                                              .+++|+.|++++|++++..|  +..+++|+.|++++|.++
T Consensus       241 ----------------------------------------~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~  278 (466)
T 1o6v_A          241 ----------------------------------------SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS  278 (466)
T ss_dssp             ----------------------------------------GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC
T ss_pred             ----------------------------------------cCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccC
Confidence                                                    34445555555555443222  334444444444444444


Q ss_pred             cccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccc
Q 002085          393 GELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSW  472 (969)
Q Consensus       393 ~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  472 (969)
                      +..+....++|+.|+|++|++++..+  +..+++|+.|++++|++++..|  +..+++|+.|++++|++++.  ..+..+
T Consensus       279 ~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l  352 (466)
T 1o6v_A          279 NISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANL  352 (466)
T ss_dssp             CCGGGTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTC
T ss_pred             ccccccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccC
Confidence            33222222344445555555544333  4445555555555555554433  44555555555555555543  345555


Q ss_pred             cCCCEEEccCccccCCCCcccccccccceEeccCccccc
Q 002085          473 TSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSG  511 (969)
Q Consensus       473 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g  511 (969)
                      ++|+.|++++|++++..|  +..+++|+.|++++|++++
T Consensus       353 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             TTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             CCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence            556666666666555444  5555556666666665553

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.4e-38  Score=358.84  Aligned_cols=257  Identities=9%  Similarity=0.000  Sum_probs=189.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc--ccCceeeEE-------EEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI--RHANIVKLW-------CCIS  706 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~  706 (969)
                      .+|+..+.||+|+||.||+|++..+++.||||++...........+.+.+|+++++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            4588999999999999999999989999999999876554556667888886555555  699988765       5554


Q ss_pred             cCC-----------------ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHH------HHHHHHHHHhhh
Q 002085          707 SEN-----------------SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR------LQIAIGAAQGLC  763 (969)
Q Consensus       707 ~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~------~~i~~~ia~~L~  763 (969)
                      .++                 ..|+||||++ |+|.+++.....            .+.+..+      ..++.|++.||+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~------------~~~~~~~~~~~vk~~i~~qi~~aL~  208 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF------------VYVFRGDEGILALHILTAQLIRLAA  208 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH------------SCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc------------ccchhhhhhhhhHHHHHHHHHHHHH
Confidence            332                 3799999998 899999987532            2455666      788899999999


Q ss_pred             hhcccCCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhccc--CCCCCccchhhHH
Q 002085          764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT--TKVNEKIDIYSFG  841 (969)
Q Consensus       764 ~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG  841 (969)
                      |||+.   +|+||||||+|||++.++.+||+|||+|+....     ......+|+.|+|||++.+  ..++.++||||||
T Consensus       209 ~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG  280 (371)
T 3q60_A          209 NLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLG  280 (371)
T ss_dssp             HHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred             HHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence            99998   999999999999999999999999999986532     1113456799999999987  6799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          842 VVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       842 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      |++|||++|+.||.+........     +. ..............+.....+..+.+++.+||+.||++||++.|+++
T Consensus       281 ~il~elltg~~Pf~~~~~~~~~~-----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          281 LSIYRVWCLFLPFGLVTPGIKGS-----WK-RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHHHHSSCSTTBCCTTCTTC-----CC-BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHHHHhCCCCCCCcCcccccc-----hh-hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99999999999997653321110     00 00000001111111222234578899999999999999999999974

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.5e-38  Score=344.52  Aligned_cols=252  Identities=24%  Similarity=0.321  Sum_probs=210.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ..+.|+..+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   97 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   97 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            34578999999999999999999998999999999865432  2235779999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++++|.+++...              .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        98 v~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  160 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEPG--------------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKL  160 (303)
T ss_dssp             EEECCTTEEHHHHHTTS--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEeCCCCcHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEE
Confidence            99999999999998642              388999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||++..+...  ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+..    .
T Consensus       161 ~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~  234 (303)
T 3a7i_A          161 ADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK----N  234 (303)
T ss_dssp             CCCTTCEECBTT--BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----S
T ss_pred             eecccceecCcc--ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc----C
Confidence            999999876432  2223446789999999999999999999999999999999999999976544332222111    1


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      ..      ...    ....+..+.+++.+||+.||++||++.|+++.
T Consensus       235 ~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          235 NP------PTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CC------CCC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CC------CCC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00      011    11223678999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=9.9e-39  Score=347.61  Aligned_cols=264  Identities=25%  Similarity=0.347  Sum_probs=202.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcC-CC--cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDING-AG--EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .++|+..+.||+|+||.||+|++.. ++  ..||||+++..........+.+.+|++++++++||||+++++++.++. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3578999999999999999998643 33  369999986654444456688999999999999999999999998764 8


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++++|.+++....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~  160 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ------------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLV  160 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG------------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEE
T ss_pred             eeeEecccCCCHHHHHHhcc------------CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCE
Confidence            89999999999999998643            2488999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCCc-cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHH
Q 002085          792 KIADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  869 (969)
                      ||+|||+++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+.........+.  
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--  238 (291)
T 1u46_A          161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID--  238 (291)
T ss_dssp             EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH--
T ss_pred             EEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH--
Confidence            999999998765433222 2234467889999999998889999999999999999999 999987665433322221  


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPT  927 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  927 (969)
                       ...          ...+.+...+..+.+++.+||+.||++||++.++++.|+++.+.
T Consensus       239 -~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          239 -KEG----------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             -TSC----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             -ccC----------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence             111          11111223346789999999999999999999999999998753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-38  Score=343.21  Aligned_cols=251  Identities=27%  Similarity=0.384  Sum_probs=201.6

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC-CceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE-NSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~l  713 (969)
                      .++|+..+.||+|+||.||+|++  +|+.||||+++...     ..+.+.+|++++++++||||+++++++.+. +..++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            46799999999999999999988  48899999986432     346789999999999999999999997554 57899


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++++|.+++.....           ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        93 v~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l  158 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGR-----------SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV  158 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHH-----------HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred             EEecCCCCCHHHHHHhccc-----------ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEE
Confidence            9999999999999976432           2378899999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||+++.....     .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...........+.    .
T Consensus       159 ~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~----~  229 (278)
T 1byg_A          159 SDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----K  229 (278)
T ss_dssp             CCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT----T
T ss_pred             eecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh----c
Confidence            999998754321     123457889999999999999999999999999999998 888887655444332221    1


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                +.....+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       230 ----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          230 ----------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence                      1111122233467899999999999999999999999998875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6e-38  Score=362.33  Aligned_cols=262  Identities=20%  Similarity=0.221  Sum_probs=211.3

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcccc-CceeeEEEEEEcCCceE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH-ANIVKLWCCISSENSKL  712 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~  712 (969)
                      +.++|++.++||+|+||.||+|++..+++.||||++.....     ...+.+|+++++.++| +++..+..++.+.+..+
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            44689999999999999999999998999999998865432     2357889999999976 66667777777888899


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE---CCCC
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL---DSEF  789 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~  789 (969)
                      +||||+ +++|.+++....            ..+++..++.|+.||+.||+|||+.   +|+||||||+|||+   +.++
T Consensus        80 lvme~~-g~sL~~ll~~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~  143 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRAN  143 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTT
T ss_pred             EEEECC-CCCHHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCC
Confidence            999999 999999998543            2489999999999999999999998   99999999999999   5789


Q ss_pred             cEEEeecccceecccCCCCc-----cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          790 KAKIADFGLAKMLAKQGEPH-----TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                      .+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+........
T Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~  223 (483)
T 3sv0_A          144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ  223 (483)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH
T ss_pred             eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH
Confidence            99999999999875533221     2235679999999999999999999999999999999999999998765443333


Q ss_pred             HHHHHhhc--cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          865 WAWRHYAE--EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       865 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ........  ...... +.        ...+.++.+++..||+.||++||++.+|++.|+++.
T Consensus       224 ~~~~i~~~~~~~~~~~-l~--------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          224 KYEKISEKKVATSIEA-LC--------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             HHHHHHHHHHHSCHHH-HH--------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHhhccccccHHH-Hh--------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            22211111  011111 11        112367899999999999999999999999998885

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.6e-38  Score=361.75  Aligned_cols=257  Identities=26%  Similarity=0.310  Sum_probs=197.4

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh-----cHHHHHHHHHHHHHHhccccCceeeEEEEEE
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL-----NQKLEKEFIAEIEILGTIRHANIVKLWCCIS  706 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  706 (969)
                      ..+.++|...+.||+|+||.||+|.+..+++.||||++......     .......+.+|++++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            45677899999999999999999999999999999999654322     1122345889999999999999999999986


Q ss_pred             cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       707 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                      . +..|+||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~  273 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVVGNK-------------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLS  273 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTSSSC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEES
T ss_pred             c-CceEEEEEcCCCCcHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEe
Confidence            4 45899999999999999887543             389999999999999999999998   999999999999997


Q ss_pred             CCC---cEEEeecccceecccCCCCccccccccCcccCchhhccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 002085          787 SEF---KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT---TKVNEKIDIYSFGVVLLELVTGKEANYGDEHT  860 (969)
Q Consensus       787 ~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~  860 (969)
                      .++   .+||+|||+++....   ........||+.|+|||++.+   ..++.++||||+||++|||++|..||......
T Consensus       274 ~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  350 (419)
T 3i6u_A          274 SQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  350 (419)
T ss_dssp             SSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred             cCCCcceEEEeecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence            554   599999999987632   223345679999999999863   56788999999999999999999999765433


Q ss_pred             -chHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          861 -SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       861 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       .+...+...   .....        .......+..+.+++.+||+.||++||+++|+++
T Consensus       351 ~~~~~~i~~~---~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          351 VSLKDQITSG---KYNFI--------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CCHHHHHHTT---CCCCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhcC---CCCCC--------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             222221110   00000        0001122467899999999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=356.05  Aligned_cols=258  Identities=22%  Similarity=0.287  Sum_probs=205.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEc---CCCcEEEEEEEeccchh-cHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDIN---GAGEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTI-RHANIVKLWCCISSEN  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  709 (969)
                      .++|+..++||+|+||.||+|+..   .+++.||||+++..... .....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            468999999999999999999984   47899999998653221 112235677899999999 6999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  196 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-------------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNG  196 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTS
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            9999999999999999998643             388999999999999999999988   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT--KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      .+||+|||+++.+... .........||+.|+|||++.+.  .++.++|||||||++|||++|+.||...........+.
T Consensus       197 ~~kl~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  275 (355)
T 1vzo_A          197 HVVLTDFGLSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS  275 (355)
T ss_dssp             CEEESCSSEEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred             cEEEeeCCCCeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH
Confidence            9999999999876432 12223345799999999999863  47889999999999999999999997654433322222


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQI  920 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~~  920 (969)
                      .......           .+.+...+..+.+++.+||..||++||     ++.|+++.
T Consensus       276 ~~~~~~~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          276 RRILKSE-----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHHHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHhccC-----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            2221111           011223346788999999999999999     88888763

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.6e-38  Score=351.68  Aligned_cols=254  Identities=16%  Similarity=0.166  Sum_probs=205.9

Q ss_pred             cCCCccceeeecCcEEEEEEE-----EcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc---cCceeeEEEEEEc
Q 002085          636 SSLTESNLIGSGGSGQVYRID-----INGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR---HANIVKLWCCISS  707 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  707 (969)
                      ++|++.++||+|+||.||+|.     ...+++.||||++....      ...+.+|+++++.++   |+||+++++++..
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            578899999999999999994     56678899999986542      246777888888775   9999999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      ++..|+||||+++|+|.+++......        ....++|..++.++.|++.||+|||+.   +|+||||||+|||++.
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~  207 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNT--------PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGN  207 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTS--------TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECG
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcc--------cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecc
Confidence            99999999999999999999854321        123599999999999999999999988   9999999999999998


Q ss_pred             -----------CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 002085          788 -----------EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG  856 (969)
Q Consensus       788 -----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~  856 (969)
                                 ++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence                       899999999999876544444555667899999999999999999999999999999999999999864


Q ss_pred             CCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhhcC
Q 002085          857 DEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSR-PSMKEVLQILRRCC  925 (969)
Q Consensus       857 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R-Ps~~evl~~L~~~~  925 (969)
                      ......            .    ........ +  ....+.+++..|++.+|.+| |+++++.+.|++..
T Consensus       288 ~~~~~~------------~----~~~~~~~~-~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          288 NEGGEC------------K----PEGLFRRL-P--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             EETTEE------------E----ECSCCTTC-S--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCCCce------------e----echhcccc-C--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            322110            0    00111111 1  13567789999999999998 68888888887775

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.5e-38  Score=358.83  Aligned_cols=264  Identities=22%  Similarity=0.265  Sum_probs=208.5

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc------ccCceeeEEEEE
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI------RHANIVKLWCCI  705 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~  705 (969)
                      ..+..+|++.++||+|+||.||+|.+..+++.||||++...    ....+.+.+|+++++.+      +|+||+++++++
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            44567899999999999999999999999999999999643    23346677888888877      477999999999


Q ss_pred             EcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE
Q 002085          706 SSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL  785 (969)
Q Consensus       706 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill  785 (969)
                      ......++||||++ ++|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl  233 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNKF-----------QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILL  233 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTTT-----------CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEE
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEE
Confidence            99999999999996 799999986542           3489999999999999999999998   99999999999999


Q ss_pred             CCCCc--EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          786 DSEFK--AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       786 ~~~~~--~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                      +.++.  +||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+..
T Consensus       234 ~~~~~~~vkL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l  308 (429)
T 3kvw_A          234 KQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL  308 (429)
T ss_dssp             SSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ccCCCcceEEeecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99987  99999999976432     223457899999999999999999999999999999999999999877655444


Q ss_pred             HHHHHHhhccC--------CchhhhccC------------------------------CCCccc-H-----HHHHHHHHH
Q 002085          864 EWAWRHYAEEK--------PITDALDKG------------------------------IAEPCY-L-----EEMTTVYRL  899 (969)
Q Consensus       864 ~~~~~~~~~~~--------~~~~~~~~~------------------------------~~~~~~-~-----~~~~~~~~l  899 (969)
                      ..+........        ......+..                              ...... .     .....+.++
T Consensus       309 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dl  388 (429)
T 3kvw_A          309 ACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDF  388 (429)
T ss_dssp             HHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHH
T ss_pred             HHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHH
Confidence            33332211100        000000000                              000000 0     113668899


Q ss_pred             HHHccCCCCCCCCCHHHHHH
Q 002085          900 ALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       900 ~~~cl~~dP~~RPs~~evl~  919 (969)
                      +.+||+.||++|||++|+++
T Consensus       389 i~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          389 LKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHCCCChhhCCCHHHHhC
Confidence            99999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=354.78  Aligned_cols=262  Identities=15%  Similarity=0.173  Sum_probs=206.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC--------CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceee-------
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING--------AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK-------  700 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------  700 (969)
                      ++|+..+.||+|+||.||+|++..        .++.||||++...        +.+.+|++++++++||||++       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            689999999999999999999986        4789999998543        46789999999999999887       


Q ss_pred             --------EEEEEEc-CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCC
Q 002085          701 --------LWCCISS-ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTP  771 (969)
Q Consensus       701 --------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~  771 (969)
                              +++++.. ++..++||||+ +++|.+++.....           ..+++..++.++.|++.||+|||+.   
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---  178 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-----------HVLSERSVLQVACRLLDALEFLHEN---  178 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-----------GCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence                    6777765 67889999999 9999999986521           3589999999999999999999998   


Q ss_pred             CeEecCCCCCcEEECCCC--cEEEeecccceecccCCCC-----ccccccccCcccCchhhcccCCCCCccchhhHHHHH
Q 002085          772 QIIHRDVKSSNILLDSEF--KAKIADFGLAKMLAKQGEP-----HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVL  844 (969)
Q Consensus       772 ~ivH~Dlkp~Nill~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il  844 (969)
                      +|+||||||+||+++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++
T Consensus       179 ~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il  258 (352)
T 2jii_A          179 EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM  258 (352)
T ss_dssp             TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence            999999999999999998  8999999999876543221     122345799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCc-cchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          845 LELVTGKEANYGDEH-TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       845 ~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      |||++|+.||..... ..........+....  ........   .....+..+.+++.+||+.||++||++.|+++.|++
T Consensus       259 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  333 (352)
T 2jii_A          259 LKWLYGFLPWTNCLPNTEDIMKQKQKFVDKP--GPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA  333 (352)
T ss_dssp             HHHHHSCCTTGGGTTCHHHHHHHHHHHHHSC--CCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             HHHHhCCCCcccCCcCHHHHHHHHHhccCCh--hhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence            999999999976532 111111111111111  01111000   001123678999999999999999999999999998


Q ss_pred             cC
Q 002085          924 CC  925 (969)
Q Consensus       924 ~~  925 (969)
                      +.
T Consensus       334 ~~  335 (352)
T 2jii_A          334 LL  335 (352)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-37  Score=351.23  Aligned_cols=264  Identities=24%  Similarity=0.269  Sum_probs=199.7

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC---
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN---  709 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  709 (969)
                      .+.++|+..+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+++++.++||||+++++++...+   
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence            35678999999999999999999999999999999986543 23455678899999999999999999999997655   


Q ss_pred             ---ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          710 ---SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       710 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                         ..|+||||++ ++|.+++..               .+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus       101 ~~~~~~lv~e~~~-~~l~~~~~~---------------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~  161 (371)
T 2xrw_A          101 EFQDVYIVMELMD-ANLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK  161 (371)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHHS---------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             cccceEEEEEcCC-CCHHHHHhh---------------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEc
Confidence               6799999997 578888752               278899999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      .++.+||+|||+++....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+
T Consensus       162 ~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i  238 (371)
T 2xrw_A          162 SDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV  238 (371)
T ss_dssp             TTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCEEEEEeeccccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999986532   22234467899999999999999999999999999999999999999876543332222


Q ss_pred             HHHhhcc-------------------CC-----chhhhccC---CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEE-------------------KP-----ITDALDKG---IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~-------------------~~-----~~~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .......                   ..     ........   .........+..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          239 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            1110000                   00     00000000   000111233578999999999999999999999996

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1e-37  Score=362.23  Aligned_cols=200  Identities=25%  Similarity=0.346  Sum_probs=158.9

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-----
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-----  707 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  707 (969)
                      .+.++|++.++||+|+||.||+|.+..+++.||||++.... .+....+.+.+|+++++.++||||+++++++..     
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  128 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK  128 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence            34578999999999999999999999999999999986532 234456789999999999999999999999843     


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      ....|+||||+ +++|.+++....             .+++..+..++.||+.||+|||+.   +|+||||||+|||++.
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~  191 (458)
T 3rp9_A          129 FDELYVVLEIA-DSDFKKLFRTPV-------------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQ  191 (458)
T ss_dssp             CCCEEEEECCC-SEEHHHHHHSSC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT
T ss_pred             CceEEEEEecc-ccchhhhcccCC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECC
Confidence            35789999998 479999997543             389999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCC-------------------------ccccccccCcccCchhhc-ccCCCCCccchhhHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEP-------------------------HTMSAVAGSFGYFAPEYA-YTTKVNEKIDIYSFG  841 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG  841 (969)
                      ++.+||+|||+|+........                         .......||+.|+|||++ .+..++.++||||+|
T Consensus       192 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG  271 (458)
T 3rp9_A          192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG  271 (458)
T ss_dssp             TCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHH
T ss_pred             CCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHH
Confidence            999999999999876432111                         123456789999999976 566799999999999


Q ss_pred             HHHHHHHhC
Q 002085          842 VVLLELVTG  850 (969)
Q Consensus       842 ~il~elltg  850 (969)
                      |++|||++|
T Consensus       272 ~il~elltg  280 (458)
T 3rp9_A          272 CIFAELLNM  280 (458)
T ss_dssp             HHHHHHHTT
T ss_pred             HHHHHHHHh
Confidence            999999993

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.5e-38  Score=340.09  Aligned_cols=250  Identities=18%  Similarity=0.259  Sum_probs=202.2

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKL  712 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  712 (969)
                      +.++|+..+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+..+..+ +||||+++++++.+++..+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            45689999999999999999999998999999999875433 233457788999999999 9999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC----
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE----  788 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----  788 (969)
                      +||||+++++|.+++......         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.+    
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~  155 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRI---------MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPN  155 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHH---------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------
T ss_pred             EEEEecCCCcHHHHHHhhccc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCc
Confidence            999999999999999864321         13488999999999999999999998   99999999999999844    


Q ss_pred             ---------------CcEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCC
Q 002085          789 ---------------FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKE  852 (969)
Q Consensus       789 ---------------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~  852 (969)
                                     ..+||+|||.+......      ....||+.|+|||.+.+. .++.++|||||||++|||++|..
T Consensus       156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~  229 (289)
T 1x8b_A          156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP  229 (289)
T ss_dssp             --------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred             ccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence                           47999999999876432      224589999999999876 56689999999999999999988


Q ss_pred             CCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          853 ANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       853 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ++...+.   .    .......          ....+...+..+.+++.+||+.||++||++.|+++
T Consensus       230 ~~~~~~~---~----~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          230 LPRNGDQ---W----HEIRQGR----------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CCSSSHH---H----HHHHTTC----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCcchhH---H----HHHHcCC----------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            7654321   1    1111110          01111223367899999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.3e-38  Score=346.52  Aligned_cols=268  Identities=28%  Similarity=0.380  Sum_probs=210.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEE----cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC-
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDI----NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN-  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  709 (969)
                      .++|+..+.||+|+||.||+|+.    ..+++.||||++...   .....+.+.+|++++++++||||+++++++...+ 
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            35688899999999999999984    557899999998653   3344578999999999999999999999987644 


Q ss_pred             -ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          710 -SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       710 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                       ..++||||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~  181 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK------------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENE  181 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST------------TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET
T ss_pred             CceEEEEECCCCCCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCC
Confidence             7899999999999999998653            2488999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCcc-ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHT-MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      +.+||+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|||++|..|+......     ..
T Consensus       182 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-----~~  256 (326)
T 2w1i_A          182 NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FM  256 (326)
T ss_dssp             TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-----HH
T ss_pred             CcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-----HH
Confidence            9999999999987654322211 23345778899999999988999999999999999999999887532100     00


Q ss_pred             HHhhccC-------CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          868 RHYAEEK-------PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       868 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .......       .+.+.+......+.+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          257 RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0000000       011112222222223344578999999999999999999999999998874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=341.55  Aligned_cols=252  Identities=25%  Similarity=0.310  Sum_probs=203.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ..+.|+..+.||+|+||.||+|.+..+|+.||||++.....     .+.+.+|++++++++||||+++++++.+.+..++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            45679999999999999999999998999999999865432     3568899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++++|.+++....            ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus       102 v~e~~~~~~L~~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  166 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRN------------KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKL  166 (314)
T ss_dssp             EEECCTTEEHHHHHHHHT------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred             EeecCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEE
Confidence            999999999999997432            2488999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||++..+...  ........||+.|+|||.+.+..++.++||||+|+++|||++|..||...........+   ....
T Consensus       167 ~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~  241 (314)
T 3com_A          167 ADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTNP  241 (314)
T ss_dssp             CCCTTCEECBTT--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSC
T ss_pred             eecccchhhhhh--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCC
Confidence            999999876432  22233457899999999999999999999999999999999999999765432221111   1110


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .       ...  ..+...+..+.+++.+||+.||++||++.|+++
T Consensus       242 ~-------~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 P-------PTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             C-------CCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-------ccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0       000  111223467899999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=338.01  Aligned_cols=254  Identities=24%  Similarity=0.304  Sum_probs=202.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|....+||+|+||.||+|.+..+++.||||.+....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            45666679999999999999999899999999986542   334577999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC-CCcEEEe
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-EFKAKIA  794 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~  794 (969)
                      ||+++++|.+++.....          ...+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+
T Consensus        99 e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~  165 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWG----------PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKIS  165 (295)
T ss_dssp             ECCSEEEHHHHHHHTTC----------CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEEC
T ss_pred             EeCCCCCHHHHHHhhcc----------CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEe
Confidence            99999999999986532          12467888999999999999999998   9999999999999987 8999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK--VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      |||+++.....  ........||+.|+|||.+.+..  ++.++||||||+++|||++|+.||..................
T Consensus       166 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  243 (295)
T 2clq_A          166 DFGTSKRLAGI--NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV  243 (295)
T ss_dssp             CTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC
T ss_pred             ecccccccCCC--CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc
Confidence            99999876432  12233457899999999987654  789999999999999999999999754332211111111100


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                  ....+...+..+.+++.+||+.||++||++.|+++
T Consensus       244 ------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 ------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                        11112223467889999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.2e-38  Score=346.00  Aligned_cols=257  Identities=27%  Similarity=0.318  Sum_probs=201.8

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh-----cHHHHHHHHHHHHHHhccccCceeeEEEEEE
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL-----NQKLEKEFIAEIEILGTIRHANIVKLWCCIS  706 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  706 (969)
                      ..+.++|+..+.||+|+||.||+|.+..+++.||||++......     .......+.+|++++++++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            34557899999999999999999999999999999998654321     1222356889999999999999999999987


Q ss_pred             cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       707 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                      .+. .|+||||+++++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~  148 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGNK-------------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLS  148 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTTC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEES
T ss_pred             CCc-eEEEEecCCCCcHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEe
Confidence            654 899999999999999987543             388999999999999999999998   999999999999998


Q ss_pred             CCCc---EEEeecccceecccCCCCccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 002085          787 SEFK---AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT  860 (969)
Q Consensus       787 ~~~~---~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~  860 (969)
                      .++.   +||+|||+++....   ........||+.|+|||++.   ...++.++|||||||++|||++|..||......
T Consensus       149 ~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (322)
T 2ycf_A          149 SQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  225 (322)
T ss_dssp             SSSSSCCEEECCCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred             cCCCCCeEEEccCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence            7664   99999999987632   22233456899999999874   567889999999999999999999999765433


Q ss_pred             -chHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          861 -SLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       861 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       .+...+....   .....        ......+..+.+++.+||+.||++||++.|+++
T Consensus       226 ~~~~~~~~~~~---~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          226 VSLKDQITSGK---YNFIP--------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SCHHHHHHHTC---CCCCH--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhCc---cccCc--------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             2222221110   00000        001122467899999999999999999999985

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.6e-37  Score=357.45  Aligned_cols=323  Identities=28%  Similarity=0.381  Sum_probs=212.5

Q ss_pred             CCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEe
Q 002085           72 FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCID  151 (969)
Q Consensus        72 ~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  151 (969)
                      ..+++.|+++++.+.+..+  +.++++|++|+|++|.+++..+  +.++++|++|+|++|.+++..+  +..+++|++|+
T Consensus        67 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~  140 (466)
T 1o6v_A           67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE  140 (466)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred             hcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEE
Confidence            4579999999999987654  9999999999999999996655  9999999999999999996533  99999999999


Q ss_pred             cCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcc
Q 002085          152 LGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANL  231 (969)
Q Consensus       152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l  231 (969)
                      |++|.+++ +| .++.+++|++|+++ |.+.+..  .++++++|++|++++|.+..   + ..+..+++|++|++++|.+
T Consensus       141 l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~---~-~~l~~l~~L~~L~l~~n~l  211 (466)
T 1o6v_A          141 LSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD---I-SVLAKLTNLESLIATNNQI  211 (466)
T ss_dssp             EEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC---C-GGGGGCTTCSEEECCSSCC
T ss_pred             CCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC---C-hhhccCCCCCEEEecCCcc
Confidence            99999985 44 58999999999996 5666443  38999999999999996432   2 2366667777777777666


Q ss_pred             cccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCcccc
Q 002085          232 IGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFG  311 (969)
Q Consensus       232 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~  311 (969)
                      .+..|  ++.+++|++|++++|++++.  ..+..+++|+.|++++|.+                       ++..+  +.
T Consensus       212 ~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l-----------------------~~~~~--~~  262 (466)
T 1o6v_A          212 SDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQI-----------------------SNLAP--LS  262 (466)
T ss_dssp             CCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC-----------------------CCCGG--GT
T ss_pred             ccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCcc-----------------------ccchh--hh
Confidence            65544  55566666666666666642  2344455555555555544                       43322  55


Q ss_pred             CcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCcc
Q 002085          312 KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTI  391 (969)
Q Consensus       312 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  391 (969)
                      .+++|+.|++++|.+++.                  |. +..+++|+.|++++|++++..|  +..+++|+.|+|++|++
T Consensus       263 ~l~~L~~L~l~~n~l~~~------------------~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l  321 (466)
T 1o6v_A          263 GLTKLTELKLGANQISNI------------------SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI  321 (466)
T ss_dssp             TCTTCSEEECCSSCCCCC------------------GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCC
T ss_pred             cCCCCCEEECCCCccCcc------------------cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcC
Confidence            566666666666666531                  11 4456666666666666664322  44555555555555555


Q ss_pred             ccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCccccc
Q 002085          392 SGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVS  471 (969)
Q Consensus       392 ~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  471 (969)
                      ++..|....++|+.|++++|++++.                          ..+..+++|+.|++++|++++..|  +..
T Consensus       322 ~~~~~~~~l~~L~~L~l~~n~l~~~--------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~  373 (466)
T 1o6v_A          322 SDISPVSSLTKLQRLFFYNNKVSDV--------------------------SSLANLTNINWLSAGHNQISDLTP--LAN  373 (466)
T ss_dssp             SCCGGGGGCTTCCEEECCSSCCCCC--------------------------GGGTTCTTCCEEECCSSCCCBCGG--GTT
T ss_pred             CCchhhccCccCCEeECCCCccCCc--------------------------hhhccCCCCCEEeCCCCccCccch--hhc
Confidence            4443333333444444444444432                          234445555555555555554443  455


Q ss_pred             ccCCCEEEccCccccC
Q 002085          472 WTSLNNLNLARNELSG  487 (969)
Q Consensus       472 l~~L~~L~Ls~N~l~~  487 (969)
                      +++|+.|++++|++++
T Consensus       374 l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          374 LTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CTTCCEEECCCEEEEC
T ss_pred             CCCCCEEeccCCcccC
Confidence            5555555555555553

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.7e-37  Score=345.94  Aligned_cols=266  Identities=23%  Similarity=0.232  Sum_probs=208.7

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cC-----ceeeEEEEE
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HA-----NIVKLWCCI  705 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~  705 (969)
                      +.+.++|+..+.||+|+||+||+|.+..+++.||||+++..    ......+..|+++++.++ |+     +++++++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            34568999999999999999999999999999999999643    233566788888888875 44     599999999


Q ss_pred             EcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE
Q 002085          706 SSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL  785 (969)
Q Consensus       706 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill  785 (969)
                      ...+..++||||++ ++|.+++.....           ..+++..+..++.|++.||+|||.+ ..+|+||||||+||++
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll  192 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTNF-----------RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILL  192 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTTT-----------SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEE
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcCc-----------CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEE
Confidence            99999999999996 599999986542           3488999999999999999999953 3389999999999999


Q ss_pred             C--CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH
Q 002085          786 D--SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA  863 (969)
Q Consensus       786 ~--~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~  863 (969)
                      +  .++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.....
T Consensus       193 ~~~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~  267 (382)
T 2vx3_A          193 CNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM  267 (382)
T ss_dssp             SSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ecCCCCcEEEEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            5  467899999999987632     223467899999999999999999999999999999999999999877655444


Q ss_pred             HHHHHHhhccC--------CchhhhccC-----------------------------------------CCCcccHHHHH
Q 002085          864 EWAWRHYAEEK--------PITDALDKG-----------------------------------------IAEPCYLEEMT  894 (969)
Q Consensus       864 ~~~~~~~~~~~--------~~~~~~~~~-----------------------------------------~~~~~~~~~~~  894 (969)
                      ..+........        ...+....-                                         -.......+..
T Consensus       268 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (382)
T 2vx3_A          268 NKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYL  347 (382)
T ss_dssp             HHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHH
T ss_pred             HHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhH
Confidence            44433221100        000000000                                         00011223446


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          895 TVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       895 ~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+.+++.+||+.||++|||++|+++
T Consensus       348 ~~~dli~~mL~~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          348 KFKDLILRMLDYDPKTRIQPYYALQ  372 (382)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHhcCCChhhCCCHHHHhc
Confidence            7899999999999999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1e-37  Score=349.16  Aligned_cols=270  Identities=21%  Similarity=0.318  Sum_probs=208.5

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-----
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-----  707 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  707 (969)
                      +..++|+..+.||+|+||.||+|++..+|+.||||++..... .......+.+|+++++.++||||+++++++.+     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence            446789999999999999999999999999999998855432 22223567899999999999999999999876     


Q ss_pred             ---CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          708 ---ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       708 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                         .+..++||||+++ +|.+.+....            ..+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl  156 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVL------------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVL  156 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEE
Confidence               3468999999984 7777776543            2489999999999999999999998   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCC--CccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccc
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGE--PHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS  861 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~  861 (969)
                      ++.++.+||+|||+++.+.....  ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.....
T Consensus       157 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  236 (351)
T 3mi9_A          157 ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH  236 (351)
T ss_dssp             ECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            99999999999999987653222  223345678999999999876 457999999999999999999999998776555


Q ss_pred             hHHHHHHHhhccCC-chhhhcc---------CCCC-cccHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          862 LAEWAWRHYAEEKP-ITDALDK---------GIAE-PCYLE------EMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       862 ~~~~~~~~~~~~~~-~~~~~~~---------~~~~-~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....+........+ .....+.         .... ....+      ....+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            44444332221110 0000000         0000 00011      1356889999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.6e-37  Score=349.30  Aligned_cols=263  Identities=24%  Similarity=0.290  Sum_probs=209.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC-----C
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE-----N  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  709 (969)
                      ..+|+..+.||+|+||.||+|.+..+++.||||++...  ......+.+.+|++++++++||||+++++++...     .
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            45899999999999999999999999999999998643  2344557899999999999999999999999654     4


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..|+||||++ ++|.+++...              .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~  165 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKTQ--------------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTC  165 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTC
T ss_pred             eEEEEEcccC-cCHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCC
Confidence            6899999997 5999998753              388999999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCc-cccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      .+||+|||+++......... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.........+.
T Consensus       166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  245 (364)
T 3qyz_A          166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL  245 (364)
T ss_dssp             CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred             CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            99999999998764432211 2345579999999998654 458999999999999999999999998876665555443


Q ss_pred             HHhhccCCchhhhccC-------------CCCcc-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          868 RHYAEEKPITDALDKG-------------IAEPC-----YLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~-------------~~~~~-----~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .......  .+.....             .....     ....+..+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          246 GILGSPS--QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHCSCC--HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCC--HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            3221111  0000000             00000     1122367899999999999999999999996

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.5e-38  Score=353.53  Aligned_cols=263  Identities=21%  Similarity=0.223  Sum_probs=200.7

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc------
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS------  707 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  707 (969)
                      ..++|+..+.||+|+||.||+|.+..+|+.||||++.....       ...+|+++++.++||||+++++++..      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34689999999999999999999999999999999865432       23479999999999999999999843      


Q ss_pred             --------------------------------CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHH
Q 002085          708 --------------------------------ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA  755 (969)
Q Consensus       708 --------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~  755 (969)
                                                      ....++||||++ |+|.+.+.....         ....+++..+..++
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~l~~~~~~~i~  147 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR---------SGRSIPMNLISIYI  147 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHH---------TTCCCCHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh---------cCCCCCHHHHHHHH
Confidence                                            334789999998 588877764321         02358999999999


Q ss_pred             HHHHHhhhhhcccCCCCeEecCCCCCcEEEC-CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCC
Q 002085          756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLD-SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNE  833 (969)
Q Consensus       756 ~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~  833 (969)
                      .|++.||+|||+.   +|+||||||+||+++ .++.+||+|||+|+.+...   .......||+.|+|||.+.+. .++.
T Consensus       148 ~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~  221 (383)
T 3eb0_A          148 YQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTP  221 (383)
T ss_dssp             HHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCT
T ss_pred             HHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCc
Confidence            9999999999988   999999999999997 6889999999999876432   223345789999999998775 4899


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC---------CchhhhccCCCC-----cccHHHHHHHHHH
Q 002085          834 KIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK---------PITDALDKGIAE-----PCYLEEMTTVYRL  899 (969)
Q Consensus       834 ~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~-----~~~~~~~~~~~~l  899 (969)
                      ++||||+||++|||++|+.||.+....+....+........         ...+...+....     ..+...+..+.++
T Consensus       222 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  301 (383)
T 3eb0_A          222 SIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL  301 (383)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred             chhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence            99999999999999999999987665544433332211110         000000000000     0112234678999


Q ss_pred             HHHccCCCCCCCCCHHHHHH
Q 002085          900 ALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       900 ~~~cl~~dP~~RPs~~evl~  919 (969)
                      +.+||+.||++|||+.|+++
T Consensus       302 i~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          302 LEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHccCChhhCCCHHHHhc
Confidence            99999999999999999984

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-37  Score=337.30  Aligned_cols=262  Identities=26%  Similarity=0.343  Sum_probs=211.5

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ...+.++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            345677899999999999999999999989999999998654322 2234678999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC--
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE--  788 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--  788 (969)
                      .++||||+++++|.+++....             .+++..++.++.|++.||+|||+.   +|+||||||+||+++.+  
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~  159 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRK-------------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEK  159 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSST
T ss_pred             EEEEEEccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCC
Confidence            999999999999999987543             388999999999999999999998   99999999999999764  


Q ss_pred             -CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          789 -FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 -~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                       +.+||+|||+++.....   .......||+.|+|||.+.+ .++.++||||+|+++|||++|..||.+.........+.
T Consensus       160 ~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (287)
T 2wei_A          160 DCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE  235 (287)
T ss_dssp             TCCEEECSTTGGGTBCCC---SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccEEEeccCcceeecCC---CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence             46999999999865332   22233458899999998875 58999999999999999999999998765443332221


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhc
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRC  924 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~  924 (969)
                      .    ....       ...+.....+..+.+++.+||+.||++|||+.|+++  .+++.
T Consensus       236 ~----~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          236 T----GKYA-------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             H----CCCC-------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             c----CCCC-------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            1    1100       001111223467899999999999999999999997  45544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1e-37  Score=341.50  Aligned_cols=255  Identities=24%  Similarity=0.317  Sum_probs=202.2

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      +..+.|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW   92 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence            34568999999999999999999999899999999985432   223467889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++++|.+++....            ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|
T Consensus        93 lv~e~~~~~~l~~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k  157 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELD------------RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIR  157 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEE
T ss_pred             EEEEeCCCCcHHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEE
Confidence            9999999999999987543            2488999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhc-----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYA-----YTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      |+|||++......  ........||+.|+|||++     .+..++.++||||||+++|||++|..||............ 
T Consensus       158 l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-  234 (302)
T 2j7t_A          158 LADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-  234 (302)
T ss_dssp             ECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-
T ss_pred             EEECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-
Confidence            9999998643221  1112335689999999988     3667899999999999999999999999765543222211 


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                        .....+         ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus       235 --~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          235 --AKSDPP---------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --HHSCCC---------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --hccCCc---------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              111110         00112223467899999999999999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.1e-38  Score=349.10  Aligned_cols=256  Identities=24%  Similarity=0.318  Sum_probs=189.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEE--------
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCIS--------  706 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------  706 (969)
                      .+|+..++||+|+||.||+|++..+++.||||++...   .....+.+.+|+.+++++. ||||+++++++.        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            4789999999999999999999989999999988543   2344577899999999996 999999999984        


Q ss_pred             cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCC--eEecCCCCCcEE
Q 002085          707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQ--IIHRDVKSSNIL  784 (969)
Q Consensus       707 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~Nil  784 (969)
                      .....++||||++ |+|.+++.....          ...+++..++.++.|++.||+|||+.   +  |+||||||+||+
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl  170 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMES----------RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLL  170 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHT----------TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCE
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhc----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEE
Confidence            3345799999996 799999875332          13489999999999999999999988   7  999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCc----------cccccccCcccCchhhc---ccCCCCCccchhhHHHHHHHHHhCC
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPH----------TMSAVAGSFGYFAPEYA---YTTKVNEKIDIYSFGVVLLELVTGK  851 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~elltg~  851 (969)
                      ++.++.+||+|||+++.........          ......||+.|+|||++   .+..++.++|||||||++|||++|+
T Consensus       171 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~  250 (337)
T 3ll6_A          171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ  250 (337)
T ss_dssp             ECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence            9999999999999998764432211          11134589999999998   5667889999999999999999999


Q ss_pred             CCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          852 EANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       852 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .||..........   .              ....+........+.+++.+||+.||++||++.|+++.|+++.
T Consensus       251 ~p~~~~~~~~~~~---~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          251 HPFEDGAKLRIVN---G--------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             CCC-----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCcchhHHHhhc---C--------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            9997543321111   0              0000111111245788999999999999999999999998885

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-37  Score=337.15  Aligned_cols=257  Identities=22%  Similarity=0.276  Sum_probs=190.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++..+++.||||++..... .....+.+.++...++.++||||+++++++.+++..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3578999999999999999999999999999999865432 223344555566668888999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++ |+|.+++.....         ....+++..++.++.|++.||+|||+.+  +|+||||||+||+++.++.+||+
T Consensus        85 ~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~  152 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVID---------KGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMC  152 (290)
T ss_dssp             EECCS-EEHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBC
T ss_pred             Eehhc-cchHHHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEe
Confidence            99997 588888765321         0235899999999999999999999742  89999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYA----YTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |||+++.....   .......||+.|+|||.+    .+..++.++||||+||++|||++|+.||......  ........
T Consensus       153 Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~  227 (290)
T 3fme_A          153 DFGISGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVV  227 (290)
T ss_dssp             CC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHHHHHHH
T ss_pred             ecCCccccccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHHHHHHh
Confidence            99999876432   222334799999999996    5567889999999999999999999999753221  11111111


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....          ........+..+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          228 EEPS----------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HSCC----------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCC----------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1111          11111123467899999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.3e-37  Score=349.00  Aligned_cols=261  Identities=25%  Similarity=0.325  Sum_probs=191.6

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC----
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE----  708 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  708 (969)
                      .+.++|+..+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+++++.++||||+++++++...    
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence            34578999999999999999999999999999999986532 2344567889999999999999999999998654    


Q ss_pred             --CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          709 --NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       709 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                        ...|+|+||+ +++|.+++...              .+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~  166 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKCQ--------------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVN  166 (367)
T ss_dssp             GCCCCEEEEECC-CEECC-----C--------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred             cCCeEEEEeccc-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEEC
Confidence              5679999999 68999888642              388999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      .++.+||+|||+++....     ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.......
T Consensus       167 ~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~  241 (367)
T 2fst_X          167 EDCELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  241 (367)
T ss_dssp             TTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCCCEEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999986532     2334678999999999887 6789999999999999999999999987765444443


Q ss_pred             HHHHhhccCCchhhhcc-----------CC---CCc----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          866 AWRHYAEEKPITDALDK-----------GI---AEP----CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~-----------~~---~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +.+.....  ..+....           .+   ...    ........+.+++.+||..||++|||+.|+++
T Consensus       242 i~~~~g~p--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          242 ILRLVGTP--GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHHCSC--CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCC--CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            33322111  0010000           00   000    00112367889999999999999999999986

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.6e-37  Score=352.98  Aligned_cols=349  Identities=17%  Similarity=0.149  Sum_probs=182.3

Q ss_pred             CCCCCCCCCCCC-CCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCC
Q 002085           53 LQSWTSTSSPCD-WPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN  131 (969)
Q Consensus        53 l~sw~~~~~~c~-w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N  131 (969)
                      +++|..+.+||. |.++.|....++   +............-..++++++|++++|.++...+..|..+++|++|+|++|
T Consensus         3 ~~~~~~~~~C~~~~~~~~c~~~~~~---i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n   79 (390)
T 3o6n_A            3 VKPRQPEYKCIDSNLQYDCVFYDVH---IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL   79 (390)
T ss_dssp             ----CCEECBCC------EEEESCE---ECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTS
T ss_pred             cCCCCCccceehhhhhhccceeeee---eecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCC
Confidence            578988888874 777777543322   2221111111222234567777777777776433344566777777777777


Q ss_pred             cCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCC
Q 002085          132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMI  211 (969)
Q Consensus       132 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~  211 (969)
                      .+++..+..|..+++|++|+|++|++++..|..|+++++|++|+|++|+++...+..|+++++|++|++++|        
T Consensus        80 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n--------  151 (390)
T 3o6n_A           80 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN--------  151 (390)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS--------
T ss_pred             cccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCC--------
Confidence            776655666777777777777777776666666666666777777666666433333455555555555554        


Q ss_pred             CccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcc
Q 002085          212 PIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK  291 (969)
Q Consensus       212 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~  291 (969)
                                        ++.+..|..|.++++|++|++++|++++.   .+..+++|+.|++++|.+++.         
T Consensus       152 ------------------~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~---------  201 (390)
T 3o6n_A          152 ------------------NLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL---------  201 (390)
T ss_dssp             ------------------CCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE---------
T ss_pred             ------------------ccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc---------
Confidence                              34444455566666666666666666532   123334444444444433310         


Q ss_pred             cccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCC
Q 002085          292 LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGEL  371 (969)
Q Consensus       292 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  371 (969)
                                         ...++|                                         +.|++++|+++.. 
T Consensus       202 -------------------~~~~~L-----------------------------------------~~L~l~~n~l~~~-  220 (390)
T 3o6n_A          202 -------------------AIPIAV-----------------------------------------EELDASHNSINVV-  220 (390)
T ss_dssp             -------------------ECCSSC-----------------------------------------SEEECCSSCCCEE-
T ss_pred             -------------------CCCCcc-----------------------------------------eEEECCCCeeeec-
Confidence                               011123                                         3333333333211 


Q ss_pred             CcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCcccc
Q 002085          372 PTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHL  451 (969)
Q Consensus       372 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  451 (969)
                      |.                        ....+|+.|+|++|++++.  ..+..+++|++|++++|.+++..|..|..+++|
T Consensus       221 ~~------------------------~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  274 (390)
T 3o6n_A          221 RG------------------------PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL  274 (390)
T ss_dssp             EC------------------------CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC
T ss_pred             cc------------------------cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccC
Confidence            11                        0112333344444444332  234445555555555555555555556666666


Q ss_pred             chhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecC
Q 002085          452 NTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSN  530 (969)
Q Consensus       452 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N  530 (969)
                      +.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++ +|  +..++ |++|++++|
T Consensus       275 ~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N  349 (390)
T 3o6n_A          275 ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHN  349 (390)
T ss_dssp             CEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSS
T ss_pred             CEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCC
Confidence            66666666665 34545555666666666666665 455556666666666666666653 22  33443 666666666


Q ss_pred             cCCC
Q 002085          531 KLYG  534 (969)
Q Consensus       531 ~l~~  534 (969)
                      ++.+
T Consensus       350 ~~~~  353 (390)
T 3o6n_A          350 DWDC  353 (390)
T ss_dssp             CEEH
T ss_pred             Cccc
Confidence            6654

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-37  Score=372.59  Aligned_cols=377  Identities=17%  Similarity=0.148  Sum_probs=209.0

Q ss_pred             CCCCCCCCCCCCC-CCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccC
Q 002085           52 SLQSWTSTSSPCD-WPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQ  130 (969)
Q Consensus        52 ~l~sw~~~~~~c~-w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~  130 (969)
                      .+++|.++.+||. |.++.|....+. ++.......  ....-..+++++.|++++|.++...+..|.++++|++|+|++
T Consensus         8 ~l~~~~~~~~C~~~~~~~~c~~~~~~-i~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~   84 (597)
T 3oja_B            8 NVKPRQPEYKCIDSNLQYDCVFYDVH-IDMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND   84 (597)
T ss_dssp             ---CCCSEECCCCC--CCSEEECSCE-ECSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTT
T ss_pred             cccCCCCCCcCcccCcCceeEecCce-ecccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCC
Confidence            4688988888874 444444322221 111111111  111122355667777777777644444566677777777777


Q ss_pred             CcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCC
Q 002085          131 NYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAM  210 (969)
Q Consensus       131 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~  210 (969)
                      |.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.|++..+..|+++++|++|+|++|       
T Consensus        85 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N-------  157 (597)
T 3oja_B           85 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN-------  157 (597)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-------
T ss_pred             CCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCC-------
Confidence            7776666666667777777777777766666666666666666666666666444444455555555555544       


Q ss_pred             CCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc
Q 002085          211 IPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL  290 (969)
Q Consensus       211 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~  290 (969)
                                         ++.+..|..|+++++|++|+|++|.+++. +  +..+++|+.|++++|.+++.        
T Consensus       158 -------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--~~~l~~L~~L~l~~n~l~~l--------  207 (597)
T 3oja_B          158 -------------------NLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPSLFHANVSYNLLSTL--------  207 (597)
T ss_dssp             -------------------CCCBCCTTTTTTCTTCCEEECTTSCCSBC-C--GGGCTTCSEEECCSSCCSEE--------
T ss_pred             -------------------cCCCCChhhhhcCCcCcEEECcCCCCCCc-C--hhhhhhhhhhhcccCccccc--------
Confidence                               34555555566666666666666666533 1  22334444444444333210        


Q ss_pred             ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCC
Q 002085          291 KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGE  370 (969)
Q Consensus       291 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  370 (969)
                                          ...+                                         +|+.|++++|.++..
T Consensus       208 --------------------~~~~-----------------------------------------~L~~L~ls~n~l~~~  226 (597)
T 3oja_B          208 --------------------AIPI-----------------------------------------AVEELDASHNSINVV  226 (597)
T ss_dssp             --------------------ECCT-----------------------------------------TCSEEECCSSCCCEE
T ss_pred             --------------------cCCc-----------------------------------------hhheeeccCCccccc
Confidence                                0111                                         233333333333311


Q ss_pred             CCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccc
Q 002085          371 LPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSH  450 (969)
Q Consensus       371 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  450 (969)
                       |.                        ....+|+.|+|++|.+++.  ..+..+++|+.|++++|.|++..|..|..+++
T Consensus       227 -~~------------------------~~~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  279 (597)
T 3oja_B          227 -RG------------------------PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR  279 (597)
T ss_dssp             -EC------------------------SCCSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSS
T ss_pred             -cc------------------------ccCCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccC
Confidence             10                        0112344444555554442  44556666666666666776666777777777


Q ss_pred             cchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeec
Q 002085          451 LNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSS  529 (969)
Q Consensus       451 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~  529 (969)
                      |+.|+|++|++++ +|..+..+++|+.|+|++|.|+ .+|..++.+++|+.|+|++|+|++. |  ++.++ |+.|+|++
T Consensus       280 L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~  354 (597)
T 3oja_B          280 LERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSH  354 (597)
T ss_dssp             CCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCS
T ss_pred             CCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeC
Confidence            7777777777773 5666666777777777777777 5677777777777777777777643 3  44443 77777777


Q ss_pred             CcCCCCCCcccccccccccccCCCCCCCCCCC
Q 002085          530 NKLYGNIPDEFNNLAYDDSFLNNSNLCVKNPI  561 (969)
Q Consensus       530 N~l~~~~p~~~~~~~~~~~~~~n~~l~~~~~~  561 (969)
                      |++.+..+..+-.......+.++...|+....
T Consensus       355 N~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~  386 (597)
T 3oja_B          355 NDWDCNSLRALFRNVARPAVDDADQHCKIDYQ  386 (597)
T ss_dssp             SCEEHHHHHHHTTTCCTTTBCCCCCCCCTTCE
T ss_pred             CCCCChhHHHHHHHHhhhccccccccCCcchh
Confidence            77766433222111112345667777876444

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.8e-38  Score=357.05  Aligned_cols=262  Identities=26%  Similarity=0.310  Sum_probs=198.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC------
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE------  708 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  708 (969)
                      ..+|+..++||+|+||.||+|++..+|+.||||++....       ....+|+++++.++||||+++++++...      
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            346889999999999999999999899999999986542       2234799999999999999999988532      


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      ...++||||+++ ++.+.+.....         ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~---------~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~  192 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSR---------AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPD  192 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETT
T ss_pred             eeEEeehhcccc-cHHHHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCC
Confidence            236799999985 67666653211         023589999999999999999999988   99999999999999965


Q ss_pred             -CcEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          789 -FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       789 -~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                       +.+||+|||+++.+....   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+....+
T Consensus       193 ~~~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i  269 (420)
T 1j1b_A          193 TAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI  269 (420)
T ss_dssp             TTEEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCeEEeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence             568999999998764322   22345789999999998765 7899999999999999999999999876644333333


Q ss_pred             HHHhhccC---------CchhhhccCCCCc-----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEK---------PITDALDKGIAEP-----CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~---------~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+......         ...+...+.+...     .....+..+.+++.+||+.||++||++.|+++
T Consensus       270 ~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          270 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            22211100         0000000000000     01122467899999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.2e-36  Score=338.93  Aligned_cols=260  Identities=19%  Similarity=0.257  Sum_probs=207.6

Q ss_pred             hccCCCccceeeecCcEEEEEEEE-cCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCc------eeeEEEEEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDI-NGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN------IVKLWCCIS  706 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~  706 (969)
                      +.++|++.+.||+|+||.||+|.+ ..+++.||||+++..    ....+.+.+|+++++.++|++      ++++++++.
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            456899999999999999999998 557899999998543    234577889999999987654      999999999


Q ss_pred             cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       707 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                      +.+..++||||+ +++|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~  152 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGF-----------LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFV  152 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEES
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCC-----------CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence            999999999999 8999999986542           3488999999999999999999998   999999999999998


Q ss_pred             C-------------------CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHH
Q 002085          787 S-------------------EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL  847 (969)
Q Consensus       787 ~-------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el  847 (969)
                      .                   ++.+||+|||+++....     ......||+.|+|||++.+..++.++||||+||++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  227 (339)
T 1z57_A          153 QSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY  227 (339)
T ss_dssp             CCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred             ccccccccCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence            8                   66899999999986432     22345789999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCccchHHHHHHHhhccCCchhhhc-----------------------------cCC--CCcccHHHHHHH
Q 002085          848 VTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD-----------------------------KGI--AEPCYLEEMTTV  896 (969)
Q Consensus       848 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~--~~~~~~~~~~~~  896 (969)
                      ++|..||...+.......+....... + .....                             ...  ........+..+
T Consensus       228 ~~g~~pf~~~~~~~~~~~~~~~~~~~-p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  305 (339)
T 1z57_A          228 YLGFTVFPTHDSKEHLAMMERILGPL-P-KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL  305 (339)
T ss_dssp             HHSSCSCCCSCHHHHHHHHHHHHCSC-C-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCC-C-HHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHH
Confidence            99999998765544333332221110 0 00000                             000  001123456789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 002085          897 YRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       897 ~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+++.+||+.||++|||+.|+++
T Consensus       306 ~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          306 FDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHhCcCcccccCHHHHhc
Confidence            99999999999999999999874

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.1e-37  Score=345.77  Aligned_cols=267  Identities=24%  Similarity=0.324  Sum_probs=206.0

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC----
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE----  708 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  708 (969)
                      .+.++|+..+.||+|+||.||+|.+..+|+.||||++....  .......+.+|++++++++||||+++++++...    
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence            34578999999999999999999999899999999985432  344456788999999999999999999988654    


Q ss_pred             -CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          709 -NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       709 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                       ...++||||++ ++|.+++...              .+++..+..++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        86 ~~~~~lv~e~~~-~~L~~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~  147 (353)
T 2b9h_A           86 FNEVYIIQELMQ-TDLHRVISTQ--------------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINS  147 (353)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred             cceEEEEEeccC-ccHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcC
Confidence             67899999997 6999998753              388999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCc--------cccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002085          788 EFKAKIADFGLAKMLAKQGEPH--------TMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDE  858 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~  858 (969)
                      ++.+||+|||+++.+.......        ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+
T Consensus       148 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             TCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999998764322111        1233578999999998765 678999999999999999999999998765


Q ss_pred             ccchHHHHHHHhhccCCc-----------hhhhccC--CCC----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          859 HTSLAEWAWRHYAEEKPI-----------TDALDKG--IAE----PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~--~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .......+..........           .+....-  ...    ......+..+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            443333222221111000           0000000  000    001123467889999999999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-37  Score=340.57  Aligned_cols=268  Identities=26%  Similarity=0.363  Sum_probs=189.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|++++++++||||+++++++..++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            4689999999999999999999988899999998854322  23456788999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++.......     ......+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKG-----EHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTT-----TTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             ehhccCCchHHHHHHHhhcc-----ccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence            99999999999997532100     00123589999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCC---CccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          795 DFGLAKMLAKQGE---PHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       795 Dfgla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |||++........   ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||............   .
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~  240 (303)
T 2vwi_A          164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT---L  240 (303)
T ss_dssp             CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH---H
T ss_pred             eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH---h
Confidence            9999976643221   112234568999999999876 56899999999999999999999999876544332221   1


Q ss_pred             hccCC-chh-hhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKP-ITD-ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....+ ... ..+...    ....+..+.+++.+||+.||++||++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          241 QNDPPSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TSSCCCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCCCccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11111 000 001111    1122357889999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-36  Score=346.17  Aligned_cols=262  Identities=24%  Similarity=0.291  Sum_probs=204.7

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc--------cCceeeEEEEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR--------HANIVKLWCCI  705 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~  705 (969)
                      +.++|++.++||+|+||+||+|++..+++.||||++...    ....+.+.+|+++++.++        ||||+++++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            346899999999999999999999999999999998543    344577889999999985        78899999998


Q ss_pred             E----cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCC
Q 002085          706 S----SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSS  781 (969)
Q Consensus       706 ~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~  781 (969)
                      .    +....++||||+ +++|.+++.....           ..+++..++.++.|++.||+|||+++  +|+||||||+
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-----------~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~  176 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNY-----------QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPE  176 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGG
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhccc-----------CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHH
Confidence            7    556789999999 5677776654431           34899999999999999999999742  8999999999


Q ss_pred             cEEECCCC-------------------------------------------------cEEEeecccceecccCCCCcccc
Q 002085          782 NILLDSEF-------------------------------------------------KAKIADFGLAKMLAKQGEPHTMS  812 (969)
Q Consensus       782 Nill~~~~-------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~  812 (969)
                      |||++.++                                                 .+||+|||+++.....     ..
T Consensus       177 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~  251 (397)
T 1wak_A          177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FT  251 (397)
T ss_dssp             GEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SC
T ss_pred             HeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----Cc
Confidence            99999775                                                 7999999999876332     33


Q ss_pred             ccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchH------HHHHHHhhccCCch---------
Q 002085          813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLA------EWAWRHYAEEKPIT---------  877 (969)
Q Consensus       813 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~------~~~~~~~~~~~~~~---------  877 (969)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......      ..+.... ...+..         
T Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~  330 (397)
T 1wak_A          252 EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL-GKVPRKLIVAGKYSK  330 (397)
T ss_dssp             SCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHH-CSCCHHHHHHCTTGG
T ss_pred             cCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhc-CCCChHHhhcccccc
Confidence            457899999999999999999999999999999999999999765433211      1111111 000000         


Q ss_pred             hhhccC-----C--------------CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          878 DALDKG-----I--------------AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       878 ~~~~~~-----~--------------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +.....     .              ....+......+.+++.+||+.||++|||++|+++
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000000     0              01224566788999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.2e-37  Score=351.24  Aligned_cols=263  Identities=24%  Similarity=0.293  Sum_probs=196.5

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc--
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS--  710 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  710 (969)
                      ....+|+..++||+|+||.||+|++..+++ ||+|++.....       ...+|+++++.++||||+++++++...+.  
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            345679999999999999999999986665 88888754432       22369999999999999999999855433  


Q ss_pred             ----eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          711 ----KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       711 ----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                          .++||||++++.+.........          ...+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~  175 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKL----------KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLD  175 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHT----------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEc
Confidence                7899999986544333321111          23588999999999999999999998   999999999999999


Q ss_pred             -CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          787 -SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       787 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                       .++.+||+|||+|+.+....   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+......
T Consensus       176 ~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~  252 (394)
T 4e7w_A          176 PPSGVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV  252 (394)
T ss_dssp             TTTTEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCcEEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence             78999999999998764322   23346789999999998765 58999999999999999999999998776544433


Q ss_pred             HHHHHhhccCC--c----hhhhccCC---CC-----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          865 WAWRHYAEEKP--I----TDALDKGI---AE-----PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       865 ~~~~~~~~~~~--~----~~~~~~~~---~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+.+.......  +    ........   ..     ......+.++.+++.+||+.||++|||+.|+++
T Consensus       253 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          253 EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            33222111000  0    00000000   00     011123468899999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-37  Score=340.30  Aligned_cols=253  Identities=22%  Similarity=0.302  Sum_probs=198.6

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc-----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS-----  707 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----  707 (969)
                      ..++|+..+.||+|+||.||+|++..+++.||||++.....    ..+.+.+|+++++++ +||||+++++++..     
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            45689999999999999999999998999999999864322    235788999999999 79999999999876     


Q ss_pred             -CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          708 -ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       708 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                       .+..++||||+++++|.+++.....           ..+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~  163 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKG-----------NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLT  163 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGG-----------GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhccc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEc
Confidence             4678999999999999999986532           3588999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccc
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS  861 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~  861 (969)
                      .++.+||+|||++......  ........||+.|+|||++.     +..++.++|||||||++|||++|..||.+.....
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  241 (326)
T 2x7f_A          164 ENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR  241 (326)
T ss_dssp             TTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             CCCCEEEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence            9999999999999865432  11223457899999999987     5678999999999999999999999997654332


Q ss_pred             hHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....+.   ....       +..   .....+..+.+++.+||..||++||++.|+++
T Consensus       242 ~~~~~~---~~~~-------~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          242 ALFLIP---RNPA-------PRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHH---HSCC-------CCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhh---cCcc-------ccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            221111   1110       000   11112367889999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-36  Score=343.38  Aligned_cols=260  Identities=22%  Similarity=0.296  Sum_probs=204.7

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce-
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK-  711 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-  711 (969)
                      ++.++|...+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+++++.++||||+++++++...+.. 
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence            34578999999999999999999999999999999996543 2345567899999999999999999999999877654 


Q ss_pred             -----EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          712 -----LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       712 -----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                           ++||||++ ++|.+++..               .+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~  178 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIMGM---------------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVN  178 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHTTS---------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             cceeEEEEEcccc-ccHHHHhhc---------------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEEC
Confidence                 99999997 688888742               388999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          787 SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       787 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      .++.+||+|||+++....     ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....
T Consensus       179 ~~~~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  253 (371)
T 4exu_A          179 EDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  253 (371)
T ss_dssp             TTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCCCEEEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            999999999999986532     2334578999999999887 6789999999999999999999999987665444333


Q ss_pred             HHHHhhccCCchhhhc---------------cCCCC---cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          866 AWRHYAEEKPITDALD---------------KGIAE---PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~---------------~~~~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +.......  ..+...               .....   ......+..+.+++.+||+.||++|||++|+++
T Consensus       254 i~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          254 ILKVTGVP--GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHHCCC--CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhCCC--cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            32211110  000000               00000   001122467899999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-37  Score=348.33  Aligned_cols=263  Identities=19%  Similarity=0.275  Sum_probs=206.1

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHH--------------HHHHHHHHHHHHhccccCcee
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK--------------LEKEFIAEIEILGTIRHANIV  699 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv  699 (969)
                      ..++|+..+.||+|+||.||+|++  +++.||||++.........              ..+.+.+|++++++++||||+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            457899999999999999999999  7999999998654322111              127899999999999999999


Q ss_pred             eEEEEEEcCCceEEEEeeccCCCHHHH------hccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCC
Q 002085          700 KLWCCISSENSKLLVYEYMENQSLDRW------LHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQ  772 (969)
Q Consensus       700 ~l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~  772 (969)
                      ++++++.+.+..++||||+++++|.++      +....           ...+++..++.++.|++.||+|||+ .   +
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~~---~  172 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-----------TCFIPIQVIKCIIKSVLNSFSYIHNEK---N  172 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-----------CCCCCHHHHHHHHHHHHHHHHHHHHTS---C
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-----------ccCCCHHHHHHHHHHHHHHHHHHhccC---C
Confidence            999999999999999999999999998      44321           2458999999999999999999998 7   9


Q ss_pred             eEecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCC-ccchhhHHHHHHHHHhC
Q 002085          773 IIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNE-KIDIYSFGVVLLELVTG  850 (969)
Q Consensus       773 ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslG~il~elltg  850 (969)
                      |+||||||+||+++.++.+||+|||.+......    ......|++.|+|||.+.+. .++. ++||||+||++|||++|
T Consensus       173 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  248 (348)
T 2pml_X          173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN  248 (348)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred             EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence            999999999999999999999999999876332    34456799999999999887 6666 99999999999999999


Q ss_pred             CCCCCCCCc-cchHHHHHHHhhccCCchhh----hccCC---CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          851 KEANYGDEH-TSLAEWAWRHYAEEKPITDA----LDKGI---AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       851 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~---~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..||..... ......+.   .........    .....   ........+..+.+++.+||+.||++||++.|+++
T Consensus       249 ~~pf~~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          249 VVPFSLKISLVELFNNIR---TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SCSSCCSSCSHHHHHHHT---SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCcHHHHHHHHh---ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            999986654 22222211   111110000    00000   00001223467899999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.6e-37  Score=338.06  Aligned_cols=271  Identities=23%  Similarity=0.325  Sum_probs=200.7

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEE------
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCIS------  706 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~------  706 (969)
                      .+.++|+..+.||+|+||.||+|.+..+++.||+|++...   +....+.+.+|++++++++||||+++++++.      
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            3456899999999999999999999989999999998543   3445678999999999999999999999874      


Q ss_pred             --------cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCC
Q 002085          707 --------SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDV  778 (969)
Q Consensus       707 --------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  778 (969)
                              +....++||||++ |+|.+++...              .+++..++.++.|++.||+|||+.   +|+||||
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl  146 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQG--------------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDL  146 (320)
T ss_dssp             CC----CCSCSEEEEEEECCS-EEHHHHHTTC--------------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCC
T ss_pred             ccccccccccCceeEEeeccC-CCHHHHhhcC--------------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCC
Confidence                    3467899999998 6999998642              378899999999999999999998   9999999


Q ss_pred             CCCcEEEC-CCCcEEEeecccceecccCCC-CccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCC
Q 002085          779 KSSNILLD-SEFKAKIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANY  855 (969)
Q Consensus       779 kp~Nill~-~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~  855 (969)
                      ||+||+++ +++.+||+|||+++....... ........+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus       147 kp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  226 (320)
T 2i6l_A          147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA  226 (320)
T ss_dssp             SGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence            99999997 567999999999987643211 122234567999999998865 678999999999999999999999998


Q ss_pred             CCCccchHHHHHHHhhccC---------CchhhhccCCCC------cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-
Q 002085          856 GDEHTSLAEWAWRHYAEEK---------PITDALDKGIAE------PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ-  919 (969)
Q Consensus       856 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~-  919 (969)
                      +.........+........         .+..........      ......+..+.+++.+||+.||++||++.|+++ 
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          227 GAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            7654433332222111000         000000000000      001123467899999999999999999999986 


Q ss_pred             -HHhhc
Q 002085          920 -ILRRC  924 (969)
Q Consensus       920 -~L~~~  924 (969)
                       .+...
T Consensus       307 p~~~~~  312 (320)
T 2i6l_A          307 PYMSIY  312 (320)
T ss_dssp             HHHHTT
T ss_pred             cccccc
Confidence             44443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.4e-37  Score=338.24  Aligned_cols=267  Identities=24%  Similarity=0.326  Sum_probs=206.2

Q ss_pred             hccCCCccceeeecCcEEEEEEEEc-CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc---ccCceeeEEEEEE---
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDIN-GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI---RHANIVKLWCCIS---  706 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---  706 (969)
                      ..++|+..+.||+|+||.||+|++. .+|+.||+|++...... ......+.+|+++++.+   +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3468999999999999999999995 67899999998654321 11123466777777766   8999999999987   


Q ss_pred             --cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          707 --SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       707 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                        .....++||||++ |+|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nil  152 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-----------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNIL  152 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCT-----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhccc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeE
Confidence              5567899999998 699999986542           3488999999999999999999998   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                      ++.++.+||+|||+++....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+........
T Consensus       153 i~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  229 (326)
T 1blx_A          153 VTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  229 (326)
T ss_dssp             ECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EcCCCCEEEecCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            99999999999999986532   223345678999999999999999999999999999999999999998776554444


Q ss_pred             HHHHHhhccCC--ch------h-hhccC---CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          865 WAWRHYAEEKP--IT------D-ALDKG---IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       865 ~~~~~~~~~~~--~~------~-~~~~~---~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+.........  ..      . .....   .........+..+.+++.+||+.||++||++.|+++
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          230 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            33332211100  00      0 00000   000111223467889999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.3e-37  Score=334.83  Aligned_cols=254  Identities=23%  Similarity=0.383  Sum_probs=195.3

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc------
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS------  707 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  707 (969)
                      +.++|+..+.||+|+||.||+|++..+++.||||++...    ....+.+.+|++++++++||||+++++++.+      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            456789999999999999999999989999999998542    3445789999999999999999999998754      


Q ss_pred             -------CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCC
Q 002085          708 -------ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKS  780 (969)
Q Consensus       708 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  780 (969)
                             .+..|+||||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp  144 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN------------LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKP  144 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSC------------GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccc------------cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCH
Confidence                   356799999999999999998643            2477889999999999999999998   999999999


Q ss_pred             CcEEECCCCcEEEeecccceecccCCC------------CccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHH
Q 002085          781 SNILLDSEFKAKIADFGLAKMLAKQGE------------PHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLEL  847 (969)
Q Consensus       781 ~Nill~~~~~~kl~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~el  847 (969)
                      +||+++.++.+||+|||+++.......            ........||+.|+|||.+.+. .++.++||||+||++|||
T Consensus       145 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l  224 (303)
T 1zy4_A          145 MNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM  224 (303)
T ss_dssp             GGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHH
T ss_pred             HhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHH
Confidence            999999999999999999986543211            1222345689999999998864 689999999999999999


Q ss_pred             HhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          848 VTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       848 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ++   ||.....  ... ........       ............+..+.+++.+||+.||++|||+.|+++
T Consensus       225 ~~---p~~~~~~--~~~-~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          225 IY---PFSTGME--RVN-ILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HS---CCSSHHH--HHH-HHHHHHST-------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Hh---ccCCchh--HHH-HHHhcccc-------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            98   4432211  111 11111111       011111222333467889999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.5e-37  Score=339.97  Aligned_cols=255  Identities=21%  Similarity=0.291  Sum_probs=176.4

Q ss_pred             hhccCCCccc-eeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc----
Q 002085          633 NILSSLTESN-LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS----  707 (969)
Q Consensus       633 ~~~~~~~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----  707 (969)
                      .+.++|.+.+ +||+|+||.||+|.+..+++.||||++....    .   ...+....++.++||||+++++++..    
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----K---ARQEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----H---HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            4567888854 6999999999999999999999999985431    1   11222234556799999999999876    


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      ....++||||+++|+|.+++.....           ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~~-----------~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~  163 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERGD-----------QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTS  163 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC-C-----------CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESC
T ss_pred             CceEEEEEeccCCCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEe
Confidence            4458999999999999999986542           3589999999999999999999998   9999999999999986


Q ss_pred             C---CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          788 E---FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       788 ~---~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                      +   +.+||+|||+++....    .......||+.|+|||++.+..++.++||||+||++|||++|..||..........
T Consensus       164 ~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  239 (336)
T 3fhr_A          164 KEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP  239 (336)
T ss_dssp             SSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cCCCceEEEeccccceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh
Confidence            4   4599999999986532    22334578999999999988889999999999999999999999997654433211


Q ss_pred             HHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .........       ......+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          240 GMKRRIRLG-------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHhhhcc-------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111111000       001111122234467899999999999999999999997

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.4e-37  Score=344.99  Aligned_cols=267  Identities=24%  Similarity=0.263  Sum_probs=199.6

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccch--------hcHHHHHHHHHHHHHHhccccCceeeEEEE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK--------LNQKLEKEFIAEIEILGTIRHANIVKLWCC  704 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  704 (969)
                      .+.++|+..+.||+|+||.||+|.+.. |+.||||++.....        .+....+.+.+|++++++++||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            456789999999999999999998864 89999999854322        223445789999999999999999999999


Q ss_pred             EEc-----CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCC
Q 002085          705 ISS-----ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK  779 (969)
Q Consensus       705 ~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  779 (969)
                      +..     ....|+||||++ |+|.+++....            ..+++..+..++.|++.||+|||+.   +|+|||||
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  161 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR------------IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLH  161 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHCTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCC
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCC
Confidence            843     335799999998 68888887543            2489999999999999999999998   99999999


Q ss_pred             CCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 002085          780 SSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDE  858 (969)
Q Consensus       780 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~  858 (969)
                      |+||+++.++.+||+|||+++....   ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hHHEEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999975432   222344578999999999877 678999999999999999999999998766


Q ss_pred             ccchHHHHHHHhhccCC----------chhhhccCCC---C----cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          859 HTSLAEWAWRHYAEEKP----------ITDALDKGIA---E----PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       859 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~---~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .......+.........          ..+.......   .    .........+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            54443333222111100          0000000000   0    011122467889999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-36  Score=342.57  Aligned_cols=268  Identities=22%  Similarity=0.283  Sum_probs=192.6

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc-
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS-  710 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  710 (969)
                      ....++|+..+.||+|+||.||+|++..+|+.||||++......    .....+|++.++.++||||+++++++...+. 
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            34567899999999999999999999989999999988554322    2345677888888999999999999865433 


Q ss_pred             ------eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhc--ccCCCCeEecCCCCCc
Q 002085          711 ------KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMH--HDCTPQIIHRDVKSSN  782 (969)
Q Consensus       711 ------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~Dlkp~N  782 (969)
                            .++||||+++ +|.+.+.....         ....+++..+..++.|++.|+.|||  +.   +|+||||||+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~N  161 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR---------RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHN  161 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHT---------TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGG
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHH
Confidence                  7899999985 55554442111         0234788999999999999999999  66   99999999999


Q ss_pred             EEECC-CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 002085          783 ILLDS-EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHT  860 (969)
Q Consensus       783 ill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~  860 (969)
                      |+++. ++.+||+|||+++.+...   .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....
T Consensus       162 Ill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  238 (360)
T 3e3p_A          162 VLVNEADGTLKLCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA  238 (360)
T ss_dssp             EEEETTTTEEEECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EEEeCCCCcEEEeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence            99997 899999999999876432   2233457899999999987654 899999999999999999999999887655


Q ss_pred             chHHHHHHHhhccCC-chhhhccC-----------C-----CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          861 SLAEWAWRHYAEEKP-ITDALDKG-----------I-----AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       861 ~~~~~~~~~~~~~~~-~~~~~~~~-----------~-----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .....+.+....... ......+.           .     ........+..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            444443332211100 00000000           0     00111123578999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.8e-37  Score=369.14  Aligned_cols=258  Identities=24%  Similarity=0.322  Sum_probs=207.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .++|+..+.||+|+||.||+|.+..+   +..||+|.++..  ......+.+.+|+.++++++||||+++++++. ++..
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            35788899999999999999998543   457999987543  23455678999999999999999999999985 4568


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||+++|+|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~v  530 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRK------------FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV  530 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTT------------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred             EEEEEcCCCCcHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCE
Confidence            99999999999999998643            2488999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+++..... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+... 
T Consensus       531 kL~DFG~a~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-  608 (656)
T 2j0j_A          531 KLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-  608 (656)
T ss_dssp             EECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-
T ss_pred             EEEecCCCeecCCC-cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-
Confidence            99999999876432 2222334557889999999999999999999999999999997 88888776544433322211 


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                         .          ..+.+...+..+.+++.+||+.||++||++.|+++.|+++.
T Consensus       609 ---~----------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          609 ---E----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             ---C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---C----------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               1          11122233467899999999999999999999999998874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=9.6e-37  Score=335.60  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=196.0

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc--cCceeeEEEEEEcCCceEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR--HANIVKLWCCISSENSKLL  713 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  713 (969)
                      ++|+..+.||+|+||.||+|.+. +++.||||++.... ......+.+.+|++++++++  ||||+++++++.+++..++
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            56999999999999999999886 58899999986543 23455678999999999997  5999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||| +.+++|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||++++ +.+||
T Consensus       106 v~e-~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL  167 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK-------------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKL  167 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEE
T ss_pred             EEe-cCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEE
Confidence            999 56799999998654             378999999999999999999998   9999999999999965 89999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCccch
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-----------TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL  862 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  862 (969)
                      +|||+++.+.............||+.|+|||.+.+           ..++.++|||||||++|||++|+.||......  
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--  245 (313)
T 3cek_A          168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--  245 (313)
T ss_dssp             CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--
T ss_pred             eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--
Confidence            99999987654333333345579999999999875           46888999999999999999999999754321  


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ........          +.......+...+..+.+++.+||+.||++||++.|+++
T Consensus       246 ~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          246 ISKLHAII----------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHHHHHH----------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHH----------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            11111111          111111111122367889999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.9e-36  Score=336.30  Aligned_cols=260  Identities=20%  Similarity=0.247  Sum_probs=205.3

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCC-cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCc------eeeEEEEEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAG-EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN------IVKLWCCIS  706 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~  706 (969)
                      +.++|++.+.||+|+||.||+|.+..++ +.||+|+++..    ....+.+.+|+++++.++|++      ++.+.+++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            3568999999999999999999997766 78999998543    234567889999999997766      999999999


Q ss_pred             cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE-
Q 002085          707 SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL-  785 (969)
Q Consensus       707 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill-  785 (969)
                      ..+..++||||+ ++++.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||++ 
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~  157 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKENNF-----------QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFV  157 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTT-----------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEES
T ss_pred             eCCeEEEEEecc-CCChHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEe
Confidence            999999999999 6777777765432           3488999999999999999999988   99999999999999 


Q ss_pred             ------------------CCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHH
Q 002085          786 ------------------DSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLEL  847 (969)
Q Consensus       786 ------------------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~el  847 (969)
                                        +.++.+||+|||+++....     ......||+.|+|||++.+..++.++||||+||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  232 (355)
T 2eu9_A          158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY  232 (355)
T ss_dssp             CCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence                              5678999999999986432     22345799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCccchHHHHHHHhhccCCchhhhcc----------C---------------------CCCcccHHHHHHH
Q 002085          848 VTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDK----------G---------------------IAEPCYLEEMTTV  896 (969)
Q Consensus       848 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~---------------------~~~~~~~~~~~~~  896 (969)
                      ++|+.||...........+....... + ......          .                     ............+
T Consensus       233 ~~g~~pf~~~~~~~~~~~~~~~~~~~-p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  310 (355)
T 2eu9_A          233 YRGFTLFQTHENREHLVMMEKILGPI-P-SHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL  310 (355)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCC-C-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHcCCC-c-HHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHH
Confidence            99999998765544333332221110 0 000000          0                     0001123345688


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 002085          897 YRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       897 ~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+++.+||+.||++|||++|+++
T Consensus       311 ~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          311 FDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCcCHHHHhc
Confidence            99999999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=338.73  Aligned_cols=261  Identities=21%  Similarity=0.288  Sum_probs=203.1

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc---
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS---  710 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  710 (969)
                      +.++|...+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+.   
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            4568999999999999999999999999999999986543 234456789999999999999999999999987654   


Q ss_pred             ---eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          711 ---KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       711 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                         .|+||||++ ++|.+++..               .+++..+..++.|++.||+|||+.   +|+||||||+||+++.
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~~---------------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~  161 (353)
T 3coi_A          101 FYDFYLVMPFMQ-TDLQKIMGL---------------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNE  161 (353)
T ss_dssp             CCCCEEEEECCS-EEGGGTTTS---------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECT
T ss_pred             ceeEEEEecccc-CCHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECC
Confidence               499999997 688877642               388999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      ++.+||+|||+++....     ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+.......+
T Consensus       162 ~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i  236 (353)
T 3coi_A          162 DCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI  236 (353)
T ss_dssp             TCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH
T ss_pred             CCcEEEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999976432     1234578999999999887 67899999999999999999999999876654433333


Q ss_pred             HHHhhccCC-c---------hhh---hccCC---CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEKP-I---------TDA---LDKGI---AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~~-~---------~~~---~~~~~---~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ......... .         ...   +....   ........+..+.+++.+|++.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            221111000 0         000   00000   00111233578899999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=342.78  Aligned_cols=259  Identities=23%  Similarity=0.309  Sum_probs=201.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++..   .||+|+++.... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            4678999999999999999999853   399999865432 222235678899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++++|.+++....            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++ ++.+||+
T Consensus       108 ~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAK------------IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             CBCCCSEEHHHHTTSSC------------CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEEC
T ss_pred             eecccCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEe
Confidence            99999999999997643            2488999999999999999999998   999999999999998 6799999


Q ss_pred             ecccceecccCC---CCccccccccCcccCchhhccc---------CCCCCccchhhHHHHHHHHHhCCCCCCCCCccch
Q 002085          795 DFGLAKMLAKQG---EPHTMSAVAGSFGYFAPEYAYT---------TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSL  862 (969)
Q Consensus       795 Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  862 (969)
                      |||+++......   .........||+.|+|||.+.+         ..++.++|||||||++|||++|+.||........
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  251 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI  251 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999987653211   1122234568999999999874         3578899999999999999999999976654333


Q ss_pred             HHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          863 AEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      ...+...   ..       +...   ....+..+.+++.+||..||++||++.|++++|+++..
T Consensus       252 ~~~~~~~---~~-------~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          252 IWQMGTG---MK-------PNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             HHHHHTT---CC-------CCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             HHHhccC---CC-------CCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            2222111   00       0000   01122568899999999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.3e-37  Score=348.12  Aligned_cols=272  Identities=21%  Similarity=0.316  Sum_probs=185.1

Q ss_pred             ccCCCc-cceeeecCcEEEEEEEEc--CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEE--cCC
Q 002085          635 LSSLTE-SNLIGSGGSGQVYRIDIN--GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCIS--SEN  709 (969)
Q Consensus       635 ~~~~~~-~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~  709 (969)
                      .+.|.. .++||+|+||.||+|++.  .+++.||||++.....     ...+.+|++++++++||||+++++++.  ...
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            344554 568999999999999975  4678999999864432     246788999999999999999999985  467


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE----
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL----  785 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill----  785 (969)
                      ..|+||||++ ++|.+++........    ......+++..++.++.|++.||+|||+.   +|+||||||+||++    
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~  165 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKA----NKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG  165 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSS
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccc----cccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCC
Confidence            8899999997 588888864332100    00122489999999999999999999998   99999999999999    


Q ss_pred             CCCCcEEEeecccceecccCCCC-ccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCcc---
Q 002085          786 DSEFKAKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHT---  860 (969)
Q Consensus       786 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~---  860 (969)
                      +.++.+||+|||+++.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....   
T Consensus       166 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  245 (405)
T 3rgf_A          166 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT  245 (405)
T ss_dssp             TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred             CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence            67789999999999876432221 233456799999999999874 5899999999999999999999999765431   


Q ss_pred             ------chHHHHHHHhhccC--Cchhh---------hc---cCCCCccc---------HHHHHHHHHHHHHccCCCCCCC
Q 002085          861 ------SLAEWAWRHYAEEK--PITDA---------LD---KGIAEPCY---------LEEMTTVYRLALICTSTLPSSR  911 (969)
Q Consensus       861 ------~~~~~~~~~~~~~~--~~~~~---------~~---~~~~~~~~---------~~~~~~~~~l~~~cl~~dP~~R  911 (969)
                            .....+........  .....         ..   ........         ......+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R  325 (405)
T 3rgf_A          246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR  325 (405)
T ss_dssp             -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred             cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence                  11111111111000  00000         00   00000000         0013567899999999999999


Q ss_pred             CCHHHHHH
Q 002085          912 PSMKEVLQ  919 (969)
Q Consensus       912 Ps~~evl~  919 (969)
                      ||++|+++
T Consensus       326 ~ta~e~L~  333 (405)
T 3rgf_A          326 ITSEQAMQ  333 (405)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999997

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=351.92  Aligned_cols=175  Identities=23%  Similarity=0.224  Sum_probs=119.3

Q ss_pred             EEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCC
Q 002085           77 GISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNN  156 (969)
Q Consensus        77 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  156 (969)
                      .+++++++++ .+|..+.  +++++|+|++|+|++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus        15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~   91 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR   91 (477)
T ss_dssp             EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence            3444455544 2444332  467778888888877667777777777777777777777677777777777777777777


Q ss_pred             CCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCc
Q 002085          157 FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIP  236 (969)
Q Consensus       157 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  236 (969)
                      +++..+..|.++++|++|+|++|++++..|..|.++++|++|++++|                          ++.+..|
T Consensus        92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n--------------------------~l~~~~~  145 (477)
T 2id5_A           92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN--------------------------DLVYISH  145 (477)
T ss_dssp             CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCT--------------------------TCCEECT
T ss_pred             CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCC--------------------------ccceeCh
Confidence            77555555677777777777777777666666666666666666555                          3555566


Q ss_pred             hhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccc
Q 002085          237 EAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILS  280 (969)
Q Consensus       237 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  280 (969)
                      ..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|.++
T Consensus       146 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~  189 (477)
T 2id5_A          146 RAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN  189 (477)
T ss_dssp             TSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCC
T ss_pred             hhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCc
Confidence            67777888888888888887655555666666666666665554

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.9e-36  Score=333.94  Aligned_cols=260  Identities=24%  Similarity=0.359  Sum_probs=180.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHH-HHhccccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIE-ILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      .++|+..+.||+|+||.||+|.+..+|+.||||++.....  ......+..|+. +++.++||||+++++++.+++..++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            3678899999999999999999998999999999965432  233345556665 7777899999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++ +|.+++......        ....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||
T Consensus        99 v~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSV--------LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHT--------TCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEE
T ss_pred             EEeecCC-ChHHHHHHHHhh--------hcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEE
Confidence            9999985 888887642110        0235889999999999999999999742  8999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYA----YTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      +|||+++.+...   .......||+.|+|||++    .+..++.++|||||||++|||++|+.||.......  ...   
T Consensus       168 ~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~---  239 (327)
T 3aln_A          168 CDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQL---  239 (327)
T ss_dssp             CCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------
T ss_pred             ccCCCceecccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHH---
Confidence            999999866432   222334789999999998    45678999999999999999999999997532210  000   


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       .   .........+........+..+.+++.+||+.||++||++.|+++
T Consensus       240 -~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          240 -T---QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -C---CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -H---HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence             0   000000011111111223467899999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=332.76  Aligned_cols=247  Identities=24%  Similarity=0.313  Sum_probs=194.5

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH---HHHHHHHHHHHHHhcc----ccCceeeEEEE
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ---KLEKEFIAEIEILGTI----RHANIVKLWCC  704 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~niv~l~~~  704 (969)
                      +.+.++|+..+.||+|+||.||+|++..+++.||||++........   .....+.+|++++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            4456789999999999999999999988999999999865432221   2234567799999988    89999999999


Q ss_pred             EEcCCceEEEEee-ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcE
Q 002085          705 ISSENSKLLVYEY-MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI  783 (969)
Q Consensus       705 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Ni  783 (969)
                      +.+.+..++|||| +++++|.+++....             .+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  170 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG-------------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENI  170 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhE
Confidence            9999999999999 78999999998643             388999999999999999999998   999999999999


Q ss_pred             EEC-CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCccc
Q 002085          784 LLD-SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTS  861 (969)
Q Consensus       784 ll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~  861 (969)
                      +++ .++.+||+|||+++.....    ......|++.|+|||++.+..+. .++||||+||++|||++|+.||.....  
T Consensus       171 l~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--  244 (312)
T 2iwi_A          171 LIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--  244 (312)
T ss_dssp             EEETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred             EEeCCCCeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--
Confidence            999 7899999999999876432    23445689999999998877765 489999999999999999999864311  


Q ss_pred             hHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                          .   .....            ..+...+..+.+++.+||+.||++||++.|+++
T Consensus       245 ----~---~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ----I---LEAEL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----H---HHTCC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----H---hhhcc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0   00000            011123367889999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-36  Score=335.70  Aligned_cols=246  Identities=23%  Similarity=0.316  Sum_probs=202.0

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH---HHHHHHHHHHHHHhccc--cCceeeEEEEEEc
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ---KLEKEFIAEIEILGTIR--HANIVKLWCCISS  707 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~  707 (969)
                      .+.++|+..+.||+|+||.||+|.+..+++.||||++........   ...+.+.+|++++++++  ||||+++++++.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            345689999999999999999999999999999999965432210   12245778999999996  5999999999999


Q ss_pred             CCceEEEEeeccC-CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC
Q 002085          708 ENSKLLVYEYMEN-QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD  786 (969)
Q Consensus       708 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~  786 (969)
                      ++..++||||+.+ ++|.+++....             .+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~  183 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG-------------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILID  183 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEE
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEe
Confidence            9999999999976 89999998643             388999999999999999999998   999999999999999


Q ss_pred             -CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          787 -SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       787 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                       .++.+||+|||+++.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....     
T Consensus       184 ~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----  254 (320)
T 3a99_A          184 LNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----  254 (320)
T ss_dssp             TTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred             CCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----
Confidence             7789999999999876432    2334579999999999987776 6789999999999999999999864311     


Q ss_pred             HHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       .   ......        .    ....+..+.+++.+||+.||++||++.|+++
T Consensus       255 -~---~~~~~~--------~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 -I---IRGQVF--------F----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -H---HHCCCC--------C----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -h---hccccc--------c----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0   001000        0    1112367889999999999999999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.7e-36  Score=336.72  Aligned_cols=266  Identities=21%  Similarity=0.249  Sum_probs=204.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-----------cCceeeEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-----------HANIVKLWC  703 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~  703 (969)
                      ..+|+..+.||+|+||.||+|++..+++.||||++...    ....+.+.+|++++++++           ||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            45899999999999999999999989999999998543    234567889999999886           899999999


Q ss_pred             EEEcCC----ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCC
Q 002085          704 CISSEN----SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK  779 (969)
Q Consensus       704 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  779 (969)
                      ++...+    ..++||||+ +++|.+++.....           ..+++..+..++.|++.||+|||+.+  +|+|||||
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-----------~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dik  159 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-----------RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIK  159 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCS
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-----------cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCC
Confidence            987644    789999999 8999999986542           34889999999999999999999742  89999999


Q ss_pred             CCcEEEC------CCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCC
Q 002085          780 SSNILLD------SEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEA  853 (969)
Q Consensus       780 p~Nill~------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p  853 (969)
                      |+||+++      ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  234 (373)
T 1q8y_A          160 PENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL  234 (373)
T ss_dssp             GGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             hHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            9999994      4458999999999876332     2345789999999999999999999999999999999999999


Q ss_pred             CCCCCccch------HHHHHHHhhccC-----------------------------CchhhhccCCCCcccHHHHHHHHH
Q 002085          854 NYGDEHTSL------AEWAWRHYAEEK-----------------------------PITDALDKGIAEPCYLEEMTTVYR  898 (969)
Q Consensus       854 ~~~~~~~~~------~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~~~  898 (969)
                      |.+......      ...+........                             +..+....  ....+...+..+.+
T Consensus       235 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  312 (373)
T 1q8y_A          235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISD  312 (373)
T ss_dssp             C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHH
T ss_pred             CCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHH
Confidence            976542211      111111110000                             00000000  01234566788999


Q ss_pred             HHHHccCCCCCCCCCHHHHHH--HHhhcC
Q 002085          899 LALICTSTLPSSRPSMKEVLQ--ILRRCC  925 (969)
Q Consensus       899 l~~~cl~~dP~~RPs~~evl~--~L~~~~  925 (969)
                      ++.+||+.||++|||++|+++  .+.+..
T Consensus       313 li~~~L~~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          313 FLSPMLQLDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             HHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             HHHHHhccCccccCCHHHHhhChhhhccc
Confidence            999999999999999999997  444443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=352.88  Aligned_cols=319  Identities=23%  Similarity=0.204  Sum_probs=225.4

Q ss_pred             CEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccC
Q 002085          124 QNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYN  203 (969)
Q Consensus       124 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  203 (969)
                      +.++.++++++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            46777777777 5666553  46778888888887766777777777777777777777766777777777777776666


Q ss_pred             CCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCC
Q 002085          204 SNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEI  283 (969)
Q Consensus       204 ~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  283 (969)
                      +                          +.+..+..|.++++|++|+|++|++++..|..+..+++|++|+|++|.+++..
T Consensus        91 ~--------------------------l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~  144 (477)
T 2id5_A           91 R--------------------------LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYIS  144 (477)
T ss_dssp             C--------------------------CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEEC
T ss_pred             c--------------------------CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeC
Confidence            3                          44444456778888888888888888777777777888888877777777655


Q ss_pred             CCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEc
Q 002085          284 PSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQL  362 (969)
Q Consensus       284 ~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L  362 (969)
                      +..+..+ +|+.|+|++|++++..+..|..+++|+.|++++|.+.                                   
T Consensus       145 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~-----------------------------------  189 (477)
T 2id5_A          145 HRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-----------------------------------  189 (477)
T ss_dssp             TTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCC-----------------------------------
T ss_pred             hhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCc-----------------------------------
Confidence            5555443 4555555555555444444555555555555555544                                   


Q ss_pred             ccccccCCCCcccccccCCCccccCCCccccccCcccc--ccccEEEeeccccCCCcccccCCcccchhhcccCCccccc
Q 002085          363 YSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTA--WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGE  440 (969)
Q Consensus       363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  440 (969)
                            +..+..+..+++|+.|++++|.+.+.++....  .+|+.|+|++|++++..+..+..+++|+.|++++|.+++.
T Consensus       190 ------~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~  263 (477)
T 2id5_A          190 ------AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI  263 (477)
T ss_dssp             ------EECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEE
T ss_pred             ------EeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCcc
Confidence                  33334444444444444444444433333221  3677888888888866667788888888888888888877


Q ss_pred             cCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCcccccc
Q 002085          441 IPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGE  512 (969)
Q Consensus       441 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~  512 (969)
                      .+..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+.
T Consensus       264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~  335 (477)
T 2id5_A          264 EGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD  335 (477)
T ss_dssp             CTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred             ChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence            777888888888888888888887788888888888888888888876667788888888888888888753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.3e-36  Score=328.58  Aligned_cols=254  Identities=23%  Similarity=0.369  Sum_probs=184.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||.||+|++..+|+.||||++..... .....+.+.++..+++.++||||+++++++.+++..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            5688999999999999999999998999999999965432 223334555566678888999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      |||+ ++.+..+.....            ..+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.+||
T Consensus       103 ~e~~-~~~~~~l~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl  166 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQ------------GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKL  166 (318)
T ss_dssp             ECCC-SEEHHHHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEE
T ss_pred             Eecc-CCcHHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEE
Confidence            9999 556665554322            348899999999999999999997 5   8999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +|||+++.....   .......||+.|+|||++.     +..++.++|||||||++|||++|+.||......  ......
T Consensus       167 ~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~  241 (318)
T 2dyl_A          167 CDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTK  241 (318)
T ss_dssp             CCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHH
T ss_pred             EECCCchhccCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHH
Confidence            999999765332   2223456899999999984     556889999999999999999999999753321  111111


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ......+.       .  +.....+..+.+++.+||+.||++||++.|+++
T Consensus       242 ~~~~~~~~-------~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          242 VLQEEPPL-------L--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHSCCCC-------C--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HhccCCCC-------C--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11111110       0  111122367889999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.8e-36  Score=324.49  Aligned_cols=237  Identities=13%  Similarity=0.026  Sum_probs=190.8

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +..+|++.+.||+|+||.||+|.+..+++.||||++......+....+.+.+|++++++++||||+++++++.+++..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            34679999999999999999999998899999999976655556667889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||++|++|.+++...               ....++.+++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       109 v~e~~~g~~L~~~l~~~---------------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl  170 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS---------------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVL  170 (286)
T ss_dssp             EEECCCEEEHHHHHTTC---------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEE
T ss_pred             EEEecCCCCHHHHHhcC---------------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEE
Confidence            99999999999998532               23456788999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +++|                      |++       .++.++|||||||++|||++|+.||.+.........+.......
T Consensus       171 ~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  221 (286)
T 3uqc_A          171 AYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ  221 (286)
T ss_dssp             CSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSC
T ss_pred             Eecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccC
Confidence            8443                      333       36889999999999999999999998754422110000000000


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                      .....        ......+..+.+++.+||+.||++| |+.|+++.|+++..
T Consensus       222 ~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          222 PIEPA--------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             BCCHH--------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CCChh--------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            00000        0111234678999999999999999 99999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.5e-35  Score=340.47  Aligned_cols=257  Identities=23%  Similarity=0.325  Sum_probs=187.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +.|...++||+|+||+||.+.. .+|+.||||++....      .+.+.+|+++++++ +||||+++++++.+++..|+|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            3455568899999999986544 478999999985432      24678899999886 899999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC------
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE------  788 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~------  788 (969)
                      |||++ |+|.+++........      ......+..++.++.||+.||+|||+.   +|+||||||+||+++.+      
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~  157 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDE------NLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTAD  157 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSC
T ss_pred             EecCC-CCHHHHHhccCCCch------hhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccc
Confidence            99996 699999986543110      001124456788999999999999998   99999999999999754      


Q ss_pred             -------CcEEEeecccceecccCCCCc--cccccccCcccCchhhccc-------CCCCCccchhhHHHHHHHHHh-CC
Q 002085          789 -------FKAKIADFGLAKMLAKQGEPH--TMSAVAGSFGYFAPEYAYT-------TKVNEKIDIYSFGVVLLELVT-GK  851 (969)
Q Consensus       789 -------~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~ellt-g~  851 (969)
                             +.+||+|||+++.+.......  ......||+.|+|||++.+       ..++.++||||+||++|||++ |.
T Consensus       158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence                   489999999998775432211  2234579999999999876       578999999999999999999 88


Q ss_pred             CCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          852 EANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       852 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .||.......  ..+....   ...     ...........+..+.+++.+||+.||++||++.|+++
T Consensus       238 ~Pf~~~~~~~--~~i~~~~---~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          238 HPFGDKYSRE--SNIIRGI---FSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CTTCSTTTHH--HHHHHTC---CCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCchhhH--HHHhcCC---CCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            8886543221  1111111   000     01111223456678999999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.1e-36  Score=353.40  Aligned_cols=272  Identities=24%  Similarity=0.310  Sum_probs=205.1

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc------
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS------  707 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  707 (969)
                      ...+|++.++||+|+||.||+|.+..+|+.||||++....  .....+.+.+|++++++++||||+++++++..      
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            4578999999999999999999998899999999986532  34556789999999999999999999998765      


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      .+..++||||+++|+|.+++.....          ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~----------~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~  156 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFEN----------CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQP  156 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSC----------TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEEC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhccc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeec
Confidence            6778999999999999999986542          13488899999999999999999998   9999999999999997


Q ss_pred             CCc---EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          788 EFK---AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       788 ~~~---~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                      ++.   +||+|||+++.....   .......||+.|+|||.+.+..++.++||||+||++|||++|..||.+....  ..
T Consensus       157 ~g~~~~vKL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~--~~  231 (676)
T 3qa8_A          157 GPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP--VQ  231 (676)
T ss_dssp             CSSSCEEEECSCCCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH--HH
T ss_pred             CCCceeEEEcccccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch--hh
Confidence            765   999999999876432   2234567999999999999999999999999999999999999999764211  00


Q ss_pred             HHH-------HHhhccCCchhhh--ccC--CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHhhcC
Q 002085          865 WAW-------RHYAEEKPITDAL--DKG--IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKE-----VLQILRRCC  925 (969)
Q Consensus       865 ~~~-------~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e-----vl~~L~~~~  925 (969)
                      |..       .............  ...  .........+..+.+++.+||..||++|||++|     +.+.++.+.
T Consensus       232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            000       0000000000000  000  111223445688999999999999999999987     344554443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=336.87  Aligned_cols=248  Identities=25%  Similarity=0.325  Sum_probs=184.1

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +|...++||+|+||+||.. ...+++.||||++.....      ..+.+|+++++.+ +||||+++++++.+....|+||
T Consensus        25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            5788899999999996643 334789999999854322      2356799999999 7999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC-----Cc
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-----FK  790 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~  790 (969)
                      ||++ |+|.+++.....            ...+..++.++.|++.||+|||+.   +|+||||||+||+++.+     ..
T Consensus        98 E~~~-g~L~~~l~~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~  161 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDF------------AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIK  161 (432)
T ss_dssp             ECCS-EEHHHHHHSSSC------------CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCC
T ss_pred             ECCC-CCHHHHHHhcCC------------CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCcee
Confidence            9996 699999986542            244556789999999999999998   99999999999999532     36


Q ss_pred             EEEeecccceecccCCCC-ccccccccCcccCchhhcc---cCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHH
Q 002085          791 AKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAY---TTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEW  865 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~  865 (969)
                      +||+|||+++........ .......||+.|+|||++.   ...++.++||||+||++|||++ |..||....... ...
T Consensus       162 ~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~  240 (432)
T 3p23_A          162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANI  240 (432)
T ss_dssp             EEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHH
T ss_pred             EEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHH
Confidence            889999999876433211 2334567999999999987   4567889999999999999999 777774432211 111


Q ss_pred             HHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                          ....... .      ...........+.+++.+||+.||++||++.|+++
T Consensus       241 ----~~~~~~~-~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          241 ----LLGACSL-D------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ----HTTCCCC-T------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----HhccCCc-c------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                1111100 0      00112234466889999999999999999999984

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.7e-35  Score=317.20  Aligned_cols=238  Identities=22%  Similarity=0.310  Sum_probs=185.3

Q ss_pred             cchhhhccCCCcc-ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHH-hccccCceeeEEEEEE
Q 002085          629 FTESNILSSLTES-NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL-GTIRHANIVKLWCCIS  706 (969)
Q Consensus       629 ~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~  706 (969)
                      .....+.++|... +.||+|+||.||+|.+..+++.||+|++...        ..+.+|++++ +..+||||+++++++.
T Consensus        10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~   81 (299)
T 3m2w_A           10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE   81 (299)
T ss_dssp             CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhh
Confidence            3445677888887 7899999999999999989999999998542        4567888888 5558999999999987


Q ss_pred             c----CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCc
Q 002085          707 S----ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSN  782 (969)
Q Consensus       707 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  782 (969)
                      .    ....++||||+++|+|.+++.....           ..+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~N  147 (299)
T 3m2w_A           82 NLYAGRKCLLIVMECLDGGELFSRIQDRGD-----------QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPEN  147 (299)
T ss_dssp             EEETTEEEEEEEECCCCSCBHHHHHHHCTT-----------CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             hhcCCCceEEEEEeecCCCcHHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHH
Confidence            6    6778999999999999999987542           3488999999999999999999998   99999999999


Q ss_pred             EEECC---CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCc
Q 002085          783 ILLDS---EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH  859 (969)
Q Consensus       783 ill~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~  859 (969)
                      |+++.   ++.+||+|||++....                        +..++.++||||+||++|||++|+.||.+...
T Consensus       148 il~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  203 (299)
T 3m2w_A          148 LLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  203 (299)
T ss_dssp             EEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred             EEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence            99998   7889999999987542                        13467789999999999999999999976533


Q ss_pred             cchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          860 TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .....       ...............+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       204 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          204 LAISP-------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ----C-------CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhH-------HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            21100       000000000000000011223478999999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-35  Score=334.88  Aligned_cols=248  Identities=16%  Similarity=0.133  Sum_probs=182.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcccc-Cc-----------------
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH-AN-----------------  697 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~n-----------------  697 (969)
                      ..|...++||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++| +|                 
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            457778999999999999999999999999999874443333445789999999999976 21                 


Q ss_pred             ----eeeEEEEEEc-----CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhccc
Q 002085          698 ----IVKLWCCISS-----ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD  768 (969)
Q Consensus       698 ----iv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~  768 (969)
                          ...+..++..     ....+++|+++ +++|.+++.......      .....++|..++.++.|++.||+|||+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~  230 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS------STHKSLVHHARLQLTLQVIRLLASLHHY  230 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT------TTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc------ccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                1111111111     22456777766 689999985321100      0123578899999999999999999988


Q ss_pred             CCCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhc----------ccCCCCCccchh
Q 002085          769 CTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYA----------YTTKVNEKIDIY  838 (969)
Q Consensus       769 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvw  838 (969)
                         +|+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||
T Consensus       231 ---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          231 ---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             ---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             ---CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence               9999999999999999999999999999865322     344567 999999998          555688899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002085          839 SFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVL  918 (969)
Q Consensus       839 slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl  918 (969)
                      ||||++|||++|+.||.........             ...+....      ..+..+.+++.+||+.||++||++.|++
T Consensus       302 SlGvil~elltg~~Pf~~~~~~~~~-------------~~~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAALGGS-------------EWIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGGSCS-------------GGGGSSCC------CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhhH-------------HHHHhhcc------cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999999999999765432211             11111111      1226789999999999999999977764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-34  Score=349.50  Aligned_cols=240  Identities=23%  Similarity=0.304  Sum_probs=194.0

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcC-CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc---
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDING-AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS---  710 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  710 (969)
                      .++|++.++||+|+||.||+|.+.. +++.||||++....  .......+.+|++++++++||||+++++++...+.   
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            4689999999999999999999975 68999999885432  34455788999999999999999999999987665   


Q ss_pred             --eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          711 --KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       711 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                        .|+||||++|++|.+++..               .++|..++.++.||+.||+|||+.   +|+||||||+||+++.+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~---------------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~  218 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ---------------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE  218 (681)
T ss_dssp             EEEEEEEECCCCEECC----C---------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS
T ss_pred             ceeEEEEEeCCCCcHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC
Confidence              6999999999999887653               388999999999999999999998   99999999999999986


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                       .+||+|||+++.....      ....||+.|+|||++.+. ++.++|||||||++|||++|..|+.+......      
T Consensus       219 -~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------  284 (681)
T 2pzi_A          219 -QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------  284 (681)
T ss_dssp             -CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC------
T ss_pred             -cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc------
Confidence             8999999999876332      345799999999998765 48899999999999999999888764211100      


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhh
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-MKEVLQILRR  923 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~evl~~L~~  923 (969)
                              .       ...........+.+++.+||+.||++||+ +.++.+.|..
T Consensus       285 --------~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          285 --------P-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             --------C-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             --------c-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                    0       00111223467889999999999999995 5556555544

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=2.4e-34  Score=317.43  Aligned_cols=262  Identities=17%  Similarity=0.245  Sum_probs=183.7

Q ss_pred             CCHHHHHHHHHHHHHcCCCC--CCCCC----CCCCCCCCCCcceee----------CCCeEEEEecCCCCCCCCCccccC
Q 002085           32 PNTEERTILLNLKQQLGNPP--SLQSW----TSTSSPCDWPEITCT----------FNSVTGISLRHKDITQKIPPIICD   95 (969)
Q Consensus        32 ~~~~~~~all~~k~~~~~~~--~l~sw----~~~~~~c~w~gv~C~----------~~~v~~l~l~~~~l~~~~~~~~~~   95 (969)
                      ...+|++||++||+++..++  ++++|    ....++|.|.|+.|.          ..+|+.|+|+++++. .+|+.+++
T Consensus        24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~  102 (328)
T 4fcg_A           24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR  102 (328)
T ss_dssp             CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred             cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence            45679999999999985443  36788    456789999999995          257888888888887 67777888


Q ss_pred             CCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccC--------
Q 002085           96 LKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGR--------  167 (969)
Q Consensus        96 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~--------  167 (969)
                      +++|++|+|++|.++ .+|..|+++++|++|+|++|.++ .+|..|+++++|++|+|++|++.+.+|..++.        
T Consensus       103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~  180 (328)
T 4fcg_A          103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ  180 (328)
T ss_dssp             GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred             CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence            888888888888888 77888888888888888888887 77878888888888888887777777776654        


Q ss_pred             -cccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchh
Q 002085          168 -LSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLE  246 (969)
Q Consensus       168 -l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  246 (969)
                       +++|++|+|++|+++ .+|..++++++|++|+|++|.+.   .+|..++.+++|++|+|++|++.+.+|..|+++++|+
T Consensus       181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~---~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~  256 (328)
T 4fcg_A          181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS---ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK  256 (328)
T ss_dssp             ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC---CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred             cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC---cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence             777777777777776 66666777777777777777532   3455566666666666666666666666666666666


Q ss_pred             hhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCc
Q 002085          247 ILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMN  300 (969)
Q Consensus       247 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N  300 (969)
                      +|+|++|++.+.+|..+..+++|++|+|++|++.+.+|..+..+ +++.+++..|
T Consensus       257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~  311 (328)
T 4fcg_A          257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH  311 (328)
T ss_dssp             EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGG
T ss_pred             EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHH
Confidence            66666666665666555555555555555555554444444433 2444444333

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=3.2e-33  Score=312.26  Aligned_cols=307  Identities=23%  Similarity=0.358  Sum_probs=155.6

Q ss_pred             cCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcc
Q 002085          117 LYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLE  196 (969)
Q Consensus       117 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  196 (969)
                      +..+++|++|++++|.+. .+| .+..+++|++|+|++|++++ +|. +.++++|++|+|++|++++ +| .+.++++|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred             chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence            456788888888888887 344 37788888888888888874 333 7788888888888888774 33 577777777


Q ss_pred             eeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccC
Q 002085          197 VLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYD  276 (969)
Q Consensus       197 ~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  276 (969)
                      +|++++|.+..   ++. +..+++|+.|++++|.....++. +..+++|++|++++|.+++..+  +..+++        
T Consensus       114 ~L~l~~n~i~~---~~~-~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~--------  178 (347)
T 4fmz_A          114 ELYLNEDNISD---ISP-LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTD--------  178 (347)
T ss_dssp             EEECTTSCCCC---CGG-GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTT--------
T ss_pred             EEECcCCcccC---chh-hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCC--------
Confidence            77777775321   222 44444444444444433333222 3444444444444444432211  222222        


Q ss_pred             cccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCcc
Q 002085          277 NILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRT  356 (969)
Q Consensus       277 N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~  356 (969)
                                     |+.|++++|.+++.. . +..+++|+.|++++|.+.+.                  +. +..+++
T Consensus       179 ---------------L~~L~l~~n~l~~~~-~-~~~l~~L~~L~l~~n~l~~~------------------~~-~~~~~~  222 (347)
T 4fmz_A          179 ---------------LYSLSLNYNQIEDIS-P-LASLTSLHYFTAYVNQITDI------------------TP-VANMTR  222 (347)
T ss_dssp             ---------------CSEEECTTSCCCCCG-G-GGGCTTCCEEECCSSCCCCC------------------GG-GGGCTT
T ss_pred             ---------------CCEEEccCCcccccc-c-ccCCCccceeecccCCCCCC------------------ch-hhcCCc
Confidence                           333333333333211 1 44444455555555544421                  00 233444


Q ss_pred             CcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCc
Q 002085          357 LRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNL  436 (969)
Q Consensus       357 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  436 (969)
                      |+.|++++|++++..+  +..+                      ++|++|++++|.+++.  ..+..+++|++|++++|.
T Consensus       223 L~~L~l~~n~l~~~~~--~~~l----------------------~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~  276 (347)
T 4fmz_A          223 LNSLKIGNNKITDLSP--LANL----------------------SQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQ  276 (347)
T ss_dssp             CCEEECCSSCCCCCGG--GTTC----------------------TTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred             CCEEEccCCccCCCcc--hhcC----------------------CCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCc
Confidence            4444444444442111  2222                      3344444444444432  234444555555555555


Q ss_pred             cccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCcccc
Q 002085          437 FSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFS  510 (969)
Q Consensus       437 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  510 (969)
                      +++.  ..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..|  +..+++|+.||+++|+|+
T Consensus       277 l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          277 ISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             CCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             cCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            5432  234455555555555555555555555555555555555555554333  555555555555555543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=5.1e-33  Score=310.65  Aligned_cols=308  Identities=21%  Similarity=0.307  Sum_probs=242.9

Q ss_pred             cccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccc
Q 002085           92 IICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSEL  171 (969)
Q Consensus        92 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  171 (969)
                      .+..+++|++|++++|.++. +| .+..+++|++|+|++|.+++. |. +..+++|++|+|++|.++. +| .+.++++|
T Consensus        39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L  112 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNL  112 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTC
T ss_pred             cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcC
Confidence            45678999999999999984 45 489999999999999999954 44 9999999999999999985 44 69999999


Q ss_pred             cceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhcc
Q 002085          172 QTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALN  251 (969)
Q Consensus       172 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  251 (969)
                      ++|+|++|++++. +. +..+++|++|++++|..  .. .+..+..+++|+.|++++|.+.+..+  +..+++|++|+++
T Consensus       113 ~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~--~~-~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~  185 (347)
T 4fmz_A          113 RELYLNEDNISDI-SP-LANLTKMYSLNLGANHN--LS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLN  185 (347)
T ss_dssp             SEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTT--CC-CCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECT
T ss_pred             CEEECcCCcccCc-hh-hccCCceeEEECCCCCC--cc-cccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEcc
Confidence            9999999999955 43 89999999999999952  22 34459999999999999999876655  8899999999999


Q ss_pred             CCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCC
Q 002085          252 GNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVP  331 (969)
Q Consensus       252 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  331 (969)
                      +|++++. +. +..+++|+.|++++|.++                       +..+  +..+++|+.|++++|++++   
T Consensus       186 ~n~l~~~-~~-~~~l~~L~~L~l~~n~l~-----------------------~~~~--~~~~~~L~~L~l~~n~l~~---  235 (347)
T 4fmz_A          186 YNQIEDI-SP-LASLTSLHYFTAYVNQIT-----------------------DITP--VANMTRLNSLKIGNNKITD---  235 (347)
T ss_dssp             TSCCCCC-GG-GGGCTTCCEEECCSSCCC-----------------------CCGG--GGGCTTCCEEECCSSCCCC---
T ss_pred             CCccccc-cc-ccCCCccceeecccCCCC-----------------------CCch--hhcCCcCCEEEccCCccCC---
Confidence            9999854 33 666666666666666554                       2222  6778999999999999983   


Q ss_pred             cccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeecc
Q 002085          332 ASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNN  411 (969)
Q Consensus       332 ~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N  411 (969)
                                     ++. +..+++|++|++++|++++.  ..+..+++|+.|++++|++                    
T Consensus       236 ---------------~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l--------------------  277 (347)
T 4fmz_A          236 ---------------LSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI--------------------  277 (347)
T ss_dssp             ---------------CGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC--------------------
T ss_pred             ---------------Ccc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCcc--------------------
Confidence                           222 67889999999999999853  3455555555555555544                    


Q ss_pred             ccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCcccc
Q 002085          412 RFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELS  486 (969)
Q Consensus       412 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  486 (969)
                        ++.  ..+..+++|+.|++++|.+++..|..+..+++|+.|+|++|++++..|  +..+++|+.|++++|.|+
T Consensus       278 --~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          278 --SDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             --CCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             --CCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence              433  246667778888888888887777888888888888888888886555  778888888888888875

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=6.2e-33  Score=315.13  Aligned_cols=286  Identities=18%  Similarity=0.151  Sum_probs=228.3

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      .+++.++++++.+....+..+..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|+++++|++|+|
T Consensus        45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  124 (390)
T 3o6n_A           45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  124 (390)
T ss_dssp             CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence            56889999999988755566899999999999999999888889999999999999999999888889999999999999


Q ss_pred             CCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccc
Q 002085          153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLI  232 (969)
Q Consensus       153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~  232 (969)
                      ++|+++...+..|+++++|++|+|++|++++..|..|+++++|++|++++|++...     .++.+++|+.|++++|.+.
T Consensus       125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-----~~~~l~~L~~L~l~~n~l~  199 (390)
T 3o6n_A          125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-----DLSLIPSLFHANVSYNLLS  199 (390)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-----CGGGCTTCSEEECCSSCCS
T ss_pred             CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-----ccccccccceeeccccccc
Confidence            99999954445579999999999999999988888999999999999999974432     3677888999999888776


Q ss_pred             ccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCcccc
Q 002085          233 GEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFG  311 (969)
Q Consensus       233 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~  311 (969)
                      +     +...++|+.|++++|+++.. |..  ..++|+.|++++|++++. + .+... +|+.|++++|.+++..|..|.
T Consensus       200 ~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~  269 (390)
T 3o6n_A          200 T-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT-A-WLLNYPGLVEVDLSYNELEKIMYHPFV  269 (390)
T ss_dssp             E-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred             c-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc-H-HHcCCCCccEEECCCCcCCCcChhHcc
Confidence            4     33446788888888888743 332  246788888888888753 2 33333 688888888888777777777


Q ss_pred             CcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCcc
Q 002085          312 KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTI  391 (969)
Q Consensus       312 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  391 (969)
                      .+++|+.|++++|+++                  .+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+
T Consensus       270 ~l~~L~~L~L~~n~l~------------------~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i  330 (390)
T 3o6n_A          270 KMQRLERLYISNNRLV------------------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI  330 (390)
T ss_dssp             TCSSCCEEECCSSCCC------------------EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCC
T ss_pred             ccccCCEEECCCCcCc------------------ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcc
Confidence            7888888888887776                  23444556777777777777777 5666666666666666666666


Q ss_pred             c
Q 002085          392 S  392 (969)
Q Consensus       392 ~  392 (969)
                      +
T Consensus       331 ~  331 (390)
T 3o6n_A          331 V  331 (390)
T ss_dssp             C
T ss_pred             c
Confidence            5

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=8.2e-33  Score=331.54  Aligned_cols=309  Identities=17%  Similarity=0.151  Sum_probs=238.3

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      .+++.++++++.+....+..+..+++|++|+|++|.|++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|
T Consensus        51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  130 (597)
T 3oja_B           51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  130 (597)
T ss_dssp             CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence            35788999999988766667899999999999999999888889999999999999999999988889999999999999


Q ss_pred             CCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccc
Q 002085          153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLI  232 (969)
Q Consensus       153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~  232 (969)
                      ++|.|++..+..|+++++|++|+|++|.+++..|..|+++++|++|++++|.+..   +  .++.+++|+.|++++|.+.
T Consensus       131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~--~~~~l~~L~~L~l~~n~l~  205 (597)
T 3oja_B          131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---V--DLSLIPSLFHANVSYNLLS  205 (597)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB---C--CGGGCTTCSEEECCSSCCS
T ss_pred             eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC---c--ChhhhhhhhhhhcccCccc
Confidence            9999996666667999999999999999999999999999999999999997433   2  3677888888888888776


Q ss_pred             ccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCcccc
Q 002085          233 GEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFG  311 (969)
Q Consensus       233 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~  311 (969)
                      +     +...++|+.|++++|.++.. +..+  .++|+.|+|++|.+++.  ..+..+ +|+.|+|++|.+++.+|..|+
T Consensus       206 ~-----l~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  275 (597)
T 3oja_B          206 T-----LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV  275 (597)
T ss_dssp             E-----EECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred             c-----ccCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhc
Confidence            5     34456788888888888743 3222  25777888888877752  333333 677777777777777777777


Q ss_pred             CcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCcc
Q 002085          312 KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTI  391 (969)
Q Consensus       312 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  391 (969)
                      .+++|+.|+|++|.+++                  +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.|
T Consensus       276 ~l~~L~~L~Ls~N~l~~------------------l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l  336 (597)
T 3oja_B          276 KMQRLERLYISNNRLVA------------------LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI  336 (597)
T ss_dssp             TCSSCCEEECTTSCCCE------------------EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCC
T ss_pred             CccCCCEEECCCCCCCC------------------CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCC
Confidence            77777777777777762                  3444556677777777777777 5666666666666666666655


Q ss_pred             ccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccc
Q 002085          392 SGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGE  440 (969)
Q Consensus       392 ~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  440 (969)
                      +                      +..   +..+++|+.|++++|.+++.
T Consensus       337 ~----------------------~~~---~~~~~~L~~L~l~~N~~~~~  360 (597)
T 3oja_B          337 V----------------------TLK---LSTHHTLKNLTLSHNDWDCN  360 (597)
T ss_dssp             C----------------------CCC---CCTTCCCSEEECCSSCEEHH
T ss_pred             C----------------------CcC---hhhcCCCCEEEeeCCCCCCh
Confidence            4                      221   44455666666666666643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=4.9e-34  Score=317.22  Aligned_cols=245  Identities=16%  Similarity=0.108  Sum_probs=185.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh-----cHHHHHHHHHHHHHHhccc---------cCceee
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL-----NQKLEKEFIAEIEILGTIR---------HANIVK  700 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~niv~  700 (969)
                      .++|+..+.||+|+||+||+|++  +|+.||||++......     .....+.+.+|+++++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  6899999999754321     2223367888888888885         888888


Q ss_pred             EEEEEE------------------------------cCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHH
Q 002085          701 LWCCIS------------------------------SENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT  750 (969)
Q Consensus       701 l~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~  750 (969)
                      +.+.+.                              +.+..|+||||+++|++.+.+..              ..+++..
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------------~~~~~~~  162 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------------KLSSLAT  162 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------------TCCCHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------------cCCCHHH
Confidence            877642                              26789999999999977766643              2378999


Q ss_pred             HHHHHHHHHHhhhhhc-ccCCCCeEecCCCCCcEEECCCC--------------------cEEEeecccceecccCCCCc
Q 002085          751 RLQIAIGAAQGLCYMH-HDCTPQIIHRDVKSSNILLDSEF--------------------KAKIADFGLAKMLAKQGEPH  809 (969)
Q Consensus       751 ~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~  809 (969)
                      +..++.|++.||+||| +.   +|+||||||+|||++.++                    .+||+|||+|+....     
T Consensus       163 ~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----  234 (336)
T 2vuw_A          163 AKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----  234 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----
T ss_pred             HHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----
Confidence            9999999999999999 88   999999999999999887                    899999999987642     


Q ss_pred             cccccccCcccCchhhcccCCCCCccchhhHHHH-HHHHHhCCCCCCCCCccchHHHHHHHhhccCCchhhhccCCCCcc
Q 002085          810 TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVV-LLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPC  888 (969)
Q Consensus       810 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  888 (969)
                        ....||+.|+|||++.+.. +.++||||+|++ .+++++|..||....   ..............    .......+.
T Consensus       235 --~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~  304 (336)
T 2vuw_A          235 --GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMT----FKTKCNTPA  304 (336)
T ss_dssp             --TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCC----CSSCCCSHH
T ss_pred             --CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhc----cCcccchhh
Confidence              1347999999999998766 889999998777 777888888873210   00001111110000    001111223


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002085          889 YLEEMTTVYRLALICTSTLPSSRPSMKEVL  918 (969)
Q Consensus       889 ~~~~~~~~~~l~~~cl~~dP~~RPs~~evl  918 (969)
                      ....+.++.+++.+||+.|     |++|++
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            4456788999999999876     888887

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.98  E-value=8.7e-32  Score=298.46  Aligned_cols=294  Identities=20%  Similarity=0.229  Sum_probs=222.6

Q ss_pred             eEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCC
Q 002085           75 VTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG  154 (969)
Q Consensus        75 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  154 (969)
                      ++.+++++++++ .+|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  111 (332)
T 2ft3_A           35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK  111 (332)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred             CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence            345666666665 4666553  6899999999999977788899999999999999999988889999999999999999


Q ss_pred             CCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccccc
Q 002085          155 NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGE  234 (969)
Q Consensus       155 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  234 (969)
                      |+++ .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|.+...+..|..+..+ +|+.|++++|++.+ 
T Consensus       112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-  186 (332)
T 2ft3_A          112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-  186 (332)
T ss_dssp             SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred             CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence            9998 6777665  78999999999999777778999999999999999765445667777777 88888888888765 


Q ss_pred             CchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCc
Q 002085          235 IPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKL  313 (969)
Q Consensus       235 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l  313 (969)
                      +|..+.  ++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+... +|+.|++++|+++ .+|..+..+
T Consensus       187 l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l  263 (332)
T 2ft3_A          187 IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL  263 (332)
T ss_dssp             CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred             cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence            554443  678888888888887777778888888888888888887777666655 6888888888887 667777888


Q ss_pred             ccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEccccccc--CCCCcccccccCCCccccCCCc
Q 002085          314 KNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS--GELPTGLWTTFNLSSLMLSDNT  390 (969)
Q Consensus       314 ~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~  390 (969)
                      ++|+.|++++|++++..+..+..         ..+  ......|+.|++++|++.  +..|..+..+++|+.+++++|+
T Consensus       264 ~~L~~L~l~~N~l~~~~~~~~~~---------~~~--~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          264 KLLQVVYLHTNNITKVGVNDFCP---------VGF--GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             TTCCEEECCSSCCCBCCTTSSSC---------SSC--CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ccCCEEECCCCCCCccChhHccc---------ccc--ccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            88888888888877433222110         000  011456777888888776  5566667777777777777663

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.97  E-value=4.5e-33  Score=305.44  Aligned_cols=249  Identities=28%  Similarity=0.432  Sum_probs=189.4

Q ss_pred             CcccEEEccCCCCCC--CCCcccCCCCCCCEEeccC-CcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccc
Q 002085           97 KNLTTIDLSSNSIPG--EFPEFLYNCTKLQNLDLSQ-NYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQT  173 (969)
Q Consensus        97 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  173 (969)
                      .++++|+|++|+++|  .+|..|.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|+++++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            479999999999999  8999999999999999995 9999999999999999999999999999999999999999999


Q ss_pred             eecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccC-CCcEEEccCCcccccCchhhcCCCchhhhhccC
Q 002085          174 LYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLK-KLKTLWMTEANLIGEIPEAMSNLSSLEILALNG  252 (969)
Q Consensus       174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~  252 (969)
                      |+|++|++++.+|..|+.+++|++|++++|++  .+.+|..++.++ +|+.|++++|++.+.+|..|..++ |++|+|++
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l--~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~  206 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRI--SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSR  206 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCC--EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCS
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcc--cCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcC
Confidence            99999999999999999999999999999862  235677777776 777777777777777777777776 77777777


Q ss_pred             CcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCc
Q 002085          253 NHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPA  332 (969)
Q Consensus       253 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  332 (969)
                      |++++..|..+..+++|+.|+|++|++++.+|.                        +..+++|++|++++|++++.   
T Consensus       207 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~------------------------~~~l~~L~~L~Ls~N~l~~~---  259 (313)
T 1ogq_A          207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK------------------------VGLSKNLNGLDLRNNRIYGT---  259 (313)
T ss_dssp             SEEEECCGGGCCTTSCCSEEECCSSEECCBGGG------------------------CCCCTTCCEEECCSSCCEEC---
T ss_pred             CcccCcCCHHHhcCCCCCEEECCCCceeeecCc------------------------ccccCCCCEEECcCCcccCc---
Confidence            777777777777777777777777766654443                        33444555555555544432   


Q ss_pred             ccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCc
Q 002085          333 SIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNT  390 (969)
Q Consensus       333 ~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  390 (969)
                                    +|..+..+++|+.|+|++|+++|.+|.. ..+++|+.|++++|.
T Consensus       260 --------------~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          260 --------------LPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             --------------CCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             --------------CChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence                          2223344555555555555555555554 555566666666665

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=4.5e-31  Score=292.47  Aligned_cols=295  Identities=22%  Similarity=0.262  Sum_probs=226.1

Q ss_pred             eEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCC
Q 002085           75 VTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG  154 (969)
Q Consensus        75 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  154 (969)
                      ++.++++++.+. .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++
T Consensus        33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  109 (330)
T 1xku_A           33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK  109 (330)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence            345566666665 3555443  6899999999999988788899999999999999999988899999999999999999


Q ss_pred             CCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccccc
Q 002085          155 NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGE  234 (969)
Q Consensus       155 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  234 (969)
                      |+++ .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|.+...+..+..+..+++|+.|++++|++.. 
T Consensus       110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-  185 (330)
T 1xku_A          110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-  185 (330)
T ss_dssp             SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-
T ss_pred             CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-
Confidence            9999 6777665  79999999999999888888999999999999999865555677788888999999998888765 


Q ss_pred             CchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCc
Q 002085          235 IPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKL  313 (969)
Q Consensus       235 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l  313 (969)
                      +|..+.  ++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+... +|+.|+|++|+++ .+|..+..+
T Consensus       186 l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l  262 (330)
T 1xku_A          186 IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH  262 (330)
T ss_dssp             CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred             CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccC
Confidence            454443  688888888888887777888888888888888888887777666655 6888888888888 667777888


Q ss_pred             ccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccC--CCCcccccccCCCccccCCCc
Q 002085          314 KNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSG--ELPTGLWTTFNLSSLMLSDNT  390 (969)
Q Consensus       314 ~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~  390 (969)
                      ++|++|++++|++++..+..+..           +........|+.|++++|++..  ..|..+..+.+++.++|++|+
T Consensus       263 ~~L~~L~l~~N~i~~~~~~~f~~-----------~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          263 KYIQVVYLHNNNISAIGSNDFCP-----------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SSCCEEECCSSCCCCCCTTSSSC-----------SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             CCcCEEECCCCcCCccChhhcCC-----------cccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            88888888888887433222210           0011224567777888887752  445666666677777776663

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.97  E-value=3.8e-31  Score=293.31  Aligned_cols=294  Identities=22%  Similarity=0.211  Sum_probs=169.0

Q ss_pred             cccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecc
Q 002085           98 NLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLY  177 (969)
Q Consensus        98 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  177 (969)
                      +++.+++++++++ .+|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            5777788877776 5666553  577777777777776666677777777777777777776667777777777777777


Q ss_pred             cccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccc--ccCchhhcCCCchhhhhccCCcC
Q 002085          178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLI--GEIPEAMSNLSSLEILALNGNHL  255 (969)
Q Consensus       178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~L~~N~l  255 (969)
                      +|+++ .+|..+.  ++|++|++++|++.  ...+..|..+++|+.|++++|.+.  +..|..+..+             
T Consensus       111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~--~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-------------  172 (332)
T 2ft3_A          111 KNHLV-EIPPNLP--SSLVELRIHDNRIR--KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-------------  172 (332)
T ss_dssp             SSCCC-SCCSSCC--TTCCEEECCSSCCC--CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-------------
T ss_pred             CCcCC-ccCcccc--ccCCEEECCCCccC--ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-------------
Confidence            77777 4554443  56666666666422  222233445555555555555443  2333444444             


Q ss_pred             CCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccc
Q 002085          256 EGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIG  335 (969)
Q Consensus       256 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  335 (969)
                                  +|++|++++|++++ +|..+. .+|+.|++++|.+++..+..|..+++|+.|++++|++++.      
T Consensus       173 ------------~L~~L~l~~n~l~~-l~~~~~-~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~------  232 (332)
T 2ft3_A          173 ------------KLNYLRISEAKLTG-IPKDLP-ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI------  232 (332)
T ss_dssp             ------------CCSCCBCCSSBCSS-CCSSSC-SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCC------
T ss_pred             ------------ccCEEECcCCCCCc-cCcccc-CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcC------
Confidence                        44455555554443 222221 2466666666666665556666667777777777766642      


Q ss_pred             cccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCC
Q 002085          336 VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSG  415 (969)
Q Consensus       336 ~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~  415 (969)
                                 .+..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+|++..+.....              
T Consensus       233 -----------~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~--------------  286 (332)
T 2ft3_A          233 -----------ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCP--------------  286 (332)
T ss_dssp             -----------CTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSC--------------
T ss_pred             -----------ChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccc--------------
Confidence                       1224555666777777777776 66666666666666666666665332221100              


Q ss_pred             CcccccCCcccchhhcccCCccc--cccCccccCccccchhhccCcc
Q 002085          416 QIQRGVGSWKNLIVFKASNNLFS--GEIPVELTSLSHLNTLLLDGNK  460 (969)
Q Consensus       416 ~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~  460 (969)
                      ..+  -.....|+.|++++|.+.  +..|..|..+++|+.|+|++|+
T Consensus       287 ~~~--~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          287 VGF--GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SSC--CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ccc--ccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            000  001234455555555544  3455566666666666666664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=1.2e-30  Score=288.98  Aligned_cols=295  Identities=21%  Similarity=0.241  Sum_probs=181.0

Q ss_pred             cccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecc
Q 002085           98 NLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLY  177 (969)
Q Consensus        98 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  177 (969)
                      +++.++++++.++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            6788999998887 5676554  678888998888887777788888888888888888887778888888888888888


Q ss_pred             cccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCC
Q 002085          178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEG  257 (969)
Q Consensus       178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  257 (969)
                      +|+++ .+|..+.  ++|++|++++|.                          +.+..+..|.++++|++|++++|+++.
T Consensus       109 ~n~l~-~l~~~~~--~~L~~L~l~~n~--------------------------l~~~~~~~~~~l~~L~~L~l~~n~l~~  159 (330)
T 1xku_A          109 KNQLK-ELPEKMP--KTLQELRVHENE--------------------------ITKVRKSVFNGLNQMIVVELGTNPLKS  159 (330)
T ss_dssp             SSCCS-BCCSSCC--TTCCEEECCSSC--------------------------CCBBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred             CCcCC-ccChhhc--ccccEEECCCCc--------------------------ccccCHhHhcCCccccEEECCCCcCCc
Confidence            88887 4555443  566666666664                          444444445555555555555555532


Q ss_pred             --CCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccc
Q 002085          258 --AIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIG  335 (969)
Q Consensus       258 --~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  335 (969)
                        ..+..+..+++|++|++++|.++. +|..+. .+|+.|++++|++++..|..|..+++|+.|++++|++++.      
T Consensus       160 ~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~------  231 (330)
T 1xku_A          160 SGIENGAFQGMKKLSYIRIADTNITT-IPQGLP-PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV------  231 (330)
T ss_dssp             GGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC-TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE------
T ss_pred             cCcChhhccCCCCcCEEECCCCcccc-CCcccc-ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCcee------
Confidence              344445555555555555555553 222221 3566666666666666666666777777777777766632      


Q ss_pred             cccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCC
Q 002085          336 VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSG  415 (969)
Q Consensus       336 ~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~  415 (969)
                                 .+..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+|++..+.....              
T Consensus       232 -----------~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~--------------  285 (330)
T 1xku_A          232 -----------DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP--------------  285 (330)
T ss_dssp             -----------CTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC--------------
T ss_pred             -----------ChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCC--------------
Confidence                       2234556667777777777776 66666666666666666666665332221110              


Q ss_pred             CcccccCCcccchhhcccCCcccc--ccCccccCccccchhhccCcc
Q 002085          416 QIQRGVGSWKNLIVFKASNNLFSG--EIPVELTSLSHLNTLLLDGNK  460 (969)
Q Consensus       416 ~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~  460 (969)
                      .  ........|+.|++++|.+..  ..|..|..+.+|+.++|++|+
T Consensus       286 ~--~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          286 P--GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             S--SCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             c--ccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            0  000112334444455554432  445566666777777777664

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=2.9e-35  Score=342.50  Aligned_cols=383  Identities=19%  Similarity=0.147  Sum_probs=217.5

Q ss_pred             CCcccEEEccCCCCCCCCCcc-cCCCCCCCEEeccCCcCCC----CCCCCcccCCCCcEEecCCCCCCCcCCCcc-cCcc
Q 002085           96 LKNLTTIDLSSNSIPGEFPEF-LYNCTKLQNLDLSQNYFVG----PIPSDIDRISGLQCIDLGGNNFSGDIPRSI-GRLS  169 (969)
Q Consensus        96 l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~  169 (969)
                      +++|++|||++|+++...... +..+++|++|+|++|.+++    .++..+..+++|++|+|++|.++...+..+ ..++
T Consensus         2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~   81 (461)
T 1z7x_W            2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ   81 (461)
T ss_dssp             CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence            356888999999887544333 7778889999999888874    345667777888888888888875444333 2344


Q ss_pred             ----cccceecccccccC----cCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhc-
Q 002085          170 ----ELQTLYLYMNEFNG----TFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMS-  240 (969)
Q Consensus       170 ----~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-  240 (969)
                          +|++|+|++|+++.    .++..+..+++|++|++++|.                          +.+..+..+. 
T Consensus        82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~--------------------------i~~~~~~~l~~  135 (461)
T 1z7x_W           82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL--------------------------LGDAGLQLLCE  135 (461)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSB--------------------------CHHHHHHHHHH
T ss_pred             hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCc--------------------------CchHHHHHHHH
Confidence                58888888888773    446677777777777777764                          2222222111 


Q ss_pred             ----CCCchhhhhccCCcCCCCC----CchhhcCcccchhhccCcccccCCCCchhh------cccccccccCcccccc-
Q 002085          241 ----NLSSLEILALNGNHLEGAI----PSGLFLLNNLTQLFLYDNILSGEIPSSVEA------LKLTDIDLSMNNLTGS-  305 (969)
Q Consensus       241 ----~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~------~~L~~L~Ls~N~l~~~-  305 (969)
                          ..++|++|+|++|++++..    +..+..+++|++|++++|.++...+..+..      .+|+.|++++|.+++. 
T Consensus       136 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~  215 (461)
T 1z7x_W          136 GLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN  215 (461)
T ss_dssp             HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred             HHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence                1234455555555444322    233334455555555555554332222211      1466666666666542 


Q ss_pred             ---CCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCC----CCcccccc
Q 002085          306 ---IPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGE----LPTGLWTT  378 (969)
Q Consensus       306 ---~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l  378 (969)
                         ++..+..+++|++|++++|.+++.....+            .+..+..+++|++|++++|++++.    ++..+..+
T Consensus       216 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l------------~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~  283 (461)
T 1z7x_W          216 CRDLCGIVASKASLRELALGSNKLGDVGMAEL------------CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK  283 (461)
T ss_dssp             HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHH------------HHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHhCCCccEEeccCCcCChHHHHHH------------HHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhC
Confidence               35556666777777777777653211100            011123467788888888877743    56666667


Q ss_pred             cCCCccccCCCccccccCccc-------cccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCcccc
Q 002085          379 FNLSSLMLSDNTISGELPSKT-------AWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHL  451 (969)
Q Consensus       379 ~~L~~L~Ls~N~l~~~~~~~~-------~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  451 (969)
                      ++|+.|+|++|.+++..+...       .++|++|+|++|.+++....                    .++..+..+++|
T Consensus       284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--------------------~l~~~l~~~~~L  343 (461)
T 1z7x_W          284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS--------------------HFSSVLAQNRFL  343 (461)
T ss_dssp             TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--------------------HHHHHHHHCSSC
T ss_pred             CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHH--------------------HHHHHHhhCCCc
Confidence            777777777777764322211       13566666666655543111                    133444455555


Q ss_pred             chhhccCcccCCCCCccccc-----ccCCCEEEccCccccC----CCCcccccccccceEeccCccccccCCCccc----
Q 002085          452 NTLLLDGNKLSGKLPSQIVS-----WTSLNNLNLARNELSG----EIPKAIGSLLVMVSLDLSGNQFSGEIPPEIG----  518 (969)
Q Consensus       452 ~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~----  518 (969)
                      +.|+|++|++++..+..+..     .++|+.|+|++|++++    .+|..+..+++|++|||++|++++.....+.    
T Consensus       344 ~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~  423 (461)
T 1z7x_W          344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR  423 (461)
T ss_dssp             CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHT
T ss_pred             cEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhc
Confidence            66666666555433333322     4566666666666664    5566666666666666666666643111111    


Q ss_pred             c-c-cccEEEeecCcCCCCC
Q 002085          519 Q-L-KLNTFNLSSNKLYGNI  536 (969)
Q Consensus       519 ~-l-~L~~l~ls~N~l~~~~  536 (969)
                      . . +|+.|++.+|......
T Consensus       424 ~~~~~L~~L~~~~~~~~~~~  443 (461)
T 1z7x_W          424 QPGCLLEQLVLYDIYWSEEM  443 (461)
T ss_dssp             STTCCCCEEECTTCCCCHHH
T ss_pred             cCCcchhheeecccccCHHH
Confidence            1 1 3556666665554433

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=4.8e-34  Score=332.27  Aligned_cols=386  Identities=18%  Similarity=0.130  Sum_probs=254.5

Q ss_pred             CeEEEEecCCCCCCCCCcc-ccCCCcccEEEccCCCCCC----CCCcccCCCCCCCEEeccCCcCCCCCCCCc-ccCC--
Q 002085           74 SVTGISLRHKDITQKIPPI-ICDLKNLTTIDLSSNSIPG----EFPEFLYNCTKLQNLDLSQNYFVGPIPSDI-DRIS--  145 (969)
Q Consensus        74 ~v~~l~l~~~~l~~~~~~~-~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~--  145 (969)
                      +++.|++++++++...... +..+++|++|+|++|++++    .++..+..+++|++|+|++|.+++..+..+ ..+.  
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~   83 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   83 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence            5789999999987655443 7889999999999999985    457788899999999999999986444444 3355  


Q ss_pred             --CCcEEecCCCCCCC----cCCCcccCcccccceecccccccCcCCccc-----CCCCCcceeecccCCCCCCC--CCC
Q 002085          146 --GLQCIDLGGNNFSG----DIPRSIGRLSELQTLYLYMNEFNGTFPKEI-----GDLSNLEVLGLAYNSNFKPA--MIP  212 (969)
Q Consensus       146 --~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~~~~~~--~~p  212 (969)
                        +|++|+|++|+++.    .+|..+..+++|++|+|++|++++..+..+     ...++|++|++++|.+....  .++
T Consensus        84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  163 (461)
T 1z7x_W           84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  163 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence              79999999999984    568889999999999999999986555433     23668999999999644322  245


Q ss_pred             ccccccCCCcEEEccCCcccccCchhhc-----CCCchhhhhccCCcCCCC----CCchhhcCcccchhhccCcccccCC
Q 002085          213 IEFGMLKKLKTLWMTEANLIGEIPEAMS-----NLSSLEILALNGNHLEGA----IPSGLFLLNNLTQLFLYDNILSGEI  283 (969)
Q Consensus       213 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~  283 (969)
                      ..+..+++|++|++++|.+....+..+.     .+++|++|+|++|.+++.    ++..+..+++|++|+|++|+++...
T Consensus       164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~  243 (461)
T 1z7x_W          164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG  243 (461)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred             HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence            5677788888888888887766555443     356888888888888763    4666667788888888888776432


Q ss_pred             CCchh------hcccccccccCcccccc----CCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCC
Q 002085          284 PSSVE------ALKLTDIDLSMNNLTGS----IPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGN  353 (969)
Q Consensus       284 ~~~~~------~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~  353 (969)
                      ...+.      ..+|+.|++++|.+++.    ++..+..+++|++|++++|.+++..+..+....            ...
T Consensus       244 ~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l------------~~~  311 (461)
T 1z7x_W          244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETL------------LEP  311 (461)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHH------------TST
T ss_pred             HHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHh------------ccC
Confidence            11111      12566666666666643    344555566666666666665432221111000            011


Q ss_pred             CccCcEEEcccccccCC----CCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCC-----c
Q 002085          354 CRTLRTVQLYSNRFSGE----LPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGS-----W  424 (969)
Q Consensus       354 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~-----l  424 (969)
                      .++|+.|++++|.+++.    ++..+..+++|+.|+|++|                      ++++..+..+..     .
T Consensus       312 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n----------------------~i~~~~~~~l~~~l~~~~  369 (461)
T 1z7x_W          312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNN----------------------RLEDAGVRELCQGLGQPG  369 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSS----------------------BCHHHHHHHHHHHHTSTT
T ss_pred             CccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCC----------------------ccccccHHHHHHHHcCCC
Confidence            23556666666665533    2333444445555555554                      444333332221     4


Q ss_pred             ccchhhcccCCcccc----ccCccccCccccchhhccCcccCCCCCcccc-----cccCCCEEEccCccccCCCCccc
Q 002085          425 KNLIVFKASNNLFSG----EIPVELTSLSHLNTLLLDGNKLSGKLPSQIV-----SWTSLNNLNLARNELSGEIPKAI  493 (969)
Q Consensus       425 ~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~~  493 (969)
                      ++|++|++++|.+++    .+|..+..+++|++|+|++|++++.....+.     ...+|+.|++.+|.+....++.+
T Consensus       370 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~l  447 (461)
T 1z7x_W          370 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL  447 (461)
T ss_dssp             CCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred             CceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHHH
Confidence            567777777777765    5677777788888888888887743221111     23467788887777765444433

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=7.7e-34  Score=341.60  Aligned_cols=433  Identities=15%  Similarity=0.107  Sum_probs=304.8

Q ss_pred             CCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCC---CCCCCcccC------------CCCCCCEEe
Q 002085           63 CDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSI---PGEFPEFLY------------NCTKLQNLD  127 (969)
Q Consensus        63 c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~L~~L~  127 (969)
                      ++|.++.+....  .+.+.++ ....++..+..+++|++|+|+++..   .+.+|..++            .+++|++|+
T Consensus        42 k~W~~~~~~~~~--~l~~~~~-~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~  118 (592)
T 3ogk_B           42 RRWFKIDSETRE--HVTMALC-YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVH  118 (592)
T ss_dssp             HHHHHHHHHHCC--EEEESCG-GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEE
T ss_pred             HHHHHhhhcccc--EEEEeec-cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEE
Confidence            378888654332  2333322 2223345567889999999988532   134444444            789999999


Q ss_pred             ccCCcCCCCCCCCcccC--CCCcEEecCCCC-CCC-cCCCcccCcccccceecccccccCc----CCcccCCCCCcceee
Q 002085          128 LSQNYFVGPIPSDIDRI--SGLQCIDLGGNN-FSG-DIPRSIGRLSELQTLYLYMNEFNGT----FPKEIGDLSNLEVLG  199 (969)
Q Consensus       128 Ls~N~l~~~~p~~l~~l--~~L~~L~L~~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~  199 (969)
                      |++|.+++..+..+...  .+|++|+|++|. ++. .++..+.++++|++|+|++|.+++.    ++..+..+++|++|+
T Consensus       119 L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~  198 (592)
T 3ogk_B          119 FRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLN  198 (592)
T ss_dssp             EESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEE
T ss_pred             eeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEE
Confidence            99999887666667664  459999999986 221 1222334789999999999998866    344556789999999


Q ss_pred             cccCCCCC--CCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCC---CCCCchhhcCcccchhhc
Q 002085          200 LAYNSNFK--PAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLE---GAIPSGLFLLNNLTQLFL  274 (969)
Q Consensus       200 L~~N~~~~--~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~l~~l~~L~~L~L  274 (969)
                      +++|.+..  ...++..+.++++|++|++++|.+.+ +|..+.++++|++|+++.+...   +..+..+..+++|+.|++
T Consensus       199 L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l  277 (592)
T 3ogk_B          199 FYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL  277 (592)
T ss_dssp             CTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEE
T ss_pred             eeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCc
Confidence            99997541  13455567789999999999988776 7788999999999999864433   234456677888999998


Q ss_pred             cCcccccCCCCchhhc-ccccccccCccccccCC-ccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCC
Q 002085          275 YDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIP-EEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLG  352 (969)
Q Consensus       275 ~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~  352 (969)
                      +++.. +.+|..+... +|++|+|++|.+++... ..+..+++|+.|+++ |.+...                .++....
T Consensus       278 ~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~----------------~l~~~~~  339 (592)
T 3ogk_B          278 SYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDR----------------GLEVLAQ  339 (592)
T ss_dssp             TTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHH----------------HHHHHHH
T ss_pred             cccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHH----------------HHHHHHH
Confidence            88643 3556655544 79999999999765443 346788999999998 444321                2222334


Q ss_pred             CCccCcEEEcc-----------cccccCC-CCcccccccCCCccccCCCccccccCccc---cccccEEEee----cccc
Q 002085          353 NCRTLRTVQLY-----------SNRFSGE-LPTGLWTTFNLSSLMLSDNTISGELPSKT---AWNLTRLEIS----NNRF  413 (969)
Q Consensus       353 ~l~~L~~L~L~-----------~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~~L~~L~Ls----~N~l  413 (969)
                      .+++|++|+++           .|.+++. ++.....+++|++|+++.|++++..+...   .++|+.|+|+    .|.+
T Consensus       340 ~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l  419 (592)
T 3ogk_B          340 YCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERI  419 (592)
T ss_dssp             HCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCC
T ss_pred             hCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccc
Confidence            67889999999           3666643 22334457899999998888887555432   4679999996    6778


Q ss_pred             CCC-----cccccCCcccchhhcccCC--ccccccCcccc-CccccchhhccCcccCC-CCCcccccccCCCEEEccCcc
Q 002085          414 SGQ-----IQRGVGSWKNLIVFKASNN--LFSGEIPVELT-SLSHLNTLLLDGNKLSG-KLPSQIVSWTSLNNLNLARNE  484 (969)
Q Consensus       414 ~~~-----~~~~~~~l~~L~~L~l~~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~  484 (969)
                      ++.     ++..+.++++|+.|++++|  .+++..+..+. .+++|+.|+|++|++++ .++..+..+++|+.|+|++|.
T Consensus       420 ~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~  499 (592)
T 3ogk_B          420 TDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCC  499 (592)
T ss_dssp             SSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCC
T ss_pred             cCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCC
Confidence            764     3444667888999999743  36666555554 37889999999999875 345556778899999999999


Q ss_pred             ccCC-CCcccccccccceEeccCccccccCCCcc
Q 002085          485 LSGE-IPKAIGSLLVMVSLDLSGNQFSGEIPPEI  517 (969)
Q Consensus       485 l~~~-~p~~~~~l~~L~~L~ls~N~l~g~~p~~~  517 (969)
                      +++. ++..+..+++|+.|+|++|++++.....+
T Consensus       500 l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l  533 (592)
T 3ogk_B          500 FSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLM  533 (592)
T ss_dssp             CBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGG
T ss_pred             CcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHH
Confidence            8754 34445678899999999999886533333

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=8.3e-31  Score=293.22  Aligned_cols=294  Identities=20%  Similarity=0.192  Sum_probs=204.3

Q ss_pred             CCCCCCCCCCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCC
Q 002085           55 SWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFV  134 (969)
Q Consensus        55 sw~~~~~~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  134 (969)
                      .|.....+|.|.|+ |+        +++++++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus        22 ~~~~~~~~C~~~~~-c~--------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~   89 (353)
T 2z80_A           22 SSNQASLSCDRNGI-CK--------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN   89 (353)
T ss_dssp             -----CCEECTTSE-EE--------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred             CCCccCCCCCCCeE-ee--------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccC
Confidence            35555678999987 64        4556665 3565544  58999999999999776778999999999999999999


Q ss_pred             CCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCC-cccCCCCCcceeecccCCCCCCCCCCc
Q 002085          135 GPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFP-KEIGDLSNLEVLGLAYNSNFKPAMIPI  213 (969)
Q Consensus       135 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~~~~~~~~p~  213 (969)
                      +..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++..+ ..|.++++|++|++++|.. .....+.
T Consensus        90 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~-~~~~~~~  168 (353)
T 2z80_A           90 TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT-FTKIQRK  168 (353)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSS-CCEECTT
T ss_pred             ccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcc-ccccCHH
Confidence            8888889999999999999999996555558999999999999999995444 4789999999999999841 2233456


Q ss_pred             cccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCch-hhcCcccchhhccCcccccCCCCchhhccc
Q 002085          214 EFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSG-LFLLNNLTQLFLYDNILSGEIPSSVEALKL  292 (969)
Q Consensus       214 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L  292 (969)
                      .|+.+++|++|++++|++.+..|..|.++++|++|++++|+++. +|.. +..+++|++|++++|.+++..+..+...  
T Consensus       169 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~--  245 (353)
T 2z80_A          169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFHFSELSTG--  245 (353)
T ss_dssp             TTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT-HHHHHHHHTTTEEEEEEESCBCTTCCCC-------
T ss_pred             HccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc-chhhhhhhcccccEEECCCCccccccccccccc--
Confidence            77888888888888888888878888888888888888888864 3443 3357788888888887776544433211  


Q ss_pred             ccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCC
Q 002085          293 TDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELP  372 (969)
Q Consensus       293 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  372 (969)
                                        .....++.+++++|.+++.             -...+|..+.++++|+.|++++|+++ .+|
T Consensus       246 ------------------~~~~~l~~l~L~~~~l~~~-------------~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~  293 (353)
T 2z80_A          246 ------------------ETNSLIKKFTFRNVKITDE-------------SLFQVMKLLNQISGLLELEFSRNQLK-SVP  293 (353)
T ss_dssp             -------------------CCCCCCEEEEESCBCCHH-------------HHHHHHHHHHTCTTCCEEECCSSCCC-CCC
T ss_pred             ------------------cccchhhccccccccccCc-------------chhhhHHHHhcccCCCEEECCCCCCC-ccC
Confidence                              1123333444444444321             00123444555666666666666666 444


Q ss_pred             cc-cccccCCCccccCCCccccccC
Q 002085          373 TG-LWTTFNLSSLMLSDNTISGELP  396 (969)
Q Consensus       373 ~~-~~~l~~L~~L~Ls~N~l~~~~~  396 (969)
                      .. +..+++|++|+|++|.+.+..|
T Consensus       294 ~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          294 DGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             HHHHhcCCCCCEEEeeCCCccCcCC
Confidence            44 3566666666666666665443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=4.1e-30  Score=281.54  Aligned_cols=251  Identities=22%  Similarity=0.255  Sum_probs=186.8

Q ss_pred             CCCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCC--CCC
Q 002085           62 PCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGP--IPS  139 (969)
Q Consensus        62 ~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~  139 (969)
                      .|.|.+|.|+...++           .+|..+.  ++|++|+|++|+++...+..|.++++|++|+|++|.++..  .|.
T Consensus         6 ~C~~~~l~c~~~~l~-----------~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~   72 (306)
T 2z66_A            6 SCSGTEIRCNSKGLT-----------SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ   72 (306)
T ss_dssp             EEETTEEECCSSCCS-----------SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEH
T ss_pred             eeCCCEEEcCCCCcc-----------cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccc
Confidence            378888888654433           2344332  5899999999999955555689999999999999998832  366


Q ss_pred             CcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCC-cccCCCCCcceeecccCCCCCCCCCCcccccc
Q 002085          140 DIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFP-KEIGDLSNLEVLGLAYNSNFKPAMIPIEFGML  218 (969)
Q Consensus       140 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l  218 (969)
                      .+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+  ....+..+..+
T Consensus        73 ~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l--~~~~~~~~~~l  149 (306)
T 2z66_A           73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT--RVAFNGIFNGL  149 (306)
T ss_dssp             HHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCC--EECSTTTTTTC
T ss_pred             ccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcC--CccchhhcccC
Confidence            7778999999999999998 677789999999999999999986655 5788899999999998863  34456667778


Q ss_pred             CCCcEEEccCCcccc-cCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-cccccc
Q 002085          219 KKLKTLWMTEANLIG-EIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDID  296 (969)
Q Consensus       219 ~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~  296 (969)
                      ++|++|++++|.+.+ .+|..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+... +|+.|+
T Consensus       150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  229 (306)
T 2z66_A          150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD  229 (306)
T ss_dssp             TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEE
T ss_pred             cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeE
Confidence            888888888887776 567777778888888888888877667777777777777777777776555455443 566666


Q ss_pred             ccCccccccCCccccCcc-cchhhhhccccCcC
Q 002085          297 LSMNNLTGSIPEEFGKLK-NLQLLGLFSNHLSG  328 (969)
Q Consensus       297 Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~  328 (969)
                      +++|++++..|..+..++ +|++|++++|.+++
T Consensus       230 L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          230 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             CTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             CCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence            666666666666665553 56666666666554

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=4.1e-28  Score=262.66  Aligned_cols=261  Identities=22%  Similarity=0.198  Sum_probs=215.1

Q ss_pred             cceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCC
Q 002085           67 EITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISG  146 (969)
Q Consensus        67 gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  146 (969)
                      ++.|.....+.+++++++++. +|..+  .++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|..+++
T Consensus         5 ~C~C~~~~~~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~   81 (285)
T 1ozn_A            5 ACVCYNEPKVTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL   81 (285)
T ss_dssp             TCEEECSSSCEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             CceECCCCCeEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccC
Confidence            667876666788888888874 45433  468999999999999877788999999999999999999888999999999


Q ss_pred             CcEEecCCCC-CCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEE
Q 002085          147 LQCIDLGGNN-FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLW  225 (969)
Q Consensus       147 L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~  225 (969)
                      |++|+|++|. ++...|..|..+++|++|+|++|++++..|..|.++++|++|++++|++.  ...+..|+.+++|++|+
T Consensus        82 L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~  159 (285)
T 1ozn_A           82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ--ALPDDTFRDLGNLTHLF  159 (285)
T ss_dssp             CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC--CCCTTTTTTCTTCCEEE
T ss_pred             CCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc--ccCHhHhccCCCccEEE
Confidence            9999999997 88666889999999999999999999888899999999999999999743  34455688899999999


Q ss_pred             ccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccc
Q 002085          226 MTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTG  304 (969)
Q Consensus       226 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~  304 (969)
                      |++|++.+..+..|.++++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+... +|+.|++++|.+..
T Consensus       160 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  239 (285)
T 1ozn_A          160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (285)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             CCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence            99999888777789999999999999999998888888899999999999999987666666655 68888999988875


Q ss_pred             cCCccccCcccchhhhhccccCcCcCCcc
Q 002085          305 SIPEEFGKLKNLQLLGLFSNHLSGEVPAS  333 (969)
Q Consensus       305 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  333 (969)
                      ..+.. .-...++.+..+.+.+.+..|..
T Consensus       240 ~~~~~-~~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          240 DCRAR-PLWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             SGGGH-HHHHHHHHCCSEECCCBEEESGG
T ss_pred             CCCcH-HHHHHHHhcccccCccccCCchH
Confidence            43321 22344666667777776655554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=2.6e-30  Score=283.59  Aligned_cols=267  Identities=18%  Similarity=0.180  Sum_probs=226.5

Q ss_pred             CCCCCCCCCCCCCCcc--eeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCC-CCCCCcccC-------CCCC
Q 002085           53 LQSWTSTSSPCDWPEI--TCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSI-PGEFPEFLY-------NCTK  122 (969)
Q Consensus        53 l~sw~~~~~~c~w~gv--~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l~~  122 (969)
                      ..+|.....|+.+..+  .|...+++.++++++.+  .+|..+...  |++|+|++|.+ .+.+|..+.       ++++
T Consensus        21 ~~~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~   96 (312)
T 1wwl_A           21 KPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISG   96 (312)
T ss_dssp             SCCGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSC
T ss_pred             ccchHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCC
Confidence            4567766677777654  56666788899999999  788776654  99999999999 456777776       8999


Q ss_pred             CCEEeccCCcCCCCCCCCc--ccCCCCcEEecCCCCCCCcCCCcccCc-----ccccceecccccccCcCCcccCCCCCc
Q 002085          123 LQNLDLSQNYFVGPIPSDI--DRISGLQCIDLGGNNFSGDIPRSIGRL-----SELQTLYLYMNEFNGTFPKEIGDLSNL  195 (969)
Q Consensus       123 L~~L~Ls~N~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L  195 (969)
                      |++|+|++|++++.+|..+  ..+++|++|+|++|++++. |..++.+     ++|++|+|++|++++..|..|+++++|
T Consensus        97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L  175 (312)
T 1wwl_A           97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL  175 (312)
T ss_dssp             CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred             ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence            9999999999999999987  9999999999999999976 8888888     999999999999999888999999999


Q ss_pred             ceeecccCCCCCCCCCCccc--cccCCCcEEEccCCcccc--cCc-hhhcCCCchhhhhccCCcCCCCCC-chhhcCccc
Q 002085          196 EVLGLAYNSNFKPAMIPIEF--GMLKKLKTLWMTEANLIG--EIP-EAMSNLSSLEILALNGNHLEGAIP-SGLFLLNNL  269 (969)
Q Consensus       196 ~~L~L~~N~~~~~~~~p~~~--~~l~~L~~L~L~~n~l~~--~~p-~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L  269 (969)
                      ++|++++|++......|..+  +.+++|++|+|++|++.+  .++ ..+.++++|++|+|++|++++..| ..+..+++|
T Consensus       176 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L  255 (312)
T 1wwl_A          176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL  255 (312)
T ss_dssp             CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTC
T ss_pred             CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCC
Confidence            99999999743211134444  899999999999999983  233 456789999999999999998775 455678999


Q ss_pred             chhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcC
Q 002085          270 TQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSG  328 (969)
Q Consensus       270 ~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  328 (969)
                      ++|+|++|+|+ .+|..+. .+|+.|+|++|++++. |. +..+++|++|++++|++++
T Consensus       256 ~~L~Ls~N~l~-~ip~~~~-~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          256 NSLNLSFTGLK-QVPKGLP-AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CEEECTTSCCS-SCCSSCC-SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             CEEECCCCccC-hhhhhcc-CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            99999999999 6676665 6899999999999976 65 9999999999999999985

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=3e-28  Score=268.63  Aligned_cols=266  Identities=21%  Similarity=0.309  Sum_probs=227.0

Q ss_pred             CCCCCCC--CCCCCCCCcceeeCCCeEEEEecCCCCCC----CCCccc--cCCCcccEEEccCCCCCCCCCcccCCCCCC
Q 002085           52 SLQSWTS--TSSPCDWPEITCTFNSVTGISLRHKDITQ----KIPPII--CDLKNLTTIDLSSNSIPGEFPEFLYNCTKL  123 (969)
Q Consensus        52 ~l~sw~~--~~~~c~w~gv~C~~~~v~~l~l~~~~l~~----~~~~~~--~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  123 (969)
                      ++.+|..  ..|+|.|.+.-|....-   .-..+...|    .++..+  ...+++++|+|++|+++ .+|..++++++|
T Consensus        31 aLl~~k~~~~~~~~~~~~~w~~~~~~---~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L  106 (328)
T 4fcg_A           31 VLSQWQRHYNADRNRWHSAWRQANSN---NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL  106 (328)
T ss_dssp             HHHHHHHHHHHCCTTHHHHHHHHTTT---CTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTC
T ss_pred             HHHHHHHhccCCchhhhhhhcccccc---cccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhCCCC
Confidence            3567764  36789998877732100   000011111    011111  24578999999999999 889999999999


Q ss_pred             CEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCC---------CCC
Q 002085          124 QNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGD---------LSN  194 (969)
Q Consensus       124 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---------l~~  194 (969)
                      ++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..|+++++|++|+|++|++.+.+|..++.         +++
T Consensus       107 ~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~  184 (328)
T 4fcg_A          107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN  184 (328)
T ss_dssp             SEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTT
T ss_pred             CEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCC
Confidence            99999999999 89999999999999999999999 88999999999999999999999999988765         999


Q ss_pred             cceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhc
Q 002085          195 LEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFL  274 (969)
Q Consensus       195 L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  274 (969)
                      |++|+|++|++.   .+|..++.+++|++|+|++|++.+ +|..+..+++|++|+|++|++.+.+|..+..+++|++|+|
T Consensus       185 L~~L~L~~n~l~---~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L  260 (328)
T 4fcg_A          185 LQSLRLEWTGIR---SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL  260 (328)
T ss_dssp             CCEEEEEEECCC---CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred             CCEEECcCCCcC---cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence            999999999643   788899999999999999999985 6667999999999999999999999999999999999999


Q ss_pred             cCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCc
Q 002085          275 YDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLS  327 (969)
Q Consensus       275 ~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  327 (969)
                      ++|++.+.+|..+..+ +|+.|+|++|++.+.+|..++.+++|+.+++..|.+.
T Consensus       261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             TTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            9999999999888776 7999999999999999999999999999999887765

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.95  E-value=5.6e-29  Score=278.38  Aligned_cols=276  Identities=20%  Similarity=0.187  Sum_probs=212.6

Q ss_pred             cccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecc
Q 002085           98 NLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLY  177 (969)
Q Consensus        98 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  177 (969)
                      .....++++|+++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus        32 ~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (353)
T 2z80_A           32 RNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS  108 (353)
T ss_dssp             TTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence            3446899999998 6787665  589999999999997777789999999999999999998888899999999999999


Q ss_pred             cccccCcCCcccCCCCCcceeecccCCCCCCCCCCc--cccccCCCcEEEccCCc-ccccCchhhcCCCchhhhhccCCc
Q 002085          178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPI--EFGMLKKLKTLWMTEAN-LIGEIPEAMSNLSSLEILALNGNH  254 (969)
Q Consensus       178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~--~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~N~  254 (969)
                      +|++++..+..|+++++|++|++++|++.   .+|.  .|..+++|++|++++|+ +.+..+..|.++++|++|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~---~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~  185 (353)
T 2z80_A          109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYK---TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD  185 (353)
T ss_dssp             SSCCSSCCHHHHTTCTTCSEEECTTCCCS---SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             CCcCCcCCHhHhCCCccCCEEECCCCCCc---ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence            99999766666999999999999999643   4554  68889999999999885 555556788888888888888888


Q ss_pred             CCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcc
Q 002085          255 LEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPAS  333 (969)
Q Consensus       255 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  333 (969)
                      +++..|..+..+++|++|++++|+++...+..+... +|+.|++++|++++..+..+.                      
T Consensus       186 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~----------------------  243 (353)
T 2z80_A          186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS----------------------  243 (353)
T ss_dssp             CCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-------------------------
T ss_pred             cCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccc----------------------
Confidence            888778888888888888888887753222222222 455555555555433222111                      


Q ss_pred             cccccccCcccccCCCCCCCCccCcEEEcccccccC----CCCcccccccCCCccccCCCccccccCcc---ccccccEE
Q 002085          334 IGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSG----ELPTGLWTTFNLSSLMLSDNTISGELPSK---TAWNLTRL  406 (969)
Q Consensus       334 ~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~~L~~L  406 (969)
                                      .......++.++|++|.+++    .+|..+..+++|+.|+|++|+++ .+|..   ..++|++|
T Consensus       244 ----------------~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L  306 (353)
T 2z80_A          244 ----------------TGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKI  306 (353)
T ss_dssp             -------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred             ----------------cccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEE
Confidence                            11234567778888887775    47888999999999999999999 45543   34789999


Q ss_pred             EeeccccCCCcc
Q 002085          407 EISNNRFSGQIQ  418 (969)
Q Consensus       407 ~Ls~N~l~~~~~  418 (969)
                      +|++|.+++..|
T Consensus       307 ~L~~N~~~~~~~  318 (353)
T 2z80_A          307 WLHTNPWDCSCP  318 (353)
T ss_dssp             ECCSSCBCCCHH
T ss_pred             EeeCCCccCcCC
Confidence            999999997544

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=5e-28  Score=286.90  Aligned_cols=279  Identities=23%  Similarity=0.381  Sum_probs=194.4

Q ss_pred             CCCCCCCCCCCCCCcc--------eeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCC
Q 002085           53 LQSWTSTSSPCDWPEI--------TCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQ  124 (969)
Q Consensus        53 l~sw~~~~~~c~w~gv--------~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  124 (969)
                      +++|..+.+||.|.|.        .|....++.|++++++++ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|+
T Consensus        12 w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~   84 (622)
T 3g06_A           12 WSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELR   84 (622)
T ss_dssp             HHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCC
T ss_pred             HHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCC
Confidence            4568777889999663        445557899999999998 6777665  79999999999998 5665   578999


Q ss_pred             EEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCC
Q 002085          125 NLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNS  204 (969)
Q Consensus       125 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  204 (969)
                      +|+|++|+|+ .+|.   .+++|++|+|++|++++ +|.   .+++|+.|+|++|++++ +|..   +++|++|+|++|+
T Consensus        85 ~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~  152 (622)
T 3g06_A           85 TLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQ  152 (622)
T ss_dssp             EEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSC
T ss_pred             EEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCc
Confidence            9999999998 5665   67899999999999984 555   56789999999999984 5553   4889999999986


Q ss_pred             CCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCC
Q 002085          205 NFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIP  284 (969)
Q Consensus       205 ~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  284 (969)
                      +..   +|.   .+++|+.|++++|++.+ +|   ..+++|+.|+|++|++++ +|..   +++|+.|++++|.++. +|
T Consensus       153 l~~---l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~  217 (622)
T 3g06_A          153 LAS---LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LP  217 (622)
T ss_dssp             CSC---CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CC
T ss_pred             CCC---cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cC
Confidence            443   332   34677788888877765 44   445677777888887774 3432   3667777777777763 33


Q ss_pred             CchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEccc
Q 002085          285 SSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYS  364 (969)
Q Consensus       285 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~  364 (969)
                      ..+  .+|+.|+|++|++++ +|   ..+++|+.|++++|+|+                  .+|.   .+++|+.|+|++
T Consensus       218 ~~~--~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~------------------~lp~---~~~~L~~L~Ls~  270 (622)
T 3g06_A          218 ALP--SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT------------------SLPM---LPSGLLSLSVYR  270 (622)
T ss_dssp             CCC--TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS------------------CCCC---CCTTCCEEECCS
T ss_pred             CCC--CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC------------------cCCc---ccccCcEEeCCC
Confidence            321  356667777776664 34   33456666666666665                  2222   345566666666


Q ss_pred             ccccCCCCcccccccCCCccccCCCcccc
Q 002085          365 NRFSGELPTGLWTTFNLSSLMLSDNTISG  393 (969)
Q Consensus       365 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  393 (969)
                      |+|+ .+|..+..+++|+.|+|++|.+++
T Consensus       271 N~L~-~lp~~l~~l~~L~~L~L~~N~l~~  298 (622)
T 3g06_A          271 NQLT-RLPESLIHLSSETTVNLEGNPLSE  298 (622)
T ss_dssp             SCCC-SCCGGGGGSCTTCEEECCSCCCCH
T ss_pred             CCCC-cCCHHHhhccccCEEEecCCCCCC
Confidence            6666 556666655555555555555543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=1.6e-27  Score=275.89  Aligned_cols=245  Identities=22%  Similarity=0.263  Sum_probs=216.1

Q ss_pred             EEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCC
Q 002085           77 GISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNN  156 (969)
Q Consensus        77 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  156 (969)
                      .+++++.+++. +|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        58 ~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~  134 (452)
T 3zyi_A           58 KVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW  134 (452)
T ss_dssp             EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence            34455555543 555443  689999999999998889999999999999999999998888999999999999999999


Q ss_pred             CCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCC-ccccccCCCcEEEccCCcccccC
Q 002085          157 FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIP-IEFGMLKKLKTLWMTEANLIGEI  235 (969)
Q Consensus       157 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~  235 (969)
                      |++..+..|.++++|++|+|++|+++...+..|.++++|++|++++|.  ....++ ..|..+++|+.|+|++|++.+. 
T Consensus       135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~--~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-  211 (452)
T 3zyi_A          135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELK--KLEYISEGAFEGLFNLKYLNLGMCNIKDM-  211 (452)
T ss_dssp             CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCT--TCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred             CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCC--CccccChhhccCCCCCCEEECCCCccccc-
Confidence            997777789999999999999999998777899999999999999864  333444 4689999999999999998864 


Q ss_pred             chhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcc
Q 002085          236 PEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLK  314 (969)
Q Consensus       236 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~  314 (969)
                      | .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+ +|+.|+|++|++++..+..|..++
T Consensus       212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  290 (452)
T 3zyi_A          212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR  290 (452)
T ss_dssp             C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred             c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence            4 58899999999999999999889999999999999999999999988888876 799999999999988888899999


Q ss_pred             cchhhhhccccCcC
Q 002085          315 NLQLLGLFSNHLSG  328 (969)
Q Consensus       315 ~L~~L~L~~N~l~~  328 (969)
                      +|+.|+|++|.+..
T Consensus       291 ~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          291 YLVELHLHHNPWNC  304 (452)
T ss_dssp             TCCEEECCSSCEEC
T ss_pred             CCCEEEccCCCcCC
Confidence            99999999999874

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=2.3e-27  Score=256.74  Aligned_cols=250  Identities=24%  Similarity=0.199  Sum_probs=219.2

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCc-CCCCCCCCcccCCCCcEEe
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNY-FVGPIPSDIDRISGLQCID  151 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~  151 (969)
                      .+++.|+++++.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|. +++..|..|..+++|++|+
T Consensus        32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~  111 (285)
T 1ozn_A           32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (285)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence            468999999999999888899999999999999999998889999999999999999997 8877789999999999999


Q ss_pred             cCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcc
Q 002085          152 LGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANL  231 (969)
Q Consensus       152 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l  231 (969)
                      |++|++++..|..|.++++|++|+|++|++++..+..|+.+++|++|++++|++.  ...+..|..+++|+.|++++|.+
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~l~~n~l  189 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS--SVPERAFRGLHSLDRLLLHQNRV  189 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC--EECTTTTTTCTTCCEEECCSSCC
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccc--ccCHHHhcCccccCEEECCCCcc
Confidence            9999999888899999999999999999999888888999999999999999633  33445699999999999999999


Q ss_pred             cccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCcccc
Q 002085          232 IGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFG  311 (969)
Q Consensus       232 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~  311 (969)
                      .+..|..|.++++|+.|+|++|++++..+..+..+++|++|+|++|.+....+.......++.+..+.+.+.+..|..+.
T Consensus       190 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~l~  269 (285)
T 1ozn_A          190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA  269 (285)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred             cccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchHhC
Confidence            99999999999999999999999998777789999999999999999987655432223477788889999988888775


Q ss_pred             C--cccchhhhhccc
Q 002085          312 K--LKNLQLLGLFSN  324 (969)
Q Consensus       312 ~--l~~L~~L~L~~N  324 (969)
                      +  +..++..++.++
T Consensus       270 g~~l~~l~~~~l~~C  284 (285)
T 1ozn_A          270 GRDLKRLAANDLQGC  284 (285)
T ss_dssp             TCBGGGSCGGGSCCC
T ss_pred             CcChhhcCHHHhccC
Confidence            5  444555444443

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=1.9e-27  Score=275.31  Aligned_cols=248  Identities=21%  Similarity=0.216  Sum_probs=175.1

Q ss_pred             cccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecc
Q 002085           98 NLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLY  177 (969)
Q Consensus        98 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  177 (969)
                      ....++.++++++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence            4578899998888 6776654  689999999999998888899999999999999999998888899999999999999


Q ss_pred             cccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCch-hhcCCCchhhhhccCCcCC
Q 002085          178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLE  256 (969)
Q Consensus       178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~  256 (969)
                      +|++++..+..|.++++|++|+|++|++.  ...+..|..+++|+.|++++|+..+.++. .|.++++|++|+|++|+++
T Consensus       132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~  209 (452)
T 3zyi_A          132 DNWLTVIPSGAFEYLSKLRELWLRNNPIE--SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK  209 (452)
T ss_dssp             SSCCSBCCTTTSSSCTTCCEEECCSCCCC--EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred             CCcCCccChhhhcccCCCCEEECCCCCcc--eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc
Confidence            99999777777888999999999988632  33344677777777777777555554443 5666666777777776666


Q ss_pred             CCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCccccc
Q 002085          257 GAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGV  336 (969)
Q Consensus       257 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  336 (969)
                      +. | .+..+++                       |+.|+|++|++++..|..|..+++|+.|++++|++++        
T Consensus       210 ~~-~-~~~~l~~-----------------------L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~--------  256 (452)
T 3zyi_A          210 DM-P-NLTPLVG-----------------------LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL--------  256 (452)
T ss_dssp             SC-C-CCTTCTT-----------------------CCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCE--------
T ss_pred             cc-c-ccccccc-----------------------ccEEECcCCcCcccCcccccCccCCCEEEeCCCcCce--------
Confidence            32 3 2344444                       4445555555555555566666666666666666653        


Q ss_pred             ccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccc
Q 002085          337 VAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTIS  392 (969)
Q Consensus       337 l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  392 (969)
                               ..|..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus       257 ---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          257 ---------IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             ---------ECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             ---------ECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence                     22344556666667777777666555555555566666655555554

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=1.8e-27  Score=274.32  Aligned_cols=246  Identities=24%  Similarity=0.275  Sum_probs=216.5

Q ss_pred             EEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCC
Q 002085           76 TGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGN  155 (969)
Q Consensus        76 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N  155 (969)
                      ..++..+.+++ .+|..+.  ++++.|+|++|+|++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|
T Consensus        46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n  122 (440)
T 3zyj_A           46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN  122 (440)
T ss_dssp             CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence            34555666665 3565544  68999999999999888899999999999999999999888889999999999999999


Q ss_pred             CCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCC-CccccccCCCcEEEccCCccccc
Q 002085          156 NFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMI-PIEFGMLKKLKTLWMTEANLIGE  234 (969)
Q Consensus       156 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~-p~~~~~l~~L~~L~L~~n~l~~~  234 (969)
                      +|+...+..|..+++|++|+|++|+++...+..|.++++|++|++++|.  ....+ +..|.++++|+.|+|++|++.. 
T Consensus       123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~--~l~~i~~~~~~~l~~L~~L~L~~n~l~~-  199 (440)
T 3zyj_A          123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELK--RLSYISEGAFEGLSNLRYLNLAMCNLRE-  199 (440)
T ss_dssp             CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCT--TCCEECTTTTTTCSSCCEEECTTSCCSS-
T ss_pred             cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCC--CcceeCcchhhcccccCeecCCCCcCcc-
Confidence            9997767789999999999999999998888899999999999999864  33334 4469999999999999999874 


Q ss_pred             CchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCc
Q 002085          235 IPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKL  313 (969)
Q Consensus       235 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l  313 (969)
                      +| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+ +|+.|+|++|++++..+..|..+
T Consensus       200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  278 (440)
T 3zyj_A          200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL  278 (440)
T ss_dssp             CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred             cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence            45 48899999999999999998889999999999999999999999888888776 79999999999998888889999


Q ss_pred             ccchhhhhccccCcC
Q 002085          314 KNLQLLGLFSNHLSG  328 (969)
Q Consensus       314 ~~L~~L~L~~N~l~~  328 (969)
                      ++|+.|+|++|.+..
T Consensus       279 ~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          279 HHLERIHLHHNPWNC  293 (440)
T ss_dssp             TTCCEEECCSSCEEC
T ss_pred             cCCCEEEcCCCCccC
Confidence            999999999999874

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=6e-31  Score=316.38  Aligned_cols=406  Identities=14%  Similarity=0.066  Sum_probs=306.1

Q ss_pred             CCCcccCCCCCCCEEeccCCcC---CCCCCCCcc------------cCCCCcEEecCCCCCCCcCCCcccCc--ccccce
Q 002085          112 EFPEFLYNCTKLQNLDLSQNYF---VGPIPSDID------------RISGLQCIDLGGNNFSGDIPRSIGRL--SELQTL  174 (969)
Q Consensus       112 ~~p~~~~~l~~L~~L~Ls~N~l---~~~~p~~l~------------~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L  174 (969)
                      ..+..+..+++|++|+|+++..   .+.+|..++            .+++|++|+|++|.+++..+..+..+  .+|++|
T Consensus        64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L  143 (592)
T 3ogk_B           64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL  143 (592)
T ss_dssp             CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred             ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence            3455567889999999988642   134554444            78999999999999987777777664  459999


Q ss_pred             eccccc-ccC-cCCcccCCCCCcceeecccCCCCCCCC--CCccccccCCCcEEEccCCccc----ccCchhhcCCCchh
Q 002085          175 YLYMNE-FNG-TFPKEIGDLSNLEVLGLAYNSNFKPAM--IPIEFGMLKKLKTLWMTEANLI----GEIPEAMSNLSSLE  246 (969)
Q Consensus       175 ~L~~N~-l~~-~~p~~~~~l~~L~~L~L~~N~~~~~~~--~p~~~~~l~~L~~L~L~~n~l~----~~~p~~~~~l~~L~  246 (969)
                      +|++|. ++. .++....++++|++|+|++|.+...+.  ++..+..+++|++|++++|.+.    +.++..+.++++|+
T Consensus       144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~  223 (592)
T 3ogk_B          144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV  223 (592)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCC
T ss_pred             ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCc
Confidence            999987 221 122334578999999999997433221  4445678999999999999987    45566678899999


Q ss_pred             hhhccCCcCCCCCCchhhcCcccchhhccCcccc---cCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhc
Q 002085          247 ILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILS---GEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLF  322 (969)
Q Consensus       247 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~---~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  322 (969)
                      .|+|++|.+.+ +|..+..+++|++|+++.+...   +..+..+... +|+.|+++++... .+|..+..+++|++|+++
T Consensus       224 ~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls  301 (592)
T 3ogk_B          224 SVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLL  301 (592)
T ss_dssp             EEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEET
T ss_pred             EEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecC
Confidence            99999999995 6788899999999999864333   1222233333 6899999886544 678888899999999999


Q ss_pred             cccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccC-----------CCcc
Q 002085          323 SNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLS-----------DNTI  391 (969)
Q Consensus       323 ~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-----------~N~l  391 (969)
                      +|.+++..                ++..+.++++|+.|+++++-..+.++..+..+++|+.|+++           .|.+
T Consensus       302 ~~~l~~~~----------------~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~  365 (592)
T 3ogk_B          302 YALLETED----------------HCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLV  365 (592)
T ss_dssp             TCCCCHHH----------------HHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCC
T ss_pred             CCcCCHHH----------------HHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCcc
Confidence            99976421                12235678999999999443333445555678999999999           3667


Q ss_pred             ccccCc---cccccccEEEeeccccCCCcccccCC-cccchhhccc----CCccccc-----cCccccCccccchhhccC
Q 002085          392 SGELPS---KTAWNLTRLEISNNRFSGQIQRGVGS-WKNLIVFKAS----NNLFSGE-----IPVELTSLSHLNTLLLDG  458 (969)
Q Consensus       392 ~~~~~~---~~~~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~l~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~  458 (969)
                      ++....   ...++|++|+++.|++++..+..+.. +++|+.|+++    .|.+++.     ++..+..+++|+.|+|++
T Consensus       366 ~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~  445 (592)
T 3ogk_B          366 SQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYL  445 (592)
T ss_dssp             CHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEEC
T ss_pred             CHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEec
Confidence            643222   23478999999999999887777766 8899999996    7888863     445577899999999985


Q ss_pred             c--ccCCCCCccccc-ccCCCEEEccCccccC-CCCcccccccccceEeccCccccccC-CCcccccc-ccEEEeecCcC
Q 002085          459 N--KLSGKLPSQIVS-WTSLNNLNLARNELSG-EIPKAIGSLLVMVSLDLSGNQFSGEI-PPEIGQLK-LNTFNLSSNKL  532 (969)
Q Consensus       459 N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~~~~l~-L~~l~ls~N~l  532 (969)
                      |  .+++..+..+.. +++|+.|+|++|++++ .++..+..+++|+.|+|++|+|++.. +..+..++ |++|+|++|++
T Consensus       446 ~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i  525 (592)
T 3ogk_B          446 RQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA  525 (592)
T ss_dssp             CGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred             CCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence            4  477665555544 8899999999999986 34566688999999999999998654 33445564 99999999998


Q ss_pred             CCC
Q 002085          533 YGN  535 (969)
Q Consensus       533 ~~~  535 (969)
                      ++.
T Consensus       526 t~~  528 (592)
T 3ogk_B          526 SMT  528 (592)
T ss_dssp             CTT
T ss_pred             CHH
Confidence            865

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.95  E-value=5.9e-28  Score=264.37  Aligned_cols=247  Identities=23%  Similarity=0.225  Sum_probs=147.3

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCC--cCCCcccCcccccceecc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSG--DIPRSIGRLSELQTLYLY  177 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~  177 (969)
                      +.+++++++++ .+|..+.  ++|++|+|++|+++...+..|.++++|++|+|++|+++.  ..|..+..+++|++|+|+
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            57889999888 6676553  688999999999885444557888999999999998873  235667778888888888


Q ss_pred             cccccCcCCcccCCCCCcceeecccCCCCCCCCCC-ccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCC
Q 002085          178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIP-IEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLE  256 (969)
Q Consensus       178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  256 (969)
                      +|.++ .+|..+..+++|++|++++|++..  ..+ ..+..+++|++|++++|.+.+..|..|.++++|++|+|++|.++
T Consensus        87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  163 (306)
T 2z66_A           87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ--MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ  163 (306)
T ss_dssp             SCSEE-EEEEEEETCTTCCEEECTTSEEES--STTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred             CCccc-cChhhcCCCCCCCEEECCCCcccc--cccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence            88887 466667777777777777775221  111 23445555555555555554444444444445555555554444


Q ss_pred             C-CCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccc
Q 002085          257 G-AIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIG  335 (969)
Q Consensus       257 ~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  335 (969)
                      + .+|..+..+++                       |+.|++++|++++..|..|..+++|+.|++++|++++..     
T Consensus       164 ~~~~~~~~~~l~~-----------------------L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----  215 (306)
T 2z66_A          164 ENFLPDIFTELRN-----------------------LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD-----  215 (306)
T ss_dssp             GGEECSCCTTCTT-----------------------CCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC-----
T ss_pred             cccchhHHhhCcC-----------------------CCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC-----
Confidence            3 23333444444                       444444444444444445555555555555555554211     


Q ss_pred             cccccCcccccCCCCCCCCccCcEEEcccccccCCCCccccccc-CCCccccCCCccc
Q 002085          336 VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTF-NLSSLMLSDNTIS  392 (969)
Q Consensus       336 ~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~  392 (969)
                                  +..+..+++|+.|+|++|++++..|..+..++ +|++|+|++|.++
T Consensus       216 ------------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~  261 (306)
T 2z66_A          216 ------------TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA  261 (306)
T ss_dssp             ------------SGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred             ------------hhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence                        11234455556666666666555555555542 4555555555544

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=6.4e-29  Score=272.49  Aligned_cols=254  Identities=21%  Similarity=0.179  Sum_probs=157.4

Q ss_pred             hcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccc-cCCCCchh--------hcccccccccCccccccCCcc
Q 002085          239 MSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILS-GEIPSSVE--------ALKLTDIDLSMNNLTGSIPEE  309 (969)
Q Consensus       239 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~~~~~~--------~~~L~~L~Ls~N~l~~~~p~~  309 (969)
                      ++..++|+.|++++|.+  .+|..+...  |+.|+|++|+++ +.+|..+.        ..+|++|+|++|++++.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            45556777788888887  566666543  777777777773 34444443        235777777777777666665


Q ss_pred             c--cCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccC
Q 002085          310 F--GKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLS  387 (969)
Q Consensus       310 ~--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  387 (969)
                      +  ..+++|++|+|++|++++. |..++.+.          .  ..+++|++|+|++|++++..|..+..+++|+.|+|+
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~----------~--~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  181 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQ----------Q--WLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS  181 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHH----------T--TCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECC
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHH----------H--hhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECC
Confidence            5  6677777777777777643 33222110          0  012667777777777776666666666666666666


Q ss_pred             CCccccccCccccccccEEEeeccccCCCcccc--cCCcccchhhcccCCcccc---ccCccccCccccchhhccCcccC
Q 002085          388 DNTISGELPSKTAWNLTRLEISNNRFSGQIQRG--VGSWKNLIVFKASNNLFSG---EIPVELTSLSHLNTLLLDGNKLS  462 (969)
Q Consensus       388 ~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~l~~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l~  462 (969)
                      +|++.+.++                    .+..  +..+++|++|++++|+|++   .....+..+++|+.|+|++|+++
T Consensus       182 ~N~l~~~~~--------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  241 (312)
T 1wwl_A          182 DNPELGERG--------------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR  241 (312)
T ss_dssp             SCTTCHHHH--------------------HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCC
T ss_pred             CCCcCcchH--------------------HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCC
Confidence            666554321                    1111  2455566666666666652   11233356677777777777777


Q ss_pred             CCCC-cccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecCcCCC
Q 002085          463 GKLP-SQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYG  534 (969)
Q Consensus       463 ~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~  534 (969)
                      +.+| ..+..+++|+.|+|++|+|+ .+|..+.  ++|+.|||++|+|++. |. +..++ |++|++++|++++
T Consensus       242 ~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          242 DAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             SSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             cccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            6554 34555677777777777776 6676665  6777777777777754 54 66664 7777777777765

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.6e-28  Score=289.53  Aligned_cols=189  Identities=18%  Similarity=0.096  Sum_probs=134.5

Q ss_pred             eeeecCcEEEEEEEEcCCCcEEEEEEEeccch-------hcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceEEE
Q 002085          643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-------LNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       643 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  714 (969)
                      ..+.|+.|.+..++....|+.||||++.....       ..+...+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35677777777777666789999999965421       1234457899999999999 799999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++|++|.+++...+.             ++.   .+|+.||+.||+|+|++   |||||||||+|||++++|.+||+
T Consensus       321 MEyv~G~~L~d~i~~~~~-------------l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~  381 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEE-------------IDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLI  381 (569)
T ss_dssp             EECCCSEEHHHHHHTTCC-------------CCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEEC
T ss_pred             EecCCCCcHHHHHHhCCC-------------CCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEe
Confidence            999999999999986543             433   35899999999999999   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEA  853 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p  853 (969)
                      |||+|+......  .......||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       382 DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          382 DFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ecccCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            999998764332  22344679999999999875 567889999999999888766544

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=4.9e-27  Score=278.39  Aligned_cols=266  Identities=27%  Similarity=0.385  Sum_probs=140.0

Q ss_pred             CcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhh
Q 002085          194 NLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLF  273 (969)
Q Consensus       194 ~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  273 (969)
                      +++.|++++|.+   ..+|..+.  ++|+.|+|++|++. .+|.   .+++|++|+|++|+|++ +|.   .+++|++|+
T Consensus        41 ~l~~L~ls~n~L---~~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~  107 (622)
T 3g06_A           41 GNAVLNVGESGL---TTLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELS  107 (622)
T ss_dssp             CCCEEECCSSCC---SCCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEE
T ss_pred             CCcEEEecCCCc---CccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEE
Confidence            577888887753   34555554  67777777777665 3444   45667777777777763 444   456677777


Q ss_pred             ccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCC
Q 002085          274 LYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGN  353 (969)
Q Consensus       274 L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~  353 (969)
                      |++|++++..+   ...+|+.|++++|++++ +|..   +++|++|++++|++++                  +|.   .
T Consensus       108 Ls~N~l~~l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~------------------l~~---~  159 (622)
T 3g06_A          108 IFSNPLTHLPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS------------------LPA---L  159 (622)
T ss_dssp             ECSCCCCCCCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC------------------CCC---C
T ss_pred             CcCCcCCCCCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC------------------cCC---c
Confidence            77776664322   12256666666666663 3332   2556666666665552                  111   1


Q ss_pred             CccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhccc
Q 002085          354 CRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKAS  433 (969)
Q Consensus       354 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  433 (969)
                      +++|+.|++++|++++ +|   ..+++|+.|++++|.|++ +|. ...+|+.|++++|.++.                  
T Consensus       160 ~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~-~~~~L~~L~L~~N~l~~------------------  215 (622)
T 3g06_A          160 PSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT-LPSELYKLWAYNNRLTS------------------  215 (622)
T ss_dssp             CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSS------------------
T ss_pred             cCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC-ccchhhEEECcCCcccc------------------
Confidence            2345556666666552 33   223455555555555543 221 12344555555554442                  


Q ss_pred             CCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccC
Q 002085          434 NNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEI  513 (969)
Q Consensus       434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~  513 (969)
                             +|..   +++|+.|+|++|+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+
T Consensus       216 -------l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~l  276 (622)
T 3g06_A          216 -------LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RL  276 (622)
T ss_dssp             -------CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SC
T ss_pred             -------cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cC
Confidence                   2321   2445555555555553 33   23345555555555555 3443   3445555555555555 45


Q ss_pred             CCcccccc-ccEEEeecCcCCCCCCcccccc
Q 002085          514 PPEIGQLK-LNTFNLSSNKLYGNIPDEFNNL  543 (969)
Q Consensus       514 p~~~~~l~-L~~l~ls~N~l~~~~p~~~~~~  543 (969)
                      |..++.++ |+.|+|++|+++|.+|..+..+
T Consensus       277 p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          277 PESLIHLSSETTVNLEGNPLSERTLQALREI  307 (622)
T ss_dssp             CGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred             CHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence            55555553 5555555555555555444433

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=1.6e-26  Score=266.46  Aligned_cols=247  Identities=23%  Similarity=0.247  Sum_probs=178.0

Q ss_pred             ccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceeccc
Q 002085           99 LTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYM  178 (969)
Q Consensus        99 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  178 (969)
                      ...++.++++++ .+|..+.  +++++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~  121 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD  121 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence            457899999998 7787665  7899999999999988889999999999999999999988788999999999999999


Q ss_pred             ccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCch-hhcCCCchhhhhccCCcCCC
Q 002085          179 NEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE-AMSNLSSLEILALNGNHLEG  257 (969)
Q Consensus       179 N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~  257 (969)
                      |+|++..+..|..+++|++|+|++|.+.  ...+..|..+++|++|+|++|+..+.++. .|.++++|++|+|++|+++ 
T Consensus       122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-  198 (440)
T 3zyj_A          122 NRLTTIPNGAFVYLSKLKELWLRNNPIE--SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-  198 (440)
T ss_dssp             SCCSSCCTTTSCSCSSCCEEECCSCCCC--EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-
T ss_pred             CcCCeeCHhHhhccccCceeeCCCCccc--ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-
Confidence            9999777778999999999999999632  33445677777777777777555554443 5677777777777777776 


Q ss_pred             CCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccc
Q 002085          258 AIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVV  337 (969)
Q Consensus       258 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  337 (969)
                      .+| .+..+++|                       +.|+|++|++++..|..|..+++|+.|+|++|++++         
T Consensus       199 ~~~-~~~~l~~L-----------------------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~---------  245 (440)
T 3zyj_A          199 EIP-NLTPLIKL-----------------------DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV---------  245 (440)
T ss_dssp             SCC-CCTTCSSC-----------------------CEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE---------
T ss_pred             ccc-ccCCCccc-----------------------CEEECCCCccCccChhhhccCccCCEEECCCCceeE---------
Confidence            333 24444444                       444555555555555556666666666666666653         


Q ss_pred             cccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccc
Q 002085          338 AFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTIS  392 (969)
Q Consensus       338 ~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  392 (969)
                              ..+..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus       246 --------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          246 --------IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             --------ECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             --------EChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence                    22334556666666666666666555555555666666666555554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=5e-26  Score=243.95  Aligned_cols=219  Identities=23%  Similarity=0.256  Sum_probs=181.8

Q ss_pred             CCCCCCCcceeeC-CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCC
Q 002085           60 SSPCDWPEITCTF-NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIP  138 (969)
Q Consensus        60 ~~~c~w~gv~C~~-~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  138 (969)
                      .++|.|.|+.|+- ..++.+++++++++. +|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.++...+
T Consensus         2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~   78 (270)
T 2o6q_A            2 EALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA   78 (270)
T ss_dssp             CCCBGGGTCSBEEETTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCT
T ss_pred             CccCCCCCCCCEeCCCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeCh
Confidence            5789999999863 457889999999985 666554  689999999999997777789999999999999999996666


Q ss_pred             CCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCcccccc
Q 002085          139 SDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGML  218 (969)
Q Consensus       139 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l  218 (969)
                      ..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|+.+++|++|+|++|.+.  ...+..|+.+
T Consensus        79 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~--~~~~~~~~~l  156 (270)
T 2o6q_A           79 GIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ--SLPKGVFDKL  156 (270)
T ss_dssp             TTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC--CCCTTTTTTC
T ss_pred             hhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC--ccCHhHccCC
Confidence            67799999999999999999777778899999999999999999888888999999999999999633  3334457888


Q ss_pred             CCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCC
Q 002085          219 KKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEI  283 (969)
Q Consensus       219 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  283 (969)
                      ++|++|+|++|++.+..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|.+....
T Consensus       157 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  221 (270)
T 2o6q_A          157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC  221 (270)
T ss_dssp             TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred             cccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence            88888888888887777777888888888888888888665666777788888888888776543

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.94  E-value=2.1e-28  Score=269.01  Aligned_cols=263  Identities=21%  Similarity=0.192  Sum_probs=141.5

Q ss_pred             EEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCcc
Q 002085          223 TLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNN  301 (969)
Q Consensus       223 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~  301 (969)
                      .++++.+++...++..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+  +..+ +|++|++++|+
T Consensus        14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~   91 (317)
T 3o53_A           14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY   91 (317)
T ss_dssp             EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSE
T ss_pred             EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCc
Confidence            33444444544444455555566666666666665555566666666666666666654433  2222 45555555555


Q ss_pred             ccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCC
Q 002085          302 LTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNL  381 (969)
Q Consensus       302 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  381 (969)
                      +++..     ..++|+.|++++|++++..+                    ..+++|++|++++|++++..|..+..+++|
T Consensus        92 l~~l~-----~~~~L~~L~l~~n~l~~~~~--------------------~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L  146 (317)
T 3o53_A           92 VQELL-----VGPSIETLHAANNNISRVSC--------------------SRGQGKKNIYLANNKITMLRDLDEGCRSRV  146 (317)
T ss_dssp             EEEEE-----ECTTCCEEECCSSCCSEEEE--------------------CCCSSCEEEECCSSCCCSGGGBCTGGGSSE
T ss_pred             ccccc-----CCCCcCEEECCCCccCCcCc--------------------cccCCCCEEECCCCCCCCccchhhhccCCC
Confidence            55322     22566666666666553111                    123456666666666665555555555555


Q ss_pred             CccccCCCccccccCccccccccEEEeeccccCCCccccc-CCcccchhhcccCCccccccCccccCccccchhhccCcc
Q 002085          382 SSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGV-GSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNK  460 (969)
Q Consensus       382 ~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  460 (969)
                      +.|+|++|.+++..                      +..+ ..+++|++|++++|.|++. + ....+++|+.|+|++|+
T Consensus       147 ~~L~Ls~N~l~~~~----------------------~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~  202 (317)
T 3o53_A          147 QYLDLKLNEIDTVN----------------------FAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNK  202 (317)
T ss_dssp             EEEECTTSCCCEEE----------------------GGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSC
T ss_pred             CEEECCCCCCCccc----------------------HHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCc
Confidence            55555555554333                      3333 2344445555555554433 1 12235566666666666


Q ss_pred             cCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCcccc-ccCCCcccccc-ccEEEee-cCcCCCCCC
Q 002085          461 LSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFS-GEIPPEIGQLK-LNTFNLS-SNKLYGNIP  537 (969)
Q Consensus       461 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-g~~p~~~~~l~-L~~l~ls-~N~l~~~~p  537 (969)
                      ++ .+|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..++.++ |+.++++ .+.+.|..|
T Consensus       203 l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          203 LA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             CC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             CC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            66 34444566666666666666665 35556666666666666666666 45555555553 6666666 344555444


Q ss_pred             c
Q 002085          538 D  538 (969)
Q Consensus       538 ~  538 (969)
                      .
T Consensus       281 ~  281 (317)
T 3o53_A          281 E  281 (317)
T ss_dssp             C
T ss_pred             h
Confidence            3

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.94  E-value=1.5e-28  Score=270.21  Aligned_cols=266  Identities=21%  Similarity=0.186  Sum_probs=158.9

Q ss_pred             eEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCC
Q 002085           75 VTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG  154 (969)
Q Consensus        75 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  154 (969)
                      ....+++.+.+...+...+..+++|++|+|++|++++..|..|..+++|++|+|++|.+++..|  +..+++|++|+|++
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence            4444455555544444444455566666666666665555666666666666666666654433  66666666666666


Q ss_pred             CCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccccc
Q 002085          155 NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGE  234 (969)
Q Consensus       155 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  234 (969)
                      |++++..     ..++|++|++++|++++..+..   +++|++|++++|                          ++.+.
T Consensus        90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N--------------------------~l~~~  135 (317)
T 3o53_A           90 NYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANN--------------------------KITML  135 (317)
T ss_dssp             SEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSS--------------------------CCCSG
T ss_pred             Ccccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCC--------------------------CCCCc
Confidence            6665321     2355666666666665433322   344455555444                          45555


Q ss_pred             CchhhcCCCchhhhhccCCcCCCCCCchhh-cCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCc
Q 002085          235 IPEAMSNLSSLEILALNGNHLEGAIPSGLF-LLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKL  313 (969)
Q Consensus       235 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l  313 (969)
                      .+..+..+++|++|+|++|++++..+..+. .+++|++|+|++|++++. +......+|+.|+|++|++++. |..|..+
T Consensus       136 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l  213 (317)
T 3o53_A          136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAFM-GPEFQSA  213 (317)
T ss_dssp             GGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCEE-CGGGGGG
T ss_pred             cchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCCcc-hhhhccc
Confidence            555566666666666666666655555443 456666666666666644 2222233577777777777743 4447777


Q ss_pred             ccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEccccccc-CCCCcccccccCCCccccCCC-cc
Q 002085          314 KNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS-GELPTGLWTTFNLSSLMLSDN-TI  391 (969)
Q Consensus       314 ~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N-~l  391 (969)
                      ++|+.|++++|+++                  .+|..+..+++|+.|++++|++. +.+|..+..+++|+.|++++| .+
T Consensus       214 ~~L~~L~L~~N~l~------------------~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l  275 (317)
T 3o53_A          214 AGVTWISLRNNKLV------------------LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL  275 (317)
T ss_dssp             TTCSEEECTTSCCC------------------EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHH
T ss_pred             CcccEEECcCCccc------------------chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhc
Confidence            77888888887776                  34556667778888888888887 667777777777777777733 34


Q ss_pred             ccccC
Q 002085          392 SGELP  396 (969)
Q Consensus       392 ~~~~~  396 (969)
                      +|..+
T Consensus       276 ~~~~~  280 (317)
T 3o53_A          276 TGQNE  280 (317)
T ss_dssp             HSSSS
T ss_pred             cCCch
Confidence            44333

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=1.7e-30  Score=312.57  Aligned_cols=424  Identities=15%  Similarity=0.157  Sum_probs=251.0

Q ss_pred             CCCCcceeeCCCeEEEEecCCCCCCCCC-ccccCCCcccEEEccCCCCC---CCCCc------------ccCCCCCCCEE
Q 002085           63 CDWPEITCTFNSVTGISLRHKDITQKIP-PIICDLKNLTTIDLSSNSIP---GEFPE------------FLYNCTKLQNL  126 (969)
Q Consensus        63 c~w~gv~C~~~~v~~l~l~~~~l~~~~~-~~~~~l~~L~~L~L~~n~l~---~~~p~------------~~~~l~~L~~L  126 (969)
                      ++|.++..  .....+++.....  ..| ..+..+++|++|+|+++...   +..|.            .+..+++|++|
T Consensus        35 k~W~~~~~--~~~~~l~~~~~~~--~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L  110 (594)
T 2p1m_B           35 KSWYEIER--WCRRKVFIGNCYA--VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEI  110 (594)
T ss_dssp             HHHHHHHH--HHCCEEEESSTTS--SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEE
T ss_pred             HHHHHhhh--hhceEEeeccccc--cCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeE
Confidence            35776622  1233455544322  222 34667888999999987522   11221            13467899999


Q ss_pred             eccCCcCCCCCCCCcc-cCCCCcEEecCCC-CCCCc-CCCcccCcccccceecccccccCcCCcccC----CCCCcceee
Q 002085          127 DLSQNYFVGPIPSDID-RISGLQCIDLGGN-NFSGD-IPRSIGRLSELQTLYLYMNEFNGTFPKEIG----DLSNLEVLG  199 (969)
Q Consensus       127 ~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~L~~L~  199 (969)
                      +|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|+.|+
T Consensus       111 ~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~  190 (594)
T 2p1m_B          111 RLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLN  190 (594)
T ss_dssp             EEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEE
T ss_pred             EeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEE
Confidence            9999998876666665 6899999999998 55532 444455889999999999998876555443    667999999


Q ss_pred             cccCCCC-CCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCC-------cCCCCCCchhhcCcccch
Q 002085          200 LAYNSNF-KPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGN-------HLEGAIPSGLFLLNNLTQ  271 (969)
Q Consensus       200 L~~N~~~-~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-------~l~~~~p~~l~~l~~L~~  271 (969)
                      +++|... ....++..+..+++|++|++++|...+.+|..+.++++|++|+++.+       .+.+ ++..+..+++|+.
T Consensus       191 l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~  269 (594)
T 2p1m_B          191 ISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRC  269 (594)
T ss_dssp             CTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCE
T ss_pred             ecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCccc
Confidence            9988510 01112222455799999999998555558888889999999985544       3443 3446777888888


Q ss_pred             h-hccCcccccCCCCchhh-cccccccccCccccccCC-ccccCcccchhhhhccccCcCcCCcccccccccCcccccCC
Q 002085          272 L-FLYDNILSGEIPSSVEA-LKLTDIDLSMNNLTGSIP-EEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVP  348 (969)
Q Consensus       272 L-~L~~N~l~~~~~~~~~~-~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p  348 (969)
                      | .+.+... ..++..+.. .+|+.|+|++|.+++... ..+..+++|+.|++++| +...                .++
T Consensus       270 Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~----------------~l~  331 (594)
T 2p1m_B          270 LSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDA----------------GLE  331 (594)
T ss_dssp             EECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHH----------------HHH
T ss_pred             ccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHH----------------HHH
Confidence            7 4443322 233333333 368888888888764322 23556788888888877 3311                111


Q ss_pred             CCCCCCccCcEEEccc---------ccccCCCCcccc-cccCCCccccCCCccccccCccc---cccccEEEee--c---
Q 002085          349 KSLGNCRTLRTVQLYS---------NRFSGELPTGLW-TTFNLSSLMLSDNTISGELPSKT---AWNLTRLEIS--N---  410 (969)
Q Consensus       349 ~~l~~l~~L~~L~L~~---------N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~---~~~L~~L~Ls--~---  410 (969)
                      .....+++|+.|++++         |.+++.....+. .+++|+.|+++.|.+++......   .++|+.|+|+  +   
T Consensus       332 ~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~  411 (594)
T 2p1m_B          332 VLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKA  411 (594)
T ss_dssp             HHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTC
T ss_pred             HHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCC
Confidence            1122467778887733         444432222222 25667777666666664433321   3467777776  3   


Q ss_pred             -cccCCCc-----ccccCCcccchhhcccCCccccccCccccC-ccccchhhccCcccCCCCCccc-ccccCCCEEEccC
Q 002085          411 -NRFSGQI-----QRGVGSWKNLIVFKASNNLFSGEIPVELTS-LSHLNTLLLDGNKLSGKLPSQI-VSWTSLNNLNLAR  482 (969)
Q Consensus       411 -N~l~~~~-----~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~  482 (969)
                       |.+++..     +..+..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++
T Consensus       412 ~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~  490 (594)
T 2p1m_B          412 PDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRD  490 (594)
T ss_dssp             CCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEES
T ss_pred             cccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcC
Confidence             4444221     11134455566666655 444444444433 5556666666666554333333 4455666666666


Q ss_pred             ccccCCCCc-ccccccccceEeccCcccc
Q 002085          483 NELSGEIPK-AIGSLLVMVSLDLSGNQFS  510 (969)
Q Consensus       483 N~l~~~~p~-~~~~l~~L~~L~ls~N~l~  510 (969)
                      |.+++..+. .+..+++|+.|++++|+++
T Consensus       491 n~~~~~~~~~~~~~l~~L~~L~l~~~~~~  519 (594)
T 2p1m_B          491 CPFGDKALLANASKLETMRSLWMSSCSVS  519 (594)
T ss_dssp             CSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred             CCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence            665433222 2234556666666666554

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.92  E-value=5.5e-27  Score=272.78  Aligned_cols=235  Identities=23%  Similarity=0.190  Sum_probs=150.2

Q ss_pred             CcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceec
Q 002085           97 KNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYL  176 (969)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  176 (969)
                      ++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|  |..+++|++|+|++|.|++..     ..++|++|+|
T Consensus        34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L  106 (487)
T 3oja_A           34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHA  106 (487)
T ss_dssp             GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEEC
T ss_pred             CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEEC
Confidence            367777777777776666677777777777777777765544  667777777777777766322     2256666666


Q ss_pred             ccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCC
Q 002085          177 YMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLE  256 (969)
Q Consensus       177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  256 (969)
                      ++|.|++..+.   .+++|+.|+|++|                          ++.+..|..|+++++|+.|+|++|.++
T Consensus       107 ~~N~l~~~~~~---~l~~L~~L~L~~N--------------------------~l~~~~~~~~~~l~~L~~L~Ls~N~l~  157 (487)
T 3oja_A          107 ANNNISRVSCS---RGQGKKNIYLANN--------------------------KITMLRDLDEGCRSRVQYLDLKLNEID  157 (487)
T ss_dssp             CSSCCCCEEEC---CCSSCEEEECCSS--------------------------CCCSGGGBCGGGGSSEEEEECTTSCCC
T ss_pred             cCCcCCCCCcc---ccCCCCEEECCCC--------------------------CCCCCCchhhcCCCCCCEEECCCCCCC
Confidence            66666654432   2344555555554                          455555555666666666666666666


Q ss_pred             CCCCchhh-cCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccc
Q 002085          257 GAIPSGLF-LLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIG  335 (969)
Q Consensus       257 ~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  335 (969)
                      +..|..+. .+++|++|+|++|.|++..+ .....+|+.|+|++|.+++.. ..|..+++|+.|+|++|.++        
T Consensus       158 ~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~--------  227 (487)
T 3oja_A          158 TVNFAELAASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLV--------  227 (487)
T ss_dssp             EEEGGGGGGGTTTCCEEECTTSCCCEEEC-CCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCC--------
T ss_pred             CcChHHHhhhCCcccEEecCCCccccccc-cccCCCCCEEECCCCCCCCCC-HhHcCCCCccEEEecCCcCc--------
Confidence            65555554 46666666666666664422 222335677777777777543 34777777888888887776        


Q ss_pred             cccccCcccccCCCCCCCCccCcEEEccccccc-CCCCcccccccCCCccccC
Q 002085          336 VVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS-GELPTGLWTTFNLSSLMLS  387 (969)
Q Consensus       336 ~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls  387 (969)
                                .+|..+..+++|+.|++++|++. +.+|..+..++.|+.++++
T Consensus       228 ----------~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          228 ----------LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             ----------EECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             ----------ccchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence                      34555667778888888888876 5666677777777666664

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=2.6e-25  Score=239.42  Aligned_cols=219  Identities=23%  Similarity=0.220  Sum_probs=152.4

Q ss_pred             CCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCc
Q 002085           89 IPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRL  168 (969)
Q Consensus        89 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l  168 (969)
                      +|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++
T Consensus        22 ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l   99 (276)
T 2z62_A           22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL   99 (276)
T ss_dssp             CCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC
T ss_pred             cCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCC
Confidence            444442  478999999999987777789999999999999999987777788999999999999999987777888899


Q ss_pred             ccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhh
Q 002085          169 SELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEIL  248 (969)
Q Consensus       169 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  248 (969)
                      ++|++|++++|++++..+..++++++|++|++++|.+... .+|..|+.+++|++|++++|++.+..+..|..+++|+.|
T Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l  178 (276)
T 2z62_A          100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF-KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL  178 (276)
T ss_dssp             TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC-CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred             ccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee-cCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcccc
Confidence            9999999999999877776788888888888888853211 134445555555555555555444444444433333310


Q ss_pred             hccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcC
Q 002085          249 ALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSG  328 (969)
Q Consensus       249 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  328 (969)
                      .+                    .|++++|++++..+..+...+|+.|++++|++++..+..|..+++|+.|++++|.+.+
T Consensus       179 ~l--------------------~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          179 NL--------------------SLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             CE--------------------EEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             ce--------------------eeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence            00                    4556666666555555555566666666666665555556667777777777777765


Q ss_pred             cC
Q 002085          329 EV  330 (969)
Q Consensus       329 ~~  330 (969)
                      ..
T Consensus       239 ~c  240 (276)
T 2z62_A          239 SC  240 (276)
T ss_dssp             CT
T ss_pred             cC
Confidence            43

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.92  E-value=1.1e-26  Score=270.11  Aligned_cols=232  Identities=17%  Similarity=0.135  Sum_probs=110.7

Q ss_pred             CCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccC
Q 002085          220 KLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSM  299 (969)
Q Consensus       220 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~  299 (969)
                      +|+.|+|++|++.+..|..|.++++|++|+|++|.+++..|  +..+++|++|+|++|.|++..+.    .+|+.|++++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~----~~L~~L~L~~  108 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG----PSIETLHAAN  108 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC----TTCCEEECCS
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC----CCcCEEECcC
Confidence            44444444445555555555555555555555555554333  45555555555555555432211    2344444444


Q ss_pred             ccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCccccccc
Q 002085          300 NNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTF  379 (969)
Q Consensus       300 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  379 (969)
                      |.+++..+.   .                                         +++|+.|+|++|++++..|..+..++
T Consensus       109 N~l~~~~~~---~-----------------------------------------l~~L~~L~L~~N~l~~~~~~~~~~l~  144 (487)
T 3oja_A          109 NNISRVSCS---R-----------------------------------------GQGKKNIYLANNKITMLRDLDEGCRS  144 (487)
T ss_dssp             SCCCCEEEC---C-----------------------------------------CSSCEEEECCSSCCCSGGGBCGGGGS
T ss_pred             CcCCCCCcc---c-----------------------------------------cCCCCEEECCCCCCCCCCchhhcCCC
Confidence            444433222   1                                         23445555555555544444555555


Q ss_pred             CCCccccCCCccccccCccc---cccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhc
Q 002085          380 NLSSLMLSDNTISGELPSKT---AWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLL  456 (969)
Q Consensus       380 ~L~~L~Ls~N~l~~~~~~~~---~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L  456 (969)
                      +|+.|+|++|.|++..|...   .++|+.|+|++|.|++..+  +..+++|+.|+|++|.|++ +|..+..+++|+.|+|
T Consensus       145 ~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~L  221 (487)
T 3oja_A          145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL  221 (487)
T ss_dssp             SEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEEC
T ss_pred             CCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEe
Confidence            55555555555554444332   1345555555555554311  1224444444444444443 2223444555555555


Q ss_pred             cCcccCCCCCcccccccCCCEEEccCcccc-CCCCcccccccccceEecc
Q 002085          457 DGNKLSGKLPSQIVSWTSLNNLNLARNELS-GEIPKAIGSLLVMVSLDLS  505 (969)
Q Consensus       457 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls  505 (969)
                      ++|+|+ .+|..+..+++|+.|+|++|.+. +.+|..+..++.|+.|+++
T Consensus       222 s~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             TTSCCC-EECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             cCCcCc-ccchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            555555 24444444555555555555554 3344444444444444443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=1.3e-24  Score=230.32  Aligned_cols=192  Identities=21%  Similarity=0.246  Sum_probs=137.5

Q ss_pred             CCCCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCC
Q 002085           61 SPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSD  140 (969)
Q Consensus        61 ~~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  140 (969)
                      +||.|.|++|.. ..+.+++++++++. +|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.|++..|..
T Consensus         3 ~Cp~~~gC~C~~-~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~   78 (251)
T 3m19_A            3 TCETVTGCTCNE-GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV   78 (251)
T ss_dssp             -CHHHHSSEEEG-GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTT
T ss_pred             cCCCCCceEcCC-CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhH
Confidence            688999999963 34568888888873 555544  57888888888888877888888888888888888888877777


Q ss_pred             cccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCC
Q 002085          141 IDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKK  220 (969)
Q Consensus       141 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~  220 (969)
                      |..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+                
T Consensus        79 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~----------------  142 (251)
T 3m19_A           79 FDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQ----------------  142 (251)
T ss_dssp             TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC----------------
T ss_pred             hccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCc----------------
Confidence            8888888888888888887767777888888888888888886666667777777777777775                


Q ss_pred             CcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccC
Q 002085          221 LKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGE  282 (969)
Q Consensus       221 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  282 (969)
                                +.+..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++.
T Consensus       143 ----------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          143 ----------LQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             ----------CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             ----------CCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence                      3333333455555555555555555544444455555555555555555543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.91  E-value=2.6e-24  Score=231.52  Aligned_cols=208  Identities=21%  Similarity=0.210  Sum_probs=178.5

Q ss_pred             CeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecC
Q 002085           74 SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLG  153 (969)
Q Consensus        74 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  153 (969)
                      +++.|+++++++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            58999999999998888899999999999999999998878899999999999999999998888999999999999999


Q ss_pred             CCCCCCcCCCcccCcccccceecccccccCc-CCcccCCCCCcceeecccCCCCCCCCCCccccccCCCc----EEEccC
Q 002085          154 GNNFSGDIPRSIGRLSELQTLYLYMNEFNGT-FPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLK----TLWMTE  228 (969)
Q Consensus       154 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~----~L~L~~  228 (969)
                      +|++++..+..++++++|++|+|++|++++. +|..|+++++|++|++++|++.  ...+..+..+++|+    .|++++
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~l~l~L~ls~  186 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ--SIYCTDLRVLHQMPLLNLSLDLSL  186 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC--EECGGGGHHHHTCTTCCEEEECCS
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC--cCCHHHhhhhhhccccceeeecCC
Confidence            9999987777899999999999999999874 6999999999999999999743  34556777777777    888888


Q ss_pred             CcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCC
Q 002085          229 ANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIP  284 (969)
Q Consensus       229 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  284 (969)
                      |.+.+..+..+... +|++|+|++|++++..+..+..+++|+.|+|++|++++..+
T Consensus       187 n~l~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          187 NPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             SCCCEECTTSSCSC-CEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             CcccccCccccCCC-cccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            88877666655543 78888888888886655566778888888888887775443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.91  E-value=3.8e-28  Score=292.06  Aligned_cols=412  Identities=14%  Similarity=0.103  Sum_probs=288.2

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCC---CCCCCC------------cccCCCCcEEecCCCCCCCcCCCc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFV---GPIPSD------------IDRISGLQCIDLGGNNFSGDIPRS  164 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~------------l~~l~~L~~L~L~~N~l~~~~p~~  164 (969)
                      +.+++++.... .....+..+++|++|+|+++...   +..|..            ...+++|++|+|++|.+++..+..
T Consensus        46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~  124 (594)
T 2p1m_B           46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL  124 (594)
T ss_dssp             CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred             eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence            45666554322 22234677899999999998632   122222            246789999999999998777777


Q ss_pred             cc-Ccccccceecccc-cccCc-CCcccCCCCCcceeecccCCCCCCC--CCCccccccCCCcEEEccCCc--cccc-Cc
Q 002085          165 IG-RLSELQTLYLYMN-EFNGT-FPKEIGDLSNLEVLGLAYNSNFKPA--MIPIEFGMLKKLKTLWMTEAN--LIGE-IP  236 (969)
Q Consensus       165 ~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~~~~~~--~~p~~~~~l~~L~~L~L~~n~--l~~~-~p  236 (969)
                      +. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+...+  .++.....+++|++|++++|.  +... ++
T Consensus       125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~  204 (594)
T 2p1m_B          125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALE  204 (594)
T ss_dssp             HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHH
T ss_pred             HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHH
Confidence            75 7899999999999 55532 4455568999999999999743322  233334577899999999986  2211 22


Q ss_pred             hhhcCCCchhhhhccCC-cCCCCCCchhhcCcccchhhccCc-------ccccCCCCchhhc-ccccc-cccCccccccC
Q 002085          237 EAMSNLSSLEILALNGN-HLEGAIPSGLFLLNNLTQLFLYDN-------ILSGEIPSSVEAL-KLTDI-DLSMNNLTGSI  306 (969)
Q Consensus       237 ~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N-------~l~~~~~~~~~~~-~L~~L-~Ls~N~l~~~~  306 (969)
                      ..+.++++|++|+|++| .+++ +|..+..+++|+.|+++.+       .+.+..+ .+... +|+.| .+.+... +.+
T Consensus       205 ~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~-~l~~~~~L~~Ls~~~~~~~-~~l  281 (594)
T 2p1m_B          205 RLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV-ALSGCKELRCLSGFWDAVP-AYL  281 (594)
T ss_dssp             HHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHH-HHHTCTTCCEEECCBTCCG-GGG
T ss_pred             HHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHH-HHhcCCCcccccCCcccch-hhH
Confidence            23456799999999998 4554 7778888999999985544       3443222 33333 57777 4444333 245


Q ss_pred             CccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCC-CCcccccccCCCccc
Q 002085          307 PEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGE-LPTGLWTTFNLSSLM  385 (969)
Q Consensus       307 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~  385 (969)
                      +..+..+++|+.|++++|.+++..                ++..+.++++|+.|++++| +... ++.....+++|+.|+
T Consensus       282 ~~~~~~~~~L~~L~L~~~~l~~~~----------------l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~  344 (594)
T 2p1m_B          282 PAVYSVCSRLTTLNLSYATVQSYD----------------LVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELR  344 (594)
T ss_dssp             GGGHHHHTTCCEEECTTCCCCHHH----------------HHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEE
T ss_pred             HHHHHhhCCCCEEEccCCCCCHHH----------------HHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEE
Confidence            556667899999999999876321                1222457889999999998 4422 233333578999998


Q ss_pred             cC---------CCccccccCcc---ccccccEEEeeccccCCCcccccC-Ccccchhhccc--C----Ccccc-----cc
Q 002085          386 LS---------DNTISGELPSK---TAWNLTRLEISNNRFSGQIQRGVG-SWKNLIVFKAS--N----NLFSG-----EI  441 (969)
Q Consensus       386 Ls---------~N~l~~~~~~~---~~~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~l~--~----N~l~~-----~~  441 (969)
                      ++         .+.+++.....   ..++|+.|+++.|.+++.....+. .+++|+.|+++  +    |.+++     .+
T Consensus       345 L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~  424 (594)
T 2p1m_B          345 VFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGF  424 (594)
T ss_dssp             EECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHH
T ss_pred             EecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHH
Confidence            83         35555432221   246899999999999877666665 58899999999  4    66662     22


Q ss_pred             CccccCccccchhhccCcccCCCCCccccc-ccCCCEEEccCccccCCCCccc-ccccccceEeccCccccccCCCcc-c
Q 002085          442 PVELTSLSHLNTLLLDGNKLSGKLPSQIVS-WTSLNNLNLARNELSGEIPKAI-GSLLVMVSLDLSGNQFSGEIPPEI-G  518 (969)
Q Consensus       442 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~g~~p~~~-~  518 (969)
                      +..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+..+ .
T Consensus       425 ~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~  503 (594)
T 2p1m_B          425 GAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANAS  503 (594)
T ss_dssp             HHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGG
T ss_pred             HHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHH
Confidence            23367789999999988 777666666665 8899999999999987655555 678999999999999976555433 3


Q ss_pred             ccc-ccEEEeecCcCC
Q 002085          519 QLK-LNTFNLSSNKLY  533 (969)
Q Consensus       519 ~l~-L~~l~ls~N~l~  533 (969)
                      .++ |++|++++|+++
T Consensus       504 ~l~~L~~L~l~~~~~~  519 (594)
T 2p1m_B          504 KLETMRSLWMSSCSVS  519 (594)
T ss_dssp             GGGGSSEEEEESSCCB
T ss_pred             hCCCCCEEeeeCCCCC
Confidence            454 999999999884

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=6.3e-25  Score=257.40  Aligned_cols=188  Identities=18%  Similarity=0.200  Sum_probs=146.1

Q ss_pred             CccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh-----cHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL-----NQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      ...++||+|+||.||+|..  .++.+|+|+.......     .....+.+.+|++++++++||||+++..++.+.+..|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            3467899999999999955  5788999986543221     12234668999999999999999966555567778899


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||++|++|.+++..                     +..++.|++.||+|||++   +|+||||||+||+++.  .+||
T Consensus       417 VmE~~~ggsL~~~l~~---------------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL  470 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYI  470 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEE
T ss_pred             EEECCCCCCHHHHHHH---------------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEE
Confidence            9999999999999874                     347999999999999988   9999999999999999  9999


Q ss_pred             eecccceecccCCCCc-----cccccccCcccCchhhccc--CCCCCccchhhHHHHHHHHHhCCCCC
Q 002085          794 ADFGLAKMLAKQGEPH-----TMSAVAGSFGYFAPEYAYT--TKVNEKIDIYSFGVVLLELVTGKEAN  854 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~  854 (969)
                      +|||+++.........     ......||+.|||||++..  ..|+..+|+|+...-..+-+.++.+|
T Consensus       471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9999999864321111     1235679999999999987  56788899999999998888877665

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.3e-24  Score=233.23  Aligned_cols=187  Identities=19%  Similarity=0.191  Sum_probs=138.9

Q ss_pred             CCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCcc--ccccccEEEeeccccCCCcccccCCcccch
Q 002085          351 LGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSK--TAWNLTRLEISNNRFSGQIQRGVGSWKNLI  428 (969)
Q Consensus       351 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  428 (969)
                      +..+++|++|++++|++++ + ..+..+++|++|+|++|.+++..+..  ..++|++|+|++|++++..+..+..+++|+
T Consensus        59 l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  136 (272)
T 3rfs_A           59 IQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT  136 (272)
T ss_dssp             GGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             cccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence            3445555555555555543 1 24455555555555555555444322  235677777777777777777788888888


Q ss_pred             hhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCcc
Q 002085          429 VFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQ  508 (969)
Q Consensus       429 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~  508 (969)
                      +|++++|.+++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..|+.+++|+.|+|++|+
T Consensus       137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  216 (272)
T 3rfs_A          137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP  216 (272)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence            88888888887777778889999999999999987777778889999999999999998777778899999999999999


Q ss_pred             ccccCCCccccccccEEEeecCcCCCCCCcccccccc
Q 002085          509 FSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAY  545 (969)
Q Consensus       509 l~g~~p~~~~~l~L~~l~ls~N~l~~~~p~~~~~~~~  545 (969)
                      +.+..|      .++.++++.|+++|.+|..+..+..
T Consensus       217 ~~~~~~------~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          217 WDCTCP------GIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             BCCCTT------TTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             ccccCc------HHHHHHHHHHhCCCcccCcccccCC
Confidence            887655      3677788899999999988776553

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.90  E-value=4.9e-24  Score=228.63  Aligned_cols=182  Identities=22%  Similarity=0.229  Sum_probs=95.1

Q ss_pred             cCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccc
Q 002085           94 CDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQT  173 (969)
Q Consensus        94 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  173 (969)
                      ..+++|+.|++++|.++. ++ .+..+++|++|+|++|.+++ + ..+..+++|++|+|++|.+++..+..|+++++|++
T Consensus        38 ~~l~~L~~L~l~~~~i~~-~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  113 (272)
T 3rfs_A           38 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE  113 (272)
T ss_dssp             HHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             ccccceeeeeeCCCCccc-cc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence            344555555555555542 22 35555555555555555553 1 24555555555555555555444444555555555


Q ss_pred             eecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCC
Q 002085          174 LYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGN  253 (969)
Q Consensus       174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N  253 (969)
                      |+|++|++++..+..|+++++|++|++++|++.  ...+..|+.+++|+.|++++|++.+..+..|.++++|++|+|++|
T Consensus       114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (272)
T 3rfs_A          114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ--SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN  191 (272)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC--CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EECCCCcCCccCHHHhccCCCCCEEECCCCccC--ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence            555555555554445555555555555555421  222233444444555555555555444445555555555555555


Q ss_pred             cCCCCCCchhhcCcccchhhccCccccc
Q 002085          254 HLEGAIPSGLFLLNNLTQLFLYDNILSG  281 (969)
Q Consensus       254 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~  281 (969)
                      ++++..+..+..+++|++|+|++|.+.+
T Consensus       192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~  219 (272)
T 3rfs_A          192 QLKSVPDGVFDRLTSLQYIWLHDNPWDC  219 (272)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cCCccCHHHHhCCcCCCEEEccCCCccc
Confidence            5555544445555555555555555443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=2.3e-24  Score=236.01  Aligned_cols=228  Identities=16%  Similarity=0.155  Sum_probs=185.9

Q ss_pred             CcccEEEccCCCCCCCCCc---ccCCCCCCCEEeccCCcCCCCCCCCc--ccCCCCcEEecCCCCCCCcCC----CcccC
Q 002085           97 KNLTTIDLSSNSIPGEFPE---FLYNCTKLQNLDLSQNYFVGPIPSDI--DRISGLQCIDLGGNNFSGDIP----RSIGR  167 (969)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~  167 (969)
                      ..++.|.+.++.++...-.   .+..+++|++|+|++|.+++..|..+  ..+++|++|+|++|.+++..|    ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            3578889988877532111   12345779999999999999999988  999999999999999997665    34567


Q ss_pred             cccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCC--CccccccCCCcEEEccCCccccc--Cch-hhcCC
Q 002085          168 LSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMI--PIEFGMLKKLKTLWMTEANLIGE--IPE-AMSNL  242 (969)
Q Consensus       168 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~--p~~~~~l~~L~~L~L~~n~l~~~--~p~-~~~~l  242 (969)
                      +++|++|+|++|++++..|..|+.+++|++|+|++|++.....+  +..++.+++|++|+|++|++...  .+. .+.++
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l  223 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG  223 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence            99999999999999988889999999999999999974321112  23357899999999999998632  222 35789


Q ss_pred             CchhhhhccCCcCCCCCCchhhcC---cccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhh
Q 002085          243 SSLEILALNGNHLEGAIPSGLFLL---NNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLL  319 (969)
Q Consensus       243 ~~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  319 (969)
                      ++|++|+|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+. .+|+.|+|++|++++. |. +..+++|+.|
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L  299 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-AKLRVLDLSSNRLNRA-PQ-PDELPEVDNL  299 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-SCCSCEECCSCCCCSC-CC-TTSCCCCSCE
T ss_pred             CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-CCCCEEECCCCcCCCC-ch-hhhCCCccEE
Confidence            999999999999998888888776   69999999999999 5566554 5899999999999964 43 7889999999


Q ss_pred             hhccccCcC
Q 002085          320 GLFSNHLSG  328 (969)
Q Consensus       320 ~L~~N~l~~  328 (969)
                      ++++|+++.
T Consensus       300 ~L~~N~l~~  308 (310)
T 4glp_A          300 TLDGNPFLV  308 (310)
T ss_dssp             ECSSTTTSC
T ss_pred             ECcCCCCCC
Confidence            999999874

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=1.9e-23  Score=225.82  Aligned_cols=205  Identities=22%  Similarity=0.188  Sum_probs=182.5

Q ss_pred             cccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCC
Q 002085          309 EFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSD  388 (969)
Q Consensus       309 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  388 (969)
                      .+.++++++.+++++|.++                  .+|..+.  ++++.|+|++|++++..|..+..+++|+.|+|++
T Consensus         5 ~~~~l~~l~~l~~~~~~l~------------------~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~   64 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLT------------------ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR   64 (290)
T ss_dssp             EEECSTTCCEEECTTSCCS------------------SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTT
T ss_pred             cccccCCccEEECCCCCCC------------------cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCC
Confidence            3677889999999999998                  3444443  6899999999999988889999999999999999


Q ss_pred             CccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcc
Q 002085          389 NTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQ  468 (969)
Q Consensus       389 N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  468 (969)
                      |.|++..+....++|++|+|++|+++ .+|..+..+++|++|++++|+|++..|..|..+++|++|+|++|+|++..+..
T Consensus        65 n~l~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~  143 (290)
T 1p9a_G           65 AELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL  143 (290)
T ss_dssp             SCCCEEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT
T ss_pred             CccCcccCCCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhh
Confidence            99998766666689999999999999 67788999999999999999999888889999999999999999999777777


Q ss_pred             cccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecCcCCCC
Q 002085          469 IVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGN  535 (969)
Q Consensus       469 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~  535 (969)
                      |..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+.... |+.++|++|++...
T Consensus       144 ~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          144 LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             TTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             cccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence            899999999999999999666667899999999999999999 7898888774 99999999999754

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.89  E-value=9.3e-23  Score=218.48  Aligned_cols=201  Identities=24%  Similarity=0.258  Sum_probs=144.2

Q ss_pred             cccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecc
Q 002085           98 NLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLY  177 (969)
Q Consensus        98 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  177 (969)
                      +++++++++++++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|+++...+..|.++++|++|+|+
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            5788999999998 5776654  689999999999997777789999999999999999986656667889999999999


Q ss_pred             cccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCC
Q 002085          178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEG  257 (969)
Q Consensus       178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  257 (969)
                      +|++++..+..|.++++|++|++++|++.  ...+..|+.+++|++|+|++|++.+..+..|..+++|++|+|++|++++
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  171 (270)
T 2o6q_A           94 DNKLQALPIGVFDQLVNLAELRLDRNQLK--SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR  171 (270)
T ss_dssp             SSCCCCCCTTTTTTCSSCCEEECCSSCCC--CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCcCCcCCHhHcccccCCCEEECCCCccC--eeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence            99999777777888888888888888632  3344456666677777776666665555556666666666666666665


Q ss_pred             CCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCcccc
Q 002085          258 AIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLT  303 (969)
Q Consensus       258 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~  303 (969)
                      ..+..|..+++|++|+|++|++++..+..+... +|+.|+|++|.+.
T Consensus       172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          172 VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             eChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence            555555566666666666666654444434332 3455555555443

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.89  E-value=5.1e-23  Score=222.45  Aligned_cols=197  Identities=25%  Similarity=0.265  Sum_probs=98.9

Q ss_pred             CeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecC
Q 002085           74 SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLG  153 (969)
Q Consensus        74 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  153 (969)
                      .++.+++++++++. +|+.+.  +++++|+|++|.|++..+..|.++++|++|+|++|.|++..+ . +.+++|++|+|+
T Consensus        11 ~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls   85 (290)
T 1p9a_G           11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLS   85 (290)
T ss_dssp             TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCCEEECC
T ss_pred             CccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCCEEECC
Confidence            45555555555542 333332  455566666666655555555566666666666665553222 1 455556666666


Q ss_pred             CCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccc
Q 002085          154 GNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIG  233 (969)
Q Consensus       154 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~  233 (969)
                      +|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|++.  ...+..|..+++|+.|+|++|++.+
T Consensus        86 ~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~  162 (290)
T 1p9a_G           86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK--TLPPGLLTPTPKLEKLSLANNNLTE  162 (290)
T ss_dssp             SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC--CCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             CCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCC--ccChhhcccccCCCEEECCCCcCCc
Confidence            66555 45555555555666666666555544455555555555555555422  2223334444444444444444443


Q ss_pred             cCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCccc
Q 002085          234 EIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNIL  279 (969)
Q Consensus       234 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  279 (969)
                      ..+..|.++++|++|+|++|+++ .+|..++.+.+|+.|+|++|.+
T Consensus       163 l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~  207 (290)
T 1p9a_G          163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (290)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             cCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence            33333444444444444444444 3344444444444444444443

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=2.7e-25  Score=249.06  Aligned_cols=258  Identities=17%  Similarity=0.189  Sum_probs=206.5

Q ss_pred             EEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCC----cccCCCC-CCCEEeccCCcCCCCCCCCcccC-----CCC
Q 002085           78 ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFP----EFLYNCT-KLQNLDLSQNYFVGPIPSDIDRI-----SGL  147 (969)
Q Consensus        78 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~L  147 (969)
                      ..++++++++.+|..+...++|++|||++|.+++..+    ..|..++ +|++|+|++|.+++..+..|..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            5688899999988888888889999999999997776    7788898 99999999999998878788775     999


Q ss_pred             cEEecCCCCCCCcCCCcccC----c-ccccceecccccccCcCCccc----CCC-CCcceeecccCCCCCCC--CCCccc
Q 002085          148 QCIDLGGNNFSGDIPRSIGR----L-SELQTLYLYMNEFNGTFPKEI----GDL-SNLEVLGLAYNSNFKPA--MIPIEF  215 (969)
Q Consensus       148 ~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~p~~~----~~l-~~L~~L~L~~N~~~~~~--~~p~~~  215 (969)
                      ++|+|++|.+++..+..+..    + ++|++|+|++|++++..+..+    ..+ ++|++|+|++|.+...+  .++..+
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l  162 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL  162 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence            99999999999777665444    4 899999999999997776554    343 69999999999754222  334455


Q ss_pred             cccC-CCcEEEccCCcccccCchhhc----CC-CchhhhhccCCcCCCC----CCchhhc-CcccchhhccCcccccCCC
Q 002085          216 GMLK-KLKTLWMTEANLIGEIPEAMS----NL-SSLEILALNGNHLEGA----IPSGLFL-LNNLTQLFLYDNILSGEIP  284 (969)
Q Consensus       216 ~~l~-~L~~L~L~~n~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~----~p~~l~~-l~~L~~L~L~~N~l~~~~~  284 (969)
                      ..++ +|++|+|++|++.+..+..+.    .+ ++|++|+|++|++++.    ++..+.. .++|++|+|++|.+++..+
T Consensus       163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~  242 (362)
T 3goz_A          163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL  242 (362)
T ss_dssp             HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred             hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence            6665 999999999999988876554    44 6999999999999863    4555555 4599999999999987655


Q ss_pred             Cchhh-----cccccccccCcccccc-------CCccccCcccchhhhhccccCcCcCCcccc
Q 002085          285 SSVEA-----LKLTDIDLSMNNLTGS-------IPEEFGKLKNLQLLGLFSNHLSGEVPASIG  335 (969)
Q Consensus       285 ~~~~~-----~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  335 (969)
                      ..+..     .+|+.|+|++|.+.+.       ++..+..+++|+.|++++|++.+..+..+.
T Consensus       243 ~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~~  305 (362)
T 3goz_A          243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPIS  305 (362)
T ss_dssp             HHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHHH
T ss_pred             HHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHHH
Confidence            44322     2699999999995533       334678899999999999999876554443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=4.9e-23  Score=216.42  Aligned_cols=185  Identities=15%  Similarity=0.157  Sum_probs=128.2

Q ss_pred             CCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCc-CCCCCCCCcccCCCCcEEecCC-CCCCCcCCCcc
Q 002085           88 KIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNY-FVGPIPSDIDRISGLQCIDLGG-NNFSGDIPRSI  165 (969)
Q Consensus        88 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~  165 (969)
                      .+|. +.  ++|++|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|
T Consensus        25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f  101 (239)
T 2xwt_C           25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL  101 (239)
T ss_dssp             SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred             ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence            4555 33  389999999999997777789999999999999997 8866667889999999999998 99987767788


Q ss_pred             cCcccccceecccccccCcCCcccCCCCCcc---eeecccC-CCCCCCCCCccccccCCCc-EEEccCCcccccCchhhc
Q 002085          166 GRLSELQTLYLYMNEFNGTFPKEIGDLSNLE---VLGLAYN-SNFKPAMIPIEFGMLKKLK-TLWMTEANLIGEIPEAMS  240 (969)
Q Consensus       166 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~~~~~~~~p~~~~~l~~L~-~L~L~~n~l~~~~p~~~~  240 (969)
                      .++++|++|+|++|++++ +|. |+.+++|+   +|++++| .+  ....+..|..+++|+ .|++++|++....+..|.
T Consensus       102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l--~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~  177 (239)
T 2xwt_C          102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYM--TSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFN  177 (239)
T ss_dssp             ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTC--CEECTTTTTTTBSSEEEEECCSCCCCEECTTTTT
T ss_pred             CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcch--hhcCcccccchhcceeEEEcCCCCCcccCHhhcC
Confidence            899999999999999985 665 77888777   8888877 42  122233455555555 555555555532222333


Q ss_pred             CCCchhhhhccCCc-CCCCCCchhhcC-cccchhhccCcccc
Q 002085          241 NLSSLEILALNGNH-LEGAIPSGLFLL-NNLTQLFLYDNILS  280 (969)
Q Consensus       241 ~l~~L~~L~L~~N~-l~~~~p~~l~~l-~~L~~L~L~~N~l~  280 (969)
                      . ++|+.|+|++|+ +++..+..|..+ ++|+.|++++|+++
T Consensus       178 ~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~  218 (239)
T 2xwt_C          178 G-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT  218 (239)
T ss_dssp             T-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred             C-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence            3 555555555553 554434444445 55555555555554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.88  E-value=7.8e-25  Score=245.34  Aligned_cols=264  Identities=17%  Similarity=0.171  Sum_probs=208.4

Q ss_pred             EEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCC----CCcccCC-CCcEEecCCCCCCCcCCCcccCc-----cc
Q 002085          101 TIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIP----SDIDRIS-GLQCIDLGGNNFSGDIPRSIGRL-----SE  170 (969)
Q Consensus       101 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~  170 (969)
                      .++|+.|+++|.+|..+...++|++|+|++|.+++..+    ..|..++ +|++|+|++|++++..+..|..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            47899999999999988888889999999999997766    7788888 99999999999998878778776     99


Q ss_pred             ccceecccccccCcCCcccCC----C-CCcceeecccCCCCCCCCCCcc----ccc-cCCCcEEEccCCcccccC----c
Q 002085          171 LQTLYLYMNEFNGTFPKEIGD----L-SNLEVLGLAYNSNFKPAMIPIE----FGM-LKKLKTLWMTEANLIGEI----P  236 (969)
Q Consensus       171 L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~L~~N~~~~~~~~p~~----~~~-l~~L~~L~L~~n~l~~~~----p  236 (969)
                      |++|+|++|++++..+..+..    + ++|++|+|++|++..  ..+..    +.. .++|++|+|++|++....    +
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~--~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~  159 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSS--KSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI  159 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGG--SCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCc--HHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH
Confidence            999999999999877775444    4 899999999997432  22223    334 369999999999998644    4


Q ss_pred             hhhcCCC-chhhhhccCCcCCCCCCchhhc----C-cccchhhccCcccccC----CCCchhh-c-ccccccccCccccc
Q 002085          237 EAMSNLS-SLEILALNGNHLEGAIPSGLFL----L-NNLTQLFLYDNILSGE----IPSSVEA-L-KLTDIDLSMNNLTG  304 (969)
Q Consensus       237 ~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~----l-~~L~~L~L~~N~l~~~----~~~~~~~-~-~L~~L~Ls~N~l~~  304 (969)
                      ..+..++ +|++|+|++|++++..+..+..    . ++|++|+|++|.++..    ++..+.. . +|+.|+|++|.+++
T Consensus       160 ~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~  239 (362)
T 3goz_A          160 QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG  239 (362)
T ss_dssp             HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCC
T ss_pred             HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCc
Confidence            4556665 9999999999999877765554    4 6999999999999863    3444443 2 79999999999987


Q ss_pred             cCC----ccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccc
Q 002085          305 SIP----EEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLW  376 (969)
Q Consensus       305 ~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  376 (969)
                      ..+    ..+..+++|+.|++++|.+.+..+..+.          .++..+.++++|+.||+++|++.+..+..+.
T Consensus       240 ~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~----------~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~~  305 (362)
T 3goz_A          240 PSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCK----------ALGAAFPNIQKIILVDKNGKEIHPSHSIPIS  305 (362)
T ss_dssp             CCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHH----------HHHTTSTTCCEEEEECTTSCBCCGGGCHHHH
T ss_pred             HHHHHHHHHHhcCCCccEEEeccCCccccCHHHHH----------HHHHHhccCCceEEEecCCCcCCCcchHHHH
Confidence            554    3457789999999999997644333222          4456677889999999999999866554443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=3.2e-25  Score=246.22  Aligned_cols=263  Identities=18%  Similarity=0.248  Sum_probs=215.8

Q ss_pred             CCCCCcceeeCCCeEEEEecCCCCCCCCCccccCC--CcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCC-CC
Q 002085           62 PCDWPEITCTFNSVTGISLRHKDITQKIPPIICDL--KNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGP-IP  138 (969)
Q Consensus        62 ~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p  138 (969)
                      |..|.++.|+...++.++++++.+.   +..+..+  ++++.|++++|.+++..+. +..+++|++|+|++|.+++. +|
T Consensus        36 c~~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~  111 (336)
T 2ast_B           36 CKRWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLH  111 (336)
T ss_dssp             CHHHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHH
T ss_pred             HHHHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHH
Confidence            4479999887777899999998876   4567777  8999999999999977665 66899999999999999866 78


Q ss_pred             CCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccc-cccCc-CCcccCCCCCcceeecccC-CCCCCCCCCccc
Q 002085          139 SDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN-EFNGT-FPKEIGDLSNLEVLGLAYN-SNFKPAMIPIEF  215 (969)
Q Consensus       139 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~~~~~~~~p~~~  215 (969)
                      ..+..+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+.. ..++..+
T Consensus       112 ~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~-~~~~~~~  190 (336)
T 2ast_B          112 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE-KHVQVAV  190 (336)
T ss_dssp             HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH-HHHHHHH
T ss_pred             HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh-HHHHHHH
Confidence            88899999999999999999888889999999999999999 68763 6777889999999999999 5321 2256778


Q ss_pred             cccC-CCcEEEccCC--ccc-ccCchhhcCCCchhhhhccCCc-CCCCCCchhhcCcccchhhccCcccccCCCC---ch
Q 002085          216 GMLK-KLKTLWMTEA--NLI-GEIPEAMSNLSSLEILALNGNH-LEGAIPSGLFLLNNLTQLFLYDNILSGEIPS---SV  287 (969)
Q Consensus       216 ~~l~-~L~~L~L~~n--~l~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~---~~  287 (969)
                      ..++ +|++|++++|  ++. +.+|..+.++++|++|+|++|. +++..+..+..+++|++|++++|.  +..+.   .+
T Consensus       191 ~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l  268 (336)
T 2ast_B          191 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLEL  268 (336)
T ss_dssp             HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGG
T ss_pred             HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHH
Confidence            8999 9999999999  555 5678888899999999999999 777778889999999999999996  23333   34


Q ss_pred             hhc-ccccccccCccccccCCccccCc-ccchhhhhccccCcCcCCcccc
Q 002085          288 EAL-KLTDIDLSMNNLTGSIPEEFGKL-KNLQLLGLFSNHLSGEVPASIG  335 (969)
Q Consensus       288 ~~~-~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~  335 (969)
                      ... +|+.|++++| ++   ...+..+ .+|+.|++++|++++..|..++
T Consensus       269 ~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          269 GEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             GGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             hcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence            433 7999999999 43   2344454 3488888999999987776543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=9.8e-23  Score=222.49  Aligned_cols=213  Identities=23%  Similarity=0.305  Sum_probs=120.7

Q ss_pred             CCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhh-cccccccccCccccccCCccccCcccchhhh
Q 002085          242 LSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEA-LKLTDIDLSMNNLTGSIPEEFGKLKNLQLLG  320 (969)
Q Consensus       242 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  320 (969)
                      +..+..+.+..+.+++.+  .+..+++|++|++++|.++. ++. +.. .+|+.|++++|++++..+  +..+++|++|+
T Consensus        18 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~~-~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~   91 (308)
T 1h6u_A           18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (308)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-chh-hhccCCCCEEEccCCcCCCChh--HccCCCCCEEE
Confidence            344556677777776532  24456777777777777763 332 332 256666666666664332  55666666666


Q ss_pred             hccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCcccc
Q 002085          321 LFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTA  400 (969)
Q Consensus       321 L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  400 (969)
                      +++|++++                  ++ .+..+++|+.|++++|++++ ++. +..+++                    
T Consensus        92 L~~n~l~~------------------~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~--------------------  130 (308)
T 1h6u_A           92 LSGNPLKN------------------VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSN--------------------  130 (308)
T ss_dssp             CCSCCCSC------------------CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTT--------------------
T ss_pred             ccCCcCCC------------------ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCC--------------------
Confidence            66665552                  11 24455555666666665553 221 444444                    


Q ss_pred             ccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEc
Q 002085          401 WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNL  480 (969)
Q Consensus       401 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  480 (969)
                        |++|+|++|++++..+  +..+++|+.|++++|.+++..+  +..+++|+.|+|++|++++..+  +..+++|+.|+|
T Consensus       131 --L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L  202 (308)
T 1h6u_A          131 --LQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHL  202 (308)
T ss_dssp             --CCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred             --CCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEc
Confidence              4455555555544333  5555666666666666654322  5666666666666666664322  566666666666


Q ss_pred             cCccccCCCCcccccccccceEeccCccccc
Q 002085          481 ARNELSGEIPKAIGSLLVMVSLDLSGNQFSG  511 (969)
Q Consensus       481 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g  511 (969)
                      ++|++++..  .+..+++|+.|+|++|++++
T Consensus       203 ~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          203 KNNQISDVS--PLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             TTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred             cCCccCccc--cccCCCCCCEEEccCCeeec
Confidence            666666433  26666666666666666663

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=7.8e-23  Score=239.32  Aligned_cols=206  Identities=20%  Similarity=0.351  Sum_probs=163.0

Q ss_pred             CCCCCCCCCC-----CCCcc-eeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEe
Q 002085           54 QSWTSTSSPC-----DWPEI-TCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLD  127 (969)
Q Consensus        54 ~sw~~~~~~c-----~w~gv-~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  127 (969)
                      .+|..+.++|     .|.|+ .|..++++.|+|+++++++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|+
T Consensus        34 ~~W~~~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~  106 (571)
T 3cvr_A           34 DKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLD  106 (571)
T ss_dssp             HHHHTTCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEE
T ss_pred             HHHhccCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEE
Confidence            4576666778     69999 7987889999999999987 777663  88999999999999 677   5579999999


Q ss_pred             ccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCC
Q 002085          128 LSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFK  207 (969)
Q Consensus       128 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~  207 (969)
                      |++|+|++ +|. +..  +|++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|++|+|++|++..
T Consensus       107 Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~  174 (571)
T 3cvr_A          107 ACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF  174 (571)
T ss_dssp             CCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred             ccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC
Confidence            99999996 777 665  99999999999996 676   68899999999999996 665   57899999999996433


Q ss_pred             CCCCCccccccCCCcEEEccCCcccccCchhhcCCCch-------hhhhccCCcCCCCCCchhhcCcccchhhccCcccc
Q 002085          208 PAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSL-------EILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILS  280 (969)
Q Consensus       208 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  280 (969)
                         +|. |.  ++|+.|+|++|++. .+|. |..  +|       +.|+|++|+|+ .+|..++.+++|+.|+|++|+++
T Consensus       175 ---lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~  243 (571)
T 3cvr_A          175 ---LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS  243 (571)
T ss_dssp             ---CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCC
T ss_pred             ---cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCC
Confidence               555 55  78888888888777 5555 544  66       77888888887 56777777777777777777777


Q ss_pred             cCCCCchhh
Q 002085          281 GEIPSSVEA  289 (969)
Q Consensus       281 ~~~~~~~~~  289 (969)
                      +.+|..+..
T Consensus       244 ~~~p~~l~~  252 (571)
T 3cvr_A          244 SRIRESLSQ  252 (571)
T ss_dssp             HHHHHHHHH
T ss_pred             CcCHHHHHH
Confidence            766665544

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.87  E-value=7.5e-23  Score=223.98  Aligned_cols=227  Identities=17%  Similarity=0.161  Sum_probs=182.9

Q ss_pred             CeEEEEecCCCCCCCCCc---cccCCCcccEEEccCCCCCCCCCccc--CCCCCCCEEeccCCcCCCCCC----CCcccC
Q 002085           74 SVTGISLRHKDITQKIPP---IICDLKNLTTIDLSSNSIPGEFPEFL--YNCTKLQNLDLSQNYFVGPIP----SDIDRI  144 (969)
Q Consensus        74 ~v~~l~l~~~~l~~~~~~---~~~~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~l~~l  144 (969)
                      .++.+.+.+..+....-.   .+..+++|++|+|++|.+++..|..+  ..+++|++|+|++|.+++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            356666666665432111   12235679999999999999999988  999999999999999997665    344679


Q ss_pred             CCCcEEecCCCCCCCcCCCcccCcccccceecccccccCc--C--CcccCCCCCcceeecccCCCCCCCCCCcc-ccccC
Q 002085          145 SGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGT--F--PKEIGDLSNLEVLGLAYNSNFKPAMIPIE-FGMLK  219 (969)
Q Consensus       145 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~~~~~~~~p~~-~~~l~  219 (969)
                      ++|++|+|++|++++..|..|+++++|++|+|++|++.+.  +  +..++.+++|++|+|++|++......+.. ++.++
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~  224 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGV  224 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTC
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCC
Confidence            9999999999999988889999999999999999998752  2  23457899999999999975432222222 57889


Q ss_pred             CCcEEEccCCcccccCchhhcCC---CchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhccccccc
Q 002085          220 KLKTLWMTEANLIGEIPEAMSNL---SSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDID  296 (969)
Q Consensus       220 ~L~~L~L~~n~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~  296 (969)
                      +|++|+|++|++.+..|..+..+   ++|++|+|++|+++ .+|..+.  ++|++|+|++|+|++. |......+|+.|+
T Consensus       225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~  300 (310)
T 4glp_A          225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLT  300 (310)
T ss_dssp             CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEE
T ss_pred             CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEE
Confidence            99999999999999988888777   69999999999999 6787775  8999999999999964 3322234799999


Q ss_pred             ccCccccc
Q 002085          297 LSMNNLTG  304 (969)
Q Consensus       297 Ls~N~l~~  304 (969)
                      |++|+++.
T Consensus       301 L~~N~l~~  308 (310)
T 4glp_A          301 LDGNPFLV  308 (310)
T ss_dssp             CSSTTTSC
T ss_pred             CcCCCCCC
Confidence            99999974

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=1.3e-21  Score=200.64  Aligned_cols=186  Identities=19%  Similarity=0.216  Sum_probs=146.1

Q ss_pred             CCCCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCC
Q 002085           61 SPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSD  140 (969)
Q Consensus        61 ~~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  140 (969)
                      ..|.|.+|.|+...++.           +|..+  .++|++|+|++|++++..+..|..+++|++|+|++|++++..+..
T Consensus         5 C~C~~~~v~c~~~~l~~-----------~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~   71 (208)
T 2o6s_A            5 CSCSGTTVECYSQGRTS-----------VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV   71 (208)
T ss_dssp             CEEETTEEECCSSCCSS-----------CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred             CEECCCEEEecCCCccC-----------CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhh
Confidence            34789999997544332           33333  358999999999999777778899999999999999999777777


Q ss_pred             cccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCC
Q 002085          141 IDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKK  220 (969)
Q Consensus       141 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~  220 (969)
                      |..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|++.  ...+..|..+++
T Consensus        72 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~  149 (208)
T 2o6s_A           72 FNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK--SVPDGVFDRLTS  149 (208)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS--CCCTTTTTTCTT
T ss_pred             cCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc--eeCHHHhccCCC
Confidence            899999999999999999776677899999999999999999777777899999999999998633  333444777777


Q ss_pred             CcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcc
Q 002085          221 LKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNN  268 (969)
Q Consensus       221 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  268 (969)
                      |+.|++++|.+.+       .+++|++|+++.|+++|.+|..++.++.
T Consensus       150 L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          150 LQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             ccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            8888887776654       3456777777777777777776665443

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.87  E-value=8e-25  Score=247.79  Aligned_cols=251  Identities=22%  Similarity=0.276  Sum_probs=178.5

Q ss_pred             CCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhcccc---CcCcCCccc
Q 002085          258 AIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNH---LSGEVPASI  334 (969)
Q Consensus       258 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~---l~~~~p~~~  334 (969)
                      .++..+..+++|++|+|++|+++...+..                   ++..+..+++|+.|+|++|.   +++.+|..+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~-------------------l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~   83 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARW-------------------LSENIASKKDLEIAEFSDIFTGRVKDEIPEAL   83 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHH-------------------HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHH
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHH-------------------HHHHHHhCCCccEEeCcccccCccccchhHHH
Confidence            34555555666666666666555332221                   22335566677777776643   333444333


Q ss_pred             ccccccCcccccCCCCCCCCccCcEEEcccccccC----CCCcccccccCCCccccCCCccccccCcccc----------
Q 002085          335 GVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSG----ELPTGLWTTFNLSSLMLSDNTISGELPSKTA----------  400 (969)
Q Consensus       335 ~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----------  400 (969)
                      .          .+...+..+++|++|+|++|++++    .+|..+..+++|+.|+|++|.+++..+....          
T Consensus        84 ~----------~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~  153 (386)
T 2ca6_A           84 R----------LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK  153 (386)
T ss_dssp             H----------HHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             H----------HHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhh
Confidence            2          122334667888888888888876    3666777788888888888888643332211          


Q ss_pred             -----ccccEEEeeccccC-CCcc---cccCCcccchhhcccCCccc--c---ccCccccCccccchhhccCcccC----
Q 002085          401 -----WNLTRLEISNNRFS-GQIQ---RGVGSWKNLIVFKASNNLFS--G---EIPVELTSLSHLNTLLLDGNKLS----  462 (969)
Q Consensus       401 -----~~L~~L~Ls~N~l~-~~~~---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----  462 (969)
                           ++|++|+|++|+++ +.++   ..+..+++|++|++++|.|+  |   ..|..+..+++|+.|+|++|+++    
T Consensus       154 ~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~  233 (386)
T 2ca6_A          154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS  233 (386)
T ss_dssp             HHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHH
T ss_pred             hcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHH
Confidence                 58899999999987 4444   45667888999999999987  3   34557888999999999999996    


Q ss_pred             CCCCcccccccCCCEEEccCccccCC----CCccc--ccccccceEeccCccccc----cCCCcc-ccc-cccEEEeecC
Q 002085          463 GKLPSQIVSWTSLNNLNLARNELSGE----IPKAI--GSLLVMVSLDLSGNQFSG----EIPPEI-GQL-KLNTFNLSSN  530 (969)
Q Consensus       463 ~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~ls~N~l~g----~~p~~~-~~l-~L~~l~ls~N  530 (969)
                      +.+|..+..+++|+.|+|++|+|++.    +|..+  +.+++|+.|+|++|++++    .+|..+ ..+ .|++|++++|
T Consensus       234 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N  313 (386)
T 2ca6_A          234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN  313 (386)
T ss_dssp             HHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTS
T ss_pred             HHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCC
Confidence            57788888999999999999999865    56666  348999999999999997    588877 555 4999999999


Q ss_pred             cCCCCCC
Q 002085          531 KLYGNIP  537 (969)
Q Consensus       531 ~l~~~~p  537 (969)
                      ++++..|
T Consensus       314 ~l~~~~~  320 (386)
T 2ca6_A          314 RFSEEDD  320 (386)
T ss_dssp             BSCTTSH
T ss_pred             cCCcchh
Confidence            9987654

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.87  E-value=2.9e-22  Score=210.44  Aligned_cols=197  Identities=15%  Similarity=0.167  Sum_probs=172.3

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCC-CCCCCCcccCCCCCCCEEeccC-CcCCCCCCCCcccCCCCcEE
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNS-IPGEFPEFLYNCTKLQNLDLSQ-NYFVGPIPSDIDRISGLQCI  150 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L  150 (969)
                      ..++.|+++++++++..+..|.++++|++|+|++|. +++..+..|.++++|++|+|++ |++++..+..|..+++|++|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            469999999999998888899999999999999997 8866677899999999999999 99997777899999999999


Q ss_pred             ecCCCCCCCcCCCcccCccccc---ceecccc-cccCcCCcccCCCCCcc-eeecccCCCCCCCCCCccccccCCCcEEE
Q 002085          151 DLGGNNFSGDIPRSIGRLSELQ---TLYLYMN-EFNGTFPKEIGDLSNLE-VLGLAYNSNFKPAMIPIEFGMLKKLKTLW  225 (969)
Q Consensus       151 ~L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~~~~~~~~p~~~~~l~~L~~L~  225 (969)
                      +|++|++++ +|. |+.+++|+   +|++++| ++++..+..|.++++|+ +|++++|++.   .+|......++|++|+
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~---~i~~~~~~~~~L~~L~  185 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT---SVQGYAFNGTKLDAVY  185 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC---EECTTTTTTCEEEEEE
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc---ccCHhhcCCCCCCEEE
Confidence            999999995 776 88899998   9999999 99988788899999999 9999999643   4555443448999999


Q ss_pred             ccCCc-ccccCchhhcCC-CchhhhhccCCcCCCCCCchhhcCcccchhhccCc
Q 002085          226 MTEAN-LIGEIPEAMSNL-SSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDN  277 (969)
Q Consensus       226 L~~n~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  277 (969)
                      +++|. +.+..+..|.++ ++|+.|+|++|++++. |..  .+++|+.|+++++
T Consensus       186 L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT  236 (239)
T ss_dssp             CTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred             cCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence            99994 887778889999 9999999999999954 543  5678888888765

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=5.6e-22  Score=220.90  Aligned_cols=236  Identities=19%  Similarity=0.152  Sum_probs=152.7

Q ss_pred             cCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCC-CCcccCCCCcE-EecCCCCCC
Q 002085           81 RHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIP-SDIDRISGLQC-IDLGGNNFS  158 (969)
Q Consensus        81 ~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~-L~L~~N~l~  158 (969)
                      ++++++ .+|..+  .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| ..|.++++|+. ++++.|+|+
T Consensus        17 ~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~   93 (350)
T 4ay9_X           17 QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL   93 (350)
T ss_dssp             ESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCC
T ss_pred             cCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCccc
Confidence            344444 355544  3578999999999985555678999999999999999876665 46788888765 666778888


Q ss_pred             CcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchh
Q 002085          159 GDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEA  238 (969)
Q Consensus       159 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~  238 (969)
                      ...|..|.++++|++|++++|++++..+..+....++..|++.++.                         ++....+..
T Consensus        94 ~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~-------------------------~i~~l~~~~  148 (350)
T 4ay9_X           94 YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI-------------------------NIHTIERNS  148 (350)
T ss_dssp             EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCT-------------------------TCCEECTTS
T ss_pred             ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccc-------------------------ccccccccc
Confidence            7778888899999999999999887666667777777777776542                         122222233


Q ss_pred             hcCCC-chhhhhccCCcCCCCCCchhhcCcccchhhccC-cccccCCCCchhhc-ccccccccCccccccCCccccCccc
Q 002085          239 MSNLS-SLEILALNGNHLEGAIPSGLFLLNNLTQLFLYD-NILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKN  315 (969)
Q Consensus       239 ~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~  315 (969)
                      |..+. .++.|+|++|+|+ .+|...+...+|+.|++++ |.++...+..|..+ +|+.|||++|+|+...+..|.++++
T Consensus       149 f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~  227 (350)
T 4ay9_X          149 FVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK  227 (350)
T ss_dssp             STTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCE
T ss_pred             hhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchH
Confidence            44433 3555666666666 3344444455566666653 44443334444444 5666666666666555555666666


Q ss_pred             chhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEccccc
Q 002085          316 LQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNR  366 (969)
Q Consensus       316 L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~  366 (969)
                      |+.+++.  .+.                  .+| .+.++++|+.++++++.
T Consensus       228 L~~l~~~--~l~------------------~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          228 LRARSTY--NLK------------------KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             EECTTCT--TCC------------------CCC-CTTTCCSCCEEECSCHH
T ss_pred             hhhccCC--CcC------------------cCC-CchhCcChhhCcCCCCc
Confidence            6655542  222                  333 25567777777776554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.86  E-value=5.7e-22  Score=209.82  Aligned_cols=159  Identities=21%  Similarity=0.187  Sum_probs=85.5

Q ss_pred             ccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccC
Q 002085          355 RTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASN  434 (969)
Q Consensus       355 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~  434 (969)
                      ++++.|+|++|++++..+..+..+++|+.|+|++|.|+                      +..+..|..+++|++|++++
T Consensus        35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~----------------------~~~~~~~~~l~~L~~L~L~~   92 (251)
T 3m19_A           35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ----------------------TLSAGVFDDLTELGTLGLAN   92 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC----------------------CCCTTTTTTCTTCCEEECTT
T ss_pred             CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCC----------------------ccCHhHhccCCcCCEEECCC
Confidence            35566666666666555555555555555555555554                      44444455555555555555


Q ss_pred             CccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCC
Q 002085          435 NLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIP  514 (969)
Q Consensus       435 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p  514 (969)
                      |+|++..+..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++..+..|+.+++|+.|||++|+|++..|
T Consensus        93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  172 (251)
T 3m19_A           93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH  172 (251)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence            55554444455555555555555555554444444555555555555555554444455555555555555555554444


Q ss_pred             Ccccccc-ccEEEeecCcCCCC
Q 002085          515 PEIGQLK-LNTFNLSSNKLYGN  535 (969)
Q Consensus       515 ~~~~~l~-L~~l~ls~N~l~~~  535 (969)
                      ..+..++ |++|+|++|++.+.
T Consensus       173 ~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          173 GAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTTTCTTCCEEECCSCCBCTT
T ss_pred             HHHhCCCCCCEEEeeCCceeCC
Confidence            4454443 55555555555554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.86  E-value=1.2e-23  Score=233.41  Aligned_cols=256  Identities=20%  Similarity=0.238  Sum_probs=162.4

Q ss_pred             cccEEEccCCCCCCCCCcccCCC--CCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCc-CCCcccCcccccce
Q 002085           98 NLTTIDLSSNSIPGEFPEFLYNC--TKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGD-IPRSIGRLSELQTL  174 (969)
Q Consensus        98 ~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L  174 (969)
                      .++.||+++|.+.   +..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L  123 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL  123 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence            3778999988876   5666777  8889999999988876655 56788899999999888765 77778888889999


Q ss_pred             ecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCC-ccccc-CchhhcCCC-chhhhhcc
Q 002085          175 YLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEA-NLIGE-IPEAMSNLS-SLEILALN  251 (969)
Q Consensus       175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~-~L~~L~L~  251 (969)
                      +|++|++++..+..++.+++|++|++++|.......++..+..+++|++|++++| ++.+. ++..+..++ +|++|+|+
T Consensus       124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~  203 (336)
T 2ast_B          124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS  203 (336)
T ss_dssp             ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred             eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence            9988888877888888888888888888731111124444566666666666666 55543 455555666 66666666


Q ss_pred             CC--cCC-CCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcC
Q 002085          252 GN--HLE-GAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSG  328 (969)
Q Consensus       252 ~N--~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  328 (969)
                      +|  .++ +.+|..+..+++|++|++++|.+                      +++..+..+..+++|+.|++++|.  +
T Consensus       204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~----------------------l~~~~~~~l~~l~~L~~L~l~~~~--~  259 (336)
T 2ast_B          204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM----------------------LKNDCFQEFFQLNYLQHLSLSRCY--D  259 (336)
T ss_dssp             SCGGGSCHHHHHHHHHHCTTCSEEECTTCTT----------------------CCGGGGGGGGGCTTCCEEECTTCT--T
T ss_pred             CCcccCCHHHHHHHHhhCCCCCEEeCCCCCc----------------------CCHHHHHHHhCCCCCCEeeCCCCC--C
Confidence            66  333 23344444455555555555441                      344444455556666666666664  1


Q ss_pred             cCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCccccccc-CCCccccCCCccccccCccc
Q 002085          329 EVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTF-NLSSLMLSDNTISGELPSKT  399 (969)
Q Consensus       329 ~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~  399 (969)
                      ..+..+              ..++++++|+.|++++| ++   ...+..+. .+..|+++.|++++..|...
T Consensus       260 ~~~~~~--------------~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~  313 (336)
T 2ast_B          260 IIPETL--------------LELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTI  313 (336)
T ss_dssp             CCGGGG--------------GGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred             CCHHHH--------------HHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcc
Confidence            111110              13445666777777766 32   12333332 36666677777776666543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.85  E-value=2.7e-24  Score=243.43  Aligned_cols=242  Identities=21%  Similarity=0.265  Sum_probs=174.8

Q ss_pred             CCccccCCCcccEEEccCCCCCCC----CCcccCCCCCCCEEeccCC---cCCCCCCCCc-------ccCCCCcEEecCC
Q 002085           89 IPPIICDLKNLTTIDLSSNSIPGE----FPEFLYNCTKLQNLDLSQN---YFVGPIPSDI-------DRISGLQCIDLGG  154 (969)
Q Consensus        89 ~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~~~p~~l-------~~l~~L~~L~L~~  154 (969)
                      ++..+..+++|++|+|++|.+++.    ++..|..+++|++|+|++|   ++++.+|..+       ..+++|++|+|++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            556677778888888888888765    3344667888888888875   4444555544       6778888888888


Q ss_pred             CCCCC----cCCCcccCcccccceecccccccCcCCcccCC----C---------CCcceeecccCCCCCCCCCC---cc
Q 002085          155 NNFSG----DIPRSIGRLSELQTLYLYMNEFNGTFPKEIGD----L---------SNLEVLGLAYNSNFKPAMIP---IE  214 (969)
Q Consensus       155 N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~----l---------~~L~~L~L~~N~~~~~~~~p---~~  214 (969)
                      |.+++    .+|..+..+++|++|+|++|.+++..+..+..    +         ++|++|+|++|++.. ..+|   ..
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~l~~~  182 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN-GSMKEWAKT  182 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG-GGHHHHHHH
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc-HHHHHHHHH
Confidence            88876    46667778888888888888886544433333    3         788888888886431 2233   45


Q ss_pred             ccccCCCcEEEccCCcccc-----cCchhhcCCCchhhhhccCCcCC----CCCCchhhcCcccchhhccCcccccC---
Q 002085          215 FGMLKKLKTLWMTEANLIG-----EIPEAMSNLSSLEILALNGNHLE----GAIPSGLFLLNNLTQLFLYDNILSGE---  282 (969)
Q Consensus       215 ~~~l~~L~~L~L~~n~l~~-----~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~L~~N~l~~~---  282 (969)
                      +..+++|++|+|++|++..     ..|..+..+++|+.|+|++|.++    +.+|..+..+++|++|+|++|++++.   
T Consensus       183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~  262 (386)
T 2ca6_A          183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA  262 (386)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred             HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence            6778888888888888763     34447788888888888888885    46677778888888888888888765   


Q ss_pred             -CCCchhh---cccccccccCccccc----cCCccc-cCcccchhhhhccccCcCcCC
Q 002085          283 -IPSSVEA---LKLTDIDLSMNNLTG----SIPEEF-GKLKNLQLLGLFSNHLSGEVP  331 (969)
Q Consensus       283 -~~~~~~~---~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~~p  331 (969)
                       ++..+..   .+|+.|+|++|.+++    .+|..+ .++++|+.|++++|++++..+
T Consensus       263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence             3444432   368888888888887    467666 668899999999999886543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=8e-22  Score=211.58  Aligned_cols=148  Identities=15%  Similarity=0.054  Sum_probs=116.9

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH---------------HHHHHHHHHHHHHhccccCceeeE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ---------------KLEKEFIAEIEILGTIRHANIVKL  701 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~niv~l  701 (969)
                      -|...+.||+|+||.||+|.+ .+|+.||||+++.......               .....+.+|++++++++|   +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence            355669999999999999999 7899999999854321110               245679999999999984   444


Q ss_pred             EEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCC
Q 002085          702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSS  781 (969)
Q Consensus       702 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~  781 (969)
                      .+++.. +..|+||||++|++|.+ +..                   .....++.|++.||+|||+.   +|+||||||+
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------------------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~  222 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------------------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQY  222 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC-------------------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch-------------------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHH
Confidence            444433 56799999999999988 421                   12447999999999999988   9999999999


Q ss_pred             cEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhccc
Q 002085          782 NILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT  828 (969)
Q Consensus       782 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  828 (969)
                      ||+++ ++.+||+|||+|+..               ..|+|||++.+
T Consensus       223 NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~r  253 (282)
T 1zar_A          223 NVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILER  253 (282)
T ss_dssp             SEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHHH
T ss_pred             HEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHHH
Confidence            99999 999999999998642               34789998754

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.85  E-value=8.3e-22  Score=215.14  Aligned_cols=175  Identities=19%  Similarity=0.267  Sum_probs=132.2

Q ss_pred             CCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhh
Q 002085          351 LGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVF  430 (969)
Q Consensus       351 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  430 (969)
                      +..+++|++|+|++|++++. +. +..+++|+.|+|++|++++........+|++|+|++|++++..+  +..+++|++|
T Consensus        59 ~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L  134 (308)
T 1h6u_A           59 VQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVL  134 (308)
T ss_dssp             GGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEE
T ss_pred             hhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCCchhhcCCCCCCEEECCCCCCCCchh--hcCCCCCCEE
Confidence            44455555555555555532 22 55555666666666665543222234567788888888876533  8899999999


Q ss_pred             cccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCcccc
Q 002085          431 KASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFS  510 (969)
Q Consensus       431 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  510 (969)
                      ++++|.+++..+  +..+++|+.|+|++|++++ ++. +..+++|+.|+|++|++++. +. +..+++|+.|+|++|+++
T Consensus       135 ~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~L~~N~l~  208 (308)
T 1h6u_A          135 YLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDI-SP-LASLPNLIEVHLKNNQIS  208 (308)
T ss_dssp             ECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECTTSCCC
T ss_pred             ECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcC-hh-hcCCCCCCEEEccCCccC
Confidence            999999996544  8899999999999999996 444 89999999999999999964 43 899999999999999999


Q ss_pred             ccCCCcccccc-ccEEEeecCcCCCCCCc
Q 002085          511 GEIPPEIGQLK-LNTFNLSSNKLYGNIPD  538 (969)
Q Consensus       511 g~~p~~~~~l~-L~~l~ls~N~l~~~~p~  538 (969)
                      +..  .+..++ |+.|++++|++++ .|.
T Consensus       209 ~~~--~l~~l~~L~~L~l~~N~i~~-~~~  234 (308)
T 1h6u_A          209 DVS--PLANTSNLFIVTLTNQTITN-QPV  234 (308)
T ss_dssp             BCG--GGTTCTTCCEEEEEEEEEEC-CCE
T ss_pred             ccc--cccCCCCCCEEEccCCeeec-CCe
Confidence            644  377775 9999999999985 443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=1.5e-21  Score=228.49  Aligned_cols=187  Identities=25%  Similarity=0.346  Sum_probs=107.7

Q ss_pred             ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCC
Q 002085          291 KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGE  370 (969)
Q Consensus       291 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  370 (969)
                      +++.|+|++|.+++ +|..+.  ++|+.|+|++|+|+                  .+|   ..+++|++|+|++|+|++ 
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~------------------~ip---~~l~~L~~L~Ls~N~l~~-  114 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI------------------SLP---ELPASLEYLDACDNRLST-  114 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS------------------CCC---CCCTTCCEEECCSSCCSC-
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc------------------ccc---cccCCCCEEEccCCCCCC-
Confidence            34455555555553 333331  45555555555555                  222   124556666666666664 


Q ss_pred             CCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccc
Q 002085          371 LPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSH  450 (969)
Q Consensus       371 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  450 (969)
                      +|. +..  +|+.|+|++|+|++ +|. ..++|+.|+|++|+|++ +|.   .+++|++|++++|.|++ +|. |.  ++
T Consensus       115 ip~-l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~  181 (571)
T 3cvr_A          115 LPE-LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ES  181 (571)
T ss_dssp             CCC-CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TT
T ss_pred             cch-hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CC
Confidence            444 433  56666666666654 333 44566666666666665 333   35566666666666664 554 44  66


Q ss_pred             cchhhccCcccCCCCCcccccccCC-------CEEEccCccccCCCCcccccccccceEeccCccccccCCCccccc
Q 002085          451 LNTLLLDGNKLSGKLPSQIVSWTSL-------NNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL  520 (969)
Q Consensus       451 L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l  520 (969)
                      |+.|+|++|+|+ .+|. +..  +|       +.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+|..++.+
T Consensus       182 L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  253 (571)
T 3cvr_A          182 LEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ  253 (571)
T ss_dssp             CCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred             CCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence            677777777766 5555 443  55       77777777776 467666667777777777777777766666554

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.84  E-value=5.5e-21  Score=212.83  Aligned_cols=199  Identities=15%  Similarity=0.125  Sum_probs=146.9

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCC-cccCcccccc-eecc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPR-SIGRLSELQT-LYLY  177 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~-L~L~  177 (969)
                      ++++.++++++ .+|..+  .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|. .|.++++|++ +.++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            46788999998 778766  36899999999999855556789999999999999998766654 6788888765 5667


Q ss_pred             cccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccC-CcCC
Q 002085          178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNG-NHLE  256 (969)
Q Consensus       178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~  256 (969)
                      .|+++...|..|.++++|++|++++|+                          +.+..+..+....++..|++.+ |+++
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~--------------------------l~~~~~~~~~~~~~l~~l~l~~~~~i~  142 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTG--------------------------IKHLPDVHKIHSLQKVLLDIQDNINIH  142 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEEC--------------------------CSSCCCCTTCCBSSCEEEEEESCTTCC
T ss_pred             CCcccccCchhhhhccccccccccccc--------------------------cccCCchhhcccchhhhhhhccccccc
Confidence            788887778888888888888888775                          3333333455555677777755 5666


Q ss_pred             CCCCchhhcCc-ccchhhccCcccccCCCCchhhcccccccccC-ccccccCCccccCcccchhhhhccccCc
Q 002085          257 GAIPSGLFLLN-NLTQLFLYDNILSGEIPSSVEALKLTDIDLSM-NNLTGSIPEEFGKLKNLQLLGLFSNHLS  327 (969)
Q Consensus       257 ~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~  327 (969)
                      ...+..|..+. .++.|+|++|+|+...+..+...+++.|++++ |.++...+..|..+++|+.|++++|+|+
T Consensus       143 ~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~  215 (350)
T 4ay9_X          143 TIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH  215 (350)
T ss_dssp             EECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred             cccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence            54445555554 57888888888887666667767788888864 5666444456777888888888888777

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.84  E-value=5.9e-22  Score=240.84  Aligned_cols=263  Identities=21%  Similarity=0.197  Sum_probs=103.6

Q ss_pred             CCHHHHHHHHHHHHHcCCCC--CCCCCCC-CCCCCCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCC
Q 002085           32 PNTEERTILLNLKQQLGNPP--SLQSWTS-TSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNS  108 (969)
Q Consensus        32 ~~~~~~~all~~k~~~~~~~--~l~sw~~-~~~~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~  108 (969)
                      ..+.++++|+++..++..+.  .-..|.. .+..+.|.++.++..+++.++|.++++... +..+     |+.++|+.|.
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~-~~~~-----l~~l~Ls~~~  202 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEA-NQAL-----LQHKKLSQYS  202 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcc-hhhH-----hhcCccCccc
Confidence            34568899999998874332  2345643 345678999999999999999999888763 3333     3444444444


Q ss_pred             CCC---------CCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccc
Q 002085          109 IPG---------EFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN  179 (969)
Q Consensus       109 l~~---------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  179 (969)
                      |.+         ..|..|..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|++|++|++|+|++|
T Consensus       203 i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N  280 (727)
T 4b8c_D          203 IDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHN  280 (727)
T ss_dssp             -------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTS
T ss_pred             ccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCC
Confidence            432         44666777777777777777776 56666667777777777777777 66777777777777777777


Q ss_pred             cccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCc-hhhhhccCCcCCCC
Q 002085          180 EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSS-LEILALNGNHLEGA  258 (969)
Q Consensus       180 ~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~  258 (969)
                      +|+ .+|..|++|++|++|+|++|.+   ..+|..|+.+++|+.|+|++|.+.+.+|..+..+.. +..|+|++|.+++.
T Consensus       281 ~l~-~lp~~~~~l~~L~~L~L~~N~l---~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~  356 (727)
T 4b8c_D          281 RLT-SLPAELGSCFQLKYFYFFDNMV---TTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIP  356 (727)
T ss_dssp             CCS-SCCSSGGGGTTCSEEECCSSCC---CCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_pred             cCC-ccChhhcCCCCCCEEECCCCCC---CccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCc
Confidence            777 5676777777777777777642   345555666666666666666666666655544322 22355556666555


Q ss_pred             CCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCc
Q 002085          259 IPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLS  327 (969)
Q Consensus       259 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  327 (969)
                      +|.      .|..|++++|...               ....+.+.+..+..+..+..+....+++|.+.
T Consensus       357 ~p~------~l~~l~l~~n~~~---------------~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          357 LPH------ERRFIEINTDGEP---------------QREYDSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             CCC------C--------------------------------------------------------CCC
T ss_pred             Ccc------ccceeEeeccccc---------------ccccCCccccccchhhcccccceeeeeccccc
Confidence            543      2333444443100               00112334444445556666667777777665

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.83  E-value=2e-20  Score=191.79  Aligned_cols=152  Identities=23%  Similarity=0.253  Sum_probs=107.5

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN  179 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  179 (969)
                      +.+++++++++ .+|..+  .++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            46778888887 556544  468999999999999777777889999999999999999666667888999999999999


Q ss_pred             cccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCC
Q 002085          180 EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLE  256 (969)
Q Consensus       180 ~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  256 (969)
                      ++++..+..|.++++|++|++++|++.  ...+..|..+++|++|++++|++.+..+..|..+++|++|+|++|.+.
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  161 (208)
T 2o6s_A           87 QLQSLPNGVFDKLTQLKELALNTNQLQ--SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD  161 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC--CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             cCCccCHhHhcCccCCCEEEcCCCcCc--ccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence            998776677788888888888888532  222333455555555555555554444444455555555555555444

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=8.8e-20  Score=189.83  Aligned_cols=137  Identities=23%  Similarity=0.331  Sum_probs=108.1

Q ss_pred             CCCCCCCCCCCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcC
Q 002085           54 QSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYF  133 (969)
Q Consensus        54 ~sw~~~~~~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  133 (969)
                      .-|+.+.+.|+|.+|.|+...++           .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus        10 ~~~~~~~~~Cs~~~v~c~~~~l~-----------~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l   76 (229)
T 3e6j_A           10 SAACPSQCSCSGTTVDCRSKRHA-----------SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL   76 (229)
T ss_dssp             -CCCCTTCEEETTEEECTTSCCS-----------SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             hccCCCCCEEeCCEeEccCCCcC-----------ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCC
Confidence            45777888999999999754433           3444332  7888999999999988888888899999999999998


Q ss_pred             CCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCC
Q 002085          134 VGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNS  204 (969)
Q Consensus       134 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  204 (969)
                      ++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+
T Consensus        77 ~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~  146 (229)
T 3e6j_A           77 GALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ  146 (229)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSC
T ss_pred             CCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCc
Confidence            7666667788888888888888888666667788888888888888888 667777777777777777775

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.79  E-value=1.1e-19  Score=187.80  Aligned_cols=137  Identities=23%  Similarity=0.194  Sum_probs=95.5

Q ss_pred             ccccEEEeeccccCCCcc-cccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEE
Q 002085          401 WNLTRLEISNNRFSGQIQ-RGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLN  479 (969)
Q Consensus       401 ~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  479 (969)
                      ..+++|+|++|+|++..+ ..|..+++|++|++++|+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+
T Consensus        32 ~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  111 (220)
T 2v70_A           32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLM  111 (220)
T ss_dssp             TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEE
T ss_pred             CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEE
Confidence            345566666666665543 3466677777777777777766666777777777777777777766666677777777777


Q ss_pred             ccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecCcCCCCCC
Q 002085          480 LARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIP  537 (969)
Q Consensus       480 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~~p  537 (969)
                      |++|+|++..|..|..+++|+.|+|++|+|++..|..+..++ |++|+|++|++.+..+
T Consensus       112 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          112 LRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             CTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            777777766677777777777777777777766677777664 7777777777776554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.79  E-value=4.8e-19  Score=182.93  Aligned_cols=151  Identities=26%  Similarity=0.311  Sum_probs=112.9

Q ss_pred             EEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCC
Q 002085           77 GISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNN  156 (969)
Q Consensus        77 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  156 (969)
                      .+++++++++. +|..+.  ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        15 ~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~   91 (220)
T 2v9t_B           15 IVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK   91 (220)
T ss_dssp             EEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence            34555555553 455443  678999999999987777788889999999999999988888889999999999999999


Q ss_pred             CCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccc
Q 002085          157 FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLI  232 (969)
Q Consensus       157 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~  232 (969)
                      |+...+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++.  ...+..|..+++|+.|+|++|.+.
T Consensus        92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ--TIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS--CCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC--EECHHHHhCCCCCCEEEeCCCCcC
Confidence            98655566788888999999999988888888888888888888888522  222334555555555555555543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=1e-19  Score=215.41  Aligned_cols=149  Identities=26%  Similarity=0.339  Sum_probs=80.8

Q ss_pred             CCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcc
Q 002085          353 NCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKA  432 (969)
Q Consensus       353 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  432 (969)
                      .+++|+.|+|++|++++..|  +..+++|+.|+|++|.|++........+|+.|+|++|+|++.  ..+..+++|+.|+|
T Consensus        63 ~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L  138 (605)
T 1m9s_A           63 YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYL  138 (605)
T ss_dssp             GCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCTTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEEC
T ss_pred             cCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCChhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEEC
Confidence            33444444444444432222  334444444444444443322112223455555555555542  23555666666666


Q ss_pred             cCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccc
Q 002085          433 SNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSG  511 (969)
Q Consensus       433 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g  511 (969)
                      ++|.|++.  ..+..+++|+.|+|++|+|++..|  +..+++|+.|+|++|+|++ + ..+..+++|+.|+|++|++++
T Consensus       139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L-RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C-GGGTTCTTCSEEECCSEEEEC
T ss_pred             CCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-C-hHHccCCCCCEEEccCCcCcC
Confidence            66666643  456666677777777777765444  6666777777777777764 3 346667777777777777764

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.78  E-value=3.5e-19  Score=192.51  Aligned_cols=173  Identities=23%  Similarity=0.320  Sum_probs=148.2

Q ss_pred             CCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhh
Q 002085          351 LGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVF  430 (969)
Q Consensus       351 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  430 (969)
                      +..+++|+.|++++|.+.. ++ .+..+++|+.|+|++|++++..+....++|++|+|++|++++.  ..+..+++|++|
T Consensus        42 ~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L  117 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSL  117 (291)
T ss_dssp             HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEE
T ss_pred             hhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcccccCCCCCEEECCCCcCCCC--hhhccCCCCCEE
Confidence            3467889999999999984 44 4888999999999999999876655567899999999999873  348999999999


Q ss_pred             cccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCcccc
Q 002085          431 KASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFS  510 (969)
Q Consensus       431 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  510 (969)
                      ++++|++++.  ..+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|++++..|  +..+++|+.|+|++|+|+
T Consensus       118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence            9999999864  5688999999999999999964  678999999999999999996544  999999999999999998


Q ss_pred             ccCCCcccccc-ccEEEeecCcCCCC
Q 002085          511 GEIPPEIGQLK-LNTFNLSSNKLYGN  535 (969)
Q Consensus       511 g~~p~~~~~l~-L~~l~ls~N~l~~~  535 (969)
                      + +| .+..++ |+.|++++|+++..
T Consensus       192 ~-l~-~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          192 D-LR-ALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             B-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred             C-Ch-hhccCCCCCEEECcCCcccCC
Confidence            5 55 477775 99999999999863

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.78  E-value=1.7e-18  Score=178.80  Aligned_cols=159  Identities=20%  Similarity=0.229  Sum_probs=109.8

Q ss_pred             CcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCC-cccCCCCCCCEEeccCCcCCCCCCCCcccC
Q 002085           66 PEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFP-EFLYNCTKLQNLDLSQNYFVGPIPSDIDRI  144 (969)
Q Consensus        66 ~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  144 (969)
                      .++.|..   +.++++++.++. +|..+.  ..+++|+|++|+|++..| ..|..+++|++|+|++|+|++..+..|..+
T Consensus         7 ~~C~C~~---~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l   80 (220)
T 2v70_A            7 EKCRCEG---TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA   80 (220)
T ss_dssp             TTCEEET---TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             CCCEECC---CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCC
Confidence            3455653   256677777664 565543  345788888888886654 457788888888888888887777788888


Q ss_pred             CCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEE
Q 002085          145 SGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTL  224 (969)
Q Consensus       145 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L  224 (969)
                      ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++  ....|..|..+++|+.|
T Consensus        81 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l--~~~~~~~~~~l~~L~~L  158 (220)
T 2v70_A           81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI--TTVAPGAFDTLHSLSTL  158 (220)
T ss_dssp             TTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCC--CCBCTTTTTTCTTCCEE
T ss_pred             CCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcC--CEECHHHhcCCCCCCEE
Confidence            8888888888888877777788888888888888888877777777777777777777752  22234444444444444


Q ss_pred             EccCCccc
Q 002085          225 WMTEANLI  232 (969)
Q Consensus       225 ~L~~n~l~  232 (969)
                      +|++|.+.
T Consensus       159 ~L~~N~l~  166 (220)
T 2v70_A          159 NLLANPFN  166 (220)
T ss_dssp             ECCSCCEE
T ss_pred             EecCcCCc
Confidence            44444443

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.78  E-value=1.1e-18  Score=195.06  Aligned_cols=183  Identities=23%  Similarity=0.269  Sum_probs=131.1

Q ss_pred             CcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccC-CCCCCCEEeccCCcCCCCCCCCcccC
Q 002085           66 PEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLY-NCTKLQNLDLSQNYFVGPIPSDIDRI  144 (969)
Q Consensus        66 ~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l  144 (969)
                      .++.|..   ..+++++++++. +|..+.  +.++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|..+
T Consensus        14 ~~C~C~~---~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l   87 (361)
T 2xot_A           14 ANCLCAS---NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPV   87 (361)
T ss_dssp             TTCEEET---TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             CCCEECC---CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCC
Confidence            4556763   356777777765 565443  4588999999999977777777 89999999999999987777889999


Q ss_pred             CCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEE
Q 002085          145 SGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTL  224 (969)
Q Consensus       145 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L  224 (969)
                      ++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++.   .+|..          
T Consensus        88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~---~l~~~----------  154 (361)
T 2xot_A           88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS---RFPVE----------  154 (361)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC---SCCGG----------
T ss_pred             CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC---eeCHH----------
Confidence            99999999999998777778889999999999999998888888888888888888888532   22322          


Q ss_pred             EccCCcccccCchhh---cCCCchhhhhccCCcCCCCCCchhhcCcc--cchhhccCcccc
Q 002085          225 WMTEANLIGEIPEAM---SNLSSLEILALNGNHLEGAIPSGLFLLNN--LTQLFLYDNILS  280 (969)
Q Consensus       225 ~L~~n~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~L~~N~l~  280 (969)
                                   .|   ..+++|+.|+|++|+|++..+..+..++.  |+.|+|++|.+.
T Consensus       155 -------------~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          155 -------------LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             -------------GTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             -------------HhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence                         22   33455555555555555433344444444  255566666554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.78  E-value=4.5e-19  Score=183.16  Aligned_cols=140  Identities=24%  Similarity=0.263  Sum_probs=110.4

Q ss_pred             CccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCC
Q 002085          396 PSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSL  475 (969)
Q Consensus       396 ~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  475 (969)
                      |.....+++.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|
T Consensus        27 P~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L  106 (220)
T 2v9t_B           27 PTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSL  106 (220)
T ss_dssp             CSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             CCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCC
Confidence            33334567777777788777777778888888888888888887778888888888888888888885555557788888


Q ss_pred             CEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecCcCCCC
Q 002085          476 NNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGN  535 (969)
Q Consensus       476 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~  535 (969)
                      +.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..++ |++|+|++|++...
T Consensus       107 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B          107 QLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             CEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence            8888888888877788888888888888888888866666677774 88888888888653

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.77  E-value=4.1e-19  Score=191.92  Aligned_cols=171  Identities=23%  Similarity=0.290  Sum_probs=99.6

Q ss_pred             CCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccce
Q 002085           95 DLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTL  174 (969)
Q Consensus        95 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  174 (969)
                      .+++|++|++++|.++.. + .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++ +| .+..+++|++|
T Consensus        44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L  117 (291)
T 1h6t_A           44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL  117 (291)
T ss_dssp             HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred             hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence            455566666666666532 2 35556666666666666654333  5666666666666666653 22 35666666666


Q ss_pred             ecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCc
Q 002085          175 YLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNH  254 (969)
Q Consensus       175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~  254 (969)
                      +|++|++++.  ..+..+++|++|++++|++...    ..++.+++|+.|++++|++.+..|  +..+++|+.|+|++|+
T Consensus       118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~----~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~  189 (291)
T 1h6t_A          118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI----TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  189 (291)
T ss_dssp             ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC----GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc----hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence            6666666542  3455666666666666643321    345556666666666666655443  6666667777777776


Q ss_pred             CCCCCCchhhcCcccchhhccCccccc
Q 002085          255 LEGAIPSGLFLLNNLTQLFLYDNILSG  281 (969)
Q Consensus       255 l~~~~p~~l~~l~~L~~L~L~~N~l~~  281 (969)
                      +++ ++ .+..+++|+.|++++|+++.
T Consensus       190 i~~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          190 ISD-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             CCC-Ch-hhccCCCCCEEECcCCcccC
Confidence            664 33 36666666666666666653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.77  E-value=2e-21  Score=228.77  Aligned_cols=211  Identities=19%  Similarity=0.185  Sum_probs=152.3

Q ss_pred             ccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEE-cccccccC
Q 002085          291 KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQ-LYSNRFSG  369 (969)
Q Consensus       291 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~-L~~N~l~~  369 (969)
                      +|+.|+|++|+++ .+|..++.+++|+.|++++|.....+|.    +....+..+.+|..++++++|+.|+ ++.|.+. 
T Consensus       350 ~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~----ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-  423 (567)
T 1dce_A          350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL----LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-  423 (567)
T ss_dssp             TSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH----HHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred             cceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH----HHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence            4555566666665 5566666777777777655542111111    1112234455666777788888887 6766553 


Q ss_pred             CCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCcc
Q 002085          370 ELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLS  449 (969)
Q Consensus       370 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~  449 (969)
                                +|..+.+++|.++...+    ..|+.|+|++|+|++ +|. ++.+++|+.|+|++|.|+ .+|..|+.++
T Consensus       424 ----------~L~~l~l~~n~i~~l~~----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~  486 (567)
T 1dce_A          424 ----------DLRSKFLLENSVLKMEY----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALR  486 (567)
T ss_dssp             ----------HHHHHHHHHHHHHHHHH----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred             ----------hhhhhhhhcccccccCc----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCC
Confidence                      56667777777764332    258899999999997 455 888999999999999998 7888999999


Q ss_pred             ccchhhccCcccCCCCCcccccccCCCEEEccCccccCCC-CcccccccccceEeccCccccccCCCcccc----cc-cc
Q 002085          450 HLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEI-PKAIGSLLVMVSLDLSGNQFSGEIPPEIGQ----LK-LN  523 (969)
Q Consensus       450 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~----l~-L~  523 (969)
                      +|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++.+ |..|+.+++|+.|+|++|+|++..| .+..    ++ |+
T Consensus       487 ~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~l~~~lp~L~  563 (567)
T 1dce_A          487 CLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG-IQERLAEMLPSVS  563 (567)
T ss_dssp             TCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS-CTTHHHHHCTTCS
T ss_pred             CCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc-HHHHHHHHCcccC
Confidence            99999999999985 67 7889999999999999999776 8999999999999999999986544 3322    33 77


Q ss_pred             EEEe
Q 002085          524 TFNL  527 (969)
Q Consensus       524 ~l~l  527 (969)
                      .||+
T Consensus       564 ~L~l  567 (567)
T 1dce_A          564 SILT  567 (567)
T ss_dssp             EEEC
T ss_pred             ccCC
Confidence            7654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.77  E-value=9.4e-19  Score=195.57  Aligned_cols=176  Identities=23%  Similarity=0.181  Sum_probs=133.8

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcc-cCCCCcEEecCCCCCCCcCCCcccCcccccceeccc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDID-RISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYM  178 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  178 (969)
                      +.+++++|+++ .+|..+.  ..+++|+|++|+|++..+..|. .+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            57888888887 5666554  3577888888888876666676 788888888888888866666777788888888888


Q ss_pred             ccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCC
Q 002085          179 NEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGA  258 (969)
Q Consensus       179 N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  258 (969)
                      |+|++..+..|.++++|++|+|++|                          ++.+..|..|.++++|+.|+|++|+|++.
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N--------------------------~i~~~~~~~~~~l~~L~~L~L~~N~l~~l  151 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNN--------------------------HIVVVDRNAFEDMAQLQKLYLSQNQISRF  151 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSS--------------------------CCCEECTTTTTTCTTCCEEECCSSCCCSC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCC--------------------------cccEECHHHhCCcccCCEEECCCCcCCee
Confidence            8877666666666666666666665                          46666778899999999999999999965


Q ss_pred             CCchh---hcCcccchhhccCcccccCCCCchhhc---ccccccccCccccc
Q 002085          259 IPSGL---FLLNNLTQLFLYDNILSGEIPSSVEAL---KLTDIDLSMNNLTG  304 (969)
Q Consensus       259 ~p~~l---~~l~~L~~L~L~~N~l~~~~~~~~~~~---~L~~L~Ls~N~l~~  304 (969)
                      .+..+   ..+++|+.|+|++|+|++..+..+..+   .++.|+|++|.+..
T Consensus       152 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             CGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             CHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence            44444   569999999999999997766666655   26899999999984

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.77  E-value=4.6e-19  Score=209.88  Aligned_cols=192  Identities=26%  Similarity=0.338  Sum_probs=120.3

Q ss_pred             CCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhh
Q 002085          242 LSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLG  320 (969)
Q Consensus       242 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  320 (969)
                      +..+..+.++.+.+++..+  +..+++|+.|++++|.++. ++. +..+ +|+.|+|++|++++..+  +..+++|+.|+
T Consensus        20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~~-l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~   93 (605)
T 1m9s_A           20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF   93 (605)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CTT-GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred             HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-ChH-HccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence            4467778888888875533  5678888888888888874 333 3333 67777777777775444  66777777777


Q ss_pred             hccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCcccc
Q 002085          321 LFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTA  400 (969)
Q Consensus       321 L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  400 (969)
                      |++|++++                  +| .+..+++|+.|+|++|++++ + ..+..+++|+.|+|++|.|+        
T Consensus        94 Ls~N~l~~------------------l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~--------  144 (605)
T 1m9s_A           94 LDENKIKD------------------LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT--------  144 (605)
T ss_dssp             CCSSCCCC------------------CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCC--------
T ss_pred             CcCCCCCC------------------Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccC--------
Confidence            77777662                  12 45666777777777777763 2 34555555555555555554        


Q ss_pred             ccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEc
Q 002085          401 WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNL  480 (969)
Q Consensus       401 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  480 (969)
                                    +.  ..+..+++|+.|+|++|.|++..|  +..+++|+.|+|++|+|++ + +.+..+++|+.|+|
T Consensus       145 --------------~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~~L~L  204 (605)
T 1m9s_A          145 --------------DI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L-RALAGLKNLDVLEL  204 (605)
T ss_dssp             --------------CC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C-GGGTTCTTCSEEEC
T ss_pred             --------------Cc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-C-hHHccCCCCCEEEc
Confidence                          33  345555666666666666654444  5666666666666666663 2 24566666666666


Q ss_pred             cCccccCC
Q 002085          481 ARNELSGE  488 (969)
Q Consensus       481 s~N~l~~~  488 (969)
                      ++|++++.
T Consensus       205 ~~N~l~~~  212 (605)
T 1m9s_A          205 FSQECLNK  212 (605)
T ss_dssp             CSEEEECC
T ss_pred             cCCcCcCC
Confidence            66666643

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=1.9e-20  Score=220.44  Aligned_cols=214  Identities=19%  Similarity=0.164  Sum_probs=134.7

Q ss_pred             cCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-cccccc
Q 002085          218 LKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDID  296 (969)
Q Consensus       218 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~  296 (969)
                      +++|+.|+|++|.+. .+|+.++++++|+.|++++|......|          . .+..+.+.+.+|..+..+ +|+.|+
T Consensus       348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~----------~-ll~~~~~~~~~~~~l~~l~~L~~L~  415 (567)
T 1dce_A          348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII----------L-LMRALDPLLYEKETLQYFSTLKAVD  415 (567)
T ss_dssp             TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHH----------H-HHHHHCTGGGHHHHHHHHHHHHHHC
T ss_pred             CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHH----------H-HHHhcccccCCHHHHHHHHhcccCc
Confidence            344444444444443 566667777777777765553210000          0 001112233444444443 355555


Q ss_pred             -ccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCccc
Q 002085          297 -LSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGL  375 (969)
Q Consensus       297 -Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  375 (969)
                       ++.|.+           .+|+.+.+++|.++.                  +|.     ..|+.|+|++|+|++ +|. +
T Consensus       416 ~l~~n~~-----------~~L~~l~l~~n~i~~------------------l~~-----~~L~~L~Ls~n~l~~-lp~-~  459 (567)
T 1dce_A          416 PMRAAYL-----------DDLRSKFLLENSVLK------------------MEY-----ADVRVLHLAHKDLTV-LCH-L  459 (567)
T ss_dssp             GGGHHHH-----------HHHHHHHHHHHHHHH------------------HHH-----TTCSEEECTTSCCSS-CCC-G
T ss_pred             chhhccc-----------chhhhhhhhcccccc------------------cCc-----cCceEEEecCCCCCC-CcC-c
Confidence             444432           345556666665552                  111     248889999999985 665 7


Q ss_pred             ccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhh
Q 002085          376 WTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLL  455 (969)
Q Consensus       376 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~  455 (969)
                      ..+++|+.|+|++|+|+                       .+|..++.+++|+.|+|++|+|++ +| .++.+++|+.|+
T Consensus       460 ~~l~~L~~L~Ls~N~l~-----------------------~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~  514 (567)
T 1dce_A          460 EQLLLVTHLDLSHNRLR-----------------------ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELL  514 (567)
T ss_dssp             GGGTTCCEEECCSSCCC-----------------------CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEE
T ss_pred             cccccCcEeecCccccc-----------------------ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEE
Confidence            76666655555555444                       456677778888888888888885 56 788899999999


Q ss_pred             ccCcccCCCC-CcccccccCCCEEEccCccccCCCCcc---cccccccceEec
Q 002085          456 LDGNKLSGKL-PSQIVSWTSLNNLNLARNELSGEIPKA---IGSLLVMVSLDL  504 (969)
Q Consensus       456 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~L~l  504 (969)
                      |++|+|++.. |..+..+++|+.|+|++|+|++.+|..   +..+++|+.||+
T Consensus       515 Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             CCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            9999998776 888999999999999999998655432   344788888875

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.75  E-value=6.1e-18  Score=175.85  Aligned_cols=152  Identities=25%  Similarity=0.210  Sum_probs=119.3

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN  179 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  179 (969)
                      +.++.++++++ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|+...+..|..+++|++|+|++|
T Consensus        22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N   98 (229)
T 3e6j_A           22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN   98 (229)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence            56888888887 6776554  89999999999999988999999999999999999998666677899999999999999


Q ss_pred             cccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCC
Q 002085          180 EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEG  257 (969)
Q Consensus       180 ~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  257 (969)
                      +|++..+..|..+++|++|+|++|++.   .+|..+..+++|+.|+|++|++.+..+..|..+++|+.|+|++|.+..
T Consensus        99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~---~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  173 (229)
T 3e6j_A           99 QLTVLPSAVFDRLVHLKELFMCCNKLT---ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC  173 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC---SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred             cCCccChhHhCcchhhCeEeccCCccc---ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence            999877778899999999999988632   456666666666666666666655555555556666666666665553

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=4.2e-18  Score=180.42  Aligned_cols=140  Identities=19%  Similarity=0.174  Sum_probs=108.5

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcE--EEEEEEeccchh---------------------cHHHHHHHHHHHHHHhccc
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEF--VAVKRIWNNRKL---------------------NQKLEKEFIAEIEILGTIR  694 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~---------------------~~~~~~~~~~E~~~l~~l~  694 (969)
                      |...+.||+|+||.||+|.+..+|+.  ||||+++.....                     .......+.+|++++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999998667888  999987543211                     0122346889999999998


Q ss_pred             cCce--eeEEEEEEcCCceEEEEeeccC-C----CHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhc-
Q 002085          695 HANI--VKLWCCISSENSKLLVYEYMEN-Q----SLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMH-  766 (969)
Q Consensus       695 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-  766 (969)
                      |+++  ..++++    +..++||||+.+ |    +|.++...                .++..+..++.|++.||.||| 
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----------------~~~~~~~~i~~qi~~~l~~lH~  188 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----------------LKELDVEGIFNDVVENVKRLYQ  188 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----------------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----------------cChHHHHHHHHHHHHHHHHHHH
Confidence            8753  444443    357899999943 4    67766432                224567789999999999999 


Q ss_pred             ccCCCCeEecCCCCCcEEECCCCcEEEeecccceec
Q 002085          767 HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML  802 (969)
Q Consensus       767 ~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~  802 (969)
                      +.   +|+||||||+|||++.  .++|+|||+|...
T Consensus       189 ~~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          189 EA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            88   9999999999999998  9999999999764

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=3.3e-18  Score=173.57  Aligned_cols=153  Identities=16%  Similarity=0.235  Sum_probs=97.9

Q ss_pred             CCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhc
Q 002085          352 GNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFK  431 (969)
Q Consensus       352 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  431 (969)
                      ..+++|+.|++++|.++ .+| .+..+++|+.|++++|.++...+....++|++|++++|++++..+..++.+++|++|+
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  118 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD  118 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence            56788999999999998 566 6777888888888877665433333345666666666666665566666666666666


Q ss_pred             ccCCccccccCccccCccccchhhccCcc-cCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCcccc
Q 002085          432 ASNNLFSGEIPVELTSLSHLNTLLLDGNK-LSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFS  510 (969)
Q Consensus       432 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  510 (969)
                      +++|.+++..|..+..+++|+.|+|++|+ ++ .+| .+..+++|+.|+|++|++++ ++ .+..+++|+.|++++|++.
T Consensus       119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred             ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence            66666665556666666666666666665 44 344 45666666666666666653 33 5566666666666666654

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.73  E-value=1.9e-18  Score=183.63  Aligned_cols=171  Identities=22%  Similarity=0.229  Sum_probs=111.0

Q ss_pred             CCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccce
Q 002085           95 DLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTL  174 (969)
Q Consensus        95 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  174 (969)
                      ++.+++.+++++|.+++. + .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++..|  +.++++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            345566666777776633 3 4666777777777777766 344 56677777777777777764333  6677777777


Q ss_pred             ecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCc
Q 002085          175 YLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNH  254 (969)
Q Consensus       175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~  254 (969)
                      +|++|++++ +|... . ++|++|++++|++..   + ..++.+++|+.|++++|++.+. + .+..+++|++|+|++|+
T Consensus        91 ~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~---~-~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~  161 (263)
T 1xeu_A           91 SVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRD---T-DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNE  161 (263)
T ss_dssp             ECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSB---S-GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSC
T ss_pred             ECCCCccCC-cCccc-c-CcccEEEccCCccCC---C-hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCc
Confidence            777777764 33322 2 677777777775332   2 2466667777777777666654 3 57777777777777777


Q ss_pred             CCCCCCchhhcCcccchhhccCcccccC
Q 002085          255 LEGAIPSGLFLLNNLTQLFLYDNILSGE  282 (969)
Q Consensus       255 l~~~~p~~l~~l~~L~~L~L~~N~l~~~  282 (969)
                      +++.  ..+..+++|+.|++++|.+++.
T Consensus       162 i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          162 ITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             Ccch--HHhccCCCCCEEeCCCCcccCC
Confidence            7754  5566777777777777777654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.72  E-value=6.8e-18  Score=171.18  Aligned_cols=107  Identities=17%  Similarity=0.301  Sum_probs=71.5

Q ss_pred             cCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccc
Q 002085           94 CDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQT  173 (969)
Q Consensus        94 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  173 (969)
                      +.+++|++|++++|+++ .+| .+..+++|++|++++|.++  .+..+..+++|++|+|++|++++..|..|+.+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            44556677777777776 445 4666777777777777554  2235666777777777777776666666777777777


Q ss_pred             eecccccccCcCCcccCCCCCcceeecccCC
Q 002085          174 LYLYMNEFNGTFPKEIGDLSNLEVLGLAYNS  204 (969)
Q Consensus       174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  204 (969)
                      |+|++|++++..|..++.+++|++|++++|.
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~  147 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNG  147 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence            7777777766666666666666666666663

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.72  E-value=4.7e-18  Score=180.63  Aligned_cols=170  Identities=26%  Similarity=0.326  Sum_probs=95.0

Q ss_pred             CcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCcc
Q 002085          312 KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTI  391 (969)
Q Consensus       312 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  391 (969)
                      .+.++..+++++|.+++                  ++ .+..+++|+.|++++|.++ .+| .+..+++|+.|+|++|+|
T Consensus        17 ~l~~l~~l~l~~~~i~~------------------~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i   75 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTD------------------LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQI   75 (263)
T ss_dssp             HHHHHHHHHHTCSCTTS------------------EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCC
T ss_pred             HHHHHHHHHhcCCCccc------------------cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCcc
Confidence            46777888888888773                  22 3566788888888888887 455 566667777666666666


Q ss_pred             ccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCccccc
Q 002085          392 SGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVS  471 (969)
Q Consensus       392 ~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  471 (969)
                      ++..+....++|++|+|++|++++.                         |. +.. ++|+.|+|++|++++ ++ .+..
T Consensus        76 ~~~~~l~~l~~L~~L~L~~N~l~~l-------------------------~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~  126 (263)
T 1xeu_A           76 SDLSPLKDLTKLEELSVNRNRLKNL-------------------------NG-IPS-ACLSRLFLDNNELRD-TD-SLIH  126 (263)
T ss_dssp             CCCGGGTTCSSCCEEECCSSCCSCC-------------------------TT-CCC-SSCCEEECCSSCCSB-SG-GGTT
T ss_pred             CCChhhccCCCCCEEECCCCccCCc-------------------------Cc-ccc-CcccEEEccCCccCC-Ch-hhcC
Confidence            6444322334455555555555532                         21 111 455555555555553 22 3455


Q ss_pred             ccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecCcCCCC
Q 002085          472 WTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGN  535 (969)
Q Consensus       472 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~  535 (969)
                      +++|+.|+|++|+|++ +| .++.+++|+.|+|++|++++.  ..+..++ |+.|++++|++++.
T Consensus       127 l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          127 LKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             cccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            5555555555555553 22 455555555555555555533  3344442 55555555555543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.72  E-value=3.4e-18  Score=172.50  Aligned_cols=158  Identities=20%  Similarity=0.301  Sum_probs=109.1

Q ss_pred             cccCCCccccccCccccccccEEEeeccccCCCccc-ccCCcccchhhcccCCccccccCccccCccccchhhccCcccC
Q 002085          384 LMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQR-GVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLS  462 (969)
Q Consensus       384 L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  462 (969)
                      +++++|.++ .+|.....++++|+|++|+|++..+. .|..+++|++|++++|+|++..|..|..+++|++|+|++|+|+
T Consensus        13 l~~s~~~l~-~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~   91 (192)
T 1w8a_A           13 VDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK   91 (192)
T ss_dssp             EECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC
T ss_pred             EEcCCCCcC-cCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCC
Confidence            334444432 33333334677777777777766654 4778888888888888888777888888888888888888888


Q ss_pred             CCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCccccc-c-ccEEEeecCcCCCCCCccc
Q 002085          463 GKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-K-LNTFNLSSNKLYGNIPDEF  540 (969)
Q Consensus       463 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l-~-L~~l~ls~N~l~~~~p~~~  540 (969)
                      +..|..|..+++|++|+|++|+|++.+|..|..+++|+.|+|++|++++..+-.  .+ . ++...+..+......|..+
T Consensus        92 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~--~~~~~l~~~~~~~~~~~C~~P~~l  169 (192)
T 1w8a_A           92 EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA--WFAEWLRKKSLNGGAARCGAPSKV  169 (192)
T ss_dssp             EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH--HHHHHHHHHCCSGGGCBBCSSTTT
T ss_pred             ccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch--HHHHHHHHcCCCCCCCCCCCChHH
Confidence            777777888888888888888888877888888888888888888888755421  11 1 3333444555555555555


Q ss_pred             cccc
Q 002085          541 NNLA  544 (969)
Q Consensus       541 ~~~~  544 (969)
                      +...
T Consensus       170 ~~~~  173 (192)
T 1w8a_A          170 RDVQ  173 (192)
T ss_dssp             TTSB
T ss_pred             cCCC
Confidence            5443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.70  E-value=4e-18  Score=207.20  Aligned_cols=177  Identities=20%  Similarity=0.246  Sum_probs=87.3

Q ss_pred             CCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccc--cccccEEEeeccccCCCcccccCCcc
Q 002085          348 PKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKT--AWNLTRLEISNNRFSGQIQRGVGSWK  425 (969)
Q Consensus       348 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~--~~~L~~L~Ls~N~l~~~~~~~~~~l~  425 (969)
                      |..+..++.|+.|+|++|.+. .+|..++.+++|+.|+|++|.|+ .+|...  ..+|+.|+|++|+|+ .+|..|++++
T Consensus       217 ~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~  293 (727)
T 4b8c_D          217 KDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCF  293 (727)
T ss_dssp             -----CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGT
T ss_pred             hhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCC
Confidence            344555555555555555555 45555555556666666666555 444322  245666666666666 5566677777


Q ss_pred             cchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccC-CCEEEccCccccCCCCcccccccccceEec
Q 002085          426 NLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTS-LNNLNLARNELSGEIPKAIGSLLVMVSLDL  504 (969)
Q Consensus       426 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  504 (969)
                      +|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+..+.. +..|+|++|.++|.+|..+      +.|++
T Consensus       294 ~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l------~~l~l  366 (727)
T 4b8c_D          294 QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER------RFIEI  366 (727)
T ss_dssp             TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC------------
T ss_pred             CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc------ceeEe
Confidence            7777777777776 56666777777777777777777766666654322 2246677777777766543      44556


Q ss_pred             cCc--------cccccCCCcccccc-ccEEEeecCcCCC
Q 002085          505 SGN--------QFSGEIPPEIGQLK-LNTFNLSSNKLYG  534 (969)
Q Consensus       505 s~N--------~l~g~~p~~~~~l~-L~~l~ls~N~l~~  534 (969)
                      ++|        .|.+.++..+..+. +....++.|.+.+
T Consensus       367 ~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~  405 (727)
T 4b8c_D          367 NTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ  405 (727)
T ss_dssp             -----------------------------------CCCG
T ss_pred             ecccccccccCCccccccchhhcccccceeeeecccccc
Confidence            655        33333333334442 4556677777654

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.69  E-value=8.4e-17  Score=162.25  Aligned_cols=126  Identities=25%  Similarity=0.331  Sum_probs=83.9

Q ss_pred             EEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCc-ccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCC
Q 002085           76 TGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPE-FLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGG  154 (969)
Q Consensus        76 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  154 (969)
                      +.+++++++++ .+|..+..  +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            34555566663 45554432  677777777777755543 367777777777777777766677777777777777777


Q ss_pred             CCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCC
Q 002085          155 NNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNS  204 (969)
Q Consensus       155 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  204 (969)
                      |+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  137 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP  137 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCC
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCC
Confidence            77776666667777777777777777776666666666666666666653

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.63  E-value=2.1e-16  Score=155.72  Aligned_cols=135  Identities=21%  Similarity=0.212  Sum_probs=102.9

Q ss_pred             cccccEEEeeccccC-CCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEE
Q 002085          400 AWNLTRLEISNNRFS-GQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNL  478 (969)
Q Consensus       400 ~~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  478 (969)
                      ..+|+.|+|++|+++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|+.|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            356788888888887 66777778888888888888888755  677788888888888888887677777778888888


Q ss_pred             EccCccccCCC-CcccccccccceEeccCccccccCC---Ccccccc-ccEEEeecCcCCCCCC
Q 002085          479 NLARNELSGEI-PKAIGSLLVMVSLDLSGNQFSGEIP---PEIGQLK-LNTFNLSSNKLYGNIP  537 (969)
Q Consensus       479 ~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~l~-L~~l~ls~N~l~~~~p  537 (969)
                      +|++|+|++.. +..+..+++|+.|++++|++++..+   ..+..++ |++|++++|.+. .+|
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~  163 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAP  163 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCC
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcc
Confidence            88888887532 2678888888888888888884333   2667674 888888888776 344

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=6.9e-16  Score=153.44  Aligned_cols=112  Identities=21%  Similarity=0.200  Sum_probs=66.1

Q ss_pred             ccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEc
Q 002085          401 WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNL  480 (969)
Q Consensus       401 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  480 (969)
                      .+|++|++++|++++..+..+..+++|++|++++|.|++..+..|..+++|+.|+|++|++++..+..+..+++|++|+|
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            45666666666666555555566666666666666666544445556666666666666666544445555666666666


Q ss_pred             cCccccCCCCcccccccccceEeccCcccccc
Q 002085          481 ARNELSGEIPKAIGSLLVMVSLDLSGNQFSGE  512 (969)
Q Consensus       481 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~  512 (969)
                      ++|+|++..+..|..+++|+.|+|++|++++.
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  139 (177)
T 2o6r_A          108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  139 (177)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             cCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence            66666544344445566666666666666543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=1.9e-15  Score=150.21  Aligned_cols=129  Identities=24%  Similarity=0.298  Sum_probs=98.5

Q ss_pred             CCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcc
Q 002085           63 CDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDID  142 (969)
Q Consensus        63 c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  142 (969)
                      |+|.++.|+..          +++. +|..+  .++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.
T Consensus         7 C~~~~l~~~~~----------~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~   73 (177)
T 2o6r_A            7 CSGTEIRCNSK----------GLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFD   73 (177)
T ss_dssp             EETTEEECCSS----------CCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTT
T ss_pred             eCCCEEEecCC----------CCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHcc
Confidence            67777777544          3332 34332  36788999999999877677788889999999999998876666778


Q ss_pred             cCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCC
Q 002085          143 RISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNS  204 (969)
Q Consensus       143 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  204 (969)
                      .+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..+..+++|++|++++|.
T Consensus        74 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  135 (177)
T 2o6r_A           74 KLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  135 (177)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCC
Confidence            88888889998888887666677888888888888888886665566777777777777774

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.62  E-value=8.1e-16  Score=151.51  Aligned_cols=105  Identities=18%  Similarity=0.238  Sum_probs=55.0

Q ss_pred             CcccEEEccCCCCC-CCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCccccccee
Q 002085           97 KNLTTIDLSSNSIP-GEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLY  175 (969)
Q Consensus        97 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  175 (969)
                      ++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            45566666666655 55555555556666666666655543  4555555555555555555544554444555555555


Q ss_pred             cccccccCcCC-cccCCCCCcceeecccC
Q 002085          176 LYMNEFNGTFP-KEIGDLSNLEVLGLAYN  203 (969)
Q Consensus       176 L~~N~l~~~~p-~~~~~l~~L~~L~L~~N  203 (969)
                      |++|++++..+ ..+..+++|++|++++|
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N  130 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNC  130 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSS
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCC
Confidence            55555553211 33444444444444433

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.62  E-value=3.1e-15  Score=150.63  Aligned_cols=124  Identities=24%  Similarity=0.269  Sum_probs=96.3

Q ss_pred             EEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCC
Q 002085           77 GISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNN  156 (969)
Q Consensus        77 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  156 (969)
                      .+++++++++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|.|++..+..|.++++|++|+|++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4566666665 3555443  57888888888887 677888888888888888888887777788888888888888888


Q ss_pred             CCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCC
Q 002085          157 FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNS  204 (969)
Q Consensus       157 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  204 (969)
                      |++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  137 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANP  137 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCC
Confidence            887777778888888888888888886666667777777777777774

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.62  E-value=7.2e-16  Score=155.33  Aligned_cols=109  Identities=25%  Similarity=0.334  Sum_probs=62.2

Q ss_pred             ccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEc
Q 002085          401 WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNL  480 (969)
Q Consensus       401 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  480 (969)
                      .+|++|+|++|+|+ .+|..|.++++|++|++++|.|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            34556666666665 34455555556666666666665555555555666666666666665554555555556666666


Q ss_pred             cCccccCCCCcccccccccceEeccCcccc
Q 002085          481 ARNELSGEIPKAIGSLLVMVSLDLSGNQFS  510 (969)
Q Consensus       481 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  510 (969)
                      ++|+|++..+..|..+++|+.|+|++|++.
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A          110 HGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            666665433444555555555555555554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=3.9e-16  Score=150.39  Aligned_cols=124  Identities=19%  Similarity=0.243  Sum_probs=58.8

Q ss_pred             eEEEEecCCCCC-CCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecC
Q 002085           75 VTGISLRHKDIT-QKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLG  153 (969)
Q Consensus        75 v~~l~l~~~~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  153 (969)
                      ++.|+++++.+. +.+|..+..+++|++|+|++|.+++.  ..+..+++|++|+|++|.+++.+|..+..+++|++|+++
T Consensus        19 l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls   96 (149)
T 2je0_A           19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS   96 (149)
T ss_dssp             CSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECT
T ss_pred             CeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECC
Confidence            445555555554 44444445555555555555555433  344445555555555555544444444445555555555


Q ss_pred             CCCCCCc-CCCcccCcccccceecccccccCcCC---cccCCCCCcceeec
Q 002085          154 GNNFSGD-IPRSIGRLSELQTLYLYMNEFNGTFP---KEIGDLSNLEVLGL  200 (969)
Q Consensus       154 ~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L  200 (969)
                      +|++++. .|..++.+++|++|++++|++++..+   ..++.+++|++|++
T Consensus        97 ~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l  147 (149)
T 2je0_A           97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG  147 (149)
T ss_dssp             TSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred             CCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence            5555431 22444445555555555555543333   23444444444444

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.58  E-value=1.8e-15  Score=145.65  Aligned_cols=105  Identities=17%  Similarity=0.231  Sum_probs=66.6

Q ss_pred             CcccEEEccCCCCC-CCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCccccccee
Q 002085           97 KNLTTIDLSSNSIP-GEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLY  175 (969)
Q Consensus        97 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  175 (969)
                      ++|++|++++|.++ +.+|..+..+++|++|+|++|.+++.  ..++.+++|++|+|++|.+++.+|..++.+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            56777777777776 66666667777777777777777644  5566666777777777766655666566666666666


Q ss_pred             cccccccCc-CCcccCCCCCcceeecccC
Q 002085          176 LYMNEFNGT-FPKEIGDLSNLEVLGLAYN  203 (969)
Q Consensus       176 L~~N~l~~~-~p~~~~~l~~L~~L~L~~N  203 (969)
                      +++|++++. .+..++.+++|++|++++|
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N  123 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNC  123 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTC
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCC
Confidence            666666642 2244555555555555544

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.57  E-value=2.7e-16  Score=173.25  Aligned_cols=240  Identities=13%  Similarity=0.075  Sum_probs=152.8

Q ss_pred             CCcccEEEccCCCCC--CCCCcccCCCCCCCEEeccCCcCCCCCCCCccc--------CCCCcEEecCCCCCCCcCCCcc
Q 002085           96 LKNLTTIDLSSNSIP--GEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDR--------ISGLQCIDLGGNNFSGDIPRSI  165 (969)
Q Consensus        96 l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~--------l~~L~~L~L~~N~l~~~~p~~~  165 (969)
                      +++|++|||++|+|.  ...+.   .++.++.+.+..|.|   .+..|.+        +++|+.|+|.+ +++...+.+|
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF  120 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF  120 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred             hccCeEEecCcceeEEecCccc---ccccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence            455666666666555  11111   111133334433322   2345566        77777777777 6765555667


Q ss_pred             cCcccccceecccccccCcCCcccCCCCCcceeecccCCC--CCCCCCCccccccCCCc---------------------
Q 002085          166 GRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSN--FKPAMIPIEFGMLKKLK---------------------  222 (969)
Q Consensus       166 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~--~~~~~~p~~~~~l~~L~---------------------  222 (969)
                      .++++|+.|++++|.++...+..|.++.++..+.+..+..  .........|..+..|+                     
T Consensus       121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~  200 (329)
T 3sb4_A          121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQ  200 (329)
T ss_dssp             TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCC
T ss_pred             hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccC
Confidence            7777788888777777766667777777666666554211  01112233344444444                     


Q ss_pred             -----EEEccCCcccccCchhh-cCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccc-c
Q 002085          223 -----TLWMTEANLIGEIPEAM-SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLT-D  294 (969)
Q Consensus       223 -----~L~L~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~-~  294 (969)
                           .+.+.++ +.......+ ..+++|+.|+|++|+++...+..|..+.+|+.|+|.+| ++.+.+..|... +|+ .
T Consensus       201 ~~~~~~l~~~~~-l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~  278 (329)
T 3sb4_A          201 PRDINFLTIEGK-LDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGT  278 (329)
T ss_dssp             GGGCSEEEEEEC-CCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEE
T ss_pred             ccccceEEEeee-ecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEE
Confidence                 2222221 111001111 13788999999999998666677888999999999998 777777888877 598 9


Q ss_pred             ccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEc
Q 002085          295 IDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQL  362 (969)
Q Consensus       295 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L  362 (969)
                      +++.+ +++...+.+|.++++|+.+++++|+++.                 .-+..|.++++|+.++.
T Consensus       279 l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~-----------------I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          279 LELPA-SVTAIEFGAFMGCDNLRYVLATGDKITT-----------------LGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EEECT-TCCEECTTTTTTCTTEEEEEECSSCCCE-----------------ECTTTTCTTCCCCEEEC
T ss_pred             EEEcc-cceEEchhhhhCCccCCEEEeCCCccCc-----------------cchhhhcCCcchhhhcc
Confidence            99988 7877778899999999999999988872                 22346888888888763

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.57  E-value=3.7e-15  Score=163.28  Aligned_cols=138  Identities=14%  Similarity=0.136  Sum_probs=100.5

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh--------------c-H----HHHHHHHHHHHHHhccccCce
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL--------------N-Q----KLEKEFIAEIEILGTIRHANI  698 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------~-~----~~~~~~~~E~~~l~~l~h~ni  698 (969)
                      |++.+.||+|+||.||+|... +|+.||||+++.....              . .    ........|...+.++.+..+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            788999999999999999885 6899999987532110              0 0    011123457777777755443


Q ss_pred             --eeEEEEEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEec
Q 002085          699 --VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHR  776 (969)
Q Consensus       699 --v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  776 (969)
                        ...+++    ...+|||||++|++|.++..                   ......++.|++.+|.|||+.   |||||
T Consensus       176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~-------------------~~~~~~l~~qll~~l~~lH~~---gIVHr  229 (397)
T 4gyi_A          176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS-------------------VPDPASLYADLIALILRLAKH---GLIHG  229 (397)
T ss_dssp             SCCCEEEE----ETTEEEEECCSCEEGGGCCC-------------------CSCHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             CCCeeeec----cCceEEEEecCCccHhhhcc-------------------cHHHHHHHHHHHHHHHHHHHC---CCcCC
Confidence              222322    23479999999988865432                   123457889999999999988   99999


Q ss_pred             CCCCCcEEECCCC----------cEEEeecccceec
Q 002085          777 DVKSSNILLDSEF----------KAKIADFGLAKML  802 (969)
Q Consensus       777 Dlkp~Nill~~~~----------~~kl~Dfgla~~~  802 (969)
                      ||||.|||+++++          .+.|+||+-+...
T Consensus       230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            9999999998876          3899999987643

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.53  E-value=4.7e-15  Score=163.34  Aligned_cols=238  Identities=13%  Similarity=0.006  Sum_probs=173.7

Q ss_pred             CCCeEEEEecCCCCC--CCCCccccCCCcccEEEccCCCCCCCCCcccCC--------CCCCCEEeccCCcCCCCCCCCc
Q 002085           72 FNSVTGISLRHKDIT--QKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYN--------CTKLQNLDLSQNYFVGPIPSDI  141 (969)
Q Consensus        72 ~~~v~~l~l~~~~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~l  141 (969)
                      ..+++.|||+++.+.  ...+..+   +.+..+++..|.|.   +.+|.+        +++|+.|+|++ .++.+-+.+|
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF  120 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF  120 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred             hccCeEEecCcceeEEecCccccc---cccccccccccccC---HHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence            457999999999987  2222222   23555666666332   345666        89999999988 7776667788


Q ss_pred             ccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccc----cCcCCcccCCCCCcc-eeec----------------
Q 002085          142 DRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF----NGTFPKEIGDLSNLE-VLGL----------------  200 (969)
Q Consensus       142 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~~~~p~~~~~l~~L~-~L~L----------------  200 (969)
                      .++++|+.|+|++|.+....+..|.++.++..+.+..+..    .......|.++..|+ .+.+                
T Consensus       121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~  200 (329)
T 3sb4_A          121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQ  200 (329)
T ss_dssp             TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCC
T ss_pred             hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccC
Confidence            8899999999999988867777888888888777765322    222333454445554 3333                


Q ss_pred             ---------ccCCCCCCCCCCcc-ccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccc
Q 002085          201 ---------AYNSNFKPAMIPIE-FGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLT  270 (969)
Q Consensus       201 ---------~~N~~~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  270 (969)
                               .++-   ....... ...+++|+.|+|++|++....+.+|.++++|+.|+|.+| ++...+.+|..+.+|+
T Consensus       201 ~~~~~~l~~~~~l---~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~  276 (329)
T 3sb4_A          201 PRDINFLTIEGKL---DNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLA  276 (329)
T ss_dssp             GGGCSEEEEEECC---CHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             ccccceEEEeeee---cHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhcc
Confidence                     2220   0000000 113789999999999998888889999999999999998 8767777888999999


Q ss_pred             -hhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhh
Q 002085          271 -QLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGL  321 (969)
Q Consensus       271 -~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  321 (969)
                       .+++.+ .++.+.+..|... +|+.|++++|+++...+.+|.++++|+.++.
T Consensus       277 ~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          277 GTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             EEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence             999998 7887778888876 7999999999999888889999999998753

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.52  E-value=4.2e-15  Score=147.56  Aligned_cols=127  Identities=18%  Similarity=0.184  Sum_probs=76.0

Q ss_pred             ccccEEEeeccccCCCcccccCCcc-cchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEE
Q 002085          401 WNLTRLEISNNRFSGQIQRGVGSWK-NLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLN  479 (969)
Q Consensus       401 ~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  479 (969)
                      .+|+.|++++|+++.. +. +..+. +|++|++++|.|++.  ..|..+++|++|+|++|++++..+..+..+++|++|+
T Consensus        19 ~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   94 (176)
T 1a9n_A           19 VRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI   94 (176)
T ss_dssp             TSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred             CCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence            3455555555555532 32 33333 666666666666643  4566666677777777776643333346666777777


Q ss_pred             ccCccccCCCCc--ccccccccceEeccCccccccCCCc----ccccc-ccEEEeecCcCC
Q 002085          480 LARNELSGEIPK--AIGSLLVMVSLDLSGNQFSGEIPPE----IGQLK-LNTFNLSSNKLY  533 (969)
Q Consensus       480 Ls~N~l~~~~p~--~~~~l~~L~~L~ls~N~l~g~~p~~----~~~l~-L~~l~ls~N~l~  533 (969)
                      |++|+|+ .+|.  .+..+++|+.|++++|+++ .+|..    ++.++ |++||+++|...
T Consensus        95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            7777764 4554  5666677777777777776 45553    55553 677777766553

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.51  E-value=7.5e-15  Score=145.71  Aligned_cols=134  Identities=20%  Similarity=0.206  Sum_probs=102.9

Q ss_pred             CCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhh
Q 002085          351 LGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVF  430 (969)
Q Consensus       351 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  430 (969)
                      +.++.+|+.|++++|+++ .+|. +..+.                     ++|++|+|++|.|++.  ..+..+++|++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~---------------------~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L   69 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATL---------------------DQFDAIDFSDNEIRKL--DGFPLLRRLKTL   69 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGT---------------------TCCSEEECCSSCCCEE--CCCCCCSSCCEE
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcC---------------------CCCCEEECCCCCCCcc--cccccCCCCCEE
Confidence            455667777777777776 3333 22222                     2455666666666654  567788899999


Q ss_pred             cccCCccccccCccccCccccchhhccCcccCCCCCc--ccccccCCCEEEccCccccCCCCcc----cccccccceEec
Q 002085          431 KASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPS--QIVSWTSLNNLNLARNELSGEIPKA----IGSLLVMVSLDL  504 (969)
Q Consensus       431 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~l  504 (969)
                      ++++|.|++..+..|..+++|++|+|++|+++ .+|.  .+..+++|+.|+|++|.++ .+|..    +..+++|+.||+
T Consensus        70 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~  147 (176)
T 1a9n_A           70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF  147 (176)
T ss_dssp             ECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred             ECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCC
Confidence            99999998665566689999999999999997 5676  7889999999999999998 56774    899999999999


Q ss_pred             cCccccc
Q 002085          505 SGNQFSG  511 (969)
Q Consensus       505 s~N~l~g  511 (969)
                      ++|.+..
T Consensus       148 ~~n~~~~  154 (176)
T 1a9n_A          148 QKVKLKE  154 (176)
T ss_dssp             EECCHHH
T ss_pred             CcCCHHH
Confidence            9999863

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.50  E-value=1.2e-16  Score=162.00  Aligned_cols=135  Identities=21%  Similarity=0.285  Sum_probs=89.6

Q ss_pred             cCCCcccEEEccCCCCCCCCCc------ccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccC
Q 002085           94 CDLKNLTTIDLSSNSIPGEFPE------FLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGR  167 (969)
Q Consensus        94 ~~l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  167 (969)
                      .....++.++++.+.++|.+|.      .|..+++|++|+|++|.+++ +| .+..+++|++|+|++|+++ .+|..+..
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~   91 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV   91 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence            3445566666666666666555      77777778888888777775 56 7777777888888888777 56777777


Q ss_pred             cccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCC--ccccccCCCcEEEccCCcccccCc
Q 002085          168 LSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIP--IEFGMLKKLKTLWMTEANLIGEIP  236 (969)
Q Consensus       168 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p--~~~~~l~~L~~L~L~~n~l~~~~p  236 (969)
                      +++|++|+|++|++++ +| .++.+++|++|++++|++..   ++  ..+..+++|+.|++++|.+.+.+|
T Consensus        92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~---~~~~~~l~~l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A           92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN---WGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC---HHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred             CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc---hhHHHHHhcCCCCCEEEecCCccccccc
Confidence            7778888888887775 34 56677777777777775321   12  245555555555555555555444

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.48  E-value=3e-13  Score=152.79  Aligned_cols=330  Identities=10%  Similarity=0.041  Sum_probs=162.4

Q ss_pred             CcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCC
Q 002085          114 PEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLS  193 (969)
Q Consensus       114 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  193 (969)
                      ..+|.++++|+.+.|..+ ++.+-..+|.++++|+.++|.++ ++..-...|.++++|+.+.+..+ +.......|.+..
T Consensus        64 ~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~  140 (394)
T 4fs7_A           64 YAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD  140 (394)
T ss_dssp             TTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred             HHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence            344555555555555432 44333445555555555555433 33233345555556655555433 2323444454443


Q ss_pred             CcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhh
Q 002085          194 NLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLF  273 (969)
Q Consensus       194 ~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  273 (969)
                      .++.......    ...-...|.++++|+.+.+.++ +......+|.++.+|+.+++..| ++......+..+..|+.+.
T Consensus       141 ~~~~~~~~~~----~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~  214 (394)
T 4fs7_A          141 FKEITIPEGV----TVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENME  214 (394)
T ss_dssp             CSEEECCTTC----CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCC
T ss_pred             ccccccCccc----cccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceee
Confidence            3332222211    1112234555566666665432 33334456667777777776655 4334444555666666666


Q ss_pred             ccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCC
Q 002085          274 LYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGN  353 (969)
Q Consensus       274 L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~  353 (969)
                      +..+... .....+...+|+.+.+..+ ++......|..                                         
T Consensus       215 ~~~~~~~-i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~-----------------------------------------  251 (394)
T 4fs7_A          215 FPNSLYY-LGDFALSKTGVKNIIIPDS-FTELGKSVFYG-----------------------------------------  251 (394)
T ss_dssp             CCTTCCE-ECTTTTTTCCCCEEEECTT-CCEECSSTTTT-----------------------------------------
T ss_pred             cCCCceE-eehhhcccCCCceEEECCC-ceecccccccc-----------------------------------------
Confidence            5554332 1122222223444443322 12122233444                                         


Q ss_pred             CccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhccc
Q 002085          354 CRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKAS  433 (969)
Q Consensus       354 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  433 (969)
                      +..|+.+.+..+... .....|..+..++.+....+.+. ........+|+.+.+..+ ++.+....|.++.+|+.+++.
T Consensus       252 ~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~-~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp  328 (394)
T 4fs7_A          252 CTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP-EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLP  328 (394)
T ss_dssp             CSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC-TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCC
T ss_pred             cccceeEEcCCCcce-eeccccccccccceeccCceeec-cccccccccccccccccc-cceechhhhcCCCCCCEEEeC
Confidence            444444444443322 22333333444444443333221 111112245555555443 444455667777777777776


Q ss_pred             CCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceE
Q 002085          434 NNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSL  502 (969)
Q Consensus       434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  502 (969)
                      ++ ++.+-..+|.++.+|+.+++..| ++..-...|.+|++|+.+++..| ++ .+..+|.+.++|+.+
T Consensus       329 ~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          329 YL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             Cc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            44 55455667777777777777666 55444556777777777777654 33 344566666666653

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.48  E-value=4.7e-16  Score=157.74  Aligned_cols=136  Identities=20%  Similarity=0.250  Sum_probs=74.3

Q ss_pred             CCccCcEEEcccccccCCCCc------ccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCccc
Q 002085          353 NCRTLRTVQLYSNRFSGELPT------GLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKN  426 (969)
Q Consensus       353 ~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~  426 (969)
                      ....++.++++.|.++|..|.      .+..+++|+.|+|++|.+++ +                      | .+..+++
T Consensus        16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l----------------------~-~~~~l~~   71 (198)
T 1ds9_A           16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-I----------------------S-SLSGMEN   71 (198)
T ss_dssp             HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-C----------------------C-CHHHHTT
T ss_pred             hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-c----------------------c-ccccCCC
Confidence            344566666666666666555      56666666655555555553 2                      2 4444444


Q ss_pred             chhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCC-cccccccccceEecc
Q 002085          427 LIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIP-KAIGSLLVMVSLDLS  505 (969)
Q Consensus       427 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls  505 (969)
                      |++|++++|.|+ .+|..+..+++|+.|+|++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|+.|+++
T Consensus        72 L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~  148 (198)
T 1ds9_A           72 LRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLA  148 (198)
T ss_dssp             CCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEEC
T ss_pred             CCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEec
Confidence            555555555554 344444555556666666666553 33 45555566666666666653211 245556666666666


Q ss_pred             CccccccCCC
Q 002085          506 GNQFSGEIPP  515 (969)
Q Consensus       506 ~N~l~g~~p~  515 (969)
                      +|++++.+|.
T Consensus       149 ~N~l~~~~~~  158 (198)
T 1ds9_A          149 GNPLYNDYKE  158 (198)
T ss_dssp             SCHHHHHHHT
T ss_pred             CCcccccccc
Confidence            6666555443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.45  E-value=4.2e-13  Score=150.94  Aligned_cols=213  Identities=15%  Similarity=0.108  Sum_probs=93.2

Q ss_pred             CcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceec
Q 002085           97 KNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYL  176 (969)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  176 (969)
                      ..++.+.+.+ +++..-..+|.++ +|+.++|..| ++.+-..+|.+ .+|+.+.|.+ .++..-+..|.++++|+.++|
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l  187 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADL  187 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence            3444444432 2332333344442 4555554443 33333334444 2355555543 333333344445555555555


Q ss_pred             ccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCC
Q 002085          177 YMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLE  256 (969)
Q Consensus       177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  256 (969)
                      ++|+++......|. .++|+.+.+..+   ...+-...|.++++|+.+.+.+ ++...-..+|.+ .+|+.+.| .|.++
T Consensus       188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~---l~~I~~~aF~~~~~L~~l~l~~-~l~~I~~~aF~~-~~L~~i~l-p~~i~  260 (401)
T 4fdw_A          188 SKTKITKLPASTFV-YAGIEEVLLPVT---LKEIGSQAFLKTSQLKTIEIPE-NVSTIGQEAFRE-SGITTVKL-PNGVT  260 (401)
T ss_dssp             TTSCCSEECTTTTT-TCCCSEEECCTT---CCEECTTTTTTCTTCCCEECCT-TCCEECTTTTTT-CCCSEEEE-ETTCC
T ss_pred             CCCcceEechhhEe-ecccCEEEeCCc---hheehhhHhhCCCCCCEEecCC-CccCcccccccc-CCccEEEe-CCCcc
Confidence            55555433333333 345555555433   2222333444555555555543 233333334444 44555555 23333


Q ss_pred             CCCCchhhcCcccchhhccCcccc-----cCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhc
Q 002085          257 GAIPSGLFLLNNLTQLFLYDNILS-----GEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLF  322 (969)
Q Consensus       257 ~~~p~~l~~l~~L~~L~L~~N~l~-----~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  322 (969)
                      ......|..+++|+.+++.+|.+.     ...+..|... +|+.++|. +.++.....+|.++++|+.+.|.
T Consensus       261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp  331 (401)
T 4fdw_A          261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIP  331 (401)
T ss_dssp             EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEEC
T ss_pred             EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEEC
Confidence            333444445555555555544443     2333334333 45555555 23444444555555555555553

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.45  E-value=4.1e-13  Score=132.51  Aligned_cols=114  Identities=21%  Similarity=0.342  Sum_probs=70.6

Q ss_pred             CCCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCc
Q 002085           62 PCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI  141 (969)
Q Consensus        62 ~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  141 (969)
                      .|. .++.|.   .+.++++++++. .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|
T Consensus         5 ~CP-~~C~C~---~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~   77 (174)
T 2r9u_A            5 GCP-SQCSCD---QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVF   77 (174)
T ss_dssp             SSC-TTSEEC---SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             CCC-CCCEEC---CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHh
Confidence            354 456674   245666666663 4555443  566677777777766666666666666666666666665444455


Q ss_pred             ccCCCCcEEecCCCCCCCcCCCcccCcccccceeccccccc
Q 002085          142 DRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFN  182 (969)
Q Consensus       142 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  182 (969)
                      ..+++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus        78 ~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           78 DKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             CCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence            66666666666666666444444666666666666666665

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.45  E-value=3.2e-13  Score=132.84  Aligned_cols=105  Identities=21%  Similarity=0.273  Sum_probs=71.4

Q ss_pred             EEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCC
Q 002085           76 TGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGN  155 (969)
Q Consensus        76 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N  155 (969)
                      +.+++++++++. +|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            345666666654 454442  66777777777777666777777777777777777777665656677777777777777


Q ss_pred             CCCCcCCCcccCcccccceecccccccC
Q 002085          156 NFSGDIPRSIGRLSELQTLYLYMNEFNG  183 (969)
Q Consensus       156 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~  183 (969)
                      +|++..+..|.++++|++|+|++|.++.
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            7775555567777777777777777663

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.45  E-value=3.8e-13  Score=151.24  Aligned_cols=262  Identities=10%  Similarity=0.023  Sum_probs=138.9

Q ss_pred             CCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeec
Q 002085          121 TKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGL  200 (969)
Q Consensus       121 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  200 (969)
                      ..++.+.+.+ .++.+-..+|.+. +|+.++|..| ++..-..+|.+. +|+.+.+.+ .++.+.+..|.++++|+.+++
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l  187 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL  187 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence            5555555543 2343444555553 5666666555 543444455553 566666654 455455566666666666666


Q ss_pred             ccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccc
Q 002085          201 AYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILS  280 (969)
Q Consensus       201 ~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  280 (969)
                      +.|++   ..++...-...+|+.+.|.+ ++...-..+|.++++|+.++|..| ++.....+|.. .+|+.+.| .|.++
T Consensus       188 ~~n~l---~~I~~~aF~~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~  260 (401)
T 4fdw_A          188 SKTKI---TKLPASTFVYAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT  260 (401)
T ss_dssp             TTSCC---SEECTTTTTTCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC
T ss_pred             CCCcc---eEechhhEeecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc
Confidence            66532   22333222246666666653 354445556666666666666654 44333334444 56666666 34455


Q ss_pred             cCCCCchhhc-ccccccccCcccc-----ccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCC
Q 002085          281 GEIPSSVEAL-KLTDIDLSMNNLT-----GSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNC  354 (969)
Q Consensus       281 ~~~~~~~~~~-~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l  354 (969)
                      ......|... +|+.+++.+|.+.     ...+.+|.++++|+.++|.+ .+..                 .-..+|.+|
T Consensus       261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~-----------------I~~~aF~~c  322 (401)
T 4fdw_A          261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRI-----------------LGQGLLGGN  322 (401)
T ss_dssp             EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCE-----------------ECTTTTTTC
T ss_pred             EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEE-----------------EhhhhhcCC
Confidence            4445555544 5666666665554     34455666666666666652 2331                 112345566


Q ss_pred             ccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCcc---ccccccEEEeeccccC
Q 002085          355 RTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSK---TAWNLTRLEISNNRFS  414 (969)
Q Consensus       355 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~~L~~L~Ls~N~l~  414 (969)
                      ++|+.++|..| ++...+..|..+ +|+.+++++|.+.......   ...+++.|++..+.+.
T Consensus       323 ~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          323 RKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             CCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            66666666443 443444555555 6666666666554322221   1134566666655543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.43  E-value=4e-13  Score=132.19  Aligned_cols=103  Identities=26%  Similarity=0.272  Sum_probs=89.1

Q ss_pred             ccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceeccc
Q 002085           99 LTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYM  178 (969)
Q Consensus        99 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  178 (969)
                      .++|++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            578999999998 5776664  8899999999999988888899999999999999999977777788999999999999


Q ss_pred             ccccCcCCcccCCCCCcceeecccCC
Q 002085          179 NEFNGTFPKEIGDLSNLEVLGLAYNS  204 (969)
Q Consensus       179 N~l~~~~p~~~~~l~~L~~L~L~~N~  204 (969)
                      |+|++..+..|..+++|++|+|++|.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~  113 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNP  113 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCC
Confidence            99997777778888888888888885

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.41  E-value=7.1e-13  Score=130.81  Aligned_cols=102  Identities=21%  Similarity=0.215  Sum_probs=84.6

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN  179 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  179 (969)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            68899999986 6777664  88899999999998888888889999999999999998665666788888999999999


Q ss_pred             cccCcCCcccCCCCCcceeecccCC
Q 002085          180 EFNGTFPKEIGDLSNLEVLGLAYNS  204 (969)
Q Consensus       180 ~l~~~~p~~~~~l~~L~~L~L~~N~  204 (969)
                      +|++..+..|..+++|++|+|++|.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~  116 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNP  116 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCC
Confidence            8886666668888888888888775

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.40  E-value=1.8e-12  Score=146.46  Aligned_cols=329  Identities=13%  Similarity=0.021  Sum_probs=225.5

Q ss_pred             CccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcc
Q 002085           90 PPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLS  169 (969)
Q Consensus        90 ~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  169 (969)
                      ..+|.++++|+.+.|.. .++..-..+|.++++|+.++|..+ ++..-...|.++.+|+.+.+..+ +.......|.++.
T Consensus        64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~  140 (394)
T 4fs7_A           64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD  140 (394)
T ss_dssp             TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred             HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence            45788999999999975 477566778999999999999865 55455678999999999888765 4435556777765


Q ss_pred             cccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhh
Q 002085          170 ELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILA  249 (969)
Q Consensus       170 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  249 (969)
                      .+........  .......|.++++|+.+.+..+   ....-...|.++.+|+.+.+..+ +......+|.++..|+.+.
T Consensus       141 ~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~---~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~  214 (394)
T 4fs7_A          141 FKEITIPEGV--TVIGDEAFATCESLEYVSLPDS---METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENME  214 (394)
T ss_dssp             CSEEECCTTC--CEECTTTTTTCTTCCEEECCTT---CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCC
T ss_pred             ccccccCccc--cccchhhhcccCCCcEEecCCc---cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceee
Confidence            5444433333  3245578999999999999866   33445567899999999999765 5555567899999999998


Q ss_pred             ccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhccccCcC
Q 002085          250 LNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSG  328 (969)
Q Consensus       250 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  328 (969)
                      +..+...  +.+......+|+.+.+..+ ++......+... .++.+.+..+... .....|..+..++.+.+..+.+. 
T Consensus       215 ~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~-  289 (394)
T 4fs7_A          215 FPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP-  289 (394)
T ss_dssp             CCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC-
T ss_pred             cCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec-
Confidence            8877553  2344455678888877644 333334444443 6888888777554 56667777877777666544322 


Q ss_pred             cCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEe
Q 002085          329 EVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEI  408 (969)
Q Consensus       329 ~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~L  408 (969)
                                         ...+..+.+|+.+.+.++ ++......|..+.+|+.++|.++                   
T Consensus       290 -------------------~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-------------------  330 (394)
T 4fs7_A          290 -------------------EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-------------------  330 (394)
T ss_dssp             -------------------TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-------------------
T ss_pred             -------------------cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-------------------
Confidence                               134667778888887654 44333445555666665555332                   


Q ss_pred             eccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEE
Q 002085          409 SNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNL  478 (969)
Q Consensus       409 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  478 (969)
                          ++.+...+|.++.+|+.+++..| ++.+-..+|.++.+|+.+++..| ++ .+...|.++++|+.+
T Consensus       331 ----v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          331 ----VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             ----CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             ----ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence                33344566777788888888766 66566677888888888888765 33 345567777777654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.31  E-value=2.7e-12  Score=142.40  Aligned_cols=108  Identities=19%  Similarity=0.171  Sum_probs=72.3

Q ss_pred             CCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccC-CCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCc
Q 002085           63 CDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSS-NSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI  141 (969)
Q Consensus        63 c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  141 (969)
                      |.|..|.|+..         ++|+. +|. |..+++|++|+|++ |.|++..+..|.+|++|++|+|++|+|++..|..|
T Consensus         8 C~~~~v~~~~~---------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~   76 (347)
T 2ifg_A            8 HGSSGLRCTRD---------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF   76 (347)
T ss_dssp             SSSSCEECCSS---------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGG
T ss_pred             ccCCEEEcCCC---------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHh
Confidence            77777766532         14443 566 77777777777775 77776666777777777777777777777667777


Q ss_pred             ccCCCCcEEecCCCCCCCcCCCcccCcccccceeccccccc
Q 002085          142 DRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFN  182 (969)
Q Consensus       142 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  182 (969)
                      .+|++|++|+|++|+|++..+..|..++ |+.|+|.+|.+.
T Consensus        77 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           77 HFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             GSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             cCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            7777777777777777754444444444 666666666655

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.29  E-value=2.7e-14  Score=159.03  Aligned_cols=165  Identities=18%  Similarity=0.145  Sum_probs=111.0

Q ss_pred             CccCcEEEcccccccCCCCcccccc-----cCCCccccCCCccccccCccc---cccccEEEeeccccCCCcccccC---
Q 002085          354 CRTLRTVQLYSNRFSGELPTGLWTT-----FNLSSLMLSDNTISGELPSKT---AWNLTRLEISNNRFSGQIQRGVG---  422 (969)
Q Consensus       354 l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~---~~~L~~L~Ls~N~l~~~~~~~~~---  422 (969)
                      ++.|+.|+|++|.++......+...     .+|+.|+|++|.|+.......   ..+|+.|+|++|+|++.....+.   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            4578999999999985544444443     588888898888864332222   24688888888888755444442   


Q ss_pred             --CcccchhhcccCCccccc----cCccccCccccchhhccCcccCCC----CCcccccccCCCEEEccCccccCC----
Q 002085          423 --SWKNLIVFKASNNLFSGE----IPVELTSLSHLNTLLLDGNKLSGK----LPSQIVSWTSLNNLNLARNELSGE----  488 (969)
Q Consensus       423 --~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----  488 (969)
                        ..++|++|+|++|.|+..    ++..+..+++|++|+|++|+|++.    ++..+..+++|+.|+|++|.|+..    
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence              346788888888887642    444556677788888888887642    245566667788888888887642    


Q ss_pred             CCcccccccccceEeccCccccccCCCccc
Q 002085          489 IPKAIGSLLVMVSLDLSGNQFSGEIPPEIG  518 (969)
Q Consensus       489 ~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~  518 (969)
                      ++..+...++|++|||++|.|++.....+.
T Consensus       231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~  260 (372)
T 3un9_A          231 LARAAREHPSLELLHLYFNELSSEGRQVLR  260 (372)
T ss_dssp             HHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred             HHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence            334455567788888888887754444443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.22  E-value=4.7e-14  Score=157.15  Aligned_cols=160  Identities=14%  Similarity=0.126  Sum_probs=77.1

Q ss_pred             CcccEEEccCCCCCCCCCcccCC-----CCCCCEEeccCCcCCCCCCCCc-ccCCCCcEEecCCCCCCCcCCCcc-----
Q 002085           97 KNLTTIDLSSNSIPGEFPEFLYN-----CTKLQNLDLSQNYFVGPIPSDI-DRISGLQCIDLGGNNFSGDIPRSI-----  165 (969)
Q Consensus        97 ~~L~~L~L~~n~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~p~~~-----  165 (969)
                      +.|++|+|++|.|+......+..     .++|++|+|++|.+++.....+ ..+.+|++|+|++|+|+......+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            45666677766666433222222     2566666666666653222222 234566666666666654333332     


Q ss_pred             cCcccccceecccccccCc----CCcccCCCCCcceeecccCCCCCCC--CCCccccccCCCcEEEccCCccccc----C
Q 002085          166 GRLSELQTLYLYMNEFNGT----FPKEIGDLSNLEVLGLAYNSNFKPA--MIPIEFGMLKKLKTLWMTEANLIGE----I  235 (969)
Q Consensus       166 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~~~~~~--~~p~~~~~l~~L~~L~L~~n~l~~~----~  235 (969)
                      ...++|++|+|++|.|+..    ++..+..+++|++|+|++|.+...+  .++..+...++|++|+|++|++...    +
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l  231 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL  231 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence            2345566666666666532    2233345556666666666422111  1122333444444444444444332    2


Q ss_pred             chhhcCCCchhhhhccCCcCC
Q 002085          236 PEAMSNLSSLEILALNGNHLE  256 (969)
Q Consensus       236 p~~~~~l~~L~~L~L~~N~l~  256 (969)
                      +..+...++|++|+|++|.|+
T Consensus       232 ~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          232 ARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             HHHHHHCSSCCEEECTTSSCC
T ss_pred             HHHHHhCCCCCEEeccCCCCC
Confidence            223333444555555555544

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.21  E-value=1.9e-11  Score=135.47  Aligned_cols=101  Identities=17%  Similarity=0.174  Sum_probs=86.2

Q ss_pred             EEEccCC-CCCCCCCcccCCCCCCCEEeccC-CcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceeccc
Q 002085          101 TIDLSSN-SIPGEFPEFLYNCTKLQNLDLSQ-NYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYM  178 (969)
Q Consensus       101 ~L~L~~n-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  178 (969)
                      .++++++ +|+ .+|. |..+++|++|+|++ |+|++..+..|.+|++|++|+|++|+|++..|..|++|++|++|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4688887 888 5788 99999999999996 999977778899999999999999999988888899999999999999


Q ss_pred             ccccCcCCcccCCCCCcceeecccCC
Q 002085          179 NEFNGTFPKEIGDLSNLEVLGLAYNS  204 (969)
Q Consensus       179 N~l~~~~p~~~~~l~~L~~L~L~~N~  204 (969)
                      |+|++..+..|..++ |+.|+|++|.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~  114 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNP  114 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCC
Confidence            999976666666655 8888888775

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.15  E-value=8.7e-11  Score=124.58  Aligned_cols=146  Identities=12%  Similarity=0.036  Sum_probs=112.4

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCce
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSK  711 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  711 (969)
                      ..+..|+....++.|+.+.||++...  ++.+++|+.......   ....+.+|+++++.+. +..+.++++++.+.+..
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            34567888888899999999998753  678999988542111   1245889999999884 67788999999888899


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC----------------------
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC----------------------  769 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------  769 (969)
                      |+||||++|.+|.+....                  ......++.+++.+++.||+..                      
T Consensus        86 ~lv~e~i~G~~l~~~~~~------------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~  147 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYED------------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN  147 (263)
T ss_dssp             EEEEECCSSEEHHHHCCT------------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred             EEEEEecCCeehhhccCC------------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHh
Confidence            999999999999876321                  1123467888899999999710                      


Q ss_pred             ----------------------------------CCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          770 ----------------------------------TPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       770 ----------------------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                                                        ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                              14699999999999998765667999998753

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.14  E-value=3.9e-10  Score=127.19  Aligned_cols=89  Identities=11%  Similarity=0.109  Sum_probs=40.8

Q ss_pred             CcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCccccc
Q 002085          416 QIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGS  495 (969)
Q Consensus       416 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  495 (969)
                      +....|.++.+|+.+++.++ ++.+-...|.++.+|+.+.|..+ ++..-...|.+|++|+.+++.+|....   ..+..
T Consensus       302 I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~  376 (394)
T 4gt6_A          302 LPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAIST  376 (394)
T ss_dssp             ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBC
T ss_pred             cCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhc
Confidence            33445555555665555543 44344455666666666666433 442333455666666666666554431   33444


Q ss_pred             ccccceEeccCccc
Q 002085          496 LLVMVSLDLSGNQF  509 (969)
Q Consensus       496 l~~L~~L~ls~N~l  509 (969)
                      ..+|+.+.+..|.+
T Consensus       377 ~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          377 DSGLQNLPVAPGSI  390 (394)
T ss_dssp             CCCC----------
T ss_pred             cCCCCEEEeCCCCE
Confidence            55555555554443

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.07  E-value=1.1e-09  Score=123.60  Aligned_cols=81  Identities=14%  Similarity=0.216  Sum_probs=48.4

Q ss_pred             ccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEc
Q 002085          401 WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNL  480 (969)
Q Consensus       401 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  480 (969)
                      .+|+.++|..+ ++.+....|.++.+|+.+.+..+ ++.+-...|.++.+|+.+++.+|....   ..+..+.+|+.+.+
T Consensus       311 ~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i  385 (394)
T 4gt6_A          311 ISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPV  385 (394)
T ss_dssp             TTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----
T ss_pred             CCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEe
Confidence            35555665543 44455667888888888888654 554566788888888888888876541   45677788888888


Q ss_pred             cCcccc
Q 002085          481 ARNELS  486 (969)
Q Consensus       481 s~N~l~  486 (969)
                      ..|.+.
T Consensus       386 ~~~~~~  391 (394)
T 4gt6_A          386 APGSID  391 (394)
T ss_dssp             ------
T ss_pred             CCCCEE
Confidence            777653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.99  E-value=6.4e-10  Score=117.73  Aligned_cols=138  Identities=14%  Similarity=0.084  Sum_probs=95.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCc--eeeEEEEEEcCCceEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN--IVKLWCCISSENSKLL  713 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~l  713 (969)
                      ..+....+.+.|..+.||++.. .+|+.+++|+.....      ...+.+|+++++.+.+.+  +.+++++..+++..++
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            3444433334566699999865 357789999875431      245778999999886444  5668888888888999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC------------------------
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC------------------------  769 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------  769 (969)
                      ||||++|.++.  ...                .   ....++.+++..++.||+..                        
T Consensus        93 v~e~i~G~~l~--~~~----------------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (264)
T 1nd4_A           93 LLGEVPGQDLL--SSH----------------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAG  151 (264)
T ss_dssp             EEECCSSEETT--TSC----------------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTT
T ss_pred             EEEecCCcccC--cCc----------------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcC
Confidence            99999998874  111                0   11244555555566665431                        


Q ss_pred             -------------------------------CCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          770 -------------------------------TPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       770 -------------------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                                                     ...++|+|++|.||++++++.+.|+|||.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          152 LVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                           12499999999999998776677999998754

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.90  E-value=1.6e-10  Score=127.42  Aligned_cols=205  Identities=16%  Similarity=0.162  Sum_probs=102.9

Q ss_pred             CCeEEEEecCCCCCC-CC-------CccccCCCcccEEEccCCCCC---------CCCCcccCCCCCCCEEeccCCcCCC
Q 002085           73 NSVTGISLRHKDITQ-KI-------PPIICDLKNLTTIDLSSNSIP---------GEFPEFLYNCTKLQNLDLSQNYFVG  135 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~-~~-------~~~~~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~Ls~N~l~~  135 (969)
                      .+|+.|.+......+ ..       ..++..+++|+.|.+.++...         +.+...+..+++|+.|+|++|.-. 
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-  185 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-  185 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence            457888887655442 21       334556778888877664331         123333455566666666655211 


Q ss_pred             CCCCCcccCCCCcEEecCCCCCCCcCCCccc--Ccccccceeccc--ccccCcCCcccCCCCCcceeecccCCCCCCCCC
Q 002085          136 PIPSDIDRISGLQCIDLGGNNFSGDIPRSIG--RLSELQTLYLYM--NEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMI  211 (969)
Q Consensus       136 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~  211 (969)
                      .++. + .+++|++|+|..|.+.......+.  .+++|++|+|+.  |...+..  .                   ...+
T Consensus       186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~-------------------~~~l  242 (362)
T 2ra8_A          186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--D-------------------MNVF  242 (362)
T ss_dssp             BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--C-------------------GGGT
T ss_pred             eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--h-------------------HHHH
Confidence            1222 2 245555555555554432222222  345555555432  1110000  0                   0000


Q ss_pred             Cccc--cccCCCcEEEccCCcccccCchhhc---CCCchhhhhccCCcCCCC----CCchhhcCcccchhhccCcccccC
Q 002085          212 PIEF--GMLKKLKTLWMTEANLIGEIPEAMS---NLSSLEILALNGNHLEGA----IPSGLFLLNNLTQLFLYDNILSGE  282 (969)
Q Consensus       212 p~~~--~~l~~L~~L~L~~n~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~  282 (969)
                      ...+  ..+++|+.|+|.+|.+....+..+.   .+++|++|+|+.|.+++.    ++..+..+++|+.|+|++|.++..
T Consensus       243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~  322 (362)
T 2ra8_A          243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE  322 (362)
T ss_dssp             GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred             HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence            0111  2356777777777766654444443   467788888888887753    233334567778888877776633


Q ss_pred             CCCchhhcccccccccCcc
Q 002085          283 IPSSVEALKLTDIDLSMNN  301 (969)
Q Consensus       283 ~~~~~~~~~L~~L~Ls~N~  301 (969)
                      .-..+...-...++++.++
T Consensus       323 ~~~~l~~alg~~~~~~~~~  341 (362)
T 2ra8_A          323 MKKELQKSLPMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHHHCCSEEECCSBC
T ss_pred             HHHHHHHHcCCEEEecCCc
Confidence            2222222112345666665

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.89  E-value=2.8e-09  Score=118.49  Aligned_cols=143  Identities=13%  Similarity=0.191  Sum_probs=105.4

Q ss_pred             ccceeeecCcEEEEEEEEcCCCcEEEEEEEe--ccchhcHHHHHHHHHHHHHHhccc--cCceeeEEEEEEcC---CceE
Q 002085          640 ESNLIGSGGSGQVYRIDINGAGEFVAVKRIW--NNRKLNQKLEKEFIAEIEILGTIR--HANIVKLWCCISSE---NSKL  712 (969)
Q Consensus       640 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~  712 (969)
                      ..+.++.|.++.||++...  +..+++|+..  ....  ......+.+|+++++.+.  +..+.+++.++.+.   +..|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            3567899999999998764  4678999764  2211  122357889999999996  45688899888776   5589


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC-----------------------
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC-----------------------  769 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----------------------  769 (969)
                      +||||++|..+.+...               ..++...+..++.+++..|+.||...                       
T Consensus       118 ~vme~v~G~~l~~~~~---------------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQSL---------------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERW  182 (359)
T ss_dssp             EEEECCCCBCCCCTTC---------------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHH
T ss_pred             EEEEecCCeecCCCcc---------------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHH
Confidence            9999999876643111               12567778889999999999999630                       


Q ss_pred             --------------------------------CCCeEecCCCCCcEEECCCCc--EEEeeccccee
Q 002085          770 --------------------------------TPQIIHRDVKSSNILLDSEFK--AKIADFGLAKM  801 (969)
Q Consensus       770 --------------------------------~~~ivH~Dlkp~Nill~~~~~--~kl~Dfgla~~  801 (969)
                                                      .+.++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          183 TKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                            257999999999999997753  68999999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.79  E-value=3.2e-10  Score=124.94  Aligned_cols=181  Identities=13%  Similarity=0.112  Sum_probs=104.4

Q ss_pred             CCCCCccCcEEEccccccc---------CCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccc
Q 002085          350 SLGNCRTLRTVQLYSNRFS---------GELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRG  420 (969)
Q Consensus       350 ~l~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~  420 (969)
                      +...+++|+.|.+..+...         +.++..+..+++|+.|+|++|.-. .++.....+|+.|+|..|.++......
T Consensus       134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~~~~~~L~~L~L~~~~l~~~~l~~  212 (362)
T 2ra8_A          134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGKKPRPNLKSLEIISGGLPDSVVED  212 (362)
T ss_dssp             THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCSCBCTTCSEEEEECSBCCHHHHHH
T ss_pred             hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eeccccCCCCcEEEEecCCCChHHHHH
Confidence            3455678888888665432         124445556677888888776311 122223467888888777776444333


Q ss_pred             cC--CcccchhhcccC--Cccccc-----cCccc--cCccccchhhccCcccCCCCCcccc---cccCCCEEEccCcccc
Q 002085          421 VG--SWKNLIVFKASN--NLFSGE-----IPVEL--TSLSHLNTLLLDGNKLSGKLPSQIV---SWTSLNNLNLARNELS  486 (969)
Q Consensus       421 ~~--~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~  486 (969)
                      +.  .+++|+.|+|+.  |...+.     +...+  ..+++|+.|+|++|++++..+..+.   .+++|+.|+|+.|.|+
T Consensus       213 l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~  292 (362)
T 2ra8_A          213 ILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT  292 (362)
T ss_dssp             HHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCB
T ss_pred             HHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCC
Confidence            43  567777777642  221111     11122  2467788888887777643333322   4677888888888776


Q ss_pred             CC----CCcccccccccceEeccCccccccCCCccccccccEEEeecCc
Q 002085          487 GE----IPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNK  531 (969)
Q Consensus       487 ~~----~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~L~~l~ls~N~  531 (969)
                      +.    ++..+..+++|+.|+|++|.++...-..+...-...+++++|.
T Consensus       293 d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~alg~~~~~~~~~  341 (362)
T 2ra8_A          293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHCCSEEECCSBC
T ss_pred             hHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHcCCEEEecCCc
Confidence            53    3444456777888888888776433333332112456777765

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.78  E-value=2.7e-09  Score=115.69  Aligned_cols=187  Identities=19%  Similarity=0.185  Sum_probs=115.0

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCc--eeeEEEEEEcCC---ceEEE
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HAN--IVKLWCCISSEN---SKLLV  714 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv  714 (969)
                      .+.++.|....||++.     ..+++|+....     .....+.+|+++++.+. +..  +.+++......+   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4568999999999863     45899986322     33567899999998883 322  445555543333   35899


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhccc--------------------------
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD--------------------------  768 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------------------------  768 (969)
                      |||++|.++.+....               .++..++..++.+++..++.||+.                          
T Consensus        95 m~~i~G~~l~~~~~~---------------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (304)
T 3sg8_A           95 FTKIKGVPLTPLLLN---------------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKK  159 (304)
T ss_dssp             EECCCCEECCHHHHH---------------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHH
T ss_pred             EcccCCeECCccccc---------------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHH
Confidence            999999877643221               133444455555555555555531                          


Q ss_pred             -----------------------------CCCCeEecCCCCCcEEECC--CCcEEEeecccceecccCCCCcccccc---
Q 002085          769 -----------------------------CTPQIIHRDVKSSNILLDS--EFKAKIADFGLAKMLAKQGEPHTMSAV---  814 (969)
Q Consensus       769 -----------------------------~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~---  814 (969)
                                                   ..+.++|+|++|.||++++  +..+.++||+.+..-+...+-......   
T Consensus       160 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~  239 (304)
T 3sg8_A          160 LLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEE  239 (304)
T ss_dssp             HHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTS
T ss_pred             HhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccc
Confidence                                         1246899999999999998  456789999998753221000000000   


Q ss_pred             ---------ccCcccCc-hhhcccCCCCCccchhhHHHHHHHHHhCCCCC
Q 002085          815 ---------AGSFGYFA-PEYAYTTKVNEKIDIYSFGVVLLELVTGKEAN  854 (969)
Q Consensus       815 ---------~gt~~y~a-PE~~~~~~~~~~sDvwslG~il~elltg~~p~  854 (969)
                               ...+++.. |+....  .....+.|++|.++|++.+|..+|
T Consensus       240 ~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          240 YGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence                     00011112 222211  122368999999999999998765

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.76  E-value=2.4e-10  Score=119.28  Aligned_cols=66  Identities=27%  Similarity=0.500  Sum_probs=35.6

Q ss_pred             CCCCCCEEeccCCcCCC--CCCCCcccCCCCcEEecCCCCCCCcCCCcccCcc--cccceecccccccCcCC
Q 002085          119 NCTKLQNLDLSQNYFVG--PIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLS--ELQTLYLYMNEFNGTFP  186 (969)
Q Consensus       119 ~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p  186 (969)
                      ++++|++|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..++  +|++|+|++|.+++.+|
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence            45566666666666655  3344455566666666666666543  2233333  55566666666554443

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.65  E-value=1.4e-07  Score=105.53  Aligned_cols=82  Identities=9%  Similarity=0.014  Sum_probs=42.1

Q ss_pred             cccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccc
Q 002085           92 IICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSEL  171 (969)
Q Consensus        92 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  171 (969)
                      .+....+|+.+.+.. +++.+-..+|.++.+|+.++|..+ ++.+-..+|.+. +|+.+.+..+ +.......|.. .+|
T Consensus        41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L  115 (379)
T 4h09_A           41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDL  115 (379)
T ss_dssp             TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCC
T ss_pred             ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCc
Confidence            344455666666653 355344556777777777777543 443444555554 4555555433 33222223333 245


Q ss_pred             cceeccc
Q 002085          172 QTLYLYM  178 (969)
Q Consensus       172 ~~L~L~~  178 (969)
                      +.+.+..
T Consensus       116 ~~i~lp~  122 (379)
T 4h09_A          116 DDFEFPG  122 (379)
T ss_dssp             SEEECCT
T ss_pred             ccccCCC
Confidence            5555543

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.59  E-value=1.7e-07  Score=104.93  Aligned_cols=301  Identities=12%  Similarity=0.032  Sum_probs=137.1

Q ss_pred             cccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCC
Q 002085          164 SIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLS  243 (969)
Q Consensus       164 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~  243 (969)
                      ++....+|+.+.+.. .++.+...+|.++.+|+.++|..+   ...+-...|.++ +|+.+.+.. ++......+|.+ .
T Consensus        41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~---v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~aF~~-~  113 (379)
T 4h09_A           41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST---VTSIGDGAFADT-KLQSYTGME-RVKKFGDYVFQG-T  113 (379)
T ss_dssp             TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT---CCEECTTTTTTC-CCCEEEECT-TCCEECTTTTTT-C
T ss_pred             ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc---ceEechhhhcCC-CCceEECCc-eeeEeccceecc-C
Confidence            456667888888864 456566677888888888888654   222223344444 444444432 122222223332 2


Q ss_pred             chhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhcc
Q 002085          244 SLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFS  323 (969)
Q Consensus       244 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  323 (969)
                      +|+.+.+..+                         ++......|...+++.+.+..+ ++......|..+.+++.+.+..
T Consensus       114 ~L~~i~lp~~-------------------------~~~i~~~~F~~~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~  167 (379)
T 4h09_A          114 DLDDFEFPGA-------------------------TTEIGNYIFYNSSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSS  167 (379)
T ss_dssp             CCSEEECCTT-------------------------CCEECTTTTTTCCCCEEEECTT-CCEECSCTTTTCTTCCEEEECT
T ss_pred             CcccccCCCc-------------------------cccccccccccceeeeeeccce-eeccccchhccccccccccccc
Confidence            3444444332                         1112222222223333333222 2223344455555555554443


Q ss_pred             ccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccc-cccCcccccc
Q 002085          324 NHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTIS-GELPSKTAWN  402 (969)
Q Consensus       324 N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~~  402 (969)
                      +..........     ..+........+..+..+..+.+..+.-. .....+....+|+.+.+..+--. +.-.......
T Consensus       168 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~~~~i~~~~f~~~~~  241 (379)
T 4h09_A          168 NNKNYVAENYV-----LYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSGVTTLGDGAFYGMKA  241 (379)
T ss_dssp             TCSSEEEETTE-----EEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTTCCEECTTTTTTCSS
T ss_pred             ccceeecccce-----ecccccceeccccccccccccccccceeE-EeecccccccccceeeeccceeEEccccccCCcc
Confidence            33221000000     00000011112223333444433322211 22333344444555444333110 0001112234


Q ss_pred             ccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccC
Q 002085          403 LTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLAR  482 (969)
Q Consensus       403 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  482 (969)
                      |+.+.+..+ ++.+....|.++.+|+.+.+..+ ++......|.++.+|+.+.+.++.++..-...|.+|.+|+.++|..
T Consensus       242 L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~  319 (379)
T 4h09_A          242 LDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPT  319 (379)
T ss_dssp             CCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCT
T ss_pred             ceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCc
Confidence            555555544 44344455666666666666443 4334445566666677777666666644445566666777777654


Q ss_pred             ccccCCCCcccccccccceEeccC
Q 002085          483 NELSGEIPKAIGSLLVMVSLDLSG  506 (969)
Q Consensus       483 N~l~~~~p~~~~~l~~L~~L~ls~  506 (969)
                      + ++..-..+|.++.+|+.+.+..
T Consensus       320 ~-l~~I~~~aF~~C~~L~~i~ip~  342 (379)
T 4h09_A          320 A-LKTIQVYAFKNCKALSTISYPK  342 (379)
T ss_dssp             T-CCEECTTTTTTCTTCCCCCCCT
T ss_pred             c-ccEEHHHHhhCCCCCCEEEECC
Confidence            3 4433345666666666666543

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.53  E-value=2.3e-08  Score=104.26  Aligned_cols=92  Identities=24%  Similarity=0.290  Sum_probs=59.8

Q ss_pred             cCCcccchh--hcccCCccc---cccCccccCccccchhhccCcccCC--CCCcccccccCCCEEEccCccccCCCCccc
Q 002085          421 VGSWKNLIV--FKASNNLFS---GEIPVELTSLSHLNTLLLDGNKLSG--KLPSQIVSWTSLNNLNLARNELSGEIPKAI  493 (969)
Q Consensus       421 ~~~l~~L~~--L~l~~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  493 (969)
                      +...+.|..  ++++.|...   +.++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            344455665  666777433   2222223457788888888888876  4456666778888888888888754  334


Q ss_pred             cccc--ccceEeccCccccccCC
Q 002085          494 GSLL--VMVSLDLSGNQFSGEIP  514 (969)
Q Consensus       494 ~~l~--~L~~L~ls~N~l~g~~p  514 (969)
                      ..+.  +|++|+|++|++++.+|
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hhcccCCcceEEccCCcCccccC
Confidence            4444  77778888888777666

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.50  E-value=6e-07  Score=95.27  Aligned_cols=137  Identities=15%  Similarity=0.118  Sum_probs=93.9

Q ss_pred             ceeeecCcE-EEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEEEEeecc
Q 002085          642 NLIGSGGSG-QVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       642 ~~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      +.+..|..| .||+......+..+++|+-...      ....+.+|..+++.+. +--+.++++++.+++..++|||+++
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            345556655 6999887767778999986432      3467888999998884 3347788889999999999999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhccc-------------------------------
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHD-------------------------------  768 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------  768 (969)
                      |.++.+......                 .....++.+++..++.||..                               
T Consensus       104 G~~~~~~~~~~~-----------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (272)
T 4gkh_A          104 GKTAFQVLEEYP-----------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASD  166 (272)
T ss_dssp             SEEHHHHHHHCG-----------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGG
T ss_pred             CccccccccCCH-----------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhh
Confidence            988766543211                 11112222333333333311                               


Q ss_pred             ------------------------CCCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          769 ------------------------CTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       769 ------------------------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                                              ..+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          167 FDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                    122489999999999999887778999998764

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.31  E-value=3.4e-08  Score=98.11  Aligned_cols=66  Identities=23%  Similarity=0.260  Sum_probs=34.0

Q ss_pred             ccCccccchhhccCcccCCC----CCcccccccCCCEEEc--cCccccCC----CCcccccccccceEeccCcccc
Q 002085          445 LTSLSHLNTLLLDGNKLSGK----LPSQIVSWTSLNNLNL--ARNELSGE----IPKAIGSLLVMVSLDLSGNQFS  510 (969)
Q Consensus       445 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~  510 (969)
                      +...++|++|+|++|+|++.    +...+...++|++|+|  ++|.|...    +...+...++|+.|+|++|.+.
T Consensus        89 L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           89 LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            33445556666666665532    2334444555666666  55665532    2233334455666666666554

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.28  E-value=5.4e-08  Score=96.66  Aligned_cols=95  Identities=16%  Similarity=0.227  Sum_probs=61.3

Q ss_pred             CCccccCCCcccEEEccCC-CCCCC----CCcccCCCCCCCEEeccCCcCCCC----CCCCcccCCCCcEEecCCCCCCC
Q 002085           89 IPPIICDLKNLTTIDLSSN-SIPGE----FPEFLYNCTKLQNLDLSQNYFVGP----IPSDIDRISGLQCIDLGGNNFSG  159 (969)
Q Consensus        89 ~~~~~~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~  159 (969)
                      +...+...+.|++|+|++| .|...    +...+...++|++|+|++|.|...    +...+...++|++|+|++|.|+.
T Consensus        28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            3445666778888888888 77632    345566677788888888887642    23334455677777777777764


Q ss_pred             c----CCCcccCcccccceec--ccccccC
Q 002085          160 D----IPRSIGRLSELQTLYL--YMNEFNG  183 (969)
Q Consensus       160 ~----~p~~~~~l~~L~~L~L--~~N~l~~  183 (969)
                      .    +...+...++|++|+|  ++|.|+.
T Consensus       108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          108 SGILALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             HHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence            2    3444555566777777  6666653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.25  E-value=7e-06  Score=88.53  Aligned_cols=75  Identities=17%  Similarity=0.138  Sum_probs=56.1

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccC---ceeeEEEEEE-cCCceEEEEe
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA---NIVKLWCCIS-SENSKLLVYE  716 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e  716 (969)
                      .+.++.|....||+.     |..+++|+...     ......+.+|+++++.+.+.   .+.+++.++. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            466889999999987     45688897522     23356899999999999642   3566677664 4566889999


Q ss_pred             eccCCCHHH
Q 002085          717 YMENQSLDR  725 (969)
Q Consensus       717 ~~~~gsL~~  725 (969)
                      |++|.++.+
T Consensus        94 ~i~G~~l~~  102 (306)
T 3tdw_A           94 KVQGQILGE  102 (306)
T ss_dssp             CCCSEECHH
T ss_pred             ccCCeECch
Confidence            999988765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.94  E-value=1e-05  Score=89.48  Aligned_cols=85  Identities=6%  Similarity=0.075  Sum_probs=56.4

Q ss_pred             ccee-eecCcEEEEEEEEc--C----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-c--CceeeEEEEEEcC--
Q 002085          641 SNLI-GSGGSGQVYRIDIN--G----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-H--ANIVKLWCCISSE--  708 (969)
Q Consensus       641 ~~~l-G~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  708 (969)
                      .+.| +.|....+|+....  .    +++.+++|+..............+.+|+++++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999988753  1    15678999764322000000145678888888884 3  3577888887665  


Q ss_pred             -CceEEEEeeccCCCHHH
Q 002085          709 -NSKLLVYEYMENQSLDR  725 (969)
Q Consensus       709 -~~~~lv~e~~~~gsL~~  725 (969)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             45789999999876653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.82  E-value=3.8e-05  Score=86.22  Aligned_cols=79  Identities=14%  Similarity=0.113  Sum_probs=49.8

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccch-hcH---HHHHHHHHHHHHHhcccc--C-ceeeEEEEEEcCCceEE
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK-LNQ---KLEKEFIAEIEILGTIRH--A-NIVKLWCCISSENSKLL  713 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  713 (969)
                      .+.+|.|..+.||++....+++.|+||....... ...   ...+.+..|.++++.+..  | .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            4678999999999997655678899998643211 000   112456778888887742  3 34455544  3456789


Q ss_pred             EEeeccCC
Q 002085          714 VYEYMENQ  721 (969)
Q Consensus       714 v~e~~~~g  721 (969)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.77  E-value=7.7e-05  Score=81.81  Aligned_cols=150  Identities=15%  Similarity=0.221  Sum_probs=80.2

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-----cCceeeEE-E--EEEcCCceEE
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-----HANIVKLW-C--CISSENSKLL  713 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~l  713 (969)
                      +.|+.|..+.||++...  +..+++|+.....       ..+..|.++++.+.     .|.++... +  +....+..++
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~  108 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV  108 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence            45666778899998774  3458999885421       23334555555542     34444310 0  1234567899


Q ss_pred             EEeeccCCCHH--------------HHhccCcCccc-cCCCCcccccCChHHH---------------------------
Q 002085          714 VYEYMENQSLD--------------RWLHGRKRSLV-SGSSSVHQHVLHWPTR---------------------------  751 (969)
Q Consensus       714 v~e~~~~gsL~--------------~~l~~~~~~~~-~~~~~~~~~~l~~~~~---------------------------  751 (969)
                      ||||++|..+.              ..+|....... +...........|...                           
T Consensus       109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  188 (346)
T 2q83_A          109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY  188 (346)
T ss_dssp             EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred             EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence            99999986542              11222111100 0000000111233221                           


Q ss_pred             ----HHHHHHHHHhhhhhcc----------cCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          752 ----LQIAIGAAQGLCYMHH----------DCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       752 ----~~i~~~ia~~L~~LH~----------~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                          ..+..++..++++|++          .....++|+|+++.||+++.++.+.++||+.+.
T Consensus       189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                0111223345666653          124589999999999999888899999999875

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.61  E-value=8.1e-06  Score=78.72  Aligned_cols=37  Identities=11%  Similarity=0.110  Sum_probs=22.6

Q ss_pred             cccEEEccCCCCCCCCCcccCCCCCCCEEeccCCc-CC
Q 002085           98 NLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNY-FV  134 (969)
Q Consensus        98 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~  134 (969)
                      +|++|||+++.|+..--..+..+++|++|+|++|. |+
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~It   99 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIE   99 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccC
Confidence            56777777766665444455666666666666663 44

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.60  E-value=9.9e-06  Score=78.08  Aligned_cols=84  Identities=12%  Similarity=0.097  Sum_probs=58.9

Q ss_pred             CCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCC-CCCcCCCcccCc----ccccceeccccc-ccCcCCcccCCCCC
Q 002085          121 TKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNN-FSGDIPRSIGRL----SELQTLYLYMNE-FNGTFPKEIGDLSN  194 (969)
Q Consensus       121 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~  194 (969)
                      .+|++|||+++.|+..--..+.++++|++|+|++|. |+..--..++.+    ++|++|+|++|. ||...-..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            468999999998886655667788888889888884 665433345543    368888888874 76554455666677


Q ss_pred             cceeecccCC
Q 002085          195 LEVLGLAYNS  204 (969)
Q Consensus       195 L~~L~L~~N~  204 (969)
                      |++|+++++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            7777776653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.46  E-value=0.00091  Score=71.63  Aligned_cols=76  Identities=18%  Similarity=0.180  Sum_probs=60.7

Q ss_pred             ccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc---cCceeeEEEEEEcCCceEEEEe
Q 002085          640 ESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR---HANIVKLWCCISSENSKLLVYE  716 (969)
Q Consensus       640 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e  716 (969)
                      ..+.|+.|....+|+...  ++..+++|+....      ....+.+|.+.++.+.   ...+.+++++....+..++|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            346789999999999875  4678899987432      1467889999999884   3578888988888888999999


Q ss_pred             eccCCCH
Q 002085          717 YMENQSL  723 (969)
Q Consensus       717 ~~~~gsL  723 (969)
                      |+++..+
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.33  E-value=0.00065  Score=76.65  Aligned_cols=78  Identities=15%  Similarity=0.190  Sum_probs=48.2

Q ss_pred             CCCeEecCCCCCcEEECCCCcEEEeecccceecccCCCCcccccccc--CcccCchhhcccC---CCCCccchhhHHHHH
Q 002085          770 TPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG--SFGYFAPEYAYTT---KVNEKIDIYSFGVVL  844 (969)
Q Consensus       770 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDvwslG~il  844 (969)
                      .+.++|+|++|.||+++.++ ++++||+.+..-...   ........  ...|++|+.....   ......++.+....+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            34899999999999999876 999999988753111   11111111  1346666654311   112234556778888


Q ss_pred             HHHHhCC
Q 002085          845 LELVTGK  851 (969)
Q Consensus       845 ~elltg~  851 (969)
                      |+.+++.
T Consensus       307 ~~~y~~~  313 (420)
T 2pyw_A          307 WNLFNKR  313 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8877653

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.96  E-value=7.5e-05  Score=73.36  Aligned_cols=64  Identities=20%  Similarity=0.216  Sum_probs=29.9

Q ss_pred             cccCccccchhhccCcccCCC----CCcccccccCCCEEEccCccccCC----CCcccccccccceEeccCc
Q 002085          444 ELTSLSHLNTLLLDGNKLSGK----LPSQIVSWTSLNNLNLARNELSGE----IPKAIGSLLVMVSLDLSGN  507 (969)
Q Consensus       444 ~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N  507 (969)
                      .+..-+.|+.|+|++|+|.+.    +.+.+..-+.|+.|+|++|+|...    +-+++..-+.|+.|+|++|
T Consensus        65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A           65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence            334444555555555555422    222233344556666666655532    2223333345666666543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.96  E-value=0.0016  Score=69.77  Aligned_cols=74  Identities=12%  Similarity=0.063  Sum_probs=45.6

Q ss_pred             CCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCce-eeEEEEEEcCCceEEEEe
Q 002085          638 LTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI-VKLWCCISSENSKLLVYE  716 (969)
Q Consensus       638 ~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  716 (969)
                      +.-.+.|+.|....+|++      +.+++|+......    ......+|+.+++.+....+ .+++++  +++..++|+|
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e   87 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR   87 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence            333678999999999998      3488998743211    01123457777777642222 455543  4445689999


Q ss_pred             ec-cCCCH
Q 002085          717 YM-ENQSL  723 (969)
Q Consensus       717 ~~-~~gsL  723 (969)
                      |+ +|.++
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66444

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.95  E-value=6.3e-05  Score=73.95  Aligned_cols=90  Identities=16%  Similarity=0.151  Sum_probs=54.5

Q ss_pred             cCCcccchhhcccCCccccc----cCccccCccccchhhccCcccCCC----CCcccccccCCCEEEccCc---cccCC-
Q 002085          421 VGSWKNLIVFKASNNLFSGE----IPVELTSLSHLNTLLLDGNKLSGK----LPSQIVSWTSLNNLNLARN---ELSGE-  488 (969)
Q Consensus       421 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~~-  488 (969)
                      +..-+.|+.|+|++|+|...    +...+..-+.|+.|+|++|+|++.    +-+.+..-+.|+.|+|++|   .+... 
T Consensus        66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g  145 (197)
T 1pgv_A           66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV  145 (197)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred             HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHH
Confidence            33344555555555555532    334455567788888888888743    2234555567888888865   33321 


Q ss_pred             ---CCcccccccccceEeccCcccc
Q 002085          489 ---IPKAIGSLLVMVSLDLSGNQFS  510 (969)
Q Consensus       489 ---~p~~~~~l~~L~~L~ls~N~l~  510 (969)
                         +-..+..-+.|+.|+++.|.+.
T Consensus       146 ~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          146 EMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHHHHhCCCcCeEeccCCCcc
Confidence               3344555578888888877654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.82  E-value=0.0026  Score=71.61  Aligned_cols=74  Identities=20%  Similarity=0.232  Sum_probs=49.5

Q ss_pred             cceeeecCcEEEEEEEEcC-------CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceE
Q 002085          641 SNLIGSGGSGQVYRIDING-------AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKL  712 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  712 (969)
                      .+.|+.|....||++....       .++.|++|+.....  .   ...+.+|..+++.+. +.-..++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            3567888899999998753       25689999873321  1   134457888888884 3333566665543    3


Q ss_pred             EEEeeccCCCH
Q 002085          713 LVYEYMENQSL  723 (969)
Q Consensus       713 lv~e~~~~gsL  723 (969)
                      +|+||++|.++
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            89999987444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.76  E-value=0.0035  Score=68.09  Aligned_cols=79  Identities=9%  Similarity=0.130  Sum_probs=41.3

Q ss_pred             ceeeecCcEE-EEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcccc--CceeeEEEEEEcCCceEEEEeec
Q 002085          642 NLIGSGGSGQ-VYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH--ANIVKLWCCISSENSKLLVYEYM  718 (969)
Q Consensus       642 ~~lG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~  718 (969)
                      +.|+.|+... +|+.... +++.+++|.......      ..+..|+++++.+..  -.+.+++.+..+.  .+++||++
T Consensus        24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l   94 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDL   94 (333)
T ss_dssp             CC--------CCEEEECT-TCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCC
T ss_pred             eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeC
Confidence            4565555554 6676542 256677876533210      234456777776632  2345666654333  37899999


Q ss_pred             cCCCHHHHhcc
Q 002085          719 ENQSLDRWLHG  729 (969)
Q Consensus       719 ~~gsL~~~l~~  729 (969)
                      .+..+.+++..
T Consensus        95 ~~~~l~~~l~~  105 (333)
T 3csv_A           95 GDALFTEVINN  105 (333)
T ss_dssp             CSCBHHHHHHH
T ss_pred             CCcchHHHhcC
Confidence            88787766543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.75  E-value=0.0014  Score=60.10  Aligned_cols=56  Identities=20%  Similarity=0.283  Sum_probs=40.5

Q ss_pred             hhhccCcccC-CCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCcccc
Q 002085          453 TLLLDGNKLS-GKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFS  510 (969)
Q Consensus       453 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  510 (969)
                      .++.+++.|+ ..+|..+.  ++|+.|+|++|+|+..-+..|..+++|+.|+|++|++.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5677777776 34565443  36888888888888655566788888888888888875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.71  E-value=0.012  Score=62.20  Aligned_cols=76  Identities=17%  Similarity=0.222  Sum_probs=53.1

Q ss_pred             CccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-c--CceeeEEEEEEcCCceEEEE
Q 002085          639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-H--ANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~  715 (969)
                      ...+.+|.|..+.||+.+.. +|+.|++|+......   .....+.+|++.|+.+. .  -.+.+++++.    ..++||
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             EEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            34577899999999999875 688999997643321   11245788999988873 2  2345555542    358899


Q ss_pred             eeccCCC
Q 002085          716 EYMENQS  722 (969)
Q Consensus       716 e~~~~gs  722 (969)
                      ||++++.
T Consensus        90 e~l~~~~   96 (288)
T 3f7w_A           90 EWVDERP   96 (288)
T ss_dssp             ECCCCCC
T ss_pred             EeecccC
Confidence            9998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.52  E-value=0.0028  Score=69.70  Aligned_cols=150  Identities=13%  Similarity=0.096  Sum_probs=82.5

Q ss_pred             ceeeecCcEEEEEEEEcC-------CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEE
Q 002085          642 NLIGSGGSGQVYRIDING-------AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLL  713 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  713 (969)
                      +.+..|....+|++....       +++.|++|+.-.. .   .....+.+|.++++.+. +.-..++++++.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            567778888999988742       3568999985221 1   11345668999998884 3334666766654    29


Q ss_pred             EEeeccCCCHHHH-hc----------cCcCccccCCCCcccccC--ChHHHHHHHHHHHHh-------------------
Q 002085          714 VYEYMENQSLDRW-LH----------GRKRSLVSGSSSVHQHVL--HWPTRLQIAIGAAQG-------------------  761 (969)
Q Consensus       714 v~e~~~~gsL~~~-l~----------~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~~-------------------  761 (969)
                      ||||++|.+|..- +.          .-.+.... .... ....  -|.++.++..++...                   
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~-~~~~-~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGM-EMPF-TKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTC-CCSS-CCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCC-CCCC-CCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            9999998655311 00          00000000 0000 0111  234444554443221                   


Q ss_pred             hhh----hccc-CCCCeEecCCCCCcEEECCC----CcEEEeeccccee
Q 002085          762 LCY----MHHD-CTPQIIHRDVKSSNILLDSE----FKAKIADFGLAKM  801 (969)
Q Consensus       762 L~~----LH~~-~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfgla~~  801 (969)
                      +..    |... ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            122    2111 13468999999999999876    7899999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.46  E-value=0.0063  Score=68.81  Aligned_cols=75  Identities=12%  Similarity=0.088  Sum_probs=47.3

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCc-eeeEEEEEEcCCceEEEEeecc
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN-IVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      .+.|+.|-...+|++.....+..|++|+.......    .-...+|..+++.+...+ ..++++.+.+    .+||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~----~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE----IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS----CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh----hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeC
Confidence            46788899999999988644578899987332110    011257888888885333 3567766632    35999999


Q ss_pred             CCCH
Q 002085          720 NQSL  723 (969)
Q Consensus       720 ~gsL  723 (969)
                      |.++
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7544

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.39  E-value=0.0062  Score=55.73  Aligned_cols=37  Identities=24%  Similarity=0.382  Sum_probs=21.3

Q ss_pred             CCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCC
Q 002085          122 KLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFS  158 (969)
Q Consensus       122 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  158 (969)
                      +|++|+|++|+|+..-+..|..+++|++|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            4556666666665444445556666666666666553

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.26  E-value=0.0073  Score=65.17  Aligned_cols=153  Identities=10%  Similarity=0.074  Sum_probs=78.0

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCc--eeeEEEE------EEcCCceE
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN--IVKLWCC------ISSENSKL  712 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~  712 (969)
                      .+.|+.|....+|++... +| .+++|+.....     ....+..|+++++.+....  +.+++..      ....+..+
T Consensus        27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            355777888999998774 23 58899875421     1234556777777763211  2233211      12235678


Q ss_pred             EEEeeccCCCHHH--------------HhccCcCccccCCCCcccccCChHHHHHH------------HHHHHHhhhhhc
Q 002085          713 LVYEYMENQSLDR--------------WLHGRKRSLVSGSSSVHQHVLHWPTRLQI------------AIGAAQGLCYMH  766 (969)
Q Consensus       713 lv~e~~~~gsL~~--------------~l~~~~~~~~~~~~~~~~~~l~~~~~~~i------------~~~ia~~L~~LH  766 (969)
                      ++|+|++|..+..              .+|............. .....|.....-            ...+...+++++
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~-~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNA-LSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCT-TSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCc-cChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            9999999865321              1121111000000000 001123221100            011223333333


Q ss_pred             c----cCCCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          767 H----DCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       767 ~----~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                      +    ....+++|+|+.+.||++++++.+.++||+.+..
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            2    1134799999999999999876668999998753

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.19  E-value=0.0084  Score=66.12  Aligned_cols=74  Identities=16%  Similarity=0.167  Sum_probs=43.3

Q ss_pred             ceeeecCcEEEEEEEEcC--------CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCc-eeeEEEEEEcCCceE
Q 002085          642 NLIGSGGSGQVYRIDING--------AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN-IVKLWCCISSENSKL  712 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~  712 (969)
                      +.++.|....+|++....        .++.+++|+......   . ......|.++++.+.... +.++++..  .  .+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~  110 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG  110 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence            567788888999988743        126788997643211   0 112357888888774333 44666544  2  37


Q ss_pred             EEEeeccCCCH
Q 002085          713 LVYEYMENQSL  723 (969)
Q Consensus       713 lv~e~~~~gsL  723 (969)
                      +||||++|..+
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999997543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.94  E-value=0.017  Score=62.42  Aligned_cols=75  Identities=9%  Similarity=0.100  Sum_probs=46.1

Q ss_pred             ceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccC--ceeeEEEE-----EEcCCceEEE
Q 002085          642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA--NIVKLWCC-----ISSENSKLLV  714 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv  714 (969)
                      +.++ |....||++... +|+.+++|+......    ....+..|..+++.+...  .+++++..     ....+..++|
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 778899987653 466799998853211    124566677777777421  23333332     1224566889


Q ss_pred             EeeccCCC
Q 002085          715 YEYMENQS  722 (969)
Q Consensus       715 ~e~~~~gs  722 (969)
                      |||++|..
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.56  E-value=0.013  Score=63.57  Aligned_cols=32  Identities=22%  Similarity=0.355  Sum_probs=28.3

Q ss_pred             CCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          770 TPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       770 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                      ...++|+|+.+.||+++.++.+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34799999999999999888899999988764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.50  E-value=0.038  Score=54.43  Aligned_cols=104  Identities=15%  Similarity=0.104  Sum_probs=67.8

Q ss_pred             CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccce
Q 002085          721 QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAK  800 (969)
Q Consensus       721 gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~  800 (969)
                      -+|.++|....            .++++.++|.++.|.+.+|.-.-.... . ..+=+.|..|++..+|.|...+ +.+.
T Consensus        33 vSL~eIL~~~~------------~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~   97 (229)
T 2yle_A           33 LSLEEILRLYN------------QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD   97 (229)
T ss_dssp             EEHHHHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C---
T ss_pred             ccHHHHHHHcC------------CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc
Confidence            48999998765            469999999999999999877621101 1 1233456899999999988764 1110


Q ss_pred             ecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCC
Q 002085          801 MLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEAN  854 (969)
Q Consensus       801 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~  854 (969)
                                    .....+.|||... ...+.+.=|||+|+++|..+--+.|.
T Consensus        98 --------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           98 --------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             -----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             --------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence                          1122456888653 34567888999999999999766553

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=92.84  E-value=0.099  Score=58.18  Aligned_cols=74  Identities=11%  Similarity=0.096  Sum_probs=46.5

Q ss_pred             ceeeecCcEEEEEEEEcCC-------CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEE
Q 002085          642 NLIGSGGSGQVYRIDINGA-------GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLL  713 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  713 (969)
                      +.+..|-...+|++.....       ++.|++|+......    ..-...+|.++++.+. +.-..++++.+.    -++
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~----~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~  147 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG----KFYDSKVELDVFRYLSNINIAPNIIADFP----EGR  147 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc----hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence            5667788889999887521       57799998633211    0112356888888774 333455555332    378


Q ss_pred             EEeeccCCCH
Q 002085          714 VYEYMENQSL  723 (969)
Q Consensus       714 v~e~~~~gsL  723 (969)
                      ||||++|.+|
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            9999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.47  E-value=1  Score=49.78  Aligned_cols=30  Identities=30%  Similarity=0.458  Sum_probs=25.3

Q ss_pred             CeEecCCCCCcEEE------CCCCcEEEeeccccee
Q 002085          772 QIIHRDVKSSNILL------DSEFKAKIADFGLAKM  801 (969)
Q Consensus       772 ~ivH~Dlkp~Nill------~~~~~~kl~Dfgla~~  801 (969)
                      .++|+|+.+.||++      +++..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4567899999998864

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=84.10  E-value=0.61  Score=32.73  Aligned_cols=26  Identities=31%  Similarity=0.249  Sum_probs=16.0

Q ss_pred             hhhhHHHHHHHHHHHHHhhheeeeee
Q 002085          581 HLALILVLAILVLLVTVSLSWFVVRD  606 (969)
Q Consensus       581 ~~~~iiv~~~~~~l~~~~l~~~~~~~  606 (969)
                      .++..++.+++++++++.++|+++|+
T Consensus        12 ~IA~gVVgGv~~~~ii~~~~~~~~RR   37 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVALGIGLFMRR   37 (44)
T ss_dssp             SSTHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eEEeehhHHHHHHHHHHHHHHHHhhh
Confidence            45666666676666666666665543

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=83.82  E-value=0.62  Score=32.61  Aligned_cols=26  Identities=15%  Similarity=0.119  Sum_probs=15.0

Q ss_pred             hhhhHHHHHHHHHHHHHhhheeeeee
Q 002085          581 HLALILVLAILVLLVTVSLSWFVVRD  606 (969)
Q Consensus       581 ~~~~iiv~~~~~~l~~~~l~~~~~~~  606 (969)
                      .++..++.+++++++++.++|+++|+
T Consensus        11 aIA~gVVgGv~~v~ii~~~~~~~~RR   36 (44)
T 2l2t_A           11 LIAAGVIGGLFILVIVGLTFAVYVRR   36 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eEEEeehHHHHHHHHHHHHHHHHhhh
Confidence            35555666666666666555665543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	969
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-63
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-58
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-54
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-48
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-27
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-27
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-13
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-18
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-12
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	9e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	9e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	6e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 1e-63
 Identities = 75/285 (26%), Positives = 115/285 (40%), Gaps = 32/285 (11%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             IGSG  G VY+   +G    VAVK + N      +  + F  E+ +L   RH NI+  
Sbjct: 14  QRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
               S+     +V ++ E  SL   LH  +                    + IA   AQG
Sbjct: 70  MGY-STAPQLAIVTQWCEGSSLYHHLHIIETKF------------EMIKLIDIARQTAQG 116

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           + Y+H      IIHRD+KS+NI L  +   KI DFGLA + ++    H    ++GS  + 
Sbjct: 117 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173

Query: 822 APEYAYT---TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
           APE          + + D+Y+FG+VL EL+TG+   Y + +               P   
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQIIFMVGRGYLSPDLS 232

Query: 879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            +     +         + RL   C       RP   ++L  +  
Sbjct: 233 KVRSNCPKA--------MKRLMAECLKKKRDERPLFPQILASIEL 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  213 bits (543), Expect = 5e-63
 Identities = 70/321 (21%), Positives = 138/321 (42%), Gaps = 36/321 (11%)

Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYR---IDINGAGEFVAVKRIWN 671
           DP T++  +     F +   +S +    +IG+G  G+V             FVA+K +  
Sbjct: 5   DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-- 62

Query: 672 NRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRK 731
                +K  ++F++E  I+G   H N++ L   ++     +++ E+MEN SLD +L    
Sbjct: 63  KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-- 120

Query: 732 RSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA 791
                     +         + +  G A G+ Y+        +HRD+ + NIL++S    
Sbjct: 121 ----------NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVC 167

Query: 792 KIADFGLAKMLAKQGEPHTMSAVAGSFG---YFAPEYAYTTKVNEKIDIYSFGVVLLELV 848
           K++DFGL++ L       T ++  G      + APE     K     D++S+G+V+ E++
Sbjct: 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 227

Query: 849 TGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLP 908
           +  E  Y D                + + +A+++    P  ++  + +++L L C     
Sbjct: 228 SYGERPYWDMT-------------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDR 274

Query: 909 SSRPSMKEVLQILRRCCPTEN 929
           + RP   +++  L +     N
Sbjct: 275 NHRPKFGQIVNTLDKMIRNPN 295

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  211 bits (538), Expect = 3e-62
 Identities = 68/300 (22%), Positives = 115/300 (38%), Gaps = 34/300 (11%)

Query: 642 NLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
             IG G  G+V++     +        VAVK +    + +  ++ +F  E  ++    + 
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDNP 76

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQH-----------V 745
           NIVKL    +      L++EYM    L+ +L       V   S                 
Sbjct: 77  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136

Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQ 805
           L    +L IA   A G+ Y+        +HRD+ + N L+      KIADFGL++ +   
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 806 GEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW 865
                    A    +  PE  +  +   + D++++GVVL E+ +     Y          
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA------ 247

Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC 925
                   + +   +  G    C       +Y L  +C S LP+ RPS   + +IL+R C
Sbjct: 248 -------HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 9e-59
 Identities = 62/307 (20%), Positives = 120/307 (39%), Gaps = 50/307 (16%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           + +G+G  G V+++    +G  +A K I  + ++   +  + I E+++L       IV  
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGF 69

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +    S+    +  E+M+  SLD+ L    R             +      +++I   +G
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGR-------------IPEQILGKVSIAVIKG 116

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+      +I+HRDVK SNIL++S  + K+ DFG++  L         ++  G+  Y 
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYM 170

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
           +PE    T  + + DI+S G+ L+E+  G+      +   L          +   T    
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230

Query: 882 KGIAEPCYLEEMTTVYRLALI-----------------------------CTSTLPSSRP 912
           +    P     M +   +A+                              C    P+ R 
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290

Query: 913 SMKEVLQ 919
            +K+++ 
Sbjct: 291 DLKQLMV 297

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 4e-58
 Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 39/299 (13%)

Query: 641 SNLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           + +IG G  G VY    +D +G     AVK +  NR  +     +F+ E  I+    H N
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 698 IVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
           ++ L   C+ SE S L+V  YM++  L  ++     +                  +   +
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP------------TVKDLIGFGL 137

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG--EPHTMSAV 814
             A+G+ ++      + +HRD+ + N +LD +F  K+ADFGLA+ +  +     H  +  
Sbjct: 138 QVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
                + A E   T K   K D++SFGV+L EL+T     Y D   +  +         +
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRR 252

Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPT---ENY 930
            +         +P Y  +   +Y + L C       RPS  E++  +     T   E+Y
Sbjct: 253 LL---------QPEYCPD--PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 7e-58
 Identities = 65/282 (23%), Positives = 112/282 (39%), Gaps = 30/282 (10%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             IG+G  G+  +I     G+ +  K + +   + +  ++  ++E+ +L  ++H NIV+ 
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68

Query: 702 -WCCISSENSKL-LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
               I   N+ L +V EY E   L   +    +          +  L     L++     
Sbjct: 69  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE---------RQYLDEEFVLRVMTQLT 119

Query: 760 QGLCYMH--HDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             L   H   D    ++HRD+K +N+ LD +   K+ DFGLA++L    +     A  G+
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGT 177

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             Y +PE       NEK DI+S G +L EL              LA           P  
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-- 235

Query: 878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
                      Y +E+     +     +     RPS++E+L+
Sbjct: 236 ---------YRYSDEL---NEIITRMLNLKDYHRPSVEEILE 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 8e-58
 Identities = 73/294 (24%), Positives = 131/294 (44%), Gaps = 35/294 (11%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGE----FVAVKRIWNNRKLNQKLEKEFIAEIEILG 691
           S +T   +IG+G  G+VY+  +  +       VA+K +       +K   +F+ E  I+G
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMG 64

Query: 692 TIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTR 751
              H NI++L   IS     +++ EYMEN +LD++L  +                     
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD------------GEFSVLQL 112

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP-HT 810
           + +  G A G   M +      +HRD+ + NIL++S    K++DFGL+++L    E  +T
Sbjct: 113 VGMLRGIAAG---MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169

Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
            S       + APE     K     D++SFG+V+ E++T  E  Y +             
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----------- 218

Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
                +  A++ G   P  ++  + +Y+L + C     + RP   +++ IL + 
Sbjct: 219 --NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 5e-57
 Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 36/281 (12%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             +G+G  G+V+    NG    VAVK +    K        F+AE  ++  ++H  +V+L
Sbjct: 19  ERLGAGQFGEVWMGYYNG-HTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +  ++ +    ++ EYMEN SL  +L                  L     L +A   A+G
Sbjct: 74  YAVVT-QEPIYIITEYMENGSLVDFLKTPSG-----------IKLTINKLLDMAAQIAEG 121

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           + ++        IHRD++++NIL+      KIADFGLA+++ +  E            + 
Sbjct: 122 MAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWT 177

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLAEWAWRHYAEEKPITDAL 880
           APE         K D++SFG++L E+VT     Y G  +  + +   R Y   +P     
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP----- 232

Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                     EE+   Y+L  +C    P  RP+   +  +L
Sbjct: 233 ------DNCPEEL---YQLMRLCWKERPEDRPTFDYLRSVL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 6e-57
 Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 34/286 (11%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
            SL     +G G  G+V+    NG    VA+K +    K      + F+ E +++  +RH
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRH 71

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+  +S E    +V EYM   SL  +L G                L  P  + +A
Sbjct: 72  EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETG-----------KYLRLPQLVDMA 119

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
              A G+ Y+        +HRD++++NIL+      K+ADFGLA+++ +  E        
Sbjct: 120 AQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAK 175

Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               + APE A   +   K D++SFG++L EL T     Y                  + 
Sbjct: 176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------------NRE 222

Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
           + D +++G   PC  E   +++ L   C    P  RP+ + +   L
Sbjct: 223 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-56
 Identities = 71/290 (24%), Positives = 114/290 (39%), Gaps = 40/290 (13%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           +  L     IG G  G V   D  G    VAVK I      N    + F+AE  ++  +R
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCI-----KNDATAQAFLAEASVMTQLR 58

Query: 695 HANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
           H+N+V+L    +  +    +V EYM   SL  +L  R RS           VL     L+
Sbjct: 59  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-----------VLGGDCLLK 107

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSA 813
            ++   + + Y+        +HRD+ + N+L+  +  AK++DFGL K         T   
Sbjct: 108 FSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDT 159

Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
                 + APE     K + K D++SFG++L E+ +     Y                  
Sbjct: 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------------L 206

Query: 874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
           K +   ++KG            VY +   C     + RPS  ++ + L  
Sbjct: 207 KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 1e-56
 Identities = 67/286 (23%), Positives = 120/286 (41%), Gaps = 34/286 (11%)

Query: 640 ESNLIGSGGSGQVYR--IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
           E   +GSG  G V +    +    + VAVK +  N   +  L+ E +AE  ++  + +  
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 69

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           IV++     +E+  +LV E  E   L+++L   +              +     +++   
Sbjct: 70  IVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH-------------VKDKNIIELVHQ 115

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML-AKQGEPHTMSAVAG 816
            + G+ Y+        +HRD+ + N+LL ++  AKI+DFGL+K L A +      +    
Sbjct: 116 VSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172

Query: 817 SFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
              ++APE     K + K D++SFGV++ E  +  +  Y                    +
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------------GSEV 219

Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
           T  L+KG    C       +Y L  +C +    +RP    V   LR
Sbjct: 220 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 4e-56
 Identities = 58/295 (19%), Positives = 105/295 (35%), Gaps = 33/295 (11%)

Query: 643 LIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHA 696
           ++GSG  G+V       I   G    VAVK +    K +    +  ++E++++  +  H 
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKMMTQLGSHE 101

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSL----------VSGSSSVHQHVL 746
           NIV L    +      L++EY     L  +L  ++                      +VL
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161

Query: 747 HWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQG 806
            +   L  A   A+G+ ++        +HRD+ + N+L+      KI DFGLA+ +    
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218

Query: 807 EPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA 866
                        + APE  +      K D++S+G++L E+ +     Y           
Sbjct: 219 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP------- 271

Query: 867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQIL 921
                 +      +  G            +Y +   C +     RPS   +   L
Sbjct: 272 -----VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 1e-55
 Identities = 69/323 (21%), Positives = 119/323 (36%), Gaps = 50/323 (15%)

Query: 634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI 693
           I  ++     IG G  G+V+R    G  E VAVK         ++      AEI     +
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIF----SSREERSWFREAEIYQTVML 54

Query: 694 RHANIVKLWCCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP 749
           RH NI+      + +N       LV +Y E+ SL  +L+              ++ +   
Sbjct: 55  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--------------RYTVTVE 100

Query: 750 TRLQIAIGAAQGLCYMHHDC-----TPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
             +++A+  A GL ++H +       P I HRD+KS NIL+       IAD GLA     
Sbjct: 101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160

Query: 805 QGEP--HTMSAVAGSFGYFAPEYAYT------TKVNEKIDIYSFGVVLLELVTGKEANYG 856
             +      +   G+  Y APE           +  ++ DIY+ G+V  E+         
Sbjct: 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220

Query: 857 DEHTSLAEWAWRHYAEEKPITDALDKGIAEPCY----------LEEMTTVYRLALICTST 906
            E     +  +       P  + + K + E              E +  + ++   C   
Sbjct: 221 HEDY---QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277

Query: 907 LPSSRPSMKEVLQILRRCCPTEN 929
             ++R +   + + L +    E 
Sbjct: 278 NGAARLTALRIKKTLSQLSQQEG 300

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-55
 Identities = 65/281 (23%), Positives = 107/281 (38%), Gaps = 37/281 (13%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW- 702
           IG G    VY+         VA   +  +RKL +   + F  E E+L  ++H NIV+ + 
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 703 ---CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
                +  +   +LV E M + +L  +L   K              +             
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-------------MKIKVLRSWCRQIL 122

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
           +GL ++H    P IIHRD+K  NI +       KI D GLA +           AV G+ 
Sbjct: 123 KGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTP 177

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITD 878
            + APE  Y  K +E +D+Y+FG+ +LE+ T +      ++ +          +      
Sbjct: 178 EFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236

Query: 879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
                + E            +   C       R S+K++L 
Sbjct: 237 VAIPEVKE------------IIEGCIRQNKDERYSIKDLLN 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (488), Expect = 1e-55
 Identities = 66/289 (22%), Positives = 113/289 (39%), Gaps = 32/289 (11%)

Query: 635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
            + +T  + +G G  G+VY          VAVK +    K +    +EF+ E  ++  I+
Sbjct: 16  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIK 71

Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H N+V+L    + E    ++ E+M   +L  +L    R             +     L +
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-----------QEVSAVVLLYM 120

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
           A   +  + Y+        IHRD+ + N L+      K+ADFGL++++         +  
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGA 176

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
                + APE     K + K D+++FGV+L E+ T   + Y                +  
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------------DLS 223

Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            + + L+K             VY L   C    PS RPS  E+ Q    
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 2e-55
 Identities = 60/279 (21%), Positives = 100/279 (35%), Gaps = 31/279 (11%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             +G G  G+V         E VAVK +  + K      +    EI I   + H N+VK 
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKF 68

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +      N + L  EY     L   +                  +  P   +       G
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------------MPEPDAQRFFHQLMAG 115

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           + Y+H      I HRD+K  N+LLD     KI+DFGLA +         ++ + G+  Y 
Sbjct: 116 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172

Query: 822 APEYAYTTKVN-EKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
           APE     + + E +D++S G+VL  ++ G+        +      W+           +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232

Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           D                 L        PS+R ++ ++ +
Sbjct: 233 DSA------------PLALLHKILVENPSARITIPDIKK 259

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 3e-55
 Identities = 61/300 (20%), Positives = 118/300 (39%), Gaps = 28/300 (9%)

Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
           + L+    +G+G  G+V       +  + A   VAVK +      +    +  ++E+++L
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVL 80

Query: 691 GTI-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVH-----QH 744
             +  H NIV L    +     L++ EY     L  +L  ++ S +   +S       + 
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 745 VLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK 804
            L     L  +   A+G+ ++        IHRD+ + NILL      KI DFGLA+ +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 805 QGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
                          + APE  +      + D++S+G+ L EL +   + Y      +  
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDS 255

Query: 865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
             ++           + +G            +Y +   C    P  RP+ K+++Q++ + 
Sbjct: 256 KFYKM----------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 4e-55
 Identities = 62/289 (21%), Positives = 118/289 (40%), Gaps = 36/289 (12%)

Query: 636 SSLTESNLIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR 694
           S LT    IGSG  G V+    +N   + VA+K I    +     E++FI E E++  + 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNK--DKVAIKTI----REGAMSEEDFIEEAEVMMKLS 58

Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H  +V+L+     +    LV+E+ME+  L  +L               + +    T L +
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT------------QRGLFAAETLLGM 106

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
            +   +G+    +     +IHRD+ + N L+      K++DFG+ + +       +    
Sbjct: 107 CLDVCEGM---AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-T 162

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
                + +PE    ++ + K D++SFGV++ E+ +  +  Y +                 
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------------NS 209

Query: 875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR 923
            + + +  G          T VY++   C    P  RP+   +L+ L  
Sbjct: 210 EVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (486), Expect = 5e-55
 Identities = 71/308 (23%), Positives = 120/308 (38%), Gaps = 45/308 (14%)

Query: 615 DPATWKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK 674
           DP   +L       F + +     ++   IG G  G VY        E VA+K++  + K
Sbjct: 1   DPDVAEL-------FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK 53

Query: 675 LNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSL 734
            + +  ++ I E+  L  +RH N ++   C   E++  LV EY    + D     +K   
Sbjct: 54  QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-- 111

Query: 735 VSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA 794
                      L       +  GA QGL Y+H      +IHRDVK+ NILL      K+ 
Sbjct: 112 -----------LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLG 157

Query: 795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT---KVNEKIDIYSFGVVLLELVTGK 851
           DFG A ++         ++  G+  + APE        + + K+D++S G+  +EL   K
Sbjct: 158 DFGSASIM------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211

Query: 852 EANYGDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSR 911
              +     +     +     E P        +    + E           C   +P  R
Sbjct: 212 PPLFNM---NAMSALYHIAQNESPA-------LQSGHWSEYF---RNFVDSCLQKIPQDR 258

Query: 912 PSMKEVLQ 919
           P+ + +L+
Sbjct: 259 PTSEVLLK 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 9e-55
 Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 36/285 (12%)

Query: 644 IGSGGSGQVYR--IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +G G  G V +    +      VA+K +   +   +   +E + E +I+  + +  IV+L
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVRL 74

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                +E   +LV E      L ++L G++  +                  ++    + G
Sbjct: 75  IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEI------------PVSNVAELLHQVSMG 121

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT-MSAVAGSFGY 820
           + Y+        +HRD+ + N+LL +   AKI+DFGL+K L      +T  SA      +
Sbjct: 122 MKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           +APE     K + + D++S+GV + E ++ G++     +   +  +  +    E P    
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP---- 234

Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
                  P    E+   Y L   C       RP    V Q +R C
Sbjct: 235 -------PECPPEL---YALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-54
 Identities = 66/278 (23%), Positives = 107/278 (38%), Gaps = 35/278 (12%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             +G G  G VY      +   +A+K ++  +     +E +   E+EI   +RH NI++L
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +          L+ EY    ++ R L    +                          A  
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK-------------FDEQRTATYITELANA 118

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y H     ++IHRD+K  N+LL S  + KIADFG     +        + + G+  Y 
Sbjct: 119 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYL 171

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
            PE       +EK+D++S GV+  E + GK     +   +  E   R    E    D + 
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFTFPDFVT 228

Query: 882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +G  +            L        PS RP ++EVL+
Sbjct: 229 EGARD------------LISRLLKHNPSQRPMLREVLE 254

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-54
 Identities = 72/296 (24%), Positives = 116/296 (39%), Gaps = 27/296 (9%)

Query: 635 LSSLTESNLIGSGGSGQVY--RIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGT 692
            + +   ++IG G  GQV   RI  +G     A+KR+      ++   ++F  E+E+L  
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCK 66

Query: 693 I-RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGR---KRSLVSGSSSVHQHVLHW 748
           +  H NI+ L           L  EY  + +L  +L      +       ++     L  
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 749 PTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEP 808
              L  A   A+G+ Y+      Q IHRD+ + NIL+   + AKIADFGL++    Q   
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVY 180

Query: 809 HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
              +       + A E    +      D++S+GV+L E+V+     Y             
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------- 231

Query: 869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
                  + + L +G      L     VY L   C    P  RPS  ++L  L R 
Sbjct: 232 ----CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 9e-54
 Identities = 59/283 (20%), Positives = 109/283 (38%), Gaps = 37/283 (13%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             +G G  G+VY+          A K I      +++  ++++ EI+IL +  H NIVKL
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVI---DTKSEEELEDYMVEIDILASCDHPNIVKL 74

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                 EN+  ++ E+    ++D  +   +R L                   +       
Sbjct: 75  LDAFYYENNLWILIEFCAGGAVDAVMLELERPL------------TESQIQVVCKQTLDA 122

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L Y+H     +IIHRD+K+ NIL   +   K+ADFG++    +  +        G+  + 
Sbjct: 123 LNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWM 177

Query: 822 APEYAYTT-----KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
           APE            + K D++S G+ L+E+   +  ++      +        A+ +P 
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL----LKIAKSEPP 233

Query: 877 TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           T A     +                 C      +R +  ++LQ
Sbjct: 234 TLAQPSRWSSNF--------KDFLKKCLEKNVDARWTTSQLLQ 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-53
 Identities = 59/287 (20%), Positives = 110/287 (38%), Gaps = 34/287 (11%)

Query: 636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH 695
             LT    +G+G  G V      G    VA+K I    K     E EFI E +++  + H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI----KEGSMSEDEFIEEAKVMMNLSH 58

Query: 696 ANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIA 755
             +V+L+   + +    ++ EYM N  L  +L   +            H       L++ 
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR------------HRFQTQQLLEMC 106

Query: 756 IGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVA 815
               + + Y+        +HRD+ + N L++ +   K++DFGL++ +    E  +     
Sbjct: 107 KDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSK 162

Query: 816 GSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
               +  PE    +K + K DI++FGV++ E+ +  +  Y                    
Sbjct: 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------------NSE 209

Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILR 922
             + + +G+           VY +   C       RP+ K +L  + 
Sbjct: 210 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-53
 Identities = 60/287 (20%), Positives = 114/287 (39%), Gaps = 35/287 (12%)

Query: 642 NLIGSGGSGQVYRIDINGAGEF----VAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN 697
            ++GSG  G VY+      GE     VA+K +      + K  KE + E  ++ ++ + +
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 72

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           + +L       ++  L+ + M    L  ++   K ++                 L   + 
Sbjct: 73  VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNI------------GSQYLLNWCVQ 119

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            A+G+ Y+      +++HRD+ + N+L+ +    KI DFGLAK+L  + + +        
Sbjct: 120 IAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             + A E         + D++S+GV + EL+T     Y                    I+
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------------ASEIS 223

Query: 878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
             L+KG   P        VY + + C      SRP  +E++    + 
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 7e-52
 Identities = 58/294 (19%), Positives = 112/294 (38%), Gaps = 26/294 (8%)

Query: 636 SSLTESNLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEIL 690
             +T S  +G G  G VY      +  +     VA+K +  N   + +   EF+ E  ++
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVM 77

Query: 691 GTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
                 ++V+L   +S     L++ E M    L  +L   + ++ +              
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP---PSLSK 134

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            +Q+A   A G+ Y++     + +HRD+ + N ++  +F  KI DFG+ + + +      
Sbjct: 135 MIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191

Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
                    + +PE           D++SFGVVL E+ T  E  Y               
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----------- 240

Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
              + +   + +G            ++ L  +C    P  RPS  E++  ++  
Sbjct: 241 --NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 3e-51
 Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 32/285 (11%)

Query: 644 IGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVK 700
           +G G  G V R      +G    VAVK +  +     +   +FI E+  + ++ H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           L+  + +   K +V E     SL   L   +   +              T  + A+  A+
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL------------LGTLSRYAVQVAE 122

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMS-AVAGSFG 819
           G+ Y+        IHRD+ + N+LL +    KI DFGL + L +  + + M       F 
Sbjct: 123 GMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
           + APE   T   +   D + FGV L E+ T  +  +   + S          E  P  + 
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

Query: 880 LDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
             +             +Y + + C +  P  RP+   +   L   
Sbjct: 240 CPQD------------IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 4e-51
 Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 29/294 (9%)

Query: 642 NLIGSGGSGQVYR-------IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI- 693
             +G G  GQV          D       VAVK +       +K   + I+E+E++  I 
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKMIG 76

Query: 694 RHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS---SSVHQHVLHWPT 750
           +H NI+ L    + +    ++ EY    +L  +L  R+   +  S   S   +  L    
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT 810
            +  A   A+G+ Y+      + IHRD+ + N+L+  +   KIADFGLA+ +        
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 811 MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
            +       + APE  +      + D++SFGV+L E+ T   + Y               
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------------ 241

Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
              + +   L +G            +Y +   C   +PS RP+ K++++ L R 
Sbjct: 242 -PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 4e-51
 Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 27/293 (9%)

Query: 642 NLIGSGGSGQVYR-----IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH- 695
             +G G  GQV       ID       VAVK +           +  ++E++IL  I H 
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHH 76

Query: 696 ANIVKLW-CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTR 751
            N+V L   C       +++ E+ +  +L  +L  ++   V        +++  L     
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 752 LQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTM 811
           +  +   A+G+ ++      + IHRD+ + NILL  +   KI DFGLA+ + K  +    
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 812 SAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA 871
                   + APE  +      + D++SFGV+L E+ +   + Y      + E   R   
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLK 251

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
           E   +        A      EM   Y+  L C    PS RP+  E+++ L   
Sbjct: 252 EGTRMR-------APDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  176 bits (447), Expect = 3e-49
 Identities = 59/303 (19%), Positives = 116/303 (38%), Gaps = 34/303 (11%)

Query: 619 WKLTSFHQLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQK 678
           WK      +     ++L        +G+G  G V+R+     G   A K +      ++ 
Sbjct: 9   WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHES 65

Query: 679 LEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGS 738
            ++    EI+ +  +RH  +V L      +N  +++YE+M    L   +           
Sbjct: 66  DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----- 120

Query: 739 SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF--KAKIADF 796
                  +     ++      +GLC+MH +     +H D+K  NI+  ++   + K+ DF
Sbjct: 121 -------MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF 170

Query: 797 GLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG 856
           GL   L       ++    G+  + APE A    V    D++S GV+   L++G     G
Sbjct: 171 GLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227

Query: 857 DEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKE 916
           +   +  E      + +  + D+   GI+E                     P++R ++ +
Sbjct: 228 E---NDDETLRNVKSCDWNMDDSAFSGISEDG--------KDFIRKLLLADPNTRMTIHQ 276

Query: 917 VLQ 919
            L+
Sbjct: 277 ALE 279

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 7e-49
 Identities = 61/278 (21%), Positives = 102/278 (36%), Gaps = 34/278 (12%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             IG G SG VY       G+ VA++++       Q  ++  I EI ++   ++ NIV  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                  +   +V EY+   SL   +                          +     Q 
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--------------EGQIAAVCRECLQA 128

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L ++H +   Q+IHRD+KS NILL  +   K+ DFG    +  +      S + G+  + 
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWM 183

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
           APE         K+DI+S G++ +E++ G+     +           +   E    + L 
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243

Query: 882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
               +                C       R S KE+LQ
Sbjct: 244 AIFRD------------FLNRCLDMDVEKRGSAKELLQ 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 8e-49
 Identities = 61/286 (21%), Positives = 106/286 (37%), Gaps = 37/286 (12%)

Query: 643 LIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIV 699
            IG G  G V++   +        VA+K        +  + ++F+ E   +    H +IV
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
           KL   I+ EN   ++ E      L  +L  RK SL               + +  A   +
Sbjct: 72  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSL------------DLASLILYAYQLS 118

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
             L Y+      + +HRD+ + N+L+ S    K+ DFGL++ + +    +  S       
Sbjct: 119 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK 174

Query: 820 YFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPITD 878
           + APE     +     D++ FGV + E++  G +   G ++  +            P   
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP--- 231

Query: 879 ALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
                   P     +   Y L   C +  PS RP   E+   L   
Sbjct: 232 --------PNCPPTL---YSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  172 bits (436), Expect = 1e-48
 Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 33/287 (11%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
           ++G GG  +V+          VAVK +  +   +      F  E +    + H  IV ++
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 703 CCISSENSKL----LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
               +E        +V EY++  +L   +H                 +     +++   A
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------------MTPKRAIEVIADA 120

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHT-MSAVAGS 817
            Q L + H      IIHRDVK +NI++ +    K+ DFG+A+ +A  G   T  +AV G+
Sbjct: 121 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             Y +PE A    V+ + D+YS G VL E++TG+    GD   S    A++H  E+    
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---SPVSVAYQHVREDPIPP 234

Query: 878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-SMKEVLQILRR 923
            A  +G++             + L   +  P +R  +  E+   L R
Sbjct: 235 SARHEGLSADL--------DAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 3e-48
 Identities = 44/278 (15%), Positives = 91/278 (32%), Gaps = 31/278 (11%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            ++G G    V            A+K +     + +        E +++  + H   VKL
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +     +        Y +N  L +++                               A+ 
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----------------FDETCTRFYTAEI 117

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           +  + +     IIHRD+K  NILL+ +   +I DFG AK+L+ + +    ++  G+  Y 
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
           +PE        +  D+++ G ++ +LV G           + +   +    E    +   
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ---KIIKLEYDFPEKFF 234

Query: 882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
               +            L         + R   +E+  
Sbjct: 235 PKARD------------LVEKLLVLDATKRLGCEEMEG 260

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  161 bits (407), Expect = 8e-45
 Identities = 59/291 (20%), Positives = 104/291 (35%), Gaps = 43/291 (14%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRI------WNNRKLNQKLEKEFIAEIEILGTIR- 694
            ++G G S  V R       +  AVK I        + +  Q+L +  + E++IL  +  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
           H NI++L     +     LV++ M+   L  +L  +               L      +I
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-------------LSEKETRKI 115

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAV 814
                + +C +H      I+HRD+K  NILLD +   K+ DFG +  L        +  V
Sbjct: 116 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREV 169

Query: 815 AGSFGYFAPEYAYT------TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR 868
            G+  Y APE              +++D++S GV++  L+ G    +  +          
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRM 226

Query: 869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
             +             ++            L        P  R + +E L 
Sbjct: 227 IMSGNYQFGSPEWDDYSDTV--------KDLVSRFLVVQPQKRYTAEEALA 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (409), Expect = 1e-44
 Identities = 54/278 (19%), Positives = 96/278 (34%), Gaps = 29/278 (10%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           +++G+G   +V   +     + VA+K I   +K  +  E     EI +L  I+H NIV L
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCI--AKKALEGKEGSMENEIAVLHKIKHPNIVAL 72

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                S     L+ + +    L   +  +                      ++       
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRIVEKGF-------------YTERDASRLIFQVLDA 119

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           + Y+H         +        LD + K  I+DFGL+KM         +S   G+ GY 
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYV 176

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
           APE       ++ +D +S GV+   L+ G    Y +   + A+   +    E        
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYEFDSPYW 233

Query: 882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
             I++                     P  R + ++ LQ
Sbjct: 234 DDISDSA--------KDFIRHLMEKDPEKRFTCEQALQ 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  162 bits (410), Expect = 2e-44
 Identities = 49/279 (17%), Positives = 92/279 (32%), Gaps = 34/279 (12%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +GSG  G V+R      G     K I          +     EI I+  + H  ++ L 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFI---NTPYPLDKYTVKNEISIMNQLHHPKLINLH 92

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                +   +L+ E++    L   +                  +     +     A +GL
Sbjct: 93  DAFEDKYEMVLILEFLSGGELFDRIAAEDYK------------MSEAEVINYMRQACEGL 140

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEF--KAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            +MH      I+H D+K  NI+ +++     KI DFGLA  L        +     +  +
Sbjct: 141 KHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEF 194

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
            APE      V    D+++ GV+   L++G     G++     +        +    +  
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ---NVKRCDWEFDEDA 251

Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
              ++                      P  R ++ + L+
Sbjct: 252 FSSVSPEA--------KDFIKNLLQKEPRKRLTVHDALE 282

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  160 bits (405), Expect = 4e-44
 Identities = 57/278 (20%), Positives = 105/278 (37%), Gaps = 31/278 (11%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             +G+G  G+V+ I     G + A+K +     +  K  +    E  +L  + H  I+++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           W          ++ +Y+E   L   L                              AA+ 
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKS----------------QRFPNPVAKFYAAEV 113

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
              + +  +  II+RD+K  NILLD     KI DFG AK +     P     + G+  Y 
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYI 168

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
           APE   T   N+ ID +SFG+++ E++ G    Y     +  +   +    E       +
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELRFPPFFN 225

Query: 882 KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           + + +   L  +     +    +  L + +   ++V  
Sbjct: 226 EDVKD--LLSRL-----ITRDLSQRLGNLQNGTEDVKN 256

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 5e-44
 Identities = 51/279 (18%), Positives = 95/279 (34%), Gaps = 35/279 (12%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G G  G V+R     + +    K +    K+    +     EI IL   RH NI+ L 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFV----KVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
               S    ++++E++    +   ++                 L+    +       + L
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFE------------LNEREIVSYVHQVCEAL 115

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDS--EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
            ++H      I H D++  NI+  +      KI +FG A+ L        +     +  Y
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEY 169

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
           +APE      V+   D++S G ++  L++G      + +  + E        E    +  
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE---NIMNAEYTFDEEA 226

Query: 881 DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
            K I+                        SR +  E LQ
Sbjct: 227 FKEISIEA--------MDFVDRLLVKERKSRMTASEALQ 257

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 9e-43
 Identities = 53/229 (23%), Positives = 90/229 (39%), Gaps = 19/229 (8%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILG-TIRHANIVK 700
            ++G G  G+V+  +     +F A+K +  +  L     +  + E  +L     H  +  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 701 LWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQ 760
           ++C   ++ +   V EY+    L   +    +                      A     
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-------------FDLSRATFYAAEIIL 114

Query: 761 GLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGY 820
           GL ++H      I++RD+K  NILLD +   KIADFG+ K               G+  Y
Sbjct: 115 GLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 169

Query: 821 FAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH 869
            APE     K N  +D +SFGV+L E++ G+   +G +   L       
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 218

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 2e-42
 Identities = 59/294 (20%), Positives = 106/294 (36%), Gaps = 34/294 (11%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRK--LNQKLEKEFIAEIEILGTIRHANIV 699
           + +G G    VY+       + VA+K+I    +      + +  + EI++L  + H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 700 KLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAA 759
            L      +++  LV+++ME                          L         +   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-------------LTPSHIKAYMLMTL 110

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFG 819
           QGL Y+H      I+HRD+K +N+LLD     K+ADFGLAK        +T      +  
Sbjct: 111 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--QVVTRW 165

Query: 820 YFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSL-------------AEW 865
           Y APE  +  ++    +D+++ G +L EL+       GD                   +W
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225

Query: 866 AWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
                  +     +         +      +  L        P +R +  + L+
Sbjct: 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-42
 Identities = 74/295 (25%), Positives = 113/295 (38%), Gaps = 37/295 (12%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             IG G  G VY+      GE VA+K+I       + +    I EI +L  + H NIVKL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKL 66

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
              I +EN   LV+E++ +Q L +++                  +  P          QG
Sbjct: 67  LDVIHTENKLYLVFEFL-HQDLKKFMDAS-----------ALTGIPLPLIKSYLFQLLQG 114

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L + H      ++HRD+K  N+L+++E   K+ADFGLA+        +T      +  Y 
Sbjct: 115 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYR 169

Query: 822 APE-YAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDAL 880
           APE        +  +DI+S G +  E+VT +    GD         +R      P     
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR--TLGTPDEVVW 227

Query: 881 DKGIAEPCYLEEMTTVYR--------------LALI--CTSTLPSSRPSMKEVLQ 919
               + P Y        R               +L+       P+ R S K  L 
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  155 bits (393), Expect = 5e-42
 Identities = 52/245 (21%), Positives = 90/245 (36%), Gaps = 24/245 (9%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAE---IEILGTIRHANI 698
            +IG GG G+VY       G+  A+K +   R   ++ E   + E   + ++ T     I
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69

Query: 699 VKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           V +     + +    + + M    L   L                           A   
Sbjct: 70  VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-------------SEADMRFYAAEI 116

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
             GL +MH+     +++RD+K +NILLD     +I+D GLA   +K+    ++    G+ 
Sbjct: 117 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTH 169

Query: 819 GYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
           GY APE        +   D +S G +L +L+ G       +     E           + 
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 229

Query: 878 DALDK 882
           D+   
Sbjct: 230 DSFSP 234

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-41
 Identities = 59/294 (20%), Positives = 108/294 (36%), Gaps = 30/294 (10%)

Query: 642 NLIGSGGSGQVYR-IDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEI---LGTIRHAN 697
             IG G  G+V++  D+   G FVA+KR+   +   + +    I E+ +   L T  H N
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPN 71

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           +V+L+   +   +       +  + +D+ L             V +  +   T   +   
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-------VPEPGVPTETIKDMMFQ 124

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGS 817
             +GL ++H      ++HRD+K  NIL+ S  + K+ADFGLA++ + Q    ++     +
Sbjct: 125 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVT 178

Query: 818 FGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPIT 877
             Y APE    +     +D++S G +  E+   K    G                     
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 878 DALDKGIAEPCYLEEMTTVYRLALICTSTL------------PSSRPSMKEVLQ 919
              D  +    +  +        +     L            P+ R S    L 
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  150 bits (380), Expect = 4e-41
 Identities = 39/299 (13%), Positives = 81/299 (27%), Gaps = 39/299 (13%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            IG G  G ++        + VA+K              +   E      +     +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNV 66

Query: 703 CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGL 762
                E    ++   +   SL+  L    R                 T    A      +
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKF------------SVKTVAMAAKQMLARV 114

Query: 763 CYMHHDCTPQIIHRDVKSSNILLDSEFK-----AKIADFGLAKMLAKQGE-----PHTMS 812
             +H      +++RD+K  N L+            + DFG+ K                 
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171

Query: 813 AVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR-HYA 871
            ++G+  Y +       + + + D+ + G V +  + G     G +  +  +   R    
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231

Query: 872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENY 930
           ++      L  G  E          Y+      +    + P    +  +  +     N 
Sbjct: 232 KQSTPLRELCAGFPEE--------FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 8e-41
 Identities = 60/298 (20%), Positives = 102/298 (34%), Gaps = 37/298 (12%)

Query: 629 FTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNR---KLNQKLEKEFIA 685
           F + N+         +GSG    V +      G   A K I   R          ++   
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 686 EIEILGTIRHANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHV 745
           E+ IL  I+H N++ L     ++   +L+ E +    L  +L  ++              
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------------- 109

Query: 746 LHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE----FKAKIADFGLAKM 801
           L      +       G+ Y+H     QI H D+K  NI+L        + KI DFGLA  
Sbjct: 110 LTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166

Query: 802 LAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS 861
           +      +    + G+  + APE      +  + D++S GV+   L++G     GD   +
Sbjct: 167 I---DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---T 220

Query: 862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
             E      A      D      +                      P  R ++++ LQ
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALA--------KDFIRRLLVKDPKKRMTIQDSLQ 270

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-40
 Identities = 62/296 (20%), Positives = 109/296 (36%), Gaps = 33/296 (11%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
           + IG G  G V     N     VA+K+I  +   +Q   +  + EI+IL   RH NI+ +
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGI 71

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
              I +   + +   Y+    +   L+            +    L             +G
Sbjct: 72  NDIIRAPTIEQMKDVYLVTHLMGADLYKL----------LKTQHLSNDHICYFLYQILRG 121

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAK-QGEPHTMSAVAGSFGY 820
           L Y+H      ++HRD+K SN+LL++    KI DFGLA++          ++    +  Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 821 FAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDA 879
            APE    +K   + IDI+S G +L E+++ +    G  +                    
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 880 LDKGIAEPCYLEEMTTVYR--------------LALI--CTSTLPSSRPSMKEVLQ 919
               +    YL  +    +              L L+    +  P  R  +++ L 
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (372), Expect = 6e-40
 Identities = 56/298 (18%), Positives = 95/298 (31%), Gaps = 39/298 (13%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            IGSG  G +Y      AGE VA+K         +    +   E +I   ++    +   
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLE-----CVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 703 -CCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
             C +  +  ++V E +     D +    ++                 T L +A      
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-------------FSLKTVLLLADQMISR 115

Query: 762 LCYMHHDCTPQIIHRDVKSSNIL---LDSEFKAKIADFGLAKML-----AKQGEPHTMSA 813
           + Y+H       IHRDVK  N L           I DFGLAK        +         
Sbjct: 116 IEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172

Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE 873
           + G+  Y +       + + + D+ S G VL+    G     G +  +  +   R   ++
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232

Query: 874 KPI-TDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENY 930
                + L KG                   C S     +P    + Q+ R     + +
Sbjct: 233 MSTPIEVLCKGYPSE--------FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 7e-40
 Identities = 51/223 (22%), Positives = 85/223 (38%), Gaps = 18/223 (8%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
            L+G G  G+V  +     G + A+K +     + +      + E  +L   RH  +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
                + +    V EY     L   L                      T  +     A+ 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRE----------------RVFTEERARFYGAEI 114

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           +  + +  +  +++RD+K  N++LD +   KI DFGL K     G   TM    G+  Y 
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYL 172

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE 864
           APE          +D +  GVV+ E++ G+   Y  +H  L E
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  146 bits (369), Expect = 1e-39
 Identities = 66/294 (22%), Positives = 107/294 (36%), Gaps = 37/294 (12%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             IG G  G VY+   N  GE  A+K+I    K ++ +    I EI IL  ++H+NIVKL
Sbjct: 8   EKIGEGTYGVVYKA-QNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
           +  I ++   +LV+E+++                          L             Q 
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-------------LESV---TAKSFLLQL 109

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L  + +    +++HRD+K  N+L++ E + KIADFGLA+             +   +   
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRA 168

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALD 881
                 + K +  IDI+S G +  E+V G     G          +R      P +    
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR--ILGTPNSKNWP 226

Query: 882 KGIAEPCYLEEMTTVYRLALI----------------CTSTLPSSRPSMKEVLQ 919
                P Y    T    L                        P+ R + K+ L+
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-38
 Identities = 55/293 (18%), Positives = 100/293 (34%), Gaps = 33/293 (11%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             IG G  G V++       E VA+KR+      ++ +    + EI +L  ++H NIV+L
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 702 WCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQG 761
              + S+    LV+E+ +      +                           +     Q 
Sbjct: 67  HDVLHSDKKLTLVFEFCDQDLKKYFDSCNG----------------DLDPEIVKSFLFQL 110

Query: 762 LCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYF 821
           L  +    +  ++HRD+K  N+L++   + K+A+FGLA+        ++   V   +   
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRP 169

Query: 822 APEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS-----LAEWAWRHYAEEKPI 876
                     +  ID++S G +  EL       +           +         E+ P 
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229

Query: 877 TDALDKGIAEPCYLEEMTTVYRLALI----------CTSTLPSSRPSMKEVLQ 919
              L      P Y    + V  +  +               P  R S +E LQ
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-38
 Identities = 60/306 (19%), Positives = 110/306 (35%), Gaps = 45/306 (14%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKL 701
             IG G  G+V++      G+ VA+K++       +      + EI+IL  ++H N+V L
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNL 74

Query: 702 WCCISS--------ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQ 753
                +        + S  LV+++ E+       +   +                 T  +
Sbjct: 75  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----------------FTLSE 118

Query: 754 IAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKML--AKQGEPHTM 811
           I       L  +++    +I+HRD+K++N+L+  +   K+ADFGLA+    AK  +P+  
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178

Query: 812 SAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY 870
           +    +  Y  PE     +     ID++  G ++ E+ T      G+          +  
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238

Query: 871 AEEKPITDALDKGIAEPCYLEEMTTVYR---------------LALI--CTSTLPSSRPS 913
               P              LE +    R               L LI       P+ R  
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298

Query: 914 MKEVLQ 919
             + L 
Sbjct: 299 SDDALN 304

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-37
 Identities = 55/284 (19%), Positives = 103/284 (36%), Gaps = 47/284 (16%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ---KLEKEFIAEIEILGTIR--HAN 697
           L+GSGG G VY          VA+K +  +R  +            E+ +L  +    + 
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 698 IVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
           +++L       +S +L+ E  E           + +            L           
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA------------LQEELARSFFWQ 118

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLD-SEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
             + + + H+     ++HRD+K  NIL+D +  + K+ DFG   +L    +    +   G
Sbjct: 119 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDG 171

Query: 817 SFGYFAPEY-AYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
           +  Y  PE+  Y         ++S G++L ++V G      DE     +  +R       
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------- 224

Query: 876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
                 + ++  C          L   C +  PS RP+ +E+  
Sbjct: 225 ------QRVSSEC--------QHLIRWCLALRPSDRPTFEEIQN 254

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 1e-37
 Identities = 71/305 (23%), Positives = 110/305 (36%), Gaps = 45/305 (14%)

Query: 637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHA 696
           S T++ +IG+G  G VY+  +  +GE VA+K++  +++   +       E++I+  + H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73

Query: 697 NIVKLWCCISSENSK------LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPT 750
           NIV+L     S   K       LV +Y+         H  +           +  L    
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA----------KQTLPVIY 123

Query: 751 RLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEPH 809
                    + L Y+H      I HRD+K  N+LLD +    K+ DFG AK L +     
Sbjct: 124 VKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180

Query: 810 TMSAVAGSFGYFAP-EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH--------- 859
           +      S  Y AP      T     ID++S G VL EL+ G+    GD           
Sbjct: 181 SY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237

Query: 860 ---TSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALI--CTSTLPSSRPSM 914
              T   E                 K           T    +AL        P++R + 
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297

Query: 915 KEVLQ 919
            E   
Sbjct: 298 LEACA 302

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-36
 Identities = 54/286 (18%), Positives = 101/286 (35%), Gaps = 42/286 (14%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKL 701
           ++G G +G+V +I      E  A+K +        +   +   E+E+     +  +IV++
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRI 70

Query: 702 WCCI----SSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIG 757
                   +     L+V E ++   L   +  R                      +I   
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-----------DQAFTEREASEIMKS 119

Query: 758 AAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK---AKIADFGLAKMLAKQGEPHTMSAV 814
             + + Y+H      I HRDVK  N+L  S+      K+ DFG AK         T    
Sbjct: 120 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-- 174

Query: 815 AGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK 874
             +  Y APE     K ++  D++S GV++  L+ G    Y +   +++          +
Sbjct: 175 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233

Query: 875 P-ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
               +     ++E            L      T P+ R ++ E + 
Sbjct: 234 YEFPNPEWSEVSEEV--------KMLIRNLLKTEPTQRMTITEFMN 271

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (343), Expect = 2e-35
 Identities = 50/276 (18%), Positives = 98/276 (35%), Gaps = 31/276 (11%)

Query: 644 IGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWC 703
           +G+G  G+V  +    +G   A+K +   + +  K  +  + E  IL  +    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLC 763
                ++  +V EY+    +   L    R                P     A        
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR-------------FSEPHARFYAAQIVLTFE 155

Query: 764 YMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAP 823
           Y+H      +I+RD+K  N+L+D +   ++ DFG AK             + G+    AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAP 207

Query: 824 EYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPITDALDKG 883
           E   +   N+ +D ++ GV++ E+  G    + D+   + E              +  K 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267

Query: 884 IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ 919
           +              L +  T    + +  + ++  
Sbjct: 268 LLRNL----------LQVDLTKRFGNLKNGVNDIKN 293

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-33
 Identities = 57/300 (19%), Positives = 106/300 (35%), Gaps = 47/300 (15%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +GSG  G V        G  VA+K++      ++   K    E+ +L  +RH N++ L 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 703 CCISSENSK------LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
              + + +        LV  +M         H +               L       +  
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---------------LGEDRIQFLVY 128

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              +GL Y+H        HRD+K  N+ ++ + + KI DFGLA+    +     M+    
Sbjct: 129 QMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVV 180

Query: 817 SFGYFAPEYAY-TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP 875
           +  Y APE      +  + +DI+S G ++ E++TGK    G +H    +   +       
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240

Query: 876 ITDALDKGIAEPCYLEEMTTVYR--------------LALI--CTSTLPSSRPSMKEVLQ 919
                 +      Y++ +  + +              + L+          R +  E L 
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 5e-33
 Identities = 62/249 (24%), Positives = 103/249 (41%), Gaps = 25/249 (10%)

Query: 642 NLIGSGGSGQVYR---IDINGAGEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTIRHA- 696
            ++G+G  G+V+    I  +  G+  A+K +     +   K  +    E ++L  IR + 
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 697 NIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAI 756
            +V L     +E    L+ +Y+    L   L  R+R                 T  ++ I
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----------------FTEHEVQI 133

Query: 757 GAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAG 816
              + +  + H     II+RD+K  NILLDS     + DFGL+K      E        G
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCG 192

Query: 817 SFGYFAPEYAYT--TKVNEKIDIYSFGVVLLELVTGKEANYGD-EHTSLAEWAWRHYAEE 873
           +  Y AP+      +  ++ +D +S GV++ EL+TG      D E  S AE + R    E
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252

Query: 874 KPITDALDK 882
            P    +  
Sbjct: 253 PPYPQEMSA 261

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-30
 Identities = 71/327 (21%), Positives = 113/327 (34%), Gaps = 56/327 (17%)

Query: 626 QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIA 685
           ++G +   +L        IGSG  G V           VA+K++ +    NQ   K    
Sbjct: 7   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYR 65

Query: 686 EIEILGTIRHANIVKLWCCISSENSK------LLVYEYMENQSLDRWLHGRKRSLVSGSS 739
           E+ ++  + H NI+ L    + + +        LV E M+                    
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------- 117

Query: 740 SVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA 799
                         +      G+ ++H      IIHRD+K SNI++ S+   KI DFGLA
Sbjct: 118 --------HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166

Query: 800 KMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD-- 857
           +     G    M+    +  Y APE        E +DI+S G ++ E+V  K    G   
Sbjct: 167 RT---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223

Query: 858 ----------------EHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYR--- 898
                           E     +   R+Y E +P    L      P  L    + +    
Sbjct: 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 283

Query: 899 ----LALI--CTSTLPSSRPSMKEVLQ 919
                 L+       P+ R S+ + LQ
Sbjct: 284 ASQARDLLSKMLVIDPAKRISVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-30
 Identities = 58/320 (18%), Positives = 113/320 (35%), Gaps = 45/320 (14%)

Query: 623 SFH--QLGFTESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLE 680
           +F+  +L  T   +       + +GSG  G V        G  VAVK++ +    +    
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHA 61

Query: 681 KEFIAEIEILGTIRHANIVKLWCCISS-----ENSKLLVYEYMENQSLDRWLHGRKRSLV 735
           K    E+ +L  ++H N++ L    +      E + + +  ++    L+  +  +K    
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---- 117

Query: 736 SGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD 795
                     L       +     +GL Y+H        HRD+K SN+ ++ + + KI D
Sbjct: 118 ----------LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILD 164

Query: 796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY 855
           FGLA+      +      VA  +             N+ +DI+S G ++ EL+TG+    
Sbjct: 165 FGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220

Query: 856 GDEHTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALI------------- 902
           G +H    +   R                +   Y++ +T + ++                
Sbjct: 221 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280

Query: 903 ---CTSTLPSSRPSMKEVLQ 919
                      R +  + L 
Sbjct: 281 LEKMLVLDSDKRITAAQALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (290), Expect = 8e-29
 Identities = 58/290 (20%), Positives = 100/290 (34%), Gaps = 35/290 (12%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVK 700
             +G G   +V+        E V VK       L    +K+   EI+IL  +R   NI+ 
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGGPNIIT 94

Query: 701 LWCCISSENSKL--LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGA 758
           L   +    S+   LV+E++ N    +                    L            
Sbjct: 95  LADIVKDPVSRTPALVFEHVNNTDFKQLYQT----------------LTDYDIRFYMYEI 138

Query: 759 AQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-KAKIADFGLAKMLAKQGEPHTMSAVAGS 817
            + L Y H      I+HRDVK  N+++D E  K ++ D+GLA+           +    S
Sbjct: 139 LKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVAS 192

Query: 818 FGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKPI 876
             +  PE     +  +  +D++S G +L  ++  KE  +                  + +
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252

Query: 877 TDALDKGIAE--PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC 924
            D +DK   E  P + + +    R          +      E L  L + 
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (279), Expect = 4e-27
 Identities = 53/298 (17%), Positives = 96/298 (32%), Gaps = 22/298 (7%)

Query: 643 LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLW 702
            +G G    V+          VA+K +    + ++   +    EI++L  +  A+  K  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKED 75

Query: 703 CCISSENSKLL-VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWP--TRLQIAIGAA 759
              ++   KLL  + +     +   +          +          P     QI+    
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 760 QGLCYMHHDCTPQIIHRDVKSSNILLDSE-FKAKIADFGLAKMLAKQGEPHTMSAVAGSF 818
            GL YMH  C   IIH D+K  N+L++       +    +A +          +    + 
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 819 GYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE----WAWRHYAEEK 874
            Y +PE           DI+S   ++ EL+TG      DE  S  +     A       +
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 875 PITDALDKGIAEPCYLEEMTTV--------YRLALICTSTLPSSRPSMKEVLQILRRC 924
             +  L  G     +      +        + L  + T     S+   KE+   L   
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  109 bits (273), Expect = 8e-27
 Identities = 85/345 (24%), Positives = 135/345 (39%), Gaps = 45/345 (13%)

Query: 33  NTEERTILLNLKQQLGNPPSLQSWTSTSSPCD--WPEITCTFNSVTGISLRHKDITQKIP 90
           N +++  LL +K+ LGNP +L SW  T+  C+  W  + C  ++ T              
Sbjct: 4   NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTY------------- 50

Query: 91  PIICDLKNLTTIDLSSNSIPGEF--PEFLYNCTKLQNLDLSQNY-FVGPIPSDIDRISGL 147
                   +  +DLS  ++P  +  P  L N   L  L +      VGPIP  I +++ L
Sbjct: 51  -------RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 148 QCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFK 207
             + +   N SG IP  + ++  L TL    N  +GT P  I  L NL  +    N    
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 208 PAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLN 267
              IP  +G   KL T      N +           +L  + L+ N LEG          
Sbjct: 164 A--IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDK 221

Query: 268 NLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLS 327
           N  ++ L  N L+ ++     +  L  +DL  N + G++P+   +LK L  L +  N+L 
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

Query: 328 GEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELP 372
           GE+P                    GN +        +N+     P
Sbjct: 282 GEIP------------------QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 73.6 bits (179), Expect = 1e-14
 Identities = 71/292 (24%), Positives = 108/292 (36%), Gaps = 33/292 (11%)

Query: 285 SSVEALKLTDIDLSMNNLTG--SIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENN 342
           +  +  ++ ++DLS  NL     IP     L  L  L +   +                N
Sbjct: 45  TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN----------------N 88

Query: 343 LSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPS--KTA 400
           L G +P ++     L  + +     SG +P  L     L +L  S N +SG LP    + 
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148

Query: 401 WNLTRLEISNNRFSGQIQRGVGSWKNLI--VFKASNNLFSGEIPVELTSLSHLNTLLLDG 458
            NL  +    NR SG I    GS+  L   +  + N L     P   T  +     +   
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP---TFANLNLAFVDLS 205

Query: 459 NKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIG 518
             +     S +                       +G    +  LDL  N+  G +P  + 
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT 265

Query: 519 QLK-LNTFNLSSNKLYGNIPDEFNNLAYDD--SFLNNSNLCVKNPIINLPKC 567
           QLK L++ N+S N L G IP +  NL   D  ++ NN  LC  +P   LP C
Sbjct: 266 QLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLC-GSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.6 bits (171), Expect = 1e-13
 Identities = 64/263 (24%), Positives = 108/263 (41%), Gaps = 13/263 (4%)

Query: 240 SNLSSLEILALNGNHLEGA--IPSGLFLLNNLTQLFL--YDNILSGEIPSSVEALKLTDI 295
           +    +  L L+G +L     IPS L  L  L  L++   +N++    P+  +  +L  +
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 296 DLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASI-------GVVAFENNLSGAVP 348
            ++  N++G+IP+   ++K L  L    N LSG +P SI       G+    N +SGA+P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 349 KSLGNCRTLRT-VQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLE 407
            S G+   L T + +  NR +G++P            +  +           +   T+  
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 408 ISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPS 467
                        VG  KNL      NN   G +P  LT L  L++L +  N L G++P 
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 468 QIVSWTSLNNLNLARNELSGEIP 490
              +    +    A N+     P
Sbjct: 287 -GGNLQRFDVSAYANNKCLCGSP 308

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.8 bits (229), Expect = 5e-21
 Identities = 66/306 (21%), Positives = 109/306 (35%), Gaps = 30/306 (9%)

Query: 63  CDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTK 122
           C    + C+   +         + + +PP      +   +DL +N I         N   
Sbjct: 10  CHLRVVQCSDLGLE-------KVPKDLPP------DTALLDLQNNKITEIKDGDFKNLKN 56

Query: 123 LQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFN 182
           L  L L  N      P     +  L+ + L  N    ++P  + +   LQ L ++ NE  
Sbjct: 57  LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT 113

Query: 183 GTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNL 242
                    L+ + V+ L  N      +    F  +KKL  + + +   I  IP+     
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD-TNITTIPQ--GLP 170

Query: 243 SSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNL 302
            SL  L L+GN +     + L  LNNL +L L  N +S     S+            NN 
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230

Query: 303 TGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQL 362
              +P      K +Q++ L +N++S     +IG   F        P       +   V L
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNIS-----AIGSNDFCP------PGYNTKKASYSGVSL 279

Query: 363 YSNRFS 368
           +SN   
Sbjct: 280 FSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 85.1 bits (209), Expect = 2e-18
 Identities = 64/314 (20%), Positives = 104/314 (33%), Gaps = 38/314 (12%)

Query: 94  CDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLG 153
           C L+ +   DL    +P + P           LDL  N        D   +  L  + L 
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLP------PDTALLDLQNNKITEIKDGDFKNLKNLHTLILI 63

Query: 154 GNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPI 213
            N  S   P +   L +L+ LYL  N+      K    L  L V     N   K      
Sbjct: 64  NNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVH---ENEITKVRKSVF 120

Query: 214 EFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLF 273
                  +  L        G    A   +  L  + +   ++   IP GL    +LT+L 
Sbjct: 121 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELH 177

Query: 274 LYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPA 332
           L  N ++    +S++ L  L  + LS N+++           +L+ L L +N L      
Sbjct: 178 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV--- 234

Query: 333 SIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSG------ELPTGLWTTFNLSSLML 386
                          P  L + + ++ V L++N  S         P       + S + L
Sbjct: 235 ---------------PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279

Query: 387 SDNTIS-GELPSKT 399
             N +   E+   T
Sbjct: 280 FSNPVQYWEIQPST 293

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 81.6 bits (200), Expect = 2e-17
 Identities = 56/303 (18%), Positives = 97/303 (32%), Gaps = 27/303 (8%)

Query: 282 EIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFEN 341
           ++P     L     DL  N +T     +F  LKNL  L L                   N
Sbjct: 28  DLPPDTALL-----DLQNNKITEIKDGDFKNLKNLHTLILI-----------------NN 65

Query: 342 NLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTIS-GELPSKTA 400
            +S   P +      L  + L  N+          T   L         +          
Sbjct: 66  KISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125

Query: 401 WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNK 460
             +  L  +  + SG         K L   + ++   +  IP  L     L  L LDGNK
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 182

Query: 461 LSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL 520
           ++    + +    +L  L L+ N +S     ++ +   +  L L+ N+            
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242

Query: 521 KLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCV-KNPIINLPKCPSRFRNSDKISS 579
            +    L +N +     ++F    Y+    + S + +  NP+      PS FR     ++
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 302

Query: 580 KHL 582
             L
Sbjct: 303 VQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 60.4 bits (145), Expect = 3e-10
 Identities = 39/248 (15%), Positives = 68/248 (27%), Gaps = 32/248 (12%)

Query: 376 WTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNN 435
                 S L L       ++P     +   L++ NN+ +        + KNL      NN
Sbjct: 12  LRVVQCSDLGLE------KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 65

Query: 436 LFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNEL---------- 485
             S   P     L  L  L L  N+L         +   L        ++          
Sbjct: 66  KISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125

Query: 486 -------------SGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKL 532
                        SG    A   +  +  + ++    +  IP  +    L   +L  NK+
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP-SLTELHLDGNKI 183

Query: 533 YGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAILV 592
                     L  + + L  S   +              R     ++K + +   LA   
Sbjct: 184 TKVDAASLKGL-NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242

Query: 593 LLVTVSLS 600
            +  V L 
Sbjct: 243 YIQVVYLH 250

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 41.9 bits (97), Expect = 2e-04
 Identities = 21/130 (16%), Positives = 40/130 (30%), Gaps = 2/130 (1%)

Query: 473 TSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL-KLNTFNLSSNK 531
                L+L  N+++        +L  + +L L  N+ S   P     L KL    LS N+
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 532 LYGNIPDEFNNLAYDDSFLNNSNLCVKNPIINLPKCPSRFRNSDKISSKHLALILVLAIL 591
           L   +P++      +     N    V+  + N                           +
Sbjct: 91  L-KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149

Query: 592 VLLVTVSLSW 601
             L  + ++ 
Sbjct: 150 KKLSYIRIAD 159

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 89.7 bits (221), Expect = 1e-19
 Identities = 81/402 (20%), Positives = 137/402 (34%), Gaps = 51/402 (12%)

Query: 119 NCTKLQNLDLSQNYFVGPIP-SDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLY 177
              +     L +      +  +D+D+++ LQ   LG  +  G     +  L+ L  +   
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74

Query: 178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE 237
            N+     P  + +L+ L  + +  N       +     +                +   
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 238 AM----------SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSV 287
            +          S++S+L  L        G   + L  L NLT L   D   +     SV
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 288 EALKLTDIDLSM--NNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSG 345
            A       L    N ++   P       NL  L L  N L                   
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD----------------- 233

Query: 346 AVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTR 405
               +L +   L  + L +N+ S   P    T   L+ L L  N IS   P      LT 
Sbjct: 234 --IGTLASLTNLTDLDLANNQISNLAPLSGLT--KLTELKLGANQISNISPLAGLTALTN 289

Query: 406 LEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKL 465
           LE++ N+   +    + + KNL       N  S   P  ++SL+ L  L    NK+S   
Sbjct: 290 LELNENQL--EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343

Query: 466 PSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGN 507
            S + + T++N L+   N++S   P  + +L  +  L L+  
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 89.3 bits (220), Expect = 2e-19
 Identities = 67/381 (17%), Positives = 122/381 (32%), Gaps = 27/381 (7%)

Query: 80  LRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPS 139
           L   ++T  +     DL  +TT+      I  +  + +     L  ++ S N      P 
Sbjct: 29  LGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP- 83

Query: 140 DIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLG 199
            +  ++ L  I +  N  +   P +        TL+                        
Sbjct: 84  -LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS-- 140

Query: 200 LAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAI 259
              N+    + +     + +      +T+   +  +               + +  + + 
Sbjct: 141 --SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERL---------DISSNKVSD 189

Query: 260 PSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLL 319
            S L  L NL  L   +N +S   P  +    L ++ L+ N L          L NL  L
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGILT-NLDELSLNGNQLKD--IGTLASLTNLTDL 246

Query: 320 GLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTT- 378
            L +N +S   P S      E  L      ++     L  +       +        +  
Sbjct: 247 DLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306

Query: 379 FNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFS 438
            NL+ L L  N IS   P  +   L RL  +NN+ S      + +  N+    A +N  S
Sbjct: 307 KNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQIS 364

Query: 439 GEIPVELTSLSHLNTLLLDGN 459
              P  L +L+ +  L L+  
Sbjct: 365 DLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 78.5 bits (192), Expect = 7e-16
 Identities = 60/360 (16%), Positives = 116/360 (32%), Gaps = 52/360 (14%)

Query: 218 LKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDN 277
           L +     + + N+   + +  ++L  +  L  +   ++     G+  LNNLTQ+   +N
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76

Query: 278 ILSGEIP-SSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGV 336
            L+   P  ++  L    ++ +       +                ++    +   ++  
Sbjct: 77  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136

Query: 337 VAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTT------------------ 378
           +   +N    +    G     +            L                         
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196

Query: 379 FNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFS 438
            NL SL+ ++N IS   P     NL  L ++ N+        + S  NL     +NN  S
Sbjct: 197 TNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS 254

Query: 439 GEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTS--------------------LNNL 478
              P  L+ L+ L  L L  N++S   P   ++  +                    L  L
Sbjct: 255 NLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYL 312

Query: 479 NLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGNIP 537
            L  N +S   P  + SL  +  L  + N+ S      +  L  +N  +   N++    P
Sbjct: 313 TLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 73.5 bits (179), Expect = 2e-14
 Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 18/232 (7%)

Query: 46  QLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLS 105
            L N  +L+    +S+      +     ++  +   +  I+   P  I    NL  + L+
Sbjct: 170 PLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLN 227

Query: 106 SNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSI 165
            N +       L + T L +LDL+ N      P  +  ++ L  + LG N  S   P  +
Sbjct: 228 GNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--L 281

Query: 166 GRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLW 225
             L+ L  L L  N+        I +L NL  L L +N+             L KL+ L+
Sbjct: 282 AGLTALTNLELNENQLE--DISPISNLKNLTYLTLYFNNISDI----SPVSSLTKLQRLF 335

Query: 226 MTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDN 277
                +      +++NL+++  L+   N +    P  L  L  +TQL L D 
Sbjct: 336 FANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 73.5 bits (179), Expect = 3e-14
 Identities = 57/259 (22%), Positives = 93/259 (35%), Gaps = 17/259 (6%)

Query: 42  NLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTT 101
           N    +     L S    S      ++    N  T   L           ++  L NL +
Sbjct: 142 NTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLES 201

Query: 102 IDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDI 161
           +  ++N I    P      T L  L L+ N         +  ++ L  +DL  N  S   
Sbjct: 202 LIATNNQISDITPL--GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA 257

Query: 162 PRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKL 221
           P  +  L++L  L L  N+ +   P  +  L+ L  L L  N     + I      LK L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS----NLKNL 309

Query: 222 KTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSG 281
             L +   N+    P  +S+L+ L+ L    N +     S L  L N+  L    N +S 
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365

Query: 282 EIPSSVEALKLTDIDLSMN 300
             P +    ++T + L+  
Sbjct: 366 LTPLA-NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 54.6 bits (130), Expect = 3e-08
 Identities = 42/291 (14%), Positives = 96/291 (32%), Gaps = 12/291 (4%)

Query: 266 LNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNH 325
           L    +  L    ++  +  + +  ++T +      +  SI +    L NL  +   +N 
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT-DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 77

Query: 326 LSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLM 385
           L+   P        +  ++      +     L  +   +   +              + +
Sbjct: 78  LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 137

Query: 386 LSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEL 445
              +    ++ + +     +     N+ +        +    +   ++       +    
Sbjct: 138 ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA--- 194

Query: 446 TSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLS 505
             L++L +L+   N++S   P  I   T+L+ L+L  N+L       + SL  +  LDL+
Sbjct: 195 -KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 506 GNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLC 556
            NQ S  + P  G  KL    L +N++    P        +     N    
Sbjct: 250 NNQISN-LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED 299

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.6 bits (210), Expect = 9e-19
 Identities = 60/293 (20%), Positives = 88/293 (30%), Gaps = 36/293 (12%)

Query: 62  PCDWPEI-TCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNC 120
           PC  P    C        S   + +   +P  I        I L  N I          C
Sbjct: 1   PC--PGACVCYNEPKVTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRAC 55

Query: 121 TKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDI-PRSIGRLSELQTLYLYMN 179
             L  L L  N       +    ++ L+ +DL  N     + P +   L  L TL+L   
Sbjct: 56  RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115

Query: 180 EFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAM 239
                 P     L+ L+ L L  N+     +    F  L  L  L++    +      A 
Sbjct: 116 GLQELGPGLFRGLAALQYLYLQDNALQA--LPDDTFRDLGNLTHLFLHGNRISSVPERAF 173

Query: 240 SNLSSLEILALNGNHLEGAIPSGLFLLN------------------------NLTQLFLY 275
             L SL+ L L+ N +    P     L                          L  L L 
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233

Query: 276 DNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSG 328
           DN    +  +      L     S + +  S+P+    L    L  L +N L G
Sbjct: 234 DNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.5 bits (189), Expect = 4e-16
 Identities = 53/279 (18%), Positives = 90/279 (32%), Gaps = 14/279 (5%)

Query: 145 SGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNS 204
                           +P  I   +  Q ++L+ N  +           NL +L   +++
Sbjct: 11  EPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILW-LHSN 66

Query: 205 NFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLF 264
                      G+    +      A L    P     L  L  L L+   L+   P    
Sbjct: 67  VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR 126

Query: 265 LLNNLTQLFLYDNILSGEIPSSV-EALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFS 323
            L  L  L+L DN L      +  +   LT + L  N ++      F  L +L  L L  
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186

Query: 324 NHLSGEVPASI-------GVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLW 376
           N ++   P +         +  F NNLS    ++L   R L+ ++L  N +  +      
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RP 245

Query: 377 TTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSG 415
               L     S + +   LP + A       ++ N   G
Sbjct: 246 LWAWLQKFRGSSSEVPCSLPQRLA-GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.1 bits (167), Expect = 3e-13
 Identities = 54/277 (19%), Positives = 86/277 (31%), Gaps = 21/277 (7%)

Query: 282 EIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFEN 341
            +P  + A     I L  N ++      F   +NL +L L SN L+    A+   +A   
Sbjct: 25  AVPVGIPAA-SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 342 NLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTA- 400
            L  +    L +                  P        L +L L    +    P     
Sbjct: 84  QLDLSDNAQLRSVD----------------PATFHGLGRLHTLHLDRCGLQELGPGLFRG 127

Query: 401 -WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGN 459
              L  L + +N              NL       N  S         L  L+ LLL  N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187

Query: 460 KLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQ 519
           +++   P        L  L L  N LS    +A+  L  +  L L+ N +  +       
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247

Query: 520 LKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLC 556
             L  F  SS+++  ++P            L  ++L 
Sbjct: 248 AWLQKFRGSSSEVPCSLPQRLAGRDLKR--LAANDLQ 282

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 80.6 bits (198), Expect = 6e-18
 Identities = 31/213 (14%), Positives = 60/213 (28%), Gaps = 35/213 (16%)

Query: 642 NLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKL-------EKEFIAEIEILGTIR 694
            L+G G    V+    +       VK         +K+       +  F           
Sbjct: 6   KLMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 695 HANIVKLWCCISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQI 754
              + KL      +      Y +  N  L   +  +             + +      ++
Sbjct: 65  FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAK-----------ELYRVRVENPDEV 108

Query: 755 AIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLAKMLA-KQGEPHTMSA 813
                + +   +H     I+H D+   N+L+  E    I DF  +  +  +         
Sbjct: 109 LDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERD 164

Query: 814 VAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLE 846
           V     YF+  Y        + DI S    +L+
Sbjct: 165 VRNIITYFSRTYRT------EKDINSAIDRILQ 191

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.4 bits (163), Expect = 1e-12
 Identities = 42/273 (15%), Positives = 93/273 (34%), Gaps = 16/273 (5%)

Query: 100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSG 159
            T+DL+  ++  +    L +   +      +++   P+         +Q +DL  +    
Sbjct: 3   QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60

Query: 160 D-IPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGML 218
             +   + + S+LQ L L     +      +   SNL  L L+  S F    +       
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 219 KKLKTL------WMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQL 272
            +L  L        TE ++   +      ++ L +     N  +  + + +    NL  L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 273 FLYDNILSGEIPSSVEALK--LTDIDLS-MNNLTGSIPEEFGKLKNLQLLGLFSNHLSGE 329
            L D+++              L  + LS   ++      E G++  L+ L +F     G 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 330 VPASIG----VVAFENNLSGAVPKSLGNCRTLR 358
           +         +    ++ +     ++GN +   
Sbjct: 241 LQLLKEALPHLQINCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.3 bits (142), Expect = 6e-10
 Identities = 39/279 (13%), Positives = 82/279 (29%), Gaps = 12/279 (4%)

Query: 248 LALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTG-SI 306
           L L G +L   +   L L   +       + +   +       ++  +DLS + +   ++
Sbjct: 5   LDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63

Query: 307 PEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNR 366
                +   LQ L L    LS  +  ++         S  V  +L  C       L +  
Sbjct: 64  HGILSQCSKLQNLSLEGLRLSDPIVNTLA------KNSNLVRLNLSGCSGFSEFALQTLL 117

Query: 367 FSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKN 426
            S      L  ++               +              N + S            
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177

Query: 427 LIVFKASNNLFSGEIPVELTSLSHLNTLLLDG-NKLSGKLPSQIVSWTSLNNLNLARNEL 485
           + +  + + +   +   E   L++L  L L     +  +   ++    +L  L +     
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237

Query: 486 SGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLKLNT 524
            G +     +L     L ++ + F+    P IG  K   
Sbjct: 238 DGTLQLLKEALP---HLQINCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.3 bits (134), Expect = 5e-09
 Identities = 42/258 (16%), Positives = 83/258 (32%), Gaps = 12/258 (4%)

Query: 73  NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGE-FPEFLYNCTKLQNLDLSQN 131
             V         + Q +       + +  +DLS++ I        L  C+KLQNL L   
Sbjct: 23  QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81

Query: 132 YFVGPIPSDIDRISGLQCIDLG--GNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFP--- 186
               PI + + + S L  ++L          +   +   S L  L L             
Sbjct: 82  RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 141

Query: 187 --KEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSS 244
               + +      L     +  K  +  +       +         L  +  +    L+ 
Sbjct: 142 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201

Query: 245 LEILALNG-NHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLT 303
           L+ L+L+    +       L  +  L  L ++  +  G +    EAL    + ++ ++ T
Sbjct: 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP--HLQINCSHFT 259

Query: 304 GSIPEEFGKLKNLQLLGL 321
                  G  KN ++ G+
Sbjct: 260 TIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.9 bits (133), Expect = 6e-09
 Identities = 39/278 (14%), Positives = 77/278 (27%), Gaps = 14/278 (5%)

Query: 148 QCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFP-KEIGDLSNLEVLGLAYNSNF 206
           Q +DL G N   D+    GRL     +           P  E      ++ + L+ +   
Sbjct: 3   QTLDLTGKNLHPDV---TGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNS-VI 58

Query: 207 KPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLL 266
           + + +        KL+ L +    L   I   ++  S+L         L  +  SG    
Sbjct: 59  EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV-------RLNLSGCSGFSEF 111

Query: 267 NNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHL 326
              T L     +    +    +  +        +             +        S  +
Sbjct: 112 ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLV 171

Query: 327 SGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQL-YSNRFSGELPTGLWTTFNLSSLM 385
                     ++    L     +       L+ + L        E    L     L +L 
Sbjct: 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 231

Query: 386 LSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGS 423
           +      G L       L  L+I+ + F+   +  +G+
Sbjct: 232 VFGIVPDGTLQ-LLKEALPHLQINCSHFTTIARPTIGN 268

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.4 bits (150), Expect = 3e-11
 Identities = 42/211 (19%), Positives = 77/211 (36%), Gaps = 12/211 (5%)

Query: 70  CTFNSVTG---ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNL 126
           C  + V     ++   +++T  +PP +   K+ T + LS N +       L   T+L  L
Sbjct: 4   CEVSKVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 127 DLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFP 186
           +L +             + G   +          + +++  L+ L   +  +        
Sbjct: 61  NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 187 KEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLE 246
           + +G+L  L         N    + P       KL+ L +   NL       ++ L +L+
Sbjct: 121 RGLGELQELY-----LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175

Query: 247 ILALNGNHLEGAIPSGLFLLNNLTQLFLYDN 277
            L L  N L   IP G F  + L   FL+ N
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 7e-09
 Identities = 44/207 (21%), Positives = 72/207 (34%), Gaps = 10/207 (4%)

Query: 119 NCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYM 178
                  ++  +      +P D+ +      + L  N        ++   + L  L L  
Sbjct: 8   KVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 179 NEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEA 238
            E              L VLG    S+ +   +P+    L  L  L ++   L      A
Sbjct: 65  AELTKLQVDG-----TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 239 MSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALK-LTDIDL 297
           +  L  L+ L L GN L+   P  L     L +L L +N L+      +  L+ L  + L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 298 SMNNLTGSIPEEFGKLKNLQLLGLFSN 324
             N+L  +IP+ F     L    L  N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 4e-07
 Identities = 45/218 (20%), Positives = 71/218 (32%), Gaps = 22/218 (10%)

Query: 292 LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSL 351
             +++    NLT ++P +  K  +  +L     HLS             N L      +L
Sbjct: 12  HLEVNCDKRNLT-ALPPDLPK--DTTIL-----HLSE------------NLLYTFSLATL 51

Query: 352 GNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNN 411
                L  + L       +L          +  +  +   S  L  +T   LT L++S N
Sbjct: 52  MPYTRLTQLNL-DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFN 110

Query: 412 RFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVS 471
           R +      +     L       N      P  LT    L  L L  N L+      +  
Sbjct: 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170

Query: 472 WTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQF 509
             +L+ L L  N L   IPK      ++    L GN +
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 2e-06
 Identities = 43/193 (22%), Positives = 65/193 (33%), Gaps = 6/193 (3%)

Query: 341 NNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTA 400
            NL+ A+P  L   +    + L  N         L     L+ L L    ++      T 
Sbjct: 20  RNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTL 76

Query: 401 WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNK 460
             L  L++S+N+       G       ++  + N L +      L  L  L  L L GN+
Sbjct: 77  PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNE 135

Query: 461 LSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQL 520
           L    P  +     L  L+LA N L+      +  L  + +L L  N     IP      
Sbjct: 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGS 194

Query: 521 K-LNTFNLSSNKL 532
             L    L  N  
Sbjct: 195 HLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (111), Expect = 4e-06
 Identities = 34/202 (16%), Positives = 50/202 (24%), Gaps = 20/202 (9%)

Query: 282 EIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFEN 341
            +P  +     T + LS N L             L  L     +L       + V     
Sbjct: 24  ALPPDLPKD-TTILHLSENLLYTFSLATLMPYTRLTQL-----NLDRAELTKLQVDGTLP 77

Query: 342 NLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAW 401
            L                 Q        ++     T+  L +L                 
Sbjct: 78  VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR-------------GLG 124

Query: 402 NLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKL 461
            L  L +  N         +     L     +NN  +      L  L +L+TLLL  N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 462 SGKLPSQIVSWTSLNNLNLARN 483
              +P        L    L  N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 30/186 (16%), Positives = 61/186 (32%), Gaps = 10/186 (5%)

Query: 6   SVFPKIPVTLILLVL-----LSIPFEVIPQSPNTEERTILLNLKQQLGNPPSLQS----W 56
           ++ P +P    +L L      +     +       +  +      +L    +L       
Sbjct: 24  ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLD 83

Query: 57  TSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEF 116
            S +     P +  T  ++T + +    +T      +  L  L  + L  N +    P  
Sbjct: 84  LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL 143

Query: 117 LYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYL 176
           L    KL+ L L+ N         ++ +  L  + L  N+    IP+       L   +L
Sbjct: 144 LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFL 202

Query: 177 YMNEFN 182
           + N + 
Sbjct: 203 HGNPWL 208

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 51.4 bits (121), Expect = 3e-07
 Identities = 45/333 (13%), Positives = 98/333 (29%), Gaps = 45/333 (13%)

Query: 219 KKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHL--EGA--IPSGLFLLNNLTQLFL 274
           K LK   +T       +   +    S++ + L+GN +  E A  +   +    +L     
Sbjct: 8   KSLKLDAIT-TEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 275 YDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASI 334
            D                  +   +      + +   K   L  + L  N         +
Sbjct: 67  SDI-------------FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPL 113

Query: 335 GVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGE 394
                ++     +             ++        +         L S++   N +   
Sbjct: 114 IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 173

Query: 395 LPS---------------KTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSG 439
                             K   N  R E   +     +          +      +L S 
Sbjct: 174 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 233

Query: 440 EIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSW------TSLNNLNLARNELSGEIPKAI 493
            + + L S  +L  L L+   LS +  + +V          L  L L  NE+  +  + +
Sbjct: 234 ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 293

Query: 494 GSLLV-----MVSLDLSGNQFSGEIPPEIGQLK 521
            +++      ++ L+L+GN+FS E    + +++
Sbjct: 294 KTVIDEKMPDLLFLELNGNRFSEE-DDVVDEIR 325

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 47.6 bits (111), Expect = 4e-06
 Identities = 42/326 (12%), Positives = 85/326 (26%), Gaps = 41/326 (12%)

Query: 74  SVTGISLRHKDIT----QKIPPIICDLKNLTTIDLSSNSIPGE----FPEFLYNCTKLQN 125
           S+ G SL+   IT    + +  ++ +  ++  I LS N+I  E      E + +   L+ 
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 126 LDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTF 185
            + S  +         + +  L    L                   Q   +     +   
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 186 PKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSL 245
                  + L     A  +     +   +           +   N +          +  
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183

Query: 246 EILALNGNHLEGAIPSGLFLLNNLTQLFLYDNIL---------------SGEIPSSVEAL 290
               L+   +         + + L +   Y   L               S    +     
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243

Query: 291 KLTDIDLSMNNLTGSIPE------EFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLS 344
            L ++ L+   L+              +   LQ L L  N +  +   ++  V       
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID----- 298

Query: 345 GAVPKSLGNCRTLRTVQLYSNRFSGE 370
                       L  ++L  NRFS E
Sbjct: 299 -------EKMPDLLFLELNGNRFSEE 317

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 3e-07
 Identities = 18/89 (20%), Positives = 35/89 (39%), Gaps = 9/89 (10%)

Query: 449 SHLNTLLLDGNKLSGK----LPSQIVSWTSLNNLNLARNELSGEIPKAIGSLL-----VM 499
           S L  L L    +S      L + +++  SL  L+L+ N L       +   +     ++
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 500 VSLDLSGNQFSGEIPPEIGQLKLNTFNLS 528
             L L    +S E+   +  L+ +  +L 
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 16/126 (12%), Positives = 34/126 (26%), Gaps = 9/126 (7%)

Query: 54  QSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGE- 112
            +  S  S             ++   L    + +    +      L  + L+   +    
Sbjct: 326 AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 385

Query: 113 ---FPEFLYNCTKLQNLDLSQNYFVGPIPSDI-----DRISGLQCIDLGGNNFSGDIPRS 164
                  L     L+ LDLS N         +          L+ + L    +S ++   
Sbjct: 386 CSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445

Query: 165 IGRLSE 170
           +  L +
Sbjct: 446 LQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 3e-06
 Identities = 13/95 (13%), Positives = 29/95 (30%), Gaps = 10/95 (10%)

Query: 98  NLTTIDLSSNSI-PGEFPEFLYNCTKLQNLDLSQNYF----VGPIPSDIDRISGLQCIDL 152
           ++ ++D+    +    + E L    + Q + L            I S +     L  ++L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 153 GGNNFSGDIPRSIGRL-----SELQTLYLYMNEFN 182
             N         + +       ++Q L L      
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 8e-06
 Identities = 16/113 (14%), Positives = 34/113 (30%), Gaps = 6/113 (5%)

Query: 451 LNTLLLDGNKLSGKLPSQIVS-WTSLNNLNLARNELSGEIPKAIGSLLV----MVSLDLS 505
           + +L +   +LS    ++++        + L    L+    K I S L     +  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 506 GNQFSGEIPPEIGQ-LKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSNLCV 557
            N+        + Q L+  +  +    L               +      L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQE 116

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 15/88 (17%), Positives = 27/88 (30%), Gaps = 10/88 (11%)

Query: 466 PSQIVSWTSLNNLNLARNELSGEIPKAIGSLLV----MVSLDLSGNQFSGEIPPEIGQL- 520
                  + L  L LA  ++S     ++ + L+    +  LDLS N        ++ +  
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 521 -----KLNTFNLSSNKLYGNIPDEFNNL 543
                 L    L        + D    L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 12/89 (13%), Positives = 25/89 (28%), Gaps = 9/89 (10%)

Query: 113 FPEFLYNCTKLQNLDLSQNYF----VGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGR- 167
                   + L+ L L+           + + +     L+ +DL  N         +   
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420

Query: 168 ----LSELQTLYLYMNEFNGTFPKEIGDL 192
                  L+ L LY   ++      +  L
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 4e-05
 Identities = 15/105 (14%), Positives = 30/105 (28%), Gaps = 14/105 (13%)

Query: 290 LKLTDIDLSMNNLTGS-IPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVP 348
           L +  +D+    L+ +   E    L+  Q++ L    L+      I              
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI-------------S 48

Query: 349 KSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISG 393
            +L     L  + L SN         +       S  +   ++  
Sbjct: 49  SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 1e-04
 Identities = 21/92 (22%), Positives = 34/92 (36%), Gaps = 9/92 (9%)

Query: 209 AMIPIEFGMLKKLKTLWMTEANL----IGEIPEAMSNLSSLEILALNGNHLEGAIPSGLF 264
            +          L+ LW+ + ++       +   +    SL  L L+ N L  A    L 
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418

Query: 265 -----LLNNLTQLFLYDNILSGEIPSSVEALK 291
                    L QL LYD   S E+   ++AL+
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 1e-04
 Identities = 17/84 (20%), Positives = 26/84 (30%), Gaps = 5/84 (5%)

Query: 426 NLIVFKASNNLFSGEIPVEL-TSLSHLNTLLLDGNKLSGK----LPSQIVSWTSLNNLNL 480
           ++          S     EL   L     + LD   L+      + S +    +L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 481 ARNELSGEIPKAIGSLLVMVSLDL 504
             NEL       +   L   S  +
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 7/69 (10%), Positives = 20/69 (28%), Gaps = 5/69 (7%)

Query: 78  ISLRHKDITQKIPPIICD-LKNLTTIDLSSNSIPGE----FPEFLYNCTKLQNLDLSQNY 132
           + ++ ++++      +   L+    + L    +           L     L  L+L  N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 133 FVGPIPSDI 141
                   +
Sbjct: 67  LGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 5e-04
 Identities = 15/86 (17%), Positives = 32/86 (37%), Gaps = 10/86 (11%)

Query: 239 MSNLSSLEILALNGNHLEG----AIPSGLFLLNNLTQLFLYDNILSGEIPSS-VEALK-- 291
               S L +L L    +      ++ + L   ++L +L L +N L        VE+++  
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 292 ---LTDIDLSMNNLTGSIPEEFGKLK 314
              L  + L     +  + +    L+
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 6e-04
 Identities = 12/85 (14%), Positives = 29/85 (34%), Gaps = 7/85 (8%)

Query: 194 NLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANL----IGEIPEAMSNLSSLEILA 249
           +++ L +        A       +L++ + + + +  L      +I  A+    +L  L 
Sbjct: 3   DIQSLDIQCE-ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 250 LNGNHLEGAIPSGLF--LLNNLTQL 272
           L  N L       +   L     ++
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 8e-04
 Identities = 20/103 (19%), Positives = 33/103 (32%), Gaps = 22/103 (21%)

Query: 314 KNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPT 373
             L++L L    +S    +S+               +L    +LR + L +N        
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLA-------------ATLLANHSLRELDLSNNCLGDAGIL 415

Query: 374 GLWTTF-----NLSSLMLSDNTISGELPSKTAWNLTRLEISNN 411
            L  +       L  L+L D   S E+  +    L  LE    
Sbjct: 416 QLVESVRQPGCLLEQLVLYDIYWSEEMEDR----LQALEKDKP 454

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 14/83 (16%), Positives = 22/83 (26%), Gaps = 6/83 (7%)

Query: 268 NLTQLFLYDNILSGE-IPSSVEALK-LTDIDLSMNNLTG----SIPEEFGKLKNLQLLGL 321
           ++  L +    LS       +  L+    + L    LT      I         L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 322 FSNHLSGEVPASIGVVAFENNLS 344
            SN L       +       +  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCK 85

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 15/89 (16%), Positives = 31/89 (34%), Gaps = 16/89 (17%)

Query: 291 KLTDIDLSMNNLTG----SIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGA 346
            L  + L+  +++     S+        +L+ L L +N L        G++    ++   
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA-----GILQLVESVR-- 422

Query: 347 VPKSLGNCRTLRTVQLYSNRFSGELPTGL 375
                     L  + LY   +S E+   L
Sbjct: 423 -----QPGCLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 11/113 (9%), Positives = 30/113 (26%), Gaps = 23/113 (20%)

Query: 378 TFNLSSLMLSDNTISGELPSKTA---WNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASN 434
           + ++ SL +    +S    ++          + + +   +    + + S           
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA---------- 50

Query: 435 NLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSG 487
                     L     L  L L  N+L       ++      +  + +  L  
Sbjct: 51  ----------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.8 bits (117), Expect = 8e-07
 Identities = 21/94 (22%), Positives = 37/94 (39%), Gaps = 8/94 (8%)

Query: 225 WMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIP 284
                    EI        SLE L ++ N L   +P+   L   L +L    N L+ E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVP 320

Query: 285 SSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQL 318
              +   L  + +  N L    P+    +++L++
Sbjct: 321 ELPQ--NLKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 23/85 (27%), Positives = 35/85 (41%), Gaps = 8/85 (9%)

Query: 459 NKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIG 518
           N  S ++ S      SL  LN++ N+L  E+P     L     L  S N  + E+P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQ 324

Query: 519 QLKLNTFNLSSNKLYGNIPDEFNNL 543
            LK    ++  N L    PD   ++
Sbjct: 325 NLK--QLHVEYNPLRE-FPDIPESV 346

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 8e-06
 Identities = 17/119 (14%), Positives = 40/119 (33%), Gaps = 9/119 (7%)

Query: 54  QSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEF 113
           +   S +       I    + +          + +I  +     +L  +++S+N +  E 
Sbjct: 241 ELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IEL 299

Query: 114 PEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQ 172
           P       +L+ L  S N+    +P        L+ + +  N      P     + +L+
Sbjct: 300 PALP---PRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.4 bits (108), Expect = 1e-05
 Identities = 22/156 (14%), Positives = 49/156 (31%), Gaps = 9/156 (5%)

Query: 42  NLKQQLGNPPSLQSWTSTSSPCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTT 101
            L     +   L++        +   +   + +      +          I   L  L  
Sbjct: 205 FLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264

Query: 102 IDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDI 161
                N+   E          L+ L++S N  +  +P+   R   L+ +    N+ + ++
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EV 319

Query: 162 PRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEV 197
           P        L+ L++  N     FP     + +L +
Sbjct: 320 PELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.0 bits (94), Expect = 5e-04
 Identities = 52/353 (14%), Positives = 102/353 (28%), Gaps = 46/353 (13%)

Query: 70  CTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLS 129
           C       + L +  ++  +P +     +L ++  S NS+  E PE   +   L   + +
Sbjct: 35  CLDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSL-TELPELPQSLKSLLVDNNN 89

Query: 130 QNYFVGPIPS-DIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKE 188
                   P  +   +S  Q   L     S  +       + L+ L              
Sbjct: 90  LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGN 149

Query: 189 IGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEIL 248
                  E+  L + +        ++      L    +   N I E    + NL  L  +
Sbjct: 150 NQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTI 209

Query: 249 ---------ALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSM 299
                      +      A+      L +L +L      L           +L      +
Sbjct: 210 YADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYL 269

Query: 300 NNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRT 359
           N  +  I        +L+ L + +N L  E+PA                        L  
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP--------------------RLER 308

Query: 360 VQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISG--ELPSKTAWNLTRLEISN 410
           +    N  + E+P       NL  L +  N +    ++P     ++  L +++
Sbjct: 309 LIASFNHLA-EVPELPQ---NLKQLHVEYNPLREFPDIPE----SVEDLRMNS 353

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 1e-06
 Identities = 23/130 (17%), Positives = 46/130 (35%), Gaps = 11/130 (8%)

Query: 148 QCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFK 207
           + + L   + +  +   + +L  +  L L  N      P  +  L  LEV      ++  
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEV----LQASDN 53

Query: 208 PAMIPIEFGMLKKLKTLWMTEANLIG-EIPEAMSNLSSLEILALNGNHL---EGAIPSGL 263
                     L +L+ L +    L      + + +   L +L L GN L   EG      
Sbjct: 54  ALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113

Query: 264 FLLNNLTQLF 273
            +L +++ + 
Sbjct: 114 EMLPSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 5e-06
 Identities = 20/97 (20%), Positives = 34/97 (35%), Gaps = 3/97 (3%)

Query: 234 EIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLT 293
            +   +  L  +  L L+ N L    P+ L  L  L ++    +     +       +L 
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCL-EVLQASDNALENVDGVANLPRLQ 68

Query: 294 DIDLSMNNLTG-SIPEEFGKLKNLQLLGLFSNHLSGE 329
           ++ L  N L   +  +       L LL L  N L  E
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.9 bits (103), Expect = 7e-06
 Identities = 24/119 (20%), Positives = 37/119 (31%), Gaps = 7/119 (5%)

Query: 78  ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPI 137
           + L HKD+T  +   +  L  +T +DLS N +    P        L+ L  S N      
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNALENVD 59

Query: 138 PSDIDRISGLQCIDLGGNNF-SGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNL 195
                     Q + L  N        + +     L  L L  N            L+ +
Sbjct: 60  GVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.3 bits (91), Expect = 3e-04
 Identities = 19/107 (17%), Positives = 34/107 (31%), Gaps = 2/107 (1%)

Query: 358 RTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQI 417
           R + L     +      L     ++ L LS N +    P+  A     +  +++     +
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58

Query: 418 QRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGK 464
                  +   +   +N L        L S   L  L L GN L  +
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.9 bits (90), Expect = 4e-04
 Identities = 24/120 (20%), Positives = 44/120 (36%), Gaps = 9/120 (7%)

Query: 295 IDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFE----NNLSGAVPKS 350
           + L+  +LT  +     +L  +  L L  N L    PA   +   E    ++ +      
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 351 LGNCRTLRTVQLYSNRF-SGELPTGLWTTFNLSSLMLSDNTISGE--LPSKTAWNLTRLE 407
           + N   L+ + L +NR         L +   L  L L  N++  E  +  + A  L  + 
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 46.7 bits (109), Expect = 3e-06
 Identities = 37/194 (19%), Positives = 69/194 (35%), Gaps = 20/194 (10%)

Query: 63  CDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLY-NCT 121
           C+   + CT   +        +I + IP       + T + L+ N +     + L+    
Sbjct: 8   CEGTTVDCTGRGLK-------EIPRDIPL------HTTELLLNDNELGRISSDGLFGRLP 54

Query: 122 KLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEF 181
            L  L+L +N   G  P+  +  S +Q + LG N       +    L +L+TL LY N+ 
Sbjct: 55  HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQI 114

Query: 182 NGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSN 241
           +   P   G   +L  L     ++             + L+   +         P   S 
Sbjct: 115 SCVMP---GSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP---SK 168

Query: 242 LSSLEILALNGNHL 255
           +  ++I  L  +  
Sbjct: 169 VRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 44.0 bits (102), Expect = 2e-05
 Identities = 38/181 (20%), Positives = 66/181 (36%), Gaps = 9/181 (4%)

Query: 376 WTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQI-QRGVGSWKNLIVFKASN 434
            TT + +   L       E+P     + T L +++N           G   +L+  +   
Sbjct: 10  GTTVDCTGRGLK------EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKR 63

Query: 435 NLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIG 494
           N  +G  P      SH+  L L  NK+        +    L  LNL  N++S  +P +  
Sbjct: 64  NQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE 123

Query: 495 SLLVMVSLDLSGNQFSGEIPPEIGQLKLNTFNLSSNKLYGNIPDEFNNLAYDDSFLNNSN 554
            L  + SL+L+ N F+           L   +L+        P +  ++   D  L +S 
Sbjct: 124 HLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKD--LPHSE 181

Query: 555 L 555
            
Sbjct: 182 F 182

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.6 bits (109), Expect = 5e-06
 Identities = 38/215 (17%), Positives = 74/215 (34%), Gaps = 8/215 (3%)

Query: 266 LNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNH 325
           L N  ++    + ++  +  + +   +T +      +T    E    L NL  L L  N 
Sbjct: 18  LANAIKIAAGKSNVTDTVTQA-DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74

Query: 326 LSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLM 385
           ++   P        E  LSG   K++     L++++      +             +  +
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT-PLAGLSNLQV 133

Query: 386 LSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVEL 445
           L  +       S  A       +S           + +   L   KA +N  S   P  L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191

Query: 446 TSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNL 480
            SL +L  + L  N++S   P  + + ++L  + L
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 30/217 (13%), Positives = 56/217 (25%), Gaps = 20/217 (9%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
             +   I+    ++T  +     DL  +TT+      +     E +     L  L+L  N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDN 73

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGD 191
                 P           +          I       +   T     +         +  
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 192 LS------------NLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAM 239
           L                      +              L KL TL   +  +    P  +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191

Query: 240 SNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYD 276
           ++L +L  + L  N +    P  L   +NL  + L +
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 5e-04
 Identities = 38/217 (17%), Positives = 69/217 (31%), Gaps = 8/217 (3%)

Query: 218 LKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDN 277
           L     +   ++N+   + +A  +L  +  L+  G  +      G+  LNNL  L L DN
Sbjct: 18  LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73

Query: 278 ILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVV 337
            +     + ++ L          N   ++    G      L    +        A +  +
Sbjct: 74  QI--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 338 AFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPS 397
                    +              L          T L     L++L   DN IS   P 
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL 191

Query: 398 KTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASN 434
            +  NL  + + NN+ S      + +  NL +   +N
Sbjct: 192 ASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 9e-06
 Identities = 32/204 (15%), Positives = 67/204 (32%), Gaps = 18/204 (8%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
           F      +L+ K +T  +     +L ++  I  +++ I       +     +  L L+ N
Sbjct: 23  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGD 191
                  +DI  ++ L+ +     + +     S  +  +        +         +  
Sbjct: 79  KL-----TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133

Query: 192 LSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALN 251
                                     L KL TL + +  +   +P  ++ L+ L+ L L+
Sbjct: 134 PQLES-----LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186

Query: 252 GNHLEGAIPSGLFLLNNLTQLFLY 275
            NH+       L  L NL  L L+
Sbjct: 187 KNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 32/205 (15%), Positives = 64/205 (31%), Gaps = 17/205 (8%)

Query: 119 NCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYM 178
              +    +L +      +    + ++ +  I    ++        I  L  +  L+L  
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 179 NEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEA 238
           N+     P     L+NL+ LG  +    K   +     +        +   +L       
Sbjct: 78  NKLTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLK------KLKSLSLEHNGISD 126

Query: 239 MSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLS 298
           ++ L  L  L              +            ++    +I       KL ++ LS
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLS 186

Query: 299 MNNLTGSIPEEFGKLKNLQLLGLFS 323
            N+++         LKNL +L LFS
Sbjct: 187 KNHISD--LRALAGLKNLDVLELFS 209

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 1e-05
 Identities = 34/249 (13%), Positives = 64/249 (25%), Gaps = 42/249 (16%)

Query: 63  CDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTK 122
           C      C  + VT           +IP  +   +N   +      +             
Sbjct: 8   CSNRVFLCQESKVT-----------EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGD 54

Query: 123 LQNLDLSQNYFVGPI--------------------------PSDIDRISGLQCIDLGGNN 156
           L+ +++SQN  +  I                          P     +  LQ + +    
Sbjct: 55  LEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG 114

Query: 157 FSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFG 216
                        +   L +  N    T  +      + E + L  N N    +    F 
Sbjct: 115 IKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN 174

Query: 217 MLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYD 276
             +  +       NL     +     S   IL ++   +      GL  L  L     Y+
Sbjct: 175 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234

Query: 277 NILSGEIPS 285
                ++P+
Sbjct: 235 L---KKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 2e-05
 Identities = 27/241 (11%), Positives = 54/241 (22%), Gaps = 13/241 (5%)

Query: 90  PPIICDLKNLTTIDLSSN---SIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISG 146
              IC   N        +    IP + P           L                    
Sbjct: 2   HHRICHCSN-RVFLCQESKVTEIPSDLP------RNAIELRFVLTKLRVIQKGAFSGFGD 54

Query: 147 LQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNF 206
           L+ I++  N+    I   +                N  +       +   +  L  ++  
Sbjct: 55  LEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG 114

Query: 207 KPAMIPIEFGMLKKLKTLWMTE--ANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLF 264
              +  +      +   L + +       E    +       IL LN N ++        
Sbjct: 115 IKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN 174

Query: 265 LLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFS 323
                      +N L                +D+S   +          LK L+    ++
Sbjct: 175 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234

Query: 324 N 324
            
Sbjct: 235 L 235

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 9e-05
 Identities = 25/201 (12%), Positives = 52/201 (25%), Gaps = 18/201 (8%)

Query: 72  FNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN 131
                   L   ++T  +     DL  +TT+      I  +  + +     L  ++ S N
Sbjct: 17  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 72

Query: 132 YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGD 191
                 P           ++         +                 +         +  
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132

Query: 192 LSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALN 251
           L                  I     +        +  ++      + ++NL++LE L ++
Sbjct: 133 L------------ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDIS 180

Query: 252 GNHLEGAIPSGLFLLNNLTQL 272
            N +     S L  L NL  L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 3e-04
 Identities = 34/202 (16%), Positives = 68/202 (33%), Gaps = 19/202 (9%)

Query: 119 NCTKLQNLDLSQNYFVGPIP-SDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLY 177
              +     L +      +  +D+D+++ LQ   LG  +  G     +  L+ L  +   
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70

Query: 178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPE 237
            N+     P     L NL  L     +N + A I     +                +  +
Sbjct: 71  NNQLTDITP-----LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 125

Query: 238 AMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDL 297
            ++NL+ LE+ +   + +            N +   + D      + +      L  +D+
Sbjct: 126 NLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTT------LERLDI 179

Query: 298 SMNNLTGSIPEEFGKLKNLQLL 319
           S N ++        KL NL+ L
Sbjct: 180 SSNKVSD--ISVLAKLTNLESL 199

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (91), Expect = 5e-04
 Identities = 19/143 (13%), Positives = 39/143 (27%), Gaps = 6/143 (4%)

Query: 84  DITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDR 143
           ++ ++      +      +DL    IP           +   +D S N            
Sbjct: 6   ELIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPL 61

Query: 144 ISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNG-TFPKEIGDLSNLEVLGLAY 202
           +  L+ + +  N            L +L  L L  N          +  L +L  L +  
Sbjct: 62  LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 121

Query: 203 -NSNFKPAMIPIEFGMLKKLKTL 224
                K          + +++ L
Sbjct: 122 NPVTNKKHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 7e-04
 Identities = 22/125 (17%), Positives = 37/125 (29%), Gaps = 7/125 (5%)

Query: 78  ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPI 137
           + LR   I   I  +   L     ID S N I     +      +L+ L ++ N      
Sbjct: 23  LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNNRICRIG 79

Query: 138 PSDIDRISGLQCIDLGGNNFSG-DIPRSIGRLSELQTLYLY---MNEFNGTFPKEIGDLS 193
                 +  L  + L  N+         +  L  L  L +    +          I  + 
Sbjct: 80  EGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVP 139

Query: 194 NLEVL 198
            + VL
Sbjct: 140 QVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 0.002
 Identities = 25/147 (17%), Positives = 41/147 (27%), Gaps = 7/147 (4%)

Query: 104 LSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPR 163
           L++  I  +  ++  N  + + LDL        I +    +     ID   N        
Sbjct: 3   LTAELI-EQAAQYT-NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGF 59

Query: 164 SIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYN--SNFKPAMIPIEFGMLKKL 221
               L  L+TL +  N            L +L  L L  N                L  L
Sbjct: 60  P--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117

Query: 222 KTLWMTEANLIGEIPEAMSNLSSLEIL 248
             L     N        +  +  + +L
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVRVL 144

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (89), Expect = 6e-04
 Identities = 17/114 (14%), Positives = 35/114 (30%), Gaps = 3/114 (2%)

Query: 70  CTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLY-NCTKLQNLDL 128
           C  +  +G+              +   +NLT + + +                +L+NL +
Sbjct: 5   CCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63

Query: 129 SQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFN 182
            ++      P        L  ++L  N     +     +   LQ L L  N  +
Sbjct: 64  VKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (87), Expect = 0.002
 Identities = 16/80 (20%), Positives = 33/80 (41%), Gaps = 2/80 (2%)

Query: 85  ITQKIPPIICDLKNLTTIDLSSNSI--PGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDID 142
           +   +  I  ++  L +++LS+N +    +    +     L+ L+LS N        D  
Sbjct: 53  MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKI 112

Query: 143 RISGLQCIDLGGNNFSGDIP 162
           +   L+ + L GN+ S    
Sbjct: 113 KGLKLEELWLDGNSLSDTFR 132

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	969
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.92
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.87
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.73
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.73
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.73
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.72
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.72
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.72
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.69
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.68
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.67
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.66
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.51
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.48
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.47
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.46
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.45
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.38
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.35
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.29
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.26
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.23
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.22
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.46
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.45
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.24
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.98
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.61
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.47
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.39
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.61
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.31
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.0
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.48
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.26

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=439.05  Aligned_cols=277  Identities=17%  Similarity=0.241  Sum_probs=227.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46899999999999999999999999999999997654434444578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||++||+|.+++...+             .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        88 Ey~~gg~L~~~~~~~~-------------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~D  151 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-------------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITD  151 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             EccCCCCHHHhhhccC-------------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecc
Confidence            9999999999988654             389999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccCC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEKP  875 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  875 (969)
                      ||+|+.+.............||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...+...+..   ... 
T Consensus       152 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~---~~~-  227 (288)
T d1uu3a_         152 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK---LEY-  227 (288)
T ss_dssp             CTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT---TCC-
T ss_pred             cccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc---CCC-
Confidence            9999987654444444566899999999999999999999999999999999999999987655443332211   111 


Q ss_pred             chhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCCCCCCCCcccccCCCCCCCCCcccceeccc
Q 002085          876 ITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCPTENYGGKKMGRDVDSAPLLGTAGYLFGFK  955 (969)
Q Consensus       876 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  955 (969)
                                 ..+...+..+.+++.+||+.||++|||++|+++.                ..+..||||+  +++|++.
T Consensus       228 -----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~----------------~~i~~Hpff~--~i~w~~l  278 (288)
T d1uu3a_         228 -----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY----------------GPLKAHPFFE--SVTWENL  278 (288)
T ss_dssp             -----------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH----------------HHHHTSGGGT--TCCCTTG
T ss_pred             -----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC----------------HHHHcCCccC--CCCHHHh
Confidence                       1112234678899999999999999999987542                2345789999  5677777


Q ss_pred             cccchh
Q 002085          956 RSKKVA  961 (969)
Q Consensus       956 ~~~~~~  961 (969)
                      +++++|
T Consensus       279 ~~~~pP  284 (288)
T d1uu3a_         279 HQQTPP  284 (288)
T ss_dssp             GGSCCC
T ss_pred             hcCCCC
Confidence            766655

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=422.16  Aligned_cols=256  Identities=24%  Similarity=0.316  Sum_probs=210.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +.++|+..+.||+|+||+||+|++..+|+.||||++.....  ....+.+.+|++++++++|||||++++++.+++..|+
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i   80 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   80 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence            35679999999999999999999999999999999865432  2334678999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||
T Consensus        81 vmEy~~gg~L~~~l~~~~-------------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL  144 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDI-------------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI  144 (271)
T ss_dssp             EEECCTTEEGGGGSBTTT-------------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred             EEeccCCCcHHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEE
Confidence            999999999999997543             489999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||+|+.+.............||+.|||||++.+..+ +.++||||+||++|||++|+.||..............   .
T Consensus       145 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~---~  221 (271)
T d1nvra_         145 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---E  221 (271)
T ss_dssp             CCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH---T
T ss_pred             ccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh---c
Confidence            99999998765444444556789999999999988876 5789999999999999999999976544332221111   1


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...         ........+..+.+++.+||+.||++|||++|+++
T Consensus       222 ~~~---------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         222 KKT---------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TCT---------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC---------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111         01111223467889999999999999999999854

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-50  Score=421.16  Aligned_cols=250  Identities=25%  Similarity=0.345  Sum_probs=213.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +++|++.+.||+|+||+||+|++..+++.||+|++...........+.+.+|++++++++|||||++++++.+++..|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            35789999999999999999999999999999999765444444467899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+++|+|.+++....             .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        85 mEy~~~g~L~~~l~~~~-------------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~  148 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLS-------------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA  148 (263)
T ss_dssp             EECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EeecCCCcHHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeec
Confidence            99999999999998654             389999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+|+....    .......||+.|||||++.+..++.++||||+||++|||++|+.||.+.+.......+.    ...
T Consensus       149 DFG~a~~~~~----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~----~~~  220 (263)
T d2j4za1         149 DFGWSVHAPS----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----RVE  220 (263)
T ss_dssp             CCCSCSCCCC----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----TTC
T ss_pred             ccceeeecCC----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH----cCC
Confidence            9999976532    22344679999999999999999999999999999999999999998765444333221    111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .           ..+...+.++.+++.+||+.||++|||++|+++
T Consensus       221 ~-----------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 F-----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             C-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            0           111223467889999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-49  Score=417.18  Aligned_cols=261  Identities=27%  Similarity=0.372  Sum_probs=205.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||+||+|+..   ..||||+++.... +....+.|.+|++++++++|||||++++++.+ +..++||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            57889999999999999999864   3599999865433 33446789999999999999999999998754 5689999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++...+            ..++|..+..++.|||.||+|||+.   +||||||||+|||++.++.+||+|
T Consensus        83 Ey~~~g~L~~~l~~~~------------~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~D  147 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIE------------TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGD  147 (276)
T ss_dssp             ECCCEEEHHHHHHTSC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECC
T ss_pred             ecCCCCCHHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcc
Confidence            9999999999997643            2489999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT---TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      ||+|+...............||+.|||||++.+   ..++.++|||||||++|||+||+.||.+.............-..
T Consensus       148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~  227 (276)
T d1uwha_         148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL  227 (276)
T ss_dssp             CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC
T ss_pred             ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence            999987755444445556789999999999864   35889999999999999999999999875543322222111110


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ....         ...+...+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus       228 ~p~~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         228 SPDL---------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             CCCG---------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcc---------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            0000         0112233468899999999999999999999999998774

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-49  Score=425.92  Aligned_cols=260  Identities=24%  Similarity=0.423  Sum_probs=204.3

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCc---EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGE---FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .++|+..++||+|+||+||+|++..+++   .||||.+....  .....+.|.+|++++++++|||||++++++.+++..
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            4678888999999999999999876654   68999875432  344567899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++|||||++|+|.+++....            ..++|.++..++.|||.||+|||+.   +|+||||||+|||++.++.+
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~------------~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~  167 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQND------------GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVC  167 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTT------------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred             EEEEEecCCCcceeeecccc------------CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcE
Confidence            99999999999999988643            2489999999999999999999988   99999999999999999999


Q ss_pred             EEeecccceecccCCCCcc---ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHH
Q 002085          792 KIADFGLAKMLAKQGEPHT---MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  867 (969)
                      ||+|||+|+.+........   .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.+....++...+.
T Consensus       168 Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~  247 (299)
T d1jpaa_         168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE  247 (299)
T ss_dssp             EECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             EECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999987654322221   223457999999999999999999999999999999998 788887665544333221


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .              +...+.+.+.+..+.+++.+||+.||++|||++||++.|+++.
T Consensus       248 ~--------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         248 Q--------------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             T--------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             c--------------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            1              1112233344578899999999999999999999999998874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-48  Score=414.55  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=211.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .++|+..+.||+|+||+||+|++..+|+.||||++......   ..+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            45799999999999999999999999999999998654322   246789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||+|.+++...              .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        96 mEy~~gg~L~~~~~~~--------------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~  158 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT  158 (293)
T ss_dssp             EECCTTCBHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred             EEecCCCcHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeec
Confidence            9999999999988653              388999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+|+.+....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+...   ..
T Consensus       159 DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~  233 (293)
T d1yhwa1         159 DFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GT  233 (293)
T ss_dssp             CCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CS
T ss_pred             cchhheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC---CC
Confidence            999998764432  2334567999999999999999999999999999999999999999876544333222111   11


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .         ....+...+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~---------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         234 P---------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             C---------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             C---------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0         01112233467899999999999999999999863

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.2e-49  Score=421.76  Aligned_cols=257  Identities=25%  Similarity=0.345  Sum_probs=215.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||+||+|++..+++.||||+++....    ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            468888999999999999999998999999999865432    2357899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++.....           ..++|..+..++.|||.||+|||+.   +|+||||||+|||+++++.+||+|
T Consensus        93 E~~~~g~l~~~l~~~~~-----------~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D  158 (287)
T d1opja_          93 EFMTYGNLLDYLRECNR-----------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD  158 (287)
T ss_dssp             ECCTTCBHHHHHHHSCT-----------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             ecccCcchHHHhhhccc-----------cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcc
Confidence            99999999999976542           4589999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCcc-chHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHT-SLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~  874 (969)
                      ||+|+..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||+..... .+.+.+    .   
T Consensus       159 FG~a~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~---  230 (287)
T d1opja_         159 FGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----E---  230 (287)
T ss_dssp             CCCTTTCCSS-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----H---
T ss_pred             ccceeecCCC-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH----h---
Confidence            9999876432 233344556899999999999999999999999999999999988877654332 221111    1   


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                             .+...+.+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       231 -------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         231 -------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                   11122223334578999999999999999999999999998875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=416.80  Aligned_cols=258  Identities=23%  Similarity=0.332  Sum_probs=200.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc--CCceEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS--ENSKLL  713 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  713 (969)
                      ++|++.+.||+|+||+||+|++..+|+.||||++..... .+...+.+.+|++++++++|||||++++++.+  .+..|+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            578999999999999999999999999999999866533 34456789999999999999999999999865  456899


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC--CCCeEecCCCCCcEEECCCCcE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC--TPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ||||+++|+|.+++.....         ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+
T Consensus        83 vmEy~~~g~L~~~i~~~~~---------~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v  153 (269)
T d2java1          83 VMEYCEGGDLASVITKGTK---------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV  153 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHH---------HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred             EEecCCCCcHHHHHHhccc---------cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence            9999999999999975432         1235899999999999999999999861  1249999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      ||+|||+|+.+...  ........||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..++...+...  
T Consensus       154 kl~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~--  229 (269)
T d2java1         154 KLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--  229 (269)
T ss_dssp             EECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--
T ss_pred             EEeeccceeecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC--
Confidence            99999999876432  22234567999999999999999999999999999999999999999876554433332211  


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                        . .         ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       230 --~-~---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         230 --K-F---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --C-C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --C-C---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              1 0         0112223467899999999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-49  Score=414.99  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=201.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||+||+|++. +++.||||+++....    ..+++.+|++++++++|||||++++++.+++..++||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            46888899999999999999986 567899999865332    2357899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....            ..++|..+..++.|+|.||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        80 E~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~D  144 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQR------------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD  144 (263)
T ss_dssp             ECCTTCBHHHHHHTTT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECS
T ss_pred             EecCCCcHHHHhhccc------------cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecc
Confidence            9999999999987654            3488999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCC-CccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGD-EHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~-~~~~~~~~~~~~~~~~~  874 (969)
                      ||+|+..... .........||+.|+|||++.+..++.++|||||||++|||+|++.|++.. ......+.+...     
T Consensus       145 FGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-----  218 (263)
T d1sm2a_         145 FGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----  218 (263)
T ss_dssp             CC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-----
T ss_pred             cchheeccCC-CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-----
Confidence            9999876443 222333467899999999999999999999999999999999976665543 322222222111     


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                               .....+...+.++.+++.+||+.||++|||++||++.|+++.
T Consensus       219 ---------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         219 ---------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                     111122233467899999999999999999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=410.79  Aligned_cols=254  Identities=26%  Similarity=0.402  Sum_probs=208.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..+.||+|+||+||+|++. +++.||||+++....    ..+.+.+|++++++++|||||++++++.+ +..++||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            57888999999999999999986 577899999965332    23579999999999999999999998755 5679999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++.....           ..++|..+++|+.||+.||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        87 Ey~~~g~L~~~~~~~~~-----------~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~D  152 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSG-----------IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD  152 (272)
T ss_dssp             ECCTTCBHHHHTTSHHH-----------HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             EeCCCCcHHHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeecc
Confidence            99999999998875432           3589999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-ccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE-HTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~~  874 (969)
                      ||+|+.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.|++... .......+    ... 
T Consensus       153 FGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i----~~~-  226 (272)
T d1qpca_         153 FGLARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERG-  226 (272)
T ss_dssp             CTTCEECSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTT-
T ss_pred             ccceEEccCC-ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hhc-
Confidence            9999976432 2333445678999999999999999999999999999999999877765443 22222221    111 


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                               ...+.+...+..+.+++.+||+.||++|||++||+++|+..
T Consensus       227 ---------~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         227 ---------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                     11122223446789999999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-48  Score=411.23  Aligned_cols=256  Identities=23%  Similarity=0.340  Sum_probs=209.4

Q ss_pred             CCCccc-eeeecCcEEEEEEEEcC--CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEE
Q 002085          637 SLTESN-LIGSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       637 ~~~~~~-~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +|...+ +||+|+||+||+|.+..  ++..||||+++...  .....+.|.+|++++++++|||||++++++.+ +..|+
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            455556 49999999999998753  45589999986542  34456789999999999999999999999875 46899


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++|+|.+++...+            ..+++..+..++.|+|.||+|||++   +|+||||||+||+++.++.+||
T Consensus        86 vmE~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl  150 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKR------------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKI  150 (285)
T ss_dssp             EEECCTTEEHHHHHTTCT------------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEE
T ss_pred             EEEeCCCCcHHHHhhccc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceee
Confidence            999999999999986543            3489999999999999999999988   9999999999999999999999


Q ss_pred             eecccceecccCCCCc-cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhh
Q 002085          794 ADFGLAKMLAKQGEPH-TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      +|||+|+.+....... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....++...+.    
T Consensus       151 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~----  226 (285)
T d1u59a_         151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE----  226 (285)
T ss_dssp             CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH----
T ss_pred             ccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence            9999999875432222 2234568999999999999999999999999999999998 899987765544333221    


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      .+          .+.+.+...+.++.+++.+||+.||++||||.+|++.|+..
T Consensus       227 ~~----------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         227 QG----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             TT----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cC----------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11          11122334457889999999999999999999999998765

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=412.89  Aligned_cols=259  Identities=28%  Similarity=0.462  Sum_probs=205.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCC----cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAG----EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      +.|+..++||+|+||+||+|.+..++    ..||||++....  .+.....|.+|++++++++|||||++++++.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            46788899999999999999986544    479999985433  344456799999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++||||++++++.+++....            ..++|..+..++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~------------~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~  149 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD------------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVC  149 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT------------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred             EEEEEecccCcchhhhhccc------------ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeE
Confidence            99999999999999887654            3489999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCC-CccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCc-cchHHHHHHH
Q 002085          792 KIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH-TSLAEWAWRH  869 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~-~~~~~~~~~~  869 (969)
                      ||+|||+|+.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ..+.+.    
T Consensus       150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~----  225 (283)
T d1mqba_         150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA----  225 (283)
T ss_dssp             EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----
T ss_pred             EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH----
Confidence            9999999987654322 2233445689999999999999999999999999999999998777665432 222211    


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..          .+.+.+.+...+..+.+++.+||+.||++||||.||+++|+++.
T Consensus       226 i~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         226 IN----------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             HH----------TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             Hh----------ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence            11          12222333344578999999999999999999999999998875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-48  Score=417.73  Aligned_cols=250  Identities=27%  Similarity=0.388  Sum_probs=209.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      .+.|+..+.||+|+||+||+|++..+|+.||||++...........+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            34588999999999999999999999999999999766555556677899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      ||||++|+|..++....             .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        94 ~E~~~~g~l~~~~~~~~-------------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~  157 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKK-------------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG  157 (309)
T ss_dssp             EECCSEEHHHHHHHHTS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEEC
T ss_pred             EEecCCCchHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEe
Confidence            99999999987766543             489999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhh
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT---TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |||+|+....      .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.+.........+   ..
T Consensus       158 DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i---~~  228 (309)
T d1u5ra_         158 DFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQ  228 (309)
T ss_dssp             CCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH
T ss_pred             ecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH---Hh
Confidence            9999986532      234579999999999864   46899999999999999999999999765543322221   11


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...+          .......+..+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~----------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         229 NESP----------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             SCCC----------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC----------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1111          1111223467899999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=420.03  Aligned_cols=270  Identities=21%  Similarity=0.338  Sum_probs=213.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCc-----EEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGE-----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSEN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  709 (969)
                      ++|+..++||+|+||+||+|++...++     .||||.+....  .......+.+|+.+++++ +|||||++++++.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            578889999999999999999865443     69999885432  233456799999999998 8999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccC----------CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSG----------SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK  779 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~----------~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  779 (969)
                      ..|+||||+++|+|.++++.........          ........++|..++.++.||+.||+|||++   +|+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence            9999999999999999998764321110          0011124589999999999999999999998   99999999


Q ss_pred             CCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 002085          780 SSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDE  858 (969)
Q Consensus       780 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~  858 (969)
                      |+||+++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987765544444556678999999999999999999999999999999998 788887654


Q ss_pred             ccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          859 HTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                      .......+   ..          .+...+.+...+.++.+++.+||+.||++|||++||+++|..
T Consensus       272 ~~~~~~~~---~~----------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         272 VDANFYKL---IQ----------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CSHHHHHH---HH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHH---Hh----------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            43322211   11          111122233345789999999999999999999999999863

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-48  Score=411.38  Aligned_cols=252  Identities=22%  Similarity=0.301  Sum_probs=209.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      +.|++.+.||+|+||+||+|++..+++.||||++....   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            35888999999999999999999999999999986542   223467889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....            ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        89 Ey~~~g~L~~~~~~~~------------~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~D  153 (288)
T d2jfla1          89 EFCAGGAVDAVMLELE------------RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLAD  153 (288)
T ss_dssp             ECCTTEEHHHHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             ecCCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEe
Confidence            9999999999987543            2489999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAY-----TTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|+.....  ........||+.|+|||++.     +..|+.++||||+||++|||++|+.||.+....+....+... 
T Consensus       154 FG~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~-  230 (288)
T d2jfla1         154 FGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-  230 (288)
T ss_dssp             CTTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-
T ss_pred             chhhhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-
Confidence            9999865331  12234567999999999984     456889999999999999999999999877665544333221 


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                        ..+         ....+...+.++.+++.+||+.||++|||++|+++
T Consensus       231 --~~~---------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         231 --EPP---------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             --CCC---------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCC---------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              111         01122334478899999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=402.66  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=213.9

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||+||+|+++ +++.||||+++.....    .+++.+|++++++++||||+++++++.+++..++||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            57889999999999999999985 6788999999764332    357999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++....            ..+++..+.+++.|+|+||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        79 Ey~~~g~l~~~~~~~~------------~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~D  143 (258)
T d1k2pa_          79 EYMANGCLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD  143 (258)
T ss_dssp             ECCTTEEHHHHHHSGG------------GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECC
T ss_pred             EccCCCcHHHhhhccc------------cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECc
Confidence            9999999999977654            3588999999999999999999988   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||+++.+... .........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....++...+..    . 
T Consensus       144 fG~a~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~----~-  217 (258)
T d1k2pa_         144 FGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ----G-  217 (258)
T ss_dssp             CSSCCBCSSS-SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT----T-
T ss_pred             chhheeccCC-CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh----C-
Confidence            9999876543 3334445679999999999999999999999999999999998 7888876655444333221    1 


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRR  923 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~  923 (969)
                               ...+.+...+..+.+++.+||+.||++|||+.|+++.|..
T Consensus       218 ---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         218 ---------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---------CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                     1112223334688999999999999999999999999865

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=409.13  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=203.4

Q ss_pred             ceeeecCcEEEEEEEEcC--CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEeecc
Q 002085          642 NLIGSGGSGQVYRIDING--AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      ++||+|+||+||+|.+..  +++.||||+++... .+....+.+.+|++++++++|||||++++++.+ +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            579999999999998643  45789999986543 334556789999999999999999999999865 46789999999


Q ss_pred             CCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecccc
Q 002085          720 NQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFGLA  799 (969)
Q Consensus       720 ~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla  799 (969)
                      +|+|.++++...             .++|..++.++.|||.||+|||+.   +|+||||||+||+++.++.+|++|||+|
T Consensus        91 ~g~L~~~l~~~~-------------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla  154 (277)
T d1xbba_          91 LGPLNKYLQQNR-------------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS  154 (277)
T ss_dssp             TEEHHHHHHHCT-------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCcHHHHHhhcc-------------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhh
Confidence            999999998654             389999999999999999999988   9999999999999999999999999999


Q ss_pred             eecccCCCCc-cccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhccCCch
Q 002085          800 KMLAKQGEPH-TMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAEEKPIT  877 (969)
Q Consensus       800 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  877 (969)
                      +.+....... ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+....++...+..    +    
T Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~----~----  226 (277)
T d1xbba_         155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----G----  226 (277)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----T----
T ss_pred             hhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc----C----
Confidence            8765433222 2234578999999999999999999999999999999998 8889877654443332221    1    


Q ss_pred             hhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          878 DALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       878 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                            .+.+.+...+.++.+++.+||+.||++|||++||+++|+..
T Consensus       227 ------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         227 ------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence                  11122333457889999999999999999999999888654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-48  Score=417.13  Aligned_cols=256  Identities=23%  Similarity=0.311  Sum_probs=198.2

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      +++.+.|+..+.||+|+||+||+|++..+|+.||||++......  ...+.+.+|++++++++|||||++++++.+++..
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   82 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL   82 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            34566799999999999999999999999999999999654332  2346788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC---CC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD---SE  788 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~  788 (969)
                      |+||||++||+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++   ++
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~  146 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKG-------------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDED  146 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTT
T ss_pred             EEEEeccCCCcHHHhhhccc-------------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCC
Confidence            99999999999999997643             389999999999999999999998   999999999999995   57


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +.+||+|||+|+.....   .......||+.|||||++.+..++.++||||+||++|||++|+.||.+.........+..
T Consensus       147 ~~vkl~DFG~a~~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~  223 (307)
T d1a06a_         147 SKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK  223 (307)
T ss_dssp             CCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred             ceEEEeccceeEEccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            89999999999865332   223446799999999999999999999999999999999999999987655443333221


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                         ....        ...+.....+..+.+++.+||+.||++|||++|+++
T Consensus       224 ---~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         224 ---AEYE--------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ---TCCC--------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---cCCC--------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence               1111        111222234467899999999999999999999987

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=421.88  Aligned_cols=262  Identities=23%  Similarity=0.337  Sum_probs=208.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|++.++||+|+||+||+|++..+|+.||+|+++...  .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57899999999999999999999999999999996543  2344578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      ||++||+|.+++.+..             .+++..+..++.|++.||.|||+ +   +|+||||||+|||+++++.+||+
T Consensus        84 Ey~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~  147 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG-------------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLC  147 (322)
T ss_dssp             ECCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EcCCCCcHHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEe
Confidence            9999999999998654             38999999999999999999996 5   89999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+|+.+...    ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+................
T Consensus       148 DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  223 (322)
T d1s9ja_         148 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA  223 (322)
T ss_dssp             CCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------
T ss_pred             eCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCc
Confidence            99999876432    22346899999999999999999999999999999999999999987654322211110000000


Q ss_pred             -------------------------Cchhhhc---cCC-CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 -------------------------PITDALD---KGI-AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 -------------------------~~~~~~~---~~~-~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                                               ...+..+   ... ........+.++.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ----------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                                     0000000   000 00000112357889999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=403.35  Aligned_cols=249  Identities=26%  Similarity=0.353  Sum_probs=200.2

Q ss_pred             CccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc----CCceEEE
Q 002085          639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS----ENSKLLV  714 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  714 (969)
                      +..++||+|+||+||+|++..+++.||+|++..... .....+.+.+|++++++++|||||++++++.+    +...|+|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            455689999999999999999999999999865433 34456789999999999999999999999865    3457999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC-CCCcEEE
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD-SEFKAKI  793 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl  793 (969)
                      |||+++|+|.+++....             .+++..+..++.||+.||+|||++ .++|+||||||+|||++ +++.+||
T Consensus        91 mE~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl  156 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK-------------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKI  156 (270)
T ss_dssp             EECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             EeCCCCCcHHHHHhccc-------------cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEE
Confidence            99999999999998644             389999999999999999999987 22399999999999997 4789999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+|+....    .......||+.|||||++.+ .++.++||||+||++|||++|+.||.+.....   .+.+.....
T Consensus       157 ~DFGla~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~---~~~~~i~~~  228 (270)
T d1t4ha_         157 GDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYRRVTSG  228 (270)
T ss_dssp             CCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHHHHTTT
T ss_pred             eecCcceeccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH---HHHHHHHcC
Confidence            99999975422    22345689999999998865 69999999999999999999999997543322   122222221


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....         ..+...++++.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~---------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 VKPA---------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCCG---------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCc---------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            1100         111122356889999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=419.66  Aligned_cols=252  Identities=24%  Similarity=0.330  Sum_probs=214.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +++|++.+.||+|+||.||+|++..+|+.||||++++.........+.+.+|++++++++||||+++++++.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            46799999999999999999999999999999999765443444467789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||+|.+++....             .+++..+..++.|++.||+|||++   +|+||||||+|||++++|.+||+
T Consensus        84 ~ey~~gg~L~~~~~~~~-------------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~  147 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-------------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             eeccCCCchhhhhhccc-------------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEe
Confidence            99999999999998754             388899999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+|+.....  ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+...+...+..   ...
T Consensus       148 DFG~a~~~~~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~---~~~  222 (337)
T d1o6la_         148 DFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---EEI  222 (337)
T ss_dssp             CCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCC
T ss_pred             ecccccccccC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc---CCC
Confidence            99999865432  2233456899999999999999999999999999999999999999988776544433322   111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-----MKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~  919 (969)
                                  ..+...+.++.+++.+||+.||++||+     +.|+++
T Consensus       223 ------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                        112223467889999999999999995     777765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=409.17  Aligned_cols=258  Identities=22%  Similarity=0.289  Sum_probs=214.0

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc---HHHHHHHHHHHHHHhccccCceeeEEEEEEcC
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN---QKLEKEFIAEIEILGTIRHANIVKLWCCISSE  708 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  708 (969)
                      +++.+.|+..+.||+|+||+||+|++..+|+.||||++.......   ....+.+.+|++++++++|||||++++++.++
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   85 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            445567999999999999999999999999999999996543222   12357899999999999999999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      +..|+|||||++|+|.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~-------------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~  149 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKE-------------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR  149 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCS
T ss_pred             CEEEEEEEcCCCccccchhcccc-------------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecC
Confidence            99999999999999999998644             389999999999999999999998   99999999999999987


Q ss_pred             C----cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          789 F----KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       789 ~----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                      +    .+|++|||+|+.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+...
T Consensus       150 ~~~~~~vkl~DfG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~  226 (293)
T d1jksa_         150 NVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  226 (293)
T ss_dssp             SSSSCCEEECCCTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCcccceEecchhhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH
Confidence            6    4999999999876432   23345679999999999999999999999999999999999999998765544333


Q ss_pred             HHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .+..   .......        ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       227 ~i~~---~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         227 NVSA---VNYEFED--------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHT---TCCCCCH--------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHh---cCCCCCc--------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2211   1111111        111223467889999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.5e-47  Score=415.93  Aligned_cols=258  Identities=20%  Similarity=0.324  Sum_probs=215.8

Q ss_pred             hhhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          631 ESNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       631 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ..+++++|++.+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|++++++++|||||++++++.+++.
T Consensus        21 ~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          21 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             CCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3456789999999999999999999999999999999996543   3345789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC--C
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS--E  788 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~  788 (969)
                      .|+|||||+||+|.+++....            ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.  +
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~------------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~  162 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEH------------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRS  162 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTT------------SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTS
T ss_pred             EEEEEEcCCCCCHHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCC
Confidence            999999999999999996543            2489999999999999999999998   9999999999999964  5


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +.+||+|||+|+.+...   .......||+.|||||++.+..++.++||||+||++|||++|+.||.+.+..+....+..
T Consensus       163 ~~vkL~DFG~a~~~~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  239 (350)
T d1koaa2         163 NELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS  239 (350)
T ss_dssp             CCEEECCCTTCEECCTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CeEEEeecchheecccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            78999999999876432   233456899999999999999999999999999999999999999987655443333221


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                         ....        .........+..+.+++.+||+.||++|||++|+++.
T Consensus       240 ---~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         240 ---CDWN--------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ---TCCC--------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ---CCCC--------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               1111        1111122334678999999999999999999999873

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.5e-47  Score=412.76  Aligned_cols=249  Identities=26%  Similarity=0.347  Sum_probs=211.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +++|++.+.||+|+||+||+|++..+|+.||||+++..........+.+.+|++++++++|||||++++++.+++..|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            46799999999999999999999999999999999765443444457899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||++||+|.+++.....             +++..+..++.|++.||+|||++   +|+||||||+|||++.+|.+||+
T Consensus        83 mE~~~gg~l~~~~~~~~~-------------~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~  146 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQR-------------FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT  146 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSS-------------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             eeecCCcccccccccccc-------------ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEe
Confidence            999999999999987553             78889999999999999999988   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+|+....     ......||+.|||||++.+..++.++||||+||++|||++|+.||.+.+.......+..   ...
T Consensus       147 DFG~a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~~~  218 (316)
T d1fota_         147 DFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---AEL  218 (316)
T ss_dssp             CCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---CCC
T ss_pred             cCccceEecc-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc---CCC
Confidence            9999987633     22346799999999999999999999999999999999999999987655443332211   111


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                      .            .+...+.++.+++.+|++.||++|+     +++|+++
T Consensus       219 ~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 R------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             C------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             C------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            1            1122336788999999999999996     7777765

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2e-46  Score=412.42  Aligned_cols=256  Identities=20%  Similarity=0.266  Sum_probs=214.7

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      ..+.+.|++.+.||+|+||.||+|++..+|+.||||++.....   ...+.+.+|++++++++|||||++++++.+++..
T Consensus        25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3456789999999999999999999999999999999865432   3346788999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEEC--CCC
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLD--SEF  789 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~  789 (969)
                      |+|||||+||+|.+++....            ..+++..++.|+.||+.||+|||+.   +|+||||||+|||++  .++
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~------------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~  166 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAED------------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKAS  166 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTT------------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCC
T ss_pred             EEEEEcCCCChHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCC
Confidence            99999999999999887543            2489999999999999999999998   999999999999998  568


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  869 (969)
                      .+||+|||+|+.+...   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+...
T Consensus       167 ~vkL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  243 (352)
T d1koba_         167 SVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC  243 (352)
T ss_dssp             CEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC
T ss_pred             eEEEeecccceecCCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            9999999999887432   2334467999999999999999999999999999999999999999876654443333221


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                         ...        .........+.++.+++.+||+.||++|||++|+++
T Consensus       244 ---~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         244 ---DWE--------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             ---CCC--------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ---CCC--------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               111        111122233467899999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-47  Score=408.23  Aligned_cols=271  Identities=26%  Similarity=0.433  Sum_probs=216.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ++|+..+.||+|+||+||+|++.+     +++.||||+++...  .....+.+.+|++++++++||||+++++++.+.+.
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            478999999999999999999753     46789999986533  34556789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCC-----------CCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCC
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGS-----------SSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVK  779 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  779 (969)
                      .++||||+++|+|.++++..........           .......++|..++.++.|++.||+|||+.   +|||||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence            9999999999999999976443111100           111124589999999999999999999988   99999999


Q ss_pred             CCcEEECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCC-CCCCCC
Q 002085          780 SSNILLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE-ANYGDE  858 (969)
Q Consensus       780 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~-p~~~~~  858 (969)
                      |+||++|.++.+||+|||+|+...........+...||+.|+|||.+.+..++.++|||||||++|||++|.. ||.+..
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            9999999999999999999987655444444456678999999999999999999999999999999999975 555554


Q ss_pred             ccchHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          859 HTSLAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..+....+    ..+.          ..+.+...+.++.+++.+||+.||++||||.||+++|++++
T Consensus       248 ~~e~~~~v----~~~~----------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 HEEVIYYV----RDGN----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHH----HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHHH----HcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            44433322    1111          11122334467899999999999999999999999999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.6e-46  Score=412.70  Aligned_cols=253  Identities=22%  Similarity=0.255  Sum_probs=205.9

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHH---HHHHHHhccccCceeeEEEEEEcCCce
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFI---AEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      +++|++.++||+|+||.||+|++..+|+.||||++.............+.   .|+++++.++|||||++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            46799999999999999999999999999999999654432222223333   446777788899999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      |+||||++||+|.+++....             .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-------------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~i  146 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-------------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  146 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCE
T ss_pred             EEEEEecCCCcHHHHHHhcc-------------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcE
Confidence            99999999999999998654             378899999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+|+.+...    ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..............
T Consensus       147 Kl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~  222 (364)
T d1omwa3         147 RISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL  222 (364)
T ss_dssp             EECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS
T ss_pred             EEeeeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence            99999999876432    2344679999999999875 568999999999999999999999998765554433222211


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-----MKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl~  919 (969)
                      ....            ..+...+.++.+++.+||+.||++|||     +.|+++
T Consensus       223 ~~~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 TMAV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SCCC------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             cCCC------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            1111            111223467899999999999999999     577764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-46  Score=413.32  Aligned_cols=249  Identities=20%  Similarity=0.264  Sum_probs=212.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  714 (969)
                      +++|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+++++.++|||||++++++.+....++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            46899999999999999999999999999999999765443444457789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEe
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIA  794 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  794 (969)
                      |||+.+|+|.+++...+             .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus       120 ~e~~~~g~l~~~l~~~~-------------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~  183 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIG-------------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVT  183 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             cccccccchhhhHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEee
Confidence            99999999999998654             389999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          795 DFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       795 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      |||+|+.+..     ......||+.|||||++.+..++.++||||+||++|||++|+.||.+.+.......+...   ..
T Consensus       184 DFG~a~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~---~~  255 (350)
T d1rdqe_         184 DFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG---KV  255 (350)
T ss_dssp             CCTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---CC
T ss_pred             eceeeeeccc-----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC---CC
Confidence            9999987632     223467999999999999999999999999999999999999999876554433332211   11


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-----SMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~evl~  919 (969)
                      .            .+...+.++.+++.+||+.||++|+     +++|+++
T Consensus       256 ~------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 R------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            1            1122346789999999999999994     8888875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=402.14  Aligned_cols=255  Identities=28%  Similarity=0.448  Sum_probs=204.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|++.+.||+|+||+||+|++.. ++.||||+++....    ..+.|.+|+.++++++|||||++++++.+ +..++||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence            579999999999999999999874 46799999865432    23679999999999999999999999865 5689999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+++|+|.+++.....           ..++|.+++.++.|||.||+|||+.   +|+||||||+|||+++++.+||+|
T Consensus        91 Ey~~~g~l~~~~~~~~~-----------~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~D  156 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETG-----------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD  156 (285)
T ss_dssp             CCCTTCBHHHHHSHHHH-----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EecCCCchhhhhhhccc-----------ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcc
Confidence            99999999999886432           3589999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCc-cchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEH-TSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~  874 (969)
                      ||+|+.+... .........||+.|+|||++.++.++.++|||||||++|||++|+.||..... .+....+..      
T Consensus       157 fGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~------  229 (285)
T d1fmka3         157 FGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------  229 (285)
T ss_dssp             CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------
T ss_pred             cchhhhccCC-CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh------
Confidence            9999876432 22334456799999999999999999999999999999999998877765433 222222211      


Q ss_pred             CchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          875 PITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       875 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                              +...+.+...+.++.+++.+||+.||++||++++|+++|+..-
T Consensus       230 --------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         230 --------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             --------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             --------cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                    1112223344568899999999999999999999999998865

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=408.36  Aligned_cols=258  Identities=22%  Similarity=0.343  Sum_probs=206.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCc----EEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCce
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGE----FVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSK  711 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  711 (969)
                      .+|+..++||+|+||+||+|.+..+|+    .||+|+++...  .....+.+.+|++++++++|||||++++++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            368999999999999999999987776    58888875432  233457899999999999999999999999865 57


Q ss_pred             EEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcE
Q 002085          712 LLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKA  791 (969)
Q Consensus       712 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  791 (969)
                      ++++||+.+|+|.+++....            ..++|..+++++.|||.||+|||++   +|+||||||+||+++.++.+
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~------------~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~  150 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV  150 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTS------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred             eEEEEeccCCcccccccccc------------cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCe
Confidence            78899999999999888654            3589999999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      ||+|||+|+.+.............||+.|+|||++.++.++.++|||||||++|||+| |..||.+.....+...+....
T Consensus       151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~  230 (317)
T d1xkka_         151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE  230 (317)
T ss_dssp             EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred             EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999998765444444455678999999999999999999999999999999999 666776655554444332221


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                    +.+.+...+..+.+++.+||+.||++|||+.||++.|+++.
T Consensus       231 --------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         231 --------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             --------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                          11223334477899999999999999999999999988764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.8e-46  Score=396.11  Aligned_cols=265  Identities=26%  Similarity=0.368  Sum_probs=212.3

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC---
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN---  709 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  709 (969)
                      .+.++|++.+.||+|+||+||+|++..+|+.||||+++.....+....+.+.+|+++++.++||||+++++++...+   
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            34567999999999999999999999999999999997766556666788999999999999999999999987644   


Q ss_pred             -ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          710 -SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       710 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                       ..|+||||++|++|.+++...+             .+++.++..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~~-------------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~  147 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTEG-------------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISAT  147 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred             ceEEEEEECCCCCEehhhhcccC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCcc
Confidence             3789999999999999987654             389999999999999999999988   99999999999999999


Q ss_pred             CcEEEeecccceecccCCC-CccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGE-PHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      +.++++|||.+........ ........||+.|+|||++.+..+++++||||+||++|||+||+.||.+.......   .
T Consensus       148 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~  224 (277)
T d1o6ya_         148 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA---Y  224 (277)
T ss_dssp             SCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H
T ss_pred             ccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH---H
Confidence            9999999999876543322 22334567999999999999999999999999999999999999999876543332   2


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhc
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRP-SMKEVLQILRRC  924 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~evl~~L~~~  924 (969)
                      +...........        .....+..+.+++.+||+.||++|| |++++.+.|.++
T Consensus       225 ~~~~~~~~~~~~--------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         225 QHVREDPIPPSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             HHHHCCCCCGGG--------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHhcCCCCCch--------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            222222211111        1122336788999999999999999 899999998876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=395.75  Aligned_cols=251  Identities=27%  Similarity=0.387  Sum_probs=202.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-CCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-ENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  713 (969)
                      .++|+..+.||+|+||.||+|++.  |+.||||+++.+.     ..+.+.+|++++++++||||+++++++.+ .+..|+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence            356788899999999999999984  7889999996543     24678999999999999999999999855 466899


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++|+|.+++.....           ..++|..+++|+.||+.||+|||+.   +|+||||||+||+++.++.+|+
T Consensus        79 v~ey~~~g~L~~~l~~~~~-----------~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl  144 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGR-----------SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV  144 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHH-----------HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred             EEeccCCCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEee
Confidence            9999999999999976532           3589999999999999999999988   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhhc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYAE  872 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  872 (969)
                      +|||+++....     ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+..    
T Consensus       145 ~dfg~s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~----  215 (262)
T d1byga_         145 SDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----  215 (262)
T ss_dssp             CCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT----
T ss_pred             cccccceecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----
Confidence            99999986532     2233467899999999999999999999999999999998 5666666555555444321    


Q ss_pred             cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          873 EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       873 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                                +...+.+...+.++.+++.+||+.||++||||.|++++|++++
T Consensus       216 ----------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         216 ----------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence                      1111223334478899999999999999999999999998874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=399.71  Aligned_cols=260  Identities=24%  Similarity=0.337  Sum_probs=203.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++|+..+.||+|+||+||+|+....   ...||||+++..........+.|.+|++++++++||||+++++++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            4688899999999999999987433   34799999876655555666789999999999999999999999976 4678


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++|++.+++....            ..+++..+++++.|+|.||+|||++   +|+||||||+||+++.++.+|
T Consensus        87 lv~e~~~~~~l~~~~~~~~------------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vk  151 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ------------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVK  151 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG------------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEE
T ss_pred             eeeeeecCcchhhhhhccc------------CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhcccccccee
Confidence            9999999999999887654            3489999999999999999999988   999999999999999999999


Q ss_pred             EeecccceecccCCCCcc-ccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHh
Q 002085          793 IADFGLAKMLAKQGEPHT-MSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  870 (969)
                      |+|||+++.+........ .....|++.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+...++.   
T Consensus       152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~---  228 (273)
T d1u46a_         152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID---  228 (273)
T ss_dssp             ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---
T ss_pred             eccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH---
Confidence            999999998755433322 234467889999999999999999999999999999998 889987765554433321   


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRC  924 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~  924 (969)
                      ...          ...+.+...+..+.+++.+||+.||++||||.||.+.|+++
T Consensus       229 ~~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         229 KEG----------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TSC----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hCC----------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111          11122233346789999999999999999999999999875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1e-45  Score=393.13  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=211.8

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh------cHHHHHHHHHHHHHHhccc-cCceeeEEEEEEc
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL------NQKLEKEFIAEIEILGTIR-HANIVKLWCCISS  707 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  707 (969)
                      .++|+..+.||+|+||+||+|++..+|+.||||+++.....      .+...+.+.+|++++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            46899999999999999999999999999999998654322      1334567899999999997 9999999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      ++..|+||||+++|+|.++++...             .+++..+..++.||++||+|||+.   +|+||||||+||+++.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~-------------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~  145 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV-------------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD  145 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcC
Confidence            999999999999999999998644             489999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCCccc
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT------TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS  861 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~  861 (969)
                      ++.+||+|||+++.+...   .......||+.|+|||++.+      ..++.++||||+||++|||++|+.||.+.....
T Consensus       146 ~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~  222 (277)
T d1phka_         146 DMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  222 (277)
T ss_dssp             TCCEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             CCCeEEccchheeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence            999999999999877442   22345679999999998863      356889999999999999999999998766544


Q ss_pred             hHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....+..   ....        ...+.....++++.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~i~~---~~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         223 MLRMIMS---GNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHH---TCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHh---CCCC--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            3332221   1111        111222334578999999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-46  Score=396.40  Aligned_cols=257  Identities=24%  Similarity=0.322  Sum_probs=202.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCC---CcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGA---GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++|+..+.||+|+||+||+|++..+   +..||||.++..  ......+.+.+|++++++++|||||++++++. ++..|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            4788899999999999999998644   356889987443  23455678999999999999999999999996 46789


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAK  792 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  792 (969)
                      +||||+++|+|.+++....            ..+++..++.++.||+.||+|||+.   +|+||||||+||++++++.+|
T Consensus        84 iv~E~~~~g~l~~~~~~~~------------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~K  148 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRK------------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVK  148 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTT------------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred             EEEEeccCCcHHhhhhccC------------CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEE
Confidence            9999999999999887543            3489999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchHHHHHHHhh
Q 002085          793 IADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLAEWAWRHYA  871 (969)
Q Consensus       793 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  871 (969)
                      |+|||+|+..... .........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+...  
T Consensus       149 l~DfG~a~~~~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~--  225 (273)
T d1mp8a_         149 LGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--  225 (273)
T ss_dssp             ECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--
T ss_pred             EccchhheeccCC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--
Confidence            9999999876432 2233345678999999999999999999999999999999998 77788776665554433221  


Q ss_pred             ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          872 EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       872 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                        .          ..+.+...+..+.+++.+||+.||++|||+.||++.|+++.
T Consensus       226 --~----------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         226 --E----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             --C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --C----------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence              1          11222334478999999999999999999999999998774

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-46  Score=402.61  Aligned_cols=251  Identities=23%  Similarity=0.364  Sum_probs=209.5

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHh-ccccCceeeEEEEEEcCCceEE
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILG-TIRHANIVKLWCCISSENSKLL  713 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~l  713 (969)
                      +++|...+.||+|+||+||+|++..+|+.||||++++.........+.+..|..++. .++|||||++++++.+++..|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            367999999999999999999999999999999997654333333456677777765 6899999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEE
Q 002085          714 VYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKI  793 (969)
Q Consensus       714 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  793 (969)
                      ||||+++|+|.+++.....             +++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||
T Consensus        81 vmEy~~~g~L~~~i~~~~~-------------~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl  144 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHK-------------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI  144 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSS-------------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEeecCCCcHHHHhhccCC-------------CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceec
Confidence            9999999999999986543             78899999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhcc
Q 002085          794 ADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEE  873 (969)
Q Consensus       794 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  873 (969)
                      +|||+|+.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.....+...+..    .
T Consensus       145 ~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~----~  218 (320)
T d1xjda_         145 ADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----D  218 (320)
T ss_dssp             CCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----C
T ss_pred             cccchhhhcccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc----C
Confidence            999999865432  2333456799999999999999999999999999999999999999987765544333321    1


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMK-EVL  918 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-evl  918 (969)
                      ..           ..+...+..+.+++.+||+.||++||++. |++
T Consensus       219 ~~-----------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         219 NP-----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             CC-----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CC-----------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            11           11122346789999999999999999985 664

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=398.64  Aligned_cols=272  Identities=24%  Similarity=0.347  Sum_probs=204.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcC-
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSE-  708 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  708 (969)
                      ++|+..++||+|+||.||+|++..     +++.||||+++...  .....+.+.+|.+++.++ +|+||+.+++++.++ 
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            578899999999999999999753     35689999986433  334456788888888887 689999999988664 


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccC---CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSG---SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL  785 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill  785 (969)
                      ...++|||||++|+|.++++.......+.   ........++|..++.++.||+.||+|||++   +|+||||||+|||+
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeE
Confidence            46899999999999999998765322111   1112345689999999999999999999988   99999999999999


Q ss_pred             CCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCC-CCCCCCccchHH
Q 002085          786 DSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE-ANYGDEHTSLAE  864 (969)
Q Consensus       786 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~-p~~~~~~~~~~~  864 (969)
                      ++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|.. ||.+........
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999987755544445556789999999999999999999999999999999999865 554443322211


Q ss_pred             HHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          865 WAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                         .....+.          ..+.+...+.++.+++.+||+.||++|||++|++++|+++.
T Consensus       248 ---~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         248 ---RRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             ---HHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHhcCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               1111111          11122233467899999999999999999999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=398.72  Aligned_cols=254  Identities=19%  Similarity=0.252  Sum_probs=212.2

Q ss_pred             hhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceE
Q 002085          633 NILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKL  712 (969)
Q Consensus       633 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  712 (969)
                      ++.++|++.+.||+|+||+||+|.+..+|+.||||+++...    .....+.+|++++++++|||||++++++.+++..|
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            45678999999999999999999999999999999996543    22356889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC--Cc
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE--FK  790 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~  790 (969)
                      +|||||+||+|.+++...+            ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.+  +.
T Consensus        78 lvmE~~~gg~L~~~i~~~~------------~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~  142 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSA------------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSST  142 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCC
T ss_pred             EEEecCCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceE
Confidence            9999999999999997643            2489999999999999999999988   99999999999999854  48


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHh
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHY  870 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  870 (969)
                      +||+|||+++....   ........+|+.|+|||...+..++.++||||+||++|||++|..||.+.........+..  
T Consensus       143 ikl~DFG~~~~~~~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~--  217 (321)
T d1tkia_         143 IKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN--  217 (321)
T ss_dssp             EEECCCTTCEECCT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--
T ss_pred             EEEcccchhhcccc---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--
Confidence            99999999987633   2233446789999999999999999999999999999999999999987765444333322  


Q ss_pred             hccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          871 AEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       871 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                       .........        +...+.++.+++.+|+..||++|||++|+++
T Consensus       218 -~~~~~~~~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         218 -AEYTFDEEA--------FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -TCCCCCHHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCCCCChhh--------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             111111111        1122367889999999999999999999987

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=401.25  Aligned_cols=257  Identities=22%  Similarity=0.296  Sum_probs=206.0

Q ss_pred             hhhhccCCCccc-eeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc-
Q 002085          631 ESNILSSLTESN-LIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS-  707 (969)
Q Consensus       631 ~~~~~~~~~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  707 (969)
                      ...++++|.+.. .||+|+||+||+|++..+++.||||+++..        ..+.+|++++.++ +|||||++++++.+ 
T Consensus         6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            345678898875 699999999999999999999999998542        4577899987665 89999999999875 


Q ss_pred             ---CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          708 ---ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       708 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                         ....|+|||||+||+|.+++.....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~-----------~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIl  143 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGD-----------QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLL  143 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSC-----------CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCC-----------CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccc
Confidence               4568999999999999999986432           3589999999999999999999998   9999999999999


Q ss_pred             ECC---CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccc
Q 002085          785 LDS---EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTS  861 (969)
Q Consensus       785 l~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~  861 (969)
                      ++.   .+.+||+|||+|+.....   .......||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.....
T Consensus       144 l~~~~~~~~~Kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~  220 (335)
T d2ozaa1         144 YTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  220 (335)
T ss_dssp             ESCSSTTCCEEECCCTTCEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred             cccccccccccccccceeeeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence            986   457999999999876432   23345679999999999999999999999999999999999999998765544


Q ss_pred             hHHHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          862 LAEWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       862 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ....+........       .....+.....+.++.+++.+|++.||++|||+.|+++
T Consensus       221 ~~~~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         221 ISPGMKTRIRMGQ-------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -------CCCSCS-------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhcCC-------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            3332221111100       01111222344578999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-45  Score=396.75  Aligned_cols=272  Identities=23%  Similarity=0.347  Sum_probs=217.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEc-----CCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCC
Q 002085          636 SSLTESNLIGSGGSGQVYRIDIN-----GAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSEN  709 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  709 (969)
                      ++|+..++||+|+||.||+|++.     .+++.||||+++...  .......+.+|+.+++++ +|||||++++++.+++
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            57888999999999999999863     456789999996543  234456899999999999 6999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccC-----CCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSG-----SSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                      ..++||||+++|+|.++++.........     ........+++..+.+++.||+.||+|||++   +|+||||||+||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccc
Confidence            9999999999999999998765321111     0111234689999999999999999999998   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCC-CCCccchH
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANY-GDEHTSLA  863 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~-~~~~~~~~  863 (969)
                      ++.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|++.|+. ........
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999998766555555566789999999999999999999999999999999999666654 33332221


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..+   .          ..+.+...+...+..+.+++.+||+.||++||||+||+++|++..
T Consensus       258 ~~~---i----------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         258 YKM---I----------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             HHH---H----------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH---H----------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence            111   1          111111222333478999999999999999999999999998753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-45  Score=393.32  Aligned_cols=254  Identities=25%  Similarity=0.364  Sum_probs=205.5

Q ss_pred             cceeeecCcEEEEEEEEcCCC---cEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-CCceEEEEe
Q 002085          641 SNLIGSGGSGQVYRIDINGAG---EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-ENSKLLVYE  716 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  716 (969)
                      .++||+|+||+||+|++..++   ..||||+++..  .+....++|.+|++++++++||||+++++++.+ ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            478999999999999986543   36999998542  345556889999999999999999999999865 568899999


Q ss_pred             eccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeec
Q 002085          717 YMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADF  796 (969)
Q Consensus       717 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  796 (969)
                      ||++|+|.++++...            ...++..+++++.|+|.||.|||+.   +|+||||||+|||+++++.+||+||
T Consensus       110 ~~~~g~l~~~~~~~~------------~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DF  174 (311)
T d1r0pa_         110 YMKHGDLRNFIRNET------------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF  174 (311)
T ss_dssp             CCTTCBHHHHHHCTT------------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSS
T ss_pred             EeecCchhhhhcccc------------ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecc
Confidence            999999999988654            2477889999999999999999988   9999999999999999999999999


Q ss_pred             ccceecccCCCC--ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-ccchHHHHHHHhhcc
Q 002085          797 GLAKMLAKQGEP--HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDE-HTSLAEWAWRHYAEE  873 (969)
Q Consensus       797 gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~  873 (969)
                      |+++........  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+....+..    +
T Consensus       175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~----g  250 (311)
T d1r0pa_         175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----G  250 (311)
T ss_dssp             GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT----T
T ss_pred             cchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----C
Confidence            999876543222  22334578999999999999999999999999999999999888886543 2222222211    1


Q ss_pred             CCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          874 KPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       874 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .          +...+...+..+.+++.+||+.||++||++.||++.|+++.
T Consensus       251 ~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         251 R----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1          11122233467899999999999999999999999999885

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-45  Score=397.54  Aligned_cols=268  Identities=26%  Similarity=0.350  Sum_probs=208.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCc--EEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEcCCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGE--FVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISSENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  712 (969)
                      ++|+..++||+|+||+||+|++..+|.  .||||+++...  .....+.+.+|+++++++ +|||||++++++.+++..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            578888999999999999999987776  46777764332  233456899999999998 7999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCcCcccc---CCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      +||||+++|+|.++++........   .........++|..+..++.|||.||.|+|+.   +|+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence            999999999999999865210000   00001124689999999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCC-CCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEA-NYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p-~~~~~~~~~~~~~~~  868 (969)
                      .+||+|||+|+.....   .......||+.|+|||.+.++.++.++|||||||++|||++|+.| |.+.....+...+  
T Consensus       165 ~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i--  239 (309)
T d1fvra_         165 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--  239 (309)
T ss_dssp             CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG--
T ss_pred             ceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH--
Confidence            9999999999865332   222345689999999999999999999999999999999998765 5444433322222  


Q ss_pred             HhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          869 HYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       869 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                        ....          ..+.+...+.++.+++.+||+.||++||||.||++.|+++.
T Consensus       240 --~~~~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         240 --PQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             --GGTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HhcC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              1111          11222334478999999999999999999999999998875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-45  Score=394.50  Aligned_cols=271  Identities=25%  Similarity=0.374  Sum_probs=212.5

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCC-------cEEEEEEEeccchhcHHHHHHHHHHHHHHhcc-ccCceeeEEEEEEc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAG-------EFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI-RHANIVKLWCCISS  707 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  707 (969)
                      ++|+..+.||+|+||.||+|+....+       ..||||+++...  .......+.+|+..+.++ +|||||++++++.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            57888999999999999999875443       479999986543  344567899999999888 89999999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCcccc---CCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEE
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVS---GSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNIL  784 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nil  784 (969)
                      ++..++||||+++|+|.+++.........   .........+++.++++++.|++.||+|||+.   +||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence            99999999999999999999876532110   01111234689999999999999999999998   9999999999999


Q ss_pred             ECCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCccchH
Q 002085          785 LDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVT-GKEANYGDEHTSLA  863 (969)
Q Consensus       785 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~  863 (969)
                      ++.++.+||+|||+++...............||+.|+|||.+.++.+++++|||||||++|||++ |..||.+.......
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence            99999999999999998766555555566789999999999999999999999999999999998 56666554433322


Q ss_pred             HHHHHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          864 EWAWRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ..+    ..+.          ..+.+...+..+.+++.+||+.||++|||+.||+++|+++.
T Consensus       248 ~~i----~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         248 KLL----KEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             HHH----HTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH----HcCC----------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            222    1111          11122233467899999999999999999999999998874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-45  Score=395.22  Aligned_cols=269  Identities=22%  Similarity=0.331  Sum_probs=216.8

Q ss_pred             cCCCccceeeecCcEEEEEEEEcC-----CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCc
Q 002085          636 SSLTESNLIGSGGSGQVYRIDING-----AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENS  710 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  710 (969)
                      ++|+..++||+|+||+||+|.+..     +++.||||+++...  .......+.+|++++++++||||+++++++..++.
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            578889999999999999998852     35689999986432  34455789999999999999999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .++||||+++|+|.+++..........   .....++|..+.+++.|+|+||.|||+.   +|+||||||+|||++++++
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANN---PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHC---TTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccc---cccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence            999999999999999997643211100   0113478999999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCC-CCCCCCccchHHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKE-ANYGDEHTSLAEWAWRH  869 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~-p~~~~~~~~~~~~~~~~  869 (969)
                      +||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||+. ||.+.........+.  
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~--  249 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--  249 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH--
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--
Confidence            99999999987755444444555679999999999999999999999999999999999965 454443333222221  


Q ss_pred             hhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcCC
Q 002085          870 YAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCCP  926 (969)
Q Consensus       870 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  926 (969)
                        ...          ..+.+...+..+.+++.+||+.||++|||+.||+++|++...
T Consensus       250 --~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 --EGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             --TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             --hCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              111          111222334679999999999999999999999999998853

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=389.92  Aligned_cols=262  Identities=23%  Similarity=0.289  Sum_probs=202.2

Q ss_pred             ccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhc--HHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEEee
Q 002085          640 ESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLN--QKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVYEY  717 (969)
Q Consensus       640 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  717 (969)
                      ..++||+|+||+||+|++..+|+.||||+++......  +...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999999999999999986543221  22235789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEeecc
Q 002085          718 MENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIADFG  797 (969)
Q Consensus       718 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  797 (969)
                      ++++++..+.....             .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~~~~-------------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG  145 (299)
T d1ua2a_          82 METDLEVIIKDNSL-------------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG  145 (299)
T ss_dssp             CSEEHHHHHTTCCS-------------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             hcchHHhhhhhccc-------------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCc
Confidence            99888777665432             488899999999999999999998   99999999999999999999999999


Q ss_pred             cceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC--
Q 002085          798 LAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK--  874 (969)
Q Consensus       798 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  874 (969)
                      +|+.....  ........||+.|+|||++.+. .++.++||||+||++|||++|..||.+....+....+.+......  
T Consensus       146 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         146 LAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE  223 (299)
T ss_dssp             GGSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccccCCC--cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            99865432  2223345799999999998754 579999999999999999999999987766555444433321110  


Q ss_pred             Cchhhhc------cCCCCccc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 PITDALD------KGIAEPCY-----LEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~~~~~~~------~~~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ...+...      .......+     ...+.++.+++.+|++.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0000000      00000011     122467899999999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-44  Score=386.10  Aligned_cols=266  Identities=26%  Similarity=0.294  Sum_probs=200.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC----c
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN----S  710 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  710 (969)
                      .++|...++||+|+||+||+|+.  +|+.||||+++...    ........|+..+.+++||||+++++++.+++    .
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            35677889999999999999997  58899999985432    11222334555556789999999999997644    5


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccC-----CCCeEecCCCCCcEEE
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDC-----TPQIIHRDVKSSNILL  785 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~Nill  785 (969)
                      .|+||||+++|+|.++++..              .++|..+++++.|+|.||+|+|+..     +++|+||||||+|||+
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~--------------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl  141 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY--------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV  141 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE
T ss_pred             EEEEEecccCCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE
Confidence            78999999999999999853              3889999999999999999999631     3599999999999999


Q ss_pred             CCCCcEEEeecccceecccCCCCc--cccccccCcccCchhhcccCC------CCCccchhhHHHHHHHHHhCCCCCCCC
Q 002085          786 DSEFKAKIADFGLAKMLAKQGEPH--TMSAVAGSFGYFAPEYAYTTK------VNEKIDIYSFGVVLLELVTGKEANYGD  857 (969)
Q Consensus       786 ~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~elltg~~p~~~~  857 (969)
                      +.++.+||+|||+++.+.......  ......||+.|+|||++.+..      ++.++|||||||++|||+||..|+...
T Consensus       142 ~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~  221 (303)
T d1vjya_         142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  221 (303)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred             cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence            999999999999999875543322  234567999999999987643      567899999999999999998877532


Q ss_pred             Cccc-----------hHHHHHHHhhccCCchhhhccCCCC-cccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          858 EHTS-----------LAEWAWRHYAEEKPITDALDKGIAE-PCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       858 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ....           .............     ..+.+.. ....+....+.+++.+||+.||++|||+.||++.|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         222 EDYQLPYYDLVPSDPSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSC-----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccchhhcccccchHHHHHHHHhccc-----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            2111           1111111111111     1111111 123345577999999999999999999999999998875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-44  Score=385.00  Aligned_cols=266  Identities=27%  Similarity=0.371  Sum_probs=204.6

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++... ..+...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            68999999999999999999999999999999996543 22333568899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+.++ +.+++....           ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus        81 e~~~~~-~~~~~~~~~-----------~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~D  145 (298)
T d1gz8a_          81 EFLHQD-LKKFMDASA-----------LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLAD  145 (298)
T ss_dssp             ECCSEE-HHHHHHHTT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             eecCCc-hhhhhhhhc-----------ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceecc
Confidence            999754 444444322           13589999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||.|+....  .........||+.|+|||.+.... ++.++||||+||++|||++|+.||.+.+.......+........
T Consensus       146 FG~a~~~~~--~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~  223 (298)
T d1gz8a_         146 FGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD  223 (298)
T ss_dssp             TTHHHHHCC--CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCcceeccC--CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            999986643  223344567999999999877765 47899999999999999999999987654443333322221111


Q ss_pred             C--chhhh---cc--C---CCCc----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 P--ITDAL---DK--G---IAEP----CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 ~--~~~~~---~~--~---~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .  .....   +.  .   ....    .....+..+.+++.+|++.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0  00000   00  0   0000    01122367889999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-44  Score=378.90  Aligned_cols=244  Identities=23%  Similarity=0.318  Sum_probs=199.7

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcH---HHHHHHHHHHHHHhccc--cCceeeEEEEEEcCC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQ---KLEKEFIAEIEILGTIR--HANIVKLWCCISSEN  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  709 (969)
                      .++|++.++||+|+||+||+|++..+|+.||||++......+.   .....+.+|++++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            3579999999999999999999999999999999865432211   11234678999999996  899999999999999


Q ss_pred             ceEEEEeeccC-CCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          710 SKLLVYEYMEN-QSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       710 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      ..|+||||+.+ +++.+++....             .+++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-------------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~  146 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-------------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN  146 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT
T ss_pred             eEEEEEEeccCcchHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecC
Confidence            99999999976 68888887543             389999999999999999999988   99999999999999854


Q ss_pred             -CcEEEeecccceecccCCCCccccccccCcccCchhhcccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          789 -FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKV-NEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       789 -~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                       +.+||+|||+|+....    .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.+.      +
T Consensus       147 ~~~vkl~DFG~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i  216 (273)
T d1xwsa_         147 RGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I  216 (273)
T ss_dssp             TTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H
T ss_pred             CCeEEECccccceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------H
Confidence             7999999999986532    23345679999999999987776 5678999999999999999999965321      1


Q ss_pred             HHHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          867 WRHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..   ....        .    +...+.++.+++.+||+.||++|||++|+++
T Consensus       217 ~~---~~~~--------~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         217 IR---GQVF--------F----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HH---CCCC--------C----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hh---cccC--------C----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11   1100        1    1112367889999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.1e-43  Score=376.84  Aligned_cols=264  Identities=25%  Similarity=0.334  Sum_probs=204.3

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|+..++||+|+||+||+|++. +|+.||||+++.... .+...+.+.+|+.++++++||||+++++++.+++..+++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            68999999999999999999986 789999999965432 3333578999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      ||+.++.+..+.....             .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|
T Consensus        80 e~~~~~~~~~~~~~~~-------------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~D  143 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEG-------------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIAD  143 (286)
T ss_dssp             ECCSEEHHHHHHTSTT-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             EeehhhhHHHHHhhcC-------------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecc
Confidence            9998877777765433             489999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHHHhhccC
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWRHYAEEK  874 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  874 (969)
                      ||.|......  ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+....+........
T Consensus       144 fG~a~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~  221 (286)
T d1ob3a_         144 FGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN  221 (286)
T ss_dssp             TTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccceecccC--ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence            9999876432  2223345689999999998765 468999999999999999999999987655444333332211110


Q ss_pred             --Cchhhh---------ccCCC---CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          875 --PITDAL---------DKGIA---EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       875 --~~~~~~---------~~~~~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                        ......         .....   .......+..+.+++.+|++.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000000         00000   0111223467889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=378.25  Aligned_cols=266  Identities=23%  Similarity=0.292  Sum_probs=202.1

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCC-CcEEEEEEEeccchhcHHHHHHHHHHHHHHhcc---ccCceeeEEEEEEc---
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGA-GEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTI---RHANIVKLWCCISS---  707 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---  707 (969)
                      .++|++.++||+|+||+||+|++..+ ++.||||+++..... +.....+.+|+++++.+   +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            36899999999999999999999655 678999998654321 11223456777777766   79999999999853   


Q ss_pred             --CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEE
Q 002085          708 --ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILL  785 (969)
Q Consensus       708 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill  785 (969)
                        ....+++|||++++++........            ..+++..+..++.|++.||+|||++   +|+||||||+|||+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi  149 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPE------------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILV  149 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCT------------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred             ccCceEEEEEEeccCCchhhhhhccC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEE
Confidence              346799999999877665544332            3488999999999999999999998   99999999999999


Q ss_pred             CCCCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH
Q 002085          786 DSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW  865 (969)
Q Consensus       786 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~  865 (969)
                      +.++.+||+|||+++....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....
T Consensus       150 ~~~~~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  226 (305)
T d1blxa_         150 TSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK  226 (305)
T ss_dssp             CTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cCCCCeeecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999999999876532   2334567899999999999999999999999999999999999999987765544444


Q ss_pred             HHHHhhccCC--------chhhhccCC----CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          866 AWRHYAEEKP--------ITDALDKGI----AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       866 ~~~~~~~~~~--------~~~~~~~~~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      +.........        .........    ........+..+.+++.+||+.||++|||++|+++
T Consensus       227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            3332211100        000000000    00111223467889999999999999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=377.50  Aligned_cols=256  Identities=24%  Similarity=0.320  Sum_probs=208.2

Q ss_pred             ccCCCccceeeecCcEEEEEEEE---cCCCcEEEEEEEeccchh-cHHHHHHHHHHHHHHhcccc-CceeeEEEEEEcCC
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDI---NGAGEFVAVKRIWNNRKL-NQKLEKEFIAEIEILGTIRH-ANIVKLWCCISSEN  709 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~  709 (969)
                      +++|+..++||+|+||+||+|+.   ..+|+.||||+++..... +....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            47799999999999999999987   346889999998654322 22234678899999999976 89999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC
Q 002085          710 SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF  789 (969)
Q Consensus       710 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  789 (969)
                      ..++||||+.+|+|.+++.....             ++...+..++.|++.|++|+|+.   +|+||||||+||+++.++
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~-------------~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~  166 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRER-------------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNG  166 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSC-------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTS
T ss_pred             ceeeeeecccccHHHHHHHhccc-------------ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCC
Confidence            99999999999999999986543             67788999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhcccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT--KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      .+||+|||+|+.+... .........|++.|+|||.+.+.  .++.++||||+||++|||++|+.||.+.........+.
T Consensus       167 ~vkL~DFG~a~~~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~  245 (322)
T d1vzoa_         167 HVVLTDFGLSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS  245 (322)
T ss_dssp             CEEESCSSEEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred             CEEEeeccchhhhccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999876432 22233456799999999998765  46789999999999999999999998876665555544


Q ss_pred             HHhhccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCC-----HHHHH
Q 002085          868 RHYAEEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPS-----MKEVL  918 (969)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~evl  918 (969)
                      ........           +.+...+..+.+++.+||+.||++|||     ++|++
T Consensus       246 ~~~~~~~~-----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil  290 (322)
T d1vzoa_         246 RRILKSEP-----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK  290 (322)
T ss_dssp             HHHHHCCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred             HhcccCCC-----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence            43322211           112234578999999999999999995     67765

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=371.74  Aligned_cols=271  Identities=20%  Similarity=0.291  Sum_probs=204.4

Q ss_pred             hhhccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc----
Q 002085          632 SNILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS----  707 (969)
Q Consensus       632 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----  707 (969)
                      .+.+++|++.++||+|+||+||+|++..+|+.||||++..... .+...+.+.+|++++++++||||+++++++..    
T Consensus         6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~   84 (318)
T d3blha1           6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASP   84 (318)
T ss_dssp             SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence            3446899999999999999999999999999999999865432 23334678899999999999999999998755    


Q ss_pred             ----CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcE
Q 002085          708 ----ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI  783 (969)
Q Consensus       708 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Ni  783 (969)
                          .+..|+||||++++.+..+.....             .++...+..++.|++.||.|||+.   +|+||||||+||
T Consensus        85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~~-------------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NI  148 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHDLAGLLSNVLV-------------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANV  148 (318)
T ss_dssp             ------CEEEEEECCCEEHHHHHTCTTC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             ccccCceEEEEEeccCCCccchhhhccc-------------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchhe
Confidence                346799999998877766554432             378889999999999999999988   999999999999


Q ss_pred             EECCCCcEEEeecccceecccCCCC--ccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 002085          784 LLDSEFKAKIADFGLAKMLAKQGEP--HTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHT  860 (969)
Q Consensus       784 ll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~  860 (969)
                      |++.++.+|++|||+++.+......  .......||+.|+|||.+.+. .+++++||||+||++|||++|+.||.+....
T Consensus       149 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~  228 (318)
T d3blha1         149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ  228 (318)
T ss_dssp             EECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             eecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH
Confidence            9999999999999999876543221  122335699999999998765 6899999999999999999999999876655


Q ss_pred             chHHHHHHHhhccCC-ch---------hhhccCCCCcccH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          861 SLAEWAWRHYAEEKP-IT---------DALDKGIAEPCYL-------EEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       861 ~~~~~~~~~~~~~~~-~~---------~~~~~~~~~~~~~-------~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .....+........+ ..         .............       .....+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            544444333211110 00         0000000001111       11346778999999999999999999985

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=6.2e-42  Score=374.20  Aligned_cols=292  Identities=27%  Similarity=0.462  Sum_probs=269.2

Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCCCCCCCC--CCcceeeC----CCeEEEEecCCCCCC--CCCccccCCCcccEEE
Q 002085           32 PNTEERTILLNLKQQLGNPPSLQSWTSTSSPCD--WPEITCTF----NSVTGISLRHKDITQ--KIPPIICDLKNLTTID  103 (969)
Q Consensus        32 ~~~~~~~all~~k~~~~~~~~l~sw~~~~~~c~--w~gv~C~~----~~v~~l~l~~~~l~~--~~~~~~~~l~~L~~L~  103 (969)
                      |.++|++||++||+++.+|..+++|+.++|||.  |.||+|+.    .+|+.|+|+++++.|  .+|+.+++|++|++||
T Consensus         3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~   82 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY   82 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred             CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccc
Confidence            789999999999999999888999999999994  99999975    269999999999998  5889999999999999


Q ss_pred             ccC-CCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceeccccccc
Q 002085          104 LSS-NSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFN  182 (969)
Q Consensus       104 L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  182 (969)
                      |++ |+++|.+|++|++|++|++|+|++|++.+..|..+..+.+|+++++++|.+.+.+|..++++++|+.+++++|.++
T Consensus        83 Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~  162 (313)
T d1ogqa_          83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS  162 (313)
T ss_dssp             EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred             cccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccc
Confidence            997 8999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCcccCCCCCc-ceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCc
Q 002085          183 GTFPKEIGDLSNL-EVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPS  261 (969)
Q Consensus       183 ~~~p~~~~~l~~L-~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  261 (969)
                      +.+|..+..+.++ +.+++++|+  ..+..|..++.+..+ .+++.++...+.+|..+..+++|+.|++++|.+++.+| 
T Consensus       163 ~~ip~~~~~l~~l~~~l~~~~n~--l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-  238 (313)
T d1ogqa_         163 GAIPDSYGSFSKLFTSMTISRNR--LTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-  238 (313)
T ss_dssp             EECCGGGGCCCTTCCEEECCSSE--EEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-
T ss_pred             ccccccccccccccccccccccc--ccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-
Confidence            9999999999886 899999997  345577778877655 79999999999999999999999999999999997655 


Q ss_pred             hhhcCcccchhhccCcccccCCCCchhhc-ccccccccCccccccCCccccCcccchhhhhcccc-CcC
Q 002085          262 GLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNH-LSG  328 (969)
Q Consensus       262 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~  328 (969)
                      .+..+++|+.|+|++|+++|.+|..+..+ +|++|+|++|+|+|.+|. ++++++|+.+++++|+ ++|
T Consensus       239 ~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g  306 (313)
T d1ogqa_         239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEES
T ss_pred             ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccC
Confidence            68889999999999999999999998877 699999999999999985 6889999999999997 554

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-42  Score=378.69  Aligned_cols=265  Identities=26%  Similarity=0.308  Sum_probs=198.7

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcC------Cc
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSE------NS  710 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  710 (969)
                      +|+..++||+|+||+||+|++..+|+.||||++.....       ...+|++++++++||||+++++++...      .+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            68889999999999999999999999999999965432       234799999999999999999998542      34


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-  789 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-  789 (969)
                      .|+||||++++.+..+.+....          ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++ 
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~----------~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~  160 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRA----------KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA  160 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHT----------TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTC
T ss_pred             EEEEEeccCCccHHHHHhhhhc----------cCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCC
Confidence            6899999986644443322111          23589999999999999999999988   999999999999999875 


Q ss_pred             cEEEeecccceecccCCCCccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          790 KAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      .+||+|||+++.+...   .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+.+
T Consensus       161 ~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~  237 (350)
T d1q5ka_         161 VLKLCDFGSAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK  237 (350)
T ss_dssp             CEEECCCTTCEECCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred             ceeEecccchhhccCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHH
Confidence            8999999999876432   22334679999999998765 4689999999999999999999999987654433322221


Q ss_pred             Hhhcc---------CCchhhhccCC-----CCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhc
Q 002085          869 HYAEE---------KPITDALDKGI-----AEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRC  924 (969)
Q Consensus       869 ~~~~~---------~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~  924 (969)
                      .....         ....+...+..     ........+.++.+++.+|++.||++|||+.|+++  .+++.
T Consensus       238 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            11000         00000000000     00011223467899999999999999999999986  35544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.6e-41  Score=369.91  Aligned_cols=256  Identities=20%  Similarity=0.236  Sum_probs=199.1

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEc--CCceE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISS--ENSKL  712 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~  712 (969)
                      ++|++.++||+|+||+||+|++..+|+.||||+++...      .+.+.+|+++++.++ ||||+++++++..  ....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            57999999999999999999999999999999986532      357889999999995 9999999999975  45689


Q ss_pred             EEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCC-cE
Q 002085          713 LVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEF-KA  791 (969)
Q Consensus       713 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~  791 (969)
                      +||||+++++|.++.+                .+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+
T Consensus       109 ~v~e~~~~~~L~~~~~----------------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~v  169 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ----------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKL  169 (328)
T ss_dssp             EEEECCCSCBGGGTTT----------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEE
T ss_pred             EEEeecCCCcHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCee
Confidence            9999999999976542                388899999999999999999998   999999999999998765 69


Q ss_pred             EEeecccceecccCCCCccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHH-HHHH
Q 002085          792 KIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEW-AWRH  869 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~-~~~~  869 (969)
                      |++|||+|+.....   .......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||........... +...
T Consensus       170 kl~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~  246 (328)
T d3bqca1         170 RLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  246 (328)
T ss_dssp             EECCGGGCEECCTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred             eecccccceeccCC---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHH
Confidence            99999999876432   2334567899999999987654 79999999999999999999999976543221111 1100


Q ss_pred             h--------h---ccC---Cchhhh--------ccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          870 Y--------A---EEK---PITDAL--------DKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       870 ~--------~---~~~---~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .        .   ...   ......        ............+.++.+++.+|++.||++|||++|+++
T Consensus       247 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0        0   000   000000        000111112223467899999999999999999999865

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-41  Score=363.74  Aligned_cols=265  Identities=23%  Similarity=0.300  Sum_probs=209.7

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCCceEEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSENSKLLVY  715 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  715 (969)
                      ++|++.++||+|+||+||+|++..+++.||||+++... ..+.....+.+|+.+++.++||||+++++++.+....++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            68999999999999999999999999999999996553 23455678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCcEEEee
Q 002085          716 EYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFKAKIAD  795 (969)
Q Consensus       716 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  795 (969)
                      |++.++++..++...+             .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|++|
T Consensus        81 ~~~~~~~l~~~~~~~~-------------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~D  144 (292)
T d1unla_          81 EFCDQDLKKYFDSCNG-------------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLAN  144 (292)
T ss_dssp             ECCSEEHHHHHHHTTT-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             eecccccccccccccc-------------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeee
Confidence            9999999988887554             378899999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCCccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCc-cchHHHHHHHhhcc
Q 002085          796 FGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEH-TSLAEWAWRHYAEE  873 (969)
Q Consensus       796 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~  873 (969)
                      ||.|+......  .......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||..... .+....+.......
T Consensus       145 FG~a~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  222 (292)
T d1unla_         145 FGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             CTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cchhhcccCCC--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCC
Confidence            99998764432  2223446788999999987665 68999999999999999999999765433 22222222211111


Q ss_pred             CC--c---hhhhc---------cCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          874 KP--I---TDALD---------KGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       874 ~~--~---~~~~~---------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      ..  .   ....+         ...........+..+.+++.+|++.||.+|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  0   00000         00011112233467889999999999999999999876

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-41  Score=370.95  Aligned_cols=266  Identities=22%  Similarity=0.323  Sum_probs=204.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC----
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN----  709 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  709 (969)
                      +.++|++.++||+|+||+||+|.+..+|+.||||+++... ..+...+.+.+|++++++++|||||++++++...+    
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            5578999999999999999999999999999999996543 34455678999999999999999999999997654    


Q ss_pred             --ceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          710 --SKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       710 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                        ..|+||||+ +.+|.++.+..              .+++..+..++.|++.||+|||++   +|+||||||+|||++.
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~  156 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMKHE--------------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNE  156 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT
T ss_pred             cceEEEEEecc-cccHHHHHHhc--------------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccc
Confidence              569999999 57888877642              389999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTT-KVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      ++.+|++|||+|+....     ..+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+........
T Consensus       157 ~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~  231 (346)
T d1cm8a_         157 DCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI  231 (346)
T ss_dssp             TCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccccccccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHH
Confidence            99999999999987533     23456799999999998764 5689999999999999999999999876544333222


Q ss_pred             HHHhhccCCchhhhc--------------cCCC----CcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhcC
Q 002085          867 WRHYAEEKPITDALD--------------KGIA----EPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQI--LRRCC  925 (969)
Q Consensus       867 ~~~~~~~~~~~~~~~--------------~~~~----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~--L~~~~  925 (969)
                      ......  ...+...              ....    .......+..+.+++.+|+..||++|||++|+++.  ++.+.
T Consensus       232 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         232 MKVTGT--PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHCC--CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HhccCC--CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            211110  0000000              0000    01112234678899999999999999999999973  55543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.2e-41  Score=362.01  Aligned_cols=260  Identities=14%  Similarity=0.156  Sum_probs=210.2

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhcccc-CceeeEEEEEEcCCceEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRH-ANIVKLWCCISSENSKLLV  714 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv  714 (969)
                      ++|++.++||+|+||+||+|++..+|+.||||++.....     ...+.+|+++++.++| +|++.+++++.++...++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            478999999999999999999999999999998855432     2356788999999965 8999999999999999999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC-----CC
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS-----EF  789 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~  789 (969)
                      |||+ +++|.+++....            ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.     ++
T Consensus        80 me~~-~~~l~~~~~~~~------------~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~  143 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCG------------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN  143 (293)
T ss_dssp             EECC-CCBHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred             EEec-CCCHHHHHHhhc------------cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCC
Confidence            9999 689999987654            2488999999999999999999988   9999999999999975     56


Q ss_pred             cEEEeecccceecccCCCC-----ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHH
Q 002085          790 KAKIADFGLAKMLAKQGEP-----HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAE  864 (969)
Q Consensus       790 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  864 (969)
                      .+||+|||+|+.+......     .......||+.|||||.+.+..+++++|||||||++|||++|+.||.+........
T Consensus       144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~  223 (293)
T d1csna_         144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  223 (293)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence            8999999999987543221     12334679999999999999999999999999999999999999998765544433


Q ss_pred             HHHHHhh--ccCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          865 WAWRHYA--EEKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       865 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      .......  ...+..+. .        ...+.++.+++..|+..+|++||+++.+.+.|+++.
T Consensus       224 ~~~~i~~~~~~~~~~~l-~--------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         224 KYERIGEKKQSTPLREL-C--------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHHHHHHHHSCHHHH-T--------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHhccCCCChHHh-c--------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            2221111  11111111 1        112357889999999999999999999988887764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=373.93  Aligned_cols=267  Identities=22%  Similarity=0.257  Sum_probs=202.4

Q ss_pred             ccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEcCC----c
Q 002085          635 LSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISSEN----S  710 (969)
Q Consensus       635 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  710 (969)
                      -++|++.++||+|+||+||+|.+..+|+.||||++....  .....+.+.+|++++++++||||+++++++....    .
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            357999999999999999999999999999999996432  3444578899999999999999999999986643    3


Q ss_pred             eEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCCCc
Q 002085          711 KLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSEFK  790 (969)
Q Consensus       711 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  790 (969)
                      .+++++|+.+|+|.+++...              .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~--------------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~  147 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQ--------------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCD  147 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred             eEEEEEeecCCchhhhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCC
Confidence            35556677799999999743              389999999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCC-ccccccccCcccCchhhccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Q 002085          791 AKIADFGLAKMLAKQGEP-HTMSAVAGSFGYFAPEYAYT-TKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAWR  868 (969)
Q Consensus       791 ~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  868 (969)
                      +||+|||+|+........ .......||+.|+|||++.. ..++.++||||+||++|||++|+.||.+.+..+.......
T Consensus       148 ~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~  227 (345)
T d1pmea_         148 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG  227 (345)
T ss_dssp             EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh
Confidence            999999999876543222 22345679999999999854 4678899999999999999999999987654433332222


Q ss_pred             HhhccCCch----------hh-hccCCCCccc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002085          869 HYAEEKPIT----------DA-LDKGIAEPCY-----LEEMTTVYRLALICTSTLPSSRPSMKEVLQI  920 (969)
Q Consensus       869 ~~~~~~~~~----------~~-~~~~~~~~~~-----~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~  920 (969)
                      .........          .. .........+     ...+.++.+++.+|++.||++|||+.|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111110000          00 0000000001     1123568899999999999999999999973

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-41  Score=363.79  Aligned_cols=260  Identities=23%  Similarity=0.248  Sum_probs=201.4

Q ss_pred             cCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCc-eeeEEEEEEcCCceEEE
Q 002085          636 SSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHAN-IVKLWCCISSENSKLLV  714 (969)
Q Consensus       636 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  714 (969)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.....     ...+.+|+++++.++|++ |+.+.+++.+.+..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            469999999999999999999999999999998865432     245788999999998665 55556666778889999


Q ss_pred             EeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC---CCcE
Q 002085          715 YEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS---EFKA  791 (969)
Q Consensus       715 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~  791 (969)
                      |||+ ++++.+.+....            ..+++..+..++.|++.||+|||++   +|+||||||+||+++.   +..+
T Consensus        82 me~~-~~~l~~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~v  145 (299)
T d1ckia_          82 MELL-GPSLEDLFNFCS------------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLV  145 (299)
T ss_dssp             EECC-CCBHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCE
T ss_pred             EEEc-CCchhhhhhhcc------------CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCcee
Confidence            9999 567777665433            3489999999999999999999998   9999999999999864   4579


Q ss_pred             EEeecccceecccCCCC-----ccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHH
Q 002085          792 KIADFGLAKMLAKQGEP-----HTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWA  866 (969)
Q Consensus       792 kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~  866 (969)
                      +++|||+|+.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............
T Consensus       146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~  225 (299)
T d1ckia_         146 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  225 (299)
T ss_dssp             EECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred             eeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence            99999999987543221     2234567999999999999999999999999999999999999999765443332222


Q ss_pred             HHHhhc--cCCchhhhccCCCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcC
Q 002085          867 WRHYAE--EKPITDALDKGIAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQILRRCC  925 (969)
Q Consensus       867 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~~L~~~~  925 (969)
                      ......  ..+... .        ....+.++.+++..||+.||++||+++++.+.|+...
T Consensus       226 ~~~~~~~~~~~~~~-~--------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         226 ERISEKKMSTPIEV-L--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHHHHHHHHSCHHH-H--------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             HHhhcccCCCChhH-h--------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            111110  011110 1        1112367899999999999999999999998888763

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=368.92  Aligned_cols=263  Identities=24%  Similarity=0.269  Sum_probs=198.1

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc------
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS------  707 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  707 (969)
                      +.++|++.++||+|+||+||+|++..+|+.||||++..... +....+.+.+|+.++++++||||+++++++..      
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            45789999999999999999999999999999999976543 45556789999999999999999999999964      


Q ss_pred             CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECC
Q 002085          708 ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDS  787 (969)
Q Consensus       708 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~  787 (969)
                      ....|+||||+.++.+. .+.               ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.
T Consensus        94 ~~~~~iv~Ey~~~~l~~-~~~---------------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~  154 (355)
T d2b1pa1          94 FQDVYLVMELMDANLCQ-VIQ---------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS  154 (355)
T ss_dssp             CCEEEEEEECCSEEHHH-HHT---------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred             CceeEEEEeccchHHHH-hhh---------------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCcccccccc
Confidence            35789999999765544 443               2378899999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          788 EFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       788 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      ++.++++|||+++....   ........||+.|+|||++.+..+++++||||+||++|||++|+.||.+.+.......+.
T Consensus       155 ~~~~kl~df~~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~  231 (355)
T d2b1pa1         155 DCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI  231 (355)
T ss_dssp             TCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccceeeechhhhhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            99999999999886533   233445679999999999999999999999999999999999999998765443333222


Q ss_pred             HHhhc------------------cC------CchhhhccC---CCCcccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002085          868 RHYAE------------------EK------PITDALDKG---IAEPCYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       868 ~~~~~------------------~~------~~~~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~  919 (969)
                      .....                  ..      .........   .........+..+.+++.+|+..||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11110                  00      000000000   011123345678899999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-40  Score=365.17  Aligned_cols=268  Identities=22%  Similarity=0.294  Sum_probs=205.6

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCceeeEEEEEEc-----C
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANIVKLWCCISS-----E  708 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~  708 (969)
                      +.++|++.++||+|+||+||+|++..+|+.||||++.... .+....+.+.+|++++++++|||+|++++++..     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            3568999999999999999999999999999999996543 234445678999999999999999999999864     3


Q ss_pred             CceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcEEECCC
Q 002085          709 NSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNILLDSE  788 (969)
Q Consensus       709 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  788 (969)
                      ...+++++|+.+|+|.+++...              .+++..+..++.||+.||+|||++   +|+||||||+||+++.+
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~~--------------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~  157 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKCQ--------------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED  157 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTTC--------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             CceEEEEEeecCCchhhhcccc--------------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccc
Confidence            3456777888899999999643              389999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCCccccccccCcccCchhhcccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCccchHHHHH
Q 002085          789 FKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTK-VNEKIDIYSFGVVLLELVTGKEANYGDEHTSLAEWAW  867 (969)
Q Consensus       789 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  867 (969)
                      +.+|++|||.+....     .......||+.|+|||...+.. ++.++||||+||++|||++|+.||.+.+.......+.
T Consensus       158 ~~~kl~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~  232 (348)
T d2gfsa1         158 CELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL  232 (348)
T ss_dssp             CCEEECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999997542     2334567899999999876654 6889999999999999999999998776554444433


Q ss_pred             HHhhccCC-c---------hhhhcc--CCCCc----ccHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhc
Q 002085          868 RHYAEEKP-I---------TDALDK--GIAEP----CYLEEMTTVYRLALICTSTLPSSRPSMKEVLQ--ILRRC  924 (969)
Q Consensus       868 ~~~~~~~~-~---------~~~~~~--~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~evl~--~L~~~  924 (969)
                      ........ .         ......  .....    .....+..+.+++.+|++.||++|||++|+++  .+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            32211100 0         000000  00000    01112367889999999999999999999997  45544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-35  Score=330.59  Aligned_cols=261  Identities=21%  Similarity=0.156  Sum_probs=190.5

Q ss_pred             CCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-----------cCceeeEEEEE
Q 002085          637 SLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-----------HANIVKLWCCI  705 (969)
Q Consensus       637 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~  705 (969)
                      +|++.++||+|+||+||+|++..+|+.||||+++...    ...+.+.+|+++++.++           |+||+++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            5999999999999999999999999999999996542    23456788888888775           57899999887


Q ss_pred             Ec--CCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcc-cCCCCeEecCCCCCc
Q 002085          706 SS--ENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHH-DCTPQIIHRDVKSSN  782 (969)
Q Consensus       706 ~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~N  782 (969)
                      ..  ....+++++++..+...........          ...+++..+..++.|++.|++|||+ .   +|+||||||+|
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~N  156 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYE----------HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPEN  156 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTT----------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGG
T ss_pred             eeccccceeeeeeeccccccccccccccc----------ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhH
Confidence            54  4556677777655443333222211          2458889999999999999999997 5   89999999999


Q ss_pred             EEECCCCc------EEEeecccceecccCCCCccccccccCcccCchhhcccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 002085          783 ILLDSEFK------AKIADFGLAKMLAKQGEPHTMSAVAGSFGYFAPEYAYTTKVNEKIDIYSFGVVLLELVTGKEANYG  856 (969)
Q Consensus       783 ill~~~~~------~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~  856 (969)
                      ||++.++.      ++++|||.|.....     ......||+.|+|||++.+..++.++||||+||+++||++|+.||..
T Consensus       157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         157 VLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             eeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence            99987653      99999999986532     22446799999999999999999999999999999999999999975


Q ss_pred             CCccc---hHHHHHHHh--hcc---------CCchhhhc---------cC----------CCCcccHHHHHHHHHHHHHc
Q 002085          857 DEHTS---LAEWAWRHY--AEE---------KPITDALD---------KG----------IAEPCYLEEMTTVYRLALIC  903 (969)
Q Consensus       857 ~~~~~---~~~~~~~~~--~~~---------~~~~~~~~---------~~----------~~~~~~~~~~~~~~~l~~~c  903 (969)
                      .+...   .........  ...         .......+         ..          .........+..+.+++.+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m  311 (362)
T d1q8ya_         232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM  311 (362)
T ss_dssp             -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred             CccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHH
Confidence            43221   111111100  000         00000000         00          01122355678899999999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 002085          904 TSTLPSSRPSMKEVLQ  919 (969)
Q Consensus       904 l~~dP~~RPs~~evl~  919 (969)
                      ++.||++|||++|+++
T Consensus       312 L~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         312 LQLDPRKRADAGGLVN  327 (362)
T ss_dssp             GCSSTTTCBCHHHHHT
T ss_pred             CCCChhHCcCHHHHhc
Confidence            9999999999999986

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=8.4e-31  Score=285.30  Aligned_cols=229  Identities=29%  Similarity=0.438  Sum_probs=163.6

Q ss_pred             CcccEEEccCCCCCC--CCCcccCCCCCCCEEeccC-CcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccc
Q 002085           97 KNLTTIDLSSNSIPG--EFPEFLYNCTKLQNLDLSQ-NYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQT  173 (969)
Q Consensus        97 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  173 (969)
                      .+++.|||++|+++|  .+|+++++|++|++|+|++ |+++|.+|.+|+++++|++|+|++|++.+..|..+..+.+|+.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            368999999999998  4789999999999999986 8999999999999999999999999999888888999999999


Q ss_pred             eecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCC-cEEEccCCcccccCchhhcCCCchhhhhccC
Q 002085          174 LYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKL-KTLWMTEANLIGEIPEAMSNLSSLEILALNG  252 (969)
Q Consensus       174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L-~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~  252 (969)
                      +++++|++.+.+|..++++++|+++++++|.  ..+.+|..+..+.++ +.+++++|++.+..|..+.++..+ .+++++
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~--l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~  206 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNR--ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSR  206 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSC--CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCS
T ss_pred             cccccccccccCchhhccCcccceeeccccc--cccccccccccccccccccccccccccccccccccccccc-cccccc
Confidence            9999999998999999999999988888886  233456666666554 556666666666666666655433 466666


Q ss_pred             CcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcC
Q 002085          253 NHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSG  328 (969)
Q Consensus       253 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  328 (969)
                      |.+.+.+|..+..+++|+.+++++|.+++.+|......+|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|
T Consensus       207 ~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g  282 (313)
T d1ogqa_         207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG  282 (313)
T ss_dssp             SEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccc
Confidence            6666666666666666666666666655444432222244445555555444444444444444444444444443

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=4e-29  Score=280.48  Aligned_cols=165  Identities=24%  Similarity=0.308  Sum_probs=89.9

Q ss_pred             CccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhccc
Q 002085          354 CRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKAS  433 (969)
Q Consensus       354 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  433 (969)
                      +++|+.|++++|+++. + ..+..+++|+.|++++|.+++..+....++|+.|++++|++++..+  +..+..++.+.++
T Consensus       218 ~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~  293 (384)
T d2omza2         218 LTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELN  293 (384)
T ss_dssp             CTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred             cCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCcccccccCCEeeccCcccCCCCc--ccccccccccccc
Confidence            3444555555555542 1 2344445555555555555544443444455555555555554332  4455555666666


Q ss_pred             CCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccC
Q 002085          434 NNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEI  513 (969)
Q Consensus       434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~  513 (969)
                      +|.+++.  ..+..+++++.|+|++|++++..  .+..+++|+.|+|++|+|++ +| .|+++++|++|||++|+|++..
T Consensus       294 ~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~  367 (384)
T d2omza2         294 ENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLT  367 (384)
T ss_dssp             SSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCG
T ss_pred             ccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCCh
Confidence            6665532  23555666666666666666432  25566666666666666653 33 4666666666666666666433


Q ss_pred             CCcccccc-ccEEEeecC
Q 002085          514 PPEIGQLK-LNTFNLSSN  530 (969)
Q Consensus       514 p~~~~~l~-L~~l~ls~N  530 (969)
                      |  +..++ |++|+|++|
T Consensus       368 ~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         368 P--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             G--GTTCTTCSEEECCCE
T ss_pred             h--hccCCCCCEeeCCCC
Confidence            2  55553 666666665

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=2.5e-28  Score=273.91  Aligned_cols=144  Identities=26%  Similarity=0.326  Sum_probs=90.6

Q ss_pred             CccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhccc
Q 002085          354 CRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKAS  433 (969)
Q Consensus       354 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  433 (969)
                      +++|+.|++++|++++..  .+..+++|+.|++++|++++..+......++.++++.|++++.  ..+..+++++.|+++
T Consensus       240 l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls  315 (384)
T d2omza2         240 LTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLY  315 (384)
T ss_dssp             CTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECC
T ss_pred             ccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCccccccccccccccccccccc--cccchhcccCeEECC
Confidence            334444444444443221  1333444444444444444333333334556666666666542  235666677777777


Q ss_pred             CCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCc
Q 002085          434 NNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGN  507 (969)
Q Consensus       434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  507 (969)
                      +|++++..  .+..+++|+.|+|++|+|++ ++ .+.++++|++|+|++|+|++..|  +.++++|+.|+|++|
T Consensus       316 ~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         316 FNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             SSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            77777543  36778888888888888874 44 57888888888888888886544  888888888988887

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=6.9e-26  Score=245.14  Aligned_cols=274  Identities=24%  Similarity=0.310  Sum_probs=198.5

Q ss_pred             CCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcc
Q 002085           63 CDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDID  142 (969)
Q Consensus        63 c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  142 (969)
                      |.|.+|.|+          +.+++ .+|+.+.  +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.
T Consensus        10 c~~~~~~C~----------~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~   76 (305)
T d1xkua_          10 CHLRVVQCS----------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA   76 (305)
T ss_dssp             EETTEEECT----------TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTT
T ss_pred             ecCCEEEec----------CCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhh
Confidence            556666665          44444 4566553  6899999999999966666899999999999999999988889999


Q ss_pred             cCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCc
Q 002085          143 RISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLK  222 (969)
Q Consensus       143 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~  222 (969)
                      ++++|++|++++|+++ .+|..+  ...|+.|++++|.+.+..+..+.....++.++...|........+..+..+++|+
T Consensus        77 ~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~  153 (305)
T d1xkua_          77 PLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS  153 (305)
T ss_dssp             TCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCC
T ss_pred             CCCccCEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccC
Confidence            9999999999999999 566654  3578999999999998777778888899999998887555555566677778888


Q ss_pred             EEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccCcc
Q 002085          223 TLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSMNN  301 (969)
Q Consensus       223 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~  301 (969)
                      .+++++|++.. +|..+  +++|+.|++++|.+++..+..+..++.++.|++++|.+++..+..+... +|++|+|++|+
T Consensus       154 ~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~  230 (305)
T d1xkua_         154 YIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK  230 (305)
T ss_dssp             EEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred             ccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccc
Confidence            88887777654 33322  4667777777777777777777777777777777777776666666554 57777777777


Q ss_pred             ccccCCccccCcccchhhhhccccCcCcCCc-ccccccccCcccccCCCCCCCCccCcEEEccccccc
Q 002085          302 LTGSIPEEFGKLKNLQLLGLFSNHLSGEVPA-SIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFS  368 (969)
Q Consensus       302 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~  368 (969)
                      |+ .+|.+|..+++|++|+|++|+|+. ++. .+           ..+..+..+.+|+.|+|++|++.
T Consensus       231 L~-~lp~~l~~l~~L~~L~Ls~N~i~~-i~~~~f-----------~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         231 LV-KVPGGLADHKYIQVVYLHNNNISA-IGSNDF-----------CPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             CS-SCCTTTTTCSSCCEEECCSSCCCC-CCTTSS-----------SCSSCCTTSCCCSEEECCSSSSC
T ss_pred             cc-ccccccccccCCCEEECCCCccCc-cChhhc-----------cCcchhcccCCCCEEECCCCcCc
Confidence            76 456667777777777777777662 211 11           11222334556666666666654

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.1e-25  Score=238.42  Aligned_cols=263  Identities=22%  Similarity=0.209  Sum_probs=205.4

Q ss_pred             CCCCCcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCc
Q 002085           62 PCDWPEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDI  141 (969)
Q Consensus        62 ~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  141 (969)
                      ||. .++.|....-..+++++.+++ .+|..+.  +.+++|+|++|+|++..+.+|.++++|++|++++|++.+..+..+
T Consensus         1 ~cp-~~C~C~~~~~~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~   76 (284)
T d1ozna_           1 PCP-GACVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF   76 (284)
T ss_dssp             CCC-TTCEEECSSSCEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred             CcC-CCCEEcCCCCeEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccc
Confidence            455 477786554455677887776 5565543  568999999999996666789999999999999999998888888


Q ss_pred             ccCCCCcEEecC-CCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCC
Q 002085          142 DRISGLQCIDLG-GNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKK  220 (969)
Q Consensus       142 ~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~  220 (969)
                      ..+..++.++.. .|.++...|..|.++++|++|++++|.+....+..+...++|+.+++++|++.  ...+..|..+++
T Consensus        77 ~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~--~i~~~~f~~~~~  154 (284)
T d1ozna_          77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ--ALPDDTFRDLGN  154 (284)
T ss_dssp             TTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC--CCCTTTTTTCTT
T ss_pred             cccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc--ccChhHhccccc
Confidence            899999998775 56777677888999999999999999998778888888999999999999743  344566888888


Q ss_pred             CcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhc-ccccccccC
Q 002085          221 LKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEAL-KLTDIDLSM  299 (969)
Q Consensus       221 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~  299 (969)
                      |+.|++++|++.+..+.+|.++++|+.+++++|++++..|..|..+++|++|++++|++++..+..+... +|++|++++
T Consensus       155 L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~  234 (284)
T d1ozna_         155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND  234 (284)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCS
T ss_pred             hhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecC
Confidence            9999999888888888888888889999999998888888888888888888888888887777777655 688888888


Q ss_pred             ccccccCCccccCcccchhhhhccccCcCcCC
Q 002085          300 NNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVP  331 (969)
Q Consensus       300 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  331 (969)
                      |.+.+.-+ ...-...++.+....+++.+..|
T Consensus       235 N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p  265 (284)
T d1ozna_         235 NPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLP  265 (284)
T ss_dssp             SCEECSGG-GHHHHHHHHHCCSEECCCBEEES
T ss_pred             CCCCCCcc-chHHHHHHHhCcCCCCceEeCCc
Confidence            88875322 11112335555555555554433

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.92  E-value=3.9e-24  Score=231.17  Aligned_cols=242  Identities=25%  Similarity=0.335  Sum_probs=153.5

Q ss_pred             ccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceeccc
Q 002085           99 LTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYM  178 (969)
Q Consensus        99 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  178 (969)
                      ++.+|-++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++
T Consensus        12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence            567899999998 7787764  6899999999999865566899999999999999999977788899999999999999


Q ss_pred             ccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcc--cccCchhhcCCCchhhhhccCCcCC
Q 002085          179 NEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANL--IGEIPEAMSNLSSLEILALNGNHLE  256 (969)
Q Consensus       179 N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l--~~~~p~~~~~l~~L~~L~L~~N~l~  256 (969)
                      |+++ .+|..+  ...|+.|++++|.+  ....+..+.....+..+....|..  ....+..+..+++|+.+++++|.++
T Consensus        89 n~l~-~l~~~~--~~~l~~L~~~~n~l--~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~  163 (305)
T d1xkua_          89 NQLK-ELPEKM--PKTLQELRVHENEI--TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT  163 (305)
T ss_dssp             SCCS-BCCSSC--CTTCCEEECCSSCC--CBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred             CccC-cCccch--hhhhhhhhccccch--hhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence            9998 455443  35677777777752  222333344555555555555432  2222334555555555555555554


Q ss_pred             CCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccCcccchhhhhccccCcCcCCccccc
Q 002085          257 GAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGV  336 (969)
Q Consensus       257 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  336 (969)
                       .+|..+  .++                       |+.|++++|.+++..+..|..++.++.|++++|.+.+.       
T Consensus       164 -~l~~~~--~~~-----------------------L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~-------  210 (305)
T d1xkua_         164 -TIPQGL--PPS-----------------------LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV-------  210 (305)
T ss_dssp             -SCCSSC--CTT-----------------------CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE-------
T ss_pred             -ccCccc--CCc-----------------------cCEEECCCCcCCCCChhHhhcccccccccccccccccc-------
Confidence             223221  234                       45555555555555555555555555555555555421       


Q ss_pred             ccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccc
Q 002085          337 VAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTIS  392 (969)
Q Consensus       337 l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  392 (969)
                                .+..+.++++|++|+|++|+|+ .+|.++..+++|+.|+|++|+|+
T Consensus       211 ----------~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         211 ----------DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             ----------CTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred             ----------ccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence                      1233445555666666666665 44555555556665555555555

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.2e-23  Score=224.55  Aligned_cols=250  Identities=24%  Similarity=0.213  Sum_probs=217.6

Q ss_pred             CeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEecc-CCcCCCCCCCCcccCCCCcEEec
Q 002085           74 SVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLS-QNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        74 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      .++.|+|++|+|+...+.+|.++++|++|++++|++.+..+..+..+..++.++.+ .|.++...|..|.++++|++|++
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l  112 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence            47899999999987777789999999999999999998888889999999999875 66777777889999999999999


Q ss_pred             CCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccc
Q 002085          153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLI  232 (969)
Q Consensus       153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~  232 (969)
                      ++|.+....+..+..+++|+.+++++|+|++..+..|..+++|++|++++|++  ....+..|.++++|+.+++++|++.
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l--~~l~~~~f~~l~~L~~l~l~~N~l~  190 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI--SSVPERAFRGLHSLDRLLLHQNRVA  190 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC--CEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcc--cccchhhhccccccchhhhhhcccc
Confidence            99999977788899999999999999999988888999999999999999974  3456778999999999999999999


Q ss_pred             ccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCccccccCCccccC
Q 002085          233 GEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLTGSIPEEFGK  312 (969)
Q Consensus       233 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~  312 (969)
                      +..|..|.++++|++|++++|++++..+..|..+++|++|+|++|.+.+.-+...-...++.+....+.+....|..+.+
T Consensus       191 ~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~l~g  270 (284)
T d1ozna_         191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAG  270 (284)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred             ccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCchHHcC
Confidence            99999999999999999999999988888999999999999999999976543222225778888888888877877654


Q ss_pred             cccchhhhhccccCcC
Q 002085          313 LKNLQLLGLFSNHLSG  328 (969)
Q Consensus       313 l~~L~~L~L~~N~l~~  328 (969)
                         +...+++.+.|+|
T Consensus       271 ---~~l~~l~~~~l~g  283 (284)
T d1ozna_         271 ---RDLKRLAANDLQG  283 (284)
T ss_dssp             ---CBGGGSCGGGSCC
T ss_pred             ---CccccCCHHHCCC
Confidence               4555666666654

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=1.7e-22  Score=213.06  Aligned_cols=199  Identities=24%  Similarity=0.259  Sum_probs=157.3

Q ss_pred             CCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEec
Q 002085           73 NSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDL  152 (969)
Q Consensus        73 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  152 (969)
                      .+..+++.++++++. +|+.+.  ++|++|||++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|
T Consensus        10 ~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~L   84 (266)
T d1p9ag_          10 ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDL   84 (266)
T ss_dssp             TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEEC
T ss_pred             CCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccc
Confidence            345567888888874 676654  57899999999998766678999999999999999998 444 4578899999999


Q ss_pred             CCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccc
Q 002085          153 GGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLI  232 (969)
Q Consensus       153 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~  232 (969)
                      ++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.++++|++++|.+  ....+..+..+++|+.|++++|++.
T Consensus        85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l--~~l~~~~~~~l~~l~~l~l~~N~l~  161 (266)
T d1p9ag_          85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL--KTLPPGLLTPTPKLEKLSLANNNLT  161 (266)
T ss_dssp             CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC--CCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             cccccc-ccccccccccccccccccccccceeecccccccccccccccccccc--ceeccccccccccchhccccccccc
Confidence            999998 5677888899999999999999888888888888899999888863  2344555677777888888888777


Q ss_pred             ccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccc
Q 002085          233 GEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILS  280 (969)
Q Consensus       233 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  280 (969)
                      +..++.|..+++|++|+|++|+|+ .+|..++.+++|+.|+|++|.+.
T Consensus       162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            777777777777888888888877 66777777777777777777665

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.9e-22  Score=212.82  Aligned_cols=202  Identities=22%  Similarity=0.184  Sum_probs=175.5

Q ss_pred             CcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccCCCccccCCCcc
Q 002085          312 KLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTI  391 (969)
Q Consensus       312 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  391 (969)
                      +...+.+++.+++.++                  .+|..+.  +++++|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus         8 ~~~~~~~v~C~~~~L~------------------~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l   67 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLT------------------ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL   67 (266)
T ss_dssp             CSTTCCEEECTTSCCS------------------SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCC
T ss_pred             ccCCCeEEEccCCCCC------------------eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccc
Confidence            4455566788888887                  3444443  5789999999999976667899999999999999999


Q ss_pred             ccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCccccchhhccCcccCCCCCccccc
Q 002085          392 SGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVS  471 (969)
Q Consensus       392 ~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  471 (969)
                      +...+....++|++|+|++|++++ .+..+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..
T Consensus        68 ~~l~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~  146 (266)
T d1p9ag_          68 TKLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP  146 (266)
T ss_dssp             CEEECCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred             cccccccccccccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccc
Confidence            865555566899999999999995 4668899999999999999999888888999999999999999999777788888


Q ss_pred             ccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeecCcCCCC
Q 002085          472 WTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSSNKLYGN  535 (969)
Q Consensus       472 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~N~l~~~  535 (969)
                      +++|+.|++++|+|++..+..|..+++|+.|||++|+|+ .+|+.+..++ |+.|+|++|++...
T Consensus       147 l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             CTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             cccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence            999999999999999888888999999999999999999 8999888885 99999999998753

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=1.1e-21  Score=195.64  Aligned_cols=166  Identities=16%  Similarity=0.165  Sum_probs=121.3

Q ss_pred             CccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchh---------------cHHHHHHHHHHHHHHhccccCceeeEEE
Q 002085          639 TESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKL---------------NQKLEKEFIAEIEILGTIRHANIVKLWC  703 (969)
Q Consensus       639 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~niv~l~~  703 (969)
                      .+.++||+|+||+||+|++. +|+.||||+++.....               ..........|...+.++.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45789999999999999985 6899999987532110               1122345667889999999999998876


Q ss_pred             EEEcCCceEEEEeeccCCCHHHHhccCcCccccCCCCcccccCChHHHHHHHHHHHHhhhhhcccCCCCeEecCCCCCcE
Q 002085          704 CISSENSKLLVYEYMENQSLDRWLHGRKRSLVSGSSSVHQHVLHWPTRLQIAIGAAQGLCYMHHDCTPQIIHRDVKSSNI  783 (969)
Q Consensus       704 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~Ni  783 (969)
                      +.    ..+++|||++++.+.+                    ++.....+++.|++.+++|||+.   +|+||||||+||
T Consensus        82 ~~----~~~lvme~~~~~~~~~--------------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NI  134 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR--------------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV  134 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG--------------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             ec----CCEEEEEeeccccccc--------------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhhe
Confidence            53    2479999998754432                    44455678999999999999998   999999999999


Q ss_pred             EECCCCcEEEeecccceecccCCCCccccccccCcccCc------hhhcccCCCCCccchhhHHHHH
Q 002085          784 LLDSEFKAKIADFGLAKMLAKQGEPHTMSAVAGSFGYFA------PEYAYTTKVNEKIDIYSFGVVL  844 (969)
Q Consensus       784 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwslG~il  844 (969)
                      |++++ .++++|||.|+......   .       ..|..      .|. ....|+.++|+||..--+
T Consensus       135 Lv~~~-~~~liDFG~a~~~~~~~---~-------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         135 LVSEE-GIWIIDFPQSVEVGEEG---W-------REILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EEETT-EEEECCCTTCEETTSTT---H-------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             eeeCC-CEEEEECCCcccCCCCC---c-------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            99965 58999999997653211   0       01111      111 235678899999976443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=3.3e-20  Score=204.27  Aligned_cols=60  Identities=28%  Similarity=0.342  Sum_probs=43.4

Q ss_pred             ccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCc
Q 002085          448 LSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPE  516 (969)
Q Consensus       448 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~  516 (969)
                      +++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +.+|+.|+|++|+|+ .+|..
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~  342 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI  342 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC
T ss_pred             CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcc
Confidence            567788888888887 56653   457888888888887 56653   456788888888887 56653

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=1.6e-19  Score=198.73  Aligned_cols=138  Identities=22%  Similarity=0.250  Sum_probs=82.8

Q ss_pred             CCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeec
Q 002085          121 TKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGL  200 (969)
Q Consensus       121 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  200 (969)
                      .+|++|||++|.++ .+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++..   .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence            46889999999988 67754   467889999999998 777654   46788888888887 33321   135778888


Q ss_pred             ccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCcccc
Q 002085          201 AYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILS  280 (969)
Q Consensus       201 ~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  280 (969)
                      ++|.+.   .+|. ++.+++|+.|++++|.+.... ..   ...+..+.+..+....  +..+..++.++.|++++|.+.
T Consensus       106 ~~n~l~---~lp~-~~~l~~L~~L~l~~~~~~~~~-~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         106 SNNQLE---KLPE-LQNSSFLKIIDVDNNSLKKLP-DL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             CSSCCS---SCCC-CTTCTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCS
T ss_pred             cccccc---cccc-hhhhccceeeccccccccccc-cc---cccccchhhccccccc--cccccccccceeccccccccc
Confidence            877532   3342 456666666666665554322 11   2233334444443331  223444455555555555444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=1.7e-18  Score=172.25  Aligned_cols=179  Identities=22%  Similarity=0.244  Sum_probs=126.3

Q ss_pred             CcceeeCCCeEEEEecCCCCCCCCCccccCCCcccEEEccCCCCCCCC-CcccCCCCCCCEEeccCCcCCCCCCCCcccC
Q 002085           66 PEITCTFNSVTGISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEF-PEFLYNCTKLQNLDLSQNYFVGPIPSDIDRI  144 (969)
Q Consensus        66 ~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  144 (969)
                      .|+.|+.   +.+++++++++ .+|+.+.  +++++|+|++|+|++.+ +..|.++++|++|+|++|.+.+..+..|..+
T Consensus         4 ~~C~C~~---~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~   77 (192)
T d1w8aa_           4 AMCHCEG---TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA   77 (192)
T ss_dssp             TTSEEET---TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC
T ss_pred             CCCEEcC---CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccc
Confidence            4555653   34566677776 4565543  57888899999887644 5567888888888888888888888888888


Q ss_pred             CCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEE
Q 002085          145 SGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTL  224 (969)
Q Consensus       145 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L  224 (969)
                      ++|++|+|++|+|+...|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.                    
T Consensus        78 ~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~--------------------  137 (192)
T d1w8aa_          78 SHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP--------------------  137 (192)
T ss_dssp             TTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCC--------------------
T ss_pred             cccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccc--------------------
Confidence            888888888888887777788888888888888888887777778888888888887774                    


Q ss_pred             EccCCcccccCch-hhcCCCchhhhhccCCcCCCCCCchhhcCcccchhhccCccccc
Q 002085          225 WMTEANLIGEIPE-AMSNLSSLEILALNGNHLEGAIPSGLFLLNNLTQLFLYDNILSG  281 (969)
Q Consensus       225 ~L~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  281 (969)
                            +...... .+  ...++.+.+..|.++...|..   +..++.++|+.|.++.
T Consensus       138 ------~~~~~~~~~~--~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~C  184 (192)
T d1w8aa_         138 ------FNCNCHLAWF--AEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKC  184 (192)
T ss_dssp             ------BCCSGGGHHH--HHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCCC
T ss_pred             ------cccccchHHH--hhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCcC
Confidence                  2211111 11  124566667777766555543   3445566666666653

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=3e-22  Score=229.25  Aligned_cols=165  Identities=19%  Similarity=0.160  Sum_probs=80.6

Q ss_pred             CCccCcEEEcccccccCC----CCcccccccCCCccccCCCccccccCc-------cccccccEEEeeccccCCCccccc
Q 002085          353 NCRTLRTVQLYSNRFSGE----LPTGLWTTFNLSSLMLSDNTISGELPS-------KTAWNLTRLEISNNRFSGQIQRGV  421 (969)
Q Consensus       353 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~-------~~~~~L~~L~Ls~N~l~~~~~~~~  421 (969)
                      ....++.+++++|.+...    ....+...+.++.+++++|.+++....       .....|+.+++++|.++......+
T Consensus       253 ~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l  332 (460)
T d1z7xw1         253 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF  332 (460)
T ss_dssp             TTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhc
Confidence            345566666666666422    222333455566666666665421111       011245555555555443221111


Q ss_pred             CCcccchhhcccCCccccccCccccCccccchhhccCcccCCC----CCcccc-cccCCCEEEccCccccCC----CCcc
Q 002085          422 GSWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGK----LPSQIV-SWTSLNNLNLARNELSGE----IPKA  492 (969)
Q Consensus       422 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~  492 (969)
                                          ...+...++|++|+|++|++++.    +++.+. ..+.|+.|+|++|+|+..    ++..
T Consensus       333 --------------------~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~  392 (460)
T d1z7xw1         333 --------------------SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT  392 (460)
T ss_dssp             --------------------HHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred             --------------------ccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHH
Confidence                                11223344566666666666532    222222 244566666666666532    3344


Q ss_pred             cccccccceEeccCccccccCCCccc----c-c-cccEEEeecCcCCCCCC
Q 002085          493 IGSLLVMVSLDLSGNQFSGEIPPEIG----Q-L-KLNTFNLSSNKLYGNIP  537 (969)
Q Consensus       493 ~~~l~~L~~L~ls~N~l~g~~p~~~~----~-l-~L~~l~ls~N~l~~~~p  537 (969)
                      +...++|++|||++|+|+......+.    . . .|+.|++++|.+....+
T Consensus       393 l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~  443 (460)
T d1z7xw1         393 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME  443 (460)
T ss_dssp             HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred             HhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHH
Confidence            55556667777777766643333221    1 1 36677777766654333

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.73  E-value=5.2e-18  Score=168.66  Aligned_cols=173  Identities=23%  Similarity=0.220  Sum_probs=113.0

Q ss_pred             ccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCC-CCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecc
Q 002085           99 LTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPI-PSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLY  177 (969)
Q Consensus        99 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  177 (969)
                      .++++.++++++ .+|..+.  +++++|+|++|+|++.+ +..|.++++|+.|+|++|++....+..|..+++|++|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            357788888887 6676553  57788888888887543 5566777888888888888877777777777778888888


Q ss_pred             cccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcCCC
Q 002085          178 MNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHLEG  257 (969)
Q Consensus       178 ~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  257 (969)
                      +|+|+...|..|.++++|++|+|++|                          ++.+..|++|..+++|++|+|++|.+..
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N--------------------------~l~~i~~~~f~~l~~L~~l~L~~N~~~~  140 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDN--------------------------QISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSS--------------------------CCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             cccccccCHHHHhCCCcccccccCCc--------------------------cccccCHHHhcCCccccccccccccccc
Confidence            88777666666666666666666665                          4666667778888888888888888874


Q ss_pred             CCCchhhcCcccchhhccCcccccCCCCchhhcccccccccCcccc
Q 002085          258 AIPSGLFLLNNLTQLFLYDNILSGEIPSSVEALKLTDIDLSMNNLT  303 (969)
Q Consensus       258 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~Ls~N~l~  303 (969)
                      ... ...-...++.+.+..|.++...|..+..  ++.++|+.|.+.
T Consensus       141 ~~~-~~~~~~~l~~~~l~~~~~~c~~p~~l~~--~~l~~L~~n~l~  183 (192)
T d1w8aa_         141 NCH-LAWFAEWLRKKSLNGGAARCGAPSKVRD--VQIKDLPHSEFK  183 (192)
T ss_dssp             SGG-GHHHHHHHHHHCCSGGGCBBCSSTTTTT--SBGGGSCTTTCC
T ss_pred             ccc-hHHHhhhhhhhcccCCCeEeCCChhhcC--CEeeecCHhhCc
Confidence            322 1121233455555555555444433322  233344444443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=2.5e-18  Score=176.25  Aligned_cols=145  Identities=22%  Similarity=0.291  Sum_probs=77.6

Q ss_pred             CCCCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhh
Q 002085          351 LGNCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVF  430 (969)
Q Consensus       351 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  430 (969)
                      +..+++|+++++++|.++ .++ .+..+++|+.++++++...+..+......+..+.++.+.+....  .+...++|+.|
T Consensus        81 l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L  156 (227)
T d1h6ua2          81 LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYL  156 (227)
T ss_dssp             GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEE
T ss_pred             cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhchhhhhchhh--hhccccccccc
Confidence            445556666666666655 222 35555566666666665554444334445566666666555332  24444555555


Q ss_pred             cccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEecc
Q 002085          431 KASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLS  505 (969)
Q Consensus       431 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  505 (969)
                      ++++|.+++..  .++++++|+.|+|++|++++ ++ .+.++++|++|+|++|+|++ +| .++++++|+.|+++
T Consensus       157 ~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         157 SIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLT  225 (227)
T ss_dssp             ECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEE
T ss_pred             cccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEee
Confidence            55555554322  25556666666666666653 22 25555666666666666653 33 25556666666655

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.73  E-value=1.2e-21  Score=224.31  Aligned_cols=110  Identities=15%  Similarity=0.241  Sum_probs=70.7

Q ss_pred             CeEEEEecCCCCCCCC-CccccCCCcccEEEccCCCCCC----CCCcccCCCCCCCEEeccCCcCCCC----CCCCcc-c
Q 002085           74 SVTGISLRHKDITQKI-PPIICDLKNLTTIDLSSNSIPG----EFPEFLYNCTKLQNLDLSQNYFVGP----IPSDID-R  143 (969)
Q Consensus        74 ~v~~l~l~~~~l~~~~-~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~-~  143 (969)
                      ++++||++++++++.. ...+..++++++|+|++|+|+.    .+...+..+++|++|||++|.|+..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            4677888887776642 3345566777788888887762    3345566777788888888777521    122222 2


Q ss_pred             CCCCcEEecCCCCCCCc----CCCcccCcccccceecccccccC
Q 002085          144 ISGLQCIDLGGNNFSGD----IPRSIGRLSELQTLYLYMNEFNG  183 (969)
Q Consensus       144 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~  183 (969)
                      ..+|++|+|++|+++..    ++..+..+++|++|+|++|+++.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            24677888887777643    34456667777777777777653

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=4.2e-18  Score=174.55  Aligned_cols=205  Identities=19%  Similarity=0.284  Sum_probs=160.6

Q ss_pred             cccccccCccccccCCccccCcccchhhhhccccCcCcCCcccccccccCcccccCCCCCCCCccCcEEEcccccccCCC
Q 002085          292 LTDIDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPASIGVVAFENNLSGAVPKSLGNCRTLRTVQLYSNRFSGEL  371 (969)
Q Consensus       292 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  371 (969)
                      +..++++.+++++..  .+..+.+|+.|++.+|.++                  .+ ..+..+++|++|++++|++++..
T Consensus        21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~------------------~l-~~l~~l~~L~~L~ls~n~i~~~~   79 (227)
T d1h6ua2          21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT------------------TI-EGVQYLNNLIGLELKDNQITDLA   79 (227)
T ss_dssp             HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC------------------CC-TTGGGCTTCCEEECCSSCCCCCG
T ss_pred             HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC------------------cc-hhHhcCCCCcEeecCCceeeccc
Confidence            445567777776543  4566788888888888876                  23 24677899999999999998543


Q ss_pred             CcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcccCCccccccCccccCcccc
Q 002085          372 PTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKASNNLFSGEIPVELTSLSHL  451 (969)
Q Consensus       372 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  451 (969)
                        .+..+++|+++++++|.++..-.....++|+.+++++|...+..  .+...+.+..+.++++.+....  .+..+++|
T Consensus        80 --~l~~l~~l~~l~~~~n~~~~i~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L  153 (227)
T d1h6ua2          80 --PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNL  153 (227)
T ss_dssp             --GGTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTC
T ss_pred             --cccccccccccccccccccccccccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--hhcccccc
Confidence              38889999999999999885433445678999999999888653  3666788888999999887443  46788999


Q ss_pred             chhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccCCCcccccc-ccEEEeec
Q 002085          452 NTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEIPPEIGQLK-LNTFNLSS  529 (969)
Q Consensus       452 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-L~~l~ls~  529 (969)
                      +.|++++|++++..  .+.++++|+.|+|++|++++ +| .++++++|++|+|++|++++ +|+ ++.++ |+.|++++
T Consensus       154 ~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         154 QYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD-VSP-LANTSNLFIVTLTN  226 (227)
T ss_dssp             CEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEEEEEE
T ss_pred             ccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCC-Ccc-cccCCCCCEEEeeC
Confidence            99999999998433  37889999999999999985 44 38899999999999999984 553 77775 99999974

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=2e-17  Score=171.33  Aligned_cols=216  Identities=17%  Similarity=0.127  Sum_probs=131.5

Q ss_pred             EEecCCCCCCCCCccccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCC-CCCcccCCCCcEEecC-CC
Q 002085           78 ISLRHKDITQKIPPIICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPI-PSDIDRISGLQCIDLG-GN  155 (969)
Q Consensus        78 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~-~N  155 (969)
                      +++++.+++ .+|+.+.  +++++|||++|.|+...+..|.++++|++|+|++|.+...+ +..|..++++++|++. .|
T Consensus        13 i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n   89 (242)
T d1xwdc1          13 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN   89 (242)
T ss_dssp             EEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred             EEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence            444455555 4565442  57899999999998555567899999999999999887654 4568889999999876 46


Q ss_pred             CCCCcCCCcccCcccccceecccccccCcCCc-ccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCccccc
Q 002085          156 NFSGDIPRSIGRLSELQTLYLYMNEFNGTFPK-EIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGE  234 (969)
Q Consensus       156 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  234 (969)
                      ++....+..|.++++|++|++++|+++...+. .+..+..|..+..+++.                          +...
T Consensus        90 ~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~--------------------------l~~i  143 (242)
T d1xwdc1          90 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN--------------------------IHTI  143 (242)
T ss_dssp             TCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTT--------------------------CCEE
T ss_pred             cccccccccccccccccccccchhhhcccccccccccccccccccccccc--------------------------cccc
Confidence            78777778888999999999999988743221 22334444444444442                          2222


Q ss_pred             CchhhcCCC-chhhhhccCCcCCCCCCchhhcCcccch-hhccCcccccCCCCchhhc-ccccccccCccccccCCcccc
Q 002085          235 IPEAMSNLS-SLEILALNGNHLEGAIPSGLFLLNNLTQ-LFLYDNILSGEIPSSVEAL-KLTDIDLSMNNLTGSIPEEFG  311 (969)
Q Consensus       235 ~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~-L~L~~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~  311 (969)
                      .+..|.+++ .++.|++++|+++.. +...+...+++. +++++|+++...+..|..+ +|+.|+|++|+|+...+..|.
T Consensus       144 ~~~~~~~~~~~l~~L~l~~n~l~~i-~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~  222 (242)
T d1xwdc1         144 ERNSFVGLSFESVILWLNKNGIQEI-HNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE  222 (242)
T ss_dssp             CTTSSTTSBSSCEEEECCSSCCCEE-CTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred             cccccccccccceeeeccccccccc-ccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHc
Confidence            222333332 444455555555522 222233333322 2345555554334444433 566666666666644455567


Q ss_pred             Ccccchhhhhcc
Q 002085          312 KLKNLQLLGLFS  323 (969)
Q Consensus       312 ~l~~L~~L~L~~  323 (969)
                      ++++|+.+++.+
T Consensus       223 ~l~~L~~l~~~~  234 (242)
T d1xwdc1         223 NLKKLRARSTYN  234 (242)
T ss_dssp             TCCEEESSSEES
T ss_pred             CCcccccCcCCC
Confidence            777777766644

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=8.3e-18  Score=174.25  Aligned_cols=203  Identities=14%  Similarity=0.134  Sum_probs=149.6

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcC-CCcccCcccccceeccc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDI-PRSIGRLSELQTLYLYM  178 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~  178 (969)
                      +.++.++++++ .+|+.+.  +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            57888888888 6776553  57888888888888555557888888888888888877544 34677888888887754


Q ss_pred             -ccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCc-hhhcCCCchhhhhccCCcCC
Q 002085          179 -NEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIP-EAMSNLSSLEILALNGNHLE  256 (969)
Q Consensus       179 -N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~  256 (969)
                       |.+....+..|.++++|++|++++|.                          +....+ ..+..+..+..+...++++.
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~--------------------------l~~~~~~~~~~~l~~l~~~~~~n~~l~  141 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTG--------------------------IKHLPDVHKIHSLQKVLLDIQDNINIH  141 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCC--------------------------CCSCCCCTTTCBSSCEEEEEESCTTCC
T ss_pred             cccccccccccccccccccccccchhh--------------------------hcccccccccccccccccccccccccc
Confidence             66776666777777777777777764                          222111 12344566666677777887


Q ss_pred             CCCCchhhcCc-ccchhhccCcccccCCCCchhhccccc-ccccCccccccCCccccCcccchhhhhccccCcCcCCc
Q 002085          257 GAIPSGLFLLN-NLTQLFLYDNILSGEIPSSVEALKLTD-IDLSMNNLTGSIPEEFGKLKNLQLLGLFSNHLSGEVPA  332 (969)
Q Consensus       257 ~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  332 (969)
                      ...+..+..++ .++.|++++|+++...+..+...++.. +++++|+++...+..|.++++|++|++++|+|+ .+|.
T Consensus       142 ~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~  218 (242)
T d1xwdc1         142 TIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS  218 (242)
T ss_dssp             EECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCS
T ss_pred             cccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCH
Confidence            65556666554 789999999999987777777766544 468889999666677999999999999999998 4443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.69  E-value=2.8e-17  Score=165.71  Aligned_cols=164  Identities=24%  Similarity=0.281  Sum_probs=97.4

Q ss_pred             CCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCccccccee
Q 002085           96 LKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLY  175 (969)
Q Consensus        96 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  175 (969)
                      +.+|++|++++|.++.. + .+..+++|++|+|++|+|++. + .++.+++|++|++++|+|+ .+| .+.++++|+.|+
T Consensus        45 L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~  118 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLS  118 (210)
T ss_dssp             HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEE
T ss_pred             hcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccccc-ccc-cccccccccccc
Confidence            44566666666666532 2 255666666666666666642 2 2556666666666666666 333 456666666666


Q ss_pred             cccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCcC
Q 002085          176 LYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNHL  255 (969)
Q Consensus       176 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  255 (969)
                      +++|.+.. + ..+..+++|+.+++++|.+..    +..+..+++|+.+++++|++.+. + .++++++|++|+|++|++
T Consensus       119 l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~----~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i  190 (210)
T d1h6ta2         119 LEHNGISD-I-NGLVHLPQLESLYLGNNKITD----ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHI  190 (210)
T ss_dssp             CTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC----CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred             cccccccc-c-ccccccccccccccccccccc----ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCC
Confidence            66666652 2 245666666666666664321    22355566666666666666543 2 266677777777777777


Q ss_pred             CCCCCchhhcCcccchhhcc
Q 002085          256 EGAIPSGLFLLNNLTQLFLY  275 (969)
Q Consensus       256 ~~~~p~~l~~l~~L~~L~L~  275 (969)
                      +. +| .+..+++|++|+|+
T Consensus       191 ~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         191 SD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             CB-CG-GGTTCTTCSEEEEE
T ss_pred             CC-Ch-hhcCCCCCCEEEcc
Confidence            63 33 46666777777665

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.68  E-value=4.1e-17  Score=164.52  Aligned_cols=165  Identities=24%  Similarity=0.342  Sum_probs=138.3

Q ss_pred             CCccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhcc
Q 002085          353 NCRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKA  432 (969)
Q Consensus       353 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  432 (969)
                      .+.+|+.|++++|.++. ++ .+..+++|+.|+|++|+|++..+....++|++|++++|++++. + .+..+++|+.|++
T Consensus        44 ~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l  119 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSL  119 (210)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEEC
T ss_pred             HhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCccccccCcccccccccccccccc-c-ccccccccccccc
Confidence            46788999999999984 33 4788999999999999999766666668899999999999864 3 5888999999999


Q ss_pred             cCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCcccccc
Q 002085          433 SNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGE  512 (969)
Q Consensus       433 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~  512 (969)
                      ++|.+.. + ..+..+++|+.+++++|++++  +..+..+++|+.+++++|++++ ++ .++++++|+.|+|++|+|+ .
T Consensus       120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~  192 (210)
T d1h6ta2         120 EHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-D  192 (210)
T ss_dssp             TTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-B
T ss_pred             ccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCC-C
Confidence            9999873 3 468889999999999999984  3457789999999999999985 44 3889999999999999998 5


Q ss_pred             CCCcccccc-ccEEEeec
Q 002085          513 IPPEIGQLK-LNTFNLSS  529 (969)
Q Consensus       513 ~p~~~~~l~-L~~l~ls~  529 (969)
                      +| .+..++ |++|+|++
T Consensus       193 l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         193 LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CG-GGTTCTTCSEEEEEE
T ss_pred             Ch-hhcCCCCCCEEEccC
Confidence            65 578885 99999975

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.67  E-value=1.2e-16  Score=159.73  Aligned_cols=161  Identities=25%  Similarity=0.350  Sum_probs=91.3

Q ss_pred             CCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccce
Q 002085           95 DLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTL  174 (969)
Q Consensus        95 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  174 (969)
                      .+.++++|++++|+|+. ++ .+..+++|++|+|++|++++..|  ++++++|++|++++|.+. .++ .++++++|+.|
T Consensus        38 ~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L  111 (199)
T d2omxa2          38 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGL  111 (199)
T ss_dssp             HHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEE
T ss_pred             HhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccc
Confidence            44556666666666652 22 35566666666666666664322  666666666666666665 233 35666666666


Q ss_pred             ecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhhhccCCc
Q 002085          175 YLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEILALNGNH  254 (969)
Q Consensus       175 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~  254 (969)
                      ++++|.+...  ..+..+++|+.|++++|++.   .+ ..+..+++|+.|++.+|++.+..  .++++++|++|++++|+
T Consensus       112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~---~~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~  183 (199)
T d2omxa2         112 TLFNNQITDI--DPLKNLTNLNRLELSSNTIS---DI-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNK  183 (199)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCSEEECCSSCCC---CC-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             cccccccccc--cccchhhhhHHhhhhhhhhc---cc-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCC
Confidence            6666666532  23556666666666666422   12 23555666666666666555432  36666666666666666


Q ss_pred             CCCCCCchhhcCcccch
Q 002085          255 LEGAIPSGLFLLNNLTQ  271 (969)
Q Consensus       255 l~~~~p~~l~~l~~L~~  271 (969)
                      +++ ++ .+..+++|+.
T Consensus       184 i~~-i~-~l~~L~~L~~  198 (199)
T d2omxa2         184 VSD-IS-VLAKLTNLES  198 (199)
T ss_dssp             CCC-CG-GGGGCTTCSE
T ss_pred             CCC-Cc-cccCCCCCCc
Confidence            663 22 3555555554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.66  E-value=7.5e-17  Score=161.13  Aligned_cols=159  Identities=25%  Similarity=0.351  Sum_probs=92.8

Q ss_pred             CccCcEEEcccccccCCCCcccccccCCCccccCCCccccccCccccccccEEEeeccccCCCcccccCCcccchhhccc
Q 002085          354 CRTLRTVQLYSNRFSGELPTGLWTTFNLSSLMLSDNTISGELPSKTAWNLTRLEISNNRFSGQIQRGVGSWKNLIVFKAS  433 (969)
Q Consensus       354 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  433 (969)
                      +.+++.|++++|.++ .+ +.+..+++|++|++++|++++..+....++|++|++++|.+....  .+.+++.|+.|+++
T Consensus        39 l~~l~~L~l~~~~i~-~l-~~l~~l~nL~~L~Ls~N~l~~~~~l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~  114 (199)
T d2omxa2          39 LDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLF  114 (199)
T ss_dssp             HTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECC
T ss_pred             hcCCCEEECCCCCCC-Cc-cccccCCCcCcCccccccccCcccccCCccccccccccccccccc--cccccccccccccc
Confidence            445555555555555 22 234555555555555555554443333445666666666655332  25666667777777


Q ss_pred             CCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCCcccccccccceEeccCccccccC
Q 002085          434 NNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMVSLDLSGNQFSGEI  513 (969)
Q Consensus       434 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~  513 (969)
                      +|.+...  ..+..+++|+.|++++|+++ .++ .+..+++|+.|++++|++++ ++ .++++++|+.|++++|++++ +
T Consensus       115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~~-i  187 (199)
T d2omxa2         115 NNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVSD-I  187 (199)
T ss_dssp             SSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-C
T ss_pred             ccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCCC-C
Confidence            6666532  23566777777777777776 233 46667777777777777764 32 36677777777777777763 4


Q ss_pred             CCcccccc-ccE
Q 002085          514 PPEIGQLK-LNT  524 (969)
Q Consensus       514 p~~~~~l~-L~~  524 (969)
                      | .++.++ |++
T Consensus       188 ~-~l~~L~~L~~  198 (199)
T d2omxa2         188 S-VLAKLTNLES  198 (199)
T ss_dssp             G-GGGGCTTCSE
T ss_pred             c-cccCCCCCCc
Confidence            3 345553 544

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.51  E-value=1.6e-14  Score=131.09  Aligned_cols=100  Identities=21%  Similarity=0.329  Sum_probs=60.2

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMN  179 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  179 (969)
                      ++|||++|+|+ .++ .+.++++|++|+|++|+|+ .+|..|+.+++|++|++++|.|+. +| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            35666666666 333 3566666666666666666 455566666666666666666663 33 3666666666666666


Q ss_pred             cccCcCC-cccCCCCCcceeecccCC
Q 002085          180 EFNGTFP-KEIGDLSNLEVLGLAYNS  204 (969)
Q Consensus       180 ~l~~~~p-~~~~~l~~L~~L~L~~N~  204 (969)
                      +|+.... ..++.+++|++|++++|+
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~  101 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNS  101 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCc
Confidence            6663321 345556666666666664

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=1.7e-14  Score=137.77  Aligned_cols=109  Identities=17%  Similarity=0.145  Sum_probs=61.0

Q ss_pred             cccCCCcccEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccc
Q 002085           92 IICDLKNLTTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSEL  171 (969)
Q Consensus        92 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  171 (969)
                      .+.+..++++|||++|+|+ .++..+..+++|++|+|++|.|+ .++ .|..+++|++|+|++|+++...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            3455566666677666666 34555556666666666666666 332 35666666666666666664333334556666


Q ss_pred             cceecccccccCcCC-cccCCCCCcceeecccC
Q 002085          172 QTLYLYMNEFNGTFP-KEIGDLSNLEVLGLAYN  203 (969)
Q Consensus       172 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N  203 (969)
                      ++|+|++|+|+.... ..+..+++|++|++++|
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N  122 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRN  122 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSS
T ss_pred             ccceeccccccccccccccccccccchhhcCCC
Confidence            666666666652211 23444444444444444

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=2.3e-14  Score=136.98  Aligned_cols=130  Identities=18%  Similarity=0.150  Sum_probs=99.5

Q ss_pred             ccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCc
Q 002085          116 FLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNL  195 (969)
Q Consensus       116 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  195 (969)
                      .|.+..+|++|+|++|+|+ .++..+..+++|++|||++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            4667788889999999988 55766678888999999999888 443 57888889999999999886666666778899


Q ss_pred             ceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccC---chhhcCCCchhhhh
Q 002085          196 EVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEI---PEAMSNLSSLEILA  249 (969)
Q Consensus       196 ~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~---p~~~~~l~~L~~L~  249 (969)
                      ++|++++|++.....+ ..+..+++|++|++++|.+....   +..+..+++|++||
T Consensus        90 ~~L~L~~N~i~~~~~l-~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCCGGGG-GGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             ccceeccccccccccc-cccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            9999998875432221 35778888999999988875543   23577888888877

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.46  E-value=1.1e-13  Score=125.53  Aligned_cols=103  Identities=18%  Similarity=0.223  Sum_probs=76.4

Q ss_pred             CEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCCCCcceeecccC
Q 002085          124 QNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYN  203 (969)
Q Consensus       124 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  203 (969)
                      |+|+|++|+++ .++ .++.+++|++|++++|+|+ .+|..|+.+++|+.|++++|+|++ +| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            57899999998 555 4889999999999999998 678888899999999999999984 44 4888888888888888


Q ss_pred             CCCCCCCCCccccccCCCcEEEccCCccc
Q 002085          204 SNFKPAMIPIEFGMLKKLKTLWMTEANLI  232 (969)
Q Consensus       204 ~~~~~~~~p~~~~~l~~L~~L~L~~n~l~  232 (969)
                      ++..... ...++.+++|+.|++++|.+.
T Consensus        76 ~i~~~~~-~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAA-IQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSST-TGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCC-chhhcCCCCCCEEECCCCcCC
Confidence            6432211 123455555555555555543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=1.3e-15  Score=160.94  Aligned_cols=200  Identities=18%  Similarity=0.203  Sum_probs=96.4

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCCcCCCC-CCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceeccc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQNYFVGP-IPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYM  178 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  178 (969)
                      ..+.++...+..... ......+|++|||++|.+++. ++..+.++++|++|+|++|.+++..+..++.+++|++|+|++
T Consensus        26 ~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~  104 (284)
T d2astb2          26 IAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG  104 (284)
T ss_dssp             SEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred             eEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence            344444444332222 223344566666666655432 223345566666666666666555555556666666666665


Q ss_pred             c-cccCc-CCcccCCCCCcceeecccCCCCCCCCCCccccc-cCCCcEEEccCC--ccccc-CchhhcCCCchhhhhccC
Q 002085          179 N-EFNGT-FPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGM-LKKLKTLWMTEA--NLIGE-IPEAMSNLSSLEILALNG  252 (969)
Q Consensus       179 N-~l~~~-~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~-l~~L~~L~L~~n--~l~~~-~p~~~~~l~~L~~L~L~~  252 (969)
                      | .++.. +...+.++++|++|+++++.......+...+.. .++|+.|+++++  ++... +...+.++++|++|+|++
T Consensus       105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~  184 (284)
T d2astb2         105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD  184 (284)
T ss_dssp             CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTT
T ss_pred             cccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccccc
Confidence            3 34321 111223456666666665431111111122222 345666666653  22221 222334556666666665


Q ss_pred             C-cCCCCCCchhhcCcccchhhccCc-ccccCCCCchhhc-ccccccccCc
Q 002085          253 N-HLEGAIPSGLFLLNNLTQLFLYDN-ILSGEIPSSVEAL-KLTDIDLSMN  300 (969)
Q Consensus       253 N-~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~~-~L~~L~Ls~N  300 (969)
                      | .+++.....+..+++|++|+|++| .++......+... +|+.|+++++
T Consensus       185 ~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             CTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            4 355455555556666666666663 4443333333322 4666666555

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=2.1e-15  Score=159.47  Aligned_cols=113  Identities=13%  Similarity=0.179  Sum_probs=74.6

Q ss_pred             ccchhhcccCC--ccccc-cCccccCccccchhhccCc-ccCCCCCcccccccCCCEEEccC-ccccCCCCccccccccc
Q 002085          425 KNLIVFKASNN--LFSGE-IPVELTSLSHLNTLLLDGN-KLSGKLPSQIVSWTSLNNLNLAR-NELSGEIPKAIGSLLVM  499 (969)
Q Consensus       425 ~~L~~L~l~~N--~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L  499 (969)
                      ++|+.|+++++  .++.. +...+.++++|++|+|++| .+++..+..+..+++|++|+|++ +.+++.....++++++|
T Consensus       148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L  227 (284)
T d2astb2         148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL  227 (284)
T ss_dssp             TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence            45556666543  23322 2233456788888888885 57777777888888899999988 46776666778888899


Q ss_pred             ceEeccCccccccCCCccccc--cccEEEeecCcCCCCCCcccc
Q 002085          500 VSLDLSGNQFSGEIPPEIGQL--KLNTFNLSSNKLYGNIPDEFN  541 (969)
Q Consensus       500 ~~L~ls~N~l~g~~p~~~~~l--~L~~l~ls~N~l~~~~p~~~~  541 (969)
                      +.|+++++ ++   ...+..+  .+..|.+..+++++..++.+.
T Consensus       228 ~~L~l~~~-~~---d~~l~~l~~~lp~L~i~~~~ls~~~~~~~~  267 (284)
T d2astb2         228 KTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG  267 (284)
T ss_dssp             CEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             CEEeeeCC-CC---HHHHHHHHHhCccccccCccCCCCCCCccC
Confidence            99998887 33   2223333  255566777777766555444

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.38  E-value=2.5e-15  Score=164.10  Aligned_cols=239  Identities=20%  Similarity=0.225  Sum_probs=147.9

Q ss_pred             CccccCCCcccEEEccCCCCCCC----CCcccCCCCCCCEEeccCCcCCCC----------CCCCcccCCCCcEEecCCC
Q 002085           90 PPIICDLKNLTTIDLSSNSIPGE----FPEFLYNCTKLQNLDLSQNYFVGP----------IPSDIDRISGLQCIDLGGN  155 (969)
Q Consensus        90 ~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----------~p~~l~~l~~L~~L~L~~N  155 (969)
                      ...+.+...|++|+|++|.|...    +-..+...++|+.|+++++.+...          +...+...++|+.|+|++|
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n  103 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN  103 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence            34455667777777777766532    334456667777777776654311          1122345567777777777


Q ss_pred             CCCCc----CCCcccCcccccceecccccccCcCCcc-------------cCCCCCcceeecccCCCCCCC--CCCcccc
Q 002085          156 NFSGD----IPRSIGRLSELQTLYLYMNEFNGTFPKE-------------IGDLSNLEVLGLAYNSNFKPA--MIPIEFG  216 (969)
Q Consensus       156 ~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~~~~~~--~~p~~~~  216 (969)
                      .++..    +...+...++|++|++++|.++......             ....+.|+.|++++|.+...+  .+...+.
T Consensus       104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~  183 (344)
T d2ca6a1         104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ  183 (344)
T ss_dssp             CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred             ccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhh
Confidence            77643    2223445667777777777664211111             134567788888877643221  1233356


Q ss_pred             ccCCCcEEEccCCccccc-----CchhhcCCCchhhhhccCCcCCCC----CCchhhcCcccchhhccCcccccCCCCch
Q 002085          217 MLKKLKTLWMTEANLIGE-----IPEAMSNLSSLEILALNGNHLEGA----IPSGLFLLNNLTQLFLYDNILSGEIPSSV  287 (969)
Q Consensus       217 ~l~~L~~L~L~~n~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~  287 (969)
                      ..+.|+.|+|++|++...     +...+..+++|+.|+|++|.++..    +...+...++|++|+|++|.|++.-...+
T Consensus       184 ~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l  263 (344)
T d2ca6a1         184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV  263 (344)
T ss_dssp             HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred             hhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHH
Confidence            677888888888876542     334566778888888888887532    23445677888888888888875422222


Q ss_pred             ----h---hcccccccccCccccccC----Ccccc-CcccchhhhhccccCcC
Q 002085          288 ----E---ALKLTDIDLSMNNLTGSI----PEEFG-KLKNLQLLGLFSNHLSG  328 (969)
Q Consensus       288 ----~---~~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~L~~N~l~~  328 (969)
                          .   ...|+.|++++|+++...    ...+. ++++|++|+|++|++..
T Consensus       264 ~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         264 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence                1   125888999999887432    22332 46789999999998863

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.35  E-value=6.2e-15  Score=160.87  Aligned_cols=46  Identities=13%  Similarity=0.126  Sum_probs=27.7

Q ss_pred             cCchhhcCCCchhhhhccCCcCCCCC----CchhhcCcccchhhccCccc
Q 002085          234 EIPEAMSNLSSLEILALNGNHLEGAI----PSGLFLLNNLTQLFLYDNIL  279 (969)
Q Consensus       234 ~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~L~~N~l  279 (969)
                      .+...+.+...|+.|+|++|.+....    ...+...++|+.|+++++..
T Consensus        22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~   71 (344)
T d2ca6a1          22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT   71 (344)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCT
T ss_pred             HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcc
Confidence            34455666777888888888775322    22333456677777666544

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.29  E-value=3.9e-14  Score=140.35  Aligned_cols=87  Identities=24%  Similarity=0.311  Sum_probs=44.3

Q ss_pred             CCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceecccccccCcCCcccCCC
Q 002085          113 FPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYMNEFNGTFPKEIGDL  192 (969)
Q Consensus       113 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  192 (969)
                      +|.++..+++|++|+|++|+|+ .++ .|..+++|++|+|++|.|+ .+|..+..+++|++|++++|+++..  +.+..+
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred             hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence            3444555555555555555555 232 3555555555555555555 3444444444555555555555522  224445


Q ss_pred             CCcceeecccCC
Q 002085          193 SNLEVLGLAYNS  204 (969)
Q Consensus       193 ~~L~~L~L~~N~  204 (969)
                      ++|++|++++|+
T Consensus       115 ~~L~~L~L~~N~  126 (198)
T d1m9la_         115 VNLRVLYMSNNK  126 (198)
T ss_dssp             HHSSEEEESEEE
T ss_pred             ccccccccccch
Confidence            555555555553

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.26  E-value=7.2e-14  Score=138.37  Aligned_cols=84  Identities=23%  Similarity=0.292  Sum_probs=36.5

Q ss_pred             cccchhhcccCCccccccCccccCccccchhhccCcccCCCCCcccccccCCCEEEccCccccCCCC--cccccccccce
Q 002085          424 WKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGKLPSQIVSWTSLNNLNLARNELSGEIP--KAIGSLLVMVS  501 (969)
Q Consensus       424 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~  501 (969)
                      +++|++|++++|.|+ .+|..+..+++|+.|++++|+++. + +.+..+++|+.|+|++|+|+. ++  ..+..+++|+.
T Consensus        69 l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~  144 (198)
T d1m9la_          69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLED  144 (198)
T ss_dssp             HTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSE
T ss_pred             CccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccccccccccchhcc-ccccccccCCCccce
Confidence            333333333333333 223333333444555555555442 2 224444555555555555542 22  23445555555


Q ss_pred             EeccCccccc
Q 002085          502 LDLSGNQFSG  511 (969)
Q Consensus       502 L~ls~N~l~g  511 (969)
                      |+|++|+++.
T Consensus       145 L~L~~N~l~~  154 (198)
T d1m9la_         145 LLLAGNPLYN  154 (198)
T ss_dssp             EEECSSHHHH
T ss_pred             eecCCCcccc
Confidence            5555555543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.23  E-value=1.2e-11  Score=116.87  Aligned_cols=93  Identities=17%  Similarity=0.098  Sum_probs=61.2

Q ss_pred             CCccccCCCcccEEEccCC-CCCCCCCcccCCCCCCCEEeccCCcCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccC
Q 002085           89 IPPIICDLKNLTTIDLSSN-SIPGEFPEFLYNCTKLQNLDLSQNYFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGR  167 (969)
Q Consensus        89 ~~~~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  167 (969)
                      .|..+..+++|++|++++| .|+...+.+|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+ .+|.....
T Consensus        23 ~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~  101 (156)
T d2ifga3          23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ  101 (156)
T ss_dssp             TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTC
T ss_pred             CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhc
Confidence            4555666777777777655 466555566777777777777777777666666777777777777777777 34433333


Q ss_pred             cccccceeccccccc
Q 002085          168 LSELQTLYLYMNEFN  182 (969)
Q Consensus       168 l~~L~~L~L~~N~l~  182 (969)
                      ..+|+.|+|++|.+.
T Consensus       102 ~~~l~~L~L~~Np~~  116 (156)
T d2ifga3         102 GLSLQELVLSGNPLH  116 (156)
T ss_dssp             SCCCCEEECCSSCCC
T ss_pred             cccccccccCCCccc
Confidence            335666676666653

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.22  E-value=8.3e-12  Score=117.97  Aligned_cols=103  Identities=15%  Similarity=0.121  Sum_probs=81.7

Q ss_pred             cEEEccCCCCCCCCCcccCCCCCCCEEeccCC-cCCCCCCCCcccCCCCcEEecCCCCCCCcCCCcccCcccccceeccc
Q 002085          100 TTIDLSSNSIPGEFPEFLYNCTKLQNLDLSQN-YFVGPIPSDIDRISGLQCIDLGGNNFSGDIPRSIGRLSELQTLYLYM  178 (969)
Q Consensus       100 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  178 (969)
                      +.++.+++++. ..|..+..+++|++|+|++| .|+..-+.+|.++++|+.|+|++|+|+...|..|..+++|++|+|++
T Consensus        11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence            44666677776 56778888999999999766 48766667789999999999999999977788899999999999999


Q ss_pred             ccccCcCCcccCCCCCcceeecccCC
Q 002085          179 NEFNGTFPKEIGDLSNLEVLGLAYNS  204 (969)
Q Consensus       179 N~l~~~~p~~~~~l~~L~~L~L~~N~  204 (969)
                      |+|+...+..|.. .+|+.|+|++|.
T Consensus        90 N~l~~l~~~~~~~-~~l~~L~L~~Np  114 (156)
T d2ifga3          90 NALESLSWKTVQG-LSLQELVLSGNP  114 (156)
T ss_dssp             SCCSCCCSTTTCS-CCCCEEECCSSC
T ss_pred             CCCcccChhhhcc-ccccccccCCCc
Confidence            9998444444544 468888888885

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.46  E-value=7.1e-09  Score=98.10  Aligned_cols=91  Identities=23%  Similarity=0.219  Sum_probs=57.0

Q ss_pred             CcccchhhcccCCccccccCccccCccccchhhccCcccCCC--CCcccccccCCCEEEccCccccCCCCcccccccccc
Q 002085          423 SWKNLIVFKASNNLFSGEIPVELTSLSHLNTLLLDGNKLSGK--LPSQIVSWTSLNNLNLARNELSGEIPKAIGSLLVMV  500 (969)
Q Consensus       423 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  500 (969)
                      .+..+..++..+|.+. .++..+..+++|++|+|++|+|+..  ++..+..+++|+.|+|++|+|+...+-.+.....|+
T Consensus        40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~  118 (162)
T d1koha1          40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE  118 (162)
T ss_dssp             TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCS
T ss_pred             hccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccc
Confidence            3334444555544443 4444455678888888888888743  234466778888888888888743332333445678


Q ss_pred             eEeccCccccccCC
Q 002085          501 SLDLSGNQFSGEIP  514 (969)
Q Consensus       501 ~L~ls~N~l~g~~p  514 (969)
                      .|++++|++++...
T Consensus       119 ~L~L~~Npl~~~~~  132 (162)
T d1koha1         119 ELWLDGNSLSDTFR  132 (162)
T ss_dssp             SCCCTTSTTSSSSS
T ss_pred             eeecCCCCcCcCcc
Confidence            88888888875443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.45  E-value=1.4e-08  Score=95.95  Aligned_cols=90  Identities=20%  Similarity=0.090  Sum_probs=44.2

Q ss_pred             ccccceecccccccCcCCcccCCCCCcceeecccCCCCCCCCCCccccccCCCcEEEccCCcccccCchhhcCCCchhhh
Q 002085          169 SELQTLYLYMNEFNGTFPKEIGDLSNLEVLGLAYNSNFKPAMIPIEFGMLKKLKTLWMTEANLIGEIPEAMSNLSSLEIL  248 (969)
Q Consensus       169 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  248 (969)
                      ..+..++..+|..+ .++..+..+++|++|+|++|++.....++..+..+++|+.|+|++|++...-+-.+....+|+.|
T Consensus        42 ~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L  120 (162)
T d1koha1          42 NIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL  120 (162)
T ss_dssp             TCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSC
T ss_pred             cchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccccee
Confidence            33444444444333 33333344556666666666544433334444455555555555555544333233334456666


Q ss_pred             hccCCcCCCCC
Q 002085          249 ALNGNHLEGAI  259 (969)
Q Consensus       249 ~L~~N~l~~~~  259 (969)
                      ++++|.++...
T Consensus       121 ~L~~Npl~~~~  131 (162)
T d1koha1         121 WLDGNSLSDTF  131 (162)
T ss_dssp             CCTTSTTSSSS
T ss_pred             ecCCCCcCcCc
Confidence            77777666443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.24  E-value=1.1e-06  Score=90.15  Aligned_cols=89  Identities=9%  Similarity=-0.000  Sum_probs=60.0

Q ss_pred             hccCCCccceeeecCcEEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceE
Q 002085          634 ILSSLTESNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKL  712 (969)
Q Consensus       634 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  712 (969)
                      ..++|+..+..+.++.+.||+...  ++..+++|+......   .....+.+|..+++.+. +--+.+++++..+++..+
T Consensus        12 ~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_          12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             hhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            345666555544455578998764  566788998744321   11234677888877763 434677788888888999


Q ss_pred             EEEeeccCCCHHHHh
Q 002085          713 LVYEYMENQSLDRWL  727 (969)
Q Consensus       713 lv~e~~~~gsL~~~l  727 (969)
                      +||++++|.++.+..
T Consensus        87 lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          87 LLMSEADGVLCSEEY  101 (263)
T ss_dssp             EEEECCSSEEHHHHT
T ss_pred             EEEEecccccccccc
Confidence            999999998775543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.98  E-value=6.8e-06  Score=83.54  Aligned_cols=74  Identities=16%  Similarity=0.152  Sum_probs=51.9

Q ss_pred             eeeecCc-EEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc--cCceeeEEEEEEcCCceEEEEeecc
Q 002085          643 LIGSGGS-GQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR--HANIVKLWCCISSENSKLLVYEYME  719 (969)
Q Consensus       643 ~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~  719 (969)
                      .+..|.. +.||+.... ++..+++|......      ...+..|++.++.+.  .-.+.+++++..+++..++||+|++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            4455554 679998764 46668889764432      234677788777763  2346777888888889999999999


Q ss_pred             CCCH
Q 002085          720 NQSL  723 (969)
Q Consensus       720 ~gsL  723 (969)
                      |.++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            8665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.61  E-value=6.2e-05  Score=81.33  Aligned_cols=80  Identities=14%  Similarity=0.111  Sum_probs=49.5

Q ss_pred             cceeeecCcEEEEEEEEcCCCcEEEEEEEeccc-hhcH---HHHHHHHHHHHHHhccc-c--CceeeEEEEEEcCCceEE
Q 002085          641 SNLIGSGGSGQVYRIDINGAGEFVAVKRIWNNR-KLNQ---KLEKEFIAEIEILGTIR-H--ANIVKLWCCISSENSKLL  713 (969)
Q Consensus       641 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~---~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l  713 (969)
                      .+.||.|....||++....+++.|+||.-.... ...+   ...++...|.+.++.+. +  ..+.+++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            356899999999999887778889999753211 1000   11234556888887662 2  345666544  4556789


Q ss_pred             EEeeccCCC
Q 002085          714 VYEYMENQS  722 (969)
Q Consensus       714 v~e~~~~gs  722 (969)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.47  E-value=7.6e-06  Score=77.03  Aligned_cols=88  Identities=13%  Similarity=0.168  Sum_probs=49.2

Q ss_pred             CCCcccEEEccCC-CCCCC----CCcccCCCCCCCEEeccCCcCCCCC----CCCcccCCCCcEEecCCCCCCCc----C
Q 002085           95 DLKNLTTIDLSSN-SIPGE----FPEFLYNCTKLQNLDLSQNYFVGPI----PSDIDRISGLQCIDLGGNNFSGD----I  161 (969)
Q Consensus        95 ~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~----~  161 (969)
                      +.++|++|+|+++ .++..    +-..+...++|++|+|++|.+....    ...+...+.|++|+|++|.|+..    +
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l   92 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL   92 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence            4567777777763 45422    2334556677777777777765322    22334456677777777766632    1


Q ss_pred             CCcccCcccccceeccccccc
Q 002085          162 PRSIGRLSELQTLYLYMNEFN  182 (969)
Q Consensus       162 p~~~~~l~~L~~L~L~~N~l~  182 (969)
                      -..+...++|++|+|++|++.
T Consensus        93 ~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          93 LRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHHTTTTCCCSEEECCCCSSC
T ss_pred             HHHHHhCCcCCEEECCCCcCC
Confidence            123444455666666655443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.39  E-value=8.4e-06  Score=76.73  Aligned_cols=39  Identities=15%  Similarity=0.161  Sum_probs=17.7

Q ss_pred             CccccchhhccCcccCCCC----CcccccccCCCEEEccCccc
Q 002085          447 SLSHLNTLLLDGNKLSGKL----PSQIVSWTSLNNLNLARNEL  485 (969)
Q Consensus       447 ~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l  485 (969)
                      ..+.|+.|+|++|.++...    -..+...++|+.|+|++|.+
T Consensus        70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~  112 (167)
T d1pgva_          70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ  112 (167)
T ss_dssp             HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred             hcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence            3444555555555554211    12233344455555555543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.61  E-value=8.1e-05  Score=69.68  Aligned_cols=90  Identities=16%  Similarity=0.220  Sum_probs=51.1

Q ss_pred             ccCCCcccEEEccC-CCCCCC----CCcccCCCCCCCEEeccCCcCCCC----CCCCcccCCCCcEEecCCCCCCCc---
Q 002085           93 ICDLKNLTTIDLSS-NSIPGE----FPEFLYNCTKLQNLDLSQNYFVGP----IPSDIDRISGLQCIDLGGNNFSGD---  160 (969)
Q Consensus        93 ~~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~---  160 (969)
                      ..+.+.|++|+|++ +.++..    +-.++...++|++|+|++|.++..    +-..+...++|+.|++++|.++..   
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~   92 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL   92 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence            34557778888876 456422    334455677777777777777532    122344556777777777776532   


Q ss_pred             -CCCcccCcccccceec--cccccc
Q 002085          161 -IPRSIGRLSELQTLYL--YMNEFN  182 (969)
Q Consensus       161 -~p~~~~~l~~L~~L~L--~~N~l~  182 (969)
                       +...+...++|+.++|  ++|.+.
T Consensus        93 ~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          93 ALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHhCccccEEeeccCCCcCc
Confidence             2234445555654333  344443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.31  E-value=0.00011  Score=68.68  Aligned_cols=15  Identities=27%  Similarity=0.341  Sum_probs=6.6

Q ss_pred             ccccchhhccCcccC
Q 002085          448 LSHLNTLLLDGNKLS  462 (969)
Q Consensus       448 l~~L~~L~Ls~N~l~  462 (969)
                      .++|+.|++++|.++
T Consensus        73 ~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          73 NNTLKSLNVESNFIS   87 (166)
T ss_dssp             CSSCCEEECCSSCCC
T ss_pred             cccchhhhhcccccc
Confidence            344444444444443

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.00  E-value=0.011  Score=63.08  Aligned_cols=73  Identities=21%  Similarity=0.241  Sum_probs=49.0

Q ss_pred             ceeeecCcEEEEEEEEcC-------CCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccc-cCceeeEEEEEEcCCceEE
Q 002085          642 NLIGSGGSGQVYRIDING-------AGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIR-HANIVKLWCCISSENSKLL  713 (969)
Q Consensus       642 ~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  713 (969)
                      +.|+.|-.-.+|++....       ..+.|.+++.-...   .  .....+|.++++.+. +.-..++++++.+    .+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~---~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---T--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---C--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc---h--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            568888889999988743       24567777663211   1  134557888888884 4444577777643    68


Q ss_pred             EEeeccCCCH
Q 002085          714 VYEYMENQSL  723 (969)
Q Consensus       714 v~e~~~~gsL  723 (969)
                      |+||++|..+
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            9999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.48  E-value=0.0096  Score=61.69  Aligned_cols=67  Identities=10%  Similarity=0.122  Sum_probs=42.0

Q ss_pred             EEEEEEEEcCCCcEEEEEEEeccchhcHHHHHHHHHHHHHHhccccCce--eeEE-----EEEEcCCceEEEEeeccCC
Q 002085          650 GQVYRIDINGAGEFVAVKRIWNNRKLNQKLEKEFIAEIEILGTIRHANI--VKLW-----CCISSENSKLLVYEYMENQ  721 (969)
Q Consensus       650 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g  721 (969)
                      -.||+++.. +|+.|++|+.+....    ..+.+..|.+.+..+....+  +..+     ..+...+..+.+++|++|.
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            479998875 688899998754321    23557778888877742211  1111     1123456678899999864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.26  E-value=0.054  Score=55.41  Aligned_cols=32  Identities=22%  Similarity=0.302  Sum_probs=28.3

Q ss_pred             CCCeEecCCCCCcEEECCCCcEEEeeccccee
Q 002085          770 TPQIIHRDVKSSNILLDSEFKAKIADFGLAKM  801 (969)
Q Consensus       770 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfgla~~  801 (969)
                      ..|++|+|+.+.||+++.+...-++||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            55899999999999999987778999998753